PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Alvite, G; Garrido, N; Kun, A; Paulino, M; Esteves, A				Alvite, Gabriela; Garrido, Natalia; Kun, Alejandra; Paulino, Margot; Esteves, Adriana			Towards an Understanding of Mesocestoides vogae Fatty Acid Binding Proteins' Roles	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; GENE-EXPRESSION; LIVER; ALPHA; PHOSPHATIDYLCHOLINE; LOCALIZATION; EVOLUTION; NUCLEI; FAMILY; GAMMA	Two fatty acid binding proteins, MvFABPa and MvFABPb were identified in the parasite Mesocestoides vogae (Platyhelmithes, Cestoda). Fatty acid binding proteins are small intracellular proteins whose members exhibit great diversity. Proteins of this family have been identified in many organisms, of which Platyhelminthes are among the most primitive. These proteins have particular relevance in flatworms since de novo synthesis of fatty acids is absent. Fatty acids should be captured from the media needing an efficient transport system to uptake and distribute these molecules. While HLBPs could be involved in the shuttle of fatty acids to the surrounding host tissues and convey them into the parasite, FABPs could be responsible for the intracellular trafficking. In an effort to understand the role of MvFABPs in fatty acid transport of M. vogae larvae, we analysed the intracellular localization of both MvFABPs and the co-localization with in vivo uptake of fatty acid analogue BODIPY FL C-16. Immunohistochemical studies on larvae sections using specific antibodies, showed a diffuse cytoplasmic distribution of each protein with some expression in nuclei and mitochondria. MvFABPs distribution was confirmed by mass spectrometry identification from 2D-electrophoresis of larvae subcellular fractions. This work is the first report showing intracellular distribution of MvFABPs as well as the co-localization of these proteins with the BODIPY FL C-16 incorporated from the media. Our results suggest that fatty acid binding proteins could target fatty acids to cellular compartments including nuclei. In this sense, M. vogae FABPs could participate in several cellular processes fulfilling most of the functions attributed to vertebrate's counterparts.	[Alvite, Gabriela; Garrido, Natalia; Kun, Alejandra; Esteves, Adriana] Univ Republica, Fac Ciencias, Secc Bioquim, Montevideo, Uruguay; [Kun, Alejandra] Inst Invest Biol Clemente Estable, Montevideo, Uruguay; [Paulino, Margot] Univ Republica, Fac Quim, Ctr Bioinformat Estruct DETEMA, Montevideo, Uruguay	Universidad de la Republica, Uruguay; Instituto de Investigaciones Biologicas Clemente Estable Uruguay; Universidad de la Republica, Uruguay	Esteves, A (corresponding author), Univ Republica, Fac Ciencias, Secc Bioquim, Montevideo, Uruguay.	aesteves@fcien.edu.uy	González, Alejandra Elizabeth Kun/AAB-7929-2019	González, Alejandra Elizabeth Kun/0000-0002-7070-0171	Programa de Desarrollo de las Ciencias Basicas; Comision Sectorial de Investigacion Cientifica [4003]; Agencia Nacional de Investigacion e Innovacion [FCE2007_57]	Programa de Desarrollo de las Ciencias Basicas; Comision Sectorial de Investigacion Cientifica; Agencia Nacional de Investigacion e Innovacion	This work was supported by Programa de Desarrollo de las Ciencias Basicas (www.pedeciba.edu.uy, AE), Comision Sectorial de Investigacion Cientifica (www.csic.edu.uy. N degrees 4003; 2008-2010, AE), Agencia Nacional de Investigacion e Innovacion (www.anii.org.uy FCE2007_57, GA and CAP fellowship), and Agencia Nacional de Investigacion e Innovacion (www.anii.org.uy FCE2007_57, GA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Alvite G, 2008, FEBS J, V275, P107, DOI 10.1111/j.1742-4658.2007.06179.x; Antony P, 2000, NEUROCHEM RES, V25, P1073, DOI 10.1023/A:1007613827552; Ayers SD, 2007, BIOCHEMISTRY-US, V46, P6744, DOI 10.1021/bi700047a; Babin PJ, 2009, FATTY ACID BINDING P, P17; Britos L, 2007, EXP PARASITOL, V116, P95, DOI 10.1016/j.exppara.2006.11.008; CHAN L, 1985, J BIOL CHEM, V260, P2629; Chemical Computing Group Inc, 2007, MOE MOL OP ENV VERS; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; COOPER TG, 1969, J BIOL CHEM, V244, P3507; Esteves A, 2006, COMP BIOCHEM PHYS C, V142, P262, DOI 10.1016/j.cbpc.2005.11.006; Esteves A, 1997, INT J PARASITOL, V27, P1013, DOI 10.1016/S0020-7519(97)00071-4; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Gillilan RE, 2007, J MOL BIOL, V372, P1246, DOI 10.1016/j.jmb.2007.07.040; Hanhoff T, 2002, MOL CELL BIOCHEM, V239, P45, DOI 10.1023/A:1020502624234; HESS E, 1980, Z PARASITENKD, V61, P135, DOI 10.1007/BF00925460; Hostetler HA, 2009, J LIPID RES, V50, P1663, DOI 10.1194/jlr.M900058-JLR200; Huang H, 2002, J BIOL CHEM, V277, P29139, DOI 10.1074/jbc.M202923200; Huang H, 2004, BIOCHEMISTRY-US, V43, P2484, DOI 10.1021/bi0352318; Hunt AN, 2001, J BIOL CHEM, V276, P8492, DOI 10.1074/jbc.M009878200; Irvine RF, 2003, NAT REV MOL CELL BIO, V4, P349, DOI 10.1038/nrm1100; Kim SH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001868; LALONDE JM, 1994, FASEB J, V8, P1240, DOI 10.1096/fasebj.8.15.8001736; Layerenza JP, 2013, BIOCHIM BIOPHYS ACTA, V1831, p3 27; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mate SM, 2006, CAN J PHYSIOL PHARM, V84, P459, DOI 10.1139/Y05-097; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; McIntosh AL, 2009, ARCH BIOCHEM BIOPHYS, V485, P160, DOI 10.1016/j.abb.2009.03.004; MEYER F, 1966, J BIOL CHEM, V241, P4224; OCHMAN H, 1988, GENETICS, V120, P621; OCKNER RK, 1972, SCIENCE, V177, P56, DOI 10.1126/science.177.4043.56; Opperman M, 1992, MONOCLONAL ANTIBODIE, P258; Pegorier JP, 2004, J NUTR, V134, p2444S, DOI 10.1093/jn/134.9.2444S; Richieri GV, 2000, BIOCHEMISTRY-US, V39, P7197, DOI 10.1021/bi000314z; SACCHETTINI JC, 1988, J BIOL CHEM, V263, P5815; Schaap FG, 2002, MOL CELL BIOCHEM, V239, P69, DOI 10.1023/A:1020519011939; Schleicher CH, 1995, BIOCHEM MOL BIOL INT, V36, P1117; Schroeder F, 2008, LIPIDS, V43, P1, DOI 10.1007/s11745-007-3111-z; Schwenk R, 2010, PROSTAG LEUKOTR ESS, V82, P49; Sessler RJ, 2005, MOL CELL, V18, P343, DOI 10.1016/j.molcel.2005.03.026; SEUBERT W, 1968, BIOCHIM BIOPHYS ACTA, V164, P498, DOI 10.1016/0005-2760(68)90180-X; Silvarrey C, 2012, THESIS MONTEVIDEO UR; Smith AJ, 2007, J BIOL CHEM, V282, P32424, DOI 10.1074/jbc.M703730200; Smith JD, 1988, IN VITRO CULTURE PAR; Smyth JD, 1989, PHYSL BIOCH CESTODES, P53; Storch J, 2010, J BIOL CHEM, V285, P32679, DOI 10.1074/jbc.R110.135210; Storch J, 2009, J LIPID RES, V50, pS126, DOI 10.1194/jlr.R800084-JLR200; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Thumser AE, 2007, MOL CELL BIOCHEM, V299, P67, DOI 10.1007/s11010-005-9041-2; VEERKAMP JH, 1993, PROSTAG LEUKOTR ESS, V49, P887, DOI 10.1016/0952-3278(93)90174-U; Vinaud MC, 2007, EXP PARASITOL, V116, P335, DOI 10.1016/j.exppara.2007.01.013; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; WARD CW, 1970, J PARASITOL, V56, P1009, DOI 10.2307/3277526; WEINER SJ, 1986, J COMPUT CHEM, V7, P230, DOI 10.1002/jcc.540070216; Wolfrum C, 2001, P NATL ACAD SCI USA, V98, P2323, DOI 10.1073/pnas.051619898; XU ZH, 1993, J BIOL CHEM, V268, P7874; Zheng YD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077636	57	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111204	10.1371/journal.pone.0111204	http://dx.doi.org/10.1371/journal.pone.0111204			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347286	Green Published, Green Submitted, gold			2022-12-27	WOS:000347994900055
J	Lv, HQ; Han, JQ; Liu, J; Zheng, JG; Liu, RL; Zhong, DX				Lv, Hongqiang; Han, Jiuqiang; Liu, Jun; Zheng, Jiguang; Liu, Ruiling; Zhong, Dexing			CarSPred: A Computational Tool for Predicting Carbonylation Sites of Human Proteins	PLOS ONE			English	Article							OXIDATIVE STRESS; POSTTRANSLATIONAL MODIFICATIONS; IDENTIFICATION; QUANTIFICATION; SELECTION; DAMAGE	Protein carbonylation is one of the most pervasive oxidative stress-induced post-translational modifications (PTMs), which plays a significant role in the etiology and progression of several human diseases. It has been regarded as a biomarker of oxidative stress due to its relatively early formation and stability compared with other oxidative PTMs. Only a subset of proteins is prone to carbonylation and most carbonyl groups are formed from lysine (K), arginine (R), threonine (T) and proline (P) residues. Recent advancements in analysis of the PTM by mass spectrometry provided new insights into the mechanisms of protein carbonylation, such as protein susceptibility and exact modification sites. However, the experimental approaches to identifying carbonylation sites are costly, time-consuming and capable of processing a limited number of proteins, and there is no bioinformatics method or tool devoted to predicting carbonylation sites of human proteins so far. In the paper, a computational method is proposed to identify carbonylation sites of human proteins. The method extracted four kinds of features and combined the minimum Redundancy Maximum Relevance (mRMR) feature selection criterion with weighted support vector machine (WSVM) to achieve total accuracies of 85.72%, 85.95%, 83.92% and 85.72% for K, R, T and P carbonylation site predictions respectively using 10-fold cross-validation. The final optimal feature sets were analysed, the position-specific composition and hydrophobicity environment of flanking residues of modification sites were discussed. In addition, a software tool named CarSPred has been developed to facilitate the application of the method. Datasets and the software involved in the paper are available at https://sourceforge.net/projects/hqlstudio/files/CarSPred-1.0/.	[Lv, Hongqiang; Han, Jiuqiang; Liu, Jun; Zheng, Jiguang; Liu, Ruiling; Zhong, Dexing] Xi An Jiao Tong Univ, Sch Elect & Informat Engn, Xian 710049, Peoples R China	Xi'an Jiaotong University	Han, JQ (corresponding author), Xi An Jiao Tong Univ, Sch Elect & Informat Engn, Xian 710049, Peoples R China.	jqhan@mail.xjtu.edu.cn; eeliujun@gmail.com			National Natural Science Foundation of China [61105021]; Ph.D. Program Foundation of the Ministry of Education of China [20110201110010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Program Foundation of the Ministry of Education of China(Ministry of Education, China)	This work was supported by grants from National Natural Science Foundation of China (No. 61105021) and Ph.D. Program Foundation of the Ministry of Education of China (No. 20110201110010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachi A, 2013, CHEM REV, V113, P596, DOI 10.1021/cr300073p; Bandyopadhyay U, 1999, CURR SCI INDIA, V77, P658; Baraibar MA, 2013, J PROTEOMICS, V92, P63, DOI 10.1016/j.jprot.2013.05.008; Bollineni RC, 2011, J PROTEOMICS, V74, P2338, DOI 10.1016/j.jprot.2011.07.002; Bollineni RC, 2014, FREE RADICAL BIO MED, V68, P186, DOI 10.1016/j.freeradbiomed.2013.11.030; Bota DA, 2002, FEBS LETT, V532, P103, DOI 10.1016/S0014-5793(02)03638-4; BREIMAN L, 1992, INT STAT REV, V60, P291, DOI 10.2307/1403680; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen X, 2013, BIOINFORMATICS, V29, P1614, DOI 10.1093/bioinformatics/btt196; Chen Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022930; Chung C, 2011, BIOINFORMATICS, V27, P797, DOI 10.1093/bioinformatics/btr017; Colzani M, 2013, J PROTEOMICS, V92, P28, DOI 10.1016/j.jprot.2013.03.030; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Dalle-Donne I, 2003, TRENDS MOL MED, V9, P169, DOI 10.1016/S1471-4914(03)00031-5; Fedorova M, 2014, MASS SPECTROM REV, V33, P79, DOI 10.1002/mas.21381; Frohnert BI, 2011, OBESITY, V19, P1735, DOI 10.1038/oby.2011.115; Gianazza E, 2007, AMINO ACIDS, V33, P51, DOI 10.1007/s00726-006-0410-2; Gribskov M, 1996, COMPUT CHEM, V20, P25, DOI 10.1016/S0097-8485(96)80004-0; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; LAXTON RR, 1978, J THEOR BIOL, V70, P51, DOI 10.1016/0022-5193(78)90302-8; Maisonneuve E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007269; Mendez D, 2010, J PROTEOME RES, V9, P5770, DOI 10.1021/pr100555v; Moller IM, 2011, J PROTEOMICS, V74, P2228, DOI 10.1016/j.jprot.2011.05.004; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Rao RSP, 2011, PROTEOMICS, V11, P4166, DOI 10.1002/pmic.201100223; Reddy VP, 2009, J ALZHEIMERS DIS, V16, P763, DOI 10.3233/JAD-2009-1013; Saha I, 2012, AMINO ACIDS, V43, P583, DOI 10.1007/s00726-011-1106-9; Tang YR, 2007, PROTEIN ENG DES SEL, V20, P405, DOI 10.1093/protein/gzm035; Trost B, 2013, BIOINFORMATICS, V29, P686, DOI 10.1093/bioinformatics/btt031; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Xue B, 2012, PLOS ONE, V7	33	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111478	10.1371/journal.pone.0111478	http://dx.doi.org/10.1371/journal.pone.0111478			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347395	gold, Green Submitted, Green Published			2022-12-27	WOS:000347994900080
J	Beas-Luna, R; Novak, M; Carr, MH; Tinker, MT; Black, A; Caselle, JE; Hoban, M; Malone, D; Iles, A				Beas-Luna, Rodrigo; Novak, Mark; Carr, Mark H.; Tinker, Martin T.; Black, August; Caselle, Jennifer E.; Hoban, Michael; Malone, Dan; Iles, Alison			An Online Database for Informing Ecological Network Models: http://kelpforest.ucsc.edu	PLOS ONE			English	Article							ALTERNATIVE STATES; FOOD WEBS; KELP; MANAGEMENT; PATTERN	Ecological network models and analyses are recognized as valuable tools for understanding the dynamics and resiliency of ecosystems, and for informing ecosystem-based approaches to management. However, few databases exist that can provide the life history, demographic and species interaction information necessary to parameterize ecological network models. Faced with the difficulty of synthesizing the information required to construct models for kelp forest ecosystems along the West Coast of North America, we developed an online database (http://kelpforest.ucsc.edu/) to facilitate the collation and dissemination of such information. Many of the database's attributes are novel yet the structure is applicable and adaptable to other ecosystem modeling efforts. Information for each taxonomic unit includes stage-specific life history, demography, and body-size allometries. Species interactions include trophic, competitive, facilitative, and parasitic forms. Each data entry is temporally and spatially explicit. The online data entry interface allows researchers anywhere to contribute and access information. Quality control is facilitated by attributing each entry to unique contributor identities and source citations. The database has proven useful as an archive of species and ecosystem-specific information in the development of several ecological network models, for informing management actions, and for education purposes (e.g., undergraduate and graduate training). To facilitate adaptation of the database by other researches for other ecosystems, the code and technical details on how to customize this database and apply it to other ecosystems are freely available and located at the following link (https://github.com/kelpforest-cameo/databaseui).	[Beas-Luna, Rodrigo; Carr, Mark H.; Tinker, Martin T.; Hoban, Michael; Malone, Dan] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Novak, Mark; Iles, Alison] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA; [Tinker, Martin T.] US Geol Survey, Western Ecol Res Ctr, Santa Cruz, CA USA; [Black, August; Caselle, Jennifer E.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Cruz; Oregon State University; United States Department of the Interior; United States Geological Survey; University of California System; University of California Santa Barbara	Carr, MH (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	mhcarr@ucsc.edu	Beas, Rodrigo/G-9046-2018; Novak, Mark/E-2194-2012; Tinker, Martin T/D-3249-2018; Hoban, Mykle/AAF-8562-2020	Beas, Rodrigo/0000-0002-7266-3394; Novak, Mark/0000-0002-7881-4253; Tinker, Martin T/0000-0002-3314-839X; Hoban, Mykle/0000-0002-2514-3599	Comparative Analysis of Marine Ecosystem Organization (CAMEO) program - National Science Foundation [OCE-1041454, OCE-10411489]; Comparative Analysis of Marine Ecosystem Organization (CAMEO) program - U.S. National Marine Fisheries Service of the National Oceanic and Atmospheric Administration [OCE-1041454, OCE-10411489]; Consejo Nacional de Ciencia y Tecnologia; University of California Institute for Mexico; University of California Santa Cruz, Open Access Fund; Directorate For Geosciences [1041454] Funding Source: National Science Foundation; Division Of Ocean Sciences [1041489] Funding Source: National Science Foundation	Comparative Analysis of Marine Ecosystem Organization (CAMEO) program - National Science Foundation; Comparative Analysis of Marine Ecosystem Organization (CAMEO) program - U.S. National Marine Fisheries Service of the National Oceanic and Atmospheric Administration; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of California Institute for Mexico; University of California Santa Cruz, Open Access Fund; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This project was supported by the Comparative Analysis of Marine Ecosystem Organization (CAMEO) program, jointly supported by the National Science Foundation and the U.S. National Marine Fisheries Service of the National Oceanic and Atmospheric Administration (award # OCE-1041454 and OCE-10411489). Additional support for Rodrigo Beas-Luna was provided by the Consejo Nacional de Ciencia y Tecnologia (www.conacyt.mx) and the University of California Institute for Mexico (www.ucmexus.ucr.edu). Funding for Open Access provided by the University of California Santa Cruz, Open Access Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth CH, 2012, J APPL ECOL, V49, P63, DOI 10.1111/j.1365-2664.2011.02064.x; Baskett ML, 2010, ECOLOGY, V91, P1763, DOI 10.1890/09-0515.1; Beas-Luna R, 2014, BOT MAR, V57, P73, DOI 10.1515/bot-2013-0114; Boit A, 2012, ECOL LETT, V15, P594, DOI 10.1111/j.1461-0248.2012.01777.x; Borrett SR, 2014, ECOL MODEL, V7158, P1; Byrnes JE, 2011, GLOBAL CHANGE BIOL, V17, P2513, DOI 10.1111/j.1365-2486.2011.02409.x; CAILLIET GM, 2000, BIOL CHARACTERISTICS; Carr MH, ECOSYSTEMS CALIFORNI; Caselle JE, 2011, CAN J FISH AQUAT SCI, V68, P288, DOI 10.1139/F10-140; Clark JS, 2001, SCIENCE, V293, P657, DOI 10.1126/science.293.5530.657; Dambacher JM, 2009, FISH FISH, V10, P305, DOI 10.1111/j.1467-2979.2008.00323.x; DAYTON PK, 1985, ANNU REV ECOL SYST, V16, P215, DOI 10.1146/annurev.es.16.110185.001243; Dunstan PK, 2006, ECOLOGY, V87, P2842, DOI 10.1890/0012-9658(2006)87[2842:LRCVAI]2.0.CO;2; EBELING AW, 1985, MAR BIOL, V84, P287, DOI 10.1007/BF00392498; Espinosa-Romero MJ, 2010, THESIS U BRIT COLUMB; ESTES JA, 1974, SCIENCE, V185, P1058, DOI 10.1126/science.185.4156.1058; Fulton EA, 2011, FISH FISH, V12, P171, DOI 10.1111/j.1467-2979.2011.00412.x; Gerber LR, 2003, ECOL APPL, V13, pS47; Graham Michael, 2008, P103; Holker F, 2007, SCIENCE, V316, P1285, DOI 10.1126/science.1139114; Hudson L, 2013, P R SOC BIOL, V19; JOHNSON CR, 1988, ECOL MONOGR, V58, P129, DOI 10.2307/1942464; Lafferty KD, 2008, ECOL LETT, V11, P533, DOI 10.1111/j.1461-0248.2008.01174.x; Levins R, 1974, ANN N Y ACAD SCI, V231; Ling S, 2009, P NATL ACAD SCI USA, P1; Ling SD, 2009, P NATL ACAD SCI USA, V106, P22341, DOI 10.1073/pnas.0907529106; MANN KH, 1973, SCIENCE, V182, P975, DOI 10.1126/science.182.4116.975; Marzloff MP, 2013, ECOL MODEL, V258, P16, DOI 10.1016/j.ecolmodel.2013.02.022; Marzloff MP, 2011, ECOL MODEL, V222, P2651, DOI 10.1016/j.ecolmodel.2011.03.040; Micheli F, 2004, ECOL APPL, V14, P1709, DOI 10.1890/03-5260; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Morales P, 2005, GLOBAL CHANGE BIOL, V11, P2211, DOI 10.1111/j.1365-2486.2005.01036.x; Ortiz M, 2010, AQUAT CONSERV, V20, P58, DOI 10.1002/aqc.1047; Plaganyi E, 2007, FAO FISH TECH PAP, V477, P107; Reed DC, 2011, ECOLOGY, V92, P2108, DOI 10.1890/11-0377.1; SCHIEL DR, 1986, OCEANOGR MAR BIOL, V24, P265; Schiel DR, BIOL ECOLOGY GIANT K; Springer YP, 2010, OCEANOGR MAR BIOL, V48, P1; Starr R. M., 2002, TRENDS FISHERIES FIS; Stein LD, 2003, NAT REV GENET, V4, P337, DOI 10.1038/nrg1065; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Tallis H, 2010, MAR POLICY, V34, P340, DOI 10.1016/j.marpol.2009.08.003; Thompson RM, 2012, TRENDS ECOL EVOL, V27, P689, DOI 10.1016/j.tree.2012.08.005; Wootton JT, 2001, NATURE, V413, P841, DOI 10.1038/35101595; Yodzis P, 2001, TRENDS ECOL EVOL, V16, P78, DOI 10.1016/S0169-5347(00)02062-0	45	14	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e109356	10.1371/journal.pone.0109356	http://dx.doi.org/10.1371/journal.pone.0109356			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343723	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943500013
J	Panuzzo, C; Crivellaro, S; Carra, G; Guerrasio, A; Saglio, G; Morotti, A				Panuzzo, Cristina; Crivellaro, Sabrina; Carra, Giovanna; Guerrasio, Angelo; Saglio, Giuseppe; Morotti, Alessandro			BCR-ABL Promotes PTEN Downregulation in Chronic Myeloid Leukemia	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; STEM-CELLS; CANCER	Chronic myeloid leukemia (CML) is a myeloproliferative disorder characterized by the t(9;22) translocation coding for the chimeric protein p210 BCR-ABL. The tumor suppressor PTEN plays a critical role in the pathogenesis of CML chronic phase, through non genomic loss of function mechanisms, such as protein down-regulation and impaired nuclear/cytoplasmic shuttling. Here we demonstrate that BCR-ABL promotes PTEN downregulation through a MEK dependent pathway. Furthermore, we describe a novel not recurrent N212D-PTEN point mutation found in the EM2 blast crisis cell line.	[Panuzzo, Cristina; Crivellaro, Sabrina; Carra, Giovanna; Guerrasio, Angelo; Saglio, Giuseppe; Morotti, Alessandro] Univ Turin, San Luigi Hosp, Dept Clin & Biol Sci, Turin, Italy	University of Turin	Morotti, A (corresponding author), Univ Turin, San Luigi Hosp, Dept Clin & Biol Sci, Turin, Italy.	alessandro.morotti@unito.it	Morotti, Alessandro/J-7590-2018; Carrà, Giovanna/ABF-4205-2020	Morotti, Alessandro/0000-0002-8407-2903; Carrà, Giovanna/0000-0002-6263-6800; Saglio, Giuseppe/0000-0002-1046-3514; CRIVELLARO, Sabrina/0000-0002-9672-8885; Panuzzo, Cristina/0000-0002-2814-6453	Giovani Ricercatori-Ricerca Finalizzata, ministero della salute; AIRC	Giovani Ricercatori-Ricerca Finalizzata, ministero della salute; AIRC(Fondazione AIRC per la ricerca sul cancro)	This research was supported by Giovani Ricercatori-Ricerca Finalizzata, ministero della salute 2010 to AM, and AIRC to GS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggerholm A, 2000, EUR J HAEMATOL, V65, P109, DOI 10.1034/j.1600-0609.2000.90181.x; Correia NC, 2014, EUR J CANCER, V50, P216, DOI 10.1016/j.ejca.2013.08.017; Georgescu MM, 2000, CANCER RES, V60, P7033; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; Huang FF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088298; Keeshan K, 2003, BRIT J HAEMATOL, V123, P34, DOI 10.1046/j.1365-2141.2003.04538.x; Leslie NR, 2011, TRENDS PHARMACOL SCI, V32, P131, DOI 10.1016/j.tips.2010.12.005; Morotti A, 2014, LEUKEMIA, V28, P1326, DOI 10.1038/leu.2013.370; Morotti A, 2014, EXPERT OPIN BIOL TH, V14, P287, DOI 10.1517/14712598.2014.867323; Pellicano F, 2011, LEUKEMIA, V25, P1159, DOI 10.1038/leu.2011.67; Peng C, 2010, BLOOD, V115, P626, DOI 10.1182/blood-2009-06-228130; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Vasudevan KM, 2007, CANCER RES, V67, P10343, DOI 10.1158/0008-5472.CAN-07-1827	15	16	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110682	10.1371/journal.pone.0110682	http://dx.doi.org/10.1371/journal.pone.0110682			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343485	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943500047
J	Chaturvedi, AK; Patel, MK; Mishra, A; Tiwari, V; Jha, B				Chaturvedi, Amit Kumar; Patel, Manish Kumar; Mishra, Avinash; Tiwari, Vivekanand; Jha, Bhavanath			The SbMT-2 Gene from a Halophyte Confers Abiotic Stress Tolerance and Modulates ROS Scavenging in Transgenic Tobacco	PLOS ONE			English	Article							HEAVY-METAL STRESS; SALICORNIA-BRACHIATA; EXTREME HALOPHYTE; OXIDATIVE STRESS; HETEROLOGOUS EXPRESSION; TYPE-2 METALLOTHIONEIN; PLANT-REGENERATION; ECTOPIC EXPRESSION; ACCUMULATION; TRANSFORMATION	Heavy metals are common pollutants of the coastal saline area and Salicornia brachiata an extreme halophyte is frequently exposed to various abiotic stresses including heavy metals. The SbMT-2 gene was cloned and transformed to tobacco for the functional validation. Transgenic tobacco lines (L2, L4, L6 and L13) showed significantly enhanced salt (NaCl), osmotic (PEG) and metals (Zn++, Cu++ and Cd++) tolerance compared to WT plants. Transgenic lines did not show any morphological variation and had enhanced growth parameters viz. shoot length, root length, fresh weight and dry weight. High seed germination percentage, chlorophyll content, relative water content, electrolytic leakage and membrane stability index confirmed that transgenic lines performed better under salt (NaCl), osmotic (PEG) and metals (Zn++, Cu++ and Cd++) stress conditions compared to WT plants. Proline, H2O2 and lipid peroxidation (MDA) analyses suggested the role of SbMT-2 in cellular homeostasis and H2O2 detoxification. Furthermore in vivo localization of H2O2 and O-2(-); and elevated expression of key antioxidant enzyme encoding genes, SOD, POD and APX evident the possible role of SbMT-2 in ROS scavenging/detoxification mechanism. Transgenic lines showed accumulation of Cu++ and Cd++ in root while Zn++ in stem under stress condition. Under control (unstressed) condition, Zn++ was accumulated more in root but accumulation of Zn++ in stem under stress condition suggested that SbMT-2 may involve in the selective translocation of Zn++ from root to stem. This observation was further supported by the up-regulation of zinc transporter encoding genes NtZIP1 and NtHMA-A under metal ion stress condition. The study suggested that SbMT-2 modulates ROS scavenging and is a potential candidate to be used for phytoremediation and imparting stress tolerance.	[Chaturvedi, Amit Kumar; Patel, Manish Kumar; Mishra, Avinash; Tiwari, Vivekanand; Jha, Bhavanath] CSIR, Discipline Marine Biotechnol & Ecol, Cent Salt & Marine Chem Res Inst, Bhavnagar, Gujarat, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Salt & Marine Chemical Research Institute (CSMCRI)	Mishra, A (corresponding author), CSIR, Discipline Marine Biotechnol & Ecol, Cent Salt & Marine Chem Res Inst, Bhavnagar, Gujarat, India.	avinash@csmcri.org; bjha@csmcri.org	Chaturvedi, Amit k/J-5187-2012; Mishra, Avinash/C-3210-2009; Patel, Manish Kumar/I-6335-2017; Mishra, Avinash/AAG-2961-2019; TIWARI, VIVEKANAND/AAD-9738-2020	Mishra, Avinash/0000-0003-0342-010X; Patel, Manish Kumar/0000-0001-5250-1008; Mishra, Avinash/0000-0003-0342-010X; TIWARI, VIVEKANAND/0000-0002-0464-6031; Chaturvedi, Amit Kumar/0000-0003-0867-6542	Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi [BSC0109-SIMPLE]	Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This study was supported by the Council of Scientific and Industrial Research (CSIR, www.csir.res.in), Government of India, New Delhi (BSC0109-SIMPLE; Senior Research Fellowship to AKC and VT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZG, 2006, J EXP BOT, V57, P3575, DOI 10.1093/jxb/erl102; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Chary NS, 2008, ECOTOX ENVIRON SAFE, V69, P513, DOI 10.1016/j.ecoenv.2007.04.013; Chaturvedi AK, 2012, GENE, V499, P280, DOI 10.1016/j.gene.2012.03.001; Cherian S, 2005, ENVIRON SCI TECHNOL, V39, P9377, DOI 10.1021/es051134l; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; DRAPER HH, 1990, METHOD ENZYMOL, V186, P421; HAMER DH, 1986, ANNU REV BIOCHEM, V55, P913, DOI 10.1146/annurev.biochem.55.1.913; Hassinen VH, 2009, J EXP BOT, V60, P187, DOI 10.1093/jxb/ern287; He ZH, 2000, SCIENCE, V288, P2360, DOI 10.1126/science.288.5475.2360; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Huang GY, 2010, AQUAT TOXICOL, V99, P86, DOI 10.1016/j.aquatox.2010.04.004; Huang XS, 2011, J EXP BOT, V62, P5191, DOI 10.1093/jxb/err229; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Jha B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071136; Jha B, 2012, J AGR FOOD CHEM, V60, P4320, DOI 10.1021/jf203632v; Jha B, 2011, MOL BIOL REP, V38, P4823, DOI 10.1007/s11033-010-0625-x; Joshi M, 2012, IND CROP PROD, V35, P313, DOI 10.1016/j.indcrop.2011.06.024; Joshi M, 2011, IND CROP PROD, V33, P67, DOI 10.1016/j.indcrop.2010.09.002; Kholodova V, 2010, SOIL BIOL, V19, P163, DOI 10.1007/978-3-642-02436-8_8; Kumar G, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-107; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lloriente I.D. Rodriguez, 2010, PLANT SCI, V178, P327; Mishra A, 2013, CARBOHYD POLYM, V92, P1942, DOI 10.1016/j.carbpol.2012.11.055; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Pandey S, 2013, APPL BIOCHEM BIOTECH, V171, P1, DOI 10.1007/s12010-013-0349-1; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; SAIRAM RK, 1994, PLANT GROWTH REGUL, V14, P173, DOI 10.1007/BF00025220; Schutzendubel A, 2002, J EXP BOT, V53, P1351, DOI 10.1093/jexbot/53.372.1351; Seth CS, 2012, PLANT CELL ENVIRON, V35, P334, DOI 10.1111/j.1365-3040.2011.02338.x; Shi J, 2010, TREE PHYSIOL, V30, P914, DOI 10.1093/treephys/tpq030; Siemianowski O, 2014, J EXP BOT, V65, P1125, DOI 10.1093/jxb/ert471; Singh N, 2014, GENE, V547, P119, DOI 10.1016/j.gene.2014.06.037; Singh N, 2014, MAR BIOTECHNOL, V16, P321, DOI 10.1007/s10126-013-9548-6; Singh N, 2010, PLANT CELL TISS ORG, V103, P1, DOI 10.1007/s11240-010-9746-0; Sreenivasulu N, 2007, GENE, V388, P1, DOI 10.1016/j.gene.2006.10.009; Tewari RK, 2002, PLANT SCI, V162, P381, DOI 10.1016/S0168-9452(01)00578-7; Tiwari V, 2015, APPL BIOCHEM BIOTECH, V175, P436, DOI 10.1007/s12010-014-1286-3; Tiwari V, 2014, PLANT CELL PHYSIOL, V55, P201, DOI 10.1093/pcp/pct172; TOPFER R, 1987, NUCLEIC ACIDS RES, V15, P5890, DOI 10.1093/nar/15.14.5890; Turchi A, 2012, PLANT SCI, V183, P50, DOI 10.1016/j.plantsci.2011.11.008; Udawat P, 2014, GENE, V536, P163, DOI 10.1016/j.gene.2013.11.020; Wong HL, 2004, PLANT PHYSIOL, V135, P1447, DOI 10.1104/pp.103.036384; Xia Y, 2012, J HAZARD MATER, V233, P65, DOI 10.1016/j.jhazmat.2012.06.047; Xue TT, 2009, J EXP BOT, V60, P339, DOI 10.1093/jxb/ern291; Yang Z, 2009, PLANT MOL BIOL, V70, P219, DOI 10.1007/s11103-009-9466-1; Zhang FQ, 2007, CHEMOSPHERE, V67, P44, DOI 10.1016/j.chemosphere.2006.10.007; Zhu JH, 2010, PLANT PHYSIOL BIOCH, V48, P710, DOI 10.1016/j.plaphy.2010.04.004	48	69	72	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111379	10.1371/journal.pone.0111379	http://dx.doi.org/10.1371/journal.pone.0111379			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340650	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662800104
J	Duan, QQ; Jiang, W; Ding, M; Lin, Y; Huang, DF				Duan, Qingqing; Jiang, Wu; Ding, Ming; Lin, Ye; Huang, Danfeng			Light Affects the Chloroplast Ultrastructure and Post-Storage Photosynthetic Performance of Watermelon (Citrullus lanatus) Plug Seedlings	PLOS ONE			English	Article							LOW-TEMPERATURE STORAGE; IN-VITRO; QUALITY PRESERVATION; SHIPPING PERFORMANCE; CARBOHYDRATE STATUS; BROCCOLI SEEDLINGS; GROWTH SUPPRESSION; RESPONSES; LEAVES; DARK	Watermelon [Citrullus lanatus (Thunb.) Matsum. and Nakai] plug seedlings were stored at 15 degrees C in the light at a photosynthetic photon flux density of 15 mu mol.m(-2).s(-1) or in darkness for 6 days, to evaluate their chloroplast ultrastructure, and associated photosynthetic characteristics. Storage in the dark caused swelling, disordered granal arrangement, and starch grain disappearance in the chloroplasts. In contrast, the chloroplasts stored in the light were relatively normal. As a result, the light-stored seedlings had a significantly higher chlorophyll content, Fv/Fm, and Pn than did dark-stored seedlings. Regardless of whether the seedlings were stored in light or darkness, the Gs and Ls of the seedlings significantly decreased, while the Ci obviously increased when the Pn decreased after 6 days of storage. This result suggests that the decreased Pn is not solely a stomatal effect, as the effects on the chloroplasts contributed to this photosynthetic inhibition. Six days after transplanting, seedlings that were stored in the light or darkness for 2 or 4 days showed complete recovery of chloroplast ultrastructure, chlorophyll content, Fv/Fm, Gs and Pn. When the storage period increased to 6 days, the dark-stored seedlings had a significantly lower Fv/Fm and Pn than the light-stored and control seedlings 6 days after transplanting, which was mainly ascribed to incomplete recovery of chloroplast ultrastructure. Furthermore, the light-stored seedlings exhibited a significantly higher shoot dry weight during storage and a higher percentage dry weight increase after transplanting than the dark-stored seedlings. These effects were enhanced by prolonged storage (4 to 6 days). This study demonstrated that dim light during storage is beneficial for maintaining chloroplast ultrastructure as well as photosynthetic efficiency in watermelon seedlings, thus contributing to the rapid recovery of post-storage photosynthetic performance, which ensures the transplant quality of the seedlings after removal from storage.	[Duan, Qingqing; Jiang, Wu; Lin, Ye; Huang, Danfeng] Shanghai Jiao Tong Univ, Sch Agr & Biol, Dept Plant Sci, Shanghai 200030, Peoples R China; [Duan, Qingqing; Jiang, Wu; Lin, Ye; Huang, Danfeng] Minist Agr, Key Lab Urban Agr South, Shanghai, Peoples R China; [Ding, Ming] Northwest A&F Univ, Dept Hort, Yangling, Peoples R China	Shanghai Jiao Tong University; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Huang, DF (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Dept Plant Sci, Shanghai 200030, Peoples R China.	hdf@sjtu.edu.cn			National High-tech Research & Development Program of China [2012AA101903]; National Natural Science Foundation of China [61233006]; National Science-tech Support Plan Project [2011BAD43B02]; Shanghai Graduate Education and Innovation Program (Horticulture)	National High-tech Research & Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science-tech Support Plan Project; Shanghai Graduate Education and Innovation Program (Horticulture)	This work was supported by funds from the National High-tech Research & Development Program of China (Grant No. 2012AA101903), National Natural Science Foundation of China (No. 61233006), the National Science-tech Support Plan Project (Grant No. 2011BAD43B02), and Shanghai Graduate Education and Innovation Program (Horticulture). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai X, 2003, SCI AGR SINICA, V37, P268; Ananieva K, 2004, PHYSIOL PLANTARUM, V122, P133, DOI 10.1111/j.1399-3054.2004.00378.x; BAKA Z A M, 1991, Beitraege zur Biologie der Pflanzen, V66, P271; BESSEMBINDER JJE, 1993, PLANT CELL TISS ORG, V33, P121, DOI 10.1007/BF01983224; Bondada BR, 1998, PHOTOSYNTHETICA, V35, P467, DOI 10.1023/A:1006980806057; Chen GX, 2004, PHOTOSYNTHETICA, V42, P573, DOI 10.1007/S11099-005-0015-0; Ding M, 2011, HORTSCIENCE, V46, P993, DOI 10.21273/HORTSCI.46.7.993; Doncheva S, 2008, AGR FOOD SCI, V10, P59; FAO, 2014, FAOSTAT DOM PROD CRO; Harper RC, 2010, PLANT BIOSYST, V144, P769, DOI 10.1080/11263504.2010.502727; Holcomb EJ, 1994, BEDDING PLANTS, VIV, P399; Hou JY, 2011, J AM SOC HORTIC SCI, V136, P364, DOI 10.21273/JASHS.136.5.364; Hou JY, 2010, J AM SOC HORTIC SCI, V135, P183, DOI 10.21273/JASHS.135.2.183; Huang Jun, 2007, Yingyong Shengtai Xuebao, V18, P352; Jiang W, 2012, SCI HORTIC-AMSTERDAM, V148, P23, DOI 10.1016/j.scienta.2012.09.016; Justus I, 2010, SCI HORTIC-AMSTERDAM, V125, P47, DOI 10.1016/j.scienta.2010.02.020; Kaczperski MP, 1996, HORTSCIENCE, V31, P361, DOI 10.21273/HORTSCI.31.3.361; KUBOTA C, 1995, SCI HORTIC-AMSTERDAM, V61, P193, DOI 10.1016/0304-4238(94)00717-T; Kubota C, 2002, SCI HORTIC-AMSTERDAM, V94, P13, DOI 10.1016/S0304-4238(01)00382-X; KUBOTA C, 1994, HORTSCIENCE, V29, P1191, DOI 10.21273/HORTSCI.29.10.1191; Kubota C, 1997, POSTHARVEST BIOL TEC, V12, P165, DOI 10.1016/S0925-5214(97)00047-1; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Mena-Petite A, 2003, TREES-STRUCT FUNCT, V17, P133, DOI 10.1007/s00468-002-0216-0; Migge A, 1999, PHOTOSYNTHETICA, V36, P107, DOI 10.1023/A:1007074921833; Oguchi R, 2005, PLANT CELL ENVIRON, V28, P916, DOI 10.1111/j.1365-3040.2005.01344.x; Park JS, 2009, EUR J HORTIC SCI, V74, P21; Peng Q, 2009, J RARE EARTH, V27, P304, DOI 10.1016/S1002-0721(08)60238-0; Peri PL, 2007, AGRON J, V99, P1502, DOI 10.2134/agronj2006.0347; Sato F, 2004, SCI HORTIC-AMSTERDAM, V101, P349, DOI 10.1016/j.scienta.2003.11.018; Shao QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085996; Spundova M, 2003, J PLANT PHYSIOL, V160, P1051, DOI 10.1078/0176-1617-00902; STITT M, 1981, PLANT PHYSIOL, V68, P755, DOI 10.1104/pp.68.3.755; Su V, 2001, SCI HORTIC-AMSTERDAM, V87, P311, DOI 10.1016/S0304-4238(00)00187-4; VIDAL D, 1990, AM J BOT, V77, P1149, DOI 10.2307/2444625; Walles B, 1975, STUD FOREST SUECICA, V127, P2; Wang YongJian, 2001, Acta Horticulturae Sinica, V28, P230; Wilson S. B., 2000, Journal of Vegetable Crop Production, V6, P51, DOI 10.1300/J068v06n02_07; Wilson SB, 1998, HORTSCIENCE, V33, P1253, DOI 10.21273/HORTSCI.33.7.1253; Wilson SB, 1998, HORTSCIENCE, V33, P1258, DOI 10.21273/HORTSCI.33.7.1258; Yang XS, 2010, J HORTIC SCI BIOTECH, V85, P323, DOI 10.1080/14620316.2010.11512675; Yao YC, 2007, SCI AGR SINICA, V4, P855	41	18	19	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111165	10.1371/journal.pone.0111165	http://dx.doi.org/10.1371/journal.pone.0111165			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340859	Green Submitted, Green Published, gold			2022-12-27	WOS:000343662800090
J	Mejard, R; Thierry, B				Mejard, Regis; Thierry, Benjamin			Systematic Study of the Surface Plasmon Resonance Signals Generated by Cells for Sensors with Different Characteristic Lengths	PLOS ONE			English	Article							LIVING CELLS; REAL-TIME; REFRACTIVE-INDEX; SPR; ADHESION	The objectives of this study were to establish an in-depth understanding of the signals induced by mammalian cells in surface plasmon resonance (SPR) sensing. To this end, two plasmonic structures with different propagation and penetration distances were used: conventional surface plasmon resonance and long-range surface plasmon resonance. Long-range SPR showed a lesser sensitivity to the absolute number of round cells but a greater resolution due to its very narrow spectral dip. The effect of cell spreading was also investigated and the resonance angle of long-range SPR was mostly insensitive unlike in the conventional SPR counterpart. Experimental data was compared with suitable models used in the SPR literature. Although these simple averaging models could be used to describe some of the experimental data, important deviations were observed which could be related to the fact that they do not take into consideration critical parameters such as plasmon scattering losses, which is particularly crucial in the case of long-range SPR structures. The comparison between conventional and long-range SPR for cellular schemes revealed important fundamental differences in their responses to the presence of cells, opening new horizons for SPR-based cell assays. From this study, long-range SPR is expected to be more sensitive towards both the detection of intracellular events resulting from biological stimulation and the detection of microorganisms captured from complex biological samples.	[Mejard, Regis; Thierry, Benjamin] Univ S Australia, Ian Wark Res Inst, Mawson Lakes, SA, Australia	University of South Australia	Thierry, B (corresponding author), Univ S Australia, Ian Wark Res Inst, Mawson Lakes Campus, Mawson Lakes, SA, Australia.	Benjamin.thierry@unisa.edu.au	Thierry, benjamin/B-2785-2009	Thierry, benjamin/0000-0002-6757-2842	Australian Research Council Discovery grant [0881254]	Australian Research Council Discovery grant(Australian Research Council)	This work was supported by the Australian Research Council Discovery grant ID 0881254. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARER R, 1954, Q J MICROSC SCI, V95, P399; Berger CEH, 1999, OPT COMMUN, V167, P183, DOI 10.1016/S0030-4018(99)00309-0; Beuthan J, 1996, PHYS MED BIOL, V41, P369, DOI 10.1088/0031-9155/41/3/002; Boss D, 2012, QUANTITATIVE MEASURE; Chabot V, 2013, BIOSENS BIOELECTRON, V50, P125, DOI 10.1016/j.bios.2013.06.018; Cottier K, 2008, APPL PHYS B-LASERS O, V91, P319, DOI 10.1007/s00340-008-2994-6; Dostalek J, 2007, PLASMONICS, V2, P97, DOI 10.1007/s11468-007-9037-8; Giebel KF, 1999, BIOPHYS J, V76, P509, DOI 10.1016/S0006-3495(99)77219-X; Golosovsky M, 2009, J APPL PHYS, V105, DOI 10.1063/1.3116143; Huang CJ, 2012, BIOMATERIALS, V33, P3626, DOI 10.1016/j.biomaterials.2012.01.059; Jenkins ATA, 2005, J R SOC INTERFACE, V2, P255, DOI 10.1098/rsif.2005.0030; Lee JN, 2003, ANAL CHEM, V75, P6544, DOI 10.1021/ac0346712; Liang XJ, 2007, SENSOR ACTUAT A-PHYS, V133, P349, DOI 10.1016/j.sna.2006.06.045; Mejard R, 2014, TRAC TRENDS ANAL CHE; Mejard R, 2013, OPT MATER, V35, P2507, DOI 10.1016/j.optmat.2013.07.011; Michaelis S, 2013, BIOSENS BIOELECTRON, V49, P63, DOI 10.1016/j.bios.2013.04.042; Milgram S, 2012, METHODS, V56, P326, DOI 10.1016/j.ymeth.2011.10.016; Ramsden JJ, 2009, J RECEPT SIG TRANSD, V29, P211, DOI 10.1080/10799890903064119; RAMSDEN JJ, 1995, CYTOMETRY, V19, P97, DOI 10.1002/cyto.990190202; RAMSDEN JJ, 1994, BIOTECHNOL BIOENG, V43, P939, DOI 10.1002/bit.260431007; Shevchenko Y, 2014, BIOSENS BIOELECTRON, V56, P359, DOI 10.1016/j.bios.2014.01.018; Stojanovic I, 2014, BIOSENS BIOELECTRON, V52, P36, DOI 10.1016/j.bios.2013.08.027; Taylor A, 2005, WRITING EARLY AMERICAN HISTORY, P202; Toma M, 2012, PLASMONICS, V7, P293, DOI 10.1007/s11468-011-9306-4; Vala M, 2009, SENSOR ACTUAT B-CHEM, V139, P59, DOI 10.1016/j.snb.2008.08.029; Viitala T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072192; Voros J, 2000, BIOSENS BIOELECTRON, V15, P423, DOI 10.1016/S0956-5663(00)00102-0; Wang Y, 2010, BIOSENS BIOELECTRON, V25, P1663, DOI 10.1016/j.bios.2009.12.003; Yanase Y, 2007, BIOSENS BIOELECTRON, V22, P1081, DOI 10.1016/j.bios.2006.03.011; Yanase Y, 2012, BIOSENS BIOELECTRON, V32, P62, DOI 10.1016/j.bios.2011.11.023; Yashunsky V, 2010, BIOPHYS J, V99, P4028, DOI 10.1016/j.bpj.2010.10.017; Ziblat R, 2006, BIOPHYS J, V90, P2592, DOI 10.1529/biophysj.105.072090	32	15	15	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e107978	10.1371/journal.pone.0107978	http://dx.doi.org/10.1371/journal.pone.0107978			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340583	gold, Green Submitted, Green Published			2022-12-27	WOS:000343662800004
J	Park, H; Kevany, BM; Dyer, DH; Thomas, MG; Forest, KT				Park, Hyunjun; Kevany, Brian M.; Dyer, David H.; Thomas, Michael G.; Forest, Katrina T.			A Polyketide Synthase Acyltransferase Domain Structure Suggests a Recognition Mechanism for Its Hydroxymalonyl-Acyl Carrier Protein Substrate	PLOS ONE			English	Article							PRODRUG ACTIVATION MECHANISM; BACILLUS-CEREUS UW85; COA-ACP TRANSACYLASE; EXTENDER UNITS; GENE-CLUSTER; CRYSTAL-STRUCTURE; ZWITTERMICIN-A; FATTY-ACID; BIOSYNTHESIS; SPECIFICITY	We have previously shown that the acyl transferase domain of ZmaA (ZmaA-AT) is involved in the biosynthesis of the aminopolyol polyketide/nonribosomal peptide hybrid molecule zwittermicin A from cereus UW85, and that it specifically recognizes the precursor hydroxymalonyl-acyl carrier protein (ACP) and transfers the hydroxymalonyl extender unit to a downstream second ACP via a transacylated AT domain intermediate. We now present the X-ray crystal structure of ZmaA-AT at a resolution of 1.7 angstrom. The structure shows a patch of solvent-exposed hydrophobic residues in the area where the AT is proposed to interact with the precursor ACP. We addressed the significance of the AT/ACP interaction in precursor specificity of the AT by testing whether malonyl-or methylmalonyl-ACP can be recognized by ZmaA-AT. We found that the ACP itself biases extender unit selection. Until now, structural information for ATs has been limited to ATs specific for the CoA-linked precursors malonyl-CoA and (2S)-methylmalonyl-CoA. This work contributes to polyketide synthase engineering efforts by expanding our knowledge of AT/substrate interactions with the structure of an AT domain that recognizes an ACP-linked substrate, the rare hydroxymalonate. Our structure suggests a model in which ACP interaction with a hydrophobic motif promotes secondary structure formation at the binding site, and opening of the adjacent substrate pocket lid to allow extender unit binding in the AT active site.	[Park, Hyunjun; Kevany, Brian M.; Dyer, David H.; Thomas, Michael G.; Forest, Katrina T.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Thomas, MG (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	thomas@bact.wisc.edu; forest@bact.wisc.edu			National Institutes of Health [GM100346, AI065850, GM59721]; U.S. DOE [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; Argonne National Laboratory; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100346, R01GM059721] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. DOE(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; Argonne National Laboratory(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institutes of Health grants GM100346 (to MGT and KTF), AI065850 (to MGT) and GM59721 (to KTF). Use of the Advanced Photon Source, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under Contract No. DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (Grant 085P1000817). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Arthur CJ, 2009, ACS CHEM BIOL, V4, P625, DOI 10.1021/cb900099e; Bian XY, 2013, CHEMBIOCHEM, V14, P1194, DOI 10.1002/cbic.201300208; Brotherton CA, 2013, J AM CHEM SOC, V135, P3359, DOI 10.1021/ja312154m; Caffrey P, 2003, CHEMBIOCHEM, V4, P654, DOI 10.1002/cbic.200300581; Chan YA, 2006, P NATL ACAD SCI USA, V103, P14349, DOI 10.1073/pnas.0603748103; Chan YA, 2009, NAT PROD REP, V26, P90, DOI 10.1039/b801658p; Chan YA, 2010, BIOCHEMISTRY-US, V49, P3667, DOI 10.1021/bi100141n; Chan YA, 2009, METHOD ENZYMOL, V459, P143, DOI 10.1016/S0076-6879(09)04607-2; Dutta S, 2014, NATURE, V510, P512, DOI 10.1038/nature13423; Emmert EAB, 2004, APPL ENVIRON MICROB, V70, P104, DOI 10.1128/AEM.70.1.104-113.2004; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; HANDELSMAN J, 1990, APPL ENVIRON MICROB, V56, P713, DOI 10.1128/AEM.56.3.713-718.1990; Haydock SF, 2005, MICROBIOL-SGM, V151, P3161, DOI 10.1099/mic.0.28194-0; HAYDOCK SF, 1995, FEBS LETT, V374, P246, DOI 10.1016/0014-5793(95)01119-Y; HE HY, 1994, TETRAHEDRON LETT, V35, P2499, DOI 10.1016/S0040-4039(00)77154-1; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Keatinge-Clay AT, 2007, CHEM BIOL, V14, P898, DOI 10.1016/j.chembiol.2007.07.009; Keatinge-Clay AT, 2003, STRUCTURE, V11, P147, DOI 10.1016/S0969-2126(03)00004-2; Kevany BM, 2009, APPL ENVIRON MICROB, V75, P1144, DOI 10.1128/AEM.02518-08; Liew CW, 2012, J BIOL CHEM, V287, P23203, DOI 10.1074/jbc.M112.362210; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Oefner C, 2006, ACTA CRYSTALLOGR D, V62, P613, DOI 10.1107/S0907444906009474; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reeves CD, 2001, BIOCHEMISTRY-US, V40, P15464, DOI 10.1021/bi015864r; Reimer D, 2011, NAT CHEM BIOL, V7, P888, DOI [10.1038/NCHEMBIO.688, 10.1038/nchembio.688]; Rottig A, 2013, MICROBIOL MOL BIOL R, V77, P277, DOI 10.1128/MMBR.00010-13; Rogers EW, 2008, ANGEW CHEM INT EDIT, V47, P8086, DOI 10.1002/anie.200801561; Rogers EW, 2007, ORG LETT, V9, pC11, DOI 10.1021/ol062804a; Schrodinger, 2010, PYMOL MOL GRAPHICS S; Silo-Suh LA, 1998, CURR MICROBIOL, V37, P6; SILOSUH LA, 1994, APPL ENVIRON MICROB, V60, P2023, DOI 10.1128/AEM.60.6.2023-2030.1994; Smith S, 2007, NAT PROD REP, V24, P1041, DOI 10.1039/b603600g; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Tang YY, 2006, P NATL ACAD SCI USA, V103, P11124, DOI 10.1073/pnas.0601924103; Tang YY, 2007, CHEM BIOL, V14, P931, DOI 10.1016/j.chembiol.2007.07.012; Tsai SC, 2009, METHOD ENZYMOL, V459, P17, DOI 10.1016/S0076-6879(09)04602-3; Tung CH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r31; Walsh CT, 2004, SCIENCE, V303, P1805, DOI 10.1126/science.1094318; Wong FT, 2011, BIOCHEMISTRY-US, V50, P6539, DOI 10.1021/bi200632j; Wu K, 2000, GENE, V251, P81, DOI 10.1016/S0378-1119(00)00171-2	42	17	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110965	10.1371/journal.pone.0110965	http://dx.doi.org/10.1371/journal.pone.0110965			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340352	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662800073
J	Sacchi, A; Rinaldi, A; Tumino, N; Casetti, R; Agrati, C; Turchi, F; Bordoni, V; Cimini, E; Martini, F				Sacchi, Alessandra; Rinaldi, Alessandra; Tumino, Nicola; Casetti, Rita; Agrati, Chiara; Turchi, Federica; Bordoni, Veronica; Cimini, Eleonora; Martini, Federico			HIV Infection of Monocytes-Derived Dendritic Cells Inhibits V gamma 9V delta 2 T Cells Functions	PLOS ONE			English	Article							CD69; ACTIVATION; ANTIGENS; REPLICATION; LYMPHOCYTES; MODULATION; MATURATION; RESPONSES; IMMATURE; IMMUNITY	DCs act as sentinel cells against incoming pathogens and represent the most potent antigen presenting cells, having the unique capability to prime naive T cells. In addition to their role in induction of adaptive immune responses, DC are also able to activate innate cells as gamma delta T cells; in particular, a reciprocal crosstalk between DC and gamma delta T cells was demonstrated. However, whether HIV infection may alter DC-V gamma 9V delta 2 T cells cross-talk was not yet described. To clarify this issue, we cultured activated V gamma 9V delta 2 T cells with HIV infected monocyte derived DC (MoDC). After 5 days we evaluated MoDC phenotype, and V gamma 9V delta 2 T cells activation and proliferation. In our model, V gamma 9V delta 2 T cells were not able to proliferate in response to HIV-infected MoDC, although an up-regulation of CD69 was observed. Upon phosphoantigens stimulation, V gamma 9V delta 2 T cells proliferation and cytokine production were inhibited when cultured with HIV-infected MoDC in a cell-contact dependent way. Moreover, HIV-infected MoDC are not able to up-regulate CD86 molecules when cultured with activated V gamma 9V delta 2 T cells, compared with uninfected MoDC. Further, activated V gamma 9V delta 2 T cells are not able to induce HLA DR up-regulation and CCR5 down-regulation on HIV-infected MoDC. These data indicate that HIV-infected DC alter the capacity of V gamma 9V delta 2 T cells to respond to their antigens, pointing out a new mechanisms of induction of V gamma 9V delta 2 T cells anergy carried out by HIV, that could contribute to immune evasion.	[Sacchi, Alessandra; Rinaldi, Alessandra; Tumino, Nicola; Casetti, Rita; Agrati, Chiara; Turchi, Federica; Bordoni, Veronica; Cimini, Eleonora; Martini, Federico] Natl Inst Infect Dis Lazzaro Spallanzani, Cellular Immunol Lab, Rome, Italy; [Tumino, Nicola] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy	IRCCS Lazzaro Spallanzani; University of Rome Tor Vergata	Sacchi, A (corresponding author), Natl Inst Infect Dis Lazzaro Spallanzani, Cellular Immunol Lab, Rome, Italy.	alessandra.sacchi@inmi.it	Casetti, Rita/K-8631-2016; Cimini, Eleonora/K-8878-2016; Tumino, Nicola/Y-4761-2019; Sacchi, Alessandra/K-7782-2016; bordoni, veronica/K-8614-2016	Casetti, Rita/0000-0002-7574-8780; Cimini, Eleonora/0000-0002-2659-0868; Tumino, Nicola/0000-0003-3773-8829; Sacchi, Alessandra/0000-0003-4964-386X; bordoni, veronica/0000-0002-1747-2245				Alter G, 2011, TRENDS IMMUNOL, V32, P219, DOI 10.1016/j.it.2011.02.003; AUTRAN B, 1989, CLIN EXP IMMUNOL, V75, P206; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Boudova S, 2012, J INFECT DIS, V205, P1448, DOI 10.1093/infdis/jis217; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Conti L, 2005, J IMMUNOL, V174, P252, DOI 10.4049/jimmunol.174.1.252; Devilder MC, 2006, J IMMUNOL, V176, P1386, DOI 10.4049/jimmunol.176.3.1386; Dieli F, 2004, EUR J IMMUNOL, V34, P3227, DOI 10.1002/eji.200425368; Enders PJ, 2003, AIDS RES HUM RETROV, V19, P21, DOI 10.1089/08892220360473934; Fernandez NC, 1999, NAT MED, V5, P405, DOI 10.1038/7403; Frleta D, 2012, J CLIN INVEST, V122, P4685, DOI 10.1172/JCI64439; Gougeon ML, 2011, CURR OPIN HIV AIDS, V6, P364, DOI 10.1097/COH.0b013e328349b089; Granelli-Piperno A, 2004, P NATL ACAD SCI USA, V101, P7669, DOI 10.1073/pnas.0402431101; Harly C, 2012, BLOOD, V120, P2269, DOI 10.1182/blood-2012-05-430470; Ismaili J, 2002, CLIN IMMUNOL, V103, P296, DOI 10.1006/clim.2002.5218; Ito T, 2005, SPRINGER SEMIN IMMUN, V26, P221, DOI 10.1007/s00281-004-0180-4; Klatt NR, 2013, IMMUNOL REV, V254, P326, DOI 10.1111/imr.12065; Lamana A, 2011, J INVEST DERMATOL, V131, P1503, DOI 10.1038/jid.2011.54; LANG F, 1995, J IMMUNOL, V154, P5986; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Manches O, 2014, TRENDS IMMUNOL, V35, P114, DOI 10.1016/j.it.2013.10.003; Martin P, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001825; Martini F, 2002, J INFECT DIS, V186, P847, DOI 10.1086/342410; Martino A, 2005, J CLIN IMMUNOL, V25, P230, DOI 10.1007/s10875-005-4080-8; Martino A, 2007, J IMMUNOL, V179, P3057, DOI 10.4049/jimmunol.179.5.3057; Meraviglia S, 2010, J IMMUNOL, V185, P1770, DOI 10.4049/jimmunol.1000966; Palakodeti A, 2012, J BIOL CHEM, V287, P32780, DOI 10.1074/jbc.M112.384354; Piguet V, 2007, TRENDS IMMUNOL, V28, P503, DOI 10.1016/j.it.2007.07.010; Pion M, 2006, J EXP MED, V203, P2887, DOI 10.1084/jem.20061519; Poccia F, 1999, J INFECT DIS, V180, P858, DOI 10.1086/314925; Poccia F, 1996, J IMMUNOL, V157, P449; Poccia F., 2002, Current Molecular Medicine (Hilversum), V2, P769, DOI 10.2174/1566524023361880; Sacchi A, 2009, J INFECT DIS, V199, P432, DOI 10.1086/596047; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sancho D, 2003, J CLIN INVEST, V112, P872, DOI 10.1172/JCI200319112; Sancho D, 2005, TRENDS IMMUNOL, V26, P136, DOI 10.1016/j.it.2004.12.006; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0; Vavassori S, 2013, NAT IMMUNOL, V14, P908, DOI 10.1038/ni.2665; Wallace M, 1997, MOL MED, V3, P60, DOI 10.1007/BF03401668	41	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111095	10.1371/journal.pone.0111095	http://dx.doi.org/10.1371/journal.pone.0111095			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340508	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662800084
J	Santegoets, KCM; Wenink, MH; van den Berg, WB; Radstake, TRDJ				Santegoets, Kim C. M.; Wenink, Mark H.; van den Berg, Wim B.; Radstake, Timothy R. D. J.			Fc Gamma Receptor IIb on GM-CSF Macrophages Controls Immune Complex Mediated Inhibition of Inflammatory Signals	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; RHEUMATOID-ARTHRITIS; T-CELLS; DENDRITIC CELLS; TYPE-2 MACROPHAGES; SYNOVIAL TISSUE; RII EXPRESSION; ISOFORMS; SPECIFICITY; INVOLVEMENT	Background: In rheumatoid arthritis (RA) macrophages play a major role in amplifying synovial inflammation. Important activating signals are those induced by Toll-like receptor (TLR) ligands and by activated T cells. The balance between activating and inhibitory Fc gamma receptors (Fc gamma Rs) on macrophages might be crucial in modulating these inflammatory responses. The purpose of this study was to determine Fc gamma R expression on pro- and anti-inflammatory macrophages (gmM phi and mM phi, respectively) and identify functional consequences on immune complex uptake and macrophage activation. Methods: Human monocytes were isolated and differentiated into gmM phi and mM phi. A full Fc gamma R characterization of both macrophage subtypes was performed and uptake of fluorescent immune complexes (ICs) was determined. Fc gamma RIIb isoforms were determined by qPCR. Macrophages were stimulated via different TLRs or cytokine activated T cells in the presence or absence of ICs and cytokine production was determined. Blocking studies were performed to look into the pathways involved. Results: mM phi expressed high levels of the activating Fc gamma RIIa and Fc gamma RIII and low levels of the inhibitory Fc gamma RIIb, while the Fc gamma R balance on gmM phi was shifted towards the inhibitory Fc gamma RIIb. This was accompanied by a clear increase in Fc gamma RIIb1 mRNA expression in gmM phi. This resulted in higher IC uptake by mM phi compared to gmM phi. Furthermore, Fc gamma R-mediated stimulation of gmM phi inhibited TLR2, 3, 4 and 7/8 mediated cytokine production via Fc gamma RIIb and PI3K signaling. In addition, gmM phi but not mM phi produced TNF alpha upon co-culture with cytokine activated T cells, which was reduced by IC binding to Fc gamma RIIb. The latter was dependent on PI3K signaling and COX2. Conclusions: Fc gamma R expression patterns on gmM phi and mM phi are significantly different, which translates in clear functional differences further substantiating Fc gamma RIIb as an interesting target for inflammation control in RA and other autoimmune/inflammatory diseases.	[Santegoets, Kim C. M.; Wenink, Mark H.; Radstake, Timothy R. D. J.] Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands; [Santegoets, Kim C. M.; Wenink, Mark H.; Radstake, Timothy R. D. J.] Univ Med Ctr Utrecht, Dept Immunol, Lab Translat Immunol, Utrecht, Netherlands; [Santegoets, Kim C. M.; Wenink, Mark H.; van den Berg, Wim B.; Radstake, Timothy R. D. J.] Radboud Univ Nijmegen, Dept Rheumatol, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen	Radstake, TRDJ (corresponding author), Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands.	T.R.D.J.Radstake@umcutrecht.nl	van den Berg, W.B./H-8010-2014; Santegoets, Kim/S-4267-2017		Dutch Arthritis Foundation (Reumafonds) [NR 09-1-3-4]; VENI; VIDI grant (NWO, Dutch science foundation)	Dutch Arthritis Foundation (Reumafonds); VENI(Netherlands Organization for Scientific Research (NWO)); VIDI grant (NWO, Dutch science foundation)	This work was supported by the Dutch Arthritis Foundation (Reumafonds) [NR 09-1-3-4] and a VENI and VIDI grant (NWO, Dutch science foundation) given to TR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi-Roodsaz S, 2008, J CLIN INVEST, V118, P205, DOI 10.1172/JCI32639; Abdollahi-Roodsaz S, 2007, ARTHRITIS RHEUM, V56, P2957, DOI 10.1002/art.22848; Agbanoma G, 2012, J IMMUNOL, V188, P1307, DOI 10.4049/jimmunol.1100625; Ambarus CA, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3796; Bewarder N, 1996, MOL CELL BIOL, V16, P4735; Blom AB, 2003, ARTHRITIS RHEUM, V48, P1002, DOI 10.1002/art.10871; Brennan FM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2390; Brennan FM, 2002, ARTHRITIS RHEUM, V46, P31, DOI 10.1002/1529-0131(200201)46:1<31::AID-ART10029>3.0.CO;2-5; Brentano F, 2005, ARTHRITIS RHEUM-US, V52, P2656, DOI 10.1002/art.21273; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; BUDDE P, 1994, J BIOL CHEM, V269, P30636; Huang QQ, 2009, J IMMUNOL, V182, P4965, DOI 10.4049/jimmunol.0801563; Joshi T, 2006, MOL IMMUNOL, V43, P839, DOI 10.1016/j.molimm.2005.06.037; Kennedy A, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00052; Magnusson SE, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2206; MIETTINEN HM, 1989, CELL, V58, P317, DOI 10.1016/0092-8674(89)90846-5; Mulherin D, 1996, ARTHRITIS RHEUM, V39, P115, DOI 10.1002/art.1780390116; Petkova SB, 2006, J EXP MED, V203, P275, DOI 10.1084/jem.20051951; Radstake TRDJ, 2005, ANN RHEUM DIS, V64, P1737, DOI 10.1136/ard.2004.034405; Radstake TRDJ, 2004, ANN RHEUM DIS, V63, P1556, DOI 10.1136/ard.2003.016550; Radstake TRDJ, 2004, ANN RHEUM DIS, V63, P696, DOI 10.1136/ard.2003.010033; Roelofs MF, 2006, J IMMUNOL, V176, P7021, DOI 10.4049/jimmunol.176.11.7021; Sacre SM, 2008, J IMMUNOL, V181, P8002, DOI 10.4049/jimmunol.181.11.8002; Schwab I, 2013, NAT REV IMMUNOL, V13, P176, DOI 10.1038/nri3401; Shi B, 2012, ANN RHEUM DIS, V71, P1411, DOI 10.1136/annrheumdis-2011-200899; Stefanescu RN, 2004, J CLIN IMMUNOL, V24, P315, DOI 10.1023/B:JOCI.0000029105.47772.04; Su KH, 2007, J IMMUNOL, V178, P3272, DOI 10.4049/jimmunol.178.5.3272; Tak PP, 1997, ARTHRITIS RHEUM, V40, P217, DOI 10.1002/art.1780400206; Ultaigh SNA, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3261; VANDENHERIKOUDIJK IE, 1994, J IMMUNOL, V152, P574; Vandooren B, 2009, ARTHRITIS RHEUM-US, V60, P966, DOI 10.1002/art.24406; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015; Wenink MH, 2009, J IMMUNOL, V183, P4509, DOI 10.4049/jimmunol.0900153; XU WD, 1989, J CLIN INVEST, V83, P876, DOI 10.1172/JCI113971; Zhang Y, 2009, J IMMUNOL, V182, P554, DOI 10.4049/jimmunol.182.1.554	37	9	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110966	10.1371/journal.pone.0110966	http://dx.doi.org/10.1371/journal.pone.0110966			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340460	gold, Green Submitted, Green Published			2022-12-27	WOS:000343662800074
J	Larjani, S; Monsalves, E; Pebdani, H; Krischek, B; Gentili, F; Cusimano, M; Laperriere, N; Hayhurst, C; Zadeh, G				Larjani, Soroush; Monsalves, Eric; Pebdani, Houman; Krischek, Boris; Gentili, Fred; Cusimano, Michael; Laperriere, Normand; Hayhurst, Caroline; Zadeh, Gelareh			Identifying Predictors of Early Growth Response and Adverse Radiation Effects of Vestibular Schwannomas to Radiosurgery	PLOS ONE			English	Article							GAMMA-KNIFE RADIOSURGERY; TUMOR-GROWTH; FOLLOW-UP; VOLUME	Purpose: To determine whether pre-treatment growth rate of vestibular schwannomas (VS) predict response to radiosurgery. Methods: A retrospective review of a prospectively maintained database of all VS patients treated with 12Gy prescription dose between September 2005 and June 2011 at our institution using the Leksell Model 4C Gamma Knife Unit was conducted. Patients who had a minimum of 12-months clinical and radiological assessment before and after radiosurgery were included in this study. Tumor growth rates were calculated using specific growth rate (SGR). Tumor volumes were measured on FIESTA-MRI scans using ITK-SNAP v2.2. Results: Following radiosurgery, twenty-seven (42.9%) patients showed a significant decrease in volume after one year, twenty-nine (46.0%) stabilized, and seven (11.1%) continued to grow. There was no correlation between VS pre-treatment SGRs with post-treatment SGRs (p = 0.34), and incidence of adverse radiation effects (ARE). The reduction in tumors' SGRs after radiosurgery was proportional to pre-treatment SGRs, although this correlation was not statistically significant (p = 0.19). Analysis of risk factors revealed a positive correlation between post-treatment SGRs and incidence of non-auditory complications, most of which were attributed to ARE (p = 0.047). Conclusion: Pre-treatment growth rate of VS does not predict tumor response to radiosurgery or incidence of ARE. VS with higher SGRs post-radiosurgery are more likely to experience ARE.	[Larjani, Soroush; Monsalves, Eric; Pebdani, Houman; Krischek, Boris; Gentili, Fred; Zadeh, Gelareh] Univ Hlth Network, Dept Neurosurg, Toronto, ON, Canada; [Cusimano, Michael] St Michaels Hosp, Dept Neurosurg, Toronto, ON M5B 1W8, Canada; [Laperriere, Normand] Princess Margaret Hosp, Radiat Oncol Program, Toronto, ON M4X 1K9, Canada; [Hayhurst, Caroline] Walton Ctr, Dept Neurosurg, Liverpool, Merseyside, England	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Walton Centre	Larjani, S (corresponding author), Univ Hlth Network, Dept Neurosurg, Toronto, ON, Canada.	Soroush.Larjani@gmail.com; Gelareh.Zadeh@uhn.ca	Cusimano, Michael/X-4059-2019; Cusimano, Michael/GWR-1025-2022	Laperriere, Normand/0000-0001-8930-9650; Cusimano, Michael/0000-0002-9989-0650				Archibald DJ, 2010, OTOL NEUROTOL, V31, P991, DOI 10.1097/MAO.0b013e3181e40e4f; Battaglia A, 2006, OTOL NEUROTOL, V27, P705, DOI 10.1097/01.mao.0000226302.59198.87; Beegle RD, 2007, J NEUROSURG, V107, P913, DOI 10.3171/JNS-07/11/0913; Foote KD, 2001, J NEUROSURG, V95, P440, DOI 10.3171/jns.2001.95.3.0440; Friedman WA, 2006, J NEUROSURG, V105, P657, DOI 10.3171/jns.2006.105.5.657; Ganz J, 2009, ACTA NEUROCHIR, V151, P9, DOI 10.1007/s00701-008-0174-4; Hayhurst C, 2012, INT J RADIAT ONCOL, V82, P2041, DOI 10.1016/j.ijrobp.2011.02.017; Hayhurst C, 2012, NEURO-ONCOLOGY, V14, P87, DOI 10.1093/neuonc/nor171; LINSKEY ME, 1993, INT J RADIAT ONCOL, V25, P227, DOI 10.1016/0360-3016(93)90343-T; Mehrara E, 2007, CANCER RES, V67, P3970, DOI 10.1158/0008-5472.CAN-06-3822; Mohyuddin A, 2003, CLIN OTOLARYNGOL, V28, P85, DOI 10.1046/j.1365-2273.2003.00670.x; Plotkin SR, 2009, J NEURO-ONCOL, V93, P61, DOI 10.1007/s11060-009-9867-7; Rockne R, 2010, PHYS MED BIOL, V55, P3271, DOI 10.1088/0031-9155/55/12/001; Timmer FCA, 2011, LARYNGOSCOPE, V121, P1834, DOI 10.1002/lary.21908; Timmer FCA, 2011, LARYNGOSCOPE, V121, P1359, DOI 10.1002/lary.21763; van de Langenberg R, 2011, OTOL NEUROTOL, V32, P338, DOI 10.1097/MAO.0b013e3182040d9f; van de Langenberg R, 2009, NEURORADIOLOGY, V51, P517, DOI 10.1007/s00234-009-0529-4; Varughese JK, 2010, CLIN OTOLARYNGOL, V35, P97, DOI 10.1111/j.1749-4486.2010.02099.x; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	19	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110823	10.1371/journal.pone.0110823	http://dx.doi.org/10.1371/journal.pone.0110823			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337892	Green Published, Green Submitted, gold			2022-12-27	WOS:000343674800079
J	Brunetto, MR; Cavallone, D; Oliveri, F; Moriconi, F; Colombatto, P; Coco, B; Ciccorossi, P; Rastelli, C; Romagnoli, V; Cherubini, B; Teilum, MW; Blondal, T; Bonino, F				Brunetto, Maurizia Rossana; Cavallone, Daniela; Oliveri, Filippo; Moriconi, Francesco; Colombatto, Piero; Coco, Barbara; Ciccorossi, Pietro; Rastelli, Carlotta; Romagnoli, Veronica; Cherubini, Beatrice; Teilum, Maria Wrang; Blondal, Thorarinn; Bonino, Ferruccio			A Serum MicroRNA Signature Is Associated with the Immune Control of Chronic Hepatitis B Virus Infection	PLOS ONE			English	Article							SURFACE-ANTIGEN; PEGINTERFERON ALPHA-2A; PCR; INTERFERON; MANAGEMENT; PLASMA; SYSTEM; TM4	Background and Aims: The virus/host interplay mediates liver pathology in chronic HBV infection. MiRNAs play a pivotal role in virus/host interactions and are detected in both serum and HBsAg-particles, but studies of their dynamics during chronic infection and antiviral therapy are missing. We studied serum miRNAs during different phases of chronic HBV infection and antiviral treatment. Methods: MiRNAs were profiled by miRCURY-LNA-Universal-RT-miRNA-PCR (Exiqon-A/S) and qPCR-panels-I/II-739-miRNA-assays and single-RT-q-PCRs. Two cohorts of well-characterized HBsAg-carriers were studied (median follow-up 34-52 months): a) training-panel (141 sera) and HBsAg-particles (32 samples) from 61 HBsAg-carriers and b) validation-panel (136 sera) from 84 carriers. Results: Thirty-one miRNAs were differentially expressed in inactive-carriers (IC) and chronic-hepatitis-B (CHB) with the largest difference for miR-122-5p, miR-99a-5p and miR-192-5p (liver-specific-miRNAs), over-expressed in both sera and HBsAg-particles of CHB (ANOVA/U-test p-values: <0.000001/0.000001; <0.000001/0.000003; <0.000001/0.000005, respectively) and significantly down-regulated during-and after-treatment in sustained-virological-responders (SVR). MiRNA-profiles of IC and SVR clustered in the heatmap. Liver-miRNAs were combined with miR-335, miR-126 and miR-320a (internal controls) to build a MiR-B-Index with 100% sensitivity, 83.3% and 92.5% specificity (-1.7 cut-off) in both training and validation cohorts to identify IC. MiR-B-Index (-5.72, -20.43/14.38) correlated with ALT (49, 10/2056 U/l, rho = -0.497, p<0.001), HBV-DNA (4.58, undetectable/>8.3 Log(10) IU/mL, rho = -0.732, p<0.001) and HBsAg (3.40, 0.11/5.49 Log(10) IU/mL, rho = -0.883, p<0.001). At multivariate analysis HBV-DNA (p = 0.002), HBsAg (p<0.001) and infection-phase (p<0.001), but not ALT (p = 0.360) correlated with MiR-B-Index. In SVR to Peg-IFN/NUCs MiR-B-Index improved during-therapy and post-treatment reaching IC-like values (5.32, -1.65/10.91 vs 6.68, 0.54/9.53, p = 0.324) beckoning sustained HBV-immune-control earlier than HBsAg-decline. Conclusions: Serum miRNA profile change dynamically during the different phases of chronic HBV infection. We identified a miRNA signature associated with both natural-occurring and therapy-induced immune control of HBV infection. The MiR-B-Index might be a useful biomarker for the early identification of the sustained switch from CHB to inactive HBV-infection in patients treated with antivirals.	[Brunetto, Maurizia Rossana; Cavallone, Daniela; Oliveri, Filippo; Moriconi, Francesco; Colombatto, Piero; Coco, Barbara; Ciccorossi, Pietro; Rastelli, Carlotta; Romagnoli, Veronica; Cherubini, Beatrice] Univ Hosp Pisa, Reference Ctr Tuscany Region Chron Liver Dis & Ca, Lab Mol Genet & Pathol Hepatitis Viruses, Hepatol Unit, Pisa, Italy; [Teilum, Maria Wrang; Blondal, Thorarinn] Exiqon AS, Div Dx & Serv, Copenhagen, Denmark; [Bonino, Ferruccio] Univ Hosp Pisa, Gen Med Unit 2, Pisa, Italy	University of Pisa; Azienda Ospedaliero Universitaria Pisana; Exiqon; University of Pisa; Azienda Ospedaliero Universitaria Pisana	Brunetto, MR (corresponding author), Univ Hosp Pisa, Reference Ctr Tuscany Region Chron Liver Dis & Ca, Lab Mol Genet & Pathol Hepatitis Viruses, Hepatol Unit, Pisa, Italy.	brunettomaurizia@gmail.com	Oliveri, Filippo/GRX-9884-2022; Bonino, Ferruccio/C-6036-2018; Brunetto, Maurizia/AAU-2906-2020; Cavallone, Daniela/AAB-2660-2019	Oliveri, Filippo/0000-0002-9794-7203; Bonino, Ferruccio/0000-0001-9942-0328; Brunetto, Maurizia/0000-0001-8364-9152; Cavallone, Daniela/0000-0001-6718-9571; Colombatto, Piero/0000-0002-5419-4109	CUCCs-grant of Tuscany Region Italy	CUCCs-grant of Tuscany Region Italy	The study was supported in part by the 2010-CUCCs-grant of Tuscany Region Italy (FB). All the additional source of support were internal to our organization (i.e. funding dedicated to research internal to our Liver Unit). The funders had no direct role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Blondal T, 2013, METHODS, V59, pS1, DOI 10.1016/j.ymeth.2012.09.015; BONINO F, 1986, GASTROENTEROLOGY, V90, P1268, DOI 10.1016/0016-5085(86)90395-1; Brunetto MR, 2013, J HEPATOL, V59, P1153, DOI 10.1016/j.jhep.2013.07.017; Brunetto MR, 2010, GASTROENTEROLOGY, V139, P483, DOI 10.1053/j.gastro.2010.04.052; Brunetto MR, 2009, HEPATOLOGY, V49, P1141, DOI 10.1002/hep.22760; Brunetto MR, 2002, J HEPATOL, V36, P263, DOI 10.1016/S0168-8278(01)00266-5; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cheng M, 2013, J VIROL, V87, P9707, DOI 10.1128/JVI.00802-13; Cullen BR, 2011, GENE DEV, V25, P1881, DOI 10.1101/gad.17352611; Hayes CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047490; Hu J, 2013, TRANSPLANTATION, V95, P991, DOI 10.1097/TP.0b013e31828618d8; Hu J, 2012, PROTEIN CELL, V3, P364, DOI 10.1007/s13238-012-2036-3; Janssen HLA, 2012, GUT, V61, P641, DOI 10.1136/gutjnl-2011-301096; Ji F, 2011, J VIRAL HEPATITIS, V18, pE242, DOI 10.1111/j.1365-2893.2011.01443.x; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Li D, 2011, J BIOL CHEM, V286, P36677, DOI 10.1074/jbc.M111.270561; Li LM, 2010, CANCER RES, V70, P9798, DOI 10.1158/0008-5472.CAN-10-1001; Liaw YF, 2012, HEPATOL INT, V6, P531, DOI 10.1007/s12072-012-9365-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Novellino L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031952; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; van der Meer AJ, 2013, J VIRAL HEPATITIS, V20, P158, DOI 10.1111/jvh.12001; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041561; Wang XW, 2012, GASTROENTEROLOGY, V142, P1431, DOI 10.1053/j.gastro.2012.04.007; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Zhang XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055733	34	34	34	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110782	10.1371/journal.pone.0110782	http://dx.doi.org/10.1371/journal.pone.0110782			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350115	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943100040
J	Alvarez-Berastegui, D; Ciannelli, L; Aparicio-Gonzalez, A; Reglero, P; Hidalgo, M; Lopez-Jurado, JL; Tintore, J; Alemany, F				Alvarez-Berastegui, Diego; Ciannelli, Lorenzo; Aparicio-Gonzalez, Alberto; Reglero, Patricia; Hidalgo, Manuel; Luis Lopez-Jurado, Jose; Tintore, Joaquin; Alemany, Francisco			Spatial Scale, Means and Gradients of Hydrographic Variables Define Pelagic Seascapes of Bluefin and Bullet Tuna Spawning Distribution	PLOS ONE			English	Article							GULF-OF-MEXICO; THUNNUS-THYNNUS; HABITAT; LARVAE; FISH; MARINE; PATTERN; METRICS; MODEL	Seascape ecology is an emerging discipline focused on understanding how features of the marine habitat influence the spatial distribution of marine species. However, there is still a gap in the development of concepts and techniques for its application in the marine pelagic realm, where there are no clear boundaries delimitating habitats. Here we demonstrate that pelagic seascape metrics defined as a combination of hydrographic variables and their spatial gradients calculated at an appropriate spatial scale, improve our ability to model pelagic fish distribution. We apply the analysis to study the spawning locations of two tuna species: Atlantic bluefin and bullet tuna. These two species represent a gradient in life history strategies. Bluefin tuna has a large body size and is a long-distant migrant, while bullet tuna has a small body size and lives year-round in coastal waters within the Mediterranean Sea. The results show that the models performance incorporating the proposed seascape metrics increases significantly when compared with models that do not consider these metrics. This improvement is more important for Atlantic bluefin, whose spawning ecology is dependent on the local oceanographic scenario, than it is for bullet tuna, which is less influenced by the hydrographic conditions. Our study advances our understanding of how species perceive their habitat and confirms that the spatial scale at which the seascape metrics provide information is related to the spawning ecology and life history strategy of each species.	[Alvarez-Berastegui, Diego; Tintore, Joaquin] Balear Islands Coastal Observing & Forecasting Sy, Palma De Mallorca, Balearic Island, Spain; [Ciannelli, Lorenzo] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Aparicio-Gonzalez, Alberto; Reglero, Patricia; Hidalgo, Manuel; Luis Lopez-Jurado, Jose; Alemany, Francisco] Ctr Oceanog Balears, Inst Espanol Oceanogra, Palma De Mallorca, Balearic Island, Spain; [Tintore, Joaquin] CSIC, Inst Adv Studies IMEDEA, Esporles, Spain; [Tintore, Joaquin] Univ Balearic Isl, Esporles, Spain	Oregon State University; Spanish Institute of Oceanography; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears	Alvarez-Berastegui, D (corresponding author), Balear Islands Coastal Observing & Forecasting Sy, Palma De Mallorca, Balearic Island, Spain.	dalvarez@socib.es	Hidalgo, Manuel/B-8023-2015; Reglero, Patricia/L-9031-2014	Hidalgo, Manuel/0000-0002-3494-9658; Alemany, F. (Francisco)/0000-0001-6265-5545; Aparicio-Gonzalez, A. (Alberto)/0000-0003-1280-0243; Alvarez-Berastegui, Diego/0000-0003-1304-7185; Reglero, P. (Patricia)/0000-0002-1093-4750; Tintore, Joaquin/0000-0002-6311-0093	Project "PERSEUS'' - Seventh Framework Program for Research (FP7) under theme "Oceans Tomorrow'' [287600]; Spanish Foundation for Science and Technology, under the project "BALEARES'' [CTM2009-07944/MAR]; Science, Engineering and Education for Sustainability NSF-Wide Investment (SEES) Research Coordination Network, "Sustainability of Marine Renewable Resources in Subarctic Systems Under Incumbent Environmental Variability and Human Exploitation'' [1140207]; Council for Economy and Competitiveness of the Balearic Islands Government [AAEE0022/08]	Project "PERSEUS'' - Seventh Framework Program for Research (FP7) under theme "Oceans Tomorrow''; Spanish Foundation for Science and Technology, under the project "BALEARES''; Science, Engineering and Education for Sustainability NSF-Wide Investment (SEES) Research Coordination Network, "Sustainability of Marine Renewable Resources in Subarctic Systems Under Incumbent Environmental Variability and Human Exploitation''; Council for Economy and Competitiveness of the Balearic Islands Government	The development of this study was supported by the Project "PERSEUS'' financed by the Seventh Framework Program for Research (FP7) under theme "Oceans Tomorrow'', grant Agreement No. 287600 (http://www.perseus-fp7.eu/), the Spanish Foundation for Science and Technology, under the project "BALEARES'' Grant number: CTM2009-07944/MAR (http://www.fecyt.es/fecyt/home.do) and the Science, Engineering and Education for Sustainability NSF-Wide Investment (SEES) Research Coordination Network, Grant 1140207 "Sustainability of Marine Renewable Resources in Subarctic Systems Under Incumbent Environmental Variability and Human Exploitation'' (http://grantome.com/grant/NSF/OCE-1140207). Hydrographic data used in the study were provided by IBAMAR (http://www.ba.ieo.es/ibamar) a public data base founded by the Council for Economy and Competitiveness of the Balearic Islands Government (http://www.caib.es/govern/organigrama/area.do?coduo=6&lang=es), grant number AAEE0022/08. The research was developed under the framework of the BLUEFIN TUNA Project driven by the Balearic Island Observing and Forecasting System (www.socib.es) and the Spanish Institute of Oceanography (www.ieo.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany F, 2010, PROG OCEANOGR, V86, P21, DOI 10.1016/j.pocean.2010.04.014; Bakun A, 2013, FISH FISH, V14, P424, DOI 10.1111/faf.12002; Balbin R, 2014, J MARINE SYST, V138, P51, DOI 10.1016/j.jmarsys.2013.12.007; Blank JM, 2004, J EXP BIOL, V207, P881, DOI 10.1242/jeb.00820; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Bostrom C, 2011, MAR ECOL PROG SER, V427, P191, DOI 10.3354/meps09051; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cushman SA, 2008, ECOL INDIC, V8, P691, DOI 10.1016/j.ecolind.2007.12.002; Cushman SA, 2010, SPATIAL COMPLEXITY, INFORMATICS, AND WILDLIFE CONSERVATION, P83, DOI 10.1007/978-4-431-87771-4_5; de la Gandara F, 2013, 14 CONGR NAC AC GIJ, P181; Druon JN, 2011, MAR ECOL PROG SER, V439, P223, DOI 10.3354/meps09321; Forman R., 2014, ECOLOGICAL DESIGN PL, P217; Gordoa A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090691; Hidalgo M, 2012, P ROY SOC B-BIOL SCI, V279, P275, DOI 10.1098/rspb.2011.0750; Hinchey EK, 2008, LANDSCAPE ECOL, V23, P1, DOI 10.1007/s10980-007-9141-3; Hobday AJ, 2006, FISHERIES MANAG ECOL, V13, P365, DOI 10.1111/j.1365-2400.2006.00515.x; Ingram GW, 2008, SCRS2008086 ICCAT; Ingram Jr GW, 2013, INT COMM CONS ATL CO, V69, P1057; Juza M, 2013, J GEOPHYS RES-OCEANS, V118, P6621, DOI 10.1002/2013JC009231; Juzza M, 2014, GEOPH RES ABSTR, V16; LAVIOLETTE PE, 1990, J GEOPHYS RES-OCEANS, V95, P1559, DOI 10.1029/JC095iC02p01559; Lehodey P, 2008, PROG OCEANOGR, V78, P304, DOI 10.1016/j.pocean.2008.06.004; Louzao M, 2011, J APPL ECOL, V48, P121, DOI 10.1111/j.1365-2664.2010.01910.x; Mannocci L, 2014, ECOGRAPHY, V37, P261, DOI 10.1111/j.1600-0587.2013.00317.x; Muhling BA, 2013, MAR ECOL PROG SER, V486, P257, DOI 10.3354/meps10397; Muhling BA, 2011, ICES J MAR SCI, V68, P1051, DOI 10.1093/icesjms/fsr008; Muhling BA, 2010, FISH OCEANOGR, V19, P526, DOI 10.1111/j.1365-2419.2010.00562.x; Pascual A, 2013, SCI MAR, V77, P19, DOI 10.3989/scimar.03740.15A; Phillips AJ, 2014, ICES J MARI IN PRESS; Pittman SJ, 2011, MAR ECOL PROG SER, V427, P187, DOI 10.3354/meps09139; Pittman SJ, 2004, MAR ECOL PROG SER, V283, P233, DOI 10.3354/meps283233; R Development Core Team R, 2011, R LANG ENV STAT COMP; Reglero P, 2014, MAR ECOL PROG SER, V501, P207, DOI 10.3354/meps10666; Reglero P, 2012, MAR ECOL PROG SER, V463, P273, DOI 10.3354/meps09800; Reglero P, MARINE ECOLOGY PROGR, V433, P205; Reglero P, 2013, SCI MAR, V77, P585, DOI 10.3989/scimar.03759.28A; Rodriguez JM, 2013, DEEP-SEA RES PT I, V77, P11, DOI 10.1016/j.dsr.2013.03.002; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; Rooker JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034180; Sabates A, 2001, SCI MAR, V65, P95, DOI 10.3989/scimar.2001.65n295; Steele JH, 1989, LANDSCAPE ECOL, V3, P185, DOI 10.1007/BF00131537; Tintore J, 2013, MAR TECHNOL SOC J, V47, P101, DOI 10.4031/MTSJ.47.1.10; Torres AP, 2011, J PLANKTON RES, V33, P1793, DOI 10.1093/plankt/fbr078; TURNER MG, 1989, ANNU REV ECOL SYST, V20, P171, DOI 10.1146/annurev.es.20.110189.001131; Wedding LM, 2011, MAR ECOL PROG SER, V427, P219, DOI 10.3354/meps09119; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Worm B, 2005, SCIENCE, V309, P1365, DOI 10.1126/science.1113399; Wu J., 2012, ECOLOGICAL SYSTEMS, DOI [10.1007/978-1-4614-5755-8_11, DOI 10.1007/978-1-4614-5755-8_11]; Wu JG, 2006, SCALING AND UNCERTAINTY ANALYSIS IN ECOLOGY: METHODS AND APPLICATIONS, P17, DOI 10.1007/1-4020-4663-4_2	51	28	29	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e109338	10.1371/journal.pone.0109338	http://dx.doi.org/10.1371/journal.pone.0109338			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347411	Green Published, gold			2022-12-27	WOS:000347994900008
J	Fukamachi, K; Iigo, M; Hagiwara, Y; Shibata, K; Futakuchi, M; Alexander, DB; Hino, O; Suzui, M; Tsuda, H				Fukamachi, Katsumi; Iigo, Masaaki; Hagiwara, Yoshiaki; Shibata, Koji; Futakuchi, Mitsuru; Alexander, David B.; Hino, Okio; Suzui, Masumi; Tsuda, Hiroyuki			Rat N-ERC/Mesothelin as a Marker for In Vivo Screening of Drugs against Pancreas Cancer	PLOS ONE			English	Article							ONCOGENE TRANSGENIC RATS; DUCTAL ADENOCARCINOMAS; MOLECULAR-CLONING; OVARIAN-CARCINOMA; C-ERC/MESOTHELIN; SERIAL ANALYSIS; ELISA SYSTEM; TUMOR-MARKER; EKER RAT; MESOTHELIOMA	Pancreatic ductal adenocarcinoma (PDA) is a highly lethal disease, which is usually diagnosed in an advanced stage. We have established transgenic rats carrying a mutated K-ras gene controlled by Cre/loxP activation. The animals develop PDA which is histopathologically similar to that in humans. Previously, we reported that serum levels of N-ERC/mesothelin were significantly higher in rats bearing PDA than in controls. In the present study, to determine whether serum levels of N-ERC/mesothelin correlated with tumor size, we measured N-ERC/mesothelin levels in rats bearing PDA. Increased serum levels of N-ERC/mesothelin correlated with increased tumor size. This result indicates an interrelationship between the serum level of N-ERC/mesothelin and tumor size. We next investigated the effect of chemotherapy on serum N-ERC/mesothelin levels. Rat pancreatic cancer cells were implanted subcutaneously into the flank of NOD-SCID mice. In the mice treated with 200 mg/kg gemcitabine, tumor weight and the serum level of N-ERC/mesothelin were significantly decreased compared to controls. These results suggest that serum N-ERC/mesothelin measurements might be useful for monitoring response to therapy.	[Fukamachi, Katsumi; Shibata, Koji; Futakuchi, Mitsuru; Suzui, Masumi] Nagoya City Univ, Grad Sch Med Sci, Dept Mol Toxicol, Nagoya, Aichi, Japan; [Iigo, Masaaki; Alexander, David B.; Tsuda, Hiroyuki] Nagoya City Univ, Nanotoxicol Project, Nagoya, Aichi, Japan; [Hagiwara, Yoshiaki] Immunobiol Labs, Fujioka, Gunma, Japan; [Shibata, Koji] Nagoya Univ, Grad Sch Med, Dept Surg, Div Surg Oncol, Nagoya, Aichi 4648601, Japan; [Hino, Okio] Juntendo Univ, Sch Med, Dept Pathol & Oncol, Tokyo 113, Japan	Nagoya City University; Nagoya City University; Nagoya University; Juntendo University	Fukamachi, K (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Mol Toxicol, Nagoya, Aichi, Japan.	kfukamac@med.nagoya-cu.ac.jp	Futakuchi, Mitsuru/S-2441-2019	Futakuchi, Mitsuru/0000-0001-8647-583X	Adaptable and Seamless Technology transfer Program through target-driven R&D (A-STEP) from Japan Science and Technology Agency; Japan Society for the Promotion of Science; Research in Nagoya City University; Aichi Cancer Research Foundation; Program for developing the supporting system for upgrading the education and research from the Ministry of Education, Culture, Sports, Science and Technology; Cancer Research from the Ministry of Health, Labour and Welfare [17S-6, 20S-8]; Grants-in-Aid for Scientific Research [221S0001] Funding Source: KAKEN	Adaptable and Seamless Technology transfer Program through target-driven R&D (A-STEP) from Japan Science and Technology Agency; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research in Nagoya City University; Aichi Cancer Research Foundation(Aichi Cancer Research Foundation); Program for developing the supporting system for upgrading the education and research from the Ministry of Education, Culture, Sports, Science and Technology; Cancer Research from the Ministry of Health, Labour and Welfare; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Adaptable and Seamless Technology transfer Program through target-driven R&D (A-STEP) from Japan Science and Technology Agency; a Grant-in-Aid for Scientific Research (C) from Japan Society for the Promotion of Science; a Grant-in-Aid for Research in Nagoya City University; the Aichi Cancer Research Foundation; the Program for developing the supporting system for upgrading the education and research from the Ministry of Education, Culture, Sports, Science and Technology; and a Grant-in-Aid for Cancer Research (17S-6, 20S-8) from the Ministry of Health, Labour and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argani P, 2001, CLIN CANCER RES, V7, P3862; CARLSSON G, 1983, J CANCER RES CLIN, V105, P20, DOI 10.1007/BF00391826; CHANG K, 1994, INT J CANCER, V57, P90, DOI 10.1002/ijc.2910570117; Chang K, 1996, P NATL ACAD SCI USA, V93, P136, DOI 10.1073/pnas.93.1.136; Fujii S, 2012, BIOCHEM BIOPH RES CO, V417, P1074, DOI 10.1016/j.bbrc.2011.12.099; Fukamachi K, 2013, GENESIS, V51, P268, DOI 10.1002/dvg.22371; Fukamachi K, 2009, BIOCHEM BIOPH RES CO, V390, P636, DOI 10.1016/j.bbrc.2009.10.019; Hagiwara Y, 2008, CANCER SCI, V99, P666, DOI 10.1111/j.1349-7006.2008.00731.x; Hassan R, 2005, AM J CLIN PATHOL, V124, P838, DOI 10.1309/F1B64CL7H8VJKEAF; HINO O, 1995, J CANCER RES CLIN, V121, P602, DOI 10.1007/BF01197777; Hough CD, 2000, CANCER RES, V60, P6281; Inami K, 2008, ONCOL REP, V20, P1375, DOI 10.3892/or_00000155; KOJIMA T, 1995, J BIOL CHEM, V270, P21984, DOI 10.1074/jbc.270.37.21984; Mori T, 2013, J THORAC DIS, V5, P145, DOI 10.3978/j.issn.2072-1439.2013.03.03; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Onda M, 2006, CLIN CANCER RES, V12, P4225, DOI 10.1158/1078-0432.CCR-06-0472; Ordonez NG, 2003, AM J SURG PATHOL, V27, P1418, DOI 10.1097/00000478-200311000-00003; Saeki H, 2012, ONCOL LETT, V4, P637, DOI 10.3892/ol.2012.796; Scholler N, 1999, P NATL ACAD SCI USA, V96, P11531, DOI 10.1073/pnas.96.20.11531; Shiomi K, 2008, CLIN CANCER RES, V14, P1431, DOI 10.1158/1078-0432.CCR-07-1613; Shiomi K, 2006, CANCER SCI, V97, P928, DOI 10.1111/j.1349-7006.2006.00246.x; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Tajima K, 2008, ANTICANCER RES, V28, P3933; Tanaka H, 2010, CANCER SCI, V101, P341, DOI 10.1111/j.1349-7006.2009.01410.x; Ueda S, 2006, CARCINOGENESIS, V27, P2497, DOI 10.1093/carcin/bgl090; Yabushita S, 2013, PANCREAS, V42, P1034, DOI 10.1097/MPA.0b013e3182883624; Yabushita S, 2013, CARCINOGENESIS, V34, P1251, DOI 10.1093/carcin/bgt053; Yabushita S, 2012, PANCREAS, V41, P1013, DOI 10.1097/MPA.0b013e31824ac3a5; Yamashita Y, 2000, BIOCHEM BIOPH RES CO, V275, P134, DOI 10.1006/bbrc.2000.3280	29	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111481	10.1371/journal.pone.0111481	http://dx.doi.org/10.1371/journal.pone.0111481			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347530	Green Submitted, Green Published, gold			2022-12-27	WOS:000347994900081
J	Spasojevic, M; Paredes-Juarez, GA; Vorenkamp, J; de Haan, BJ; Schouten, AJ; de Vos, P				Spasojevic, Milica; Paredes-Juarez, Genaro A.; Vorenkamp, Joop; de Haan, Bart J.; Schouten, Arend Jan; de Vos, Paul			Reduction of the Inflammatory Responses against Alginate-Poly-L-Lysine Microcapsules by Anti-Biofouling Surfaces of PEG-b-PLL Diblock Copolymers	PLOS ONE			English	Article							MICROENCAPSULATED PANCREATIC-ISLETS; MOLECULAR-WEIGHT CUTOFF; POLYLYSINE MICROCAPSULES; FIBROTIC OVERGROWTH; HOST-REACTION; RAT ISLETS; IN-VIVO; CELLS; BIOCOMPATIBILITY; CAPSULES	Large-scale application of alginate-poly-L-lysine (alginate-PLL) capsules used for microencapsulation of living cells is hampered by varying degrees of success, caused by tissue responses against the capsules in the host. A major cause is proinflammatory PLL which is applied at the surface to provide semipermeable properties and immunoprotection. In this study, we investigated whether application of poly(ethylene glycol)-block-poly(L-lysine hydrochloride) diblock copolymers (PEG-b-PLL) can reduce the responses against PLL on alginate-matrices. The application of PEG-b-PLL was studied in two manners: (i) as a substitute for PLL or (ii) as an anti-biofouling layer on top of a proinflammatory, but immunoprotective, semipermeable alginate-PLL100 membrane. Transmission FTIR was applied to monitor the binding of PEG-b-PLL. When applied as a substitute for PLL, strong host responses in mice were observed. These responses were caused by insufficient binding of the PLL block of the diblock copolymers confirmed by FTIR. When PEG-b-PLL was applied as an anti-biofouling layer on top of PLL100 the responses in mice were severely reduced. Building an effective anti-biofouling layer required 50 hours as confirmed by FTIR, immunocytochemistry and XPS. Our study provides new insight in the binding requirements of polyamino acids necessary to provide an immunoprotective membrane. Furthermore, we present a relatively simple method to mask proinflammatory components on the surface of microcapsules to reduce host responses. Finally, but most importantly, our study illustrates the importance of combining physicochemical and biological methods to understand the complex interactions at the capsules' surface that determine the success or failure of microcapsules applicable for cell-encapsulation.	[Spasojevic, Milica; Vorenkamp, Joop; Schouten, Arend Jan] Univ Groningen, Dept Polymer Chem, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands; [Spasojevic, Milica; Paredes-Juarez, Genaro A.; de Haan, Bart J.; de Vos, Paul] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol, Groningen, Netherlands; [Spasojevic, Milica; Paredes-Juarez, Genaro A.; de Haan, Bart J.; de Vos, Paul] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Sect Med Biol,Div Immunoendocrinol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	de Vos, P (corresponding author), Univ Groningen, Dept Pathol, Groningen, Netherlands.	P.de.Vos@umcg.nl	de Vos, Paul/A-3170-2013; Paredes, Genaro A/R-6633-2016; Institute, Zernike/W-7033-2019	Paredes, Genaro A/0000-0002-6621-7830; de vos, paul/0000-0001-9618-2408	Kollf institute; Juvenile Diabetes research foundation	Kollf institute; Juvenile Diabetes research foundation(Juvenile Diabetes Research Foundation)	This work was supported by a project from The Kollf institute and the Juvenile Diabetes research foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBISCHER P, 1994, EXP NEUROL, V126, P151, DOI 10.1006/exnr.1994.1053; Basta G, 2004, TRANSPL IMMUNOL, V13, P289, DOI 10.1016/j.trim.2004.10.003; Bruns H, 2013, CLIN TRANSPLANT, V27, P30, DOI 10.1111/ctr.12153; Bunger CM, 2005, BIOMATERIALS, V26, P2353, DOI 10.1016/j.biomaterials.2004.07.017; BYSTRICKY S, 1991, CARBOHYD POLYM, V15, P299, DOI 10.1016/0144-8617(91)90044-D; CHANG PL, 1993, HUM GENE THER, V4, P433, DOI 10.1089/hum.1993.4.4-433; CIESLINSKI DA, 1994, BIOTECHNOL BIOENG, V43, P678, DOI 10.1002/bit.260430718; COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S; COROMILI V, 1993, BIOMAT ARTIF CELL IM, V21, P427, DOI 10.3109/10731199309117382; de Haan BJ, 2011, J BIOMED MATER RES A, V98A, P394, DOI 10.1002/jbm.a.33123; de Haan BJ, 2003, CELL TRANSPLANT, V12, P617, DOI 10.3727/000000003108747226; De Haan BJ, 2002, BIOTECHNIQUES, V32, P612, DOI 10.2144/02323rr03; De Vos P, 1999, DIABETES, V48, P1381, DOI 10.2337/diabetes.48.7.1381; de Vos P, 2002, J BIOMED MATER RES, V62, P430, DOI 10.1002/jbm.10345; de Vos P, 2003, DIABETOLOGIA, V46, P666, DOI 10.1007/s00125-003-1087-7; de Vos P, 2003, BIOMATERIALS, V24, P305, DOI 10.1016/S0142-9612(02)00319-8; de Vos P, 2002, J BIOMED MATER RES, V60, P252, DOI 10.1002/jbm.10060; de Vos P, 2007, J BIOMED MATER RES A, V80A, P813, DOI 10.1002/jbm.a.30979; de Vos P, 2006, BIOMATERIALS, V27, P5603, DOI 10.1016/j.biomaterials.2006.07.010; de Vos P, 2012, BIOMATERIALS, V33, P5552, DOI 10.1016/j.biomaterials.2012.04.039; de Vos P, 2009, BIOMATERIALS, V30, P2559, DOI 10.1016/j.biomaterials.2009.01.014; DEENEN GJ, 1987, J IMMUNOL, V139, P702; DeVos P, 1997, BIOMATERIALS, V18, P1085, DOI 10.1016/S0142-9612(97)00040-9; DeVos P, 1996, TRANSPLANTATION, V62, P888, DOI 10.1097/00007890-199610150-00003; DeVos P, 1996, TRANSPLANTATION, V62, P893, DOI 10.1097/00007890-199610150-00004; DeVos P, 1997, DIABETOLOGIA, V40, P262; DEVOS P, 1994, TRANSPLANT P, V26, P782; DeVos P, 1997, BIOMATERIALS, V18, P273, DOI 10.1016/S0142-9612(96)00135-4; DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589; Goto Y, 2008, BIOMACROMOLECULES, V9, P828, DOI 10.1021/bm701161d; Hesse M.S., 1997, STARCH STARKE, V49, P257, DOI [10.1002/star.19970490613, DOI 10.1002/STAR.19970490613]; Holland NB, 1998, NATURE, V392, P799, DOI 10.1038/33894; HUNIG T, 1989, J EXP MED, V169, P73, DOI 10.1084/jem.169.1.73; KING GA, 1987, BIOTECHNOL PROGR, V3, P231, DOI 10.1002/btpr.5420030407; KOO J, 1993, INT J ARTIF ORGANS, V16, P557, DOI 10.1177/039139889301600710; Leblond FA, 1996, BIOMATERIALS, V17, P2097, DOI 10.1016/0142-9612(96)00027-0; LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628; LIU HW, 1993, HUM GENE THER, V4, P291, DOI 10.1089/hum.1993.4.3-291; Omer A, 2003, XENOTRANSPLANTATION, V10, P240, DOI 10.1034/j.1399-3089.2003.01150.x; Orive G, 2006, BIOMATERIALS, V27, P3691, DOI 10.1016/j.biomaterials.2006.02.048; Orive G, 2005, J BIOMED MATER RES B, V74B, P429, DOI 10.1002/jbm.b.30146; Orive G, 2014, NAT MED, V20, P233, DOI 10.1038/nm.3486; Paredes-Juarez GA, 2013, J CONTROL RELEASE, V172, P983, DOI 10.1016/j.jconrel.2013.09.009; Ponce S, 2006, BIOMATERIALS, V27, P4831, DOI 10.1016/j.biomaterials.2006.05.014; Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027; Robitaille R, 2000, J BIOMED MATER RES, V50, P420, DOI 10.1002/(SICI)1097-4636(20000605)50:3<420::AID-JBM17>3.0.CO;2-S; Rokstad AM, 2013, BIOMATERIALS, V34, P621, DOI 10.1016/j.biomaterials.2012.10.012; Rokstad AM, 2011, ACTA BIOMATER, V7, P2566, DOI 10.1016/j.actbio.2011.03.011; Rokstad AMA, 2014, ADV DRUG DELIVER REV, V67-68, P111, DOI 10.1016/j.addr.2013.07.010; SAWHNEY AS, 1993, BIOMATERIALS, V14, P1008, DOI 10.1016/0142-9612(93)90194-7; SAWHNEY AS, 1992, BIOMATERIALS, V13, P863, DOI 10.1016/0142-9612(92)90180-V; SKJAKBRAEK G, 1989, BIOTECHNOL BIOENG, V33, P90, DOI 10.1002/bit.260330112; Smelt MJ, 2012, PANCREAS, V41, P39, DOI 10.1097/MPA.0b013e31821fc90c; Sobol M, 2013, J BIOMED MATER RES A, V101, P1907, DOI 10.1002/jbm.a.34500; Spasojevic M, 2014, J BIOMED MATER RES A, V102, P1887, DOI 10.1002/jbm.a.34863; STOKKE BT, 1991, MACROMOLECULES, V24, P4637, DOI 10.1021/ma00016a026; Strand BL, 2001, CELL TRANSPLANT, V10, P263, DOI 10.3727/000000001783986800; Tam SK, 2011, ACTA BIOMATER, V7, P1683, DOI 10.1016/j.actbio.2010.12.006; Tam SK, 2011, J BIOMED MATER RES A, V98A, P40, DOI 10.1002/jbm.a.33047; Tatarkiewicz K, 2001, DIABETOLOGIA, V44, P646, DOI 10.1007/s001250051672; Thu B, 1996, BIOMATERIALS, V17, P1031, DOI 10.1016/0142-9612(96)84680-1; Thu B, 1997, CARBOHYD RES, V297, P101, DOI 10.1016/S0008-6215(96)00257-1; Thu B, 1996, BIOMATERIALS, V17, P1069, DOI 10.1016/0142-9612(96)85907-2; ULUDAG H, 1993, CELL TRANSPLANT, V2, P175, DOI 10.1177/096368979300200210; Uludag H, 2000, ADV DRUG DELIVER REV, V42, P29, DOI 10.1016/S0169-409X(00)00053-3; van Hoogmoed CG, 2003, J BIOMED MATER RES A, V67A, P172, DOI 10.1002/jbm.a.10086; van Schilfgaarde R, 1999, J MOL MED-JMM, V77, P199, DOI 10.1007/s001090050336; VANDENBOSSCHE GMR, 1993, J PHARM PHARMACOL, V45, P115, DOI 10.1111/j.2042-7158.1993.tb03694.x; VANDENBOSSCHE GMR, 1993, J PHARM PHARMACOL, V45, P121, DOI 10.1111/j.2042-7158.1993.tb03695.x; VANDENBOSSCHE GMR, 1991, J PHARM PHARMACOL, V43, P275, DOI 10.1111/j.2042-7158.1991.tb06683.x; VANDENBOSSCHE GMR, 1993, BIOTECHNOL BIOENG, V42, P381, DOI 10.1002/bit.260420316; Weir GC, 2013, DIABETOLOGIA, V56, P1458, DOI 10.1007/s00125-013-2921-1; Xu Y, 2009, BIOMACROMOLECULES, V10, P267, DOI 10.1021/bm801279y	73	34	34	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e109837	10.1371/journal.pone.0109837	http://dx.doi.org/10.1371/journal.pone.0109837			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347191	Green Published, gold			2022-12-27	WOS:000347994900014
J	Stepanenko, OV; Stepanenko, OV; Kuznetsova, IM; Verkhusha, VV; Turoverov, KK				Stepanenko, Olesya V.; Stepanenko, Olga V.; Kuznetsova, Irina M.; Verkhusha, Vladislav V.; Turoverov, Konstantin K.			Sensitivity of Superfolder GFP to Ionic Agents	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; BINDING PROTEIN; ENVIRONMENTAL SENSITIVITY; GUANIDINE-HYDROCHLORIDE; CHROMOPHORE FORMATION; CRYSTAL-STRUCTURE; PROTON-TRANSFER; STABILITY; MUTANT; MATURATION	Superfolder variant of the green fluorescent protein (sfGFP) became a favorite probe for examination of the unfolding-refolding processes of fluorescent proteins with beta-barrel structure owing to its reversible unfolding in comparison with other fluorescent proteins. Its benefit is the proper folding even in fusion constructions with poorly folded polypeptides. We noticed that guanidine thiocyanate affects not only the structure of protein but its chromophore directly. Therefore we studied the influence of ionic denaturants and salts including guanidine thiocyanate, guanidine hydrochloride, sodium chloride and sodium thiocyanate on spectral features of sfGFP. It was shown that moderate amounts of the studied agents do not disrupt sfGFP structure but provoke pronounced alteration of its spectral characteristics. Changes in absorption and CD spectra in visible spectral range indicate the specific binding of SCN- and Cl- anions in the sfGFP chromophore vicinity. The anion binding results in the redistribution of sfGFP molecules with neutral and anionic chromophores. This also hinders the proton transfer in the chromophore excited state, considerably decreasing the fluorescence intensity of sfGFP. Our results indicate that when ionic denaturants are used in the studies of fluorescent protein folding their effect on fluorophore charge state should be taken into account.	[Stepanenko, Olesya V.; Stepanenko, Olga V.; Kuznetsova, Irina M.; Turoverov, Konstantin K.] Russian Acad Sci, Inst Cytol, Lab Struct Dynam Stabil & Folding Prot, St Petersburg 194064, Russia; [Verkhusha, Vladislav V.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA; [Verkhusha, Vladislav V.] Univ Helsinki, Inst Biomed, Dept Biochem & Dev Biol, Helsinki, Finland; [Kuznetsova, Irina M.; Turoverov, Konstantin K.] St Petersburg State Polytech Univ, Dept Biophys, St Petersburg, Russia	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS; Yeshiva University; Albert Einstein College of Medicine; University of Helsinki; Peter the Great St. Petersburg Polytechnic University	Turoverov, KK (corresponding author), Russian Acad Sci, Inst Cytol, Lab Struct Dynam Stabil & Folding Prot, St Petersburg 194064, Russia.	kkt@incras.ru	Stepanenko, Olga/S-3427-2017; Kuznetsova, Irina M./R-9844-2017; Stepanenko, Olesya V/S-3433-2017; Verkhusha, Vladislav/AAU-7784-2020; Turoverov, Konstantin/S-2079-2016	Kuznetsova, Irina M./0000-0002-3336-4834; Verkhusha, Vladislav/0000-0002-2083-8121; Turoverov, Konstantin/0000-0002-6977-1896; Stepanenko, Olga/0000-0002-9145-3480; Stepanenko, Olesya/0000-0003-3779-6711	Russian Foundation of Basic Research [12-04-31469]; Russian Federation; Russian Academy of Sciences; Academy of Finland [263371, 266992]; US National Institutes of Health [GM073913, CA164468]; NATIONAL CANCER INSTITUTE [R01CA164468] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073913] Funding Source: NIH RePORTER	Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Federation(Russian Federation); Russian Academy of Sciences(Russian Academy of Sciences); Academy of Finland(Academy of Finland); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was in part supported by the grants from the Russian Foundation of Basic Research (12-04-31469 to Olesya V. Stepanenko), the scholarships of the President of Russian Federation (to Olesya V. Stepanenko and Olga V. Stepanenko), the MCB Program of Russian Academy of Sciences (to K.K.T.), the Academy of Finland (263371 and 266992 to V.V.V.) and the US National Institutes of Health (GM073913 and CA164468 to V.V.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews BT, 2009, J MOL BIOL, V392, P218, DOI 10.1016/j.jmb.2009.06.072; Arosio D, 2007, BIOPHYS J, V93, P232, DOI 10.1529/biophysj.106.102319; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; Bizzarri R, 2007, BIOCHEMISTRY-US, V46, P5494, DOI 10.1021/bi602646r; Bizzarri R, 2009, ANAL BIOANAL CHEM, V393, P1107, DOI 10.1007/s00216-008-2515-9; Bushmarina NA, 2001, CHEMBIOCHEM, V2, P813, DOI 10.1002/1439-7633(20011105)2:11<813::AID-CBIC813>3.0.CO;2-W; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Cotlet M, 2006, CHEMPHYSCHEM, V7, P250, DOI 10.1002/cphc.200500247; Di Donato M, 2011, PHYS CHEM CHEM PHYS, V13, P16295, DOI 10.1039/c1cp20387h; Fang C, 2009, NATURE, V462, P200, DOI 10.1038/nature08527; Fok MV, 1972, ANN PN LEBEDEV PHYS, P3; Fonin AV, 2014, PLOS ONE IN PRESS; Frommer WB, 2009, CHEM SOC REV, V38, P2833, DOI 10.1039/b907749a; Fukuda H, 2000, BIOCHEMISTRY-US, V39, P12025, DOI 10.1021/bi000543l; Galietta LJV, 2001, FEBS LETT, V499, P220, DOI 10.1016/S0014-5793(01)02561-3; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Hsu STD, 2010, J BIOL CHEM, V285, P4859, DOI 10.1074/jbc.M109.000695; Ibraheem A, 2010, CURR OPIN CHEM BIOL, V14, P30, DOI 10.1016/j.cbpa.2009.09.033; Jayaraman S, 2000, J BIOL CHEM, V275, P6047, DOI 10.1074/jbc.275.9.6047; Kuznetsova IM, 2002, BBA-PROTEIN STRUCT M, V1596, P138, DOI 10.1016/S0167-4838(02)00212-1; Kuznetsova IM, 2002, BIOCHEMISTRY-US, V41, P13127, DOI 10.1021/bi026412x; Kuznetsova IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040845; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lawrence MS, 2007, J AM CHEM SOC, V129, P10110, DOI 10.1021/ja071641y; Maddalo SL, 2006, PHOTOCHEM PHOTOBIOL, V82, P367, DOI 10.1562/2005-04-11-RA-485; Mishin AS, 2008, BIOCHEMISTRY-US, V47, P4666, DOI 10.1021/bi702130s; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Pakhomov AA, 2008, CHEM BIOL, V15, P755, DOI 10.1016/j.chembiol.2008.07.009; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Povarova OI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015035; Rekas A, 2002, J BIOL CHEM, V277, P50573, DOI 10.1074/jbc.M209524200; Seward HE, 2009, CHEM SOC REV, V38, P2842, DOI 10.1039/b901355p; Shcherbakova DM, 2012, ANGEW CHEM INT EDIT, V51, P10724, DOI 10.1002/anie.201200408; Staiano M, 2005, BIOCHEMISTRY-US, V44, P5625, DOI 10.1021/bi0478300; Staiano M, 2007, BIOCHEMISTRY-US, V46, P11120, DOI 10.1021/bi7008129; Stepanenko OV, 2013, INT REV CEL MOL BIO, V302, P221, DOI 10.1016/B978-0-12-407699-0.00004-2; Stepanenko OV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048809; Stepanenko OV, 2011, BIOTECHNIQUES, V51, P313, DOI 10.2144/000113765; Stepanenko OV, 2010, SPECTROSC-INT J, V24, P367, DOI 10.1155/2010/935656; Stepanenko OV, 2011, J PHYS CHEM B, V115, P9022, DOI 10.1021/jp204555h; Stepanenko OV, 2004, BIOCHEMISTRY-US, V43, P14913, DOI 10.1021/bi048725t; Stepartenko OV, 2008, PROTEINS, V73, P539, DOI 10.1002/prot.22089; Subach FV, 2011, NAT METHODS, V8, P1019, DOI [10.1038/nmeth.1776, 10.1038/NMETH.1776]; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Turoverov K K, 1998, Tsitologiia, V40, P806; Wachter RM, 2000, J MOL BIOL, V301, P157, DOI 10.1006/jmbi.2000.3905; Wachter RM, 1999, CURR BIOL, V9, pR628, DOI 10.1016/S0960-9822(99)80408-4; Weber W, 1999, P NATL ACAD SCI USA, V96, P6177, DOI 10.1073/pnas.96.11.6177	49	14	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e110750	10.1371/journal.pone.0110750	http://dx.doi.org/10.1371/journal.pone.0110750			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347822	gold, Green Published, Green Submitted			2022-12-27	WOS:000347994900028
J	Wang, JB; Yang, J; Mao, S; Chai, XQ; Hu, YL; Hou, XG; Tang, YH; Bi, C; Li, X				Wang, Jiabin; Yang, Jian; Mao, Song; Chai, Xiaoqiang; Hu, Yuling; Hou, Xugang; Tang, Yiheng; Bi, Cheng; Li, Xiao			MitProNet: A Knowledgebase and Analysis Platform of Proteome, Interactome and Diseases for Mammalian Mitochondria	PLOS ONE			English	Article							COMPLEX I DEFICIENCY; SYSTEMATIC CHARACTERIZATION; SUBUNIT COMPOSITION; NETWORK ANALYSIS; GENE-EXPRESSION; GLOBAL SURVEY; DATABASE; MOUSE; IDENTIFICATION; DYSFUNCTION	Mitochondrion plays a central role in diverse biological processes in most eukaryotes, and its dysfunctions are critically involved in a large number of diseases and the aging process. A systematic identification of mitochondrial proteomes and characterization of functional linkages among mitochondrial proteins are fundamental in understanding the mechanisms underlying biological functions and human diseases associated with mitochondria. Here we present a database MitProNet which provides a comprehensive knowledgebase for mitochondrial proteome, interactome and human diseases. First an inventory of mammalian mitochondrial proteins was compiled by widely collecting proteomic datasets, and the proteins were classified by machine learning to achieve a high-confidence list of mitochondrial proteins. The current version of MitProNet covers 1124 high-confidence proteins, and the remainders were further classified as middle-or low-confidence. An organelle-specific network of functional linkages among mitochondrial proteins was then generated by integrating genomic features encoded by a wide range of datasets including genomic context, gene expression profiles, protein-protein interactions, functional similarity and metabolic pathways. The functional-linkage network should be a valuable resource for the study of biological functions of mitochondrial proteins and human mitochondrial diseases. Furthermore, we utilized the network to predict candidate genes for mitochondrial diseases using prioritization algorithms. All proteins, functional linkages and disease candidate genes in MitProNet were annotated according to the information collected from their original sources including GO, GEO, OMIM, KEGG, MIPS, HPRD and so on. MitProNet features a user-friendly graphic visualization interface to present functional analysis of linkage networks. As an up-to-date database and analysis platform, MitProNet should be particularly helpful in comprehensive studies of complicated biological mechanisms underlying mitochondrial functions and human mitochondrial diseases. MitProNet is freely accessible at http://bio.scu.edu.cn:8085/MitProNet.	[Wang, Jiabin; Yang, Jian; Mao, Song; Chai, Xiaoqiang; Hu, Yuling; Hou, Xugang; Tang, Yiheng; Bi, Cheng; Li, Xiao] Sichuan Univ, Sichuan Key Lab Mol Biol & Biotechnol, Key Lab Bioresource & Ecoenvironm, Coll Life Sci,Minist Educ, Chengdu 610064, Peoples R China	Sichuan University	Li, X (corresponding author), Sichuan Univ, Sichuan Key Lab Mol Biol & Biotechnol, Key Lab Bioresource & Ecoenvironm, Coll Life Sci,Minist Educ, Chengdu 610064, Peoples R China.	lix@scu.edu.cn			National Natural Science Foundation of China [61001149]; National Science and Technology Major Project of the Ministry of Science and Technology of China [2012ZX10005001-010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project of the Ministry of Science and Technology of China	This work was supported partially by National Natural Science Foundation of China (Grant No. 61001149) and the National Science and Technology Major Project of the Ministry of Science and Technology of China (Grant No. 2012ZX10005001-010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Basu S, 2006, BIOINFORMATICS, V22, P485, DOI 10.1093/bioinformatics/btk009; Beal MF, 1998, BBA-BIOENERGETICS, V1366, P211, DOI 10.1124/jpet.112.192138; Benit P, 2004, J MED GENET, V41, P14, DOI 10.1136/jmg.2003.014316; Bordych C, 2013, PLANT BIOLOGY, V15, P686, DOI 10.1111/plb.12027; Bousette N, 2009, J PROTEOME RES, V8, P1887, DOI 10.1021/pr800845a; Bowers PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r35; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; Catalano D, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-36; Catherman AD, 2013, MOL CELL PROTEOMICS, V12, P3465, DOI 10.1074/mcp.M113.030114; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chappell NP, 2012, J PROTEOME RES, V11, P4605, DOI 10.1021/pr300403d; Chen J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-73; Chen XL, 2013, PROTEOMICS, V13, P3030, DOI 10.1002/pmic.201200448; Cherry JM, 1997, NATURE, V387, P67, DOI 10.1038/387s067; Cotter D, 2004, NUCLEIC ACIDS RES, V32, pD463, DOI 10.1093/nar/gkh048; Da Cruz S, 2003, J BIOL CHEM, V278, P41566, DOI 10.1074/jbc.M304940200; Deng WJ, 2010, MOL CELL PROTEOMICS, V9, P100, DOI 10.1074/mcp.M900020-MCP200; Distler AM, 2008, PROTEOMICS, V8, P4066, DOI 10.1002/pmic.200800102; Dwyer TM, 1999, BIOCHEMISTRY-US, V38, P9735, DOI 10.1021/bi9903906; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elstner M, 2009, METHOD ENZYMOL, V457, P3, DOI 10.1016/S0076-6879(09)05001-0; Facecchia K, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/683728; Fang XP, 2008, ELECTROPHORESIS, V29, P2215, DOI 10.1002/elps.200700609; Forner F, 2006, MOL CELL PROTEOMICS, V5, P608, DOI 10.1074/mcp.M500298-MCP200; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Freund Y., 1996, P 13 INT C MACH LEAR, V96, P148, DOI DOI 10.5555/3091696.3091715; Goncalves JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049634; Gregersen N, 2012, J INHERIT METAB DIS, V35, P715, DOI 10.1007/s10545-012-9480-3; Gu ZG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-335; Guan YF, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000165; Guda C, 2004, BIOINFORMATICS, V20, P1785, DOI 10.1093/bioinformatics/bth171; Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hansen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026634; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Jin JH, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-67; Johnson DT, 2007, AM J PHYSIOL-CELL PH, V292, pC689, DOI 10.1152/ajpcell.00108.2006; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Kohavi R., 1995, PROC 14 INT JOINT C, P1137; Lefort N, 2009, J PROTEOMICS, V72, P1046, DOI 10.1016/j.jprot.2009.06.011; Linghu Bolan, 2013, Methods Mol Biol, V939, P215, DOI 10.1007/978-1-62703-107-3_14; Linghu B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r91; Loeffen JLCM, 1998, BIOCHEM BIOPH RES CO, V253, P415, DOI 10.1006/bbrc.1998.9786; LOMAX MI, 1991, GENOMICS, V10, P1, DOI 10.1016/0888-7543(91)90476-U; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Meisinger C, 2008, CELL, V134, P22, DOI 10.1016/j.cell.2008.06.043; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Murray J, 2003, J BIOL CHEM, V278, P13619, DOI 10.1074/jbc.C300064200; Nitsch D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-460; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oliver S, 2000, NATURE, V403, P601, DOI 10.1038/35001165; Ozawa T, 2003, NAT BIOTECHNOL, V21, P287, DOI 10.1038/nbt791; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Palmfeldt J, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-20; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Prokisch H, 2006, NUCLEIC ACIDS RES, V34, pD705, DOI 10.1093/nar/gkj127; Reifschneider NH, 2006, J PROTEOME RES, V5, P1117, DOI 10.1021/pr0504440; Reja R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S3-S20; Rezaul K, 2005, MOL CELL PROTEOMICS, V4, P169, DOI 10.1074/mcp.M400115-MCP200; Salminen A, 2012, CELL MOL LIFE SCI, V69, P2999, DOI 10.1007/s00018-012-0962-0; Scott MS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-239; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Shenouda SM, 2011, CIRCULATION, V124, P444, DOI 10.1161/CIRCULATIONAHA.110.014506; Siddiqui AS, 2005, P NATL ACAD SCI USA, V102, P18485, DOI 10.1073/pnas.0509455102; Smith AC, 2009, MOL CELL PROTEOMICS, V8, P1324, DOI 10.1074/mcp.M800373-MCP200; Smith CL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r7; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stein A, 2011, NUCLEIC ACIDS RES, V39, pD718, DOI 10.1093/nar/gkq962; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; Traish AM, 2011, HORM MOL BIOL CLIN I, V8, P431, DOI 10.1515/HMBCI.2011.132; Triepels R, 2000, HUM GENET, V106, P385, DOI 10.1007/s004390000278; Vianna CR, 2006, CELL METAB, V4, P453, DOI 10.1016/j.cmet.2006.11.003; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Weiller GF, 1998, MOL BIOL EVOL, V15, P326, DOI 10.1093/oxfordjournals.molbev.a025929; White S., 2003, P 9 ACM SIGKDD INT C, P266, DOI [DOI 10.1145/956750.956782, 10.1145/956750.956782]; Wolfe LA, 2010, J INHERIT METAB DIS, V33, pS481, DOI 10.1007/s10545-010-9246-8; Wu L, 2007, MOL CELL PROTEOMICS, V6, P1343, DOI 10.1074/mcp.M700017-MCP200; Xie J, 2005, PROTEOMICS, V5, P2981, DOI 10.1002/pmic.200401191; Zhang J, 2010, BMC BIOINFORMATICS, V11, DOI [10.1186/1471-2105-11-S9-S5, 10.1186/1471-2105-11-s9-s5]; Zhang J, 2008, PROTEOMICS, V8, P1564, DOI 10.1002/pmic.200700851	91	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111187	10.1371/journal.pone.0111187	http://dx.doi.org/10.1371/journal.pone.0111187			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347823	gold, Green Submitted, Green Published			2022-12-27	WOS:000347994900052
J	Xie, H; Zhang, YH; Zhang, PP; Wang, JM; Wu, Y; Wu, XR; Netoff, T; Jiang, YW				Xie, Han; Zhang, Yuehua; Zhang, Pingping; Wang, Jingmin; Wu, Ye; Wu, Xiru; Netoff, Theoden; Jiang, Yuwu			Functional Study of NIPA2 Mutations Identified from the Patients with Childhood Absence Epilepsy	PLOS ONE			English	Article							HEREDITARY SPASTIC PARAPLEGIA; NMDA RESPONSES; NEURONS; CHANNELS; CACNA1H; BINDING; BLOCK; GENE	Recently many genetic mutations that are associated with epilepsy have been identified. The protein NIPA2 ( non-imprinted in Prader-Willi/Angelman syndrome region protein 2) is a highly selective magnesium transporter encoded by the gene NIPA2 in which we have found three mutations (p.I178F, p.N244S and p.N334_E335insD) within a population of patients with childhood absence epilepsy (CAE). In this study, immunofluorescence labeling, inductively coupled plasma-optical emission spectroscopy (ICP-OES), MTT metabolic rate detection and computational modeling were utilized to elucidate how these mutations result in CAE. We found in cultured neurons that NIPA2 (wild-type) proteins were localized to the cell periphery, whereas mutant proteins were not effectively trafficked to the cell membrane. Furthermore, we found a decrease in intracellular magnesium concentration in the neurons transfected with mutant NIPA2, but no effect on the survival of neurons. To understand how low intracellular magnesium resulted in hyperexcitability, we built and analyzed a computational model to simulate the effects of mutations. The model suggested that lower intracellular magnesium concentration enhanced synaptic N-methyl-D-aspartate receptor (NMDAR) currents. This study primarily reveals that a selective magnesium transporter NIPA2 may play a role in the pathogenesis of CAE.	[Xie, Han; Zhang, Yuehua; Zhang, Pingping; Wang, Jingmin; Wu, Ye; Wu, Xiru; Jiang, Yuwu] Peking Univ, Hosp 1, Dept Pediat, Beijing 100871, Peoples R China; [Netoff, Theoden] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA	Peking University; University of Minnesota System; University of Minnesota Twin Cities	Netoff, T (corresponding author), Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA.	tnetoff@umn.edu; drjiangyw@gmail.com	jiang, yu/HGU-0029-2022; han, xie/AAO-9359-2021	Netoff, Theoden/0000-0002-0115-1930; Zhang, Yuehua/0000-0003-1432-5423	National Natural Science Fund of China [81271439]; National Key Research Project "973'' [2012CB944602]; National Science Funding [1135581]; Epilepsy Foundation [190960]; China Scholarship Council Program [201206010800]; Academic Scholarship for Doctoral Candidates (Ministry of Education, P.R. China); Directorate For Engineering [0954797] Funding Source: National Science Foundation	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); National Key Research Project "973''(National Basic Research Program of China); National Science Funding; Epilepsy Foundation; China Scholarship Council Program(China Scholarship Council); Academic Scholarship for Doctoral Candidates (Ministry of Education, P.R. China); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by National Natural Science Fund of China (Grant Number 81271439 to Y.J.); National Key Research Project "973'', sub-project (Grant No. 2012CB944602 to Y.J.); National Science Funding (Grant Number 1135581 to T.N.); Epilepsy Foundation (Grant Number 190960 to T.N.); China Scholarship Council Program (Student Number 201206010800 to H.X.); Academic Scholarship for Doctoral Candidates (Ministry of Education, P.R. China to H.X.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Botzolakis EJ, 2011, MOL CELL NEUROSCI, V46, P122, DOI 10.1016/j.mcn.2010.08.012; Chai JH, 2003, AM J HUM GENET, V73, P898, DOI 10.1086/378816; Chen YC, 2003, ANN NEUROL, V54, P239, DOI 10.1002/ana.10607; COAN EJ, 1985, NEUROSCI LETT, V53, P21, DOI 10.1016/0304-3940(85)90091-6; CREST M, 1993, J PHYSIOL-LONDON, V465, P265, DOI 10.1113/jphysiol.1993.sp019676; Destexhe A, 1994, J Comput Neurosci, V1, P195, DOI 10.1007/BF00961734; DESTEXHE A, 1994, NEURAL COMPUT, V6, P14, DOI 10.1162/neco.1994.6.1.14; Ferre S, 2011, CURR OPIN NEPHROL HY, V20, P169, DOI 10.1097/MNH.0b013e3283435ee4; Futatsugi Y, 1998, BRAIN DEV-JPN, V20, P75, DOI 10.1016/S0387-7604(97)00107-1; Gorman AM, 2012, PHARMACOL THERAPEUT, V134, P306, DOI 10.1016/j.pharmthera.2012.02.003; Goytain A, 2008, AM J PHYSIOL-CELL PH, V295, pC944; Goytain A, 2007, J BIOL CHEM, V282, P8060, DOI 10.1074/jbc.M610314200; Hildebrand MS, 2014, HUM GENET, V133, P673, DOI 10.1007/s00439-013-1414-0; HUSSAIN RF, 1993, J IMMUNOL METHODS, V160, P89, DOI 10.1016/0022-1759(93)90012-V; Jiang YW, 2014, HUM GENET, V133, P675, DOI 10.1007/s00439-014-1428-2; Jiang YW, 2012, HUM GENET, V131, P1217, DOI 10.1007/s00439-012-1149-3; Li-Smerin YY, 2001, J PHYSIOL-LONDON, V533, P729, DOI 10.1111/j.1469-7793.2001.t01-1-00729.x; Liang JM, 2006, NEUROSCI LETT, V406, P27, DOI 10.1016/j.neulet.2006.06.073; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Peloquin JB, 2006, EPILEPSIA, V47, P655, DOI 10.1111/j.1528-1167.2006.00482.x; Quamme GA, 2010, AM J PHYSIOL-CELL PH, V298, pC407, DOI 10.1152/ajpcell.00124.2009; Yang YC, 2010, J PHYSIOL-LONDON, V588, P633, DOI 10.1113/jphysiol.2009.178913; Yu J, 2010, J ALZHEIMERS DIS, V20, P1091, DOI 10.3233/JAD-2010-091444; Zhao JL, 2008, J NEUROSCI, V28, P13938, DOI 10.1523/JNEUROSCI.4668-08.2008	25	21	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e109749	10.1371/journal.pone.0109749	http://dx.doi.org/10.1371/journal.pone.0109749			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347071	gold, Green Submitted, Green Published			2022-12-27	WOS:000347994900013
J	Ball, LG; Hanna, MD; Lambrecht, AD; Mitchell, BA; Ziola, B; Cobb, JA; Xiao, W				Ball, Lindsay G.; Hanna, Michelle D.; Lambrecht, Amanda D.; Mitchell, Bryan A.; Ziola, Barry; Cobb, Jennifer A.; Xiao, Wei			The Mre11-Rad50-Xrs2 Complex Is Required for Yeast DNA Postreplication Repair	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; MRE11 COMPLEX; MRE11/RAD50/XRS2 COMPLEX; END RESECTION; S-PHASE; DAMAGE; UBIQUITIN; PROTEINS	Yeast DNA postreplication repair (PRR) bypasses replication-blocking lesions to prevent damage-induced cell death. PRR employs two different mechanisms to bypass damaged DNA, namely translesion synthesis (TLS) and error-free PRR, which are regulated via sequential ubiquitination of proliferating cell nuclear antigen (PCNA). We previously demonstrated that error-free PRR utilizes homologous recombination to facilitate template switching. To our surprise, genes encoding the Mre11-Rad50-Xrs2 (MRX) complex, which are also required for homologous recombination, are epistatic to TLS mutations. Further genetic analyses indicated that two other nucleases involved in double-strand end resection, Sae2 and Exo1, are also variably required for efficient lesion bypass. The involvement of the above genes in TLS and/or error-free PRR could be distinguished by the mutagenesis assay and their differential effects on PCNA ubiquitination. Consistent with the observation that the MRX complex is required for both branches of PRR, the MRX complex was found to physically interact with Rad18 in vivo. In light of the distinct and overlapping activities of the above nucleases in the resection of double-strand breaks, we propose that the interplay between distinct single-strand nucleases dictate the preference between TLS and error-free PRR for lesion bypass.	[Ball, Lindsay G.; Hanna, Michelle D.; Lambrecht, Amanda D.; Mitchell, Bryan A.; Xiao, Wei] Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK, Canada; [Ball, Lindsay G.; Cobb, Jennifer A.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Ziola, Barry] Univ Saskatchewan, Dept Pathol & Lab Med, Saskatoon, SK, Canada; [Xiao, Wei] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China	University of Saskatchewan; University of Calgary; University of Saskatchewan; Capital Normal University	Xiao, W (corresponding author), Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK, Canada.	wei.xiao@usask.ca		Xiao, Wei/0000-0001-7568-0782	Canadian Institutes of Health Research [MOP-93612]; Natural Sciences and Engineering Research Council of Canada [RGPIN-2014-04580]; University of Saskatchewan Arthur Smyth Memorial Scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Saskatchewan Arthur Smyth Memorial Scholarship	This work was supported by the Canadian Institutes of Health Research operating grant MOP-93612 and the Natural Sciences and Engineering Research Council of Canada Discovery Grant No. RGPIN-2014-04580 to WX. LGB was the recipient of the University of Saskatchewan Arthur Smyth Memorial Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DE, 2001, J BIOL CHEM, V276, P37027, DOI 10.1074/jbc.M106179200; [Anonymous], 2005, MOL BIOL CELL, V16, P597, DOI 10.1097/mbc.E04-09-0782; Ball LG, 2009, MOL MICROBIOL, V73, P89, DOI 10.1111/j.1365-2958.2009.06748.x; Barbour L, 2000, GENOME, V43, P910, DOI 10.1139/gen-43-5-910; Barbour L, 2006, MOL MICROBIOL, V59, P637, DOI 10.1111/j.1365-2958.2005.04965.x; Barbour L, 2003, MUTAT RES-FUND MOL M, V532, P137, DOI 10.1016/j.mrfmmm.2003.08.014; Barbour L, 2006, GENETICS, V174, P1789, DOI 10.1534/genetics.106.056283; BERBEN G, 1991, YEAST, V7, P475, DOI 10.1002/yea.320070506; Bonetti D, 2009, MOL CELL, V35, P70, DOI 10.1016/j.molcel.2009.05.015; Bressan DA, 1998, GENETICS, V150, P591; Broomfield S, 1998, P NATL ACAD SCI USA, V95, P5678, DOI 10.1073/pnas.95.10.5678; Brusky J, 2000, CURR GENET, V37, P168, DOI 10.1007/s002940050515; Clerici M, 2005, J BIOL CHEM, V280, P38631, DOI 10.1074/jbc.M508339200; Connelly JC, 1999, NUCLEIC ACIDS RES, V27, P1039, DOI 10.1093/nar/27.4.1039; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; Davies AA, 2008, MOL CELL, V29, P625, DOI 10.1016/j.molcel.2007.12.016; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Furuse M, 1998, EMBO J, V17, P6412, DOI 10.1093/emboj/17.21.6412; Grenon M, 2001, NAT CELL BIOL, V3, P844, DOI 10.1038/ncb0901-844; Hartsuiker E, 2009, MOL CELL, V33, P117, DOI 10.1016/j.molcel.2008.11.021; Hashimoto Y, 2010, NAT STRUCT MOL BIOL, V17, P1305, DOI 10.1038/nsmb.1927; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; IVANOV EL, 1994, MOL CELL BIOL, V14, P3414, DOI 10.1128/MCB.14.5.3414; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Lawrence CW, 2004, ADV PROTEIN CHEM, V69, P167; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Liberti SE, 2004, MOL CANCER RES, V2, P427; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; McKee AHZ, 1997, GENETICS, V146, P797; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mimitou EP, 2009, DNA REPAIR, V8, P983, DOI 10.1016/j.dnarep.2009.04.017; Muramatsu S, 2010, GENE DEV, V24, P602, DOI 10.1101/gad.1883410; Nelms BE, 1998, SCIENCE, V280, P590, DOI 10.1126/science.280.5363.590; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; PRAKASH S, 1993, ANNU REV GENET, V27, P33, DOI 10.1146/annurev.ge.27.120193.000341; Prinz S, 1997, GENETICS, V146, P781; ROCHE H, 1994, GENETICS, V137, P637; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Sherman F, 1983, COLD SPRING HARBOR; Steininger S, NUCL ACIDS RES, V38, P1853; Steininger S, 2008, DNA REPAIR, V7, P1563, DOI 10.1016/j.dnarep.2008.06.004; Tittel-Elmer M, 2009, EMBO J, V28, P1142, DOI 10.1038/emboj.2009.60; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tran PT, 2007, DNA REPAIR, V6, P1572, DOI 10.1016/j.dnarep.2007.05.004; Tran PT, 2004, DNA REPAIR, V3, P1549, DOI 10.1016/j.dnarep.2004.05.015; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; Xiao W, 1999, MUTAT RES-DNA REPAIR, V435, P1, DOI 10.1016/S0921-8777(99)00034-8; Xiao W, 1996, CURR GENET, V30, P461, DOI 10.1007/s002940050157; Yanagihara H, 2011, MOL CELL, V43, P788, DOI 10.1016/j.molcel.2011.07.026; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	65	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e109292	10.1371/journal.pone.0109292	http://dx.doi.org/10.1371/journal.pone.0109292			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343618	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943500012
J	Macdonald, SPJ; Stone, SF; Neil, CL; van Eeden, PE; Fatovich, DM; Arendts, G; Brown, SGA				Macdonald, Stephen P. J.; Stone, Shelley F.; Neil, Claire L.; van Eeden, Pauline E.; Fatovich, Daniel M.; Arendts, Glenn; Brown, Simon G. A.			Sustained Elevation of Resistin, NGAL and IL-8 Are Associated with Severe Sepsis/Septic Shock in the Emergency Department	PLOS ONE			English	Article							REGIONAL PRO-ADRENOMEDULLIN; MIGRATION INHIBITORY FACTOR; C-REACTIVE PROTEIN; SEVERE SEPSIS; INFLAMMATORY MARKERS; RISK STRATIFICATION; ORGAN DYSFUNCTION; CRITICAL ILLNESS; PROCALCITONIN; SURVIVAL	Objective: To identify biomarkers which distinguish severe sepsis/septic shock from uncomplicated sepsis in the Emergency Department (ED). Methods: Patients with sepsis underwent serial blood sampling, including arrival in the ED and up to three subsequent time points over the first 24 hours. Messenger RNA (mRNA) levels of 13 genes representing arms of the innate immune response, organ dysfunction or shock were measured in peripheral blood leucocytes using quantitative PCR, and compared with healthy controls. Serum protein concentrations of targets differentially expressed between uncomplicated sepsis and severe sepsis/septic shock were then measured at each time point and compared between the two patient groups. Results: Of 27 participants (median age 66 years, (IQR 35, 78)), 10 had uncomplicated sepsis and 17 had sepsis with organ failure (14 septic shock; 3 had other sepsis-related organ failures). At the time of first sample collection in the ED, gene expression of Interleukin (IL)-10 and Neutrophil Gelatinase Associated Lipocalin (NGAL) were significantly higher in severe sepsis than uncomplicated sepsis. Expression did not significantly change over time for any target gene. Serum concentrations of IL-6, IL-8, IL-10, NGAL and Resistin were significantly higher in severe sepsis than uncomplicated sepsis at the time of first sample collection in the ED, but only IL-8, NGAL and Resistin were consistently higher in severe sepsis compared to uncomplicated sepsis at all time points up to 24 h after presentation. Conclusions: These mediators, produced by both damaged tissues and circulating leukocytes, may have important roles in the development of severe sepsis. Further work will determine whether they have any value, in addition to clinical risk parameters, for the early identification of patients that will subsequently deteriorate and/or have a higher risk of death.	[Macdonald, Stephen P. J.; Stone, Shelley F.; Neil, Claire L.; van Eeden, Pauline E.; Fatovich, Daniel M.; Arendts, Glenn; Brown, Simon G. A.] Harry Perkins Inst Med Res, Ctr Clin Res Emergency Med, Perth, WA, Australia; [Macdonald, Stephen P. J.; Stone, Shelley F.; Neil, Claire L.; van Eeden, Pauline E.; Fatovich, Daniel M.; Arendts, Glenn; Brown, Simon G. A.] Univ Western Australia, Sch Primary Aboriginal & Rural Hlth Care, Discipline Emergency Med, Perth, WA 6009, Australia; [Macdonald, Stephen P. J.] Armadale Hlth Serv, Emergency Dept, Perth, WA, Australia; [Fatovich, Daniel M.; Arendts, Glenn; Brown, Simon G. A.] Royal Perth Hosp, Emergency Dept, Perth, WA 6001, Australia	Harry Perkins Institute of Medical Research; University of Western Australia; Royal Perth Hospital; University of Western Australia	Stone, SF (corresponding author), Harry Perkins Inst Med Res, Ctr Clin Res Emergency Med, Perth, WA, Australia.	Shelley.Stone@uwa.edu.au	Macdonald, Stephen PJ/H-5339-2014; van Eeden, Pauline/O-8713-2014; Fatovich, Daniel/J-5510-2013	Macdonald, Stephen/0000-0001-9921-4620; Fatovich, Daniel/0000-0001-9414-6905; Arendts, Glenn/0000-0001-7830-7756	NHMRC Career Development Fellowship Award [ID1023265]; Royal Perth Hospital Medical Research Foundation; University of Western Australia	NHMRC Career Development Fellowship Award(National Health and Medical Research Council (NHMRC) of Australia); Royal Perth Hospital Medical Research Foundation; University of Western Australia	SB is supported by a NHMRC Career Development Fellowship Award ID1023265. Additional funding was received from the Royal Perth Hospital Medical Research Foundation and the University of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Arendts G, 2012, EMERG MED AUSTRALAS, V24, P31, DOI 10.1111/j.1742-6723.2011.01500.x; Aziz M, 2013, J LEUKOCYTE BIOL, V93, P329, DOI 10.1189/jlb.0912437; Bagshaw SM, 2009, CRIT CARE, V13, DOI 10.1186/cc7768; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; Brenner T, 2010, J SURG RES, V164, pE163, DOI 10.1016/j.jss.2010.05.004; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carson SS, 2003, CRIT CARE CLIN, V19, P605, DOI 10.1016/S0749-0704(03)00051-4; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Christ-Crain M, 2005, CRIT CARE, V9, pR816, DOI 10.1186/cc3885; Constantin JM, 2010, J CRIT CARE, V25; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Freund Y, 2012, BIOMARKERS; Gille-Johnson P, 2012, SCAND J INFECT DIS, V44, P745, DOI 10.3109/00365548.2012.689846; Gustafsson A, 2012, BIOMARK INSIGHTS, V7, P39, DOI 10.4137/BMI.S9460; Herzum I, 2008, CURR MED CHEM, V15, P581, DOI 10.2174/092986708783769704; Ip M, 2007, DIAGN MICR INFEC DIS, V59, P131, DOI 10.1016/j.diagmicrobio.2007.04.019; Koch A, 2009, CRIT CARE, V13, DOI 10.1186/cc7925; Kofoed K, 2007, CRIT CARE, V11, DOI 10.1186/cc5723; Lentini P, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/856401; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lichtenstern C, 2012, CURR OPIN INFECT DIS, V25, P328, DOI 10.1097/QCO.0b013e3283522038; Lindig S, 2013, INT J ANTIMICROB AG, V42, pS2, DOI 10.1016/j.ijantimicag.2013.04.012; Lvovschi V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028870; Martin GS, 2006, CRIT CARE MED, V34, P15, DOI 10.1097/01.CCM.0000194535.82812.BA; Nakamura T, 2009, PHARMACOL RES, V60, P515, DOI 10.1016/j.phrs.2009.05.002; Pang SS, 2006, CELL MOL IMMUNOL, V3, P29; Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872; Punyadeera Chamindie, 2010, J Emerg Trauma Shock, V3, P26, DOI 10.4103/0974-2700.58666; Shapiro NI, 2010, ANN EMERG MED, V56, P52, DOI 10.1016/j.annemergmed.2010.02.010; Shapiro NI, 2009, CRIT CARE MED, V37, P96, DOI 10.1097/CCM.0b013e318192fd9d; Stone SF, 2009, J ALLERGY CLIN IMMUN, V124, P786, DOI 10.1016/j.jaci.2009.07.055; Strehlow MC, 2006, ANN EMERG MED, V48, P326, DOI 10.1016/j.annemergmed.2006.05.003; Sunden-Cullberg J, 2007, CRIT CARE MED, V35, P1536, DOI 10.1097/01.CCM.0000266536.14736.03; Travaglino F, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-184; Wong HR, 2014, CRIT CARE MED, V42, P781, DOI 10.1097/CCM.0000000000000106	36	66	67	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110678	10.1371/journal.pone.0110678	http://dx.doi.org/10.1371/journal.pone.0110678			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343379	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943500045
J	Novack, L; Kogan, S; Gimpelevich, L; Howell, M; Borer, A; Kelly, CP; Leffler, DA; Novack, V				Novack, Lena; Kogan, Slava; Gimpelevich, Larisa; Howell, Michael; Borer, Abraham; Kelly, Ciaran P.; Leffler, Daniel A.; Novack, Victor			Acid Suppression Therapy Does Not Predispose to Clostridium difficile Infection: The Case of the Potential Bias	PLOS ONE			English	Article							PROTON-PUMP INHIBITORS; RISK-FACTORS; DIARRHEA; DISEASE; EPIDEMIC; ASSOCIATION; MORBIDITY; MORTALITY; COLITIS	Objective: An adverse effect of acid-suppression medications on the occurrence of Clostridium difficile infection (CDI) has been a common finding of many, but not all studies. We hypothesized that association between acid-suppression medications and CDI is due to the residual confounding in comparison between patients with infection to those without, predominantly from non-tested and less sick subjects. We aimed to evaluate the effect of acid suppression therapy on incidence of CDI by comparing patients with CDI to two control groups: not tested patients and patients suspected of having CDI, but with a negative test. Methods: We conducted a case-control study of adult patients hospitalized in internal medicine department of tertiary teaching hospital between 2005-2010 for at least three days. Controls from each of two groups (negative for CDI and non-tested) were individually matched (1:1) to cases by primary diagnosis, Charlson comorbidity index, year of hospitalization and gender. Primary outcomes were diagnoses of International Classification of Diseases (ICD-9)-coded CDI occurring 72 hours or more after admission. Results: Patients with CDI were similar to controls with a negative test, while controls without CDI testing had lower clinical severity. In multivariable analysis, treatment by acid suppression medications was associated with CDI compared to those who were not tested (OR = 1.88, p-value = 0.032). Conversely, use of acid suppression medications in those who tested negative for the infection was not associated with CDI risk as compared to the cases (OR = 0.66; p = 0.059). Conclusions: These findings suggest that the reported epidemiologic associations between use of acid suppression medications and CDI risk may be spurious. The control group choice has an important impact on the results. Clinical differences between the patients with CDI and those not tested and not suspected of having the infection may explain the different conclusions regarding the acid suppression effect on CDI risk.	[Novack, Lena; Gimpelevich, Larisa] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Epidemiol, Beer Sheva, Israel; [Kogan, Slava; Novack, Victor] Ben Gurion Univ Negev, Soroka Univ, Med Ctr, Clin Res Ctr, IL-84105 Beer Sheva, Israel; [Howell, Michael] Univ Chicago Med, Chicago, IL USA; [Borer, Abraham] Soroka Univ, Med Ctr, Infect Dis Unit, Beer Sheva, Israel; [Kelly, Ciaran P.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gastroenterol, Boston, MA 02215 USA; [Leffler, Daniel A.] Beth Israel Deaconess Med Ctr, Celiac Ctr, Div Gastroenterol, Boston, MA 02215 USA	Ben Gurion University; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Novack, L (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Epidemiol, Beer Sheva, Israel.	novack@bgu.ac.il	Howell, Michael/B-8065-2009; NOVACK, LENA/AAH-8343-2021	Howell, Michael/0000-0001-7003-6971; NOVACK, LENA/0000-0003-3748-2632				Aseeri M, 2008, AM J GASTROENTEROL, V103, P2308, DOI 10.1111/j.1572-0241.2008.01975.x; Bavishi C, 2011, ALIMENT PHARM THER, V34, P1269, DOI 10.1111/j.1365-2036.2011.04874.x; Bignardi GE, 1998, J HOSP INFECT, V40, P1, DOI 10.1016/S0195-6701(98)90019-6; Cadle RM, 2007, AM J HEALTH-SYST PH, V64, P2359, DOI 10.2146/ajhp060629; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Choudhry MN, 2008, QJM-INT J MED, V101, P445, DOI 10.1093/qjmed/hcn035; Cunningham R, 2008, J HOSP INFECT, V70, P1, DOI 10.1016/j.jhin.2008.04.023; Dalton BR, 2009, ALIMENT PHARM THER, V29, P626, DOI 10.1111/j.1365-2036.2008.03924.x; Dial S, 2005, JAMA-J AM MED ASSOC, V294, P2989, DOI 10.1001/jama.294.23.2989; Gujja D, 2009, ALIMENT PHARM THER, V29, P635, DOI 10.1111/j.1365-2036.2008.03914.x; Howell MD, 2010, ARCH INTERN MED, V170, P784, DOI 10.1001/archinternmed.2010.89; Jump RLP, 2007, ANTIMICROB AGENTS CH, V51, P2883, DOI 10.1128/AAC.01443-06; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Kwok CS, 2012, AM J GASTROENTEROL, V107, P1011, DOI 10.1038/ajg.2012.108; Kyne L, 2002, INFECT CONT HOSP EP, V23, P653, DOI 10.1086/501989; McFarland LV, 2008, NAT CLIN PRACT GASTR, V5, P40, DOI 10.1038/ncpgasthep1029; McFarland LV, 2007, CLIN INFECT DIS, V45, P1141, DOI 10.1086/522187; Miller MA, 2002, INFECT CONT HOSP EP, V23, P137, DOI 10.1086/502023; O'Connor JR, 2009, GASTROENTEROLOGY, V136, P1913, DOI 10.1053/j.gastro.2009.02.073; Oake N, 2010, ARCH INTERN MED, V170, P1804, DOI 10.1001/archinternmed.2010.405; Owens RC, 2008, CLIN INFECT DIS, V46, pS19, DOI 10.1086/521859; Pakyz AL, 2014, J ANTIMICROB CHEMOTH, V69, P1127, DOI 10.1093/jac/dkt489; Pepin J, 2005, CLIN INFECT DIS, V41, P1254, DOI 10.1086/496986; PIERCE PF, 1982, J INFECT DIS, V145, P269, DOI 10.1093/infdis/145.2.269; Pohl JF, 2012, CURR OPIN PEDIATR, V24, P627, DOI 10.1097/MOP.0b013e328355a3e1; Rashid S, 2012, ISRN GASTROENTEROL; Shah S, 2000, QJM-MON J ASSOC PHYS, V93, P175, DOI 10.1093/qjmed/93.3.175; Surawicz CM, 2013, GUIDELINES DIAGNOSIS; UpToDate, ANT C DIFF PPI; Warmy M, 2005, LANCET, V366, P9491; Yearsley KA, 2006, ALIMENT PHARM THER, V24, P613, DOI 10.1111/j.1365-2036.2006.03015.x	31	38	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110790	10.1371/journal.pone.0110790	http://dx.doi.org/10.1371/journal.pone.0110790			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343667	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943500055
J	Yisireyili, M; Saito, S; Abudureyimu, S; Adelibieke, Y; Ng, HY; Nishijima, F; Takeshita, K; Murohara, T; Niwa, T				Yisireyili, Maimaiti; Saito, Shinichi; Abudureyimu, Shaniya; Adelibieke, Yelixiati; Ng, Hwee-Yeong; Nishijima, Fuyuhiko; Takeshita, Kyosuke; Murohara, Toyoaki; Niwa, Toshimitsu			Indoxyl Sulfate-Induced Activation of (Pro)renin Receptor Promotes Cell Proliferation and Tissue Factor Expression in Vascular Smooth Muscle Cells	PLOS ONE			English	Article							NF-KAPPA-B; OSTEOBLAST-SPECIFIC PROTEINS; REGULATES RENAL EXPRESSION; FIBROTIC GENE-EXPRESSION; OXIDATIVE STRESS; PRORENIN RECEPTOR; UP-REGULATION; UREMIC SERUM; ANGIOTENSIN; SENESCENCE	Chronic kidney disease (CKD) is associated with an increased risk of cardiovascular disease (CVD). (Pro) renin receptor (PRR) is activated in the kidney of CKD. The present study aimed to determine the role of indoxyl sulfate (IS), a uremic toxin, in PRR activation in rat aorta and human aortic smooth muscle cells (HASMCs). We examined the expression of PRR and renin/prorenin in rat aorta using immunohistochemistry. Both CKD rats and IS-administrated rats showed elevated expression of PRR and renin/prorenin in aorta compared with normal rats. IS upregulated the expression of PRR and prorenin in HASMCs. N-acetylcysteine, an antioxidant, and diphenyleneiodonium, an inhibitor of nicotinamide adenine dinucleotide phosphate oxidase, suppressed IS-induced expression of PRR and prorenin in HASMCs. Knock down of organic anion transporter 3 (OAT3), aryl hydrocarbon receptor (AhR) and nuclear factor-kappa B p65 (NF-kappa B p65) with small interfering RNAs inhibited IS-induced expression of PRR and prorenin in HASMCs. Knock down of PRR inhibited cell proliferation and tissue factor expression induced by not only prorenin but also IS in HASMCs. Conclusion: IS stimulates aortic expression of PRR and renin/prorenin through OAT3-mediated uptake, production of reactive oxygen species, and activation of AhR and NF-kappa B p65 in vascular smooth muscle cells. IS-induced activation of PRR promotes cell proliferation and tissue factor expression in vascular smooth muscle cells.	[Yisireyili, Maimaiti; Saito, Shinichi; Abudureyimu, Shaniya; Adelibieke, Yelixiati; Niwa, Toshimitsu] Nagoya Univ, Grad Sch Med, Dept Adv Med Uremia, Nagoya, Aichi 4648601, Japan; [Nishijima, Fuyuhiko] Kureha Co, Biomed Res Labs, Tokyo, Japan; [Yisireyili, Maimaiti; Takeshita, Kyosuke; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan; [Ng, Hwee-Yeong] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan; [Ng, Hwee-Yeong] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Niwa, Toshimitsu] Shubun Univ, Fac Hlth & Nutr, Aichi, Japan	Nagoya University; Nagoya University; Chang Gung Memorial Hospital; Chang Gung University	Niwa, T (corresponding author), Nagoya Univ, Grad Sch Med, Dept Adv Med Uremia, Nagoya, Aichi 4648601, Japan.	tniwa@med.nagoya.u-ac.jp	Takeshita, Kyosuke/AAD-9515-2020; Murohara, Toyoaki/M-4958-2014; Takeshita, Kyosuke/B-7008-2012	Takeshita, Kyosuke/0000-0002-8283-3799; Takeshita, Kyosuke/0000-0002-8283-3799	Aichi Kidney Foundation; Kureha Corporation, Japan	Aichi Kidney Foundation; Kureha Corporation, Japan	This work was supported by the research grant from Aichi Kidney Foundation, and a grant from Kureha Corporation, Japan. The funder provided support in the form of salaries for FN, but did not have additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of these authors are articulated in the 'author contributions' section.	Adelibieke Y, 2013, CIRC J, V77, P1326, DOI 10.1253/circj.CJ-12-0884; Adijiang A, 2008, NEPHROL DIAL TRANSPL, V23, P1892, DOI 10.1093/ndt/gfm861; Adijiang A, 2011, J RENAL NUTR, V21, P105, DOI 10.1053/j.jrn.2010.10.020; Barreto FC, 2009, CLIN J AM SOC NEPHRO, V4, P1551, DOI 10.2215/CJN.03980609; Batenburg WW, 2011, HYPERTENSION, V58, P1111, DOI 10.1161/HYPERTENSIONAHA.111.180737; Bolati D, 2012, J RENAL NUTR, V22, P176, DOI 10.1053/j.jrn.2011.10.015; Chitalia VC, 2013, CIRCULATION, V127, P365, DOI 10.1161/CIRCULATIONAHA.112.118174; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; Enomoto A, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000022017.96399.B2; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Gondouin B, 2013, KIDNEY INT, V84, P733, DOI 10.1038/ki.2013.133; Greco CM, 2012, CARDIOVASC RES, V95, P366, DOI 10.1093/cvr/cvs204; HILGERS KF, 1993, HYPERTENSION, V21, P1030, DOI 10.1161/01.HYP.21.6.1030; Huang Y, 2006, KIDNEY INT, V69, P105, DOI 10.1038/sj.ki.5000011; INAGAMI T, 1991, BLOOD VESSELS, V28, P217; KATO H, 1993, HYPERTENSION, V21, P446, DOI 10.1161/01.HYP.21.4.446; Kinouchi K, 2010, CIRC RES, V107, P30, DOI 10.1161/CIRCRESAHA.110.224667; Lekawanvijit S, 2012, CIRC RES, V111, P1470, DOI 10.1161/CIRCRESAHA.112.278457; Liu G, 2011, J HYPERTENS, V29, P696, DOI 10.1097/HJH.0b013e328343c62b; Miyazaki T, 1997, KIDNEY INT, V52, pS15; Muller DN, 1998, BASIC RES CARDIOL, V93, P7; Muteliefu G, 2009, J RENAL NUTR, V19, P29, DOI 10.1053/j.jrn.2008.10.014; Muteliefu G, 2012, AM J PHYSIOL-CELL PH, V303, pC126, DOI 10.1152/ajpcell.00329.2011; Muteliefu G, 2009, NEPHROL DIAL TRANSPL, V24, P2051, DOI 10.1093/ndt/gfn757; Nguyen G, 2010, J AM SOC NEPHROL, V21, P18, DOI 10.1681/ASN.2009030300; Niwa T, 1997, KIDNEY INT, V52, pS23; NIWA T, 1988, CLIN CHEM, V34, P2264; NIWA T, 1994, J LAB CLIN MED, V124, P96; Niwa T, 2011, THER APHER DIAL, V15, P120, DOI 10.1111/j.1744-9987.2010.00882.x; Niwa T, 2010, J RENAL NUTR, V20, pS2, DOI 10.1053/j.jrn.2010.05.002; Oshima Y, 2011, J AM SOC NEPHROL, V22, P2203, DOI 10.1681/ASN.2011020202; Riediger F, 2011, J AM SOC NEPHROL, V22, P2193, DOI 10.1681/ASN.2011020200; Saito S, 2014, ENDOCRINOLOGY; Sakoda M, 2007, HYPERTENS RES, V30, P1139, DOI 10.1291/hypres.30.1139; Sallee M, 2014, TOXINS, V6, P934, DOI 10.3390/toxins6030934; Schroeder JC, 2010, BIOCHEMISTRY-US, V49, P393, DOI 10.1021/bi901786x; Shimizu H, 2013, LIFE SCI, V92, P143, DOI 10.1016/j.lfs.2012.11.012; Shimizu H, 2012, AM J NEPHROL, V36, P184, DOI 10.1159/000341515; Shimizu H, 2012, LIFE SCI, V90, P525, DOI 10.1016/j.lfs.2012.01.013; Shimizu H, 2011, AM J PHYSIOL-CELL PH, V301, pC1201, DOI 10.1152/ajpcell.00471.2010; Shimizu H, 2010, AM J PHYSIOL-CELL PH, V299, pC1110, DOI 10.1152/ajpcell.00217.2010; Siragy HM, 2008, EXP PHYSIOL, V93, P709, DOI 10.1113/expphysiol.2007.040550; TAKII Y, 1985, HYPERTENSION, V7, P236, DOI 10.1161/01.HYP.7.2.236; Tumur Z, 2010, AM J NEPHROL, V31, P435, DOI 10.1159/000299798; Watanabe I, 2013, CIRC J, V77, P224, DOI 10.1253/circj.CJ-12-0647; Yamamoto H, 2006, KIDNEY INT, V69, P1780, DOI 10.1038/sj.ki.5000340; Yisireyili M, 2013, LIFE SCI, V92, P1180, DOI 10.1016/j.lfs.2013.05.008	47	39	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e109268	10.1371/journal.pone.0109268	http://dx.doi.org/10.1371/journal.pone.0109268			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343458	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943500010
J	Marstaller, L; Burianova, H; Sowman, PF				Marstaller, Lars; Burianova, Hana; Sowman, Paul F.			High Gamma Oscillations in Medial Temporal Lobe during Overt Production of Speech and Gestures	PLOS ONE			English	Article							WORKING-MEMORY; BAND SYNCHRONIZATION; RECOGNITION MEMORY; EPISODIC MEMORY; VERB GENERATION; THETA; SYSTEMS; HIPPOCAMPAL; RETRIEVAL; DYNAMICS	The study of the production of co-speech gestures (CSGs), i.e., meaningful hand movements that often accompany speech during everyday discourse, provides an important opportunity to investigate the integration of language, action, and memory because of the semantic overlap between gesture movements and speech content. Behavioral studies of CSGs and speech suggest that they have a common base in memory and predict that overt production of both speech and CSGs would be preceded by neural activity related to memory processes. However, to date the neural correlates and timing of CSG production are still largely unknown. In the current study, we addressed these questions with magnetoencephalography and a semantic association paradigm in which participants overtly produced speech or gesture responses that were either meaningfully related to a stimulus or not. Using spectral and beamforming analyses to investigate the neural activity preceding the responses, we found a desynchronization in the beta band (15-25 Hz), which originated 900 ms prior to the onset of speech and was localized to motor and somatosensory regions in the cortex and cerebellum, as well as right inferior frontal gyrus. Beta desynchronization is often seen as an indicator of motor processing and thus reflects motor activity related to the hand movements that gestures add to speech. Furthermore, our results show oscillations in the high gamma band (50-90 Hz), which originated 400 ms prior to speech onset and were localized to the left medial temporal lobe. High gamma oscillations have previously been found to be involved in memory processes and we thus interpret them to be related to contextual association of semantic information in memory. The results of our study show that high gamma oscillations in medial temporal cortex play an important role in the binding of information in human memory during speech and CSG production.	[Marstaller, Lars; Burianova, Hana] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia; [Marstaller, Lars] Univ Queensland, ARC Sci Learning Res Ctr, Brisbane, Qld, Australia; [Burianova, Hana; Sowman, Paul F.] Macquarie Univ, ARC Ctr Excellence Cognit & Disorders, Sydney, NSW 2109, Australia; [Sowman, Paul F.] Macquarie Univ, Dept Cognit Sci, Sydney, NSW 2109, Australia	University of Queensland; University of Queensland; Macquarie University; Macquarie University	Marstaller, L (corresponding author), Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia.	l.marstaller@uq.edu.au	Sowman, Paul/H-3352-2019; Marstaller, Lars/F-8434-2014	Sowman, Paul/0000-0002-3863-6675; Marstaller, Lars/0000-0003-2814-5474; Burianova, Hana/0000-0003-2051-9494	international Macquarie University research scholarship	international Macquarie University research scholarship	LM was supported by an international Macquarie University research scholarship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminoff EM, 2013, TRENDS COGN SCI, V17, P379, DOI 10.1016/j.tics.2013.06.009; Axmacher N, 2007, J NEUROSCI, V27, P7807, DOI 10.1523/JNEUROSCI.0962-07.2007; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; Burianova H, 2007, J COGNITIVE NEUROSCI, V19, P1520, DOI 10.1162/jocn.2007.19.9.1520; Burke JF, 2013, J NEUROSCI, V33, P292, DOI 10.1523/JNEUROSCI.2057-12.2013; Cheyne DO, 2013, EXP NEUROL, V245, P27, DOI 10.1016/j.expneurol.2012.08.030; de Ruiter J.P., 2000, LANGUAGE GESTURE, P284, DOI DOI 10.1017/CBO9780511620850.018; Dipoppa M, 2013, P NATL ACAD SCI USA, V110, P12828, DOI 10.1073/pnas.1303270110; Doesburg SM, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00195; Duzel E, 2003, J NEUROSCI, V23, P9439; Edwards E, 2010, NEUROIMAGE, V50, P291, DOI 10.1016/j.neuroimage.2009.12.035; Goldin-Meadow S, 2001, PSYCHOL SCI, V12, P516, DOI 10.1111/1467-9280.00395; Henke K, 1999, P NATL ACAD SCI USA, V96, P5884, DOI 10.1073/pnas.96.10.5884; Herrmann CS, 2004, TRENDS COGN SCI, V8, P347, DOI 10.1016/j.tics.2004.06.006; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; Jeneson A, 2012, LEARN MEMORY, V19, P15, DOI 10.1101/lm.024018.111; Jensen O, 2006, NEUROSCIENCE, V139, P237, DOI 10.1016/j.neuroscience.2005.06.004; Kado H, 1999, IEEE T APPL SUPERCON, V9, P4057, DOI 10.1109/77.783918; Kendon A., 2004, GESTURE VISIBLE ACTI, DOI DOI 10.1017/CBO9780511807572; Kita S, 2003, J MEM LANG, V48, P16, DOI 10.1016/S0749-596X(02)00505-3; Korzeniewska A, 2011, NEUROIMAGE, V56, P2218, DOI 10.1016/j.neuroimage.2011.03.030; Kroes MCW, 2012, NEUROSCI BIOBEHAV R, V36, P1646, DOI 10.1016/j.neubiorev.2012.02.014; Lundqvist M, 2011, J COGNITIVE NEUROSCI, V23, P3008, DOI 10.1162/jocn_a_00029; Manto M, 2012, CEREBELLUM, V11, P457, DOI 10.1007/s12311-011-0331-9; Marstaller L, 2013, PSYCHON B REV, V20, P496, DOI 10.3758/s13423-012-0365-0; Martin T, 2007, INT J PSYCHOPHYSIOL, V64, P247, DOI 10.1016/j.ijpsycho.2006.09.010; McNeill D., 1992, HAND MIND WHAT GESTU; Mellem MS, 2013, BRAIN LANG, V127, P440, DOI 10.1016/j.bandl.2013.09.003; Muthukumaraswamy SD, 2013, FRONTIERS HUMAN NEUR, V7; Nee DE, 2007, NEUROIMAGE, V38, P740, DOI 10.1016/j.neuroimage.2007.07.066; Nee DE, 2011, NEUROIMAGE, V54, P1540, DOI 10.1016/j.neuroimage.2010.09.002; Nieuwenhuis ILC, 2012, CEREB CORTEX, V22, P2622, DOI 10.1093/cercor/bhr338; Nyhus E, 2010, NEUROSCI BIOBEHAV R, V34, P1023, DOI 10.1016/j.neubiorev.2009.12.014; Olson IR, 2006, J NEUROSCI, V26, P4596, DOI 10.1523/JNEUROSCI.1923-05.2006; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Osipova D, 2006, J NEUROSCI, V26, P7523, DOI 10.1523/JNEUROSCI.1948-06.2006; Oztekin I, 2009, J COGNITIVE NEUROSCI, V21, P1967, DOI 10.1162/jocn.2008.21146; Palva S, 2011, J NEUROSCI, V31, P5013, DOI 10.1523/JNEUROSCI.5592-10.2011; Pang EW, 2011, NEUROSCI LETT, V490, P215, DOI 10.1016/j.neulet.2010.12.055; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Roy M, 2012, TRENDS COGN SCI, V16, P147, DOI 10.1016/j.tics.2012.01.005; Sakai K, 2004, CEREB CORTEX, V14, P914, DOI 10.1093/cercor/bhh050; Salmelin R, 1995, NEUROIMAGE, V2, P237, DOI 10.1006/nimg.1995.1031; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Segal JB, 2003, NEUROLOGY, V61, P252, DOI 10.1212/01.WNL.0000073145.08816.E2; Serruya MD, 2012, CEREB CORTEX; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Uehara G, 2003, IEICE T ELECTRON, VE86C, P43; Uhlhaas PJ, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.017.2009; Ullman MT, 2004, COGNITION, V92, P231, DOI 10.1016/j.cognition.2003.10.008; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Watson HC, 2013, J NEUROSCI, V33, P4192, DOI 10.1523/JNEUROSCI.2075-12.2013; Whitney C, 2011, CEREB CORTEX, V21, P1066, DOI 10.1093/cercor/bhq180; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Zion-Golumbic E, 2010, J COGNITIVE NEUROSCI, V22, P263, DOI 10.1162/jocn.2009.21251	57	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111473	10.1371/journal.pone.0111473	http://dx.doi.org/10.1371/journal.pone.0111473			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340347	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000343662800109
J	Rajkumar, P; Aisenberg, WH; Acres, OW; Protzko, RJ; Pluznick, JL				Rajkumar, Premraj; Aisenberg, William H.; Acres, Omar W.; Protzko, Ryan J.; Pluznick, Jennifer L.			Identification and Characterization of Novel Renal Sensory Receptors	PLOS ONE			English	Article							MAMMALIAN ODORANT RECEPTORS; PROTEIN-COUPLED RECEPTORS; BLOOD-PRESSURE REGULATION; BITTER TASTE RECEPTORS; OLFACTORY RECEPTOR; FUNCTIONAL EXPRESSION; GENE-EXPRESSION; GUT MICROBIOTA; EPITHELIAL-CELLS; VALPROIC ACID	Recent studies have highlighted the important roles that "sensory'' receptors (olfactory receptors, taste receptors, and orphan "GPR'' receptors) play in a variety of tissues, including the kidney. Although several studies have identified important roles that individual sensory receptors play in the kidney, there has not been a systematic analysis of the renal repertoire of sensory receptors. In this study, we identify novel renal sensory receptors belonging to the GPR (n = 76), olfactory receptor (n = 6), and taste receptor (n = 11) gene families. A variety of reverse transcriptase (RT)-PCR screening strategies were used to identify novel renal sensory receptors, which were subsequently confirmed using gene-specific primers. The tissue-specific distribution of these receptors was determined, and the novel renal ORs were cloned from whole mouse kidney. Renal ORs that trafficked properly in vitro were screened for potential ligands using a dual-luciferase ligand screen, and novel ligands were identified for Olfr691. These studies demonstrate that multiple sensory receptors are expressed in the kidney beyond those previously identified. These results greatly expand the known repertoire of renal sensory receptors. Importantly, the mRNA of many of the receptors identified in this study are expressed highly in the kidney (comparable to well-known and extensively studied renal GPCRs), and in future studies it will be important to elucidate the roles that these novel renal receptors play in renal physiology.	[Rajkumar, Premraj; Aisenberg, William H.; Acres, Omar W.; Protzko, Ryan J.; Pluznick, Jennifer L.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University	Pluznick, JL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.	jpluznick@jhmi.edu		Aisenberg, William/0000-0002-8715-1439	NIH [DK081610]; National Kidney Foundation, Maryland; Open Access Promotion Fund of the Johns Hopkins University Libraries; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK081610, R00DK081610] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Kidney Foundation, Maryland; Open Access Promotion Fund of the Johns Hopkins University Libraries; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by funding from the NIH (DK081610 to J.L.P.) and the minigrant from the National Kidney Foundation, Maryland (to P.R.). Publication of this article was funded in part by the Open Access Promotion Fund of the Johns Hopkins University Libraries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaffy T, 2006, J NEUROCHEM, V97, P1506, DOI 10.1111/j.1471-4159.2006.03859.x; ARTHUR K, 1995, J CHROMATOGR B, V673, P132, DOI 10.1016/0378-4347(95)00255-H; Bezencon C, 2007, CHEM SENSES, V32, P41, DOI 10.1093/chemse/bjl034; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Dang YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089835; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Dyer J, 2005, BIOCHEM SOC T, V33, P302, DOI 10.1042/BST0330302; Elliott RA, 2011, J UROLOGY, V186, P2455, DOI 10.1016/j.juro.2011.07.083; Endo A, 2010, PEDIATR NEUROL, V42, P287, DOI 10.1016/j.pediatrneurol.2009.12.003; Feldmesser E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-121; Foster SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064579; Fukuda N, 2004, J CELL SCI, V117, P5835, DOI 10.1242/jcs.01507; Godfrey PA, 2004, P NATL ACAD SCI USA, V101, P2156, DOI 10.1073/pnas.0308051100; Griffin CA, 2009, DEV CELL, V17, P649, DOI 10.1016/j.devcel.2009.09.004; Haddad R, 2008, NAT METHODS, V5, P425, DOI [10.1038/nmeth.1197, 10.1038/NMETH.1197]; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; HECK GL, 1984, SCIENCE, V223, P403, DOI 10.1126/science.6691151; Hofmeister MV, 2012, AM J PHYSIOL-RENAL, V302, pF358, DOI 10.1152/ajprenal.00343.2011; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Huling JC, 2012, AM J PHYSIOL-RENAL, V302, pF401, DOI 10.1152/ajprenal.00457.2011; Hummler E, 1999, J STEROID BIOCHEM, V69, P385, DOI 10.1016/S0960-0760(99)00073-4; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; Kajiya K, 2001, J NEUROSCI, V21, P6018, DOI 10.1523/JNEUROSCI.21-16-06018.2001; Kimura I, 2011, P NATL ACAD SCI USA, V108, P8030, DOI 10.1073/pnas.1016088108; Knorr M, 2004, EPILEPSIA, V45, P868, DOI 10.1111/j.0013-9580.2004.05504.x; Lu M, 2003, TRAFFIC, V4, P416, DOI 10.1034/j.1600-0854.2003.00097.x; Ma MH, 2000, P NATL ACAD SCI USA, V97, P12869, DOI 10.1073/pnas.220301797; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; Nara K, 2011, J NEUROSCI, V31, P9179, DOI 10.1523/JNEUROSCI.1282-11.2011; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Otaki JM, 2004, J NEUROBIOL, V58, P315, DOI 10.1002/neu.10272; Pluznick JL, 2014, CURR OPIN NEPHROL HY, V23, P507, DOI 10.1097/MNH.0000000000000048; Pluznick JL, 2013, AM J PHYSIOL-RENAL, V305, pF439, DOI 10.1152/ajprenal.00252.2013; Pluznick JL, 2013, P NATL ACAD SCI USA, V110, P4410, DOI 10.1073/pnas.1215927110; Pluznick JL, 2012, CURR OPIN NEPHROL HY, V21, P404, DOI 10.1097/MNH.0b013e328354a6bd; Pluznick JL, 2009, P NATL ACAD SCI USA, V106, P2059, DOI 10.1073/pnas.0812859106; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Shepard BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068758; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Toda Y, 2013, J BIOL CHEM, V288, P36863, DOI 10.1074/jbc.M113.494443; Vargas SL, 2009, J AM SOC NEPHROL, V20, P1002, DOI 10.1681/ASN.2008070740; Wang J, 2012, J AM SOC NEPHROL, V23, P281, DOI 10.1681/ASN.2011040351; Wu SV, 2002, P NATL ACAD SCI USA, V99, P2392, DOI 10.1073/pnas.042617699; Zhang XH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r86; Zhang XM, 2004, P NATL ACAD SCI USA, V101, P14168, DOI 10.1073/pnas.0405350101; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4; Zhuang H, 2008, NAT PROTOC, V3, P1402, DOI 10.1038/nprot.2008.120; Zhuang HY, 2007, J BIOL CHEM, V282, P15284, DOI 10.1074/jbc.M700386200	52	41	45	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111053	10.1371/journal.pone.0111053	http://dx.doi.org/10.1371/journal.pone.0111053			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340336	gold, Green Published, Green Submitted			2022-12-27	WOS:000343662800082
J	Sarfo, FS; Sarfo, MA; Norman, B; Phillips, R; Bedu-Addo, G; Chadwick, D				Sarfo, Fred Stephen; Sarfo, Maame Anima; Norman, Betty; Phillips, Richard; Bedu-Addo, George; Chadwick, David			Risk of Deaths, AIDS-Defining and Non-AIDS Defining Events among Ghanaians on Long-Term Combination Antiretroviral Therapy	PLOS ONE			English	Article							RECONSTITUTION INFLAMMATORY SYNDROME; HIV-INFECTED ADULTS; CD4 CELL COUNTS; IMMUNE RECONSTITUTION; HIV-1-INFECTED PATIENTS; RENAL DYSFUNCTION; TREATMENT PROGRAM; LOW-INCOME; DISEASE; INDIVIDUALS	Combination antiretroviral therapy (cART) has been widely available in Ghana since 2004. The aim of this cohort study was to assess the incidences of death, AIDS-defining events and non-AIDS defining events and associated risk factors amongst patients initiating cART in a large treatment centre. Clinical and laboratory data were extracted from clinic and hospital case notes for patients initiating cART between 2004 and 2010 and clinical events graded according to recognised definitions for AIDS, non-AIDS events (NADE) and death, with additional events not included in such definitions such as malaria also included. The cumulative incidence of events was calculated using Kaplan Meier analysis, and association of risk factors with events by Cox proportional hazards regression. Data were closed for analysis on 31st December, 2011 after a median follow-up of 30 months (range, 0-90 months). Amongst 4,039 patients starting cART at a median CD4 count of 133 cells/mm(3), there were 324 (8%) confirmed deaths, with an event rate of 28.83 (95% CI 25.78-32.15) deaths per 1000-person follow-up years; the commonest established causes were pulmonary TB and gastroenteritis. There were 681 AIDS-defining events (60.60 [56.14-65.33] per 1000 person years) with pulmonary TB and chronic diarrhoea being the most frequent causes. Forty-one NADEs were recorded (3.64 [2.61-4.95] per 1000 person years), of which hepatic and cardiovascular events were most common. Other common events recorded outside these definitions included malaria (746 events) and respiratory tract infections (666 events). Overall 24% of patients were lost-to-follow-up. Alongside expected risk factors, stavudine use was associated with AIDS [adjusted HR of 1.08 (0.90-1.30)] and death (adjusted HR of 1.60 [1.21-2.11]). Whilst frequency of AIDS and deaths in this cohort were similar to those described in other sub-Saharan African cohorts, rates of NADEs were lower and far exceeded by events such as malaria and respiratory tract infections.	[Sarfo, Fred Stephen; Sarfo, Maame Anima; Norman, Betty; Phillips, Richard; Bedu-Addo, George] Komfo Anokye Teaching Hosp, Kumasi, Ghana; [Sarfo, Fred Stephen; Phillips, Richard; Bedu-Addo, George] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana; [Chadwick, David] James Cook Univ Hosp, Middlesbrough, Cleveland, England	Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology; James Cook University Hospital	Sarfo, FS (corresponding author), Komfo Anokye Teaching Hosp, Kumasi, Ghana.	stephensarfo78@gmail.com	Phillips, Richard Odame/ABD-5394-2021	Phillips, Richard Odame/0000-0001-8992-0222	HIV Research Trust, UK; Medical Research Council [MR/J01477X/1] Funding Source: researchfish; MRC [MR/J01477X/1] Funding Source: UKRI	HIV Research Trust, UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for setting up the database was provided by the HIV Research Trust, UK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akileswaran C, 2005, CLIN INFECT DIS, V41, P376, DOI 10.1086/431482; [Anonymous], 1992, MMWR RECOMM REP, V41, P1; Belloso WH, 2010, HIV MED, V11, P554, DOI 10.1111/j.1468-1293.2010.00824.x; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Calza L, 2010, AIDS, V24, P789, DOI 10.1097/QAD.0b013e328337afdf; Charalambous S, 2007, AIDS, V21, pS73, DOI 10.1097/01.aids.0000279696.63438.aa; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Cooney EL, 2002, CLIN INFECT DIS, V34, P224, DOI 10.1086/323898; Crum-Cianflone N, 2009, AIDS, V23, P41, DOI 10.1097/QAD.0b013e328317cc2d; Currier JS, 2002, JAIDS-J ACQ IMM DEF, V31, pS16, DOI 10.1097/00126334-200209011-00004; Dai Y, 2006, CHINESE MED J-PEKING, V119, P1677, DOI 10.1097/00029330-200610020-00002; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Desclaux A, 2003, AIDS, V17, pS95, DOI 10.1097/00002030-200317003-00013; *DIV AIDS, 2004, DIV AIDS TABL GRAD S; Division of AIDS NIAID, 1994, DIV AIDS TABL GRAD S; Erhabor O, 2006, Niger J Clin Pract, V9, P128; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; French MA, 2004, AIDS, V18, P1615, DOI 10.1097/01.aids.0000131375.21070.06; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Gras L, 2007, JAIDS-J ACQ IMM DEF, V45, P183, DOI 10.1097/QAI.0b013e31804d685b; Hawkins C, 2007, JAIDS-J ACQ IMM DEF, V45, P304; Kilaru KR, 2006, HIV MED, V7, P99, DOI 10.1111/j.1468-1293.2006.00347.x; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lau B, 2006, ARCH INTERN MED, V166, P64, DOI 10.1001/archinte.166.1.64; Laurent C, 2005, JAIDS-J ACQ IMM DEF, V38, P14, DOI 10.1097/00126334-200501010-00003; Lawden C, 2007, J ACQ IMMUN DEF SYND, V44, P262; Lawn SD, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-59; Marins JRP, 2003, AIDS, V17, P1675, DOI 10.1097/00002030-200307250-00012; Mocroft A, 2007, LANCET, V370, P407, DOI 10.1016/S0140-6736(07)60948-9; Mocroft A, 2010, JAIDS-J ACQ IMM DEF, V55, P262, DOI 10.1097/QAI.0b013e3181e9be6b; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Muller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8; Nash D, 2008, AIDS, V22, P2291, DOI 10.1097/QAD.0b013e3283121ca9; Neuhaus J, 2010, AIDS, V24, P697, DOI 10.1097/QAD.0b013e3283365356; Novak RM, 2012, AIDS, V26, P721, DOI 10.1097/QAD.0b013e3283511e91; Obel N, 2007, CLIN INFECT DIS, V44, P1625, DOI 10.1086/518285; Phillips AN, 2008, AIDS, V22, P2409, DOI 10.1097/QAD.0b013e3283174636; Ratnam I, 2006, CLIN INFECT DIS, V42, P418, DOI 10.1086/499356; Reid A, 2008, CLIN INFECT DIS, V46, P1271, DOI 10.1086/533468; Sarfo FS, 2014, J ANTIMICROB CHEMOTH, V69, P254, DOI 10.1093/jac/dkt336; Sarfo FS, 2013, J INFECTION, V67, P43, DOI 10.1016/j.jinf.2013.03.008; Severe P, 2005, NEW ENGL J MED, V353, P2325, DOI 10.1056/NEJMoa051908; Shelburne SA, 2002, MEDICINE, V81, P213, DOI 10.1097/00005792-200205000-00005; Smith CJ, 2004, J INFECT DIS, V190, P1860, DOI 10.1086/425075; Sow PS, 2007, JAIDS-J ACQ IMM DEF, V44, P262, DOI 10.1097/QAI.0b013e31802bf109; Srasuebkul P, 2007, HIV MED, V8, P46, DOI 10.1111/j.1468-1293.2007.00427.x; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Torriani FJ, 2008, J AM COLL CARDIOL, V52, P569, DOI 10.1016/j.jacc.2008.04.049; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Tuboi SH, 2005, JAIDS-J ACQ IMM DEF, V40, P324, DOI 10.1097/01.qai.0000182627.28595.01; Wester CW, 2011, AIDS, V25, P1471, DOI 10.1097/QAD.0b013e328347f9d4; Wester CW, 2005, JAIDS-J ACQ IMM DEF, V40, P336, DOI 10.1097/01.qai.0000159668.80207.5b; WHO, 2010, ANT THER HIV INF AD; Wolbers M, 2007, ANTIVIR THER, V12, P889	54	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111400	10.1371/journal.pone.0111400	http://dx.doi.org/10.1371/journal.pone.0111400			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340766	Green Submitted, Green Published, gold			2022-12-27	WOS:000343662800106
J	Alperstein, A; Ulrich, B; Garofalo, DM; Dreisbach, R; Raff, H; Sheppard, K				Alperstein, Ariel; Ulrich, Brittany; Garofalo, Denise M.; Dreisbach, Ruth; Raff, Hannah; Sheppard, Kelly			The Predatory Bacterium Bdellovibrio bacteriovorus Aspartyl-tRNA Synthetase Recognizes tRNA(Asn) as a Substrate	PLOS ONE			English	Article							AMINO-ACID BIOSYNTHESIS; THERMUS-THERMOPHILUS; ASPARAGINE FORMATION; ESCHERICHIA-COLI; ASP-TRNA(ASN) AMIDOTRANSFERASE; HELICOBACTER-PYLORI; CRYSTAL-STRUCTURE; LIFE-CYCLE; GLU-TRNA(GLN); TRANSAMIDATION	The predatory bacterium Bdellovibrio bacteriovorus preys on other Gram-negative bacteria and was predicted to be an asparagine auxotroph. However, despite encoding asparaginyl-tRNA synthetase and glutaminyl-tRNA synthetase, B. bacteriovorus also contains the amidotransferase GatCAB. Deinococcus radiodurans, and Thermus thermophilus also encode both of these aminoacyl-tRNA synthetases with GatCAB. Both also code for a second aspartyl-tRNA synthetase and use the additional aspartyl-tRNA synthetase with GatCAB to synthesize asparagine on tRNA(Asn). Unlike those two bacteria, B. bacteriovorus encodes only one aspartyl-tRNA synthetase. Here we demonstrate the lone B. bacteriovorus aspartyl-tRNA synthetase catalyzes aspartyl-tRNA(Asn) formation that GatCAB can then amidate to asparaginyl-tRNA(Asn). This nondiscriminating aspartyl-tRNA synthetase with GatCAB thus provides B. bacteriovorus a second route for Asn-tRNA(Asn) formation with the asparagine synthesized in a tRNA-dependent manner. Thus, in contrast to a previous prediction, B. bacteriovorus codes for a biosynthetic route for asparagine. Analysis of bacterial genomes suggests a significant number of other bacteria may also code for both routes for Asn-tRNA(Asn) synthesis with only a limited number encoding a second aspartyl-tRNA synthetase.	[Alperstein, Ariel; Ulrich, Brittany; Garofalo, Denise M.; Dreisbach, Ruth; Raff, Hannah; Sheppard, Kelly] Skidmore Coll, Dept Chem, Saratoga Springs, NY 12866 USA	Skidmore College	Sheppard, K (corresponding author), Skidmore Coll, Dept Chem, Saratoga Springs, NY 12866 USA.	ksheppar@skidmore.edu			National Science Foundation [MCB-1244326]; Skidmore Faculty/Student Summer Research Program; Direct For Biological Sciences [1244326] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Skidmore Faculty/Student Summer Research Program; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation (MCB-1244326 to KS, www.nsf.gov) and the Skidmore Faculty/Student Summer Research Program (to AA, DG, BU, and KS, http://www.skidmore.edu/dof-vpaa/summer-research/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aklujkar M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-109; Atterbury RJ, 2011, APPL ENVIRON MICROB, V77, P5794, DOI 10.1128/AEM.00426-11; Bailly M, 2006, NUCLEIC ACIDS RES, V34, P6083, DOI 10.1093/nar/gkl622; Becker HD, 2000, BIOCHEMISTRY-US, V39, P3216, DOI 10.1021/bi992573y; Becker HD, 1997, BIOCHEMISTRY-US, V36, P8785, DOI 10.1021/bi970392v; Becker HD, 2000, FEBS LETT, V476, P140, DOI 10.1016/S0014-5793(00)01697-5; Becker HD, 1998, P NATL ACAD SCI USA, V95, P12832, DOI 10.1073/pnas.95.22.12832; Blaise M, 2010, EMBO J, V29, P3118, DOI 10.1038/emboj.2010.192; Bullock TL, 2003, J MOL BIOL, V328, P395, DOI 10.1016/S0022-2836(03)00305-X; Cathopoulis T, 2007, MOL BIOSYST, V3, P408, DOI 10.1039/b618899k; Cathopoulis TJT, 2008, BIOCHEMISTRY-US, V47, P7610, DOI 10.1021/bi800369q; Charriere F, 2009, J BIOL CHEM, V284, P16210, DOI 10.1074/jbc.M109.005348; Chuawong P, 2006, BIOCHEMISTRY-US, V45, P8079, DOI 10.1021/bi060189c; Curnow AW, 1996, NATURE, V382, P589, DOI 10.1038/382589b0; Curnow AW, 1998, P NATL ACAD SCI USA, V95, P12838, DOI 10.1073/pnas.95.22.12838; Curnow AW, 1997, P NATL ACAD SCI USA, V94, P11819, DOI 10.1073/pnas.94.22.11819; Dashiff A, 2011, J APPL MICROBIOL, V110, P431, DOI 10.1111/j.1365-2672.2010.04900.x; DELARUE M, 1994, EMBO J, V13, P3219, DOI 10.1002/j.1460-2075.1994.tb06623.x; Dwidar M, 2012, BMB REP, V45, P71, DOI 10.5483/BMBRep.2012.45.2.71; FELTON J, 1980, J BACTERIOL, V142, P221, DOI 10.1128/JB.142.1.221-228.1980; Feng L, 2005, J BIOL CHEM, V280, P8150, DOI 10.1074/jbc.M411098200; Goldman BS, 2006, P NATL ACAD SCI USA, V103, P15200, DOI 10.1073/pnas.0607335103; Karlin S, 2006, P NATL ACAD SCI USA, V103, P11352, DOI 10.1073/pnas.0604311103; Karunker I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061850; Kim SI, 1996, NUCLEIC ACIDS RES, V24, P2648, DOI 10.1093/nar/24.14.2648; Lambert C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008599; Min B, 2003, J BACTERIOL, V185, P3524, DOI 10.1128/JB.185.12.3524-3526.2003; Min B, 2002, P NATL ACAD SCI USA, V99, P2678, DOI 10.1073/pnas.012027399; Mladenova SR, 2014, FEBS LETT, V588, P1808, DOI 10.1016/j.febslet.2014.03.042; Molofsky AB, 2004, MOL MICROBIOL, V53, P29, DOI 10.1111/j.1365-2958.2004.04129.x; Monnappa AK, 2014, SCI REP-UK, V4, DOI 10.1038/srep03811; Nakamura A, 2006, SCIENCE, V312, P1954, DOI 10.1126/science.1127156; Raczniak G, 2001, J BIOL CHEM, V276, P45862, DOI 10.1074/jbc.M109494200; Rendulic S, 2004, SCIENCE, V303, P689, DOI 10.1126/science.1093027; Roy H, 2003, P NATL ACAD SCI USA, V100, P9837, DOI 10.1073/pnas.1632156100; Saad NY, 2013, P NATL ACAD SCI USA, V110, P12756, DOI 10.1073/pnas.1304307110; Saad NY, 2012, J BIOL CHEM, V287, P20382, DOI 10.1074/jbc.M111.332304; Salazar JC, 2001, FEBS LETT, V500, P129, DOI 10.1016/S0014-5793(01)02600-X; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Sheppard K, 2008, J MOL BIOL, V377, P831, DOI 10.1016/j.jmb.2008.01.016; Sheppard K, 2008, METHODS, V44, P139, DOI 10.1016/j.ymeth.2007.06.010; Sheppard K, 2007, J BIOL CHEM, V282, P11866, DOI 10.1074/jbc.M700398200; SHIRVANEE L, 1990, J BIOL CHEM, V265, P6624; Silva GN, 2013, J BIOL CHEM, V288, P3816, DOI 10.1074/jbc.M112.441394; Sockett RE, 2009, ANNU REV MICROBIOL, V63, P523, DOI 10.1146/annurev.micro.091208.073346; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Wand H, 2007, WATER RES, V41, P159, DOI 10.1016/j.watres.2006.08.024; Washington EJ, 2013, MICROBIOL MOL BIOL R, V77, P527, DOI 10.1128/MMBR.00013-13; Weissenmayer BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017570; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; Wolfson AD, 2002, P NATL ACAD SCI USA, V99, P5965, DOI 10.1073/pnas.092152799; Wu J, 2009, J MOL BIOL, V391, P703, DOI 10.1016/j.jmb.2009.06.014; Yang HQ, 2010, ELECTROPHORESIS, V31, P1764, DOI 10.1002/elps.201000027; Yuan J, 2008, ACTA BIOCH BIOPH SIN, V40, P539, DOI 10.1111/j.1745-7270.2008.00435.x	54	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110842	10.1371/journal.pone.0110842	http://dx.doi.org/10.1371/journal.pone.0110842			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338061	Green Submitted, Green Published, gold			2022-12-27	WOS:000343674800081
J	Gonzalez-Curiel, I; Trujillo, V; Montoya-Rosales, A; Rincon, K; Rivas-Calderon, B; deHaro-Acosta, J; Marin-Luevano, P; Lozano-Lopez, D; Enciso-Moreno, JA; Rivas-Santiago, B				Gonzalez-Curiel, Irma; Trujillo, Valentin; Montoya-Rosales, Alejandra; Rincon, Kublai; Rivas-Calderon, Bruno; deHaro-Acosta, Jeny; Marin-Luevano, Paulina; Lozano-Lopez, Daniel; Enciso-Moreno, Jose A.; Rivas-Santiago, Bruno			1,25-Dihydroxyvitamin D-3 Induces LL-37 and HBD-2 Production in Keratinocytes from Diabetic Foot Ulcers Promoting Wound Healing: An In Vitro Model	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; HOST-DEFENSE; MYCOBACTERIUM-TUBERCULOSIS; CELL-PROLIFERATION; BETA-DEFENSINS; EXPRESSION; RECEPTOR; ACTIVATION; RESISTANCE; INDUCTION	Diabetic foot ulcers (DFU) are one of the most common diabetes-related cause of hospitalization and often lead to severe infections and poor healing. It has been recently reported that patients with DFU have lower levels of antimicrobial peptides (AMPs) at the lesion area, which contributes with the impairment of wound healing. The aim of this study was to determine whether 1,25-dihydroxyvitamin D-3 (1,25 (OH)(2) D-3) and L-isoleucine induced HBD-2 and LL-37 in primary cultures from DFU. We developed primary cell cultures from skin biopsies from 15 patients with DFU and 15 from healthy donors. Cultures were treated with 1,25 (OH)(2)D-3 or L-isoleucine for 18 h. Keratinocytes phenotype was identified by western blot and flow cytometry. Real time qPCR for DEFB4, CAMP and VDR gene expression was performed as well as an ELISA to measure HBD-2 and LL-37 in supernatant. Antimicrobial activity, in vitro, wound healing and proliferation assays were performed with conditioned supernatant. The results show that primary culture from DFU treated with 1,25(OH)(2)D-3, increased DEFB4 and CAMP gene expression and increased the production of HBD-2 and LL-37 in the culture supernatant. These supernatants had antimicrobial activity over E. coli and induced remarkable keratinocyte migration. In conclusion the 1,25(OH)(2)D-3 restored the production of AMPs in primary cell from DFU which were capable to improve the in vitro wound healing assays, suggesting their potential therapeutic use on the treatment of DFU.	[Gonzalez-Curiel, Irma; Trujillo, Valentin; Montoya-Rosales, Alejandra; Rincon, Kublai; Rivas-Calderon, Bruno; deHaro-Acosta, Jeny; Marin-Luevano, Paulina; Lozano-Lopez, Daniel; Enciso-Moreno, Jose A.; Rivas-Santiago, Bruno] Mexican Inst Social Secur IMSS, Med Res Unit Zacatecas, Zacatecas, Mexico; [Gonzalez-Curiel, Irma] Autonomous Univ San Luis Potosi, Fac Med, Dept Immunol, San Luis Potosi, Mexico	Instituto Mexicano del Seguro Social; Universidad Autonoma de San Luis Potosi	Rivas-Santiago, B (corresponding author), Mexican Inst Social Secur IMSS, Med Res Unit Zacatecas, Zacatecas, Mexico.	rondo_vm@yahoo.com	Rivas-Santiago, Bruno/AAJ-1885-2020; Gonzalez, Irma/G-8490-2019	Rivas-Santiago, Bruno/0000-0002-1521-1519; Montoya-Rosales, Alejandra del Rocio/0000-0003-0565-4380; Gonzalez, Irma/0000-0002-0044-9196	Mexican Institute for Social Security [FIS/IMSS/PROT/G12/1103, FIS/IMSS/PROT/PRIO/13//025]; CONACyT-Mexico [333283/CVU 231315]	Mexican Institute for Social Security; CONACyT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Financial support to BRS by Mexican Institute for Social Security: FIS/IMSS/PROT/G12/1103, FIS/IMSS/PROT/PRIO/13//025. IGC acknowledges CONACyT-Mexico for the scholarship 333283/CVU 231315. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andra J, 2011, J BIOL CHEM, V286, P18692, DOI 10.1074/jbc.M111.226886; Badr G, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-46; Bardana EJ, 2004, ALLERGY, V59, P25, DOI 10.1111/j.1398-9995.2004.00565.x; Beisswenger C, 2005, CURR PROTEIN PEPT SC, V6, P255, DOI 10.2174/1389203054065428; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Carretero M, 2008, J INVEST DERMATOL, V128, P223, DOI 10.1038/sj.jid.5701043; Castaneda-Delgado JE, 2013, CLIN IMMUNOL, V148, P198, DOI 10.1016/j.clim.2013.05.015; Chan RK, 2006, J BURN CARE RES, V27, P202, DOI 10.1097/01.BCR.0000202898.11277.58; Dorschner RA, 2001, J INVEST DERMATOL, V117, P91, DOI 10.1046/j.1523-1747.2001.01340.x; Ernst CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000660; Fehlbaum P, 2000, P NATL ACAD SCI USA, V97, P12723, DOI 10.1073/pnas.220424597; Gallo RL, 2008, J INVEST DERMATOL, V128, P5, DOI 10.1038/sj.jid.5701073; Gonzalez-Curiel I, 2011, HUM IMMUNOL, V72, P656, DOI 10.1016/j.humimm.2011.03.027; Heilborn JD, 2010, EXP DERMATOL, V19, P332, DOI 10.1111/j.1600-0625.2009.00997.x; Hobizal KB, 2012, DIABET FOOT ANKLE, V3, DOI 10.3402/dfa.v3i0.18409; Jindeel A, 2012, INT J LOW EXTREM WOU; Khanolkar MP, 2008, QJM-INT J MED, V101, P685, DOI 10.1093/qjmed/hcn027; Kim BJ, 2009, CLIN DEV IMMUNOL, DOI 10.1155/2009/645898; Kim WS, 2010, PHARMACOLOGY, V85, P68, DOI 10.1159/000276495; Klein S, 2009, MOL MICROBIOL, V71, P551, DOI 10.1111/j.1365-2958.2008.06562.x; Koczulla R, 2003, J CLIN INVEST, V111, P1665, DOI 10.1172/JCI200317545; Lahaye DHTP, 1998, J CELL PHYSIOL, V174, P9, DOI 10.1002/(SICI)1097-4652(199801)174:1<9::AID-JCP2>3.0.CO;2-S; Lee WJ, 2012, ARCH DERMATOL RES; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Niyonsaba F, 2007, J INVEST DERMATOL, V127, P594, DOI 10.1038/sj.jid.5700599; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Paola LD, 2006, CURR DIABETES REV, V2, P431, DOI 10.2174/1573399810602040431; Presicce P, 2009, J LEUKOCYTE BIOL, V86, P941, DOI 10.1189/jlb.0708412; Rivas-Santiago B, 2005, INFECT IMMUN, V73, P4505, DOI 10.1128/IAI.73.8.4505-4511.2005; Rivas-Santiago B, 2008, INFECT IMMUN, V76, P935, DOI 10.1128/IAI.01218-07; Rivas-Santiago B, 2012, J DERMATOL SCI, V65, P19, DOI 10.1016/j.jdermsci.2011.09.013; Rivas-Santiago CE, 2011, CLIN EXP IMMUNOL, V164, P80, DOI 10.1111/j.1365-2249.2010.04313.x; Roy H, 2008, P NATL ACAD SCI USA, V105, P4667, DOI 10.1073/pnas.0800006105; Shaykhiev R, 2005, AM J PHYSIOL-LUNG C, V289, pL842, DOI 10.1152/ajplung.00286.2004; Steinstraesser L, 2008, MOL MED, V14, P528, DOI 10.2119/2008-00002.Steinstraesser; STEPHENS K, 1995, AM J HUM GENET, V56, P577; Tokumaru S, 2005, J IMMUNOL, V175, P4662, DOI 10.4049/jimmunol.175.7.4662; Turner FE, 2006, J BIOL CHEM, V281, P21321, DOI 10.1074/jbc.M509731200; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909	40	48	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e111355	10.1371/journal.pone.0111355	http://dx.doi.org/10.1371/journal.pone.0111355			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337708	Green Published, gold, Green Submitted			2022-12-27	WOS:000343674800119
J	Patursky-Polischuk, I; Kasir, J; Miloslavski, R; Hayouka, Z; Hausner-Hanochi, M; Stolovich-Rain, M; Tsukerman, P; Biton, M; Mudhasani, R; Jones, SN; Meyuhas, O				Patursky-Polischuk, Ilona; Kasir, Judith; Miloslavski, Rachel; Hayouka, Zvi; Hausner-Hanochi, Mirit; Stolovich-Rain, Miri; Tsukerman, Pinchas; Biton, Moshe; Mudhasani, Rajini; Jones, Stephen N.; Meyuhas, Oded			Reassessment of the Role of TSC, mTORC1 and MicroRNAs in Amino Acids-Meditated Translational Control of TOP mRNAs	PLOS ONE			English	Article							RIBOSOMAL-PROTEIN; S6 KINASE; MAMMALIAN TARGET; RAG GTPASES; FKBP12-RAPAMYCIN-ASSOCIATED PROTEIN; DEPENDENT TRANSLATION; RPS6 PHOSPHORYLATION; INDEPENDENT MANNER; KEY REGULATOR; GAP ACTIVITY	TOP mRNAs encode components of the translational apparatus, and repression of their translation comprises one mechanism, by which cells encountering amino acid deprivation downregulate the biosynthesis of the protein synthesis machinery. This mode of regulation involves TSC as knockout of TSC1 or TSC2 rescued TOP mRNAs translation in amino acidstarved cells. The involvement of mTOR in translational control of TOP mRNAs is demonstrated by the ability of constitutively active mTOR to relieve the translational repression of TOP mRNA upon amino acid deprivation. Consistently, knockdown of this kinase as well as its inhibition by pharmacological means blocked amino acid-induced translational activation of these mRNAs. The signaling of amino acids to TOP mRNAs involves RagB, as overexpression of active RagB derepressed the translation of these mRNAs in amino acid-starved cells. Nonetheless, knockdown of raptor or rictor failed to suppress translational activation of TOP mRNAs by amino acids, suggesting that mTORC1 or mTORC2 plays a minor, if any, role in this mode of regulation. Finally, miR10a has previously been suggested to positively regulate the translation of TOP mRNAs. However, we show here that titration of this microRNA failed to downregulate the basal translation efficiency of TOP mRNAs. Moreover, Drosha knockdown or Dicer knockout, which carries out the first and second processing steps in microRNAs biosynthesis, respectively, failed to block the translational activation of TOP mRNAs by amino acid or serum stimulation. Evidently, these results are questioning the positive role of microRNAs in this mode of regulation.	[Patursky-Polischuk, Ilona; Kasir, Judith; Miloslavski, Rachel; Hayouka, Zvi; Hausner-Hanochi, Mirit; Stolovich-Rain, Miri; Meyuhas, Oded] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Biochem & Mol Biol, IL-91010 Jerusalem, Israel; [Tsukerman, Pinchas; Biton, Moshe] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Lautenberg Ctr Gen & Tumor Immunol, IL-91010 Jerusalem, Israel; [Mudhasani, Rajini; Jones, Stephen N.] Univ Massachusetts, Sch Med, Dept Cell Biol, North Worcester, MA USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of Massachusetts System; University of Massachusetts Worcester	Meyuhas, O (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Biochem & Mol Biol, IL-91010 Jerusalem, Israel.	meyuhas@cc.huji.ac.il		Tsukerman, Pinchas/0000-0002-5813-7048; Biton, Moshe/0000-0001-8330-1674; Mudhasani, Rajini/0000-0001-7824-6949				Bar-Peled L, 2014, TRENDS CELL BIOL, V24, P400, DOI 10.1016/j.tcb.2014.03.003; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531; Bilanges B, 2007, MOL CELL BIOL, V27, P5746, DOI 10.1128/MCB.02136-06; Biton M, 2011, NAT IMMUNOL, V12, P239, DOI 10.1038/ni.1994; BRATTAIN MG, 1981, ONCODEV BIOL MED, V2, P355; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; CHANDRASEKARAN EV, 1979, CANCER RES, V39, P870; CHEN J, 1995, P NATL ACAD SCI USA, V92, P4947, DOI 10.1073/pnas.92.11.4947; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; CHUNG S, 1989, MOL CELL BIOL, V9, P2075, DOI 10.1128/MCB.9.5.2075; Dai N, 2011, GENE DEV, V25, P1159, DOI 10.1101/gad.2042311; Damgaard CK, 2011, GENE DEV, V25, P2057, DOI 10.1101/gad.17355911; Demetriades C, 2014, CELL, V156, P786, DOI 10.1016/j.cell.2014.01.024; Duran A, 2011, MOL CELL, V44, P134, DOI 10.1016/j.molcel.2011.06.038; Duran RV, 2012, EMBO REP, V13, P121, DOI 10.1038/embor.2011.257; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Foley NH, 2011, CELL DEATH DIFFER, V18, P1089, DOI 10.1038/cdd.2010.172; Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; GINZBURG I, 1985, EMBO J, V4, P3667, DOI 10.1002/j.1460-2075.1985.tb04133.x; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Granneman S, 2007, CURR BIOL, V17, pR415, DOI 10.1016/j.cub.2007.04.011; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hornstein E, 2001, COLD SPRING HARB SYM, V66, P477, DOI 10.1101/sqb.2001.66.477; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kim J, 2011, ANNU REV BIOCHEM, V80, P1001, DOI 10.1146/annurev-biochem-062209-094414; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; LALANNE JL, 1987, NUCLEIC ACIDS RES, V15, P4990, DOI 10.1093/nar/15.12.4990; Meyuhas O, 2009, PROG MOL BIOL TRANSL, V90, P109, DOI 10.1016/S1877-1173(09)90003-5; Miloslavski R, 2014, J MOL CELL BIOL, V6, P255, DOI 10.1093/jmcb/mju008; MINTY AJ, 1981, J BIOL CHEM, V256, P1008; Mudhasani R, 2008, J CELL BIOL, V181, P1055, DOI 10.1083/jcb.200802105; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586; Ohne Y, 2008, J BIOL CHEM, V283, P31861, DOI 10.1074/jbc.M801546200; OLIVER MH, 1989, J CELL SCI, V92, P513; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; Parrott LA, 1999, J BIOL CHEM, V274, P24731, DOI 10.1074/jbc.274.35.24731; Patursky-Polischuk I, 2009, MOL CELL BIOL, V29, P640, DOI 10.1128/MCB.00980-08; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Peterson RT, 2000, J BIOL CHEM, V275, P7416, DOI 10.1074/jbc.275.10.7416; Proud CG, 2009, BIOCHEM SOC T, V37, P227, DOI 10.1042/BST0370227; Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131; Roccio M, 2006, ONCOGENE, V25, P657, DOI 10.1038/sj.onc.1209106; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Stern-Ginossar N, 2008, NAT IMMUNOL, V9, P1065, DOI 10.1038/ni.1642; Stolovich M, 2005, J BIOL CHEM, V280, P5336, DOI 10.1074/jbc.M412434200; Stolovich M, 2002, MOL CELL BIOL, V22, P8101, DOI 10.1128/MCB.22.23.8101-8113.2002; Tang H, 2001, MOL CELL BIOL, V21, P8671, DOI 10.1128/MCB.21.24.8671-8683.2001; Tcherkezian J, 2014, GENE DEV, V28, P357, DOI 10.1101/gad.231407.113; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tsukerman P, 2012, CANCER RES, V72, P5463, DOI 10.1158/0008-5472.CAN-11-2671; Weng QP, 1998, J BIOL CHEM, V273, P16621, DOI 10.1074/jbc.273.26.16621; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	68	22	22	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e109410	10.1371/journal.pone.0109410	http://dx.doi.org/10.1371/journal.pone.0109410			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338081	gold, Green Published, Green Submitted			2022-12-27	WOS:000343674800012
J	Schulp, CJE; Burkhard, B; Maes, J; Van Vliet, J; Verburg, PH				Schulp, Catharina J. E.; Burkhard, Benjamin; Maes, Joachim; Van Vliet, Jasper; Verburg, Peter H.			Uncertainties in Ecosystem Service Maps: A Comparison on the European Scale	PLOS ONE			English	Article							SUPPLY-AND-DEMAND; CLIMATE-CHANGE; FRAMEWORK; BIODIVERSITY; POLLINATION; FLOWS	Safeguarding the benefits that ecosystems provide to society is increasingly included as a target in international policies. To support such policies, ecosystem service maps are made. However, there is little attention for the accuracy of these maps. We made a systematic review and quantitative comparison of ecosystem service maps on the European scale to generate insights in the uncertainty of ecosystem service maps and discuss the possibilities for quantitative validation. Maps of climate regulation and recreation were reasonably similar while large uncertainties among maps of erosion protection and flood regulation were observed. Pollination maps had a moderate similarity. Differences among the maps were caused by differences in indicator definition, level of process understanding, mapping aim, data sources and methodology. Absence of suitable observed data on ecosystem services provisioning hampers independent validation of the maps. Consequently, there are, so far, no accurate measures for ecosystem service map quality. Policy makers and other users need to be cautious when applying ecosystem service maps for decision-making. The results illustrate the need for better process understanding and data acquisition to advance ecosystem service mapping, modelling and validation.	[Schulp, Catharina J. E.; Van Vliet, Jasper; Verburg, Peter H.] Vrije Univ Amsterdam, Fac Earth & Life Sci, Amsterdam, Netherlands; [Burkhard, Benjamin] Univ Kiel, Inst Nat Resource Conservat, Kiel, Germany; [Maes, Joachim] European Commiss, Joint Res Ctr, Inst Environm & Sustainabil, Ispra, Varese, Italy; [Burkhard, Benjamin] Leibniz Ctr Agr Landscape Res ZALF, Muncheberg, Germany	Vrije Universiteit Amsterdam; University of Kiel; European Commission Joint Research Centre; EC JRC ISPRA Site; Leibniz Zentrum fur Agrarlandschaftsforschung (ZALF)	Schulp, CJE (corresponding author), Vrije Univ Amsterdam, Fac Earth & Life Sci, Amsterdam, Netherlands.	nynke.schulp@vu.nl	Schulp, Catharina JE/G-1451-2013; Burkhard, Benjamin/ABF-1090-2021; Verburg, Peter h./A-8469-2010; BITOUN, RACHEL Elisabeth/AAC-9538-2021; Maes, Joachim/ABG-8549-2020; Verburg, Peter H/Z-1582-2019; van Vliet, Jasper/G-3163-2013	Burkhard, Benjamin/0000-0001-8636-9009; Verburg, Peter h./0000-0002-6977-7104; BITOUN, RACHEL Elisabeth/0000-0002-3614-9910; Maes, Joachim/0000-0002-8272-1607; van Vliet, Jasper/0000-0002-3996-5278; Schulp, Nynke/0000-0002-5068-8566	ERA-net BiodivERsA; NWO, BiodivERsA call within the project CONNECT; European Commission-funded FP7 project OPERAs; German BMBF-funded project LEGATO [FKZ 01LL0917F]	ERA-net BiodivERsA; NWO, BiodivERsA call within the project CONNECT; European Commission-funded FP7 project OPERAs; German BMBF-funded project LEGATO	The authors acknowledge financial support of ERA-net BiodivERsA, with the national funder NWO, part of the 2011 BiodivERsA call within the project CONNECT (http://www.biodiversa.org/; http://www.nwo.nl/) (CJES, PV), the European Commission-funded FP7 project OPERAs (PV) and the German BMBF-funded project LEGATO (FKZ 01LL0917F) (http://www.bmbf.de/en/)(BB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagstad KJ, 2013, ECOSYST SERV, V4, P117, DOI 10.1016/j.ecoser.2012.07.012; BAI ZG, 2008, 5 GLADA ISRIC; Bennett EM, 2009, ECOL LETT, V12, P1394, DOI 10.1111/j.1461-0248.2009.01387.x; BIO by Deloitte, 2014, STUD SUPP POT LAND S; Bivand R, 2014, RGDAL BINDINGS GEOSP; Brakenridge, 2010, GLOBAL ACTIVE ARCH L; Burkhard B, 2014, LANDSCAPE ONLINE, V34, P1, DOI [DOI 10.3097/LO.201434, 10.3097/lo.201434, 10.3097/LO.201434]; Burkhard B, 2012, ECOL INDIC, V21, P17, DOI 10.1016/j.ecolind.2011.06.019; Carre G, 2009, AGR ECOSYST ENVIRON, V133, P40, DOI 10.1016/j.agee.2009.05.001; Cheaib A, 2012, ECOL LETT, V15, P533, DOI 10.1111/j.1461-0248.2012.01764.x; Costanza R, 2008, BIOL CONSERV, V141, P350, DOI 10.1016/j.biocon.2007.12.020; Crossman ND, 2013, ECOSYST SERV, V4, P4, DOI 10.1016/j.ecoser.2013.02.001; de Groot RS, 2010, ECOL COMPLEX, V7, P260, DOI 10.1016/j.ecocom.2009.10.006; De Groot R.S., 2010, EC ECOSYSTEMS BIODIV, P9; EEA, 2000, CORINE LAND COV 2000; Egoh B, 2008, AGR ECOSYST ENVIRON, V127, P135, DOI 10.1016/j.agee.2008.03.013; Eigenbrod F, 2010, J APPL ECOL, V47, P377, DOI 10.1111/j.1365-2664.2010.01777.x; European Commission, 2009, SEC200992 EUR COMM, P92; European Commission, 2011, COMMUNICATION; EUROSTAT, 2011, EUROSTAT METH WORK P, DOI [10.2785/15544, DOI 10.2785/15544]; Garcia-Nieto AP, 2013, ECOSYST SERV, V4, P126, DOI 10.1016/j.ecoser.2013.03.003; Gimona A, 2007, LANDSCAPE ECOL, V22, P1255, DOI 10.1007/s10980-007-9105-7; Hagen-Zanker A., 2006, COMP CONTINUOUS VALU; Hernandez-Morcillo M, 2013, ECOL INDIC, V29, P434, DOI 10.1016/j.ecolind.2013.01.013; Hijmans RJ., 2012, RASTER GEOGRAPHIC AN; Hou Y, 2013, J ENV MANAG IN PRESS; Imhoff M. L., 2004, HANPP COLLECTION GLO; Janssens I. A., 2004, Biogeosciences Discussions, V1, P167; Kandziora M, 2013, ECOSYST SERV, V4, P47, DOI 10.1016/j.ecoser.2013.04.001; Kienast F, 2009, ENVIRON MANAGE, V44, P1099, DOI 10.1007/s00267-009-9384-7; Kozak J, 2011, APPL GEOGR, V31, P303, DOI 10.1016/j.apgeog.2010.07.001; Larigauderie A, 2012, CURR OPIN ENV SUST, V4, P101, DOI 10.1016/j.cosust.2012.01.007; Lautenbach S, 2011, ECOL INDIC, V11, P676, DOI 10.1016/j.ecolind.2010.09.007; Lehsten V, 2014, GLOBAL EC BIOG UNPUB; Mace GM, 2010, CURR OPIN ENV SUST, V2, P3, DOI 10.1016/j.cosust.2010.03.003; Maes J., 2011, EUROPEAN ASSESSMENT; Maes J, 2013, CURR OPIN E IN PRESS; Maes J., 2013, MAPPING ASSESSMENT E, DOI DOI 10.2779/12398; Maes J, 2012, ECOSYST SERV, V1, P31, DOI 10.1016/j.ecoser.2012.06.004; Millennium Assessment, 2005, EC HUM WELL BEING; Nedkov S, 2012, ECOL INDIC, V21, P67, DOI 10.1016/j.ecolind.2011.06.022; Pagella TF, 2014, LANDSCAPE ECOL, V29, P383, DOI 10.1007/s10980-013-9983-9; Paracchini ML, 2014, ECOL INDIC, V45, P371, DOI 10.1016/j.ecolind.2014.04.018; Pe'er G, 2014, SCIENCE, V344, P1090, DOI 10.1126/science.1253425; Rosenzweig C, 2014, P NATL ACAD SCI USA, V111, P3268, DOI 10.1073/pnas.1222463110; Schulp CJE, 2014, ECOL INDIC, V36, P131, DOI 10.1016/j.ecolind.2013.07.014; Schulp CJE, 2008, AGR ECOSYST ENVIRON, V127, P251, DOI 10.1016/j.agee.2008.04.010; Schulp Catharina J. E., 2012, International Journal of Biodiversity Science Ecosystem Services & Management, V8, P156, DOI 10.1080/21513732.2011.645880; Seppelt R, 2011, J APPL ECOL, V48, P630, DOI 10.1111/j.1365-2664.2010.01952.x; Serna-Chavez HM, 2014, ECOL INDIC, V39, P24, DOI 10.1016/j.ecolind.2013.11.024; Sturck J, 2014, ECOL INDIC, V38, P198, DOI 10.1016/j.ecolind.2013.11.010; Syrbe RU, 2012, ECOL INDIC, V21, P80, DOI 10.1016/j.ecolind.2012.02.013; Tucker G., 2013, REPORT EUROPEAN COMM; van Berkel DB, 2011, LAND USE POLICY, V28, P447, DOI 10.1016/j.landusepol.2010.09.002; Villamagna AM, 2013, ECOL COMPLEX, V15, P114, DOI 10.1016/j.ecocom.2013.07.004; Zulian G, 2013, LAND-BASEL, V2, P472, DOI 10.3390/land2030472	56	119	126	4	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e109643	10.1371/journal.pone.0109643	http://dx.doi.org/10.1371/journal.pone.0109643			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337913	Green Submitted, Green Published, gold			2022-12-27	WOS:000343674800016
J	Comar, M; Wong, C; Tognon, M; Butel, JS				Comar, Manola; Wong, Connie; Tognon, Mauro; Butel, Janet S.			Neutralizing and IgG Antibodies against Simian Virus 40 in Healthy Pregnant Women in Italy	PLOS ONE			English	Article							POLYOMAVIRUS SV40 INFECTIONS; CAPSID PROTEIN MIMOTOPES; PERIPHERAL-BLOOD CELLS; LARGE T-ANTIGEN; DNA-SEQUENCES; BK VIRUS; TRANSPLACENTAL TRANSMISSION; MOLECULAR-IDENTIFICATION; SV40-LIKE SEQUENCES; HYPERENDEMIC AREA	Objective: Polyomavirus simian virus 40 (SV40) sequences have been detected in various human specimens and SV40 antibodies have been found in human sera from both healthy individuals and cancer patients. This study analyzed serum samples from healthy pregnant women as well as cord blood samples to determine the prevalence of SV40 antibodies in pregnancy. Methods: Serum samples were collected at the time of delivery from two groups of pregnant women as well as cord bloods from one group. The women were born between 1967 and 1993. Samples were assayed by two different serological methods, one group by neutralization of viral infectivity and the other by indirect ELISA employing specific SV40 mimotopes as antigens. Viral DNA assays by real-time polymerase chain reaction were carried out on blood samples. Results: Neutralization and ELISA tests indicated that the pregnant women were SV40 antibody-positive with overall prevalences of 10.6% (13/123) and 12.7% (14/110), respectively. SV40 neutralizing antibodies were detected in a low number of cord blood samples. Antibody titers were generally low. No viral DNA was detected in either maternal or cord bloods. Conclusions: SV40-specific serum antibodies were detected in pregnant women at the time of delivery and in cord bloods. There was no evidence of transplacental transmission of SV40. These data indicate that SV40 is circulating at a low prevalence in the northern Italian population long after the use of contaminated vaccines.	[Comar, Manola] Univ Trieste, Dept Med Sci, Trieste, Italy; [Comar, Manola] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [Wong, Connie; Butel, Janet S.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Tognon, Mauro] Univ Ferrara, Sch Med, Dept Morphol Surg & Expt Med, Sect Pathol Oncol & Expt Biol, I-44100 Ferrara, Italy	University of Trieste; IRCCS Burlo Garofolo; Baylor College of Medicine; University of Ferrara	Comar, M (corresponding author), Univ Trieste, Dept Med Sci, Trieste, Italy.	manola.comar@burlo.trieste.it	Comar, Manola/K-4613-2016; COMAR, Manola/K-4613-2016	Comar, Manola/0000-0001-6310-3320; COMAR, Manola/0000-0002-9487-861X; Butel, Janet/0000-0002-6876-3245	National Institutes of Health, United States of America [R01 CA104818]; University of Trieste; University of Ferrara, Italy; NATIONAL CANCER INSTITUTE [R01CA104818] Funding Source: NIH RePORTER	National Institutes of Health, United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Trieste; University of Ferrara, Italy; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by research grant R01 CA104818 (JSB) from the National Institutes of Health, United States of America, the University of Trieste (MC), and the University of Ferrara (MT), Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara K, 2007, INT J CANCER, V121, P2693, DOI 10.1002/ijc.23038; Arrington AS, 2004, ONCOGENE, V23, P2231, DOI 10.1038/sj.onc.1207341; BERGSAGEL DJ, 1992, NEW ENGL J MED, V326, P988, DOI 10.1056/NEJM199204093261504; Boldorini R, 2008, PATHOLOGY, V40, P72, DOI 10.1080/00313020701716458; Boldorini R, 2011, J GEN VIROL, V92, P1044, DOI 10.1099/vir.0.028571-0; Boldorini R, 2010, J MED VIROL, V82, P2127, DOI 10.1002/jmv.21923; BROWN P, 1976, P SOC EXP BIOL MED, V152, P130; Butel J S, 2003, Cent Eur J Public Health, V11, P3; Butel J. S., 2010, Viral oncology: basic science and clinical applications, P165; Butel JS, 2012, CURR OPIN VIROL, V2, P508, DOI 10.1016/j.coviro.2012.06.004; Butel JS, 2012, CURR CANCER RES, P377, DOI 10.1007/978-1-4614-0016-5_15; Butel JS, 1999, HUM PATHOL, V30, P1496, DOI 10.1016/S0046-8177(99)90173-9; Cajaiba MM, 2011, J MED VIROL, V83, P1031, DOI 10.1002/jmv.22082; Campello C, 2010, J MED VIROL, V82, P1197, DOI 10.1002/jmv.21798; CARBONE M, 1994, ONCOGENE, V9, P1781; Carbone M, 1996, ONCOGENE, V13, P527; Comar M, 2007, CANCER RES, V67, P8456, DOI 10.1158/0008-5472.CAN-07-2232; Comar M, 2014, PEDIATR BLOOD CANCER, V61, P1347, DOI 10.1002/pbc.24943; Comar M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079683; Comar M, 2012, TUMORI J, V98, P210, DOI 10.1700/1088.11931; Comar M, 2010, J MED VIROL, V82, P1236, DOI 10.1002/jmv.21786; Corallini A, 2012, HUM IMMUNOL, V73, P502, DOI 10.1016/j.humimm.2012.02.009; Crovari P, 2010, EPIDEMIOL BIOSTAT PU, V7, P322; Csoma E, 2012, J CLIN VIROL, V55, P262, DOI 10.1016/j.jcv.2012.07.009; David H, 2001, CANCER LETT, V162, P57, DOI 10.1016/S0304-3835(00)00628-5; Gjoerup O, 2010, ADV CANCER RES, V106, P1, DOI 10.1016/S0065-230X(10)06001-X; Guerrini R, 2010, MED RES REV, V30, P751, DOI 10.1002/med.20180; Heinsohn S, 2009, ONCOL REP, V21, P289, DOI 10.3892/or_00000220; HORVATH LB, 1972, ACTA VIROL, V16, P141; International Agency for Research on Cancer, 2013, IARC MON EV CARC RIS, V104; Jafar S, 1998, J MED VIROL, V54, P276, DOI 10.1002/(SICI)1096-9071(199804)54:4<276::AID-JMV7>3.0.CO;2-1; Javier RT, 2008, CANCER RES, V68, P7693, DOI 10.1158/0008-5472.CAN-08-3301; Kalvatchev Z, 2008, J CLIN VIROL, V43, P328, DOI 10.1016/j.jcv.2008.08.002; Kean JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000363; Lapin B. A., 2009, Vestnik Rossiiskoi Akademii Meditsinskikh Nauk, P7; Lednicky JA, 1998, J VIROL, V72, P3980, DOI 10.1128/JVI.72.5.3980-3990.1998; Lednicky JA, 1997, INT J CANCER, V72, P791; LEDNICKY JA, 1995, VIROLOGY, V212, P710, DOI 10.1006/viro.1995.1529; Li RM, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000028249.06596.CF; Lundstig A, 2005, J GEN VIROL, V86, P1703, DOI 10.1099/vir.0.80783-0; Martini F, 1996, CANCER RES, V56, P4820; Martini F, 2002, CANCER-AM CANCER SOC, V94, P1037, DOI 10.1002/cncr.10272; Martini F, 1998, INT J CANCER, V78, P669, DOI 10.1002/(SICI)1097-0215(19981209)78:6<669::AID-IJC1>3.0.CO;2-B; Martini F, 2007, INFECT AGENTS CANCER, V2, pe13; Martini F, 2013, EPIDEMIOLOGY, V24, P464, DOI 10.1097/EDE.0b013e31828d3ae6; Mazzoni E, 2013, J INFECTION, V67, P356, DOI 10.1016/j.jinf.2013.06.002; Mazzoni E, 2014, NEURO-ONCOLOGY, V16, P513, DOI 10.1093/neuonc/not217; Mazzoni E, 2012, P NATL ACAD SCI USA, V109, P18066, DOI 10.1073/pnas.1213238109; MCCANCE DJ, 1977, INFECT IMMUN, V18, P196, DOI 10.1128/IAI.18.1.196-202.1977; McNees AL, 2005, J CLIN VIROL, V34, P52, DOI 10.1016/j.jcv.2004.12.018; Meneses A, 2005, HAEMATOLOGICA, V90, P1635; Milstone A, 2004, TRANSPLANTATION, V77, P1019, DOI 10.1097/01.TP.0000119156.52197.CA; Minor P, 2003, J MED VIROL, V70, P490, DOI 10.1002/jmv.10422; Nurgalieva ZZ, 2005, J INFECTION, V50, P142, DOI 10.1016/j.jinf.2004.03.001; Pancaldi C, 2009, J INFECTION, V58, P53, DOI 10.1016/j.jinf.2008.10.014; Paracchin V, 2005, MOL MED, V11, P48, DOI 10.2119/2005-00007.Taioli; Paracchini V, 2006, MUTAT RES-REV MUTAT, V612, P77, DOI 10.1016/j.mrrev.2005.06.001; Patel NC, 2008, J CLIN VIROL, V43, P66, DOI 10.1016/j.jcv.2008.04.011; Patel NC, 2009, VIROLOGY, V386, P94, DOI 10.1016/j.virol.2008.12.040; Penta M, 2003, MICROBIOLOGICA, V26, P329; Pietropaolo V, 1998, J MED VIROL, V56, P372, DOI 10.1002/(SICI)1096-9071(199812)56:4&lt;372::AID-JMV14&gt;3.0.CO;2-4; Pipas JM, 2009, VIROLOGY, V384, P294, DOI 10.1016/j.virol.2008.11.024; RACHLIN J, 1988, LAB INVEST, V58, P26; Sadeghi M, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-251; SHAH K, 1976, AM J EPIDEMIOL, V103, P1; Shah KV, 2004, REV MED VIROL, V14, P231, DOI 10.1002/rmv.432; SHAH KV, 1972, J NATL CANCER I, V48, P557; SHAH KV, 1971, NATURE, V231, P448, DOI 10.1038/231448a0; SHAH KV, 1972, AM J EPIDEMIOL, V95, P199, DOI 10.1093/oxfordjournals.aje.a121387; Shivapurkar N, 2004, CANCER RES, V64, P3757, DOI 10.1158/0008-5472.CAN-03-3307; Shivapurkar N, 2000, INT J CANCER, V85, P743, DOI 10.1002/(SICI)1097-0215(20000301)85:5<743::AID-IJC24>3.3.CO;2-V; SWEET BH, 1960, P SOC EXP BIOL MED, V105, P420, DOI 10.3181/00379727-105-26128; Taronna A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061182; Vanchiere JA, 2005, J INFECT DIS, V192, P658, DOI 10.1086/432076; Vanchiere JA, 2005, J MED VIROL, V75, P447, DOI 10.1002/jmv.20287; Vanchiere JA, 2014, J PEDIAT IN IN PRESS; Vanchiere JA, 2009, J CLIN MICROBIOL, V47, P2388, DOI 10.1128/JCM.02472-08; VERHAGEN W, 1993, ARCH VIROL, V133, P459, DOI 10.1007/BF01313783; Vilchez RA, 2002, LANCET, V359, P817, DOI 10.1016/S0140-6736(02)07950-3; Vilchez RA, 2002, J ACQ IMMUN DEF SYND, V29, P109, DOI 10.1097/00042560-200202010-00001; Wong C, 2013, J INFECTION, V66, P67, DOI 10.1016/j.jinf.2012.08.014; Yamamoto H, 2000, BRIT J CANCER, V82, P1677; Zhang SJ, 2005, J GEN VIROL, V86, P2721, DOI 10.1099/vir.0.81168-0; ZIMMERMANN W, 1983, ZBL BAKT-INT J MED M, V254, P187, DOI 10.1016/S0174-3031(83)80145-0	84	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110700	10.1371/journal.pone.0110700	http://dx.doi.org/10.1371/journal.pone.0110700			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25335106	Green Published, gold, Green Submitted			2022-12-27	WOS:000343731200068
J	Weiss, A; Joerss, H; Brockmeyer, J				Weiss, Andre; Joerss, Hanna; Brockmeyer, Jens			Structural and Functional Characterization of Cleavage and Inactivation of Human Serine Protease Inhibitors by the Bacterial SPATE Protease EspP alpha from Enterohemorrhagic E-coli	PLOS ONE			English	Article							C1 ESTERASE INHIBITOR; SHIGA TOXIN; ALPHA-1-PROTEINASE INHIBITOR; HUMAN ALPHA-1-ANTICHYMOTRYPSIN; PROTEINASE-INHIBITORS; PROTEOLYTIC ACTIVITY; SERRATIA-MARCESCENS; ALZHEIMERS-DISEASE; REACTIVE-SITE; HUMAN-PLASMA	EspP alpha and EspI are serine protease autotransporters found in enterohemorrhagic Escherichia coli. They both belong to the SPATE autotransporter family and are believed to contribute to pathogenicity via proteolytic cleavage and inactivation of different key host proteins during infection. Here, we describe the specific cleavage and functional inactivation of serine protease inhibitors (serpins) by EspP alpha and compare this activity with the related SPATE EspI. Serpins are structurally related proteins that regulate vital protease cascades, such as blood coagulation and inflammatory host response. For the rapid determination of serpin cleavage sites, we applied direct MALDI-TOF-MS or ESI-FTMS analysis of coincubations of serpins and SPATE proteases and confirmed observed cleavage positions using in-gel-digest of SDS-PAGE-separated degradation products. Activities of both serpin and SPATE protease were assessed in a newly developed photometrical assay using chromogenic peptide substrates. EspP alpha cleaved the serpins alpha 1-protease inhibitor (alpha 1-PI), alpha 1-antichymotrypsin, angiotensinogen, and alpha 2-antiplasmin. Serpin cleavage led to loss of inhibitory function as demonstrated for alpha 1-PI while EspPa activity was not affected. Notably, EspP alpha showed pronounced specificity and cleaved procoagulatory serpins such as alpha 2-antiplasmin while the anticoagulatory antithrombin III was not affected. Together with recently published research, this underlines the interference of EspP alpha with hemostasis or inflammatory responses during infection, while the observed interaction of EspI with serpins is likely to be not physiologically relevant. EspP alpha-mediated serpin cleavage occurred always in flexible loops, indicating that this structural motif might be required for substrate recognition.	[Weiss, Andre; Joerss, Hanna; Brockmeyer, Jens] Univ Munster, Inst Food Chem, D-48149 Munster, Germany	University of Munster	Brockmeyer, J (corresponding author), Univ Munster, Inst Food Chem, D-48149 Munster, Germany.	jbrockm@uni-muenster.de			Deutsche Forschungsgemeinschaft (DFG) [BR 4258/1-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The study was supported by the Deutsche Forschungsgemeinschaft (DFG) (http://dfg.de), grant BR 4258/1-1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM CR, 1988, CELL, V52, P487, DOI 10.1016/0092-8674(88)90462-X; AOKI N, 1984, SEMIN THROMB HEMOST, V10, P42, DOI 10.1055/s-2007-1004406; ARAKAWA K, 1968, BIOCHIM BIOPHYS ACTA, V168, P106, DOI 10.1016/0005-2795(68)90239-0; BEATTY K, 1980, J BIOL CHEM, V255, P3931; Bielaszewska M, 2009, J CLIN MICROBIOL, V47, P2061, DOI 10.1128/JCM.00201-09; Brockmeyer J, 2007, APPL ENVIRON MICROB, V73, P6351, DOI 10.1128/AEM.00920-07; Brockmeyer J, 2011, ENVIRON MICROBIOL, V13, P1327, DOI 10.1111/j.1462-2920.2011.02431.x; Brockmeyer J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006100; Brunder W, 1997, MOL MICROBIOL, V24, P767, DOI 10.1046/j.1365-2958.1997.3871751.x; Burghaus B, 2006, ACTA HAEMATOL-BASEL, V115, P186, DOI 10.1159/000090933; CHANDRA T, 1983, BIOCHEMISTRY-US, V22, P5055, DOI 10.1021/bi00291a001; COLLEN D, 1979, BLOOD, V53, P313; Coughlin PB, 2005, FEBS J, V272, P4852, DOI 10.1111/j.1742-4658.2005.04881.x; dos Santos LF, 2010, J MED MICROBIOL, V59, P634, DOI 10.1099/jmm.0.015263-0; Dutta PR, 2002, INFECT IMMUN, V70, P7105, DOI 10.1128/IAI.70.12.7105-7113.2002; Elliott PR, 2000, PROTEIN SCI, V9, P1274, DOI 10.1110/ps.9.7.1274; Favier R, 2001, BRIT J HAEMATOL, V114, P4, DOI 10.1046/j.1365-2141.2001.02845.x; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; HEEB MJ, 1988, J BIOL CHEM, V263, P11613; HOLMES WE, 1987, J BIOL CHEM, V262, P1659; HORTIN GL, 1988, BIOCHEM BIOPH RES CO, V155, P591, DOI 10.1016/S0006-291X(88)80535-7; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Izaguirre G, 2003, J BIOL CHEM, V278, P51433, DOI 10.1074/jbc.M309266200; JOHNSON D, 1978, J BIOL CHEM, V253, P7142; KAMBOH MI, 1995, NAT GENET, V10, P486, DOI 10.1038/ng0895-486; Karmali MA, 2004, MOL BIOTECHNOL, V26, P117, DOI 10.1385/MB:26:2:117; Khan AB, 2009, INT J MED MICROBIOL, V299, P247, DOI 10.1016/j.ijmm.2008.08.006; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lathem WW, 2004, J EXP MED, V199, P1077, DOI 10.1084/jem.20030255; Lathem WW, 2002, MOL MICROBIOL, V45, P277, DOI 10.1046/j.1365-2958.2002.02997.x; Law D, 2000, J APPL MICROBIOL, V88, P729, DOI 10.1046/j.1365-2672.2000.01031.x; Law RHP, 2008, BLOOD, V111, P2049, DOI 10.1182/blood-2007-09-114215; LENTZ KE, 1956, J EXP MED, V104, P183, DOI 10.1084/jem.104.2.183; Lijnen HR, 2001, BBA-PROTEIN STRUCT M, V1547, P206, DOI 10.1016/S0167-4838(01)00186-8; Lijnen HR, 2000, J BIOL CHEM, V275, P37645, DOI 10.1074/jbc.M006475200; Liu Z, 2000, CELL, V102, P647, DOI 10.1016/S0092-8674(00)00087-8; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; LOMAS DA, 1995, J BIOL CHEM, V270, P16864, DOI 10.1074/jbc.270.28.16864; LOMAS DA, 1993, J BIOL CHEM, V268, P15333; MARSHALL CJ, 1993, PHILOS T ROY SOC B, V342, P101, DOI 10.1098/rstb.1993.0141; MAST AE, 1991, J BIOL CHEM, V266, P15810; Mauray S, 1998, BBA-PROTEIN STRUCT M, V1387, P184, DOI 10.1016/S0167-4838(98)00120-4; MOLLA A, 1989, INFECT IMMUN, V57, P1868, DOI 10.1128/IAI.57.6.1868-1871.1989; MORII M, 1983, J BIOL CHEM, V258, P2749; Nielsen HM, 2007, NEUROLOGY, V69, P1569, DOI 10.1212/01.wnl.0000271077.82508.a0; Olson ST, 2004, THROMB HAEMOSTASIS, V92, P929, DOI 10.1160/TH04-06-0384; Orth D, 2010, INFECT IMMUN, V78, P4294, DOI 10.1128/IAI.00488-10; Pearce MC, 2010, J MOL BIOL, V403, P459, DOI 10.1016/j.jmb.2010.09.007; POTEMPA J, 1988, SCIENCE, V241, P699, DOI 10.1126/science.2456616; POULSEN K, 1976, BIOCHIM BIOPHYS ACTA, V452, P533, DOI 10.1016/0005-2744(76)90205-9; Rau JC, 2007, J THROMB HAEMOST, V5, P102, DOI 10.1111/j.1538-7836.2007.02516.x; ROGERS SJ, 1992, J BIOL CHEM, V267, P3613; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHECHTER NM, 1989, J BIOL CHEM, V264, P21308; Schmidt H, 2001, INFECT IMMUN, V69, P6863, DOI 10.1128/IAI.69.11.6863-6873.2001; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; STEIN PE, 1989, BIOCHEM J, V262, P103, DOI 10.1042/bj2620103; Thelwell C, 2011, VOX SANG, V101, P83, DOI 10.1111/j.1423-0410.2010.01459.x; Toszeghy M, 2012, RES VET SCI, V93, P1142, DOI 10.1016/j.rvsc.2012.05.001; VIRCA GD, 1982, BIOCHIM BIOPHYS ACTA, V704, P267, DOI 10.1016/0167-4838(82)90155-8; Weiss A, 2013, TOXINS, V5, P25, DOI 10.3390/toxins5010025; Zhou AW, 2010, NATURE, V468, P108, DOI 10.1038/nature09505	62	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111363	10.1371/journal.pone.0111363	http://dx.doi.org/10.1371/journal.pone.0111363			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347319	Green Submitted, Green Published, gold			2022-12-27	WOS:000347994900063
J	Zhang, RC; Zhang, YH; Zhang, J; An, T; Huang, Y; Guo, X; Januzzi, JL; Cappola, TP; Yin, SJ; Wang, YH; Zhou, Q; Zou, CH; Ji, SM; Lv, R				Zhang, Rongcheng; Zhang, Yuhui; Zhang, Jian; An, Tao; Huang, Yan; Guo, Xiao; Januzzi, James L.; Cappola, Thomas P.; Yin, Shijie; Wang, Yunhong; Zhou, Qiong; Zou, Changhong; Ji, Shiming; Lv, Rong			The Prognostic Value of Plasma Soluble ST2 in Hospitalized Chinese Patients with Heart Failure	PLOS ONE			English	Article							FAMILY-MEMBER ST2; NATIONAL REGISTRY ADHERE; MYOCARDIAL-INFARCTION; NATRIURETIC PEPTIDE; RISK STRATIFICATION; EJECTION FRACTION; ACUTE DYSPNEA; MORTALITY; EPIDEMIC; OUTCOMES	Background: sST2 has been shown to be a risk predictor in heart failure (HF). Our aim was to explore the characteristics and prognostic value of soluble ST2 (sST2) in hospitalized Chinese patients with HF. Methods and Results: We consecutively enrolled 1528 hospitalized patients with HF. Receiver operating characteristic (ROC) and multivariable Cox proportional hazards analysis were used to assess the prognostic values of sST2. Adverse events were defined as all-cause death and cardiac transplantation. During a median follow-up of 19.1 months, 325 patients experienced adverse events. Compared with patients free of events, sST2 concentrations were significantly higher in patients with events (P<0.001). Univariable and multivariable Cox regression analyses showed sST2 concentrations were significantly associated with adverse events (per 1 log unit, adjusted hazard ratio 1.52, 95% confidence interval: 1.30 to 1.78, P<0.001). An sST2 concentration in the highest quartiles (>55.6 ng/mL) independently predicted events in comparison to the lowest quartile (>= 25.2 ng/mL) when adjusted by multivariable model. In ROC analysis, the area under the curve for sST2 was not different from that for NT-proBNP in short and longer term. Over time, sST2 also improved discrimination and reclassification of risk beyond NT-proBNP. Conclusions: sST2 is a strong independent risk predictor in Chinese patients hospitalized with HF and can significantly provide additional prognostic value to NT-proBNP in risk prediction.	[Zhang, Rongcheng; Zhang, Yuhui; Zhang, Jian; An, Tao; Huang, Yan; Guo, Xiao; Yin, Shijie; Wang, Yunhong; Zhou, Qiong; Zou, Changhong; Ji, Shiming; Lv, Rong] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Heart Failure Ctr Fuwai Hosp, State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China; [Zhang, Rongcheng; Zhang, Yuhui; Zhang, Jian; An, Tao; Huang, Yan; Guo, Xiao; Yin, Shijie; Wang, Yunhong; Zhou, Qiong; Zou, Changhong; Ji, Shiming; Lv, Rong] Peking Union Med Coll, Beijing 100021, Peoples R China; [Januzzi, James L.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Cappola, Thomas P.] Univ Penn, Sch Med, Penn Cardiovasc Inst, Philadelphia, PA 19104 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Harvard University; Massachusetts General Hospital; University of Pennsylvania	Zhang, YH (corresponding author), Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Heart Failure Ctr Fuwai Hosp, State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China.	yuhuizhangjoy@163.com; fwzhangjian62@126.com	Januzzi, James/Y-2436-2019		Key Projects in the National Science & Technology Pillar Program of the 12th Five-year Plan Period, Beijing, China [2011BAI11B02]	Key Projects in the National Science & Technology Pillar Program of the 12th Five-year Plan Period, Beijing, China	This study was supported by grants from the Key Projects in the National Science & Technology Pillar Program of the 12th Five-year Plan Period (No. 2011BAI11B02, project for heart failure), Beijing, China. ST2 assays were provided by Critical Diagnostics, and NT-proBNP assays were provided by Alere Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the	Adams KF, 2005, AM HEART J, V149, P209, DOI 10.1016/j.ahj.2004.08.005; Allen LA, 2009, EUR J HEART FAIL, V11, P170, DOI 10.1093/eurjhf/hfn031; Ambrosy AP, 2012, EUR J HEART FAIL, V14, P302, DOI 10.1093/eurjhf/hfs007; Bayes-Genis A, 2013, J AM COLL CARDIOL; Boisot S, 2008, J CARD FAIL, V14, P732, DOI 10.1016/j.cardfail.2008.06.415; Chinese Society of Cardiology of Chinese Medical Association, 2007, Zhonghua Xin Xue Guan Bing Za Zhi, V35, P1076; Chinese Society of Cardiology of Chinese Medical Association, 2010, Zhonghua Xin Xue Guan Bing Za Zhi, V38, P195; Fang J, 2008, J AM COLL CARDIOL, V52, P428, DOI 10.1016/j.jacc.2008.03.061; Fonarow GC, 2005, JAMA-J AM MED ASSOC, V293, P572, DOI 10.1001/jama.293.5.572; Giamouzis G, 2011, J CARD FAIL, V17, P54, DOI 10.1016/j.cardfail.2010.08.010; Januzzi JL, 2007, J AM COLL CARDIOL, V50, P607, DOI 10.1016/j.jacc.2007.05.014; Kociol RD, 2010, AM HEART J, V160, P885, DOI 10.1016/j.ahj.2010.07.020; Ky B, 2011, CIRC-HEART FAIL, V4, P180, DOI 10.1161/CIRCHEARTFAILURE.110.958223; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Manzano-Fernandez S, 2012, CARDIOLOGY, V122, P158, DOI 10.1159/000338800; Manzano-Fernandez S, 2011, AM J CARDIOL, V107, P259, DOI 10.1016/j.amjcard.2010.09.011; Moons KGM, 2012, CLIN CHEM, V58, P1408, DOI 10.1373/clinchem.2012.182550; Mueller T, 2008, CLIN CHEM, V54, P752, DOI 10.1373/clinchem.2007.096560; Pascual-Figal DA, 2011, EUR J HEART FAIL, V13, P718, DOI 10.1093/eurjhf/hfr047; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Rehman SU, 2008, J AM COLL CARDIOL, V52, P1458, DOI 10.1016/j.jacc.2008.07.042; Sabatine MS, 2008, CIRCULATION, V117, P1936, DOI 10.1161/CIRCULATIONAHA.107.728022; Sanada S, 2007, J CLIN INVEST, V117, P1538, DOI 10.1172/JCI30634; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shimpo M, 2004, CIRCULATION, V109, P2186, DOI 10.1161/01.CIR.0000127958.21003.5A; Socrates T, 2010, J INTERN MED, V268, P493, DOI 10.1111/j.1365-2796.2010.02263.x; Wu AH, 2013, AM J CARDIOL, V111, P1192, DOI 10.1016/j.amjcard.2012.12.048	28	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e110976	10.1371/journal.pone.0110976	http://dx.doi.org/10.1371/journal.pone.0110976			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347817	gold, Green Published, Green Submitted			2022-12-27	WOS:000347994900036
J	Chung, SD; Tsai, MC; Liu, SP; Lin, HC; Kang, JH				Chung, Shiu-Dong; Tsai, Ming-Chieh; Liu, Shih-Ping; Lin, Herng-Ching; Kang, Jiunn-Horng			Herpes Zoster Is Associated with Prior Statin Use: A Population-Based Case-Control Study	PLOS ONE			English	Article							COA REDUCTASE INHIBITORS; SIMVASTATIN; DISORDERS; ARTHRITIS; THERAPY; COST; RISK	Background: This study investigated the association between statin use and herpes zoster (HZ) occurrence in a population-based case-control study. Methods: Study subjects were retrieved from the Taiwan Longitudinal Health Insurance Database 2000. This study included 47,359 cases with HZ and 142,077 controls. We performed conditional logistic regression analyses to calculate the odds ratio (OR) to present the association between HZ and having previously been prescribed statin. Results: We found that 13.0% of the sampled subjects had used statins, at 15.5% and 12.1% for cases and controls, respectively (p<0.001). A conditional logistic regression analysis suggested that the adjusted OR of being a statin user before the index date for cases was 1.28 (95% confidence interval (CI): 1.24 similar to 1.32) compared to controls. Subjects aged 18 similar to 44 years had the highest adjusted OR for prior statin use among cases compared to controls (OR: 1.69; 95% CI: 1.45 similar to 1.92). Furthermore, we found that the ORs of being a regular and irregular statin user before the index date for cases were 1.32 (95% CI: 1.27 similar to 1.38) and 1.23 (95% CI: 1.181.29), respectively, compared to controls. Conclusions: We concluded that prior statin use was associated with HZ occurrence.	[Chung, Shiu-Dong] Far Eastern Mem Hosp, Dept Surg, Div Urol, New Taipei City, Taiwan; [Chung, Shiu-Dong] Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan; [Tsai, Ming-Chieh] Cathay Gen Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan; [Tsai, Ming-Chieh; Lin, Herng-Ching] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan; [Liu, Shih-Ping] Natl Taiwan Univ Hosp & Coll Med, Dept Urol, Taipei, Taiwan; [Kang, Jiunn-Horng] Taipei Med Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Kang, Jiunn-Horng] Taipei Med Univ, Coll Med, Sch Med, Dept Phys Med & Rehabil, Taipei, Taiwan	Far Eastern Memorial Hospital; Taipei Medical University; Taipei Medical University Hospital; Cathay General Hospital; Taipei Medical University; National Taiwan University; National Taiwan University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University	Kang, JH (corresponding author), Taipei Med Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan.	jhk@tmu.edu.tw		LIU, SHIH-PING/0000-0002-8015-0695				Antoniou T, 2014, CLIN INFECT DIS, V58, P350, DOI 10.1093/cid/cit745; Bongartz T, 2009, NAT REV RHEUMATOL, V5, P361, DOI 10.1038/nrrheum.2009.120; Che H, JOINT BONE IN PRESS; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Hakamada-Taguchi R, 2003, CIRC RES, V93, P948, DOI 10.1161/01.RES.0000101298.76864.14; Kaneider NC, 2001, ATHEROSCLEROSIS, V158, P23, DOI 10.1016/S0021-9150(00)00764-4; Kang JH, 2010, ANN RHEUM DIS, V69, P1165, DOI 10.1136/ard.2009.116178; Leung BP, 2003, J IMMUNOL, V170, P1524, DOI 10.4049/jimmunol.170.3.1524; McFarlane SI, 2002, J CLIN ENDOCR METAB, V87, P1451, DOI 10.1210/jc.87.4.1451; Mihos CG, 2012, RHEUMATOL INT, V32, P287, DOI 10.1007/s00296-011-2008-6; Mihos CG, 2010, CARDIOL REV, V18, P298, DOI 10.1097/CRD.0b013e3181f52a7f; Rezaie-Majd A, 2002, ARTERIOSCL THROM VAS, V22, P1194, DOI 10.1161/01.ATV.0000022694.16328.CC; Rosenson RS, 1999, LANCET, V353, P983, DOI 10.1016/S0140-6736(98)05917-0; Schmader K, 2008, J INFECT DIS, V197, pS207, DOI 10.1086/522152; Stein AN, 2009, VACCINE, V27, P520, DOI 10.1016/j.vaccine.2008.11.012; Terao M, 2005, SKIN RES, V4, P335; Weaver BA, 2007, J AM OSTEOPATH ASSOC, V107, pS2; Whitley RJ, 2009, JAMA-J AM MED ASSOC, V301, P774, DOI 10.1001/jama.2009.150; Wolfe F, 2006, RHEUMATOLOGY, V45, P1370, DOI 10.1093/rheumatology/kel328; Yawn BP, 2009, MAYO CLIN PROC, V84, P787, DOI [10.4065/84.9.787, 10.1016/S0025-6196(11)60488-6]; Yende S, 2011, CRIT CARE MED, V39, P1871, DOI 10.1097/CCM.0b013e31821b8290	21	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111268	10.1371/journal.pone.0111268	http://dx.doi.org/10.1371/journal.pone.0111268			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343666	gold, Green Submitted, Green Published			2022-12-27	WOS:000343943500090
J	Khrennikov, A; Basieva, I; Dzhafarov, EN; Busemeyer, JR				Khrennikov, Andrei; Basieva, Irina; Dzhafarov, Ehtibar N.; Busemeyer, Jerome R.			Quantum Models for Psychological Measurements: An Unsolved Problem	PLOS ONE			English	Article								There has been a strong recent interest in applying quantum theory (QT) outside physics, including in cognitive science. We analyze the applicability of QT to two basic properties in opinion polling. The first property (response replicability) is that, for a large class of questions, a response to a given question is expected to be repeated if the question is posed again, irrespective of whether another question is asked and answered in between. The second property (question order effect) is that the response probabilities frequently depend on the order in which the questions are asked. Whenever these two properties occur together, it poses a problem for QT. The conventional QT with Hermitian operators can handle response replicability, but only in the way incompatible with the question order effect. In the generalization of QT known as theory of positive-operator-valued measures (POVMs), in order to account for response replicability, the POVMs involved must be conventional operators. Although these problems are not unique to QT and also challenge conventional cognitive theories, they stand out as important unresolved problems for the application of QT to cognition. Either some new principles are needed to determine the bounds of applicability of QT to cognition, or quantum formalisms more general than POVMs are needed.	[Khrennikov, Andrei; Basieva, Irina] Linnaeus Univ, Dept Math, Vaxjo, Sweden; [Dzhafarov, Ehtibar N.] Purdue Univ, Dept Psychol Sci, W Lafayette, IN 47907 USA; [Busemeyer, Jerome R.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA	Linnaeus University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University Bloomington	Dzhafarov, EN (corresponding author), Purdue Univ, Dept Psychol Sci, W Lafayette, IN 47907 USA.	ehtibar@purdue.edu	Busemeyer, Jerome R./H-9707-2017; Basieva, Irina/U-8382-2019; khrennikov, Andrei/E-4310-2014	Busemeyer, Jerome R./0000-0002-7594-1871; Basieva, Irina/0000-0003-2396-6193	National Science Foundation [SES-1155956]; Air Force Office of Scientific Research [FA9550-12-1-0397]; Linnaeus University Modeling of Complex Hierarchic Systems grant; Direct For Social, Behav & Economic Scie [1155956] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Linnaeus University Modeling of Complex Hierarchic Systems grant; Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	Funding provided by National Science Foundation grant SES-1155956 to ED (http://www.nsf.gov), Air Force Office of Scientific Research grant FA9550-12-1-0397 to JB (http://www.wpafb.af.mil/afrl/afosr/) and Linnaeus University Modeling of Complex Hierarchic Systems grant to IB and AK (http://lnu.se/research?l=en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson R, 1962, IEEE T INFORM THEORY, V8, P155; Bina M, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.012305; Busch P., 1997, LECT NOTES PHYS MONO; Busemeyer Jerome R., 2012, QUANTUM MODELS COGNI; Haven E., 2012, QUANTUM SOCIAL SCI; Moore DW, 2002, PUBLIC OPIN QUART, V66, P80, DOI 10.1086/338631; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Pauli W., 1980, GEN PRINCIPLES QUANT; Pothos EM, 2013, BEHAV BRAIN SCI, V36, P255, DOI 10.1017/S0140525X12001525; Wang Z, 2013, TOP COGN SCI, V5, P689, DOI 10.1111/tops.12040; Woodworth RobertS., 1921, PSYCHOL STUDY MENTAL	11	54	54	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110909	10.1371/journal.pone.0110909	http://dx.doi.org/10.1371/journal.pone.0110909			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BL	25343581	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000343943500066
J	Loh, CCY; Suwanarusk, R; Lee, YQ; Chan, KWK; Choy, KY; Renia, L; Russell, B; Lear, MJ; Nosten, FH; Tan, KSW; Chow, LMC				Loh, Cheryl C. Y.; Suwanarusk, Rossarin; Lee, Yan Quan; Chan, Kitti W. K.; Choy, Kit-Ying; Renia, Laurent; Russell, Bruce; Lear, Martin J.; Nosten, Francois H.; Tan, Kevin S. W.; Chow, Larry M. C.			Characterization of the Commercially-Available Fluorescent Chloroquine-BODIPY Conjugate, LynxTag-CQ(GREEN), as a Marker for Chloroquine Resistance and Uptake in a 96-Well Plate Assay	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; IN-VITRO; DRUG-RESISTANCE; MALARIA; PARASITES; TRANSPORT; REVERSAL; EFFLUX; VERAPAMIL; DERIVATIVES	Chloroquine was a cheap, extremely effective drug against Plasmodium falciparum until resistance arose. One approach to reversing resistance is the inhibition of chloroquine efflux from its site of action, the parasite digestive vacuole. Chloroquine accumulation studies have traditionally relied on radiolabelled chloroquine, which poses several challenges. There is a need for development of a safe and biologically relevant substitute. We report here a commercially-available green fluorescent chloroquine-BODIPY conjugate, LynxTag-CQ(GREEN), as a proxy for chloroquine accumulation. This compound localized to the digestive vacuole of the parasite as observed under confocal microscopy, and inhibited growth of chloroquine-sensitive strain 3D7 more extensively than in the resistant strains 7G8 and K1. Microplate reader measurements indicated suppression of LynxTag-CQ(GREEN) efflux after pretreatment of parasites with known reversal agents. Microsomes carrying either sensitiveor resistant-type PfCRT were assayed for uptake; resistant-type PfCRT exhibited increased accumulation of LynxTag-CQ(GREEN), which was suppressed by pretreatment with known chemosensitizers. Eight laboratory strains and twelve clinical isolates were sequenced for PfCRT and Pgh1 haplotypes previously reported to contribute to drug resistance, and pfmdr1 copy number and chloroquine IC(50)s were determined. These data were compared with LynxTag-CQ(GREEN) uptake/fluorescence by multiple linear regression to identify genetic correlates of uptake. Uptake of the compound correlated with the logIC(50) of chloroquine and, more weakly, a mutation in Pgh1, F1226Y.	[Loh, Cheryl C. Y.; Lee, Yan Quan; Chan, Kitti W. K.; Russell, Bruce; Tan, Kevin S. W.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117548, Singapore; [Suwanarusk, Rossarin; Renia, Laurent] Singapore Immunol Network Agcy Sci Technol & Res, Biopolis, Singapore, Singapore; [Lee, Yan Quan; Tan, Kevin S. W.] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Choy, Kit-Ying; Chow, Larry M. C.] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, State Key Lab Chirosci, Kowloon, Hong Kong, Peoples R China; [Lear, Martin J.] Tohoku Univ, Grad Sch Sci, Dept Chem, Aoba Ku, Sendai, Miyagi 980, Japan; [Nosten, Francois H.] Univ Oxford, Ctr Trop Med, Nuffield Dept Med, Oxford, England; [Nosten, Francois H.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Shoklo Malaria Res Unit, Mae Sot, Thailand; [Nosten, Francois H.] Univ Oxford, Churchill Hosp, Ctr Trop Med, Oxford, England	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National University of Singapore; Hong Kong Polytechnic University; Tohoku University; University of Oxford; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford	Tan, KSW (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117548, Singapore.	kevin_tan@nuhs.edu.sg; larry.chow@polyu.edu.hk	Lee, Yan Quan/T-1058-2019; Lear, Martin/Y-2724-2019; Lear, Martin/D-3350-2013; Renia, Laurent/E-2117-2011; Russell, Bruce/A-9240-2011; Nosten, Francois/AAC-5509-2019; Suwanarusk, Rossarin/E-2115-2013; Chow, Larry/C-2639-2009	Lee, Yan Quan/0000-0001-7509-7474; Lear, Martin/0000-0003-2556-2029; Lear, Martin/0000-0003-2556-2029; Renia, Laurent/0000-0003-0349-1557; Russell, Bruce/0000-0003-2333-4348; Nosten, Francois/0000-0002-7951-0745; Suwanarusk, Rossarin/0000-0002-7310-245X; Chow, Larry/0000-0002-9222-8322	Wellcome Trust of Great Britain; National Research Foundation [NRF2009NRF-POC002-102]; National Medical Research Council [NMRC/1310/2011, NMRC/EDG/1038/2011]; Agency for Science, Technology and Research (A*STAR, Singapore)	Wellcome Trust of Great Britain(Wellcome Trust); National Research Foundation; National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Agency for Science, Technology and Research (A*STAR, Singapore)(Agency for Science Technology & Research (A*STAR))	As part of the Oxford Tropical Medicine Research Program of Wellcome Trust-Mahidol University, Shoklo Malaria Research Unit (SMRU) is funded by the Wellcome Trust of Great Britain. The authors further thank the National Research Foundation (NRF2009NRF-POC002-102), the National Medical Research Council (NMRC/1310/2011; NMRC/EDG/1038/2011), and the Agency for Science, Technology and Research (A*STAR, Singapore) for their generous support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adovelande J, 1998, BIOCHEM PHARMACOL, V55, P433, DOI 10.1016/S0006-2952(97)00482-6; Alcantara LM, 2013, EXP PARASITOL, V134, P235, DOI 10.1016/j.exppara.2013.03.022; [Anonymous], 2006, DRUG DISCOV TODAY TH; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; BAYOUMI RAL, 1994, ACTA TROP, V58, P141, DOI 10.1016/0001-706X(94)90053-1; Burgess SJ, 2006, J MED CHEM, V49, P5623, DOI 10.1021/jm060399n; Butler AR, 2010, J ROY COLL PHYS EDIN, V40, P172, DOI 10.4997/JRCPE.2010.216; Cabrera M, 2009, BIOCHEMISTRY-US, V48, P9471, DOI 10.1021/bi901034r; Ch'ng JH, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.97; Ch'ng JH, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.2; Ch'ng JH, 2013, SCI REP-UK, V3, DOI 10.1038/srep01734; COATNEY GR, 1963, AM J TROP MED HYG, V12, P121, DOI 10.4269/ajtmh.1963.12.121; De DY, 1996, AM J TROP MED HYG, V55, P579, DOI 10.4269/ajtmh.1996.55.579; Egan TJ, 2007, CURR OPIN INFECT DIS, V20, P598, DOI 10.1097/QCO.0b013e3282f1673a; Gildenhuys J, 2013, J AM CHEM SOC, V135, P1037, DOI 10.1021/ja308741e; Hempelmann E, 2007, PARASITOL RES, V100, P671, DOI 10.1007/s00436-006-0313-x; HOMEWOOD CA, 1972, NATURE, V235, P50, DOI 10.1038/235050a0; Kelly JX, 2007, ANTIMICROB AGENTS CH, V51, P4133, DOI 10.1128/AAC.00669-07; Krafts K, 2012, PARASITOL RES, V111, P1, DOI 10.1007/s00436-012-2886-x; KROGSTAD DJ, 1992, BIOCHEM PHARMACOL, V43, P57, DOI 10.1016/0006-2952(92)90661-2; KYLE DE, 1990, T ROY SOC TROP MED H, V84, P474, DOI 10.1016/0035-9203(90)90004-X; Lakshmanan V, 2005, EMBO J, V24, P2294, DOI 10.1038/sj.emboj.7600681; Martin RE, 2012, ANTIMICROB AGENTS CH, V56, P2283, DOI 10.1128/AAC.00166-12; Martin RE, 2009, SCIENCE, V325, P1680, DOI 10.1126/science.1175667; MARTIN SK, 1987, SCIENCE, V235, P899, DOI 10.1126/science.3544220; MARTINEY JA, 1995, J BIOL CHEM, V270, P22393, DOI 10.1074/jbc.270.38.22393; Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624; Mok S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-391; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Oduola AMJ, 1998, AM J TROP MED HYG, V58, P625, DOI 10.4269/ajtmh.1998.58.625; Peyton DH, 2012, CURR TOP MED CHEM, V12, P400; Pradines B, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-268; Price RN, 2004, LANCET, V364, P438, DOI 10.1016/S0140-6736(04)16767-6; Raj DK, 2009, J BIOL CHEM, V284, P7687, DOI 10.1074/jbc.M806944200; Sanchez CP, 2010, INT J PARASITOL, V40, P1109, DOI 10.1016/j.ijpara.2010.04.001; Sanchez CP, 2004, BIOCHEMISTRY-US, V43, P16365, DOI 10.1021/bi048241x; Sanchez CP, 2003, BIOCHEMISTRY-US, V42, P9383, DOI 10.1021/bi034269h; Sullivan DJ, 1996, SCIENCE, V271, P219, DOI 10.1126/science.271.5246.219; Summers RL, 2014, P NATL ACAD SCI USA, V111, pE1759, DOI 10.1073/pnas.1322965111; Summers RL, 2010, VIRULENCE, V1, P304, DOI 10.4161/viru.1.4.12012; Takala-Harrison S, 2013, P NATL ACAD SCI USA, V110, P240, DOI 10.1073/pnas.1211205110; Tan W, 2006, ARCH BIOCHEM BIOPHYS, V452, P119, DOI 10.1016/j.abb.2006.06.017; Tram K, 2009, DYES PIGMENTS, V82, P392, DOI 10.1016/j.dyepig.2009.03.001; Valderramos SG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000887; van Schalkwyk DA, 2001, ANTIMICROB AGENTS CH, V45, P3171, DOI 10.1128/AAC.45.11.3171-3174.2001; Veiga MI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020212; Wellems TE, 2001, J INFECT DIS, V184, P770, DOI 10.1086/322858; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Witkowski B, 2013, LANCET INFECT DIS, V13, P1043, DOI 10.1016/S1473-3099(13)70252-4; YAYON A, 1984, EMBO J, V3, P2695, DOI 10.1002/j.1460-2075.1984.tb02195.x; Zishiri VK, 2011, EUR J MED CHEM, V46, P1729, DOI 10.1016/j.ejmech.2011.02.026	51	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110800	10.1371/journal.pone.0110800	http://dx.doi.org/10.1371/journal.pone.0110800			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343249	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000343943500056
J	Huang, TX; Li, S; Li, GC; Tian, Y; Wang, HY; Shi, LF; Perez-Cordon, G; Mao, L; Wang, X; Wang, JF; Feng, HP				Huang, Tuxiong; Li, Shan; Li, Guangchao; Tian, Yuan; Wang, Haiying; Shi, Lianfa; Perez-Cordon, Gregorio; Mao, Li; Wang, Xiaoning; Wang, Jufang; Feng, Hanping			Utility of Clostridium difficile Toxin B for Inducing Anti-Tumor Immunity	PLOS ONE			English	Article							APOPTOTIC TUMOR-CELLS; DENDRITIC CELLS; CALRETICULIN EXPOSURE; HUMAN MONOCYTES; CANCER; IMMUNOGENICITY; INFECTION; PROTEINS; DEATH; RHO	Clostridium difficile toxin B (TcdB) is a key virulence factor of bacterium and induces intestinal inflammatory disease. Because of its potent cytotoxic and proinflammatory activities, we investigated the utility of TcdB in developing anti-tumor immunity. TcdB induced cell death in mouse colorectal cancer CT26 cells, and the intoxicated cells stimulated the activation of mouse bone marrow-derived dendritic cells and subsequent T cell activation in vitro. Immunization of BALB/c mice with toxin-treated CT26 cells elicited potent anti-tumor immunity that protected mice from a lethal challenge of the same tumor cells and rejected pre-injected tumors. The anti-tumor immunity generated was cell-mediated, long-term, and tumor-specific. Further experiments demonstrated that the intact cell bodies were important for the immunogenicity since lysing the toxin-treated tumor cells reduced their ability to induce antitumor immunity. Finally, we showed that TcdB is able to induce potent anti-tumor immunity in B16-F10 melanoma model. Taken together, these data demonstrate the utility of C. difficile toxin B for developing anti-tumor immunity.	[Huang, Tuxiong; Li, Shan; Li, Guangchao; Tian, Yuan; Wang, Haiying; Wang, Jufang] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China; [Huang, Tuxiong; Li, Shan; Shi, Lianfa; Perez-Cordon, Gregorio; Feng, Hanping] Univ Maryland, Sch Dent, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA; [Mao, Li] Univ Maryland, Sch Dent, Dept Oncol & Diagnost, Baltimore, MD 21201 USA; [Wang, Xiaoning] Gen Hosp Peoples Liberat Army, Inst Life Sci, Beijing, Peoples R China	South China University of Technology; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Wang, JF (corresponding author), S China Univ Technol, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China.	jufwang@scut.edu.cn; hfeng@umaryland.edu	Pérez-Cordon, Gregorio/F-7944-2018	Pérez-Cordon, Gregorio/0000-0002-2295-3852	National Institutes of Health (NIH) [R01AI088748, R01DK084509, R56AI99458, U19AI109776]; Department of Health and Human Services; National High Technology Development Program of China [2007AA021702]; Scientific and Technological Specialized Project for the national New Medicine Formulation from China [2011ZX09506-001]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI099458, U19AI109776, R01AI088748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084509] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; National High Technology Development Program of China; Scientific and Technological Specialized Project for the national New Medicine Formulation from China; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by grants R01AI088748, R01DK084509, R56AI99458, and U19AI109776 from National Institutes of Health (NIH) and the Department of Health and Human Services to HF; and grants from the National High Technology Development Program of China (2007AA021702) and the Scientific and Technological Specialized Project for the national New Medicine Formulation (2011ZX09506-001) from China to JW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albesa-Jove D, 2010, J MOL BIOL, V396, P1260, DOI 10.1016/j.jmb.2010.01.012; BEKESI JG, 1971, CANCER RES, V31, P2130; Bobo LD, 2013, INFECT IMMUN, V81, P713, DOI 10.1128/IAI.00186-12; BOON T, 1994, ANNU REV IMMUNOL, V12, P337, DOI 10.1146/annurev.immunol.12.1.337; BUZZI S, 1974, CANCER RES, V34, P3481; Casares N, 2005, J EXP MED, V202, P1691, DOI 10.1084/jem.20050915; Chumbler NM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003072; Farrow MA, 2013, P NATL ACAD SCI USA, V110, P18674, DOI 10.1073/pnas.1313658110; Feng HP, 2001, BLOOD, V97, P3505, DOI 10.1182/blood.V97.11.3505; Feng HP, 2002, BLOOD, V100, P4108, DOI 10.1182/blood-2002-05-1389; Feng HP, 2005, J IMMUNOL, V175, P421, DOI 10.4049/jimmunol.175.1.421; Feng HP, 2003, BLOOD, V101, P245, DOI 10.1182/blood-2002-05-1580; FLEGEL WA, 1991, INFECT IMMUN, V59, P3659, DOI 10.1128/IAI.59.10.3659-3666.1991; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Hippenstiel S, 2002, AM J PHYSIOL-LUNG C, V283, pL830, DOI 10.1152/ajplung.00467.2001; Huelsenbeck J, 2007, INFECT IMMUN, V75, P801, DOI 10.1128/IAI.01705-06; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; JUST I, 1995, J CLIN INVEST, V95, P1026, DOI 10.1172/JCI117747; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; KUSHNARYOV VM, 1992, CANCER RES, V52, P5096; Linevsky JK, 1997, AM J PHYSIOL-GASTR L, V273, pG1333, DOI 10.1152/ajpgi.1997.273.6.G1333; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; Ng EK, 2003, MEDIAT INFLAMM, V12, P3, DOI 10.1080/0962935031000096917; Obeid M, 2007, CELL DEATH DIFFER, V14, P1848, DOI 10.1038/sj.cdd.4402201; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Pothoulakis C, 1996, EUR J GASTROEN HEPAT, V8, P1041, DOI 10.1097/00042737-199611000-00003; Poxton IR, 2001, CLIN MICROBIOL INFEC, V7, P421, DOI 10.1046/j.1198-743x.2001.00287.x; Pruitt RN, 2010, P NATL ACAD SCI USA, V107, P13467, DOI 10.1073/pnas.1002199107; Qa'Dan M, 2002, CELL MICROBIOL, V4, P425, DOI 10.1046/j.1462-5822.2002.00201.x; REDLICH PN, 1994, J SURG ONCOL, V57, P191; RIHN B, 1985, BIOL CELL, V53, P23, DOI 10.1111/j.1768-322X.1985.tb00351.x; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Savidge TC, 2003, GASTROENTEROLOGY, V125, P413, DOI 10.1016/S0016-5085(03)00902-8; Steinman RM, 2004, SCIENCE, V305, P197, DOI 10.1126/science.1099688; Sun XM, 2009, MICROB PATHOGENESIS, V46, P298, DOI 10.1016/j.micpath.2009.03.002; Tesniere A, 2008, CELL DEATH DIFFER, V15, P3, DOI 10.1038/sj.cdd.4402269; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Wang HY, 2012, INFECT IMMUN, V80, P2678, DOI 10.1128/IAI.00215-12; WANG M, 1995, J IMMUNOL, V154, P4685; Yang GL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-192; Zitvogel L, 2006, NAT REV IMMUNOL, V6, P715, DOI 10.1038/nri1936	42	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110826	10.1371/journal.pone.0110826	http://dx.doi.org/10.1371/journal.pone.0110826			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340750	gold, Green Published, Green Submitted			2022-12-27	WOS:000343662800060
J	Liu, H; Chen, GD; Pan, YF; Chen, ZX; Jin, W; Sun, C; Chen, C; Dong, XJ; Chen, K; Xu, ZP; Zhang, SC; Yu, YX				Liu, Hui; Chen, Guangdi; Pan, Yifeng; Chen, Zexin; Jin, Wen; Sun, Chuan; Chen, Chunjing; Dong, Xuanjun; Chen, Kun; Xu, Zhengping; Zhang, Shanchun; Yu, Yunxian			Occupational Electromagnetic Field Exposures Associated with Sleep Quality: A Cross-Sectional Study	PLOS ONE			English	Article							PHONE BASE STATIONS; CEREBRAL-BLOOD-FLOW; MAGNETIC-FIELDS; MOBILE PHONES; OF-LIFE; PREVALENCE; SYMPTOMS; EXCRETION; WORKERS; CANCER	Background: Exposure to electromagnetic field (EMF) emitted by mobile phone and other machineries concerns half the world's population and raises the problem of their impact on human health. The present study aims to explore the effects of electromagnetic field exposures on sleep quality and sleep duration among workers from electric power plant. Methods: A cross-sectional study was conducted in an electric power plant of Zhejiang Province, China. A total of 854 participants were included in the final analysis. The detailed information of participants was obtained by trained investigators using a structured questionnaire, which including socio-demographic characteristics, lifestyle variables, sleep variables and electromagnetic exposures. Physical examination and venous blood collection were also carried out for every study subject. Results: After grouping daily occupational electromagnetic exposure into three categories, subjects with long daily exposure time had a significantly higher risk of poor sleep quality in comparison to those with short daily exposure time. The adjusted odds ratios were 1.68 (95%CI: 1.18, 2.39) and 1.57 (95%CI: 1.10, 2.24) across tertiles. Additionally, among the subjects with long-term occupational exposure, the longer daily occupational exposure time apparently increased the risk of poor sleep quality (OR (95%CI): 2.12 (1.23 similar to 3.66)in the second tertile; 1.83 (1.07 similar to 3.15) in the third tertile). There was no significant association of long-term occupational exposure duration, monthly electric fee or years of mobile-phone use with sleep quality or sleep duration. Conclusions: The findings showed that daily occupational EMF exposure was positively associated with poor sleep quality. It implies EMF exposure may damage human sleep quality rather than sleep duration.	[Liu, Hui; Pan, Yifeng; Chen, Zexin; Jin, Wen; Chen, Kun; Zhang, Shanchun; Yu, Yunxian] Zhejiang Univ, Sch Med, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Guangdi; Sun, Chuan; Chen, Chunjing; Xu, Zhengping] Zhejiang Univ, Sch Med, Bioelectromagnet Lab, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Hui; Pan, Yifeng; Chen, Zexin; Jin, Wen; Zhang, Shanchun; Yu, Yunxian] Zhejiang Univ, Sch Med, Sch Publ Hlth, Chron Dis Res Inst, Hangzhou 310003, Zhejiang, Peoples R China; [Dong, Xuanjun] Yiwu Ctr Dis Control & Prevent, Yiwu, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Yu, YX (corresponding author), Zhejiang Univ, Sch Med, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Hangzhou 310003, Zhejiang, Peoples R China.	yunxianyu@gmail.com			National Basic Research Program of China (973 Program) [2011CB503706]; National Natural Science Foundation of China [81172624]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was funded by grants from the National Basic Research Program of China (973 Program) (Grant No.: 2011CB503706) and the National Natural Science Foundation of China (Grant No.: 81172624). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelin T, 2005, SLEEP DISTURBANCES V, P203; Ahlbom A, 2004, ENVIRON HEALTH PERSP, V112, P1741, DOI 10.1289/ehp.7306; Altpeter ES, 2006, BIOELECTROMAGNETICS, V27, P142, DOI 10.1002/bem.20183; Berg-Beckhoff G, 2009, OCCUP ENVIRON MED, V66, P124, DOI 10.1136/oem.2008.039834; Bryant PA, 2004, NAT REV IMMUNOL, V4, P457, DOI 10.1038/nri1369; Burch JB, 1998, SCAND J WORK ENV HEA, V24, P183, DOI 10.5271/sjweh.297; Dean GE, 2013, ONCOL NURS FORUM, V40, P441, DOI 10.1188/13.ONF.441-451; Fogler KA, 2012, EMERG HLTH THREATS J, V5; Frei P, 2009, ENVIRON RES, V109, P779, DOI 10.1016/j.envres.2009.04.015; Fritzer G, 2007, BIOELECTROMAGNETICS, V28, P316, DOI 10.1002/bem.20301; Gami AS, 2004, EUR HEART J, V25, P709, DOI 10.1016/j.ehj.2004.03.008; Genuis SJ, 2008, PUBLIC HEALTH, V122, P113, DOI 10.1016/j.puhe.2007.04.008; Gottlieb DJ, 2005, ARCH INTERN MED, V165, P863, DOI 10.1001/archinte.165.8.863; Guo YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071107; Halgamuge MN, 2012, PINEAL MELATONIN LEV; Huber R, 2005, EUR J NEUROSCI, V21, P1000, DOI 10.1111/j.1460-9568.2005.03929.x; Huber R, 2002, J SLEEP RES, V11, P289, DOI 10.1046/j.1365-2869.2002.00314.x; Hutter HP, 2006, OCCUP ENVIRON MED, V63, P307, DOI 10.1136/oem.2005.020784; Khurana VG, 2009, SURG NEUROL, V72, P205, DOI 10.1016/j.surneu.2009.01.019; Liu R, SLEEP MED, V12, P914; Lo CMH, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-72; Loughran SP, 2005, NEUROREPORT, V16, P1973, DOI 10.1097/01.wnr.0000186593.79705.3c; Lowden A, 2011, BIOELECTROMAGNETICS, V32, P4, DOI 10.1002/bem.20609; Manabe K, 2000, GERONTOLOGY, V46, P318, DOI 10.1159/000022184; Mohler E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037455; Mohler E, 2010, RADIAT RES, V174, P347, DOI 10.1667/RR2153.1; Monterrosa-Castro A, 2012, MENOPAUSE; Pfluger DH, 1996, J PINEAL RES, V21, P91, DOI 10.1111/j.1600-079X.1996.tb00275.x; Reiter Russel J., 1994, Reviews on Environmental Health, V10, P171; Repacholi MH, 2012, BIOELECTROMAGNETICS, V33, P187, DOI 10.1002/bem.20716; Roberts RE, 2012, J AFFECT DISORD; Roosli M, 2010, B WORLD HEALTH ORGAN, V88, P887, DOI 10.2471/BLT.09.071852; Schreier N, 2006, SOZ PRAVENTIV MED, V51, P202, DOI 10.1007/s00038-006-5061-2; Siu YF, 2012, PAIN MED, V13, P1292, DOI 10.1111/j.1526-4637.2012.01473.x; Taheri S, 2004, PLOS MED, V1, P210, DOI 10.1371/journal.pmed.0010062; Thomas S, 2008, BIOELECTROMAGNETICS, V29, P463, DOI 10.1002/bem.20414; Valberg PA, 2007, ENVIRON HEALTH PERSP, V115, P416, DOI 10.1289/ehp.9633; Wang Hui-shan, 2007, Zhonghua Yufang Yixue Zazhi, V41, P204; WILSON BW, 1990, J PINEAL RES, V9, P259, DOI 10.1111/j.1600-079X.1990.tb00901.x; Yu YX, 2007, SLEEP, V30, P1688, DOI 10.1093/sleep/30.12.1688	40	7	7	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110825	10.1371/journal.pone.0110825	http://dx.doi.org/10.1371/journal.pone.0110825			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340654	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662800059
J	Lopez-Carretero, A; Diaz-Castelazo, C; Boege, K; Rico-Gray, V				Lopez-Carretero, Antonio; Diaz-Castelazo, Cecilia; Boege, Karina; Rico-Gray, Victor			Evaluating the Spatio-Temporal Factors that Structure Network Parameters of Plant-Herbivore Interactions	PLOS ONE			English	Article							ANIMAL MUTUALISTIC NETWORKS; FOOD-WEB; SPECIES COMPOSITION; INSECT HERBIVORES; HOST-SPECIFICITY; BETA-DIVERSITY; FOREST; COMMUNITIES; SPECIALIZATION; TREE	Despite the dynamic nature of ecological interactions, most studies on species networks offer static representations of their structure, constraining our understanding of the ecological mechanisms involved in their spatio-temporal stability. This is the first study to evaluate plant-herbivore interaction networks on a small spatio-temporal scale. Specifically, we simultaneously assessed the effect of host plant availability, habitat complexity and seasonality on the structure of plant-herbivore networks in a coastal tropical ecosystem. Our results revealed that changes in the host plant community resulting from seasonality and habitat structure are reflected not only in the herbivore community, but also in the emergent properties (network parameters) of the plant-herbivore interaction network such as connectance, selectiveness and modularity. Habitat conditions and periods that are most stressful favored the presence of less selective and susceptible herbivore species, resulting in increased connectance within networks. In contrast, the high degree of selectivennes (i.e. interaction specialization) and modularity of the networks under less stressful conditions was promoted by the diversification in resource use by herbivores. By analyzing networks at a small spatio-temporal scale we identified the ecological factors structuring this network such as habitat complexity and seasonality. Our research offers new evidence on the role of abiotic and biotic factors in the variation of the properties of species interaction networks.	[Lopez-Carretero, Antonio; Diaz-Castelazo, Cecilia] Inst Ecol AC, Xalapa, Veracruz, Mexico; [Boege, Karina] Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico; [Rico-Gray, Victor] Univ Veracruzana, Inst Neuroetol, Xalapa 91000, Veracruz, Mexico	Instituto de Ecologia - Mexico; Universidad Nacional Autonoma de Mexico; Universidad Veracruzana	Diaz-Castelazo, C (corresponding author), Inst Ecol AC, Xalapa, Veracruz, Mexico.	diazcastelazogm@gmail.com	Díaz Castelazo, Cecilia/Q-8973-2018; Paré, Karina Boege/AAP-9596-2021	Díaz Castelazo, Cecilia/0000-0002-0185-6607; 	CONACYT [106575, 302184]; Instituto de Ecologia A.C. (INECOL); Universidad Veracruzana, CONACYT [I010/152/2014 C-133/2014]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Instituto de Ecologia A.C. (INECOL); Universidad Veracruzana, CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Research was supported by grant (project) number 106575 from CONACYT to Cecilia Diaz-Castelazo, CONACYT fellowship number 302184 to Antonio Lopez-Carretero, and Universidad Veracruzana, I010/152/2014 C-133/2014 provided by CONACYT. We acknowledge the financial support provided by Instituto de Ecologia A.C. (INECOL) through the Postgraduate Secretary to Antonio Lopez-Carretero. CONACYT URL is http://www.conacyt.gob.mx/Paginas/InicioNueva.aspx, INECOL URL is http://www.inecol.mx/posgrado/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon R, 2008, OIKOS, V117, P1796, DOI 10.1111/j.0030-1299.2008.16987.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Barber NA, 2011, ECOLOGY, V92, P699, DOI 10.1890/10-0125.1; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Basset Y, 1996, ECOLOGY, V77, P1906, DOI 10.2307/2265793; BERNAYS E, 1988, ECOLOGY, V69, P886, DOI 10.2307/1941237; Bernays EA, 2001, ANNU REV ENTOMOL, V46, P703, DOI 10.1146/annurev.ento.46.1.703; Bezemer TM, 1998, OIKOS, V82, P212, DOI 10.2307/3546961; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Boege K, 2005, OECOLOGIA, V143, P117, DOI 10.1007/s00442-004-1779-9; Brehm G, 2003, DIVERS DISTRIB, V9, P351, DOI 10.1046/j.1472-4642.2003.00023.x; Cagnolo L., 2011, J ANIM ECOL, V12, P1; Chacoff NP, 2012, J ANIM ECOL, V81, P190, DOI 10.1111/j.1365-2656.2011.01883.x; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; de Ruiter PC, 2005, SCIENCE, V309, P68, DOI 10.1126/science.1096112; Diaz-Castelazo C, 2010, ECOLOGY, V91, P793, DOI 10.1890/08-1883.1; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Dormann C.F., 2009, OPN ECOL J, V2, P7, DOI 10.2174/1874213000902010007; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Dupont YL, 2009, OIKOS, V118, P1261, DOI 10.1111/j.1600-0706.2009.17594.x; Dupont YL, 2009, J ANIM ECOL, V78, P346, DOI 10.1111/j.1365-2656.2008.01501.x; Fontaine C, 2009, P R SOC B, V276, P3027, DOI 10.1098/rspb.2009.0635; Futuyma DJ, 2009, P NATL ACAD SCI USA, V106, P18054, DOI 10.1073/pnas.0904106106; GASTON KJ, 1988, AM NAT, V132, P662, DOI 10.1086/284881; Heleno R, 2012, ECOL INDIC, V14, P7, DOI 10.1016/j.ecolind.2011.06.032; Holt RD, 1999, ECOLOGY, V80, P1495, DOI 10.2307/176542; Hughes JB, 2000, OECOLOGIA, V123, P375, DOI 10.1007/s004420051024; Janzen Daniel H., 1993, P448; JANZEN DH, 1988, BIOTROPICA, V20, P120, DOI 10.2307/2388184; Jeffries JM, 2006, ECOL APPL, V16, P901, DOI 10.1890/1051-0761(2006)016[0901:FAIOIH]2.0.CO;2; JEFFRIES MJ, 1984, BIOL J LINN SOC, V23, P269, DOI 10.1111/j.1095-8312.1984.tb00145.x; Kaartinen R, 2011, J ANIM ECOL, V80, P622, DOI 10.1111/j.1365-2656.2011.01811.x; Laliberte E, 2010, ECOLOGY, V91, P1740, DOI 10.1890/09-1328.1; Leps J, 1998, OIKOS, V81, P538, DOI 10.2307/3546774; Leps J, 2001, J ECOL, V89, P186, DOI 10.1046/j.1365-2745.2001.00540.x; Lewinsohn TM, 2008, ECOL LETT, V11, P398, DOI 10.1111/j.1461-0248.2008.01155.x; Lewinsohn TM, 2005, ANNU REV ECOL EVOL S, V36, P597, DOI 10.1146/annurev.ecolsys.36.091704.175520; Lewinsohn TM, 2006, OIKOS, V113, P174, DOI 10.1111/j.0030-1299.2006.14583.x; Lopez-Carretero A, 2010, COMPOSICION DIVERSID; Marquitti FMD, 2013, ECOGRAPHY; Martinez ML, 1994, SOBREVIVENCIA ESTABL; Melian CJ, 2002, ECOL LETT, V5, P705, DOI 10.1046/j.1461-0248.2002.00386.x; MORENO-CASASOLA P, 1982, Biotica (Mexico), V7, P577; MORENO-CASASOLA P., 2006, ENTORNOS VERACRUZANO, P205; Murakami M, 2008, ECOL RES, V23, P179, DOI 10.1007/s11284-007-0353-4; Novotny V, 2000, OIKOS, V89, P564, DOI 10.1034/j.1600-0706.2000.890316.x; Novotny V, 2005, P ROY SOC B-BIOL SCI, V272, P1083, DOI 10.1098/rspb.2004.3023; Novotny V, 2004, ECOL LETT, V7, P1090, DOI 10.1111/j.1461-0248.2004.00666.x; NYLIN S, 1988, OIKOS, V53, P381, DOI 10.2307/3565539; Olesen JM, 2008, ECOLOGY, V89, P1573, DOI 10.1890/07-0451.1; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Perez-Maqueo O, 1995, ANALISIS EFECTO DIST; Poorter L, 2004, PLANT BIOLOGY, V6, P746, DOI 10.1055/s-2004-821269; Prado PI, 2004, J ANIM ECOL, V73, P1168, DOI 10.1111/j.0021-8790.2004.00891.x; Price PW, 2004, CONSERV BIOL, V18, P1405, DOI 10.1111/j.1523-1739.2004.00547.x; Price PW, 2002, ECOL RES, V17, P241, DOI 10.1046/j.1440-1703.2002.00483.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Core Team, 2021, R LANGUAGE ENV STAT; RAUSHER MD, 1987, ECOLOGY, V68, P869, DOI 10.2307/1938358; RAUSHER MD, 1983, ANIM BEHAV, V31, P341, DOI 10.1016/S0003-3472(83)80052-9; REDFEARN A, 1988, ECOL MONOGR, V58, P39, DOI 10.2307/1942633; Rico-Gray V, 2012, ARTHROPOD-PLANT INTE, V6, P289, DOI 10.1007/s11829-011-9170-3; RicoGray V, 1996, SOUTHWEST NAT, V41, P434; Sanchez-Galvan IR, 2012, J TROP ECOL, V28, P603, DOI 10.1017/S0266467412000582; Staley JT, 2006, ECOL ENTOMOL, V31, P460, DOI 10.1111/j.1365-2311.2006.00808.x; Thebault E, 2007, OIKOS, V116, P163, DOI 10.1111/j.2006.0030-1299.15007.x; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Thompson JN, 1999, HERBIVORES: BETWEEN PLANTS AND PREDATORS, P7; Travieso-Bello AC, 2006, ENTORNOS VERACRUZANO, P140; Trotter RT, 2008, ECOL ENTOMOL, V33, P1, DOI 10.1111/j.1365-2311.2007.00941.x; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Valladares G, 2012, OIKOS, V121, P299, DOI 10.1111/j.1600-0706.2011.19671.x; Vazquez DP, 2009, ANN BOT-LONDON, V103, P1445, DOI 10.1093/aob/mcp057; Villa-Galaviz E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053009; Whittaker JB, 2001, J ECOL, V89, P507, DOI 10.1046/j.0022-0477.2001.00582.x	76	38	38	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110430	10.1371/journal.pone.0110430	http://dx.doi.org/10.1371/journal.pone.0110430			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340790	gold, Green Published, Green Submitted			2022-12-27	WOS:000343662800035
J	Sanchez-Baracaldo, P; Thomas, GH				Sanchez-Baracaldo, Patricia; Thomas, Gavin H.			Adaptation and Convergent Evolution within the Jamesonia-Eriosorus Complex in High-Elevation Biodiverse Andean Hotspots	PLOS ONE			English	Article							RELAXED PHYLOGENETICS; PLANT DIVERSIFICATION; ALTITUDINAL GRADIENT; MOLECULAR PHYLOGENY; ESPELETIA; BIOGEOGRAPHY; TEMPERATURE; RADIATION; RATES; PHOTOSYNTHESIS	The recent uplift of the tropical Andes (since the late Pliocene or early Pleistocene) provided extensive ecological opportunity for evolutionary radiations. We test for phylogenetic and morphological evidence of adaptive radiation and convergent evolution to novel habitats (exposed, high-altitude paramo habitats) in the Andean fern genera Jamesonia and Eriosorus. We construct time-calibrated phylogenies for the Jamesonia-Eriosorus clade. We then use recent phylogenetic comparative methods to test for evolutionary transitions among habitats, associations between habitat and leaf morphology, and ecologically driven variation in the rate of morphological evolution. Paramo species (Jamesonia) display morphological adaptations consistent with convergent evolution in response to the demands of a highly exposed environment but these adaptations are associated with microhabitat use rather than the paramo per se. Species that are associated with exposed microhabitats (including Jamesonia and Eriorsorus) are characterized by many but short pinnae per frond whereas species occupying sheltered microhabitats (primarily Eriosorus) have few but long pinnae per frond. Pinnae length declines more rapidly with altitude in sheltered species. Rates of speciation are significantly higher among paramo than non-paramo lineages supporting the hypothesis of adaptation and divergence in the unique Paramo biodiversity hotspot.	[Sanchez-Baracaldo, Patricia] Univ Bristol, Sch Geog Sci, Bristol, Avon, England; [Thomas, Gavin H.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Bristol; University of Sheffield	Sanchez-Baracaldo, P (corresponding author), Univ Bristol, Sch Geog Sci, Bristol, Avon, England.	p.sanchez-baracaldo@bristol.ac.uk; gavin.thomas@sheffield.ac.uk	Sanchez-Baracaldo, Patricia/A-5309-2017; Thomas, Gavin/AAE-8959-2019	Thomas, Gavin/0000-0002-1982-6051; Sanchez-Baracaldo, Patricia/0000-0002-5216-2664	National Science Foundation [9801245]; Vice Chancellor for Research; Department of Integrative Biology, University of California at Berkeley; Royal Society Dorothy Hodgkin Fellowship and Colciencias, Colombia; NERC [NERC NE/G012938/1]	National Science Foundation(National Science Foundation (NSF)); Vice Chancellor for Research; Department of Integrative Biology, University of California at Berkeley; Royal Society Dorothy Hodgkin Fellowship and Colciencias, Colombia; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by a National Science Foundation Doctoral Dissertation Improvement Grant (9801245), the Vice Chancellor for Research Fund Award, and several grants from the Department of Integrative Biology, University of California at Berkeley. PSB has received funding support from the Royal Society Dorothy Hodgkin Fellowship and Colciencias, Colombia. GHT was supported by a NERC Postdoctoral Fellowship NERC NE/G012938/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azocar A, 1980, ESTUDIO VARIABILIDAD; Baldwin BG, 1998, MOL PHYLOGENET EVOL, V10, P449, DOI 10.1006/mpev.1998.0545; BARUCH Z, 1979, ECOLOGY, V60, P85, DOI 10.2307/1936471; Baselga A, 2012, METHODS ECOL EVOL, V3, P808, DOI 10.1111/j.2041-210X.2012.00224.x; Beck E., 1994, TROPICAL ALPINE ENV, P77; Bell CD, 2005, ORG DIVERS EVOL, V5, P147, DOI 10.1016/j.ode.2004.10.014; Burnham RJ, 1999, ANN MO BOT GARD, V86, P546, DOI 10.2307/2666185; Cabrera HM, 1996, REV CHIL HIST NAT, V69, P309; Cabrera HM, 1998, OECOLOGIA, V114, P145, DOI 10.1007/s004420050430; Cochran AT, 2014, PHYTOKEYS, V35, P23, DOI 10.3897/phytokeys.35.6886; Cosacov A, 2010, J BIOGEOGR, V37, P1463, DOI 10.1111/j.1365-2699.2010.02307.x; de Lange PJ, 2010, AUST SYST BOT, V23, P309, DOI 10.1071/SB10019; Donoghue MJ, 2008, P NATL ACAD SCI USA, V105, P11549, DOI 10.1073/pnas.0801962105; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; FitzJohn RG, 2012, METHODS ECOL EVOL, V3, P1084, DOI 10.1111/j.2041-210X.2012.00234.x; Goldberg EE, 2008, EVOLUTION, V62, P2727, DOI 10.1111/j.1558-5646.2008.00505.x; Hagen Bernhard von, 2001, ORG DIVERS EVOL, V1, P61, DOI [10.1078/1439-6092-00005., DOI 10.1078/1439-6092-00005]; HEDBERG OLOV, 1964, ACTA PHYTOGEOGR SUECICA, V49, P1; Heled J, 2012, SYST BIOL, V61, P138, DOI 10.1093/sysbio/syr087; HOOGHIEMSTRA H, 1989, PALAEOGEOGR PALAEOCL, V72, P11, DOI 10.1016/0031-0182(89)90129-6; Hughes C, 2006, P NATL ACAD SCI USA, V103, P10334, DOI 10.1073/pnas.0601928103; Jabaily RS, 2013, BOT J LINN SOC, V171, P201, DOI 10.1111/j.1095-8339.2012.01307.x; Johnson DM, 2004, TREE PHYSIOL, V24, P377, DOI 10.1093/treephys/24.4.377; Karl R, 2013, ANN BOT-LONDON, V112, P983, DOI 10.1093/aob/mct165; KEELEY JE, 1984, NATURE, V310, P694, DOI 10.1038/310694a0; Korner C., 2003, ALPINE PLANT LIFE FU, V2nd ed.; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Logacheva MD, 2010, MOL PHYLOGENET EVOL, V57, P471, DOI 10.1016/j.ympev.2010.06.001; Luteyn J.L., 1992, PARAMO ANDEAN ECOSYS, P1; Luteyn JL, 1999, NEW YORK BOT GARDEN; Maddison WP, 2007, SYST BIOL, V56, P701, DOI 10.1080/10635150701607033; Madrinan Santiago, 2013, Frontiers in Genetics, V4, P192, DOI 10.3389/fgene.2013.00192; MEINZER F, 1985, ECOLOGY, V66, P512, DOI 10.2307/1940399; Meinzer F, 1994, TROPICAL ALPINE ENV, P45; MILLER GA, 1986, OECOLOGIA, V70, P155, DOI 10.1007/BF00377126; MONASTERIO M, 1991, TRENDS ECOL EVOL, V6, P387, DOI 10.1016/0169-5347(91)90159-U; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nuerk Nicolai M., 2013, Frontiers in Genetics, V4, P175, DOI 10.3389/fgene.2013.00175; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pennington RT, 2010, P NATL ACAD SCI USA, V107, P13783, DOI 10.1073/pnas.1001317107; Rada F, 1998, ACTA OECOL, V19, P73, DOI 10.1016/S1146-609X(98)80010-6; Rambaut A, 1996, RAMBAUT SE AL V2 0A1; Rambaut A, 2009, RAMBAUT TRACER V1 4; Rauscher JT, 2002, AM J BOT, V89, P1074, DOI 10.3732/ajb.89.7.1074; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Sakai A., 1987, Frost survival of plants. Responses and adaptation to freezing stress.; Sanchez-Baracaldo P, 2004, AM J BOT, V91, P274, DOI 10.3732/ajb.91.2.274; Sarmiento G., 1986, HIGH ALTITUDE TROPIC, V11, P45; Sidlauskas B, 2008, EVOLUTION, V62, P3135, DOI 10.1111/j.1558-5646.2008.00519.x; Sklenar P, 2011, BOT REV, V77, P71, DOI 10.1007/s12229-010-9061-9; SMITH AP, 1980, J ECOL, V68, P63, DOI 10.2307/2259244; SMITH AP, 1987, ANNU REV ECOL SYST, V18, P137, DOI 10.1146/annurev.es.18.110187.001033; Thomas GH, 2006, P ROY SOC B-BIOL SCI, V273, P1619, DOI 10.1098/rspb.2006.3488; Thomas GH, 2012, METHODS ECOL EVOL, V3, P145, DOI 10.1111/j.2041-210X.2011.00132.x; Thomas GH, 2009, EVOLUTION, V63, P2017, DOI 10.1111/j.1558-5646.2009.00694.x; Tropicos.org, 2014, MISS BOT GARD; Tryon AF, 1970, CONTRIB GRAY HERB HA, V200, P54, DOI [10.5962/p.336423, DOI 10.5962/P.336423]; TRYON ALICE F., 1962, CONTRIB GRAY HERBARIUM HARVARD UNIV, V191, P109; Tryon RM, 1982, PTERIDACEAE FERNS AL, P213; Van der Hammen T., 1960, LEI DES GEOL MEDED, V25, P261; VANDERHAMMEN T, 1985, J GEOL SOC LONDON, V142, P483, DOI 10.1144/gsjgs.142.3.0483; Wikstrom N, 1999, PLANT SYST EVOL, V218, P221, DOI 10.1007/BF01089229; Wolf PG, 2011, PLANT MOL BIOL, V76, P251, DOI 10.1007/s11103-010-9706-4; Yoder JB, 2010, J EVOLUTION BIOL, V23, P1581, DOI 10.1111/j.1420-9101.2010.02029.x; Zacharias EH, 2010, SYST BOT, V35, P839, DOI 10.1600/036364410X539907	69	19	19	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110618	10.1371/journal.pone.0110618	http://dx.doi.org/10.1371/journal.pone.0110618			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340770	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000343662800043
J	Sicking, I; Edlund, K; Wesbuer, E; Weyer, V; Battista, MJ; Lebrecht, A; Solbach, C; Grinberg, M; Lotz, J; Hoffmann, G; Rahnenfuhrer, J; Hengstler, JG; Schmidt, M				Sicking, Isabel; Edlund, Karolina; Wesbuer, Eva; Weyer, Veronika; Battista, Marco J.; Lebrecht, Antje; Solbach, Christine; Grinberg, Marianna; Lotz, Johannes; Hoffmann, Gerald; Rahnenfuehrer, Joerg; Hengstler, Jan G.; Schmidt, Marcus			Prognostic Influence of Pre-Operative C-Reactive Protein in Node-Negative Breast Cancer Patients	PLOS ONE			English	Article							SYSTEMIC INFLAMMATORY RESPONSE; SURVIVAL; RISK; RECURRENCE; PREDICTOR; MARKER	The importance of inflammation is increasingly noticed in cancer. The aim of this study was to analyze the prognostic influence of pre-operative serum C-reactive protein (CRP) in a cohort of 148 lymph node-negative breast cancer patients. The prognostic significance of CRP level for disease-free survival (DFS), metastasis-free survival (MFS) and overall survival (OS) was evaluated using univariate and multivariate Cox regression, also including information on age at diagnosis, tumor size, tumor grade, estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) status, proliferation index (Ki67) and molecular subtype, as well as an assessment of the presence of necrosis and inflammation in the tumor tissue. Univariate analysis showed that CRP, as a continuous variable, was significantly associated with DFS (P = 0.002, hazard ratio [HR] = 1.04, 95% confidence interval [CI] = 1.02-1.07) and OS (P = 0.036, HR = 1.03, 95% CI = 1.00-1.06), whereas a trend was observed for MFS (P = 0.111). In the multivariate analysis, CRP retained its significance for DFS (P = 0.033, HR = 1.01, 95% CI = 1.00-1.07) as well as OS (P = 0.023, HR = 1.03, 95% CI = 1.00-1.06), independent of established prognostic factors. Furthermore, large-scale gene expression analysis by Affymetrix HG-U133A arrays was performed for 72 (48.6%) patients. The correlations between serum CRP and gene expression levels in the corresponding carcinoma of the breast were assessed using Spearman's rank correlation, controlled for false-discovery rate. No significant correlation was observed between CRP level and gene expression indicative of an ongoing local inflammatory process. In summary, pre-operatively elevated CRP levels at the time of diagnosis were associated with shorter DFS and OS independent of established prognostic factors in node-negative breast cancer, supporting a possible link between inflammation and prognosis in breast cancer.	[Sicking, Isabel; Wesbuer, Eva; Battista, Marco J.; Lebrecht, Antje; Solbach, Christine; Hoffmann, Gerald; Schmidt, Marcus] Johannes Gutenberg Univ Mainz, Dept Obstet & Gynecol, D-55122 Mainz, Germany; [Edlund, Karolina; Hengstler, Jan G.] Dortmund Univ Technol, Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany; [Weyer, Veronika] Johannes Gutenberg Univ Mainz, Inst Med Biometry Epidemiol & Informat, D-55122 Mainz, Germany; [Grinberg, Marianna; Rahnenfuehrer, Joerg] Dortmund Univ Technol, Dept Stat, Dortmund, Germany; [Lotz, Johannes] Johannes Gutenberg Univ Mainz, Inst Clin Chem, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz; Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); Johannes Gutenberg University of Mainz; Dortmund University of Technology; Johannes Gutenberg University of Mainz	Schmidt, M (corresponding author), Johannes Gutenberg Univ Mainz, Dept Obstet & Gynecol, D-55122 Mainz, Germany.	marcus.schmidt@unimedizin-mainz.de	Schmidt, Marcus/H-3383-2013; Weyer-Elberich, Veronika/AAB-8993-2020; Solbach, Christine/AAU-7379-2020	Schmidt, Marcus/0000-0003-1365-2414; Hengstler, Jan/0000-0002-1427-5246; Rahnenfuhrer, Jorg/0000-0002-8947-440X	Federal Ministry of Education and Research	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the Federal Ministry of Education and Research (BMBF, NGFN project Oncoprofile). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Murri AM, 2007, BRIT J CANCER, V96, P891, DOI 10.1038/sj.bjc.6603682; Albuquerque K V, 1995, Eur J Surg Oncol, V21, P504, DOI 10.1016/S0748-7983(95)96935-7; Allin KH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2891; Allin KH, 2009, J CLIN ONCOL, V27, P2217, DOI 10.1200/JCO.2008.19.8440; ALTMAN DG, 1989, STAT MED, V8, P771, DOI 10.1002/sim.4780080702; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Crumley ABC, 2006, BRIT J CANCER, V94, P1568, DOI 10.1038/sj.bjc.6603150; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Ferro DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020706; Filipits M, 2011, CLIN CANCER RES, V17, P6012, DOI 10.1158/1078-0432.CCR-11-0926; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Han YJ, 2011, INT J BIOL MARKER, V26, P209, DOI 10.5301/JBM.2011.8872; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heikkila K, 2007, J EPIDEMIOL COMMUN H, V61, P824, DOI 10.1136/jech.2006.051292; Heys SD, 1998, INT J ONCOL, V13, P589; Laghi L, 2009, LANCET ONCOL, V10, P877, DOI 10.1016/S1470-2045(09)70186-X; McArdle PA, 2006, UROL INT, V77, P127, DOI 10.1159/000093905; McShane LM, 2006, BREAST CANCER RES TR, V100, P229, DOI 10.1007/s10549-006-9242-8; Metze K, 2008, PATHOL RES PRACT, V204, P213, DOI 10.1016/j.prp.2007.12.002; Metze K, 2011, LANCET ONCOL, V12, P1095, DOI 10.1016/S1470-2045(11)70309-6; Metze K, 2011, J AM COLL SURGEONS, V212, P132, DOI 10.1016/j.jamcollsurg.2010.10.004; O'Hanlon DM, 2002, ANTICANCER RES, V22, P1289; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pierce BL, 2009, J CLIN ONCOL, V27, P3437, DOI 10.1200/JCO.2008.18.9068; Ravishankaran P, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-18; Reis-Alves SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081048; ROBERTSON JFR, 1991, CANCER IMMUNOL IMMUN, V33, P403, DOI 10.1007/BF01741602; SAUERBREI W, 1992, STAT MED, V11, P2093, DOI 10.1002/sim.4780111607; Schmidt M, 2012, Minerva Ginecol, V64, P53; Schmidt M, 2009, ANN ONCOL, V20, P258, DOI 10.1093/annonc/mdn590; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Schmidt M, 2012, CLIN CANCER RES, V18, P2695, DOI 10.1158/1078-0432.CCR-11-2210; Scott HR, 2002, BRIT J CANCER, V87, P264, DOI 10.1038/sj.bjc.6600466; Swann JB, 2007, J CLIN INVEST, V117, P1137, DOI 10.1172/JCI31405; Tibau A, 2013, BREAST CANCER RES TR, V141, P485, DOI 10.1007/s10549-013-2694-8; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Yigit E, 2008, EUR J INTERN MED, V19, P602, DOI 10.1016/j.ejim.2007.06.036	38	34	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111306	10.1371/journal.pone.0111306	http://dx.doi.org/10.1371/journal.pone.0111306			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340395	Green Submitted, Green Published, gold			2022-12-27	WOS:000343662800101
J	Dombert, B; Sivadasan, R; Simon, CM; Jablonka, S; Sendtner, M				Dombert, Benjamin; Sivadasan, Rajeeve; Simon, Christian M.; Jablonka, Sibylle; Sendtner, Michael			Presynaptic Localization of Smn and hnRNP R in Axon Terminals of Embryonic and Postnatal Mouse Motoneurons	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; MOTOR-NEURON PROTEIN; NUCLEAR RIBONUCLEOPROTEIN-R; DETERMINING GENE-PRODUCT; ACTIN MESSENGER-RNA; NEUROMUSCULAR-JUNCTIONS; EXON 7; SYNAPTIC DEFECTS; GROWTH CONES; DISEASES ALS	Spinal muscular atrophy (SMA) is caused by deficiency of the ubiquitously expressed survival motoneuron (SMN) protein. SMN is crucial component of a complex for the assembly of spliceosomal small nuclear ribonucleoprotein (snRNP) particles. Other cellular functions of SMN are less characterized so far. SMA predominantly affects lower motoneurons, but the cellular basis for this relative specificity is still unknown. In contrast to nonneuronal cells where the protein is mainly localized in perinuclear regions and the nucleus, Smn is also present in dendrites, axons and axonal growth cones of isolated motoneurons in vitro. However, this distribution has not been shown in vivo and it is not clear whether Smn and hnRNP R are also present in presynaptic axon terminals of motoneurons in postnatal mice. Smn also associates with components not included in the classical SMN complex like RNA-binding proteins FUS, TDP43, HuD and hnRNP R which are involved in RNA processing, subcellular localization and translation. We show here that Smn and hnRNP R are present in presynaptic compartments at neuromuscular endplates of embryonic and postnatal mice. Smn and hnRNP R are localized in close proximity to each other in axons and axon terminals both in vitro and in vivo. We also provide new evidence for a direct interaction of Smn and hnRNP R in vitro and in vivo, particularly in the cytosol of motoneurons. These data point to functions of SMN beyond snRNP assembly which could be crucial for recruitment and transport of RNA particles into axons and axon terminals, a mechanism which may contribute to SMA pathogenesis.	[Dombert, Benjamin; Sivadasan, Rajeeve; Simon, Christian M.; Jablonka, Sibylle; Sendtner, Michael] Univ Hosp Wuerzburg, Inst Clin Neurobiol, Wurzburg, Germany	University of Wurzburg	Sendtner, M (corresponding author), Univ Hosp Wuerzburg, Inst Clin Neurobiol, Wurzburg, Germany.	Sendtner_M@ukw.de	Sendtner, Michael/M-8137-2014; Sendtner, Michael/J-1542-2012; Jablonka, Sibylle/S-1843-2018	Sendtner, Michael/0000-0002-4737-2974; Sendtner, Michael/0000-0002-4737-2974; Jablonka, Sibylle/0000-0002-4517-3760; Sivadasan, Rajeeve/0000-0001-7547-0662	Hermann und Lilly Schilling Stiftung im Stifterverband der Deutschen Wissenschaft; German Research Foundation (DFG) through the research training group 1048 'organogenesis'; Graduate School of Life Sciences of the University of Wuerzburg; DFG; University of Wuerzburg	Hermann und Lilly Schilling Stiftung im Stifterverband der Deutschen Wissenschaft; German Research Foundation (DFG) through the research training group 1048 'organogenesis'(German Research Foundation (DFG)); Graduate School of Life Sciences of the University of Wuerzburg; DFG(German Research Foundation (DFG)); University of Wuerzburg	This work was supported by the 'Hermann und Lilly Schilling Stiftung im Stifterverband der Deutschen Wissenschaft', the German Research Foundation (DFG) through the research training group 1048 'organogenesis,' and the Graduate School of Life Sciences of the University of Wuerzburg. This publication was funded by the DFG and the University of Wuerzburg in the funding programme 'Open Access Publishing.' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achsel T, 2013, BIOCHEM SOC T, V41, P1593, DOI 10.1042/BST20130142; Akten B, 2011, P NATL ACAD SCI USA, V108, P10337, DOI 10.1073/pnas.1104928108; Alami NH, 2014, NEURON, V81, P536, DOI 10.1016/j.neuron.2013.12.018; [Anonymous], 2014, HNRNP R IS; Armstrong GAB, 2013, HUM MOL GENET, V22, P4282, DOI 10.1093/hmg/ddt278; Battle DJ, 2006, COLD SPRING HARB SYM, V71, P313, DOI 10.1101/sqb.2006.71.001; Bose JK, 2008, J BIOL CHEM, V283, P28852, DOI 10.1074/jbc.M805376200; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Burlet P, 1998, HUM MOL GENET, V7, P1927, DOI 10.1093/hmg/7.12.1927; Carnegie GK, 2003, J CELL SCI, V116, P1905, DOI 10.1242/jcs.00409; Carvalho T, 1999, J CELL BIOL, V147, P715, DOI 10.1083/jcb.147.4.715; Chari A, 2009, CURR OPIN CELL BIOL, V21, P387, DOI 10.1016/j.ceb.2009.02.004; Chaudhury A, 2010, RNA, V16, P1449, DOI 10.1261/rna.2254110; Chen HH, 2008, MOL CELL BIOL, V28, P6929, DOI 10.1128/MCB.01332-08; Cho S, 2014, BBA-GENE REGUL MECH, V1839, P306, DOI 10.1016/j.bbagrm.2014.02.006; Dale JM, 2011, ACTA NEUROPATHOL, V122, P331, DOI 10.1007/s00401-011-0848-5; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Fallini C, 2014, DEV NEUROBIOL, V74, P319, DOI 10.1002/dneu.22111; Fallini C, 2011, J NEUROSCI, V31, P3914, DOI 10.1523/JNEUROSCI.3631-10.2011; Fayzullina S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093329; Gerbino V, 2013, NEUROBIOL DIS, V55, P120, DOI 10.1016/j.nbd.2013.03.003; Glinka M, 2010, HUM MOL GENET, V19, P1951, DOI 10.1093/hmg/ddq073; Gogliotti RG, 2013, HUM MOL GENET, V22, P4084, DOI 10.1093/hmg/ddt258; Grimmler M, 2005, HUM MOL GENET, V14, P3099, DOI 10.1093/hmg/ddi343; Grimmler M, 2005, EMBO REP, V6, P70, DOI 10.1038/sj.embor.7400301; Groen EJN, 2013, HUM MOL GENET, V22, P3690, DOI 10.1093/hmg/ddt222; Gubitz AK, 2004, EXP CELL RES, V296, P51, DOI 10.1016/j.yexcr.2004.03.022; Han SP, 2010, BIOCHEM J, V430, P379, DOI 10.1042/BJ20100396; Harahap ISK, 2012, BRAIN DEV-JPN, V34, P213, DOI 10.1016/j.braindev.2011.04.010; Hofmann Y, 2002, HUM MOL GENET, V11, P2037, DOI 10.1093/hmg/11.17.2037; Hua YM, 2008, AM J HUM GENET, V82, P834, DOI 10.1016/j.ajhg.2008.01.014; Hubers L, 2011, HUM MOL GENET, V20, P553, DOI 10.1093/hmg/ddq500; Husedzinovic A, 2014, EUR J CELL BIOL, V93, P106, DOI 10.1016/j.ejcb.2014.01.006; Jablonka S, 2000, HUM MOL GENET, V9, P341, DOI 10.1093/hmg/9.3.341; Jablonka S, 2007, J CELL BIOL, V179, P139, DOI 10.1083/jcb.200703187; Jablonka S, 2014, J ANAT, V224, P3, DOI 10.1111/joa.12097; Kariya S, 2008, HUM MOL GENET, V17, P2552, DOI 10.1093/hmg/ddn156; Kariya S, 2014, J CLIN INVEST, V124, P785, DOI 10.1172/JCI72017; Kashima T, 2007, HUM MOL GENET, V16, P3149, DOI 10.1093/hmg/ddm276; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Kim JH, 2000, J MOL BIOL, V298, P395, DOI 10.1006/jmbi.2000.3687; Kolb SJ, 2007, J CHILD NEUROL, V22, P990, DOI 10.1177/0883073807305666; Kong LL, 2009, J NEUROSCI, V29, P842, DOI 10.1523/JNEUROSCI.4434-08.2009; Le TT, 2011, HUM MOL GENET, V20, P3578, DOI 10.1093/hmg/ddr275; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Li DK, 2014, SEMIN CELL DEV BIOL, V32, P22, DOI 10.1016/j.semcdb.2014.04.026; Ling KKY, 2012, HUM MOL GENET, V21, P185, DOI 10.1093/hmg/ddr453; Ling KKY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015457; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lotti F, 2012, CELL, V151, P440, DOI 10.1016/j.cell.2012.09.012; Martinez TL, 2012, J NEUROSCI, V32, P8703, DOI 10.1523/JNEUROSCI.0204-12.2012; Martinez-Hernandez R, 2013, J PATHOL, V229, P49, DOI 10.1002/path.4080; McWhorter ML, 2003, J CELL BIOL, V162, P919, DOI 10.1083/jcb.200303168; Mizutani A, 2000, J BIOL CHEM, V275, P9823, DOI 10.1074/jbc.275.13.9823; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Mourelatos Z, 2001, EMBO J, V20, P5443, DOI 10.1093/emboj/20.19.5443; Moursy A, 2014, NUCLEIC ACIDS RES, V42, P6659, DOI 10.1093/nar/gku244; Nishimune H, 2004, NATURE, V432, P580, DOI 10.1038/nature03112; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; Novelli G, 1997, BIOCHEM MOL MED, V61, P102, DOI 10.1006/bmme.1997.2590; Otter S, 2007, J BIOL CHEM, V282, P5825, DOI 10.1074/jbc.M608528200; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Petri S, 2007, J CELL BIOL, V179, P451, DOI 10.1083/jcb.200704163; Piazzon N, 2008, J BIOL CHEM, V283, P5598, DOI 10.1074/jbc.M707304200; PORTER BE, 1995, NEURON, V14, P549, DOI 10.1016/0896-6273(95)90311-9; Rage F, 2013, RNA, V19, P1755, DOI 10.1261/rna.040204.113; Renvoise B, 2012, J CELL SCI, V125, P2862, DOI 10.1242/jcs.096255; Rossoll W, 2002, HUM MOL GENET, V11, P93, DOI 10.1093/hmg/11.1.93; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Rossoll W, 2009, RESULTS PROBL CELL D, V48, P289, DOI 10.1007/400_2009_4; Ruiz R, 2010, J NEUROSCI, V30, P849, DOI 10.1523/JNEUROSCI.4496-09.2010; Sanchez G, 2013, HUM MOL GENET, V22, P668, DOI 10.1093/hmg/dds474; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Shahidullah M, 2013, J NEUROSCI, V33, P19590, DOI 10.1523/JNEUROSCI.3396-13.2013; Shan X, 2010, P NATL ACAD SCI USA, V107, P16325, DOI 10.1073/pnas.1003459107; Simon CM, 2010, HUM MOL GENET, V19, P973, DOI 10.1093/hmg/ddp562; Sleeman J, 2013, BIOCHEM SOC T, V41, P871, DOI 10.1042/BST20120016; Subramanian N, 2012, HUM MOL GENET, V21, P3655, DOI 10.1093/hmg/dds195; Swoboda KJ, 2005, ANN NEUROL, V57, P704, DOI 10.1002/ana.20473; Tadesse H, 2008, HUM MOL GENET, V17, P506, DOI 10.1093/hmg/ddm327; Torres-Benito L, 2012, DEV NEUROBIOL, V72, P126, DOI 10.1002/dneu.20912; Torres-Benito L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026164; Tsuiji H, 2013, EMBO MOL MED, V5, P221, DOI 10.1002/emmm.201202303; Turner BJ, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-104; Walker MP, 2008, HUM MOL GENET, V17, P3399, DOI 10.1093/hmg/ddn234; Wiese S, 2010, NAT PROTOC, V5, P31, DOI 10.1038/nprot.2009.193; Williams BY, 1999, BIOCHEM BIOPH RES CO, V254, P10, DOI 10.1006/bbrc.1998.9885; Yamazaki T, 2012, CELL REP, V2, P799, DOI 10.1016/j.celrep.2012.08.025; Zhang HL, 2006, J NEUROSCI, V26, P8622, DOI 10.1523/JNEUROSCI.3967-05.2006; Zhang ZX, 2013, P NATL ACAD SCI USA, V110, P19348, DOI 10.1073/pnas.1319280110	91	50	51	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110846	10.1371/journal.pone.0110846	http://dx.doi.org/10.1371/journal.pone.0110846			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338097	Green Published, Green Submitted, gold			2022-12-27	WOS:000343674800082
J	Gorre, N; Adhikari, D; Lindkvist, R; Brannstrom, M; Liu, K; Shen, Y				Gorre, Nagaraju; Adhikari, Deepak; Lindkvist, Rebecca; Brannstrom, Mats; Liu, Kui; Shen, Yan			mTORC1 Signaling in Oocytes Is Dispensable for the Survival of Primordial Follicles and for Female Fertility	PLOS ONE			English	Article							RAPTOR; ACTIVATION; KINASE; GROWTH; ABLATION; COMPLEX; RICTOR; ROLES; PDK1; MICE	The molecular mechanisms underlying reproductive aging and menopausal age in female mammals are poorly understood. Mechanistic target of rapamycin complex 1 (mTORC1) is a central controller of cell growth and proliferation. To determine whether mTORC1 signaling in oocytes plays a direct role in physiological follicular development and fertility in female mice, we conditionally deleted the specific and essential mTORC1 component Rptor (regulatory-associated protein of mTORC1) from the oocytes of primordial follicles by using transgenic mice expressing growth differentiation factor 9 (Gdf-9) promoter-mediated Cre recombinase. We provide in vivo evidence that deletion of Rptor in the oocytes of both primordial and further-developed follicles leads to the loss of mTORC1 signaling in oocytes as indicated by loss of phosphorylation of S6K1 and 4e-bp1 at T389 and S65, respectively. However, the follicular development and fertility of mice lacking Rptor in oocytes were not affected. Mechanistically, the loss of mTORC1 signaling in Rptor-deleted mouse oocytes led to the elevation of phosphatidylinositol 3-kinase (PI3K) signaling that maintained normal follicular development and fertility. Therefore, this study shows that loss of mTORC1 signaling in oocytes triggers a compensatory activation of the PI3K signaling cascade that maintains normal ovarian follicular development and fertility.	[Gorre, Nagaraju; Adhikari, Deepak; Lindkvist, Rebecca; Liu, Kui; Shen, Yan] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden; [Brannstrom, Mats] Univ Gothenburg, Sahlgrenska Acad, Dept Obstet & Gynecol, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Gorre, N (corresponding author), Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden.	nagarajubio@gmail.com; yan.shen@vgregion.se		Adhikari, Deepak/0000-0002-3404-8753	Young Researcher Award (Umea University); Jane and Dan Olssons Foundation; LUA/ALF-medel Vastra Gotalandsregionen; AFA Insurance; Swedish Research Council; Swedish Cancer Foundation; Faculty of Natural Science of the University of Gothenburg; Novo Nordisk Foundation (Denmark)	Young Researcher Award (Umea University); Jane and Dan Olssons Foundation; LUA/ALF-medel Vastra Gotalandsregionen; AFA Insurance; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Faculty of Natural Science of the University of Gothenburg; Novo Nordisk Foundation (Denmark)(Novo Nordisk Foundation)	This work was supported by grants (to K. L.) from the Young Researcher Award (Umea University), the Jane and Dan Olssons Foundation, the LUA/ALF-medel Vastra Gotalandsregionen, AFA Insurance, the Swedish Research Council, the Swedish Cancer Foundation, the Faculty of Natural Science of the University of Gothenburg and the Novo Nordisk Foundation (Denmark). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari BN, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075072, 10.1371/journal.pone.0053810]; Adhikari D, 2010, HUM MOL GENET, V19, P397, DOI 10.1093/hmg/ddp483; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Broekmans FJ, 2007, TRENDS ENDOCRIN MET, V18, P58, DOI 10.1016/j.tem.2007.01.004; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; FADDY MJ, 1992, HUM REPROD, V7, P1342, DOI 10.1093/oxfordjournals.humrep.a137570; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hansen KR, 2008, HUM REPROD, V23, P699, DOI 10.1093/humrep/dem408; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Lan ZJ, 2004, BIOL REPROD, V71, P1469, DOI 10.1095/biolreprod.104.031757; Liu K, 2006, DEV BIOL, V299, P1, DOI 10.1016/j.ydbio.2006.07.038; McGee EA, 2000, ENDOCR REV, V21, P200, DOI 10.1210/er.21.2.200; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Reddy P, 2005, DEV BIOL, V281, P160, DOI 10.1016/j.ydbio.2005.02.013; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257; Reddy P, 2009, HUM MOL GENET, V18, P2813, DOI 10.1093/hmg/ddp217; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	26	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110491	10.1371/journal.pone.0110491	http://dx.doi.org/10.1371/journal.pone.0110491			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338086	Green Published, Green Submitted, gold			2022-12-27	WOS:000343674800047
J	Hou, HY; Liu, WY; Wu, SJ; Lu, YJ; Peng, J; Zhu, YW; Lu, YF; Wang, F; Sun, ZY				Hou, Hongyan; Liu, Weiyong; Wu, Shiji; Lu, Yanjun; Peng, Jing; Zhu, Yaowu; Lu, Yanfang; Wang, Feng; Sun, Ziyong			Tim-3 Negatively Mediates Natural Killer Cell Function in LPS-Induced Endotoxic Shock	PLOS ONE			English	Article							DOMAIN-CONTAINING MOLECULE-3; CHRONIC HEPATITIS-B; T-CELL; NK CELLS; SEVERE SEPSIS; GALECTIN-9; LIPOPOLYSACCHARIDE; INFECTION; IMMUNITY; MICE	Sepsis is an exaggerated inflammatory condition response to different microorganisms with high mortality rates and extremely poor prognosis. Natural killer (NK) cells have been reported to be the major producers of IFN-gamma and key players in promoting systematic inflammation in lipopolysaccharide (LPS)-induced endotoxic shock. T-cell immunoglobulin and mucin domain (Tim)-3 pathway has been demonstrated to play an important role in the process of sepsis, however, the effect of Tim-3 on NK cell function remains largely unknown. In this study, we observed a dynamic inverse correlation between Tim-3 expression and IFN-gamma production in NK cells from LPS-induced septic mice. Blockade of the Tim-3 pathway could increase IFN-gamma production and decrease apoptosis of NK cells in vitro, but had no effect on the expression of CD107a. Furthermore, NK cell cytotoxicity against K562 target cells was enhanced after blocking Tim-3 pathway. In conclusion, our results suggest that Tim-3 pathway plays an inhibitory role in NK cell function, which might be a potential target in modulating the excessive inflammatory response of LPS-induced endotoxic shock.	[Hou, Hongyan; Liu, Weiyong; Wu, Shiji; Lu, Yanjun; Peng, Jing; Zhu, Yaowu; Lu, Yanfang; Wang, Feng; Sun, Ziyong] Huazhong Univ Sci & Technol, Dept Clin Lab, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Wang, F (corresponding author), Huazhong Univ Sci & Technol, Dept Clin Lab, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China.	Fengwang@tjh.tjmu.edu.cn; tjszyong@163.com			Ministry of Health of China [2012zx10004-207]	Ministry of Health of China	This work was supported by the Infectious Diseases Control Project from Ministry of Health of China (2012zx10004-207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adib-Conquy M, 2009, THROMB HAEMOSTASIS, V101, P36, DOI 10.1160/TH08-07-0421; Aktas E, 2009, CELL IMMUNOL, V254, P149, DOI 10.1016/j.cellimm.2008.08.007; Andaluz-Ojeda D, 2011, CRIT CARE, V15, DOI 10.1186/cc10501; Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Barkhausen T, 2008, SHOCK, V30, P401, DOI 10.1097/SHK.0b013e31816e2cda; Chiche L, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/986491; da Silva IP, 2014, CANCER IMMUNOL RES, V2, P410, DOI 10.1158/2326-6066.CIR-13-0171; Dinges MM, 2001, INFECT IMMUN, V69, P1256, DOI 10.1128/IAI.69.3.1256-1264.2001; Emoto M, 2002, J IMMUNOL, V169, P1426, DOI 10.4049/jimmunol.169.3.1426; Etogo AO, 2008, J IMMUNOL, V180, P6334, DOI 10.4049/jimmunol.180.9.6334; Giamarellos-Bourboulis EJ, 2006, CRIT CARE, V10, DOI 10.1186/cc5111; Gleason MK, 2012, BLOOD, V119, P3064, DOI 10.1182/blood-2011-06-360321; Gogos C, 2010, CRIT CARE, V14, DOI 10.1186/cc9031; Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09; Hack CE, 1997, ADV IMMUNOL, V66, P101, DOI 10.1016/S0065-2776(08)60597-0; HEREMANS H, 1994, EUR J IMMUNOL, V24, P1155, DOI 10.1002/eji.1830240522; Hotchkiss RS, 2005, J IMMUNOL, V174, P5110, DOI 10.4049/jimmunol.174.8.5110; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Hou N, 2012, ATHEROSCLEROSIS, V222, P67, DOI 10.1016/j.atherosclerosis.2012.02.009; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Ju Y, 2010, J HEPATOL, V52, P322, DOI 10.1016/j.jhep.2009.12.005; Kanzaki M, 2012, ENDOCRINOLOGY, V153, P612, DOI 10.1210/en.2011-1579; Khademi M, 2004, J IMMUNOL, V172, P7169, DOI 10.4049/jimmunol.172.11.7169; Napoli AM, 2012, SHOCK, V37, P257, DOI 10.1097/SHK.0b013e31823fca44; Ndhlovu LC, 2012, BLOOD, V119, P3734, DOI 10.1182/blood-2011-11-392951; Ndhlovu LC, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001030; Nobumoto A, 2009, CLIN IMMUNOL, V130, P322, DOI 10.1016/j.clim.2008.09.014; Rodriguez-Manzanet R, 2009, IMMUNOL REV, V229, P259, DOI 10.1111/j.1600-065X.2009.00772.x; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Stearns-Kurosawa DJ, 2011, ANNU REV PATHOL-MECH, V6, P19, DOI 10.1146/annurev-pathol-011110-130327; Tang DL, 2012, NAT IMMUNOL, V13, P808, DOI 10.1038/ni.2396; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Wang F, 2008, TRANSPL IMMUNOL, V19, P12, DOI 10.1016/j.trim.2008.01.008; Wang F, 2007, CELL IMMUNOL, V250, P68, DOI 10.1016/j.cellimm.2008.01.006; Wang F, 2014, HUM IMMUNOL, V75, P470, DOI 10.1016/j.humimm.2014.02.001; Wu W, 2012, EUR J IMMUNOL, V42, P1180, DOI 10.1002/eji.201141852; Yang XM, 2013, J IMMUNOL, V190, P2068, DOI 10.4049/jimmunol.1202661; Zeerleder S, 2005, CLIN IMMUNOL, V116, P158, DOI 10.1016/j.clim.2005.03.006; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	41	19	22	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110585	10.1371/journal.pone.0110585	http://dx.doi.org/10.1371/journal.pone.0110585			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337993	Green Published, gold, Green Submitted			2022-12-27	WOS:000343674800059
J	Streitberger, KJ; Reiss-Zimmermann, M; Freimann, FB; Bayerl, S; Guo, J; Arlt, F; Wuerfel, J; Braun, J; Hoffmann, KT; Sack, I				Streitberger, Kaspar-Josche; Reiss-Zimmermann, Martin; Freimann, Florian Baptist; Bayerl, Simon; Guo, Jing; Arlt, Felix; Wuerfel, Jens; Braun, Juergen; Hoffmann, Karl-Titus; Sack, Ingolf			High-Resolution Mechanical Imaging of Glioblastoma by Multifrequency Magnetic Resonance Elastography	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; PRIMARY BRAIN-TUMORS; IN-VIVO; UNITED-STATES; VISCOELASTIC PROPERTIES; MR ELASTOGRAPHY; STIFFNESS; BEHAVIOR; RECONSTRUCTION; INVERSION	Objective: To generate high-resolution maps of the viscoelastic properties of human brain parenchyma for presurgical quantitative assessment in glioblastoma (GB). Methods: Twenty-two GB patients underwent routine presurgical work-up supplemented by additional multifrequency magnetic resonance elastography. Two three-dimensional viscoelastic parameter maps, magnitude vertical bar G*vertical bar, and phase angle phi of the complex shear modulus were reconstructed by inversion of full wave field data in 2-mm isotropic resolution at seven harmonic drive frequencies ranging from 30 to 60 Hz. Results: Mechanical brain maps confirmed that GB are composed of stiff and soft compartments, resulting in high intratumor heterogeneity. GB could be easily differentiated from healthy reference tissue by their reduced viscous behavior quantified by phi (0.37 +/- 0.08 vs. 0.58 +/- 0.07). vertical bar G*vertical bar, which in solids more relates to the material's stiffness, was significantly reduced in GB with a mean value of 1.32 +/- 0.26 kPa compared to 1.54 +/- 0.27 kPa in healthy tissue (P = 0.001). However, some GB (5 of 22) showed increased stiffness. Conclusion: GB are generally less viscous and softer than healthy brain parenchyma. Unrelated to the morphology-based contrast of standard magnetic resonance imaging, elastography provides an entirely new neuroradiological marker and contrast related to the biomechanical properties of tumors.	[Streitberger, Kaspar-Josche; Guo, Jing; Sack, Ingolf] Charite, Dept Radiol, D-13353 Berlin, Germany; [Reiss-Zimmermann, Martin; Hoffmann, Karl-Titus] Univ Med Leipzig, Dept Neuroradiol, Leipzig, Germany; [Freimann, Florian Baptist] Univ Med Gottingen, Dept Neurosurg, Gottingen, Germany; [Bayerl, Simon] Charite, Dept Neurosurg, D-13353 Berlin, Germany; [Arlt, Felix] Univ Med Leipzig, Dept Neurosurg, Leipzig, Germany; [Wuerfel, Jens] Univ Med Gottingen, Inst Neuroradiol, Gottingen, Germany; [Wuerfel, Jens] Charite, NeuroCure, D-13353 Berlin, Germany; [Braun, Juergen] Charite, Inst Med Informat, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leipzig University; University of Gottingen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leipzig University; University of Gottingen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Sack, I (corresponding author), Charite, Dept Radiol, D-13353 Berlin, Germany.	ingolf.sack@charite.de		Hoffmann, Karl-Titus/0000-0001-7693-887X; Braun, Jurgen/0000-0001-5183-7546; Reiss-Zimmermann, Martin/0000-0002-4961-8712; Wuerfel, Jens/0000-0002-0034-8053; Guo, Jing/0000-0002-1170-8157	German Research Foundation (DFG) [Sa901/10]	German Research Foundation (DFG)(German Research Foundation (DFG))	IS received a grant of the German Research Foundation (DFG Sa901/10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aster R. C., 2013, PARAMETER ESTIMATION; Baghani A, 2011, IEEE T MED IMAGING, V30, P1555, DOI 10.1109/TMI.2011.2131674; Bailey P, 1926, CLASSIFICATION TUMOR; Basan M, 2009, HFSP J, V3, P265, DOI 10.2976/1.3086732; BERNSTEIN M, 1994, J NEUROSURG, V81, P165, DOI 10.3171/jns.1994.81.2.0165; Braun J, 2014, NEUROIMAGE, V90, P308, DOI 10.1016/j.neuroimage.2013.12.032; Buhring U, 2001, NEUROLOGY, V57, P393, DOI 10.1212/WNL.57.3.393; Davis FG, 2001, NEURO-ONCOLOGY, V3, P152, DOI 10.1093/neuonc/3.3.152; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Ehman, 2012, PHASE CORRECTION INT, P3426; Freimann FB, 2013, NMR BIOMED, V26, P1534, DOI 10.1002/nbm.2987; Freimann FB, 2012, NEURORADIOLOGY, V54, P189, DOI 10.1007/s00234-011-0871-1; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Green MA, 2008, NMR BIOMED, V21, P755, DOI 10.1002/nbm.1254; Guo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071807; Hamhaber U, 2010, J MAGN RESON IMAGING, V32, P577, DOI 10.1002/jmri.22294; Hirsch S, 2013, MAGN RESON MED, V70, P671, DOI 10.1002/mrm.24499; Jiang X, 2014, EUROPEAN RA IN PRESS, DOI [10.1007/s00330-00014-03305-00338, DOI 10.1007/S00330-00014-03305-00338]; Johnson CL, 2013, MAGN RESON MED, V70, P404, DOI 10.1002/mrm.24473; Johnson CL, 2013, NEUROIMAGE, V79, P145, DOI 10.1016/j.neuroimage.2013.04.089; Kruse SA, 2008, NEUROIMAGE, V39, P231, DOI 10.1016/j.neuroimage.2007.08.030; Lipp A, 2013, NEUROIMAGE-CLIN, V3, P381, DOI 10.1016/j.nicl.2013.09.006; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Murphy MC, 2013, J NEUROSURG, V118, P643, DOI 10.3171/2012.9.JNS12519; Murphy MC, 2011, J MAGN RESON IMAGING, V34, P494, DOI 10.1002/jmri.22707; Muthupillai R, 1996, NAT MED, V2, P601, DOI 10.1038/nm0596-601; Oliphant TE, 2001, MAGNET RESON MED, V45, P299, DOI 10.1002/1522-2594(200102)45:2<299::AID-MRM1039>3.0.CO;2-O; Papazoglou S, 2012, PHYS MED BIOL, V57, P2329, DOI 10.1088/0031-9155/57/8/2329; Papazoglou S, 2009, PHYS MED BIOL, V54, P2229, DOI 10.1088/0031-9155/54/7/025; Porter KR, 2010, NEURO-ONCOLOGY, V12, P520, DOI 10.1093/neuonc/nop066; Riek K, 2012, NEUROIMAGE-CLIN, V1, P81, DOI 10.1016/j.nicl.2012.09.003; Romano A, 2012, MAGN RESON MED, V68, P1410, DOI 10.1002/mrm.24141; Rump J, 2007, MAGN RESON MED, V57, P388, DOI 10.1002/mrm.21152; Sack I, 2008, NMR BIOMED, V21, P265, DOI 10.1002/nbm.1189; Sack I, 2013, SOFT MATTER, V9, P5672, DOI 10.1039/c3sm50552a; Sack I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023451; Sack I, 2009, NEUROIMAGE, V46, P652, DOI 10.1016/j.neuroimage.2009.02.040; Schregel K, 2012, P NATL ACAD SCI USA, V109, P6650, DOI 10.1073/pnas.1200151109; Simon M, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/8/085024; Streitberger KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029888; Streitberger KJ, 2011, NMR BIOMED, V24, P385, DOI 10.1002/nbm.1602; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Toh CH, 2011, AM J NEURORADIOL, V32, P1646, DOI 10.3174/ajnr.A2581; Wuerfel J, 2010, NEUROIMAGE, V49, P2520, DOI 10.1016/j.neuroimage.2009.06.018; Xu L, 2007, ACTA RADIOL, V48, P327, DOI 10.1080/02841850701199967	45	91	94	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110588	10.1371/journal.pone.0110588	http://dx.doi.org/10.1371/journal.pone.0110588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338072	Green Submitted, Green Published, gold			2022-12-27	WOS:000343674800060
J	Zhang, YM; Mao, RC; Yan, R; Cai, DW; Zhang, YJ; Zhu, HX; Kang, YY; Liu, HY; Wang, JY; Qin, YL; Huang, YX; Guo, HT; Zhang, JM				Zhang, Yongmei; Mao, Richeng; Yan, Ran; Cai, Dawei; Zhang, Yijun; Zhu, Haoxiang; Kang, Yaoyue; Liu, Hongyan; Wang, Jinyu; Qin, Yanli; Huang, Yuxian; Guo, Haitao; Zhang, Jiming			Transcription of Hepatitis B Virus Covalently Closed Circular DNA Is Regulated by CpG Methylation during Chronic Infection	PLOS ONE			English	Article							EPIGENETIC REGULATION; CELL-CULTURES; LIVER-TISSUES; BREAK REPAIR; CCCDNA; MINICHROMOSOME; REPLICATION; EXPRESSION; GENOME; HEPATOCARCINOGENESIS	The persistence of hepatitis B virus (HBV) infection is maintained by the nuclear viral covalently closed circular DNA (cccDNA), which serves as transcription template for viral mRNAs. Previous studies suggested that cccDNA contains methylation-prone CpG islands, and that the minichromosome structure of cccDNA is epigenetically regulated by DNA methylation. However, the regulatory effect of each CpG island methylation on cccDNA activity remains elusive. In the present study, we analyzed the distribution of CpG methylation within cccDNA in patient samples and investigated the impact of CpG island methylation on cccDNA-driven virus replication. Our study revealed the following observations: 1) Bisulfite sequencing of cccDNA from chronic hepatitis B patients indicated that CpG island I was seldom methylated, 2) CpG island II methylation was correlated to the low level of serum HBV DNA in patients, and in vitro methylation studies confirmed that CpG island II methylation markedly reduced cccDNA transcription and subsequent viral core DNA replication, 3) CpG island III methylation was associated with low serum HBsAg titers, and 4) Furthermore, we found that HBV genotype, HBeAg positivity, and patient age and liver fibrosis stage were also relevant to cccDNA CpG methylation status. Therefore, we clearly demonstrated that the status of cccDNA methylation is connected to the biological behavior of HBV. Taken together, our study provides a complete profile of CpG island methylation within HBV cccDNA and new insights for the function of CpG methylation in regulating HBV cccDNA transcription.	[Zhang, Yongmei; Mao, Richeng; Zhang, Yijun; Zhu, Haoxiang; Kang, Yaoyue; Liu, Hongyan; Wang, Jinyu; Qin, Yanli; Huang, Yuxian; Zhang, Jiming] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Infect Dis, Shanghai 200433, Peoples R China; [Yan, Ran; Cai, Dawei; Guo, Haitao] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Inst Biotechnol & Virol Res, Doylestown, PA 18902 USA; [Zhang, Jiming] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol, MOH, Shanghai 200433, Peoples R China; [Zhang, Jiming] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol, MOE, Shanghai 200433, Peoples R China	Fudan University; Drexel University; Fudan University; Fudan University	Guo, HT (corresponding author), Drexel Univ, Coll Med, Dept Microbiol & Immunol, Inst Biotechnol & Virol Res, Doylestown, PA 18902 USA.	haitguo@iupui.edu; jmzhang@fudan.edu.cn			National Natural Science Foundation of China [81071354, 81271833]; 973 project [2012CB519001]; National Science and Technology Major Project of China [2012ZX10002007-001-002, 2013ZX10002001]; National Institutes of Health (NIH) [R01AI094474]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094474] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 project(National Basic Research Program of China); National Science and Technology Major Project of China; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Natural Science Foundation of China (81071354, 81271833), 973 project (2012CB519001), and National Science and Technology Major Project of China (2012ZX10002007-001-002, 2013ZX10002001) (to Jiming Zhang) and National Institutes of Health (NIH) R01AI094474 (to Haitao Guo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belloni L, 2012, J CLIN INVEST, V122, P529, DOI 10.1172/JCI58847; Belloni L, 2009, P NATL ACAD SCI USA, V106, P19975, DOI 10.1073/pnas.0908365106; Block Timothy M, 2007, Clin Liver Dis, V11, P685, DOI 10.1016/j.cld.2007.08.002; Bock CT, 2001, J MOL BIOL, V307, P183, DOI 10.1006/jmbi.2000.4481; BOCK CT, 1994, VIRUS GENES, V8, P215, DOI 10.1007/BF01703079; Cai DW, 2012, ANTIMICROB AGENTS CH, V56, P4277, DOI 10.1128/AAC.00473-12; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; Doerfler W, 2005, BIOCHEMISTRY-MOSCOW+, V70, P505, DOI 10.1007/s10541-005-0145-9; Guerrieri F, 2013, SEMIN LIVER DIS, V33, P147, DOI 10.1055/s-0033-1345721; GUNTHER S, 1995, J VIROL, V69, P5437; Guo H, 2007, J VIROL, V81, P12472, DOI 10.1128/JVI.01123-07; Guo HT, 2010, J VIROL, V84, P387, DOI 10.1128/JVI.01921-09; Guo YH, 2011, EPIGENETICS-US, V6, P720, DOI 10.4161/epi.6.6.15815; Guo YH, 2009, J MED VIROL, V81, P1177, DOI 10.1002/jmv.21525; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kim JW, 2011, INTERVIROLOGY, V54, P316, DOI 10.1159/000321450; Krueger F, 2012, NAT METHODS, V9, P145, DOI [10.1038/NMETH.1828, 10.1038/nmeth.1828]; Liang TJ, 2009, HEPATOLOGY, V49, pS13, DOI 10.1002/hep.22881; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lucifora J, 2014, SCIENCE, V343, P1221, DOI 10.1126/science.1243462; Mao RC, 2011, J VIROL, V85, P1048, DOI 10.1128/JVI.01998-10; McMahon BJ, 2014, MED CLIN N AM, V98, P39, DOI 10.1016/j.mcna.2013.08.004; MILLER RH, 1983, P NATL ACAD SCI-BIOL, V80, P2534, DOI 10.1073/pnas.80.9.2534; NEWBOLD JE, 1995, J VIROL, V69, P3350, DOI 10.1128/JVI.69.6.3350-3357.1995; Okamoto Y, 2014, GASTROENTEROLOGY, V146, P562, DOI 10.1053/j.gastro.2013.10.056; Park HK, 2013, BIOCHEM BIOPH RES CO, V436, P152, DOI 10.1016/j.bbrc.2013.04.108; Pollicino T, 2006, GASTROENTEROLOGY, V130, P823, DOI 10.1053/j.gastro.2006.01.001; Rottach A, 2009, J CELL BIOCHEM, V108, P43, DOI 10.1002/jcb.22253; Saito Y, 2001, HEPATOLOGY, V33, P561, DOI 10.1053/jhep.2001.22507; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Vivekanandan P, 2008, J VIRAL HEPATITIS, V15, P103, DOI 10.1111/j.1365-2893.2007.00905.x; Vivekanandan P, 2010, J VIROL, V84, P4321, DOI 10.1128/JVI.02280-09; Vivekanandan P, 2009, J INFECT DIS, V199, P1286, DOI 10.1086/597614; Volz T, 2007, GASTROENTEROLOGY, V133, P843, DOI 10.1053/j.gastro.2007.06.057; Wieland SF, 2004, P NATL ACAD SCI USA, V101, P2129, DOI 10.1073/pnas.0308478100; Zhang JM, 2005, J MED VIROL, V77, P203, DOI 10.1002/jmv.20453; Zhang YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056711; Zhou TL, 2006, ANTIVIR RES, V72, P116, DOI 10.1016/j.antiviral.2006.05.006; Zoulim F, 2005, J HEPATOL, V42, P302, DOI 10.1016/j.jhep.2004.12.015	44	60	65	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110442	10.1371/journal.pone.0110442	http://dx.doi.org/10.1371/journal.pone.0110442			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337821	Green Submitted, Green Published, gold			2022-12-27	WOS:000343674800043
J	Saito, M; Kondo, K; Kondo, N; Abe, A; Ojima, T; Suzuki, K				Saito, Masashige; Kondo, Katsunori; Kondo, Naoki; Abe, Aya; Ojima, Toshiyuki; Suzuki, Kayo		JAGES Grp	Relative Deprivation, Poverty, and Subjective Health: JAGES Cross-Sectional Study	PLOS ONE			English	Article							SELF-RATED HEALTH; AREA DEPRIVATION; SOCIOECONOMIC POSITION; ORAL-HEALTH; MORTALITY; OLDER; DEPRESSION; DIMENSIONS; INEQUALITY; ENGLAND	To evaluate the association between relative deprivation (lacking daily necessities) and subjective health in older Japanese adults, we performed a cross-sectional analysis using data from the Japan Gerontological Evaluation Study (JAGES). The data were obtained from functionally independent residents aged >= 65 years from 24 municipalities in Japan (n = 24,742). Thirteen items in three dimensions were used to evaluate relative deprivation of material conditions. Approximately 28% of older Japanese people indicated that they lacked some daily necessities (non-monetary poverty). A two-level Poisson regression analysis revealed that relative deprivation was associated with poor self-rated health (PR = 1.3-1.5) and depressive symptoms (PR = 1.5-1.8) in both men and women, and these relationships were stronger than those observed in people living in relative poverty (monetary poverty). The interaction effect between relative deprivation and relative poverty was not associated with poor health. As a dimension of the social determinants of health, poverty should be evaluated from a multidimensional approach, capturing not only monetary conditions but also material-based, non-monetary conditions.	[Saito, Masashige] Nihon Fukushi Univ, Dept Social Welf, Aichi, Japan; [Kondo, Katsunori] Chiba Univ, Ctr Prevent Med Sci, Chiba, Japan; [Kondo, Naoki] Univ Tokyo, Dept Hlth Econ & Epidemiol Res, Tokyo, Japan; [Abe, Aya] Natl Inst Populat & Social Secur Res, Dept Empir Social Secur Res, Tokyo, Japan; [Ojima, Toshiyuki] Hamamatsu Univ, Sch Med, Dept Community Hlth & Prevent Med, Shizuoka, Japan; [Suzuki, Kayo] Aichi Gakuin Univ, Dept Social Studies, Aichi, Japan	Chiba University; University of Tokyo; Hamamatsu University School of Medicine; Aichi Gakuin University	Saito, M (corresponding author), Nihon Fukushi Univ, Dept Social Welf, Aichi, Japan.	masa-s@n-fukushi.ac.jp	Kondo, Katsunori/AAI-6373-2020; Kondo, Naoki/K-3898-2012; Kondo, Naoki/ABC-5865-2020	Kondo, Naoki/0000-0002-6425-6844; Kondo, Naoki/0000-0002-6425-6844; Ashida, Toyo/0000-0002-0334-121X	Japan Society for the Promotion of Science [KAKENHI 26285138, 23243070]; Japanese Ministry of Health, Labour and Welfare [H25-Choju-ippan-003]; MEXT; Health Labour Sciences Research Grant, Comprehensive Research on Aging and Health [H22-Choju-shitei-008]; JSPS KA-KENHI Grant [23243070, 22330172, 22119506, 22390400, 22592327, 22700694, 23590786, 23700819]; Japan Foundation for Aging and Health; Grants-in-Aid for Scientific Research [26460831, 26285138] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health Labour Sciences Research Grant, Comprehensive Research on Aging and Health; JSPS KA-KENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Foundation for Aging and Health; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Grant-in-Aid for Scientific Research (KAKENHI 26285138 and 23243070) from the Japan Society for the Promotion of Science, and Health Labour Sciences Research Grant, Comprehensive Research on Aging and Health (H25-Choju-ippan-003) from the Japanese Ministry of Health, Labour and Welfare. This survey data was supported by MEXT Supported Program for the Strategic Research Foundation at Private Universities 2009-2013, Health Labour Sciences Research Grant, Comprehensive Research on Aging and Health (H22-Choju-shitei-008), JSPS KA-KENHI Grant Number 22330172, 22119506, 22390400, 22592327, 22700694, 23590786, 23700819 & 23243070, and Japan Foundation for Aging and Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2006, J SOCIAL POLICY LABO, V16, P251; Abe A, 2007, Q SOCIAL SECURITY RE, V43, P27; Abe A, 2014, Q SOCIAL SECURITY RE, V49, P360; Aida J, 2009, SOC SCI MED, V69, P512, DOI 10.1016/j.socscimed.2009.06.003; [Anonymous], 2002, RELATIVE DEPRIVATION; Bower E, 2007, COMMUNITY DENT ORAL, V35, P118, DOI 10.1111/j.1600-0528.2007.00308.x; Bradshaw J, 2003, J SOC POLICY, V32, P513, DOI 10.1017/S004727940300713X; CARP FM, 1981, RES AGING, V3, P279, DOI 10.1177/016402758133002; Claussen B, 2003, J EPIDEMIOL COMMUN H, V57, P40, DOI 10.1136/jech.57.1.40; Crosby F.J., 1982, RELATIVE DEPRIVATION; EAMES M, 1993, BRIT MED J, V307, P1097, DOI 10.1136/bmj.307.6912.1097; Ellwood RP, 2004, COMMUNITY DENT ORAL, V32, P159, DOI 10.1111/j.1600-0528.2004.00150.x; European Commission, 2011, SOC DIM EUR 2020 STR; Forster M., 1994, OECD LABOUR MARKET S, DOI [10.1787/112854878327, DOI 10.1787/112854878327]; GOLANT SM, 1995, J GERONTOL B-PSYCHOL, V50, pS13, DOI 10.1093/geronb/50B.1.S13; Gordon D., 2000, POVERTY SOCIAL EXCLU; Hiraoka K., 2002, SOCIAL INEQUALITIES; Ichida Y, 2009, SOC SCI MED, V69, P489, DOI 10.1016/j.socscimed.2009.05.006; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Iwata M, 2004, JOSEI TACHI HEISEI F, P203; Kondo K., 2010, HLTH INEQUALITIES JA; Kondo N, 2009, J EPIDEMIOL COMMUN H, V63, P461, DOI 10.1136/jech.2008.078642; KOSAKA K, 1986, J MATH SOCIOL, V12, P35, DOI 10.1080/0022250X.1986.9990003; Krueger A, 2012, EC REPORT PRESIDENT; Langford IH, 1996, SOC SCI MED, V42, P897, DOI 10.1016/0277-9536(95)00188-3; Lawlor DA, 2005, AM J PUBLIC HEALTH, V95, P91, DOI 10.2105/AJPH.2003.035592; Lynch JW., 2000, SOCIAL EPIDEMIOLOGY, P13; Mack J., 1985, POOR BRITAIN; McLoone P, 1996, BRIT MED J, V312, P543, DOI 10.1136/bmj.312.7030.543; MCLOONE P, 1994, BRIT MED J, V309, P1465, DOI 10.1136/bmj.309.6967.1465; Ministry of Internal Affairs and Communications, 2009, NAT SURV FAM INC EXP; Murata C, 2011, JAPANESE J GERONTOLO, V33, P15; Nakaya T., 2011, P I STAT MATH, V59, P239; National Institute of Population and Social Security Research, 2013, JAP PUBL STAT DAT BA; O'Reilly D, 2002, AGE AGEING, V31, P197, DOI 10.1093/ageing/31.3.197; Royall DR, 2007, J AM MED DIR ASSOC, V8, P318, DOI 10.1016/j.jamda.2006.12.018; Runciman Walter Garrison, 1966, RELATIVE DEPRIVATION; Sacker A, 2001, SOC SCI MED, V52, P763, DOI 10.1016/S0277-9536(00)00176-3; Saito M, 2014, Q SOCIAL SE IN PRESS, V50; Saito M, 2012, SOC SCI MED, V75, P940, DOI 10.1016/j.socscimed.2012.04.006; Saunders P, 2008, FAMILY MATTERS, P8; Saunders P, 2010, POVERTY PUBLIC POLIC, V2, P67, DOI 10.2202/1944-2858.1030; Scase R, 1974, POVERTY INEQUALITY C, P197; Shaw M, 2006, SOCIAL DETERMINANTS, P196; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Stouffer S. A., 1949, AM SOLDIER, V1; Tougas F, 2004, INT J AGING HUM DEV, V59, P1, DOI 10.2190/3WTN-63QQ-EJMG-BGYA; Townsend P., 1979, POVERTY UK SURVEY HO; Turley RNL, 2002, J COMMUNITY PSYCHOL, V30, P671, DOI 10.1002/jcop.10033; Walters K, 2004, AM J PUBLIC HEALTH, V94, P1768, DOI 10.2105/AJPH.94.10.1768; Watanabe M., 2013, JAPANESE J PERSONALI, V22, P193, DOI [10.2132/personality.22.193, DOI 10.2132/PERSONALITY.22.193]; Whelan CT, 2003, J SOC POLICY, V32, P1, DOI 10.1017/S0047279402006864; Wilkinson RG, 2003, SOCIAL DETERMINANTS; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	54	46	47	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111169	10.1371/journal.pone.0111169	http://dx.doi.org/10.1371/journal.pone.0111169			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BH	25350284	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943100059
J	Wang, XM; Hou, XQ; Zhang, YQ; Li, Y				Wang, Xu-Mei; Hou, Xiao-Qi; Zhang, Yu-Qu; Li, Yan			Morphological Variation in Leaf Dissection of Rheum palmatum Complex (Polygonaceae)	PLOS ONE			English	Article							PHYLOGENY; SEQUENCES; EVOLUTION; RHUBARB	Aims: Rheum palmatum complex comprises all taxa within section Palmata in the genus Rheum, including R. officinale, R. palmatum, R. tanguticum, R. tanguticum var. liupanshanense and R. laciniatum. The identification of the taxa in section Palmata is based primarily on the degree of leaf blade dissection and the shape of the lobes; however, difficulties in species identification may arise from their significant variation. The aim of this study is to analyze the patterns of variation in leaf blade characteristics within and among populations through population-based sampling covering the entire distribution range of R. palmatum complex. Methods: Samples were taken from 2340 leaves from 780 individuals and 44 populations representing the four species, and the degree of leaf blade dissection and the shape of the lobe were measured to yield a set of quantitative data. Furthermore, those data were statistically analyzed. Important Findings: The statistical analysis showed that the degree of leaf blade dissection is continuous from lobed to parted, and the shape of the lobe is also continuous from broadly triangular to lanceolate both within and between populations. We suggested that taxa in section Palmata should be considered as one species. Based on the research on the R. palmatum complex, we considered that the quantitative characteristics were greatly influenced by the environment. Therefore, it is not reliable to delimitate the species according to the continuously quantitative vegetative characteristics.	[Wang, Xu-Mei; Li, Yan] Xi An Jiao Tong Univ, Sch Pharm, Xian 710049, Peoples R China; [Hou, Xiao-Qi] Guiyang Bot Garden Med Plants, Guiyang Museum Med Resources, Guiyang, Peoples R China; [Zhang, Yu-Qu] Shaanxi Normal Univ, Coll Life Sci, Xian, Peoples R China	Xi'an Jiaotong University; Shaanxi Normal University	Wang, XM (corresponding author), Xi An Jiao Tong Univ, Sch Pharm, Xian 710049, Peoples R China.	wangxumei@mail.xjtu.edu.cn	Li, Yang/GWM-7879-2022; Li, Yuan/GXV-1310-2022; li, yong/HDN-3885-2022		National Natural Science Foundation of China [81001602]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (No. 81001602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao BJ., 2003, FLORA CHINA, V5, P341; Chang CS, 2004, ACTA PHYTOTAXON SIN, V42, P222; Chen JY, 2008, J SYST EVOL, V46, P93, DOI 10.3724/SP.J.1002.2008.06177; Cui Da-fang, 2010, Journal of Plant Resources and Environment, V19, P1; Davis PH, 1963, PRINCIPLES ANGIOSPER; Gallego MT, 2004, BOT J LINN SOC, V145, P219, DOI 10.1111/j.1095-8339.2003.00271.x; Ge S., 1998, ACTA PHYTOTAXONOMICA, V36, P481; Ge S, 1994, ACTA PHYTOTAXONOMICA, V32, P489; Ge S, 2010, J SYST EVOL, V48, P445, DOI 10.1111/j.1759-6831.2010.00104.x; GOTTLIEB LD, 1984, AM NAT, V123, P681, DOI 10.1086/284231; Hsu PS, 1983, B BOT RES, V3, P9; Li PQ, 2010, LIAONING J TRAD CHIN, V37, P136; Li SY, 2000, ACTA BOT BOREALI-OCC, V20, P268; Northwest Institute of Botany of the Chinese Academy of Sciences, 1976, FLOR TSINL, V1, P139; [史刚荣 Shi Gangrong], 2003, [植物研究, Bulletin of Botanical Research], V23, P220; Sun ZY, 1999, B BOT RES, V19, P143; Suo FengMei, 2010, Zhongcaoyao = Chinese Traditional and Herbal Drugs, V41, P292; Wang AL, 2005, ANN BOT-LONDON, V96, P489, DOI 10.1093/aob/mci201; Wang XM, 2010, J MED PLANTS RES, V4, P1865; Wei XM, 2008, J SYST EVOL, V46, P919, DOI 10.3724/SP.J.1002.2008.08046; Wiens JJ, 2000, P ROY SOC B-BIOL SCI, V267, P631, DOI 10.1098/rspb.2000.1049; Wu JK, 1992, ACTA BOT BOREALI-OCC, V12, P309; Yang DY, 2004, BIOL PHARM BULL, V27, P375, DOI 10.1248/bpb.27.375; Yang HaiJun, 2011, Pratacultural Science, V28, P207; Yang Li-Juan, 2008, Wuhan Zhiwuxue Yanjiu, V26, P589; Yu YF, 1999, PLANTS, V1999, P3; Zhang FM, 2003, ACTA PHYTOTAXON SIN, V41, P220; Zhang K, 2009, J HANGZHOU NORMAL U, V8, P214; Zhao YZ, 1998, ACTA PHYTOTAXON SIN, V36, P193; 葛颂, 1995, 植物分类学报, V33, P433	30	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110760	10.1371/journal.pone.0110760	http://dx.doi.org/10.1371/journal.pone.0110760			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25349989	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943100039
J	Batista, AB; Oliveira, JTA; Gifoni, JM; Pereira, ML; Almeida, MGG; Gomes, VM; Da Cunha, M; Ribeiro, SFF; Dias, GB; Beltramini, LM; Lopes, JLS; Grangeiro, TB; Vasconcelos, IM				Batista, Adelina B.; Oliveira, Jose T. A.; Gifoni, Juliana M.; Pereira, Mirella L.; Almeida, Marina G. G.; Gomes, Valdirene M.; Da Cunha, Maura; Ribeiro, Suzanna F. F.; Dias, Germana B.; Beltramini, Leila M.; Lopes, Jose Luiz S.; Grangeiro, Thalles B.; Vasconcelos, Ilka M.			New Insights into the Structure and Mode of Action of Mo-CBP3, an Antifungal Chitin-Binding Protein of Moringa oleifera Seeds	PLOS ONE			English	Article							PLASMA-MEMBRANE; 2S ALBUMIN; PLANT; DEFENSIN; PEPTIDE; APOPTOSIS; ASSAY	Mo-CBP3 is a chitin-binding protein purified from Moringa oleifera Lam. seeds that displays inhibitory activity against phytopathogenic fungi. This study investigated the structural properties and the antifungal mode of action of this protein. To this end, circular dichroism spectroscopy, antifungal assays, measurements of the production of reactive oxygen species and microscopic analyses were utilized. Mo-CBP3 is composed of 30.3% alpha-helices, 16.3% beta-sheets, 22.3% turns and 30.4% unordered forms. The Mo-CBP3 structure is highly stable and retains its antifungal activity regardless of temperature and pH. Fusarium solani was used as a model organism for studying the mechanisms by which this protein acts as an antifungal agent. Mo-CBP3 significantly inhibited spore germination and mycelial growth at 0.05 mg.mL(-1). Mo-CBP3 has both fungistatic and fungicidal effects, depending on the concentration used. Binding of Mo-CBP3 to the fungal cell surface is achieved, at least in part, via electrostatic interactions, as salt was able to reduce its inhibitory effect. Mo-CBP3 induced the production of ROS and caused disorganization of both the cytoplasm and the plasma membrane in F. solani cells. Based on its high stability and specific toxicity, with broad-spectrum efficacy against important phytopathogenic fungi at low inhibitory concentrations but not to human cells, Mo-CBP3 has great potential for the development of new antifungal drugs or transgenic crops with enhanced resistance to phytopathogens.	[Batista, Adelina B.; Oliveira, Jose T. A.; Gifoni, Juliana M.; Pereira, Mirella L.; Almeida, Marina G. G.; Vasconcelos, Ilka M.] Univ Fed Ceara, Dept Biochem & Mol Biol, Fortaleza, Ceara, Brazil; [Gomes, Valdirene M.; Da Cunha, Maura; Ribeiro, Suzanna F. F.; Dias, Germana B.] State Univ North Fluminense, Biosci & Biotecnol Ctr, Rio De Janeiro, Brazil; [Beltramini, Leila M.; Lopes, Jose Luiz S.] Univ Sao Paulo, Phys Inst Sao Carlos, Sao Carlos, SP, Brazil; [Grangeiro, Thalles B.] Univ Fed Ceara, Dept Biol, Fortaleza, Ceara, Brazil	Universidade Federal do Ceara; Universidade de Sao Paulo; Universidade Federal do Ceara	Vasconcelos, IM (corresponding author), Univ Fed Ceara, Dept Biochem & Mol Biol, Fortaleza, Ceara, Brazil.	imvasco@ufc.br	Grangeiro, Thalles Barbosa/E-9606-2010; Beltramini, Leila M/I-5523-2012; Da Cunha, Maura/L-1412-2014; Lopes, Jose Luiz S/AAC-2917-2021; Lopes, Jose L S/D-3213-2012; Gomes, Valdirene/G-1805-2015	Grangeiro, Thalles Barbosa/0000-0001-8276-3092; Beltramini, Leila M/0000-0001-5741-8238; Lopes, Jose L S/0000-0003-1281-0521; Gomes, Valdirene/0000-0003-4145-428X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES; Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico - FUNCAP	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico - FUNCAP(Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (www.cnpq.br), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES (www.capes.gov.br), and Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico - FUNCAP (www.funcap.ce.gov.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts AM, 2007, J MOL MICROB BIOTECH, V13, P243, DOI 10.1159/000104753; Agizzio AP, 2006, PLANT SCI, V171, P515, DOI 10.1016/j.plantsci.2006.06.001; Asensio JL, 2000, CHEM BIOL, V7, P529, DOI 10.1016/S1074-5521(00)00136-8; BEINTEMA JJ, 1994, FEBS LETT, V350, P159, DOI 10.1016/0014-5793(94)00753-5; BIGNAMI GS, 1993, TOXICON, V31, P817, DOI 10.1016/0041-0101(93)90389-Z; Bindschedler LV, 2006, FEBS LETT, V580, P1541, DOI 10.1016/j.febslet.2006.01.079; Borges AF, 2013, PLANT PHYSIOL BIOCH, V68, P71, DOI 10.1016/j.plaphy.2013.03.024; Bormann C, 1999, J BACTERIOL, V181, P7421, DOI 10.1128/JB.181.24.7421-7429.1999; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROEKAERT WF, 1990, FEMS MICROBIOL LETT, V69, P55, DOI [10.1111/j.1574-6968.1990.tb04174.x, 10.1016/S0378-1097(98)00477-7]; BROEKAERT WF, 1992, BIOCHEMISTRY-US, V31, P4308, DOI 10.1021/bi00132a023; Brul S, 1997, J MICROBIOL METH, V28, P169, DOI 10.1016/S0167-7012(97)00975-5; Carvalho AD, 2011, CURR PHARM DESIGN, V17, P4270, DOI 10.2174/138161211798999447; Choi H, 2012, BBA-BIOMEMBRANES, V1818, P1648, DOI 10.1016/j.bbamem.2012.02.026; Duan XH, 2013, PLANT PHYSIOL BIOCH, V66, P84, DOI 10.1016/j.plaphy.2013.01.015; Gessler NN, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1091, DOI 10.1134/S0006297907100070; Gifoni JM, 2012, BIOPOLYMERS, V98, P406, DOI 10.1002/bip.22068; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Ji C, 1996, PHYSIOL MOL PLANT P, V49, P257, DOI 10.1006/pmpp.1996.0053; KOK LT, 1972, COMP BIOCHEM PHYSIOL, V42, P245, DOI 10.1016/0305-0491(72)90271-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee JK, 2012, INT J MOL SCI, V13, P4021, DOI 10.3390/ijms13044021; Lindquist W, 1953, J I BREWING, V59, P59; Mello EO, 2011, CURR MICROBIOL, V62, P1209, DOI 10.1007/s00284-010-9847-3; Mendieta JR, 2006, MICROBIOL-SGM, V152, P2039, DOI 10.1099/mic.0.28816-0; Morais JKS, 2010, J AGR FOOD CHEM, V58, P10356, DOI 10.1021/jf101688k; Narasimhan ML, 2001, MOL CELL, V8, P921, DOI 10.1016/S1097-2765(01)00365-3; Prasad BD, 2008, PLANT SCI, V175, P364, DOI 10.1016/j.plantsci.2008.05.015; Qi GF, 2010, PEPTIDES, V31, P1978, DOI 10.1016/j.peptides.2010.08.003; Ranjbar B, 2009, CHEM BIOL DRUG DES, V74, P101, DOI 10.1111/j.1747-0285.2009.00847.x; Riaz M, 2012, MOLECULES, V17, P14275, DOI 10.3390/molecules171214275; Richards Andrea, 2010, Fungal Biology Reviews, V24, P93, DOI 10.1016/j.fbr.2010.04.002; Selitrennikoff CP, 2001, APPL ENVIRON MICROB, V67, P2883, DOI 10.1128/AEM.67.7.2883-2894.2001; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; de Freitas CDT, 2011, BBA-BIOMEMBRANES, V1808, P2501, DOI 10.1016/j.bbamem.2011.07.014; Theis T, 2003, ANTIMICROB AGENTS CH, V47, P588, DOI 10.1128/AAC.47.2.588-593.2003; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Trindade MB, 2006, BBA-PROTEINS PROTEOM, V1764, P146, DOI 10.1016/j.bbapap.2005.09.011; Wong JH, 2012, FOOD CHEM, V135, P408, DOI 10.1016/j.foodchem.2012.04.119; Yao Q, 2010, PROCESS BIOCHEM, V45, P1477, DOI 10.1016/j.procbio.2010.05.026; Zottich U, 2011, BBA-GEN SUBJECTS, V1810, P375, DOI 10.1016/j.bbagen.2010.12.002	41	28	30	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111427	10.1371/journal.pone.0111427	http://dx.doi.org/10.1371/journal.pone.0111427			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347074	Green Published, Green Submitted, gold			2022-12-27	WOS:000347994900069
J	Li, J; Geisbush, TR; Arnold, WD; Rosen, GD; Zaworski, PG; Rutkove, SB				Li, Jia; Geisbush, Tom R.; Arnold, William D.; Rosen, Glenn D.; Zaworski, Phillip G.; Rutkove, Seward B.			A Comparison of Three Electrophysiological Methods for the Assessment of Disease Status in a Mild Spinal Muscular Atrophy Mouse Model	PLOS ONE			English	Article							UNIT NUMBER ESTIMATION; ELECTRICAL-IMPEDANCE MYOGRAPHY; MOTOR-NEURON PROTEIN; SKELETAL-MUSCLE; SURVIVAL; MICE; CHILDREN; GENE; TAIL	Objectives: There is a need for better, noninvasive quantitative biomarkers for assessing the rate of progression and possible response to therapy in spinal muscular atrophy (SMA). In this study, we compared three electrophysiological measures: compound muscle action potential (CMAP) amplitude, motor unit number estimate (MUNE), and electrical impedance myography (EIM) 50 kHz phase values in a mild mouse model of spinal muscular atrophy, the Smn1(c/c) mouse. Methods: Smn1(c/c) mice (N = 11) and wild type (WT) animals ((-/-), N = 13) were measured on average triweekly until approximately 1 year of age. Measurements included CMAP, EIM, and MUNE of the gastrocnemius muscle as well as weight and front paw grip strength. At the time of sacrifice at one year, additional analyses were performed on the animals including serum survival motor neuron (SMN) protein levels and muscle fiber size. Results: Both EIM 50 kHz phase and CMAP showed strong differences between WT and SMA animals (repeated measures 2-way ANOVA, P < 0.0001 for both) whereas MUNE did not. Both body weight and EIM showed differences in the trajectory over time (p < 0.001 and p = 0.005, respectively). At the time of sacrifice at one year, EIM values correlated to motor neuron counts in the spinal cord and SMN levels across both groups of animals (r = 0.41, p = 0.047 and r = 0.57, p = 0.003, respectively), while CMAP did not. Motor neuron number in Smn1(c/c) mice was not significantly reduced compared to WT animals. Conclusions: EIM appears sensitive to muscle status in this mild animal model of SMA. The lack of a reduction in MUNE or motor neuron number but reduced EIM and CMAP values support that much of the pathology in these animals is distal to the cell body, likely at the neuromuscular junction or the muscle itself.	[Li, Jia; Geisbush, Tom R.; Rosen, Glenn D.; Rutkove, Seward B.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Neurol, Boston, MA 02215 USA; [Arnold, William D.] Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA; [Zaworski, Phillip G.] PharmOptima LLC, Portage, MI USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University System of Ohio; Ohio State University	Rutkove, SB (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Neurol, Boston, MA 02215 USA.	srutkove@bidmc.harvard.edu	Arnold, W. David/AAM-5649-2020; Arnold, W. David/E-2659-2011	Rutkove, Seward/0000-0002-6375-3312	Spinal Muscular Atrophy Foundation; National Institutes of Health [R01NS055099]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055099] Funding Source: NIH RePORTER	Spinal Muscular Atrophy Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research has been supported by the Spinal Muscular Atrophy Foundation and the National Institutes of Health, Grant R01NS055099. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahad MA, 2009, PHYSIOL MEAS, V30, P1415, DOI 10.1088/0967-3334/30/12/009; Arnold WD, 2014, ANN CLIN TRANSL NEUR, V1, P34, DOI 10.1002/acn3.23; Boyer JG, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-24; Bromberg MB, 2002, MUSCLE NERVE, V25, P445, DOI 10.1002/mus.10050; Chen TH, 2013, J CHILD NEUROL; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; Finkel RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035462; Foust KD, 2010, NAT BIOTECHNOL, V28, P271, DOI 10.1038/nbt.1610; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Kasselman LJ, 2009, MUSCLE NERVE, V40, P115, DOI 10.1002/mus.21248; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; Lewelt A, 2010, MUSCLE NERVE, V42, P703, DOI 10.1002/mus.21838; Li J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065976; Ling KKY, 2012, HUM MOL GENET, V21, P185, DOI 10.1093/hmg/ddr453; MASTAGLIA FL, 1971, J NEUROL SCI, V12, P15, DOI 10.1016/0022-510X(71)90249-8; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Nizzardo M, 2014, CLIN THER, V36, P340, DOI 10.1016/j.clinthera.2014.02.004; Osborne M, 2012, HUM MOL GENET, V21, P4431, DOI 10.1093/hmg/dds285; Paganoni S, 2013, PHYS MED REH CLIN N, V24, P193, DOI 10.1016/j.pmr.2012.08.017; Robbins K. L., 2014, HUM MOL GENET; Rutkove SB, 2012, MUSCLE NERVE, V45, P642, DOI 10.1002/mus.23233; Rutkove SB, 2009, MUSCLE NERVE, V40, P936, DOI 10.1002/mus.21362; Shefner JM, 2002, MUSCLE NERVE, V25, P39, DOI 10.1002/mus.10000; Shefner JM, 2001, CLIN NEUROPHYSIOL, V112, P955, DOI 10.1016/S1388-2457(01)00520-X; Sleigh JN, 2011, DIS MODEL MECH, V4, P457, DOI 10.1242/dmm.007245; Souayah N, 2009, AM J PHYSIOL-ENDOC M, V297, pE602, DOI 10.1152/ajpendo.00245.2009; Sproule DM, 2011, J CHILD NEUROL, V26, P1252, DOI 10.1177/0883073811405053; Williams BY, 1999, BIOCHEM BIOPH RES CO, V254, P10, DOI 10.1006/bbrc.1998.9885; Wu JS, 2010, NEUROLOGY, V75, P526, DOI 10.1212/WNL.0b013e3181eccf8f; Xia RH, 2010, MUSCLE NERVE, V41, P850, DOI 10.1002/mus.21588; Yalvac ME, 2014, MOL THER, V22, P1353, DOI 10.1038/mt.2014.77	31	2	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111428	10.1371/journal.pone.0111428	http://dx.doi.org/10.1371/journal.pone.0111428			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347197	Green Published, gold, Green Submitted			2022-12-27	WOS:000347994900070
J	Riedl, J; Posch, F; Konigsbrugge, O; Lotsch, F; Reitter, EM; Eigenbauer, E; Marosi, C; Schwarzinger, I; Zielinski, C; Pabinger, I; Ay, C				Riedl, Julia; Posch, Florian; Koenigsbruegge, Oliver; Loetsch, Felix; Reitter, Eva-Maria; Eigenbauer, Ernst; Marosi, Christine; Schwarzinger, Ilse; Zielinski, Christoph; Pabinger, Ingrid; Ay, Cihan			Red Cell Distribution Width and Other Red Blood Cell Parameters in Patients with Cancer: Association with Risk of Venous Thromboembolism and Mortality	PLOS ONE			English	Article							VIENNA CANCER; HEART-FAILURE; THROMBOSIS; ANEMIA; MODEL; CHEMOTHERAPY; METAANALYSIS; SURVIVAL; ADULTS; COUNT	Background: Cancer patients are at high risk of developing venous thromboembolism (VTE). Red cell distribution width (RDW) has been reported to be associated with arterial and venous thrombosis and mortality in several diseases. Here, we analyzed the association between RDW and other red blood cell (RBC) parameters with risk of VTE and mortality in patients with cancer. Methods: RBC parameters were measured in 1840 patients with cancers of the brain, breast, lung, stomach, colon, pancreas, prostate, kidney; lymphoma, multiple myeloma and other tumor sites, that were included in the Vienna Cancer and Thrombosis Study (CATS), which is an ongoing prospective, observational cohort study of patients with newly diagnosed or progressive cancer after remission. Primary study outcome is occurrence of symptomatic VTE and secondary outcome is death during a maximum follow-up of 2 years. Results: During a median follow-up of 706 days, 131 (7.1%) patients developed VTE and 702 (38.2%) died. High RDW (>16%) was not associated with a higher risk of VTE in the total study cohort; in competing risk analysis accounting for death as competing variable the univariable subhazard ratio (SHR) was 1.34 (95% confidence interval [CI]: 0.80-2.23, p = 0.269). There was also no significant association between other RBC parameters and risk of VTE. High RDW was associated with an increased risk of mortality in the total study population (hazard ratio [HR, 95% CI]: 1.72 [1.39-2.12], p<0.001), and this association prevailed after adjustment for age, sex, hemoglobin, leukocyte and platelet count (HR [95% CI]: 1.34 [1.06-1.70], p = 0.016). Conclusions: RDW and other RBC parameters were not independently associated with risk of VTE in patients with cancer and might therefore not be of added value for estimating risk of VTE in patients with cancer. We could confirm that high RDW is an independent predictor of poor overall survival in cancer.	[Riedl, Julia; Posch, Florian; Koenigsbruegge, Oliver; Loetsch, Felix; Reitter, Eva-Maria; Pabinger, Ingrid; Ay, Cihan] Med Univ Vienna, Comprehens Canc Ctr Vienna, Dept Med 1, Clin Div Haematol & Haemostaseol, Vienna, Austria; [Eigenbauer, Ernst] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria; [Marosi, Christine; Zielinski, Christoph] Med Univ Vienna, Comprehens Canc Ctr Vienna, Dept Med 1, Div Clin Oncol, Vienna, Austria; [Schwarzinger, Ilse] Med Univ Vienna, Dept Lab Med, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Ay, C (corresponding author), Med Univ Vienna, Comprehens Canc Ctr Vienna, Dept Med 1, Clin Div Haematol & Haemostaseol, Vienna, Austria.	cihan.ay@meduniwien.ac.at		Posch, Florian/0000-0002-0448-6314; Ay, Cihan/0000-0003-2607-9717; Konigsbrugge, Oliver/0000-0002-6183-3685; Lotsch, Felix/0000-0002-6938-9523; Riedl, Julia/0000-0003-4663-9830	"Oesterreichische Nationalbank" (Anniversary Fund) [14744]; Hochschuljubilaumsstiftung der Stadt Wien	"Oesterreichische Nationalbank" (Anniversary Fund); Hochschuljubilaumsstiftung der Stadt Wien	This study was supported by funds of the "Oesterreichische Nationalbank" (Anniversary Fund, project number 14744) and by a grant from the "Hochschuljubilaumsstiftung der Stadt Wien" (http://www.oenb.at/en/About-Us/Research-Promotion/The-OeNB-Anniversary-Fund.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlbrecht J, 2012, J CLIN ONCOL, V30, P3870, DOI 10.1200/JCO.2011.40.1810; Andrews D A, 1999, Curr Opin Hematol, V6, P76, DOI 10.1097/00062752-199903000-00004; Ay C, 2008, BLOOD, V112, P2703, DOI 10.1182/blood-2008-02-142422; Ay C, 2010, BLOOD, V116, P5377, DOI 10.1182/blood-2010-02-270116; Ay C, 2009, J CLIN ONCOL, V27, P4124, DOI 10.1200/JCO.2008.21.7752; Barr JD, 2013, BLOOD, V121, P3733, DOI 10.1182/blood-2012-11-468983; Bennett CL, 2008, JAMA-J AM MED ASSOC, V299, P914, DOI 10.1001/jama.299.8.914; BESSMAN JD, 1983, AM J CLIN PATHOL, V80, P322, DOI 10.1093/ajcp/80.3.322; Braekkan SK, 2010, HAEMATOL-HEMATOL J, V95, P270, DOI 10.3324/haematol.2009.008417; Caro JJ, 2001, CANCER-AM CANCER SOC, V91, P2214, DOI 10.1002/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P; Cay N, 2013, BLOOD COAGUL FIBRIN, V24, P727, DOI 10.1097/MBC.0b013e32836261fe; Dickmann B, 2013, HAEMATOLOGICA, V98, P1309, DOI 10.3324/haematol.2012.073338; ERYD SA, 2014, J INTERN MED, V275, P84, DOI DOI 10.1111/JOIM.12143; Felker GM, 2007, J AM COLL CARDIOL, V50, P40, DOI 10.1016/j.jacc.2007.02.067; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fornal M, 2014, CLIN HEMORHEOL MICRO, V56, P325, DOI 10.3233/CH-131745; Gao S, 2014, TUMOR BIOL, V35, P603, DOI 10.1007/s13277-013-1084-5; Horsted F, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001275; Kanz R, 2011, J THROMB HAEMOST, V9, P57, DOI 10.1111/j.1538-7836.2010.04069.x; Khorana AA, 2008, BLOOD, V111, P4902, DOI 10.1182/blood-2007-10-116327; Khorana AA, 2013, CANCER-AM CANCER SOC, V119, P648, DOI 10.1002/cncr.27772; Khorana AA, 2010, THROMB RES, V125, P490, DOI 10.1016/j.thromres.2009.12.023; Konigsbrugge O, 2013, J THROMB HAEMOST, V11, P1993, DOI 10.1111/jth.12408; Konigsbrugge O, 2014, THROMB RES, V134, P44, DOI 10.1016/j.thromres.2014.04.002; Konigsbrugge O, 2014, THROMB RES, V133, pS39, DOI 10.1016/S0049-3848(14)50007-2; Koma Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080240; LEVINE B, 1990, NEW ENGL J MED, V323, P236, DOI 10.1056/NEJM199007263230405; Montagnana M, 2012, CLIN CHEM LAB MED, V50, P635, DOI [10.1515/CCLM.2011.831, 10.1515/cclm.2011.831]; Patel KV, 2010, J GERONTOL A-BIOL, V65, P258, DOI 10.1093/gerona/glp163; Rezende SM, 2014, HAEMATOLOGICA, V99, P194, DOI 10.3324/haematol.2013.083840; Sen HS, 2014, WIEN KLIN WOCHENSCHR, V126, P347, DOI 10.1007/s00508-014-0537-1; SEVITT S, 1974, J CLIN PATHOL, V27, P517, DOI 10.1136/jcp.27.7.517; Song CS, 2012, DIGEST DIS SCI, V57, P1033, DOI 10.1007/s10620-011-1978-2; Tefferi A, 2005, MAYO CLIN PROC, V80, P923, DOI 10.4065/80.7.923; Thaler J, 2012, THROMB HAEMOSTASIS, V108, P1042, DOI 10.1160/TH12-04-0241; Zoller B, 2014, THROMB RES, V133, P334, DOI 10.1016/j.thromres.2013.12.013	36	49	50	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111440	10.1371/journal.pone.0111440	http://dx.doi.org/10.1371/journal.pone.0111440			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347577	Green Published, gold, Green Submitted			2022-12-27	WOS:000347994900073
J	Yan, ZH; Zhang, HJ; Maher, C; Arteaga-Solis, E; Champagne, FA; Wu, LC; McDonald, JD; Yan, BZ; Schwartz, GJ; Miller, RL				Yan, Zhonghai; Zhang, Hanjie; Maher, Christina; Arteaga-Solis, Emilio; Champagne, Frances A.; Wu, Licheng; McDonald, Jacob D.; Yan, Beizhan; Schwartz, Gary J.; Miller, Rachel L.			Prenatal Polycyclic Aromatic Hydrocarbon, Adiposity, Peroxisome Proliferator-Activated Receptor (PPAR) gamma Methylation in Offspring, Grand-Offspring Mice	PLOS ONE			English	Article							AIR-POLLUTION EXPOSURE; DNA METHYLATION; TRANSPLACENTAL EXPOSURE; ENDOCRINE DISRUPTORS; LIPID-ACCUMULATION; CHILDHOOD OBESITY; MATERNAL EXPOSURE; PHYSICAL-ACTIVITY; COX-2 EXPRESSION; GENE-EXPRESSION	Rationale: Greater levels of prenatal exposure to polycyclic aromatic hydrocarbon (PAH) have been associated with childhood obesity in epidemiological studies. However, the underlying mechanisms are unclear. Objectives: We hypothesized that prenatal PAH over-exposure during gestation would lead to weight gain and increased fat mass in offspring and grand-offspring mice. Further, we hypothesized that altered adipose gene expression and DNA methylation in genes important to adipocyte differentiation would be affected. Materials and Methods: Pregnant dams were exposed to a nebulized PAH mixture versus negative control aerosol 5 days a week, for 3 weeks. Body weight was recorded from postnatal day (PND) 21 through PND60. Body composition, adipose cell size, gene expression of peroxisome proliferator-activated receptor (PPAR) gamma, CCAAT/enhancer-binding proteins (C/EBP) alpha, cyclooxygenase (Cox)-2, fatty acid synthase (FAS) and adiponectin, and DNA methylation of PPAR gamma, were assayed in both the offspring and grand-offspring adipose tissue. Findings: Offspring of dams exposed to greater PAH during gestation had increased weight, fat mass, as well as higher gene expression of PPAR gamma, C/EBP alpha, Cox2, FAS and adiponectin and lower DNA methylation of PPAR gamma. Similar differences in phenotype and DNA methylation extended through the grand-offspring mice. Conclusions: Greater prenatal PAH exposure was associated with increased weight, fat mass, adipose gene expression and epigenetic changes in progeny.	[Yan, Zhonghai; Zhang, Hanjie; Maher, Christina; Miller, Rachel L.] Columbia Univ, Coll Phys & Surg, Dept Med, Div Pulm Allergy & Crit Care Med, New York, NY 10027 USA; [Arteaga-Solis, Emilio] Columbia Univ, Coll Phys & Surg, Dept Pediat, Div Pediat Pulm, New York, NY USA; [Champagne, Frances A.] Columbia Univ, Dept Psychol, New York, NY 10027 USA; [Wu, Licheng; Schwartz, Gary J.] Albert Einstein Coll Med, Diabet Res Ctr, Dept Med, New York, NY USA; [Wu, Licheng; Schwartz, Gary J.] Albert Einstein Coll Med, Diabet Res Ctr, Dept Neurosci, New York, NY USA; [McDonald, Jacob D.] Lovelace Resp Res Inst, Dept Toxicol, Albuquerque, NM USA; [Yan, Beizhan] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA; [Miller, Rachel L.] Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY USA; [Miller, Rachel L.] Columbia Univ, Coll Phys & Surg, Dept Pediat, Div Pediat Allergy Immunol & Rheumatol, New York, NY USA	Columbia University; Columbia University; Columbia University; Yeshiva University; Yeshiva University; Lovelace Respiratory Research Institute; Columbia University; Columbia University; Columbia University	Miller, RL (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Med, Div Pulm Allergy & Crit Care Med, New York, NY 10027 USA.	rlm14@cumc.columbia.edu	; Champagne, Frances Anne/Q-1220-2018	Zhang, Hanjie/0000-0002-0015-5614; Champagne, Frances Anne/0000-0002-3922-084X	United States Environmental Protection Agency (US EPA) [RD-83214101]; National Institute for Environmental Health Sciences (NIEHS) [5P01ES09600, P50ES015905, P01 ES009089]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES009600, P50ES015905, P30ES009089] Funding Source: NIH RePORTER	United States Environmental Protection Agency (US EPA)(United States Environmental Protection Agency); National Institute for Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This publication was made possible by a United States Environmental Protection Agency (US EPA) grant RD-83214101(RLM, FAC) and National Institute for Environmental Health Sciences (NIEHS) grants 5P01ES09600 (RLM, FAC), P50ES015905 (RLM, JDM) and P01 ES009089 (RLM). Its contents are solely the responsibility of the grantee and do not necessarily represent the official views of the United States EPA. Further, the United States EPA does not endorse the purchase of any commercial products or services mentioned in the publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn EK, 2008, TOXICOL LETT, V176, P178, DOI 10.1016/j.toxlet.2007.11.005; Almeda R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074476; Arshad SH, 2012, J ALLERGY CLIN IMMUN, V130, P427, DOI 10.1016/j.jaci.2012.03.042; Bai N, 2012, INHAL TOXICOL, V24, P518, DOI 10.3109/08958378.2012.696221; Billiard SM, 2002, COMP BIOCHEM PHYS B, V133, P55, DOI 10.1016/S1096-4959(02)00105-7; Blouet C, 2012, CELL METAB, V16, P579, DOI 10.1016/j.cmet.2012.10.003; Bolton JL, 2012, FASEB J, V26, P4743, DOI 10.1096/fj.12-210989; Bostrom CE, 2002, ENVIRON HEALTH PERSP, V110, P451, DOI 10.1289/ehp.02110s3451; Bourez S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031834; Centers for Disease Control, 2004, SAS PROGR CDC GROWTH; Chamorro-Garcia R, 2013, ENVIRON HEALTH PERSP, V121, P359, DOI 10.1289/ehp.1205701; Champagne FA, 2006, BIOL PSYCHIAT, V59, P1227, DOI 10.1016/j.biopsych.2005.10.016; Choi H, 2008, ENVIRON HEALTH PERSP, V116, P658, DOI 10.1289/ehp.10958; Choi SS, 2014, J BIOL CHEM, V289, P26618, DOI 10.1074/jbc.M114.566794; Chou WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072511; Chu S, 2013, J CHEM, V2013, P1; DiVall SA, 2013, CURR OPIN ENDOCRINOL, V20, P50, DOI 10.1097/MED.0b013e32835b7ee6; Dunbar JC, 2001, SCI TOTAL ENVIRON, V279, P1, DOI 10.1016/S0048-9697(01)00686-6; Fearnside JF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001668; Ghoshal S, 2011, J BIOL CHEM, V286, P889, DOI 10.1074/jbc.M110.139139; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Grun F, 2006, ENDOCRINOLOGY, V147, pS50, DOI 10.1210/en.2005-1129; Hamada K, 2007, J TOXICOL ENV HEAL A, V70, P688, DOI 10.1080/15287390600974692; Hossain MG, 2010, J BIOSCI BIOENG, V109, P297, DOI 10.1016/j.jbiosc.2009.09.003; Irigaray P, 2006, FEBS J, V273, P1362, DOI 10.1111/j.1742-4658.2006.05159.x; Jiang T, 2005, J BIOL CHEM, V280, P32317, DOI 10.1074/jbc.M500801200; Jin D, 2014, CYTOKINE, V69, P196, DOI 10.1016/j.cyto.2014.06.005; JOHNSON PR, 1972, J LIPID RES, V13, P2; Kap M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027704; Kim JH, 2005, TOXICOL SCI, V85, P585, DOI 10.1093/toxsci/kfi118; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; Komatsu M, 2010, GENES CELLS, V15, P91, DOI 10.1111/j.1365-2443.2009.01368.x; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Kumazawa M, 2007, J LIPID RES, V48, P2039, DOI 10.1194/jlr.M700222-JLR200; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Lewtas J, 2007, MUTAT RES-REV MUTAT, V636, P95, DOI 10.1016/j.mrrev.2007.08.003; Li J, 2012, J HEPATOLOGY, V56; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Lonn M, 2010, FASEB J, V24, P326, DOI 10.1096/fj.09-133058; Madsen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011391; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Marcelin G, 2012, J LIPID RES, V53, P964, DOI 10.1194/jlr.M022467; Masuyama H, 2012, ENDOCRINOLOGY, V153, P2823, DOI 10.1210/en.2011-2161; Miller LL, 2014, CHEST, V145, P1213, DOI 10.1378/chest.13-1371; Miller RL, 2004, CHEST, V126, P1071, DOI 10.1378/chest.126.4.1071; Newbold RR, 2010, HORM-INT J ENDOCRINO, V9, P206, DOI 10.14310/horm.2002.1271; Niedzwiecki M, 2012, ALLERGY, V67, P904, DOI 10.1111/j.1398-9995.2012.02841.x; NTAMBI JM, 1988, J BIOL CHEM, V263, P17291; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Patel MM, 2009, CURR OPIN PEDIATR, V21, P235, DOI 10.1097/MOP.0b013e3283267726; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Perera FP, 2005, NEUROTOXICOLOGY, V26, P573, DOI 10.1016/j.neuro.2004.07.007; Perera FP, 2003, ENVIRON HEALTH PERSP, V111, P201, DOI 10.1289/ehp.5742; Perera F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004488; Perera FP, 2009, PEDIATRICS, V124, pE195, DOI 10.1542/peds.2008-3506; Reed DR, 2007, PHYSIOL BEHAV, V91, P593, DOI 10.1016/j.physbeh.2007.03.026; Rosa MJ, 2011, RESP MED, V105, P869, DOI 10.1016/j.rmed.2010.11.022; Rosen ED, 2000, GENE DEV, V14, P1293; Rundle A, 2012, AM J EPIDEMIOL, V175, P1163, DOI 10.1093/aje/kwr455; Sadagurski M, 2014, AM J PHYSIOL-ENDOC M, V306, pE1305, DOI 10.1152/ajpendo.00031.2014; Sallis JF, 2009, MILBANK Q, V87, P123, DOI 10.1111/j.1468-0009.2009.00550.x; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; Sallis JF, 2006, FUTURE CHILD, V16, P89, DOI 10.1353/foc.2006.0009; Sato M, 2008, BRIT J NUTR, V99, P1013, DOI 10.1017/S0007114507839006; Schadinger SE, 2005, AM J PHYSIOL-ENDOC M, V288, pE1195, DOI 10.1152/ajpendo.00513.2004; Schmidt SF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-152; Schneider JE, 2014, HORM BEHAV, V66, P104, DOI 10.1016/j.yhbeh.2014.03.011; Scinicariello F, 2014, ENVIRON HEALTH PERSP, V122, P299, DOI 10.1289/ehp.1307234; Seale P, 2009, DIABETES, V58, P1482, DOI 10.2337/db09-0622; Sievers CK, 2013, TOXICOL SCI, V132, P359, DOI 10.1093/toxsci/kfs287; Speakman J, 2007, OBES REV, V8, P55, DOI 10.1111/j.1467-789X.2007.00319.x; Stillerman KP, 2008, REPROD SCI, V15, P631, DOI 10.1177/1933719108322436; Tang WY, 2012, ENVIRON HEALTH PERSP, V120, P1195, DOI 10.1289/ehp.1103744; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Trombino AF, 2000, BREAST CANCER RES TR, V63, P117, DOI 10.1023/A:1006443104670; Valdar W, 2006, GENETICS, V174, P959, DOI 10.1534/genetics.106.060004; VanHeek M, 1997, J CLIN INVEST, V99, P385, DOI 10.1172/JCI119171; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Wolstenholme JT, 2012, ENDOCRINOLOGY, V153, P3828, DOI 10.1210/en.2012-1195; Wu GY, 2013, PPAR RES, V2013, DOI 10.1155/2013/701017; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Xu XH, 2010, ARTERIOSCL THROM VAS, V30, P2518, DOI 10.1161/ATVBAHA.110.215350; Yan BZ, 2005, ENVIRON SCI TECHNOL, V39, P7012, DOI 10.1021/es0506105	83	47	48	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e110706	10.1371/journal.pone.0110706	http://dx.doi.org/10.1371/journal.pone.0110706			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347678	Green Published, gold			2022-12-27	WOS:000347994900026
J	Itakura, S; Hama, S; Ohgita, T; Kogure, K				Itakura, Shoko; Hama, Susumu; Ohgita, Takashi; Kogure, Kentaro			Development of Nanoparticles Incorporating a Novel Liposomal Membrane Destabilization Peptide for Efficient Release of Cargos into Cancer Cells	PLOS ONE			English	Article							PH-SENSITIVE LIPOSOMES; GAMMA-SECRETASE; SOLID TUMORS; THERAPY; DELIVERY; IMPROVEMENT; INHIBITION; EXPRESSION; BIOLOGY; DRUGS	In anti-cancer therapy mediated by a nanoparticle-based drug delivery system (DDS), overall efficacy depends on the release efficiency of cargos from the nanoparticles in the cancer cells as well as the specificity of delivery to tumor tissue. However, conventional liposome-based DDS have no mechanism for specifically releasing the encapsulated cargos inside the cancer cells. To overcome this barrier, we developed nanoparticles containing a novel liposomal membrane destabilization peptide (LMDP) that can destabilize membranes by cleavage with intramembranous proteases on/in cancer cells. Calcein encapsulated in liposomes modified with LMDP (LMDP-lipo) was effectively released in the presence of a membrane fraction containing an LMDP-cleavable protease. The release was inhibited by a protease inhibitor, suggesting that LMD-Plipo could effectively release its cargo into cells in response to a cancer-specific protease. Moreover, when LMDP-lipo contained fusogenic lipids, the release of cargo was accelerated, suggesting that the fusion of LMDP-lipo with cellular membranes was the initial step in the intracellular delivery. Time-lapse microscopic observations showed that the release of cargo from LMDP-lipo occurred immediately after association of LMDP-lipo with target cells. Consequently, LMDP-lipo could be a useful nanoparticle capable of effective release of cargos specifically into targeted cancer cells.	[Itakura, Shoko; Hama, Susumu; Ohgita, Takashi; Kogure, Kentaro] Kyoto Pharmaceut Univ, Dept Biophys Chem, Kyoto 607, Japan	Kyoto Pharmaceutical University	Kogure, K (corresponding author), Kyoto Pharmaceut Univ, Dept Biophys Chem, Kyoto 607, Japan.	kogure@mb.kyoto-phu.ac.jp		Hama, Susumu/0000-0002-2989-6168	JSPS KAKENHI [25860030, 26-9314]; Kyoto Pharmaceutical University Fund for the Promotion of Scientific Research; Grants-in-Aid for Scientific Research [14J09314] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kyoto Pharmaceutical University Fund for the Promotion of Scientific Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by JSPS KAKENHI Grant Numbers 25860030, 26-9314, and by the Kyoto Pharmaceutical University Fund for the Promotion of Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Lila AS, 2010, PHARM RES-DORDR, V27, P1171, DOI 10.1007/s11095-010-0110-1; Banerjee J, 2009, BIOCONJUGATE CHEM, V20, P1332, DOI 10.1021/bc9000646; Biswas S, NAT CHEM, V5, P613; Biswas S, 2013, EUR J PHARM BIOPHARM, V84, P517, DOI 10.1016/j.ejpb.2012.12.021; Bulic B, 2011, CURR NEUROPHARMACOL, V9, P598, DOI 10.2174/157015911798376352; Capaccione KM, 2013, CARCINOGENESIS, V34, P1420, DOI 10.1093/carcin/bgt127; Carvalho FLF, 2014, PROSTATE, V74, P933, DOI 10.1002/pros.22811; Chen YQ, 2011, CANCER BIOL THER, V11, P14, DOI 10.4161/cbt.11.1.13730; Cho S, 2011, P NATL ACAD SCI USA, V108, P20778, DOI 10.1073/pnas.1019452108; Farmery MR, 2003, J BIOL CHEM, V278, P24277, DOI 10.1074/jbc.M211992200; Gomi M., 2004, CHEM BIO INFORMATICS, V4, P142, DOI DOI 10.1273/CBIJ.4.142; Hatakeyama H, 2007, GENE THER, V14, P68, DOI 10.1038/sj.gt.3302843; Hayashi I, 2012, ONCOGENE, V31, P787, DOI 10.1038/onc.2011.265; Huang L, 2014, ADV DRUG DELIV REV, V66, P110; Kano MR, 2007, P NATL ACAD SCI USA, V104, P3460, DOI 10.1073/pnas.0611660104; Lehtinen J, 2008, J CONTROL RELEASE, V131, P145, DOI 10.1016/j.jconrel.2008.07.018; Maeda H, 2013, ADV DRUG DELIVER REV, V65, P71, DOI 10.1016/j.addr.2012.10.002; Maraver A, 2012, CANCER CELL, V22, P222, DOI 10.1016/j.ccr.2012.06.014; Maruyama K, 2011, ADV DRUG DELIVER REV, V63, P161, DOI 10.1016/j.addr.2010.09.003; Momekova D, 2007, EUR J PHARM SCI, V32, P308, DOI 10.1016/j.ejps.2007.08.009; Pasternak SH, 2003, J BIOL CHEM, V278, P26687, DOI 10.1074/jbc.M304009200; Peppicelli S, 2014, CANCER METAST REV, V33, P823, DOI 10.1007/s10555-014-9506-4; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Sahay G, 2013, NAT BIOTECHNOL, V31, P653, DOI 10.1038/nbt.2614; Sandin P, 2012, ACS NANO, V6, P1513, DOI 10.1021/nn204448x; Schwendener RA, 2007, ADV EXP MED BIOL, V620, P117; Shih IM, 2007, CANCER RES, V67, P1879, DOI 10.1158/0008-5472.CAN-06-3958; Svastova E, 2004, FEBS LETT, V577, P439, DOI 10.1016/j.febslet.2004.10.043; Toita R, 2009, J CONTROL RELEASE, V139, P133, DOI 10.1016/j.jconrel.2009.06.011; Tomiyama T, 2010, J CONTROL RELEASE, V148, P101, DOI 10.1016/j.jconrel.2010.08.017; Vanic Z, 2012, J LIPOSOME RES, V22, P148, DOI 10.3109/08982104.2011.633267; Varkouhi AK, 2011, J CONTROL RELEASE, V151, P220, DOI 10.1016/j.jconrel.2010.11.004; Wolfe MS, 2006, BIOCHEMISTRY-US, V45, P7931, DOI 10.1021/bi060799c; Wu XL, 2010, BIOCONJUGATE CHEM, V21, P208, DOI 10.1021/bc9005283; Yingyuad Peerada, 2014, J RNAi Gene Silencing, V10, P490	35	5	5	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111181	10.1371/journal.pone.0111181	http://dx.doi.org/10.1371/journal.pone.0111181			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343714	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943500085
J	Gafford, G; Jasnow, AM; Ressler, KJ				Gafford, Georgette; Jasnow, Aaron M.; Ressler, Kerry J.			Grin1 Receptor Deletion within CRF Neurons Enhances Fear Memory	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; CORTICOTROPIN-RELEASING-FACTOR; DEPENDENT SYNAPTIC PLASTICITY; D-ASPARTATE RECEPTOR; RAT CENTRAL NUCLEUS; LATERAL AMYGDALA; STRIA TERMINALIS; CONDITIONED FEAR; BINDING PROTEIN; NERVOUS-SYSTEM	Corticotropin releasing factor (CRF) dysregulation is implicated in mood and anxiety disorders such as posttraumatic stress disorder (PTSD). CRF is expressed in areas engaged in fear and anxiety processing including the central amygdala (CeA). Complicating our ability to study the contribution of CRF-containing neurons to fear and anxiety behavior is the wide variety of cell types in which CRF is expressed. To manipulate specific subpopulations of CRF containing neurons, our lab has developed a mouse with a Cre recombinase gene driven by a CRF promoter (CRFp3.0Cre) (Martin et al., 2010). In these studies, mice that have the gene that encodes NR1 (Grin1) flanked by loxP sites (floxed) were crossed with our previously developed CRFp3.0Cre mouse to selectively disrupt Grin1 within CRF containing neurons (Cre+/(fGrin1+)). We find that disruption of Grin1 in CRF neurons did not affect baseline levels of anxiety, locomotion, pain sensitivity or exploration of a novel object. However, baseline expression of Grin1 was decreased in Cre+/(fGrin1+) mice as measured by RTPCR. Cre+/(fGrin1+) mice showed enhanced auditory fear acquisition and retention without showing any significant effect on fear extinction. We measured Gria1, the gene that encodes AMPAR1 and the CREB activator Creb1 in the amygdala of Cre+/(fGrin1+) mice after fear conditioning. Both Gria1 and Creb1 were enhanced in the amygdala after training. To determine if the Grin1-expressing CRF neurons within the CeA are responsible for the enhancement of fear memory in adults, we infused a lentivirus with Cre driven by a CRF promoter (LV pCRF-Cre/(fGrin1+)) into the CeA of floxed Grin1 mice. Cre driven deletion of Grin1 specifically within CRF expressing cells in the CeA also resulted in enhanced fear memory acquisition and retention. Altogether, these findings suggest that selective disruption of Grin1 within CeA CRF neurons strongly enhances fear memory.	[Gafford, Georgette; Ressler, Kerry J.] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Jasnow, Aaron M.] Kent State Univ, Dept Psychol Sci, Kent, OH 44242 USA	Emory University; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Ressler, KJ (corresponding author), Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA.	kressle@emory.edu	Ressler, Kerry J/N-8741-2018	Ressler, Kerry J/0000-0002-5158-1103	Howard Hughes Medical Institute; NIH/National Center for Research Resources [P51RR000165]; Office of Research Infrastructure Programs [OD P51OD011132]; NIH [R01-MH096764, MH088467, MH090785]; Burroughs Wellcome Fund; Viral Vector Core of the Emory Neuroscience NINDS Core Facilities grant [P30NS055077]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096764, F32MH090785, RC1MH088467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS055077] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Viral Vector Core of the Emory Neuroscience NINDS Core Facilities grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research was supported by Howard Hughes Medical Institute KJR, the NIH/National Center for Research Resources base grant P51RR000165 to Yerkes National Primate Research Center KJR and is currently supported by the Office of Research Infrastructure Programs/OD P51OD011132 to Yerkes National Primate Research Center. Other support for this project comes from NIH R01-MH096764 KJR, NIH MH088467 KJR, Burroughs Wellcome Fund and NIH MH090785 GMG, This research project was also supported in part by the Viral Vector Core of the Emory Neuroscience NINDS Core Facilities grant, P30NS055077. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinfiresoye L, 2013, PSYCHOPHARMACOLOGY, V230, P291, DOI 10.1007/s00213-013-3153-2; Amano T, 2010, NAT NEUROSCI, V13, P489, DOI 10.1038/nn.2499; Beckerman MA, 2013, EXP NEUROL, V239, P120, DOI 10.1016/j.expneurol.2012.10.009; Bremner JD, 1997, AM J PSYCHIAT, V154, P624; CASSELL MD, 1986, J COMP NEUROL, V246, P478, DOI 10.1002/cne.902460406; Chhatwal JP, 2007, GENE THER, V14, P575, DOI 10.1038/sj.gt.3302898; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; Day HEW, 1999, J COMP NEUROL, V413, P113; Duvarci S, 2011, J NEUROSCI, V31, P289, DOI 10.1523/JNEUROSCI.4985-10.2011; Dykman RA, 1997, INTEGR PHYS BEH SCI, V32, P9, DOI 10.1007/BF02688609; Gafford GM, 2012, P NATL ACAD SCI USA, V109, P16330, DOI 10.1073/pnas.1119261109; Goosens KA, 2003, BEHAV NEUROSCI, V117, P738, DOI 10.1037/0735-7044.117.4.738; Hand GA, 2002, BRAIN RES, V949, P122, DOI 10.1016/S0006-8993(02)02972-4; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Heldt SA, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.022.2009; Hu HL, 2007, CELL, V131, P160, DOI 10.1016/j.cell.2007.09.017; Jasnow AM, 2013, J NEUROSCI, V33, P10396, DOI 10.1523/JNEUROSCI.5539-12.2013; Jasnow Aaron M., 2009, V515, P199, DOI 10.1007/978-1-59745-559-6_13; Josselyn SA, 2005, CURR DRUG TARGETS CN, V4, P481; Krugers HJ, 2010, NAT REV NEUROSCI, V11, P675, DOI 10.1038/nrn2913; Li HH, 2013, NAT NEUROSCI, V16, P332, DOI 10.1038/nn.3322; Machado-Vieira R, 2009, CURR PHARM DESIGN, V15, P1595, DOI 10.2174/138161209788168010; Maeng S, 2008, BIOL PSYCHIAT, V63, P349, DOI 10.1016/j.biopsych.2007.05.028; Makino S, 1999, BRAIN RES, V850, P136, DOI 10.1016/S0006-8993(99)02114-9; Maren S, 1999, TRENDS NEUROSCI, V22, P561, DOI 10.1016/S0166-2236(99)01465-4; Martin EI, 2010, BIOL PSYCHIAT, V67, P1212, DOI 10.1016/j.biopsych.2010.01.026; Merali Z, 2008, EUR J NEUROSCI, V28, P165, DOI 10.1111/j.1460-9568.2008.06281.x; MONAGHAN DT, 1985, J NEUROSCI, V5, P2909; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Orr SP, 1998, J TRAUMA STRESS, V11, P155, DOI 10.1023/A:1024421502881; Orr SP, 2000, J ABNORM PSYCHOL, V109, P290, DOI 10.1037//0021-843X.109.2.290; Paxinos GFKBJ, 2004, MOUSE BRAIN STEREOTA; Perkinton MS, 1999, J NEUROSCI, V19, P5861, DOI 10.1523/JNEUROSCI.19-14-05861.1999; PETRALIA RS, 1994, J NEUROSCI, V14, P667; PITMAN RK, 1988, PSYCHIAT ANN, V18, P182, DOI 10.3928/0048-5713-19880301-11; Pitts MW, 2011, NEUROBIOL LEARN MEM, V95, P86, DOI 10.1016/j.nlm.2010.11.006; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; Rao VR, 2007, TRENDS NEUROSCI, V30, P284, DOI 10.1016/j.tins.2007.03.012; Rodrigues SM, 2004, NEURON, V44, P75, DOI 10.1016/j.neuron.2004.09.014; SAKURADA K, 1993, J BIOL CHEM, V268, P410; Samson RD, 2005, J NEUROSCI, V25, P1847, DOI 10.1523/JNEUROSCI.3713-04.2005; SATO K, 1995, NEUROSCIENCE, V64, P459, DOI 10.1016/0306-4522(94)00335-3; Sautter FJ, 2003, BIOL PSYCHIAT, V54, P1382, DOI 10.1016/S0006-3223(03)00571-7; Siegmund A, 2007, PHYSIOL BEHAV, V90, P103, DOI 10.1016/j.physbeh.2006.08.032; Skorzewska A, 2009, NEUROPHARMACOLOGY, V57, P148, DOI 10.1016/j.neuropharm.2009.04.016; Slutsky I, 2010, NEURON, V65, P165, DOI 10.1016/j.neuron.2009.12.026; Tian XJ, 2006, J BIOL CHEM, V281, P7578, DOI 10.1074/jbc.M512060200; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Wessa M, 2007, AM J PSYCHIAT, V164, P1684, DOI 10.1176/appi.ajp.2007.07030525; Wilensky AE, 2006, J NEUROSCI, V26, P12387, DOI 10.1523/JNEUROSCI.4316-06.2006; Zimmerman JM, 2010, EUR J NEUROSCI, V31, P1664, DOI 10.1111/j.1460-9568.2010.07223.x	53	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111009	10.1371/journal.pone.0111009	http://dx.doi.org/10.1371/journal.pone.0111009			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340785	Green Submitted, gold, Green Published			2022-12-27	WOS:000343662800078
J	Mpanya, A; Boelaert, M; Baloji, S; Matangila, J; Lubanza, S; Bottieau, E; Chappuis, F; Lutumba, P; Hendrickx, D				Mpanya, Alain; Boelaert, Marleen; Baloji, Sylvain; Matangila, Junior; Lubanza, Symphorien; Bottieau, Emmanuel; Chappuis, Francois; Lutumba, Pascal; Hendrickx, David			Diagnostic Work-Up of Neurological Syndromes in a Rural African Setting: Knowledge, Attitudes and Practices of Health Care Providers	PLOS ONE			English	Article							SLEEPING SICKNESS; TRYPANOSOMIASIS; DISEASE	Background: Neurological disorders of infectious origin are common in rural sub-Saharan Africa and usually have serious consequences. Unfortunately, these syndromes are often poorly documented for lack of diagnostic tools. Clinical management of these diseases is a major challenge in under-equipped rural health centers and hospitals. We documented health care provider knowledge, attitudes and practices related to this syndrome in two rural health zones in Bandundu Province, Democratic Republic of Congo. Methods: We used a qualitative research approach combining observation, in-depth interviews and focus group discussions. We observed 20 patient-provider contacts related to a neurological syndrome, conducted 12 individual interviews and 4 focus group discussions with care providers. All interviews were audiotaped and the transcripts were analyzed with the software ATLAS. ti. Results: Care providers in this region usually limit their diagnostic work-up to clinical examination primarily because of the financial hurdles in this entirely out-of-pocket payment system. The patients prefer to purchase drugs rather than diagnostic tests. Moreover the general lack of diagnostic tools and the representation of the clinician as a "diviner'' do not enhance any use of laboratory or other diagnostic methods. Conclusion: Innovation in diagnostic technology for neurological disorders is badly needed in Central-Africa, but its uptake in clinical practice will only be a success if tools are simple, affordable and embedded in a patient-centered approach.	[Mpanya, Alain] Programme Natl Lutte Trypanosomiase Humaine Afric, Div Rech, Kinshasa, DEM REP CONGO; [Mpanya, Alain; Boelaert, Marleen; Hendrickx, David] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Baloji, Sylvain] Univ Pedagog Natl, Kinshasa, DEM REP CONGO; [Matangila, Junior; Lutumba, Pascal] Univ Kinshasa, Dept Trop Med, Kinshasa, DEM REP CONGO; [Lubanza, Symphorien] Univ Kinshasa, Dept Anthropol, Kinshasa, DEM REP CONGO; [Bottieau, Emmanuel] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Chappuis, Francois] Univ Hosp Geneva, Div Trop & Humanitarian Med, Geneva, Switzerland; [Lutumba, Pascal] Inst Natl Rech Biomed, Dept Epidemiol, Kinshasa, DEM REP CONGO; [Hendrickx, David] Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia	Institute of Tropical Medicine (ITM); Universite de Kinshasa; Universite de Kinshasa; Institute of Tropical Medicine (ITM); University of Geneva; Institute Nacional de Recherche Biomedical; Telethon Kids Institute; University of Western Australia	Mpanya, A (corresponding author), Programme Natl Lutte Trypanosomiase Humaine Afric, Div Rech, Kinshasa, DEM REP CONGO.	mpanya_alain@yahoo.fr	Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776; Chappuis, Francois/0000-0003-0442-7610	European Commission under the Health Cooperation Work Programme of the 7th Framework Programme [260260]	European Commission under the Health Cooperation Work Programme of the 7th Framework Programme	This work is part of the NIDIAG network research partnership supported by the European Commission under the Health Cooperation Work Programme of the 7th Framework Programme (Grant agreement no. 260260, http://cordis.europa.eu/fp7/home_en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birbeck GL, 2001, TROP DOCT, V31, P82, DOI 10.1177/004947550103100209; Blum J, 2006, ACTA TROP, V97, P55, DOI 10.1016/j.actatropica.2005.08.001; Boelaert M, 2010, ANN TROP MED PARASIT, V104, P535, DOI 10.1179/136485910X12786389891641; Bower JH, 2007, NEUROLOGY, V68, P338, DOI 10.1212/01.wnl.0000252801.61190.e8; Buscher P, 2013, NEW ENGL J MED, V368, P1069, DOI 10.1056/NEJMc1210373; Cohen DB, 2010, TROP MED INT HEALTH, V15, P910, DOI 10.1111/j.1365-3156.2010.02565.x; Glaser B, 1992, BASICS GROUNDED THEO, P129; Gouteux J P, 1985, Med Trop (Mars), V45, P259; Hasker E, 2011, TROP MED INT HEALTH, V16, P869, DOI 10.1111/j.1365-3156.2011.02772.x; Husserl Edmund, 1989, IDEAS PERTAINING PUR; KWASA TOO, 1992, E AFR MED J, V69, P236; LEYGUES M, 1989, SOC SCI MED, V28, P1255, DOI 10.1016/0277-9536(89)90344-4; Lorent N, 2008, INT J TUBERC LUNG D, V12, P392; Mabey D, 2004, NAT REV MICROBIOL, V2, P231, DOI 10.1038/nrmicro841; Matovu E, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/340538; Mitashi P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002504; Mitashi P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001919; Mpanya A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001467; Palmer JJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002003; PAUKER SG, 1980, NEW ENGL J MED, V302, P1109, DOI 10.1056/NEJM198005153022003; Saldana J, 2013, CODING MANUAL QUALIT; Wagstaff A, 2002, B WORLD HEALTH ORGAN, V80, P97; WHO, 2013, WHO TECH REP SER, V984, P1; Winkler AS, 2009, TROP DOCT, V39, P102, DOI 10.1258/td.2008.080144; World Health Organization, 2012, GLOB REP RES INF DIS; Yansouni CP, 2013, LANCET INFECT DIS, V13, P546, DOI 10.1016/S1473-3099(13)70004-5	26	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110167	10.1371/journal.pone.0110167	http://dx.doi.org/10.1371/journal.pone.0110167			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340726	Green Published, gold			2022-12-27	WOS:000343662800023
J	Usami, M; Iwadare, Y; Watanabe, K; Kodaira, M; Ushijima, H; Tanaka, T; Harada, M; Tanaka, H; Sasaki, Y; Saito, K				Usami, Masahide; Iwadare, Yoshitaka; Watanabe, Kyota; Kodaira, Masaki; Ushijima, Hirokage; Tanaka, Tetsuya; Harada, Maiko; Tanaka, Hiromi; Sasaki, Yoshinori; Saito, Kazuhiko			Decrease in the Traumatic Symptoms Observed in Child Survivors within Three Years of the 2011 Japan Earthquake and Tsunami	PLOS ONE			English	Article							POSTTRAUMATIC STRESS REACTIONS; NORWEGIAN CHILDREN; ADOLESCENTS; DISORDER; DISASTER; IMPACT	Background: On March 11, 2011, Japan was struck by a massive earthquake and tsunami. The tsunami caused tremendous damage and traumatized several people, including children. The aim of this study was to assess changes in traumatic symptoms 8, 20, and 30 months of the 2011 tsunami. Methods: The study comprised three groups. Copies of the Post-Traumatic Stress Symptoms for Children 15 items (PTSSC-15), a self-rating questionnaire on traumatic symptoms, were distributed to 12,524 children (8-month period), 12,193 children (20-month period), and 11,819 children (30-month period). An effective response of children 8 months, 20 months, and 30 month after the disaster was obtained in 11,639 (92.9%), 10,597 (86.9%), and 10,812 children (91.4%), respectively. We calculated the total score, PTSD subscale, and Depression subscale of PTSSC-15. We calculated the total score, PTSD subscale, and Depression subscale of PTSSC-15. Results: The PTSSC-15 total score and PTSD subscale of children belonging to 1st-9th grade groups who were tested 30 and 20 months after the tsunami significantly decreased compared with those of children tested 8 months after the tsunami. The PTSSC-15 total score and PTSD subscale of children in 1st-9th grade groups tested after 30 months did not decrease significantly compared with those of children tested after 20 months. The PTSSC-15 Depression subscale and PTSD subscale of children in 1st-9th grade groups tested after 30 months significantly decreased compared with those of children tested 8 months after the tsunami. The PTSSC-15 Depression subscale of children in 1st-9th grade groups evaluated after 30 months significantly decreased compared with those of children evaluated after 20 months. Conclusions: This study demonstrates that the traumatic symptoms of children who survived the massive tsunami improved with time. Nonetheless, the traumatic symptoms, which in some cases did not improve with time.	[Usami, Masahide; Iwadare, Yoshitaka; Watanabe, Kyota; Ushijima, Hirokage; Tanaka, Tetsuya] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Child & Adolescent Psychiat, Chiba, Japan; [Kodaira, Masaki; Saito, Kazuhiko] Aiiku Hosp, Imperial Gift Fdn, Dept Child Mental Hlth, Tokyo, Japan; [Harada, Maiko] Yamaguchi Univ, Grad Sch Med, Dept Neurosci, Div Neuropsychiat, Yamaguchi, Japan; [Tanaka, Hiromi] Tokyo Womens Med Univ, Inst Womens Hlth, Tokyo, Japan; [Sasaki, Yoshinori] Tokyo Metropolitan Tama Med Ctr, Dept Psychiat, Tokyo, Japan	National Center for Global Health & Medicine - Japan; Saiseikai Imperial Gift Foundation, Inc.; Yamaguchi University; Tokyo Women's Medical University	Usami, M (corresponding author), Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Child & Adolescent Psychiat, Chiba, Japan.	usami.masahide@hospk.ncgm.go.jp	Usami, Masahide/G-1404-2015	Usami, Masahide/0000-0002-1145-9971	National Center for Global Health and Medicine [24-108]; Soroptimist International of the Americas Japan Shimomatsu Region; Ishinomaki; Yaohigashi; Tokuyama Rotary Clubs	National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); Soroptimist International of the Americas Japan Shimomatsu Region; Ishinomaki; Yaohigashi; Tokuyama Rotary Clubs	Our deepest appreciation goes to the Educational Committee of Ishinomaki City. This work was supported by grants from the National Center for Global Health and Medicine (24-108), Soroptimist International of the Americas Japan Shimomatsu Region, and Ishinomaki, Yaohigashi, and Tokuyama Rotary Clubs. The funders were not involved in study design, data collection and analysis, the decision to publish, or preparation of the manuscript.	Balsari S, 2010, NEW ENGL J MED, V362, DOI 10.1056/NEJMp1001820; Becker SM, 2007, J CHILD ADOL PS NURS, V20, P148, DOI 10.1111/j.1744-6171.2007.00105.x; Butler D, 2011, NATURE, V472, P13, DOI 10.1038/472400a; Carballo M, 2005, PSYCHOSOCIAL ASPECTS; Chemtob CM, 2008, ARCH PEDIAT ADOL MED, V162, P126, DOI 10.1001/archpediatrics.2007.36; Dyb Grete, 2011, Clin Child Psychol Psychiatry, V16, P621, DOI 10.1177/1359104510391048; Hafstad GS, 2011, PSYCHOL TRAUMA-US, V3, P130, DOI 10.1037/a0023236; Hayashi K, 2012, ASIA-PAC J PUBLIC HE, V24, P681, DOI 10.1177/1010539512453255; Iwadare Y, 2014, J PEDIATR-US, V164, P917, DOI 10.1016/j.jpeds.2013.11.061; Iwadare Y, 2014, SLEEP BIOL RHYTHMS, V12, P53, DOI 10.1111/sbr.12047; Jensen TK, 2009, ARCH PEDIAT ADOL MED, V163, P856, DOI 10.1001/archpediatrics.2009.151; Jia ZB, 2010, QUAL LIFE RES, V19, P1381, DOI 10.1007/s11136-010-9703-8; John Prashantham Baddam, 2007, Disaster Manag Response, V5, P3; Kadak MT, 2013, COMPR PSYCHIAT, V54, P982, DOI 10.1016/j.comppsych.2013.04.003; Kato H, 1996, ACTA PSYCHIAT SCAND, V93, P477, DOI 10.1111/j.1600-0447.1996.tb10680.x; Kim BN, 2009, J CLIN PSYCHIAT, V70, P1148, DOI 10.4088/JCP.08m04896; Kuwabara H, 2015, BRAIN DEV-JPN, V37, P130, DOI 10.1016/j.braindev.2014.02.003; Ma XH, 2011, PSYCHIAT RES, V189, P385, DOI [10.1016/j.psychres.2010.12.016, 10.1016/j.psychres.2011.02.016]; Mike T, 2011, No To Hattatsu, V43, P342; Mullett-Hume E, 2008, AM J ORTHOPSYCHIAT, V78, P103, DOI 10.1037/0002-9432.78.1.103; Nakahara S, 2013, J EPIDEMIOL, V23, P70, DOI 10.2188/jea.JE20120114; Oncu EC, 2010, CHILD DEV, V81, P1161, DOI 10.1111/j.1467-8624.2010.01460.x; Piyasil V, 2008, ASEAN J PSYCHIAT, V9, P1; Piyasil V, 2008, ASEAN J PSYCHIATR, V9, P99; Piyasil Vinadda, 2011, J Med Assoc Thai, V94 Suppl 3, pS138; Piyasil Vinadda, 2007, Journal of the Medical Association of Thailand, V90, P2370; Procter NG, 2011, HOLIST NURS PRACT, V25, P162, DOI 10.1097/HNP.0b013e31821a6955; Tominaga Y, 2002, HATTATSU SHINRI RINS, V8, p29.36; Ularntinon Sirirat, 2008, J Med Assoc Thai, V91 Suppl 3, pS69; Usami M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096459; Usami M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088885; Usami M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065398; Usami M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050721; WEISAETH L, 1989, ACTA PSYCHIAT SCAND, V80, P13, DOI 10.1111/j.1600-0447.1989.tb05250.x; Weisz J.R., 2001, EUROPEAN CHILD ADOLE, V10, P12, DOI DOI 10.1007/S007870170003; WHO, 2005, TSUN WREAKS MENT HLT; Wiguna T, 2010, ASIA-PAC PSYCHIAT, V2, P151, DOI 10.1111/j.1758-5872.2010.00079.x; Zhang YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022371	38	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110898	10.1371/journal.pone.0110898	http://dx.doi.org/10.1371/journal.pone.0110898			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR5ZY	25340759	Green Published, gold			2022-12-27	WOS:000343662800069
J	Burrows, AM; Parr, LA; Durham, EL; Matthews, LC; Smith, TD				Burrows, Anne M.; Parr, Lisa A.; Durham, Emily L.; Matthews, Lea C.; Smith, Timothy D.			Human Faces Are Slower than Chimpanzee Faces	PLOS ONE			English	Article							MOVEMENT CODING SYSTEM; FACIAL EXPRESSION; EVOLUTIONARY DIVERGENCE; MUSCLE; MUSCULATURE; PRIMATES; COMMUNICATION; SPEECH	Background: While humans (like other primates) communicate with facial expressions, the evolution of speech added a new function to the facial muscles (facial expression muscles). The evolution of speech required the development of a coordinated action between visual (movement of the lips) and auditory signals in a rhythmic fashion to produce "visemes" (visual movements of the lips that correspond to specific sounds). Visemes depend upon facial muscles to regulate shape of the lips, which themselves act as speech articulators. This movement necessitates a more controlled, sustained muscle contraction than that produced during spontaneous facial expressions which occur rapidly and last only a short period of time. Recently, it was found that human tongue musculature contains a higher proportion of slow-twitch myosin fibers than in rhesus macaques, which is related to the slower, more controlled movements of the human tongue in the production of speech. Are there similar unique, evolutionary physiologic biases found in human facial musculature related to the evolution of speech? Methodology/Prinicipal Findings: Using myosin immunohistochemistry, we tested the hypothesis that human facial musculature has a higher percentage of slow-twitch myosin fibers relative to chimpanzees (Pan troglodytes) and rhesus macaques (Macaca mulatta). We sampled the orbicularis oris and zygomaticus major muscles from three cadavers of each species and compared proportions of fiber-types. Results confirmed our hypothesis: humans had the highest proportion of slow-twitch myosin fibers while chimpanzees had the highest proportion of fast-twitch fibers. Conclusions/significance: These findings demonstrate that the human face is slower than that of rhesus macaques and our closest living relative, the chimpanzee. They also support the assertion that human facial musculature and speech coevolved. Further, these results suggest a unique set of evolutionary selective pressures on human facial musculature to slow down while the function of this muscle group diverged from that of other primates.	[Burrows, Anne M.; Durham, Emily L.] Duquesne Univ, Dept Phys Therapy, Pittsburgh, PA 15219 USA; [Burrows, Anne M.; Smith, Timothy D.] Univ Pittsburgh, Dept Anthropol, Pittsburgh, PA 15260 USA; [Parr, Lisa A.] Emory Univ, Dept Psychiat & Behav Sci, Ctr Translat Neurosci, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Matthews, Lea C.] Duquesne Univ, Dept Hlth Management Syst, Pittsburgh, PA 15219 USA; [Smith, Timothy D.] Slippery Rock Univ, Sch Phys Therapy, Slippery Rock, PA 16057 USA	Duquesne University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Emory University; Duquesne University; Pennsylvania State System of Higher Education (PASSHE); Slippery Rock University - Pennsylvania	Burrows, AM (corresponding author), Duquesne Univ, Dept Phys Therapy, Pittsburgh, PA 15219 USA.	burrows@duq.edu	Burrows, Anne M/AAP-3577-2021	Burrows, Anne M/0000-0002-9952-8125; Durham, Emily/0000-0002-6322-9393	Samuel & Emma Winters Foundation;  [MH082282]; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH082282] Funding Source: NIH RePORTER	Samuel & Emma Winters Foundation; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by contract grant number MH082282 to lap (www.nih.gov); funding from the Samuel & Emma Winters Foundation to AMB (no website). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergman TJ, 2013, CURR BIOL, V23, pR268, DOI 10.1016/j.cub.2013.02.038; Burrows AM, 2006, J ANAT, V208, P153, DOI 10.1111/j.1469-7580.2006.00523.x; Burrows AM, 2003, ANAT REC PART A, V274A, P827, DOI 10.1002/ar.a.10093; BURROWS AM, ENCY BIOMET IN PRESS; Burrows AM, 2008, BIOESSAYS, V30, P212, DOI 10.1002/bies.20719; Burrows AM, 2014, ANAT REC, V297, P1250, DOI 10.1002/ar.22913; Burrows AM, 2011, ANAT REC, V294, P645, DOI 10.1002/ar.21355; Burrows AM, 2009, J ANAT, V215, P320, DOI 10.1111/j.1469-7580.2009.01113.x; Caeiro CC, 2013, INT J PRIMATOL, V34, P115, DOI 10.1007/s10764-012-9652-x; Chandrasekaran C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000436; Cheney Dorothy L., 2007, BABOON METAPHYSICS; EKMAN P, 1982, J NONVERBAL BEHAV, V6, P238, DOI 10.1007/BF00987191; Elliott TM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000302; Flack J.C., 2004, MACAQUE SOC, P157; Ghazanfar AA, 2014, J COGNITIVE NEUROSCI, V26, P1196, DOI 10.1162/jocn_a_00575; Ghazanfar AA, 2013, BEHAV ECOL SOCIOBIOL, V67, P1441, DOI 10.1007/s00265-013-1491-z; Goodall J., 1986, CHIMPANZEES GOMBE PA; Groves C.P., 2001, PRIMATE TAXONOMY; Liebal K., 2013, COMMUNICATION; Lieberman P, 2007, CURR ANTHROPOL, V48, P39, DOI 10.1086/509092; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Muchlinski MN, 2013, AM J PHYS ANTHROPOL, V150, P301, DOI 10.1002/ajpa.22206; Nishida T, 2004, FOLIA PRIMATOL, V75, P31, DOI 10.1159/000073429; Parr LA, 2010, AM J PHYS ANTHROPOL, V143, P625, DOI 10.1002/ajpa.21401; Popat H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057368; Raphael L. J., 2007, SPEECH SCI PRIMER PH, V5th; RASTATTER M, 1984, PERCEPT MOTOR SKILL, V58, P191, DOI 10.2466/PMS.58.1.191-196; Rogers CR, 2009, J ANAT, V214, P36, DOI 10.1111/j.1469-7580.2008.01004.x; Sanders I, 2013, ANAT REC, V296, P1615, DOI 10.1002/ar.22755; Schmidt KL, 2003, BIOL PSYCHOL, V65, P49, DOI 10.1016/S0301-0511(03)00098-X; Sokal RR, 1995, BIOMETRY; Taylor S., 2012, ACM EUR S COMP AN SC; Titze IR, 1994, PRINCIPLES VOICE PRO; Vick SJ, 2007, J NONVERBAL BEHAV, V31, P1, DOI 10.1007/s10919-006-0017-z; Waller BM, 2012, INT J PRIMATOL, V33, P809, DOI 10.1007/s10764-012-9611-6; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415	36	10	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110523	10.1371/journal.pone.0110523	http://dx.doi.org/10.1371/journal.pone.0110523			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338058	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000343674800053
J	Johnson, HL; Willenbring, RC; Jin, F; Manhart, WA; LaFrance, SJ; Pirko, I; Johnson, AJ				Johnson, Holly L.; Willenbring, Robin C.; Jin, Fang; Manhart, Whitney A.; LaFrance, Stephanie J.; Pirko, Istvan; Johnson, Aaron J.			Perforin Competent CD8 T Cells Are Sufficient to Cause Immune-Mediated Blood-Brain Barrier Disruption	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL CEREBRAL MALARIA; NATURAL-KILLER-CELLS; MULTIPLE-SCLEROSIS; VIRUS-INFECTION; MURINE MODEL; GRANZYME-B; TIGHT JUNCTION; TARGET-CELLS; DEMYELINATION	Numerous neurological disorders are characterized by central nervous system (CNS) vascular permeability. However, the underlying contribution of inflammatory-derived factors leading to pathology associated with blood-brain barrier (BBB) disruption remains poorly understood. In order to address this, we developed an inducible model of BBB disruption using a variation of the Theiler's murine encephalomyelitis virus (TMEV) model of multiple sclerosis. This peptide induced fatal syndrome (PIFS) model is initiated by virus-specific CD8 T cells and results in severe CNS vascular permeability and death in the C57BL/6 mouse strain. While perforin is required for BBB disruption, the cellular source of perforin has remained unidentified. In addition to CD8 T cells, various innate immune cells also express perforin and therefore could also contribute to BBB disruption. To investigate this, we isolated the CD8 T cell as the sole perforin-expressing cell type in the PIFS model through adoptive transfer techniques. We determined that C57BL/6 perforin(-/-) mice reconstituted with perforin competent CD8 T cells and induced to undergo PIFS exhibited: 1) heightened CNS vascular permeability, 2) increased astrocyte activation as measured by GFAP expression, and 3) loss of linear organization of BBB tight junction proteins claudin-5 and occludin in areas of CNS vascular permeability when compared to mock-treated controls. These results are consistent with the characteristics associated with PIFS in perforin competent mice. Therefore, CD8 T cells are sufficient as a sole perforin-expressing cell type to cause BBB disruption in the PIFS model.	[Johnson, Holly L.; Pirko, Istvan; Johnson, Aaron J.] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA; [Johnson, Holly L.; Willenbring, Robin C.; Jin, Fang; Manhart, Whitney A.; LaFrance, Stephanie J.; Johnson, Aaron J.] Mayo Clin, Dept Immunol, Rochester, MN USA; [Johnson, Holly L.] Mayo Grad Sch, Neurobiol Dis Grad Program, Rochester, MN USA; [Willenbring, Robin C.] Mayo Grad Sch, Virol & Gene Therapy Grad Program, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Johnson, AJ (corresponding author), Mayo Clin, Dept Neurol, Rochester, MN 55905 USA.	Johnson.Aaron2@mayo.edu		Orozco, Robin/0000-0002-2138-2912	National Institutes of Health [R01 NS060881]; Mayo Graduate School; NATIONAL CANCER INSTITUTE [P50CA108961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060881] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Graduate School; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by the National Institutes of Health grant R01 NS060881 and Mayo Graduate School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argaw AT, 2009, P NATL ACAD SCI USA, V106, P1977, DOI 10.1073/pnas.0808698106; Brown H, 1999, NEUROPATH APPL NEURO, V25, P331; BUKOWSKI JF, 1983, J IMMUNOL, V131, P1531; Denic A, 2011, NEUROTHERAPEUTICS, V8, P3, DOI 10.1007/s13311-010-0002-4; Eugenin EA, 2006, J NEUROSCI, V26, P1098, DOI 10.1523/JNEUROSCI.3863-05.2006; Froelich CJ, 1996, J BIOL CHEM, V271, P29073, DOI 10.1074/jbc.271.46.29073; Grossman WJ, 2003, CURR OPIN IMMUNOL, V15, P544, DOI 10.1016/S0952-7915(03)00099-2; Hao JW, 2010, J EXP MED, V207, P1907, DOI 10.1084/jem.20092749; Haque A, 2011, J IMMUNOL, V186, P6148, DOI 10.4049/jimmunol.1003955; Huber JD, 2001, TRENDS NEUROSCI, V24, P719, DOI 10.1016/S0166-2236(00)02004-X; Janigro D, 2012, EPILEPSIA, V53, P26, DOI 10.1111/j.1528-1167.2012.03472.x; Johnson AJ, 2005, J IMMUNOL, V174, P6854, DOI 10.4049/jimmunol.174.11.6854; Johnson AJ, 1999, J VIROL, V73, P3702, DOI 10.1128/JVI.73.5.3702-3708.1999; Johnson AJ, 2001, FASEB J, V15, P2760, DOI 10.1096/fj.01-0373fje; Johnson HL, 2013, J NEUROVIROLOGY; Johnson HL, 2012, J IMMUNOL, V189, P1937, DOI 10.4049/jimmunol.1200658; Khickeibein JE, 2008, SCIENCE, V322, P268; Kish DD, 2012, J IMMUNOL, V189, P2191, DOI 10.4049/jimmunol.1102729; Lacerda-Queiroz N, 2012, AM J PATHOL, V180, P246, DOI 10.1016/j.ajpath.2011.09.038; Lykens JE, 2011, BLOOD, V118, P618, DOI 10.1182/blood-2010-12-324533; Marchi N, 2012, EPILEPSIA, V53, P1877, DOI 10.1111/j.1528-1167.2012.03637.x; Marchi N, 2011, EPILEPSIA, V52, P1627, DOI 10.1111/j.1528-1167.2011.03080.x; McDole J, 2006, NEUROL RES, V28, P256, DOI 10.1179/016164106X98125; Medana IM, 2006, INT J PARASITOL, V36, P555, DOI 10.1016/j.ijpara.2006.02.004; Metkar SS, 2002, IMMUNITY, V16, P417, DOI 10.1016/S1074-7613(02)00286-8; Minagar A, 2003, MULT SCLER J, V9, P540, DOI 10.1191/1352458503ms965oa; PAYA CV, 1989, J IMMUNOL, V143, P95; Pipkin ME, 2007, CURR OPIN IMMUNOL, V19, P301, DOI 10.1016/j.coi.2007.04.011; Pirko I, 2004, NEUROIMAGE, V21, P576, DOI 10.1016/j.neuroimage.2003.09.037; Pirko I, 2011, NEUROIMAGE, V54, P802, DOI 10.1016/j.neuroimage.2010.08.055; Pirko I, 2008, RADIOLOGY, V246, P790, DOI 10.1148/radiol.2463070338; Pirko I, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-31; Revelo XS, 2014, DIABETES; Robb RA, 2001, IEEE T MED IMAGING, V20, P854, DOI 10.1109/42.952724; Robb RA, 1999, ANNU REV BIOMED ENG, V1, P377, DOI 10.1146/annurev.bioeng.1.1.377; RODRIGUEZ M, 1987, CRIT REV IMMUNOL, V7, P325; Schneider SW, 2004, ACTA NEUROPATHOL, V107, P272, DOI 10.1007/s00401-003-0810-2; Stewart SE, 2014, J BIOL CHEM, V289, P9172, DOI 10.1074/jbc.M113.544890; Suidan GL, 2010, J IMMUNOL, V184, P1031, DOI 10.4049/jimmunol.0902773; Suidan GL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003037; Talavera D, 2004, J GEN VIROL, V85, P1801, DOI 10.1099/vir.0.19652-0; Terrell CE, 2013, BLOOD, V121, P5184, DOI 10.1182/blood-2013-04-495309; TSCHOPP J, 1986, NATURE, V322, P831, DOI 10.1038/322831a0; Wang T, 2003, J IMMUNOL, V171, P2524, DOI 10.4049/jimmunol.171.5.2524; Xu W, 2005, J NEUROIMMUNOL, V163, P24, DOI 10.1016/j.jneuroim.2005.02.011; Zhang BN, 1997, J EXP MED, V186, P1677, DOI 10.1084/jem.186.10.1677	46	22	24	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e111401	10.1371/journal.pone.0111401	http://dx.doi.org/10.1371/journal.pone.0111401			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337791	Green Submitted, gold, Green Published			2022-12-27	WOS:000343674800120
J	Juras, A; Dabert, M; Kushniarevich, A; Malmstrom, H; Raghavan, M; Kosicki, JZ; Metspalu, E; Willerslev, E; Piontek, J				Juras, Anna; Dabert, Miroslawa; Kushniarevich, Alena; Malmstroem, Helena; Raghavan, Maanasa; Kosicki, Jakub Z.; Metspalu, Ene; Willerslev, Eske; Piontek, Janusz			Ancient DNA Reveals Matrilineal Continuity in Present-Day Poland over the Last Two Millennia	PLOS ONE			English	Article							MTDNA HAPLOGROUPS; CZECH POPULATION; MITOCHONDRIAL; VARIABILITY; EASTERN; PATTERNS; ORIGIN	While numerous ancient human DNA datasets from across Europe have been published till date, modern-day Poland in particular, remains uninvestigated. Besides application in the reconstruction of continent-wide human history, data from this region would also contribute towards our understanding of the history of the Slavs, whose origin is hypothesized to be in East or Central Europe. Here, we present the first population-scale ancient human DNA study from the region of modern-day Poland by establishing mitochondrial DNA profiles for 23 samples dated to 200 BC - 500 AD (Roman Iron Age) and for 20 samples dated to 1000-1400 AD (Medieval Age). Our results show that mitochondrial DNA sequences from both periods belong to haplogroups that are characteristic of contemporary West Eurasia. Haplotype sharing analysis indicates that majority of the ancient haplotypes are widespread in some modern Europeans, including Poles. Notably, the Roman Iron Age samples share more rare haplotypes with Central and Northeast Europeans, whereas the Medieval Age samples share more rare haplotypes with East-Central and South-East Europeans, primarily Slavic populations. Our data demonstrates genetic continuity of certain matrilineages (H5a1 and N1a1a2) in the area of present-day Poland from at least the Roman Iron Age until present. As such, the maternal gene pool of present-day Poles, Czechs and Slovaks, categorized as Western Slavs, is likely to have descended from inhabitants of East-Central Europe during the Roman Iron Age.	[Juras, Anna; Piontek, Janusz] Adam Mickiewicz Univ, Dept Human Evolutionary Biol, Fac Biol, Poznan, Poland; [Dabert, Miroslawa] Adam Mickiewicz Univ, Fac Biol, Mol Biol Tech Lab, Poznan, Poland; [Kushniarevich, Alena; Metspalu, Ene] Estonian Bioctr, Evolutionary Biol Grp, Tartu, Estonia; [Malmstroem, Helena; Raghavan, Maanasa; Willerslev, Eske] Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum Denmark, Copenhagen, Denmark; [Malmstroem, Helena] Uppsala Univ, Dept Evolutionary Biol, Uppsala, Sweden; [Kosicki, Jakub Z.] Adam Mickiewicz Univ, Inst Environm Biol, Fac Biol, Poznan, Poland; [Metspalu, Ene] Univ Tartu, Dept Evolutionary Biol, EE-50090 Tartu, Estonia	Adam Mickiewicz University; Adam Mickiewicz University; Estonian Biocentre; University of Copenhagen; Uppsala University; Adam Mickiewicz University; University of Tartu	Juras, A (corresponding author), Adam Mickiewicz Univ, Dept Human Evolutionary Biol, Fac Biol, Poznan, Poland.	ajuras.anthropology@gmail.com	Malmström, Helena/C-2476-2017; Juras, Anna/HGB-9467-2022; Willerslev, Eske/A-9619-2011; Willerslev, Eske/AAA-5686-2019	Malmström, Helena/0000-0002-6456-8055; Willerslev, Eske/0000-0002-7081-6748; Raghavan, Maanasa/0000-0003-1997-0739; Kosicki, Jakub/0000-0002-9044-7775; Dabert, Miroslawa/0000-0001-5930-3346	Polish Ministry of Science and Higher Education; Estonian Research Council [IUT24-1, N N303 406836]; European Regional Development Fund (European Union) through the Centre of Excellence in Genomics	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Estonian Research Council(Estonian Research Council); European Regional Development Fund (European Union) through the Centre of Excellence in Genomics	Funding provided by Polish Ministry of Science and Higher Education; grant N N303 406836, Estonian Research Council IUT24-1 and the European Regional Development Fund (European Union) through the Centre of Excellence in Genomics to Estonian Biocentre and University of Tartu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alinei M, 2003, QUADERNI SEMANTICA, V24, P187; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Barford P. M., 2001, EARLY SLAVS CULTURE; Belyaeva O, 2003, HUM BIOL, V75, P647, DOI 10.1353/hub.2003.0069; Bollongino R, 2013, SCIENCE, V342, P479, DOI 10.1126/science.1245049; Brandt G, 2013, SCIENCE, V342, P257, DOI 10.1126/science.1241844; Branicki W, 2005, J FORENSIC SCI, V50, P732; Brotherton P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2656; Buko A, 2006, POLISH ARCHAEOLOGY E; Canty A, 2013, BOOT BOOTSTRAP FUNCT; Curta F, 2001, CAMBRIDGE STUDIES ME, V52, pxxv; Dabrowski R, 2007, SERIES ANTHR, V23; Deguilloux MF, 2011, AM J PHYS ANTHROPOL, V144, P108, DOI 10.1002/ajpa.21376; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gilbert MTP, 2003, AM J HUM GENET, V72, P32, DOI 10.1086/345378; Gimbutas M., 1963, BALTS; Godlowski K, 2000, 1 SETTLEMENTS SLAVS; Grzybowski T, 2007, FORENSIC SCI INT-GEN, V1, P141, DOI 10.1016/j.fsigen.2007.01.010; Haak W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000536; Hansen AJ, 2001, MOL BIOL EVOL, V18, P262, DOI 10.1093/oxfordjournals.molbev.a003800; Hervella M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034417; Karachanak S, 2012, INT J LEGAL MED, V126, P497, DOI 10.1007/s00414-011-0589-y; Kostrzewski J, 1965, PREHISTORY POLAND; Kushniarevich A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066499; Makiewicz T, 2001, HOMELAND SLAVS; Malmstrom H, 2007, MOL BIOL EVOL, V24, P998, DOI 10.1093/molbev/msm015; Malmstrom H, 2009, CURR BIOL, V19, P1758, DOI 10.1016/j.cub.2009.09.017; Malyarchuk B, 2008, MOL BIOL EVOL, V25, P1651, DOI 10.1093/molbev/msn114; Malyarchuk BA, 2003, ANN HUM GENET, V67, P412, DOI 10.1046/j.1469-1809.2003.00042.x; Malyarchuk BA, 2002, ANN HUM GENET, V66, P261, DOI 10.1017/S0003480002001161; Malyarchuk BA, 2001, ANN HUM GENET, V65, P63, DOI 10.1046/j.1469-1809.2001.6510063.x; Malyarchuk B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010285; Malyarchuk BA, 2008, ANN HUM GENET, V72, P228, DOI 10.1111/j.1469-1809.2007.00410.x; Malyarchuk BA, 2006, HUM BIOL, V78, P681, DOI 10.1353/hub.2007.0014; Melchior L, 2008, AM J PHYS ANTHROPOL, V135, P206, DOI 10.1002/ajpa.20721; Melchior L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002214; Melchior L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011898; Mielnik-Sikorska M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054360; Palanichamy MG, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-304; Pilli E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052524; Piontek J., 2008, MONOGRAFIE I ANTROPO, V12; Pohl Walter, 2006, NIE SLOWIANIE POCZAT, P11; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rudbeck L, 2005, AM J PHYS ANTHROPOL, V128, P424, DOI 10.1002/ajpa.20294; Sedov VV, 2002, SLAVIANE ISTORIKO AR; Soares P, 2010, CURR BIOL, V20, pR174, DOI 10.1016/j.cub.2009.11.054; Stiller M, 2006, P NATL ACAD SCI USA, V103, P13578, DOI 10.1073/pnas.0605327103; Sussex R, 2006, CAMB LANG SURV, P1; Svensson EM, 2007, ANIM GENET, V38, P378, DOI 10.1111/j.1365-2052.2007.01620.x; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Vanecek T, 2004, INT J LEGAL MED, V118, P14, DOI 10.1007/s00414-003-0407-2; Wilde S, 2014, P NATL ACAD SCI USA, V111, P4832, DOI 10.1073/pnas.1316513111; Yang DY, 1998, AM J PHYS ANTHROPOL, V105, P539, DOI 10.1002/(SICI)1096-8644(199804)105:4<539::AID-AJPA10>3.3.CO;2-2; Zgonjanin D, 2010, LEGAL MED, V12, P104, DOI 10.1016/j.legalmed.2009.10.007; Zimmermann Bettina, 2007, Forensic Sci Int Genet, V1, pe4, DOI 10.1016/j.fsigen.2007.03.002	55	17	17	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110839	10.1371/journal.pone.0110839	http://dx.doi.org/10.1371/journal.pone.0110839			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337992	Green Published, Green Submitted, gold			2022-12-27	WOS:000343674800080
J	Pender, S; Gilbert, SJ; Serpell, L				Pender, Sarah; Gilbert, Sam J.; Serpell, Lucy			The Neuropsychology of Starvation: Set-Shifting and Central Coherence in a Fasted Nonclinical Sample	PLOS ONE			English	Article							ANOREXIA-NERVOSA; COGNITIVE REMEDIATION; EATING-DISORDERS; METAANALYSIS; DEPRESSION; OBSESSIONALITY; ANXIETY	Objectives: Recent research suggests certain neuropsychological deficits occur in anorexia nervosa (AN). The role of starvation in these deficits remains unclear. Studies of individuals without AN can elucidate our understanding of the effect of short-term starvation on neuropsychological performance. Methods: Using a within-subjects repeated measures design, 60 healthy female participants were tested once after fasting for 18 hours, and once when satiated. Measures included two tasks to measure central coherence and a set-shifting task. Results: Fasting exacerbated set-shifting difficulties on a rule-change task. Fasting was associated with stronger local and impaired global processing, indicating weaker central coherence. Conclusions: Models of AN that propose a central role for set-shifting difficulties or weak central coherence should also consider the impact of short-term fasting on these processes.	[Pender, Sarah; Serpell, Lucy] UCL, Res Dept Clin Educ & Hlth Psychol, London, England; [Gilbert, Sam J.] UCL, Inst Cognit Neurosci, London, England; [Serpell, Lucy] North East London Fdn Trust, Eating Disorders Serv, Ilford, Essex, England	University of London; University College London; University of London; University College London	Serpell, L (corresponding author), UCL, Res Dept Clin Educ & Hlth Psychol, London, England.	lucy@serpell.com	Gilbert, Sam J./C-1909-2008; Gilbert, Sam/V-2503-2019	Gilbert, Sam J./0000-0002-3839-7045; Gilbert, Sam/0000-0002-3839-7045; Serpell, Lucy/0000-0001-8543-8383	Royal Society University Research Fellowship	Royal Society University Research Fellowship(Royal Society of London)	This work was supported by the Royal Society University Research Fellowship to SJG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benau EM, 2014, APPETITE, V77, P52, DOI 10.1016/j.appet.2014.02.014; Bolton HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101946; Brandenburg BMP, 2007, EAT WEIGHT DISORD-ST, V12, P97, DOI 10.1007/BF03327584; Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P429, DOI 10.1348/014466501163904; Davies H, 2012, EUR EAT DISORD REV, V20, P211, DOI 10.1002/erv.2170; Duchesne Monica, 2004, Rev. Bras. Psiquiatr., V26, P107, DOI 10.1590/S1516-44462004000200008; EPLING WF, 1983, INT J EAT DISORDER, V3, P27, DOI 10.1002/1098-108X(198323)3:1<27::AID-EAT2260030104>3.0.CO;2-T; FAIRBURN CG, 1994, INT J EAT DISORDER, V16, P363; Fairburn CG, 2008, EATING DISORDER EXAM; Fitzpatrick S, 2013, NEUROPSYCHOL REV, V23, P138, DOI 10.1007/s11065-013-9224-7; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; Holliday J, 2005, AM J PSYCHIAT, V162, P2269, DOI 10.1176/appi.ajp.162.12.2269; Ilonen T, 2000, NORD J PSYCHIAT, V54, P275, DOI 10.1080/080394800448156; Keys A, 1950, BIOL HUMAN STARVATIO; Kingston K, 1996, PSYCHOL MED, V26, P15, DOI 10.1017/S0033291700033687; Lopez C, 2008, PSYCHOL MED, V38, P1393, DOI 10.1017/S0033291708003486; Lopez C, 2008, INT J EAT DISORDER, V41, P143, DOI 10.1002/eat.20478; Lopez C, 2009, J CLIN EXP NEUROPSYC, V31, P117, DOI 10.1080/13803390802036092; Martinez-Aran A, 2004, AM J PSYCHIAT, V161, P262, DOI 10.1176/appi.ajp.161.2.262; McAnarney ER, 2011, J ADOLESCENT HEALTH, V49, P99, DOI 10.1016/j.jadohealth.2010.11.259; McConellogue D, 2013, INT C EAT DIS MONTR; Mond JM, 2006, BEHAV RES THER, V44, P53, DOI 10.1016/j.brat.2004.12.003; Muhlau M, 2007, AM J PSYCHIAT, V164, P1850, DOI 10.1176/appi.ajp.2007.06111861; Nieuwenstein MR, 2001, J PSYCHIATR RES, V35, P119, DOI 10.1016/S0022-3956(01)00014-0; Oldershaw A, 2011, EUR EAT DISORD REV, V19, P462, DOI 10.1002/erv.1069; Pollice C, 1997, INT J EAT DISORDER, V21, P367, DOI 10.1002/(SICI)1098-108X(1997)21:4&lt;367::AID-EAT10&gt;3.0.CO;2-W; Pretorius N, 2012, EUR EAT DISORD REV, V20, P321, DOI 10.1002/erv.2176; Roberts ME, 2007, PSYCHOL MED, V37, P1075, DOI 10.1017/S0033291707009877; Roberts ME, 2013, WORLD J BIOL PSYCHIA, V14, P452, DOI 10.3109/15622975.2011.639804; Roberts ME, 2010, J PSYCHIATR RES, V44, P964, DOI 10.1016/j.jpsychires.2010.03.001; Serpell L, 2009, BEHAV THER, V40, P260, DOI 10.1016/j.beth.2008.07.001; Sidiropoulos Michael, 2007, Mcgill J Med, V10, P20; Snyder HR, 2013, PSYCHOL BULL, V139, P81, DOI 10.1037/a0028727; Suchan B, 2010, BEHAV BRAIN RES, V206, P63, DOI 10.1016/j.bbr.2009.08.035; Tchanturia K, 2002, Eat Weight Disord, V7, P312; Tchanturia K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020462; Treasure J, 2013, J EAT DISORD, V1, DOI 10.1186/2050-2974-1-13; Treasure JL, 2007, CAN J PSYCHIAT, V52, P212, DOI 10.1177/070674370705200402; Waller G, 2012, BEHAV COGN PSYCHOTH, V40, P462, DOI 10.1017/S135246581200015X; White S, 2009, NEUROPSYCHOLOGIA, V47, P1274, DOI 10.1016/j.neuropsychologia.2009.01.012; Wilmsmeier A, 2010, J PSYCHIATR NEUROSCI, V35, P321, DOI 10.1503/jpn.090181; Wilsdon A, 2006, J PSYCHIATR RES, V40, P746, DOI 10.1016/j.jpsychires.2005.10.006; Witkin, 1971, MANUAL GROUP EMBEDDE; Zakzanis KK, 2010, J NEUROPSYCHOL, V4, P89, DOI 10.1348/174866409X459674; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	45	23	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110743	10.1371/journal.pone.0110743	http://dx.doi.org/10.1371/journal.pone.0110743			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6DY	25338075	Green Published, gold			2022-12-27	WOS:000343674800068
J	Piper, BJ; Gray, HM; Corbett, SM; Birkett, MA; Raber, J				Piper, Brian J.; Gray, Hilary M.; Corbett, Selena M.; Birkett, Melissa A.; Raber, Jacob			Executive Function and Mental Health in Adopted Children with a History of Recreational Drug Exposures	PLOS ONE			English	Article							PRENATAL ALCOHOL EXPOSURE; BEHAVIOR PROBLEMS; MATERNAL SMOKING; SPECTRUM DISORDERS; HAIR ANALYSIS; PREGNANCY; ATTENTION	Adoptive children are at increased risk for problematic behaviors but the origin of these individual differences in neurobehavioral function is unclear. This investigation examined whether adopted children with prenatal exposure to a wide variety of recreational drugs exhibited higher scores (i.e. more problems) with executive function and psychiatric symptomology. Caregivers of children ages 5 to 18 completed an online survey with items about use of alcohol, nicotine, or methamphetamine during pregnancy followed by the Behavior Rating Inventory of Executive Function (BRIEF, N = 437 including 59 adoptive parents) or the Child Behavior Checklist (CBCL, N = 549 including 54 adoptive parents). Relative to a comparison group of children raised by their biological parents, adoptive children that were polysubstance exposed during prenatal development exhibited higher rates of academic difficulties and were behind their classmates in math and reading. Adoptive children had statistically and clinically significant higher BRIEF ratings and this pattern was similar for boys and girls. CBCL ratings were significantly increased in adoptive children, particularly for Externalizing and Attention problems. Adoptive children with a history of polysubstance exposures including alcohol, nicotine, and methamphetamine are at heightened risk for difficulties with executive function as well as various psychopathologies. These findings suggest that increased monitoring to identify and implement remediation strategies may be warranted for adopted children with a history of in utero drug exposures.	[Piper, Brian J.] Husson Univ, Dept Basic Pharmaceut Sci, Bangor, ME 04401 USA; [Piper, Brian J.; Gray, Hilary M.; Corbett, Selena M.; Raber, Jacob] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Gray, Hilary M.] Portland State Univ, Sch Community Hlth, Portland, OR 97207 USA; [Gray, Hilary M.] Portland State Univ, Dept Counselor Educ, Portland, OR 97207 USA; [Corbett, Selena M.] Western Univ Hlth Sci, Coll Osteopath Med Pacific NW, Pomona, CA USA; [Birkett, Melissa A.] No Arizona Univ, Dept Psychol Sci, Flagstaff, AZ 86011 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, ONPRC, Dept Neurol & Radiat Med, Portland, OR 97201 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, ONPRC, Div Neurosci, Portland, OR 97201 USA	Oregon Health & Science University; Portland State University; Portland State University; Western University of Health Sciences; Northern Arizona University; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon National Primate Research Center	Piper, BJ (corresponding author), Husson Univ, Dept Basic Pharmaceut Sci, Bangor, ME 04401 USA.	piperbj@husson.edu	Birkett, Melissa A/O-1313-2013	Birkett, Melissa A/0000-0001-7376-4851	National Institute of Drug Abuse [L30 DA027582, T32 DA07262]; National Institute of Environmental Health Sciences [T32 ES007060-31A1]; Oregon Clinical Translational Research Institute [UL1 RR024140]; Husson University School of Pharmacy; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007262] Funding Source: NIH RePORTER	National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Oregon Clinical Translational Research Institute; Husson University School of Pharmacy; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institute of Drug Abuse (L30 DA027582, T32 DA07262), the National Institute of Environmental Health Sciences (T32 ES007060-31A1), the Oregon Clinical Translational Research Institute (UL1 RR024140, and the Husson University School of Pharmacy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T M, 2000, Pediatr Rev, V21, P265, DOI 10.1542/pir.21-8-265; Achenbach T.M., 2001, MANUAL ASEBA SCH AGE; Almeida ND, 2011, NICOTINE TOB RES, V13, P328, DOI 10.1093/ntr/ntq259; Carter S, 2008, EARLY HUM DEV, V84, P59, DOI 10.1016/j.earlhumdev.2007.03.009; Chang L, 2009, NEUROIMAGE, V48, P391, DOI 10.1016/j.neuroimage.2009.06.062; Davies JK, 2005, PEDIATR CLIN N AM, V52, P1369, DOI 10.1016/j.pcl.2005.06.015; Dixon DR, 2008, RES DEV DISABIL, V29, P483, DOI 10.1016/j.ridd.2007.05.006; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Gioia GA, 2000, BEHAV RATING INVENTO; Grotevant HD, 2014, ANNU REV PSYCHOL, V65, P235, DOI 10.1146/annurev-psych-010213-115020; Han E, 2013, INT J LEGAL MED, V127, P405, DOI 10.1007/s00414-012-0766-7; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hoyme HE, 2005, PEDIATRICS, V115, P39, DOI 10.1542/peds.2004-0259; Jacobs E, 2010, CHILD PSYCHIAT HUM D, V41, P15, DOI 10.1007/s10578-009-0149-6; Juffer F, 2005, JAMA-J AM MED ASSOC, V293, P2501, DOI 10.1001/jama.293.20.2501; Julvez J, 2007, INT J EPIDEMIOL, V36, P825, DOI 10.1093/ije/dym107; Kesmodel US, 2012, BJOG-INT J OBSTET GY, V119, P1180, DOI 10.1111/j.1471-0528.2012.03393.x; Kiblawi ZN, 2013, J DEV BEHAV PEDIATR, V34, P31, DOI 10.1097/DBP.0b013e318277a1c5; LaGasse LL, 2012, PEDIATRICS, V129, P681, DOI 10.1542/peds.2011-2209; Landgren M, 2010, PEDIATRICS, V125, pE1178, DOI 10.1542/peds.2009-0712; Langberg JM, 2013, J ABNORM CHILD PSYCH, V41, P1145, DOI 10.1007/s10802-013-9750-z; Lange S, 2013, PEDIATRICS, V132, pE980, DOI 10.1542/peds.2013-0066; Lendoiro E, 2013, THER DRUG MONIT, V35, P296, DOI 10.1097/FTD.0b013e318288453f; Merz EC, 2011, J CHILD PSYCHOL PSYC, V52, P537, DOI 10.1111/j.1469-7610.2010.02335.x; Meyer JS, 2011, REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY, P341, DOI 10.1016/B978-0-12-382032-7.10026-8; Minnes S, 2014, J YOUTH ADOLESCENCE, V43, P53, DOI 10.1007/s10964-013-9927-3; Morini L, 2013, THER DRUG MONIT, V35, P402, DOI 10.1097/FTD.0b013e318283f719; Nulman I, 2001, CLIN INVEST MED, V24, P129; O'Leary CM, 2010, ADDICTION, V105, P74, DOI 10.1111/j.1360-0443.2009.02756.x; Palacios J, 2010, INT J BEHAV DEV, V34, P270, DOI 10.1177/0165025410362837; Piper BJ, 2012, NICOTINE TOB RES, V14, P191, DOI 10.1093/ntr/ntr181; Piper BJ, 2012, DRUG ALCOHOL DEPEN, V121, P62, DOI 10.1016/j.drugalcdep.2011.08.004; Piper BJ, 2011, PHARMACOL BIOCHEM BE, V98, P432, DOI 10.1016/j.pbb.2011.02.013; Rasmussen C, 2007, J FAS INT, V5, pe2; Robinson M, 2010, BJOG-INT J OBSTET GY, V117, P1139, DOI 10.1111/j.1471-0528.2010.02596.x; Sayal K, 2007, PEDIATRICS, V119, pE426, DOI 10.1542/peds.2006-1840	36	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110459	10.1371/journal.pone.0110459	http://dx.doi.org/10.1371/journal.pone.0110459			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337917	Green Published, Green Submitted, gold			2022-12-27	WOS:000343674800044
J	Shu, Y; Zhang, N; Kong, XY; Huang, T; Cai, YD				Shu, Yang; Zhang, Ning; Kong, Xiangyin; Huang, Tao; Cai, Yu-Dong			Predicting A-to-I RNA Editing by Feature Selection and Random Forest	PLOS ONE			English	Article							ADENOSINE DEAMINASES; MESSENGER-RNA; ROLES; SITES; DEFICIENT; RELEVANCE; FAMILY; MICE	RNA editing is a post-transcriptional RNA process that provides RNA and protein complexity for regulating gene expression in eukaryotes. It is challenging to predict RNA editing by computational methods. In this study, we developed a novel method to predict RNA editing based on a random forest method. A careful feature selection procedure was performed based on the Maximum Relevance Minimum Redundancy (mRMR) and Incremental Feature Selection (IFS) algorithms. Eighteen optimal features were selected from the 77 features in our dataset and used to construct a final predictor. The accuracy and MCC (Matthews correlation coefficient) values for the training dataset were 0.866 and 0.742, respectively; for the testing dataset, the accuracy and MCC were 0.876 and 0.576, respectively. The performance was higher using 18 features than all 77, suggesting that a small feature set was sufficient to achieve accurate prediction. Analysis of the 18 features was performed and may shed light on the mechanism and dominant factors of RNA editing, providing a basis for future experimental validation.	[Shu, Yang; Kong, Xiangyin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China; [Zhang, Ning] Tianjin Univ, Dept Biomed Engn, Tianjin Key Lab BME Measurement, Tianjin 300072, Peoples R China; [Huang, Tao] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Tianjin University; Icahn School of Medicine at Mount Sinai; Shanghai University	Kong, XY (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China.	xykong@sibs.ac.cn; tohuangtao@126.com; cai_yud@126.com		Zhang, Ning/0000-0002-1559-111X; cai, yudong/0000-0001-5664-7979; Shu, Yang/0000-0002-8304-1531	National Basic Research Program of China [2011CB510101, 2011CB510102]; National Natural Science Foundation of China [31371335, 81171342, 81201148, 61401302]; Tianjin Research Program of Application Foundation and Advanced Technology [14JCQNJC09500]; National Research Foundation for the Doctoral Program of Higher Education of China [20130032120070, 20120032120073]; Independent Innovation Foundation of Tianjin University [60302064, 60302069]; Innovation Program of Shanghai Municipal Education Commission [12ZZ087]; The First-class Discipline of Universities in Shanghai	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Research Program of Application Foundation and Advanced Technology; National Research Foundation for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Independent Innovation Foundation of Tianjin University; Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); The First-class Discipline of Universities in Shanghai	This work was supported by grants from the National Basic Research Program of China (2011CB510101, 2011CB510102), the National Natural Science Foundation of China (31371335, 81171342, 81201148, 61401302), the Tianjin Research Program of Application Foundation and Advanced Technology (14JCQNJC09500), the National Research Foundation for the Doctoral Program of Higher Education of China (20130032120070, 20120032120073), the Independent Innovation Foundation of Tianjin University (60302064, 60302069), and the Innovation Program of Shanghai Municipal Education Commission (12ZZ087), and by a grant from "The First-class Discipline of Universities in Shanghai". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonzo JD, 1997, NUCLEIC ACIDS RES, V25, P3751, DOI 10.1093/nar/25.19.3751; Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bazak L, 2014, GENOME RES, V24, P365, DOI 10.1101/gr.164749.113; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chester A, 2000, BBA-GENE STRUCT EXPR, V1494, P1, DOI 10.1016/S0167-4781(00)00219-0; Ge H, 2014, J THEOR BIOL; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Keegan LP, 2001, NAT REV GENET, V2, P869, DOI 10.1038/35098584; Lehmann KA, 2000, BIOCHEMISTRY-US, V39, P12875, DOI 10.1021/bi001383g; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045854; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039308; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033393; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Maas S, 2001, P NATL ACAD SCI USA, V98, P14687, DOI 10.1073/pnas.251531398; Mao R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104049; Morrison JR, 1996, P NATL ACAD SCI USA, V93, P7154, DOI 10.1073/pnas.93.14.7154; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrm2061; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Park E, 2012, GENOME RES, V22, P1626, DOI 10.1101/gr.134957.111; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Picardi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044184; POLSON AG, 1994, EMBO J, V13, P5701, DOI 10.1002/j.1460-2075.1994.tb06908.x; Rogers J, 2006, LECT NOTES COMPUT SC, V3940, P173; SHAW JM, 1988, CELL, V53, P401, DOI 10.1016/0092-8674(88)90160-2; Sloof P, 1997, TRENDS MICROBIOL, V5, P189, DOI 10.1016/S0966-842X(97)01034-2; St Laurent G, 2013, NAT STRUCT MOL BIOL, V20, P1333, DOI 10.1038/nsmb.2675; Tang W, 2012, MOL BIOTECHNOL, V52, P91, DOI 10.1007/s12033-012-9498-7; Valente L, 2005, PROG NUCLEIC ACID RE, V79, P299, DOI 10.1016/S0079-6603(04)79006-6; Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4; Witten I.H., 2005, DATA MINING PRACTICA; Zhang N, 2012, MOL BIOSYST, V8, P2946, DOI 10.1039/c2mb25185j	34	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110607	10.1371/journal.pone.0110607	http://dx.doi.org/10.1371/journal.pone.0110607			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338210	Green Submitted, gold, Green Published			2022-12-27	WOS:000343674800062
J	Orton, E; Kendrick, D; West, J; Tata, LJ				Orton, Elizabeth; Kendrick, Denise; West, Joe; Tata, Laila J.			Persistence of Health Inequalities in Childhood Injury in the UK; A Population-Based Cohort Study of Children under 5	PLOS ONE			English	Article							PRACTICE RESEARCH DATABASE; NEIGHBORHOOD VARIATIONS; UNITED-STATES; SOCIAL-CLASS; EPIDEMIOLOGY; FRACTURES; ACCIDENTS; RATES; AREAS; RISK	Background: Injury is a significant cause of childhood death and can result in substantial long-term disability. Injuries are more common in children from socio-economically deprived families, contributing to health inequalities between the most and least affluent. However, little is known about how the relationship between injuries and deprivation has changed over time in the UK. Methods: We conducted a cohort study of all children under 5 registered in one of 495 UK general practices that contributed medical data to The Health Improvement Network database between 1990-2009. We estimated the incidence of fractures, burns and poisonings by age, sex, socio-economic group and calendar period and adjusted incidence rate ratios (IRR) comparing the least and most socio-economically deprived areas over time. Estimates of the UK annual burden of injuries and the excess burden attributable to deprivation were derived from incidence rates. Results: The cohort of 979,383 children experienced 20,804 fractures, 15,880 burns and 10,155 poisonings, equating to an incidence of 75.8/10,000 person-years (95% confidence interval 74.8-76.9) for fractures, 57.9 (57.0-58.9) for burns and 37.3 (35.6-38.0) for poisonings. Incidence rates decreased over time for burns and poisonings and increased for fractures (p, 0.001 test for trend for each injury). They were significantly higher in more deprived households (IRR test for trend p, 0.001 for each injury type) and these gradients persisted over time. We estimate that 865 fractures, 3,763 burns and 3,043 poisonings could be prevented each year in the UK if incidence rates could be reduced to those of the most affluent areas. Conclusions: The incidence of burns and poisonings declined between 1990 and 2009 but increased for fractures. Despite these changes, strong socio-economic inequalities persisted resulting in an estimated 9,000 additional medically-attended injuries per year in under-5s.	[Orton, Elizabeth; Kendrick, Denise] Univ Nottingham, Div Primary Care, Nottingham NG7 2RD, England; [West, Joe; Tata, Laila J.] Univ Nottingham, City Hosp Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England	University of Nottingham; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham	Orton, E (corresponding author), Univ Nottingham, Div Primary Care, Univ Pk, Nottingham NG7 2RD, England.	elizabeth.orton@nottingham.ac.uk	West, Joe/I-6637-2012; Orton, Elizabeth/AAI-1377-2021; West, Joe/M-3867-2019; Tata, Laila/J-5227-2012	West, Joe/0000-0002-1135-9356; Orton, Elizabeth/0000-0002-2531-8846; West, Joe/0000-0002-1135-9356; Tata, Laila/0000-0002-6404-8658; Kendrick, Denise/0000-0003-3603-6542				Alaghehbandan R, 2012, BURNS, V38, P136, DOI 10.1016/j.burns.2011.06.010; Blak Betina T, 2011, Inform Prim Care, V19, P251; Bourke Alison, 2004, Inform Prim Care, V12, P171; BROWN GW, 1978, LANCET, V1, P378; Centre. HaSCI, 2012, ATTR DAT SET GP REG; Cooper C, 2004, J BONE MINER RES, V19, P1976, DOI 10.1359/JBMR.040902; Do, 2012, CROWN COPYRIGHT; Franklin RL, 2008, PEDIATRICS, V122, P1244, DOI 10.1542/peds.2007-3551; Haynes R, 2008, HEALTH PLACE, V14, P693, DOI 10.1016/j.healthplace.2007.11.001; Herrett EL, 2011, BRIT J GEN PRACT, V61, P438, DOI 10.3399/bjgp11X583092; Hippisley-Cox J, 2002, BRIT MED J, V324, P1132, DOI 10.1136/bmj.324.7346.1132; Kendrick D, 2001, PUBLIC HEALTH, V115, P103, DOI 10.1016/S0033-3506(01)00427-9; Kendrick D, 2009, HEALTH EDUC RES, V24, P32, DOI 10.1093/her/cym083; Lyons RA, 2000, BRIT MED J, V320, P149, DOI 10.1136/bmj.320.7228.149; MacInnes K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-120; Mayranpaa MK, 2010, J BONE MINER RES, V25, P2476, DOI 10.1002/jbmr.155; Mayranpaa MK, 2010, J BONE MINER RES, V26, P439; Mulvaney C, 2009, J PUBLIC HEALTH-UK, V31, P154, DOI 10.1093/pubmed/fdn103; NICE, 2010, STRAT PREV UN INJ UN, pPH 29; Pomerantz WJ, 2001, J URBAN HEALTH, V78, P141, DOI 10.1093/jurban/78.1.141; Reading R, 2008, SOC SCI MED, V67, P915, DOI 10.1016/j.socscimed.2008.05.018; Region WHOE, 2010, 5 MIN C ENV HLTH PAR; Rennie L, 2007, INJURY, V38, P913, DOI 10.1016/j.injury.2007.01.036; Roberts I, 1996, BRIT MED J, V313, P784; ROBERTS I, 1992, J PAEDIATR CHILD H, V28, P438, DOI 10.1111/j.1440-1754.1992.tb02713.x; Stark AD, 2002, BRIT MED J, V324, P457, DOI 10.1136/bmj.324.7335.457; Statistics, OFN ALL REL POP EST; Steenland K, 2006, EPIDEMIOLOGY, V17, P512, DOI 10.1097/01.ede.0000229155.05644.43; Townsend PP., 1988, HLTH DEPRIVATION INE; Vloemans AFPM, 2011, BURNS, V37, P1161, DOI 10.1016/j.burns.2011.05.001; Xiang YX, 2012, AM J EMERG MED, V30, P293, DOI 10.1016/j.ajem.2010.11.031	31	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111631	10.1371/journal.pone.0111631	http://dx.doi.org/10.1371/journal.pone.0111631			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ1JF	25347771	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000347994900083
J	Pandey, V; Sultan, M; Kashofer, K; Ralser, M; Amstislavskiy, V; Starmann, J; Osprian, I; Grimm, C; Hache, H; Yaspo, ML; Sultmann, H; Trauner, M; Denk, H; Zatloukal, K; Lehrach, H; Wierling, C				Pandey, Vikash; Sultan, Marc; Kashofer, Karl; Ralser, Meryem; Amstislavskiy, Vyacheslav; Starmann, Julia; Osprian, Ingrid; Grimm, Christina; Hache, Hendrik; Yaspo, Marie-Laure; Sueltmann, Holger; Trauner, Michael; Denk, Helmut; Zatloukal, Kurt; Lehrach, Hans; Wierling, Christoph			Comparative Analysis and Modeling of the Severity of Steatohepatitis in DDC-Treated Mouse Strains	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; DIFFERENTIAL EXPRESSION; MOLECULAR-MECHANISMS; METABOLISM; DISEASE; ACID; 5-LIPOXYGENASE; ALPHA; PROSTAGLANDINS; INACTIVATION	Non-alcoholic fatty liver disease (NAFLD) has a broad spectrum of disease states ranging from mild steatosis characterized by an abnormal retention of lipids within liver cells to steatohepatitis (NASH) showing fat accumulation, inflammation, ballooning and degradation of hepatocytes, and fibrosis. Ultimately, steatohepatitis can result in liver cirrhosis and hepatocellular carcinoma. Methodology and Results: In this study we have analyzed three different mouse strains, A/J, C57BL/6J, and PWD/PhJ, that show different degrees of steatohepatitis when administered a 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) containing diet. RNA-Seq gene expression analysis, protein analysis and metabolic profiling were applied to identify differentially expressed genes/proteins and perturbed metabolite levels of mouse liver samples upon DDC-treatment. Pathway analysis revealed alteration of arachidonic acid (AA) and S-adenosylmethionine (SAMe) metabolism upon other pathways. To understand metabolic changes of arachidonic acid metabolism in the light of disease expression profiles a kinetic model of this pathway was developed and optimized according to metabolite levels. Subsequently, the model was used to study in silico effects of potential drug targets for steatohepatitis. Conclusions: We identified AA/eicosanoid metabolism as highly perturbed in DDC-induced mice using a combination of an experimental and in silico approach. Our analysis of the AA/eicosanoid metabolic pathway suggests that 5-hydroxyeicosatetraenoic acid (5-HETE), 15-hydroxyeicosatetraenoic acid (15-HETE) and prostaglandin D2 (PGD2) are perturbed in DDC mice. We further demonstrate that a dynamic model can be used for qualitative prediction of metabolic changes based on transcriptomics data in a disease-related context. Furthermore, SAMe metabolism was identified as being perturbed due to DDC treatment. Several genes as well as some metabolites of this module show differences between A/J and C57BL/6J on the one hand and PWD/PhJ on the other.	[Pandey, Vikash; Sultan, Marc; Ralser, Meryem; Amstislavskiy, Vyacheslav; Hache, Hendrik; Yaspo, Marie-Laure; Lehrach, Hans; Wierling, Christoph] Max Planck Inst Mol Genet, Dept Vertebrate Genom, D-14195 Berlin, Germany; [Kashofer, Karl; Denk, Helmut; Zatloukal, Kurt] Med Univ Graz, Inst Pathol, Graz, Austria; [Starmann, Julia; Sueltmann, Holger] German Canc Res Ctr, Heidelberg, Germany; [Osprian, Ingrid] BIOCRATES Life Sci AG, Innsbruck, Austria; [Osprian, Ingrid] LKH Wagna, Dept Internal Med, Wagna, Austria; [Grimm, Christina] Charite, D-13353 Berlin, Germany; [Yaspo, Marie-Laure; Lehrach, Hans] Dahlem Ctr Genome Res & Med Syst Biol, Berlin, Germany; [Trauner, Michael] Med Univ Vienna, Dept Med, Div Gastroenterol & Hepatol, Hans Popper Lab Mol Hepatol, Vienna, Austria	Max Planck Society; Medical University of Graz; Helmholtz Association; German Cancer Research Center (DKFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Medical University of Vienna	Wierling, C (corresponding author), Max Planck Inst Mol Genet, Dept Vertebrate Genom, Ihnestr 73, D-14195 Berlin, Germany.	wierling@molgen.mpg.de	Grimm, Christina/Z-6172-2019	Grimm, Christina/0000-0002-4676-8870; Trauner, Michael/0000-0002-1275-6425; Wierling, Christoph/0000-0002-8856-8412	Austrian Nationalstiftung; Austria Wirtschaftsservice GmbH; Max Planck Society	Austrian Nationalstiftung; Austria Wirtschaftsservice GmbH; Max Planck Society(Max Planck Society)	This work was funded by a grant of the Austrian Nationalstiftung and the Austria Wirtschaftsservice GmbH in the framework of the IMGuS research program (Institute for Medical Genome Research and Systems Biology, Vienna) and by the Max Planck Society. Co-author Ingrid Osprian was employed by BIOCRATES Life Sciences AG during the runtime of the IMGuS project where she did the metabolic analysis presented in this manuscript. BIOCRATES Life Sciences AG provided support in the form of salary for author Ingrid Osprian, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	AHARONY D, 1987, PROSTAGLANDINS, V33, P85, DOI 10.1016/0090-6980(87)90307-8; Anderson N, 2008, PHARMACOL REV, V60, P311, DOI 10.1124/pr.108.00001; Anfuso CD, 2007, J LIPID RES, V48, P782, DOI 10.1194/jlr.M600489-JLR200; Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; Bhattacharjee A, 2006, J IMMUNOL, V177, P3771, DOI 10.4049/jimmunol.177.6.3771; Brase JC, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-36; Broekman F, 2011, WORLD J CLIN ONCOL, V2, P80, DOI 10.5306/wjco.v2.i2.80; Brunt EM, 2004, HUM PATHOL, V35, P1070, DOI 10.1016/j.humpath.2004.04.017; Cano A, 2011, HEPATOLOGY, V54, P1975, DOI 10.1002/hep.24607; Charlton M, 2009, HEPATOLOGY, V49, P1375, DOI 10.1002/hep.22927; Connor SC, 2010, MOL BIOSYST, V6, P909, DOI 10.1039/b914182k; Denk H, 2000, J HEPATOL, V32, P689, DOI 10.1016/S0168-8278(00)80233-0; Ferrara CT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000034; Gan QA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r42; Geddis MS, 2004, CELL MOTIL CYTOSKEL, V57, P53, DOI 10.1002/cm.10156; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Giannitrapani L, 2009, ANN NY ACAD SCI, V1155, P293, DOI 10.1111/j.1749-6632.2009.03698.x; Gupta S, 2009, BIOPHYS J, V96, P4542, DOI 10.1016/j.bpj.2009.03.011; HAYAISHI O, 1991, FASEB J, V5, P2575, DOI 10.1096/fasebj.5.11.1907936; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hoppe A, 2012, METABOLITES, V2, P614, DOI 10.3390/metabo2030614; Ishihara K, 2012, FASEB J, V26, P4111, DOI 10.1096/fj.12-205625; Jauhiainen A, 2012, BIOSTAT OXF ENGL; Juni P, 2002, BRIT MED J, V324, P1287, DOI 10.1136/bmj.324.7349.1287; Kalhan SC, 2011, CLIN SCI, V121, P179, DOI 10.1042/CS20110060; Kamburov A, 2011, BIOINFORMATICS, V27, P2917, DOI 10.1093/bioinformatics/btr499; Kamburov A, 2011, NUCLEIC ACIDS RES, V39, pD712, DOI 10.1093/nar/gkq1156; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Klipp Edda, 2009, SYSTEMS BIOL TXB; LEPLEY RA, 1994, J BIOL CHEM, V269, P2627; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Loebke C, 2007, PROTEOMICS, V7, P558, DOI 10.1002/pmic.200600757; Mahipal SVK, 2007, BIOCHEM PHARMACOL, V74, P202, DOI 10.1016/j.bcp.2007.04.005; Mannsperger HA, 2010, BIOINFORMATICS, V26, P2202, DOI 10.1093/bioinformatics/btq347; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; Martinez-Clemente M, 2010, HEPATOLOGY, V51, P817, DOI 10.1002/hep.23463; Mato JM, 2013, ANN HEPATOL, V12, P183, DOI 10.1016/S1665-2681(19)31355-9; Miller SB, 2006, SEMIN ARTHRITIS RHEU, V36, P37, DOI 10.1016/j.semarthrit.2006.03.005; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Perrone MG, 2010, CURR MED CHEM, V17, P3769; Puri P, 2009, HEPATOLOGY, V50, P1827, DOI 10.1002/hep.23229; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Scheer M, 2011, NUCLEIC ACIDS RES, V39, pD670, DOI 10.1093/nar/gkq1089; Sigurdsson MI, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-140; Titos E, 2005, J LEUKOCYTE BIOL, V78, P871, DOI 10.1189/jlb.1204747; Tosello-Trampont AC, 2012, J BIOL CHEM, V287, P40161, DOI 10.1074/jbc.M112.417014; Ulbrich H, 2005, BIOCHEM PHARMACOL, V70, P30, DOI 10.1016/j.bcp.2005.03.031; Unterwurzacher I, 2008, CLIN CHEM LAB MED, V46, P1589, DOI 10.1515/CCLM.2008.323; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Wierling Christoph, 2007, Briefings in Functional Genomics & Proteomics, V6, P240, DOI 10.1093/bfgp/elm027; Yang K, 2007, PLOS COMPUT BIOL, V3, P523, DOI 10.1371/journal.pcbi.0030055; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968	53	9	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111006	10.1371/journal.pone.0111006	http://dx.doi.org/10.1371/journal.pone.0111006			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347188	gold, Green Submitted, Green Published			2022-12-27	WOS:000347994900038
J	Qin, H; Pan, F; Li, JJ; Zhang, XL; Liang, HJ; Ruan, ZH				Qin, Hong; Pan, Feng; Li, Jianjun; Zhang, Xiaoli; Liang, Houjie; Ruan, Zhihua			Whole Brain Radiotherapy Plus Concurrent Chemotherapy in Non-Small Cell Lung Cancer Patients with Brain Metastases: A Meta-Analysis	PLOS ONE			English	Article							PHASE-III TRIAL; RADIATION-THERAPY; CNS-METASTASES; TEMOZOLOMIDE; CARCINOMA; CARBOPLATIN; CISPLATIN	Objective: The aim of the present meta-analysis is to evaluate the response rate, median survival time (MST) and toxicity in patients with brain metastases (BM) originating from non-small cell lung cancer (NSCLC) and who were treated using either whole brain radiotherapy (WBRT) plus concurrent chemotherapy or WBRT alone. Methods: PubMed, EMBASE, Web of Science, The Cochrane Library, clinical trials and current controlled trials were searched to identify any relevant publications. After screening the literature and undertaking quality assessment and data extraction, the meta-analysis was performed using Stata11.0 software. Results: In total, six randomized controlled trials (RCT) involving 910 participants were included in the meta-analysis. The results of the analysis indicate that WBRT plus concurrent chemotherapy was more effective at improving response rate (RR = 2.06, 95% CI [1.13, 3.77]; P = 0.019) than WBRT alone. However, WBRT plus concurrent chemotherapy did not improve median survival time (MST) (HR = 1.09, 95% CI [0.94, 1.26]; P = 0.233) or time of neurological progression (CNS-TTP) (HR = 0.93, 95%CI [0.75, 1.16]; P = 0.543), and increased adverse events (Grade >= 3) (RR = 2.59, 95% CI [1.88, 3.58]; P = 0.000). There were no significant differences in Grade 3-5 neurological or hematological toxicity between two patient groups (RR = 1.08, 95%CI [0.23, 5.1]; P = 0.92). Conclusion: The combination of chemotherapy plus WBRT in patients with BM originating from NSCLC may increase treatment response rates of brain metastases with limited toxicity. Although the therapy schedule did not prolong MST or CNS-TTP, further assessment is warranted.	[Qin, Hong; Pan, Feng; Li, Jianjun; Zhang, Xiaoli; Liang, Houjie; Ruan, Zhihua] Third Mil Med Univ, Southwest Hosp, Dept Oncol, Chongqing, Peoples R China	Army Medical University	Liang, HJ (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Oncol, Chongqing, Peoples R China.	lianghoujie@sina.com; zhihuaruan@gmail.com						Addeo R, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-18; Addeo R, 2011, EXPERT OPIN INV DRUG, V20, P881, DOI 10.1517/13543784.2011.580736; Adonizio Christian S, 2002, Clin Lung Cancer, V3, P254, DOI 10.3816/CLC.2002.n.009; Bailon O, 2012, NEURO-ONCOLOGY, V14, P491, DOI 10.1093/neuonc/nos004; Barlesi F, 2011, ANN ONCOL, V22, P2466, DOI 10.1093/annonc/mdr003; Berger LA, 2013, LUNG CANCER, V80, P242, DOI 10.1016/j.lungcan.2013.02.004; Biswas G, 2006, J Cancer Res Ther, V2, P5; Chua D, 2010, CLIN LUNG CANCER, V11, P176, DOI 10.3816/CLC.2010.n.022; Ford AC, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3174; Gijtenbeek J M M Anja, 2011, Ned Tijdschr Geneeskd, V155, pA4141; Guerrieri M, 2004, LUNG CANCER, V46, P107, DOI 10.1016/j.lungcan.2004.02.019; Hassler MR, 2013, WIEN KLIN WOCHENSCHR, V125, P481, DOI 10.1007/s00508-013-0402-7; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Kaba SE, 1997, J CLIN ONCOL, V15, P1063, DOI 10.1200/JCO.1997.15.3.1063; Mehta MP, 2009, INT J RADIAT ONCOL, V73, P1069, DOI 10.1016/j.ijrobp.2008.05.068; Neuhaus T, 2009, BRIT J CANCER, V100, P291, DOI 10.1038/sj.bjc.6604835; Nieder C, 1999, CANCER, V86, P900, DOI 10.1002/(SICI)1097-0142(19990901)86:5<900::AID-CNCR30>3.0.CO;2-5; Seoane J, 2014, MOL ONCOL, V8, P1120, DOI 10.1016/j.molonc.2014.05.009; Siu TL, 2011, J CLIN NEUROSCI, V18, P1429, DOI 10.1016/j.jocn.2011.04.002; Sperduto PW, 2013, INT J RADIAT ONCOL, V85, P1312, DOI 10.1016/j.ijrobp.2012.11.042; Sperduto PW, 2012, J CLIN ONCOL, V30, P419, DOI 10.1200/JCO.2011.38.0527; USHIO Y, 1991, NEUROSURGERY, V28, P201, DOI 10.1227/00006123-199102000-00005; Verger E, 2005, INT J RADIAT ONCOL, V61, P185, DOI 10.1016/j.ijrobp.2004.04.061	23	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111475	10.1371/journal.pone.0111475	http://dx.doi.org/10.1371/journal.pone.0111475			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347291	Green Submitted, Green Published, gold			2022-12-27	WOS:000347994900079
J	Russo, GT; Giorda, CB; Cercone, S; Nicolucci, A; Cucinotta, D				Russo, Giuseppina T.; Giorda, Carlo Bruno; Cercone, Stefania; Nicolucci, Antonio; Cucinotta, Domenico		BetaDecline Study Grp	Factors Associated with Beta-Cell Dysfunction in Type 2 Diabetes: The BETADECLINE Study	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; INSULIN-SECRETION; PROINSULIN LEVELS; DOUBLE-BLIND; APOPTOSIS; PATHOPHYSIOLOGY; DETERMINANTS; RESISTANCE; ROSIGLITAZONE; SULFONYLUREA	Aims: Beta-cell dysfunction is an early event in the natural history of type 2 diabetes. However, its progression is variable and potentially influenced by several clinical factors. We report the baseline data of the BetaDecline study, an Italian prospective multicenter study on clinical predictors of beta-cell dysfunction in type 2 diabetes. Materials and Methods: Clinical, lifestyle, and laboratory data, including circulating levels of inflammatory markers and nonesterified fatty acids, were collected in 507 type 2 diabetic outpatients on stable treatment with oral hypoglycemic drugs or diet for more than 1 year. Beta-cell dysfunction was evaluated by calculating the proinsulin/insulin ratio (P/I). Results: At baseline, the subjects in the upper PI/I ratio quartile were more likely to be men and receiving secretagogue drugs; they also showed a borderline longer diabetes duration (P = 0.06) and higher serum levels of glycated hemoglobin (HbA(1c)), fasting blood glucose, and triglycerides. An inverse trend across all PI/I quartiles was noted for BMI and serum levels of total cholesterol (T-C), LDL-C, HDL-C and C reactive protein (CRP), and with homeostatic model assessment (HOMA-B) and HOMA of insulin resistance (HOMA-IR) values (P<0.05 for all). At multivariate analysis, the risk of having a P/I ratio in the upper quartile was higher in the subjects on secretagogue drugs (odds ratio [OR] 4.2; 95% confidence interval [CI], 2.6-6.9) and in the males (OR 1.8; 95% CI, 1.1-2.9). Conclusions: In the BetaDecline study population, baseline higher PI/I values, a marker of beta-cell dysfunction, were more frequent in men and in patients on secretagogues drugs. Follow-up of this cohort will allow the identification of clinical predictors of beta-cell failure in type 2 diabetic outpatients.	[Russo, Giuseppina T.; Cucinotta, Domenico] Univ Messina, Dept Clin & Expt Med, Messina, Italy; [Giorda, Carlo Bruno] Metab & Diabet Unit ASL TO5, Chieri, Italy; [Cercone, Stefania] MSD, Rome, Italy; [Nicolucci, Antonio] Fdn Mario Negri Sud, Dept Clin Pharmacol & Epidemiol, Santa Maria Imbaro, Italy	University of Messina	Russo, GT (corresponding author), Univ Messina, Dept Clin & Expt Med, Messina, Italy.	Giuseppina.russo@unime.it	Giorda, Carlo B/D-4485-2018; De Cosmo, Salvatore/J-7420-2016	Giorda, Carlo B/0000-0002-4709-8696; De Cosmo, Salvatore/0000-0001-8787-8286; CUCINOTTA, Domenico Maria/0000-0002-8159-5709	Merck Sharp Dohme Corp.	Merck Sharp Dohme Corp.(Merck & Company)	This study was organized by AMD Foundation Rome, and was in part funded by Merck Sharp & Dohme Corp. The funds are used for the costs of laboratory and data monitoring. There is no one outside of the author SC who is employed or has relationships with Merck Sharp & Dohme. SC's contribution is in data analysis and interpretation. No additional funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu R, 2003, DIABETES, V52, P1738, DOI 10.2337/diabetes.52.7.1738; Bonora E, 2008, NUTR METAB CARDIOVAS, V18, P74, DOI 10.1016/j.numecd.2007.05.004; BRUNZELL JD, 1976, J CLIN ENDOCR METAB, V42, P222, DOI 10.1210/jcem-42-2-222; Bryhni B, 2010, BMC ENDOCR DISORD, V10, DOI 10.1186/1472-6823-10-21; Chandler-Laney PC, 2010, OBESITY, V18, P2086, DOI 10.1038/oby.2010.44; de Mello VDF, 2012, DIABETES CARE, V35, P211, DOI 10.2337/dc11-1272; DeFronzo RA, 2010, DIABETOLOGIA, V53, P435, DOI 10.1007/s00125-009-1614-2; Dworacka M, 2006, INT J CLIN PHARM TH, V44, P14; Federici M, 2001, DIABETES, V50, P1290, DOI 10.2337/diabetes.50.6.1290; Federici M, 2005, J CLIN INVEST, V115, P3494, DOI 10.1172/JCI26052; Festa A, 2008, DIABETES, V57, P1638, DOI 10.2337/db07-0954; Folli F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028050; Ford ES, 2005, DIABETES CARE, V28, P2745, DOI 10.2337/diacare.28.11.2745; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gavin JR, 1997, DIABETES CARE, V20, P1183; Godsland IF, 2005, DIABETOLOGIA, V48, P2213, DOI 10.1007/s00125-005-1930-0; Guardado-Mendoza R, 2013, INT J OBESITY, V37, P1071, DOI 10.1038/ijo.2012.205; Guardado-Mendoza R, 2009, P NATL ACAD SCI USA, V106, P13992, DOI 10.1073/pnas.0906471106; Jurgens CA, 2011, AM J PATHOL, V178, P2632, DOI 10.1016/j.ajpath.2011.02.036; Kahn SE, 2008, DIABETES OBES METAB, V10, P63, DOI 10.1111/j.1463-1326.2008.00945.x; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kahn SE, 2011, DIABETES, V60, P1552, DOI 10.2337/db10-1392; Kanaya AM, 2003, ANN INTERN MED, V138, P1, DOI 10.7326/0003-4819-138-1-200301070-00005; Kitabchi AE, 2005, DIABETES, V54, P2404, DOI 10.2337/diabetes.54.8.2404; Le May C, 2006, P NATL ACAD SCI USA, V103, P9232, DOI 10.1073/pnas.0602956103; Lee SC, 2007, INT J BIOCHEM CELL B, V39, P497, DOI 10.1016/j.biocel.2006.09.007; Margolis KL, 2004, DIABETOLOGIA, V47, P1175, DOI 10.1007/s00125-004-1448-x; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI [10.1001/jama.289.1.76, DOI 10.1001/JAMA.289.1.76]; Monroy A, 2009, DIABETOLOGIA, V52, P2169, DOI 10.1007/s00125-009-1451-3; Mudaliar S, 2013, INT J CLIN PRACT, V67, P876, DOI 10.1111/ijcp.12154; Pfutzner A, 2006, DIABETES TECHNOL THE, V8, P375, DOI 10.1089/dia.2006.8.375; Pfutzner Andreas, 2011, J Diabetes Sci Technol, V5, P784; PHILLIPS DIW, 1994, DIABETIC MED, V11, P286, DOI 10.1111/j.1464-5491.1994.tb00273.x; Reaven GM, 2009, J DIABETES, V1, P142, DOI 10.1111/j.1753-0407.2009.00016.x; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Rivellese AA, 2010, NUTR METAB CARDIOVAS, V20, P474, DOI 10.1016/j.numecd.2010.01.008; Roder ME, 1999, DIABETES CARE, V22, P609, DOI 10.2337/diacare.22.4.609; Rossi MC, 2013, DIABETES CARE, V36, P3162, DOI 10.2337/dc13-0184; Shi HF, 2009, FRONT NEUROENDOCRIN, V30, P396, DOI 10.1016/j.yfrne.2009.03.004; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Tiano JP, 2012, NAT REV ENDOCRINOL, V8, P342, DOI 10.1038/nrendo.2011.242; Tripathy D, 2013, DIABETOLOGIA, V56, P2153, DOI 10.1007/s00125-013-2976-z; Verchere CB, 1996, P NATL ACAD SCI USA, V93, P3492, DOI 10.1073/pnas.93.8.3492; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Westermark P, 2011, PHYSIOL REV, V91, P795, DOI 10.1152/physrev.00042.2009; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Wright A, 2002, DIABETES CARE, V25, P330, DOI 10.2337/diacare.25.2.330	48	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e109702	10.1371/journal.pone.0109702	http://dx.doi.org/10.1371/journal.pone.0109702			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347846	gold, Green Published, Green Submitted			2022-12-27	WOS:000347994900012
J	Scholten, DJ; Timmer, CM; Peacock, JD; Pelle, DW; Williams, BO; Steensma, MR				Scholten, Donald J., II; Timmer, Christine M.; Peacock, Jacqueline D.; Pelle, Dominic W.; Williams, Bart O.; Steensma, Matthew R.			Down Regulation of Wnt Signaling Mitigates Hypoxia-Induced Chemoresistance in Human Osteosarcoma Cells	PLOS ONE			English	Article							INDUCIBLE FACTOR 1-ALPHA; BETA-CATENIN; TUMOR HYPOXIA; CANCER; PATHWAY; HIF-1; METASTASIS; EXPRESSION; OVEREXPRESSION; ANGIOGENESIS	Osteosarcoma (OS) is the most common type of solid bone cancer and remains the second leading cause of cancer-related death for children and young adults. Hypoxia is an element intrinsic to most solid-tumor microenvironments, including that of OS, and is associated with resistance to therapy, poor survival, and a malignant phenotype. Cells respond to hypoxia through alterations in gene expression, mediated most notably through the hypoxia-inducible factor (HIF) class of transcription factors. Here we investigate hypoxia-induced changes in the Wnt/beta-catenin signaling pathway, a key signaling cascade involved in OS pathogenesis. We show that hypoxia results in increased expression and signaling activation of HIF proteins in human osteosarcoma cells. Wnt/beta-catenin signaling is down-regulated by hypoxia in human OS cells, as demonstrated by decreased active beta-catenin protein levels and axin2 mRNA expression (p<0.05). This down-regulation appears to rely on both HIF-independent and HIF-dependent mechanisms, with HIF-1 alpha standing out as an important regulator. Finally, we show that hypoxia results in resistance of human OS cells to doxorubicin-mediated toxicity (6-13 fold increase, p<0.01). These hypoxic OS cells can be sensitized to doxorubicin treatment by further inhibition of the Wnt/bcatenin signaling pathway (p<0.05). These data support the conclusion that Wnt/b-catenin signaling is down-regulated in human OS cells under hypoxia and that this signaling alteration may represent a viable target to combat chemoresistant OS subpopulations in a hypoxic niche.	[Scholten, Donald J., II; Timmer, Christine M.; Pelle, Dominic W.; Steensma, Matthew R.] Michigan State Univ, Coll Human Med, Grand Rapids, MI 49503 USA; [Scholten, Donald J., II; Peacock, Jacqueline D.; Pelle, Dominic W.; Williams, Bart O.; Steensma, Matthew R.] Van Andel Res Inst, Grand Rapids, MI USA; [Pelle, Dominic W.; Steensma, Matthew R.] Spectrum Hlth Syst, Helen DeVos Childens Hosp, Grand Rapids, MI USA	Michigan State University; Michigan State University College of Human Medicine; Van Andel Institute	Steensma, MR (corresponding author), Michigan State Univ, Coll Human Med, Grand Rapids, MI 49503 USA.	matt.steensma@vai.org	Williams, Bart/A-3539-2013	Williams, Bart/0000-0002-5261-5301	Van Andel Research Institute and Spectrum Health	Van Andel Research Institute and Spectrum Health	The authors thank the Van Andel Research Institute and Spectrum Health for financial support of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamski J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065304; Agani F, 2013, CURR CANCER DRUG TAR, V13, P245, DOI 10.2174/1568009611313030003; Anninga JK, 2011, EUR J CANCER, V47, P2431, DOI 10.1016/j.ejca.2011.05.030; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bielack S, 2009, ANN ONCOL, V20, P137, DOI 10.1093/annonc/mdp154; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Cai YP, 2010, J PATHOL, V220, P24, DOI 10.1002/path.2628; Cai Y, 2014, J CELL BIOCHEM, V115, P625, DOI 10.1002/jcb.24708; Chan DA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002394; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065940; Chen DF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052948; Chen D, 2013, TUMOR BIOL, V34, P1895, DOI 10.1007/s13277-013-0733-z; Deng ZM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/496193; Du XL, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-450; El Naggar A, 2012, PEDIATR BLOOD CANCER, V59, P1215, DOI 10.1002/pbc.24191; Enomoto M, 2009, ONCOGENE, V28, P3197, DOI 10.1038/onc.2009.175; Flores RJ, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-50; Genetos DC, 2010, J CELL BIOCHEM, V110, P457, DOI 10.1002/jcb.22559; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Guo Y, 2008, CLIN ORTHOP RELAT R, V466, P2039, DOI 10.1007/s11999-008-0344-y; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Knowles HJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-372; Kuijjer ML, 2013, INT J CANCER, V133, P2512, DOI 10.1002/ijc.28124; Kumar N, 2009, NUCLEIC ACIDS RES, V37, P3321, DOI 10.1093/nar/gkp196; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Liao D, 2007, CANCER METAST REV, V26, P281, DOI 10.1007/s10555-007-9066-y; Lin Carol H., 2013, Sarcoma, V2013, P147541, DOI 10.1155/2013/147541; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Ma YM, 2013, BIOCHEM BIOPH RES CO, V431, P274, DOI 10.1016/j.bbrc.2012.12.118; Martin SK, 2011, LEUKEMIA, V25, P1533, DOI 10.1038/leu.2011.122; Mazumdar J, 2009, J CELL MOL MED, V13, P4319, DOI 10.1111/j.1582-4934.2009.00963.x; Michaylira CZ, 2006, CANCER BIOL THER, V5, P476, DOI 10.4161/cbt.5.5.2749; Mizukami Y, 2007, CLIN CANCER RES, V13, P5670, DOI 10.1158/1078-0432.CCR-07-0111; Mohseny AB, 2011, LAB INVEST, V91, P1195, DOI 10.1038/labinvest.2011.72; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Onnis B, 2009, J CELL MOL MED, V13, P2780, DOI 10.1111/j.1582-4934.2009.00876.x; RCore Team, 2020, R LANG ENV STAT COMP; Rubin EM, 2010, MOL CANCER THER, V9, P731, DOI 10.1158/1535-7163.MCT-09-0147; Siclari VA, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-78; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Tormos KV, 2010, J CELL MOL MED, V14, P795, DOI 10.1111/j.1582-4934.2010.01031.x; Turner DC, 2014, CLIN CANCER RES, V20, P2783, DOI 10.1158/1078-0432.CCR-13-2364; Vacchelli E, 2014, ONCOIMMUNOLOGY, V3, DOI [10.4161/onci.27048, 10.4161/onci.27878]; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Wang DP, 2011, CANCER SCI, V102, P1322, DOI 10.1111/j.1349-7006.2011.01950.x; Wilson-Edell KA, 2014, BREAST CANCER RES TR, V144, P287, DOI 10.1007/s10549-014-2877-y; Yang QC, 2007, JPN J CLIN ONCOL, V37, P127, DOI 10.1093/jjco/hyl137	54	28	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111431	10.1371/journal.pone.0111431	http://dx.doi.org/10.1371/journal.pone.0111431			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347326	gold, Green Submitted, Green Published			2022-12-27	WOS:000347994900071
J	Tan, YW; Pan, TL; Ye, Y; Ge, GH; Chen, L; Wen, DF; Zou, SQ				Tan, Youwen; Pan, Tengli; Ye, Yun; Ge, Guohong; Chen, Li; Wen, Danfeng; Zou, Shengqiang			Serum MicroRNAs as Potential Biomarkers of Primary Biliary Cirrhosis	PLOS ONE			English	Article							CIRCULATING MICRORNAS; LIVER-DISEASE; HEPATOCELLULAR-CARCINOMA; RT-PCR; EXPRESSION; MIR-122; CANCER; INJURY; IDENTIFICATION; HEPATITIS	Background: Circulating microRNAs (miRNAs), which are extremely stable and protected from RNAse-mediated degradation in body fluids, have emerged as candidate biomarkers for many diseases. The present study aimed to identify a serum microRNA (miRNA) expression profile that could serve as a novel diagnostic biomarker for primary biliary cirrhosis (PBC). Methods: Serum miRNA expression was investigated using four cohorts comprising 380 participants (healthy controls and patients with PBC) recruited between August 2010 and June 2013. miRNA expression was initially analyzed by Illumina sequencing using serum samples pooled from 3 patients and 3 controls. Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) was then used to evaluate the expression of selected miRNAs in a screening set (n = 40). A logistic regression model was then constructed using a training cohort (n = 192) and validated using another cohort (n = 142). The area under the receiver operating characteristic curve (AUC) was used to evaluate diagnostic accuracy. Results: We identified a miRNA panel (hsa-miR-122-5p, hsa-miR-141-3p, and hsa-miR-26b-5p) with a high diagnostic accuracy for PBC (AUC = 0.905, 95% confidence interval (CI) = 0.857 to 0.953; sensitivity = 80.5%, specificity = 88.3%). There was a significant difference between AUC values of the miRNA panel and those of alkaline phosphatase (ALP) (AUC = 0.537, difference between areas = 0.314, 95% CI = 0.195 to 0.434, P < 0.001), and those of antinuclear antibody (ANA) (AUC = 0.739, difference between areas = 0.112, 95% CI = 0.012 to 0.213, P = 0.0282). Conclusion: We identified a serum microRNA panel with considerable clinical value in PBC diagnosis. The results indicate that the miRNA panel is a more sensitive and specific biomarker for PBC than ALP and ANA.	[Tan, Youwen; Ye, Yun; Ge, Guohong; Chen, Li; Wen, Danfeng; Zou, Shengqiang] Jiangsu Univ, Hosp Zhenjiang 3, Dept Hepatosis, Zhenjiang, Peoples R China; [Pan, Tengli] Peoples Hosp Bozhou, Dept Infect, Bozhou, Peoples R China	Jiangsu University	Tan, YW (corresponding author), Jiangsu Univ, Hosp Zhenjiang 3, Dept Hepatosis, Zhenjiang, Peoples R China.	tyw915@sina.com; 1210xyz@163.com			Natural Science Foundation of Jiangsu Province, China [BK2011151]; Medical Project of Health Department, Jiangsu Province [H201248]; Social Development Project of Zhenjiang City [SH201346]	Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); Medical Project of Health Department, Jiangsu Province; Social Development Project of Zhenjiang City	This work was supported by the Natural Science Foundation of Jiangsu Province, China (BK2011151) (http://www.jstd.gov.cn/), Medical Project of Health Department, Jiangsu Province (H201248) (http://www.jswst.gov.cn/), and the Social Development Project of Zhenjiang City (SH201346) (http://kjj.zhenjiang.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bala S, 2012, HEPATOLOGY, V56, P1946, DOI 10.1002/hep.25873; Bala S, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-151; Banales JM, 2012, HEPATOLOGY, V56, P687, DOI 10.1002/hep.25691; Blanco-Calvo M, 2012, SENSORS-BASEL, V12, P9349, DOI 10.3390/s120709349; Cermelli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023937; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066577; Chen YP, 2013, LIVER INT, V33, P1257, DOI 10.1111/liv.12196; Corpechot C, 2007, HEPATOLOGY, V46, P963, DOI 10.1002/hep.21871; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Ge Yan, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P908, DOI 10.3969/j.issn.1672-7347.2011.09.017; Gershwin ME, 2008, HEPATOLOGY, V47, P737, DOI 10.1002/hep.22042; GERSHWIN ME, 1987, J IMMUNOL, V138, P3525; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Giordano S, 2013, HEPATOLOGY, V57, P840, DOI 10.1002/hep.26095; Gougelet A, 2013, M S-MED SCI, V29, P861, DOI 10.1051/medsci/20132910013; He Y, 2012, CELL SIGNAL, V24, P2268, DOI 10.1016/j.cellsig.2012.07.023; Hirschfield GM, 2009, HEPATOLOGY, V50, P1347, DOI 10.1002/hep.23252; Hsu Shu-Hao, 2013, Curr Pathobiol Rep, V1, P53; Hu J, 2012, PROTEIN CELL, V3, P364, DOI 10.1007/s13238-012-2036-3; Iino I, 2013, CANCER SCI, V104, P624, DOI 10.1111/cas.12122; Koutsaki M, 2014, CANCER LETT, V351, P173, DOI 10.1016/j.canlet.2014.05.022; Lewis AP, 2010, BIOCHEM SOC T, V38, P1553, DOI 10.1042/BST0381553; Lewis PJS, 2012, CLIN PHARMACOL THER, V92, P291, DOI 10.1038/clpt.2012.101; Li G, 2014, POSTGRAD MED J, V90, P106, DOI 10.1136/postgradmedj-2013-131883; Li ZJ, 2014, CELL SIGNAL, V26, P141, DOI 10.1016/j.cellsig.2013.09.018; Lindor KD, 2009, HEPATOLOGY, V50, P291, DOI 10.1002/hep.22906; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marin JJ, 2014, CURR OPIN GASTROENTE; Mei Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046890; Munoz-Garrido P, 2012, WORLD J GASTROENTERO, V18, P6189, DOI 10.3748/wjg.v18.i43.6189; Ninomiya M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066086; Oertelt S, 2007, HEPATOLOGY, V45, P659, DOI 10.1002/hep.21583; Padgett KA, 2009, J AUTOIMMUN, V32, P246, DOI 10.1016/j.jaut.2009.02.022; Papaconstantinou I, 2012, EUR J GASTROEN HEPAT, V24, P223, DOI 10.1097/MEG.0b013e3283505063; Pares Albert, 2008, Gastroenterol Hepatol, V31, P500; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Qin BD, 2013, J GASTROEN HEPATOL, V28, P543, DOI 10.1111/jgh.12040; Qiu WM, 2014, BBA-MOL CELL RES, V1843, P2114, DOI 10.1016/j.bbamcr.2014.06.004; Smith-Vikos T, 2012, J CELL SCI, V125, P7, DOI 10.1242/jcs.099200; Steer CJ, 2012, LIVER TRANSPLANT, V18, P265, DOI 10.1002/lt.23377; Wang XW, 2012, GASTROENTEROLOGY, V142, P1431, DOI 10.1053/j.gastro.2012.04.007; Yan S, 2013, TOXICOL LETT; Zhang H, 2012, WORLD J GASTROENTERO, V18, P5188, DOI 10.3748/wjg.v18.i37.5188; Zhang Y, 2010, CLIN CHEM, V56, P1830, DOI 10.1373/clinchem.2010.147850; Zhou Q, 2012, INT J BIOL SCI, V8, P118, DOI 10.7150/ijbs.8.118	46	45	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111424	10.1371/journal.pone.0111424	http://dx.doi.org/10.1371/journal.pone.0111424			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347847	Green Published, gold, Green Submitted			2022-12-27	WOS:000347994900068
J	Terryn, S; Francart, A; Lamoral, S; Hultberg, A; Rommelaere, H; Wittelsberger, A; Callewaert, F; Stohr, T; Meerschaert, K; Ottevaere, I; Stortelers, C; Vanlandschoot, P; Kalai, M; Van Gucht, S				Terryn, Sanne; Francart, Aurelie; Lamoral, Sophie; Hultberg, Anna; Rommelaere, Heidi; Wittelsberger, Angela; Callewaert, Filip; Stohr, Thomas; Meerschaert, Kris; Ottevaere, Ingrid; Stortelers, Catelijne; Vanlandschoot, Peter; Kalai, Michael; Van Gucht, Steven			Protective Effect of Different Anti-Rabies Virus VHH Constructs against Rabies Disease in Mice	PLOS ONE			English	Article							DOMAIN ANTIBODY FRAGMENTS; CENTRAL-NERVOUS-SYSTEM; MONOCLONAL-ANTIBODIES; CVS STRAIN; INFECTION; IMMUNIZATION; MECHANISMS; PREVENTION; NANOBODIES; IMMUNITY	Rabies virus causes lethal brain infection in about 61000 people per year. Each year, tens of thousands of people receive anti-rabies prophylaxis with plasma-derived immunoglobulins and vaccine soon after exposure. Anti-rabies immunoglobulins are however expensive and have limited availability. VHH are the smallest antigen-binding functional fragments of camelid heavy chain antibodies, also called Nanobodies. The therapeutic potential of anti-rabies VHH was examined in a mouse model using intranasal challenge with a lethal dose of rabies virus. Anti-rabies VHH were administered directly into the brain or systemically, by intraperitoneal injection, 24 hours after virus challenge. Anti-rabies VHH were able to significantly prolong survival or even completely rescue mice from disease. The therapeutic effect depended on the dose, affinity and brain and plasma half-life of the VHH construct. Increasing the affinity by combining two VHH with a glycine-serine linker into bivalent or biparatopic constructs, increased the neutralizing potency to the picomolar range. Upon direct intracerebral administration, a dose as low as 33 mu g of the biparatopic Rab-E8/H7 was still able to establish an anti-rabies effect. The effect of systemic treatment was significantly improved by increasing the half-life of Rab-E8/H7 through linkage with a third VHH targeted against albumin. Intraperitoneal treatment with 1.5 mg (2505 IU, 1 ml) of anti-albumin Rab-E8/H7 prolonged the median survival time from 9 to 15 days and completely rescued 43% of mice. For comparison, intraperitoneal treatment with the highest available dose of human anti-rabies immunoglobulins (65 mg, 111 IU, 1 ml) only prolonged survival by 2 days, without rescue. Overall, the therapeutic benefit seemed well correlated with the time of brain exposure and the plasma half-life of the used VHH construct. These results, together with the ease-of-production and superior thermal stability, render anti-rabies VHH into valuable candidates for development of alternative post exposure treatment drugs against rabies.	[Terryn, Sanne; Francart, Aurelie; Lamoral, Sophie; Kalai, Michael; Van Gucht, Steven] Sci Inst Publ Hlth WIV ISP, Natl Reference Ctr Rabies, Brussels, Belgium; [Terryn, Sanne; Van Gucht, Steven] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Virol Lab, Merelbeke, Belgium; [Hultberg, Anna; Rommelaere, Heidi; Wittelsberger, Angela; Callewaert, Filip; Stohr, Thomas; Meerschaert, Kris; Ottevaere, Ingrid; Stortelers, Catelijne; Vanlandschoot, Peter] Ablynx NV, Ghent, Belgium	Ghent University	Van Gucht, S (corresponding author), Sci Inst Publ Hlth WIV ISP, Natl Reference Ctr Rabies, Brussels, Belgium.	Steven.VanGucht@wiv-isp.be			Research Foundation Flanders (FWO Vlaanderen) [G.0657.08]; Interuniversity Attraction Poles Programme - Belgian Science Policy Office (BELSPO) [IUAP P7/32]; WIV-ISP; Belgian Ministry of Social Affairs through Health Insurance System	Research Foundation Flanders (FWO Vlaanderen)(FWO); Interuniversity Attraction Poles Programme - Belgian Science Policy Office (BELSPO); WIV-ISP; Belgian Ministry of Social Affairs through Health Insurance System	This work was supported by funds from the Research Foundation Flanders (FWO Vlaanderen, www.fwo.be), grant number G.0657.08, and the Interuniversity Attraction Poles Programme initiated by the Belgian Science Policy Office (BELSPO, www.belspo.be), grant number IUAP P7/32. Sanne Terryn received a fellowship from the WIV-ISP. The National Reference Centre of Rabies is partially supported by the Belgian Ministry of Social Affairs through a fund from the Health Insurance System (https://nrchm.wiv-isp.be/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASTIC L, 1993, BRAIN RES, V619, P146, DOI 10.1016/0006-8993(93)91606-S; Boruah BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071383; Both L, 2012, LANCET INFECT DIS, V12, P397, DOI 10.1016/S1473-3099(11)70340-1; Brown RP, 1997, TOXICOL IND HEALTH, V13, P407, DOI 10.1177/074823379701300401; Chennareddy Chakravarthy, 2005, THESIS; Demeule M, 2008, J PHARMACOL EXP THER, V324, P1064, DOI 10.1124/jpet.107.131318; DIETZSCHOLD B, 1992, P NATL ACAD SCI USA, V89, P7252, DOI 10.1073/pnas.89.15.7252; Dietzschold B, 2008, FUTURE VIROL, V3, P481, DOI 10.2217/17460794.3.5.481; Gage GJ, 2012, WHOLE ANIMAL PERFUSI, pe3564; Hanlon CA, 2001, VACCINE, V19, P2273, DOI 10.1016/S0264-410X(00)00516-8; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Harmsen MM, 2009, VACCINE, V27, P1904, DOI 10.1016/j.vaccine.2009.01.110; Harmsen MM, 2005, VACCINE, V23, P4926, DOI 10.1016/j.vaccine.2005.05.017; Hemachudha T, 2002, LANCET NEUROL, V1, P101, DOI 10.1016/S1474-4422(02)00041-8; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hultberg A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017665; Ibanez LI, 2011, J INFECT DIS, V203, P1063, DOI 10.1093/infdis/jiq168; Jahnichen S, 2010, P NATL ACAD SCI USA, V107, P20565, DOI 10.1073/pnas.1012865107; LAFAY F, 1991, VIROLOGY, V183, P320, DOI 10.1016/0042-6822(91)90145-2; Lang J, 1998, ACTA TROP, V70, P317, DOI 10.1016/S0001-706X(98)00038-2; Law M, 2008, CURR OPIN IMMUNOL, V20, P486, DOI 10.1016/j.coi.2008.06.005; Lewis P, 2000, MUSCLE NERVE, V23, P720, DOI 10.1002/(SICI)1097-4598(200005)23:5<720::AID-MUS9>3.0.CO;2-5; Li TF, 2012, FASEB J, V26, P3969, DOI 10.1096/fj.11-201384; Lu JH, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-43; Pepinsky RB, 2011, J PHARMACOL EXP THER, V339, P519, DOI 10.1124/jpet.111.183483; Prosniak M, 2003, J INFECT DIS, V188, P53, DOI 10.1086/375247; Roovers RC, 2011, INT J CANCER, V129, P2013, DOI 10.1002/ijc.26145; Rosseels V, 2011, J VIROL METHODS, V173, P127, DOI 10.1016/j.jviromet.2011.01.019; Rossenu R, 2012, CLIN PHARM DRUG DEV, V1; Saerens D, 2008, CURR OPIN PHARMACOL, V8, P600, DOI 10.1016/j.coph.2008.07.006; Schepens B, 2011, J INFECT DIS, V204, P1692, DOI 10.1093/infdis/jir622; SCHUMACHER CL, 1989, J CLIN INVEST, V84, P971, DOI 10.1172/JCI114260; Shah DK, 2013, BIOANALYSIS, V5, P989, DOI [10.4155/bio.13.78, 10.4155/BIO.13.78]; Suin V, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/256175; Tuffereau C, 2007, J VIROL, V81, P13622, DOI 10.1128/JVI.02368-06; Vega CG, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003334; Wesolowski J, 2009, MED MICROBIOL IMMUN, V198, P157, DOI 10.1007/s00430-009-0116-7; WHO, 2007, 4950 WHO, V49, P425	38	25	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e109367	10.1371/journal.pone.0109367	http://dx.doi.org/10.1371/journal.pone.0109367			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347556	Green Published, gold, Green Submitted			2022-12-27	WOS:000347994900009
J	van Kampen, E; Beaslas, O; Hildebrand, RB; Lammers, B; Van Berkel, TJC; Olkkonen, VM; Van Eck, M				van Kampen, Erik; Beaslas, Olivier; Hildebrand, Reeni B.; Lammers, Bart; Van Berkel, Theo J. C.; Olkkonen, Vesa M.; Van Eck, Miranda			Orp8 Deficiency in Bone Marrow-Derived Cells Reduces Atherosclerotic Lesion Progression in LDL Receptor Knockout Mice	PLOS ONE			English	Article							CHOLESTEROL EFFLUX; EXPRESSION; MACROPHAGES; ABCA1; INFLAMMATION; LIPOPROTEINS; METABOLISM; ACTIVATION; PHENOTYPE; RISK	Introduction: Oxysterol binding protein Related Proteins (ORPs) mediate intracellular lipid transport and homeostatic regulation. ORP8 downregulates ABCA1 expression in macrophages and cellular cholesterol efflux to apolipoprotein A-I. In line, ORP8 knockout mice display increased amounts of HDL cholesterol in blood. However, the role of macrophage ORP8 in atherosclerotic lesion development is unknown. Methods and Results: LDL receptor knockout (KO) mice were transplanted with bone marrow (BM) from ORP8 KO mice and C57Bl/6 wild type mice. Subsequently, the animals were challenged with a high fat/high cholesterol Western-type diet to induce atherosclerosis. After 9 weeks of Western-Type diet feeding, serum levels of VLDL cholesterol were increased by 50% in ORP8 KO BM recipients compared to the wild-type recipients. However, no differences were observed in HDL cholesterol. Despite the increase in VLDL cholesterol, lesions in mice transplanted with ORP8 KO bone marrow were 20% smaller compared to WT transplanted controls. In addition, ORP8 KO transplanted mice displayed a modest increase in the percentage of macrophages in the lesion as compared to the wild-type transplanted group. ORP8 deficient macrophages displayed decreased production of pro-inflammatory factors IL-6 and TNF alpha, decreased expression of differentiation markers and showed a reduced capacity to form foam cells in the peritoneal cavity. Conclusions: Deletion of ORP8 in bone marrow-derived cells, including macrophages, reduces lesion progression after 9 weeks of WTD challenge, despite increased amounts of circulating pro-atherogenic VLDL. Reduced macrophage foam cell formation and lower macrophage inflammatory potential are plausible mechanisms contributing to the observed reduction in atherosclerosis.	[van Kampen, Erik; Hildebrand, Reeni B.; Lammers, Bart; Van Berkel, Theo J. C.; Van Eck, Miranda] Leiden Acad Ctr Drug Res, Div Biopharmaceut, Cluster BioTherapeut, Leiden, Netherlands; [Beaslas, Olivier; Olkkonen, Vesa M.] Minerva Fdn, Dept Lipid Signalling & Homeostasis, Helsinki, Finland		van Kampen, E (corresponding author), Leiden Acad Ctr Drug Res, Div Biopharmaceut, Cluster BioTherapeut, Leiden, Netherlands.	e.van.kampen.3@lacdr.leidenuniv.nl	Van Berkel, Theo/ABD-7677-2021	van Eck, Miranda/0000-0003-3936-3194; Olkkonen, Vesa/0000-0001-5553-7997	Netherlands Heart Foundation [2009B075, 2007T056]; Netherlands Organization for Scientific Research [91813603]; Sigrid Juselius Foundation; Finnish Foundation for Cardiovascular Research; Magnus Ehrnrooth Foundation; Academy of Finland [121457]; Novo Nordisk Fonden [NNF11OC1014724] Funding Source: researchfish	Netherlands Heart Foundation(Netherlands Heart Foundation); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Foundation for Cardiovascular Research; Magnus Ehrnrooth Foundation; Academy of Finland(Academy of Finland); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by The Netherlands Heart Foundation (Grant 2009B075 (EvK)), www.hartstichting.nl; The Netherlands Organization for Scientific Research (VICI Grant 91813603 (MVE)), www.nwo.nl/; the Sigrid Juselius Foundation, the Finnish Foundation for Cardiovascular Research, the Magnus Ehrnrooth Foundation, and the Academy of Finland (grant 121457 to VMO), www.sigridjuselius.fi/foundation, www.sydantutkimussaatio.fi, pro.tsv.fi/magnusehrnrooth, www.aka.fi. MVE is an Established Investigator of the Netherlands Heart Foundation (Grant 2007T056), www.hartstichting.nl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaslas O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058856; Beaslas O, 2012, EXP CELL RES, V318, P1933, DOI 10.1016/j.yexcr.2012.05.026; Cho KY, 2013, J STROKE CEREBROVASC, V22, P910, DOI 10.1016/j.jstrokecerebrovasdis.2012.11.020; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Dion S, 2011, INT J PARASITOL, V41, P685, DOI 10.1016/j.ijpara.2011.01.008; Du XM, 2011, J CELL BIOL, V192, P121, DOI 10.1083/jcb.201004142; Feig JE, 2011, P NATL ACAD SCI USA, V108, P7166, DOI 10.1073/pnas.1016086108; Haghpassand M, 2001, J CLIN INVEST, V108, P1315, DOI 10.1172/JCI200112810; Im SS, 2011, CIRC RES, V108, P996, DOI 10.1161/CIRCRESAHA.110.226878; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Lehto M, 2008, J CELL SCI, V121, P695, DOI 10.1242/jcs.016964; Lemaire-Ewing S, 2005, CELL BIOL TOXICOL, V21, P97, DOI 10.1007/s10565-005-0141-2; Ma L, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-55; MAHLEY RW, 1985, ANN NY ACAD SCI, V454, P209, DOI 10.1111/j.1749-6632.1985.tb11860.x; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Nair MG, 2003, IMMUNOL LETT, V85, P173, DOI 10.1016/S0165-2478(02)00225-0; Naugler WE, 2008, TRENDS MOL MED, V14, P109, DOI 10.1016/j.molmed.2007.12.007; Oh J, 2012, J BIOL CHEM, V287, P11629, DOI 10.1074/jbc.M111.338673; Olkkonen VM, 2006, BIOCHEM SOC T, V34, P389, DOI 10.1042/BST0340389; Patel PJ, 2013, EUROPEAN J HEART FAI; REDGRAVE TG, 1975, ANAL BIOCHEM, V65, P42, DOI 10.1016/0003-2697(75)90488-1; Ridker PM, 2000, CIRCULATION, V101, P2149, DOI 10.1161/01.CIR.101.18.2149; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Shibata N, 2010, CIRC J, V74, P2045, DOI 10.1253/circj.CJ-10-0860; Stoger JL, 2012, ATHEROSCLEROSIS, V225, P461, DOI 10.1016/j.atherosclerosis.2012.09.013; Tall AR, 2003, ARTERIOSCL THROM VAS, V23, P710, DOI 10.1161/01.ATV.0000068683.51375.59; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Van Eck M, 2004, AM J PATHOL, V165, P785, DOI 10.1016/S0002-9440(10)63341-X; Vihervaara T, 2011, CELL MOL LIFE SCI, V68, P537, DOI 10.1007/s00018-010-0470-z; von der Thusen JH, 2001, CIRCULATION, V103, P1164, DOI 10.1161/01.CIR.103.8.1164; Wellington CL, 2002, LAB INVEST, V82, P273, DOI 10.1038/labinvest.3780421; Yan D, 2008, J BIOL CHEM, V283, P332, DOI 10.1074/jbc.M705313200; Yan D, 2007, ARTERIOSCL THROM VAS, V27, P1618, DOI 10.1161/ATVBAHA.107.144121; Zhou TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021078	35	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e109024	10.1371/journal.pone.0109024	http://dx.doi.org/10.1371/journal.pone.0109024			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347070	Green Published, gold, Green Submitted			2022-12-27	WOS:000347994900005
J	Chao, LL; Liu, LL; Ho, TY; Shih, CM				Chao, Li-Lian; Liu, Li-Ling; Ho, Tsung-Yu; Shih, Chien-Ming			First Detection and Molecular Identification of Borrelia garinii Spirochete from Ixodes ovatus Tick Ectoparasitized on Stray Cat in Taiwan	PLOS ONE			English	Article							BURGDORFERI-SENSU-LATO; FRAGMENT-LENGTH-POLYMORPHISM; MULTILOCUS SEQUENCE-ANALYSIS; LYME-DISEASE SPIROCHETE; GENOSPECIES IDENTIFICATION; GENOMIC GROUPS; KINMEN ISLAND; SP NOV.; RODENTS; ACARI	Borrelia garinii spirochete was detected for the first time in Ixodes ovatus tick ectoparasitized on stray cat in Taiwan. The genetic identity of this detected spirochete was determined by analyzing the gene sequence amplified by genospecies-specific polymerase chain reaction assays based on the 5S-23S intergenic spacer amplicon (rrf-rrl) and outer surface protein A (ospA) genes of B. burgdorferi sensu lato. Phylogenetic relationships were analyzed by comparing the sequences of rrf-rrl and ospA genes obtained from 27 strains of Borrelia spirochetes representing six genospecies of Borrelia. Seven major clades can be easily distinguished by neighbour-joining analysis and were congruent by maximum-parsimony method. Phylogenetic analysis based on rrf-rrl gene revealed that this detected spirochete (strain IO-TP-TW) was genetically affiliated to the same clade with a high homogeneous sequences (96.7 to 98.1% similarity) within the genospecies of B. garinii and can be discriminated from other genospecies of Borrelia spirochetes. Interspecies analysis based on the genetic distance values indicates a lower level (<0.022) of genetic divergence (GD) within the genospecies of B. garinii, and strain IO-TP-TW was genetically more distant (>0.113) to the strains identified in I. ovatus collected from Japan and China. Intraspecies analysis also reveals a higher homogeneity (GD<0.005) between tick (strain IO-TP-TW) and human (strain Bg-PP-TW1) isolates of B. garinii in Taiwan. This study provides the first evidence of B. garinii isolated and identified in an I. ovatus tick in Asia, and the higher homogeneity of B. garinii between tick and human strain may imply the risk of human infection by I. ovatus bite.	[Chao, Li-Lian; Liu, Li-Ling; Ho, Tsung-Yu; Shih, Chien-Ming] Natl Def Med Ctr, Grad Inst Pathol & Parasitol, Dept Parasitol & Trop Med, Taipei, Taiwan; [Shih, Chien-Ming] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Shih, Chien-Ming] Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Kaohsiung, Taiwan	National Defense Medical Center; Kaohsiung Medical University; Kaohsiung Medical University	Shih, CM (corresponding author), Natl Def Med Ctr, Grad Inst Pathol & Parasitol, Dept Parasitol & Trop Med, Taipei, Taiwan.	cmshih@kmu.edu.tw		Shih, Chien-Ming/0000-0003-4399-3295	National Science Council, Taipei [NSC99-2314-B-760-001-MY2]; Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan, Republic of China [KMU-TP103E17]	National Science Council, Taipei(Ministry of Science and Technology, Taiwan); Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan, Republic of China	This work was supported by grants from the National Science Council, Taipei (NSC99-2314-B-760-001-MY2) and Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung (KMU-TP103E17), Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AI CX, 1988, ANN NY ACAD SCI, V539, P302; BARANTON G, 1992, INT J SYST BACTERIOL, V42, P378, DOI 10.1099/00207713-42-3-378; BERGSTROM S, 1989, MOL MICROBIOL, V3, P479, DOI 10.1111/j.1365-2958.1989.tb00194.x; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; CAPORALE DA, 1994, MOL BIOL EVOL, V11, P51; Chao LL, 2013, INT J INFECT DIS, V17, pE1141, DOI 10.1016/j.ijid.2013.08.004; Chao LL, 2013, TICKS TICK-BORNE DIS, V4, P246, DOI 10.1016/j.ttbdis.2012.11.002; Chao LL, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-167; Chao LL, 2011, INT J INFECT DIS, V15, pE182, DOI 10.1016/j.ijid.2010.11.002; Chao LL, 2009, EXP APPL ACAROL, V48, P329, DOI 10.1007/s10493-009-9244-4; Chao LL, 2009, AM J TROP MED HYG, V80, P389, DOI 10.4269/ajtmh.2009.80.389; Chao LL, 2002, AM J TROP MED HYG, V67, P504, DOI 10.4269/ajtmh.2002.67.504; Chen HC, 2004, J RHEUMATOL, V31, P811; Chen Z, 2010, EXP APPL ACAROL, V51, P393, DOI 10.1007/s10493-010-9335-2; Chu C, 2008, J MED MICROBIOL, V57, P980, DOI 10.1099/jmm.0.47663-0; Chu CY, 2008, J CLIN MICROBIOL, V46, P3130, DOI 10.1128/JCM.01195-08; Clark K, 2005, APPL ENVIRON MICROB, V71, P2616, DOI 10.1128/AEM.71.5.2616-2625.2005; DEMAERSCHALCK I, 1995, J CLIN MICROBIOL, V33, P602, DOI 10.1128/JCM.33.3.602-608.1995; Estrada-Pena A, 1999, EXP APPL ACAROL, V23, P685, DOI 10.1023/A:1006241108739; Felsenstein J, 1985, EVOLUTION, V52, P1119; FUKUNAGA M, 1992, BIOCHEM BIOPH RES CO, V183, P952, DOI 10.1016/S0006-291X(05)80282-7; Fukunaga M, 1996, INT J SYST BACTERIOL, V46, P898, DOI 10.1099/00207713-46-4-898; Hao Q, 2011, J CLIN MICROBIOL, V49, P647, DOI 10.1128/JCM.00725-10; JOBE DA, 1993, J CLIN MICROBIOL, V31, P1896, DOI 10.1128/JCM.31.7.1896-1898.1993; JONSSON M, 1992, INFECT IMMUN, V60, P1845, DOI 10.1128/IAI.60.5.1845-1853.1992; KAWABATA H, 1993, MICROBIOL IMMUNOL, V37, P843, DOI 10.1111/j.1348-0421.1993.tb01714.x; KAWABATA M, 1987, J INFECT DIS, V156, P854, DOI 10.1093/infdis/156.5.854; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kurtenbach K, 2002, TRENDS MICROBIOL, V10, P74, DOI 10.1016/S0966-842X(01)02298-3; MARCONI RT, 1992, J CLIN MICROBIOL, V30, P628, DOI 10.1128/JCM.30.3.628-632.1992; Margos G, 2011, INFECT GENET EVOL, V11, P1545, DOI 10.1016/j.meegid.2011.07.022; Masuzawa T, 2001, INT J SYST EVOL MICR, V51, P1817, DOI 10.1099/00207713-51-5-1817; Mathiesen DA, 1997, J INFECT DIS, V175, P98, DOI 10.1093/infdis/175.1.98; MATUSCHKA FR, 1990, J MED ENTOMOL, V27, P385, DOI 10.1093/jmedent/27.3.385; MAUPIN GO, 1994, J INFECT DIS, V170, P636, DOI 10.1093/infdis/170.3.636; Miyamoto K., 1991, Japanese Journal of Sanitary Zoology, V42, P267; MIYAMOTO K, 1992, J MED ENTOMOL, V29, P216, DOI 10.1093/jmedent/29.2.216; NAKAO M, 1994, J MED ENTOMOL, V31, P467, DOI 10.1093/jmedent/31.3.467; NAKAO M, 1992, AM J TROP MED HYG, V47, P505, DOI 10.4269/ajtmh.1992.47.505; PARK KH, 1993, J CLIN MICROBIOL, V31, P1831, DOI 10.1128/JCM.31.7.1831-1837.1993; POSTIC D, 1993, RES MICROBIOL, V144, P467, DOI 10.1016/0923-2508(93)90054-6; Postic D, 1998, J CLIN MICROBIOL, V36, P3497, DOI 10.1128/JCM.36.12.3497-3504.1998; POSTIC D, 1994, INT J SYST BACTERIOL, V44, P743, DOI 10.1099/00207713-44-4-743; Postic D, 2007, INT J MED MICROBIOL, V297, P263, DOI 10.1016/j.ijmm.2007.01.006; Richter D, 2006, INT J SYST EVOL MICR, V56, P873, DOI 10.1099/ijs.0.64050-0; RIJPKEMA SGT, 1995, J CLIN MICROBIOL, V33, P3091, DOI 10.1128/JCM.33.12.3091-3095.1995; Robbins RG, 2005, P ENTOMOL SOC WASH, V107, P245; SCHWARTZ JJ, 1992, J BACTERIOL, V174, P3757, DOI 10.1128/JB.174.11.3757-3765.1992; Shih CM, 2002, AM J TROP MED HYG, V66, P611, DOI 10.4269/ajtmh.2002.66.611; Shih CM, 1998, J CLIN MICROBIOL, V36, P3127, DOI 10.1128/JCM.36.11.3127-3132.1998; Shih CM, 1998, J CLIN MICROBIOL, V36, P807, DOI 10.1128/JCM.36.3.807-808.1998; Shih CM, 1998, AM J TROP MED HYG, V59, P687, DOI 10.4269/ajtmh.1998.59.687; Spielman A., 1988, MBL (Marine Biology Laboratory) Lectures in Biology, V9, P147; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang GQ, 1999, CLIN MICROBIOL REV, V12, P633, DOI 10.1128/CMR.12.4.633; WILSON N, 1970, Oriental Insects, V4, P37; Zhang Z F, 1997, Zhonghua Liu Xing Bing Xue Za Zhi, V18, P8; ZUMSTEIN G, 1992, MED MICROBIOL IMMUN, V181, P57, DOI 10.1007/BF00189424	59	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110599	10.1371/journal.pone.0110599	http://dx.doi.org/10.1371/journal.pone.0110599			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343260	gold, Green Submitted, Green Published			2022-12-27	WOS:000343943500038
J	Chen, Y; Xin, XX; Zhang, HY; Xu, JF; Gao, Y; Tan, AH; Yang, XB; Qin, X; Hu, YL; Mo, ZN				Chen, Yang; Xin, Xianxiang; Zhang, Haiying; Xu, Jianfeng; Gao, Yong; Tan, Aihua; Yang, Xiaobo; Qin, Xue; Hu, Yanling; Mo, Zengnan			Immunization Associated with Erectile Dysfunction Based on Cross-Sectional and Genetic Analyses	PLOS ONE			English	Article							C-REACTIVE PROTEIN; METABOLIC SYNDROME; RISK-FACTORS; MEN; INFLAMMATION; RECEPTOR; HEALTH; CELLS; CD40; EPIDEMIOLOGY	Erectile dysfunction (ED) is a global disease affecting a large number of people. Some studies have found a relationship between low-grade inflammation and ED. We hypothesized that the immune system might play a key role in the outcome of ED. Five immune agents (C3, C4, IgA, IgM, and IgG) were collected based on the Fangchenggang Area Male Health and Examination Survey (FAMHES), using methods of a traditional cross-sectional analysis. Our results repeated the significant association between ED and metabolic syndrome, obesity, and so forth. However, there seemed to be no positive relation between the tested indexes and ED risk in the baseline analysis (C3: P = 0.737; C4: P = 0.274; IgA: P = 0.943; IgG: P = 0.069; IgM: P = 0.985). Then, after adjusting for age and multivariate covariates, a potentially significant association between ED and IgG was discovered (P = 0.025 and P = 0.034, respectively). Meanwhile, in order to describe the development of ED on a gene level, SNP-set kernel-machine association test (SKAT) was applied with the known humoral immune genes involved. The outcomes suggested that PTAFR (binary P value: 0.0096; continuous P value: 0.00869), IL27 (0.0029; 0.1954), CD37 (0.0248; 0.5196), CD40 (0.7146; 0.0413), IL7R (0.1223; 0.0222), PSMB9 (0.1237; 0.0212), and CXCR3 (0.0849; 0.0478) might be key genes in ED, especially IL27, when we restricted the family-wise error rate (FWER) to 0.5. Our study shows that IgG and seven genes (PTAFR, CD37, CD40, IL7R, PSMB9, CXCR3, and especially IL27) might be key factors in the pathogenesis of ED, which could pave the way for future gene and immune therapies.	[Chen, Yang; Zhang, Haiying; Gao, Yong; Tan, Aihua; Yang, Xiaobo; Qin, Xue; Hu, Yanling; Mo, Zengnan] Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning, Guangxi Zhuang, Peoples R China; [Chen, Yang; Gao, Yong; Mo, Zengnan] Guangxi Med Univ, Affiliated Hosp 1, Inst Urol & Nephrol, Nanning, Guangxi Zhuang, Peoples R China; [Zhang, Haiying; Yang, Xiaobo] Guangxi Med Univ, Sch Publ Hlth, Dept Occupat Hlth & Environm Hlth, Nanning, Guangxi Zhuang, Peoples R China; [Qin, Xue] Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi Zhuang, Peoples R China; [Xin, Xianxiang; Hu, Yanling] Guangxi Med Univ, Med Sci Res Ctr, Nanning, Guangxi Zhuang, Peoples R China; [Xu, Jianfeng] Fudan Univ, Huashan Hosp, Fudan Inst Urol, Shanghai 200433, Peoples R China; [Xu, Jianfeng] Fudan Univ, Sch Life Sci, Fudan Ctr Genet Epidemiol, Shanghai 200433, Peoples R China; [Xu, Jianfeng] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Xu, Jianfeng] Wake Forest Univ, Bowman Gray Sch Med, Ctr Canc Gen, Winston Salem, NC USA	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Fudan University; Fudan University; Fudan University; Wake Forest University; Wake Forest Baptist Medical Center	Hu, YL (corresponding author), Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning, Guangxi Zhuang, Peoples R China.	yangchen91316@yeah.net; zengnanmo@hotmail.com	Yang, Xiaobo/G-3854-2016	mo, zengnan/0000-0002-3047-3138	National Natural Science Foundation of China [81472414, 81272853, 81370857, 81260130, 81060234, 30945204]; University Talents Highland Innovation Team of Guangxi [2012012D003, GJR201147-09]; Key Program [2012012D003, GJR201147-09]; Chairman Science and Technology Fund [1116-03, GKG1298003-07-01]; Tackle Program of Guangxi [1116-03, GKG1298003-07-01]; Guangxi Natural Science Foundation [2012GXNSFDA053016, 2012GXNSFAA053152]; Guangxi Graduate Education Innovation Program [2010105981002M175, 2011105981002M202]; Guangxi Medical University Future Scholar Training Program [02304001012]; Guangxi Provincial Department of Finance and Education [2009GJCJ150]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University Talents Highland Innovation Team of Guangxi; Key Program; Chairman Science and Technology Fund; Tackle Program of Guangxi; Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); Guangxi Graduate Education Innovation Program; Guangxi Medical University Future Scholar Training Program; Guangxi Provincial Department of Finance and Education	This study was supported by grants from the National Natural Science Foundation of China (81472414, 81272853, 81370857, 81260130, 81060234, 30945204), Key Program and University Talents Highland Innovation Team of Guangxi (2012012D003, GJR201147-09), Chairman Science and Technology Fund and Tackle Program of Guangxi (1116-03, GKG1298003-07-01), Guangxi Natural Science Foundation (2012GXNSFDA053016), Guangxi Graduate Education Innovation Program (2010105981002M175 and 2011105981002M202), Guangxi Natural Science Foundation (2012GXNSFAA053152), Guangxi Medical University Future Scholar Training Program (02304001012) and Guangxi Provincial Department of Finance and Education (2009GJCJ150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; [Anonymous], 1993, Int J Impot Res, V5, P181; Rosainz MDA, 2011, J SEX MED, V8, P2017, DOI 10.1111/j.1743-6109.2011.02277.x; Aytac IA, 1999, BJU INT, V84, P50; Bacon CG, 2003, ANN INTERN MED, V139, P161, DOI 10.7326/0003-4819-139-3-200308050-00005; Blans MCA, 2006, EUR J CLIN INVEST, V36, P497, DOI 10.1111/j.1365-2362.2006.01653.x; Bosmann M, 2013, J LEUKOCYTE BIOL, V94, P1159, DOI 10.1189/jlb.0213107; Braun M, 2000, INT J IMPOT RES, V12, P305, DOI 10.1038/sj.ijir.3900622; Cander S, 2014, METAB SYNDR RELAT D, V12, P324, DOI 10.1089/met.2013.0150; Chen Chunming, 2004, Biomed Environ Sci, V17 Suppl, P1; Chen Y, 2012, IMMUNOGENETICS, V64, P747, DOI 10.1007/s00251-012-0636-y; Dunsmuir WD, 1996, DIABETIC MED, V13, P700, DOI 10.1002/(SICI)1096-9136(199608)13:8<700::AID-DIA174>3.0.CO;2-8; Ettala OO, 2014, J SEX MED; Feeley RJ, 2009, THESCIENTIFICWORLDJO, V9, P676, DOI 10.1100/tsw.2009.79; Frigerio S, 2002, NAT MED, V8, P1414, DOI 10.1038/nm792; Glina S, 2013, J SEX MED, V10, P115, DOI 10.1111/j.1743-6109.2012.02816.x; Guo CA, 2013, AM J PHYSIOL-ENDOC M, V304, pE951, DOI 10.1152/ajpendo.00514.2012; Hancock WW, 2000, J EXP MED, V192, P1515, DOI 10.1084/jem.192.10.1515; Hatzimouratidis K, 2010, EUR UROL, V57, P804, DOI 10.1016/j.eururo.2010.02.020; Honda Z, 2002, J BIOCHEM, V131, P773, DOI 10.1093/oxfordjournals.jbchem.a003164; Huber AK, 2012, J IMMUNOL, V189, P3043, DOI 10.4049/jimmunol.1200311; Koga MM, 2013, PROSTAG LEUKOTR ESS, V89, P319, DOI 10.1016/j.plefa.2013.09.003; Kumar J, 2013, J SEX MED, V10, P1372, DOI 10.1111/jsm.12041; Kupelian V, 2010, PREV MED, V50, P19, DOI 10.1016/j.ypmed.2009.11.006; Larousserie F, 2006, J IMMUNOL, V176, P5890, DOI 10.4049/jimmunol.176.10.5890; Lewis RW, 2010, J SEX MED, V7, P1598, DOI 10.1111/j.1743-6109.2010.01778.x; Liao MZ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034085, 10.1371/journal.pone.0039234]; Lu Z, 2012, PROSTATE, V72, P193, DOI 10.1002/pros.21421; LUGG JA, 1995, J ANDROL, V16, P2; Mach F, 1999, J CLIN INVEST, V104, P1041, DOI 10.1172/JCI6993; Nehra A, 2013, J UROLOGY, V189, P2031, DOI 10.1016/j.juro.2012.12.107; Nicolosi A, 2005, BJU INT, V95, P609, DOI 10.1111/j.1464-410X.2005.05348.x; Nicolosi A, 2003, UROLOGY, V61, P201, DOI 10.1016/S0090-4295(02)02102-7; Ortutay C, 2006, CELL IMMUNOL, V244, P87, DOI 10.1016/j.cellimm.2007.01.012; Pasceri V, 2000, CIRCULATION, V102, P2165; Pickens SR, 2011, ARTHRITIS RHEUM-US, V63, P2884, DOI 10.1002/art.30493; Pinnock CB, 1999, MED J AUSTRALIA, V171, P353, DOI 10.5694/j.1326-5377.1999.tb123691.x; Predescu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075846; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Rendell MS, 1999, JAMA-J AM MED ASSOC, V281, P421, DOI 10.1001/jama.281.5.421; Rosen RC, 1999, INT J IMPOT RES, V11, P319, DOI 10.1038/sj.ijir.3900472; Shah J, 2002, BJU INT, V90, P433, DOI 10.1046/j.1464-410X.2002.02911.x; Shi M-D, 2014, Int J Impot Res, V26, P235, DOI 10.1038/ijir.2014.26; Shiels MS, 2009, CANCER CAUSE CONTROL, V20, P877, DOI 10.1007/s10552-009-9318-y; Stephen J, 2013, J IMMUNOL, V191, P5677, DOI 10.4049/jimmunol.1301250; Tan AH, 2012, HUM MOL GENET, V21, P1658, DOI 10.1093/hmg/ddr587; Thorve VS, 2011, J DIABETES COMPLICAT, V25, P129, DOI 10.1016/j.jdiacomp.2010.03.003; van Spriel AB, 2004, J IMMUNOL, V172, P2953, DOI 10.4049/jimmunol.172.5.2953; Villarino AV, 2004, J IMMUNOL, V173, P715, DOI 10.4049/jimmunol.173.2.715; Weinberg AE, 2013, J SEX MED, V10, P3102, DOI 10.1111/jsm.12318; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290; Yin GN, 2013, J SEX MED, V10, P1488, DOI 10.1111/jsm.12129; Yu Liang, 2013, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V30, P222, DOI 10.3760/cma.j.issn.1003-9406.2013.04.023; Zhang XY, 2013, J IMMUNOL, V190, P6015, DOI 10.4049/jimmunol.1203366; Zwaka TP, 2001, CIRCULATION, V103, P1194	57	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111269	10.1371/journal.pone.0111269	http://dx.doi.org/10.1371/journal.pone.0111269			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343742	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943500091
J	Grasis, JA; Lachnit, T; Anton-Erxleben, F; Lim, YW; Schmieder, R; Fraune, S; Franzenburg, S; Insua, S; Machado, G; Haynes, M; Little, M; Kimble, R; Rosenstiel, P; Rohwer, FL; Bosch, TCG				Grasis, Juris A.; Lachnit, Tim; Anton-Erxleben, Friederike; Lim, Yan Wei; Schmieder, Robert; Fraune, Sebastian; Franzenburg, Soeren; Insua, Santiago; Machado, GloriaMay; Haynes, Matthew; Little, Mark; Kimble, Robert; Rosenstiel, Philip; Rohwer, Forest L.; Bosch, Thomas C. G.			Species-Specific Viromes in the Ancestral Holobiont Hydra	PLOS ONE			English	Article							COMPARATIVE METAGENOMICS; VIRAL METAGENOMES; INNATE IMMUNITY; METAZOAN HYDRA; HUMAN GUT; VIRUSES; EVOLUTION; MICROBIOTA; COMMUNITIES; MAINTENANCE	Recent evidence showing host specificity of colonizing bacteria supports the view that multicellular organisms are holobionts comprised of the macroscopic host in synergistic interdependence with a heterogeneous and host-specific microbial community. Whereas host-bacteria interactions have been extensively investigated, comparatively little is known about host-virus interactions and viral contribution to the holobiont. We sought to determine the viral communities associating with different Hydra species, whether these viral communities were altered with environmental stress, and whether these viruses affect the Hydra-associated holobiont. Here we show that each species of Hydra harbors a diverse host-associated virome. Primary viral families associated with Hydra are Myoviridae, Siphoviridae, Inoviridae, and Herpesviridae. Most Hydra-associated viruses are bacteriophages, a reflection of their involvement in the holobiont. Changes in environmental conditions alter the associated virome, increase viral diversity, and affect the metabolism of the holobiont. The specificity and dynamics of the virome point to potential viral involvement in regulating microbial associations in the Hydra holobiont. While viruses are generally regarded as pathogenic agents, our study suggests an evolutionary conserved ability of viruses to function as holobiont regulators and, therefore, constitutes an emerging paradigm shift in host-microbe interactions.	[Grasis, Juris A.; Lim, Yan Wei; Schmieder, Robert; Haynes, Matthew; Little, Mark; Kimble, Robert; Rohwer, Forest L.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Grasis, Juris A.; Lachnit, Tim; Anton-Erxleben, Friederike; Fraune, Sebastian; Franzenburg, Soeren; Insua, Santiago; Bosch, Thomas C. G.] Univ Kiel, Inst Zool, D-24098 Kiel, Germany; [Machado, GloriaMay; Rosenstiel, Philip] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany	California State University System; San Diego State University; University of Kiel; University of Kiel	Grasis, JA (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	jagrasis@gmail.com	Lachnit, Tim/H-9537-2017; Bosch, Thomas C. G./D-5218-2011; Rosenstiel, Philip/A-5137-2009; Rohwer, Forest/AAC-5315-2019; Grasis, Juris A./K-2568-2012; Fraune, Sebastian/B-7970-2010	Rosenstiel, Philip/0000-0002-9692-8828; Grasis, Juris A./0000-0002-3945-0135; Fraune, Sebastian/0000-0002-6940-9571; Insua, Santiago/0000-0002-9247-243X; Little, Mark/0000-0002-6783-8452; Rohwer, Forest/0000-0003-1548-5429; Lachnit, Tim/0000-0002-2880-5930	National Institutes of Health (NIH) [1R21AI094534, 1F32AI098518]; Deutsche Forschungsgemeinschaft (DFG) [BO 848/17-1]; DFG Excellence Initiative [BO 848/17-1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI098418, R21AI094534] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG Excellence Initiative(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants 1R21AI094534 and 1F32AI098518 from the National Institutes of Health (NIH), by grant BO 848/17-1 from the Deutsche Forschungsgemeinschaft (DFG), and the DFG Excellence Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann HW, 2007, ARCH VIROL, V152, P227, DOI 10.1007/s00705-006-0849-1; Angly F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-41; Angly FE, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000593; Bevins CL, 2011, CELL MOL LIFE SCI, V68, P3675, DOI 10.1007/s00018-011-0830-3; Bosch TCG, 2013, ANNU REV MICROBIOL, V67, P499, DOI 10.1146/annurev-micro-092412-155626; Brucker RM, 2013, SCIENCE, V341, P667, DOI 10.1126/science.1240659; Brucker RM, 2012, TRENDS ECOL EVOL, V27, P443, DOI 10.1016/j.tree.2012.03.011; Dale C, 2006, CELL, V126, P453, DOI 10.1016/j.cell.2006.07.014; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Dutilh BE, 2012, BIOINFORMATICS, V28, P3225, DOI 10.1093/bioinformatics/bts613; Felix MA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000586; Feschotte C, 2012, NAT REV GENET, V13, P283, DOI 10.1038/nrg3199; Foret S, 2010, TRENDS GENET, V26, P154, DOI 10.1016/j.tig.2010.01.003; Franzenburg S, 2013, P NATL ACAD SCI USA, V110, pE3730, DOI 10.1073/pnas.1304960110; Franzenburg S, 2013, ISME J, V7, P781, DOI 10.1038/ismej.2012.156; Franzenburg S, 2012, P NATL ACAD SCI USA, V109, P19374, DOI 10.1073/pnas.1213110109; Fraune S, 2009, MICROBE, V4, P457; Fraune S, 2007, P NATL ACAD SCI USA, V104, P13146, DOI 10.1073/pnas.0703375104; Fraune S, 2009, ENVIRON MICROBIOL, V11, P2361, DOI 10.1111/j.1462-2920.2009.01963.x; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Littman R, 2011, ENV MICROBIOL REP, V3, P651, DOI 10.1111/j.1758-2229.2010.00234.x; MARGULIS L, 1991, SYMBIOSIS, V11, P1; Marine R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-3; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; McGeoch DJ, 2006, VIRUS RES, V117, P90, DOI 10.1016/j.virusres.2006.01.002; Minot S, 2013, P NATL ACAD SCI USA, V110, P12450, DOI 10.1073/pnas.1300833110; Moal VLL, 2006, CLIN MICROBIOL REV, V19, P315, DOI 10.1128/CMR.19.2.315-337.2006; Ng TFF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020579; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Reyes A, 2012, NAT REV MICROBIOL, V10, P607, DOI 10.1038/nrmicro2853; Rodriguez-Brito B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-162; Rodriguez-Brito B, 2010, ISME J, V4, P739, DOI 10.1038/ismej.2010.1; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Roossinck MJ, 2011, NAT REV MICROBIOL, V9, P99, DOI 10.1038/nrmicro2491; Roux S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033641; Roux S, 2011, BIOINFORMATICS, V27, P3074, DOI 10.1093/bioinformatics/btr519; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schmieder R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-341; Schoenfeld T, 2008, APPL ENVIRON MICROB, V74, P4164, DOI 10.1128/AEM.02598-07; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Technau U, 2005, TRENDS GENET, V21, P633, DOI 10.1016/j.tig.2005.09.007; Thurber RLV, 2011, J EXP MAR BIOL ECOL, V408, P102, DOI 10.1016/j.jembe.2011.07.030; Thurber RLV, 2008, P NATL ACAD SCI USA, V105, P18413, DOI 10.1073/pnas.0808985105; Thurber RV, 2009, NAT PROTOC, V4, P470, DOI 10.1038/nprot.2009.10; Unckless RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026564; VANETTEN JL, 1982, P NATL ACAD SCI-BIOL, V79, P3867; VANETTEN JL, 1981, VIROLOGY, V113, P704, DOI 10.1016/0042-6822(81)90199-9; Wichman HA, 2005, GENETICS, V170, P19, DOI 10.1534/genetics.104.034488; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Yau S, 2011, P NATL ACAD SCI USA, V108, P6163, DOI 10.1073/pnas.1018221108; Zilber-Rosenberg I, 2008, FEMS MICROBIOL REV, V32, P723, DOI 10.1111/j.1574-6976.2008.00123.x	54	35	36	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e109952	10.1371/journal.pone.0109952	http://dx.doi.org/10.1371/journal.pone.0109952			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343582	Green Published, gold			2022-12-27	WOS:000343943500024
J	Jeon, HG; Ju, HU; Kim, GY; Jeong, J; Kim, MH; Jun, JB				Jeon, Hong Gil; Ju, Hyeong Uk; Kim, Gyu Yeol; Jeong, Joseph; Kim, Min-Ho; Jun, Jae-Bum			Bacteriology and Changes in Antibiotic Susceptibility in Adults with Community-Acquired Perforated Appendicitis	PLOS ONE			English	Article							PEDIATRIC COMPLICATED APPENDICITIS; INTRAABDOMINAL INFECTIONS; INTRAOPERATIVE CULTURE; CHILDREN; EPIDEMIOLOGY; MANAGEMENT; RESISTANCE; SMART	This study evaluated bacterial etiology and antibiotic susceptibility in patients diagnosed with community-acquired perforated appendicitis over a 12-year-period. We retrospectively reviewed records of adult patients diagnosed with perforated appendicitis at an 800-bed teaching hospital between January 2000 and December 2011. In total, 415 culture-positive perforated appendicitis cases were analyzed. Escherichia coli was the most common pathogen (277/415, 66.7%), followed by Streptococcus species (61/415, 14.7%). The susceptibility of E. coli to ampicillin, piperacillin/tazobactam, ceftriaxone, cefepime, amikacin, gentamicin, and imipenem was 35.1%, 97.1%, 97.0%, 98.2%, 98.9%, 81.8%, and 100%, respectively. The overall susceptibility of E. coli to quinolones (ciprofloxacin or levofloxacin) was 78.7%. During the study period, univariate logistic regression analysis showed a significant decrease in E. coli susceptibility to quinolones (OR = 0.91, 95% CI 0.84-0.99, P = 0.040). We therefore do not recommend quinolones as empirical therapy for community-acquired perforated appendicitis.	[Jeon, Hong Gil; Ju, Hyeong Uk; Jun, Jae-Bum] Univ Ulsan, Ulsan Univ Hosp, Coll Med, Dept Internal Med, Ulsan 680749, South Korea; [Kim, Gyu Yeol] Univ Ulsan, Ulsan Univ Hosp, Coll Med, Dept Surg, Ulsan 680749, South Korea; [Jeong, Joseph] Univ Ulsan, Ulsan Univ Hosp, Coll Med, Dept Lab Med, Ulsan 680749, South Korea; [Kim, Min-Ho] Univ Ulsan, Ulsan Univ Hosp, Coll Med, Biomed Res Ctr, Ulsan 680749, South Korea	University of Ulsan; Ulsan University Hospital; University of Ulsan; Ulsan University Hospital; University of Ulsan; Ulsan University Hospital; University of Ulsan; Ulsan University Hospital	Jun, JB (corresponding author), Univ Ulsan, Ulsan Univ Hosp, Coll Med, Dept Internal Med, Ulsan 680749, South Korea.	uvgotletter@hanmail.net		Kim, Min-ho/0000-0003-4909-2308				Andersen BR, 2001, COCHRANE DB SYST REV; BENNION RS, 1990, ANN SURG, V211, P165, DOI 10.1097/00000658-199002000-00008; BERNE TV, 1982, AM J SURG, V144, P8, DOI 10.1016/0002-9610(82)90594-3; Bochicchio Grant V, 2006, Surg Infect (Larchmt), V7, P537, DOI 10.1089/sur.2006.7.537; BONE RC, 1992, CHEST, V101, P1481, DOI 10.1378/chest.101.6.1481; Chan KWE, 2010, PEDIATR SURG INT, V26, P157, DOI 10.1007/s00383-009-2540-6; Chen CY, 2012, SURG INFECT, V13, P383, DOI 10.1089/sur.2011.135; Clinical and Laboratory Standards Institute, 2009, M100S19 CLSI; Fallon SC, 2013, J SURG RES, V185, P273, DOI 10.1016/j.jss.2013.05.088; Foo FJ, 2008, SURG-J R COLL SURG E, V6, P278, DOI 10.1016/S1479-666X(08)80051-0; Guillet-Caruba C, 2011, DIAGN MICR INFEC DIS, V69, P376, DOI 10.1016/j.diagmicrobio.2010.11.003; Kokoska ER, 1999, J PEDIATR SURG, V34, P749, DOI 10.1016/S0022-3468(99)90368-8; LAU WY, 1984, ANN SURG, V200, P576, DOI 10.1097/00000658-198411000-00003; Lau YJ, 2012, J MICROBIOL IMMUNOL, V45, P1, DOI 10.1016/j.jmii.2011.11.010; Lee S, 2014, KOREAN J INTERN MED, V29, P49, DOI 10.3904/kjim.2014.29.1.49; Lob SH, 2013, SURG INFECT, V14, P203, DOI 10.1089/sur.2012.034; Montravers P, 2009, J ANTIMICROB CHEMOTH, V63, P785, DOI 10.1093/jac/dkp005; Paterson DL, 2005, J ANTIMICROB CHEMOTH, V55, P965, DOI 10.1093/jac/dki117; SCHMIT PJ, 1994, J AM COLL SURGEONS, V179, P721; Solomkin JS, 2010, CLIN INFECT DIS, V50, P133, DOI 10.1086/649554; WAN YL, 1981, AM J SURG, V142, P393, DOI 10.1016/0002-9610(81)90358-5; Wojcik-Stojek Barbara, 2000, Acta Microbiologica Polonica, V49, P171; YELLIN AE, 1985, SURG GYNECOL OBSTET, V161, P303; 박상원, 2005, Infection and Chemotherapy, V37, P255	24	14	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111144	10.1371/journal.pone.0111144	http://dx.doi.org/10.1371/journal.pone.0111144			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343342	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943500081
J	Kunasegaran, K; Ho, V; Chang, THT; De Silva, D; Bakker, ML; Christoffels, VM; Pietersen, AM				Kunasegaran, Kamini; Ho, Victor; Chang, Ted H-. T.; De Silva, Duvini; Bakker, Martijn L.; Christoffels, Vincent M.; Pietersen, Alexandra M.			Transcriptional Repressor Tbx3 Is Required for the Hormone-Sensing Cell Lineage in Mammary Epithelium	PLOS ONE			English	Article							BREAST-CANCER; GLAND DEVELOPMENT; STEM-CELLS; DOWNSTREAM TARGET; GENE; MOUSE; EXPRESSION; ESTROGEN; MORPHOGENESIS; PATHWAY	The transcriptional repressor Tbx3 is involved in lineage specification in several tissues during embryonic development. Germ-line mutations in the Tbx3 gene give rise to Ulnar-Mammary Syndrome (comprising reduced breast development) and Tbx3 is required for mammary epithelial cell identity in the embryo. Notably Tbx3 has been implicated in breast cancer, which develops in adult mammary epithelium, but the role of Tbx3 in distinct cell types of the adult mammary gland has not yet been characterized. Using a fluorescent reporter knock-in mouse, we show that in adult virgin mice Tbx3 is highly expressed in luminal cells that express hormone receptors, and not in luminal cells of the alveolar lineage (cells primed for milk production). Flow cytometry identified Tbx3 expression already in progenitor cells of the hormone-sensing lineage and co-immunofluorescence confirmed a strict correlation between estrogen receptor (ER) and Tbx3 expression in situ. Using in vivo reconstitution assays we demonstrate that Tbx3 is functionally relevant for this lineage because knockdown of Tbx3 in primary mammary epithelial cells prevented the formation of ER+ cells, but not luminal ER-or basal cells. Interestingly, genes that are repressed by Tbx3 in other cell types, such as E-cadherin, are not repressed in hormone-sensing cells, highlighting that transcriptional targets of Tbx3 are cell type specific. In summary, we provide the first analysis of Tbx3 expression in the adult mammary gland at a single cell level and show that Tbx3 is important for the generation of hormone-sensing cells.	[Kunasegaran, Kamini; Ho, Victor; Chang, Ted H-. T.; De Silva, Duvini; Pietersen, Alexandra M.] Natl Canc Ctr, Dept Cellular & Mol Res, Singapore, Singapore; [Kunasegaran, Kamini; Ho, Victor; Chang, Ted H-. T.; De Silva, Duvini; Pietersen, Alexandra M.] Duke NUS Grad Med Sch Singapore, Program Canc & Stem Cell Biol, Singapore, Singapore; [Bakker, Martijn L.; Christoffels, Vincent M.] Univ Amsterdam, Acad Med Ctr, Ctr Heart Failure Res, NL-1105 AZ Amsterdam, Netherlands; [Pietersen, Alexandra M.] Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore	National Cancer Centre Singapore (NCCS); National University of Singapore; University of Amsterdam; Academic Medical Center Amsterdam; National University of Singapore	Pietersen, AM (corresponding author), Natl Canc Ctr, Dept Cellular & Mol Res, Singapore, Singapore.	apietersen@gmail.com	Ho, Victor/F-3298-2015	Ho, Victor/0000-0001-8167-5242	Agency for Science, Technology and Research Singapore [SSCC10/022]	Agency for Science, Technology and Research Singapore(Agency for Science Technology & Research (A*STAR))	This work was funded by the Agency for Science, Technology and Research Singapore (www.a-star.edu.sg); grant number SSCC10/022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; Bamshad M, 1999, AM J HUM GENET, V64, P1550, DOI 10.1086/302417; Beleut M, 2010, P NATL ACAD SCI USA, V107, P2989, DOI 10.1073/pnas.0915148107; Boulanger CA, 2005, ONCOGENE, V24, P552, DOI 10.1038/sj.onc.1208185; Brisken C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003178; Brummelkamp TR, 2002, J BIOL CHEM, V277, P6567, DOI 10.1074/jbc.M110492200; Chang THT, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3593; Davenport TG, 2003, DEVELOPMENT, V130, P2263, DOI 10.1242/dev.00431; Douglas NC, 2013, J MAMMARY GLAND BIOL, V18, P143, DOI 10.1007/s10911-013-9282-8; Eblaghie MC, 2004, J ANAT, V205, P1, DOI 10.1111/j.0021-8782.2004.00309.x; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Ewan KBR, 2005, AM J PATHOL, V167, P409, DOI 10.1016/S0002-9440(10)62985-9; Fillmore CM, 2010, P NATL ACAD SCI USA, V107, P21737, DOI 10.1073/pnas.1007863107; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Han JY, 2010, NATURE, V463, P1096, DOI 10.1038/nature08735; Ho V, 2013, BIOTECHNIQUES, V54, P208, DOI 10.2144/000114019; Hoogaars WMH, 2008, PIGM CELL MELANOMA R, V21, P379, DOI 10.1111/j.1755-148X.2008.00461.x; Hoogaars WMH, 2007, GENE DEV, V21, P1098, DOI 10.1101/gad.416007; Hoogaars WMH, 2004, CARDIOVASC RES, V62, P489, DOI 10.1016/j.cardiores.2004.01.030; Jerome-Majewska LA, 2005, DEV DYNAM, V234, P922, DOI 10.1002/dvdy.20575; Li J, 2013, MOL BIOL CELL, V24, P3569, DOI 10.1091/mbc.E13-05-0273; Li M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051283; Lingbeek ME, 2002, J BIOL CHEM, V277, P26120, DOI 10.1074/jbc.M200403200; Lu JA, 2010, BBA-REV CANCER, V1806, P268, DOI 10.1016/j.bbcan.2010.07.001; Lu PF, 2008, DEV BIOL, V321, P77, DOI 10.1016/j.ydbio.2008.06.005; Ludtke THW, 2009, HEPATOLOGY, V49, P969, DOI 10.1002/hep.22700; Mastroianni M, 2010, CANCER LETT, V289, P23, DOI 10.1016/j.canlet.2009.07.012; Meier-Abt F, 2014, TRENDS MOL MED, V20, P143, DOI 10.1016/j.molmed.2013.11.002; Michalak EM, 2013, STEM CELLS, V31, P1910, DOI 10.1002/stem.1437; Oakes SR, 2008, GENE DEV, V22, P581, DOI 10.1101/gad.1614608; Parsa S, 2008, DEV BIOL, V317, P121, DOI 10.1016/j.ydbio.2008.02.014; Peres Jade, 2010, Genes Cancer, V1, P272, DOI 10.1177/1947601910365160; Propper AY, 2013, J MAMMARY GLAND BIOL, V18, P93, DOI 10.1007/s10911-013-9298-0; Regan JL, 2012, ONCOGENE, V31, P869, DOI 10.1038/onc.2011.289; Renard CA, 2007, CANCER RES, V67, P901, DOI 10.1158/0008-5472.CAN-06-2344; Rios AC, 2014, NATURE, V506, P322, DOI 10.1038/nature12948; Rodriguez M, 2008, CANCER RES, V68, P7872, DOI 10.1158/0008-5472.CAN-08-0301; Sale S, 2013, NAT CELL BIOL, V15, P451, DOI 10.1038/ncb2725; Santagata S, 2014, J CLIN INVEST, V124, P859, DOI 10.1172/JCI70941; Shehata M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3334; Sleeman KE, 2007, J CELL BIOL, V176, P19, DOI 10.1083/jcb.200604065; Smalley MJ, 2010, METHODS MOL BIOL, V633, P139, DOI 10.1007/978-1-59745-019-5_11; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Tarulli GA, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3381; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; van den Boogaard M, 2012, J CLIN INVEST, V122, P2519, DOI 10.1172/JCI62613; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Washkowitz AJ, 2012, WIRES SYST BIOL MED, V4, P273, DOI 10.1002/wsbm.1162; Yarosh W, 2008, CANCER RES, V68, P693, DOI 10.1158/0008-5472.CAN-07-5012	49	8	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110191	10.1371/journal.pone.0110191	http://dx.doi.org/10.1371/journal.pone.0110191			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343378	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943500027
J	Lai, PC; Chiu, LY; Srivastava, P; Trento, C; Dazzi, F; Petretto, E; Cook, HT; Behmoaras, J				Lai, Ping-Chin; Chiu, Ling-Yin; Srivastava, Prashant; Trento, Cristina; Dazzi, Francesco; Petretto, Enrico; Cook, H. Terence; Behmoaras, Jacques			Unique Regulatory Properties of Mesangial Cells Are Genetically Determined in the Rat	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; STROMAL CELLS; EXPERIMENTAL GLOMERULONEPHRITIS; CRESCENTIC GLOMERULONEPHRITIS; MACROPHAGE ACTIVATION; RENAL-FAILURE; T-CELLS; PROLIFERATION; DISEASE; SUSCEPTIBILITY	Mesangial cells are glomerular cells of stromal origin. During immune complex mediated crescentic glomerulonephritis (Crgn), infiltrating and proliferating pro-inflammatory macrophages lead to crescent formation. Here we have hypothesised that mesangial cells, given their mesenchymal stromal origin, show similar immunomodulatory properties as mesenchymal stem cells (MSCs), by regulating macrophage function associated with glomerular crescent formation. We show that rat mesangial cells suppress conA-stimulated splenocyte proliferation in vitro, as previously shown for MSCs. We then investigated mesangial cell-macrophage interaction by using mesangial cells isolated from nephrotoxic nephritis (NTN)-susceptible Wistar Kyoto (WKY) and NTN-resistant Lewis (LEW) rats. We first determined the mesangial cell transcriptome in WKY and LEW rats and showed that this is under marked genetic control. Supernatant transfer results show that WKY mesangial cells shift bone marrow derived macrophage (BMDM) phenotype to M1 or M2 according to the genetic background (WKY or LEW) of the BMDMs. Interestingly, these effects were different when compared to those of MSCs suggesting that mesangial cells can have unique immunomodulatory effects in the kidney. These results demonstrate the importance of the genetic background in the immunosuppressive effects of cells of stromal origin and specifically of mesangial cell-macrophage interactions in the pathophysiology of crescentic glomerulonephritis.	[Lai, Ping-Chin; Chiu, Ling-Yin] Chang Gung Univ, Chang Gung Mem Hosp, Sch Med, Kidney Inst,Dept Nephrol, Taipei, Taiwan; [Chiu, Ling-Yin; Cook, H. Terence; Behmoaras, Jacques] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, CCIR, London, England; [Srivastava, Prashant; Petretto, Enrico] Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC Clin Sci Ctr, London, England; [Trento, Cristina; Dazzi, Francesco] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England	Chang Gung Memorial Hospital; Chang Gung University; Imperial College London; Imperial College London; Imperial College London	Behmoaras, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, CCIR, London, England.	Jacquesb@imperial.ac.uk	Dazzi, Francesco/ABD-6171-2021	Dazzi, Francesco/0000-0003-2407-236X	Wellcome Trust [WT092523MA]; National Science Council (Taiwan) [NSC 102-2314-B-182A-021]; Kidney Research UK [RP9/13]; Kidney Research UK [RP9/2013] Funding Source: researchfish; Medical Research Council [MC_U120097112] Funding Source: researchfish; MRC [MC_U120097112] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); National Science Council (Taiwan)(Ministry of Science and Technology, Taiwan); Kidney Research UK(Kidney Research UK (KRUK)); Kidney Research UK(Kidney Research UK (KRUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust (WT092523MA) (www.wellcome.ac.uk); National Science Council (Taiwan, NSC 102-2314-B-182A-021) (www.taiwan.gov.tw); and Kidney Research UK RP9/13 (www.kidneyresearchuk.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders HJ, 2003, KIDNEY INT, V63, P401, DOI 10.1046/j.1523-1755.2003.00750.x; Behmoaras J, 2008, NAT GENET, V40, P553, DOI 10.1038/ng.137; Behmoaras J, 2010, J AM SOC NEPHROL, V21, P1136, DOI 10.1681/ASN.2009090968; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chavele KM, 2010, J CLIN INVEST, V120, P1469, DOI 10.1172/JCI41560; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dazzi F, 2012, IMMUNOLOGY, V137, P206, DOI 10.1111/j.1365-2567.2012.03621.x; Eggenhofer E, 2012, TRANSPLANT RES, V1, DOI 10.1186/2047-1440-1-12; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ghannam S, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt2; Groh ME, 2005, EXP HEMATOL, V33, P928, DOI 10.1016/j.exphem.2005.05.002; Hayakawa K, 2006, J IMMUNOL, V176, P2529, DOI 10.4049/jimmunol.176.4.2529; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Isome M, 2004, NEPHROL DIAL TRANSPL, V19, P2997, DOI 10.1093/ndt/gfh558; JOHNSON RJ, 1992, J EXP MED, V175, P1413, DOI 10.1084/jem.175.5.1413; Kang H, 2014, CELL REP, V8, P1210, DOI 10.1016/j.celrep.2014.07.032; Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004; Kluth DC, 2004, KIDNEY INT, V66, P542, DOI 10.1111/j.1523-1755.2004.00773.x; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Kunter U, 2007, J AM SOC NEPHROL, V18, P1754, DOI 10.1681/ASN.2007010044; Kunter U, 2006, J AM SOC NEPHROL, V17, P2202, DOI 10.1681/ASN.2005080815; Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103; Maggini J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009252; Maratou K, 2011, GENES IMMUN, V12, P78, DOI 10.1038/gene.2010.61; Min DQ, 2009, AM J PHYSIOL-RENAL, V297, pF1229, DOI 10.1152/ajprenal.00074.2009; Morigi M, 2013, NEPHROL DIAL TRANSPL, V28, P788, DOI 10.1093/ndt/gfs556; Nakajima H, 2012, J NEUROTRAUM, V29, P1614, DOI 10.1089/neu.2011.2109; Nelson PJ, 2012, J AM SOC NEPHROL, V23, P194, DOI 10.1681/ASN.2011070680; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Nikolic-Paterson DJ, 2001, NEPHROL DIAL TRANSPL, V16, P3, DOI 10.1093/ndt/16.suppl_5.3; Reinders ME, 2013, CURRENT PHARM DESIGN; Schlondorff D, 2009, J AM SOC NEPHROL, V20, P1179, DOI 10.1681/ASN.2008050549; Smith J, 2007, J AM SOC NEPHROL, V18, P1816, DOI 10.1681/ASN.2006070733; Sudres M, 2006, J IMMUNOL, V176, P7761, DOI 10.4049/jimmunol.176.12.7761; Tam FWK, 1999, NEPHROL DIAL TRANSPL, V14, P1658, DOI 10.1093/ndt/14.7.1658; Tesch GH, 1997, AM J PATHOL, V151, P141	36	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111452	10.1371/journal.pone.0111452	http://dx.doi.org/10.1371/journal.pone.0111452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343449	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943500100
J	Wacker, I; Behrens, J				Wacker, Ingrid; Behrens, juergen			Activin B Antagonizes RhoA Signaling to Stimulate Mesenchymal Morphology and Invasiveness of Clear Cell Renal Cell Carcinomas	PLOS ONE			English	Article							LINDAU TUMOR-SUPPRESSOR; BINDING PROTEIN RHO; EPITHELIAL-CELLS; DOWN-REGULATION; TGF-BETA; CANCER; ACTIVATION; EXPRESSION; ADHESION; KINASE	Activin B belongs to the TGF beta family of growth factors and is upregulated in clear cell renal cell carcinoma cells by hypoxia inducible factors. Expression of Activin B is required for tumor growth in vivo and tumor cell invasion in vitro. Here we show that activation of RhoA signaling counteracts Activin B mediated disassembly of actin stress fibers, mesenchymal cell morphology and invasiveness, whereas inhibition of RhoA rescues these effects in Activin B knockdown cells. Conversely, Activin B inhibits RhoA signaling suggesting that there is an antagonistic connection between both pathways. In addition we found that Rac1 plays an opposite role to RhoA, i.e. activation of Rac1 initiates loss of actin stress fibers, promotes a mesenchymal cell morphology and induces invasion in Activin B knockown cells, whereas inhibition of Rac1 abolishes these Activin B effects. Collectively, our data provide evidence that reduction of RhoA signaling by Activin B together with persistent Rac1 activity is a prerequisite for inducing an invasive phenotype in clear cell renal cell carcinoma.	[Wacker, Ingrid; Behrens, juergen] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Behrens, J (corresponding author), Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr, D-91054 Erlangen, Germany.	jbehrens@molmed.uni-erlangen.de			Deutsche Krebshilfe [109995]	Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by the Deutsche Krebshilfe (www.krebshilfe.de) Grant 109995 to: IW and JB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ageta H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001869; Alberts AS, 2005, J BIOL CHEM, V280, P12152, DOI 10.1074/jbc.M405073200; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Antsiferova M, 2012, J CELL SCI, V125, P3929, DOI 10.1242/jcs.094789; Antsiferova M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1585; BEHRENS J, 1989, J CELL BIOL, V108, P2435, DOI 10.1083/jcb.108.6.2435; Bertolino P, 2008, P NATL ACAD SCI USA, V105, P7246, DOI 10.1073/pnas.0801285105; Besson-Fournier C, 2012, BLOOD, V120, P431, DOI 10.1182/blood-2012-02-411470; Brown CW, 2000, NAT GENET, V25, P453, DOI 10.1038/78140; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chen JL, 2014, FASEB J, V28, P1711, DOI 10.1096/fj.13-245894; Fincham VJ, 1999, J CELL SCI, V112, P947; GLUCK U, 1994, J CELL SCI, V107, P1773; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Janke J, 2000, J EXP MED, V191, P1675, DOI 10.1084/jem.191.10.1675; Krieg M, 2000, ONCOGENE, V19, P5435, DOI 10.1038/sj.onc.1203938; Lehmann K, 2000, GENE DEV, V14, P2610, DOI 10.1101/gad.181700; Leto G, 2006, CLIN EXP METASTAS, V23, P117, DOI 10.1007/s10585-006-9010-5; Mukerji SS, 2009, J NEUROCHEM, V111, P1138, DOI 10.1111/j.1471-4159.2009.06406.x; Munz B, 1999, EMBO J, V18, P5205, DOI 10.1093/emboj/18.19.5205; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Pawlak G, 2002, MOL BIOL CELL, V13, P336, DOI 10.1091/mbc.01-02-0302; Ratcliffe PJ, 2013, J PHYSIOL-LONDON, V591, P2027, DOI 10.1113/jphysiol.2013.251470; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Sadok A., 2014, SMALL GTPASES, V5; Safina AF, 2009, CELL CYCLE, V8, P284, DOI 10.4161/cc.8.2.7590; Sangrar W, 2007, MOL CELL BIOL, V27, P6140, DOI 10.1128/MCB.01744-06; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Semenza GL, 2008, IUBMB LIFE, V60, P591, DOI 10.1002/iub.93; Shen C, 2013, SEMIN CANCER BIOL, V23, P18, DOI 10.1016/j.semcancer.2012.06.001; Sirven A, 2001, MOL THER, V3, P438, DOI 10.1006/mthe.2001.0282; Tomizawa M, 2013, J CELL BIOCHEM, V114, P584, DOI 10.1002/jcb.24395; Vallet S, 2010, P NATL ACAD SCI USA, V107, P5124, DOI 10.1073/pnas.0911929107; von Thun A, 2013, MOL CELL BIOL, V33, P4526, DOI 10.1128/MCB.00585-13; Wacker I, 2009, MOL CELL BIOL, V29, P1707, DOI 10.1128/MCB.01184-07; Weiss A, 2013, WIRES DEV BIOL, V2, P47, DOI 10.1002/wdev.86; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Yang S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088489; Zhang M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025143; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011	45	9	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111276	10.1371/journal.pone.0111276	http://dx.doi.org/10.1371/journal.pone.0111276			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343250	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943500092
J	Alves, JP; Nunes, RB; Stefani, GP; Dal Lago, P				Alves, Jadson P.; Nunes, Ramiro B.; Stefani, Giuseppe P.; Dal Lago, Pedro			Resistance Training Improves Hemodynamic Function, Collagen Deposition and Inflammatory Profiles: Experimental Model of Heart Failure	PLOS ONE			English	Article							SKELETAL-MUSCLE; MYOCARDIAL-INFARCTION; EXTRACELLULAR-MATRIX; VENTRICULAR-FUNCTION; EXERCISE; RATS; STRENGTH; CARDIOMYOPATHY; ASSOCIATION; DYSFUNCTION	The role of resistance training on collagen deposition, the inflammatory profile and muscle weakness in heart failure remains unclear. Therefore, this study evaluated the influence of a resistance training program on hemodynamic function, maximum strength gain, collagen deposition and inflammatory profile in chronic heart failure rats. Thirty-two male Wistar rats submitted to myocardial infarction by coronary artery ligation or sham surgery were assigned into four groups: sedentary sham (S-Sham, n = 8); trained sham (T-Sham, n = 8); sedentary chronic heart failure (S-CHF, n = 8) and trained chronic heart failure (T-CHF, n = 8). The maximum strength capacity was evaluated by the one maximum repetition test. Trained groups were submitted to an 8-week resistance training program (4 days/week, 4 sets of 10-12 repetitions/session, at 65% to 75% of one maximum repetition). After 8 weeks of the resistance training program, the T-CHF group showed lower left ventricular end diastolic pressure (P<0.001), higher left ventricular systolic pressure (P<0.05), higher systolic blood pressure (P<0.05), an improvement in the maximal positive derivative of ventricular pressure (P<0.05) and maximal negative derivative of ventricular pressure (P<0.05) when compared to the S-CHF group; no differences were observed when compared to Sham groups. In addition, resistance training was able to reduce myocardial hypertrophy (P<0.05), left ventricular total collagen volume fraction (P<0.01), IL-6 (P<0.05), and TNF-alpha/IL-10 ratio (P<0.05), as well as increasing IL-10 (P<0.05) in chronic heart failure rats when compared to the S-CHF group. Eight weeks of resistance training promotes an improvement of cardiac function, strength gain, collagen deposition and inflammatory profile in chronic heart failure rats.	[Alves, Jadson P.; Nunes, Ramiro B.; Stefani, Giuseppe P.; Dal Lago, Pedro] Univ Fed Ciencias Saude Porto Alegre, Physiol Lab, Porto Alegre, RS, Brazil; [Dal Lago, Pedro] Univ Fed Ciencias Saude Porto Alegre, Dept Phys Therapy, Porto Alegre, RS, Brazil	Universidade Federal de Ciencias da Saude de Porto Alegre; Universidade Federal de Ciencias da Saude de Porto Alegre	Dal Lago, P (corresponding author), Univ Fed Ciencias Saude Porto Alegre, Physiol Lab, Porto Alegre, RS, Brazil.	pdallago@ufcspa.edu.br	Dal Lago, Pedro/AAM-9136-2020; Stefani, Giuseppe Potrick/D-4561-2014; Dal Lago, Pedro/K-4414-2013; Alves, Jadson/R-1882-2016	Dal Lago, Pedro/0000-0001-9907-7689; Stefani, Giuseppe Potrick/0000-0001-5492-4530; Dal Lago, Pedro/0000-0001-9907-7689; Alves, Jadson/0000-0002-4131-6058	CAPES, Brasilia, Brazil; CNPq, Brasilia, Brazil; PROAP/UFCSPA, Porto Alegre, Brazil	CAPES, Brasilia, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq, Brasilia, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PROAP/UFCSPA, Porto Alegre, Brazil	This work was supported by grants from the following: CAPES and CNPq, Brasilia, Brazil, and PROAP/UFCSPA, Porto Alegre, Brazil (http://www.capes.gov.br/; http://www.ufcspa.edu.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamopoulos S, 2002, J AM COLL CARDIOL, V39, P653, DOI 10.1016/S0735-1097(01)01795-8; Anker SD, 2004, HEART, V90, P464, DOI 10.1136/hrt.2002.007005; Anker SD, 1997, LANCET, V349, P1050, DOI 10.1016/S0140-6736(96)07015-8; Barauna VG, 2007, CLIN MED RES, V5, P114, DOI 10.3121/cmr.2007.707; Batista ML, 2010, CYTOKINE, V49, P102, DOI 10.1016/j.cyto.2009.10.007; Cheetham C, 2002, J APPL PHYSIOL, V93, P175, DOI 10.1152/japplphysiol.01240.2001; de Cassia Cypriano Ervati Pinter R, 2008, EUROPEAN J APPL PHYS, V103, P605; de Leon EB, 2011, ACTA PHYSIOL, V201, P265, DOI 10.1111/j.1748-1716.2010.02176.x; Emter CA, 2010, AM J PHYSIOL-HEART C, V299, pH1348, DOI 10.1152/ajpheart.00578.2010; Francis J, 2001, AM J PHYSIOL-REG I, V281, pR1734, DOI 10.1152/ajpregu.2001.281.5.R1734; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Georgiadou Panagiota, 2012, Curr Heart Fail Rep, V9, P128, DOI 10.1007/s11897-012-0090-z; Gielen S, 2003, J AM COLL CARDIOL, V42, P861, DOI 10.1016/S0735-1097(03)00848-9; Goswami B, 2009, CLIN CHIM ACTA, V408, P14, DOI 10.1016/j.cca.2009.06.029; Gurtl B, 2009, INT J EXP PATHOL, V90, P338, DOI 10.1111/j.1365-2613.2009.00647.x; Houser SR, 2012, CIRC RES, V111, P131, DOI 10.1161/RES.0b013e3182582523; Hulsmann M, 2004, EUR J HEART FAIL, V6, P101, DOI 10.1016/j.ejheart.2003.07.008; Hunt SA, 2009, CIRCULATION, V119, pE391, DOI 10.1161/CIRCULATIONAHA.109.192065; Hutchinson KR, 2010, J MOL CELL CARDIOL, V48, P564, DOI 10.1016/j.yjmcc.2009.06.001; Jaenisch RB, 2011, J APPL PHYSL; Jankowska EA, 2008, INT J CARDIOL, V130, P36, DOI 10.1016/j.ijcard.2007.07.158; Jannig PR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085820; Krisan AD, 2004, J APPL PHYSIOL, V96, P1691, DOI 10.1152/japplphysiol.01054.2003; Kwan G, 2012, CIRCULATION, V125, pE369, DOI 10.1161/CIRCULATIONAHA.112.093310; Levinger I, 2005, INT J CARDIOL, V105, P159, DOI 10.1016/j.ijcard.2004.11.022; LINDPAINTNER K, 1993, J MOL CELL CARDIOL, V25, P133, DOI 10.1006/jmcc.1993.1017; Lunde PK, 2001, ACTA PHYSIOL SCAND, V171, P277, DOI 10.1046/j.1365-201x.2001.00830.x; Matsubara LS, 2000, AM J PHYSIOL-HEART C, V279, pH1534, DOI 10.1152/ajpheart.2000.279.4.H1534; MCKELVIE RS, 1995, AM J CARDIOL, V76, P977, DOI 10.1016/S0002-9149(99)80277-X; McMurray JJV, 2010, NEW ENGL J MED, V362, P228, DOI 10.1056/NEJMcp0909392; Mihl C, 2008, NETH HEART J, V16, P129, DOI 10.1007/BF03086131; Musch TI, 2002, J APPL PHYSIOL, V92, P2326, DOI 10.1152/japplphysiol.00686.2001; Nunes RB, 2008, J APPL PHYSIOL, V104, P1641, DOI 10.1152/japplphysiol.00062.2008; Palevo G, 2009, J CARDIOPULM REHABIL, V29, P294, DOI 10.1097/HCR.0b013e3181ac784b; PFEFFER MA, 1979, CIRC RES, V44, P503, DOI 10.1161/01.RES.44.4.503; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Pfeifer PC, 2001, MED SCI SPORT EXER, V33, P542; Piepoli MF, 2001, ACTA PHYSIOL SCAND, V171, P295, DOI 10.1046/j.1365-201x.2001.00831.x; Savage PA, 2011, MED SCI SPORT EXER, V43, P1379, DOI 10.1249/MSS.0b013e31820eeea1; Smart NA, 2013, INT J CARDIOL, V166, P352, DOI 10.1016/j.ijcard.2011.10.075; Vanzelli AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062452; Weber KT, 2008, J AM COLL CARDIOL, V52, P2029, DOI 10.1016/j.jacc.2008.09.012; WHITTAKER P, 1991, CIRCULATION, V84, P2123, DOI 10.1161/01.CIR.84.5.2123; WHITTAKER P, 1994, BASIC RES CARDIOL, V89, P397, DOI 10.1007/BF00788278; Xu XH, 2008, J MOL CELL CARDIOL, V44, P114, DOI 10.1016/j.yjmcc.2007.10.004; Yengo CM, 2012, MED SCI SPORT EXER, V44, P1005, DOI 10.1249/MSS.0b013e318244bc8a; Yu CM, 1996, EUR HEART J, V17, P1694	47	33	35	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110317	10.1371/journal.pone.0110317	http://dx.doi.org/10.1371/journal.pone.0110317			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340545	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662800030
J	Russo, D; Di Febbraro, M; Rebelo, H; Mucedda, M; Cistrone, L; Agnelli, P; De Pasquale, PP; Martinoli, A; Scaravelli, D; Spilinga, C; Bosso, L				Russo, Danilo; Di Febbraro, Mirko; Rebelo, Hugo; Mucedda, Mauro; Cistrone, Luca; Agnelli, Paolo; De Pasquale, Pier Paolo; Martinoli, Adriano; Scaravelli, Dino; Spilinga, Cristiano; Bosso, Luciano			What Story Does Geographic Separation of Insular Bats Tell? A Case Study on Sardinian Rhinolophids	PLOS ONE			English	Article							MEDITERRANEAN HORSESHOE BAT; MYOTIS-MYOTIS CHIROPTERA; CHARACTER DISPLACEMENT; HABITAT SELECTION; DISTRIBUTION MODELS; COMMUNITY STRUCTURE; ECHOLOCATION CALLS; MEHELYI CHIROPTERA; EURYALE CHIROPTERA; PREY SELECTION	Competition may lead to changes in a species' environmental niche in areas of sympatry and shifts in the niche of weaker competitors to occupy areas where stronger ones are rarer. Although mainland Mediterranean (Rhinolophus euryale) and Mehely's (R. mehelyi) horseshoe bats mitigate competition by habitat partitioning, this may not be true on resource-limited systems such as islands. We hypothesize that Sardinian R. euryale (SAR) have a distinct ecological niche suited to persist in the south of Sardinia where R. mehelyi is rarer. Assuming that SAR originated from other Italian populations (PES) -mostly allopatric with R. mehelyi -once on Sardinia the former may have undergone niche displacement driven by R. mehelyi. Alternatively, its niche could have been inherited from a Maghrebian source population. We: a) generated Maxent Species Distribution Models (SDM) for Sardinian populations; b) calibrated a model with PES occurrences and projected it to Sardinia to see whether PES niche would increase R. euryale's sympatry with R. mehelyi; and c) tested for niche similarity between R. mehelyi and PES, PES and SAR, and R. mehelyi and SAR. Finally we predicted R. euryale's range in Northern Africa both in the present and during the Last Glacial Maximum (LGM) by calibrating SDMs respectively with SAR and PES occurrences and projecting them to the Maghreb. R. mehelyi and PES showed niche similarity potentially leading to competition. According to PES' niche, R. euryale would show a larger sympatry with R. mehelyi on Sardinia than according to SAR niche. Such niches have null similarity. The current and LGM Maghrebian ranges of R. euryale were predicted to be wide according to SAR's niche, negligible according to PES' niche. SAR's niche allows R. euryale to persist where R. mehelyi is rarer and competition probably mild. Possible explanations may be competition-driven niche displacement or Maghrebian origin.	[Russo, Danilo; Bosso, Luciano] Univ Naples Federico II, Dipartimento Agr, Wildlife Res Unit, Naples, Italy; [Russo, Danilo; Rebelo, Hugo] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Di Febbraro, Mirko] Univ Molise, EnvixLab, Dipartimento Biosci & Terr, Pesche, Italy; [Rebelo, Hugo] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, CIBIO, Vairao, Portugal; [Mucedda, Mauro] Ctr Studio & Protez Pipistrelli Sardegna, Sassari, Italy; [Cistrone, Luca] Forestry & Conservat, Cassino, Frosinone, Italy; [Agnelli, Paolo] Univ Florence, Museo Storia Nat, Sez Zool La Specola, Florence, Italy; [De Pasquale, Pier Paolo] Wildlife Consulting, Bari, Italy; [Martinoli, Adriano] Univ Insubria, Dipartimento Sci Teor & Applicate, Guido Tosi Res Grp, Unita Anal & Gest Risorse Ambientali, Varese, Italy; [Scaravelli, Dino] Univ Bologna, Dipartimento Sci Med Vet, Bologna, Italy; [Spilinga, Cristiano] Studio Naturalist Hyla Snc, Perugia, Italy	University of Naples Federico II; University of Bristol; University of Molise; Universidade do Porto; University of Florence; University of Insubria; University of Bologna	Russo, D (corresponding author), Univ Naples Federico II, Dipartimento Agr, Wildlife Res Unit, Naples, Italy.	danrusso@unina.it	Di Febbraro, Mirko/GQA-4462-2022; Di Febbraro, Mirko/I-3167-2019; Rebelo, Hugo/C-9005-2009; Martinoli, Adriano/L-4924-2016	Rebelo, Hugo/0000-0002-7118-4068; Martinoli, Adriano/0000-0003-0298-0869; Russo, Danilo/0000-0002-1934-7130; Bosso, Luciano/0000-0002-9472-3802; AGNELLI, PAOLO/0000-0002-0004-8325; Di Febbraro, Mirko/0000-0001-8898-7046	Italian Ministry of the Environment and the Protection of Land and Sea, CIG [464598541B]; Programme Investigador FCT [IF/00497/2013]	Italian Ministry of the Environment and the Protection of Land and Sea, CIG; Programme Investigador FCT	DR and LB were funded by Italian Ministry of the Environment and the Protection of Land and Sea, CIG nr.464598541B (www.minambiente.it).HR was funded by the Programme Investigador FCT, IF/00497/2013 (www.fct.pt).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson RC, 2008, COPEIA, P689, DOI 10.1643/CG-07-217; Albrecht M, 2001, OECOLOGIA, V126, P134, DOI 10.1007/s004420000494; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Arlettaz R, 1999, J ANIM ECOL, V68, P460, DOI 10.1046/j.1365-2656.1999.00293.x; Biollaz F, 2010, J BIOGEOGR, V37, P1557, DOI 10.1111/j.1365-2699.2010.02282.x; BOGDANOWICZ W, 1983, ACTA THERIOL, V28, P357, DOI 10.4098/AT.arch.83-31; Bosso L, 2013, J NAT CONSERV, V21, P72, DOI 10.1016/j.jnc.2012.10.003; Brito JC, 2014, BIOL REV, V89, P215, DOI 10.1111/brv.12049; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; BROWN WL, 1956, SYST ZOOL, V5, P49, DOI 10.2307/2411924; Busby JR, 1991, NATURE CONSERVATION, P64, DOI DOI 10.1046/J.1365-294X.2001.01244.X; Castella V, 2000, MOL ECOL, V9, P1761, DOI 10.1046/j.1365-294x.2000.01069.x; CastilloRivera M, 1996, J FISH BIOL, V49, P1102; Cox C.B., 2010, BIOGEOGRAPHY ECOLOGI; Dayan T, 2005, ECOL LETT, V8, P875, DOI 10.1111/j.1461-0248.2005.00791.x; Di Febbraro M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066559; Dietz C, 2006, J MAMMAL, V87, P1241, DOI 10.1644/05-MAMM-A-299R2.1; Dondini G, 2014, HYSTRIX, V25, P59, DOI 10.4404/hystrix-25.1-9248; Dragu A, 2011, ACTA THERIOL, V56, P383, DOI 10.1007/s13364-011-0043-z; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Flaquer Carles, 2010, Galemys, V22, P29; Garcia-Mudarra JL, 2009, BIOL J LINN SOC, V96, P434, DOI 10.1111/j.1095-8312.2008.01128.x; Goiti U, 2004, MAMMALIA, V68, P397, DOI 10.1515/mamm.2004.039; Goldberg EE, 2006, EVOLUTION, V60, P1344, DOI 10.1111/j.0014-3820.2006.tb01214.x; GRANT P R, 1972, Biological Journal of the Linnean Society, V4, P39, DOI 10.1111/j.1095-8312.1972.tb00690.x; Guillen A, 2003, HORSESHOE BATS WORLD, P7; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Hutson AM, 2008, IUCN 2013 IUCN RED L; Jones G, 2007, P R SOC B, V274, P905, DOI 10.1098/rspb.2006.0200; Jones G, 2011, J COMP PHYSIOL A, V197, P447, DOI 10.1007/s00359-010-0565-x; Keith DA, 2014, DIVERS DISTRIB, V20, P440, DOI 10.1111/ddi.12173; KIEFER A., 2007, THESIS GUTENBERG U M; Kingston T, 2000, OECOLOGIA, V124, P332, DOI 10.1007/PL00008866; Krijgsman W, 1999, NATURE, V400, P652, DOI 10.1038/23231; Kronfeld-Schor N, 1999, OECOLOGIA, V121, P123, DOI 10.1007/s004420050913; Krzanowski A., 1967, Acta Zoologica Cracoviensia, V12, P281; Lomolino MV, 2005, J BIOGEOGR, V32, P1683, DOI 10.1111/j.1365-2699.2005.01314.x; McNab Brian K., 2009, P153; Medley KA, 2010, GLOBAL ECOL BIOGEOGR, V19, P122, DOI 10.1111/j.1466-8238.2009.00497.x; MitchellJones A.J., 1999, ATLAS EUROPEAN MAMMA; Navarro J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062897; Peers MJL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2495; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Puechmaille SJ, 2014, MAMMALIA, V78, P251, DOI 10.1515/mammalia-2013-0040; Rodder D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072855; Rohling EJ, 1998, NATURE, V394, P162, DOI 10.1038/28134; Rombaut Dominique, 2002, Arvicola, V14, P18; Ruedi M, 2008, MOL ECOL, V17, P1801, DOI 10.1111/j.1365-294X.2008.03702.x; Russo D, 2005, J ZOOL, V266, P327, DOI 10.1017/S0952836905006990; Russo D, 2001, MAMMALIA, V65, P429, DOI 10.1515/mamm.2001.65.4.429; Russo D, 2002, BIOL CONSERV, V107, P71, DOI 10.1016/S0006-3207(02)00047-2; Russo D, 2007, J BIOGEOGR, V34, P2129, DOI 10.1111/j.1365-2699.2007.01762.x; Russo D, 2009, J BIOGEOGR, V36, P2212, DOI 10.1111/j.1365-2699.2009.02158.x; Salsamendi E, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-30; Salsamendi E, 2008, ACTA CHIROPTEROL, V10, P279, DOI 10.3161/150811008X414854; Schuchmann M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012842; Siemers BM, 2004, NATURE, V429, P657, DOI 10.1038/nature02547; Siemers BM, 2006, BEHAV ECOL SOCIOBIOL, V59, P373, DOI 10.1007/s00265-005-0060-5; SPENCER LM, 1995, J MAMMAL, V76, P448, DOI 10.2307/1382355; Stadelmann B, 2007, MOL PHYLOGENET EVOL, V43, P32, DOI 10.1016/j.ympev.2006.06.019; Stadelmann B, 2004, J MAMMAL, V85, P133, DOI 10.1644/1545-1542(2004)085<0133:MSOTFB>2.0.CO;2; Theodoridis S, 2013, J BIOGEOGR, V40, P1278, DOI 10.1111/jbi.12085; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; Veith M, 2011, ACTA CHIROPTEROL, V13, P89, DOI 10.3161/150811011X578642; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Weiss S, 2007, PHYLOGEOGRAPHY SO EU; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x; Zhou ZM, 2009, J MAMMAL, V90, P57, DOI 10.1644/08-MAMM-A-048.1	73	33	33	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110894	10.1371/journal.pone.0110894	http://dx.doi.org/10.1371/journal.pone.0110894			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340737	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662800068
J	Suzuki, T; Miyaki, K; Sasaki, Y; Song, Y; Tsutsumi, A; Kawakami, N; Shimazu, A; Takahashi, M; Inoue, A; Kurioka, S; Shimbo, T				Suzuki, Tomoko; Miyaki, Koichi; Sasaki, Yasuharu; Song, Yixuan; Tsutsumi, Akizumi; Kawakami, Norito; Shimazu, Akihito; Takahashi, Masaya; Inoue, Akiomi; Kurioka, Sumiko; Shimbo, Takuro			Optimal Cutoff Values of WHO-HPQ Presenteeism Scores by ROC Analysis for Preventing Mental Sickness Absence in Japanese Prospective Cohort	PLOS ONE			English	Article							PERFORMANCE QUESTIONNAIRE HPQ; HEALTH-ORGANIZATION HEALTH; 2 PREDICTION MODELS; PSYCHOLOGICAL DISTRESS; DEPRESSIVE SYMPTOMS; FOLLOW-UP; WORK; RISK; EMPLOYEES; POPULATION	Objectives: Sickness absence due to mental disease in the workplace has become a global public health problem. Previous studies report that sickness presenteeism is associated with sickness absence. We aimed to determine optimal cutoff scores for presenteeism in the screening of the future absences due to mental disease. Methods: A prospective study of 2195 Japanese employees from all areas of Japan was conducted. Presenteeism and depression were measured by the validated Japanese version of the World Health Organization Health and Work Performance Questionnaire (WHO-HPQ) and K6 scale, respectively. Absence due to mental disease across a 2-year follow-up was surveyed using medical certificates obtained for work absence. Socioeconomic status was measured via a self-administered questionnaire. Receiver operating curve (ROC) analysis was used to determine optimal cutoff scores for absolute and relative presenteeism in relation to the area under the curve (AUC), sensitivity, and specificity. Results: The AUC values for absolute and relative presenteeism were 0.708 (95% CI, 0.618-0.797) and 0.646 (95% CI, 0.546-0.746), respectively. Optimal cutoff scores of absolute and relative presenteeism were 40 and 0.8, respectively. With multivariate adjustment, cohort participants with our proposal cutoff scores for absolute and relative presenteeism were significantly more likely to be absent due to mental disease (OR = 4.85, 95% CI: 2.20-10.73 and OR = 5.37, 95% CI: 2.42-11.93, respectively). The inclusion or exclusion of depressive symptoms (K6 >= 13) at baseline in the multivariate adjustment did not influence the results. Conclusions: Our proposed optimal cutoff scores of absolute and relative presenteeism are 40 and 0.8, respectively. Participants who scored worse than the cutoff scores for presenteeism were significantly more likely to be absent in future because of mental disease. Our findings suggest that the utility of presenteeism in the screening of sickness absence due to mental disease would help prevent such an absence.	[Suzuki, Tomoko; Miyaki, Koichi; Sasaki, Yasuharu; Song, Yixuan; Shimbo, Takuro] Natl Ctr Global Hlth & Med, Dept Clin Res & Informat, Tokyo, Japan; [Suzuki, Tomoko; Tsutsumi, Akizumi] Kitasato Univ, Dept Publ Hlth, Sch Med, Sagamihara, Kanagawa, Japan; [Kawakami, Norito; Shimazu, Akihito] Univ Tokyo, Dept Mental Hlth, Grad Sch Med, Tokyo, Japan; [Takahashi, Masaya] NIOSH, Hlth Adm & Psychosocial Factor Res Grp, Yokohama, Kanagawa, Japan; [Inoue, Akiomi] Univ Occupat & Environm Hlth, Inst Ind Ecol Sci, Dept Mental Hlth, Fukuoka, Japan; [Kurioka, Sumiko] Univ Occupat & Environm Hlth, Dept Hlth Policy & Management, Fukuoka, Japan	National Center for Global Health & Medicine - Japan; Kitasato University; University of Tokyo; University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan	Miyaki, K (corresponding author), Natl Ctr Global Hlth & Med, Dept Clin Res & Informat, Tokyo, Japan.	miyaki-keio@umin.net		Suzuki, Tomoko/0000-0003-1420-2298	Ministry of Education, Culture, Sports, Science and Technology, Japan [24390160, 21119001]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	1. This research is funded by a Grant-in-Aid for Scientific Research (B) (No. 24390160, Chief: Dr. Koichi Miyaki, http://kaken.nii.ac.jp/d/p/24390160.en.html) and a Grant-in-Aid for Scientific Research on Innovative Areas (Research in a Proposed Research Area) (No. 21119001, Chief: Dr. Norito Kawakami, http://kaken.nii.ac.jp/d/p/21119001.en.html) by the Ministry of Education, Culture, Sports, Science and Technology, Japan. 2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergstrom G, 2009, J OCCUP ENVIRON MED, V51, P629, DOI [10.1097/JOM.0b913e3181a8281b, 10.1097/JOM.0b013e3181a8281b]; Bockerman P, 2010, EUR J PUBLIC HEALTH, V20, P43, DOI 10.1093/eurpub/ckp076; Boyd J, 2007, STAT ANAL PRESENTATI, V2, P113; COPELAND KT, 1977, AM J EPIDEMIOL, V105, P488, DOI 10.1093/oxfordjournals.aje.a112408; Despiegel N, 2012, VALUE HEALTH, V15, P1148, DOI 10.1016/j.jval.2012.08.2206; Florkowski Christopher M, 2008, Clin Biochem Rev, V29 Suppl 1, pS83; Furukawa TA, 2008, INT J METH PSYCH RES, V17, P152, DOI 10.1002/mpr.257; Hansen CD, 2009, J EPIDEMIOL COMMUN H, V63, P397, DOI 10.1136/jech.2008.078238; Henderson M, 2005, BMJ-BRIT MED J, V330, P802, DOI 10.1136/bmj.330.7495.802; Holden L, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-417; Jain G, 2013, J OCCUP ENVIRON MED, V55, P252, DOI 10.1097/JOM.0b013e31828349c9; Japan, 2013, SUMMARY LONG TERM SI; JARVISALO J, 2005, 66 SOC INS I FINL; Kessler R., 2007, WHO HLTH WORK PERFOR; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kessler RC, 2004, J OCCUP ENVIRON MED, V46, pS23, DOI 10.1097/01.jom.0000126683.75201.c5; Kessler RC, 2003, J OCCUP ENVIRON MED, V45, P156, DOI 10.1097/01.jom.0000052967.43131.51; Lack DM, 2011, AAOHN J, V59, P77, DOI 10.3928/08910162-20110126-01; Melchior M, 2010, AM J EPIDEMIOL, V172, P700, DOI 10.1093/aje/kwq186; Miyaki K, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-33; Roelen CA, 2013, EUR J PUBLIC HEALTH, V23, P128, DOI 10.1093/eurpub/cks036; Roelen CAM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-105; Sakurai K, 2011, PSYCHIAT CLIN NEUROS, V65, P434, DOI 10.1111/j.1440-1819.2011.02236.x; Suzuki T, 2013, J AFFECT DISORDERS, V150, P490, DOI 10.1016/j.jad.2013.04.044; Taloyan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044721	26	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111191	10.1371/journal.pone.0111191	http://dx.doi.org/10.1371/journal.pone.0111191			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR5ZY	25340520	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662800093
J	Biz, A; Farias, FC; Motter, FA; de Paula, DH; Richard, P; Krieger, N; Mitchell, DA				Biz, Alessandra; Farias, Fernanda Cardoso; Motter, Francine Aline; de Paula, Diogo Henrique; Richard, Peter; Krieger, Nadia; Mitchell, David Alexander			Pectinase Activity Determination: An Early Deceleration in the Release of Reducing Sugars Throws a Spanner in the Works!	PLOS ONE			English	Article							SOLID-STATE FERMENTATION; ASPERGILLUS-NIGER; POLYGALACTURONASE PRODUCTION; SACCHAROMYCES-CEREVISIAE; PECTOLYTIC ENZYMES; XYLANASE; BIOMASS; ASSAY	Recently, it has been suggested that pectinases could be used to hydrolyze pectin in biorefineries based on pectin-rich agro-industrial wastes. However, for this to be viable, the cost of their production would need to be lowered significantly. In fact, over the last few decades, there have been many attempts to improve pectinase production by existing strains or to screen for new strains from environmental isolates. In these studies, it is necessary to measure pectinase activities. Many researchers use single-time-point assays that involve incubation of pectinolytic extracts with pectic substrates for a fixed time, followed by determination of the liberated reducing sugars. However, different researchers use quite different conditions for this assay. Furthermore, no attention has been given to the reaction profile during the assay. In the current work, we show, for the first time, that a significant deceleration of the rate of liberation of reducing sugars occurs over the first ten minutes of the reaction. As a consequence, the incubation time used in a single-time-point assay has a large effect on the value obtained for the activity. In fact, we demonstrate that, depending on the particular combination of incubation time, pectin concentration and reaction temperature, the same extract could be reported to have activities that differ by an order of magnitude. In addition, we show that the relative activities obtained with polygalacturonic acid do not correlate with those obtained with pectin. We conclude that it is currently impossible to make meaningful comparisons between pectinase activities reported in the literature by workers who have used different assay conditions. Therefore there is an urgent need for the development of a standardized assay for evaluating the saccharification potential of pectinase complexes.	[Biz, Alessandra; Farias, Fernanda Cardoso; Motter, Francine Aline; de Paula, Diogo Henrique; Mitchell, David Alexander] Univ Fed Parana, Dept Bioquim & Biol Mol, BR-80060000 Curitiba, Parana, Brazil; [Richard, Peter] VTT Tech Res Ctr Finland, Espoo, Finland; [Krieger, Nadia] Univ Fed Parana, Dept Quim, BR-80060000 Curitiba, Parana, Brazil	Universidade Federal do Parana; VTT Technical Research Center Finland; Universidade Federal do Parana	Mitchell, DA (corresponding author), Univ Fed Parana, Dept Bioquim & Biol Mol, BR-80060000 Curitiba, Parana, Brazil.	davidmitchell@ufpr.br	Richard, Peter/A-4229-2009; Mitchell, David A/A-8935-2008; Krieger, Nadia/A-5749-2011	Richard, Peter/0000-0003-0922-6092; Mitchell, David A/0000-0001-9355-5520; Krieger, Nadia/0000-0003-0492-7308				Ahlawat S, 2007, J IND MICROBIOL BIOT, V34, P763, DOI 10.1007/s10295-007-0251-3; Alkorta I, 1998, PROCESS BIOCHEM, V33, P21, DOI 10.1016/S0032-9592(97)00046-0; Andersen MR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-313; Baciu IE, 2004, ENZYME MICROB TECH, V34, P505, DOI 10.1016/j.enzmictec.2003.12.008; Beg QK, 2000, WORLD J MICROB BIOT, V16, P211, DOI 10.1023/A:1008979512413; Belafi-Bako K, 2007, J FOOD ENG, V78, P438, DOI 10.1016/j.jfoodeng.2005.10.012; BERNFELD P, 1955, METHOD ENZYMOL, V1, P149, DOI 10.1016/0076-6879(55)01021-5; Blandino A, 2002, APPL MICROBIOL BIOT, V58, P164, DOI 10.1007/s00253-001-0893-4; COLLMER A, 1988, METHOD ENZYMOL, V161, P329; De Gregorio A, 2002, BIORESOURCE TECHNOL, V83, P89, DOI 10.1016/S0960-8524(01)00209-7; de Vries RP, 2001, MICROBIOL MOL BIOL R, V65, P497, DOI 10.1128/MMBR.65.4.497-522.2001; Edwards MC, 2012, APPL MICROBIOL BIOT, V95, P565, DOI 10.1007/s00253-012-4173-2; GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257; Hadj-Taieb N, 2002, ENZYME MICROB TECH, V30, P662, DOI 10.1016/S0141-0229(02)00029-7; Heerd D, 2012, FOOD BIOPROD PROCESS, V90, P102, DOI 10.1016/j.fbp.2011.08.003; Kapoor M, 2002, LETT APPL MICROBIOL, V34, P317, DOI 10.1046/j.1472-765X.2002.01107.x; Kashyap DR, 2003, BIORESOURCE TECHNOL, V88, P251, DOI 10.1016/S0960-8524(02)00206-7; Kashyap DR, 2001, BIORESOURCE TECHNOL, V77, P215, DOI 10.1016/S0960-8524(00)00118-8; Kumar YS, 2010, WORLD J MICROB BIOT, V26, P1973, DOI 10.1007/s11274-010-0380-0; Lohrasbi M, 2010, BIORESOURCE TECHNOL, V101, P7382, DOI 10.1016/j.biortech.2010.04.078; Mamma D, 2008, BIORESOURCE TECHNOL, V99, P2373, DOI 10.1016/j.biortech.2007.05.018; Martin N, 2010, MICROBIOLOGY+, V79, P306, DOI 10.1134/S0026261710030057; Martinez-Trujillo A, 2011, LETT APPL MICROBIOL, V53, P202, DOI 10.1111/j.1472-765X.2011.03096.x; Martins ES, 2002, PROCESS BIOCHEM, V37, P949, DOI 10.1016/S0032-9592(01)00300-4; Naidu GS, 1998, BIOCHEM ENG J, V2, P71; Navarro D, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-58; Nelson N, 1944, J BIOL CHEM, V153, P375; Nikolic MV, 2007, FOOD CHEM, V101, P1, DOI 10.1016/j.foodchem.2005.12.053; Niture SK, 2008, BIOLOGIA, V63, P1, DOI 10.2478/s11756-008-0018-y; Ortiz GE, 2014, ANAL BIOCHEM, V454, P33, DOI 10.1016/j.ab.2014.02.028; Panda T, 1999, PROCESS BIOCHEM, V35, P187, DOI 10.1016/S0032-9592(99)00050-3; Patil SR, 2006, BIORESOURCE TECHNOL, V97, P2054, DOI 10.1016/j.biortech.2005.09.015; Perry F. G., 1995, Biotechnology in animal feeds and animal feeding., P1, DOI 10.1002/9783527615353.ch1; Richard P, 2009, APPL MICROBIOL BIOT, V82, P597, DOI 10.1007/s00253-009-1870-6; Rodriguez-Nogales JM, 2008, FOOD CHEM, V107, P112, DOI 10.1016/j.foodchem.2007.07.057; SCHUBERT E, 1952, NATURE, V169, P931, DOI 10.1038/169931a0; Lopez JAS, 2010, CRIT REV BIOTECHNOL, V30, P63, DOI 10.3109/07388550903425201; Silva D, 2005, PROCESS BIOCHEM, V40, P2885, DOI 10.1016/j.procbio.2005.01.008; SOMOGYI M, 1945, J BIOL CHEM, V160, P61; Taragano V, 1997, BIOTECHNOL LETT, V19, P233, DOI 10.1023/A:1018301522997; Taskin E, 2008, J FOOD AGRIC ENVIRON, V6, P5; Teixeira JA, 2011, J APPL MICROBIOL, V111, P818, DOI 10.1111/j.1365-2672.2011.05099.x; Torres S, 2011, ENZYME MICROB TECH, V48, P123, DOI 10.1016/j.enzmictec.2010.04.004; Ustok FI, 2007, J BIOTECHNOL, V127, P322, DOI 10.1016/j.jbiotec.2006.07.010; van Maris AJA, 2006, ANTON LEEUW INT J G, V90, P391, DOI 10.1007/s10482-006-9085-7; Wilkins MR, 2007, PROCESS BIOCHEM, V42, P1614, DOI 10.1016/j.procbio.2007.09.006	47	35	36	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e109529	10.1371/journal.pone.0109529	http://dx.doi.org/10.1371/journal.pone.0109529			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337712	Green Submitted, gold, Green Published			2022-12-27	WOS:000343674800014
J	Margiotta-Casaluci, L; Owen, SF; Cumming, RI; de Polo, A; Winter, MJ; Panter, GH; Rand-Weaver, M; Sumpter, JP				Margiotta-Casaluci, Luigi; Owen, Stewart F.; Cumming, Rob I.; de Polo, Anna; Winter, Matthew J.; Panter, Grace H.; Rand-Weaver, Mariann; Sumpter, John P.			Quantitative Cross-Species Extrapolation between Humans and Fish: The Case of the Anti-Depressant Fluoxetine	PLOS ONE			English	Article							ENVIRONMENTAL RISK-ASSESSMENT; PLASMA-CONCENTRATIONS; HUMAN PHARMACEUTICALS; ENDOCRINE DISRUPTION; TRANSPORTER BINDING; ZEBRAFISH; NORFLUOXETINE; IDENTIFICATION; RESPONSES; DRUGS	Fish are an important model for the pharmacological and toxicological characterization of human pharmaceuticals in drug discovery, drug safety assessment and environmental toxicology. However, do fish respond to pharmaceuticals as humans do? To address this question, we provide a novel quantitative cross-species extrapolation approach (qCSE) based on the hypothesis that similar plasma concentrations of pharmaceuticals cause comparable target-mediated effects in both humans and fish at similar level of biological organization (Read-Across Hypothesis). To validate this hypothesis, the behavioural effects of the anti-depressant drug fluoxetine on the fish model fathead minnow (Pimephales promelas) were used as test case. Fish were exposed for 28 days to a range of measured water concentrations of fluoxetine (0.1, 1.0, 8.0, 16, 32, 64 mu g/L) to produce plasma concentrations below, equal and above the range of Human Therapeutic Plasma Concentrations (HTPCs). Fluoxetine and its metabolite, norfluoxetine, were quantified in the plasma of individual fish and linked to behavioural anxiety-related endpoints. The minimum drug plasma concentrations that elicited anxiolytic responses in fish were above the upper value of the HTPC range, whereas no effects were observed at plasma concentrations below the HTPCs. In vivo metabolism of fluoxetine in humans and fish was similar, and displayed bi-phasic concentration-dependent kinetics driven by the auto-inhibitory dynamics and saturation of the enzymes that convert fluoxetine into norfluoxetine. The sensitivity of fish to fluoxetine was not so dissimilar from that of patients affected by general anxiety disorders. These results represent the first direct evidence of measured internal dose response effect of a pharmaceutical in fish, hence validating the Read-Across hypothesis applied to fluoxetine. Overall, this study demonstrates that the qCSE approach, anchored to internal drug concentrations, is a powerful tool to guide the assessment of the sensitivity of fish to pharmaceuticals, and strengthens the translational power of the cross-species extrapolation.	[Margiotta-Casaluci, Luigi; de Polo, Anna; Sumpter, John P.] Brunel Univ, Inst Environm, London, England; [Margiotta-Casaluci, Luigi; Owen, Stewart F.; Cumming, Rob I.; Winter, Matthew J.; Panter, Grace H.] AstraZeneca, Global Environm, Freshwater Quarry, Brixham, England; [Rand-Weaver, Mariann] Brunel Univ, Sch Hlth Sci & Social Care, London, England	Brunel University; AstraZeneca; Brunel University	Margiotta-Casaluci, L (corresponding author), Brunel Univ, Inst Environm, London, England.	Luigi.Margiotta-Casaluci@brunel.ac.uk	sumpter, john/HGB-7584-2022; Margiotta-Casaluci, Luigi/A-5402-2011; Owen, Stewart/ABF-1216-2021	Margiotta-Casaluci, Luigi/0000-0001-6938-0396; Owen, Stewart/0000-0003-1398-7142; de Polo, Anna/0000-0002-5607-8048; Winter, Matthew/0000-0002-3668-6564	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/100646X/1]; AstraZeneca Global Environment research programme; Isambard Scholarship awarded by Brunel University; AstraZeneca; BBSRC [BB/I00646X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I00646X/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); AstraZeneca Global Environment research programme; Isambard Scholarship awarded by Brunel University; AstraZeneca(AstraZeneca); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by a Biotechnology and Biological Sciences Research Council (BBSRC) Research Grant (BB/100646X/1), co-funded by the AstraZeneca Global Environment research programme, to JPS and MR-W supporting LM-C. AdP was supported by the Isambard Scholarship awarded by Brunel University. BBSRC had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SFO is an employee of AstraZeneca; RIC, MJW and GHP were also AstraZeneca employees. AstraZeneca provided support in the form of salaries for authors SFO, RIC, MJW and GHP and grant to JPS and MR-W supporting LM-C, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Airhart MJ, 2007, NEUROTOXICOL TERATOL, V29, P652, DOI 10.1016/j.ntt.2007.07.005; ALTAMURA AC, 1994, CLIN PHARMACOKINET, V26, P201, DOI 10.2165/00003088-199426030-00004; Amsterdam JD, 1997, AM J PSYCHIAT, V154, P963; Anderson PD, 2012, ENVIRON TOXICOL CHEM, V31, P1407, DOI 10.1002/etc.1824; Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34; Baldwin D, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1718; Baldwin DS, 2011, INT J NEUROPSYCHOPH, V14, P697, DOI 10.1017/S1461145710001434; Baraban SC, 2007, CURR OPIN NEUROL, V20, P164, DOI 10.1097/WCO.0b013e328042bae0; Bencan Z, 2009, PHARMACOL BIOCHEM BE, V94, P75, DOI 10.1016/j.pbb.2009.07.009; BERGSTROM RF, 1988, BRIT J PSYCHIAT, V153, P47, DOI 10.1192/S0007125000297286; Berninger JP, 2010, TOXICOL LETT, V193, P69, DOI 10.1016/j.toxlet.2009.12.006; BJERKENSTEDT L, 1985, EUR J CLIN PHARMACOL, V28, P553, DOI 10.1007/BF00544066; Boxall ABA, 2012, ENVIRON HEALTH PERSP, V120, P1221, DOI 10.1289/ehp.1104477; Cachat J, 2010, NAT PROTOC, V5, P1786, DOI 10.1038/nprot.2010.140; Calabrese E.J., 1991, PRINCIPLES ANIMAL EX; Caldwell DJ, 2014, CHEMOSPHERE, V115, P4, DOI 10.1016/j.chemosphere.2014.01.021; Celander MC, 2011, ENVIRON TOXICOL CHEM, V30, P52, DOI 10.1002/etc.382; Charlier C, 2003, THER DRUG MONIT, V25, P738, DOI 10.1097/00007691-200312000-00014; Dulawa SC, 2004, NEUROPSYCHOPHARMACOL, V29, P1321, DOI 10.1038/sj.npp.1300433; Eap CB, 2001, J CLIN PSYCHOPHARM, V21, P330, DOI 10.1097/00004714-200106000-00013; Egan RJ, 2009, BEHAV BRAIN RES, V205, P38, DOI 10.1016/j.bbr.2009.06.022; Ellis LD, 2012, BEHAV BRAIN RES, V233, P450, DOI 10.1016/j.bbr.2012.05.043; Fjordside L, 1999, PHARMACOGENETICS, V9, P55, DOI 10.1097/00008571-199902000-00008; Goldstone JV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-643; Gould GG, 2007, BASIC CLIN PHARMACOL, V101, P203, DOI 10.1111/j.1742-7843.2007.00100.x; Gunnarsson L, 2008, ENVIRON SCI TECHNOL, V42, P5807, DOI 10.1021/es8005173; Hiemke C, 2000, PHARMACOL THERAPEUT, V85, P11, DOI 10.1016/S0163-7258(99)00048-0; Huggett DB, 2003, HUM ECOL RISK ASSESS, V9, P1789, DOI 10.1080/714044797; Ibrahim L, 2013, ENVIRON SCI POLLUT R, V20, P2679, DOI 10.1007/s11356-013-1471-x; Jannuzzi G, 2002, THER DRUG MONIT, V24, P616, DOI 10.1097/00007691-200210000-00006; Johnson AC, 2007, ENVIRON POLLUT, V146, P155, DOI 10.1016/j.envpol.2006.05.037; KELLY MW, 1989, THER DRUG MONIT, V11, P165, DOI 10.1097/00007691-198903000-00008; Kim YJ, 2004, NEUROSCI LETT, V355, P29, DOI 10.1016/j.neulet.2003.10.024; Klooster J, 2009, J CHEM NEUROANAT, V37, P254, DOI 10.1016/j.jchemneu.2009.02.004; Kohlert JG, 2012, PSYCHOL REP, V110, P51, DOI 10.2466/02.13.PR0.110.1.51-62; Kokel D, 2010, NAT CHEM BIOL, V6, P231, DOI 10.1038/NCHEMBIO.307; Kristensen JH, 1999, BRIT J CLIN PHARMACO, V48, P521, DOI 10.1046/j.1365-2125.1999.00040.x; Kummerer K, 2009, J ENVIRON MANAGE, V90, P2354, DOI 10.1016/j.jenvman.2009.01.023; LaLone CA, 2013, ENVIRON TOXICOL CHEM, V32, P2528, DOI 10.1002/etc.2330; Levin ED, 2007, PHYSIOL BEHAV, V90, P54, DOI 10.1016/j.physbeh.2006.08.026; Lillesaar C, 2011, J CHEM NEUROANAT, V41, P294, DOI 10.1016/j.jchemneu.2011.05.009; Lipsky M S, 2001, J Am Board Fam Pract, V14, P362; Lopez-Patino MA, 2008, PHYSIOL BEHAV, V93, P160, DOI 10.1016/j.physbeh.2007.08.013; Lundmark J, 2001, THER DRUG MONIT, V23, P139, DOI 10.1097/00007691-200104000-00008; Margiotta-Casaluci L, 2013, AQUAT TOXICOL, V128, P113, DOI 10.1016/j.aquatox.2012.12.003; Maximino C, 2010, BEHAV BRAIN RES, V214, P157, DOI 10.1016/j.bbr.2010.05.031; McRobb FM, 2014, ENVIRON SCI TECHNOL, V48, P1964, DOI 10.1021/es404568a; Mennigen JA, 2011, J TOXICOL ENV HEAL B, V14, P387, DOI 10.1080/10937404.2011.578559; NORMAN TR, 1993, INT CLIN PSYCHOPHARM, V8, P25, DOI 10.1097/00004850-199300810-00004; Oakes Ken D., 2010, Integrated Environmental Assessment and Management, V6, P524, DOI 10.1002/ieam.77; Owens MJ, 1997, J PHARMACOL EXP THER, V283, P1305; Perkins EJ, 2013, ENVIRON HEALTH PERSP, V121, P1002, DOI 10.1289/ehp.1306638; Pittman JT, 2013, PHARMACOL BIOCHEM BE, V106, P137, DOI 10.1016/j.pbb.2013.03.013; PRESKORN SH, 1994, J CLIN PSYCHOPHARM, V14, P90; Preskorn SH, 1996, CLIN PHARMACOL THER, V59, pPII85; Preskorn SH, 1996, CLIN PHARM SELECTIVE; Rand-Weaver M, 2013, ENVIRON SCI TECHNOL, V47, P11384, DOI 10.1021/es402065a; Rhomberg LR, 2004, 3W0477NASX; Rihel J, 2012, DEV NEUROBIOL, V72, P373, DOI 10.1002/dneu.20910; Rihel J, 2010, SCIENCE, V327, P348, DOI 10.1126/science.1183090; Ring BJ, 2001, J PHARMACOL EXP THER, V297, P1044; Runnalls TJ, 2010, HUM ECOL RISK ASSESS, V16, P1318, DOI 10.1080/10807039.2010.526503; Schulz M, 2003, PHARMAZIE, V58, P447; Scordo MG, 2005, BASIC CLIN PHARMACOL, V97, P296, DOI 10.1111/j.1742-7843.2005.pto_194.x; Seiler JP, 2002, TOXICOL LETT, V131, P105, DOI 10.1016/S0378-4274(02)00045-0; Smeets WJAJ, 2000, BRAIN RES REV, V33, P308, DOI 10.1016/S0165-0173(00)00034-5; Sumpter JP, 2014, AQUAT TOXICOL, V151, P57, DOI 10.1016/j.aquatox.2013.12.010; Sumpter JP, 2006, ENVIRON SCI TECHNOL, V40, P5478, DOI 10.1021/es052554d; Sundvik M, 2012, J COMP NEUROL, V520, P3827, DOI 10.1002/cne.23126; TASKER TCG, 1989, ACTA PSYCHIAT SCAND, V80, P152, DOI 10.1111/j.1600-0447.1989.tb07201.x; Valenti TW, 2012, ENVIRON SCI TECHNOL, V46, P2427, DOI 10.1021/es204164b; Valenti TW, 2009, ENVIRON TOXICOL CHEM, V28, P2685, DOI 10.1897/08-546.1; Winter Matthew J., 2010, Integrated Environmental Assessment and Management, V6, P38, DOI 10.1897/IEAM_2009-044.1; Wolman M, 2012, DEV NEUROBIOL, V72, P366, DOI 10.1002/dneu.20872; Wong RY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-348; Wong RY, 2012, BEHAVIOUR, V149, P1205, DOI 10.1163/1568539X-00003018; Zar JH., 2010, BIOSTAT ANAL, V5th; Zhang YH, 2000, BRAIN RES, V855, P58, DOI 10.1016/S0006-8993(99)02289-1	78	80	80	3	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110467	10.1371/journal.pone.0110467	http://dx.doi.org/10.1371/journal.pone.0110467			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338069	Green Published, Green Submitted, gold			2022-12-27	WOS:000343674800046
J	Liu, Y; Jiang, YG				Liu, Yu; Jiang, Yu-Gang			Podocalyxin Promotes Glioblastoma Multiforme Cell Invasion and Proliferation via beta-Catenin Signaling	PLOS ONE			English	Article							PROSTATE-CANCER; MALIGNANT GLIOMAS; POOR-PROGNOSIS; P38 MAPK; ACTIVATION; PROTEIN; OVEREXPRESSION; SURVIVAL; PATHWAY; BREAST	Both podocalyxin (PODX) and beta-catenin (beta-cat) signaling reportedly play important roles in glioblastoma multiforme (GBM) progression. In this study, we for the first time explored crosstalk between PODX and beta-cat signaling in GBM cells, and assessed its impact on GBM cell invasion and proliferation. Stable overexpression of PODX in LN-229 and U-118 MG human GBM cells increased the soluble/intracellular beta-cat level, TOPflash luciferase reporter activity, the mRNA levels of beta-cat signaling target genes, matrix metalloproteinase 9 (MMP9) expression/activity, and cell invasion and proliferation, which was abolished by selective p38 mitogen-activated protein kinase (MAPK) inhibitor PD169316 and selective beta-cat signaling inhibitor CCT031374. On the other hand, stable knockdown of PODX in LN-229 and U-118 MG cells decreased the soluble beta-cat level, TOPflash luciferase reporter activity, the mRNA levels of beta-cat signaling target genes, MMP9 expression/activity, and cell invasion and proliferation, which was completely reversed by overexpression of a constitutively active beta-cat mutant. In addition, overexpression of PODX induced p38 MAPK activity and inactivating phosphorylation of glycogen synthase kinase-3 beta (GSK-3 beta) at serine 389 in LN-229 and U-118 MG cells, which was abolished by PD169316, but not CCT031374; knockdown of PODX decreased p38 MAPK activity and inactivating phosphorylation of GSK-3 beta at serine 389 in both cell lines, which was not significantly affected by overexpression of constitutively active beta-cat. In conclusion, this study indicates that PODX promotes GBM cell invasion and proliferation by elevating the soluble beta-cat level/beta-cat signaling through the p38 MAPK/GSK-3 beta pathway. Uncovering the PODX/beta-cat signaling axis adds new insights not only into the biological functions of PODX and beta-cat, but also into the molecular mechanisms underlying GBM progression.	[Liu, Yu; Jiang, Yu-Gang] Cent S Univ, Xiangya Hosp 2, Dept Neurosurg, Changsha, Hunan, Peoples R China	Central South University	Jiang, YG (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Neurosurg, Changsha, Hunan, Peoples R China.	13707315567@139.com			Hunan Provincial Natural Science Foundation, Hunan, China [14A2256]	Hunan Provincial Natural Science Foundation, Hunan, China	This work was supported by Hunan Provincial Natural Science Foundation (grants #14A2256), Hunan, China. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cawthorn WP, 2007, CELL DEATH DIFFER, V14, P1361, DOI 10.1038/sj.cdd.4402127; Cheng BQ, 2014, GENET MOL RES, V13, P5115, DOI 10.4238/2014.July.7.4; Chesire DR, 2003, ENDOCR-RELAT CANCER, V10, P537, DOI 10.1677/erc.0.0100537; Ewan K, 2010, CANCER RES, V70, P5963, DOI 10.1158/0008-5472.CAN-10-1028; Fu YX, 2003, BIOCHEM BIOPH RES CO, V310, P391, DOI 10.1016/j.bbrc.2003.09.021; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Kaprio T, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-493; Kaur N, 2013, MOL CELL NEUROSCI, V54, P44, DOI 10.1016/j.mcn.2013.01.001; Larsson A, 2011, BRIT J CANCER, V105, P666, DOI 10.1038/bjc.2011.295; Lee WS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068030; Li Y, 2012, MOL MED REP, V5, P1391, DOI 10.3892/mmr.2012.842; Medina Miguel, 2011, Int J Alzheimers Dis, V2011, P479249, DOI 10.4061/2011/479249; Nielsen JS, 2009, J AM SOC NEPHROL, V20, P1669, DOI 10.1681/ASN.2008070782; Nusse R, 1999, TRENDS GENET, V15, P1, DOI 10.1016/S0168-9525(98)01634-5; Pifer MA, 2014, AM J SPORT MED, V42, P1211, DOI 10.1177/0363546514524710; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sizemore S, 2007, CANCER RES, V67, P6183, DOI 10.1158/0008-5472.CAN-06-3575; Somasiri A, 2004, CANCER RES, V64, P5068, DOI 10.1158/0008-5472.CAN-04-0240; Spolidoro M, 2012, CEREB CORTEX, V22, P725, DOI 10.1093/cercor/bhr158; Sun P, 2006, MOL PHARMACOL, V69, P520, DOI 10.1124/mol.105.019620; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Von Schulz-Hausmann SA, 2014, ANTICANCER RES, V34, P4101; Wang X, 2004, MOL PSYCHIATR, V9, P65, DOI 10.1038/sj.mp.4001339; Wang Z, 2014, CARCINOGENESIS; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wu H, 2013, EXP THER MED, V5, P1025, DOI 10.3892/etm.2013.957; Yasuoka H, 2012, J CLIN PATHOL, V65, P399, DOI 10.1136/jclinpath-2011-200359; Zhang D, 2011, J BIOL CHEM, V286, P44913, DOI 10.1074/jbc.M111.310052; Zhang ZY, 2014, EUR J NEUROSCI, V40, P2859, DOI 10.1111/ejn.12655	30	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111343	10.1371/journal.pone.0111343	http://dx.doi.org/10.1371/journal.pone.0111343			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25349993	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943100066
J	Yeh, JJ; Chen, HJ; Li, TC; Wong, YS; Tang, HC; Yeh, TC; Kao, CH				Yeh, Jun-Jun; Chen, Hsuan-Ju; Li, Tsai-Chung; Wong, Yi-Sin; Tang, Hsien-Chin; Yeh, Ting-Chun; Kao, Chia-Hung			Association between Sjogren's Syndrome and Respiratory Failure: Put Airway, Interstitia, and Vessels Close Together: A National Cohort Study	PLOS ONE			English	Article							CONNECTIVE-TISSUE DISEASE; PULMONARY INVOLVEMENT; LUNG-DISEASE; MANIFESTATIONS; HYPERTENSION; ALVEOLITIS; ABNORMALITIES; REAPPRAISAL; POPULATION; DIAGNOSIS	Objectives: Few studies have evaluated the association between Sjogren's syndrome (SS) and respiratory failure (RF). Thus, we conducted a retrospective national cohort study to investigate whether Sjogren's syndrome (SS) increases the risk of respiratory failure (RF). Methods: The cohort consisted of 4954 newly diagnosed patients with SS but without a previous diagnosis of RF, and 19816 patients as the comparison cohort from the catastrophic illnesses registry, obtained from the 2000-2005 period. All of the study participants were followed from the index date to December 31, 2011. We analyzed the association between the risk of RF and SS by using a Cox proportional hazards regression model, controlling for sex, age, and comorbidities. Results: The overall incidence rate of RF showed a 3.21-fold increase in the SS cohort compared with the comparison cohort. The adjusted HR of RF was 3.04 for the SS cohort compared with the comparison cohort, after we adjusted for sex, age, and comorbidities. The HRs of RF for patients with primary SS and secondary SS compared with the comparison cohort were 2.99 and 3.93, respectively (P for trend,. 001). The HRs of RF increased as the severity of SS increased, from 2.34 for those with no inpatient care experience to 5.15 for those with inpatient care experience (P for trend, <.001). Conclusion: This study indicates that clinical physicians should not only consider secondary SS but also primary SS as a critical factor that increases the risk of RF.	[Yeh, Jun-Jun; Wong, Yi-Sin; Tang, Hsien-Chin; Yeh, Ting-Chun] Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Family Med & Pulm Med, Chiayi, Taiwan; [Yeh, Jun-Jun] Chia Nan Univ Pharm & Sci, Tainan, Taiwan; [Yeh, Jun-Jun] Meiho Univ, Pingtung, Taiwan; [Chen, Hsuan-Ju] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Chen, Hsuan-Ju] China Med Univ, Coll Med, Taichung, Taiwan; [Li, Tsai-Chung] China Med Univ, Coll Management, Grad Inst Biostat, Taichung, Taiwan; [Li, Tsai-Chung] Asia Univ, Coll Hlth Sci, Dept Healthcare Adm, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan	Chia Nan University of Pharmacy & Science; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Kao, CH (corresponding author), China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan.	d10040@mail.cmuh.org.tw	Li, Tsai-Chung/P-2052-2015	Li, Tsai-Chung/0000-0002-3346-7462	China Medical University Hospital [DMR-102-014, DMR-102-023]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW103-TDU-B-212-113002]; Taiwan Ministry Health and Welfare Cancer Research Center for Excellence [MOHW103-TD-B-111-03]; International Research-Intensive Centers of Excellence in Taiwan (I-RiCE) [NSC101-2911-I-002-303]	China Medical University Hospital; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; Taiwan Ministry Health and Welfare Cancer Research Center for Excellence; International Research-Intensive Centers of Excellence in Taiwan (I-RiCE)	This study was supported by study projects DMR-102-014 and DMR-102-023 in China Medical University Hospital, the Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW103-TDU-B-212-113002), the Taiwan Ministry Health and Welfare Cancer Research Center for Excellence (MOHW103-TD-B-111-03), and the International Research-Intensive Centers of Excellence in Taiwan (I-RiCE) (NSC101-2911-I-002-303). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Afessa B, 2004, CHEST, V126, P1905, DOI 10.1378/chest.126.6.1905; Asherson RA, 2007, CLIN REV ALLERG IMMU, V32, P153, DOI 10.1007/s12016-007-0012-0; Booth CM, 2011, CURR ONCOL, V18, P105; Burgel PR, 2013, EUR RESPIR REV, V22, P131, DOI 10.1183/09059180.00001313; Chiorini JA, 2009, J AUTOIMMUN, V33, P190, DOI 10.1016/j.jaut.2009.09.009; Chung WS, 2014, J RHEUMATOL, V41, P909, DOI 10.3899/jrheum.131345; Chung WS, 2014, EUR RESPIR J, V43, P801, DOI 10.1183/09031936.00043313; CONSTANTOPOULOS SH, 1985, CHEST, V88, P226, DOI 10.1378/chest.88.2.226; DALAVANGA YA, 1991, CHEST, V99, P1394, DOI 10.1378/chest.99.6.1394; Deheinzelin D, 1996, AM J RESP CRIT CARE, V154, P794, DOI 10.1164/ajrccm.154.3.8810621; Enomoto Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073774; Fernandez-Perez ER, 2008, CHEST, V133, P1113, DOI 10.1378/chest.07-1481; Fischer A, 2012, LANCET, V380, P689, DOI 10.1016/S0140-6736(12)61079-4; FRANKLIN DJ, 1986, OTOLARYNG HEAD NECK, V94, P230, DOI 10.1177/019459988609400217; Fukumura A, 2001, Ryumachi, V41, P37; Gomes Pde S, 2012, J ORAL MAXILLOFAC RE, V3, pe3; Gunning JE, 2003, SURGERY, V21, P72; HUMBERT P, 1988, ANN MED INTERNE, V139, P159; Ismael S, 2014, RESP CARE, V59, pE156, DOI 10.4187/respcare.02929; Ito I, 2005, AM J RESP CRIT CARE, V171, P632, DOI 10.1164/rccm.200403-417OC; Juarez M, 2014, ARTHRIT CARE RES, V66, P757, DOI 10.1002/acr.22227; Kikuchi A, 1996, J Obstet Gynaecol Res, V22, P421; Kokosi M, 2010, CLIN CHEST MED, V31, P489, DOI 10.1016/j.ccm.2010.05.007; Konstantinides SV, 2014, EUR RESPIR J, V43, P694, DOI 10.1183/09031936.00009414; Launay D, 2007, MEDICINE, V86, P299, DOI 10.1097/MD.0b013e3181579781; LEWANDOWSKI K, 1995, AM J RESP CRIT CARE, V151, P1121; Meiners PM, 2014, ANN RHEUM DIS, V73, P1393, DOI 10.1136/annrheumdis-2013-204653; Moerman RV, 2013, DRUG AGING, V30, P137, DOI 10.1007/s40266-013-0050-7; Naffaa Mohammad, 2013, Isr Med Assoc J, V15, P195; Nannini C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003569; NEWBALL HH, 1977, AM REV RESPIR DIS, V115, P295; PAPATHANASIOU MP, 1986, CHEST, V90, P370, DOI 10.1378/chest.90.3.370; Papiris SA, 1999, ANN RHEUM DIS, V58, P61, DOI 10.1136/ard.58.1.61; Papiris SA, 2007, RESP MED, V101, P84, DOI 10.1016/j.rmed.2006.04.005; Perez-De-Lis M, 2010, LUPUS, V19, P941, DOI 10.1177/0961203310367504; Pirildar T, 2010, RHEUMATOL INT, V30, P599, DOI 10.1007/s00296-009-1023-3; Roussos C, 2003, Eur Respir J Suppl, V47, p3s; Salaffi F, 1998, BRIT J RHEUMATOL, V37, P263; Sarkar Pralay K, 2009, Indian J Chest Dis Allied Sci, V51, P93; SEGAL I, 1981, THORAX, V36, P286, DOI 10.1136/thx.36.4.286; STRIMLAN CV, 1976, CHEST, V70, P354, DOI 10.1378/chest.70.3.354; Thomas E, 1998, BRIT J RHEUMATOL, V37, P1069; Tuder RM, 1998, CHEST, V114, p1S, DOI 10.1378/chest.114.1_Supplement.1S-a; Usuba FS, 2014, CLINICS, V69, P158, DOI 10.6061/clinics/2014(03)02; Vij R, 2013, CHEST, V143, P814, DOI 10.1378/chest.12-0741; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; VITALI C, 1985, ANN RHEUM DIS, V44, P455, DOI 10.1136/ard.44.7.455; WALLAERT B, 1986, AM REV RESPIR DIS, V133, P574; Wright SA, 2003, RHEUMATOLOGY, V42, P697, DOI 10.1093/rheumatology/keg149; Yazisiz V, 2010, RHEUMATOL INT, V30, P1317, DOI 10.1007/s00296-009-1152-8	50	0	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110783	10.1371/journal.pone.0110783	http://dx.doi.org/10.1371/journal.pone.0110783			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350278	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943100041
J	Chiang, HH; Tseng, FY; Wang, CY; Chen, CL; Chen, YC; See, TT; Chen, HF				Chiang, Hou-Hsien; Tseng, Fen-Yu; Wang, Chih-Yuan; Chen, Chi-Ling; Chen, Yi-Chun; See, Ting-Ting; Chen, Hua-Fen			All-Cause Mortality in Patients with Type 2 Diabetes in Association with Achieved Hemoglobin A(1c), Systolic Blood Pressure, and Low-Density Lipoprotein Cholesterol Levels	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR OUTCOMES; GLUCOSE CONTROL; RISK-FACTOR; MYOCARDIAL-INFARCTION; PEOPLE; COMPLICATIONS; DEATH; SIMVASTATIN; REDUCTION	Background: To identify the ranges of hemoglobin A(1c) (HbA1c), systolic blood pressure (SBP), and low-density lipoprotein cholesterol (LDL-C) levels which are associated with the lowest all-cause mortality. Methods: A retrospective cohort of 12,643 type 2 diabetic patients (aged >= 18 years) were generated from 2002 to 2010, in Far-Eastern Memorial Hospital, New Taipei city, Taiwan. Patients were identified to include any outpatient diabetes diagnosis (ICD-9: 250), and drug prescriptions that included any oral hypoglycemic agents or insulin prescribed during the 6 months following their first outpatient visit for diabetes. HbA1c, SBP, and LDL-C levels were assessed by the mean value of all available data, from index date to death or censor date. Deaths were ascertained by matching patient records with the Taiwan National Register of Deaths. Results: Our results showed general U-shaped associations, where the lowest hazard ratios occurred at HbA1c 7.0-8.0%, SBP 130-140 mmHg, and LDL-C 100-130 mg/dL. The risk of mortality gradually increases if the patient's mean HbA1c, SBP, or LDL-C during the follow-up period was higher or lower than these ranges. In comparison to the whole population, the adjusted hazard ratio (95% CI) for patients with HbA1c 7.0-8.0%, SBP 130-140 mmHg, and LDL-C 100-130 mg/dL were 0.69 (0.62-0.77), 0.80 (0.72-0.90), and 0.68 (0.61-0.75), respectively. Conclusions: In our type 2 diabetic cohort, the patients with HbA1c 7.0-8.0%, SBP 130-140 mmHg, or LDL-C 100-130 mg/dL had the lowest all-cause mortality. Additional research is needed to confirm these associations and to further investigate their detailed mechanisms.	[Chiang, Hou-Hsien; See, Ting-Ting; Chen, Hua-Fen] Far Eastern Mem Hosp, Dept Internal Med, Sect Endocrinol & Metab, New Taipei City, Taiwan; [Tseng, Fen-Yu; Wang, Chih-Yuan] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Internal Med, Taipei 10764, Taiwan; [Chen, Chi-Ling; Chen, Yi-Chun] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan	Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University	See, TT (corresponding author), Far Eastern Mem Hosp, Dept Internal Med, Sect Endocrinol & Metab, New Taipei City, Taiwan.	ting2see@gmail.com		Chiang, Hou-Hsien/0000-0002-4801-0262; WANG, CHIH-YUAN/0000-0002-6742-3935; Tseng, Fen-Yu/0000-0003-1571-5255	Section of Endocrinology & Metabolism, Department of Internal Medicine, Far-Eastern Memorial Hospital	Section of Endocrinology & Metabolism, Department of Internal Medicine, Far-Eastern Memorial Hospital	This research was supported by the funds of Section of Endocrinology & Metabolism, Department of Internal Medicine, Far-Eastern Memorial Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Chen HF, 2011, DIABETES CARE, V34, P1177, DOI 10.2337/dc10-2006; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Colayco DC, 2011, DIABETES CARE, V34, P77, DOI 10.2337/dc10-1318; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Collins R, 2003, LANCET, V361, P2005; Cooper-DeHoff RM, 2010, JAMA-J AM MED ASSOC, V304, P61, DOI 10.1001/jama.2010.884; Currie CJ, 2010, LANCET, V375, P481, DOI 10.1016/S0140-6736(09)61969-3; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; de Lemos JA, 2004, JAMA-J AM MED ASSOC, V292, P1307, DOI 10.1001/jama.292.11.1307; Dharmarajan K, 2013, JAMA-J AM MED ASSOC, V309, P355, DOI 10.1001/jama.2012.216476; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Eeg-Olofsson K, 2010, J INTERN MED, V268, P471, DOI 10.1111/j.1365-2796.2010.02265.x; Epstein AE, 2013, J AM COLL CARDIOL, V62, P2000, DOI 10.1016/j.jacc.2013.05.086; Gerstein HC, 2008, ARCH INTERN MED, V168, P1699, DOI 10.1001/archinte.168.15.1699; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gerstein HC, 2011, NEW ENGL J MED, V364, P818, DOI 10.1056/NEJMoa1006524; Goldberg RB, 1998, CIRCULATION, V98, P2513, DOI 10.1161/01.CIR.98.23.2513; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Hayes AJ, 2011, DIABETIC MED, V28, P428, DOI 10.1111/j.1464-5491.2010.03189.x; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Huang ES, 2011, DIABETES CARE, V34, P1329, DOI 10.2337/dc10-2377; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Kennedy BS, 2002, NEUROEPIDEMIOLOGY, V21, P131, DOI 10.1159/000054810; Li HY, 2012, J FORMOS MED ASSOC, V111, P645, DOI 10.1016/j.jfma.2012.09.013; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Pyorala K, 1997, DIABETES CARE, V20, P614, DOI 10.2337/diacare.20.4.614; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Schupf N, 2005, J AM GERIATR SOC, V53, P219, DOI 10.1111/j.1532-5415.2005.53106.x; Sever PS, 2005, DIABETES CARE, V28, P1151, DOI 10.2337/diacare.28.5.1151; Shepherd J, 2006, DIABETES CARE, V29, P1220, DOI 10.2337/dc05-2465; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Tikhonoff V, 2005, J AM GERIATR SOC, V53, P2159, DOI 10.1111/j.1532-5415.2005.00492.x; Tseng CH, 2004, DIABETES CARE, V27, P1605, DOI 10.2337/diacare.27.7.1605; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vamos EP, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5567; Wright RJ, 2010, DIABETES CARE, V33, P1591, DOI 10.2337/dc10-0013; Wu MY, 2012, AM J KIDNEY DIS, V60, P548, DOI 10.1053/j.ajkd.2012.03.018; Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795	43	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e109501	10.1371/journal.pone.0109501	http://dx.doi.org/10.1371/journal.pone.0109501			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347712	Green Published, gold, Green Submitted			2022-12-27	WOS:000347994900010
J	Li, CG; Zhang, E; Sun, Y; Lee, PS; Zhan, YZ; Guo, YN; Osorio, JC; Rosas, IO; Xu, KF; Kwiatkowski, DJ; Yu, JJ				Li, Chenggang; Zhang, Erik; Sun, Yang; Lee, Po-Shun; Zhan, Yongzhong; Guo, Yanan; Osorio, Juan C.; Rosas, Ivan O.; Xu, Kai-Feng; Kwiatkowski, David J.; Yu, Jane J.			Rapamycin-Insensitive Up-Regulation of Adipocyte Phospholipase A2 in Tuberous Sclerosis and Lymphangioleiomyomatosis	PLOS ONE			English	Article							REPRODUCTIVE-TRACT LEIOMYOMATA; TUMOR-SUPPRESSOR TSC2; MAMMALIAN TARGET; TSC1-TSC2 COMPLEX; SMOOTH-MUSCLE; RODENT MODEL; CELL-GROWTH; GENE; ANGIOMYOLIPOMA; ACTIVATION	Tuberous sclerosis syndrome (TSC) is an autosomal dominant tumor suppressor gene syndrome affecting multiple organs, including renal angiomyolipomas and pulmonary lymphangioleiomyomatosis (LAM). LAM is a female-predominant interstitial lung disease characterized by the progressive cyst formation and respiratory failure, which is also seen in sporadic patients without TSC. Mutations in TSC1 or TSC2 cause TSC, result in hyperactivation of mammalian target of rapamycin (mTOR), and are also seen in LAM cells in sporadic LAM. We recently reported that prostaglandin biosynthesis and cyclooxygenase-2 were deregulated in TSC and LAM. Phospholipase A2 (PLA2) is the rate-limiting enzyme that catalyzes the conversion of plasma membrane phospholipids into prostaglandins. In this study, we identified upregulation of adipocyte AdPLA2 (PLA2G16) in LAM nodule cells using publicly available expression data. We showed that the levels of AdPLA2 transcript and protein were higher in LAM lungs compared with control lungs. We then showed that TSC2 negatively regulates the expression of AdPLA2, and loss of TSC2 is associated with elevated production of prostaglandin E-2 (PGE(2)) and prostacyclin (PGI(2)) in cell culture models. Mouse model studies also showed increased expression of AdPLA2 in xenograft tumors, estrogen-induced lung metastatic lesions of Tsc2 null leiomyoma-derived cells, and spontaneous renal cystadenomas from Tsc2(+/-) mice. Importantly, rapamycin treatment did not affect the expression of AdPLA2 and the production of PGE(2) by TSC2-deficient mouse embryonic fibroblast (Tsc2(-/-) MEFs), rat uterine leiomyoma-derived ELT3 cells, and LAM patient-associated renal angiomyolipoma-derived "mesenchymal'' cells. Furthermore, methyl arachidonyl fluorophosphate (MAFP), a potent irreversible PLA2 inhibitor, selectively suppressed the growth and induced apoptosis of TSC2-deficient LAM patient-derived cells relative to TSC2-addback cells. Our findings suggest that AdPLA2 plays an important role in promoting tumorigenesis and disease progression by modulating the production of prostaglandins and may serve as a potential therapeutic target in TSC and LAM.	[Li, Chenggang; Zhang, Erik; Sun, Yang; Lee, Po-Shun; Guo, Yanan; Osorio, Juan C.; Rosas, Ivan O.; Kwiatkowski, David J.; Yu, Jane J.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02163 USA; [Zhan, Yongzhong; Xu, Kai-Feng] Peking Union Med Coll, Beijing 100021, Peoples R China	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Yu, JJ (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02163 USA.	jyu13@rics.bwh.harvard.edu	, 孙阳/B-2495-2016; Xu, Kai-Feng/AAO-2445-2020	, 孙阳/0000-0002-1463-689X; Osorio, Juan C/0000-0001-8090-1551	National Cancer Institute [PO1CA120964]; National Heart, Lung and blood Institute [HL098216]; Department of Defense [W81XWH-12-1-0442]; LAM Foundation [LAM00101F01-14]; Biomedical Research Institute (BRI); NATIONAL CANCER INSTITUTE [P01CA120964] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098331] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung and blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Defense(United States Department of Defense); LAM Foundation; Biomedical Research Institute (BRI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the following: The National Cancer Institute PO1 (PO1CA120964, http://www.cancer.gov/) to DJK; The National Heart, Lung and blood Institute (HL098216, https://www.nhlbi.nih.gov/) and Department of Defense Exploratory Idea Development Award (W81XWH-12-1-0442, http://www. defense.gov/) to JJY; The LAM Foundation Fellowship Award (LAM00101F01-14, http://www.thelamfoundation.org/) and Biomedical Research Institute (BRI) -BWH Micro Grants (http://www.brighamandwomens.org/research/microgrants/default.aspx) to CL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbaraly TN, 2013, CAN MED ASSOC J, V185, pE763, DOI 10.1503/cmaj.122072; Astrinidis A, 2002, ONCOGENE, V21, P8470, DOI 10.1038/sj.onc.1205962; Barnes EA, 2010, AM J PATHOL, V177, P1765, DOI 10.2353/ajpath.2010.090233; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Bissler JJ, 2013, LANCET, V381, P817, DOI 10.1016/S0140-6736(12)61767-X; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; Burke JE, 2009, CARDIOVASC DRUG THER, V23, P49, DOI 10.1007/s10557-008-6132-9; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Dibble CC, 2012, MOL CELL, V47, P535, DOI 10.1016/j.molcel.2012.06.009; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Duffy K, 2002, MODERN PATHOL, V15, P205, DOI 10.1038/modpathol.3880517; Duncan RE, 2008, J BIOL CHEM, V283, P25428, DOI 10.1074/jbc.M804146200; El-Hashemite N, 2003, CANCER RES, V63, P5173; EVERITT JI, 1995, AM J PATHOL, V146, P1556; FitzGerald GA, 2001, NEW ENGL J MED, V345, P433, DOI 10.1056/NEJM200108093450607; Franz DN, 2006, ANN NEUROL, V59, P490, DOI 10.1002/ana.20784; Goncharova EA, 2006, AM J RESP CELL MOL, V34, P473, DOI 10.1165/rcmb.2005-0374OC; Hartman TR, 2009, HUM MOL GENET, V18, P151, DOI 10.1093/hmg/ddn325; HOWE SR, 1995, ENDOCRINOLOGY, V136, P4996, DOI 10.1210/en.136.11.4996; HOWE SR, 1995, AM J PATHOL, V146, P1568; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; HUANG Z, 1994, ANAL BIOCHEM, V222, P110, DOI 10.1006/abio.1994.1461; Jaworski K, 2009, NAT MED, V15, P159, DOI 10.1038/nm.1904; Kang SA, 2013, SCIENCE, V341, P364, DOI 10.1126/science.1236566; Karbowniczek M, 2004, J BIOL CHEM, V279, P29930, DOI 10.1074/jbc.M402591200; Karbowniczek M, 2003, AM J PATHOL, V162, P491, DOI 10.1016/S0002-9440(10)63843-6; Karbowniczek M, 2006, J BIOL CHEM, V281, P25447, DOI 10.1074/jbc.M605273200; Karbowniczek M, 2010, J CLIN INVEST, V120, P93, DOI 10.1172/JCI40221; Kenerson HL, 2002, CANCER RES, V62, P5645; Krymskaya Vera P, 2008, Proc Am Thorac Soc, V5, P119, DOI 10.1513/pats.200705-061VS; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; Lee L, 2005, GENE CHROMOSOME CANC, V42, P213, DOI 10.1002/gcc.20118; Lee PS, 2010, AM J RESP CELL MOL, V42, P227, DOI 10.1165/rcmb.2009-0050OC; Li CG, 2014, J EXP MED, V211, P15, DOI 10.1084/jem.20131080; Liu Y, 2013, CANCER DISCOV, V3, P870, DOI 10.1158/2159-8290.CD-13-0015; Lu TP, 2010, CANCER EPIDEM BIOMAR, V19, P2590, DOI 10.1158/1055-9965.EPI-10-0332; Matsumoto Y, 1999, AM J RESP CELL MOL, V21, P327, DOI 10.1165/ajrcmb.21.3.3693; McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; Muller R, 2004, J CANCER RES CLIN, V130, P429, DOI 10.1007/s00432-004-0570-y; Neuman NA, 2011, EMBO MOL MED, V3, P189, DOI 10.1002/emmm.201100131; Onda H, 1999, J CLIN INVEST, V104, P687, DOI 10.1172/JCI7319; Pacheco-Rodriguez G, 2007, CANCER RES, V67, P10573, DOI 10.1158/0008-5472.CAN-07-1356; Pacheco-Rodriguez G, 2009, J IMMUNOL, V182, P1270, DOI 10.4049/jimmunol.182.3.1270; Pezze PD, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002469; Plank TL, 1998, CANCER RES, V58, P4766; Prevost N, 2009, BLOOD, V113, P447, DOI 10.1182/blood-2008-06-162032; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Young LR, 2013, LANCET RESP MED, V1, P445, DOI 10.1016/S2213-2600(13)70090-0; Young LR, 2010, CHEST, V138, P674, DOI 10.1378/chest.10-0573; Yu J, 2004, AM J PHYSIOL-LUNG C, V286, pL694, DOI 10.1152/ajplung.00204.2003; Yu JJ, 2009, P NATL ACAD SCI USA, V106, P2635, DOI 10.1073/pnas.0810790106; Yuan C, 2006, P NATL ACAD SCI USA, V103, P6142, DOI 10.1073/pnas.0601805103; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhe XN, 2004, J HISTOCHEM CYTOCHEM, V52, P1537, DOI 10.1369/jhc.4A6438.2004	54	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e104809	10.1371/journal.pone.0104809	http://dx.doi.org/10.1371/journal.pone.0104809			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347447	Green Published, gold, Green Submitted			2022-12-27	WOS:000347994900001
J	Choi, ES; Kim, MK; Song, MK; Kim, JM; Kim, ES; Chung, WJ; Park, KS; Cho, KB; Hwang, JS; Jang, BK				Choi, Eun Sung; Kim, Mi Kyung; Song, Min Kyung; Kim, Jeong Min; Kim, Eun Soo; Chung, Woo Jin; Park, Kyung Sik; Cho, Kwang Bum; Hwang, Jae Seok; Jang, Byoung Kuk			Association between Serum Irisin Levels and Non-Alcoholic Fatty Liver Disease in Health Screen Examinees	PLOS ONE			English	Article							EXERCISE	Irisin is a recently found myokine that aids obesity control and improves glucose homeostasis by acting on white adipose tissue cells and increases total energy consumption. The aim of this study was to evaluate serum irisin levels in patients with non-alcoholic fatty liver disease (NAFLD) and to compare these levels with those of normal controls. Among 595 health screen examinees who had visited our institute between January 2013 to March 2013, 355 patients (84 NAFLD patients and 271 normal controls) were enrolled depending on whether they gave written informed consents and their history of alcohol intake, blood tests, and abdominal ultrasonographic findings. Age; sex; laboratory test parameters; homeostasis model assessment-insulin resistance; and levels of leptin, adiponectin, and irisin were assessed. Serum irisin levels (ng/ml) were significantly higher in the NAFLD group than in normal controls (63.4 +/- 32.6 vs. 43.0 +/- 29.7, p<0.001) and higher in the mild fatty liver group than in the moderate-to-severe fatty liver group (68.3 +/- 38.2 vs. 56.6 +/- 21.2, p<0.001). Additionally, serum irisin levels were not different between the non-obese and obese groups (48.4 +/- 34.2 vs. 45.8 +/- 22.9, p = 0.492); however, the levels were significantly lowest in normal controls and highest in the mild fatty liver group in the non-obese (44.9 +/- 31.7 vs. 73.1 +/- 48.5 vs 59.7 +/- 18.0, p<0.001) and obese groups (35.0 +/- 17.0 vs. 62.9 +/- 21.2 vs. 54.6 +/- 23.3, p<0.001). Serum irisin levels were significantly higher in NAFLD patients, which is not consistent with the results of previously published studies. Therefore, more studies are needed to confirm the role of irisin in NAFLD.	[Choi, Eun Sung; Kim, Mi Kyung; Kim, Jeong Min; Kim, Eun Soo; Chung, Woo Jin; Park, Kyung Sik; Cho, Kwang Bum; Hwang, Jae Seok; Jang, Byoung Kuk] Keimyung Univ, Sch Med, Dept Internal Med, Taegu, South Korea; [Song, Min Kyung] Keimyung Univ, Grad Sch, Dept Food Sci & Nutr, Taegu, South Korea; [Jang, Byoung Kuk] Keimyung Univ, Inst Canc Res, Taegu, South Korea	Keimyung University; Keimyung University; Keimyung University	Jang, BK (corresponding author), Keimyung Univ, Sch Med, Dept Internal Med, Taegu, South Korea.	jangha106@dsmc.or.kr		Jang, Byoung Kuk/0000-0002-8950-0866	Keimyung University Dongsan Medical Center	Keimyung University Dongsan Medical Center	This work was supported by the research promoting grant from the Keimyung University Dongsan Medical Center in 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Bostrom PA, 2014, METABOLISM, V63, P178, DOI 10.1016/j.metabol.2013.11.009; Chang Y, 2013, AM J GASTROENTEROL, V108, P1861, DOI 10.1038/ajg.2013.349; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Kassi E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-48; Kraemer RR, 2014, HORM METAB RES, V46, P150, DOI 10.1055/s-0033-1355381; Liu JJ, 2013, J DIABETES COMPLICAT, V27, P365, DOI 10.1016/j.jdiacomp.2013.03.002; Moon HS, 2013, METABOLISM, V62, P1131, DOI 10.1016/j.metabol.2013.04.007; Park KH, 2013, J CLIN ENDOCR METAB, V98, P4899, DOI 10.1210/jc.2013-2373; Polyzos SA, 2014, METABOLISM, V63, P207, DOI 10.1016/j.metabol.2013.09.013; Polyzos SA, 2013, METABOLISM, V62, P1037, DOI 10.1016/j.metabol.2013.04.008; Raschke S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073680; Sahini N, 2014, PROG LIPID RES, V54, P86, DOI 10.1016/j.plipres.2014.02.002; Sanchis-Gomar F, 2014, HORMONE METABOLIC RE; Sanchis-Gomar F, 2014, ENDOCRINE; Zhang HJ, 2013, J HEPATOL, V59, P557, DOI 10.1016/j.jhep.2013.04.030	17	38	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110680	10.1371/journal.pone.0110680	http://dx.doi.org/10.1371/journal.pone.0110680			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343462	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943500046
J	Magee, AF; May, MR; Moore, BR				Magee, Andrew F.; May, Michael R.; Moore, Brian R.			The Dawn of Open Access to Phylogenetic Data	PLOS ONE			English	Article							INFORMATION; AVAILABILITY; REUSE; TREE; NEED	The scientific enterprise depends critically on the preservation of and open access to published data. This basic tenet applies acutely to phylogenies (estimates of evolutionary relationships among species). Increasingly, phylogenies are estimated from increasingly large, genome-scale datasets using increasingly complex statistical methods that require increasing levels of expertise and computational investment. Moreover, the resulting phylogenetic data provide an explicit historical perspective that critically informs research in a vast and growing number of scientific disciplines. One such use is the study of changes in rates of lineage diversification (speciation - extinction) through time. As part of a meta-analysis in this area, we sought to collect phylogenetic data (comprising nucleotide sequence alignment and tree files) from 217 studies published in 46 journals over a 13-year period. We document our attempts to procure those data (from online archives and by direct request to corresponding authors), and report results of analyses (using Bayesian logistic regression) to assess the impact of various factors on the success of our efforts. Overall, complete phylogenetic data for similar to 60% of these studies are effectively lost to science. Our study indicates that phylogenetic data are more likely to be deposited in online archives and/or shared upon request when: (1) the publishing journal has a strong data-sharing policy; (2) the publishing journal has a higher impact factor, and; (3) the data are requested from faculty rather than students. Importantly, our survey spans recent policy initiatives and infrastructural changes; our analyses indicate that the positive impact of these community initiatives has been both dramatic and immediate. Although the results of our study indicate that the situation is dire, our findings also reveal tremendous recent progress in the sharing and preservation of phylogenetic data.	[Magee, Andrew F.; May, Michael R.; Moore, Brian R.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA	University of California System; University of California Davis	Moore, BR (corresponding author), Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA.	brianmoore@ucdavis.edu			NSF grants [DEB-0842181, DEB-0919529]; NSF grant [DBI-1356737]	NSF grants(National Science Foundation (NSF)); NSF grant(National Science Foundation (NSF))	This research was supported by NSF grants DEB-0842181 and DEB-0919529 awarded to BRM (http://www.nsf.gov/div/index.jsp?div=DEB) and by NSF grant DBI-1356737 awarded to BRM (http://www.nsf.gov/div/index.jsp?div=DBI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsheikh-Ali AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024357; [Anonymous], 2006, NATURE, V444, P653, DOI 10.1038/444653b; [Anonymous], 2007, TREE LIFE WEB PROJEC; Blackburne BP, 2013, MOL BIOL EVOL, V30, P642, DOI 10.1093/molbev/mss256; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; CECI SJ, 1983, AM PSYCHOL, V38, P414, DOI 10.1037/0003-066X.38.4.414; Cranston K, 2014, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.bf01eff4a6b60ca4825c69293dc59645; Donoghue MJ, 2000, ANN MO BOT GARD, V87, P110, DOI 10.2307/2666212; Drew BT, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001636; Drew BT, 2013, NATURE, V493, P305, DOI 10.1038/493305f; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Evangelou E, 2005, FASEB J, V19, P1943, DOI 10.1096/fj.05-4784lsf; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Geweke J., 1992, BAYESIAN STAT, V4, P169, DOI DOI 10.21034/SR.148; Hughes J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-178; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Leebens-Mack J, 2006, OMICS, V10, P231, DOI 10.1089/omi.2006.10.231; Moore AJ, 2010, J EVOLUTION BIOL, V23, P659, DOI 10.1111/j.1420-9101.2010.01937.x; Morrison DA, 2009, SYST BIOL, V58, P150, DOI 10.1093/sysbio/syp009; Noor MAF, 2006, PLOS BIOL, V4, P1113, DOI 10.1371/journal.pbio.0040228; Notredame C, 2007, PLOS COMPUT BIOL, V3, P1405, DOI 10.1371/journal.pcbi.0030123; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Piwowar HA, 2011, P AM SOC INFORM SCI, V48, P1, DOI DOI 10.1002/MEET.2011.14504801337; Piwowar H, 2013, NATURE, V493, P159, DOI 10.1038/493159a; Piwowar HA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000308; Piwowar HA, 2013, PEERJ, V1, DOI 10.7717/peerj.175; Piwowar HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018657; Piwowar HA, 2011, NATURE, V473, P285, DOI 10.1038/473285a; Piwowar HA, 2010, J BIOMED DISCOV COLL, V5, P7; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Polson NG, 2012, ARXIV E PRINTS; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; R Core Team, 2021, R LANGUAGE ENV STAT; Rabosky DL, 2006, EVOLUTION, V60, P1152; Rausher MD, 2010, EVOLUTION, V64, P603, DOI 10.1111/j.1558-5646.2009.00940.x; Rieseberg L, 2010, MOL ECOL, V19, P1, DOI 10.1111/j.1365-294X.2009.04450.x; Roche DG, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001779; Sanderson Michael J., 1994, American Journal of Botany, V81, P183; SANDERSON MJ, 1993, SYST BIOL, V42, P562, DOI 10.2307/2992488; Savage CJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007078; Stoltzfus Arlin, 2012, BMC Res Notes, V5, P574, DOI 10.1186/1756-0500-5-574; Suchard MA, 2009, BIOINFORMATICS, V25, P1370, DOI 10.1093/bioinformatics/btp244; Thompson JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018093; Uyenoyama MK, 2010, MOL BIOL EVOL, V27, P742; Vines TH, 2014, CURR BIOL, V24, P94, DOI 10.1016/j.cub.2013.11.014; Vines TH, 2013, FASEB J, V27, P1304, DOI 10.1096/fj.12-218164; Vision TJ, 2010, BIOSCIENCE, V60, P330, DOI 10.1525/bio.2010.60.5.2; Whitlock MC, 2011, TRENDS ECOL EVOL, V26, P61, DOI 10.1016/j.tree.2010.11.006; Whitlock MC, 2010, AM NAT, V175, pE45, DOI 10.1086/650340; Wicherts JM, 2006, AM PSYCHOL, V61, P726, DOI 10.1037/0003-066X.61.7.726; Wicherts JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026828; Wong KM, 2008, SCIENCE, V319, P473, DOI 10.1126/science.1151532	52	28	28	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110268	10.1371/journal.pone.0110268	http://dx.doi.org/10.1371/journal.pone.0110268			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343725	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943500031
J	Mehan, WA; Gonzalez, RG; Buchbinder, BR; Chen, JW; Copen, WA; Gupta, R; Hirsch, JA; Hunter, GJ; Hunter, S; Johnson, JM; Kelly, HR; Larvie, M; Lev, MH; Pomerantz, SR; Rapalino, O; Rincon, S; Romero, JM; Schaefer, PW; Shah, V				Mehan, William A., Jr.; Gonzalez, R. Gilberto; Buchbinder, Bradley R.; Chen, John W.; Copen, William A.; Gupta, Rajiv; Hirsch, Joshua A.; Hunter, George J.; Hunter, Scott; Johnson, Jason M.; Kelly, Hillary R.; Larvie, Mykol; Lev, Michael H.; Pomerantz, Stuart R.; Rapalino, Otto; Rincon, Sandra; Romero, Javier M.; Schaefer, Pamela W.; Shah, Vinil			Optimal Brain MRI Protocol for New Neurological Complaint	PLOS ONE			English	Article							ATTENUATED INVERSION-RECOVERY; GRADIENT-ECHO MR; SPIN-ECHO; INTRACRANIAL HEMORRHAGE; MULTIPLE-SCLEROSIS; PLANAR SEQUENCES; THIN-SECTION; FLAIR; LESIONS; IMAGES	Background/Purpose: Patients with neurologic complaints are imaged with MRI protocols that may include many pulse sequences. It has not been documented which sequences are essential. We assessed the diagnostic accuracy of a limited number of sequences in patients with new neurologic complaints. Methods: 996 consecutive brain MRI studies from patients with new neurological complaints were divided into 2 groups. In group 1, reviewers used a 3-sequence set that included sagittal T1-weighted, axial T2-weighted fluid-attenuated inversion recovery, and axial diffusion-weighted images. Subsequently, another group of studies were reviewed using axial susceptibility-weighted images in addition to the 3 sequences. The reference standard was the study's official report. Discrepancies between the limited sequence review and the reference standard including Level I findings (that may require immediate change in patient management) were identified. Results: There were 84 major findings in 497 studies in group 1 with 21 not identified in the limited sequence evaluations: 12 enhancing lesions and 3 vascular abnormalities identified on MR angiography. The 3-sequence set did not reveal microhemorrhagic foci in 15 of 19 studies. There were 117 major findings in 499 studies in group 2 with 19 not identified on the 4-sequence set: 17 enhancing lesions and 2 vascular lesions identified on angiography. All 87 Level I findings were identified using limited sequence (56 acute infarcts, 16 hemorrhages, and 15 mass lesions). Conclusion: A 4-pulse sequence brain MRI study is sufficient to evaluate patients with a new neurological complaint except when contrast or angiography is indicated.	[Mehan, William A., Jr.; Gonzalez, R. Gilberto; Buchbinder, Bradley R.; Chen, John W.; Copen, William A.; Gupta, Rajiv; Hirsch, Joshua A.; Hunter, George J.; Hunter, Scott; Johnson, Jason M.; Kelly, Hillary R.; Larvie, Mykol; Lev, Michael H.; Pomerantz, Stuart R.; Rapalino, Otto; Rincon, Sandra; Romero, Javier M.; Schaefer, Pamela W.; Shah, Vinil] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Neuroradiol Div, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Gonzalez, RG (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Neuroradiol Div, Boston, MA 02115 USA.	rggonzalez@mgh.harvard.edu	Hunter, Scott J./AAB-8814-2020; Schaefer, Pamela/AAA-1323-2019	johnson, jason/0000-0001-7724-5784; Kelly, Hillary/0000-0002-6655-8723; Rapalino, Otto/0000-0002-5038-4183; Romero, Javier/0000-0001-5749-3000				Aprile I, 1999, AM J NEURORADIOL, V20, P1259; Ashikaga R, 1997, NEURORADIOLOGY, V39, P239, DOI 10.1007/s002340050401; ATLAS SW, 1988, RADIOLOGY, V168, P803, DOI 10.1148/radiology.168.3.3406410; Bakshi R, 1999, AM J NEURORADIOL, V20, P629; BrantZawadzki M, 1996, STROKE, V27, P1187, DOI 10.1161/01.STR.27.7.1187; Casey SO, 2000, AM J NEURORADIOL, V21, P1199; Chan S, 1996, AM J NEURORADIOL, V17, P1821; Demaerel P, 1998, NEURORADIOLOGY, V40, P355, DOI 10.1007/s002340050598; Essig M, 2000, INVEST RADIOL, V35, P689, DOI 10.1097/00004424-200011000-00007; HASHEMI RH, 1995, RADIOLOGY, V196, P505, DOI 10.1148/radiology.196.2.7617868; Herskovits EH, 2001, AM J ROENTGENOL, V176, P1313, DOI 10.2214/ajr.176.5.1761313; Koennecke HC, 2006, NEUROLOGY, V66, P165, DOI 10.1212/01.wnl.0000194266.55694.1e; Lam WWM, 2003, J NEUROIMAGING, V13, P99, DOI 10.1177/1051228403251083; Lin DDM, 2001, AM J NEURORADIOL, V22, P1275; Maeda M, 2001, AM J NEURORADIOL, V22, P632; Maubon AJ, 1998, RADIOLOGY, V208, P671, DOI 10.1148/radiology.208.3.9722844; Meiners LC, 1999, INVEST RADIOL, V34, P134, DOI 10.1097/00004424-199902000-00006; Noguchi K, 1997, RADIOLOGY, V203, P257, DOI 10.1148/radiology.203.1.9122404; Palmer S, 1999, RADIOLOGY, V210, P149, DOI 10.1148/radiology.210.1.r99ja38149; Saleh A, 2004, BRIT J RADIOL, V77, P183, DOI 10.1259/bjr/62546157; Taillibert S, 1999, EUR NEUROL, V41, P64, DOI 10.1159/000008005; Thurnher MM, 1997, AM J NEURORADIOL, V18, P1601; Tsushima Y, 2003, AM J NEURORADIOL, V24, P88	23	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110803	10.1371/journal.pone.0110803	http://dx.doi.org/10.1371/journal.pone.0110803			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343371	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943500057
J	Rowbotham, S; Wardy, AJ; Lloyd, DM; Wearden, A; Holler, J				Rowbotham, Samantha; Wardy, April J.; Lloyd, Donna M.; Wearden, Alison; Holler, Judith			Increased Pain Intensity Is Associated with Greater Verbal Communication Difficulty and Increased Production of Speech and Co-Speech Gestures	PLOS ONE			English	Article							FAKED FACIAL EXPRESSIONS; SEX-DIFFERENCES; GENERAL-POPULATION; SELF-REPORT; BEHAVIOR; GENDER; METAANALYSIS; PREVALENCE; DIMENSIONS; GENUINE	Effective pain communication is essential if adequate treatment and support are to be provided. Pain communication is often multimodal, with sufferers utilising speech, nonverbal behaviours (such as facial expressions), and co-speech gestures (bodily movements, primarily of the hands and arms that accompany speech and can convey semantic information) to communicate their experience. Research suggests that the production of nonverbal pain behaviours is positively associated with pain intensity, but it is not known whether this is also the case for speech and co-speech gestures. The present study explored whether increased pain intensity is associated with greater speech and gesture production during face-to-face communication about acute, experimental pain. Participants (N = 26) were exposed to experimentally elicited pressure pain to the fingernail bed at high and low intensities and took part in video-recorded semi-structured interviews. Despite rating more intense pain as more difficult to communicate (t(25) = 2.21, p = .037), participants produced significantly longer verbal pain descriptions and more co-speech gestures in the high intensity pain condition (Words: t(25) = 3.57, p = .001; Gestures: t(25) = 3.66, p = .001). This suggests that spoken and gestural communication about pain is enhanced when pain is more intense. Thus, in addition to conveying detailed semantic information about pain, speech and co-speech gestures may provide a cue to pain intensity, with implications for the treatment and support received by pain sufferers. Future work should consider whether these findings are applicable within the context of clinical interactions about pain.	[Rowbotham, Samantha; Wardy, April J.; Wearden, Alison] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England; [Lloyd, Donna M.] Univ Leeds, Inst Psychol Sci, Leeds, W Yorkshire, England; [Holler, Judith] Max Planck Inst Psycholinguist, Nijmegen, Netherlands	University of Manchester; University of Leeds; Max Planck Society	Rowbotham, S (corresponding author), Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England.	samantha.rowbotham@manchester.ac.uk	Holler, Judith/U-9654-2018; Rowbotham, Samantha/I-2229-2019; Rowbotham, Samantha/G-7124-2015	Rowbotham, Samantha/0000-0002-2242-6921; Rowbotham, Samantha/0000-0002-2242-6921; HOLLER, JUDITH/0000-0003-0671-6651; Lloyd, Donna/0000-0003-3589-7383	University of Manchester School of Psychological Sciences Postgraduate Research Fund; ERC Advanced Grant [269484-INTERACT]	University of Manchester School of Psychological Sciences Postgraduate Research Fund; ERC Advanced Grant	Funding for participant payment was provided by The University of Manchester School of Psychological Sciences Postgraduate Research Fund. JH was supported by ERC Advanced Grant #269484-INTERACT during parts of this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibali MW, 2001, J MEM LANG, V44, P169, DOI 10.1006/jmla.2000.2752; Badali M, 2008, THESIS U BRIT COLUMB; Bavelas J.B., 1994, RES LANG SOC INTERAC, V27, P201, DOI [DOI 10.1207/S15327973RLSI2703_3, 10.1207/s15327973rlsi2703_3]; BAVELAS JB, 1992, DISCOURSE PROCESS, V15, P469, DOI 10.1080/01638539209544823; Briggs Emma, 2010, Nurs Stand, V25, P35; Catala E, 2002, EUR J PAIN-LONDON, V6, P133, DOI 10.1053/eujp.2001.0310; Craig KD, 2009, CAN PSYCHOL, V50, P22, DOI 10.1037/a0014772; CROOK J, 1984, PAIN, V18, P299, DOI 10.1016/0304-3959(84)90824-8; Cypress IK, 1975, VITAL HLTH STAT DATA, V13; DINDIA K, 1992, PSYCHOL BULL, V112, P106, DOI 10.1037/0033-2909.112.1.106; Ekman P., 2002, FACIAL ACTION CODING; Ekman Paul, 1968, RES PSYCHOTHERAPY, V3, P179, DOI [10.1037/10546-011, DOI 10.1037/10546-011]; Gauthier N, 2011, PAIN RES MANAG, V16, P293, DOI 10.1155/2011/247940; Hadjistavropoulos HD, 1996, PAIN, V65, P251, DOI 10.1016/0304-3959(95)00218-9; Hadjistavropoulos T, 2002, BEHAV RES THER, V40, P551, DOI 10.1016/S0005-7967(01)00072-9; Hadjistavropoulos T, 2011, PSYCHOL BULL, V137, P910, DOI 10.1037/a0023876; HALL JA, 1994, HEALTH PSYCHOL, V13, P384, DOI 10.1037/0278-6133.13.5.384; HAYTHORNTHWAITE JA, 1991, PAIN, V46, P177, DOI 10.1016/0304-3959(91)90073-7; Heath C, 2002, J COMMUN, V52, P597, DOI 10.1093/joc/52.3.597; Hill ML, 2002, PAIN, V98, P135, DOI 10.1016/S0304-3959(02)00037-4; Holler J, 2002, SEMIOTICA, V142, P31; Hostetter AB, 2011, PSYCHOL BULL, V137, P297, DOI 10.1037/a0022128; Hurwitz B., 2003, PERCEPTIONS PAIN, P7; Hyden LC, 2002, HEALTH, V6, P325, DOI 10.1177/136345930200600305; IBM Corp, 2016, IBM SPSS STAT WINDOW; KEEFE FJ, 1986, J CONSULT CLIN PSYCH, V54, P665, DOI 10.1037/0022-006X.54.5.665; Kendon A., 2004, GESTURE VISIBLE ACTI, DOI DOI 10.1017/CBO9780511807572; KLECK RE, 1976, J PERS SOC PSYCHOL, V34, P1211, DOI 10.1037/0022-3514.34.6.1211; KROENKE K, 1989, AM J MED, V86, P262, DOI 10.1016/0002-9343(89)90293-3; Kunz M, 2004, J PAIN, V5, P368, DOI 10.1016/j.jpain.2004.06.002; Kunz M, 2008, PAIN, V140, P127, DOI 10.1016/j.pain.2008.07.019; Labus JS, 2003, PAIN, V102, P109, DOI 10.1016/S0304-3959(02)00354-8; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Larochette AC, 2006, PAIN, V126, P64, DOI 10.1016/j.pain.2006.06.013; McNeill D., 1992, HAND MIND WHAT GESTU; National Cancer Institute, 2011, PAIN ASS; Newton-John TRO, 2002, PAIN REV, V9, P7, DOI 10.1191/0968130202pr186ra; POOLE GD, 1992, J PERS SOC PSYCHOL, V63, P797, DOI 10.1037/0022-3514.63.5.797; PRKACHIN KM, 1995, J NONVERBAL BEHAV, V19, P191, DOI 10.1007/BF02173080; PRKACHIN KM, 1989, PAIN, V39, P257, DOI 10.1016/0304-3959(89)90038-9; Riley JL, 1998, PAIN, V74, P181, DOI 10.1016/S0304-3959(97)00199-1; Rosenthal R., 2005, NEW HDB METHODS NONV; Roter D., 2006, DOCTORS TALKING PATI, V2nd ed.; Roter DL, 2002, JAMA-J AM MED ASSOC, V288, P756, DOI 10.1001/jama.288.6.756; Rowbotham S, 2014, I SEE WHAT IN PRESS; Rowbotham S., 2013, HLTH PSYCHOL UPDATE, V22, P19; Rowbotham S, 2014, SPEECH COMMUN, V57, P244, DOI 10.1016/j.specom.2013.04.002; Rowbotham S, 2012, J NONVERBAL BEHAV, V36, P1, DOI 10.1007/s10919-011-0122-5; Sarlani E, 2004, PAIN, V109, P115, DOI 10.1016/j.pain.2004.01.019; Sarlani E, 2003, PAIN, V106, P9, DOI 10.1016/S0304-3959(03)00211-2; Sullivan MJL, 2006, PAIN, V122, P282, DOI 10.1016/j.pain.2006.02.001; Sullivan MJL, 2006, PAIN, V125, P270, DOI 10.1016/j.pain.2006.06.019; Sullivan MJL, 2000, COGNITIVE THER RES, V24, P121, DOI 10.1023/A:1005459110063; Sullivan MJL, 2004, PAIN, V107, P220, DOI 10.1016/j.pain.2003.11.003; Swann J, 2010, NURS RESIDENTIAL CAR, V12, P212; Taylor Laurie Jowers, 2005, Rehabil Nurs, V30, P55; Thibault P, 2008, PAIN, V139, P47, DOI 10.1016/j.pain.2008.02.029; Thomas E, 2004, PAIN, V110, P361, DOI 10.1016/j.pain.2004.04.017; Tian TN, 2011, PAIN, V152, P1210, DOI 10.1016/j.pain.2011.02.022; Vervoort T, 2008, PAIN, V134, P59, DOI 10.1016/j.pain.2007.03.038; Vervoort T, 2009, PAIN, V146, P170, DOI 10.1016/j.pain.2009.07.021; Vickers ER, 1998, AUST DENT J, V43, P403, DOI 10.1111/j.1834-7819.1998.tb00200.x; Ware LJ, 2006, PAIN MANAG NURS, V7, P117, DOI 10.1016/j.pmn.2006.06.005; WOODROW KM, 1972, PSYCHOSOM MED, V34, P548, DOI 10.1097/00006842-197211000-00007	64	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110779	10.1371/journal.pone.0110779	http://dx.doi.org/10.1371/journal.pone.0110779			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BL	25343486	Green Published, gold			2022-12-27	WOS:000343943500053
J	Cheong, HT; Ng, KT; Ong, LY; Chook, JB; Chan, KG; Takebe, Y; Kamarulzaman, A; Tee, KK				Cheong, Hui Ting; Ng, Kim Tien; Ong, Lai Yee; Chook, Jack Bee; Chan, Kok Gan; Takebe, Yutaka; Kamarulzaman, Adeeba; Tee, Kok Keng			Cross-Border Sexual Transmission of the Newly Emerging HIV-1 Clade CRF51_01B	PLOS ONE			English	Article							KUALA-LUMPUR; RECOMBINANT FORMS; RISK BEHAVIOR; TYPE-1; IDENTIFICATION; SINGAPORE; TRAVELERS; PREVALENCE; DIVERSITY; EMERGENCE	A novel HIV-1 recombinant clade (CRF51_01B) was recently identified among men who have sex with men (MSM) in Singapore. As cases of sexually transmitted HIV-1 infection increase concurrently in two socioeconomically intimate countries such as Malaysia and Singapore, cross transmission of HIV-1 between said countries is highly probable. In order to investigate the timeline for the emergence of HIV-1 CRF51_01B in Singapore and its possible introduction into Malaysia, 595 HIV-positive subjects recruited in Kuala Lumpur from 2008 to 2012 were screened. Phylogenetic relationship of 485 amplified polymerase gene sequences was determined through neighbour-joining method. Next, near-full length sequences were amplified for genomic sequences inferred to be CRF51_01B and subjected to further analysis implemented through Bayesian Markov chain Monte Carlo (MCMC) sampling and maximum likelihood methods. Based on the near full length genomes, two isolates formed a phylogenetic cluster with CRF51_01B sequences of Singapore origin, sharing identical recombination structure. Spatial and temporal information from Bayesian MCMC coalescent and maximum likelihood analysis of the protease, gp120 and gp41 genes suggest that Singapore is probably the country of origin of CRF51_01B (as early as in the mid-1990s) and featured a Malaysian who acquired the infection through heterosexual contact as host for its ancestral lineages. CRF51_01B then spread rapidly among the MSM in Singapore and Malaysia. Although the importation of CRF51_01B from Singapore to Malaysia is supported by coalescence analysis, the narrow timeframe of the transmission event indicates a closely linked epidemic. Discrepancies in the estimated divergence times suggest that CRF51_01B may have arisen through multiple recombination events from more than one parental lineage. We report the cross transmission of a novel CRF51_01B lineage between countries that involved different sexual risk groups. Understanding the cross-border transmission of HIV-1 involving sexual networks is crucial for effective intervention strategies in the region.	[Cheong, Hui Ting; Ng, Kim Tien; Ong, Lai Yee; Chook, Jack Bee; Kamarulzaman, Adeeba; Tee, Kok Keng] Univ Malaya, Fac Med, Dept Med, Ctr Excellence Res AIDS CERiA, Kuala Lumpur, Malaysia; [Chan, Kok Gan] Univ Malaya, Inst Biol Sci, Div Genet & Mol Biol, Fac Sci, Kuala Lumpur, Malaysia; [Takebe, Yutaka] Natl Inst Infect Dis, AIDS Res Ctr, Shinjuku Ku, Tokyo 1628640, Japan	Universiti Malaya; Universiti Malaya; National Institute of Infectious Diseases (NIID)	Tee, KK (corresponding author), Univ Malaya, Fac Med, Dept Med, Ctr Excellence Res AIDS CERiA, Kuala Lumpur, Malaysia.	k2tee@um.edu.my	Tee, Kok Keng/A-8148-2008; Ng, Kim Tien/K-7667-2013; Chan, Kok Gan/B-8347-2010; KAMARULZAMAN, ADEEBA/B-5216-2010	Tee, Kok Keng/0000-0002-7923-5448; Ng, Kim Tien/0000-0002-4097-9984; Chan, Kok Gan/0000-0002-1883-1115; 	Ministry of Education, Malaysia: High Impact Research [E-000001-20001]; High Impact Research [H-500001-00-A000011-000001, H-500001-00-A000012-000001]	Ministry of Education, Malaysia: High Impact Research; High Impact Research	This work was supported in part by grants from the Ministry of Education, Malaysia: High Impact Research E-000001-20001 to AK, and High Impact Research H-500001-00-A000011-000001 and H-500001-00-A000012-000001 to KKT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah ASM, 2004, CLIN INFECT DIS, V39, P533, DOI 10.1086/422721; Abubakar YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080487; Ansart S, 2009, J TRAVEL MED, V16, P79, DOI 10.1111/j.1708-8305.2008.00279.x; Charpentier C, 2006, J VIROL, V80, P2472, DOI 10.1128/JVI.80.5.2472-2482.2006; Chow WZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085250; Chow WZ, 2012, J VIROL, V86, P11398, DOI 10.1128/JVI.01932-12; Deng XT, 2008, ALGORITHMICA, V52, P1, DOI 10.1007/s00453-007-9001-1; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Feng Y, 2013, AIDS, V27, P1793, DOI 10.1097/QAD.0b013e328360db2d; Hamlyn E, 2007, OCCUP MED-OXFORD, V57, P313, DOI 10.1093/occmed/kqm044; HAWKES S, 1994, AIDS, V8, P247, DOI 10.1097/00002030-199402000-00013; Kalish ML, 2002, VIROLOGY, V304, P311, DOI 10.1006/viro.2002.1691; Kanter J, 2011, INT J STD AIDS, V22, P30, DOI 10.1258/ijsa.2010.010277; Ng KT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080884; Kondo M, 2013, J VIROL, V87, P5351, DOI 10.1128/JVI.02370-12; Li Y, 2010, JAIDS-J ACQ IMM DEF, V54, P129, DOI 10.1097/QAI.0b013e3181d82ce5; Liao HA, 2009, VIROLOGY, V391, P51, DOI 10.1016/j.virol.2009.05.023; Liu YJ, 2012, AIDS RES HUM RETROV, V28, P1357, DOI 10.1089/aid.2011.0376; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Malaysia - Department of Statistics, 2012, TOUR SAT ACC 2000 20; Malaysian Ministry of Health, 2012, GLOB AIDS RESP COUNT; Ng KT, 2012, J VIROL, V86, P11405, DOI 10.1128/JVI.01949-12; Ng OT, 2012, AIDS RES HUM RETROV, V28, P527, DOI [10.1089/aid.2011.0177, 10.1089/AID.2011.0177]; Ong LY, 2014, J MED VIROL, V86, P38, DOI 10.1002/jmv.23772; Ng OT, 2011, AIDS RES HUM RETROV, V27, P1135, DOI [10.1089/aid.2010.0364, 10.1089/AID.2010.0364]; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Philpott S, 2005, J VIROL, V79, P353, DOI 10.1128/JVI.79.1.353-363.2005; Rousseau CM, 2007, J VIROL, V81, P4492, DOI 10.1128/JVI.02050-06; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Schierup MH, 2000, GENETICS, V156, P879; Shriner D, 2004, GENETICS, V156, P879; SIEPEL AC, 1995, AIDS RES HUM RETROV, V11, P1413, DOI 10.1089/aid.1995.11.1413; Singapore Ministry of Health, 2012, HIV STAT UPD HIV AID; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tee KK, 2005, AIDS, V19, P119, DOI 10.1097/00002030-200501280-00003; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; Tee KK, 2008, AIDS, V22, P156, DOI 10.1097/QAD.0b013e3282f2d77a; Tee KK, 2006, JAIDS-J ACQ IMM DEF, V43, P523; Worobey M, 2001, MOL BIOL EVOL, V18, P1425, DOI 10.1093/oxfordjournals.molbev.a003928; Zhao J, 2014, JAIDS-J ACQ IMM DEF, V66, pE65, DOI 10.1097/QAI.0000000000000144	42	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111236	10.1371/journal.pone.0111236	http://dx.doi.org/10.1371/journal.pone.0111236			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340817	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662800098
J	Cockerham, LR; Siliciano, JD; Sinclair, E; O'Doherty, U; Palmer, S; Yukl, SA; Strain, MC; Chomont, N; Hecht, FM; Siliciano, RF; Richman, DD; Deeks, SG				Cockerham, Leslie R.; Siliciano, Janet D.; Sinclair, Elizabeth; O'Doherty, Una; Palmer, Sarah; Yukl, Steven A.; Strain, Matt C.; Chomont, Nicolas; Hecht, Frederick M.; Siliciano, Robert F.; Richman, Douglas D.; Deeks, Steven G.			CD4(+) and CD8(+) T Cell Activation Are Associated with HIV DNA in Resting CD4(+) T Cells	PLOS ONE			English	Article							SUPPRESSIVE ANTIRETROVIRAL THERAPY; IMMUNE ACTIVATION; VIRAL PERSISTENCE; INFECTED PATIENTS; RESERVOIR; SIZE; REPLICATION; INTEGRATION; LYMPHOCYTES; EXPRESSION	The association between the host immune environment and the size of the HIV reservoir during effective antiretroviral therapy is not clear. Progress has also been limited by the lack of a well-accepted assay for quantifying HIV during therapy. We examined the association between multiple measurements of HIV and T cell activation (as defined by markers including CD38, HLA-DR, CCR5 and PD-1) in 30 antiretroviral-treated HIV-infected adults. We found a consistent association between the frequency of CD4(+) and CD8(+) T cells expressing HLA-DR and the frequency of resting CD4(+) T cells containing HIV DNA. This study highlights the need to further examine this relationship and to better characterize the biology of markers commonly used in HIV studies. These results may also have implications for reactivation strategies.	[Cockerham, Leslie R.; Hecht, Frederick M.; Deeks, Steven G.] Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA 94143 USA; [Siliciano, Janet D.; Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Sinclair, Elizabeth] Univ Calif San Francisco, Div Expt Med, San Francisco, CA 94143 USA; [O'Doherty, Una] Univ Penn, Philadelphia, PA 19104 USA; [Palmer, Sarah] Westmead Millennium Inst Med Res, Westmead, NSW, Australia; [Palmer, Sarah] Univ Sydney, Sydney, NSW 2006, Australia; [Palmer, Sarah] Karolinska Inst, Stockholm, Sweden; [Yukl, Steven A.] San Francisco VA Med Ctr, San Francisco, CA USA; [Strain, Matt C.; Richman, Douglas D.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Richman, Douglas D.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Chomont, Nicolas] Vaccine & Gene Therapy Inst Florida, Port St Lucie, FL USA; [Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Johns Hopkins University; University of California System; University of California San Francisco; University of Pennsylvania; University of Sydney; Karolinska Institutet; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; Vaccine & Gene Therapy Institute of Florida; Howard Hughes Medical Institute; Johns Hopkins University	Cockerham, LR (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA 94143 USA.	leslie.cockerham@ucsf.edu	Chomont, Nicolas/ABG-2545-2020	Chomont, Nicolas/0000-0001-9747-5018; Deeks, Steven/0000-0001-6371-747X; Hecht, Frederick/0000-0002-5782-1171	ARCHE Collaborative Research Grant from the Foundation for AIDS Research [amFAR 108165-50-RGRL]; Martin Delaney CARE and DARE Collaboratories (NIH) [AI096113, 1U19AI096109]; NIH [43222]; Howard Hughes Medical Institute; Department of Veterans Affairs; James Pendleton Charitable Trust; National Institutes of Health [AI080193, AI74621, AI69432-S]; CFAR [AI306214]; Department of Veterans Affairs (VA Career Development Award) [1 IK2 CX000520-01]; NIAID [RO1AIO87145, K24AIO69994]; UCSF/Gladstone CFAR [P30 AIO27763]; UCSF Clinical and Translational Research Institute Clinical Research Center [UL 1 RR024131]; Center for AIDS Prevention Studies [P30 MH62246]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000004] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [K24AT007827] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087145, U01AI069432, P01AI080193, P30AI027763, U19AI096113, P30AI045008, U19AI096109, P01AI074621, K24AI069994, P30AI036214, UM1AI069432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER; Veterans Affairs [IK2CX000520] Funding Source: NIH RePORTER	ARCHE Collaborative Research Grant from the Foundation for AIDS Research; Martin Delaney CARE and DARE Collaboratories (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Department of Veterans Affairs(US Department of Veterans Affairs); James Pendleton Charitable Trust; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CFAR; Department of Veterans Affairs (VA Career Development Award)(US Department of Veterans Affairs); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UCSF/Gladstone CFAR; UCSF Clinical and Translational Research Institute Clinical Research Center; Center for AIDS Prevention Studies; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by an ARCHE Collaborative Research Grant from the Foundation for AIDS Research (amFAR 108165-50-RGRL), by the Martin Delaney CARE and DARE Collaboratories (NIH grants AI096113 and 1U19AI096109), and by NIH grant 43222 (RFS), and by the Howard Hughes Medical Institute (RFS). For MCS and DDR, this work was supported by the Department of Veterans Affairs, the James Pendleton Charitable Trust, National Institutes of Health (AI080193, AI74621, AI69432-S), and CFAR grant AI306214. For SAY, this work was supported by the Department of Veterans Affairs (VA Career Development Award 1 IK2 CX000520-01). The UCSF SCOPE cohort was supported in part by the NIAID (RO1AIO87145, K24AIO69994), the UCSF/Gladstone CFAR (P30 AIO27763), the UCSF Clinical and Translational Research Institute Clinical Research Center (UL 1 RR024131) and the Center for AIDS Prevention Studies (P30 MH62246). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brenchley JM, 2012, BLOOD, V120, P4172, DOI 10.1182/blood-2012-06-437608; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 2011, J INFECT DIS, V204, P135, DOI 10.1093/infdis/jir208; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Eriksson S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003174; Graf EH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001300; Hatano H, 2013, J INFECT DIS, V208, P50, DOI 10.1093/infdis/jis630; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Hunt PW, 2011, CLIN INFECT DIS, V52, P681, DOI 10.1093/cid/ciq202; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Josefsson L, 2013, P NATL ACAD SCI USA, V110, pE4987, DOI 10.1073/pnas.1308313110; Kaplan RC, 2011, J INFECT DIS, V203, P452, DOI 10.1093/infdis/jiq071; Kinter AL, 2008, J IMMUNOL, V181, P6738, DOI 10.4049/jimmunol.181.10.6738; Liszewski MK, 2009, METHODS, V47, P254, DOI 10.1016/j.ymeth.2009.01.002; Maldarelli F, 2007, PLOS PATHOG, V3, P484, DOI 10.1371/journal.ppat.0030046; Murray JM, 2014, J VIROL, V88, P3516, DOI 10.1128/JVI.03331-13; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; O'Doherty U, 2002, J VIROL, V76, P10942, DOI 10.1128/JVI.76.21.10942-10950.2002; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; Perreau M, 2013, J EXP MED, V210, P143, DOI 10.1084/jem.20121932; Persaud D, 2011, AIDS, V25, P2227, DOI 10.1097/QAD.0b013e32834cdaba; Poizot-Martin I, 2013, J CLIN VIROL, V57, P351, DOI 10.1016/j.jcv.2013.04.007; PRINCE HE, 1992, CELL IMMUNOL, V145, P254, DOI 10.1016/0008-8749(92)90329-N; Sereti I, 2009, BLOOD, V113, P6304, DOI 10.1182/blood-2008-10-186601; Shacklett Barbara L., 2009, V485, P347, DOI 10.1007/978-1-59745-170-3_23; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Siliciano Janet D, 2005, Methods Mol Biol, V304, P3; Steel A, 2007, ANTIVIR THER, V12, P971; Strain MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055943; Suto A, 2008, J EXP MED, V205, P1369, DOI 10.1084/jem.20072057; Trautmann L, 2012, BLOOD, V120, P3466, DOI 10.1182/blood-2012-04-422550; Vandergeeten C, 2013, BLOOD, V121, P4321, DOI 10.1182/blood-2012-11-465625; Yu JJQ, 2008, VIROLOGY, V379, P78, DOI 10.1016/j.virol.2008.05.030; Yukl SA, 2010, J INFECT DIS, V202, P1553, DOI 10.1086/656722	39	79	80	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110731	10.1371/journal.pone.0110731	http://dx.doi.org/10.1371/journal.pone.0110731			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340755	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662800051
J	Matsuo, R; Morihara, H; Mohri, T; Murasawa, S; Takewaki, K; Nakayama, H; Maeda, M; Fujio, Y				Matsuo, Reo; Morihara, Hirofumi; Mohri, Tomomi; Murasawa, Shiho; Takewaki, Kana; Nakayama, Hiroyuki; Maeda, Makiko; Fujio, Yasushi			The Inhibition of N-Glycosylation of Glycoprotein 130 Molecule Abolishes STAT3 Activation by IL-6 Family Cytokines in Cultured Cardiac Myocytes	PLOS ONE			English	Article							SIGNAL; GP130; IDENTIFICATION; EXPRESSION; RECEPTOR; TARGET	Interleukin-6 (IL-6) family cytokines play important roles in cardioprotection against pathological stresses. IL-6 cytokines bind to their specific receptors and activate glycoprotein 130 (gp130), a common receptor, followed by further activation of STAT3 and extracellular signal-regulated kinase (ERK)1/2 through janus kinases (JAKs); however the importance of glycosylation of gp130 remains to be elucidated in cardiac myocytes. In this study, we examined the biological significance of gp130 glycosylation using tunicamycin (Tm), an inhibitor of enzyme involved in N-linked glycosylation. In cardiomyocytes, the treatment with Tm completely replaced the glycosylated form of gp130 with its unglycosylated one. Tm treatment inhibited leukemia inhibitory factor (LIF)-mediated activation of STAT3 and ERK1/2. Similarly, IL-11 failed to activate STAT3 and ERK1/2 in the presence of Tm. Interestingly, Tm inhibited the activation of JAKs 1 and 2, without influencing the expression of suppressor of cytokine signalings (SOCSs) and protein-tyrosine phosphatase 1B (PTP1B), which are endogenous inhibitors of JAKs. To exclude the possibility that Tm blocks LIF and IL-11 signals by inhibiting the glycosylation of their specific receptors, we investigated whether the stimulation with IL-6 plus soluble IL-6 receptor (sIL-6R) could transduce their signals in Tm-treated cardiomyocytes and found that this stimulation was unable to activate the downstream signals. Collectively, these findings indicate that glycosylation of gp130 is essential for signal transduction of IL-6 family cytokines in cardiomyocytes.	[Matsuo, Reo; Morihara, Hirofumi; Mohri, Tomomi; Murasawa, Shiho; Takewaki, Kana; Nakayama, Hiroyuki; Maeda, Makiko; Fujio, Yasushi] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka, Japan	Osaka University	Maeda, M (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka, Japan.	makikom@phs.osaka-u.ac.jp; fujio@phs.osaka-u.ac.jp	Fujio, Yasushi/H-3421-2017	Fujio, Yasushi/0000-0003-0828-2930	Japan society for the promotion of science; MEXT/JSPS KAKENHI [23390057, 26293054, 25860061, 22590160]	Japan society for the promotion of science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant-in-aid for scientific research from the Japan society for the promotion of science; YF, HN, MM. This study was supported by MEXT/JSPS KAKENHI Grant Numbers 23390057, 26293054, 25860061 and 22590160. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Denzel MS, 2014, CELL, V156, P1167, DOI 10.1016/j.cell.2014.01.061; DORNER AJ, 1990, J BIOL CHEM, V265, P22029; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Fujio Y, 2011, J PHARMACOL SCI, V117, P213, DOI 10.1254/jphs.11R05CR; Fukuda S, 2010, DIABETES OBES METAB, V12, P299, DOI 10.1111/j.1463-1326.2009.01162.x; Funamoto M, 2003, J BIOL CHEM, V7, P10561; Hosoi T, 2008, MOL PHARMACOL, V74, P1610, DOI 10.1124/mol.108.050070; Iwakura I, 2001, J MOL CELL CARDIOL, V51, P207; Kimura R, 2007, CYTOKINE, V38, P107, DOI 10.1016/j.cyto.2007.05.011; KISHIMOTO T, 1995, BLOOD, V86, P1243, DOI 10.1182/blood.V86.4.1243.bloodjournal8641243; Kunisada K, 1996, CIRCULATION, V94, P2626, DOI 10.1161/01.CIR.94.10.2626; Moritz RL, 2001, J BIOL CHEM, V276, P8244, DOI 10.1074/jbc.M009979200; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Waetzig GH, 2010, J BIOL CHEM, V285, P1781, DOI 10.1074/jbc.M109.075952; Wang ZV, 2014, CELL, V156, P1179, DOI 10.1016/j.cell.2014.01.014; Wollert KC, 1996, J BIOL CHEM, V271, P9535, DOI 10.1074/jbc.271.16.9535; Yanagisawa M, 2009, BIOCHEM BIOPH RES CO, V386, P101, DOI 10.1016/j.bbrc.2009.05.132	19	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111097	10.1371/journal.pone.0111097	http://dx.doi.org/10.1371/journal.pone.0111097			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340554	Green Submitted, Green Published, gold			2022-12-27	WOS:000343662800085
J	Phillips, O; Squitieri, F; Sanchez-Castaneda, C; Elifani, F; Caltagirone, C; Sabatini, U; Di Paola, M				Phillips, Owen; Squitieri, Ferdinando; Sanchez-Castaneda, Cristina; Elifani, Francesca; Caltagirone, Carlo; Sabatini, Umberto; Di Paola, Margherita			Deep White Matter in Huntington's Disease	PLOS ONE			English	Article							CORPUS-CALLOSUM; LONGITUDINAL FASCICLE; MAGNETIC-RESONANCE; HUMAN BRAIN; LIFE-SPAN; IN-VIVO; MRI; MYELIN; PATHOGENESIS; CONNECTIONS	White matter (WM) abnormalities have already been shown in presymptomatic (Pre-HD) and symptomatic HD subjects using Magnetic Resonance Imaging (MRI). In the present study, we examined the microstructure of the long-range large deep WM tracts by applying two different MRI approaches: Diffusion Tensor Imaging (DTI) -based tractography, and T2*weighted (iron sensitive) imaging. We collected Pre-HD subjects (n = 25), HD patients (n = 25) and healthy control subjects (n = 50). Results revealed increased axial (AD) and radial diffusivity (RD) and iron levels in Pre-HD subjects compared to controls. Fractional anisotropy decreased between the Pre-HD and HD phase and AD/RD increased and although impairment was pervasive in HD, degeneration occurred in a pattern in Pre-HD. Furthermore, iron levels dropped for HD patients. As increased iron levels are associated with remyelination, the data suggests that Pre-HD subjects attempt to repair damaged deep WM years before symptoms occur but this process fails with disease progression.	[Phillips, Owen; Caltagirone, Carlo; Di Paola, Margherita] IRCCS Santa Lucia Fdn, Clin & Behav Neurol Dept, Rome, Italy; [Squitieri, Ferdinando; Elifani, Francesca] IRCSS Neuromed, Pozzilli, Italy; [Sanchez-Castaneda, Cristina; Sabatini, Umberto] IRCCS Santa Lucia Fdn, Dept Radiol, Rome, Italy; [Caltagirone, Carlo] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy	IRCCS Santa Lucia; IRCCS Neuromed; IRCCS Santa Lucia; University of Rome Tor Vergata	Squitieri, F (corresponding author), IRCSS Neuromed, Pozzilli, Italy.	ferdinando.squitieri@lirh.it; m.dipaola@hsantalucia.it	Sabatini, Umberto/K-4659-2016; Sanchez-Castañeda, Cristina/J-2303-2015; Elifani, Francesca/AAE-2509-2020; phillips, owen/J-3651-2017; Squitieri, Ferdinando/N-1852-2019	Sabatini, Umberto/0000-0001-5321-8626; Sanchez-Castañeda, Cristina/0000-0002-6827-9146; Elifani, Francesca/0000-0002-0824-9543; phillips, owen/0000-0002-5391-707X; Squitieri, Ferdinando/0000-0002-7397-1727	Italian Ministry of Health [204/GR-2009-1606835]; European Commission: Marie Curie Fellowship; Italian Ministry of Health (Ricerca Corrente); European Huntington's Disease Network; Italian League for Huntington and related diseases onlus	Italian Ministry of Health(Ministry of Health, Italy); European Commission: Marie Curie Fellowship; Italian Ministry of Health (Ricerca Corrente)(Ministry of Health, Italy); European Huntington's Disease Network; Italian League for Huntington and related diseases onlus	This work was supported by the Italian Ministry of Health grant 204/GR-2009-1606835. Also, support was provided by the European Commission: Marie Curie Fellowship for career development to CS (FP7-PEOPLE-2011-IEF). The authors are grateful for the support they received from the Italian Ministry of Health (Ricerca Corrente), European Huntington's Disease Network for the Registry Study, by the "Italian League for Huntington and related diseases onlus (www.lirh.it)" to FS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors are grateful to all patients for contributing to the work.	Aylward EH, 1998, NEUROLOGY, V50, P252, DOI 10.1212/WNL.50.1.252; Bartzokis G, 2007, NEUROCHEM RES, V32, P1655, DOI 10.1007/s11064-007-9352-7; Bartzokis G, 2012, BIOL PSYCHIAT, V72, P1026, DOI 10.1016/j.biopsych.2012.07.010; Bartzokis G, 2012, NEUROPHARMACOLOGY, V62, P2137, DOI 10.1016/j.neuropharm.2012.01.015; Bartzokis G, 2011, NEUROBIOL AGING, V32, P1341, DOI 10.1016/j.neurobiolaging.2009.08.007; Bohanna I, 2011, BRAIN IMAGING BEHAV, V5, P171, DOI 10.1007/s11682-011-9121-8; Browne SE, 2008, ANN NY ACAD SCI, V1147, P358, DOI 10.1196/annals.1427.018; Cherubini A, 2009, NEUROIMAGE, V48, P29, DOI 10.1016/j.neuroimage.2009.06.035; Cherubini A, 2009, MAGN RESON MED, V61, P1066, DOI 10.1002/mrm.21978; Deichmann R, 2004, NEUROIMAGE, V21, P757, DOI 10.1016/j.neuroimage.2003.09.062; DELAMONTE SM, 1988, J NEUROPATH EXP NEUR, V47, P516, DOI 10.1097/00005072-198809000-00003; Di Paola M, 2014, HUM BRAIN MAPP, V35, P3143, DOI 10.1002/hbm.22391; Di Paola M, 2012, CEREB CORTEX, V22, P2858, DOI 10.1093/cercor/bhr360; Di Paola M, 2010, NEUROIMAGE, V49, P141, DOI 10.1016/j.neuroimage.2009.07.050; Dick A. S., 2013, NEUROSCIENTIST; Dumas EM, 2012, HUM BRAIN MAPP, V33, P203, DOI 10.1002/hbm.21205; Ehrlich ME, 2012, NEUROTHERAPEUTICS, V9, P270, DOI 10.1007/s13311-012-0112-2; Esmaeilzadeh M, 2011, CNS NEUROSCI THER, V17, P368, DOI 10.1111/j.1755-5949.2010.00157.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gomez-Tortosa E, 2001, ANN NEUROL, V49, P29, DOI 10.1002/1531-8249(200101)49:1<29::AID-ANA7>3.0.CO;2-B; Han I, 2010, J NEUROCHEM, V113, P1073, DOI 10.1111/j.1471-4159.2010.06672.x; Hasan KM, 2007, NEUROREPORT, V18, P1735, DOI 10.1097/WNR.0b013e3282f0d40c; Jones DK, 2012, NEUROIMAGE; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Kloppel S, 2008, BRAIN, V131, P196, DOI 10.1093/brain/awm275; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Makris N, 2013, BRAIN STRUCT FUNCT, V218, P951, DOI 10.1007/s00429-012-0441-2; Marrakchi-Kacem L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053135; Matsui J.T., 2013, HUM BRAIN MAPP; Muthusami P, 2013, J MAGN RESON IMAGING; MYERS RH, 1991, J NEUROPATH EXP NEUR, V50, P729, DOI 10.1097/00005072-199111000-00005; Nopoulos PC, 2010, NEUROBIOL DIS, V40, P544, DOI 10.1016/j.nbd.2010.07.014; Novak MJ, 2013, CORTEX; Paulsen JS, 2006, BIOL PSYCHIAT, V59, P57, DOI 10.1016/j.biopsych.2005.06.003; Penney JB, 1997, ANN NEUROL, V41, P689, DOI 10.1002/ana.410410521; Peran P, 2007, J MAGN RESON IMAGING, V26, P1413, DOI 10.1002/jmri.21204; Perge JA, 2012, J NEUROSCI, V32, P626, DOI 10.1523/JNEUROSCI.4254-11.2012; Phillips O, 2014, CEREB CORTEX; Phillips O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073280; Phillips OR, 2013, BRAIN CONNECT, V3, P146, DOI 10.1089/brain.2012.0111; Phillips OR, 2011, BIOL PSYCHIAT, V70, P680, DOI 10.1016/j.biopsych.2011.03.039; Ravera S, 2009, INT J BIOCHEM CELL B, V41, P1581, DOI 10.1016/j.biocel.2009.01.009; Rosas HD, 2010, NEUROIMAGE, V49, P2995, DOI 10.1016/j.neuroimage.2009.10.015; Schmahmann J. D., 2006, FIBER PATHWAYS BRAIN, V18; Schmierer K, 2008, MAGN RESON MED, V59, P268, DOI 10.1002/mrm.21487; SOTREL A, 1991, NEUROLOGY, V41, P1117, DOI 10.1212/WNL.41.7.1117; Squitieri F, 2009, CNS NEUROSCI THER, V15, P1, DOI 10.1111/j.1755-5949.2008.00068.x; Takahashi M, 2000, RADIOLOGY, V216, P881, DOI 10.1148/radiology.216.3.r00se41881; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Xiang ZM, 2011, J NEUROSCI, V31, P9544, DOI 10.1523/JNEUROSCI.1291-11.2011; Zoppelt D, 2003, NEUROPSYCHOLOGIA, V41, P1160, DOI 10.1016/S0028-3932(03)00019-8	51	34	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e109676	10.1371/journal.pone.0109676	http://dx.doi.org/10.1371/journal.pone.0109676			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340651	gold, Green Submitted, Green Published			2022-12-27	WOS:000343662800014
J	Van den Heuvel, F				Van den Heuvel, Frank			A Closed Parameterization of DNA-Damage by Charged Particles, as a Function of Energy - A Geometrical Approach	PLOS ONE			English	Article							MONTE-CARLO-SIMULATION; PROTON-BEAM; ELECTRONS; SOLIDS; MODEL	Purpose: To present a closed formalism calculating charged particle radiation damage induced in DNA. The formalism is valid for all types of charged particles and due to its closed nature is suited to provide fast conversion of dose to DNA-damage. Methods: The induction of double strand breaks in DNA-strings residing in irradiated cells is quantified using a single particle model. This leads to a proposal to use the cumulative Cauchy distribution to express the mix of high and low LET type damage probability generated by a single particle. A microscopic phenomenological Monte Carlo code is used to fit the parameters of the model as a function of kinetic energy related to the damage to a DNA molecule embedded in a cell. The model is applied for four particles: electrons, protons, alpha-particles, and carbon ions. A geometric interpretation of this observation using the impact ionization mean free path as a quantifier, allows extension of the model to very low energies. Results: The mathematical expression describes the model adequately using a chi-square test (chi(2)/NDF<1). This applies to all particle types with an almost perfect fit for protons, while the other particles seem to result in some discrepancies at very low energies. The implementation calculating a strict version of the RBE based on complex damage alone is corroborated by experimental data from the measured RBE. The geometric interpretation generates a unique dimensionless parameter k for each type of charged particle. In addition, it predicts a distribution of DNA damage which is different from the current models.	[Van den Heuvel, Frank] Univ Oxford, Dept Oncol, CRUK MRC Oxford Inst Radiat Oncol, Oxford, England; [Van den Heuvel, Frank] Univ Leuven, Dept Oncol, Lab Expt Radiotherapy, Leuven, Belgium	University of Oxford; KU Leuven	Van den Heuvel, F (corresponding author), Univ Oxford, Dept Oncol, CRUK MRC Oxford Inst Radiat Oncol, Oxford, England.	frank.vandenheuvel@oncology.ox.ac.uk	Van den Heuvel, Frank/CAE-9338-2022; Van den Heuvel, Frank/GOK-2337-2022	Van den Heuvel, Frank/0000-0001-9904-502X; Van den Heuvel, Frank/0000-0001-9904-502X				[Anonymous], CR ACAD SCI PARIS; BARKAS WH, 1963, PHYS REV LETT, V11, P26, DOI 10.1103/PhysRevLett.11.26; Bethe H, 1930, ANN PHYS, V5; Breit G, 1959, HDB PHYS, VXLI/1; BRENNER DJ, 1992, INT J RADIAT BIOL, V61, P737, DOI 10.1080/09553009214551591; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Chaudhary P, 2014, INT J RADIAT ONCOL, V90, P27, DOI 10.1016/j.ijrobp.2014.05.010; Cucinotta FA, 2000, RADIAT RES, V153, P459, DOI 10.1667/0033-7587(2000)153[0459:MFRDOF]2.0.CO;2; Goitein M, 2008, BIOL MED PHYS BIOMED, P1, DOI 10.1007/978-0-387-72645-8; Hall E.J, 1978, RADIOBIOLOGY RADIOLO, V1st; Hsiao Y, 2008, PHYS MED BIOL, V53, P233, DOI 10.1088/0031-9155/53/1/016; ICRU International Commission on Radiation Units and Measurements, 1970, 16 ICRU; ICRU International Commission on Radiation Units and Measurements, 1983, 36 ICRU; ICRU International Commission on Radiation Units and Measurements, 1971, 19 ICRU; Katz R, 2003, RADIAT RES, V160, P724, DOI 10.1667/RR3088; Kavanagh JN, 2013, SCI REP-UK, V3, DOI 10.1038/srep01770; Kramer M, 2006, PHYS MED BIOL, V51, P1959, DOI 10.1088/0031-9155/51/8/001; Nikjoo H, 1997, INT J RADIAT BIOL, V71, P467, DOI 10.1080/095530097143798; Paganetti H, 2002, INT J RADIAT ONCOL, V53, P407, DOI 10.1016/S0360-3016(02)02754-2; Paganetti H, 2001, INT J RADIAT BIOL, V77, P911, DOI 10.1080/0953000110066059; Powell C. J., 2010, NIST ELECT INELASTIC; Sato T, 2009, RADIAT RES, V171, P107, DOI 10.1667/RR1510.1; Semenenko VA, 2006, PHYS MED BIOL, V51, P1693, DOI 10.1088/0031-9155/51/7/004; SINDEN R. R., 1994, DNA STRUCTURE FUNCTI; Stewart RD, 2011, RADIAT RES, V176, P587, DOI 10.1667/RR2663.1; Tanuma S, 2005, SURF INTERFACE ANAL, V37, P1, DOI 10.1002/sia.1997; Van den Heuvel F, 2010, PHYS MED BIOL, V55, P4509, DOI 10.1088/0031-9155/55/16/S06; WARD JF, 1985, RADIAT RES, V104, pS103, DOI 10.2307/3576637; Waters LS, 2007, AIP CONF PROC, V896, P81, DOI 10.1063/1.2720459; Zhen-Yu T, 2010, CHINESE PHYS LETT, V27; Ziaja B, 2006, J APPL PHYS, V99, DOI 10.1063/1.2161821	31	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110333	10.1371/journal.pone.0110333	http://dx.doi.org/10.1371/journal.pone.0110333			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340636	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662800031
J	Xiang, Z; Wang, S; Xiang, Y				Xiang, Zheng; Wang, Sen; Xiang, Yao			Up-Regulated MicroRNA499a by Hepatitis B Virus Induced Hepatocellular Carcinogenesis via Targeting MAPK6	PLOS ONE			English	Article							KINASES; ASSOCIATIONS; ACTIVATION; CARCINOMA; MIR-499; RISK; ERK3	Emerging evidence showed miR499a could not only function as an oncogene but also as a tumor suppressor in various types of cancer, such as melanoma. However, whether miR499a was involved in hepatocarcinogenesis remains unknown. We previously reported that miR499a was up-regulated in HBV-mediated hepatocellular carcinoma (HCC). In this study, we found that HBV could induce the expression of miR499a by promoting its promoter activity. In addition, we reported that miR499a increased cell proliferation and cell migration of HCC cells. MAPK6 was further identified as a target of miR499a, which could also be down-regulated by HBV. Moreover, we demonstrated that MAPK6 could rescue the cell growth induced by miR499a and HBV. These findings indicated that miR499a might play an oncogene role by targeting MAPK6 in the development and progression of HBV-related HCC.	[Xiang, Zheng; Xiang, Yao] Chongqing Med Univ, Affiliated Hosp 1, Dept Gastrointestinal Surg, Chongqing, Peoples R China; [Xiang, Zheng; Xiang, Yao] Chongqing Med Univ, Dept Gen Surg, Chongqing Key Lab, Chongqing, Peoples R China; [Wang, Sen] Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Xiang, Z (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Gastrointestinal Surg, Chongqing, Peoples R China.	13330209937@163.com			Natural Science Foundation Project of CQ CSTC [cstc2012gg-yyjs0644]	Natural Science Foundation Project of CQ CSTC(Natural Science Foundation Project of CQ CSTC)	This work was supported by Natural Science Foundation Project of CQ CSTC (cstc2012gg-yyjs0644). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbuthnot P, 2001, INT J EXP PATHOL, V82, P77, DOI 10.1111/j.1365-2613.2001.iep178.x; BEASLEY RP, 1981, LANCET, V2, P1129; Buxade M, 2008, FRONT BIOSCI-LANDMRK, V13, P5359, DOI 10.2741/3086; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Coulombe P, 2007, BBA-MOL CELL RES, V1773, P1376, DOI 10.1016/j.bbamcr.2006.11.001; Deleris P, 2008, J CELL PHYSIOL, V217, P778, DOI 10.1002/jcp.21560; Du W, 2014, ASIAN PAC J CANCER P, V15, P1047, DOI 10.7314/APJCP.2014.15.2.1047; Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005; Kew MC, 2010, PATHOL BIOL, V58, P273, DOI 10.1016/j.patbio.2010.01.005; Kostenko Sergiy, 2012, J Mol Signal, V7, P9, DOI 10.1186/1750-2187-7-9; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai CL, 2008, NEW ENGL J MED, V359, P2488, DOI 10.1056/NEJMe0808185; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Li M, 2014, ONCOL REP, V31, P1961, DOI 10.3892/or.2014.3029; Li XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074504; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Olivieri F, 2014, INT J CARDIOL, V172, pE276, DOI 10.1016/j.ijcard.2013.12.203; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Seeff LB, 2006, ONCOGENE, V25, P3771, DOI 10.1038/sj.onc.1209560; Sengupta S, 2008, P NATL ACAD SCI USA, V105, P5874, DOI 10.1073/pnas.0801130105; Seternes OM, 2004, EMBO J, V23, P4780, DOI 10.1038/sj.emboj.7600489; Wang ZX, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/719202; Yang HI, 2008, JNCI-J NATL CANCER I, V100, P1134, DOI 10.1093/jnci/djn243	24	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111410	10.1371/journal.pone.0111410	http://dx.doi.org/10.1371/journal.pone.0111410			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340781	gold, Green Submitted, Green Published			2022-12-27	WOS:000343662800107
J	Bedessem, B; Stephanou, A				Bedessem, Baptiste; Stephanou, Angelique			Role of Compartmentalization on HiF-1 alpha Degradation Dynamics during Changing Oxygen Conditions: A Computational Approach	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE-FACTOR; TUMOR-SUPPRESSOR GENE; NUCLEAR-CYTOPLASMIC TRAFFICKING; SQUAMOUS-CELL CARCINOMA; FACTOR 1-ALPHA; INTERMITTENT HYPOXIA; UP-REGULATION; HIF-ALPHA; ENDOTHELIAL-CELLS; INDUCED APOPTOSIS	HiF-1 alpha is the central protein driving the cellular response to hypoxia. Its accumulation in cancer cells is linked to the appearance of chemoresistant and aggressive tumor phenotypes. As a consequence, understanding the regulation of HiF-1 alpha dynamics is a major issue to design new anti-cancer therapies. In this paper, we propose a model of the hypoxia pathway, involving HiF-1 alpha and its inhibitor pVHL. Based on data from the literature, we made the hypothesis that the regulation of HiF-1 alpha involves two compartments (nucleus and cytoplasm) and a constitutive shuttle of the pVHL protein between them. We first show that this model captures correctly the main features of HiF-1 alpha dynamics, including the bi-exponential degradation profile in normoxia, the kinetics of induction in hypoxia, and the switch-like accumulation. Second, we simulated the effects of a hypoxia/reoxygenation event, and show that it generates a strong instability of HiF-1 alpha. The protein concentration rapidly increases 3 hours after the reoxygenation, and exhibits an oscillating pattern. This effect vanishes if we do not consider compartmentalization of HiF-1 alpha. This result can explain various counter-intuitive observations about the specific molecular and cellular response to the reoxygenation process. Third, we simulated the HiF-1 alpha dynamics in the tumor case. We considered different types of mutations associated with tumorigenesis, and we compared their consequences on HiF-1 alpha dynamics. Then, we tested different therapeutics strategies. We show that a therapeutic decrease of HiF-1 alpha nuclear level is not always correlated with an attenuation of reoxygenation-induced instabilities. Thus, it appears that the design of anti-HiF-1 alpha therapies have to take into account these two aspects to maximize their efficiency.	[Bedessem, Baptiste; Stephanou, Angelique] UJF Grenoble 1, CNRS, Lab TIMC IMAG DyCTIM, UMR 5525, La Tronche, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA)	Stephanou, A (corresponding author), UJF Grenoble 1, CNRS, Lab TIMC IMAG DyCTIM, UMR 5525, La Tronche, France.	angelique.stephanou@imag.fr	; Stephanou, Angelique/M-6361-2014	Bedessem, Baptiste/0000-0002-9603-6686; Stephanou, Angelique/0000-0001-6399-0425				Bedessem B, 2014, MATH BIOSCI, V248, P31, DOI 10.1016/j.mbs.2013.11.007; Berchner-Pfannschmidt U, 2008, EUR RESPIR J, V32, P210, DOI 10.1183/09031936.00013408; Blagosklonny MV, 2001, ONCOGENE, V20, P395, DOI 10.1038/sj.onc.1204055; Cao D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-432; Cavadas MAS, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-42; Conde E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033258; Dai ZJ, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-28; Dewhirst MW, 2007, CANCER RES, V67, P854, DOI 10.1158/0008-5472.CAN-06-4744; Filippi S, 2008, EMBO J, V27, P2545, DOI 10.1038/emboj.2008.180; Fujiwara S, 2007, INT J ONCOL, V30, P793; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Gardner LB, 2001, J BIOL CHEM, V276, P7919, DOI 10.1074/jbc.M010189200; Groulx I, 2002, MOL CELL BIOL, V22, P5319, DOI 10.1128/MCB.22.15.5319-5336.2002; Gwak GY, 2005, J HEPATOL, V42, P358, DOI 10.1016/j.jhep.2004.11.020; Hara S, 1999, Mol Cell Biol Res Commun, V2, P119, DOI 10.1006/mcbr.1999.0160; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Heiner M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008600; Hernandez-Luna MA, 2012, LEUK LYMPHOMA; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Hsieh CH, 2009, J NUCL MED, V50, P2049, DOI 10.2967/jnumed.108.061234; Hunziker A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-94; Hyseni A, 2011, CELL ONCOL, V34, P565, DOI 10.1007/s13402-011-0053-5; Illingworth CJR, 2010, BIOCHEMISTRY-US, V49, P6936, DOI 10.1021/bi100358t; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Jokilehto T, 2006, CLIN CANCER RES, V12, P1080, DOI 10.1158/1078-0432.CCR-05-2022; Kamat CD, 2007, CANCER LETT, V249, P209, DOI 10.1016/j.canlet.2006.08.017; Kang PM, 2000, CIRC RES, V87, P118, DOI 10.1161/01.RES.87.2.118; Karhausen J, 2005, J CELL BIOCHEM, V95, P1264, DOI 10.1002/jcb.20489; Kohn KW, 2004, MOL BIOL CELL, V15, P3042, DOI 10.1091/mbc.e03-12-0897; Kooner P, 2006, P 2005 INT S MATH CO, P281; Krieg M, 2000, ONCOGENE, V19, P5435, DOI 10.1038/sj.onc.1203938; Kubis HP, 2005, BBA-MOL CELL RES, V1745, P187, DOI 10.1016/j.bbamcr.2005.05.007; Kunz Manfred, 2003, Mol Cancer, V2, P23, DOI 10.1186/1476-4598-2-23; Lee S, 1996, P NATL ACAD SCI USA, V93, P1770, DOI 10.1073/pnas.93.5.1770; Lee S, 1999, MOL CELL BIOL, V19, P1486; Lesart AC, 2012, MICROVASC RES, V84, P188, DOI 10.1016/j.mvr.2012.06.001; Lidgren, 2008, J CANC MOL, V4, P153; Los M, 1996, LAB INVEST, V75, P231; Luo L, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-91; Martinive P, 2006, CANCER RES, V66, P11736, DOI 10.1158/0008-5472.CAN-06-2056; Martinive P, 2009, FEBS J, V276, P509, DOI 10.1111/j.1742-4658.2008.06798.x; Matsuyama T, 2005, CANCER SCI, V96, P176, DOI 10.1111/j.1349-7006.2005.00025.x; Maxwell PH, 2001, ADV EXP MED BIOL, V502, P365; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mekhail K, 2007, MOL BIOL CELL, V18, P3966, DOI 10.1091/mbc.E07-03-0295; MICHIELS C, 1994, EXP CELL RES, V213, P43, DOI 10.1006/excr.1994.1171; Moroz E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005077; Nguyen LK, 2013, J CELL SCI, V126, P1454, DOI 10.1242/jcs.119974; Qutub AA, 2007, BBA-MOL CELL RES, V1773, P1511, DOI 10.1016/j.bbamcr.2007.07.004; Rechsteiner MP, 2011, CANCER RES, V71, P5500, DOI 10.1158/0008-5472.CAN-11-0757; Renbaum P, 1996, HUM GENET, V98, P666, DOI 10.1007/s004390050281; Semenza G. L., 2007, SCI STKE, pcm8; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Sermeus A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.48; Stroka DM, 2001, FASEB J, V15, P2445, DOI 10.1096/fj.01-0125com; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Tan EY, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1838; Turner KJ, 2002, CANCER RES, V62, P2957; Wang XO, 2012, BIOCHEM BIOPH RES CO, V417, P1227, DOI 10.1016/j.bbrc.2011.12.115; Wiesener MS, 2001, CANCER RES, V61, P5215; Yang BC, 1999, J PHARMACOL EXP THER, V291, P733; Yang CZ, 2013, CELL REP, V3, P52, DOI 10.1016/j.celrep.2012.12.007; Yoshikawa T, 2006, ANTICANCER RES, V26, P3849; Yu YH, 2007, PLOS COMPUT BIOL, V3, P1657, DOI 10.1371/journal.pcbi.0030171; Yuan G, 2008, J CELL PHYSIOL, V217, P674, DOI 10.1002/jcp.21537; Zheng XW, 2006, MOL CELL BIOL, V26, P4628, DOI 10.1128/MCB.02236-05; Zhong H, 1998, CANCER RES, V58, P5280; Zhong H, 1999, CANCER RES, V59, P5830	71	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110495	10.1371/journal.pone.0110495	http://dx.doi.org/10.1371/journal.pone.0110495			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338163	Green Submitted, gold, Green Published			2022-12-27	WOS:000343674800048
J	Drewes, J; Zhu, WN; Hu, YZ; Hu, XT				Drewes, Jan; Zhu, Weina; Hu, Yingzhou; Hu, Xintian			Smaller Is Better: Drift in Gaze Measurements due to Pupil Dynamics	PLOS ONE			English	Article							LIGHT REFLEX	Camera-based eye trackers are the mainstay of eye movement research and countless practical applications of eye tracking. Recently, a significant impact of changes in pupil size on gaze position as measured by camera-based eye trackers has been reported. In an attempt to improve the understanding of the magnitude and population-wise distribution of the pupil-size dependent shift in reported gaze position, we present the first collection of binocular pupil drift measurements recorded from 39 subjects. The pupil-size dependent shift varied greatly between subjects (from 0.3 to 5.2 deg of deviation, mean 2.6 deg), but also between the eyes of individual subjects (0.1 to 3.0 deg difference, mean difference 1.0 deg). We observed a wide range of drift direction, mostly downward and nasal. We demonstrate two methods to partially compensate the pupil-based shift using separate calibrations in pupil-constricted and pupil-dilated conditions, and evaluate an improved method of compensation based on individual look-up-tables, achieving up to 74% of compensation.	[Drewes, Jan] York Univ, Ctr Vis Res, Toronto, ON M3J 2R7, Canada; [Drewes, Jan; Zhu, Weina] Trento Univ, Ctr Mind Brain Sci, Rovereto, Italy; [Zhu, Weina] Yunnan Univ, Sch Informat Sci, Kunming, Peoples R China; [Zhu, Weina; Hu, Yingzhou; Hu, Xintian] Chinese Acad Sci, Kunming Inst Zool, Kunming, Peoples R China	York University - Canada; University of Trento; Yunnan University; Chinese Academy of Sciences; Kunming Institute of Zoology	Drewes, J (corresponding author), York Univ, Ctr Vis Res, Toronto, ON M3J 2R7, Canada.	mail@jandrewes.de			National Natural Science Foundation of China [62263042, 61005087]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	WZ was supported by the National Natural Science Foundation of China (62263042, 61005087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, P S EYE TRACKING RES, DOI [DOI 10.1145/2168556.2168563, DOI 10.3758/s13428-012-0234-9]; BEATTY J, 1982, PSYCHOL BULL, V91, P276, DOI 10.1037/0033-2909.91.2.276; Binda P, 2013, J VIS, V13; Cleveland D, 2003, Patent, Patent No. [US20030086057, 20030086057]; Darwin C, 1850, EXPRESSION EMOTIONS; Drewes J., 2012, P S EYE TRACKING RES, P209, DOI [DOI 10.1145/2168556.2168596, 10.1145/2168556.2168596]; ELLIS CJK, 1981, BRIT J OPHTHALMOL, V65, P754, DOI 10.1136/bjo.65.11.754; HESS EH, 1964, SCIENCE, V143, P1190, DOI 10.1126/science.143.3611.1190; Iqbal S.T., 2004, P 2004 C HUMAN FACTO, P1477, DOI [10.1145/985921.986094, DOI 10.1145/985921.986094]; Pong M, 2000, J NEUROPHYSIOL, V84, P953, DOI 10.1152/jn.2000.84.2.953; Privitera CM, 2010, J VISION, V10, DOI 10.1167/10.10.3; Wyatt HJ, 2010, VISION RES, V50, P1982, DOI 10.1016/j.visres.2010.07.008	12	43	43	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e111197	10.1371/journal.pone.0111197	http://dx.doi.org/10.1371/journal.pone.0111197			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338168	Green Published, gold, Green Submitted			2022-12-27	WOS:000343674800110
J	Francis, TB; Wolkovich, EM; Scheuerell, MD; Katz, SL; Holmes, EE; Hampton, SE				Francis, Tessa B.; Wolkovich, Elizabeth M.; Scheuerell, Mark D.; Katz, Stephen L.; Holmes, Elizabeth E.; Hampton, Stephanie E.			Shifting Regimes and Changing Interactions in the Lake Washington, USA, Plankton Community from 1962-1994	PLOS ONE			English	Article							SOCKEYE-SALMON FRY; CLIMATE-CHANGE; TIME-SERIES; FOOD-WEB; ENVIRONMENTAL-CHANGE; ECOSYSTEM; DYNAMICS; TEMPERATURE; VARIABILITY; STABILITY	Understanding how changing climate, nutrient regimes, and invasive species shift food web structure is critically important in ecology. Most analytical approaches, however, assume static species interactions and environmental effects across time. Therefore, we applied multivariate autoregressive (MAR) models in a moving window context to test for shifting plankton community interactions and effects of environmental variables on plankton abundance in Lake Washington, U.S.A. from 1962-1994, following reduced nutrient loading in the 1960s and the rise of Daphnia in the 1970s. The moving-window MAR (mwMAR) approach showed shifts in the strengths of interactions between Daphnia, a dominant grazer, and other plankton taxa between a high nutrient, Oscillatoria-dominated regime and a low nutrient, Daphnia-dominated regime. The approach also highlighted the inhibiting influence of the cyanobacterium Oscillatoria on other plankton taxa in the community. Overall community stability was lowest during the period of elevated nutrient loading and Oscillatoria dominance. Despite recent warming of the lake, we found no evidence that anomalous temperatures impacted plankton abundance. Our results suggest mwMAR modeling is a useful approach that can be applied across diverse ecosystems, when questions involve shifting relationships within food webs, and among species and abiotic drivers.	[Francis, Tessa B.] Univ Washington, Puget Sound Inst, Tacoma, WA 98402 USA; [Wolkovich, Elizabeth M.; Hampton, Stephanie E.] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA; [Wolkovich, Elizabeth M.] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Scheuerell, Mark D.] NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Fish Ecol Div, Seattle, WA 98112 USA; [Katz, Stephen L.] NOAA, Channel Isl Natl Marine Sanctuary, Natl Ocean Serv, Seattle, WA USA; [Holmes, Elizabeth E.] NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Conservat Biol Div, Seattle, WA 98112 USA	University of Washington; University of Washington Tacoma; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; University of British Columbia; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Oceanic Atmospheric Admin (NOAA) - USA	Francis, TB (corresponding author), Univ Washington, Puget Sound Inst, Tacoma, WA 98402 USA.	tessa@uw.edu	Scheuerell, Mark/N-6683-2016	Scheuerell, Mark/0000-0002-8284-1254; Wolkovich, Elizabeth M/0000-0001-7653-893X; Holmes, Elizabeth/0000-0001-9128-8393; Hampton, Stephanie/0000-0003-2389-4249	Environmental Protection Agency [PC-00J303-01]; National Science Foundation [EF-0553768]; University of California, Santa Barbara; State of California; NSERC	Environmental Protection Agency(United States Environmental Protection Agency); National Science Foundation(National Science Foundation (NSF)); University of California, Santa Barbara(University of California System); State of California; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was initiated while TBF held a National Research Council Research Associateship Award at NOAA's Northwest Fisheries Science Center, and conducted in part while TBF was employed by the Puget Sound Institute, funded by the Environmental Protection Agency (Grant #PC-00J303-01). This work was conducted in part while EMW was a postdoctoral associate at the National Center for Ecological Analysis and Synthesis, a Center funded by the National Science Foundation (Grant #EF-0553768), the University of California, Santa Barbara, and the State of California, and in part while she was a National Science Foundation Postdoctoral Research Fellow in Biology (DBI-0905806), and also while she was supported by the NSERC CREATE training program in biodiversity research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauchamp DA, 2004, T AM FISH SOC, V133, P1014, DOI 10.1577/T03-093.1; Beninca E, 2009, ECOL LETT, V12, P1367, DOI 10.1111/j.1461-0248.2009.01391.x; Breaker LC, 2006, PROG OCEANOGR, V69, P61, DOI 10.1016/j.pocean.2006.02.015; Burkle LA, 2013, SCIENCE, V339, P1611, DOI 10.1126/science.1232728; Carpenter SR, 2011, SCIENCE, V332, P1079, DOI 10.1126/science.1203672; Carpenter S.R., 1992, FOOD WEB MANAGEMENT, P461; Dakos V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041010, 10.1371/journal.pone.0045586]; EDMONDSON WT, 1982, LIMNOL OCEANOGR, V27, P272, DOI 10.4319/lo.1982.27.2.0272; EDMONDSON WT, 1991, LIMNOL OCEANOGR, V36, P1031, DOI 10.4319/lo.1991.36.5.1031; EDMONDSON WT, 1970, SCIENCE, V169, P690, DOI 10.1126/science.169.3946.690; Edmondson WT., 1991, USES ECOLOGY LAKE WA; Elkinton JS, 1996, ECOLOGY, V77, P2332, DOI 10.2307/2265735; Francis TB, 2012, GLOBAL CHANGE BIOL, V18, P2498, DOI 10.1111/j.1365-2486.2012.02702.x; Francis TB, 2009, OIKOS, V118, P1872, DOI 10.1111/j.1600-0706.2009.17723.x; Hampton SE, 2006, J PLANKTON RES, V28, P399, DOI 10.1093/plankt/fbi125; Hampton SE, 2005, LIMNOL OCEANOGR, V50, P421, DOI 10.4319/lo.2005.50.2.0421; Hampton SE, 2008, GLOBAL CHANGE BIOL, V14, P1947, DOI 10.1111/j.1365-2486.2008.01616.x; Hampton SE, 2006, LIMNOL OCEANOGR, V51, P2042, DOI 10.4319/lo.2006.51.5.2042; Hampton SE, 2006, OIKOS, V113, P424, DOI 10.1111/j.2006.0030-1299.14643.x; Hampton SE, 2013, ECOLOGY, V94, P2663, DOI 10.1890/13-0996.1; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Hastings A, 2004, TRENDS ECOL EVOL, V19, P39, DOI 10.1016/j.tree.2003.09.007; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Holyoak M, 2000, ECOL LETT, V3, P509, DOI 10.1046/j.1461-0248.2000.00180.x; Hsieh CH, 2009, FISH OCEANOGR, V18, P102, DOI 10.1111/j.1365-2419.2008.00498.x; Infante A, 1985, LIMNOL OCEANOGR, V30, P1046; Ives AR, 1999, SCIENCE, V286, P542, DOI 10.1126/science.286.5439.542; IVES AR, 1995, ECOLOGY, V76, P926, DOI 10.2307/1939357; IVES AR, 1995, ECOL MONOGR, V65, P217, DOI 10.2307/2937138; Ives AR, 2003, ECOL MONOGR, V73, P301, DOI 10.1890/0012-9615(2003)073[0301:ECSAEI]2.0.CO;2; Jevrejeva S, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020871; Kordas RL, 2011, P ROY SOC B-BIOL SCI, V278, P1804, DOI 10.1098/rspb.2010.2246; Law T, 2009, ECOL MODEL, V220, P979, DOI 10.1016/j.ecolmodel.2009.01.001; Lindegren M, 2009, P NATL ACAD SCI USA, V106, P14722, DOI 10.1073/pnas.0906620106; Mac Nally R, 2010, ECOL APPL, V20, P1417, DOI 10.1890/09-1724.1; MAZUMDER A, 1990, SCIENCE, V247, P312, DOI 10.1126/science.247.4940.312; Menard F, 2007, FISH OCEANOGR, V16, P95, DOI 10.1111/j.1365-2419.2006.00415.x; SARNELLE O, 1993, ECOL MONOGR, V63, P129, DOI 10.2307/2937177; Schlesinger MD, 2008, ECOLOGY, V89, P2302, DOI 10.1890/07-0256.1; Seekell DA, 2011, AM NAT, V178, P442, DOI 10.1086/661898; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Torrence C, 1999, J CLIMATE, V12, P2679, DOI 10.1175/1520-0442(1999)012<2679:ICITEM>2.0.CO;2; Tunney TD, 2014, P NATL ACAD SCI USA, V111, P8077, DOI 10.1073/pnas.1319618111; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Viscido SV, 2010, ENVIRON MODELL SOFTW, V25, P1905, DOI 10.1016/j.envsoft.2010.05.010; Walther GR, 2010, PHILOS T R SOC B, V365, P2019, DOI 10.1098/rstb.2010.0021; Winder M, 2004, GLOBAL CHANGE BIOL, V10, P1844, DOI 10.1111/j.1365-2486.2004.00849.x; Winder M, 2004, ECOLOGY, V85, P2100, DOI 10.1890/04-0151; Winder M, 2010, PHILOS T R SOC B, V365, P3215, DOI 10.1098/rstb.2010.0125; Winder M, 2009, LIMNOL OCEANOGR, V54, P2493, DOI 10.4319/lo.2009.54.6_part_2.2493	50	14	14	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e0110363	10.1371/journal.pone.0110363	http://dx.doi.org/10.1371/journal.pone.0110363			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338087	Green Published, gold, Green Submitted			2022-12-27	WOS:000343674800040
J	Lakoma, J; Rimondini, R; Donadio, V; Liguori, R; Caprini, M				Lakoma, Jarmila; Rimondini, Roberto; Donadio, Vincenzo; Liguori, Rocco; Caprini, Marco			Pain Related Channels Are Differentially Expressed in Neuronal and Non-Neuronal Cells of Glabrous Skin of Fabry Knockout Male Mice	PLOS ONE			English	Article							RESISTANT SODIUM-CHANNEL; ENZYME REPLACEMENT THERAPY; SMALL-FIBER NEUROPATHY; ION CHANNELS; ALPHA-GALACTOSIDASE; CAPSAICIN-RECEPTOR; SENSORY NEURONS; MOLECULAR-MECHANISMS; INFLAMMATORY PAIN; DEFICIENT MICE	Fabry disease (FD) is one of the X-linked lysosomal storage disorders caused by deficient functioning of the alpha-galactosidase A (alpha-GalA) enzyme. The alpha-GalA deficiency leads to multi-systemic clinical manifestations caused by the preferential accumulation of globotriaosylceramide in the endothelium and vascular smooth muscles. A hallmark symptom of FD patients is peripheral pain that appears in the early stage of the disease. Pain in FD patients is a peripheral small-fiber idiopathic neuropathy, with intra-epidermal fiber density and integrity being used for diagnosing FD in humans. However, the molecular correlates underlying pain sensation in FD remain elusive. Here, we have employed the alpha-GalA gene KO mouse as a model of FD in rodents to investigate molecular changes in their peripheral nervous system that may account for their algesic symptoms. The alpha-GalA null mice display neuropathic pain as evidenced by thermal hyperalgesia and mechanical allodynia, with histological analyses showing alterations in cutaneous innervation. Additionally, KO mice showed a decreased and scattered pattern of neuronal terminations consistent with the reduction in neuronal terminations in skin biopsies of patients with small fiber neuropathies. At the molecular level KO animals showed an increase in the expression of TRPV1 and Nav1.8, and a decrease in the expression of TRPM8. Notably, these alterations are observed in young animals. Taken together, our findings imply that the alpha-GalA KO mouse is a good model in which to study the peripheral small fiber neuropathy exhibited by FD patients, and provides molecular evidence for a hyperexcitability of small nociceptors in FD.	[Lakoma, Jarmila; Caprini, Marco] Univ Bologna, Dept Pharm & Biotechnol FaBiT, Lab Human & Gen Physiol, Bologna, Italy; [Rimondini, Roberto] Univ Bologna, Dept Med & Clin Sci DIMEC, Bologna, Italy; [Donadio, Vincenzo; Liguori, Rocco] AUSL Bologna, IRCCS, Inst Neurol Sci, Bologna, Italy; [Liguori, Rocco] Univ Bologna, Dept Biomed & Neuromotor Sci DIBINEM, Bologna, Italy	University of Bologna; University of Bologna; AUSL di Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna	Caprini, M (corresponding author), Univ Bologna, Dept Pharm & Biotechnol FaBiT, Lab Human & Gen Physiol, Bologna, Italy.	m.caprini@unibo.it	Liguori, Rocco/AAB-7860-2020; Rimondini, Roberto/B-2500-2010; Donadio, Vincenzo/AAB-9165-2020; roberto, rimondini/AAC-3525-2019	Rimondini, Roberto/0000-0003-4099-513X; roberto, rimondini/0000-0003-4099-513X; Donadio, Vincenzo/0000-0002-1290-7318; Liguori, Rocco/0000-0002-1815-1013	Ministero della Salute, Bando Progetti di Ricerca Finalizzata IRCCS - Istituto delle Scienze Neurologiche di Bologna, Italy [2010 RF-2010-2313899]	Ministero della Salute, Bando Progetti di Ricerca Finalizzata IRCCS - Istituto delle Scienze Neurologiche di Bologna, Italy	This work was supported by Ministero della Salute, Bando Progetti di Ricerca Finalizzata IRCCS - Istituto delle Scienze Neurologiche di Bologna, Italy, (2010 RF-2010-2313899) grant to M.C, R.L, V.D. and R.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2000, J CLIN INVEST, V105, P1563, DOI 10.1172/JCI9711; Almaraz L, 2014, HANDB EXP PHARMACOL, V222, P547, DOI 10.1007/978-3-642-54215-2_22; Amaya F, 2000, MOL CELL NEUROSCI, V15, P331, DOI 10.1006/mcne.1999.0828; Andreev YA, 2013, MAR DRUGS, V11, P5100, DOI 10.3390/md11125100; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Belkouch M, 2011, J NEUROSCI, V31, P18381, DOI 10.1523/JNEUROSCI.3386-11.2011; Belmonte C, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-14; Bennett DLH, 2014, LANCET NEUROL, V13, P587, DOI 10.1016/S1474-4422(14)70024-9; Biegstraaten M, 2011, EUR J PAIN, V15, P822, DOI 10.1016/j.ejpain.2011.01.014; Black JA, 2013, NEURON, V80, P280, DOI 10.1016/j.neuron.2013.09.012; Brenner DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039765; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Chatelier A, 2012, J PHYSIOL-LONDON, V590, P4307, DOI 10.1113/jphysiol.2012.233593; Coggeshall RE, 2004, NEUROSCI LETT, V355, P45, DOI 10.1016/j.neulet.2003.10.023; Cortright DN, 2007, BBA-MOL BASIS DIS, V1772, P978, DOI 10.1016/j.bbadis.2007.03.003; Coward K, 2000, PAIN, V85, P41, DOI 10.1016/S0304-3959(99)00251-1; Crawley JN, 2007, WHATS WRONG MY MOUSE, P344; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Desnick RJ, 2001, CONTRIB NEPHROL, V136, P174; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Dong XW, 2007, NEUROSCIENCE, V146, P812, DOI 10.1016/j.neuroscience.2007.01.054; Dubin AE, 2010, J CLIN INVEST, V120, P3760, DOI 10.1172/JCI42843; Dutsch M, 2002, J CLIN NEUROPHYSIOL, V19, P575; Eijkelkamp N, 2013, ANNU REV NEUROSCI, V36, P519, DOI 10.1146/annurev-neuro-062012-170412; ESTACION M, 1991, J PHYSIOL-LONDON, V436, P579, DOI 10.1113/jphysiol.1991.sp018568; Faber CG, 2012, P NATL ACAD SCI USA, V109, P19444, DOI 10.1073/pnas.1216080109; Faber CG, 2012, ANN NEUROL, V71, P26, DOI 10.1002/ana.22485; Filoni C, 2010, BBA-MOL BASIS DIS, V1802, P247, DOI 10.1016/j.bbadis.2009.11.003; Garcia-Martinez C, 2002, P NATL ACAD SCI USA, V99, P2374, DOI 10.1073/pnas.022285899; Giannoccaro MP, 2011, NEUROL SCI, V32, P361, DOI 10.1007/s10072-010-0475-2; Golden JP, 2010, J NEUROSCI, V30, P3983, DOI 10.1523/JNEUROSCI.5930-09.2010; Hughes DA, 2011, MOL GENET METAB, V103, P207, DOI 10.1016/j.ymgme.2011.03.022; Ioannou YA, 2001, AM J HUM GENET, V68, P14, DOI 10.1086/316953; Jentsch TJ, 2004, NAT CELL BIOL, V6, P1039, DOI 10.1038/ncb1104-1039; Kullmann DM, 2002, LANCET NEUROL, V1, P157, DOI 10.1016/S1474-4422(02)00071-6; Lai J, 2002, PAIN, V95, P143, DOI 10.1016/S0304-3959(01)00391-8; Lee Y, 2005, MOL CELLS, V20, P315; Leo S, 2010, BEHAV BRAIN RES, V208, P149, DOI 10.1016/j.bbr.2009.11.023; Li GR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007307; Liguori R, 2010, MUSCLE NERVE, V41, P409, DOI 10.1002/mus.21606; Minett MS, 2014, CELL REP, V6, P301, DOI 10.1016/j.celrep.2013.12.033; Minett MS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1795; Moller AT, 2006, J PERIPHER NERV SYST, V11, P119, DOI 10.1111/j.1085-9489.2006.00076.x; Momin A, 2008, CURR OPIN NEUROBIOL, V18, P383, DOI 10.1016/j.conb.2008.08.017; Morrone A, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.8.e103; Muthusamy VR, 2012, FREE RADICAL BIO MED, V52, P366, DOI 10.1016/j.freeradbiomed.2011.10.440; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; Niemann M, 2011, J AM SOC ECHOCARDIOG, V24, P1026, DOI 10.1016/j.echo.2011.05.021; Novakovic SD, 1998, J NEUROSCI, V18, P2174; Ohshima T, 1995, GENE, V166, P277, DOI 10.1016/0378-1119(95)00592-7; Ohshima T, 1997, P NATL ACAD SCI USA, V94, P2540, DOI 10.1073/pnas.94.6.2540; Okuse K, 2007, INT J BIOCHEM CELL B, V39, P490, DOI 10.1016/j.biocel.2006.11.016; Pabbidi RM, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-9; Periquet MI, 1999, NEUROLOGY, V53, P1641, DOI 10.1212/WNL.53.8.1641; Pogatzki-Zahn EM, 2005, PAIN, V115, P296, DOI 10.1016/j.pain.2005.03.010; Rodrigues LG, 2009, NEUROBIOL DIS, V33, P48, DOI 10.1016/j.nbd.2008.09.001; Rowland KC, 2007, J ENDODONT, V33, P245, DOI 10.1016/j.joen.2006.11.020; Schley M, 2012, EUR J PAIN, V16, P1414, DOI 10.1002/j.1532-2149.2012.00157.x; Strickland IT, 2008, EUR J PAIN, V12, P564, DOI 10.1016/j.ejpain.2007.09.001; Toyooka K, 2011, CURR OPIN NEUROL, V24, P463, DOI 10.1097/WCO.0b013e32834a9433; Viana F, 2011, ACS CHEM NEUROSCI, V2, P38, DOI 10.1021/cn100102c; Wilcox WR, 2008, MOL GENET METAB, V93, P112, DOI 10.1016/j.ymgme.2007.09.013; Wood JN, 2000, AM J PHYSIOL-GASTR L, V278, pG507, DOI 10.1152/ajpgi.2000.278.4.G507; Yu L, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-61; Zhao P, 2008, PAIN, V139, P90, DOI 10.1016/j.pain.2008.03.016; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015	69	35	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e108641	10.1371/journal.pone.0108641	http://dx.doi.org/10.1371/journal.pone.0108641			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337704	gold, Green Published			2022-12-27	WOS:000343674800007
J	Okebe, J; Affara, M; Correa, S; Muhammad, AK; Nwakanma, D; Drakeley, C; D'Alessandro, U				Okebe, Joseph; Affara, Muna; Correa, Simon; Muhammad, Abdul Khalie; Nwakanma, Davis; Drakeley, Chris; D'Alessandro, Umberto			School-Based Countrywide Seroprevalence Survey Reveals Spatial Heterogeneity in Malaria Transmission in the Gambia	PLOS ONE			English	Article							INTERVENTIONS; PREVALENCE	Background: As the geographical distribution of malaria transmission becomes progressively clustered, identifying residual pockets of transmission is important for research and for targeting interventions. Malarial antibody-based surveillance is increasingly recognised as a valuable complement to classic methods for the detection of infection foci especially at low transmission levels. The study presents serological evidence for transmission heterogeneity among school children in The Gambia measured during the dry, non-transmission season. Methods: Healthy primary school children were randomly selected from 30 schools across the country and screened for malaria infection (microscopy) and antimalarial antibodies (MSP119). Antibody distribution was modelled using 2-component finite mixture model with cut-off for positivity from pooled sera set at 2-standard deviation from the mean of the first component. Factors associated with a positive serological status were identified in a univariate model and then combined in a multilevel mixed-effects logistic regression model, simultaneously adjusting for variations between individuals and school. Results: A total of 4140 children, 1897 (46%) boys, were enrolled with mean age of 10.2 years (SD 2.6, range 4-20 years). Microscopy results available for 3640 (87.9%) children showed that 1.9% (69) were positive for Plasmodium falciparum infections, most of them (97.1%, 67/69) asymptomatic. The overall seroprevalence was 12.7% (527/4140) with values for the schools ranging from 0.6% to 43.8%. Age (OR 1.12, 95% CI 1.07-1.16,) and parasite carriage (OR 3.36, 95% CI 1.95-5.79) were strongly associated with seropositivity. Conclusion: Serological responses to malaria parasites could identify individuals who were or had been infected, and clusters of residual transmission. Field-adapted antibody tests able to guide mass screening and treatment campaigns would be extremely useful.	[Okebe, Joseph; Affara, Muna; Correa, Simon; Muhammad, Abdul Khalie; Nwakanma, Davis; D'Alessandro, Umberto] MRC Unit, Fajara, Gambia; [Drakeley, Chris] London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1, England; [D'Alessandro, Umberto] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Dis Control, London WC1, England; [D'Alessandro, Umberto] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Institute of Tropical Medicine (ITM)	Okebe, J (corresponding author), MRC Unit, Fajara, Gambia.	jokebe@mrc.gm	D'Alessandro, Umberto/D-3457-2015; Okebe, Joseph/Y-1664-2019	D'Alessandro, Umberto/0000-0001-6341-5009; Okebe, Joseph/0000-0001-5466-1611; , Abdul Khalie/0000-0003-0040-2416; Nwakanma, Davis/0000-0002-6706-6069	Medical Research Council United Kingdom; MRC [MC_UP_A900_1117, MC_EX_MR/J002364/1] Funding Source: UKRI; Medical Research Council [MC_EX_MR/J002364/1, MC_UP_A900_1117] Funding Source: researchfish	Medical Research Council United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study is funded by a grant from the Medical Research Council United Kingdom to UDA. The funders had not role in the design, data collection, analysis, decision and where to publish the results of the study.	[Anonymous], 2011, PLOS MED, V8; Bejon P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021711; Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304; Bogh C, 2007, AM J TROP MED HYG, V76, P875; Bottius E, 1996, T ROY SOC TROP MED H, V90, P15, DOI 10.1016/S0035-9203(96)90463-0; Bousema T, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-36; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Cook J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025137; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; Drakeley CJ, 2000, T ROY SOC TROP MED H, V94, P472, DOI 10.1016/S0035-9203(00)90056-7; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Elissa N, RELATIONSHIP ENTOMOL; Gambia, CIA WORLD FACTBOOK; Greenwood B.M., 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene, V83, P25, DOI 10.1016/0035-9203(89)90599-3; Messina JP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-161; Mosha JF, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-221; Satoguina J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-274; Stresman GH, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-265; Supargiyono S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-444; Takem EN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067108; The malEra Consultative Group on Monitoring Surveillance and Evaluation, 2011, PLOS MED, V8; Tusting LS, 2014, ADV PARASIT, V84, P151, DOI 10.1016/B978-0-12-800099-1.00003-X; WHO, 2010, WORLD MALARIA REPORT 2010, P1	25	22	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110926	10.1371/journal.pone.0110926	http://dx.doi.org/10.1371/journal.pone.0110926			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338083	Green Accepted, gold, Green Published			2022-12-27	WOS:000343674800089
J	Yeh, JJ; Wang, YC; Sung, FC; Kao, CH				Yeh, Jun-Jun; Wang, Yu-Chiao; Sung, Fung-Chang; Kao, Chia-Hung			Rheumatoid Arthritis Increases the Risk of Nontuberculosis Mycobacterial Disease and Active Pulmonary Tuberculosis	PLOS ONE			English	Article							CLASSIFICATION; COMORBIDITY; INFECTIONS; VALIDATION; THERAPIES; FEATURES; CRITERIA; UPDATE	Background: Few studies have examined the association of rheumatoid arthritis (RA) with nontuberculosis mycobacterium (NTM) disease and pulmonary tuberculosis (PTB). Methods: We identified 29 131 patients with RA from the catastrophic illness registry who were diagnosed from 1998-2008; 116 524 patients without RA from inpatient data files were randomly frequency matched according to sex, age, and index year and used as a comparison group. Both groups were followed-up until the end of 2010 to measure the incidence of NTM disease and active PTB. We analyzed the risk of NTM disease and active PTB using the Cox proportional hazards regression models, controlling for sex, age, and Charlson comorbidity index (CCI). Results: The incidence of NTM disease was 4.22 times greater in the RA group than in the non-RA group (1.91 vs 0.45 per 10,000 person-years). The incidence of PTB was 2.99 times greater in the RA group than in the non-RA group (25.3 vs 8.46 per 10,000 person-years). After adjusting for age, sex, and CCI, the adjusted hazard ratios (HRs) of NTM disease and active PTB for the RA group were 4.17 (95% CI = 2.61-6.65) and 2.87 (95% CI = 2.55-3.23), respectively, compared with the non-RA group. In the first 2 years of follow-up, the RA group yielded corresponding adjusted HRs of 4.98 and 3.39 compared with the non-RA group. The follow-up time-specific RA group to the non-RA group HR of both the NTM disease and active PTB varied. Conclusion: This study can serve as a reference for clinical physicians to increase awareness regarding the detection of NTM disease and active PTB in RA patients among the any stage of the clinical course even without CCI.	[Yeh, Jun-Jun] Ditmanson Med Fdn, Chia Yi Christian Hosp, Dept Internal Med & Family Med, Chiayi, Taiwan; [Yeh, Jun-Jun] Chia Nan Univ Pharm & Sci, Tainan, Taiwan; [Yeh, Jun-Jun] Meiho Univ, Pingtung, Taiwan; [Wang, Yu-Chiao] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Wang, Yu-Chiao; Sung, Fung-Chang] China Med Univ, Coll Med, Taichung, Taiwan; [Sung, Fung-Chang; Kao, Chia-Hung] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan	Chia Nan University of Pharmacy & Science; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Kao, CH (corresponding author), China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan.	d10040@mail.cmuh.org.tw			Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW103-TDU-B-212-113002]; Health and welfare surcharge of tobacco products, China Medical University Hospital Cancer Research Center of Excellence (Taiwan) [MOHW103-TD-B-111-03];  [DMR-103-018];  [DMR-103-020]	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; Health and welfare surcharge of tobacco products, China Medical University Hospital Cancer Research Center of Excellence (Taiwan); ; 	This study was supported in part by the study projects DMR-103-018 and DMR-103-020 in our hospital. This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW103-TDU-B-212-113002), Health and welfare surcharge of tobacco products, China Medical University Hospital Cancer Research Center of Excellence (MOHW103-TD-B-111-03, Taiwan). The funders had no role in the study design, data collection and analysis, the decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Booth CM, 2011, CURR ONCOL, V18, P105; Chan ED, 2010, GENDER MED, V7, P5, DOI 10.1016/j.genm.2010.01.005; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen YY, 2014, J INFECTION, V68, P332, DOI 10.1016/j.jinf.2013.12.004; Collins CS, 2013, BMJ CASE REP, V2013; Crowson CS, 2012, ARTHRITIS RHEUM-US, V64, P2847, DOI 10.1002/art.34530; Erbes R, 2006, EUR RESPIR J, V27, P1223, DOI 10.1183/09031936.06.00088105; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Hall SF, 2006, J CLIN EPIDEMIOL, V59, P849, DOI 10.1016/j.jclinepi.2005.11.013; Harboe Erna, 2012, Tidsskr Nor Laegeforen, V132, P1867, DOI 10.4045/tidsskr.12.0180; Hsia EC, 2013, ARTHRIT CARE RES, V65, P309, DOI 10.1002/acr.21788; Lash T.L., 2014, INT J EPIDEMIOL; Listing J, 2013, RHEUMATOLOGY, V52, P53, DOI 10.1093/rheumatology/kes305; Menzies D, 2013, AM J RESP CRIT CARE, V188, P923, DOI 10.1164/rccm.201304-0687UP; Mori S, 2012, MOD RHEUMATOL, V22, P727, DOI 10.1007/s10165-011-0577-6; MUTRU O, 1985, BMJ-BRIT MED J, V290, P1797, DOI 10.1136/bmj.290.6484.1797; Newton SM, 2008, CLIN VACCINE IMMUNOL, V15, P506, DOI 10.1128/CVI.00401-07; Notarangelo L, 2006, J ALLERGY CLIN IMMUN, V117, P883, DOI 10.1016/j.jaci.2005.12.1347; Park JS, 2013, TUBERC RESPIR DIS, V75, P28, DOI 10.4046/trd.2013.75.1.28; Perez-Guzman C, 2010, SEMIN RESP CRIT CARE, V31, P575, DOI 10.1055/s-0030-1265898; Petersson IF, 2013, ANN RHEUM DIS; Seong SS, 2007, J RHEUMATOL, V34, P706; Seve P, 2013, REV MED INTERNE, V34, P148, DOI 10.1016/j.revmed.2012.05.007; Sleasman J W, 1996, Adv Dent Res, V10, P57; Solovic I, 2010, EUR RESPIR J, V36, P1185, DOI 10.1183/09031936.00028510; Swart RM, 2009, EMERG INFECT DIS, V15, P1700, DOI 10.3201/eid1510.090110; Takabayashi Katsuhiko, 2004, Nihon Rinsho Meneki Gakkai Kaishi, V27, P156; Tiippana-Kinnunen T, 2013, SCAND J RHEUMATOL; Wagner UG, 1998, P NATL ACAD SCI USA, V95, P14447, DOI 10.1073/pnas.95.24.14447; Wallace RJ, 1997, AM J RESP CRIT CARE, V156, pS1, DOI 10.1164/ajrccm.156.2.atsstatement; Winthrop KL, 2013, ANN RHEUM DIS, V72, P37, DOI 10.1136/annrheumdis-2011-200690; Winthrop KL, 2013, NAT REV RHEUMATOL, V9, P524, DOI 10.1038/nrrheum.2013.82; Winthrop KL, 2010, AM J RESP CRIT CARE, V182, P977, DOI 10.1164/rccm.201003-0503OC; Wolfe F, 2004, ARTHRITIS RHEUM-US, V50, P372, DOI 10.1002/art.20009; World Health Organization, 1994, WHO TUB PROGR FRAM E; Yamakawa H, 2013, J RHEUMATOL, V40, P1307, DOI 10.3899/jrheum.121347; Yeh JJ, 2014, EUR RADIOL; Yeh JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099260; Yeh JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093847; Yeh JJ, 2014, LUNG, V192, P403, DOI 10.1007/s00408-014-9574-9	43	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110922	10.1371/journal.pone.0110922	http://dx.doi.org/10.1371/journal.pone.0110922			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337995	Green Published, gold, Green Submitted			2022-12-27	WOS:000343674800087
J	Zeskind, PS; McMurray, MS; Lippard, ETC; Grewen, KM; Garber, KA; Johns, JM				Zeskind, Philip Sanford; McMurray, Matthew S.; Lippard, Elizabeth T. Cox; Grewen, Karen M.; Garber, Kristin A.; Johns, Josephine M.			Translational Analysis of Effects of Prenatal Cocaine Exposure on Human Infant Cries and Rat Pup Ultrasonic Vocalizations	PLOS ONE			English	Article							MATERNAL LIFE-STYLE; SUBSTANCE USE; CRY ANALYSIS; PERCEPTIONS; REACTIVITY; PREGNANCY; CHILDREN; BEHAVIOR; SCORES; CALLS	Spectral and temporal features of human infant crying may detect neurobehavioral effects of prenatal cocaine exposure (PCE). Finding comparable measures of rodent ultrasonic vocalizations (USVs) would promote translational analyses by controlling the effects of correlated variables that confound human studies. To this end, two studies examined the sensitivity of similar acoustic structures in human infant and rat pup vocalizations to effects of PCE. In Study 1, cry sounds of 107 one month-old infants were spectrum analyzed to create a novel set of measures and to detect the presence of hyperphonation - a qualitative shift to an atypically high fundamental frequency (basic pitch) associated with neurobehavioral insult. Infants with PCE were compared to infants with prenatal polydrug-exposure (PPE) without cocaine and with infants in a standard comparison (SC) group with no prenatal drug exposure. In Study 2, USVs of 118 five day-old rat pups with either PCE, prenatal saline exposure or no prenatal exposures were spectrum analyzed to detect the presence of frequency shifts - acoustic features that have a frequency waveform similar to that of hyperphonation. Results of study 1 showed PCE had two sets of sex-dependent effects on human infants: PCE males had higher pitched cries with more dysphonation (turbulence); PCE females had longer pauses between fewer cry sounds that were of lower amplitude than comparison groups. PCE and PPE infants had more cries with hyperphonation than SC infants. In study 2, PCE pups had a greater percentage of USVs with shift in the acoustic structure than pups in the two control groups. As such, the novel measures of human infant crying and rat pup USVs were sensitive to effects of PCE. These studies provide the first known translational analysis of similar acoustic structures of vocalizations in two species to detect adverse effects of prenatal drug exposure.	[Zeskind, Philip Sanford; Garber, Kristin A.] Carolina Healthcare Syst, Levine Childrens Hosp, Dept Pediat, Charlotte, NC 28202 USA; [Zeskind, Philip Sanford] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA; [McMurray, Matthew S.] Univ Illinois, Dept Psychol, Chicago, IL 60680 USA; [Lippard, Elizabeth T. Cox] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA; [Grewen, Karen M.; Johns, Josephine M.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA	Carolinas HealthCare System; University of North Carolina; University of North Carolina Chapel Hill; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Yale University; University of North Carolina; University of North Carolina Chapel Hill	Zeskind, PS (corresponding author), Carolina Healthcare Syst, Levine Childrens Hosp, Dept Pediat, Charlotte, NC 28202 USA.	Zeskind@Mindspring.com	McMurray, Matthew/AAO-5310-2021; Lippard, Elizabeth/AAX-2896-2020	McMurray, Matthew/0000-0002-1898-2933; Lippard, Elizabeth/0000-0002-0528-3308	National Institute on Drug Abuse [DA022446, DA030060, DA026251]; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA022446, F31DA026251, F31DA030060] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institute on Drug Abuse [grant numbers DA022446 to JMJ, DA030060 to ETC and DA026251 to MSM]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenmuller E, 2012, EVOLUTION EMOTIONAL; Arendt RE, 2004, J DEV BEHAV PEDIATR, V25, P83, DOI 10.1097/00004703-200404000-00002; Barron S, 2005, BEHAV GENET, V35, P93, DOI 10.1007/s10519-004-0859-2; Behnke M, 2002, NEUROTOXICOL TERATOL, V24, P283, DOI 10.1016/S0892-0362(02)00191-5; Behnke M, 2013, PEDIATRICS, V131, pE1009, DOI 10.1542/peds.2012-3931; Branchi I, 1998, DEV PSYCHOBIOL, V33, P249, DOI 10.1002/(SICI)1098-2302(199811)33:3<249::AID-DEV5>3.0.CO;2-R; Bridgett DJ, 2011, NEUROTOXICOL TERATOL, V33, P47, DOI 10.1016/j.ntt.2010.08.002; Brudzynski S.M., 2010, HDB MAMMALIAN VOCALI, DOI 10.1016/s1569-7339(10)70001-1; Brudzynski SM, 1999, DEV PSYCHOBIOL, V34, P195, DOI 10.1002/(SICI)1098-2302(199904)34:3<195::AID-DEV4>3.0.CO;2-S; Brudzynski SM, 2010, HBK BEHAV NEUROSCI, V19, P69, DOI 10.1016/B978-0-12-374593-4.00008-5; Burgdorf J, 2010, HBK BEHAV NEUROSCI, V19, P209, DOI 10.1016/B978-0-12-374593-4.0021-8; Cain MA, 2013, CLIN OBSTET GYNECOL, V56, P124, DOI 10.1097/GRF.0b013e31827ae167; COLES CD, 1992, NEUROTOXICOL TERATOL, V14, P23, DOI 10.1016/0892-0362(92)90025-6; CORWIN MJ, 1992, PEDIATRICS, V89, P1199; Cox ET, 2012, BEHAV BRAIN RES, V235, P166, DOI 10.1016/j.bbr.2012.07.035; CROWE HP, 1992, CHILD ABUSE NEGLECT, V16, P19, DOI 10.1016/0145-2134(92)90005-C; Das Eiden R, 1999, PSYCHOL ADDICT BEHAV, V13, P293; DiPietro JA, 1995, INFANT BEHAV DEV, V18, P407, DOI 10.1016/0163-6383(95)90030-6; Dow-Edwards D, 2011, NEUROTOXICOL TERATOL, V33, P9, DOI 10.1016/j.ntt.2010.06.007; Eiden RD, 2014, PSYCHOL ADDICT BEHAV, V28, P139, DOI 10.1037/a0032632; Eiden RD, 2009, CHILD DEV, V80, P528, DOI 10.1111/j.1467-8624.2009.01277.x; Eyler FD, 1998, PEDIATRICS, V101, P237, DOI 10.1542/peds.101.2.237; Golub H. L., 1985, INFANT CRYING, P59; GRUNAU RVE, 1987, PAIN, V28, P395, DOI 10.1016/0304-3959(87)90073-X; Hahn ME, 2000, PHARMACOL BIOCHEM BE, V67, P729, DOI 10.1016/S0091-3057(00)00418-4; HUNTINGTON L, 1990, INFANT BEHAV DEV, V13, P533, DOI 10.1016/0163-6383(90)90021-Y; KEHOE P, 1992, BEHAV NEUROSCI, V106, P374; LaGasse LL, 2005, MENT RETARD DEV D R, V11, P83, DOI 10.1002/mrdd.20050; LaGasse LL, 1999, CLIN PERINATOLOGY PR, P9; Lambert BL, 2012, J PERINATOL, V32, P819, DOI 10.1038/jp.2012.90; Lehr VT, 2007, CLIN J PAIN, V23, P417, DOI 10.1097/AJP.0b013e31805476f2; Lester B. M, 1984, ADV INFANT RES, P167, DOI DOI 10.1126/sciadv.aao5838; Lester BM, 2012, DRUG ALCOHOL DEPEN, V126, P80, DOI 10.1016/j.drugalcdep.2012.04.014; Lester BM, 2010, J PEDIATR-US, V157, P288, DOI 10.1016/j.jpeds.2010.02.039; Lester BM, 2009, DEV NEUROSCI-BASEL, V31, P23, DOI 10.1159/000207491; Lester BM, 1998, SCIENCE, V282, P633, DOI 10.1126/science.282.5389.633; Lester BM, 2002, PEDIATRICS, V110, P1182, DOI 10.1542/peds.110.6.1182; LESTER BM, 1989, CHILD DEV, V60, P765, DOI 10.1111/j.1467-8624.1989.tb03507.x; LESTER BM, 1991, CHILD DEV, V62, P694, DOI 10.2307/1131171; Lewis M., 2012, GENDER DIFFERENCES P; Mayes LC, 1996, DEV PSYCHOPATHOL, V8, P29, DOI 10.1017/S0954579400006957; McMurray MS, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00882; Messinger DS, 2004, PEDIATRICS, V113, P1677, DOI 10.1542/peds.113.6.1677; Nephew BC, 2012, CURR NEUROPHARMACOL, V10, P53, DOI 10.2174/157015912799362760; Nugent JK, 1996, CHILD DEV, V67, P1806, DOI 10.2307/1131733; Owren MJ, 2001, EVOL ANTHROPOL, V10, P58, DOI 10.1002/evan.1014; Rando K, 2013, BIOL PSYCHIAT, V74, P482, DOI 10.1016/j.biopsych.2013.04.030; ROBERTS LH, 1975, J ZOOL, V175, P243, DOI 10.1111/j.1469-7998.1975.tb01399.x; SALES GD, 1978, DEV PSYCHOBIOL, V11, P595, DOI 10.1002/dev.420110609; Schuetze P, 2003, INFANCY, V4, P65, DOI 10.1207/S15327078IN0401_4; Schuetze P, 2012, J APPL DEV PSYCHOL, V33, P282, DOI 10.1016/j.appdev.2012.08.002; Schuetze P, 2009, J CHILD PSYCHOL PSYC, V50, P1401, DOI 10.1111/j.1469-7610.2009.02165.x; Spear LP, 1998, ANN NY ACAD SCI, V846, P76, DOI 10.1111/j.1749-6632.1998.tb09728.x; Strathearn L, 2010, ANN NY ACAD SCI, V1187, P172, DOI 10.1111/j.1749-6632.2009.05142.x; Zeskind Philip Sanford, 2011, Front Psychiatry, V2, P56, DOI 10.3389/fpsyt.2011.00056; ZESKIND PS, 1988, CHILD DEV, V59, P193; ZESKIND PS, 1992, DEV PSYCHOL, V28, P1153, DOI 10.1037/0012-1649.28.6.1153; ZESKIND PS, 1978, CHILD DEV, V49, P580, DOI 10.1111/j.1467-8624.1978.tb02357.x; Zeskind PS, 1996, INFANT BEHAV DEV, V19, P497, DOI 10.1016/S0163-6383(96)90009-0; ZESKIND PS, 1981, CHILD DEV, V52, P213; Zeskind PS, 2001, BIOBEHAVIORAL ASSESS; Zeskind PS, 1983, INFANTS BORN RISK PH, P23; Zeskind PS, 2012, EVOLUTION EMOTIONAL, P155; Zimmerberg B, 2003, ANN NY ACAD SCI, V1008, P308, DOI 10.1196/annals.1301.039	64	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110349	10.1371/journal.pone.0110349	http://dx.doi.org/10.1371/journal.pone.0110349			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338015	Green Published, Green Submitted, gold			2022-12-27	WOS:000343674800038
J	Varanda, CMR; Machado, M; Martel, P; Nolasco, G; Clara, MIE; Felix, MR				Varanda, Carla M. R.; Machado, Marco; Martel, Paulo; Nolasco, Gustavo; Clara, Maria I. E.; Felix, Maria R.			Genetic Diversity of the Coat Protein of Olive Mild Mosaic Virus (OMMV) and Tobacco Necrosis Virus D (TNV-D) Isolates and Its Structural Implications	PLOS ONE			English	Article							CITRUS-TRISTEZA-VIRUS; COMPLETE NUCLEOTIDE-SEQUENCE; COMPLETE GENOME SEQUENCE; PHYLOGENETIC ANALYSIS; CAPSID PROTEINS; AMINO-ACIDS; VARIABILITY; POPULATIONS; TRANSMISSION; GRAPEFRUIT	The genetic variability among 13 isolates of Olive mild mosaic virus (OMMV) and of 11 isolates of Tobacco necrosis virus D (TNV-D) recovered from Olea europaea L. samples from various sites in Portugal, was assessed through the analysis of the coat protein (CP) gene sequences. This gene was amplified through reverse transcriptase polymerase chain reaction (RTPCR), cloned, and 5 clone sequences of each virus isolate, were analysed and compared, including sequences from OMMV and TNV-D isolates originally recovered from different hosts and countries and available in the GenBank, totalling 131 sequences. The encoded CP sequences consisted of 269 amino acids (aa) in OMMV and 268 in TNV-D. Comparison of the CP genomic and amino acid sequences of the isolates showed a very low variability among OMMV isolates, 0.005 and 0.007, respectively, as well as among TNV-D isolates, 0.006 and 0.008. The maximum nucleotide distances of OMMV and TNV-D sequences within isolates were also low, 0.013 and 0.031, respectively, and close to that found between isolates, 0.018 and 0.034, respectively. In some cases, less variability was found in clone sequences between isolates than in clone sequences within isolates, as also shown through phylogenetic analysis. CP aa sequence identities among OMMV and TNV-D isolates ranged from 84.3% to 85.8%. Comparison between the CP genomic sequences of the two viruses, showed a relatively low variability, 0.199, and a maximum nucleotide distance between isolates of 0.411. Analysis of comparative models of OMMV and TNV-D CPs, showed that naturally occurring substitutions in their respective sequences do not seem to cause significant alterations in the virion structure. This is consistent with a high selective pressure to preserve the structure of viral capsid proteins.	[Varanda, Carla M. R.; Machado, Marco; Clara, Maria I. E.; Felix, Maria R.] Univ Evora, Inst Ciencias Agr & Ambientais Mediterran, Lab Virol Vegetal, Evora, Portugal; [Martel, Paulo] Univ Algarve, Fac Ciencias & Tecnol, Dept Ciencias Biol & Bioengn, Faro, Portugal; [Nolasco, Gustavo] Univ Algarve, Lab Virol Vegetal, Faro, Portugal	University of Evora; Universidade do Algarve; Universidade do Algarve	Varanda, CMR (corresponding author), Univ Evora, Inst Ciencias Agr & Ambientais Mediterran, Lab Virol Vegetal, Evora, Portugal.	carlavaranda@uevora.pt	Varanda, Carla Marisa Reis/W-2502-2018; Felix, Maria/L-1118-2016; Martel, Paulo J/AFV-2568-2022	Varanda, Carla Marisa Reis/0000-0002-6915-1793; Felix, Maria/0000-0003-3870-5033; Martel, Paulo J/0000-0001-8237-1267	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BPD/76194/2011]; FEDER; Programa Operacional Regional do Alentejo (InAlentejo) Operation [ALENT-07-0262-FEDER-001871]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FEDER(European Commission); Programa Operacional Regional do Alentejo (InAlentejo) Operation	Carla Marisa R. Varanda is the recipient of a Post doctoral fellowship from Fundacao para a Ciencia e a Tecnologia (FCT), SFRH/BPD/76194/2011. This work has been supported by FEDER and National funds, through the Programa Operacional Regional do Alentejo (InAlentejo) Operation ALENT-07-0262-FEDER-001871/Laboratorio de Biotecnologia Aplicada e Tecnologias Agro-Ambientais. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayllon MA, 2006, VIRUS GENES, V32, P119, DOI 10.1007/s11262-005-6866-4; Boulila M, 2011, GENET MOL BIOL, V34, P647, DOI 10.1590/S1415-47572011005000046; Callaway A, 2001, ANNU REV PHYTOPATHOL, V39, P419, DOI 10.1146/annurev.phyto.39.1.419; Canizares MC, 2001, ARCH VIROL, V146, P2039, DOI 10.1007/s007050170051; Cardoso JMS, 2005, ARCH VIROL, V150, P815, DOI 10.1007/s00705-004-0453-1; Cardoso JMS, 2004, ARCH VIROL, V149, P1129, DOI 10.1007/s00705-003-0258-7; Cardoso JMS, 2009, ARCH VIROL, V154, P1169, DOI 10.1007/s00705-009-0414-9; Castano A, 2011, VIRUS RES, V155, P274, DOI 10.1016/j.virusres.2010.10.022; Chare ER, 2004, J GEN VIROL, V85, P3149, DOI 10.1099/vir.0.80134-0; COUTTS RHA, 1991, J GEN VIROL, V72, P1521, DOI 10.1099/0022-1317-72-7-1521; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; DOLJA VV, 1991, J GEN VIROL, V72, P1481, DOI 10.1099/0022-1317-72-7-1481; Felix MR, 2005, VIRUS RES, V108, P195, DOI 10.1016/j.virusres.2004.09.007; Fraile A, 1996, VIROLOGY, V223, P148, DOI 10.1006/viro.1996.0463; Garcia-Arenal F, 2001, ANNU REV PHYTOPATHOL, V39, P157, DOI 10.1146/annurev.phyto.39.1.157; Gratsia ME, 2012, PLANT DIS, V96, P1230, DOI 10.1094/PDIS-03-12-0273-PDN; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hull R., 2014, PLANT VIROLOGY; Kakani K, 2001, J VIROL, V75, P5576, DOI 10.1128/JVI.75.12.5576-5583.2001; KASSANIS B, 1949, ANN APPL BIOL, V36, P14, DOI 10.1111/j.1744-7348.1949.tb06396.x; King A. M. Q, 2012, VIRUS TAXONOMY; Lin HX, 2003, J GEN VIROL, V84, P249, DOI 10.1099/vir.0.18673-0; Lommel S, 2008, DESK ENCY PLANT FUNG; Manrubia SC, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.188102; Matos LA, 2013, PLANT DIS, V97, P339, DOI 10.1094/PDIS-05-12-0421-RE; MEULEWAETER F, 1990, VIROLOGY, V177, P699, DOI 10.1016/0042-6822(90)90536-Z; Molnar A, 1997, J GEN VIROL, V78, P1235, DOI 10.1099/0022-1317-78-6-1235; Moreno P, 2008, MOL PLANT PATHOL, V9, P251, DOI 10.1111/J.1364-3703.2007.00455.X; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Pantaleo V, 2006, ARCH VIROL, V151, P1973, DOI 10.1007/s00705-006-0767-2; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Powell CA, 2003, PLANT DIS, V87, P1116, DOI 10.1094/PDIS.2003.87.9.1116; Qu F, 2005, FEBS LETT, V579, P5958, DOI 10.1016/j.febslet.2005.08.041; Rico P, 2006, J VIROL, V80, P8124, DOI 10.1128/JVI.00603-06; Rubio L, 2001, J VIROL, V75, P8054, DOI 10.1128/JVI.75.17.8054-8062.2001; Rubio L, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00151; Saeki K, 2001, BIOSCI BIOTECH BIOCH, V65, P719, DOI 10.1271/bbb.65.719; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sambade A, 2002, PLANT PATHOL, V51, P257, DOI 10.1046/j.1365-3059.2002.00720.x; Scott KA, 2013, ARCH VIROL, V158, P27, DOI 10.1007/s00705-012-1450-4; Sit TL, 2001, J VIROL, V75, P9538, DOI 10.1128/JVI.75.19.9538-9542.2001; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Varanda CMR, 2014, ARCH VIROL, V159, P1351, DOI 10.1007/s00705-013-1953-7; Varanda C, 2011, J GEN VIROL, V92, P2209, DOI 10.1099/vir.0.032284-0; Varanda C, 2010, EUR J PLANT PATHOL, V127, P161, DOI 10.1007/s10658-010-9593-1; Varanda CMR, 2011, EUR J PLANT PATHOL, V130, P165, DOI 10.1007/s10658-011-9742-1; Vives MC, 2002, J GEN VIROL, V83, P2587, DOI 10.1099/0022-1317-83-10-2587	47	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110941	10.1371/journal.pone.0110941	http://dx.doi.org/10.1371/journal.pone.0110941			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350108	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943100049
J	Coutinho-Abreu, IV; Forster, L; Guda, T; Ray, A				Coutinho-Abreu, Iliano V.; Forster, Lisa; Guda, Tom; Ray, Anandasankar			Odorants for Surveillance and Control of the Asian Citrus Psyllid (Diaphorina citri)	PLOS ONE			English	Article							TRIOZA-APICALIS HOMOPTERA; DISEASE; HEMIPTERA; VOLATILES; KUWAYAMA; NEURONS; CO2	Background: The Asian Citrus Psyllid (ACP), Diaphorina citri, can transmit the bacterium Candidatus Liberibacter while feeding on citrus flush shoots. This bacterium causes Huanglongbing (HLB), a major disease of citrus cultivation worldwide necessitating the development of new tools for ACP surveillance and control. The olfactory system of ACP is sensitive to variety of odorants released by citrus plants and offers an opportunity to develop new attractants and repellents. Results: In this study, we performed single-unit electrophysiology to identify odorants that are strong activators, inhibitors, and prolonged activators of ACP odorant receptor neurons (ORNs). We identified a suite of odorants that activated the ORNs with high specificity and sensitivity, which may be useful in eliciting behavior such as attraction. In separate experiments, we also identified odorants that evoked prolonged ORN responses and antagonistic odorants able to suppress neuronal responses to activators, both of which can be useful in lowering attraction to hosts. In field trials, we tested the electrophysiologically identified activating odorants and identified a 3-odor blend that enhances trap catches by similar to 230%. Conclusion: These findings provide a set of odorants that can be used to develop affordable and safe odor-based surveillance and masking strategies for this dangerous pest insect.	[Coutinho-Abreu, Iliano V.; Forster, Lisa; Guda, Tom; Ray, Anandasankar] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Ray, Anandasankar] Univ Calif Riverside, Ctr Dis Vector Res, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Ray, A (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.	anand.ray@ucr.edu	Coutinho-Abreu, Iliano/AAQ-5754-2020	Coutinho-Abreu, Iliano/0000-0002-1389-1071; Ray, Anandasankar/0000-0003-4133-2581	Citrus Research Board [5500-186]	Citrus Research Board	This study was supported by funding from the Citrus Research Board (#5500-186) to Anandasankar Ray. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bove JM, 2006, J PLANT PATHOL, V88, P7; CHAPMAN RF, 1982, ADV INSECT PHYSIOL, V16, P247, DOI 10.1016/S0065-2806(08)60155-1; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; Coutinho-Abreu IV, 2014, CHEM SENSES, V39, P539, DOI 10.1093/chemse/bju023; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; HODKINSON ID, 1974, B ENTOMOL RES, V64, P325, DOI 10.1017/S0007485300031217; Kristoffersen L, 2008, CHEM SENSES, V33, P759, DOI 10.1093/chemse/bjn034; Kristoffersen L, 2008, CHEM SENSES, V33, P771, DOI 10.1093/chemse/bjn044; Kristoffersen L, 2006, ARTHROPOD STRUCT DEV, V35, P85, DOI 10.1016/j.asd.2006.04.001; Lei Hong, 2009, Journal of Biology (London), V8, P21, DOI 10.1186/jbiol120; Mann RS, 2011, B ENTOMOL RES, V101, P89, DOI 10.1017/S0007485310000222; Mann RS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002610; Onagbola EO, 2011, J APPL ENTOMOL, V135, P404, DOI 10.1111/j.1439-0418.2010.01565.x; Onagbola EO, 2008, MICRON, V39, P1184, DOI 10.1016/j.micron.2008.05.002; Park KC, 2002, J INSECT PHYSIOL, V48, P527, DOI 10.1016/S0022-1910(02)00082-3; Patti JM, 2010, ENVIRON ENTOMOL, V39, P618, DOI 10.1603/EN09216; Riffell Jeffrey A, 2009, Proc Natl Acad Sci U S A, V106, P19219, DOI 10.1073/pnas.0910592106; Riffell JA, 2009, CURR BIOL, V19, P335, DOI 10.1016/j.cub.2009.01.041; Su CY, 2011, P NATL ACAD SCI USA, V108, P5075, DOI 10.1073/pnas.1100369108; Tauxe GM, 2013, CELL, V155, P1365, DOI 10.1016/j.cell.2013.11.013; Tiwari S, 2011, PEST MANAG SCI, V67, P1258, DOI 10.1002/ps.2181; Tiwari S, 2010, J ECON ENTOMOL, V103, P1972, DOI 10.1603/EC10149; Turner SL, 2011, NATURE, V474, P87, DOI 10.1038/nature10081; Turner SL, 2009, NATURE, V461, P277, DOI 10.1038/nature08295; Valterova I, 1997, BIOCHEM SYST ECOL, V25, P477, DOI 10.1016/S0305-1978(97)00028-8; van Naters WV, 2006, NATURE, V444, P302, DOI 10.1038/nature05403; Webster B, 2010, ANIM BEHAV, V79, P451, DOI 10.1016/j.anbehav.2009.11.028; Wenninger EJ, 2007, FLA ENTOMOL, V90, P715, DOI 10.1653/0015-4040(2007)90[715:DTOMAA]2.0.CO;2; Yasuda K, 2005, JPN J APPL ENTOMOL Z, V49, P146, DOI 10.1303/jjaez.2005.146	29	28	29	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e109236	10.1371/journal.pone.0109236	http://dx.doi.org/10.1371/journal.pone.0109236			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347318	Green Published, Green Submitted, gold			2022-12-27	WOS:000347994900007
J	Lesaint, F; Sigaud, O; Khamassi, M				Lesaint, Florian; Sigaud, Olivier; Khamassi, Mehdi			Accounting for Negative Automaintenance in Pigeons: A Dual Learning Systems Approach and Factored Representations	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS; CENTRAL AMYGDALA; REWARD; DOPAMINE; CUE; UNCERTAINTY; MISBEHAVIOR; ACTIVATION; ADDICTION; TRACKING	Animals, including Humans, are prone to develop persistent maladaptive and suboptimal behaviours. Some of these behaviours have been suggested to arise from interactions between brain systems of Pavlovian conditioning, the acquisition of responses to initially neutral stimuli previously paired with rewards, and instrumental conditioning, the acquisition of active behaviours leading to rewards. However the mechanics of these systems and their interactions are still unclear. While extensively studied independently, few models have been developed to account for these interactions. On some experiment, pigeons have been observed to display a maladaptive behaviour that some suggest to involve conflicts between Pavlovian and instrumental conditioning. In a procedure referred as negative automaintenance, a key light is paired with the subsequent delivery of food, however any peck towards the key light results in the omission of the reward. Studies showed that in such procedure some pigeons persisted in pecking to a substantial level despite its negative consequence, while others learned to refrain from pecking and maximized their cumulative rewards. Furthermore, the pigeons that were unable to refrain from pecking could nevertheless shift their pecks towards a harmless alternative key light. We confronted a computational model that combines dual-learning systems and factored representations, recently developed to account for sign-tracking and goal-tracking behaviours in rats, to these negative automaintenance experimental data. We show that it can explain the variability of the observed behaviours and the capacity of alternative key lights to distract pigeons from their detrimental behaviours. These results confirm the proposed model as an interesting tool to reproduce experiments that could involve interactions between Pavlovian and instrumental conditioning. The model allows us to draw predictions that may be experimentally verified, which could help further investigate the neural mechanisms underlying theses interactions.	[Lesaint, Florian; Sigaud, Olivier; Khamassi, Mehdi] Univ Paris 06, Sorbonne Univ, Inst Syst Intelligents & Robot, UMR 7222, Paris, France; [Lesaint, Florian; Sigaud, Olivier; Khamassi, Mehdi] CNRS, UMR 7222, Inst Syst Intelligents & Robot, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Lesaint, F (corresponding author), Univ Paris 06, Sorbonne Univ, Inst Syst Intelligents & Robot, UMR 7222, Paris, France.	lesaint@isir.upmc.fr	Khamassi, Mehdi/B-2425-2012	Khamassi, Mehdi/0000-0002-2515-1046	L'Agence Nationale de la Recherche, France [ANR-11-BSV4-006 "LU2" (Learning Under Uncertainty)]	L'Agence Nationale de la Recherche, France(French National Research Agency (ANR))	This work was supported by Grant ANR-11-BSV4-006 "LU2" (Learning Under Uncertainty) from L'Agence Nationale de la Recherche, France (FL, OS, MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLOY LB, 1981, LEARN MOTIV, V12, P109, DOI 10.1016/0023-9690(81)90027-8; Balkenius C, 1999, AUTON ROBOT, V7, P41, DOI 10.1023/A:1008965713435; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Beierholm UR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000903; Bellman R., 1957, DYNAMIC PROGRAMMING; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Boakes RA, 1977, OPERANT PAVLOVIAN IN, V1st, P35; Boutilier C, 2000, ARTIF INTELL, V121, P49, DOI 10.1016/S0004-3702(00)00033-3; BRELAND K, 1961, AM PSYCHOL, V16, P681, DOI 10.1037/h0040090; BROWN PL, 1968, J EXP ANAL BEHAV, V11, P1, DOI 10.1901/jeab.1968.11-1; Clark JJ, 2012, CURR OPIN NEUROBIOL, V22, P1054, DOI 10.1016/j.conb.2012.06.004; Corbit LH, 2005, J NEUROSCI, V25, P962, DOI 10.1523/JNEUROSCI.4507-04.2005; Courville AC, 2006, TRENDS COGN SCI, V10, P294, DOI 10.1016/j.tics.2006.05.004; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Daw ND, 2011, DECISION MAKING AFFE, V23; Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; Dayan P, 2014, COGN AFFECT BEHAV NE, P1; Dayan P, 2006, NEURAL NETWORKS, V19, P1153, DOI 10.1016/j.neunet.2006.03.002; Degris T., 2006, 23 INT C MACH LEARN, P257; DEICH JD, 1977, J EXP ANAL BEHAV, V27, P399, DOI 10.1901/jeab.1977.27-399; DICKINSON A, 1994, ANIM LEARN BEHAV, V22, P1, DOI 10.3758/BF03199951; DiFeliceantonio AG, 2012, BEHAV BRAIN RES, V230, P399, DOI 10.1016/j.bbr.2012.02.032; Dolan RJ, 2013, NEURON, V80, P312, DOI 10.1016/j.neuron.2013.09.007; Doya K, 2002, NEURAL COMPUT, V14, P1347, DOI 10.1162/089976602753712972; Elfwing S, 2013, FRONT NEUROROBOTICS, V7, DOI 10.3389/fnbot.2013.00003; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Fitzpatrick CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075042; Flagel SB, 2011, NATURE, V469, P53, DOI 10.1038/nature09588; GAMZU E, 1974, J EXP ANAL BEHAV, V21, P361, DOI 10.1901/jeab.1974.21-361; Gargiulo PA, 2005, PHARMACOL BIOCHEM BE, V81, P732, DOI 10.1016/j.pbb.2005.05.009; Gershman SJ, 2012, LEARN BEHAV, V40, P255, DOI 10.3758/s13420-012-0080-8; Geurts DEM, 2013, J COGNITIVE NEUROSCI, V25, P1428, DOI 10.1162/jocn_a_00425; GORMEZANO I, 1972, PSYCHON SCI, V29, P276; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; GRIFFIN RW, 1973, B PSYCHONOMIC SOC, V2, P402; Guitart-Masip M, 2014, TRENDS COGN SCI, V18, P194, DOI 10.1016/j.tics.2014.01.003; Guitart-Masip M, 2012, NEUROIMAGE, V62, P154, DOI 10.1016/j.neuroimage.2012.04.024; HERSHBERGER WA, 1986, ANIM LEARN BEHAV, V14, P443, DOI 10.3758/BF03200092; Huys QJM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002028; Kamin L.J., 1967, PUNISHMENT AVERSIVE, P279; Keramati M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002055; Khamassi M, 2006, LECT NOTES COMPUT SC, V4095, P394; Killeen PR, 2003, J EXP PSYCHOL-ANIM B, V29, P49, DOI 10.1037//0097-7403.29.1.49; Lattal KM, 1998, ANIM LEARN BEHAV, V26, P351, DOI 10.3758/BF03199227; Lesaint F, 2014, J PHYSL PAR IN PRESS; Lesaint F, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003466; LOCURTO C, 1976, J EXP ANAL BEHAV, V26, P451, DOI 10.1901/jeab.1976.26-451; LOCURTO CM, 1978, B PSYCHONOMIC SOC, V12, P11; Mahler SV, 2009, J NEUROSCI, V29, P6500, DOI 10.1523/JNEUROSCI.3875-08.2009; Meyer PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098163; Meyer PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038987; Miyata H, 2008, ANIM COGN, V11, P505, DOI 10.1007/s10071-008-0141-8; Nicola SM, 2010, J NEUROSCI, V30, P16585, DOI 10.1523/JNEUROSCI.3958-10.2010; Niv Y, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-6; Niv Y, 2009, J MATH PSYCHOL, V53, P139, DOI 10.1016/j.jmp.2008.12.005; OCONNELL MF, 1979, J EXP ANAL BEHAV, V31, P31, DOI 10.1901/jeab.1979.31-31; Pezzulo G, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00092; POLING A, 1978, J EXP ANAL BEHAV, V30, P37, DOI 10.1901/jeab.1978.30-37; Prevost C, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002918; Redish AD, 2008, BEHAV BRAIN SCI, V31, P415, DOI 10.1017/S0140525X0800472X; Redish AD, 2007, PSYCHOL REV, V114, P784, DOI 10.1037/0033-295X.114.3.784; Sanabria F, 2006, J EXP ANAL BEHAV, V86, P1, DOI 10.1901/jeab.2006.36-05; Schmajuk NA, 1996, J EXP PSYCHOL ANIM B, V22, P321, DOI 10.1037/0097-7403.22.3.321; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Skinner B.F, 1938, BEHAV ORGANISMS EXPT; Stout SC, 2007, PSYCHOL REV, V114, P759, DOI 10.1037/0033-295X.114.3.759; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Vigorito CM, 2008, YAL WORKSH AD LEARN; Williams DR, 1969, J EXP ANAL BEHAV; WOODARD WT, 1974, J EXP ANAL BEHAV, V22, P47, DOI 10.1901/jeab.1974.22-47; Yin HH, 2008, EUR J NEUROSCI, V28, P1437, DOI 10.1111/j.1460-9568.2008.06422.x	71	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111050	10.1371/journal.pone.0111050	http://dx.doi.org/10.1371/journal.pone.0111050			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347531	Green Submitted, gold, Green Published			2022-12-27	WOS:000347994900041
J	Yamamoto, R; Okada, Y; Hirose, J; Koshika, T; Kawato, Y; Maeda, M; Saito, R; Hattori, K; Harada, H; Nagasaka, Y; Morokata, T				Yamamoto, Rie; Okada, Youhei; Hirose, Jun; Koshika, Tadatsura; Kawato, Yuka; Maeda, Masashi; Saito, Rika; Hattori, Kazuyuki; Harada, Hironori; Nagasaka, Yasuhisa; Morokata, Tatsuaki			ASP4058, a Novel Agonist for Sphingosine 1-Phosphate Receptors 1 and 5, Ameliorates Rodent Experimental Autoimmune Encephalomyelitis with a Favorable Safety Profile	PLOS ONE			English	Article							RELAPSING MULTIPLE-SCLEROSIS; FINGOLIMOD FTY720; LYMPHOCYTE EGRESS; ORAL FINGOLIMOD; SPHINGOSINE-1-PHOSPHATE RECEPTOR; AIRWAY HYPERREACTIVITY; HEART-RATE; ORGANS; DEMYELINATION; TRAFFICKING	Sphingosine-1-phosphate (S1P) is a biologically active sphingolipid that acts through the members of a family of five G protein-coupled receptors (S1P(1)-S1P(5)). S1P(1) is a major regulator of lymphocyte trafficking, and fingolimod, whose active metabolite fingolimod phosphate acts as a nonselective S1P receptor agonist, exerts its immunomodulatory effect, at least in part, by regulating the lymphocyte trafficking by inducing down regulation of lymphocyte S1P(1). Here, we detail the pharmacological profile of 5-{5-[3-(trifluoromethyl)-4-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy} phenyl]-1,2,4-oxadiazol-3-yl}-1Hbenzimidazole (ASP4058), a novel next-generation S1P receptor agonist selective for S1P(1) and S1P(5). ASP4058 preferentially activates S1P(1) and S1P(5) compared with S1P(2), (3), (4) in GTP gamma S binding assays in vitro. Oral administration of ASP4058 reduced the number of peripheral lymphocytes and inhibited the development of experimental autoimmune encephalomyelitis (EAE) in Lewis rats. Further, ASP4058 prevented relapse of disease in a mouse model of relapsing-remitting EAE. Although these immunomodulatory effects were comparable to those of fingolimod, ASP4058 showed a wider safety margin than fingolimod for bradycardia and bronchoconstriction in rodents. These observations suggest that ASP4058 represents a new therapeutic option for treating multiple sclerosis that is safer than nonselective S1P receptor agonists such as fingolimod.	[Yamamoto, Rie; Okada, Youhei; Hirose, Jun; Koshika, Tadatsura; Kawato, Yuka; Maeda, Masashi; Hattori, Kazuyuki; Harada, Hironori; Nagasaka, Yasuhisa; Morokata, Tatsuaki] Astellas Pharma Inc, Tsukuba Res Ctr, Drug Discovery Res, Ibaraki, Japan; [Saito, Rika] Astellas Pharma Inc, Kashima R&D Ctr, Drug Discovery Res, Osaka, Japan	Astellas Pharmaceuticals; Astellas Pharmaceuticals	Morokata, T (corresponding author), Astellas Pharma Inc, Tsukuba Res Ctr, Drug Discovery Res, Ibaraki, Japan.	tatsuaki.morokata@astellas.com			Astellas Pharma Inc.	Astellas Pharma Inc.(Astellas Pharmaceuticals)	All of the research was funded by Astellas Pharma Inc. The funder did have a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript as the authors are employed by the funder.	Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2007, PHARMACOL THERAPEUT, V115, P84, DOI 10.1016/j.pharmthera.2007.04.006; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Chun J, 2011, DISCOV MED, V12, P213; Cohen JA, 2011, ANN NEUROL, V69, P759, DOI 10.1002/ana.22426; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; DiMarco JP, 2010, MULT SCLER, V16, pS290; Forrest M, 2004, J PHARMACOL EXP THER, V309, P758, DOI 10.1124/jpet.103.062828; Gergely P, 2012, BRIT J PHARMACOL, V167, P1035, DOI 10.1111/j.1476-5381.2012.02061.x; Groves A, 2013, J NEUROL SCI, V328, P9, DOI 10.1016/j.jns.2013.02.011; Hemmer B, 2006, NAT CLIN PRACT NEURO, V2, P201, DOI 10.1038/ncpneuro0154; Jaillard C, 2005, J NEUROSCI, V25, P1459, DOI 10.1523/JNEUROSCI.4645-04.2005; Jenne CN, 2009, J EXP MED, V206, P2469, DOI 10.1084/jem.20090525; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Kennedy PC, 2011, J PHARMACOL EXP THER, V338, P879, DOI 10.1124/jpet.111.181552; Kume H, 2007, J PHARMACOL EXP THER, V320, P766, DOI 10.1124/jpet.106.110718; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Miller RH, 2007, NAT NEUROSCI, V10, P1351, DOI 10.1038/nn1995; Miron VE, 2008, AM J PATHOL, V173, P1143, DOI 10.2353/ajpath.2008.080478; Miron VE, 2008, ANN NEUROL, V63, P61, DOI 10.1002/ana.21227; Miron VE, 2010, AM J PATHOL, V176, P2682, DOI 10.2353/ajpath.2010.091234; Rosenfeldt HM, 2003, FASEB J, V17, P1789, DOI 10.1096/fj.02-0836com; Roviezzo F, 2010, AM J RESP CELL MOL, V42, P572, DOI 10.1165/rcmb.2009-0108OC; Sanna MG, 2004, J BIOL CHEM, V279, P13839, DOI 10.1074/jbc.M311743200; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Trifilieff A, 2012, J PHARMACOL EXP THER, V342, P399, DOI 10.1124/jpet.112.191585; Walzer T, 2007, NAT IMMUNOL, V8, P1337, DOI 10.1038/ni1523; ZAMVIL SS, 1990, ANNU REV IMMUNOL, V8, P579, DOI 10.1146/annurev.iy.08.040190.003051	34	19	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e110819	10.1371/journal.pone.0110819	http://dx.doi.org/10.1371/journal.pone.0110819			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347187	Green Submitted, Green Published, gold			2022-12-27	WOS:000347994900030
J	Chung, YA; Burkle, LA; Knight, TM				Chung, Y. Anny; Burkle, Laura A.; Knight, Tiffany M.			Minimal Effects of an Invasive Flowering Shrub on the Pollinator Community of Native Forbs	PLOS ONE			English	Article							MUTUALISTIC NETWORKS; FLORAL CHARACTERS; PLANT FITNESS; ALIEN PLANTS; VISITATION; DENSITY; SUCCESS; SPECIALIZATION; METAANALYSIS; INTEGRATION	Biological invasions can strongly influence species interactions such as pollination. Most of the documented effects of exotic plant species on plant-pollinator interactions have been observational studies using single pairs of native and exotic plants, and have focused on dominant exotic plant species. We know little about how exotic plants alter interactions in entire communities of plants and pollinators, especially at low to medium invader densities. In this study, we began to address these gaps by experimentally removing the flowers of a showy invasive shrub, Rosa multiflora, and evaluating its effects on the frequency, richness, and composition of bee visitors to co-flowering native plants. We found that while R. multiflora increased plot-level richness of bee visitors to co-flowering native plant species at some sites, its presence had no significant effects on bee visitation rate, visitor richness, bee community composition, or abundance overall. In addition, we found that compared to co-flowering natives, R. multiflora was a generalist plant that primarily received visits from generalist bee species shared with native plant species. Our results suggest that exotic plants such as R. multiflora may facilitate native plant pollination in a community context by attracting a more diverse assemblage of pollinators, but have limited and idiosyncratic effects on the resident plant-pollinator network in general.	[Chung, Y. Anny; Burkle, Laura A.; Knight, Tiffany M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Chung, Y. Anny] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Burkle, Laura A.] Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA	Washington University (WUSTL); University of New Mexico; Montana State University System; Montana State University Bozeman	Chung, YA (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	yyachung@unm.edu		Chung, Yan Yi/0000-0001-5207-2872	National Science Foundation [DEB-934376]; Washington University	National Science Foundation(National Science Foundation (NSF)); Washington University	This research was supported by the National Science Foundation (grant DEB-934376) awarded to LAB and TMK (www.nsf.gov), and fellowships at Washington University awarded to YAC (Howard Hughes Summer Undergraduate Research Fellowship, Tyson Research Center Fellowship, and Lennette Undergraduate Research Fellowship, www.wustl.edu). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2008, PLOS BIOL, V6, P396, DOI 10.1371/journal.pbio.0060031; ASCHER JS, 2012, DISCOVER LIFE BEE SP; Ashworth L, 2004, J ECOL, V92, P717, DOI 10.1111/j.0022-0477.2004.00910.x; Bartomeus I, 2008, OECOLOGIA, V155, P761, DOI 10.1007/s00442-007-0946-1; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Brown BJ, 2002, ECOLOGY, V83, P2328, DOI 10.1890/0012-9658(2002)083[2328:CFPBAI]2.0.CO;2; Burkle LA, 2009, PLANT ECOL, V203, P83, DOI 10.1007/s11258-008-9512-0; Campbell C, 2011, P NATL ACAD SCI USA, V108, P197, DOI 10.1073/pnas.1008204108; Carvalheiro LG, 2010, ECOLOGY, V91, P1063, DOI 10.1890/08-2092.1; Chittka L, 2001, NATURE, V411, P653, DOI 10.1038/35079676; Chrobock T, 2013, BIOL INVASIONS, V15, P2577, DOI 10.1007/s10530-013-0474-3; Essenberg CJ, 2012, AM NAT, V180, P153, DOI 10.1086/666610; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; Gibson MR, 2013, BIOL CONSERV, V157, P196, DOI 10.1016/j.biocon.2012.07.011; Gilbert B, 2005, ECOLOGY, V86, P1848, DOI 10.1890/04-09997; Gotelli NJ, 2004, ECOSIM NULL MODELS S; Guimaraes PR, 2006, P ROY SOC B-BIOL SCI, V273, P2041, DOI 10.1098/rspb.2006.3548; Jesse LC, 2006, WEED BIOL MANAG, V6, P235, DOI 10.1111/j.1445-6664.2006.00221.x; Johnson SD, 2000, TRENDS ECOL EVOL, V15, P140, DOI 10.1016/S0169-5347(99)01811-X; Kaiser-Bunbury CN, 2011, J ECOL, V99, P202, DOI 10.1111/j.1365-2745.2010.01732.x; Kaiser-Bunbury CN, 2010, ECOL LETT, V13, P442, DOI 10.1111/j.1461-0248.2009.01437.x; KLINKHAMER PGL, 1990, OIKOS, V57, P399, DOI 10.2307/3565970; Kunin W, 1996, THEOR POPUL BIOL, V49, P232, DOI 10.1006/tpbi.1996.0013; Morales CL, 2009, ECOL LETT, V12, P716, DOI 10.1111/j.1461-0248.2009.01319.x; Levine JM, 2004, ECOL LETT, V7, P975, DOI 10.1111/j.1461-0248.2004.00657.x; Lopezaraiza-Mikel ME, 2007, ECOL LETT, V10, P539, DOI 10.1111/j.1461-0248.2007.01055.x; Lortie CJ, 2007, J ECOL, V95, P468, DOI 10.1111/j.1365-2745.2007.01231.x; Mack RN, 2000, ECOLOGICAL APPL, V10, P489; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Memmott J, 2002, P ROY SOC B-BIOL SCI, V269, P2395, DOI 10.1098/rspb.2002.2174; Moragues E, 2005, BIOL CONSERV, V122, P611, DOI 10.1016/j.biocon.2004.09.015; Morales CL, 2008, CRIT REV PLANT SCI, V27, P221, DOI 10.1080/07352680802205631; Moron D, 2009, BIOL CONSERV, V142, P1322, DOI 10.1016/j.biocon.2008.12.036; Munger G. T., 2002, FIRE EFFECTS INFORM; Munoz AA, 2008, J ECOL, V96, P459, DOI 10.1111/j.1365-2745.2008.01361.x; Olesen JM, 2002, DIVERS DISTRIB, V8, P181, DOI 10.1046/j.1472-4642.2002.00148.x; Osborne JL, 1999, J APPL ECOL, V36, P519, DOI 10.1046/j.1365-2664.1999.00428.x; Proctor M., 1996, NATURAL HIST POLLINA; Pysek P, 2011, ECOL MONOGR, V81, P277, DOI 10.1890/10-0630.1; Robertson C., 1929, FLOWERS INSECTS LIST; Roulston TH, 2000, ECOL MONOGR, V70, P617, DOI 10.1890/0012-9615(2000)070[0617:WGPCOP]2.0.CO;2; Sargent RD, 2008, TRENDS ECOL EVOL, V23, P123, DOI 10.1016/j.tree.2007.11.003; Stang M, 2006, OIKOS, V112, P111, DOI 10.1111/j.0030-1299.2006.14199.x; STEAVENSON HA, 1946, J WILDLIFE MANAGE, V10, P227, DOI 10.2307/3795837; Strauss SY, 1997, ECOLOGY, V78, P1640, DOI 10.1890/0012-9658(1997)078[1640:FCLHPA]2.0.CO;2; USDA NRCS, 2013, PLANTS DAT; Vanparys V, 2008, ACTA OECOL, V34, P361, DOI 10.1016/j.actao.2008.06.008; Vila M, 2009, P ROY SOC B-BIOL SCI, V276, P3887, DOI 10.1098/rspb.2009.1076; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; Waser NM., 2006, PLANT POLLINATOR INT; Williamson M, 1996, ECOLOGY, V77, P1661, DOI 10.2307/2265769	52	10	10	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e109088	10.1371/journal.pone.0109088	http://dx.doi.org/10.1371/journal.pone.0109088			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343718	Green Published, gold			2022-12-27	WOS:000343943500007
J	Colman, R; Whittingham, H; Tomlinson, G; Granton, J				Colman, Rebecca; Whittingham, Heather; Tomlinson, George; Granton, John			Utility of the Physical Examination in Detecting Pulmonary Hypertension. A Mixed Methods Study	PLOS ONE			English	Article							SECOND HEART SOUND; PHONOCARDIOGRAPHIC SIGNS; ARTERIAL-HYPERTENSION; DIAGNOSIS; GUIDELINES	Introduction: Patients with pulmonary hypertension (PH) often present with a variety of physical findings reflecting a volume or pressure overloaded right ventricle (RV). However, there is no consensus regarding the diagnostic utility of the physical examination in PH. Methods: We conducted a systematic review of publications that evaluated the clinical examination and diagnosis of PH using MEDLINE (1946-2013) and EMBASE (1947-2013). We also prospectively evaluated the diagnostic utility of the physical examination findings. Patients who underwent right cardiac catheterization for any reason were recruited. After informed consent, participants were examined by 6 physicians (3 "specialists'' and 3 "generalists'') who were unaware of the results of the patient's hemodynamics. Each examiner independently assessed patients for the presence of a RV lift, loud P2, jugular venous distension (JVD), tricuspid insufficiency murmur and right-sided 4th heart sound at rest and during a slow inspiration. A global rating (scale of 1-5) of the likelihood that the patient had pulmonary hypertension was provided by each examiner. Results: 31 articles that assessed the physical examination in PH were included in the final analysis. There was heterogeneity amongst the studies and many did not include control data. The sign most associated with PH in the literature was a loud pulmonic component of the second heart sound (P2). In our prospective study physical examination was performed on 52 subjects (25 met criteria for PH; mPAP >= 25 mmHg). The physical sign with the highest likelihood ratio (LR) was a loud P2 on inspiration with a LR +ve 1.9, 95% CrI [1.2, 3.1] when data from all examiners was analyzed together. Results from the specialist examiners had higher diagnostic utility; a loud P2 on inspiration was associated with a positive LR of 3.2, 95% CrI [1.5, 6.2] and a right sided S4 on inspiration had a LR +ve 4.7, 95% CI [1.0, 15.6]. No aspect of the physical exam, could consistently rule out PH (negative LRs 0.7-1.3). Conclusions: The presence of a loud P2 or audible right-sided 4th heart sound are associated with PH. However the physical examination is unreliable for determining the presence of PH.	[Colman, Rebecca; Granton, John] Univ Toronto, Toronto Gen Hosp, Div Respirol, Pulm Hypertens Program, Toronto, ON M5G 1L7, Canada; [Whittingham, Heather] McMaster Univ, Hamilton Gen Hosp, Dept Crit Care Med, Hamilton, ON, Canada; [Tomlinson, George] Univ Toronto, Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Tomlinson, George] Univ Toronto, Fac Med, Univ Hlth Network, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; McMaster University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Granton, J (corresponding author), Univ Toronto, Toronto Gen Hosp, Div Respirol, Pulm Hypertens Program, Toronto, ON M5G 1L7, Canada.	John.granton@uhn.ca	Tomlinson, George/L-5432-2016	Tomlinson, George/0000-0002-9328-6399	Toronto General Hospital Foundation	Toronto General Hospital Foundation	This study was funded through the Toronto General Hospital Foundation. The funder had no role in the design, execution or interpretation of the study results.	BLEIFER S, 1960, AM J CARDIOL, V5, P191, DOI 10.1016/0002-9149(60)90198-3; Chan W, 2013, BMJ OPEN, V3; CRAIGE E, 1960, AM HEART J, V60, P51, DOI 10.1016/0002-8703(60)90058-2; Dennis A, 2010, COMPUT BIOL MED, V40, P758, DOI 10.1016/j.compbiomed.2010.07.003; Gaine S, 2000, JAMA-J AM MED ASSOC, V284, P3160, DOI 10.1001/jama.284.24.3160; Gaine SP, 1998, LANCET, V352, P719, DOI 10.1016/S0140-6736(98)02111-4; Galie N, 2009, EUR RESPIR J, V34, P1219, DOI 10.1183/09031936.00139009; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Goryanina NK, 1964, TERAPEVTICHESKII ARC, V36, P85; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HARRIS A, 1970, AM HEART J, V79, P145, DOI 10.1016/0002-8703(70)90302-9; HARRIS A, 1968, BRIT HEART J, V30, P739; Javed F., 2007, Journal of Medical Engineering & Technology, V31, P341, DOI 10.1080/03091900600887876; KARNEGIS JN, 1964, AM J CARDIOL, V14, P75, DOI 10.1016/0002-9149(64)90109-2; LEATHAM A, 1956, BRIT HEART J, V18, P193; McGoon M, 2004, CHEST, V126, p14S, DOI 10.1378/chest.126.1_suppl.14S; Nigam V, 2006, PHYSIOL MEAS, V27, P553, DOI 10.1088/0967-3334/27/7/001; Pilatis ND, 2000, LIVER TRANSPLANT, V6, P85, DOI 10.1016/S1527-6465(00)80038-6; Plummer M, 2013, PLUMMER MARTYN RIAGS; SHAVER JA, 1974, CIRCULATION, V49, P316, DOI 10.1161/01.CIR.49.2.316; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Slodki S J, 1965, Chic Med Sch Q, V25, P108; STEIN P D, 1980, Henry Ford Hospital Medical Journal, V28, P205; Sung L, 2005, J CLIN EPIDEMIOL, V58, P261, DOI 10.1016/j.jclinepi.2004.08.010; SUTTON G, 1968, BRIT HEART J, V30, P743; UNGERER RG, 1983, AM J MED, V75, P65, DOI 10.1016/0002-9343(83)91169-5; WOOD P, 1952, BRIT MED BULL, V8, P348, DOI 10.1093/oxfordjournals.bmb.a074201; Xu J, 2002, HEART, V88, P76, DOI 10.1136/heart.88.1.76	28	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e108499	10.1371/journal.pone.0108499	http://dx.doi.org/10.1371/journal.pone.0108499			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343585	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943500006
J	Huang, GH; Yao, WQ; Yu, W; Mao, LL; Sun, HB; Yao, W; Tian, J; Wang, L; Bo, ZJ; Zhu, Z; Zhang, Y; Zhao, Z; Xu, WB				Huang, Guohong; Yao, Wenqing; Yu, Wei; Mao, Lingling; Sun, Haibo; Yao, Wei; Tian, Jiang; Wang, Ling; Bo, Zhijian; Zhu, Zhen; Zhang, Yan; Zhao, Zhuo; Xu, Wenbo			Outbreak of Epidemic Keratoconjunctivitis Caused by Human Adenovirus Type 56, China, 2012	PLOS ONE			English	Article							NOSOCOMIAL OUTBREAK; CONJUNCTIVITIS; INFECTIONS; JAPAN; CARE	HAdV-56 is a new recombinant type isolated from epidemic keratoconjunctivitis (EKC) patients and has been sporadically isolated in Japan several times. Here, an outbreak of EKC in the city of Dalian, China involving a large number of workers in two factories was reported; this was the first outbreak of EKC associated with HAdV-56 worldwide.	[Huang, Guohong; Zhu, Zhen; Zhang, Yan; Xu, Wenbo] Natl Inst Viral Dis Control & Prevent, Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Yao, Wenqing; Yu, Wei; Mao, Lingling; Sun, Haibo; Tian, Jiang; Wang, Ling; Zhao, Zhuo] Liaoning Ctr Dis Control & Prevent, Shenyang, Liaoning Provin, Peoples R China; [Yao, Wei; Bo, Zhijian] Dalian Ctr Dis Control & Prevent, Dalian, Liaoning Provin, Peoples R China; [Huang, Guohong] Peoples Hosp Xinjiang Uygur Autonomous Reg, Clin Lab, Urumqi, Xinjiang Uygur, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Zhao, Z (corresponding author), Liaoning Ctr Dis Control & Prevent, Shenyang, Liaoning Provin, Peoples R China.	zhaozhuo699@163.com; wenbo_xu1@aliyun.com			National Basic Research Program of China (973 Program) [2011CB504902]; Key Technologies R&D Program of National Ministry of Science [2013ZX10004-202, 2012ZX10004201-003]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Key Technologies R&D Program of National Ministry of Science	This study was supported by National Basic Research Program of China (973 Program): (Grant No. 2011CB504902); Key Technologies R&D Program of National Ministry of Science (Grant No. 2013ZX10004-202; 2012ZX10004201-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOKI K, 1982, BRIT J OPHTHALMOL, V66, P776, DOI 10.1136/bjo.66.12.776; AOKI K, 1986, JPN J OPHTHALMOL, V30, P158; Aoki Koki, 2002, International Ophthalmology Clinics, V42, P49; FORD E, 1987, EPIDEMIOL REV, V9, P244, DOI 10.1093/oxfordjournals.epirev.a036304; Hamada N, 2008, J HOSP INFECT, V68, P262, DOI 10.1016/j.jhin.2007.12.012; Hiroi S, 2012, JPN J INFECT DIS, V65, P273, DOI 10.7883/yoken.65.273; Ishiko H, 2008, J CLIN MICROBIOL, V46, P2002, DOI 10.1128/JCM.01835-07; Kaneko H, 2011, J GEN VIROL, V92, P1251, DOI 10.1099/vir.0.030361-0; Kaneko H, 2011, J CLIN MICROBIOL, V49, P484, DOI 10.1128/JCM.01044-10; Lu X, 2006, ARCH VIROL, V151, P1587, DOI 10.1007/s00705-005-0722-7; Nakamura M, 2012, J MED VIROL, V84, P81, DOI 10.1002/jmv.22252; PACINI DL, 1987, J INFECT DIS, V156, P920, DOI 10.1093/infdis/156.6.920; Percivalle E, 2003, J CLIN VIROL, V28, P257, DOI 10.1016/S1386-6532(03)00011-8; Robinson CM, 2011, VIROLOGY, V409, P141, DOI 10.1016/j.virol.2010.10.020; Sambursky Robert P, 2007, Optometry, V78, P236, DOI 10.1016/j.optm.2006.11.012; Sriwanna P, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-193; Weitgasser U, 2002, OPHTHALMOLOGICA, V216, P329, DOI 10.1159/000066175; WOLD WSM, 2007, FIELD VIROLOGY, P02395	18	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110781	10.1371/journal.pone.0110781	http://dx.doi.org/10.1371/journal.pone.0110781			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343525	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943500054
J	Nozaki, K; Kagamu, H; Shoji, S; Igarashi, N; Ohtsubo, A; Okajima, M; Miura, S; Watanabe, S; Yoshizawa, H; Narita, I				Nozaki, Koichiro; Kagamu, Hiroshi; Shoji, Satoshi; Igarashi, Natsue; Ohtsubo, Aya; Okajima, Masaaki; Miura, Satoru; Watanabe, Satoshi; Yoshizawa, Hirohisa; Narita, Ichiei			DDX3X Induces Primary EGFR-TKI Resistance Based on Intratumor Heterogeneity in Lung Cancer Cells Harboring EGFR-Activating Mutations	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; STEM-CELLS; MESENCHYMAL TRANSITION; PROSTATE-CANCER; RNA HELICASE; GEFITINIB; MEDULLOBLASTOMA; DIFFERENTIATION; PROGRESSION; PROTEINS	The specific mechanisms how lung cancer cells harboring epidermal growth factor receptor (EGFR) activating mutations can survive treatment with EGFR-tyrosine kinase inhibitors (TKIs) until they eventually acquire treatment-resistance genetic mutations are unclear. The phenotypic diversity of cancer cells caused by genetic or epigenetic alterations (intratumor heterogeneity) confers treatment failure and may foster tumor evolution through Darwinian selection. Recently, we found DDX3X as the protein that was preferentially expressed in murine melanoma with cancer stem cell (CSC)-like phenotypes by proteome analysis. In this study, we transfected PC9, human lung cancer cells harboring EGFR exon19 deletion, with cDNA encoding DDX3X and found that DDX3X, an ATP-dependent RNA helicase, induced CSC-like phenotypes and the epithelial-mesenchymal transition (EMT) accompanied with loss of sensitivity to EGFR-TKI. DDX3X expression was associated with upregulation of Sox2 and increase of cancer cells exhibiting CSC-like phenotypes, such as anchorage-independent proliferation, strong expression of CD44, and aldehyde dehydrogenase (ALDH). The EMT with switching from E-cadherin to N-cadherin was also facilitated by DDX3X. Either ligand-independent or ligand-induced EGFR phosphorylation was inhibited in lung cancer cells that strongly expressed DDX3X. Lack of EGFR signal addiction resulted in resistance to EGFR-TKI. Moreover, we found a small nonadherent subpopulation that strongly expressed DDX3X accompanied by the same stem cell-like properties and the EMT in parental PC9 cells. The unique subpopulation lacked EGFR signaling and was highly resistant to EGFR-TKI. In conclusion, our data indicate that DDX3X may play a critical role for inducing phenotypic diversity, and that treatment targeting DDX3X may overcome primary resistance to EGFR-TKI resulting from intratumor heterogeneity.	[Nozaki, Koichiro; Kagamu, Hiroshi; Shoji, Satoshi; Igarashi, Natsue; Ohtsubo, Aya; Okajima, Masaaki; Miura, Satoru; Narita, Ichiei] Niigata Univ, Grad Sch Med & Dent Sci, Dept Homeostat Regulat & Dev, Div Resp Med, Niigata, Japan; [Watanabe, Satoshi; Yoshizawa, Hirohisa] Niigata Univ, Med & Dent Hosp, Biosci Med Res Ctr, Niigata, Japan	Niigata University; Niigata University	Kagamu, H (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Homeostat Regulat & Dev, Div Resp Med, Niigata, Japan.	hkagamu@med.niigata-u.ac.jp	Narita, Ichiei/G-5204-2017	Narita, Ichiei/0000-0001-7692-3096	Ministry of Education, Science, and Culture of Japan [20590915, 23591141, 24591157, 26293196]; Otsuka Pharmaceutical Co., Ltd.	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Otsuka Pharmaceutical Co., Ltd.(Otsuka Pharmaceutical)	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan (#20590915, #23591141, #24591157, #26293196), and by research funding from Otsuka Pharmaceutical Co., Ltd. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhaleem M, 2005, CLIN BIOCHEM, V38, P499, DOI 10.1016/j.clinbiochem.2005.01.010; Ambrus AM, 2009, CELL CYCLE, V8, P3500, DOI 10.4161/cc.8.21.9887; Araki K, 2011, BRIT J CANCER, V105, P1885, DOI 10.1038/bjc.2011.452; Botlagunta M, 2008, ONCOGENE, V27, P3912, DOI 10.1038/onc.2008.33; Chao CH, 2006, CANCER RES, V66, P6579, DOI 10.1158/0008-5472.CAN-05-2415; Chen YR, 2006, ONCOGENE, V25, P1205, DOI 10.1038/sj.onc.1209159; Cruciat CM, 2013, SCIENCE, V339, P1436, DOI 10.1126/science.1231499; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fan X, 2008, J CLIN ONCOL, V26, P2821, DOI 10.1200/JCO.2007.15.2264; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Koizumi F, 2005, INT J CANCER, V116, P36, DOI 10.1002/ijc.20985; Koshio J, 2013, CANC IMMUNOLOGY IMMU; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Miyabayashi T, 2011, CANC IMMUNOLOGY IMMU; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Rojas M, 1996, J BIOL CHEM, V271, P27456, DOI 10.1074/jbc.271.44.27456; Rosinski KV, 2008, BLOOD, V111, P4817, DOI 10.1182/blood-2007-06-096313; Shah GV, 2009, J BIOL CHEM, V284, P1018, DOI 10.1074/jbc.M807823200; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Singh SK, 2003, CANCER RES, V63, P5821; STOVER DR, 1995, J BIOL CHEM, V270, P15591, DOI 10.1074/jbc.270.26.15591; Sun M, 2011, BIOCH BIOPHYS ACTA; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; Tomita K, 2000, CANCER RES, V60, P3650; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455	36	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111019	10.1371/journal.pone.0111019	http://dx.doi.org/10.1371/journal.pone.0111019			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343452	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943500076
J	Safari, D; Kurniati, N; Waslia, L; Khoeri, MM; Putri, T; Bogaert, D; Trzcinski, K				Safari, Dodi; Kurniati, Nia; Waslia, Lia; Khoeri, Miftahuddin Majid; Putri, Tiara; Bogaert, Debby; Trzcinski, Krzysztof			Serotype Distribution and Antibiotic Susceptibility of Streptococcus pneumoniae Strains Carried by Children Infected with Human Immunodeficiency Virus	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; NASOPHARYNGEAL CARRIAGE; DISEASE; COLONIZATION; RESISTANCE; REPLACEMENT; PREVALENCE; TRENDS; IMPACT; COHORT	Background: We studied the serotype distribution and antibiotic susceptibility of Streptococcus pneumoniae isolates carried by children infected with HIV in Jakarta, Indonesia. Methods: Nasopharyngeal swabs were collected from 90 HIV infected children aged 4 to 144 months. S. pneumoniae was identified by conventional and molecular methods. Serotyping was performed with sequential multiplex PCR and antibiotic susceptibility with the disk diffusion method. Results: We identified S. pneumoniae carriage in 41 children (46%). Serotype 19F was most common among 42 cultured strains (19%) followed by 19A and 6A/B (10% each), and 23F (7%). Most isolates were susceptible to chloramphenicol (86%), followed by clindamycin (79%), erythromycin (76%), tetracycline (43%), and sulphamethoxazole/trimethoprim (41%). Resistance to penicillin was most common with only 33% of strains being susceptible. Strains of serotypes targeted by the 13-valent pneumococcal conjugate polysaccharide vaccine (PCV13) were more likely to be multidrug resistant (13 of 25 or 52%) compared to non-PCV13 serotype isolates (3 of 17 or 18%; Fisher exact test p = 0.05). Conclusion: Our study provides insight into the epidemiology of pneumococcal carriage in young HIV patients in Indonesia. These findings may facilitate potential preventive strategies that target invasive pneumococcal disease in Indonesia.	[Safari, Dodi; Khoeri, Miftahuddin Majid] Eijkman Inst Mol Biol, Jakarta, Indonesia; [Kurniati, Nia] Univ Indonesia, Dr Cipto Mangunkusumo Hospital, Fac Med, Dept Child Hlth, Jakarta, Indonesia; [Waslia, Lia] Eijkman Oxford Clin Res Unit, Jakarta, Indonesia; [Putri, Tiara] Gajah Mada Univ, Fac Biol, Yogyakarta, Indonesia; [Bogaert, Debby; Trzcinski, Krzysztof] Wilhelminas Children Hosp, Univ Med Ctr Utrecht, Dept Pediat Immunol & Infect Dis, Utrecht, Netherlands	Eijkman Institute; University of Indonesia; Eijkman Institute; Gadjah Mada University; Utrecht University; Utrecht University Medical Center	Safari, D (corresponding author), Eijkman Inst Mol Biol, Jakarta, Indonesia.	safari@eijkman.go.id	Trzcinski, Krzysztof/I-8840-2019	Trzcinski, Krzysztof/0000-0002-5433-8846; Khoeri, Miftahuddin Majid/0000-0002-8862-6707; Bogaert, Debby/0000-0003-2651-7000	International Society of Infectious Disease (ISID)	International Society of Infectious Disease (ISID)	This study was supported by a small grant from International Society of Infectious Disease (ISID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullahi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030787; Anthony L, 2012, INT J INFECT DIS, V16, pE753, DOI 10.1016/j.ijid.2012.05.1037; Auranen K, 2013, VACCINE, V32, P153, DOI 10.1016/j.vaccine.2013.08.061; Bliss SJ, 2008, LANCET INFECT DIS, V8, P67, DOI 10.1016/S1473-3099(07)70242-6; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Browall S, 2014, J INFECT DIS, V209, P377, DOI 10.1093/infdis/jit481; Cardoso Viviane C., 2006, J. Pediatr. (Rio J.), V82, P51, DOI 10.2223/JPED.1437; Clinical and Laboratory Standards Institute, 2007, PERF STAND ANT SUS S; Dagan R, 2009, CLIN MICROBIOL INFEC, V15, P16, DOI 10.1111/j.1469-0691.2009.02726.x; Farida H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087431; Feikin DR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001517; Gilks CF, 1996, LANCET, V347, P718, DOI 10.1016/S0140-6736(96)90076-8; Jansen AGSC, 2009, CLIN INFECT DIS, V49, pE23, DOI 10.1086/600045; Kaplan SL, 2010, PEDIATRICS, V125, P429, DOI 10.1542/peds.2008-1702; Kim SH, 2012, ANTIMICROB AGENTS CH, V56, P1418, DOI 10.1128/AAC.05658-11; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Le CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019547; Leibovitz E, 1999, Int J Infect Dis, V3, P211, DOI 10.1016/S1201-9712(99)90027-9; Link-Gelles R, 2013, J INFECT DIS, V208, P1266, DOI 10.1093/infdis/jit315; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Morrison KE, 2000, J CLIN MICROBIOL, V38, P434; Mwenya DM, 2010, ANTIMICROB AGENTS CH, V54, P3756, DOI 10.1128/AAC.01409-09; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Oliver MB, 2013, J BIOL CHEM, V288, P25976, DOI 10.1074/jbc.M113.480152; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Polack FP, 2000, PEDIATR INFECT DIS J, V19, P608, DOI 10.1097/00006454-200007000-00005; Satzke C, 2013, VACCINE, V32, P165, DOI 10.1016/j.vaccine.2013.08.062; Shiri T, 2013, AM J EPIDEMIOL, V178, P1629, DOI 10.1093/aje/kwt200; Soewignjo S, 2001, CLIN INFECT DIS, V32, P1039, DOI 10.1086/319605; Spijkerman J, 2011, EMERG INFECT DIS, V17, P584, DOI 10.3201/eid1704.101115; Valente C, 2013, PEDIATR INFECT DIS J, V32, P703, DOI 10.1097/INF.0b013e31828692be; van der Linden M, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-70; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8	35	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110526	10.1371/journal.pone.0110526	http://dx.doi.org/10.1371/journal.pone.0110526			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343448	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943500034
J	Heimerl, S; Fischer, M; Baessler, A; Liebisch, G; Sigruener, A; Wallner, S; Schmitz, G				Heimerl, Susanne; Fischer, Marcus; Baessler, Andrea; Liebisch, Gerhard; Sigruener, Alexander; Wallner, Stefan; Schmitz, Gerd			Alterations of Plasma Lysophosphatidylcholine Species in Obesity and Weight Loss	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; ESI-MS/MS; CHOLESTEROL; LIPIDOMICS; CERAMIDE; SEPSIS; ETHER	Background: Obesity and related diseases of the metabolic syndrome contribute to the major health problems in industrialized countries. Alterations in the metabolism of lipid classes and lipid species may significantly be involved in these metabolic overload diseases. However, little is known about specific lipid species in this syndrome and existing data are contradictive. Methods: In this study, we quantified plasma lipid species by electrospray ionization tandem mass spectrometry (ESI-MS/MS) in obese subjects before and after 3 month weight loss as well as in a control group. Results: The comparison of obese subjects with control subjects before weight loss revealed significantly lower lysophosphatidylcholine (LPC) concentrations in obesity. LPC concentrations did not significantly increase during the observed period in the weight loss group. Analysis of LPC species revealed a decrease of most species in obesity and negative correlations with C-reactive protein (CRP) and body mass index (BMI). Correlating BMI ratio before and after weight loss with the ratio of total LPC and individual LPC species revealed significant negative relationships of LPC ratios with BMI ratio. Conclusions: Our findings contribute to the contradictive discussion of the role of LPC in obesity and related chronic inflammation strongly supporting pre-existing data in the literature that show a decrease of LPC species in plasma of obese and a potentially anti-inflammatory role in these subjects.	[Heimerl, Susanne; Liebisch, Gerhard; Sigruener, Alexander; Wallner, Stefan; Schmitz, Gerd] Univ Med Ctr, Inst Clin Chem & Lab Med, Regensburg, Germany; [Fischer, Marcus; Baessler, Andrea] Univ Med Ctr, Clin Internal Med 2, Regensburg, Germany	University of Regensburg; University of Regensburg	Schmitz, G (corresponding author), Univ Med Ctr, Inst Clin Chem & Lab Med, Regensburg, Germany.	gerd.schmitz@klinik.uni-regensburg.de	Liebisch, Gerhard/G-6130-2010	Liebisch, Gerhard/0000-0003-4886-0811; Schmitz, Gerd/0000-0002-1325-1007	German Competence Network of Obesity - Federal Ministry of Education and Research [01GI1320]	German Competence Network of Obesity - Federal Ministry of Education and Research	This study was supported by the German Competence Network of Obesity funded by the Federal Ministry of Education and Research (01GI1320 to AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arends J, 2007, LIPIDS HLTH DIS, V6, P17, DOI [10.1186/1476-511X-6-17, DOI 10.1186/1476-511X-6-17]; Baessler A, 2012, EUR J HEART FAIL, V14, P1240, DOI 10.1093/eurjhf/hfs116; Barber MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041456; Berry KAZ, 2004, J AM SOC MASS SPECTR, V15, P1499, DOI 10.1016/j.jasms.2004.07.009; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Choi J, 2013, OBES REV, V14, P232, DOI 10.1111/obr.12003; Drobnik W, 2003, J LIPID RES, V44, P754, DOI 10.1194/jlr.M200401-JLR200; Graessler J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006261; Kabarowski JH, 2009, PROSTAG OTH LIPID M, V89, P73, DOI 10.1016/j.prostaglandins.2009.04.007; Kita T, 1999, DIABETES RES CLIN PR, V45, P123, DOI 10.1016/S0168-8227(99)00041-8; Klop B, 2013, NUTRIENTS, V5, P1218, DOI 10.3390/nu5041218; Liebisch G, 1999, J LIPID RES, V40, P1539; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; Liebisch G, 2002, CLIN CHEM, V48, P2217; Liebisch G, 2004, BBA-MOL CELL BIOL L, V1686, P108, DOI 10.1016/j.bbalip.2004.09.003; Liebisch G, 2013, J LIPID RES, V54, P1523, DOI 10.1194/jlr.M033506; Mapstone M, 2014, NAT MED, V20, P415, DOI 10.1038/nm.3466; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Meikle PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074341; Meikle PJ, 2011, ARTERIOSCL THROM VAS, V31, P2723, DOI 10.1161/ATVBAHA.111.234096; Nestel PJ, 2014, AM J CLIN NUTR, V99, P46, DOI 10.3945/ajcn.113.071712; Pietilainen KH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000218; Rosenson RS, 2012, EUR HEART J, V33, P2899, DOI 10.1093/eurheartj/ehs148; Scherer M, 2010, ANAL CHEM, V82, P8794, DOI 10.1021/ac1021826; Schmitz G, 2010, ATHEROSCLEROSIS, V208, P10, DOI 10.1016/j.atherosclerosis.2009.05.029; Schwab U, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002630; Schwenk RW, 2013, MOL METAB, V2, P337, DOI 10.1016/j.molmet.2013.09.002; SEKAS G, 1985, J LAB CLIN MED, V105, P190; Sigruener A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085724; Strack C, 2012, J ATHEROSCLER THROMB, V19, P539, DOI 10.5551/jat.10918; SUBBAIAH PV, 1992, BIOCHIM BIOPHYS ACTA, V1128, P83, DOI 10.1016/0005-2760(92)90261-S; Wiesner P, 2009, J LIPID RES, V50, P574, DOI 10.1194/jlr.D800028-JLR200; Wong G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076577; Yan JJ, 2004, NAT MED, V10, P161, DOI 10.1038/nm989	34	80	81	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111348	10.1371/journal.pone.0111348	http://dx.doi.org/10.1371/journal.pone.0111348			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340546	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662800103
J	Dong, HP; Huang, KX; Wang, HL; Lu, SH; Cen, JY; Dong, YL				Dong, Hong-Po; Huang, Kai-Xuan; Wang, Hua-Long; Lu, Song-Hui; Cen, Jing-Yi; Dong, Yue-Lei			Understanding Strategy of Nitrate and Urea Assimilation in a Chinese Strain of Aureococcus anophagefferens through RNA-Seq Analysis	PLOS ONE			English	Article							GENE-EXPRESSION; NITROGEN UPTAKE; ALGAL BLOOMS; GROWTH; CYCLE; NUTRIENT; NITRITE; PELAGOPHYCEAE; BIOSYNTHESIS; HYDROLYSIS	Aureococcus anophagefferens is a harmful alga that dominates plankton communities during brown tides in North America, Africa, and Asia. Here, RNA-seq technology was used to profile the transcriptome of a Chinese strain of A. anophagefferens that was grown on urea, nitrate, and a mixture of urea and nitrate, and that was under N-replete, limited and recovery conditions to understand the molecular mechanisms that underlie nitrate and urea utilization. The number of differentially expressed genes between urea-grown and mixture N-grown cells were much less than those between urea-grown and nitrate-grown cells. Compared with nitrate-grown cells, mixture N-grown cells contained much lower levels of transcripts encoding proteins that are involved in nitrate transport and assimilation. Together with profiles of nutrient changes in media, these results suggest that A. anophagefferens primarily feeds on urea instead of nitrate when urea and nitrate coexist. Furthermore, we noted that transcripts upregulated by nitrate and N-limitation included those encoding proteins involved in amino acid and nucleotide transport, degradation of amides and cyanates, and nitrate assimilation pathway. The data suggest that A. anophagefferens possesses an ability to utilize a variety of dissolved organic nitrogen. Moreover, transcripts for synthesis of proteins, glutamate-derived amino acids, spermines and sterols were upregulated by urea. Transcripts encoding key enzymes that are involved in the ornithine-urea and TCA cycles were differentially regulated by urea and nitrogen concentration, which suggests that the OUC may be linked to the TCA cycle and involved in reallocation of intracellular carbon and nitrogen. These genes regulated by urea may be crucial for the rapid proliferation of A. anophagefferens when urea is provided as the N source.	[Dong, Hong-Po; Huang, Kai-Xuan; Wang, Hua-Long; Lu, Song-Hui; Cen, Jing-Yi; Dong, Yue-Lei] Jinan Univ, Res Ctr Harmful Algae & Marine Biol, Key Lab Eutrophicat & Red Tide Prevent, Guangdong Higher Educ Inst, Guangzhou, Guangdong, Peoples R China	Jinan University	Lu, SH (corresponding author), Jinan Univ, Res Ctr Harmful Algae & Marine Biol, Key Lab Eutrophicat & Red Tide Prevent, Guangdong Higher Educ Inst, Guangzhou, Guangdong, Peoples R China.	lusonghui1963@163.com	cen, jingyi/T-9121-2019; Cen, jingyi/T-9107-2019; Wang, Hualong/AAX-2049-2020		National Natural Science Foundation of China [41206126, 41176087]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA11020304]; National Basic Research Program of China (973 Program) [2010CB428702]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This study was funded by the National Natural Science Foundation of China through grant 41206126 and 41176087 (http://www.nsfc.gov.cn/), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA11020304) (http://www.cas.ac.cn/), and the National Basic Research Program of China (973 Program) through grant 2010CB428702 (http://www.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AE, 2011, NATURE, V473, P203, DOI 10.1038/nature10074; Anderson DM, 2008, HARMFUL ALGAE, V8, P39, DOI 10.1016/j.hal.2008.08.017; ANDERSON L, 1979, ANAL CHIM ACTA, V110, P123, DOI 10.1016/S0003-2670(01)83537-6; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Berg GM, 2002, APPL ENVIRON MICROB, V68, P401, DOI 10.1128/AEM.68.1.401-404.2002; Berg GM, 1997, MAR BIOL, V129, P377, DOI 10.1007/s002270050178; Berg GM, 2008, J PHYCOL, V44, P1235, DOI 10.1111/j.1529-8817.2008.00571.x; BRUNSWICK P, 1988, PLANT PHYSIOL, V86, P378, DOI 10.1104/pp.86.2.378; Carland F, 2010, PLANT PHYSIOL, V153, P741, DOI 10.1104/pp.109.152587; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Coschigano KT, 1998, PLANT CELL, V10, P741, DOI 10.1105/tpc.10.5.741; CRAWFORD NM, 1995, PLANT CELL, V7, P859, DOI 10.1105/tpc.7.7.859; Dixon RA, 2001, NATURE, V411, P843, DOI 10.1038/35081178; Fan C, 2003, MAR BIOL, V142, P949, DOI 10.1007/s00227-003-1017-8; Fernandez E, 2008, EUKARYOT CELL, V7, P555, DOI 10.1128/EC.00431-07; GAO JW, 1994, PLANT MOL BIOL, V25, P761, DOI 10.1007/BF00028872; Gobler CJ, 2011, P NATL ACAD SCI USA, V108, P4352, DOI 10.1073/pnas.1016106108; Gobler CJ, 2005, ESTUARIES, V28, P726, DOI 10.1007/BF02732911; GOLDMAN JC, 1978, LIMNOL OCEANOGR, V23, P695, DOI 10.4319/lo.1978.23.4.0695; Gonzalez-Ballester D, 2010, PLANT CELL, V22, P2058, DOI 10.1105/tpc.109.071167; He JX, 2003, PLANT PHYSIOL, V131, P1258, DOI 10.1104/pp.014605; Ito T, 2000, PLANT J, V22, P257, DOI 10.1046/j.1365-313x.2000.00728.x; Kinoshita Y, 2001, J BIOL CHEM, V276, P6656, DOI 10.1074/jbc.M008536200; Kong FZ, 2012, CHIN J OCEANOL LIMN, V30, P361, DOI 10.1007/s00343-012-1239-z; Kumar A, 1997, TRENDS PLANT SCI, V2, P124, DOI 10.1016/S1360-1385(97)01013-3; Lee B, 2000, P NATL ACAD SCI USA, V97, P8021, DOI 10.1073/pnas.140082197; Lefebvre SC, 2010, J PHYCOL, V46, P123, DOI 10.1111/j.1529-8817.2009.00793.x; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lomas MW, 2001, J PLANKTON RES, V23, P1339, DOI 10.1093/plankt/23.12.1339; Merigout P, 2008, PLANT PHYSIOL, V147, P1225, DOI 10.1104/pp.108.119339; Morris SM, 2002, ANNU REV NUTR, V22, P87, DOI 10.1146/annurev.nutr.22.110801.140547; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Mulholland MR, 2002, LIMNOL OCEANOGR, V47, P1094, DOI 10.4319/lo.2002.47.4.1094; Pustizzi F, 2004, HARMFUL ALGAE, V3, P343, DOI 10.1016/j.hal.2004.06.006; RAHMATULLAH M, 1980, CLIN CHIM ACTA, V107, P3, DOI 10.1016/0009-8981(80)90407-6; Ravanel S, 1998, P NATL ACAD SCI USA, V95, P7805, DOI 10.1073/pnas.95.13.7805; Rexach J, 2000, PLANT CELL, V12, P1441, DOI 10.1105/tpc.12.8.1441; Song B, 2007, J PHYCOL, V43, P542, DOI 10.1111/j.1529-8817.2007.00352.x; Takabayashi M, 2005, J PHYCOL, V41, P84, DOI 10.1111/j.1529-8817.2005.04115.x; Tzin V, 2010, MOL PLANT, V3, P956, DOI 10.1093/mp/ssq048; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WEBB WL, 1974, OECOLOGIA, V17, P281, DOI 10.1007/BF00345747; Wurch LL, 2011, ENVIRON MICROBIOL, V13, P468, DOI 10.1111/j.1462-2920.2010.02351.x; Zhang QC, 2012, HARMFUL ALGAE, V19, P117, DOI 10.1016/j.hal.2012.06.007	45	24	33	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e111069	10.1371/journal.pone.0111069	http://dx.doi.org/10.1371/journal.pone.0111069			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338000	Green Published, Green Submitted, gold			2022-12-27	WOS:000343674800101
J	Keyes, H; Dlugokencka, A				Keyes, Helen; Dlugokencka, Aleksandra			Do I Have My Attention? Speed of Processing Advantages for the Self-Face Are Not Driven by Automatic Attention Capture	PLOS ONE			English	Article							OWN FACE; FAMILIAR FACES; VISUAL-SEARCH; REACTION-TIME; RECOGNITION; STIMULI; TASK; NAME; REPETITION; HANDEDNESS	We respond more quickly to our own face than to other faces, but there is debate over whether this is connected to attention-grabbing properties of the self-face. In two experiments, we investigate whether the self-face selectively captures attention, and the attentional conditions under which this might occur. In both experiments, we examined whether different types of face (self, friend, stranger) provide differential levels of distraction when processing self, friend and stranger names. In Experiment 1, an image of a distractor face appeared centrally - inside the focus of attention - behind a target name, with the faces either upright or inverted. In Experiment 2, distractor faces appeared peripherally - outside the focus of attention - in the left or right visual field, or bilaterally. In both experiments, self-name recognition was faster than other name recognition, suggesting a self-referential processing advantage. The presence of the self-face did not cause more distraction in the naming task compared to other types of face, either when presented inside (Experiment 1) or outside (Experiment 2) the focus of attention. Distractor faces had different effects across the two experiments: when presented inside the focus of attention (Experiment 1), self and friend images facilitated self and friend naming, respectively. This was not true for stranger stimuli, suggesting that faces must be robustly represented to facilitate name recognition. When presented outside the focus of attention (Experiment 2), no facilitation occurred. Instead, we report an interesting distraction effect caused by friend faces when processing strangers' names. We interpret this as a "social importance" effect, whereby we may be tuned to pick out and pay attention to familiar friend faces in a crowd. We conclude that any speed of processing advantages observed in the self-face processing literature are not driven by automatic attention capture.	[Keyes, Helen; Dlugokencka, Aleksandra] Anglia Ruskin Univ, Dept Psychol, Cambridge, England	Anglia Ruskin University	Keyes, H (corresponding author), Anglia Ruskin Univ, Dept Psychol, Cambridge, England.	helen.keyes@anglia.ac.uk		Keyes, Helen/0000-0001-7654-3181				Arnell KM, 1999, VIS COGN, V6, P609, DOI 10.1080/135062899394876; Ben-Shakhar G, 2002, J APPL PSYCHOL, V87, P972, DOI 10.1037//0021-9010.87.5.972; Bredart S, 2006, PERCEPTION, V35, P101, DOI 10.1068/p5382; Bredart S, 2003, PERCEPTION, V32, P805, DOI 10.1068/p3354; Bundesen C, 1997, PERCEPT PSYCHOPHYS, V59, P714, DOI 10.3758/BF03206017; Buttle H, 2003, PERCEPT PSYCHOPHYS, V65, P1296, DOI 10.3758/BF03194853; Caharel S, 2006, INT J PSYCHOPHYSIOL, V62, P141, DOI 10.1016/j.ijpsycho.2006.03.002; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; Devue C, 2008, ACTA PSYCHOL, V128, P290, DOI 10.1016/j.actpsy.2008.02.004; Devue C, 2009, PERCEPTION, V38, P552, DOI 10.1068/p6049; Devue C, 2009, COGNITION, V111, P114, DOI 10.1016/j.cognition.2009.01.003; Greenberg SN, 2009, J EXP PSYCHOL LEARN, V35, P499, DOI 10.1037/a0014640; Gronau N, 2003, J EXP PSYCHOL GEN, V132, P512, DOI 10.1037/0096-3445.132.4.512; Harris CR, 2004, Q J EXP PSYCHOL-A, V57, P1, DOI 10.1080/02724980343000107; Keyes H, 2014, DATA EXPT; Keyes H, 2014, DATA EXPT; Keyes H, 2012, Q J EXP PSYCHOL, V65, P760, DOI 10.1080/17470218.2011.636822; Keyes H, 2010, Q J EXP PSYCHOL, V63, P840, DOI 10.1080/17470211003611264; Keyes H, 2010, BRAIN COGNITION, V72, P244, DOI 10.1016/j.bandc.2009.09.006; Kircher TTJ, 2001, COGNITION, V78, pB1, DOI 10.1016/S0010-0277(00)00104-9; Knecht S, 2000, BRAIN, V123, P2512, DOI 10.1093/brain/123.12.2512; Mack A., 1998, INATTENTIONAL BLINDN; Megreya AM, 2006, MEM COGNITION, V34, P865, DOI 10.3758/BF03193433; MITA TH, 1977, J PERS SOC PSYCHOL, V35, P597, DOI 10.1037/0022-3514.35.8.597; MORAY N, 1959, Q J EXP PSYCHOL, V11, P56, DOI 10.1080/17470215908416289; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Platek SM, 2006, HUM BRAIN MAPP, V27, P91, DOI 10.1002/hbm.20168; Ramon M, 2008, J VISION, V8, p886a; RATCLIFF R, 1993, PSYCHOL BULL, V114, P510, DOI 10.1037/0033-2909.114.3.510; RIZZOLAT.G, 1971, BRAIN, V94, P431, DOI 10.1093/brain/94.3.431; Rossion B, 2000, J COGNITIVE NEUROSCI, V12, P793, DOI 10.1162/089892900562606; Shapiro KL, 1997, J EXP PSYCHOL HUMAN, V23, P504, DOI 10.1037/0096-1523.23.2.504; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sugiura M, 2005, NEUROIMAGE, V24, P143, DOI 10.1016/j.neuroimage.2004.07.063; Sugiura M, 2000, NEUROIMAGE, V11, P36, DOI 10.1006/nimg.1999.0519; Sui J, 2006, NEUROREPORT, V17, P423, DOI 10.1097/01.wnr.0000203357.65190.61; Tacikowski P, 2010, BIOL PSYCHOL, V84, P318, DOI 10.1016/j.biopsycho.2010.03.009; Tong F, 1999, J EXP PSYCHOL HUMAN, V25, P1016, DOI 10.1037/0096-1523.25.4.1016; Troje NF, 1999, PERCEPTION, V28, P483, DOI 10.1068/p2901; Turk DJ, 2003, ANN NY ACAD SCI, V1001, P65, DOI 10.1196/annals.1279.005	40	25	28	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110792	10.1371/journal.pone.0110792	http://dx.doi.org/10.1371/journal.pone.0110792			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6DY	25338170	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000343674800076
J	Juhas, M; Evans, LDB; Frost, J; Davenport, PW; Yarkoni, O; Fraser, GM; Ajioka, JW				Juhas, Mario; Evans, Lewis D. B.; Frost, Joe; Davenport, Peter W.; Yarkoni, Orr; Fraser, Gillian M.; Ajioka, James W.			Escherichia coli Flagellar Genes as Target Sites for Integration and Expression of Genetic Circuits	PLOS ONE			English	Article							DNA; PROTEIN; PCR; CHROMOSOME; SEQUENCES; RESOURCE; SYSTEMS; CLONING; GENOME; TOOL	E. coli is a model platform for engineering microbes, so genetic circuit design and analysis will be greatly facilitated by simple and effective approaches to introduce genetic constructs into the E. coli chromosome at well-characterised loci. We combined the Red recombinase system of bacteriophage lambda and Isothermal Gibson Assembly for rapid integration of novel DNA constructs into the E. coli chromosome. We identified the flagellar region as a promising region for integration and expression of genetic circuits. We characterised integration and expression at four candidate loci, fliD, fliS, fliT, and fliY, of the E. coli flagellar region 3a. The integration efficiency and expression from the four integrations varied considerably. Integration into fliD and fliS significantly decreased motility, while integration into fliT and fliY had only a minor effect on the motility. None of the integrations had negative effects on the growth of the bacteria. Overall, we found that fliT was the most suitable integration site.	[Juhas, Mario; Evans, Lewis D. B.; Frost, Joe; Davenport, Peter W.; Yarkoni, Orr; Fraser, Gillian M.; Ajioka, James W.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England	University of Cambridge	Juhas, M (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	mj417@cam.ac.uk	Fraser, Gillian/I-1846-2013	Fraser, Gillian/0000-0002-4874-8734; Frost, Joe/0000-0002-5946-6062; Evans, Lewis/0000-0001-7279-7651	UK Engineering and Physical Sciences Research Council; Welcome Trust	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Welcome Trust(Wellcome Trust)	This work was supported by grants from the UK Engineering and Physical Sciences Research Council and the Welcome Trust to JWA and GMF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Chen XZ, 2013, BIOTECHNOL ADV, V31, P1200, DOI 10.1016/j.biotechadv.2013.02.009; Cunningham DS, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-27; Das B, 2010, P NATL ACAD SCI USA, V107, P4377, DOI 10.1073/pnas.0910212107; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Fraser GM, 1999, MOL MICROBIOL, V32, P569, DOI 10.1046/j.1365-2958.1999.01372.x; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Haldimann A, 2001, J BACTERIOL, V183, P6384, DOI 10.1128/JB.183.21.6384-6393.2001; HANAHAN D, 1991, METHOD ENZYMOL, V204, P63; Hayashi K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100049; Ikeda T, 1996, J MOL BIOL, V259, P679, DOI 10.1006/jmbi.1996.0349; Jandu N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004889; Juhas M, 2013, BIOTECHNOL J; Juhas M, 2014, MICROBIOLOGY; Juhas M, 2012, TRENDS BIOTECHNOL, V30, P601, DOI 10.1016/j.tibtech.2012.08.002; Juhas M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040064; Juhas M, 2011, TRENDS CELL BIOL, V21, P562, DOI 10.1016/j.tcb.2011.07.005; Kahramanoglou C, 2011, NUCLEIC ACIDS RES, V39, P2073, DOI 10.1093/nar/gkq934; Keseler IM, 2005, NUCLEIC ACIDS RES, V33, pD334, DOI 10.1093/nar/gki108; Marcellin E, 2010, METAB ENG, V12, P62, DOI 10.1016/j.ymben.2009.09.001; Merryman C, 2012, METAB ENG, V14, P196, DOI 10.1016/j.ymben.2012.02.005; MIESCHENDAHL M, 1985, J BACTERIOL, V164, P1366, DOI 10.1128/JB.164.3.1366-1369.1985; Miller E M, 1995, Methods Mol Biol, V47, P105; Minty JJ, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-18; Murphy KC, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-11; Ozin AJ, 2003, FEMS MICROBIOL LETT, V219, P219, DOI 10.1016/S0378-1097(02)01208-9; Park SJ, 2012, APPL MICROBIOL BIOT, V93, P273, DOI 10.1007/s00253-011-3530-x; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Sabri S, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-60; St-Pierre F, 2013, ACS SYNTH BIOL, V2, P537, DOI 10.1021/sb400021j; Ublinskaya AA, 2012, J MICROBIOL METH, V89, P167, DOI 10.1016/j.mimet.2012.03.013; Vora T, 2009, MOL CELL, V35, P247, DOI 10.1016/j.molcel.2009.06.035; Yim H, 2011, NAT CHEM BIOL, V7, P445, DOI [10.1038/NCHEMBIO.580, 10.1038/nchembio.580]	36	17	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111451	10.1371/journal.pone.0111451	http://dx.doi.org/10.1371/journal.pone.0111451			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350000	gold, Green Submitted, Green Published			2022-12-27	WOS:000343943100075
J	Kockx, M; Karunakaran, D; Traini, M; Xue, J; Huang, KY; Nawara, D; Gaus, K; Jessup, W; Robinson, PJ; Kritharides, L				Kockx, Maaike; Karunakaran, Denuja; Traini, Mathew; Xue, Jing; Huang, Kuan Yen; Nawara, Diana; Gaus, Katharina; Jessup, Wendy; Robinson, Phillip J.; Kritharides, Leonard			Pharmacological Inhibition of Dynamin II Reduces Constitutive Protein Secretion from Primary Human Macrophages	PLOS ONE			English	Article							APOLIPOPROTEIN-E SECRETION; TRANS-GOLGI NETWORK; CELL BIOLOGY; ENDOCYTOSIS; ATHEROSCLEROSIS; VESICLES; ISOFORMS; IDENTIFICATION; MICROTUBULES; FIBRONECTIN	Dynamins are fission proteins that mediate endocytic and exocytic membrane events and are pharmacological therapeutic targets. These studies investigate whether dynamin II regulates constitutive protein secretion and show for the first time that pharmacological inhibition of dynamin decreases secretion of apolipoprotein E (apoE) and several other proteins constitutively secreted from primary human macrophages. Inhibitors that target recruitment of dynamin to membranes (MiTMABs) or directly target the GTPase domain (Dyngo or Dynole series), dose- and time-dependently reduced the secretion of apoE. SiRNA oligo's targeting all isoforms of dynamin II confirmed the involvement of dynamin II in apoE secretion. Inhibition of secretion was not mediated via effects on mRNA or protein synthesis. 2D-gel electrophoresis showed that inhibition occurred after apoE was processed and glycosylated in the Golgi and live cell imaging showed that inhibited secretion was associated with reduced post-Golgi movement of apoE-GFP-containing vesicles. The effect was not restricted to macrophages, and was not mediated by the effects of the inhibitors on microtubules. Inhibition of dynamin also altered the constitutive secretion of other proteins, decreasing the secretion of fibronectin, matrix metalloproteinase 9, Chitinase-3-like protein 1 and lysozyme but unexpectedly increasing the secretion of the inflammatory mediator cyclophilin A. We conclude that pharmacological inhibitors of dynamin II modulate the constitutive secretion of macrophage apoE as a class effect, and that their capacity to modulate protein secretion may affect a range of biological processes.	[Kockx, Maaike; Traini, Mathew; Nawara, Diana; Jessup, Wendy] Univ Sydney, ANZAC Res Inst, Atherosclerosis Lab, Sydney, NSW 2006, Australia; [Karunakaran, Denuja; Huang, Kuan Yen; Gaus, Katharina] Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia; [Karunakaran, Denuja] Univ Ottawa, Inst Heart, Ottawa, ON, Canada; [Xue, Jing; Robinson, Phillip J.] Univ Sydney, Childrens Med Res Inst, Sydney, NSW 2006, Australia; [Kritharides, Leonard] Univ Sydney, Concord Hosp, Dept Cardiol, Sydney, NSW 2006, Australia; [Kritharides, Leonard] Univ Sydney, Concord Hosp, ANZAC Res Inst, Sydney, NSW 2006, Australia	University of Sydney; ANZAC Research Institute; University of New South Wales Sydney; University of Ottawa; University of Ottawa Heart Institute; Children's Medical Research Institute - Australia; University of Sydney; Concord Repatriation General Hospital; University of Sydney; Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute	Kritharides, L (corresponding author), Univ Sydney, Concord Hosp, Dept Cardiol, Sydney, NSW 2006, Australia.	leonard.kritharides@sydney.edu.au	Xue, Jingling/AAE-1991-2020; Kritharides, Leonard/AAQ-2720-2020; Ekanayake, Kanchana/P-8817-2016; Karunakaran, Denuja/G-2275-2010; Research Institute, ANZAC/CAE-9030-2022; Robinson, Phillip J/G-4008-2011	Xue, Jingling/0000-0003-0380-3506; Karunakaran, Denuja/0000-0002-4789-8634; Robinson, Phillip J/0000-0002-7878-0313; Traini, Mathew/0000-0002-9423-5294; Gaus, Katharina/0000-0002-8009-9658	National Health and Medical Research Council [482820, APP1011457]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the National Health and Medical Research Council (482820 for LK and WJ and APP1011457 for PJR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschuler Y, 1998, J CELL BIOL, V143, P1871, DOI 10.1083/jcb.143.7.1871; BALCH WE, 1986, J BIOL CHEM, V261, P4690; Berbee JFP, 2005, J ENDOTOXIN RES, V11, P97, DOI 10.1179/096805105X35215; Bonazzi M, 2005, NAT CELL BIOL, V7, P570, DOI 10.1038/ncb1260; Boot RG, 1999, ARTERIOSCL THROM VAS, V19, P687, DOI 10.1161/01.ATV.19.3.687; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Coffman F, 2008, CRIT REV CL LAB SCI, V45, P531, DOI [10.1080/10408360802334743, 10.1080/10408360802334743 ]; COOK TA, 1994, P NATL ACAD SCI USA, V91, P644, DOI 10.1073/pnas.91.2.644; Coppinger JA, 2004, BLOOD, V103, P2096, DOI 10.1182/blood-2003-08-2804; DECURTIS I, 1989, CELL, V58, P719, DOI 10.1016/0092-8674(89)90106-2; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Gaborik Z, 2001, MOL PHARMACOL, V59, P239, DOI 10.1124/mol.59.2.239; Harper CB, 2011, J BIOL CHEM, V286, P35966, DOI 10.1074/jbc.M111.283879; Hill TA, 2004, BIOORG MED CHEM LETT, V14, P3275, DOI 10.1016/j.bmcl.2004.03.096; Hill TA, 2009, J MED CHEM, V52, P3762, DOI 10.1021/jm900036m; Huang ZH, 2013, J LIPID RES, V54, P202, DOI 10.1194/jlr.M031906; Jin ZG, 2000, CIRC RES, V87, P789, DOI 10.1161/01.RES.87.9.789; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Karunakaran D, 2013, J BIOL CHEM, V288, P5186, DOI 10.1074/jbc.M112.428961; Kasai K, 1999, J BIOCHEM, V125, P780, DOI 10.1093/oxfordjournals.jbchem.a022349; Kockx M, 2004, J BIOL CHEM, V279, P25966, DOI 10.1074/jbc.M401177200; Kockx M, 2008, ARTERIOSCL THROM VAS, V28, P1060, DOI 10.1161/ATVBAHA.108.164350; Kockx M, 2007, CIRC RES, V101, P607, DOI 10.1161/CIRCRESAHA.107.157198; Kockx M, 2012, BIOCHEM J, V447, P51, DOI 10.1042/BJ20111891; Kockx M, 2009, J BIOL CHEM, V284, P24144, DOI 10.1074/jbc.M109.032615; Lee Y, 2010, MOL CELL PROTEOMICS, V9, P1968, DOI 10.1074/mcp.M900430-MCP200; Liu HX, 2006, AM J PATHOL, V169, P303, DOI 10.2353/ajpath.2006.050885; Liu YW, 2008, MOL BIOL CELL, V19, P5347, DOI 10.1091/mbc.E08-08-0890; Ly S, 2013, J BIOL CHEM, V288, P11628, DOI 10.1074/jbc.M112.411900; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; McCluskey A, 2013, TRAFFIC, V14, P1272, DOI 10.1111/tra.12119; Nigro P, 2011, J EXP MED, V208, P53, DOI 10.1084/jem.20101174; Palazzo A, 2003, NATURE, V421, P230, DOI 10.1038/421230a; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Park RJ, 2013, J CELL SCI, V126, P5305, DOI 10.1242/jcs.138578; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Quan A, 2007, MOL PHARMACOL, V72, P1425, DOI 10.1124/mol.107.034207; Raimondi A, 2011, NEURON, V70, P1100, DOI 10.1016/j.neuron.2011.04.031; Rohwedder I, 2012, EMBO MOL MED, V4, P564, DOI 10.1002/emmm.201200237; Sadowski L, 2013, TRAFFIC; SHPETNER HS, 1989, CELL, V59, P421, DOI 10.1016/0092-8674(89)90027-5; TAKEMURA R, 1984, AM J PHYSIOL, V246, pC1, DOI 10.1152/ajpcell.1984.246.1.C1; Tanabe K, 2009, J CELL BIOL, V185, P939, DOI 10.1083/jcb.200803153; Thant AA, 2001, CLIN EXP METASTAS, V18, P423, DOI 10.1023/A:1010921730952; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Wang P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-226; Weller SG, 2010, P NATL ACAD SCI USA, V107, P5863, DOI 10.1073/pnas.0915123107	48	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111186	10.1371/journal.pone.0111186	http://dx.doi.org/10.1371/journal.pone.0111186			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347775	gold, Green Published, Green Submitted			2022-12-27	WOS:000347994900051
J	Sahagun-Ruiz, A; Martinez, APG; Breda, LCD; Fraga, TR; Valencia, MMC; Barbosa, AS; Isaac, L				Sahagun-Ruiz, Alfredo; Granados Martinez, Adriana Patricia; Dantas Breda, Leandro Carvalho; Fraga, Tatiana Rodrigues; Castiblanco Valencia, Monica Marcela; Barbosa, Angela Silva; Isaac, Lourdes			Pasteurella pneumotropica Evades the Human Complement System by Acquisition of the Complement Regulators Factor H and C4BP	PLOS ONE			English	Article							C4B-BINDING PROTEIN CONTRIBUTES; BORRELIA-BURGDORFERI; IMMUNE EVASION; MULTOCIDA; BINDING; PATHOGENESIS; ACTIVATION; STRATEGIES; VIRULENCE	Pasteurella pneumotropica is an opportunist Gram negative bacterium responsible for rodent pasteurellosis that affects upper respiratory, reproductive and digestive tracts of mammals. In animal care facilities the presence of P. pneumotropica causes severe to lethal infection in immunodeficient mice, being also a potential source for human contamination. Indeed, occupational exposure is one of the main causes of human infection by P. pneumotropica. The clinical presentation of the disease includes subcutaneous abscesses, respiratory tract colonization and systemic infections. Given the ability of P. pneumotropica to fully disseminate in the organism, it is quite relevant to study the role of the complement system to control the infection as well as the possible evasion mechanisms involved in bacterial survival. Here, we show for the first time that P. pneumotropica is able to survive the bactericidal activity of the human complement system. We observed that host regulatory complement C4BP and Factor H bind to the surface of P. pneumotropica, controlling the activation pathways regulating the formation and maintenance of C3-convertases. These results show that P. pneumotropica has evolved mechanisms to evade the human complement system that may increase the efficiency by which this pathogen is able to gain access to and colonize inner tissues where it may cause severe infections.	[Sahagun-Ruiz, Alfredo] Univ Nacl Autonoma Mexico, Fac Med Vet & Zootecnia, Dept Microbiol & Inmunol, Mexico City 04510, DF, Mexico; [Granados Martinez, Adriana Patricia; Dantas Breda, Leandro Carvalho; Fraga, Tatiana Rodrigues; Castiblanco Valencia, Monica Marcela; Isaac, Lourdes] Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, BR-05508 Sao Paulo, Brazil; [Barbosa, Angela Silva] Inst Butantan, Bacteriol Lab, Sao Paulo, Brazil	Universidad Nacional Autonoma de Mexico; Universidade de Sao Paulo; Instituto Butantan	Isaac, L (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, BR-05508 Sao Paulo, Brazil.	louisaac@icb.usp.br	Barbosa, Angela S/I-3518-2013; Sahagún-Ruiz, Alfredo/AAE-2549-2020; Breda, Leandro C D/C-1552-2018; Breda, Leandro/A-8458-2015; FRAGA, TATIANA RODRIGUES/ABD-8152-2020; Isaac, Lourdes/I-7186-2012	Barbosa, Angela S/0000-0002-6458-9489; Breda, Leandro C D/0000-0001-9556-1676; Breda, Leandro/0000-0001-9556-1676; Sahagun-Ruiz, Alfredo/0000-0002-9737-1945; Rodrigues Fraga, Tatiana/0000-0002-5896-5994; Isaac, Lourdes/0000-0002-7746-8942	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/50043-0]; Programa de Apoyos para la Superacion del Personal Academico (PASPA-DGAPA) from Universidad Nacional Autonoma de Mexico (UNAM)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Programa de Apoyos para la Superacion del Personal Academico (PASPA-DGAPA) from Universidad Nacional Autonoma de Mexico (UNAM)	Funding provided by Grant #2010/50043-0, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). A.S.R. was supported by a fellowship from the Programa de Apoyos para la Superacion del Personal Academico (PASPA-DGAPA) from Universidad Nacional Autonoma de Mexico (UNAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alitalo A, 2001, INFECT IMMUN, V69, P3685, DOI 10.1128/IAI.69.6.3685-3691.2001; Barbosa AS, 2010, INFECT IMMUN, V78, P3207, DOI 10.1128/IAI.00279-10; Barbosa AS, 2009, INFECT IMMUN, V77, P1137, DOI 10.1128/IAI.01310-08; BARNUM SR, 1991, IMMUNOL RES, V10, P28, DOI 10.1007/BF02918165; BLAU KA, 1987, CAN J VET RES, V51, P157; Blom AM, 2009, MOL IMMUNOL, V46, P2808, DOI 10.1016/j.molimm.2009.04.025; Botto M., 2000, COMPLEMENT FACTS BOO, P88; Boyce JD, 2000, INFECT IMMUN, V68, P3463, DOI 10.1128/IAI.68.6.3463-3468.2000; Campos A, 2000, PEDIATR NEPHROL, V15, P31, DOI 10.1007/s004670000432; Castiblanco-Valencia MM, 2012, J INFECT DIS, V205, P995, DOI 10.1093/infdis/jir875; CUADRADOGOMEZ JM, 1995, CLIN INFECT DIS, V21, P445, DOI 10.1093/clinids/21.2.445; Dan Maria, 2005, Rev Med Chir Soc Med Nat Iasi, V109, P743; de Paula PF, 2003, SCAND J IMMUNOL, V58, P572, DOI 10.1046/j.1365-3083.2003.01326.x; Ferreira VP, 2010, MOL IMMUNOL, V47, P2187, DOI 10.1016/j.molimm.2010.05.007; Frebourg NB, 2002, J CLIN MICROBIOL, V40, P687, DOI 10.1128/JCM.40.2.687-689.2002; GADBERRY JL, 1984, J CLIN MICROBIOL, V19, P926, DOI 10.1128/JCM.19.6.926-927.1984; GIGLI I, 1985, J IMMUNOL, V135, P440; Granoff DM, 2009, INFECT IMMUN, V77, P764, DOI 10.1128/IAI.01191-08; Guillard T, 2010, DIAGN MICR INFEC DIS, V68, P190, DOI 10.1016/j.diagmicrobio.2010.06.004; Hallstrom T, 2008, J IMMUNOL, V181, P537, DOI 10.4049/jimmunol.181.1.537; Hallstrom T, 2007, J IMMUNOL, V178, P6359, DOI 10.4049/jimmunol.178.10.6359; Harper M, 2006, FEMS MICROBIOL LETT, V265, P1, DOI 10.1111/j.1574-6968.2006.00442.x; Hellwage J, 2001, J BIOL CHEM, V276, P8427, DOI 10.1074/jbc.M007994200; JAWETZ E, 1950, J INFECT DIS, V86, P172, DOI 10.1093/infdis/86.2.172; Kraiczy P, 2001, EUR J IMMUNOL, V31, P1674, DOI 10.1002/1521-4141(200106)31:6&lt;1674::AID-IMMU1674&gt;3.0.CO;2-2; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Meri T, 2006, INFECT IMMUN, V74, P4157, DOI 10.1128/IAI.00007-06; Meri T, 2005, MICROB PATHOGENESIS, V39, P139, DOI 10.1016/j.micpath.2005.07.003; MINTON EJ, 1990, POSTGRAD MED J, V66, P125, DOI 10.1136/pgmj.66.772.125; MISASI R, 1989, EUR J IMMUNOL, V19, P1765, DOI 10.1002/eji.1830190936; Pasteur Louis, 1880, COMPTES RENDUS ACAD, V91, P673; Potempa M, 2008, J IMMUNOL, V181, P5537, DOI 10.4049/jimmunol.181.8.5537; Reid KBM, 1988, FRONTIERS MOL BIOL, P189; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Schneider MC, 2006, J IMMUNOL, V176, P7566, DOI 10.4049/jimmunol.176.12.7566; Tatum FM, 2009, MICROB PATHOGENESIS, V46, P337, DOI 10.1016/j.micpath.2009.04.003; Tirmizi A, 2012, INT J CARDIOL, V161, pE44, DOI 10.1016/j.ijcard.2012.04.007; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; WARD GE, 1978, J CLIN MICROBIOL, V8, P177; WEBER DJ, 1984, MEDICINE, V63, P133, DOI 10.1097/00005792-198405000-00001; WEILER JM, 1976, P NATL ACAD SCI USA, V73, P3268, DOI 10.1073/pnas.73.9.3268; Zipfel PF, 2007, MOL IMMUNOL, V44, P3850, DOI 10.1016/j.molimm.2007.06.149; Zipfel PF, 2013, MOL IMMUNOL, V56, P152, DOI 10.1016/j.molimm.2013.05.222; Zipfel PF, 2008, VACCINE, V26, pI67, DOI 10.1016/j.vaccine.2008.11.015	44	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111194	10.1371/journal.pone.0111194	http://dx.doi.org/10.1371/journal.pone.0111194			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347183	Green Published, Green Submitted, gold			2022-12-27	WOS:000347994900054
J	Connolly, F; Rae, MT; Butler, M; Klibanov, AL; Sboros, V; McNeilly, AS; Duncan, WC				Connolly, Fiona; Rae, Michael T.; Butler, Mairead; Klibanov, Alexander L.; Sboros, Vassilis; McNeilly, Alan S.; Duncan, W. Colin			The Local Effects of Ovarian Diathermy in an Ovine Model of Polycystic Ovary Syndrome	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; STROMAL BLOOD-FLOW; PRENATAL TESTOSTERONE EXCESS; INSULIN-SENSITIZING DRUGS; CORPUS-LUTEUM; CLOMIPHENE CITRATE; SYNDROME PCOS; ANDROGEN PRODUCTION; FOLLICULAR-GROWTH; INFERTILE WOMEN	In order to develop a medical alternative to surgical ovarian diathermy (OD) in polycystic ovary syndrome (PCOS) more mechanistic information is required about OD. We therefore studied the cellular, molecular and vascular effects of diathermy on the ovary using an established ovine model of PCOS. Pregnant sheep were treated twice weekly with testosterone propionate (100 mg) from day 30-100 gestation. Their female offspring (n = 12) were studied during their second breeding season when the PCOS-like phenotype, with anovulation, is fully manifest. In one group (n = 4) one ovary underwent diathermy and it was collected and compared to the contralateral ovary after 24 hours. In another group a treatment PCOS cohort underwent diathermy (n = 4) and the ovaries were collected and compared to the control PCOS cohort (n = 4) after 5 weeks. Ovarian vascular indices were measured using contrast-enhanced ultrasound and colour Doppler before, immediately after, 24 hours and five weeks after diathermy. Antral follicles were assessed by immunohistochemistry and ovarian stromal gene expression by quantitative RT-PCR 24 hours and 5 weeks after diathermy. Diathermy increased follicular atresia (P<0.05) and reduced antral follicle numbers after 5 weeks (P<0.05). There was an increase in stromal CCL2 expression 24 hours after diathermy (P<0.01) but no alteration in inflammatory indices at 5 weeks. Immediately after diathermy there was increased microbubble transit time in the ovarian microvasculature (P = 0.05) but this was not seen at 24 hours. However 24 hours after diathermy there was a reduction in the stromal Doppler blood flow signal (P<0.05) and an increased ovarian resistance index (P<0.05) both of which persisted at 5 weeks (P<0.01; P<0.05). In the ovine model of PCOS, OD causes a sustained reduction in ovarian stromal blood flow with an increased ovarian artery resistance index associated with atresia of antral follicles.	[Connolly, Fiona; McNeilly, Alan S.; Duncan, W. Colin] Univ Edinburgh, Ctr Reprod Hlth, MRC, Edinburgh, Midlothian, Scotland; [Rae, Michael T.] Edinburgh Napier Univ, Sch Hlth Life & Social Sci, Edinburgh, Midlothian, Scotland; [Butler, Mairead; Sboros, Vassilis] Heriot Watt Univ, Inst Biophys Biochem & Bioengn, Edinburgh, Midlothian, Scotland; [Klibanov, Alexander L.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA USA	University of Edinburgh; Edinburgh Napier University; Heriot Watt University; University of Virginia	Duncan, WC (corresponding author), Univ Edinburgh, Ctr Reprod Hlth, MRC, Edinburgh, Midlothian, Scotland.	W.C.Duncan@ed.ac.uk		Sboros, Vassilis/0000-0002-9133-7252	Medical Research Council [G0901807]; Scottish Funding Council; MRC [G0800896, G0500717, G1002033, G0901807] Funding Source: UKRI; Medical Research Council [G1002033, G0500717] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Scottish Funding Council; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was funded by the Medical Research Council (G0901807) and WCD was supported by a Senior Clinical Fellowship from the Scottish Funding Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovich D, 2012, ENDOCRINOLOGY, V153, P3446, DOI 10.1210/en.2012-1105; Agrawal R, 1998, HUM REPROD, V13, P651, DOI 10.1093/humrep/13.3.651; Aleem FA, 1996, FERTIL STERIL, V65, P510, DOI 10.1016/S0015-0282(16)58145-X; Amer S, 2011, ACTA OBSTET GYN SCAN, V90, P338, DOI 10.1111/j.1600-0412.2010.01061.x; Amer SAKS, 2003, FERTIL STERIL, V79, P1211, DOI 10.1016/S0015-0282(02)04960-9; Amer SAKS, 2002, HUM REPROD, V17, P2851, DOI 10.1093/humrep/17.11.2851; Amin AF, 2003, FERTIL STERIL, V79, P938, DOI 10.1016/S0015-0282(02)04849-5; Anderson RA, 1998, CLIN ENDOCRINOL, V48, P577, DOI 10.1046/j.1365-2265.1998.00442.x; Averkiou M, 2010, ULTRASOUND MED BIOL, V36, P68, DOI 10.1016/j.ultrasmedbio.2009.07.005; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046; Baer M, 1998, MOL CELL BIOL, V18, P5678, DOI 10.1128/MCB.18.10.5678; BATTAGLIA C, 1995, AM J OBSTET GYNECOL, V172, P108, DOI 10.1016/0002-9378(95)90094-2; Birch RA, 2003, ENDOCRINOLOGY, V144, P1426, DOI 10.1210/en.2002-220965; BRANNSTROM M, 1993, ENDOCRINOLOGY, V132, P399, DOI 10.1210/en.132.1.399; Connolly F, 2013, ENDOCRINOLOGY, V154, P1921, DOI 10.1210/en.2012-2153; Dale PO, 2004, GYNECOL ENDOCRINOL, V19, P182, DOI 10.1080/09513590400012093; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Dunaif A, 2008, NAT CLIN PRACT ENDOC, V4, P272, DOI 10.1038/ncpendmet0787; Duncan W. C., 2009, Animal Reproduction, V6, P34; Duncan WC, 2013, REPROD FERT DEVELOP, V25, P362, DOI 10.1071/RD12112; Duncan WC, 1998, HUM REPROD, V13, P2435, DOI 10.1093/humrep/13.9.2435; Duncan WC, 1994, CONT REV OBSTET GYNE, V6, P154; El Behery MM, 2011, INT J GYNECOL OBSTET, V112, P119, DOI 10.1016/j.ijgo.2010.08.018; FRANKS S, 1995, NEW ENGL J MED, V333, P853, DOI 10.1056/NEJM199509283331307; Fraser Hamish M., 2005, Angiogenesis, V8, P101, DOI 10.1007/s10456-005-9004-y; Fraser HM, 2009, REPROD FERT DEVELOP, V21, P277; GILLINGSMITH C, 1994, J CLIN ENDOCR METAB, V79, P1158, DOI 10.1210/jc.79.4.1158; GJONNAESS H, 1994, ACTA OBSTET GYN SCAN, V73, P407, DOI 10.3109/00016349409006253; GONEN Y, 1990, HUM REPROD, V5, P670, DOI 10.1093/oxfordjournals.humrep.a137165; Goodarzi MO, 2011, NAT REV ENDOCRINOL, V7, P219, DOI 10.1038/nrendo.2010.217; Hogg K, 2012, ENDOCRINOLOGY, V153, P450, DOI 10.1210/en.2011-1607; Hogg K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024877; Homburg R, 2005, HUM REPROD, V20, P2043, DOI 10.1093/humrep/dei042; Homburg R, 2012, HUM REPROD, V27, P468, DOI 10.1093/humrep/der401; Homburg R, 1998, J ENDOCRINOL INVEST, V21, P552, DOI 10.1007/BF03350780; KECKSTEIN J, 1989, BAILLIERE CLIN OB GY, V3, P563, DOI 10.1016/S0950-3552(89)80009-4; Klibanov AL, 2004, INVEST RADIOL, V39, P187, DOI 10.1097/01.rli.0000115926.96796.75; Li HWR, 2010, HUM FERTIL, V13, P35, DOI 10.3109/14647270903490765; Liguori G, 1996, GYNECOL ENDOCRINOL, V10, P257, DOI 10.3109/09513599609012317; Lopez E, 2004, REPROD BIOMED ONLINE, V9, P382, DOI 10.1016/S1472-6483(10)61273-4; Manikkam M, 2006, ENDOCRINOLOGY, V147, P1997, DOI 10.1210/en.2005-1338; Nelson VL, 1999, MOL ENDOCRINOL, V13, P946, DOI 10.1210/me.13.6.946; Nieuwenhuis-Ruifrok AE, 2009, HUM REPROD UPDATE, V15, P57, DOI 10.1093/humupd/dmn043; Ozkan S, 2007, J CLIN ULTRASOUND, V35, P305, DOI 10.1002/jcu.20358; Padmanabhan V, 2006, MOL CELL ENDOCRINOL, V246, P165, DOI 10.1016/j.mce.2005.11.016; Padmanabhan V, 2010, ENDOCRINOLOGY, V151, P595, DOI 10.1210/en.2009-1015; Padmanabhan V, 2013, MOL CELL ENDOCRINOL, V373, P8, DOI 10.1016/j.mce.2012.10.005; Palomba S, 2010, HUM REPROD, V25, P1005, DOI 10.1093/humrep/dep466; Pate JL, 2010, AM J REPROD IMMUNOL, V64, P275, DOI 10.1111/j.1600-0897.2010.00906.x; Peluffo MC, 2009, MOL REPROD DEV, V76, P367, DOI 10.1002/mrd.20970; Rae M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056263; Recabarren SE, 2005, AM J PHYSIOL-ENDOC M, V289, pE801, DOI 10.1152/ajpendo.00107.2005; Richards JS, 2002, ANNU REV PHYSIOL, V64, P69, DOI 10.1146/annurev.physiol.64.081501.131029; Sboros V, 2011, ULTRASOUND MED BIOL, V37, P59, DOI 10.1016/j.ultrasmedbio.2010.10.013; Schmidt J, 2014, MOL HUM REPROD, V20, P49, DOI 10.1093/molehr/gat051; Strouthos C, 2010, IEEE T ULTRASON FERR, V57, P1296, DOI 10.1109/TUFFC.2010.1550; Sunj M, 2013, HUM REPROD, V28, P2417, DOI 10.1093/humrep/det273; Takayama K, 1996, HUM REPROD, V11, P1387; Tan Seang Lin, 2002, Reprod Biomed Online, V4 Suppl 1, P18; TOZAWA H, 1995, HUM REPROD, V10, P544, DOI 10.1093/oxfordjournals.humrep.a135986; Tulandi T, 2000, FERTIL STERIL, V74, P585, DOI 10.1016/S0015-0282(00)00684-1; Tulandi T, 1997, INT J FERTIL WOMEN M, V42, P436; Veiga-Lopez A, 2008, BIOL REPROD, V78, P636, DOI 10.1095/biolreprod.107.065904; Veiga-Lopez A, 2010, ENDOCRINOLOGY, V151, P4007, DOI 10.1210/en.2010-0124; Vendola KA, 1998, J CLIN INVEST, V101, P2622, DOI 10.1172/JCI2081; Wulff C, 2002, ENDOCRINOLOGY, V143, P2797, DOI 10.1210/en.143.7.2797; Yoshioka S, 2012, MOL REPROD DEV, V79, P689, DOI 10.1002/mrd.22075; ZAIDI J, 1995, HUM REPROD, V10, P1992, DOI 10.1093/oxfordjournals.humrep.a136222	68	10	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111280	10.1371/journal.pone.0111280	http://dx.doi.org/10.1371/journal.pone.0111280			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343339	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943500093
J	Katsura, M; Hirose, S; Sasaki, H; Mori, H; Kunimatsu, A; Ohtomo, K; Jimura, K; Konishi, S				Katsura, Masaki; Hirose, Satoshi; Sasaki, Hiroki; Mori, Harushi; Kunimatsu, Akira; Ohtomo, Kuni; Jimura, Koji; Konishi, Seiki			Decreased Fronto-Temporal Interaction during Fixation after Memory Retrieval	PLOS ONE			English	Article							VENTROLATERAL PREFRONTAL CORTEX; TEMPORAL CONTEXT MEMORY; AGE-RELATED DIFFERENCES; BRAINS DEFAULT NETWORK; FALSE DISCOVERY RATE; EVENT-RELATED FMRI; LONG-TERM-MEMORY; FUNCTIONAL CONNECTIVITY; UNWANTED MEMORIES; DECLARATIVE MEMORY	Previous studies have revealed top-down control during memory retrieval from the prefrontal cortex to the temporal cortex. In the present functional MRI study, we investigated whether the fronto-temporal functional interaction occurs even during fixation periods after memory retrieval trials. During recency judgments, subjects judged the temporal order of two items in a study list. The task used in the present study consisted of memory trials of recency judgments and non-memory trials of counting dots, and post-trial fixation periods. By comparing the brain activity during the fixation periods after the memory trials with that during the fixation periods after the non-memory trials, we detected heightened brain activity in the lateral prefrontal cortex, the lateral temporal cortex and the hippocampus. Functional interactions during the fixation periods after the memory vs. non-memory trials as examined using a psychophysiological interaction revealed a decreased interaction from the lateral prefrontal cortex to the lateral temporal cortex, but not to the hippocampus. The functional interaction between the same frontal and temporal regions was also present during the memory trials. A trial-based functional connectivity analysis further revealed that the fronto-temporal interaction was positive and decreased during the fixation periods after the memory trials, relative to the fixation periods after the non-memory trials. These results suggest that the fronto-temporal interaction existed during the post-trial fixation periods, which had been present during the memory trials and temporally extended into the fixation periods.	[Katsura, Masaki; Sasaki, Hiroki; Mori, Harushi; Kunimatsu, Akira; Ohtomo, Kuni] Univ Tokyo, Sch Med, Dept Radiol, Tokyo 113, Japan; [Hirose, Satoshi; Jimura, Koji; Konishi, Seiki] Univ Tokyo, Sch Med, Dept Physiol, Tokyo 113, Japan; [Hirose, Satoshi; Jimura, Koji; Konishi, Seiki] Juntendo Univ, Sch Med, Dept Physiol, Tokyo 113, Japan; [Jimura, Koji] Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 227, Japan	University of Tokyo; University of Tokyo; Juntendo University; Tokyo Institute of Technology	Konishi, S (corresponding author), Univ Tokyo, Sch Med, Dept Physiol, Tokyo 113, Japan.	skonishi@juntendo.ac.jp	Kunimatsu, Akira/AAC-8617-2019; MORI, Harushi/AAA-2669-2022	Kunimatsu, Akira/0000-0002-7141-2585; MORI, Harushi/0000-0003-1370-5272	Uehara Memorial Foundation;  [22300134]	Uehara Memorial Foundation(Uehara Memorial Foundation); 	Funding was provided by the Uehara Memorial Foundation and a Grant-in-Aid for Scientific Research B (22300134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MC, 2004, SCIENCE, V303, P232, DOI 10.1126/science.1089504; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Badre D, 2005, NEURON, V47, P907, DOI 10.1016/j.neuron.2005.07.023; Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; Badre David, 2002, Behav Cogn Neurosci Rev, V1, P206, DOI 10.1177/1534582302001003002; Benoit RG, 2012, NEURON, V76, P450, DOI 10.1016/j.neuron.2012.07.025; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2013, NAT NEUROSCI, V16, P832, DOI 10.1038/nn.3423; Buckner RL, 2003, J NEUROSCI, V23, P3999; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P197, DOI 10.1162/089892900561832; Cabeza R, 1997, NEURON, V19, P863, DOI 10.1016/S0896-6273(00)80967-8; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; Chumbley JR, 2009, NEUROIMAGE, V44, P62, DOI 10.1016/j.neuroimage.2008.05.021; Damasio H, 1996, NATURE, V380, P499, DOI 10.1038/380499a0; Davachi L, 2002, J NEUROPHYSIOL, V88, P982, DOI 10.1152/jn.2002.88.2.982; Davachi L, 2008, CURR DIR PSYCHOL SCI, V17, P112, DOI 10.1111/j.1467-8721.2008.00559.x; Depue BE, 2007, SCIENCE, V317, P215, DOI 10.1126/science.1139560; Dobbins IG, 2002, NEURON, V35, P989, DOI 10.1016/S0896-6273(02)00858-9; Dobbins IG, 2003, NEUROPSYCHOLOGIA, V41, P318, DOI 10.1016/S0028-3932(02)00164-1; Duarte A, 2005, J NEUROSCI, V25, P8333, DOI 10.1523/JNEUROSCI.1392-05.2005; Dudukovic NM, 2007, NEUROPSYCHOLOGIA, V45, P2608, DOI 10.1016/j.neuropsychologia.2007.02.025; Duzel E, 1999, P NATL ACAD SCI USA, V96, P1794, DOI 10.1073/pnas.96.4.1794; Fair DA, 2007, NEUROIMAGE, V35, P396, DOI 10.1016/j.neuroimage.2006.11.051; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Fujii T, 2004, NEUROIMAGE, V21, P1596, DOI 10.1016/j.neuroimage.2004.01.005; Gagnepain P, 2014, P NATL ACAD SCI USA, V111, pE1310, DOI 10.1073/pnas.1311468111; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greve A, 2010, J NEUROSCI, V30, P7099, DOI 10.1523/JNEUROSCI.0345-10.2010; Grove KL, 2009, J COGNITIVE NEUROSCI, V21, P461, DOI 10.1162/jocn.2009.21040; Hayama H, 2009, FUNCTIONAL SIGNIFICA; Hayama HR, 2008, NEUROPSYCHOLOGIA, V46, P1211, DOI 10.1016/j.neuropsychologia.2007.11.021; Hayama HR, 2009, NEUROPSYCHOLOGIA, V47, P2409, DOI 10.1016/j.neuropsychologia.2009.04.010; Higuchi S, 1996, P NATL ACAD SCI USA, V93, P739, DOI 10.1073/pnas.93.2.739; Hintzman DL, 2003, MEM COGNITION, V31, P26, DOI 10.3758/BF03196079; Hintzman DL, 2001, J EXP PSYCHOL LEARN, V27, P1347, DOI 10.1037//0278-7393.27.6.1347; Hirose S, 2013, CEREB CORTEX, V23, P2863, DOI 10.1093/cercor/bhs268; Hirose S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071210; Honey CJ, 2010, NEUROIMAGE, V52, P766, DOI 10.1016/j.neuroimage.2010.01.071; Jimura K, 2009, EUR J NEUROSCI, V29, P1915, DOI 10.1111/j.1460-9568.2009.06731.x; Kan IP, 2004, COGN AFFECT BEHAV NE, V4, P43, DOI 10.3758/CABN.4.1.43; Kimura HM, 2010, NEUROIMAGE, V49, P3474, DOI 10.1016/j.neuroimage.2009.11.003; Konishi S, 2006, CEREB CORTEX, V16, P469, DOI 10.1093/cercor/bhi126; Konishi S, 2002, J NEUROSCI, V22, P9549; Lehn H, 2009, J NEUROSCI, V29, P3475, DOI 10.1523/JNEUROSCI.5370-08.2009; Levy BJ, 2008, ACTA PSYCHOL, V127, P623, DOI 10.1016/j.actpsy.2007.12.004; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; Messinger A, 2001, P NATL ACAD SCI USA, V98, P12239, DOI 10.1073/pnas.211431098; MILNER B, 1971, BRIT MED BULL, V27, P272, DOI 10.1093/oxfordjournals.bmb.a070866; Naya Y, 2003, J NEUROSCI, V23, P2861; PETRIDES M, 1991, P ROY SOC B-BIOL SCI, V246, P299, DOI 10.1098/rspb.1991.0158; Rajah MN, 2008, BRAIN RES, V1199, P111, DOI 10.1016/j.brainres.2007.12.051; Rajah MN, 2011, J NEUROSCI, V31, P17941, DOI 10.1523/JNEUROSCI.1690-11.2011; Rajah MN, 2011, NEUROIMAGE, V54, P1549, DOI 10.1016/j.neuroimage.2010.09.001; Rajah MN, 2006, NEUROPSYCHOLOGIA, V44, P350, DOI 10.1016/j.neuropsychologia.2005.06.003; Ranganath C, 2007, NEUROIMAGE, V35, P1663, DOI 10.1016/j.neuroimage.2007.01.020; Rissman J, 2004, NEUROIMAGE, V23, P752, DOI 10.1016/j.neuroimage.2004.06.035; Rugg MD, 2003, NEUROPSYCHOLOGIA, V41, P40, DOI 10.1016/S0028-3932(02)00129-X; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Schott BH, 2011, P NATL ACAD SCI USA, V108, P5408, DOI 10.1073/pnas.1013287108; Snodgrass JS, 1980, J EXP PSYCHOL HUM LE, V9, P164; Spreng RN, 2013, J COGNITIVE NEUROSCI, V25, P74, DOI 10.1162/jocn_a_00281; Spreng RN, 2012, CEREB CORTEX, V22, P2610, DOI 10.1093/cercor/bhr339; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; St Jacques P, 2008, J COGNITIVE NEUROSCI, V20, P1327, DOI 10.1162/jocn.2008.20091; Suzuki M, 2002, NEUROIMAGE, V17, P1790, DOI 10.1006/nimg.2002.1303; Takashima A, 2006, P NATL ACAD SCI USA, V103, P756, DOI 10.1073/pnas.0507774103; Thompson-Schill SL, 1999, NEURON, V23, P513, DOI 10.1016/S0896-6273(00)80804-1; Thompson-Schill SL, 1998, P NATL ACAD SCI USA, V95, P15855, DOI 10.1073/pnas.95.26.15855; Tsukiura T, 2006, NEUROIMAGE, V30, P617, DOI 10.1016/j.neuroimage.2005.09.043; Tsukiura T, 2002, J COGNITIVE NEUROSCI, V14, P922, DOI 10.1162/089892902760191144; Tubridy S, 2011, CEREB CORTEX, V21, P272, DOI 10.1093/cercor/bhq092; Watanabe T, 2012, J NEUROSCI, V32, P9659, DOI 10.1523/JNEUROSCI.5553-11.2012; Werkle-Bergner M, 2005, COGNITIVE BRAIN RES, V24, P599, DOI 10.1016/j.cogbrainres.2005.03.011; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Yamashita K, 2009, J NEUROSCI, V29, P10335, DOI 10.1523/JNEUROSCI.1328-09.2009; Zorrilla LTE, 1996, NEUROREPORT, V7, P2803	82	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110798	10.1371/journal.pone.0110798	http://dx.doi.org/10.1371/journal.pone.0110798			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340398	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662800056
J	Mittal, N; Malpani, S; Dyson, M; Ono, M; Coon, JS; Kim, JJ; Schink, JC; Bulun, SE; Pavone, ME				Mittal, Navdha; Malpani, Saurabh; Dyson, Matthew; Ono, Masanori; Coon, John S.; Kim, Julie J.; Schink, Julian C.; Bulun, Serdar E.; Pavone, Mary Ellen			Fenretinide: A Novel Treatment for Endometrial Cancer	PLOS ONE			English	Article							TRANS-RETINOIC ACID; CARCINOMA-CELL-LINES; BREAST-CANCER; HUMAN HEAD; PHASE-II; APOPTOSIS; TRIAL; N-(4-HYDROXYPHENYL)RETINAMIDE; EXPRESSION; SURVIVAL	Resistance to progestin treatment is a major hurdle in the treatment of advanced and reoccurring endometrial cancer. Fenretinide is a synthetic retinoid that has been evaluated in clinical trials as a cancer therapeutic and chemo-preventive agent. Fenretinide has been established to be cytotoxic to many kinds of cancer cells. In the present study, we demonstrate that fenretinide decreased cell viability and induced apoptosis in Ishikawa cells, which are an endometrial cancer cell line, in dose dependent manner in-vitro. This effect was found to be independent of retinoic acid nuclear receptor signaling pathway. Further, we have shown that this induction of apoptosis by fenretinide may be caused by increased retinol uptake via STRA6. Silencing of STRA6 was shown to decrease apoptosis which was inhibited by knockdown of STRA6 expression in Ishikawa cells. Results of an in-vivo study demonstrated that intraperitoneal injections of fenretinide in endometrial cancer tumors (created using Ishikawa cells) in mice inhibited tumor growth effectively. Immunohistochemistry of mice tumors showed a decrease in Ki67 expression and an increase in cleaved caspase-3 staining after fenretinide treatment when compared to vehicle treated mice. Collectively, our results are the first to establish the efficacy of fenretinide as an antitumor agent for endometrial cancer both in-vitro and in-vivo, providing a valuable rationale for initiating more preclinical studies and clinical trials using fenretinide for the treatment of endometrial cancer.	[Mittal, Navdha; Malpani, Saurabh; Dyson, Matthew; Ono, Masanori; Coon, John S.; Kim, Julie J.; Bulun, Serdar E.; Pavone, Mary Ellen] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Div Reprod Biol, Chicago, IL 60611 USA; [Bulun, Serdar E.; Pavone, Mary Ellen] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Chicago, IL 60611 USA; [Schink, Julian C.] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Div Gynecol Oncol, Chicago, IL 60611 USA; [Schink, Julian C.] Spectrum Hlth Med Grp, Dept Obstet & Gynecol, Grand Rapids, MI USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Spectrum Health Medical Group	Pavone, ME (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Div Reprod Biol, Chicago, IL 60611 USA.	mpavone@nmff.org	; Ono, Masanori/F-7443-2019	Kim, J Julie/0000-0001-9834-8213; Dyson, Matthew/0000-0003-3596-5753; Ono, Masanori/0000-0001-9249-6813	Reproductive Biology Division, NU; ASRM Career Development Award; Center Support Grant [NCI CA060553]; NCI CCSG [P30 CA060553];  [K12HD050121]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD050121] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA060553, R01CA155513] Funding Source: NIH RePORTER	Reproductive Biology Division, NU; ASRM Career Development Award; Center Support Grant; NCI CCSG; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. These studies were supported by generous funds from John and Diane O'Donnell (to division of Gynecology Oncology, NU) and Reproductive Biology Division, NU. Studies were also supported by K12HD050121 and the ASRM Career Development Award which were awarded to Mary Ellen Pavone. Center Support Grant (NCI CA060553) was used for embedding, sectioning and staining of tumor tissues. NU Cell Imaging Facility was generously supported by NCI CCSG P30 CA060553 which was awarded to the Robert H Lurie Comprehensive Cancer Center.	Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Bonanni B, 2009, RECENT RES CANCER, V181, P77; Carrera S, 2013, CELL DEATH DIFFER, V20, P910, DOI 10.1038/cdd.2013.14; Cazzaniga M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/172897; Cheng YH, 2008, J CLIN ENDOCR METAB, V93, P1915, DOI 10.1210/jc.2007-1536; Cheng YH, 2011, J MOL ENDOCRINOL, V46, P139, DOI 10.1530/JME-10-0064; Chiesa F, 2005, INT J CANCER, V115, P625, DOI 10.1002/ijc.20923; Children's Oncology G, 2006, J CLIN ONCOL, V24, P3423; Choi Y, 2003, INT J CANCER, V107, P145, DOI 10.1002/ijc.11354; Cooper JP, 2011, BRIT J PHARMACOL, V163, P1263, DOI 10.1111/j.1476-5381.2011.01310.x; DELIA D, 1993, CANCER RES, V53, P6036; Deng L, 2003, J CLIN ENDOCR METAB, V88, P2157, DOI 10.1210/jc.2002-021844; Di CH, 2005, CANCER RES, V65, P919; Formelli F, 2000, EUR J CANCER, V36, P2411, DOI 10.1016/S0959-8049(00)00335-X; Garaventa A, 2003, CLIN CANCER RES, V9, P2032; Holmes WF, 2004, J CELL PHYSIOL, V199, P317, DOI 10.1002/jcp.10338; Howlader N, 2012, AM J EPIDEMIOL, V176, P347, DOI 10.1093/aje/kwr512; Hu Y, 2013, BIOCHEM PHARMACOL, V85, P1007, DOI 10.1016/j.bcp.2013.01.023; Invitrogen, 2012, PRESTOBLUE CELL VIAB; KALEMKERIAN GP, 1995, J NATL CANCER I, V87, P1674, DOI 10.1093/jnci/87.22.1674; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kim JJ, 2013, ENDOCR REV, V34, P130, DOI 10.1210/er.2012-1043; Kim JJ, 2010, SEMIN REPROD MED, V28, P81, DOI 10.1055/s-0029-1242998; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma JJ, 2013, HORM CANCER-US, V4, P358, DOI 10.1007/s12672-013-0157-7; MARIOTTI A, 1994, J NATL CANCER I, V86, P1245, DOI 10.1093/jnci/86.16.1245; Myatt SS, 2010, CANCER RES, V70, P367, DOI 10.1158/0008-5472.CAN-09-1891; Nishida Masato, 2002, Hum Cell, V15, P104, DOI 10.1111/j.1749-0774.2002.tb00105.x; O'Donnell PH, 2002, LEUKEMIA, V16, P902, DOI 10.1038/sj.leu.2402485; Oridate N, 1996, CLIN CANCER RES, V2, P855; Pant A, 2012, INHIBITION AKT ORALL; Pant A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041593; Pavone ME, 2010, J CLIN ENDOCR METAB, V95, pE300, DOI 10.1210/jc.2010-0459; Puduvalli VK, 2004, J CLIN ONCOL, V22, P4282, DOI 10.1200/JCO.2004.09.096; Ray M, 2009, SEMIN ONCOL, V36, P145, DOI 10.1053/j.seminoncol.2008.12.006; Reynolds CP FT, 2007, HIGH PLASMA LEVELS F; Sabichi AL, 2008, CLIN CANCER RES, V14, P224, DOI 10.1158/1078-0432.CCR-07-0733; Society AC, 2013, CANC FACTS FIG 2013; Ulukaya E, 2003, CELL DEATH DIFFER, V10, P856, DOI 10.1038/sj.cdd.4401242; Vaishampayan U, 2005, INVEST NEW DRUG, V23, P179, DOI 10.1007/s10637-005-5864-7; Veronesi U, 2006, ANN ONCOL, V17, P1065, DOI 10.1093/annonc/mdl047; Zhao SJ, 2013, ONCOL LETT, V5, P139, DOI 10.3892/ol.2012.975	42	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110410	10.1371/journal.pone.0110410	http://dx.doi.org/10.1371/journal.pone.0110410			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340777	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662800034
J	Moore, LS; Wei, W; Stolovicki, E; Benbenishty, T; Wilkening, S; Steinmetz, LM; Braun, E; David, L				Moore, Lindsay S.; Wei, Wu; Stolovicki, Elad; Benbenishty, Tamar; Wilkening, Stefan; Steinmetz, Lars M.; Braun, Erez; David, Lior			Induced Mutations in Yeast Cell Populations Adapting to an Unforeseen Challenge	PLOS ONE			English	Article							GENE-REGULATION; EVOLUTION; HYPERMUTATION; ADAPTATION; RATES	The modern evolutionary synthesis assumes that mutations occur at random, independently of the environment in which they confer an advantage. However, there are indications that cells facing challenging conditions can adapt rapidly, utilizing processes beyond selection of pre-existing genetic variation. Here, we show that a strong regulatory challenge can induce mutations in many independent yeast cells, in the absence of general mutagenesis. Whole genome sequencing of cell lineages reveals a repertoire of independent mutations within a single lineage that arose only after the cells were exposed to the challenging environment, while other cells in the same lineage adapted without any mutation in their genomes. Thus, our experiments uncovered multiple alternative routes for heritable adaptation that were all induced in the same lineage during a short time period. Our results demonstrate the existence of adaptation mechanisms beyond random mutation, suggesting a tight connection between physiological and genetic processes.	[Moore, Lindsay S.; Stolovicki, Elad; Braun, Erez] Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel; [Moore, Lindsay S.; Stolovicki, Elad; Braun, Erez] Technion Israel Inst Technol, Network Biol Res Labs, IL-32000 Haifa, Israel; [Wei, Wu; Steinmetz, Lars M.] Stanford Genome Technol Ctr, Palo Alto, CA USA; [Benbenishty, Tamar; David, Lior] Hebrew Univ Jerusalem, Dept Anim Sci, IL-76100 Rehovot, Israel; [Wilkening, Stefan; Steinmetz, Lars M.] European Mol Biol Lab, Genome Biol Unit, D-69012 Heidelberg, Germany	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Stanford University; Hebrew University of Jerusalem; European Molecular Biology Laboratory (EMBL)	David, L (corresponding author), Hebrew Univ Jerusalem, Dept Anim Sci, IL-76100 Rehovot, Israel.	lior.david@mail.huji.ac.il	David, Lior/G-8754-2012; Wei, Wu/AAC-8285-2020; Stolovicki, Elad/AAT-1742-2021	Wei, Wu/0000-0001-5643-8739; Steinmetz, Lars/0000-0002-3962-2865; David, Lior/0000-0002-6555-0594	Aly Kaufman postdoctoral Fellowship; Israeli Science Foundation [95/08, 496/10]; National Institutes of Health; European Research Council under the European Union's Seventh Framework Programme (FP7/ERC) [AdG-294542]	Aly Kaufman postdoctoral Fellowship; Israeli Science Foundation(Israel Science Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council under the European Union's Seventh Framework Programme (FP7/ERC)(European Research Council (ERC))	LSM was supported by the Aly Kaufman postdoctoral Fellowship. This study was funded by the Israeli Science Foundation grants FIRST program 95/08 to EB and LD and 496/10 to EB. Funding for this research was obtained also from the National Institutes of Health and the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement no. AdG-294542 to LMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], EVOLUTION MODERN SYN; David L, 2013, MOL BIOL EVOL, V30, P1514, DOI 10.1093/molbev/mst071; David L, 2010, HFSP J, V4, P131, DOI 10.2976/1.3353782; Hall BG, 1998, GENETICA, V102-3, P109, DOI 10.1023/A:1017015815643; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Johannes F, 2008, NAT REV GENET, V9, P883, DOI 10.1038/nrg2467; Kondrashov FA, 2010, PHILOS T R SOC B, V365, P1169, DOI 10.1098/rstb.2009.0286; Lang GI, 2008, GENETICS, V178, P67, DOI 10.1534/genetics.107.071506; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Luria SE, 1943, GENETICS, V28, P491; Martincorena I, 2013, BIOESSAYS, V35, P123, DOI 10.1002/bies.201200150; Ram Y, 2012, EVOLUTION, V66, P2315, DOI 10.1111/j.1558-5646.2012.01576.x; Rando OJ, 2007, CELL, V128, P655, DOI 10.1016/j.cell.2007.01.023; Rosenberg SM, 2012, BIOESSAYS, V34, P885, DOI 10.1002/bies.201200050; Roth JR, 2006, ANNU REV MICROBIOL, V60, P477, DOI 10.1146/annurev.micro.60.080805.142045; Sniegowski PD, 2006, CURR BIOL, V16, pR831, DOI 10.1016/j.cub.2006.08.080; Sniegowski PD, 2000, BIOESSAYS, V22, P1057, DOI 10.1002/1521-1878(200012)22:12&lt;1057::AID-BIES3&gt;3.0.CO;2-W; Stern S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100147; Stolovicki E, 2006, GENETICS, V173, P75, DOI 10.1534/genetics.106.055442; Stolovicki E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020530; Wilkening S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-90; Zeyl C, 2004, RES MICROBIOL, V155, P217, DOI 10.1016/j.resmic.2003.12.006	22	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111133	10.1371/journal.pone.0111133	http://dx.doi.org/10.1371/journal.pone.0111133			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340744	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662800087
J	Rodriguez, M; Delibes, M; Fedriani, JM				Rodriguez, Marta; Delibes, Miguel; Fedriani, Jose Ma			Hierarchical Levels of Seed Predation Variation by Introduced Beetles on an Endemic Mediterranean Palm	PLOS ONE			English	Article							CHAMAEROPS-HUMILIS; BRUCHID BEETLES; COLEOPTERA; DISPERSAL; FRUITS	Seed predators can limit plant recruitment and thus profoundly impinge the dynamics of plant populations, especially when diverse seed predators (e.g., native and introduced) attack particular plant populations. Surprisingly, however, we know little concerning the potential hierarchy of spatial scales (e.g., region, population, patch) and coupled ecological correlates governing variation in the overall impact that native and introduced seed predators have on plant populations. We investigated several spatial scales and ecological correlates of pre-dispersal seed predation by invasive borer beetles in Chamaerops humilis (Arecaceae), a charismatic endemic palm of the Mediteranean basin. To this end, we considered 13 palm populations (115 palms) within four geographical regions of the Iberian Peninsula. The observed interregional differences in percentages of seed predation by invasive beetles were not significant likely because of considerable variation among populations within regions. Among population variation in seed predation was largely related to level of human impact. In general, levels of seed predation were several folds higher in human-altered populations than in natural populations. Within populations, seed predation declined significantly with the increase in amount of persisting fruit pulp, which acted as a barrier against seed predators. Our results revealed that a native species (a palm) is affected by the introduction of related species because of the concurrent introduction of seed predators that feed on both the introduced and native palms. We also show how the impact of invasive seed predators on plants can vary across a hierarchy of levels ranging from variation among individuals within local populations to large scale regional divergences.	[Rodriguez, Marta; Delibes, Miguel; Fedriani, Jose Ma] CSIC, Dept Conservat Biol, Estn Biol Donana, E-41080 Seville, Spain; [Fedriani, Jose Ma] Helmholtz Ctr Environm Res GmbH UFZ, Dept Ecol Modelling, Leipzig, Germany; [Fedriani, Jose Ma] Univ Lisbon, Inst Super Agron, Ctr Appl Ecol Prof Baeta Neves, P-1699 Lisbon, Portugal	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Universidade de Lisboa	Fedriani, JM (corresponding author), CSIC, Dept Conservat Biol, Estn Biol Donana, E-41080 Seville, Spain.	fedriani@ebd.csic.es	Fedriani, Jose/R-1328-2018; Delibes, Miguel/K-2744-2014	Fedriani, Jose/0000-0002-1581-2621; Delibes, Miguel/0000-0002-3569-567X	Spanish Ministerio de Medio Ambiente (National Park Service) [070/2009]; Ministerio de Educacion y Ciencia [CGL2007-63488/BOS, CGL2010-21926/BOS]; Marie Curie Intraeuropean fellowship [FP7-PEOPLE-2011-IEF-298137]	Spanish Ministerio de Medio Ambiente (National Park Service); Ministerio de Educacion y Ciencia(Spanish Government); Marie Curie Intraeuropean fellowship(European Commission)	The Spanish Ministerio de Medio Ambiente (National Park Service, grant 070/2009) and Ministerio de Educacion y Ciencia (CGL2007-63488/BOS and CGL2010-21926/BOS) supported this study. JMF was funded by a Marie Curie Intraeuropean fellowship (FP7-PEOPLE-2011-IEF-298137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain R, 2010, BIORISK, V4; ANDERSEN AN, 1988, OIKOS, V52, P337, DOI 10.2307/3565207; [Anonymous], 2006, SAS MIXED MODELS; Anstett MC, 1999, ACTA OECOL, V20, P551, DOI 10.1016/S1146-609X(00)86622-9; Bernabo E., 1991, Bollettino della Societa Entomologica Italiana, V122, P185; Blumberg D, 2008, PHYTOPARASITICA, V36, P411, DOI 10.1007/BF03020290; Cipollini ML, 1997, AM NAT, V150, P346, DOI 10.1086/286069; Delobel A, 1995, AMAZONIANA, V13, P209; Delobel B, 2006, OECOLOGIA, V149, P428, DOI 10.1007/s00442-006-0461-9; Fedriani JM, 2006, FUNCT ECOL, V20, P1070, DOI 10.1111/j.1365-2435.2006.01199.x; Fedriani JM, 2004, OIKOS, V105, P181, DOI 10.1111/j.0030-1299.2004.12782.x; Fedriani JM, 2001, ECOGRAPHY, V24, P325, DOI 10.1034/j.1600-0587.2001.240310.x; Fedriani JM, 2013, J ECOL, V101, P1581, DOI 10.1111/1365-2745.12146; Fedriani JM, 2011, ECOLOGY, V92, P304, DOI 10.1890/09-2194.1; FORGET PM, 1994, BIOTROPICA, V26, P420, DOI 10.2307/2389236; Fragoso JMV, 2003, ECOLOGY, V84, P1998, DOI 10.1890/01-0621; Gomez Vives S., 2004, Boletin de Sanidad Vegetal Plagas, V30, P497; Herrera C.M., 2009, MULTIPLICITY UNITY P; HERRERA CM, 1989, OIKOS, V54, P185, DOI 10.2307/3565264; HERRERA J, 1989, Principes, V33, P27; Holzman JP, 2009, J EVOLUTION BIOL, V22, P1076, DOI 10.1111/j.1420-9101.2009.01722.x; Hulme Philip E., 2002, P132; JANZEN D, 1972, ECOLOGY, V53, P350, DOI 10.2307/1934092; Janzen DH, 1982, BRENESIA, V20, P165; Kiers ET, 2010, ECOL LETT, V13, P1459, DOI 10.1111/j.1461-0248.2010.01538.x; Kirkendall LR, 2010, ZOOKEYS, P227, DOI 10.3897/zookeys.56.529; Lombardero M. J., 1994, Boletin de la Asociacion Espanola de Entomologia, V18, P181; Medail F, 1996, CR ACAD SCI III-VIE, V319, P139; Merlo M. E., 1993, Principes, V37, P151; Moore D, 2001, INSECTS ON PALMS, P233, DOI 10.1079/9780851993263.0233; Nunez MA, 2008, BIOL INVASIONS, V10, P1389, DOI 10.1007/s10530-007-9214-x; Palacios J., 1973, Miscelanea Zoologica, V3, P69; Rodriguez A, 2013, NEW PHYTOL, V197, P36, DOI 10.1111/j.1469-8137.2012.04382.x; Rose KE, 2005, ECOLOGY, V86, P453, DOI 10.1890/03-0697; Sauvard Daniel, 2010, BioRisk, V4, P219; Shiels AB, 2011, BIOL INVASIONS, V13, P781, DOI 10.1007/s10530-010-9868-7; Silvius KM, 2002, J ECOL, V90, P1024, DOI 10.1046/j.1365-2745.2002.00728.x; Thompson J. N., 2005, INTERSPEC INTERACT; Thompson JD., 2005, PLANT EVOLUTION MEDI, DOI DOI 10.1093/ACPROF:OSO/9780198515340.001.0001; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Valladares F, 2004, ECOLOGIA BOSQUE MEDI, P163; Vila M, 2008, INVASIONES BIOL COLE; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Whitehead PF, 2000, ANZ SCHADL-J PEST SC, V73, P17; Wotton DM, 2011, P ROY SOC B-BIOL SCI, V278, P3345, DOI 10.1098/rspb.2011.0185; Zorzenon FJ, 1995, REV AGR PIRACICABA, P7017	46	7	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e109867	10.1371/journal.pone.0109867	http://dx.doi.org/10.1371/journal.pone.0109867			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340462	gold, Green Published, Green Submitted			2022-12-27	WOS:000343662800020
J	Akutse, KS; Fiaboe, KKM; Van den Berg, J; Ekesi, S; Maniania, NK				Akutse, Komivi S.; Fiaboe, Komi K. M.; Van den Berg, Johnnie; Ekesi, Sunday; Maniania, Nguya K.			Effects of Endophyte Colonization of Vicia faba (Fabaceae) Plants on the Life-History of Leafminer Parasitoids Phaedrotoma scabriventris (Hymenoptera: Braconidae) and Diglyphus isaea (Hymenoptera: Eulophidae)	PLOS ONE			English	Article							LIRIOMYZA-HUIDOBRENSIS DIPTERA; FUNGAL ENDOPHYTES; BEAUVERIA-BASSIANA; INSECT HERBIVORES; SATIVAE DIPTERA; AGROMYZIDAE; HOST; INFECTION; LEPIDOPTERA; TEMPERATURE	Effects of the fungal endophytes Beauveria bassiana (isolates ICIPE 279, G1LU3, S4SU1) and Hypocrea lixii (isolate F3ST1) on the life-history of Phaedrotoma scabriventris and Diglyphus isaea, parasitoids of the pea leafminer Liriomyza huidobrensis, were studied in the laboratory. Parasitoids were allowed to parasitize 2nd and 3rd instar L. huidobrensis larvae reared on endophytically-inoculated faba bean, Vicia faba. In the control, parasitoids were reared on non-inoculated host plants. Parasitism, pupation, adult emergence and survival were recorded. No significant difference was observed between the control and the endophyte-inoculated plants in terms of parasitism rates of P. scabriventris (p = 0.68) and D. isaea (p = 0.45) and adult' survival times (p = 0.06). The survival period of the F1 progeny of P. scabriventris was reduced (p<0.0001) in B. bassiana S4SU1 to 28 days as compared to more than 40 days for B. bassiana G1LU3, ICIPE 279 and H. lixii F3ST1. However, no significant difference (p = 0.54) was observed in the survival times of the F1 progeny of D. isaea. This study has demonstrated that together, endophytes and parasitoids have beneficial effects in L. huidobrensis population suppression.	[Akutse, Komivi S.; Fiaboe, Komi K. M.; Ekesi, Sunday; Maniania, Nguya K.] Int Ctr Insect Physiol & Ecol, Plant Hlth Div, Nairobi, Kenya; [Akutse, Komivi S.; Van den Berg, Johnnie] North West Univ, Unit Environm Sci & Management, Potchefstroom, South Africa	International Centre of Insect Physiology & Ecology (ICIPE); North West University - South Africa	Maniania, NK (corresponding author), Int Ctr Insect Physiol & Ecol, Plant Hlth Div, POB 30772, Nairobi, Kenya.	nmaniania@icipe.org	Akutse, Komivi Senyo/I-8137-2019; Van den Berg, Johnnie/M-7256-2013; Ekesi, Sunday/P-8944-2019	Akutse, Komivi Senyo/0000-0002-2124-1626; Van den Berg, Johnnie/0000-0002-6831-3180; 	icipe's research project on IPM of vegetable leafminers - Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ); German Ministry of Economic Cooperation and Development (BMZ); German Academic Exchange Service/Deutcher Akademischer Austausch Dienst (DAAD), through the African Regional Postgraduate Programme in Insect Science (ARPPIS) of icipe	icipe's research project on IPM of vegetable leafminers - Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ); German Ministry of Economic Cooperation and Development (BMZ); German Academic Exchange Service/Deutcher Akademischer Austausch Dienst (DAAD), through the African Regional Postgraduate Programme in Insect Science (ARPPIS) of icipe(Deutscher Akademischer Austausch Dienst (DAAD))	This research work was supported by the icipe's research project on IPM of vegetable leafminers funded by the Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ) and the German Ministry of Economic Cooperation and Development (BMZ). The first author was financed through a PhD fellowship provided by the German Academic Exchange Service/Deutcher Akademischer Austausch Dienst (DAAD), through the African Regional Postgraduate Programme in Insect Science (ARPPIS) of icipe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akello J, 2012, ECOLOGY DEV SERIES, V86; Akutse KS, 2013, FUNGAL ECOL, V6, P293, DOI 10.1016/j.funeco.2013.01.003; BARBOSA P, 1991, ECOLOGY, V72, P1567, DOI 10.2307/1940956; Barker GM, 1996, BIOL CONTROL, V7, P281, DOI 10.1006/bcon.1996.0095; Bazzocchi GG, 2003, BIOL CONTROL, V26, P74, DOI 10.1016/S1049-9644(02)00118-4; Bixby-Brosi AJ, 2012, ARTHROPOD-PLANT INTE, V6, P27, DOI 10.1007/s11829-011-9163-2; BREEN JP, 1994, ANNU REV ENTOMOL, V39, P401, DOI 10.1146/annurev.en.39.010194.002153; Bultman TL, 2003, OIKOS, V102, P491, DOI 10.1034/j.1600-0706.2003.11477.x; Bultman TL, 1997, OIKOS, V78, P170, DOI 10.2307/3545812; CAMPBELL BC, 1979, SCIENCE, V205, P700, DOI 10.1126/science.205.4407.700; Chabi-Olaye A., 2008, P 23 INT C ENT JUL 2, P6; Chabi-Olaye A, 2013, BIOL CONTROL, V65, P1, DOI 10.1016/j.biocontrol.2013.01.007; CHANDLER L D, 1981, Southwestern Entomologist, V6, P23; CHANDLER LD, 1984, J GEORGIA ENTOMOL SO, V19, P199; Chongsuvivatwong V, 2012, EPICALC EPIDEMIOLOGI; COOK AA, 1988, PLANT DIS, V72, P546, DOI 10.1094/PD-72-0546D; Dingle J, 2003, MYCOL RES, V107, P310, DOI 10.1017/S0953756203007512; *EPPO, 2009, A2 LIST PESTS REC RE; EPPO/CABI, 2006, DAT SHEETS QUAR PEST; Faeth SH, 2012, FUNGAL ECOL, V5, P364, DOI 10.1016/j.funeco.2011.09.003; Gitonga ZM, 2010, CROP PROT, V29, P1472, DOI 10.1016/j.cropro.2010.08.007; Goettel Mark S., 1997, P213, DOI 10.1016/B978-012432555-5/50013-0; Gurulingappa P, 2010, BIOL CONTROL, V55, P34, DOI 10.1016/j.biocontrol.2010.06.011; Harri SA, 2008, OECOLOGIA, V157, P399, DOI 10.1007/s00442-008-1094-y; Haghani M, 2007, J PEST SCI, V80, P71, DOI 10.1007/s10340-006-0154-5; Hartley SE, 2009, ANNU REV ENTOMOL, V54, P323, DOI 10.1146/annurev.ento.54.110807.090614; Istifadah N, 2006, AUSTRALAS PLANT PATH, V35, P411, DOI 10.1071/AP06038; JOHNSON MW, 1980, J ECON ENTOMOL, V73, P67, DOI 10.1093/jee/73.1.67; Lampert EC, 2010, ENTOMOL EXP APPL, V134, P287, DOI 10.1111/j.1570-7458.2009.00956.x; Liu WanXue, 2013, Acta Entomologica Sinica, V56, P427; M.L.Deadman, 2002, The Plant Pathology Journal, V18, P210; MACDONALD OC, 1991, CROP PROT, V10, P509, DOI 10.1016/S0261-2194(91)80142-3; Mafi S., 2010, Journal of Entomological Society of Iran, V30, P29; MATTEONI JA, 1988, CAN J PLANT PATHOL, V10, P47, DOI 10.1080/07060668809501763; Migiro LN, 2010, ENVIRON ENTOMOL, V39, P468, DOI 10.1603/EN09359; Mujica N, 2011, ENVIRON ENTOMOL, V40, P217, DOI 10.1603/EN10170; Mujica N, 2009, TEMPERATURE DEPENDEN, P105; Murphy ST., 1999, BIOCONTROL NEWS INFO, V20, p91N; Omacini M, 2001, NATURE, V409, P78, DOI 10.1038/35051070; Parrella M. P., 1984, California Agriculture, V38, P22; PETRINI O, 1986, T BRIT MYCOL SOC, V87, P647, DOI 10.1016/S0007-1536(86)80109-7; Powell WA, 2009, J ENTOMOL SCI, V44, P391, DOI 10.18474/0749-8004-44.4.391; PRICE PW, 1980, ANNU REV ECOL SYST, V11, P41, DOI 10.1146/annurev.es.11.110180.000353; R Core Team, 2016, R FDN STAT COMP; Raman A, 2012, ENVIRON ENTOMOL, V41, P433, DOI 10.1603/EN11317; Richmond DS, 2000, J ECON ENTOMOL, V93, P1662, DOI 10.1603/0022-0493-93.6.1662; Rodstrom JL, 2007, GRASSLANDS RES PRACT, V13, P329; Schulz B, 1998, SYMBIOSIS, V25, P213; Schulz B, 2005, MYCOL RES, V109, P661, DOI 10.1017/S095375620500273X; SENTHAMIZHSELVAN M, 1989, PARASITOL RES, V76, P166, DOI 10.1007/BF00930840; Smith IM, 1996, QUARANTINE PESTS EUR; Spencer K.A., 1973, Series Ent, V9, P1; Turlings TCJ, 1998, ECOSCIENCE, V5, P321, DOI 10.1080/11956860.1998.11682472; Valladares G. R., 1999, Horticultura Argentina, V18, P56; Valladares GR, 2001, ECOL RES, V16, P925, DOI 10.1046/j.1440-1703.2001.00453.x; ZITTER TA, 1977, PLANT DIS REP, V61, P1025	56	32	32	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e109965	10.1371/journal.pone.0109965	http://dx.doi.org/10.1371/journal.pone.0109965			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338084	Green Published, gold			2022-12-27	WOS:000343674800019
J	Bravo, C; Bautista, LM; Garcia-Paris, M; Blanco, G; Alonso, JC				Bravo, Carolina; Miguel Bautista, Luis; Garcia-Paris, Mario; Blanco, Guillermo; Alonso, Juan Carlos			Males of a Strongly Polygynous Species Consume More Poisonous Food than Females	PLOS ONE			English	Article							BUSTARD OTIS-TARDA; SELF-MEDICATION; GREAT; MITOCHONDRIAL; CANTHARIDIN; SELECTION; PARASITES; DISPLAY; BIRDS; DIET	We present evidence of a possible case of self-medication in a lekking bird, the great bustard Otis tarda. Great bustards consumed blister beetles (Meloidae), in spite of the fact that they contain cantharidin, a highly toxic compound that is lethal in moderate doses. In addition to anthelminthic properties, cantharidin was effective against gastrointestinal bacteria that cause sexually-transmitted diseases. Although both sexes consumed blister beetles during the mating season, only males selected them among all available insects, and ingested more and larger beetles than females. The male-biased consumption suggests that males could use cantharidin to reduce their parasite load and increase their sexual attractiveness. This plausibly explains the intense cloaca display males perform to approaching females, and the meticulous inspection females conduct of the male's cloaca, a behaviour only observed in this and another similar species of the bustard family. A white, clean cloaca with no infection symptoms (e.g., diarrhoea) is an honest signal of both, resistance to cantharidin and absence of parasites, and represents a reliable indicator of the male quality to the extremely choosy females. Our results do not definitely prove, but certainly strongly suggest that cantharidin, obtained by consumption of blister beetles, acts in great bustards as an oral anti-microbial and pathogen-limiting compound, and that males ingest these poisonous insects to increase their mating success, pointing out that self-medication might have been overlooked as a sexually-selected mechanism enhancing male fitness.	[Bravo, Carolina; Miguel Bautista, Luis; Blanco, Guillermo; Alonso, Juan Carlos] CSIC, Museo Nacl Ciencias Nat, Dept Evolutionary Ecol, E-28006 Madrid, Spain; [Garcia-Paris, Mario] CSIC, Museo Nacl Ciencias Nat, Dept Biodivers & Evolutionary Biol, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Bravo, C (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Evolutionary Ecol, E-28006 Madrid, Spain.	c.bravo@mncn.csic.es	Garcia-Paris, Mario/AAA-7411-2019; Alonso, Juan Carlos/C-9974-2012; Bautista-Sopelana, Luis M./B-1735-2008; Bravo, Carolina/L-4558-2019; Blanco, Guillermo/L-3170-2014	Alonso, Juan Carlos/0000-0003-0450-7434; Bautista-Sopelana, Luis M./0000-0002-1503-652X; Bravo, Carolina/0000-0001-5640-255X; Blanco, Guillermo/0000-0001-5742-4929; Garcia-Paris, Mario/0000-0002-9361-9405	HENARSA-CSIC; Direccion General de Investigacion, Spanish Ministry of Economy and Competitiveness [CGL2005-04893, CGL2008-02567, CGL2012-36345, CGL2009-12753-C02-01]	HENARSA-CSIC; Direccion General de Investigacion, Spanish Ministry of Economy and Competitiveness	C.B. was supported by a contract HENARSA-CSIC. This study was funded by projects CGL2005-04893, CGL2008-02567, CGL2012-36345 and CGL2009-12753-C02-01 of the Direccion General de Investigacion, Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JC, 2003, ARDEOLA, V50, P21; Alonso Juan C., 2010, Chinese Birds, V1, P141; Alonso JC, 2010, ETHOLOGY, V116, P1084, DOI 10.1111/j.1439-0310.2010.01827.x; Alonso JC, 2010, BEHAV ECOL SOCIOBIOL, V64, P1589, DOI 10.1007/s00265-010-0972-6; Bailey TA, 1998, COMP BIOCHEM PHYS C, V120, P365, DOI 10.1016/S0742-8413(98)10012-9; Bailey TA, 2008, DIS MED MANAGEMENT H; Bartram S, 2001, CHEMBIOCHEM, V2, P809, DOI 10.1002/1439-7633(20011105)2:11<809::AID-CBIC809>3.0.CO;2-C; Bautista LM, 2013, EUR J WILDLIFE RES, V59, P815, DOI 10.1007/s10344-013-0735-6; Beaulieu M, 2013, ANIM BEHAV, V86, P17, DOI 10.1016/j.anbehav.2013.05.022; Benskin CMH, 2009, BIOL REV, V84, P349, DOI 10.1111/j.1469-185X.2008.00076.x; Birkhead T, 2000, PROMISCUITY EVOLUTIO; Bologna M. A., 1991, COLEOPTERA MELOIDAE; BOYCE MS, 1990, AM ZOOL, V30, P263; Campbell BE, 2011, BIOORG MED CHEM LETT, V21, P3277, DOI 10.1016/j.bmcl.2011.04.031; Campbell BE, 2011, BIOTECHNOL ADV, V29, P28, DOI 10.1016/j.biotechadv.2010.08.008; CARREL JE, 1974, SCIENCE, V183, P755, DOI 10.1126/science.183.4126.755; CLAYTON DH, 1991, PARASITOL TODAY, V7, P329, DOI 10.1016/0169-4758(91)90211-6; DAVIES NB, 1983, NATURE, V302, P334, DOI 10.1038/302334a0; de Roode JC, 2013, SCIENCE, V340, P150, DOI 10.1126/science.1235824; DETRUCIOS SJH, 1991, ORNIS SCAND, V22, P360, DOI 10.2307/3676509; Dettner K., 1997, Ecological Studies, V130, P115; Eisner T., 1990, Chemoecology, V1, P57, DOI 10.1007/BF01325229; Ekblom R, 2005, BEHAV ECOL, V16, P346, DOI 10.1093/beheco/arh168; Finkelstein MM, 2001, AIHAJ, V62, P195, DOI 10.1080/15298660108984622; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Forbey JS, 2009, INTEGR COMP BIOL, V49, P314, DOI 10.1093/icb/icp046; Garcia JT, 2011, MOL PHYLOGENET EVOL, V61, P671, DOI 10.1016/j.ympev.2011.07.017; Garcia-Montijano M, 2002, POSTMORTEM FINDINGS; Garcia-Paris M., 1998, Graellsia, V54, P97; Garcia-Paris M., 2006, Graellsia, V62, P333; Gewalt W, 1959, GROSSTRAPPE OTIS TRA; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Hart B. L., 1997, HOST PARASITE EVOLUT; Hellmich J, 1991, ALYTES, V2, P127; Hodar J. A., 1997, Miscellania Zoologica (Barcelona), V20, P1; Hodar JA, 1996, ACTA OECOL, V17, P421; HOGLUND J, 1992, BEHAV ECOL SOCIOBIOL, V30, P71; Hoste H, 2010, TRENDS PARASITOL, V26, P376, DOI 10.1016/j.pt.2010.04.007; Institute CLS, 2006, M2A9 CLSI; Johnsgard P.A., 1994, ARENA BIRDS SEXUAL S; King A.S., 1984, BIRDS THEIR STRUCTUR; KIRKPATRICK M, 1991, NATURE, V350, P33, DOI 10.1038/350033a0; KOK OB, 1990, OSTRICH, V61, P107, DOI 10.1080/00306525.1990.9634155; Lane SJ, 1999, J ZOOL, V247, P201, DOI 10.1111/j.1469-7998.1999.tb00984.x; Lane SJ, 2001, J APPL ECOL, V38, P193, DOI 10.1046/j.1365-2664.2001.00577.x; Lombardo MP, 1998, J AVIAN BIOL, V29, P314, DOI 10.2307/3677114; Loye JE, 1991, OXFORD ORNITHOLOGY S, Vi-xv, P1; Lozano GA, 1998, ADV STUD BEHAV, V27, P291; Lucio A. J., 1985, ALYTES, V3, P69; Luckmann J, 2003, PARASITOL RES, V90, P82, DOI 10.1007/s00436-002-0812-3; Magana M, 2010, IBIS, V152, P77, DOI 10.1111/j.1474-919X.2009.00976.x; Martin B, 2012, ECOL MODEL, V228, P39, DOI 10.1016/j.ecolmodel.2011.12.024; Meynier J, 1893, ARCH MED PHARM MIL, V22, P53; Moed L, 2001, ARCH DERMATOL, V137, P1357; MOLLER AP, 1987, ANIM BEHAV, V35, P203, DOI 10.1016/S0003-3472(87)80225-7; Morales MB, 2003, J ETHOL, V21, P51, DOI 10.1007/s10164-002-0076-5; NAKAMURA M, 1990, AUK, V107, P284, DOI 10.2307/4087611; NICKOLLS LC, 1954, BRIT MED J, V2, P1384, DOI 10.1136/bmj.2.4901.1384; Palacios F., 1975, Ardeola, V21, P347; Percino-Daniel N, 2013, J ETHNOPHARMACOL, V147, P570, DOI 10.1016/j.jep.2013.03.037; Pitra C, 2000, MOL ECOL, V9, P1165, DOI 10.1046/j.1365-294x.2000.00983.x; Pitra C, 2002, MOL PHYLOGENET EVOL, V23, P63, DOI 10.1006/mpev.2001.1078; Poiana Aldo, 2010, Open Ornithology Journal, V3, P72, DOI 10.2174/1874453201003010072; Quinn P., 2002, VET MICROBIOLOGY MIC; R Development Core Team, 2012, R LANG ENV STAT COMP; Rahmani A. R, 1989, GREAT INDIAN BUSTARD; RAY AC, 1980, AM J VET RES, V41, P932; Roberts ML, 2004, ANIM BEHAV, V68, P227, DOI 10.1016/j.anbehav.2004.05.001; Rocha P, 2005, ARDEOLA, V52, P371; RODRIGUEZ E, 1993, RECENT ADV PHYTOCHEM, V27, P89; Rotherham ID, 2008, FOOD WINE FESTIVALS, P47; Sanchez AM, 1995, BIRDS STRATIGRAPHIC, P137; Sanchez-Barbudo IS, 2012, TOXICON, V59, P100, DOI 10.1016/j.toxicon.2011.10.002; Sandroni P, 2001, CLIN AUTON RES, V11, P303, DOI 10.1007/BF02332975; SHELDON BC, 1993, PHILOS T R SOC B, V339, P491, DOI 10.1098/rstb.1993.0044; Vezien M., 1861, RECUEIL MEMOIRES MED, V4, P457	76	18	23	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e111057	10.1371/journal.pone.0111057	http://dx.doi.org/10.1371/journal.pone.0111057			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337911	Green Published, gold, Green Submitted			2022-12-27	WOS:000343674800100
J	Fettweis, JM; Serrano, MG; Huang, B; Brooks, JP; Glascock, AL; Sheth, NU; Strauss, JF; Jefferson, KK; Buck, GA				Fettweis, Jennifer M.; Serrano, Myrna G.; Huang, Bernice; Brooks, J. Paul; Glascock, Abigail L.; Sheth, Nihar U.; Strauss, Jerome F., III; Jefferson, Kimberly K.; Buck, Gregory A.		Vaginal Microbiome Consortium	An Emerging Mycoplasma Associated with Trichomoniasis, Vaginal Infection and Disease	PLOS ONE			English	Article							BACTERIAL COMMUNITY; GENETIC DIVERSITY; EPITHELIAL-CELLS; SURFACE-PROTEINS; GRAM STAIN; HOMINIS; GUT; MICROBIOME; IDENTIFICATION; ANNOTATION	Humans are colonized by thousands of bacterial species, but it is difficult to assess the metabolic and pathogenic potential of the majority of these because they have yet to be cultured. Here, we characterize an uncultivated vaginal mycoplasma tightly associated with trichomoniasis that was previously known by its 16S rRNA sequence as "Mnola.'' In this study, the mycoplasma was found almost exclusively in women infected with the sexually transmitted pathogen Trichomonas vaginalis, but rarely observed in women with no diagnosed disease. The genomes of four strains of this species were reconstructed using metagenome sequencing and assembly of DNA from four discrete mid-vaginal samples, one of which was obtained from a pregnant woman with trichomoniasis who delivered prematurely. These bacteria harbor several putative virulence factors and display unique metabolic strategies. Genes encoding proteins with high similarity to potential virulence factors include two collagenases, a hemolysin, an O-sialoglycoprotein endopeptidase and a feoB-type ferrous iron transport system. We propose the name "Candidatus Mycoplasma girerdii'' for this potential new pathogen.	[Fettweis, Jennifer M.; Serrano, Myrna G.; Huang, Bernice; Glascock, Abigail L.; Jefferson, Kimberly K.; Buck, Gregory A.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Fettweis, Jennifer M.; Serrano, Myrna G.; Sheth, Nihar U.; Buck, Gregory A.] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA 23298 USA; [Brooks, J. Paul] Virginia Commonwealth Univ, Dept Stat Sci & Operat Res, Richmond, VA 23298 USA; [Strauss, Jerome F., III] Virginia Commonwealth Univ, Dept Obstet & Gynecol, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Fettweis, JM (corresponding author), Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA.	fettweisjm@vcu.edu		Friedline, Christopher/0000-0002-6373-4971; Jefferson, Kimberly/0000-0003-1052-1988	National Institutes of Health [NHGRI/NIAID 4UH3AI083263]; Vaginal Microbiome: Disease, Genetics and the Environment [NHGRI/NIDCR/NICHD/NCCAM/ORWH 1U54DE023786-01/8U54HD080784-02, NIH P60MD002256]; VCU NIMHD Comprehensive Center of Excellence; NIH/NCI [2P30 CA16059]; NIH-NINDS Center [5P30NS047463]; NIH [MH-20030]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD080784] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UH3AI083263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U54DE023786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047463] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P60MD002256] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vaginal Microbiome: Disease, Genetics and the Environment; VCU NIMHD Comprehensive Center of Excellence; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH-NINDS Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by several grants from the National Institutes of Health: Grant NHGRI/NIAID 4UH3AI083263, The Vaginal Microbiome: Disease, Genetics and the Environment, Grant NHGRI/NIDCR/NICHD/NCCAM/ORWH 1U54DE023786-01/8U54HD080784-02 and Grant NIH P60MD002256, VCU NIMHD Comprehensive Center of Excellence. Sequencing was performed in the Next Generation Sequencing Core of the Nucleic Acids Research Facilities at VCU, supported in part by funding from NIH/NCI 2P30 CA16059. Sequence analysis was performed with infrastructure and support from the Bioinformatics Computational Core Laboratories and the Center for High Performance Computing at VCU. Microscopy was performed at the VCU Department of Neurobiology and Anatomy Microscopy Facility, supported, in part, with funding from NIH-NINDS Center core grant (5P30NS047463). ARW was supported by NIH Grant MH-20030. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves JMP, 2007, CHEM BIODIVERS, V4, P2593, DOI 10.1002/cbdv.200790212; AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Bai XD, 2009, MOL PLANT MICROBE IN, V22, P18, DOI 10.1094/MPMI-22-1-0018; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Bland C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-209; Brotman RM, 2012, SEX TRANSM DIS, V39, P807, DOI 10.1097/OLQ.0b013e3182631c79; Browning GF, 2011, VET MICROBIOL, V153, P44, DOI 10.1016/j.vetmic.2011.05.031; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Conrad M, 2011, MOL BIOCHEM PARASIT, V175, P30, DOI 10.1016/j.molbiopara.2010.08.006; Conrad MD, 2013, SEX TRANSM INFECT, V89, P473, DOI 10.1136/sextrans-2013-051053; Conrad MD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001573; Costello EK, 2013, MBIO, V4, DOI 10.1128/mBio.00782-13; Cotch MF, 1997, SEX TRANSM DIS, V24, P353, DOI 10.1097/00007435-199707000-00008; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; DeLuca TF, 2006, BIOINFORMATICS, V22, P2044, DOI 10.1093/bioinformatics/btl286; Dessi D, 2006, FRONT BIOSCI-LANDMRK, V11, P2028, DOI 10.2741/1944; Diaz N, 2010, DIAGN MICR INFEC DIS, V67, P30, DOI 10.1016/j.diagmicrobio.2009.12.022; DiGiulio DB, 2010, AM J REPROD IMMUNOL, V64, P38, DOI 10.1111/j.1600-0897.2010.00830.x; Djigma F, 2011, J INFECT DEV COUNTR, V5, P176, DOI 10.3855/jidc.950; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Fettweis JM, 2014, MICROBIOL-SGM, V160, P2272, DOI 10.1099/mic.0.081034-0; Fettweis JM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S17; Fettweis JM, 2012, CHEM BIODIVERS, V9, P965, DOI 10.1002/cbdv.201100359; Fichorova RN, 2009, J REPROD IMMUNOL, V83, P185, DOI 10.1016/j.jri.2009.08.007; Fiori PL, 2013, SEX TRANSM INFECT, V89, P449, DOI 10.1136/sextrans-2012-051006; GLASFELD A, 1990, J BIOL CHEM, V265, P11692; Haggerty Catherine L, 2011, Infect Dis Obstet Gynecol, V2011, P959816, DOI 10.1155/2011/959816; Harwich MD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-375; Hay P, 2007, BEST PRACT RES CL OB, V21, P403, DOI 10.1016/j.bpobgyn.2007.02.002; HENRICH B, 1993, INFECT IMMUN, V61, P2945, DOI 10.1128/IAI.61.7.2945-2951.1993; HILLIER SL, 1992, AM J OBSTET GYNECOL, V166, P938, DOI 10.1016/0002-9378(92)91368-K; Hirt RP, 2007, TRENDS PARASITOL, V23, P540, DOI 10.1016/j.pt.2007.08.020; Hongoh Y, 2003, FEMS MICROBIOL ECOL, V44, P231, DOI 10.1016/S0168-6496(03)00026-6; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Hyman RW, 2014, REPROD SCI, V21, P32, DOI 10.1177/1933719113488838; Inagaki S, 2006, INFECT IMMUN, V74, P5023, DOI 10.1128/IAI.00062-06; INAMINE JM, 1990, J BACTERIOL, V172, P504, DOI 10.1128/JB.172.1.504-506.1990; Kacerovsky M, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.04.028; KRIEGER JN, 1983, INFECT IMMUN, V41, P1291, DOI 10.1128/IAI.41.3.1291-1295.1983; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larsen B, 2010, INFECT DIS OBSTET GY, V2010; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Li MJ, 2012, VET MICROBIOL, V155, P72, DOI 10.1016/j.vetmic.2011.08.007; LO SC, 1992, INT J SYST BACTERIOL, V42, P357, DOI 10.1099/00207713-42-3-357; Loimaranta V, 2009, J BIOL CHEM, V284, P18614, DOI 10.1074/jbc.M900581200; Martin DH, 2013, J INFECT DIS, V207, P1922, DOI 10.1093/infdis/jit100; Myneni SR, 2012, BIOCHEM BIOPH RES CO, V423, P577, DOI 10.1016/j.bbrc.2012.06.008; Noel CJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-99; Nouvel LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-86; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Onishi S, 2008, INFECT IMMUN, V76, P198, DOI 10.1128/IAI.01139-07; Schirm J, 2007, J MICROBIOL METH, V68, P243, DOI 10.1016/j.mimet.2006.08.002; Sha BE, 2005, J CLIN MICROBIOL, V43, P4607, DOI 10.1128/JCM.43.9.4607-4612.2005; Shinzato N, 2005, BIOSCI BIOTECH BIOCH, V69, P1145, DOI 10.1271/bbb.69.1145; Silva FJ, 2006, NUCLEIC ACIDS RES, V34, P6015, DOI 10.1093/nar/gkl739; Sirand-Pugnet P, 2007, PLOS GENET, V3, P744, DOI 10.1371/journal.pgen.0030075; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Taylor-Robinson D, 2011, BJOG-INT J OBSTET GY, V118, P164, DOI 10.1111/j.1471-0528.2010.02766.x; Treangen TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001284; Trulzsch K, 2001, MICROBIOL-UK, V147, P203; van der Schee C, 2001, J MICROBIOL METH, V45, P61, DOI 10.1016/S0167-7012(01)00224-X; Volokhov DV, 2012, MOL PHYLOGENET EVOL, V62, P515, DOI 10.1016/j.ympev.2011.11.002; World Health Organization, 2001, GLOB PROGR AIDS; Wu YW, 2011, J COMPUT BIOL, V18, P523, DOI 10.1089/cmb.2010.0245; Yang H, 2005, ENVIRON MICROBIOL, V7, P916, DOI 10.1111/j.1462-2920.2005.00760.x; York TP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012391	67	35	37	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110943	10.1371/journal.pone.0110943	http://dx.doi.org/10.1371/journal.pone.0110943			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337710	Green Published, Green Submitted, gold			2022-12-27	WOS:000343674800091
J	Degiuseppe, JI; Parra, GI; Stupka, JA				Ignacio Degiuseppe, Juan; Ignacio Parra, Gabriel; Andres Stupka, Juan			Genetic Diversity of G3 Rotavirus Strains Circulating in Argentina during 1998-2012 Assessed by Full Genome Analyses	PLOS ONE			English	Article							GROUP-A ROTAVIRUS; MOLECULAR CHARACTERIZATION; INTERSPECIES TRANSMISSION; PHYLOGENETIC ANALYSIS; CHILDREN; EMERGENCE; GASTROENTERITIS; IDENTIFICATION; SURVEILLANCE; REASSORTMENT	Seasonal shifts in the predominant strains and the periodic emergence of new strains are epidemiological features of human rotaviruses. After the sporadic detection in two samples in 1998, G3P[8] strains reemerged as the predominant rotavirus during 2008-2009 in Argentina. Notably, in 2011 6.3% (37/587) of samples presented the G3P[6] genotypes, which coincided with the recent detection of G3P[6] and G2P[6] strains in South America and Europe. Analyses of the 11 gene segments of four G3P[8] and two G3P[6] strains revealed that G3P[8] strains detected a decade apart (1998 and 2009) presented minor differences, while the G3P[6] strains presented a complete different genomic constellation albeit showing a similar VP7 gene. This study provides insights in the dynamics and evolution of one of the genotypes with the wider range of hosts and inter-species transmission potential.	[Ignacio Degiuseppe, Juan; Andres Stupka, Juan] Adm Nacl Labs & Inst Salud ANLIS Dr Carlos G Malb, Inst Nacl Enfermedades Infecciosas, Lab Gastroenteritis Virales, Buenos Aires, DF, Argentina; [Ignacio Parra, Gabriel] Univ Nacl Asuncion, Inst Invest Ciencias Salud, Asuncion, Paraguay	Research Institute for Health Sciences (IICS); Universidad Nacional de Asuncion	Degiuseppe, JI (corresponding author), Adm Nacl Labs & Inst Salud ANLIS Dr Carlos G Malb, Inst Nacl Enfermedades Infecciosas, Lab Gastroenteritis Virales, Buenos Aires, DF, Argentina.	jdegiuseppe@anlis.gov.ar	DEGIUSEPPE, JUAN/L-6438-2019; Parra, Gabriel I./H-4339-2019	Parra, Gabriel I./0000-0002-1102-4740				Arnold MM, 2013, J VIROL, V87, P9813, DOI 10.1128/JVI.01146-13; Arnold MM, 2009, VIRUSES-BASEL, V1, P1035, DOI 10.3390/v1031035; Bok K, 2001, J MED VIROL, V65, P190, DOI 10.1002/jmv.2020; Bok K, 2001, J CLIN MICROBIOL, V39, P4020, DOI 10.1128/JCM.39.11.4020-4025.2001; Cashman O, 2012, EPIDEMIOL INFECT, V140, P247, DOI 10.1017/S0950268811000306; Castello AA, 2006, J CLIN MICROBIOL, V44, P2046, DOI 10.1128/JCM.02436-05; Castello Alejandro A, 2004, Pediatr Infect Dis J, V23, pS168, DOI 10.1097/01.inf.0000142466.57262.2a; Ciarlet M, 2009, VACCINE, V27, pG72, DOI 10.1016/j.vaccine.2009.09.107; DAS BK, 1994, J CLIN MICROBIOL, V32, P1820, DOI 10.1128/JCM.32.7.1820-1822.1994; De Grazia S, 2009, J MED VIROL, V81, P2089, DOI 10.1002/jmv.21615; Degiuseppe JI, 2013, CLIN MICROBIOL INFEC, V19, pE367, DOI 10.1111/1469-0691.12216; Dey SK, 2009, INFECT GENET EVOL, V9, P983, DOI 10.1016/j.meegid.2009.06.016; Estes MK, 2007, FIELDS VIROLOGY, P1917; Gentsch JR, 2005, J INFECT DIS, V192, pS146, DOI 10.1086/431499; GENTSCH JR, 1992, J CLIN MICROBIOL, V30, P1365, DOI 10.1128/JCM.30.6.1365-1373.1992; Ghosh S, 2012, J GEN VIROL, V93, P1700, DOI 10.1099/vir.0.043026-0; GOUVEA V, 1990, J CLIN MICROBIOL, V28, P276, DOI 10.1128/JCM.28.2.276-282.1990; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Heylen E, 2013, INFECT GENET EVOL, V13, P27, DOI 10.1016/j.meegid.2012.08.019; Hu LY, 2012, CURR OPIN VIROL, V2, P380, DOI 10.1016/j.coviro.2012.06.003; Degiuseppe JI, 2013, ARCH ARGENT PEDIATR, V111, P148, DOI 10.5546/aap.2013.148; Iturriza-Gomara M, 2011, EPIDEMIOL INFECT, V139, P895, DOI 10.1017/S0950268810001810; Lee JB, 2003, ARCH VIROL, V148, P643, DOI 10.1007/s00705-002-0963-7; Linhares AC, 2008, LANCET, V371, P1181, DOI 10.1016/S0140-6736(08)60524-3; Linhares AC, 2011, REV MED VIROL, V21, P89, DOI 10.1002/rmv.682; Martella V, 2003, VIROLOGY, V314, P358, DOI 10.1016/S0042-6822(03)00418-5; Martella V, 2001, VIRUS RES, V74, P17, DOI 10.1016/S0168-1702(00)00230-6; Martinez-Laso J, 2009, J GEN VIROL, V90, P935, DOI 10.1099/vir.0.007807-0; Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07; Matthijnssens J, 2012, CURR OPIN VIROL, V2, P426, DOI 10.1016/j.coviro.2012.04.007; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; Matthijnssens J, 2009, FUTURE MICROBIOL, V4, P1303, DOI [10.2217/fmb.09.96, 10.2217/FMB.09.96]; Maunula L, 2002, J VIROL, V76, P11793, DOI 10.1128/JVI.76.23.11793-11800.2002; McDonald SM, 2011, INFECT GENET EVOL, V11, P1586, DOI 10.1016/j.meegid.2011.05.023; McDonald SM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000634; Mitui MT, 2011, J CLIN VIROL, V50, P325, DOI 10.1016/j.jcv.2011.01.008; Mukherjee A, 2012, INFECT GENET EVOL, V12, P1933, DOI 10.1016/j.meegid.2012.08.009; Parra GI, 2004, J GEN VIROL, V85, P1713, DOI 10.1099/vir.0.79851-0; Patel MM, 2009, J INFECT DIS, V200, pS291, DOI 10.1086/605059; Phan TG, 2007, CLIN LAB, V53, P41; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Soares LD, 2014, J MED VIROL, V86, P1065, DOI 10.1002/jmv.23797; Steyer A, 2008, J GEN VIROL, V89, P1690, DOI 10.1099/vir.0.2008/001206-0; Stupka JA, 2007, J MED VIROL, V79, P838, DOI 10.1002/jmv.20841; Stupka JA, 2012, J CLIN VIROL, V54, P162, DOI 10.1016/j.jcv.2012.02.011; Stupka JA, 2009, INFECT GENET EVOL, V9, P1225, DOI 10.1016/j.meegid.2009.07.002; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Thongprachum A, 2013, INFECT GENET EVOL, V13, P168, DOI 10.1016/j.meegid.2012.09.010; Tran T N Hoa, 2013, Trop Med Health, V41, P13, DOI 10.2149/tmh.2012-29; Trinh QD, 2007, J MED VIROL, V79, P1611, DOI 10.1002/jmv.20931; Trojnar E, 2013, J GEN VIROL, V94, P136, DOI 10.1099/vir.0.047381-0; Wang YH, 2009, J MED VIROL, V81, P382, DOI 10.1002/jmv.21387	53	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110341	10.1371/journal.pone.0110341	http://dx.doi.org/10.1371/journal.pone.0110341			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337915	Green Submitted, Green Published, gold			2022-12-27	WOS:000343674800037
J	Park, AY; Son, EJ; Kim, JA; Youk, JH; Park, YJ; Park, CS; Chang, HS				Park, Ah Young; Son, Eun Ju; Kim, Jeong-Ah; Youk, Ji Hyun; Park, Yun Joo; Park, Cheong Soo; Chang, Hang Seok			Associations of the BRAF(V600E) Mutation with Sonographic Features and Clinicopathologic Characteristics in a Large Population with Conventional Papillary Thyroid Carcinoma	PLOS ONE			English	Article							BRAF V600E MUTATION; NEEDLE-ASPIRATION BIOPSIES; CLINICAL-IMPLICATIONS; PROGNOSTIC-FACTORS; PATHOGENIC ROLE; GENE MUTATION; CANCER; NODULES; RISK; STRATIFICATION	Objective: To evaluate the association of the BRAF(V600E) mutation with sonographic features and clinicopathologic characteristics in a large population with conventional papillary thyroid carcinoma (PTC). Methods: We retrospectively reviewed the sonographic features, clinicopathologic characteristics, and presence of the BRAF(V600E) mutation in 688 patients who underwent thyroidectomy for conventional PTC between January and July 2010 at a single institution. The incidence of the BRAF(V600E) mutation was calculated. The sonographic features and clinicopathologic characteristics were compared between BRAF-positive and BRAF-negative patients. BRAF-positive patients were subdivided into those with papillary thyroid microcarcinoma (the PTMC group) and those with PTC larger than 10 mm (the PTC>10 mm group), and their sonographic features were compared. Results: The BRAF(V600E) mutation was detected in 69.2% of patients (476 of 688). Sonographic features were not significantly different between BRAF-positive and BRAF-negative PTC, nor between PTMC and PTC>10 mm groups. The BRAF(V600E) mutation was associated with male sex (P = 0.028), large tumor size, extrathyroidal extension, central and lateral lymph node metastasis, and advanced tumor stage (P<0.0001). Conclusion: The BRAF(V600E) mutation was significantly associated with several poor clinicopathologic characteristics, but was not associated with sonographic features, regardless of tumor size. We recommend that patients with a thyroid nodule with any suspicious sonographic feature undergo preoperative BRAF(V600E) testing for risk stratification and to guide the initial surgical approach in PTC.	[Park, Ah Young; Son, Eun Ju; Kim, Jeong-Ah; Youk, Ji Hyun; Park, Yun Joo] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Radiol, Seoul, South Korea; [Park, Ah Young; Son, Eun Ju; Kim, Jeong-Ah; Youk, Ji Hyun; Park, Yun Joo] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Res Inst Radiol Sci, Seoul, South Korea; [Park, Yun Joo] Soonchunghyang Univ, Coll Med, Soonchunghyang Univ Hosp, Dept Radiol, Seoul, South Korea; [Park, Cheong Soo; Chang, Hang Seok] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Surg,Thyroid Canc Ctr, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Soonchunhyang University; Yonsei University; Yonsei University Health System	Son, EJ (corresponding author), Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Radiol, Seoul, South Korea.	ejsonrd@yuhs.ac		Son, Eun Ju/0000-0002-7895-0335; Chang, Hang-Seok/0000-0002-5162-103X; Kim, Jeong-Ah/0000-0003-4949-4913				Alexander EK, 2008, J CLIN ENDOCR METAB, V93, P4175, DOI 10.1210/jc.2008-1328; Chakraborty A, 2012, ENDOCR PATHOL, V23, P83, DOI 10.1007/s12022-011-9184-5; Cohen Y, 2004, CLIN CANCER RES, V10, P2761, DOI 10.1158/1078-0432.CCR-03-0273; Edge SB, 2010, AJCC CANC STAGING MA; Elisei R, 2008, J CLIN ENDOCR METAB, V93, P3943, DOI 10.1210/jc.2008-0607; Fugazzola L, 2006, ENDOCR-RELAT CANCER, V13, P455, DOI 10.1677/erc.1.01086; Gouveia C, 2013, JAMA OTOLARYNGOL, V139, P1164, DOI 10.1001/jamaoto.2013.4501; Howell GM, 2013, ANN SURG ONCOL, V20, P47, DOI 10.1245/s10434-012-2611-0; Hwang J, 2010, AM J ROENTGENOL, V194, pW425, DOI 10.2214/AJR.09.3512; Ito Y, 2009, ENDOCR J, V56, P89, DOI 10.1507/endocrj.K08E-208; Jo YS, 2006, J CLIN ENDOCR METAB, V91, P3667, DOI 10.1210/jc.2005-2836; Kabaker AS, 2012, THYROID, V22, P585, DOI 10.1089/thy.2011.0274; Kebebew E, 2007, ANN SURG, V246, P466, DOI 10.1097/SLA.0b013e318148563d; Kim J, 2006, ANN SURG, V244, P799, DOI 10.1097/01.sla.0000224751.80858.13; Kim KH, 2004, YONSEI MED J, V45, P818, DOI 10.3349/ymj.2004.45.5.818; Kim SJ, 2012, WORLD J SURG, V36, P310, DOI 10.1007/s00268-011-1383-1; Kim TH, 2012, CANCER-AM CANCER SOC, V118, P1764, DOI 10.1002/cncr.26500; Kim TY, 2006, CLIN ENDOCRINOL, V65, P364, DOI 10.1111/j.1365-2265.2006.02605.x; Kim TY, 2005, CLIN ENDOCRINOL, V63, P588, DOI 10.1111/j.1365-2265.2005.02389.x; Kwak JY, 2011, RADIOLOGY, V260, P892, DOI 10.1148/radiol.11110206; Kwak JY, 2009, RADIOLOGY, V253, P854, DOI 10.1148/radiol.2533090471; Lee EJ, 2011, CLIN ENDOCRINOL, V75, P844, DOI 10.1111/j.1365-2265.2011.04154.x; Lee JH, 2007, CANCER-AM CANCER SOC, V110, P38, DOI 10.1002/cncr.22754; Lin KL, 2010, ANN SURG ONCOL, V17, P3294, DOI 10.1245/s10434-010-1129-6; Lupi C, 2007, J CLIN ENDOCR METAB, V92, P4085, DOI 10.1210/jc.2007-1179; Marchetti I, 2009, THYROID, V19, P837, DOI 10.1089/thy.2009.0074; Moon HJ, 2011, ANN SURG ONCOL, V18, P792, DOI 10.1245/s10434-010-1354-z; Moon WJ, 2008, RADIOLOGY, V247, P762, DOI 10.1148/radiol.2473070944; Moon WJ, 2012, AM J ROENTGENOL, V198, P668, DOI 10.2214/AJR.11.7185; Nam SY, 2010, THYROID, V20, P273, DOI 10.1089/thy.2009.0226; Tang KT, 2010, J CHIN MED ASSOC, V73, P113, DOI 10.1016/S1726-4901(10)70025-3; Tufano RP, 2012, MEDICINE, V91, P274, DOI 10.1097/MD.0b013e31826a9c71; Xing M, 2005, ENDOCR-RELAT CANCER, V12, P245, DOI 10.1677/erc.1.0978; Xing MZ, 2007, ENDOCR REV, V28, P742, DOI 10.1210/er.2007-0007; Xing MZ, 2009, J CLIN ONCOL, V27, P2977, DOI 10.1200/JCO.2008.20.1426; Xing MZ, 2005, J CLIN ENDOCR METAB, V90, P6373, DOI 10.1210/jc.2005-0987; Xu XL, 2003, CANCER RES, V63, P4561; Yip L, 2009, SURGERY, V146, P1215, DOI 10.1016/j.surg.2009.09.011; Zatelli MC, 2009, EUR J ENDOCRINOL, V161, P467, DOI 10.1530/EJE-09-0353	39	17	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110868	10.1371/journal.pone.0110868	http://dx.doi.org/10.1371/journal.pone.0110868			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337709	Green Submitted, gold, Green Published			2022-12-27	WOS:000343674800084
J	Pericolini, E; Gabrielli, E; Alunno, A; Bocci, EB; Perito, S; Chow, SK; Cenci, E; Casadevall, A; Gerli, R; Vecchiarelli, A				Pericolini, Eva; Gabrielli, Elena; Alunno, Alessia; Bocci, Elena Bartoloni; Perito, Stefano; Chow, Siu-Kei; Cenci, Elio; Casadevall, Arturo; Gerli, Roberto; Vecchiarelli, Anna			Functional Improvement of Regulatory T Cells from Rheumatoid Arthritis Subjects Induced by Capsular Polysaccharide Glucuronoxylomannogalactan (Publication with Expression of Concern. See vol. 16, 2021) (Publication with Expression of Concern. See vol. 16, 2021)	PLOS ONE			English	Article; Publication with Expression of Concern							TNF-ALPHA; SUPPRESSIVE FUNCTION; PERIPHERAL-BLOOD; TH17; FOXP3; TREG; PHOSPHORYLATION; POPULATION; EXPRESSION; DEPLETION	Objective: Regulatory T cells (Treg) play a critical role in the prevention of autoimmunity, and the suppressive activity of these cells is impaired in rheumatoid arthritis (RA). The aim of the present study was to investigate function and properties of Treg of RA patients in response to purified polysaccharide glucuronoxylomannogalactan (GXMGal). Methods: Flow cytometry and western blot analysis were used to investigate the frequency, function and properties of Treg cells. Results: GXMGal was able to: i) induce strong increase of FOXP3 on CD4(+) T cells without affecting the number of CD4(+)CD25(+)FOXP3(+) Treg cells with parallel increase in the percentage of non-conventional CD4(+)CD25(-)FOXP3(+) Treg cells; ii) increase intracellular levels of TGF-beta 1 in CD4(+)CD25(-)FOXP3(+) Treg cells and of IL-10 in both CD4(+)CD25(+)FOXP3(+) and CD4(+)CD25(-)FOXP3(+) Treg cells; iii) enhance the suppressive activity of CD4(+)CD25(+)FOXP3(+) and CD4(+)CD25(-)FOXP3(+) Treg cells in terms of inhibition of effector T cell activity and increased secretion of IL-10; iv) decrease Th1 response as demonstrated by inhibition of T-bet activation and down-regulation of IFN-gamma and IL-12p70 production; v) decrease Th17 differentiation by down-regulating pSTAT3 activation and IL-17A, IL-23, IL-21, IL-22 and IL-6 production. Conclusion: These data show that GXMGal improves Treg functions and increases the number and function of CD4(+)CD25(-)FOXP3(+) Treg cells of RA patients. It is suggested that GXMGal may be potentially useful for restoring impaired Treg functions in autoimmune disorders and for developing Treg cell-based strategies for the treatment of these diseases.	[Pericolini, Eva; Gabrielli, Elena; Perito, Stefano; Cenci, Elio; Vecchiarelli, Anna] Univ Perugia, Microbiol Sect, Dept Expt Med, I-06100 Perugia, Italy; [Alunno, Alessia; Bocci, Elena Bartoloni; Gerli, Roberto] Univ Perugia, Rheumatol Unit, Dept Med, I-06100 Perugia, Italy; [Chow, Siu-Kei; Casadevall, Arturo] Albert Einstein Coll Med, Dept Microbiol & Immunol, New York, NY USA	University of Perugia; University of Perugia; Yeshiva University	Vecchiarelli, A (corresponding author), Univ Perugia, Microbiol Sect, Dept Expt Med, I-06100 Perugia, Italy.	anna.vecchiarelli@unipg.it	Alunno, Alessia/AAC-8842-2022; Pericolini, Eva/AAZ-5848-2021	Vecchiarelli, Anna/0000-0002-3185-6720; CENCI, ELIO/0000-0003-0752-7262; Pericolini, Eva/0000-0002-5299-8197; PERITO, STEFANO/0000-0003-3181-523X	Fondazione Cassa di Risparmio [2012.0128.021]	Fondazione Cassa di Risparmio	This work was supported by "Fondazione Cassa di Risparmio 2012.0128.021." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alunno A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/823085; Anderson AE, 2008, ACTA REUMATOL PORT, V33, P17; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bianchini R, 2011, EUR J IMMUNOL, V41, P2269, DOI 10.1002/eji.201040943; Booth NJ, 2010, J IMMUNOL, V184, P4317, DOI 10.4049/jimmunol.0903781; Cao DJ, 2004, ARTHRITIS RES THER, V6, pR335, DOI 10.1186/ar1192; Chan ESL, 2010, NAT REV RHEUMATOL, V6, P175, DOI 10.1038/nrrheum.2010.5; Chen GJ, 2010, ARTHRITIS RHEUM-US, V62, P2900, DOI 10.1002/art.27603; de Herve MGD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011784; De Jesus M, 2009, J IMMUNOL, V183, P3885, DOI 10.4049/jimmunol.0900449; Ehrenstein MR, 2004, J EXP MED, V200, P277, DOI 10.1084/jem.20040165; Fites JS, 2013, SCIENCE, V342, P366, DOI 10.1126/science.1243316; Gabrielli E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008187; Geiger TL, 2012, HUM IMMUNOL, V73, P232, DOI 10.1016/j.humimm.2011.12.012; Gol-Ara M, 2012, ARTHRITIS, DOI 10.1155/2012/805875; Haas J, 2007, J IMMUNOL, V179, P1322, DOI 10.4049/jimmunol.179.2.1322; Han GM, 2008, CELL IMMUNOL, V253, P92, DOI 10.1016/j.cellimm.2008.05.007; Heiss C, 2009, CARBOHYD RES, V344, P915, DOI 10.1016/j.carres.2009.03.003; Herman S, 2008, CLIN EXP RHEUMATOL, V26, P317; Huang ZC, 2012, CELL IMMUNOL, V279, P25, DOI 10.1016/j.cellimm.2012.09.001; JAMES PG, 1992, INFECT IMMUN, V60, P1084, DOI 10.1128/IAI.60.3.1084-1088.1992; Jandus C, 2008, ARTHRITIS RHEUM, V58, P2307, DOI 10.1002/art.23655; Kavanaugh A, 2010, CLIN EXP RHEUMATOL, V28, pS2; Kim JR, 2012, J KOREAN MED SCI, V27, P1009, DOI 10.3346/jkms.2012.27.9.1009; Liberman AC, 2007, FASEB J, V21, P1177, DOI 10.1096/fj.06-7452com; Lin L, 2010, CANCER RES, V70, P2445, DOI 10.1158/0008-5472.CAN-09-2468; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Morgan ME, 2003, ARTHRITIS RHEUM, V48, P1452, DOI 10.1002/art.11063; Nie H, 2013, NAT MED, V19, P322, DOI 10.1038/nm.3085; Nistala K, 2009, RHEUMATOLOGY, V48, P602, DOI 10.1093/rheumatology/kep028; Ohta A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00190; Pericolini E, 2006, CELL MICROBIOL, V8, P267, DOI 10.1111/j.1462-5822.2005.00619.x; Pericolini E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053336; Pericolini E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012720; Pericolini E, 2009, J IMMUNOL, V182, P6003, DOI 10.4049/jimmunol.0803833; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Seitz M, 2000, RHEUMATOLOGY, V39, P637, DOI 10.1093/rheumatology/39.6.637; Song XQ, 2010, BIOMED PHARMACOTHER, V64, P463, DOI 10.1016/j.biopha.2010.01.007; Valencia X, 2006, BLOOD, V108, P253, DOI 10.1182/blood-2005-11-4567; Vecchiarelli A, 2013, FUTURE MICROBIOL, V8, P1107, DOI 10.2217/fmb.13.84; Venken K, 2008, J IMMUNOL, V180, P6411, DOI 10.4049/jimmunol.180.9.6411; Volin MV, 2011, RHEUMATOLOGY SUNNYVA, V1; Wehrens EJ, 2010, RHEUMATOLOGY, V49, P1632, DOI 10.1093/rheumatology/keq130; Yagi H, 2004, INT IMMUNOL, V16, P1643, DOI 10.1093/intimm/dxh165; Yang J, 2011, RHEUMATOLOGY, V50, P1366, DOI 10.1093/rheumatology/ker116; Yang J, 2009, ARTHRITIS RHEUM-US, V60, P1472, DOI 10.1002/art.24499; Zelenay S, 2005, P NATL ACAD SCI USA, V102, P4091, DOI 10.1073/pnas.0408679102	50	8	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e111163	10.1371/journal.pone.0111163	http://dx.doi.org/10.1371/journal.pone.0111163			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338013	Green Published, gold			2022-12-27	WOS:000343674800108
J	Shang, L; Liu, HJ; Hao, JJ; Jiang, YY; Shi, F; Zhang, Y; Cai, Y; Xu, X; Jia, XM; Zhan, QM; Wang, MR				Shang, Li; Liu, Hui-Juan; Hao, Jia-Jie; Jiang, Yan-Yi; Shi, Feng; Zhang, Yu; Cai, Yan; Xu, Xin; Jia, Xue-Mei; Zhan, Qi-Min; Wang, Ming-Rong			A Panel of Overexpressed Proteins for Prognosis in Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; C-KIT; LUNG-CANCER; EXPRESSION; P53; AMPLIFICATION; SURVIVAL; PIK3CA	Esophageal squamous cell carcinoma (ESCC) is a common cancer with poor prognosis. In order to identify useful biomarkers for accurately classifying prognostic risks for ESCC patients, we examined the expression of six proteins by immunohistochemistry (IHC) in 590 paraffin-embedded ESCC samples. The candidate proteins include p53, EGFR, c-KIT, TIMP1 and PI3K-p110 alpha reported to be altered in ESCC tissues as well as another important component of PI3K, PI3K-p85 alpha. Of the six proteins tested, p53, EGFR, c-KIT, TIMP1 and PI3K-p85 alpha were detected with high expression in 43.0%, 36.6%, 55.9%, 70.7% and 57.1% of tumors, respectively. Significant associations were found between high expression of PI3K-p85 alpha, EGFR and p53 and poor prognosis (P = 0.00111; 0.00001; 0.00426). Applying these three proteins as an IHC panel could divide patients into different subgroups (P<0.000001). Multivariate cox regression analysis indicated that the three-protein panel was an independent prognostic factor with very high statistical significance (HR = 2.090, 95% CI: 1.621-2.696, P = 0.00000001). The data suggest that the protein panel of PI3K-p85 alpha, EGFR and p53 is an important candidate biomarker for the prognosis of patients with ESCC.	[Shang, Li; Hao, Jia-Jie; Jiang, Yan-Yi; Shi, Feng; Zhang, Yu; Cai, Yan; Xu, Xin; Zhan, Qi-Min; Wang, Ming-Rong] Peking Union Med Coll, Canc Inst Hosp, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [Shang, Li; Hao, Jia-Jie; Jiang, Yan-Yi; Shi, Feng; Zhang, Yu; Cai, Yan; Xu, Xin; Zhan, Qi-Min; Wang, Ming-Rong] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Liu, Hui-Juan; Jia, Xue-Mei] Anhui Med Univ, Dept Histol & Embryol, Hefei, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Anhui Medical University	Wang, MR (corresponding author), Peking Union Med Coll, Canc Inst Hosp, State Key Lab Mol Oncol, Beijing 100021, Peoples R China.	wangmr2015@126.com			National High Technology Research and Development Program of China [2012AA02A503, 2011YQ17006710]; National Natural Science Foundation of China [81330052]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National High Technology Research and Development Program of China (2012AA02A503, 2011YQ17006710) and National Natural Science Foundation of China (81330052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi I, 2009, INT J ONCOL, V34, P767, DOI 10.3892/ijo_00000202; Boone J, 2009, DIS ESOPHAGUS, V22, P496, DOI 10.1111/j.1442-2050.2009.00951.x; Bunney TD, 2010, NAT REV CANCER, V10, P342, DOI 10.1038/nrc2842; Camps C, 2006, LUNG CANCER, V52, P343, DOI 10.1016/j.lungcan.2006.02.003; Eroglu A, 2007, MED ONCOL, V24, P169, DOI 10.1007/BF02698036; Fan HJ, 2013, HISTOPATHOLOGY, V62, P1028, DOI 10.1111/his.12111; Feng YB, 2009, INT J CANCER, V124, P578, DOI 10.1002/ijc.23990; Goh XY, 2011, GUT, V60, P1317, DOI 10.1136/gut.2010.234179; Groblewska M, 2012, FOLIA HISTOCHEM CYTO, V50, P12, DOI [10.5603/FHC.2012.0002, 10.2478/18691]; Hanawa M, 2006, INT J CANCER, V118, P1173, DOI 10.1002/ijc.21454; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Lennartsson J, 2012, PHYSIOL REV, V92, P1619, DOI 10.1152/physrev.00046.2011; Lin DC, 2009, DIS ESOPHAGUS, V22, P9, DOI 10.1111/j.1442-2050.2008.00845.x; Liu YZ, 2012, LUNG CANCER, V77, P176, DOI 10.1016/j.lungcan.2012.03.001; Liu YS, 2007, J DIGEST DIS, V8, P133, DOI 10.1111/j.1443-9573.2007.00299.x; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Ong CAJ, 2013, J CLIN ONCOL, V31, P1576, DOI 10.1200/JCO.2012.45.9636; Peters CJ, 2010, GASTROENTEROLOGY, V139, P1995, DOI 10.1053/j.gastro.2010.05.080; Shang L, 2013, FRONT MED; Sharma R, 2004, ONCOLOGY-BASEL, V67, P300, DOI 10.1159/000081331; Sun Yan, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P416; Wada S, 2006, ANN SURG ONCOL, V13, P961, DOI 10.1245/ASO.2006.08.006; Yang YL, 2008, GENE CHROMOSOME CANC, V47, P127, DOI 10.1002/gcc.20514; Yi CJ, 2012, ONCOL LETT, V3, P369, DOI 10.3892/ol.2011.481; Yu WW, 2011, HEPATO-GASTROENTEROL, V58, P426; Zhang SS, 2013, ANN SURG ONCOL, V20, P2419, DOI 10.1245/s10434-012-2859-4	26	30	30	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e111045	10.1371/journal.pone.0111045	http://dx.doi.org/10.1371/journal.pone.0111045			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337715	Green Published, gold, Green Submitted			2022-12-27	WOS:000343674800098
J	Arefin, AS; Vimieiro, R; Riveros, C; Craig, H; Moscato, P				Arefin, Ahmed Shamsul; Vimieiro, Renato; Riveros, Carlos; Craig, Hugh; Moscato, Pablo			An Information Theoretic Clustering Approach for Unveiling Authorship Affinities in Shakespearean Era Plays and Poems	PLOS ONE			English	Article							'LOVERS-COMPLAINT'; 'CYMBELINE'; EXPRESSION	In this paper we analyse the word frequency profiles of a set of works from the Shakespearean era to uncover patterns of relationship between them, highlighting the connections within authorial canons. We used a text corpus comprising 256 plays and poems from the 16th and 17th centuries, with 17 works of uncertain authorship. Our clustering approach is based on the Jensen-Shannon divergence and a graph partitioning algorithm, and our results show that authors' characteristic styles are very powerful factors in explaining the variation of word use, frequently transcending cross-cutting factors like the differences between tragedy and comedy, early and late works, and plays and poems. Our method also provides an empirical guide to the authorship of plays and poems where this is unknown or disputed.	[Arefin, Ahmed Shamsul; Vimieiro, Renato; Riveros, Carlos; Moscato, Pablo] Univ Newcastle, Ctr Bioinformat Biomarker Discovery & Informat Ba, Callaghan, NSW 2308, Australia; [Craig, Hugh] Univ Newcastle, Ctr Literary & Linguist Comp, Callaghan, NSW 2308, Australia	University of Newcastle; University of Newcastle	Moscato, P (corresponding author), Univ Newcastle, Ctr Bioinformat Biomarker Discovery & Informat Ba, Callaghan, NSW 2308, Australia.	Pablo.Moscato@newcastle.edu.au	MOSCATO, PABLO ALBERTO/G-7668-2013; Arefin, Ahmed Shamsul/G-8130-2013; Vimieiro, Renato/G-8109-2013	Arefin, Ahmed Shamsul/0000-0002-9290-3551; Vimieiro, Renato/0000-0002-7911-2456; Craig, Hugh/0000-0002-9336-1678; Moscato, Pablo/0000-0003-2570-5966	Australian Research Council (ARC) Discovery Project [DP120102576, DP140104183]; ARC Future Fellowship [FT120100060]	Australian Research Council (ARC) Discovery Project(Australian Research Council); ARC Future Fellowship(Australian Research Council)	This work was partially funded by Australian Research Council (ARC) Discovery Project Grants DP120102576 and DP140104183. PM is funded by ARC Future Fellowship FT120100060. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arefin AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045535; Arefin AS, 2012, INT CONF COMP SCI ED, P585, DOI 10.1109/ICCSE.2012.6295143; Arefin AS, 2011, LECT NOTES COMPUT SC, V7017, P375, DOI 10.1007/978-3-642-24669-2_36; Arefin AS, 2012, LECT NOTES COMPUT SC, V7333, P71, DOI 10.1007/978-3-642-31125-3_6; Burrows J., 2007, Literary & Linguistic Computing, V22. no 1, P27, DOI 10.1093/llc/fqi067; Burrows J. F., 1987, Literary & Linguistic Computing, V2, P61, DOI 10.1093/llc/2.2.61; Burrows J. F., 1988, EIGHTEENTH-CENT STUD, V21, P427; Capp A, 2009, RADIOTHER ONCOL, V90, P400, DOI 10.1016/j.radonc.2008.09.019; Chesler E. J., 2006, COMBINATORIAL GENETI; Craig H, 2009, 3 PARTS HENRY 6, P40; Craig H, 2009, 1602 ADDITIONS SPANI, P162; Craig H, 2012, SHAKESPEARE QUART, V63, P147, DOI 10.1353/shq.2012.0025; Craig H, 2010, LIT LINGUIST COMPUT, V25, P37, DOI 10.1093/llc/fqp033; Csardi ~ G, 2006, INTERJ COMP SYST, V1695; Curran JE, 2009, COMP DRAMA, V43, P317; Ellegard A, 1962, AUSTR J STAT, P13; Elliott WEY, 2004, TENN LAW REV, V72, P323; Forsyth R. S., 1999, Literary & Linguistic Computing, V14, P375, DOI 10.1093/llc/14.3.375; Fox C., 1990, SIGIR Forum, V24, P19, DOI 10.1145/378881.378888; Griswold W, 1986, RENAISSANCE REVIVALS; HIEATT AK, 1987, NOTES QUERIES, V34, P219; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; Holmes D. I., 2001, Literary & Linguistic Computing, V16, P403, DOI 10.1093/llc/16.4.403; Holmes D. I., 1998, Literary & Linguistic Computing, V13, P111, DOI 10.1093/llc/13.3.111; HOLMES DI, 1994, COMPUT HUMANITIES, V28, P87, DOI 10.1007/BF01830689; Hoover D. L., 2003, Literary & Linguistic Computing, V18, P341, DOI 10.1093/llc/18.4.341; Hoover D. L., 2001, Literary & Linguistic Computing, V16, P421, DOI 10.1093/llc/16.4.421; Inostroza-Ponta M, 2007, LECT NOTES ARTIF INT, V4828, P156; Inostroza-Ponta M, 2006, INT FED INFO PROC, V217, P179; Jackson MP, 2008, MOD LANG REV, V103, P621, DOI 10.2307/20467901; Johnstone B, 1997, LANG SOC, V26, P221, DOI 10.1017/S0047404500020911; LANCASTER HO, 1965, AUST J STAT, V7, P32; Marsden J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066813; Pincombe M, 1996, PREFACE, pvii; Rybicki J, 2011, LIT LINGUIST COMPUT, V26, P315, DOI 10.1093/llc/fqr031; Stamatatos E, 2009, J AM SOC INF SCI TEC, V60, P538, DOI 10.1002/asi.21001; Vickers B., 2002, COUNTERFEITING SHAKE; Watt TI, 2009, AUTHORSHIP RAIGNE ED, P116; Wells S, 2000, KING LEAR; WILBUR WJ, 1992, J INF SCI, V18, P45, DOI 10.1177/016555159201800106; Williams GW, 1996, TEXTUAL INTRO ROLLO, V10, P46	41	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111445	10.1371/journal.pone.0111445	http://dx.doi.org/10.1371/journal.pone.0111445			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AZ1JF	25347727	Green Published, gold			2022-12-27	WOS:000347994900074
J	Gordon, DS; Madden, JR; Lea, SEG				Gordon, David S.; Madden, Joah R.; Lea, Stephen E. G.			Both Loved and Feared: Third Party Punishers Are Viewed as Formidable and Likeable, but These Reputational Benefits May Only Be Open to Dominant Individuals	PLOS ONE			English	Article							ALTRUISTIC PUNISHMENT; INDIRECT RECIPROCITY; COOPERATION; EVOLUTION; RETALIATION; GENEROSITY; DETERRENCE; LEADERSHIP; THREATS; POWER	Third party punishment can be evolutionarily stable if there is heterogeneity in the cost of punishment or if punishers receive a reputational benefit from their actions. A dominant position might allow some individuals to punish at a lower cost than others and by doing so access these reputational benefits. Three vignette-based studies measured participants' judgements of a third party punisher in comparison to those exhibiting other aggressive/dominant behaviours (Study 1), when there was variation in the success of punishment (Study 2), and variation in the status of the punisher and the type of punishment used (Study 3). Third party punishers were judged to be more likeable than (but equally dominant as) those who engaged in other types of dominant behaviour (Study 1), were judged to be equally likeable and dominant whether their intervention succeeded or failed (Study 2), and participants believed that only a dominant punisher could intervene successfully (regardless of whether punishment was violent or non-violent) and that subordinate punishers would face a higher risk of retaliation (Study 3). The results suggest that dominance can dramatically reduce the cost of punishment, and that while individuals can gain a great deal of reputational benefit from engaging in third party punishment, these benefits are only open to dominant individuals. Taking the status of punishers into account may therefore help explain the evolution of third party punishment.	[Gordon, David S.; Madden, Joah R.; Lea, Stephen E. G.] Univ Exeter, Sch Psychol, Exeter, Devon, England	University of Exeter	Gordon, DS (corresponding author), Univ Exeter, Sch Psychol, Exeter, Devon, England.	dsg204@exeter.ac.uk	Lea, Stephen/B-4811-2009	Lea, Stephen/0000-0002-8498-4187; Gordon, David/0000-0003-0807-834X; Madden, Joah/0000-0002-0691-0967	School of Psychology, University of Exeter	School of Psychology, University of Exeter	Funding for this project was provided internally by the School of Psychology, University of Exeter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 2008, PERS SOC PSYCHOL B, V34, P90, DOI 10.1177/0146167207307489; Balliet D, 2011, PSYCHOL BULL, V137, P594, DOI 10.1037/a0023489; Barclay P, 2006, EVOL HUM BEHAV, V27, P325, DOI 10.1016/j.evolhumbehav.2006.01.003; Barclay P, 2013, EVOL HUM BEHAV, V34, P164, DOI 10.1016/j.evolhumbehav.2013.02.002; Barclay P, 2010, BRIT J PSYCHOL, V101, P123, DOI 10.1348/000712609X435733; Barr Abigail, 2001, SOCIAL DILEMMAS SHAM; Bazzan ALC, 2010, ADV COMPLEX SYST, V13, P755, DOI 10.1142/S0219525910002815; Benard S, 2013, SOC SCI RES, V42, P230, DOI 10.1016/j.ssresearch.2012.09.004; Bowles S, 2004, THEOR POPUL BIOL, V65, P17, DOI 10.1016/j.tpb.2003.07.001; Brosnan SF, 2011, J EC BEHAV ORG; BUSS DM, 1981, J PERS SOC PSYCHOL, V40, P147, DOI 10.1037/0022-3514.40.1.147; Cant MA, 2009, AM NAT, V173, P759, DOI 10.1086/598489; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; Cummins D., 2005, HDB EVOLUTIONARY PSY, P676; Cummins DD, 1996, MIND MACH, V6, P463; Dasgupta P, 2011, J THEORETICAL BIOL; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; de Weerd H, 2011, J THEORETICAL BIOL; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; Dreber A, 2012, BEHAV BRAIN SCI, V35, DOI 10.1017/S0140525X11001221; Eckel CC, 2010, J PUBLIC ECON THEORY, V12, P737, DOI 10.1111/j.1467-9779.2010.01472.x; Falk A, 2005, ECONOMETRICA, V73, P2017, DOI 10.1111/j.1468-0262.2005.00644.x; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fessler DMT, 2014, EVOL HUM BEHAV, V35, P26, DOI 10.1016/j.evolhumbehav.2013.09.003; Flack JC, 2006, NATURE, V439, P426, DOI 10.1038/nature04326; Flack JC, 2005, AM NAT, V165, pE126, DOI 10.1086/429277; Frank SA, 1996, ANIM BEHAV, V52, P1163, DOI 10.1006/anbe.1996.0263; Fudenberg D, 2010, J PUBLIC ECON, V94, P78, DOI 10.1016/j.jpubeco.2009.10.007; Griskevicius V, 2009, J PERS SOC PSYCHOL, V96, P980, DOI 10.1037/a0013907; Gurerk O, 2006, SCIENCE, V312, P108, DOI 10.1126/science.1123633; Hawley PH, 2008, INT J BEHAV DEV, V32, P76, DOI 10.1177/0165025407084054; Hawley PH, 1999, DEV REV, V19, P97, DOI 10.1006/drev.1998.0470; Henrich J, 2001, EVOL HUM BEHAV, V22, P165, DOI 10.1016/S1090-5138(00)00071-4; Hogg MA, 2012, EUR REV SOC PSYCHOL, V23, P258, DOI 10.1080/10463283.2012.741134; HUSTON TL, 1981, SOC PSYCHOL QUART, V44, P14, DOI 10.2307/3033858; Iredale W, 2008, EVOL PSYCHOL-US, V6, P386, DOI 10.1177/147470490800600302; Jennings DJ, 2011, ANIM BEHAV, V81, P1217, DOI 10.1016/j.anbehav.2011.03.007; Jones B, 2006, PSYCHOL SCI, V17, P283, DOI 10.1111/j.1467-9280.2006.01699.x; Jones BC, 2011, ANIMAL BEHAV; Kim SH, 1998, PERS SOC PSYCHOL B, V24, P353, DOI 10.1177/0146167298244002; Kurzban R, 2007, EVOL HUM BEHAV, V28, P75, DOI 10.1016/j.evolhumbehav.2006.06.001; Levine M, 2011, PSYCHOL SCI; Lewis RJ, 2002, Q REV BIOL, V77, P149, DOI 10.1086/343899; Maner JK, 2010, J PERS SOC PSYCHOL, V99, P482, DOI 10.1037/a0018559; Marlowe FW, 2008, P R SOC B, V275, P587, DOI 10.1098/rspb.2007.1517; Masclet D, 2003, AM ECON REV, V93, P366, DOI 10.1257/000282803321455359; Mathew S, 2011, P NATL ACAD SCI; McCullough ME, 2013, BEHAV BRAIN SCI, V36, P1, DOI 10.1017/S0140525X11002160; McNamara JM, 2002, PHILOS T R SOC B, V357, P1607, DOI 10.1098/rstb.2002.1069; Melis AP, 2010, PHILOS T R SOC B, V365, P2663, DOI 10.1098/rstb.2010.0157; Nelissen RMA, 2008, EVOL HUM BEHAV, V29, P242, DOI 10.1016/j.evolhumbehav.2008.01.001; Nikiforakis N, 2008, EXP ECON, V11, P358, DOI 10.1007/s10683-007-9171-3; Nikiforakis N, 2008, J PUBLIC ECON, V92, P91, DOI 10.1016/j.jpubeco.2007.04.008; Nikiforakis N, 2010, SOUTH ECON J, V76, P638, DOI 10.4284/sej.2010.76.3.638; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; OSTROM E, 1992, AM POLIT SCI REV, V86, P404, DOI 10.2307/1964229; Ottone S, 2008, EC B, V3, P1; Panchanathan K, 2004, NATURE, V432, P499, DOI 10.1038/nature02978; Pedersen EJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2723; Platek S. M., 2009, J SOCIAL EVOLUTIONAR, V3, P182, DOI [10.1037/h0099323, DOI 10.1037/H0099323]; Przepiorka W, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0247; Rand DG, 2010, J THEOR BIOL, V265, P624, DOI 10.1016/j.jtbi.2010.06.010; Reuben E, 2009, J CONFLICT RESOLUT, V53, P72, DOI 10.1177/0022002708322361; Santos MD, 2010, P ROYAL SOC B, V278, P371, DOI DOI 10.1098/RSPB.2010.1275; Schino G, 2009, ADV STUD BEHAV, V39, P45, DOI 10.1016/S0065-3454(09)39002-6; Sell A, 2009, P NATL ACAD SCI USA, V106, P15073, DOI 10.1073/pnas.0904312106; Sell A, 2009, P R SOC B, V276, P575, DOI 10.1098/rspb.2008.1177; Silk JB, 2002, EVOL ANTHROPOL, V11, P221, DOI 10.1002/evan.10038; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Szamado S, 2011, ANIMAL BEHAV; Tarling R, 2010, BRIT J CRIMINOL, V50, P474, DOI 10.1093/bjc/azq011; Tennie C, 2012, BEHAV BRAIN SCI, V35, DOI 10.1017/S0140525X11001336; Tibbetts EA, 2010, CURR BIOL, V20, P1637, DOI 10.1016/j.cub.2010.07.042; Topalli V, 2002, BRIT J CRIMINOL, V42, P337, DOI 10.1093/bjc/42.2.337; Widdig A, 2000, AM J PRIMATOL, V50, P37, DOI 10.1002/(SICI)1098-2345(200001)50:1<37::AID-AJP4>3.3.CO;2-V; Wilson DS, 2003, HUM NATURE-INT BIOS, V14, P277, DOI 10.1007/s12110-003-1007-z; Wong MYL, 2007, P ROY SOC B-BIOL SCI, V274, P1093, DOI 10.1098/rspb.2006.0284	77	18	18	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e110045	10.1371/journal.pone.0110045	http://dx.doi.org/10.1371/journal.pone.0110045			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ1JF	25347781	Green Published, gold			2022-12-27	WOS:000347994900019
J	Kobayashi, S; Hara, A; Isagawa, T; Manabe, I; Takeda, K; MaruYama, T				Kobayashi, Shuhei; Hara, Akira; Isagawa, Takayuki; Manabe, Ichiro; Takeda, Kiyoshi; MaruYama, Takashi			The Nuclear I kappa B Family Protein I kappa B-NS Influences the Susceptibility to Experimental Autoimmune Encephalomyelitis in a Murine Model	PLOS ONE			English	Article							REGULATORY T-CELLS; ROR-GAMMA-T; DIFFERENTIATION; TRANSCRIPTION; RECEPTOR; INFLAMMATION; INDUCTION; T(H)17; TH17; BNS	The nuclear I kappa B family protein I kappa B-NS is expressed in T cells and plays an important role in Interferon (IFN)-gamma and Interleukin (IL)-2 production. I kappa B-zeta, the most similar homolog of I kappa B-NS, plays an important role in the generation of T helper (Th)17 cells in cooperation with ROR gamma t, a master regulator of Th17 cells. Thus, I kappa B-zeta deficient mice are resistant to Th17-dependent experimental autoimmune encephalomyelitis (EAE). However, I kappa B-zeta deficient mice develop the autoimmune-like Sjogren syndrome with aging. Here we found that I kappa B-NS-deficient (Nfkbid(-/-)) mice show resistance against developing Th17-dependent EAE. We found that Nfkbid(-/-) T cells have decreased expression of IL-17-related genes and ROR gamma t in response to Transforming Growth Factor (TGF)-beta 1 and IL-6 stimulation. Thus, I kappa B-NS plays a pivotal role in the generation of Th17 cells and in the control of Th17-dependent EAE.	[Kobayashi, Shuhei; MaruYama, Takashi] Tohoku Univ, Lab Cell Recognit & Response, Sendai, Miyagi 980, Japan; [Hara, Akira] Gifu Univ, Grad Sch Med, Dept Pathol, Gifu, Japan; [Isagawa, Takayuki] Tokyo Med & Dent Univ, Dept Genom Pathol, Tokyo, Japan; [Manabe, Ichiro] Univ Tokyo, Dept Cardiovasc Med, Tokyo, Japan; [Takeda, Kiyoshi] Osaka Univ, Lab Immune Regulat, Osaka, Japan; [MaruYama, Takashi] Gifu Univ, Grad Sch Med, Dept Cell Signaling, Gifu, Japan	Tohoku University; Gifu University; Tokyo Medical & Dental University (TMDU); University of Tokyo; Osaka University; Gifu University	MaruYama, T (corresponding author), Tohoku Univ, Lab Cell Recognit & Response, Sendai, Miyagi 980, Japan.	ta-maru@umin.ac.jp	Manabe, Ichiro/AAE-5105-2021; MaruYama, Takashi/N-5994-2014; Manabe, Ichiro/E-1529-2014; Takeda, Kiyoshi/C-9331-2009	MaruYama, Takashi/0000-0003-0820-3219; Takeda, Kiyoshi/0000-0002-1778-6332	Ministry of Education [25118702]; Japan Society for the Promotion of Science [24790458]; Takeda Science Foundation; Uehara Memorial Foundation; Novartis Foundation; Sumitomo Foundation	Ministry of Education; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Novartis Foundation(Novartis); Sumitomo Foundation	This work was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas (25118702) from the Ministry of Education, a Grant-in-Aid for Young Scientists (B) (24790458) from the Japan Society for the Promotion of Science, and by grants from the Takeda Science Foundation, the Uehara Memorial Foundation, the Novartis Foundation, and the Sumitomo Foundation to TMY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Arnold CN, 2012, P NATL ACAD SCI USA, V109, P12286, DOI 10.1073/pnas.1209134109; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Fiorini E, 2002, MOL CELL, V9, P637, DOI 10.1016/S1097-2765(02)00469-0; Fujita S, 2006, BLOOD, V107, P3656, DOI 10.1182/blood-2005-10-4190; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Hermann-Kleiter N, 2012, J AUTOIMMUN, V39, P428, DOI 10.1016/j.jaut.2012.07.007; Hirotani T, 2005, J IMMUNOL, V174, P3650, DOI 10.4049/jimmunol.174.6.3650; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kleinschek MA, 2007, J EXP MED, V204, P161, DOI 10.1084/jem.20061738; Kuwata H, 2006, IMMUNITY, V24, P41, DOI 10.1016/j.immuni.2005.11.004; Manavalan B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015782; Maruyama T, 2011, SEMIN IMMUNOL, V23, P418, DOI 10.1016/j.smim.2011.06.005; Maruyama T, 2011, NAT IMMUNOL, V12, P86, DOI 10.1038/ni.1965; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; Okuma A, 2013, IMMUNITY, V38, P450, DOI 10.1016/j.immuni.2012.11.016; Oukka M, 2007, ANN RHEUM DIS, V66, P87, DOI 10.1136/ard.2007.078527; Perruche S, 2008, NAT MED, V14, P528, DOI 10.1038/nm1749; Reichert F, 1999, EXP NEUROL, V160, P508, DOI 10.1006/exnr.1999.7229; Ruan QG, 2011, J EXP MED, V208, P2321, DOI 10.1084/jem.20110462; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Satoh K, 2011, BRAIN RES, V1382, P266, DOI 10.1016/j.brainres.2011.01.049; Schuster M, 2012, IMMUNITY, V37, P998, DOI 10.1016/j.immuni.2012.08.023; Touma M, 2007, J IMMUNOL, V179, P1681, DOI 10.4049/jimmunol.179.3.1681; Veldhoen M, 2006, TRENDS IMMUNOL, V27, P358, DOI 10.1016/j.it.2006.06.001; Wang XH, 2012, IMMUNITY, V36, P23, DOI 10.1016/j.immuni.2011.10.019; Yamamoto Masahiro, 2008, Journal of Infection and Chemotherapy, V14, P265, DOI 10.1007/s10156-008-0619-y; Yamazaki S, 2005, J BIOL CHEM, V280, P1678, DOI 10.1074/jbc.M409983200; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663	29	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e110838	10.1371/journal.pone.0110838	http://dx.doi.org/10.1371/journal.pone.0110838			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347393	gold, Green Published, Green Submitted			2022-12-27	WOS:000347994900032
J	Nallanchakravarthula, S; Mahmood, S; Alstrom, S; Finlay, RD				Nallanchakravarthula, Srivathsa; Mahmood, Shahid; Alstrom, Sadhna; Finlay, Roger D.			Influence of Soil Type, Cultivar and Verticillium dahliae on the Structure of the Root and Rhizosphere Soil Fungal Microbiome of Strawberry	PLOS ONE			English	Article							ENDOPHYTIC BACTERIAL COMMUNITIES; ARABIDOPSIS-THALIANA; DIVERSITY; RESISTANCE; POPULATIONS; BIOCONTROL; WILT; MANAGEMENT; IMPACT; GENES	Sustainable management of crop productivity and health necessitates improved understanding of the ways in which rhizosphere microbial populations interact with each other, with plant roots and their abiotic environment. In this study we examined the effects of different soils and cultivars, and the presence of a soil-borne fungal pathogen, Verticillium dahliae, on the fungal microbiome of the rhizosphere soil and roots of strawberry plants, using high-throughput pyrosequencing. Fungal communities of the roots of two cultivars, Honeoye and Florence, were statistically distinct from those in the rhizosphere soil of the same plants, with little overlap. Roots of plants growing in two contrasting field soils had high relative abundance of Leptodontidium sp. C2 BESC 319 g whereas rhizosphere soil was characterised by high relative abundance of Trichosporon dulcitum or Cryptococcus terreus, depending upon the soil type. Differences between different cultivars were not as clear. Inoculation with the pathogen V. dahliae had a significant influence on community structure, generally decreasing the number of rhizosphere soil-and root-inhabiting fungi. Leptodontidium sp. C2 BESC 319 g was the dominant fungus responding positively to inoculation with V. dahliae. The results suggest that 1) plant roots select microorganisms from the wider rhizosphere pool, 2) that both rhizosphere soil and root inhabiting fungal communities are influenced by V. dahliae and 3) that soil type has a stronger influence on both of these communities than cultivar.	[Nallanchakravarthula, Srivathsa; Mahmood, Shahid; Alstrom, Sadhna; Finlay, Roger D.] Swedish Univ Agr Sci, Dept Forest Mycol & Plant Pathol, Uppsala BioCtr, Uppsala, Sweden	Swedish University of Agricultural Sciences	Nallanchakravarthula, S (corresponding author), Swedish Univ Agr Sci, Dept Forest Mycol & Plant Pathol, Uppsala BioCtr, Uppsala, Sweden.	srivathsa.nallan@gmail.com	Finlay, Roger/Q-7796-2019; Finlay, Roger D/B-4731-2009; Mahmood, Shahid/AAK-2276-2020; Nallan, Srivathsa/U-8199-2019	Finlay, Roger/0000-0002-3652-2930; Finlay, Roger D/0000-0002-3652-2930; Mahmood, Shahid/0000-0001-6280-4387; Nallan, Srivathsa/0000-0002-3488-273X	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning [2007-1689]	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas)	This work was funded by Grant No. 2007-1689 to RF from The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly AH, 2011, APPL MICROBIOL BIOT, V90, P1829, DOI 10.1007/s00253-011-3270-y; An MJ, 2011, CAN J MICROBIOL, V57, P355, DOI [10.1139/w11-015, 10.1139/W11-015]; Andrade-Linares DR, 2011, MYCORRHIZA, V21, P413, DOI 10.1007/s00572-010-0351-1; Andreote FD, 2010, ANTON LEEUW INT J G, V97, P389, DOI 10.1007/s10482-010-9421-9; AZAD HR, 1987, APPL MICROBIOL BIOT, V26, P99, DOI 10.1007/BF00282156; Berg G, 2005, APPL ENVIRON MICROB, V71, P4203, DOI 10.1128/AEM.71.8.4203-4213.2005; Berg G, 2009, APPL MICROBIOL BIOT, V84, P11, DOI 10.1007/s00253-009-2092-7; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Mestre MC, 2011, FEMS MICROBIOL ECOL, V78, P531, DOI 10.1111/j.1574-6941.2011.01183.x; Costa R, 2006, FEMS MICROBIOL ECOL, V56, P236, DOI 10.1111/j.1574-6941.2005.00026.x; Davik J, 2000, ADV STRAWBERRY RES, V19, P13; Favaro LCD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036826; Drigo B, 2010, P NATL ACAD SCI USA, V107, P10938, DOI 10.1073/pnas.0912421107; Edel-Hermann V, 2009, FEMS MICROBIOL ECOL, V68, P37, DOI 10.1111/j.1574-6941.2009.00656.x; El-Deeb HM, 2013, ARCH PHYTOPATHOL PLA, P1; Ellis MA, 2008, VERTICILLIUM WILT ST; Fan L, 2011, BOTANY, V89, P397, DOI [10.1139/B11-028, 10.1139/b11-028]; Fradin EF, 2006, MOL PLANT PATHOL, V7, P71, DOI [10.1111/j.1364-3703.2006.00323.x, 10.1111/J.1364-3703.2006.00323.X]; Gao GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031806; Girvan MS, 2003, APPL ENVIRON MICROB, V69, P1800, DOI 10.1128/AEM.69.3.1800-1809.2003; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Harris DC, 1996, PLANT PATHOL, V45, P106, DOI 10.1046/j.1365-3059.1996.d01-96.x; Hartmann A, 2009, PLANT SOIL, V321, P235, DOI 10.1007/s11104-008-9814-y; Heale JB, 1999, CAN J PLANT PATHOL, V21, P1; Hoitink HAJ, 1999, ANNU REV PHYTOPATHOL, V37, P427, DOI 10.1146/annurev.phyto.37.1.427; Ihrmark K, 2012, FEMS MICROBIOL ECOL, V82, P666, DOI 10.1111/j.1574-6941.2012.01437.x; Johansson JF, 2004, FEMS MICROBIOL ECOL, V48, P1, DOI 10.1016/j.femsec.2003.11.012; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kent AD, 2002, ANNU REV MICROBIOL, V56, P211, DOI 10.1146/annurev.micro.56.012302.161120; Klosterman SJ, 2009, ANNU REV PHYTOPATHOL, V47, P39, DOI 10.1146/annurev-phyto-080508-081748; Lodewyckx C, 2002, CRIT REV PLANT SCI, V21, P583, DOI 10.1080/0735-260291044377; Lord Cheryl A S, 1994, FACT SHEET; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Margesin R, 2005, RES MICROBIOL, V156, P68, DOI 10.1016/j.resmic.2004.08.002; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Meszka B, 2009, PHYTOPATHOLOGIA, V52, P21; MIDDELHOVEN WJ, 1992, PLANT SOIL, V145, P37, DOI 10.1007/BF00009539; Morgan JAW, 2005, J EXP BOT, V56, P1729, DOI 10.1093/jxb/eri205; Mousa WK, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00065; Norman JR, 1996, PLANT SOIL, V185, P191, DOI 10.1007/BF02257524; Norman JR, 2000, MYCOL RES, V104, P1069, DOI 10.1017/S0953756299002191; Olbricht K, 2008, STRAWBERRY BREEDING, P144; Philippot L, 2013, NAT REV MICROBIOL, V11, P789, DOI 10.1038/nrmicro3109; Raaijmakers JM, 2012, ANNU REV PHYTOPATHOL, V50, P403, DOI 10.1146/annurev-phyto-081211-172908; Rastogi G, 2011, MICROBES AND MICROBIAL TECHNOLOGY: AGRICULTURAL AND ENVIRONMENTAL APPLICATIONS, P29, DOI 10.1007/978-1-4419-7931-5_2; Reeve JR, 2010, ISME J, V4, P1099, DOI 10.1038/ismej.2010.42; Reganold JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012346; Reiter B, 2002, APPL ENVIRON MICROB, V68, P2261, DOI 10.1128/AEM.68.5.2261-2268.2002; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Rudrappa T, 2008, PLANT PHYSIOL, V148, P1547, DOI 10.1104/pp.108.127613; Ryan RP, 2008, FEMS MICROBIOL LETT, V278, P1, DOI 10.1111/j.1574-6968.2007.00918.x; Santos-Gonzalez JC, 2011, MICROB ECOL, V62, P25, DOI 10.1007/s00248-011-9834-7; Shade A, 2012, ENVIRON MICROBIOL, V14, P4, DOI 10.1111/j.1462-2920.2011.02585.x; Simpson DW, 2002, ACTA HORTIC, P165, DOI 10.17660/ActaHortic.2002.567.29; Smalla K, 2001, APPL ENVIRON MICROB, V67, P4742, DOI 10.1128/AEM.67.10.4742-4751.2001; Smith KP, 1999, ANNU REV PHYTOPATHOL, V37, P473, DOI 10.1146/annurev.phyto.37.1.473; Tjamos SE, 2005, MOL PLANT MICROBE IN, V18, P555, DOI 10.1094/MPMI-18-0555; Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7; Trivedi P, 2012, ISME J, V6, P363, DOI 10.1038/ismej.2011.100; Trivedi P, 2010, APPL ENVIRON MICROB, V76, P3427, DOI 10.1128/AEM.02901-09; Vandemark GEJ, 2010, J PHYTOPATHOL, V158, P117, DOI 10.1111/j.1439-0434.2009.01583.x; Weinert N, 2011, FEMS MICROBIOL ECOL, V75, P497, DOI 10.1111/j.1574-6941.2010.01025.x; Weller DM, 2002, ANNU REV PHYTOPATHOL, V40, P309, DOI 10.1146/annurev.phyto.40.030402.110010; White TJ, 1990, PCR PROTOCOLS GUIDE, DOI [DOI 10.1016/B978-0-12-372180-8.50042-1, 10.1016/B978-0-12-372180-8.50042-1]; Wissuwa M, 2009, PLANT SOIL, V321, P409, DOI 10.1007/s11104-008-9693-2; Xu LH, 2012, FEMS MICROBIOL ECOL, V82, P736, DOI 10.1111/j.1574-6941.2012.01445.x; Yang CH, 2001, FEMS MICROBIOL ECOL, V35, P129, DOI 10.1111/j.1574-6941.2001.tb00796.x; Yao HY, 2010, FEMS MICROBIOL ECOL, V72, P456, DOI 10.1111/j.1574-6941.2010.00859.x; Yuxiang Wu, 2008, Frontiers of Agriculture in China, V2, P435, DOI 10.1007/s11703-008-0079-2; Zhao Y, 2005, EUR J SOIL BIOL, V41, P21, DOI 10.1016/j.ejsobi.2005.03.002	70	34	34	1	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111455	10.1371/journal.pone.0111455	http://dx.doi.org/10.1371/journal.pone.0111455			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347069	Green Published, gold, Green Submitted			2022-12-27	WOS:000347994900077
J	Eisses, JF; Davis, AW; Tosun, AB; Dionise, ZR; Chen, C; Ozolek, JA; Rohde, GK; Husain, SZ				Eisses, John F.; Davis, Amy W.; Tosun, Akif Burak; Dionise, Zachary R.; Chen, Cheng; Ozolek, John A.; Rohde, Gustavo K.; Husain, Sohail Z.			A Computer-Based Automated Algorithm for Assessing Acinar Cell Loss after Experimental Pancreatitis	PLOS ONE			English	Article							ACTIVATION; CHOLECYSTOKININ; SEGMENTATION; MORPHOLOGY	The change in exocrine mass is an important parameter to follow in experimental models of pancreatic injury and regeneration. However, at present, the quantitative assessment of exocrine content by histology is tedious and operator-dependent, requiring manual assessment of acinar area on serial pancreatic sections. In this study, we utilized a novel computer-generated learning algorithm to construct an accurate and rapid method of quantifying acinar content. The algorithm works by learning differences in pixel characteristics from input examples provided by human experts. HE-stained pancreatic sections were obtained in mice recovering from a 2-day, hourly caerulein hyperstimulation model of experimental pancreatitis. For training data, a pathologist carefully outlined discrete regions of acinar and non-acinar tissue in 21 sections at various stages of pancreatic injury and recovery (termed the "ground truth''). After the expert defined the ground truth, the computer was able to develop a prediction rule that was then applied to a unique set of high-resolution images in order to validate the process. For baseline, non-injured pancreatic sections, the software demonstrated close agreement with the ground truth in identifying baseline acinar tissue area with only a difference of 1% 60.05% (p = 0.21). Within regions of injured tissue, the software reported a difference of 2.5% 60.04% in acinar area compared with the pathologist (p = 0.47). Surprisingly, on detailed morphological examination, the discrepancy was primarily because the software outlined acini and excluded inter-acinar and luminal white space with greater precision. The findings suggest that the software will be of great potential benefit to both clinicians and researchers in quantifying pancreatic acinar cell flux in the injured and recovering pancreas.	[Eisses, John F.; Davis, Amy W.; Dionise, Zachary R.; Ozolek, John A.; Husain, Sohail Z.] Univ Pittsburgh, UPMC, Childrens Hosp Pittsburgh, Pittsburgh, PA 15260 USA; [Tosun, Akif Burak; Chen, Cheng; Rohde, Gustavo K.] Carnegie Mellon Univ, Ctr Bioimage Informat, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University	Husain, SZ (corresponding author), Univ Pittsburgh, UPMC, Childrens Hosp Pittsburgh, Pittsburgh, PA 15260 USA.	sohail.husain@chp.edu		Rohde, Gustavo/0000-0003-1703-9035; Husain, Sohail Z/0000-0003-3012-1308	National Institutes of Health (NIH) Grants [DK083327, DK093491, DK103002]; National Pancreas Foundation Grant; NIH T32 Training Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD052892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK071492, R01DK093491, R01DK103002, R01DK083327, T32DK007017] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Pancreas Foundation Grant; NIH T32 Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) Grants DK083327, DK093491, and DK103002 (to S.Z.H.) and National Pancreas Foundation Grant and an NIH T32 Training Grant (to J.F.E.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatia M, 2005, SCAND J SURG, V94, P97, DOI 10.1177/145749690509400203; Bhatia M, 2005, PANCREATOLOGY, V5, P132, DOI 10.1159/000085265; Bhatia M, 2004, AM J PHYSIOL-GASTR L, V286, pG189, DOI 10.1152/ajpgi.00304.2003; Bockman DE, 1997, MICROSC RES TECHNIQ, V37, P509, DOI 10.1002/(SICI)1097-0029(19970601)37:5/6<509::AID-JEMT13>3.3.CO;2-Q; Chen C, 2013, THESIS CARNEGIE MELL, pxvi; Chen C, 2011, INT J BIOMED IMAGING, V2011, DOI 10.1155/2011/606857; Coelho LP, 2009, I S BIOMED IMAGING, P518, DOI 10.1109/ISBI.2009.5193098; Criscimanna A, 2011, GASTROENTEROLOGY, V141, P1451, DOI 10.1053/j.gastro.2011.07.003; Deng YN, 2001, IEEE T PATTERN ANAL, V23, P800, DOI 10.1109/34.946985; Desai BM, 2007, J CLIN INVEST, V117, P971, DOI 10.1172/JCI29988; Felzenszwalb PF, 2004, INT J COMPUT VISION, V59, P167, DOI 10.1023/B:VISI.0000022288.19776.77; Gaisano HY, 2009, GASTROENTEROLOGY, V136, P2040, DOI 10.1053/j.gastro.2009.04.023; Giger ML, 2008, MED PHYS, V35, P5799, DOI 10.1118/1.3013555; Gukovskaya AS, 2002, J BIOL CHEM, V277, P22595, DOI 10.1074/jbc.M202929200; Gunduz-Demir C, 2010, MED IMAGE ANAL, V14, P1, DOI 10.1016/j.media.2009.09.001; Gurcan Metin N, 2009, IEEE Rev Biomed Eng, V2, P147, DOI 10.1109/RBME.2009.2034865; Hoque R, 2011, GASTROENTEROLOGY, V141, P358, DOI 10.1053/j.gastro.2011.03.041; Jensen JN, 2005, GASTROENTEROLOGY, V128, P728, DOI 10.1053/j.gastro.2004.12.008; Lerch MM, 1997, GASTROENTEROLOGY, V113, P1355, DOI 10.1053/gast.1997.v113.pm9322531; Lerch MM, 2000, MED CLIN N AM, V84, P549, DOI 10.1016/S0025-7125(05)70239-X; Liu YH, 2014, EXCLI J, V13, P19; Mendez AJ, 1998, MED PHYS, V25, P957, DOI 10.1118/1.598274; Mills SE, 2007, HISTOLOGY PATHOLOGIS; Morris JP, 2010, J CLIN INVEST, V120, P508, DOI 10.1172/JCI40045; Naik S, 2008, I S BIOMED IMAGING, P284, DOI 10.1109/ISBI.2008.4540988; Ross M. H., 1985, HISTOLOGY TEXT ATLAS; Rubin R., 2012, RUBINS PATHOLOGY CLI; Saluja AK, 2007, ANNU REV PHYSIOL, V69, P249, DOI 10.1146/annurev.physiol.69.031905.161253; Satoh A, 2004, AM J PHYSIOL-GASTR L, V287, pG582, DOI 10.1152/ajpgi.00087.2004; Sleisenger M. H., 2010, SLEISENGER FORDTRANS; Stanger BZ, 2013, GASTROENTEROLOGY, V144, P1170, DOI 10.1053/j.gastro.2013.01.074; Strobel O, 2007, GASTROENTEROLOGY, V133, P1999, DOI 10.1053/j.gastro.2007.09.009; Tosun AB, 2011, IEEE T MED IMAGING, V30, P721, DOI 10.1109/TMI.2010.2094200; Veta M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070221	34	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110220	10.1371/journal.pone.0110220	http://dx.doi.org/10.1371/journal.pone.0110220			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343460	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000343943500028
J	Matoso, RI; Freire, AR; Santos, LSD; Daruge, E; Rossi, AC; Prado, FB				Matoso, Rodrigo Ivo; Freire, Alexandre Rodrigues; de Mello Santos, Leonardo Soriano; Daruge Junior, Eduardo; Rossi, Ana Claudia; Prado, Felippe Bevilacqua			Comparison of Gunshot Entrance Morphologies Caused by .40-Caliber Smith & Wesson, .380-Caliber, and 9-mm Luger Bullets: A Finite Element Analysis Study	PLOS ONE			English	Article							SKULL-BRAIN MODEL; WOUNDS; SIMULATION; INJURIES; RECONSTRUCTION; HOMICIDE; DEATH; HEAD	Firearms can cause fatal wounds, which can be identified by traces on or around the body. However, there are cases where neither the bullet nor gun is found at the crime scene. Ballistic research involving finite element models can reproduce computational biomechanical conditions, without compromising bioethics, as they involve no direct tests on animals or humans. This study aims to compare the morphologies of gunshot entrance holes caused by .40-caliber Smith & Wesson (S&W), .380-caliber, and 9619-mm Luger bullets. A fully metal-jacketed.40 S&W projectile, a fully metal-jacketed.380 projectile, and a fully metal-jacketed 9619-mm Luger projectile were computationally fired at the glabellar region of the finite element model from a distance of 10 cm, at perpendicular incidence. The results show different morphologies in the entrance holes produced by the three bullets, using the same skull at the same shot distance. The results and traits of the entrance holes are discussed. Finite element models allow feasible computational ballistic research, which may be useful to forensic experts when comparing and analyzing data related to gunshot wounds in the forehead.	[Matoso, Rodrigo Ivo; Daruge Junior, Eduardo] Univ Estadual Campinas, FOP, Piracicaba Dent Sch, Dept Forens Dent, Piracicaba, SP, Brazil; [Matoso, Rodrigo Ivo] IML RR, Civil Police Roraima, Boa Vista, Roraima, Brazil; [Freire, Alexandre Rodrigues; de Mello Santos, Leonardo Soriano; Rossi, Ana Claudia; Prado, Felippe Bevilacqua] Univ Estadual Campinas, FOP, Piracicaba Dent Sch, Dept Morphol, Piracicaba, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas	Matoso, RI (corresponding author), Univ Estadual Campinas, FOP, Piracicaba Dent Sch, Dept Forens Dent, Piracicaba, SP, Brazil.	rimatoso@hotmail.com	Rossi, Ana Cláudia/J-8692-2015; Rossi, Ana Cláudia/AFW-7441-2022; Rossi, Ana Cláudia/F-2690-2012; Freire, Alexandre Rodrigues/F-2697-2012; JUNIOR, EDUARDO DARUGE/AAC-2461-2020	Rossi, Ana Cláudia/0000-0002-8718-4898; Rossi, Ana Cláudia/0000-0002-8718-4898; Rossi, Ana Cláudia/0000-0002-8718-4898; Freire, Alexandre Rodrigues/0000-0002-0175-0896; 				Arbenz GO, 1988, MED LEGAL ANTROPOLOG; Berens S, 2011, FORENSIC SCI MED PAT, V7, P209, DOI 10.1007/s12024-010-9201-x; BERRYMAN HE, 1995, J FORENSIC SCI, V40, P751; Bisagni C, 2005, COMPOS STRUCT, V68, P491, DOI 10.1016/j.compstruct.2004.04.015; Caglar A, 2010, INT J ORAL MAX IMPL, V25, P95; CDC Natl Ctr Injury Prevent Control, 2000, JAMA-J AM MED ASSOC, V283, P47; Champion HR, 2010, J TRAUMA, V68, P1139, DOI 10.1097/TA.0b013e3181d86a0d; Chen YB, 2010, J BIOMECH, V43, P1131, DOI 10.1016/j.jbiomech.2009.12.009; Cunningham LL, 2003, J ORAL MAXIL SURG, V61, P932, DOI 10.1016/S0278-2391(03)00293-3; Doctor Vishal S, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P213, DOI 10.1097/MOO.0b013e3281fbd3ef; Gawryszewski Vilma Pinheiro, 2004, Cad. Saúde Pública, V20, P995, DOI 10.1590/S0102-311X2004000400014; Geiger M, 2013, COMPUT METHOD BIOMEC, V16, P639, DOI 10.1080/10255842.2011.629996; Hauer T, 2011, HNO, V59, P752, DOI 10.1007/s00106-011-2365-1; Labbe D, 2009, J PLAST RECONSTR AES, V62, P1174, DOI 10.1016/j.bjps.2007.05.020; Li Zheng-dong, 2010, Fa Yi Xue Za Zhi, V26, P406; Mahoney PF., 2005, BALLISTIC TRAUMA PRA; Mises R.v., 1913, NACHR GES WISS G TTI, V1913, P582; Mota A, 2003, COMPUT MECH, V31, P115, DOI 10.1007/s00466-002-0398-8; Nikolic S, 2012, AM J FOREN MED PATH, V33, P43, DOI 10.1097/PAF.0b013e31823a8a32; Nor FM, 2012, J FORENSIC LEG MED, V19, P42, DOI 10.1016/j.jflm.2011.07.008; Ormianer Z, 2012, IMPLANT DENT, V21, P39, DOI 10.1097/ID.0b013e31823fce22; Peres MFT, 2005, REV SAUDE PUBL, V39, P58, DOI 10.1590/S0034-89102005000100008; Pintar F A, 2001, Biomed Sci Instrum, V37, P429; Pollak S, 2004, FORENSIC SCI INT, V144, P201, DOI 10.1016/j.forsciint.2004.04.054; Quatrehomme G, 1998, FORENSIC SCI INT, V94, P141, DOI 10.1016/S0379-0738(98)00056-5; Quatrehomme G, 1999, J FORENSIC SCI, V44, P568; Quatrehomme G, 1997, FORENSIC SCI INT, V89, P93, DOI 10.1016/S0379-0738(97)00121-7; Raul JS, 2008, INT J LEGAL MED, V122, P359, DOI 10.1007/s00414-008-0248-0; Raul JS, 2007, INT J LEGAL MED, V121, P143, DOI 10.1007/s00414-005-0070-x; Sands JM, 2009, J EUR CERAM SOC, V29, P261, DOI 10.1016/j.jeurceramsoc.2008.03.010; Sarmah Anirban, 2011, J Contemp Dent Pract, V12, P259; Shao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052366; Shen WX, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4002699; SMITH OC, 1993, J FORENSIC SCI, V38, P323; Smojver I, 2010, COMPOS STRUCT, V92, P2016, DOI 10.1016/j.compstruct.2009.12.006; Solarino B, 2007, FORENSIC SCI INT, V168, P95, DOI 10.1016/j.forsciint.2007.01.023; Soumah MM, 2012, J FORENSIC LEG MED, V19, P60, DOI 10.1016/j.jflm.2011.10.001; Tang Z, 2012, INJURY, V43, P660, DOI 10.1016/j.injury.2011.03.012; Thali MJ, 2002, FORENSIC SCI INT, V125, P195, DOI 10.1016/S0379-0738(01)00639-9; Thali MJ, 2002, FORENSIC SCI INT, V125, P190, DOI 10.1016/S0379-0738(01)00638-7; Thali MJ, 2002, FORENSIC SCI INT, V125, P178, DOI 10.1016/S0379-0738(01)00637-5; Tocchetto D, 2011, BALISTICA FORENSE AS; Wilson Jorge L, 2011, Rev. Col. Bras. Cir., V38, P122; Wroe S, 2010, P ROY SOC B-BIOL SCI, V277, P3579, DOI 10.1098/rspb.2010.0509; Zhao YB, 2013, J SPINAL DISORD TECH, V26, P347, DOI 10.1097/BSD.0b013e318246b163	45	14	14	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111192	10.1371/journal.pone.0111192	http://dx.doi.org/10.1371/journal.pone.0111192			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343337	Green Published, gold			2022-12-27	WOS:000343943500087
J	Shimizu, M; Yasuda, H; Hara, K; Takahashi, K; Nagata, M; Yokono, K				Shimizu, Mami; Yasuda, Hisafumi; Hara, Kenta; Takahashi, Kazuma; Nagata, Masao; Yokono, Koichi			The Dual Role of Scavenger Receptor Class A in Development of Diabetes in Autoimmune NOD Mice	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; TOLL-LIKE RECEPTORS; DENDRITIC CELLS; IFN-GAMMA; T-CELLS; IL-17 PRODUCTION; INNATE IMMUNITY; DEFICIENT MICE; LIVE CELLS; TNF-ALPHA	Human type 1 diabetes is an autoimmune disease that results from the autoreactive destruction of pancreatic beta cells by T cells. Antigen presenting cells including dendritic cells and macrophages are required to activate and suppress antigen-specific T cells. It has been suggested that antigen uptake from live cells by dendritic cells via scavenger receptor class A (SR-A) may be important. However, the role of SR-A in autoimmune disease is unknown. In this study, SR-A(-/-) nonobese diabetic (NOD) mice showed significant attenuation of insulitis, lower levels of insulin autoantibodies, and suppression of diabetes development compared with NOD mice. We also found that diabetes progression in SR-A(-/-) NOD mice treated with low-dose polyinosinic-polycytidylic acid (poly(I:C)) was significantly accelerated compared with that in disease-resistant NOD mice treated with low-dose poly(I:C). In addition, injection of high-dose poly(I: C) to mimic an acute RNA virus infection significantly accelerated diabetes development in young SR-A 2/2 NOD mice compared with untreated SR-A(-/-) NOD mice. Pathogenic cells including CD4(+) CD25(+) activated T cells were increased more in SR-A(-/-) NOD mice treated with poly(I:C) than in untreated SR-A(-/-) NOD mice. These results suggested that viral infection might accelerate diabetes development even in diabetes-resistant subjects. In conclusion, our studies demonstrated that diabetes progression was suppressed in SR-A(-/-) NOD mice and that acceleration of diabetes development could be induced in young mice by poly(I:C) treatment even in SR-A(-/-) NOD mice. These results suggest that SR-A on antigen presenting cells such as dendritic cells may play an unfavorable role in the steady state and a protective role in a mild infection. Our findings imply that SR-A may be an important target for improving therapeutic strategies for type 1 diabetes.	[Shimizu, Mami; Yasuda, Hisafumi; Hara, Kenta; Yokono, Koichi] Kobe Univ, Grad Sch Med, Dept Gen Internal Med, Chuo Ku, Kobe, Hyogo 657, Japan; [Yasuda, Hisafumi] Kobe Univ, Grad Sch Hlth Sci, Dept Community Hlth Sci, Div Hlth Sci,Suma Ku, Kobe, Hyogo 657, Japan; [Takahashi, Kazuma] Iwate Med Univ, Sch Med, Dept Internal Med, Div Diabet & Metab, Morioka, Iwate 020, Japan; [Nagata, Masao] Kakogawa West City Hosp, Div Internal Med & Diabet, Kakogawa, Hyogo, Japan	Kobe University; Kobe University; Iwate Medical University	Yasuda, H (corresponding author), Kobe Univ, Grad Sch Med, Dept Gen Internal Med, Chuo Ku, Kobe, Hyogo 657, Japan.	yasuda@med.kobe-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23590880]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported, in part, by a Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 23590880). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Becker M, 2006, EUR J IMMUNOL, V36, P950, DOI 10.1002/eji.200535660; Chu CQ, 2000, J EXP MED, V192, P123, DOI 10.1084/jem.192.1.123; Daffis S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000607; Dansako H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003345; DeWitte-Orr SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000829; EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360; Ferber IA, 1996, J IMMUNOL, V156, P5; Fukushima K, 2008, BIOCHEM BIOPH RES CO, V367, P719, DOI 10.1016/j.bbrc.2007.12.191; Grant CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072989; Green EA, 1998, IMMUNITY, V9, P733, DOI 10.1016/S1074-7613(00)80670-6; Haasken S, 2013, J IMMUNOL, V191, P1055, DOI 10.4049/jimmunol.1201680; Harshyne LA, 2001, J IMMUNOL, V166, P3717, DOI 10.4049/jimmunol.166.6.3717; Harshyne LA, 2003, J IMMUNOL, V170, P2302, DOI 10.4049/jimmunol.170.5.2302; Honkanen J, 2010, J IMMUNOL, V185, P1959, DOI 10.4049/jimmunol.1000788; Hu CY, 2007, J CLIN INVEST, V117, P3857, DOI 10.1172/JCI32405; Hu CY, 2013, DIABETES, V62, P2849, DOI 10.2337/db12-1175; Imagawa A, 2000, NEW ENGL J MED, V342, P301, DOI 10.1056/NEJM200002033420501; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; JACOB CO, 1990, P NATL ACAD SCI USA, V87, P968, DOI 10.1073/pnas.87.3.968; Jain R, 2008, J EXP MED, V205, P207, DOI 10.1084/jem.20071878; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kelley JL, 2014, CRIT REV IMMUNOL, V34, P241, DOI 10.1615/CritRevImmunol.2014010267; Kim HS, 2007, IMMUNITY, V27, P321, DOI 10.1016/j.immuni.2007.06.010; Kobayashi H, 2007, J PATHOL, V212, P38, DOI 10.1002/path.2150; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Krakowski M, 1996, EUR J IMMUNOL, V26, P1641, DOI 10.1002/eji.1830260735; Levy-Barazany H, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-120; Liao JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026463; Limmon GV, 2008, FASEB J, V22, P159, DOI 10.1096/fj.07-8348com; Marwaha AK, 2010, J IMMUNOL, V185, P3814, DOI 10.4049/jimmunol.1001860; Mori Y, 2009, INT IMMUNOL, V21, P1291, DOI 10.1093/intimm/dxp097; Raycroft MT, 2012, J BIOL CHEM, V287, P5310, DOI 10.1074/jbc.M111.316356; Saeki K, 2009, J IMMUNOL, V182, P5929, DOI 10.4049/jimmunol.0802672; SATOH J, 1989, J CLIN INVEST, V84, P1345, DOI 10.1172/JCI114304; Serreze DV, 2001, J IMMUNOL, V166, P1352, DOI 10.4049/jimmunol.166.2.1352; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Tada A, 2011, J IMMUNOL, V187, P4947, DOI 10.4049/jimmunol.1000837; Tai NW, 2011, CLIN IMMUNOL, V139, P336, DOI 10.1016/j.clim.2011.03.003; Takemura K, 2010, BIOCHEM BIOPH RES CO, V391, P1675, DOI 10.1016/j.bbrc.2009.12.126; Tatematsu M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2857; Tsujita K, 2007, CIRCULATION, V115, P1904, DOI 10.1161/CIRCULATIONAHA.106.671198; Usui HK, 2007, DIABETES, V56, P363, DOI 10.2337/db06-0359; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wong FS, 2008, ANN NY ACAD SCI, V1150, P146, DOI 10.1196/annals.1447.039; Yu LP, 2000, P NATL ACAD SCI USA, V97, P1701, DOI 10.1073/pnas.040556697; Zhang J, 2012, J AUTOIMMUN, V38, P20, DOI 10.1016/j.jaut.2011.11.017	48	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e109531	10.1371/journal.pone.0109531	http://dx.doi.org/10.1371/journal.pone.0109531			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343451	gold, Green Submitted, Green Published			2022-12-27	WOS:000343943500016
J	Antonio, FJ; de Picoli, S; Teixeira, JJV; Mendes, RD				Antonio, Fernando Jose; de Picoli, Sergio, Jr.; Vieira Teixeira, Jorge Juarez; Mendes, Renio dos Santos			Growth Patterns and Scaling Laws Governing AIDS Epidemic in Brazilian Cities	PLOS ONE			English	Article							TRANSMISSION DYNAMICS; REPRODUCTION NUMBER; HIV; INFECTION; SPREAD; IMPACT; LIFE; MEN	Brazil holds approximately 1/3 of population living infected with AIDS (acquired immunodeficiency syndrome) in Central and South Americas, and it was also the first developing country to implement a large-scale control and intervention program against AIDS epidemic. In this scenario, we investigate the temporal evolution and current status of the AIDS epidemic in Brazil. Specifically, we analyze records of annual absolute frequency of cases for more than 5000 cities for the first 33 years of the infection in Brazil. We found that (i) the annual absolute frequencies exhibit a logistic-type growth with an exponential regime in the first few years of the AIDS spreading; (ii) the actual reproduction number decaying as a power law; (iii) the distribution of the annual absolute frequencies among cities decays with a power law behavior; (iv) the annual absolute frequencies and the number of inhabitants have an allometric relationship; (v) the temporal evolution of the annual absolute frequencies have different profile depending on the average annual absolute frequencies in the cities. These findings yield a general quantitative description of the AIDS infection dynamics in Brazil since the beginning. They also provide clues about the effectiveness of treatment and control programs against the infection, that has had a different impact depending on the number of inhabitants of cities. In this framework, our results give insights into the overall dynamics of AIDS epidemic, which may contribute to select empirically accurate models.	[Antonio, Fernando Jose; de Picoli, Sergio, Jr.; Mendes, Renio dos Santos] Univ Estadual Maringa, Dept Fis, Maringa, Parana, Brazil; [Antonio, Fernando Jose; de Picoli, Sergio, Jr.; Mendes, Renio dos Santos] Natl Inst Sci & Technol Complex Syst, Maringa, Parana, Brazil; [Vieira Teixeira, Jorge Juarez] Univ Estadual Maringa, Dept Anal Clin & Biomed, Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa	Antonio, FJ (corresponding author), Univ Estadual Maringa, Dept Fis, Maringa, Parana, Brazil.	fja@dfi.uem.br	Antonio, Fernando Jose/D-3024-2016	Antonio, Fernando Jose/0000-0001-6931-3046				Acuna-Soto R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023467; Alsallaq RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054575; Alves LGA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069580; Amundsen EJ, 2004, EPIDEMIOL INFECT, V132, P1139, DOI 10.1017/S0950268804002997; BAILEY NTJ, 1988, J ROY STAT SOC A STA, V151, P31, DOI 10.2307/2982180; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Beyrer C, 2010, EPIDEMIOL REV, V32, P137, DOI 10.1093/epirev/mxq011; BOR R, 1993, J FAM THER, V15, P187, DOI 10.1111/j.1467-6427.1993.00753.x; Coe JB, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.051925; CURRAN JW, 1988, SCIENCE, V239, P610, DOI 10.1126/science.3340847; Fonseca MGP, 2007, CAD SAUDE PUBLICA, V23, pS333, DOI 10.1590/S0102-311X2007001500002; Gaillard JM, 1997, P ROY SOC B-BIOL SCI, V264, P859, DOI 10.1098/rspb.1997.0120; Gomez-Lievano A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040393; Gompertz B, 1825, PHILOS T ROY SOC LON, V115, P513, DOI DOI 10.1098/RSTL.1825.0026; Gran JM, 2008, STAT MED, V27, P4819, DOI 10.1002/sim.3219; Grangeiro A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014585; Grangeiro A, 2010, REV SAUDE PUBL, V44, P430, DOI 10.1590/S0034-89102010005000013; Hall HI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012756; Hayes R, 2006, SCIENCE, V311, P620, DOI 10.1126/science.1124072; KREISS JK, 1986, NEW ENGL J MED, V314, P414, DOI 10.1056/NEJM198602133140704; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Malacarne LC, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.017106; Meiners C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023478; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Moura NJ, 2006, PHYSICA A, V367, P441, DOI 10.1016/j.physa.2005.11.038; Murray, 2002, MATH BIOL I INTRO IN; NELDER JA, 1961, BIOMETRICS, V17, P89, DOI 10.2307/2527498; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Ni SJ, 2008, PHYSICA A, V387, P5295, DOI 10.1016/j.physa.2008.05.051; Ni SJ, 2011, PHYSICA A, V390, P4528, DOI 10.1016/j.physa.2011.07.042; Niklas KJ, 2004, BIOL REV, V79, P871, DOI 10.1017/S1464793104006499; Nishiura H, 2010, INT J ENV RES PUB HE, V7, P291, DOI 10.3390/ijerph7010291; Nunn AS, 2007, PLOS MED, V4, P1804, DOI 10.1371/journal.pmed.0040305; Porco TC, 2004, AIDS, V18, P81, DOI 10.1097/00002030-200401020-00010; Quinn TC, 1996, LANCET, V348, P99, DOI 10.1016/S0140-6736(96)01029-X; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; Teixeira PR, 2004, AIDS, V18, pS5, DOI 10.1097/00002030-200406003-00002; UNAIDS, 2010, UNAIDS REP GLOB AIDS; UNAIDS, AH WORLD AIDS DAY 20; Vogl D, 1999, J PAIN SYMPTOM MANAG, V18, P253, DOI 10.1016/S0885-3924(99)00066-4; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Wallenstein S, 2004, AM J SURG, V188, p73S, DOI 10.1016/S0002-9610(03)00294-0; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; Winsor CP, 1932, P NATL ACAD SCI USA, V18, P1, DOI 10.1073/pnas.18.1.1	45	7	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111015	10.1371/journal.pone.0111015	http://dx.doi.org/10.1371/journal.pone.0111015			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340796	Green Submitted, gold, Green Published			2022-12-27	WOS:000343662800079
J	Chapman, S; Stevens, LJ; Boevink, PC; Engelhardt, S; Alexander, CJ; Harrower, B; Champouret, N; McGeachy, K; Van Weymers, PSM; Chen, XW; Birch, PRJ; Hein, I				Chapman, Sean; Stevens, Laura J.; Boevink, Petra C.; Engelhardt, Stefan; Alexander, Colin J.; Harrower, Brian; Champouret, Nicolas; McGeachy, Kara; Van Weymers, Pauline S. M.; Chen, Xinwei; Birch, Paul R. J.; Hein, Ingo			Detection of the Virulent Form of AVR3a from Phytophthora infestans following Artificial Evolution of Potato Resistance Gene R3a	PLOS ONE			English	Article							LATE BLIGHT RESISTANCE; HYPERSENSITIVE RESPONSE; CELL-DEATH; NUCLEOTIDE-BINDING; EFFECTOR AVR3A; PROTEIN; HOST; TRANSFORMATION; SUPERFAMILY; PERCEPTION	Engineering resistance genes to gain effector recognition is emerging as an important step in attaining broad, durable resistance. We engineered potato resistance gene R3a to gain recognition of the virulent AVR3a(EM) effector form of Phytophthora infestans. Random mutagenesis, gene shuffling and site-directed mutagenesis of R3a were conducted to produce R3a* variants with gain of recognition towards AVR3a(EM). Programmed cell death following gain of recognition was enhanced in iterative rounds of artificial evolution and neared levels observed for recognition of AVR3a(KI) by R3a. We demonstrated that R3a*-mediated recognition responses, like for R3a, are dependent on SGT1 and HSP90. In addition, this gain of response is associated with re-localisation of R3a* variants from the cytoplasm to late endosomes when co-expressed with either AVR3a(KI) or AVR3a(EM) a mechanism that was previously only seen for R3a upon co-infiltration with AVR3a(KI). Similarly, AVR3a(EM) specifically re-localised to the same vesicles upon recognition by R3a* variants, but not with R3a. R3a and R3a* provide resistance to P. infestans isolates expressing AVR3a(KI) but not those homozygous for AVR3a(EM).	[Chapman, Sean; Stevens, Laura J.; Boevink, Petra C.; Harrower, Brian; McGeachy, Kara; Van Weymers, Pauline S. M.; Chen, Xinwei; Birch, Paul R. J.; Hein, Ingo] James Hutton Inst, Dundee, Scotland; [Stevens, Laura J.; Engelhardt, Stefan; Van Weymers, Pauline S. M.; Birch, Paul R. J.] Univ Dundee, James Hutton Inst, Div Plant Sci, Invergowrie Dundee, Scotland; [Stevens, Laura J.; Boevink, Petra C.; Engelhardt, Stefan; Van Weymers, Pauline S. M.; Chen, Xinwei; Birch, Paul R. J.; Hein, Ingo] Dundee Effector Consortium, Invergowrie Dundee, Scotland; [Alexander, Colin J.] Biomath & Stat Scotland, Invergowrie Dundee, Scotland; [Champouret, Nicolas] JR Simplot Co, Simplot Plant Sci, Boise, ID USA	James Hutton Institute; James Hutton Institute; University of Dundee; James Hutton Institute	Hein, I (corresponding author), James Hutton Inst, Dundee, Scotland.	Ingo.Hein@hutton.ac.uk	Alexander, Colin/C-5802-2009; Chapman, Sean N/H-5193-2013; Engelhardt, Stefan/AAA-9329-2019; Boevink, Petra/AAO-6498-2021	Alexander, Colin/0000-0003-4995-1678; Engelhardt, Stefan/0000-0001-5378-8661; Boevink, Petra/0000-0002-7021-9097; Hein, Ingo/0000-0002-0128-2084; Birch, Paul/0000-0002-6559-3746	James Hutton Institute; University of Dundee; U.S. Department of Agriculture through National Institute of Food and Agriculture (NIFA) [2011-68004-30154]; Rural & Environment Science & Analytical Services (RESAS) Division of the Scottish Government; Biotechnology and Biological Sciences Research Council (BBSRC) [CRF/2009/SCRI/SOP & BB/H018441/1 (IH), BB/K018299/1]; RESAS; BBSRC [BB/K018299/1, BB/L01050X/1, BB/L008025/1, BB/H018697/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K018299/1, BB/L008025/1, BB/H018697/1, BB/L01050X/1] Funding Source: researchfish	James Hutton Institute; University of Dundee; U.S. Department of Agriculture through National Institute of Food and Agriculture (NIFA); Rural & Environment Science & Analytical Services (RESAS) Division of the Scottish Government; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); RESAS; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	LS is supported by The James Hutton Institute and the University of Dundee through a joint PhD student bursary. PSMVW is supported by the U.S. Department of Agriculture through National Institute of Food and Agriculture (NIFA) project 2011-68004-30154 (http://www.csrees.usda.gov/). NC is employed by J.R. Simplot Company, Simplot Plant Sciences, 5369 West Irving Street, Boise, ID 83706, USA. This work was funded by the Rural & Environment Science & Analytical Services (RESAS) Division of the Scottish Government (http://www.scotland.gov.uk/Topics/Research/About/EBAR/research-providers) and the Biotechnology and Biological Sciences Research Council (BBSRC) (http://www.bbsrc.ac.uk/home/home.aspx) through the joint projects CRF/2009/SCRI/SOP & BB/H018441/1 (IH), BB/K018299/1 and RESAS funded work package 6.4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Azevedo C, 2006, EMBO J, V25, P2007, DOI 10.1038/sj.emboj.7601084; Bendahmane A, 1999, PLANT CELL, V11, P781, DOI 10.1105/tpc.11.5.781; Bernal AJ, 2005, J BIOL CHEM, V280, P23073, DOI 10.1074/jbc.M500992200; Birch PRJ, 2008, CURR OPIN PLANT BIOL, V11, P373, DOI 10.1016/j.pbi.2008.04.005; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; Bos JIB, 2010, P NATL ACAD SCI USA, V107, P9909, DOI 10.1073/pnas.0914408107; Cardenas M, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-23; Deslandes L, 2012, TRENDS PLANT SCI, V17, P644, DOI 10.1016/j.tplants.2012.06.011; Duan H, 2012, TRANSGENIC RES, V21, P929, DOI 10.1007/s11248-011-9576-9; Engelhardt S, 2012, PLANT CELL, V24, P5142, DOI 10.1105/tpc.112.104992; Segretin ME, 2014, MOL PLANT MICROBE IN, V27, P624, DOI 10.1094/MPMI-02-14-0040-R; Farnham G, 2006, P NATL ACAD SCI USA, V103, P18828, DOI 10.1073/pnas.0605777103; Foster SJ, 2009, MOL PLANT MICROBE IN, V22, P589, DOI 10.1094/MPMI-22-5-0589; Gilroy EM, 2007, PLANT J, V52, P1, DOI 10.1111/j.1365-313X.2007.03226.x; Gilroy EM, 2011, NEW PHYTOL, V190, P653, DOI 10.1111/j.1469-8137.2011.03643.x; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Harris CJ, 2013, P NATL ACAD SCI USA, V110, P21189, DOI 10.1073/pnas.1311134110; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; Hein I, 2009, MOL PLANT PATHOL, V10, P547, DOI [10.1111/J.1364-3703.2009.00547.X, 10.1111/j.1364-3703.2009.00547.x]; Huang SW, 2005, PLANT J, V42, P251, DOI 10.1111/j.1365-313X.2005.02365.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jupe F, 2013, PLANT J, V76, P530, DOI 10.1111/tpj.12307; Jupe F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-75; LAZO GR, 1991, BIO-TECHNOL, V9, P963, DOI 10.1038/nbt1091-963; Leung DW, 1989, TECHNIQUE, V1, P11; Li GC, 2011, MOL PLANT MICROBE IN, V24, P1132, DOI 10.1094/MPMI-11-10-0276; Liu YL, 2004, J BIOL CHEM, V279, P2101, DOI 10.1074/jbc.M310029200; Maffei ME, 2012, NAT PROD REP, V29, P1288, DOI 10.1039/c2np20053h; Mcdowell JM, 2006, MOL PLANT PATHOL, V7, P437, DOI 10.1111/j.1364-3703.2006.00342.x; Newman MA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00139; Ori N, 1997, PLANT CELL, V9, P521, DOI 10.1105/tpc.9.4.521; Raffaele S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-637; Rietman H, 2012, MOL PLANT MICROBE IN, V25, P910, DOI 10.1094/MPMI-01-12-0010-R; Saint-Jean B, 2010, PLANT CELL, V22, P2825, DOI 10.1105/tpc.109.072215; Saunders DGO, 2012, PLANT CELL, V24, P3420, DOI 10.1105/tpc.112.099861; Simpson CG, 2014, NEW PHYTOL, V203, P424, DOI 10.1111/nph.12821; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Stirnweis D, 2014, MOL PLANT MICROBE IN, V27, P265, DOI 10.1094/MPMI-10-13-0297-FI; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; van der Fits L, 2000, PLANT MOL BIOL, V43, P495, DOI 10.1023/A:1006440221718; van Poppel PMJA, 2008, MOL PLANT MICROBE IN, V21, P1460, DOI 10.1094/MPMI-21-11-1460; Vetukuri RR, 2011, FUNGAL BIOL-UK, V115, P1225, DOI 10.1016/j.funbio.2011.08.007; Vleeshouwers VGAA, 2000, PLANTA, V210, P853, DOI 10.1007/s004250050690; Vleeshouwers VGAA, 2011, ANNU REV PHYTOPATHOL, V49, P507, DOI 10.1146/annurev-phyto-072910-095326; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wang QQ, 2011, PLANT CELL, V23, P2064, DOI 10.1105/tpc.111.086082; Yoshida K, 2013, ELIFE, V2, DOI 10.7554/eLife.00731	48	27	28	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110158	10.1371/journal.pone.0110158	http://dx.doi.org/10.1371/journal.pone.0110158			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340613	Green Submitted, Green Published, gold			2022-12-27	WOS:000343662800022
J	Kobayashi, M; Ray, SM; Hanfelt, J; Wang, YF				Kobayashi, Miwako; Ray, Susan M.; Hanfelt, John; Wang, Yun F.			Diagnosis of Tuberculosis by Using a Nucleic Acid Amplification Test in an Urban Population with High HIV Prevalence in the United States	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; COST-EFFECTIVENESS; PULMONARY; INFECTION; RISK; DISEASE	Background: Use of nucleic acid amplification tests (NAAT) for the diagnosis of Mycobacterium tuberculosis (TB) has been recommended on respiratory specimens submitted for acid-fast bacilli (AFB) testing. It also helps distinguish between TB and non-tuberculous mycobacteria (NTM) species in a setting where NTM rates are relatively high. The purposes of this study are to describe the trend and characteristics of all AFB smear-positive respiratory samples that underwent amplified Mycobacterium tuberculosis direct (MTD) testing, a type of NAAT, and to evaluate the clinical utility and necessity of the test for diagnosis of TB in a population with high-HIV prevalence. Methods: Prospective diagnostic testing and retrospective data analyses were conducted on all AFB smear-positive respiratory samples that underwent MTD testing from 2001 to 2011 at Grady Memorial Hospital (GMH), Atlanta, USA. The test performance was compared to culture. Results: A total of 2,240 AFB smear-positive specimens from 1,412 patients were tested and analyzed in the study. The proportion of specimens that were culture-positive for TB was 28.5%. Sensitivity, specificity, positive predictive value, and negative predictive value of the MTD were 99.0%, 98.0%, 95.3% and 99.6%, respectively. A downward trend was observed in the yearly numbers as well as the proportions of MTD-positive specimens during the study period (p<0.01). There were 2,027 (90.5%) specimens from patients with known HIV status, of which 70.6% was HIV positive and the majority of them (81.8%) had CD4 counts of less than 200 cells/mu L. HIV-positives were more likely to have NTM compared to HIV negatives (67.7% vs. 35.4%, p<0.01). Conclusion: Despite the decrease in the incidence of TB, NAAT continues to be an accurate and important diagnostic test in a population with high HIV prevalence, and it differentiates TB and NTM organisms.	[Kobayashi, Miwako; Ray, Susan M.] Emory Univ, Sch Med, Dept Med, Atlanta, GA 30322 USA; [Wang, Yun F.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Hanfelt, John] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat, Atlanta, GA 30322 USA; [Wang, Yun F.] Grady Mem Hosp, Atlanta, GA USA	Emory University; Emory University; Emory University; Rollins School Public Health	Wang, YF (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.	yfwang@emory.edu		Ray, Susan/0000-0002-6327-088X	National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000454]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health (Award Number UL1TR000454 to co-author JH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The manuscript does not necessarily represent the official views of the National Institutes of Health.	Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P7; Centers for Disease Control and Prevention, 2011, REP TUB US; Centers for Disease Control and Prevention, 2011, HIV SURV REP; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P593; Dowdy DW, 2003, J CLIN MICROBIOL, V41, P948, DOI 10.1128/JCM.41.3.948-953.2003; Gen Probe Incorporated, 2011, AMPL MYC TUB DIR TES; Georgia Department of Public Health, 2011, 2009 GEORG TUB REP; Guerra RL, 2007, CHEST, V132, P946, DOI 10.1378/chest.06-2959; Hopewell P C, 1989, Semin Respir Infect, V4, P111; Hughes R, 2012, RESP MED, V106, P300, DOI 10.1016/j.rmed.2011.10.005; Jorgensen JH, 1999, J CLIN MICROBIOL, V37, P175, DOI 10.1128/JCM.37.1.175-178.1999; Kambashi B, 2001, INT J TUBERC LUNG D, V5, P364; Lemaitre N, 2004, J CLIN MICROBIOL, V42, P4307, DOI 10.1128/JCM.42.9.4307-4309.2004; Leonard MK, 2006, AM J INFECT CONTROL, V34, P69, DOI 10.1016/j.ajic.2005.09.003; Marks SM, 2013, CLIN INFECT DIS, V57, P532, DOI 10.1093/cid/cit336; NOLTE FS, 1995, MYCOBACTERIUM; Salama C, 2003, CLIN INFECT DIS, V37, pE35, DOI 10.1086/375895; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Syre H, 2009, J CLIN MICROBIOL, V47, P3635, DOI 10.1128/JCM.00411-09; Teo J, 2011, J CLIN MICROBIOL, V49, P3659, DOI 10.1128/JCM.00211-11; Tjhie JHT, 2001, J CLIN MICROBIOL, V39, P2311, DOI 10.1128/JCM.39.6.2311-2312.2001; Wallace JM, 1997, AM J RESP CRIT CARE, V155, P72, DOI 10.1164/ajrccm.155.1.9001292; Wood R, 2000, J ACQ IMMUN DEF SYND, V23, P75; Zaki MES, 2008, ARCH PATHOL LAB MED, V132, P244, DOI 10.1043/1543-2165(2008)132[244:CEOGAM]2.0.CO;2; ZAZA S, 1995, J INFECT DIS, V172, P1542, DOI 10.1093/infdis/172.6.1542	25	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e107552	10.1371/journal.pone.0107552	http://dx.doi.org/10.1371/journal.pone.0107552			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340424	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662800002
J	Sadaka, A; Palmer, K; Suzuki, T; Gilmore, MS				Sadaka, Ama; Palmer, Kelli; Suzuki, Takashi; Gilmore, Michael S.			In Vitro and In Vivo Models of Staphylococcus aureus Endophthalmitis Implicate Specific Nutrients in Ocular Infection	PLOS ONE			English	Article							STATIONARY-PHASE; VITREOUS FLUID; SIALIC ACIDS; AMINO-ACIDS; VIRULENCE; CODY; IDENTIFICATION; REGULATOR; ASCORBATE; METABOLISM	Purpose: To define global transcriptional responses of Staphylococcus aureus and its codY mutant (CodY is a transcription regulator of virulence and metabolic genes in response to branched-chain amino acids) when growing in bovine aqueous (AH) and vitreous humor (VH) in vitro, and to investigate the impact of codY deletion on S. aureus virulence in a novel murine anterior chamber (AC) infection model. Methods: For the in vitro model, differential transcriptomic gene expression of S. aureus and its codY mutant grown in chemically defined medium (CDM), AH, and VH was analyzed. Furthermore, the strains were inoculated into the AC of mice. Changes in bacterial growth, electroretinography and inflammation scores were monitored. Results: Bovine AH and VH provide sufficient nutrition for S. aureus growth in vitro. Transcriptome analysis identified 72 unique open reading frames differentially regulated >= 10-fold between CDM, AH, and VH. In the AC model, we found comparable growth of the codY mutant and wild type strains in vivo. Average inflammation scores and retinal function were significantly worse for codY mutant-infected eyes at 24 h post-infection. Conclusion: Our in vitro bovine AH and VH models identified likely nutrient sources for S. aureus in the ocular milieu. The in vivo model suggests that control of branched-chain amino acid availability has therapeutic potential in limiting S. aureus endophthalmitis severity.	[Sadaka, Ama; Palmer, Kelli; Suzuki, Takashi; Gilmore, Michael S.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02215 USA; [Sadaka, Ama; Palmer, Kelli; Suzuki, Takashi; Gilmore, Michael S.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Sadaka, Ama; Palmer, Kelli; Suzuki, Takashi; Gilmore, Michael S.] Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA; [Sadaka, Ama; Palmer, Kelli; Suzuki, Takashi; Gilmore, Michael S.] Harvard Microbial Sci Initiat, Cambridge, MA USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary	Gilmore, MS (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02215 USA.	michael_gilmore@meei.harvard.edu			NIH/NEI [EY008289]; NIH fellowship [EY020734]; NATIONAL EYE INSTITUTE [F32EY020734, R01EY008289] Funding Source: NIH RePORTER	NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This project has been funded in part by NIH/NEI grant EY008289. KP was supported by NIH fellowship EY020734. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affymetrix I, GENECHIP MAD TO ORD; Andreoli CM, 2009, AM J OPHTHALMOL, V147, P601, DOI 10.1016/j.ajo.2008.10.023; Balzli CL, 2010, INVEST OPHTH VIS SCI, V51, P5114, DOI 10.1167/iovs.10-5179; Barry P, 2007, J CATARACT REFR SURG, V33, P978, DOI 10.1016/j.jcrs.2007.02.032; Bennett HJ, 2007, MOL MICROBIOL, V63, P1453, DOI 10.1111/j.1365-2958.2007.05597.x; Bertram KM, 2008, EYE, V22, P582, DOI 10.1038/sj.eye.6702993; BOOTH MC, 1995, INVEST OPHTH VIS SCI, V36, P1828; Booth MC, 1997, INFECT IMMUN, V65, P1550, DOI 10.1128/IAI.65.4.1550-1556.1997; Callegan MC, 2002, CLIN MICROBIOL REV, V15, P111, DOI 10.1128/CMR.15.1.111-124.2002; Campos E, 2007, MICROBIOL-SGM, V153, P3399, DOI 10.1099/mic.0.2007/009613-0; den Hengst CD, 2006, J BACTERIOL, V188, P3280, DOI 10.1128/JB.188.9.3280-3289.2006; DURHAM DG, 1971, CLIN CHEM, V17, P285; Geiger T, 2010, INFECT IMMUN, V78, P1873, DOI 10.1128/IAI.01439-09; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Guedon E, 2001, MOL MICROBIOL, V40, P1227, DOI 10.1046/j.1365-2958.2001.02470.x; HADDAD HM, 1962, ARCH OPHTHALMOL-CHIC, V67, P459, DOI 10.1001/archopht.1962.00960020459013; Hanscom T, 1996, ARCH OPHTHALMOL-CHIC, V114, P1029, DOI 10.1001/archopht.1996.01100140233036; JOHNSEN H, 1985, ACTA OPHTHALMOL, V63, P31; Jonas JB, 2000, OPHTHALMOLOGY, V107, P823, DOI 10.1016/S0161-6420(00)00079-8; Kowalski RP, 2008, JPN J OPHTHALMOL, V52, P211, DOI 10.1007/s10384-008-0530-1; Labit CM, 2001, EUR J OPHTHALMOL, V11, P160, DOI 10.1177/112067210101100210; Levdikov VM, 2009, J MOL BIOL, V390, P1007, DOI 10.1016/j.jmb.2009.05.077; Levdikov VM, 2006, J BIOL CHEM, V281, P11366, DOI 10.1074/jbc.M513015200; Majerczyk CD, 2008, J BACTERIOL, V190, P2257, DOI 10.1128/JB.01545-07; Majerczyk CD, 2010, J BACTERIOL, V192, P2861, DOI 10.1128/JB.00220-10; Mattis DM, 2013, PROTEIN ENG DES SEL, V26, P133, DOI 10.1093/protein/gzs094; Nakatsukasa M, 2011, AM J OPHTHALMOL, V151, P799, DOI 10.1016/j.ajo.2010.11.003; Olson ME, 2013, J BACTERIOL, V195, P1779, DOI 10.1128/JB.02294-12; ORTWERTH BJ, 1975, EXP EYE RES, V20, P417, DOI 10.1016/0014-4835(75)90084-6; Palmer KL, 2005, J BACTERIOL, V187, P5267, DOI 10.1128/JB.187.15.5267-5277.2005; Pohl K, 2009, J BACTERIOL, V191, P2953, DOI 10.1128/JB.01492-08; Pragman AA, 2004, J BACTERIOL, V186, P2430, DOI 10.1128/JB.186.8.2430-2438.2004; Preumont A, 2008, J BIOL CHEM, V283, P25238, DOI 10.1074/jbc.M804122200; SLACK FJ, 1995, MOL MICROBIOL, V15, P689, DOI 10.1111/j.1365-2958.1995.tb02378.x; SOCRANSKY SS, 1985, J CLIN MICROBIOL, V22, P303, DOI 10.1128/JCM.22.2.303-305.1985; Sonenshein AL, 2005, CURR OPIN MICROBIOL, V8, P203, DOI 10.1016/j.mib.2005.01.001; Spaulding AR, 2012, VACCINE, V30, P5099, DOI 10.1016/j.vaccine.2012.05.067; Strandberg KL, 2010, J INFECT DIS, V202, P1690, DOI 10.1086/657156; Suzuki T, 2008, J CATARACT REFR SURG, V34, P1776, DOI 10.1016/j.jcrs.2008.06.033; Suzuki T, 2011, INVEST OPHTH VIS SCI, V52, P3187, DOI 10.1167/iovs.10-6558; TSO MOM, 1984, CURR EYE RES, V3, P181, DOI 10.3109/02713688408997200; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; WM H, 1992, ADL PHYSL EYE; Wu PC, 2006, GRAEF ARCH CLIN EXP, V244, P920, DOI 10.1007/s00417-005-0170-9; Wu XG, 2012, J OCUL PHARMACOL TH, V28, P186, DOI 10.1089/jop.2011.0136; Zhang ZG, 2003, J BACTERIOL, V185, P2243, DOI 10.1128/JB.185.7.2243-2250.2003	48	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e0110872	10.1371/journal.pone.0110872	http://dx.doi.org/10.1371/journal.pone.0110872			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340474	Green Submitted, Green Published, gold			2022-12-27	WOS:000343662800065
J	Weng, SL; Chiu, CM; Lin, FM; Huang, WC; Liang, C; Yang, T; Yang, TL; Liu, CY; Wu, WY; Chang, YA; Chang, TH; Huang, HD				Weng, Shun-Long; Chiu, Chih-Min; Lin, Feng-Mao; Huang, Wei-Chih; Liang, Chao; Yang, Ting; Yang, Tzu-Ling; Liu, Chia-Yu; Wu, Wei-Yun; Chang, Yi-An; Chang, Tzu-Hao; Huang, Hsien-Da			Bacterial Communities in Semen from Men of Infertile Couples: Metagenomic Sequencing Reveals Relationships of Seminal Microbiota to Semen Quality	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; MALE GENITAL-TRACT; GARDNERELLA-VAGINALIS; MEDICAL-TREATMENT; ESCHERICHIA-COLI; HUMAN HEALTH; IDENTIFICATION; LACTOBACILLUS; INFECTIONS; BLOOD	Some previous studies have identified bacteria in semen as being a potential factor in male infertility. However, only few types of bacteria were taken into consideration while using PCR-based or culturing methods. Here we present an analysis approach using next-generation sequencing technology and bioinformatics analysis to investigate the associations between bacterial communities and semen quality. Ninety-six semen samples collected were examined for bacterial communities, measuring seven clinical criteria for semen quality (semen volume, sperm concentration, motility, Kruger's strict morphology, antisperm antibody (IgA), Atypical, and leukocytes). Computer-assisted semen analysis (CASA) was also performed. Results showed that the most abundant genera among all samples were Lactobacillus (19.9%), Pseudomonas (9.85%), Prevotella (8.51%) and Gardnerella (4.21%). The proportion of Lactobacillus and Gardnerella was significantly higher in the normal samples, while that of Prevotella was significantly higher in the low quality samples. Unsupervised clustering analysis demonstrated that the seminal bacterial communities were clustered into three main groups: Lactobacillus, Pseudomonas, and Prevotella predominant group. Remarkably, most normal samples (80.6%) were clustered in Lactobacillus predominant group. The analysis results showed seminal bacteria community types were highly associated with semen health. Lactobacillus might not only be a potential probiotic for semen quality maintenance, but also might be helpful in countering the negative influence of Prevotella and Pseudomonas. In this study, we investigated whole seminal bacterial communities and provided the most comprehensive analysis of the association between bacterial community and semen quality. The study significantly contributes to the current understanding of the etiology of male fertility.	[Weng, Shun-Long; Chiu, Chih-Min; Lin, Feng-Mao; Huang, Wei-Chih; Liang, Chao; Yang, Ting; Yang, Tzu-Ling; Liu, Chia-Yu; Wu, Wei-Yun; Chang, Yi-An; Huang, Hsien-Da] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Weng, Shun-Long; Huang, Hsien-Da] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Weng, Shun-Long] Hsinchu Mackay Mem Hosp, Dept Obstet & Gynecol, Hsinchu, Taiwan; [Weng, Shun-Long] Mackay Jr Coll Med Nursing & Management, Taipei, Taiwan; [Weng, Shun-Long] Mackay Med Coll, Dept Med, New Taipei City, Taiwan; [Chang, Yi-An] Hlth GeneTech Corp, Taoyuan, Taiwan; [Chang, Tzu-Hao] Taipei Med Univ, Grad Inst Biomed Informat, Taipei, Taiwan; [Huang, Hsien-Da] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan; [Huang, Hsien-Da] Natl Chiao Tung Univ, Ctr Bioinformat Res, Hsinchu, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; Mackay Medical College; Taipei Medical University; Kaohsiung Medical University; National Yang Ming Chiao Tung University	Chang, TH (corresponding author), Taipei Med Univ, Grad Inst Biomed Informat, Taipei, Taiwan.	kevinchang@tmu.edu.tw; bryan@mail.nctu.edu.tw	Huang, Hsien-Da/AAA-7376-2019; Kuo, Hao-chung/ABF-9568-2020		Ministry of Science and Technology of the Republic of China [NSC 101-2311-B-009-005-MY3, NSC 102-2627-B-009-001, NSC 103-2628-B-009 -001 -MY3, NSC 103-2221-E-038-013-My2]; UST-UCSD International Center of Excellence in Advanced Bio-engineering - Taiwan Ministry of Science and Technology I-RiCE Program [NSC 102-2911-I-009-101]; Veterans General Hospitals and University System of Taiwan (VGHUST) Joint Research Program [VGHUST103-G5-1-2]; MOE ATU	Ministry of Science and Technology of the Republic of China(Ministry of Science and Technology, Taiwan); UST-UCSD International Center of Excellence in Advanced Bio-engineering - Taiwan Ministry of Science and Technology I-RiCE Program; Veterans General Hospitals and University System of Taiwan (VGHUST) Joint Research Program; MOE ATU(Ministry of Education, Taiwan)	Ministry of Science and Technology of the Republic of China financially supported this research under contract nos. NSC 101-2311-B-009-005-MY3, NSC 102-2627-B-009-001, NSC 103-2628-B-009 -001 -MY3 and NSC 103-2221-E-038-013-My2. This work was supported in part by the UST-UCSD International Center of Excellence in Advanced Bio-engineering sponsored by the Taiwan Ministry of Science and Technology I-RiCE Program under grant nos. NSC 102-2911-I-009-101, and Veterans General Hospitals and University System of Taiwan (VGHUST) Joint Research Program under grant no. VGHUST103-G5-1-2. This work was also partially supported by MOE ATU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu T, 2012, LEGAL MED-TOKYO, V14, P160, DOI 10.1016/j.legalmed.2012.01.005; Andrade-Rocha FT, 2009, GYNECOL OBSTET INVES, V68, P134, DOI 10.1159/000228583; Anzai Y, 2000, INT J SYST EVOL MICR, V50, P1563, DOI 10.1099/00207713-50-4-1563; Atassi F, 2006, FEMS IMMUNOL MED MIC, V48, P424, DOI 10.1111/j.1574-695X.2006.00162.x; BARRATT CLR, 1990, HUM REPROD, V5, P639, DOI 10.1093/oxfordjournals.humrep.a137162; Benjamini Y, 2000, J EDUC BEHAV STAT, V25, P60, DOI 10.3102/10769986025001060; Berktas M, 2008, INT UROL NEPHROL, V40, P383, DOI 10.1007/s11255-007-9289-4; Bukharin O. V., 2000, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P106; Cao Xing-Wu, 2011, Zhonghua Nan Ke Xue, V17, P1059; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Carr BR, 2013, SEMIN REPROD MED, V31, P231, DOI 10.1055/s-0033-1345267; CATLIN BW, 1992, CLIN MICROBIOL REV, V5, P213, DOI 10.1128/CMR.5.3.213-237.1992; CLOSE CE, 1990, J UROLOGY, V144, P900, DOI 10.1016/S0022-5347(17)39618-0; Cox MJ, 2013, HUM MOL GENET, V22, pR88, DOI 10.1093/hmg/ddt398; De Francesco MA, 2011, EUR J CONTRACEP REPR, V16, P47, DOI 10.3109/13625187.2010.533219; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; DeSantis TZ, 2003, BIOINFORMATICS, V19, P1461, DOI 10.1093/bioinformatics/btg200; Dicks LMT, 2000, INT J SYST EVOL MICR, V50, P1253, DOI 10.1099/00207713-50-3-1253; Diemer T, 2003, ANDROLOGIA, V35, P283, DOI 10.1046/j.1439-0272.2003.00556.x; Diemer T, 2003, ANDROLOGIA, V35, P100, DOI 10.1046/j.1439-0272.2003.00523.x; Domes T, 2012, FERTIL STERIL, V97, P1050, DOI 10.1016/j.fertnstert.2012.01.124; Donders G, 2010, OBSTET GYNECOL SURV, V65, P462, DOI 10.1097/OGX.0b013e3181e09621; ELSNER P, 1988, ZBL BAKT-INT J MED M, V269, P56; Euzeby JP, 1997, INT J SYST BACTERIOL, V47, P590, DOI 10.1099/00207713-47-2-590; Fraczek M, 2007, FERTIL STERIL, V88, P1076, DOI 10.1016/j.fertnstert.2006.12.025; Goldenberger D, 1997, J CLIN MICROBIOL, V35, P2733, DOI 10.1128/JCM.35.11.2733-2739.1997; Gonzalez Pedraza Aviles A, 1999, Rev Latinoam Microbiol, V41, P25; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; HARPER JJ, 1982, INT J SYST BACTERIOL, V32, P48, DOI 10.1099/00207713-32-1-48; Hattemer A, 2013, ANTIMICROB AGENTS CH, V57, P3969, DOI 10.1128/AAC.02467-12; Henkel R, 2006, WORLD J UROL, V24, P39, DOI 10.1007/s00345-005-0038-y; Hou DS, 2013, FERTIL STERIL, V100, P1261, DOI 10.1016/j.fertnstert.2013.07.1991; Isaiah IN, 2011, N AM J MED SCI, V3, P562, DOI 10.4297/najms.2011.3559; Ivanov IB, 2009, INT J ANDROL, V32, P462, DOI 10.1111/j.1365-2605.2008.00878.x; Jarvi K, 1994, Can J Urol, V1, P25; Jarvi K, 1996, FERTIL STERIL, V66, P463, DOI 10.1016/S0015-0282(16)58520-3; Jordan JA, 2005, J MOL DIAGN, V7, P575, DOI 10.1016/S1525-1578(10)60590-9; Kaewsrichan J, 2006, FEMS IMMUNOL MED MIC, V48, P75, DOI 10.1111/j.1574-695X.2006.00124.x; Kamischke A, 1999, HUM REPROD, V14, P1; Keck C, 1998, HUM REPROD UPDATE, V4, P891, DOI 10.1093/humupd/4.6.891; Kiessling AA, 2008, FERTIL STERIL, V90, P1744, DOI 10.1016/j.fertnstert.2007.08.083; Kozak M, 2012, COMMUN STAT-THEOR M, V41, P2279, DOI 10.1080/03610926.2011.560741; Lacroix JM, 1996, J MICROBIOL METH, V26, P61, DOI 10.1016/0167-7012(96)00844-5; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lbadin OKaI I N, 2008, MALAYSIAN J MICROBIO, V4, P65; Liu YM, 2014, INT J INFECT DIS, V23, P105, DOI 10.1016/j.ijid.2014.02.013; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Madupu Ramana, 2013, Science Progress, V96, P153, DOI 10.3184/003685013X13683759820813; Mandar R, 2013, PHARMACOL RES, V69, P32, DOI 10.1016/j.phrs.2012.10.019; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Marchandin H, 2005, RES MICROBIOL, V156, P603, DOI 10.1016/j.resmic.2005.01.013; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Moretti E, 2009, J ASSIST REPROD GEN, V26, P47, DOI 10.1007/s10815-008-9283-5; Ochsendorf FR, 2008, ANDROLOGIA, V40, P72, DOI 10.1111/j.1439-0272.2007.00825.x; Osset J, 2001, J INFECT DIS, V183, P485, DOI 10.1086/318070; Pascual LM, 2008, J GEN APPL MICROBIOL, V54, P141, DOI 10.2323/jgam.54.141; Pleckaityte M, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-301; Reid G, 2009, CURR OPIN CLIN NUTR, V12, P583, DOI 10.1097/MCO.0b013e328331b611; Rittenberg V, 2010, HUM FERTIL, V13, P208, DOI 10.3109/14647273.2010.534833; Saha Rumpa, 2010, J Indian Med Assoc, V108, P344; Sanocka-Maciejewska D, 2005, J REPROD IMMUNOL, V67, P51, DOI 10.1016/j.jri.2005.06.003; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schulz M, 2010, FERTIL STERIL, V94, P619, DOI 10.1016/j.fertnstert.2009.01.140; SHAH HN, 1990, INT J SYST BACTERIOL, V40, P205, DOI 10.1099/00207713-40-2-205; SMITH SM, 1992, J CLIN MICROBIOL, V30, P1575, DOI 10.1128/JCM.30.6.1575-1577.1992; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Srinivasan Sujatha, 2008, Interdiscip Perspect Infect Dis, V2008, P750479, DOI 10.1155/2008/750479; Stumpf RM, 2013, AM J PHYS ANTHROPOL, V152, P119, DOI 10.1002/ajpa.22395; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taneja Neelam, 2004, Journal of Communicable Diseases, V36, P27; Tanner MA, 1999, J CLIN MICROBIOL, V37, P1863, DOI 10.1128/JCM.37.6.1863-1870.1999; Virecoulon F, 2005, ANDROLOGIA, V37, P160, DOI 10.1111/j.1439-0272.2005.00673.x; Yang CH, 1996, J FORMOS MED ASSOC, V95, P754	74	123	133	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110152	10.1371/journal.pone.0110152	http://dx.doi.org/10.1371/journal.pone.0110152			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340531	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662800021
J	Sanjurjo, CIL; Tovey, SC; Taylor, CW				Sanjurjo, Cristina I. Lopez; Tovey, Stephen C.; Taylor, Colin W.			Rapid Recycling of Ca2+ between IP3-Sensitive Stores and Lysosomes	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; INTRACELLULAR CA2+; CALCIUM; NAADP; MITOCHONDRIA; CHANNELS; ENTRY; ORGANIZATION; MEMBRANE; RELEASE	Inositol 1,4,5-trisphosphate (IP3) evokes release of Ca2+ from the endoplasmic reticulum (ER), but the resulting Ca2+ signals are shaped by interactions with additional intracellular organelles. Bafilomycin A(1), which prevents lysosomal Ca2+ uptake by inhibiting H+ pumping into lysosomes, increased the amplitude of the initial Ca2+ signals evoked by carbachol in human embryonic kidney (HEK) cells. Carbachol alone and carbachol in combination with parathyroid hormone (PTH) evoke Ca2+ release from distinct IP3-sensitive Ca2+ stores in HEK cells stably expressing human type 1 PTH receptors. Bafilomycin A(1) similarly exaggerated the Ca2+ signals evoked by carbachol or carbachol with PTH, indicating that Ca2+ released from distinct IP3-sensitive Ca2+ stores is sequestered by lysosomes. The Ca2+ signals resulting from store-operated Ca2+ entry, whether evoked by thapsigargin or carbachol, were unaffected by bafilomycin A(1). Using Gd3+ (1 mM) to inhibit both Ca2+ entry and Ca2+ extrusion, HEK cells were repetitively stimulated with carbachol to assess the effectiveness of Ca2+ recycling to the ER after IP3-evoked Ca2+ release. Blocking lysosomal Ca2+ uptake with bafilomycin A(1) increased the amplitude of each carbachol-evoked Ca2+ signal without affecting the rate of Ca2+ recycling to the ER. This suggests that Ca2+ accumulated by lysosomes is rapidly returned to the ER. We conclude that lysosomes rapidly, reversibly and selectively accumulate the Ca2+ released by IP3 receptors residing within distinct Ca2+ stores, but not the Ca2+ entering cells via receptor-regulated, store-operated Ca2+ entry pathways.	[Sanjurjo, Cristina I. Lopez; Tovey, Stephen C.; Taylor, Colin W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England	University of Cambridge	Taylor, CW (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1QJ, England.	cwt1000@cam.ac.uk	Taylor, Colin/G-2447-2010	Taylor, Colin/0000-0001-7771-1044	Wellcome Trust [101844]; Caica Galicia Foundation, Spain; Obra Social La Caixa, Spain	Wellcome Trust(Wellcome TrustEuropean Commission); Caica Galicia Foundation, Spain; Obra Social La Caixa, Spain(La Caixa Foundation)	This work was supported by the Wellcome Trust (101844), Caica Galicia Foundation, Spain (studentship to CILS) and the Obra Social La Caixa, Spain (studentship to CILS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpy F, 2013, J CELL SCI, V126, P5500, DOI 10.1242/jcs.139295; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bird GSJ, 2004, J PHYSL, V562, P697; Brailoiu E, 2010, J BIOL CHEM, V285, P38511, DOI 10.1074/jbc.M110.162073; Broad LM, 1999, J PHYSIOL-LONDON, V517, P121, DOI 10.1111/j.1469-7793.1999.0121z.x; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cang CL, 2013, CELL, V152, P778, DOI 10.1016/j.cell.2013.01.023; Courjaret R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4916; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; de Brito OM, 2010, EMBO J, V29, P2715, DOI 10.1038/emboj.2010.177; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Elbaz Y, 2011, TRENDS BIOCHEM SCI, V36, P616, DOI 10.1016/j.tibs.2011.08.004; English AR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013227; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Gomes DA, 2006, CAN J PHYSIOL PHARM, V84, P325, DOI 10.1139/Y05-117; Hajnoczky G, 1999, J BIOL CHEM, V274, P14157, DOI 10.1074/jbc.274.20.14157; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Helle SCJ, 2013, BBA-MOL CELL RES, V1833, P2526, DOI 10.1016/j.bbamcr.2013.01.028; Huang P, 2014, J BIOL CHEM, V289, P17658, DOI 10.1074/jbc.M114.552158; Ishii K, 2006, EMBO REP, V7, P390, DOI 10.1038/sj.embor.7400620; Kar P, 2012, CURR BIOL, V22, P242, DOI 10.1016/j.cub.2011.12.025; Kilpatrick BS, 2013, J CELL SCI, V126, P60, DOI 10.1242/jcs.118836; Kiselyov K, 2010, CELL CALCIUM, V47, P103, DOI 10.1016/j.ceca.2009.12.007; Lewis RS, 2012, COLD SPRING HARB PER; Lopez-Sanjurjo CI, 2013, J CELL SCI, V126, P289, DOI 10.1242/jcs.116103; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Malli R, 2005, J BIOL CHEM, V280, P12114, DOI 10.1074/jbc.M409353200; Mignen O, 2001, J BIOL CHEM, V276, P35676, DOI 10.1074/jbc.M105626200; Morgan AJ, 2013, J CELL BIOL, V200, P789, DOI 10.1083/jcb.201204078; Morgan AJ, 2011, BIOCHEM J, V439, P349, DOI 10.1042/BJ20110949; Naghdi S, 2010, J CELL SCI, V123, P2553, DOI 10.1242/jcs.070151; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; Olson ML, 2010, J BIOL CHEM, V285, P2040, DOI 10.1074/jbc.M109.027094; Orci L, 2009, P NATL ACAD SCI USA, V106, P19358, DOI 10.1073/pnas.0911280106; Patel S, 2011, CELL CALCIUM, V50, P157, DOI 10.1016/j.ceca.2011.03.011; Pitt SJ, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004854; Pitt SJ, 2010, J BIOL CHEM, V285, P35039, DOI 10.1074/jbc.M110.156927; Putney JW, 2009, IMMUNOL REV, V231, P10, DOI 10.1111/j.1600-065X.2009.00810.x; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Schwaller B, 2012, COLD SPRING HARB PER, V2; Shuttleworth TJ, 1999, J BIOL CHEM, V274, P31174, DOI 10.1074/jbc.274.44.31174; Shuttleworth TJ, 2004, SCI STKE, ppe40; Smith IF, 2009, P NATL ACAD SCI USA, V106, P6404, DOI 10.1073/pnas.0810799106; Suzuki J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5153; Taylor CW, 2012, MOL CELL ENDOCRINOL, V353, P21, DOI 10.1016/j.mce.2011.08.028; Taylor CW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004010; Toulmay A, 2011, CURR OPIN CELL BIOL, V23, P458, DOI 10.1016/j.ceb.2011.04.006; Tovey SC, 2008, J CELL BIOL, V183, P297, DOI 10.1083/jcb.200803172; Tovey SC, 2013, J CELL SCI, V126, P2305, DOI 10.1242/jcs.126144; Willoughby D, 2007, PHYSIOL REV, V87, P965, DOI 10.1152/physrev.00049.2006; Yamaguchi S, 2011, J BIOL CHEM, V286, P22934, DOI 10.1074/jbc.M110.210930; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707	56	28	28	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e111275	10.1371/journal.pone.0111275	http://dx.doi.org/10.1371/journal.pone.0111275			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337829	Green Published, Green Submitted, gold			2022-12-27	WOS:000343674800114
J	Yang, Y; Wen, C; Wang, SL; Feng, YQ				Yang, Yan; Wen, Chuang; Wang, Shuli; Feng, Yuqing			Effect of Inlet and Outlet Flow Conditions on Natural Gas Parameters in Supersonic Separation Process	PLOS ONE			English	Article							NUMERICAL-SIMULATION; PURIFICATION; STATE	A supersonic separator has been introduced to remove water vapour from natural gas. The mechanisms of the upstream and downstream influences are not well understood for various flow conditions from the wellhead and the back pipelines. We used a computational model to investigate the effect of the inlet and outlet flow conditions on the supersonic separation process. We found that the shock wave was sensitive to the inlet or back pressure compared to the inlet temperature. The shock position shifted forward with a higher inlet or back pressure. It indicated that an increasing inlet pressure declined the pressure recovery capacity. Furthermore, the shock wave moved out of the diffuser when the ratio of the back pressure to the inlet one was greater than 0.75, in which the state of the low pressure and temperature was destroyed, resulting in the re-evaporation of the condensed liquids. Natural gas would be the subsonic flows in the whole supersonic separator, if the mass flow rate was less than the design value, and it could not reach the low pressure and temperature for the condensation and separation of the water vapor. These results suggested a guidance mechanism for natural gas supersonic separation in various flow conditions.	[Yang, Yan; Wen, Chuang; Wang, Shuli] Changzhou Univ, Jiangsu Key Lab Oil Gas Storage & Transportat Tec, Changzhou, Jiangsu, Peoples R China; [Feng, Yuqing] CSIRO, Melbourne, Vic, Australia	Changzhou University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Wen, C (corresponding author), Changzhou Univ, Jiangsu Key Lab Oil Gas Storage & Transportat Tec, Changzhou, Jiangsu, Peoples R China.	wenchuang2008@gmail.com	Wen, Chuang/I-5663-2016; Yang, Yan/I-5671-2016	Wen, Chuang/0000-0002-4445-1589; Yang, Yan/0000-0001-5796-7990	National Natural Science Foundation of China [51176015]; Jiangsu Key Laboratory of Oil-Gas Storage and Transportation Technology [SCZ1211200004/001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Key Laboratory of Oil-Gas Storage and Transportation Technology	This work was supported in part by the National Natural Science Foundation of China (No. 51176015) and Jiangsu Key Laboratory of Oil-Gas Storage and Transportation Technology (No. SCZ1211200004/001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfyorov V, 2005, OIL GAS J, V103, P53; ANSYS, 2011, ANSYS FLUENT US MAN; Arina R, 2004, APPL NUMER MATH, V51, P409, DOI 10.1016/j.apnum.2004.06.002; Benmekki E. H., 1987, SUPERCRITICAL FLUIDS; Economides MJ, 2009, J NAT GAS SCI ENG, V1, P1, DOI 10.1016/j.jngse.2009.03.005; FOELSCH K, 1949, J AERONAUT SCI, V16, P161, DOI 10.2514/8.11758; Jiang D, 2011, SPE PROJECTS FACILIT, V6(, P58, DOI DOI 10.2118/1210-0071-JPT; Karimi A, 2009, CHEM ENG PROCESS, V48, P560, DOI 10.1016/j.cep.2008.09.002; KWAK TY, 1986, CHEM ENG SCI, V41, P1303, DOI 10.1016/0009-2509(86)87103-2; Machado PB, 2012, J NAT GAS SCI ENG, V6, P43, DOI 10.1016/j.jngse.2012.03.001; Malyshkina MM, 2008, HIGH TEMP+, V46, P69, DOI 10.1134/S0018151X08010100; Malyshkina MM, 2010, HIGH TEMP+, V48, P244, DOI 10.1134/S0018151X10020161; MENTER FR, 1994, AIAA J, V32, P1598, DOI 10.2514/3.12149; Mokhatab S, 2006, HANDBOOK OF NATURAL GAS TRANSMISSION AND PROCESSING, P1, DOI 10.1016/B978-075067776-9/50006-3; Okimoto F, 2002, WORLD OIL, V223, P89; PATANKAR SV, 1972, INT J HEAT MASS TRAN, V15, P1787, DOI 10.1016/0017-9310(72)90054-3; REDLICH O, 1949, CHEM REV, V44, P233, DOI 10.1021/cr60137a013; Shooshtari SHR, 2013, SEP PURIF TECHNOL, V116, P458, DOI 10.1016/j.seppur.2013.06.009; Soldo B, 2012, APPL ENERG, V92, P26, DOI 10.1016/j.apenergy.2011.11.003; Vaziri BM, 2013, J NAT GAS SCI ENG, V13, P30, DOI 10.1016/j.jngse.2013.03.004; Wen C, 2012, ENERGY, V37, P195, DOI 10.1016/j.energy.2011.11.047; Wen C, 2011, CHEM ENG TECHNOL, V34, P1575, DOI 10.1002/ceat.201100095; Wen C, 2011, CHEM ENG PROCESS, V50, P644, DOI 10.1016/j.cep.2011.03.008; Wen C, 2012, ADV POWDER TECHNOL, V23, P228, DOI 10.1016/j.apt.2011.02.012; Yang Y, 2014, APPL ENERG, V132, P248, DOI 10.1016/j.apenergy.2014.07.018	25	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110313	10.1371/journal.pone.0110313	http://dx.doi.org/10.1371/journal.pone.0110313			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338207	Green Published, Green Submitted, gold			2022-12-27	WOS:000343674800034
J	MacNaughton, S; Ammu, S; Manohar, SK; Sonkusale, S				MacNaughton, Samuel; Ammu, Srikanth; Manohar, Sanjeev K.; Sonkusale, Sameer			High-Throughput Heterogeneous Integration of Diverse Nanomaterials on a Single Chip for Sensing Applications	PLOS ONE			English	Article							SENSOR ARRAY; GAS; GRAPHENE; NANOTUBE; CHEMIRESISTOR; POLYPYRROLE; SYSTEM	There is a large variety of nanomaterials each with unique electronic, optical and sensing properties. However, there is currently no paradigm for integration of different nanomaterials on a single chip in a low-cost high-throughput manner. We present a high throughput integration approach based on spatially controlled dielectrophoresis executed sequentially for each nanomaterial type to realize a scalable array of individually addressable assemblies of graphene, carbon nanotubes, metal oxide nanowires and conductive polymers on a single chip. This is a first time where such a diversity of nanomaterials has been assembled on the same layer in a single chip. The resolution of assembly can range from mesoscale to microscale and is limited only by the size and spacing of the underlying electrodes on chip used for assembly. While many applications are possible, the utility of such an array is demonstrated with an example application of a chemical sensor array for detection of volatile organic compounds below parts-per-million sensitivity.	[MacNaughton, Samuel; Sonkusale, Sameer] Tufts Univ, Dept Elect & Comp Engn, Nanolab, Medford, MA 02155 USA; [Ammu, Srikanth; Manohar, Sanjeev K.] Univ Massachusetts, Dept Chem Engn, Lowell, MA USA	Tufts University; University of Massachusetts System; University of Massachusetts Lowell	Sonkusale, S (corresponding author), Tufts Univ, Dept Elect & Comp Engn, Nanolab, Medford, MA 02155 USA.	sameer@ece.tufts.edu	Sonkusale, Sameer/B-3023-2011; Ammu, Srikanth/D-2698-2014	Sonkusale, Sameer/0000-0003-3579-910X; Ammu, Srikanth/0000-0002-5617-3272	National Science Foundation [ECCS-0955024]; Div Of Electrical, Commun & Cyber Sys [0955024] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Electrical, Commun & Cyber Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	Support from the National Science Foundation grant no: ECCS-0955024 is acknowledged. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 2006, SCIENCE, V314, P1754, DOI 10.1126/science.1132394; Ammu S, 2012, J AM CHEM SOC, V134, P4553, DOI 10.1021/ja300420t; Baik JM, 2010, ACS NANO, V4, P3117, DOI 10.1021/nn100394a; BARTLETT PN, 1989, SENSOR ACTUATOR, V19, P141, DOI 10.1016/0250-6874(89)87066-0; Bietsch A, 2004, NANOTECHNOLOGY, V15, P873, DOI 10.1088/0957-4484/15/8/002; Castellanos A, 2003, J PHYS D APPL PHYS, V36, P2584, DOI 10.1088/0022-3727/36/20/023; Chen CL, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/9/095504; Chen CL, 2009, NANOTECHNOLOGY, V20, P225; DeMeo D, 2014, MATER RES EXPRESS, V1, DOI 10.1088/2053-1591/1/2/025002; Dua V., 2010, ANGEW CHEM INT EDIT, V122, P2200, DOI [10.1002/ange.200905089, DOI 10.1002/ANGE.200905089]; Fan ZY, 2008, P NATL ACAD SCI USA, V105, P11066, DOI 10.1073/pnas.0801994105; Fan ZY, 2008, NANO LETT, V8, P20, DOI 10.1021/nl071626r; FREUND MS, 1995, P NATL ACAD SCI USA, V92, P2652, DOI 10.1073/pnas.92.7.2652; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Gomez-Navarro C, 2007, NANO LETT, V7, P3499, DOI 10.1021/nl072090c; Gou XL, 2008, J MATER CHEM, V18, P965, DOI 10.1039/b716745h; HATFIELD JV, 1994, SENSOR ACTUAT B-CHEM, V18, P221, DOI 10.1016/0925-4005(94)87086-1; Hong HK, 1996, SENSOR ACTUAT B-CHEM, V36, P338, DOI 10.1016/S0925-4005(97)80092-5; HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017; Im J, 2011, SENSOR ACTUAT B-CHEM, V156, P715, DOI 10.1016/j.snb.2011.02.025; Javey A, 2007, NANO LETT, V7, P773, DOI 10.1021/nl063056l; Jung YS, 2008, NANO LETT, V8, P3776, DOI 10.1021/nl802099k; Kehayias CE, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/24/245502; Kim YS, 2006, SENSOR ACTUAT B-CHEM, V114, P410, DOI 10.1016/j.snb.2005.06.016; Li B, 2007, SENSOR ACTUAT B-CHEM, V123, P651, DOI 10.1016/j.snb.2006.09.064; Li X, 2010, SENSOR ACTUAT B-CHEM, V158, P199; Lu YJ, 2006, J ELECTROANAL CHEM, V593, P105, DOI 10.1016/j.jelechem.2006.03.056; MacNaughton S, 2011, IEEE SENSOR, P125; Nikolaev P, 1999, CHEM PHYS LETT, V313, P91, DOI 10.1016/S0009-2614(99)01029-5; Penza M, 2001, SENSOR ACTUAT B-CHEM, V81, P115, DOI 10.1016/S0925-4005(01)00941-8; Pohl HA, 1978, DIELECTROPHORESIS BE, Vxii; Qu LT, 2010, ACS NANO, V4, P1321, DOI 10.1021/nn901850u; Robinson JT, 2008, NANO LETT, V8, P3137, DOI 10.1021/nl8013007; Robinson JA, 2006, NANO LETT, V6, P1747, DOI 10.1021/nl0612289; Shevade AV, 2003, SENSOR ACTUAT B-CHEM, V93, P84, DOI 10.1016/S0925-4005(03)00245-4; Stoller MD, 2008, NANO LETT, V8, P3498, DOI 10.1021/nl802558y; Sysoev VV, 2007, NANO LETT, V7, P3182, DOI 10.1021/nl071815+; Virojanadara C, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.245403; WATSON J, 1993, MEAS SCI TECHNOL, V4, P711, DOI 10.1088/0957-0233/4/7/001; Zhang XY, 2004, J AM CHEM SOC, V126, P12714, DOI 10.1021/ja046359v	40	7	15	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111377	10.1371/journal.pone.0111377	http://dx.doi.org/10.1371/journal.pone.0111377			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350279	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943100068
J	Xu, ZZ; Sun, L; Wang, JJ; Wang, P				Xu, Zhongzhi; Sun, Li; Wang, Junjie; Wang, Pu			The Loss of Efficiency Caused by Agents' Uncoordinated Routing in Transport Networks	PLOS ONE			English	Article							TRAFFIC ASSIGNMENT; AIR-POLLUTION; PARADOX; CHOICE; USAGE	Large-scale daily commuting data were combined with detailed geographical information system (GIS) data to analyze the loss of transport efficiency caused by drivers' uncoordinated routing in urban road networks. We used Price of Anarchy (POA) to quantify the loss of transport efficiency and found that both volume and distribution of human mobility demand determine the POA. In order to reduce POA, a small number of highways require considerable decreases in traffic, and their neighboring arterial roads need to attract more traffic. The magnitude of the adjustment in traffic flow can be estimated using the fundamental measure traffic flow only, which is widely available and easy to collect. Surprisingly, the most congested roads or the roads with largest traffic flow were not those requiring the most reduction of traffic. This study can offer guidance for the optimal control of urban traffic and facilitate improvements in the efficiency of transport networks.	[Xu, Zhongzhi; Sun, Li; Wang, Junjie; Wang, Pu] Cent S Univ, Sch Traff & Transportat Engn, Changsha, Hunan, Peoples R China	Central South University	Wang, P (corresponding author), Cent S Univ, Sch Traff & Transportat Engn, Changsha, Hunan, Peoples R China.	wangpu@csu.edu.cn			National Natural Science Foundation of China [51208520]; FokYing Tong Education Foundation [141075]; Shenghua Scholar Program of Central South University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); FokYing Tong Education Foundation(Fok Ying Tung Education Foundation); Shenghua Scholar Program of Central South University	The work is supported by the National Natural Science Foundation of China (No. 51208520), the FokYing Tong Education Foundation (No. 141075), and the Shenghua Scholar Program of Central South University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acemoglu D, 2007, IEEE J SEL AREA COMM, V25, P1148, DOI 10.1109/JSAC.2007.070809; Barthelemy M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.138702; Beckmann M.J., 1956, STUDIES EC TRANSPORT; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Chin ATH, 1996, ATMOS ENVIRON, V30, P787, DOI 10.1016/1352-2310(95)00173-5; Crucitti P, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.036125; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Du WB, 2013, PHYSICA A, V392, P3505, DOI 10.1016/j.physa.2013.03.032; GARTNER NH, 1980, TRANSPORT SCI, V14, P192, DOI 10.1287/trsc.14.2.192; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Helbing D, 2003, J PHYS A-MATH GEN, V36, pL593, DOI 10.1088/0305-4470/36/46/L03; Jiang B, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/07/P07008; Koutsoupias E, 1999, LECT NOTES COMPUT SC, V1563, P404; Kurant M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.138701; LEBLANC LJ, 1975, TRANSPORT RES, V9, P309, DOI 10.1016/0041-1647(75)90030-1; Liu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097822; Nagurney A, 2010, EPL-EUROPHYS LETT, V91, DOI 10.1209/0295-5075/91/48002; Rosenlund M, 2008, J EXPO SCI ENV EPID, V18, P192, DOI 10.1038/sj.jes.7500571; Roughgarden T, 2005, SELFISH ROUTING PRIC; Roughgarden T, 2006, J COMPUT SYST SCI, V72, P922, DOI 10.1016/j.jcss.2005.05.009; Schrank D., 2009, ANN URBAN MOBILITY R; Selten R, 2007, GAME ECON BEHAV, V58, P394, DOI 10.1016/j.geb.2006.03.012; Seto EYW, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-24; Stein WE, 2007, GAME ECON BEHAV, V59, P345, DOI 10.1016/j.geb.2006.08.008; Wang P, 2012, SCI REP-UK, V2, DOI 10.1038/srep01001; Wu ZH, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.148702; Yan G, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.046108; Youn H, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.128701	29	2	2	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111088	10.1371/journal.pone.0111088	http://dx.doi.org/10.1371/journal.pone.0111088			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25349995	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943100057
J	Cohen, OR; Steele, JA; Zhang, QS; Schmidt, DJ; Wang, YK; Hamel, PES; Beamer, G; Xu, BL; Tzipori, S				Cohen, Ocean R.; Steele, Jennifer A.; Zhang, Quanshun; Schmidt, Diane J.; Wang, Yuankai; Hamel, Philip E. S.; Beamer, Gillian; Xu, Bingling; Tzipori, Saul			Systemically Administered IgG Anti-Toxin Antibodies Protect the Colonic Mucosa during Infection with Clostridium difficile in the Piglet Model	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; TOXIN-A; DISEASE	The use of anti-toxin human monoclonal antibodies (HMab) as treatment for C. difficile infection has been investigated in animal models and human clinical trials as an alternative to or in combination with traditional antibiotic therapy. While HMab therapy appears to be a promising option, how systemically administered IgG antibodies protect the colonic mucosa during Clostridium difficile infection is unknown. Using the gnotobiotic piglet model of Clostridium difficile infection, we administered a mixture of anti-TcdA and anti-TcdB HMabs systemically to piglets infected with either pathogenic or nonpathogenic C. difficile strains. The HMabs were present throughout the small and large intestinal tissue of both groups, but significant HMabs were present in the lumen of the large intestines only in the pathogenic strain-infected group. Similarly, HMabs measured in the large intestine over a period of 2-4 days following antibody administration were not significantly different over time in the gut mucosa among the groups, but concentrations in the lumen of the large intestine were again consistently higher in the pathogenic strain-infected group. These results indicate that systemically administered HMab IgG reaches the gut mucosa during the course of CDI, protecting the host against systemic intoxication, and that leakage through the damaged colon likely protects the mucosa from further damage, allowing initiation of repair and recovery.	[Cohen, Ocean R.; Steele, Jennifer A.; Zhang, Quanshun; Schmidt, Diane J.; Wang, Yuankai; Hamel, Philip E. S.; Beamer, Gillian; Xu, Bingling; Tzipori, Saul] Tufts Cummings Sch Vet Med, Dept Infect Dis & Global Hlth, North Grafton, MA 01536 USA		Tzipori, S (corresponding author), Tufts Cummings Sch Vet Med, Dept Infect Dis & Global Hlth, North Grafton, MA 01536 USA.	Saul.Tzipori@tufts.edu			Merck, Inc. award VT ID [40660]; National Institutes of Health [R01-AI-0022748]; Merck, Inc.	Merck, Inc. award VT ID; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck, Inc.(Merck & Company)	The work was supported by the following: Merck, Inc. award VT ID#40660 (ST) and National Institutes of Health award R01-AI-0022748 (ST). Merck, Inc. approved the study design in the award application but had no role in the data collection, analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Babcock GJ, 2006, INFECT IMMUN, V74, P6339, DOI 10.1128/IAI.00982-06; Bakken JS, 2013, ANAEROBE, V24, P20, DOI 10.1016/j.anaerobe.2013.08.007; Carter GP, 2010, GUT MICROBES, V1, P58, DOI 10.4161/gmic.1.1.10768; Hussack G, 2010, TOXINS, V2, P998, DOI 10.3390/toxins2050998; Killgore G, 2008, J CLIN MICROBIOL, V46, P431, DOI 10.1128/JCM.01484-07; Leav BA, 2010, VACCINE, V28, P965, DOI 10.1016/j.vaccine.2009.10.144; Lowy I, 2010, NEW ENGL J MED, V362, P197, DOI 10.1056/NEJMoa0907635; McCollum DL, 2012, CLIN GASTROENTEROL H, V10, P581, DOI 10.1016/j.cgh.2012.03.008; Mohawk KL, 2010, VACCINE, V28, P4777, DOI 10.1016/j.vaccine.2010.04.099; Rath T, 2013, J CLIN IMMUNOL, V33, pS9, DOI 10.1007/s10875-012-9768-y; Steele J, 2013, J INFECT DIS, V207, P323, DOI 10.1093/infdis/jis669; Steele J, 2012, J INFECT DIS, V205, P384, DOI 10.1093/infdis/jir748; Steele J, 2010, J INFECT DIS, V201, P428, DOI 10.1086/649799; Sun XM, 2010, TOXINS, V2, P1848, DOI 10.3390/toxins2071848; Taylor CP, 2008, VACCINE, V26, P3404, DOI 10.1016/j.vaccine.2008.04.042; Yang GL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-192; Yoshida M, 2006, J CLIN INVEST, V116, P2142, DOI 10.1172/JCI27821	17	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111075	10.1371/journal.pone.0111075	http://dx.doi.org/10.1371/journal.pone.0111075			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347821	Green Published, Green Submitted, gold			2022-12-27	WOS:000347994900044
J	Henderson, LJ; Evans, NP; Heidinger, BJ; Adams, A; Arnold, KE				Henderson, Lindsay J.; Evans, Neil P.; Heidinger, Britt J.; Adams, Aileen; Arnold, Kathryn E.			Maternal Condition but Not Corticosterone Is Linked to Offspring Sex Ratio in a Passerine Bird	PLOS ONE			English	Article							BLUE TITS; PARENTAL CONDITION; FOOD AVAILABILITY; STRESS HORMONES; BODY CONDITION; PARUS-MAJOR; POPULATION; QUALITY; EGGS; SEGREGATION	There is evidence of offspring sex ratio adjustment in a range of species, but the potential mechanisms remain largely unknown. Elevated maternal corticosterone (CORT) is associated with factors that can favour brood sex ratio adjustment, such as reduced maternal condition, food availability and partner attractiveness. Therefore, the steroid hormone has been suggested to play a key role in sex ratio manipulation. However, despite correlative and causal evidence CORT is linked to sex ratio manipulation in some avian species, the timing of adjustment varies between studies. Consequently, whether CORT is consistently involved in sex-ratio adjustment, and how the hormone acts as a mechanism for this adjustment remains unclear. Here we measured maternal baseline CORT and body condition in free-living blue tits (Cyanistes caeruleus) over three years and related these factors to brood sex ratio and nestling quality. In addition, a non-invasive technique was employed to experimentally elevate maternal CORT during egg laying, and its effects upon sex ratio and nestling quality were measured. We found that maternal CORT was not correlated with brood sex ratio, but mothers with elevated CORT fledged lighter offspring. Also, experimental elevation of maternal CORT did not influence brood sex ratio or nestling quality. In one year, mothers in superior body condition produced male biased broods, and maternal condition was positively correlated with both nestling mass and growth rate in all years. Unlike previous studies maternal condition was not correlated with maternal CORT. This study provides evidence that maternal condition is linked to brood sex ratio manipulation in blue tits. However, maternal baseline CORT may not be the mechanistic link between the maternal condition and sex ratio adjustment. Overall, this study serves to highlight the complexity of sex ratio adjustment in birds and the difficulties associated with identifying sex biasing mechanisms.	[Henderson, Lindsay J.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Henderson, Lindsay J.; Evans, Neil P.; Heidinger, Britt J.; Adams, Aileen; Arnold, Kathryn E.] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Heidinger, Britt J.] N Dakota State Univ, Dept Biol Sci, Fargo, ND 58105 USA; [Arnold, Kathryn E.] Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England	University of California System; University of California Davis; University of Glasgow; North Dakota State University Fargo; University of York - UK	Henderson, LJ (corresponding author), Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA.	lindsayhenderson@hotmail.com	Arnold, Kathryn E/F-8683-2016	Arnold, Kathryn E/0000-0002-6485-6065; Henderson, Lindsay J./0000-0001-7794-3048	Natural Environment Research Council [NE/H526886/1]; Royal Society University Research Fellowship	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society University Research Fellowship(Royal Society of London)	LJH, KEA, and NPE received PhD funding from Natural Environment Research Council (award number NE/H526886/1, http://www.nerc.com/). KEA was also supported by a Royal Society University Research Fellowship (https://royalsociety.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslam MA, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.115352; Badyaev AV, 2002, SCIENCE, V295, P316, DOI 10.1126/science.1066651; Bonier F, 2007, BEHAV ECOL, V18, P1045, DOI 10.1093/beheco/arm075; Buck CL, 2007, GEN COMP ENDOCR, V150, P430, DOI 10.1016/j.ygcen.2006.10.011; Cameron EZ, 2008, P ROY SOC B-BIOL SCI, V275, P323, DOI 10.1098/rspb.2007.1401; Cameron EZ, 2007, BIOL LETTERS, V3, P395, DOI 10.1098/rsbl.2007.0089; Charmantier A, 2004, J AVIAN BIOL, V35, P524, DOI 10.1111/j.0908-8857.2004.03296.x; CHARNOV E L, 1982; Clout MN, 2002, BIOL CONSERV, V107, P13, DOI 10.1016/S0006-3207(01)00267-1; Criscuolo Francois, 2001, Marine Ornithology, V29, P47; Cyr NE, 2007, GEN COMP ENDOCR, V151, P82, DOI 10.1016/j.ygcen.2006.12.003; Delhey K, 2007, BEHAV ECOL SOCIOBIOL, V61, P853, DOI 10.1007/s00265-006-0314-x; Dreiss A, 2006, BEHAV ECOL, V17, P13, DOI 10.1093/beheco/ari089; Ewen JG, 2004, P ROY SOC B-BIOL SCI, V271, P1277, DOI 10.1098/rspb.2004.2735; Gam AE, 2011, J AVIAN BIOL, V42, P253, DOI 10.1111/j.1600-048X.2010.05251.x; Goerlich VC, 2010, PHYSIOL BIOCHEM ZOOL, V83, P490, DOI 10.1086/651315; Griffith SC, 2003, J EVOLUTION BIOL, V16, P1045, DOI 10.1046/j.1420-9101.2003.00550.x; Griffith SC, 2011, P ROY SOC B-BIOL SCI, V278, P2798, DOI 10.1098/rspb.2010.2672; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; GULLBERG A, 1992, HEREDITAS, V117, P103, DOI 10.1111/j.1601-5223.1992.tb00164.x; Hardy I.C.W, 2002, SEX RATIOS CONCEPTS; Hayward LS, 2004, GEN COMP ENDOCR, V135, P365, DOI 10.1016/j.ygcen.2003.11.002; Henderson LJ, 2013, BEHAV ECOL, V24, P1299, DOI 10.1093/beheco/art066; Henderson LJ, ARE GLUCOCORTI UNPUB; Hunt S, 1999, ANIM BEHAV, V58, P809, DOI 10.1006/anbe.1999.1214; Jones KS, 2009, AM NAT, V174, P122, DOI 10.1086/599299; Kilner R, 1998, ANIM BEHAV, V56, P155, DOI 10.1006/anbe.1998.0775; Kitaysky AS, 2007, MAR ECOL PROG SER, V352, P245, DOI 10.3354/meps07074; Kitaysky AS, 2001, J COMP PHYSIOL B, V171, P701, DOI 10.1007/s003600100230; Kitaysky AS, 1999, FUNCT ECOL, V13, P577, DOI 10.1046/j.1365-2435.1999.00352.x; Koenig WD, 1996, AUK, V113, P902, DOI 10.2307/4088867; Komdeur J, 2002, PHILOS T R SOC B, V357, P373, DOI 10.1098/rstb.2001.0927; Komdeur J, 2002, P ROY SOC B-BIOL SCI, V269, P1067, DOI 10.1098/rspb.2002.1965; Korpimaki E, 2000, J AVIAN BIOL, V31, P128, DOI 10.1034/j.1600-048X.2000.310204.x; Korsten P, 2006, BEHAV ECOL, V17, P539, DOI 10.1093/beheco/arj061; Kruuk LEB, 1999, NATURE, V399, P459, DOI 10.1038/20917; Leech DI, 2001, BEHAV ECOL, V12, P674, DOI 10.1093/beheco/12.6.674; Love OP, 2005, AM NAT, V166, P751, DOI 10.1086/497440; Marra PP, 1998, OECOLOGIA, V116, P284, DOI 10.1007/s004420050590; Nager RG, 1999, P NATL ACAD SCI USA, V96, P570, DOI 10.1073/pnas.96.2.570; Nicholls JA, 2000, J AVIAN BIOL, V31, P165, DOI 10.1034/j.1600-048X.2000.310208.x; Oddie K, 1998, TRENDS ECOL EVOL, V13, P130, DOI 10.1016/S0169-5347(97)01320-7; OLSEN MW, 1950, J EXP ZOOL, V114, P475, DOI 10.1002/jez.1401140304; Pendlebury CJ, 2005, IBIS, V147, P342, DOI 10.1111/j.1474-919x.2005.00409.x; Perrins C.M., 1979, BRIT TITS; Perrins CM, 1996, IBIS, V138, P2, DOI 10.1111/j.1474-919X.1996.tb04308.x; Pike TW, 2005, ANIM BEHAV, V70, P745, DOI 10.1016/j.anbehav.2004.12.020; Pike TW, 2003, BIOL REV, V78, P553, DOI 10.1017/S1464793103006146; PIKE TW, 2005, OFFSPRING SEX RATIO, V1, P204; Pinson SE, 2011, PHYSIOL BIOCHEM ZOOL, V84, P292, DOI 10.1086/659373; Pryke SR, 2011, BEHAV ECOL, V22, P717, DOI 10.1093/beheco/arr040; Pryke SR, 2014, FUNCTIONAL ECOLOGY; Radford AN, 2000, BEHAV ECOL, V11, P294, DOI 10.1093/beheco/11.3.294; Romanoff A., 1960, THE AVIAN EMBRYO, V1, P429; Rutkowska J, 2008, PHILOS T R SOC B, V363, P1675, DOI 10.1098/rstb.2007.0006; Saino N, 2005, J EXP ZOOL PART A, V303A, P998, DOI 10.1002/jez.a.224; Schoech SJ, 1997, PHYSIOL ZOOL, V70, P68, DOI 10.1086/639545; Sheldon BC, 1999, NATURE, V402, P874, DOI 10.1038/47239; Stauss M, 2005, OIKOS, V109, P367, DOI 10.1111/j.0030-1299.2005.13333.x; Sturkie P.D., 2000, STURKIES AVIAN PHYSL; Svensson L., 1992, IDENTIFICATION GUIDE; Tilgar V, 2010, J ORNITHOL, V151, P61, DOI 10.1007/s10336-009-0426-y; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; West SA, 2009, MONOGR POPUL BIOL, V44, P162; Whittingham LA, 2005, P ROY SOC B-BIOL SCI, V272, P1775, DOI 10.1098/rspb.2005.3167; Wilkin TA, 2009, CURR BIOL, V19, P1998, DOI 10.1016/j.cub.2009.09.065; Wilson K, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P48, DOI 10.1017/CBO9780511542053.004; WINGFIELD JC, 1976, CONDOR, V78, P570, DOI 10.2307/1367117; WINGFIELD JC, 1978, BIOL REPROD, V19, P1046, DOI 10.1095/biolreprod19.5.1046; Wingfield JC, 2005, J MAMMAL, V86, P248, DOI 10.1644/BHE-004.1; WINGFIELD JC, 1982, CONDOR, V84, P399, DOI 10.2307/1367443	71	15	16	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e110858	10.1371/journal.pone.0110858	http://dx.doi.org/10.1371/journal.pone.0110858			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347532	Green Accepted, Green Published, gold			2022-12-27	WOS:000347994900033
J	Tiffin-Richards, FE; Costa, AS; Holschbach, B; Frank, RD; Vassiliadou, A; Kruger, T; Kuckuck, K; Gross, T; Eitner, F; Floege, J; Schulz, JB; Reetz, K				Tiffin-Richards, Frances E.; Costa, Ana S.; Holschbach, Bernhard; Frank, Rolf D.; Vassiliadou, Athina; Krueger, Thilo; Kuckuck, Karl; Gross, Theresa; Eitner, Frank; Floege, Juergen; Schulz, Joerg B.; Reetz, Kathrin			The Montreal Cognitive Assessment (MoCA) - A Sensitive Screening Instrument for Detecting Cognitive Impairment in Chronic Hemodialysis Patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; MINI-MENTAL-STATE; RELIABILITY; DEMENTIA; PERFORMANCE; PREVALENCE; DIALYSIS; VALIDITY; ADULTS; TIME	Background: Chronic kidney disease (CKD) patients undergoing hemodialysis (HD) therapy have an increased risk of developing cognitive impairment and dementia, which are known relevant factors in disease prognosis and therapeutic success, but still lack adequate screening in clinical routine. We evaluated the Montreal Cognitive Assessment (MoCA) for suitability in assessing cognitive performance in HD patients in comparison to the commonly used Mini-Mental State Examination (MMSE) and a detailed neuropsychological test battery, used as gold standard. Methods: 43 HD patients and 42 healthy controls with an average age of 58 years, were assessed with the MoCA, the MMSE and a detailed neuropsychological test battery, covering the domains of memory, attention, language, visuospatial and executive functions. Composite scores were created for comparison of cognitive domains and test results were analyzed using Spearman's correlation and linear regression. Cognitive dysfunction was defined using z-score values and predictive values were calculated. Sensitivity and specificity of the MoCA were determined using receiver operating characteristic (ROC) analysis. Results: HD patients performed worse in all cognitive domains, especially in memory recall and executive functions. The MoCA correlated well with the detailed test battery and identified patients with cognitive impairment with a sensitivity of 76.7% and specificity of 78.6% for a cut-off value of <= 24 out of 30 points. In the detailed assessment executive functions accounted significantly for performance in the MoCA. The MMSE only discriminated weakly between groups. Conclusions: The MoCA represents a suitable cognitive screening tool for hemodialysis patients, demonstrating good sensitivity and specificity levels, and covering executive functions, which appear to play an important role in cognitive performance of HD patients.	[Tiffin-Richards, Frances E.; Costa, Ana S.; Kuckuck, Karl; Schulz, Joerg B.; Reetz, Kathrin] RWTH Aachen Univ Hosp, Dept Neurol, Aachen, Germany; [Tiffin-Richards, Frances E.; Costa, Ana S.; Kuckuck, Karl; Schulz, Joerg B.; Reetz, Kathrin] Julich Aachen Res Alliance JARA, Translat Brain Med, Aachen, Germany; [Tiffin-Richards, Frances E.; Costa, Ana S.; Kuckuck, Karl; Schulz, Joerg B.; Reetz, Kathrin] Julich Aachen Res Alliance JARA, Translat Brain Med, Julich, Germany; [Holschbach, Bernhard] KfH Nephrol Ctr, KfH Curatorship Dialysis & Kidney Transplant EV, Stolberg, Germany; [Frank, Rolf D.] St Antonius Hosp Eschweiler, Dept Internal Med, Eschweiler, Germany; [Vassiliadou, Athina] Dialysis Ctr Aachen, Dialysis Ctr, Aachen, Germany; [Krueger, Thilo; Gross, Theresa; Eitner, Frank; Floege, Juergen] Rhein Westfal TH Aachen, Div Nephrol & Clin Immunol, Aachen, Germany; [Gross, Theresa] Dresden Friedreichstadt Hosp, Dept Internal Med, Dresden, Germany; [Eitner, Frank] Bayer Pharma AG, Wuppertal, Germany; [Reetz, Kathrin] Res Ctr Julich GmbH, Inst Neurosci & Med INM 4, Julich, Germany	RWTH Aachen University; RWTH Aachen University Hospital; Saint Antonius Hospital; RWTH Aachen University; Bayer AG; Bayer Healthcare Pharmaceuticals; Helmholtz Association; Research Center Julich	Reetz, K (corresponding author), RWTH Aachen Univ Hosp, Dept Neurol, Aachen, Germany.	kreetz@ukaachen.de	Schulz, Jörg B/D-9786-2012; Costa, Ana Sofia/O-3913-2017; Reetz, Kathrin/H-9510-2012	Schulz, Jörg B/0000-0002-8903-0593; Costa, Ana Sofia/0000-0002-1999-6616; Reetz, Kathrin/0000-0002-9730-9228	Fundacao para a Ciencia e Tecnologia (FCT, Portugal) [SFRH/BD/65743/2009]; Excellence Initiative of the German federal and state governments (DFG) [ZUK32/1]; Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association; POPH - QREN Program	Fundacao para a Ciencia e Tecnologia (FCT, Portugal)(Portuguese Foundation for Science and Technology); Excellence Initiative of the German federal and state governments (DFG)(German Research Foundation (DFG)); Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association; POPH - QREN Program	Ana S. Costa was supported by a PhD fellowship (SFRH/BD/65743/2009) from Fundacao para a Ciencia e Tecnologia (FCT, Portugal) and financed by the POPH - QREN Program. Kathrin Reetz was funded by the Excellence Initiative of the German federal and state governments (DFG ZUK32/1). Jorg B. Schulz was in part funded by the Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi C, 2002, VALIEDIRUNG NEUROPSY; Agganis BT, 2010, AM J KIDNEY DIS, V56, P704, DOI 10.1053/j.ajkd.2010.04.018; Ahmed S, 2011, NEUROCASE; Aschenbrenner S., 2000, REGENSBURGER WORTFLU; Beddhu S, 2000, AM J MED, V108, P609, DOI 10.1016/S0002-9343(00)00371-5; Bossola M, 2011, J PSYCHOSOM RES, V71, P50, DOI 10.1016/j.jpsychores.2011.01.001; Bossola Maurizio, 2009, Blood Purif, V28, P245, DOI 10.1159/000231985; Bugnicourt JM, 2013, J AM SOC NEPHROL, V24, P353, DOI 10.1681/ASN.2012050536; Buumler G., 1985, FARBE WORT INTERFERE; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cohen J.E., 1988, STAT POWER ANAL BEHA; Costa AS, 2012, DEMENT GERIATR COGN, V33, P379, DOI 10.1159/000340006; Costa AS, 2014, AM J KIDNEY DIS, pS0272; Elias MF, 2009, NEPHROL DIAL TRANSPL, V24, P2446, DOI 10.1093/ndt/gfp107; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freitas S, 2011, ALZ DIS ASSOC DIS, V00, P1; Gill DJ, 2008, MOVEMENT DISORD, V23, P1043, DOI 10.1002/mds.22017; Griva K, 2010, AM J KIDNEY DIS, V56, P693, DOI 10.1053/j.ajkd.2010.07.003; Helmer C, 2011, NEUROLOGY, V77, P2043, DOI 10.1212/WNL.0b013e31823b4765; Herrmann-Lingen C., 1995, HOSP ANXIETY DEPRESS; Ingram F, 1997, NEUROPSY NEUROPSY BE, V10, P144; Johns M, 1991, SLEEP; Kessler J, 2000, MINIMENTALSTATUSTEST; Kurella M, 2004, J AM GERIATR SOC, V52, P1863, DOI 10.1111/j.1532-5415.2004.52508.x; Lessig S, 2012, MOVEMENT DISORD, V27, P1125, DOI 10.1002/mds.25070; Luis CA, 2009, INT J GERIATR PSYCHI; Madero M, SEMIN DIAL, V21, P29; McLennan SN, 2011, J GERIATR PSYCH NEUR, V24, P33, DOI 10.1177/0891988710390813; Murray AM, 2006, NEUROLOGY, V67, P216, DOI 10.1212/01.wnl.0000225182.15532.40; Murray AM, 2010, AM J KIDNEY DIS, V56, P615, DOI 10.1053/j.ajkd.2010.08.003; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Niemann H., 2008, CALIFORNIA VERBAL LE; Pereira Arema A, 2007, Hemodial Int, V11, P309, DOI 10.1111/j.1542-4758.2007.00185.x; Perk J, 2012, EUR HEART J, V33, P2126, DOI 10.1093/eurheartj/ehs254; Post JB, 2010, NEPHRON CLIN PRACT, V116, pC247, DOI 10.1159/000317206; Radbruch L, 2003, J PAIN SYMPTOM MANAG, V25, P449, DOI 10.1016/S0885-3924(03)00073-3; Sanchez-Roman S, 2011, J INT NEUROPSYCH SOC, V17, P80, DOI 10.1017/S1355617710001219; Sarnak MJ, 2013, NEUROLOGY, V80, P471, DOI 10.1212/WNL.0b013e31827f0f7f; Sehgal AR, 1997, AM J KIDNEY DIS, V30, P41, DOI 10.1016/S0272-6386(97)90563-1; Sorensen EP, 2012, AM J KIDNEY DIS, P1; Tamura MK, 2008, AM J KIDNEY DIS, V52, P227, DOI 10.1053/j.ajkd.2008.05.004; Tamura MK, 2011, KIDNEY INT, V79, P14, DOI 10.1038/ki.2010.336; Tholen S, 2014, DEMENT GERIATR COGN, V38, P31, DOI 10.1159/000357803; Von Aste M, 2006, WECHSLER INTELLIGENZ; Wagner S, 2011, ARCH CLIN NEUROPSYCH, V26, P314, DOI 10.1093/arclin/acr024; Wang F, 2010, AM J NEPHROL, V32, P117, DOI 10.1159/000315618; Warrington E, 1992, TESTBATTERIE VISUELL; Watnick S, 2003, AM J KIDNEY DIS, V41, P105, DOI 10.1053/ajkd.2003.50029; Williams MA, 2004, AM J KIDNEY DIS, V43, P705, DOI 10.1053/j.ajkd.2003.12.031; Wong A, 2009, DEMENT GERIATR COGN, V28, P81, DOI 10.1159/000232589; Yaffe K, 2010, J AM GERIATR SOC, V58, P338, DOI 10.1111/j.1532-5415.2009.02670.x; Zadikoff C, 2008, MOVEMENT DISORD, V23, P297, DOI 10.1002/mds.21837; Zhao J, 2012, METAB BRAIN DIS, V27, P17, DOI 10.1007/s11011-011-9275-5; Zimmermann P, 2012, TESTBATTERIE AUFMERK	54	102	110	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e106700	10.1371/journal.pone.0106700	http://dx.doi.org/10.1371/journal.pone.0106700			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ1JF	25347578	Green Published, Green Submitted, gold			2022-12-27	WOS:000347994900002
J	De Vuyst, H; Mugo, NR; Franceschi, S; McKenzie, K; Tenet, V; Njoroge, J; Rana, FS; Sakr, SR; Snijders, PJF; Chung, MH				De Vuyst, Hugo; Mugo, Nelly R.; Franceschi, Silvia; McKenzie, Kevin; Tenet, Vanessa; Njoroge, Julia; Rana, Farzana S.; Sakr, Samah R.; Snijders, Peter J. F.; Chung, Michael H.			Residual Disease and HPV Persistence after Cryotherapy for Cervical Intraepithelial Neoplasia Grade 2/3 in HIV-Positive Women in Kenya	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN-PAPILLOMAVIRUS; HIGH-RISK; INFECTED WOMEN; FOLLOW-UP; RESIDUAL/RECURRENT DISEASE; ANTIRETROVIRAL THERAPY; RECURRENCE; CYTOLOGY; DYSPLASIA	Objective: To assess residual cervical intraepithelial neoplasia (CIN) 2/3 disease and clearance of high-risk (hr) human papillomavirus (HPV) infections at 6 months after cryotherapy among HIV-positive women. Design: Follow-up study. Methods: 79 HIV-positive women received cryotherapy for CIN2/3 in Nairobi, Kenya, and underwent conventional cytology 6 months later. Biopsies were performed on high grade cytological lesions and hrHPV was assessed before (cervical cells and biopsy) and after cryotherapy (cells). Results: At 6 months after cryotherapy CIN2/3 had been eliminated in 61 women (77.2%; 95% Confidence Interval, (CI): 66.4-85.9). 18 women (22.8%) had residual CIN2/3, and all these women had hrHPV at baseline. CD4 count and duration of combination antiretroviral therapy (cART) were not associated with residual CIN2/3. CIN3 instead of CIN2 was the only significant risk factor for residual disease (odds ratio, OR vs CIN2 = 4.3; 95% CI: 1.2-15.0) among hrHPV-positive women after adjustment for age and HPV16 infection. Persistence of hrHPV types previously detected in biopsies was found in 77.5% of women and was associated with residual CIN2/3 (OR = 8.1, 95% CI: 0.9-70). The sensitivity, specificity, and negative predictive value of hrHPV test in detecting residual CIN2/3 were 0.94, 0.36, and 0.96 respectively. Conclusions: Nearly one quarter of HIV-positive women had residual CIN2/3 disease at 6 months after cryotherapy, and the majority had persistent hrHPV. CD4 count and cART use were not associated with residual disease or hrHPV persistence. The value of hrHPV testing in the detection of residual CIN2/3 was hampered by a low specificity.	[De Vuyst, Hugo; Franceschi, Silvia; Tenet, Vanessa] Int Agcy Res Canc, F-69372 Lyon, France; [Mugo, Nelly R.] Kenyatta Natl Hosp, Dept Obstet & Gynecol, Nairobi, Kenya; [McKenzie, Kevin; Njoroge, Julia; Chung, Michael H.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Rana, Farzana S.] Aga Khan Univ Hosp, Nairobi, Kenya; [Sakr, Samah R.] Coptic Hosp, Coptic Hope Ctr, Nairobi, Kenya; [Snijders, Peter J. F.] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Chung, Michael H.] Univ Washington, Dept Med, Seattle, WA USA; [Chung, Michael H.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	World Health Organization; International Agency for Research on Cancer (IARC); Kenyatta National Hospital; University of Washington; University of Washington Seattle; Vrije Universiteit Amsterdam; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	De Vuyst, H (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon, France.	devuysth@iarc.fr	franceschi, silvia/M-2452-2014	franceschi, silvia/0000-0003-4181-8071	Washington Global Health Alliance; National Institutes of Health [5K23AI065222-04]; Fondation de France [00016673]; Bill & Melinda Gates Foundation [35537]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI065222] Funding Source: NIH RePORTER	Washington Global Health Alliance; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation de France(Fondation de France); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the Washington Global Health Alliance, the National Institutes of Health (grant number 5K23AI065222-04), the Fondation de France (grant number 00016673), and the Bill & Melinda Gates Foundation (grant number 35537). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso I, 2006, GYNECOL ONCOL, V103, P631, DOI 10.1016/j.ygyno.2006.04.016; Bais AG, 2009, INT J CANCER, V124, P889, DOI 10.1002/ijc.23824; Cejtin HE, 2011, J LOW GENIT TRACT DI, V15, P37, DOI 10.1097/LGT.0b013e3181eb3115; Chirenje Z M, 2003, J Low Genit Tract Dis, V7, P16, DOI 10.1097/00128360-200301000-00005; Chung MH, 2013, AIDS, V27, P2909, DOI 10.1097/01.aids.0000432472.92120.1b; Chung MH, 2011, AIDS, V25, P1915, DOI 10.1097/QAD.0b013e32834a3654; Clifford GM, 2006, AIDS, V20, P2337, DOI 10.1097/01.aids.0000253361.63578.14; De Vuyst H, 2012, BRIT J CANCER, V107, P1624, DOI 10.1038/bjc.2012.441; De Vuyst H, 2008, EUR J CANCER PREV, V17, P545, DOI 10.1097/CEJ.0b013e3282f75ea1; De Vuyst H, 2013, INT J CANCER, V133, P1441, DOI 10.1002/ijc.28131; Elfgren K, 2002, OBSTET GYNECOL, V100, P965, DOI 10.1016/S0029-7844(02)02280-9; Foulot H, 2008, EUR J OBSTET GYN R B, V141, P153, DOI 10.1016/j.ejogrb.2008.07.015; Fruchter RG, 1996, OBSTET GYNECOL, V87, P338, DOI 10.1016/0029-7844(95)00408-4; Gilles C, 2005, GYNECOL ONCOL, V96, P112, DOI 10.1016/j.ygyno.2004.10.003; Gingelmaier A, 2007, ANTICANCER RES, V27, P1795; Heard I, 2005, JAIDS-J ACQ IMM DEF, V39, P412, DOI 10.1097/01.qai.0000167157.83098.60; Holcomb K, 1999, GYNECOL ONCOL, V74, P428, DOI 10.1006/gyno.1999.5479; Jacobs MV, 2000, INT J CANCER, V87, P221, DOI 10.1002/1097-0215(20000715)87:2&lt;221::AID-IJC11&gt;3.0.CO;2-2; Jones J, 2011, J CLIN VIROL, V52, P88, DOI 10.1016/j.jcv.2011.06.021; Kitchener HC, 2008, BJOG-INT J OBSTET GY, V115, P1001, DOI 10.1111/j.1471-0528.2008.01748.x; Kocken M, 2012, BRIT J CANCER, V106, P817, DOI 10.1038/bjc.2012.5; Kocken M, 2012, GYNECOL ONCOL, V125, P500, DOI 10.1016/j.ygyno.2012.01.015; Kocken M, 2011, LANCET ONCOL, V12, P441, DOI 10.1016/S1470-2045(11)70078-X; Kreimer AR, 2006, CANCER EPIDEM BIOMAR, V15, P908, DOI 10.1158/1055-9965.EPI-05-0845; Lehtovirta P, 2008, INT J STD AIDS, V19, P37, DOI 10.1258/ijsa.2007.005672; LUFF RD, 1992, AM J CLIN PATHOL, V98, P152, DOI 10.1093/ajcp/98.2.152; Martin-Hirsch PPL, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001421.pub3; Massad L Stewart, 2007, J Low Genit Tract Dis, V11, P90, DOI 10.1097/01.lgt.0000245038.06977.a7; Nene BM, 2008, INT J GYNECOL OBSTET, V103, P232, DOI 10.1016/j.ijgo.2008.07.016; Nobbenhuis MAE, 2001, BRIT J CANCER, V84, P796, DOI 10.1054/bjoc.2000.1689; Ojoo S, 2007, KENYA NATL CLIN MANU; Quint W, 2012, J PATHOL, V227, P62, DOI 10.1002/path.3970; Reimers LL, 2010, GYNECOL ONCOL, V119, P92, DOI 10.1016/j.ygyno.2010.06.012; Rijkaart DC, 2012, LANCET ONCOL, V13, P78, DOI 10.1016/S1470-2045(11)70296-0; Sankaranarayanan R, 2007, BRIT J CANCER, V96, P738, DOI 10.1038/sj.bjc.6603633; Santesso N, 2012, INT J GYNECOL OBSTET, V118, P97, DOI 10.1016/j.ijgo.2012.01.029; Schiffman Mark, 2009, Infect Agent Cancer, V4, P8, DOI 10.1186/1750-9378-4-8; Sellors J. W., 2003, COLPOSCOPY TREATMENT; Strander B, 2007, EUR J CANCER, V43, P1849, DOI 10.1016/j.ejca.2007.05.016; Tate DR, 2002, AM J OBSTET GYNECOL, V186, P880, DOI 10.1067/mob.2002.123607; Tebeu PM, 2006, INT J STD AIDS, V17, P507, DOI 10.1258/095646206778145703; Valasoulis G, 2011, GYNECOL ONCOL, V121, P43, DOI 10.1016/j.ygyno.2010.12.003; van den Brule AJC, 2002, J CLIN MICROBIOL, V40, P779, DOI 10.1128/JCM.40.3.779-787.2002; van der Marel J, 2012, INT J CANCER, V131, pE946, DOI 10.1002/ijc.27532; Zielinski GD, 2003, GYNECOL ONCOL, V91, P67, DOI 10.1016/S0090-8258(03)00415-3	45	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111037	10.1371/journal.pone.0111037	http://dx.doi.org/10.1371/journal.pone.0111037			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343563	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943500078
J	Izawa, K; Okada, M; Sumitomo, K; Nakagawa, N; Aizawa, Y; Kawabe, J; Kikuchi, K; Hasebe, N				Izawa, Kazuma; Okada, Motoi; Sumitomo, Kazuhiro; Nakagawa, Naoki; Aizawa, Yoshiaki; Kawabe, Junichi; Kikuchi, Kenjiro; Hasebe, Naoyuki			Impaired Glutathione Redox System Paradoxically Suppresses Angiotensin II-Induced Vascular Remodeling	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; PROTEIN-KINASE-C; E-DEFICIENT MICE; OXIDATIVE STRESS; NITRIC-OXIDE; ENDOTHELIAL-CELLS; APOPTOSIS; ATHEROSCLEROSIS; RAT; PROLIFERATION	Background: Angiotensin II (AII) plays a central role in vascular remodeling via oxidative stress. However, the interaction between AII and reduced glutathione (GSH) redox status in cardiovascular remodeling remains unknown. Methods: In vivo: The cuff-induced vascular injury model was applied to Sprague Dawley rats. Then we administered saline or a GSH inhibitor, buthionine sulfoximine (BSO, 30 mmol/L in drinking water) for a week, subsequently administered 4 more weeks by osmotic pump with saline or AII (200 ng/kg/minute) to the rats. In vitro: Incorporation of bromodeoxyuridine (BrdU) was measured to determine DNA synthesis in cultured rat vascular smooth muscle cells (VSMCs). Results: BSO reduced whole blood GSH levels. Systolic blood pressure was increased up to 215 +/- 4 mmHg by AII at 4 weeks (p<0.01), which was not affected by BSO. Superoxide production in vascular wall was increased by AII and BSO alone, and was markedly enhanced by AII+BSO. The left ventricular weight to body weight ratio was significantly increased in AII and AII+BSO as compared to controls (2.52 +/- 0.08, 2.50 +/- 0.09 and 2.10 +/- 0.07 mg/g respectively, p<0.05). Surprisingly, the co-treatment of BSO totally abolished these morphological changes. Although the vascular circumferential wall stress was well compensated in AII, significantly increased in AII+BSO. The anti-single-stranded DNA staining revealed increasing apoptotic cells in the neointima of injured arteries in BSO groups. BrdU incorporation in cultured VSMCs with AII was increased dose-dependently. Furthermore it was totally abolished by BSO and was reversed by GSH monoethyl ester. Conclusions: We demonstrated that a vast oxidative stress in impaired GSH redox system totally abolished AII-induced vascular, not cardiac remodeling via enhancement of apoptosis in the neointima and suppression of cell growth in the media. The drastic suppression of remodeling may result in fragile vasculature intolerable to mechanical stress by AII.	[Izawa, Kazuma; Okada, Motoi; Sumitomo, Kazuhiro; Nakagawa, Naoki; Aizawa, Yoshiaki; Kawabe, Junichi; Kikuchi, Kenjiro; Hasebe, Naoyuki] Asahikawa Med Univ, Dept Internal Med, Div Cardiol Nephrol Pulmonol & Neurol, Asahikawa, Hokkaido, Japan	Asahikawa Medical College	Hasebe, N (corresponding author), Asahikawa Med Univ, Dept Internal Med, Div Cardiol Nephrol Pulmonol & Neurol, Asahikawa, Hokkaido, Japan.	haselove@asahikawa-med.ac.jp	Okada, Motoi/CAF-5178-2022	Okada, Motoi/0000-0003-3779-6703	Kaken [16590655]; Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Society for the Promotion of Science (JSPS)	Kaken(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from Kaken (Grant-in-Aid for Scientific Research C 16590655). KAKEN is the database which is established and provided by the National Institute of Informatics (NII) with support of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa Y, 2001, CIRCULATION, V104, P455, DOI 10.1161/hc3001.092040; Akishita M, 1997, ATHEROSCLEROSIS, V130, P1, DOI 10.1016/S0021-9150(96)06023-6; Bhunia AK, 1997, J BIOL CHEM, V272, P15642, DOI 10.1074/jbc.272.25.15642; Bishop SP, 1996, J MOL CELL CARDIOL, V28, P141, DOI 10.1006/jmcc.1996.0014; CARTER WO, 1994, J LEUKOCYTE BIOL, V55, P253; Chen ZP, 2001, ARTERIOSCL THROM VAS, V21, P759, DOI 10.1161/01.ATV.21.5.759; Daugherty A, 2004, TRENDS CARDIOVAS MED, V14, P117, DOI 10.1016/j.tcm.2004.01.002; Domenicotti C, 2000, FREE RADICAL BIO MED, V29, P1280, DOI 10.1016/S0891-5849(00)00429-9; Ejiri J, 2003, CARDIOVASC RES, V59, P988, DOI 10.1016/S0008-6363(03)00523-6; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; Griendling KK, 1998, J LAB CLIN MED, V132, P9, DOI 10.1016/S0022-2143(98)90019-1; Griendling KK, 2003, CIRCULATION, V108, P2034, DOI 10.1161/01.CIR.0000093661.90582.c4; Halliwell B, 1989, FREE RADICAL BIO MED, P87; Hermann C, 1997, ARTERIOSCL THROM VAS, V17, P3588, DOI 10.1161/01.ATV.17.12.3588; Hiraku Y, 2002, BBA-GEN SUBJECTS, V1570, P47, DOI 10.1016/S0304-4165(02)00152-6; HIROSUMI J, 1987, ATHEROSCLEROSIS, V64, P243, DOI 10.1016/0021-9150(87)90252-8; Huth F, 1975, Curr Top Pathol, V60, P1; KAWABE J, 1992, BIOCHIM BIOPHYS ACTA, V1175, P81, DOI 10.1016/0167-4889(92)90012-Z; Kawarada Y, 1998, J BIOCHEM-TOKYO, V123, P492; Liao SX, 2001, J VASC SURG, V33, P1057, DOI 10.1067/mva.2001.112810; MADAMANCHI NR, 2005, ARTERIOSCLER THROMB, V25, P1; MEISTER A, 1983, SCIENCE, V220, P472, DOI 10.1126/science.6836290; Miller FJ, 1998, CIRC RES, V82, P1298, DOI 10.1161/01.RES.82.12.1298; Nishimoto M, 2002, LIFE SCI, V71, P2195, DOI 10.1016/S0024-3205(02)01998-7; Ogihara T, 2004, DIABETOLOGIA, V47, P794, DOI 10.1007/s00125-004-1391-x; Okada M, 2004, CIRCULATION, V109, P1763, DOI 10.1161/01.CIR.0000124226.88860.55; Ono Y, 1999, HYPERTENSION, V34, P609, DOI 10.1161/01.HYP.34.4.609; Pollman MJ, 1996, CIRC RES, V79, P748, DOI 10.1161/01.RES.79.4.748; PORRECA E, 1993, ATHEROSCLEROSIS, V100, P141, DOI 10.1016/0021-9150(93)90200-E; PURI PL, 1995, J BIOL CHEM, V270, P22129, DOI 10.1074/jbc.270.38.22129; Rosenblat M, 2002, ATHEROSCLEROSIS, V163, P17, DOI 10.1016/S0021-9150(01)00744-4; ROTHE G, 1990, J LEUKOCYTE BIOL, V47, P440, DOI 10.1002/jlb.47.5.440; Saraff K, 2003, ARTERIOSCL THROM VAS, V23, P1621, DOI 10.1161/01.ATV.0000085631.76095.64; Schmidt-Ott KM, 2000, REGUL PEPTIDES, V93, P65, DOI 10.1016/S0167-0115(00)00178-6; Sharpe PC, 1998, DIABETOLOGIA, V41, P1210, DOI 10.1007/s001250051054; Sugiyama S, 2004, ARTERIOSCL THROM VAS, V24, P1309, DOI 10.1161/01.ATV.0000131784.50633.4f; Suzuki J, 2002, CIRCULATION, V106, P847, DOI 10.1161/01.CIR.0000024103.04821.86; SZEJDA P, 1984, J IMMUNOL, V133, P3303; Tanaka K, 2003, CIRC RES, V93, P783, DOI 10.1161/01.RES.0000096651.13001.B4; Touyz RM, 1999, J HYPERTENS, V17, P907, DOI 10.1097/00004872-199917070-00006; VANDEPUTTE C, 1994, CELL BIOL TOXICOL, V10, P415, DOI 10.1007/BF00755791; Vaziri ND, 2000, HYPERTENSION, V36, P142, DOI 10.1161/01.HYP.36.1.142; Yamakawa T, 2000, HYPERTENSION, V35, P313, DOI 10.1161/01.HYP.35.1.313; Zafari AM, 1998, HYPERTENSION, V32, P488, DOI 10.1161/01.HYP.32.3.488	44	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e108115	10.1371/journal.pone.0108115	http://dx.doi.org/10.1371/journal.pone.0108115			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343455	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943500004
J	Mead, B; Thompson, A; Scheven, BA; Logan, A; Berry, M; Leadbeater, W				Mead, Ben; Thompson, Adam; Scheven, Ben A.; Logan, Ann; Berry, Martin; Leadbeater, Wendy			Comparative Evaluation of Methods for Estimating Retinal Ganglion Cell Loss in Retinal Sections and Wholemounts	PLOS ONE			English	Article							RAT OPTIC-NERVE; EXPERIMENTAL GLAUCOMA; REGENERATION; SURVIVAL; NEURONS; DEATH; QUANTIFICATION; POPULATION; FLUOROGOLD; MORPHOLOGY	To investigate the reliability of different methods of quantifying retinal ganglion cells (RGCs) in rat retinal sections and wholemounts from eyes with either intact optic nerves or those axotomised after optic nerve crush (ONC). Adult rats received a unilateral ONC and after 21 days the numbers of Brn3a(+), beta III-tubulin(+) and Islet-1(+) RGCs were quantified in either retinal radial sections or wholemounts in which FluoroGold (FG) was injected 48 h before harvesting. Phenotypic antibody markers were used to distinguish RGCs from astrocytes, macrophages/microglia and amacrine cells. In wholemounted retinae, counts of FG(+) and Brn3a(+) RGCs were of similar magnitude in eyes with intact optic nerves and were similarly reduced after ONC. Larger differences in RGC number were detected between intact and ONC groups when images were taken closer to the optic nerve head. In radial sections, Brn3a did not stain astrocytes, macrophages/microglia or amacrine cells, whereas beta III-tubulin and Islet-1 did localize to amacrine cells as well as RGCs. The numbers of beta III-tubulin(+) RGCs was greater than Brn3a(+) RGCs, both in retinae from eyes with intact optic nerves and eyes 21 days after ONC. Islet-1 staining also overestimated the number of RGCs compared to Brn3a, but only after ONC. Estimates of RGC loss were similar in Brn3a-stained radial retinal sections compared to both Brn3a-stained wholemounts and retinal wholemounts in which RGCs were backfilled with FG, with sections having the added advantage of reducing experimental animal usage.	[Mead, Ben; Thompson, Adam; Logan, Ann; Berry, Martin; Leadbeater, Wendy] Univ Birmingham, Sch Clin & Expt Med, Neurotrauma Res Grp, Neurobiol Sect, Birmingham, W Midlands, England; [Mead, Ben; Scheven, Ben A.] Univ Birmingham, Sch Dent, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham	Mead, B (corresponding author), Univ Birmingham, Sch Clin & Expt Med, Neurotrauma Res Grp, Neurobiol Sect, Birmingham, W Midlands, England.	BXM813@bham.ac.uk		Logan, Ann/0000-0003-3215-5042; Mead, Ben/0000-0001-5855-0097	Rosetrees trust; BBSRC studentship [BB/F017553/1]; Biotechnology and Biological Sciences Research Council [1090357] Funding Source: researchfish; Rosetrees Trust [M306] Funding Source: researchfish	Rosetrees trust(Rosetrees Trust); BBSRC studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Rosetrees Trust(Rosetrees Trust)	The work was supported by the following: Rosetrees trust and BBSRC studentship, grant number BB/F017553/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Majid RM, 2005, BRAIN RES, V1063, P114, DOI 10.1016/j.brainres.2005.09.046; Agudo-Barriuso M, 2013, CURR OPIN PHARMACOL, V13, P5, DOI 10.1016/j.coph.2012.09.006; Ahmed Z, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.54; BARNSTABLE CJ, 1984, NEUROSCIENCE, V11, P847, DOI 10.1016/0306-4522(84)90195-7; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Berry M, 1996, J NEUROCYTOL, V25, P147, DOI 10.1007/BF02284793; Berry M, 2008, RESTOR NEUROL NEUROS, V26, P147; Bodeutsch N, 1999, J NEUROBIOL, V38, P116, DOI 10.1002/(SICI)1097-4695(199901)38:1<116::AID-NEU9>3.0.CO;2-F; BUHL EH, 1988, J COMP NEUROL, V269, P210, DOI 10.1002/cne.902690206; BUNT AH, 1974, EXP NEUROL, V45, P288, DOI 10.1016/0014-4886(74)90119-8; Cui Q, 2003, MOL CELL NEUROSCI, V22, P49, DOI 10.1016/S1044-7431(02)00037-4; DREHER B, 1985, BRAIN BEHAV EVOLUT, V26, P10, DOI 10.1159/000118764; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Galindo-Romero C, 2011, EXP EYE RES, V92, P377, DOI 10.1016/j.exer.2011.02.008; GARRETT WT, 1991, NEUROSCI LETT, V128, P137, DOI 10.1016/0304-3940(91)90778-R; Gomez-Ramirez AM, 1999, INVEST OPHTH VIS SCI, V40, P414; Huang W, 2006, CURR EYE RES, V31, P265, DOI 10.1080/02713680500545671; Johnson TV, 2013, BRAIN; Kalesnykas G, 2012, INVEST OPHTH VIS SCI, V53, P3847, DOI 10.1167/iovs.12-9712; Kielczewski JL, 2005, INVEST OPHTH VIS SCI, V46, P3188, DOI 10.1167/iovs.05-0321; Kunzevitzky NJ, 2010, INVEST OPHTH VIS SCI, V51, P3800, DOI 10.1167/iovs.09-4540; LEIBINGER M, 2013, CELL DEATH DIS, V4; Lorber B, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-56; Martin KRG, 2002, METHODS, V28, P267, DOI 10.1016/S1046-2023(02)00232-3; Mead B, 2013, INVEST OPHTH VIS SCI, V54, P7544, DOI 10.1167/iovs.13-13045; MEY J, 1993, BRAIN RES, V602, P304, DOI 10.1016/0006-8993(93)90695-J; Nadal-Nicolas FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049830; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Ortin-Martinez A, 2010, INVEST OPHTH VIS SCI, V51, P3171, DOI 10.1167/iovs.09-4861; PERRY VH, 1981, NEUROSCIENCE, V6, P931, DOI 10.1016/0306-4522(81)90174-3; Quigley HA, 1999, PROG RETIN EYE RES, V18, P39, DOI 10.1016/S1350-9462(98)00014-7; Ramirez AI, 2010, INVEST OPHTH VIS SCI, V51, P5690, DOI 10.1167/iovs.10-5248; RINAMAN L, 1991, NEUROSCIENCE, V44, P765, DOI 10.1016/0306-4522(91)90096-7; Rojas B, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-133; Salinas-Navarro M, 2009, VISION RES, V49, P115, DOI 10.1016/j.visres.2008.09.029; Salinas-Navarro M, 2010, EXP EYE RES, V90, P168, DOI 10.1016/j.exer.2009.10.003; SellesNavarro I, 1996, INVEST OPHTH VIS SCI, V37, P2002; Sharma RK, 2007, BRAIN RES, V1176, P11, DOI 10.1016/j.brainres.2007.07.090; Soto I, 2011, INVEST OPHTH VIS SCI, V52, P434, DOI 10.1167/iovs.10-5856; VANEY DI, 1976, J COMP NEUROL, V170, P241, DOI 10.1002/cne.901700208; Vereczki V, 2006, NEUROSCIENCE, V140, P1089, DOI 10.1016/j.neuroscience.2006.02.081; Vidal-Sanz M, 2012, PROG RETIN EYE RES, V31, P1, DOI 10.1016/j.preteyeres.2011.08.001; WESSENDORF MW, 1991, BRAIN RES, V553, P135, DOI 10.1016/0006-8993(91)90241-M; Wolburg H, 1993, J Hirnforsch, V34, P445	45	44	44	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110612	10.1371/journal.pone.0110612	http://dx.doi.org/10.1371/journal.pone.0110612			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343338	Green Accepted, Green Published, gold			2022-12-27	WOS:000343943500039
J	Pak, Y; Pastan, I; Kreitman, RJ; Lee, B				Pak, Youngshang; Pastan, Ira; Kreitman, Robert J.; Lee, Byungkook			Effect of Antigen Shedding on Targeted Delivery of Immunotoxins in Solid Tumors from a Mathematical Model	PLOS ONE			English	Article							RECOMBINANT IMMUNOTOXIN; ANTITUMOR-ACTIVITY; ANIMAL TOXICITY; CANCER; CELL; MESOTHELIN; THERAPY; PENETRATION; BINDING; IMMUNOTHERAPY	Most cancer-specific antigens used as targets of antibody-drug conjugates and immunotoxins are shed from the cell surface (Zhang & Pastan (2008) Clin. Cancer Res. 14: 7981-7986), although at widely varying rates and by different mechanisms (Dello Sbarba & Rovida (2002) Biol. Chem. 383: 69-83). Why many cancer-specific antigens are shed and how the shedding affects delivery efficiency of antibody-based protein drugs are poorly understood questions at present. Before a detailed numerical study, it was assumed that antigen shedding would reduce the efficacy of antibody-drug conjugates and immunotoxins. However, our previous study using a comprehensive mathematical model showed that antigen shedding can significantly improve the efficacy of the mesothelin-binding immunotoxin, SS1P (anti-mesothelin-Fv-PE38), and suggested that receptor shedding can be a general mechanism for enhancing the effect of inter-cellular signaling molecules. Here, we improved this model and applied it to both SS1P and another recombinant immunotoxin, LMB-2, which targets CD25. We show that the effect of antigen shedding is influenced by a number of factors including the number of antigen molecules on the cell surface and the endocytosis rate. The high shedding rate of mesothelin is beneficial for SS1P, for which the antigen is large in number and endocytosed rapidly. On the other hand, the slow shedding of CD25 is beneficial for LMB-2, for which the antigen is small in number and endocytosed slowly.	[Pak, Youngshang] Pusan Natl Univ, Dept Chem, Pusan, South Korea; [Pak, Youngshang] Pusan Natl Univ, Inst Funct Mat, Pusan, South Korea; [Pak, Youngshang; Pastan, Ira; Kreitman, Robert J.; Lee, Byungkook] NCI, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	Pusan National University; Pusan National University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pak, Y (corresponding author), Pusan Natl Univ, Dept Chem, Pusan, South Korea.	ypak@pusan.ac.kr; bk@nih.gov	pastan, ira/P-9319-2019	pastan, ira/0000-0002-9223-0270	NCI; Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC011233] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by an appointment to the ORISE Research Participation Program at NCI. This program is administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the US department of Energy and the National Cancer Institute. This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman ME, 2008, MOL CANCER THER, V7, P2233, DOI 10.1158/1535-7163.MCT-08-0067; Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Arribas J, 2002, CHEM REV, V102, P4627, DOI 10.1021/cr010202t; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Chen KC, 2008, ANN BIOMED ENG, V36, P486, DOI 10.1007/s10439-007-9425-4; Dello Sbarba P, 2002, BIOL CHEM, V383, P69; Dosio F, 2014, RECENT PAT ANTI-CANC, V9, P35; Dreher MR, 2006, JNCI-J NATL CANCER I, V98, P335, DOI 10.1093/jnci/djj070; FUJIMORI K, 1990, J NUCL MED, V31, P1191; GREENE WC, 1986, ANN INTERN MED, V105, P560, DOI 10.7326/0003-4819-105-4-560; Hassan R, 2004, CLIN CANCER RES, V10, P3937, DOI 10.1158/1078-0432.CCR-03-0801; Hassan R, 2008, EUR J CANCER, V44, P46, DOI 10.1016/j.ejca.2007.08.028; HONDA M, 1990, J IMMUNOL, V145, P4131; Jain RK, 2001, ADV DRUG DELIVER REV, V46, P149, DOI 10.1016/S0169-409X(00)00131-9; Junghans RP, 1996, J EXP MED, V183, P1587, DOI 10.1084/jem.183.4.1587; Kobayashi H, 2000, J NUCL MED, V41, P755; Kreitman RJ, 1998, CANCER RES, V58, P968; KREITMAN RJ, 1994, BLOOD, V83, P426; Kulasingam V, 2008, NAT CLIN PRACT ONCOL, V5, P588, DOI 10.1038/ncponc1187; LAIRD AK, 1964, BRIT J CANCER, V18, P490, DOI 10.1038/bjc.1964.55; LAUK S, 1989, CANCER RES, V49, P4557; Michaelis L, 1913, BIOCHEM Z, V49, P333; Onda M, 2001, CANCER RES, V61, P5070; Pak Y, 2012, CANCER RES, V72, P3143, DOI 10.1158/0008-5472.CAN-11-3925; Pastan I, 2006, NAT REV CANCER, V6, P559, DOI 10.1038/nrc1891; Reiter Y, 1996, NAT BIOTECHNOL, V14, P1239, DOI 10.1038/nbt1096-1239; Rippe B, 1985, Microvasc Res, V30, P246, DOI 10.1016/0026-2862(85)90055-X; Schmidt MM, 2009, MOL CANCER THER, V8, P2861, DOI 10.1158/1535-7163.MCT-09-0195; Singh R, 2012, CLIN CANCER RES, V18, P152, DOI 10.1158/1078-0432.CCR-11-1839; Thurber GM, 2008, ADV DRUG DELIVER REV, V60, P1421, DOI 10.1016/j.addr.2008.04.012; Tsutsumi Y, 2000, P NATL ACAD SCI USA, V97, P8548, DOI 10.1073/pnas.140210597; Zhang YJ, 2008, CLIN CANCER RES, V14, P7981, DOI 10.1158/1078-0432.CCR-08-0324; Zhang YJ, 2007, P NATL ACAD SCI USA, V104, P17099, DOI 10.1073/pnas.0708101104; Zhang YJ, 2011, CANCER RES, V71, P5915, DOI 10.1158/0008-5472.CAN-11-0466; Zhang YJ, 2010, CANCER RES, V70, P1082, DOI 10.1158/0008-5472.CAN-09-2405	35	9	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110716	10.1371/journal.pone.0110716	http://dx.doi.org/10.1371/journal.pone.0110716			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343405	gold, Green Submitted, Green Published			2022-12-27	WOS:000343943500051
J	Su, YY; Zhang, FJ; Liu, HX; Smith, MK; Zhu, L; Wu, J; Wang, N				Su, Yingying; Zhang, Fujie; Liu, Huixin; Smith, M. Kumi; Zhu, Lin; Wu, Jing; Wang, Ning			The Prevalence of HIV-1 Drug Resistance among Antiretroviral Treatment Naive Individuals in Mainland China: A Meta-Analysis	PLOS ONE			English	Article							MUTATIONS; SEX; MEN; SURVEILLANCE; HETEROGENEITY; DIVERSITY; HIV/AIDS; SUBTYPES; THERAPY; TRENDS	Background: Surveillance of drug resistance in antiretroviral treatment-naive patients in China is needed to ensure optimal treatment outcomes and control of the human immunodeficiency virus (HIV) epidemic. Methods: A systematic literature search was conducted in English and Chinese through PubMed (English), China National Knowledge Infrastructure (Chinese), Chinese Biomedical Literature Database (Chinese), and Wanfang (Chinese). Random effects models were used to calculate the pooled prevalence of transmitted drug resistance and subgroup analyses examined prevalence estimates across time periods, study locations, and study populations. Results: Analysis of data from 71 studies (47 in Chinese and 24 in English) yielded a pooled prevalence of transmitted HIV drug resistance to any antiretroviral drug class of 3.64% (95% confidence interval [CI]: 3.00%-4.32%). Rates were significantly high at initial stage of free ART program from 2003 to 2005 (5.18%, 95% CI: 3.13%-7.63%), and were much lower among studies conducted in 2006-2008 (3.02%, 95% CI: 2.03%-4.16%). A slight increase was observed again in the most recent study period from 2009 to 2012 (3.68%, 95% CI: 2.78%-4.69%). Subgroup analysis revealed highest prevalence levels of transmitted drug resistance in Beijing city, and Henan and Hubei provinces (above 5%), and although differences in prevalence rates among risk groups were negligible, men who have sex with men were unique in their relatively large portion of protease inhibitor resistance, a second-line drug of limited availability in China. Conclusions: Overall prevalence of transmitted HIV drug resistance in China is classified as "low'' by the World Health Organization. However regional and temporal variability suggest a more complex epidemic for which closer HIV drug resistance surveillance is needed. A nationwide HIV drug resistance surveillance system to monitor both treatment-experienced and treatment-naive patients will be a cornerstone to ensure the effectiveness of treatment scale-up, particularly as China seeks to expand a national policy of antiretroviral treatment as prevention.	[Su, Yingying; Zhang, Fujie; Liu, Huixin; Zhu, Lin; Wu, Jing; Wang, Ning] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Smith, M. Kumi] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; University of North Carolina; University of North Carolina Chapel Hill	Wang, N (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	wangnbj@163.com		Smith, M. Kumi/0000-0001-5861-8100	Mega-projects of national science research for the 12th Five-Year Plan of China [2012ZX10001-001]	Mega-projects of national science research for the 12th Five-Year Plan of China	This work was supported by funding from the Mega-projects of national science research for the 12th Five-Year Plan (2012ZX10001-001) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, MANUAL NATL FREE HIV; [Anonymous], 2005, MANUAL NATL FREE HIV; Avila-Rios S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027812; Bennett DE, 2008, ANTIVIR THER, V13, P25; Bennett DE, 2008, ANTIVIR THER, V13, P1; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Chen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087033; Dou ZH, 2010, INT J EPIDEMIOL, V39, pII56, DOI 10.1093/ije/dyq215; Gupta RK, 2012, LANCET, V380, P1250, DOI 10.1016/S0140-6736(12)61038-1; [韩晓旭 Han Xiaoxu], 2012, [中国公共卫生, China Public Health], V28, P810; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Kuang JQ, 2007, GENOTYPIC HIV 1 DRUG; Li L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075777; Li L, 2013, AIDS RES HUM RETROV, V29, P633, DOI [10.1089/AID.2012.0281, 10.1089/aid.2012.0281]; Li L, 2011, INFECT GENET EVOL, V11, P1487, DOI 10.1016/j.meegid.2011.05.017; Li TS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003918; Li WJ, 2012, CHIN J VIRAL DIS, V2, P40; Liao LJ, 2007, AIDS RES HUM RETROV, V23, P1062, DOI 10.1089/aid.2007.0050; Liao LJ, 2013, AIDS, V27, P1815, DOI 10.1097/QAD.0b013e3283611931; Liao LJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS10, DOI 10.1097/QAI.0b013e3181c7d363; Little SJ, 2000, ANTIVIR THER, V5, P33; Ministry of Health People's Republic of China Joint United Nations Programme on HIV/AIDS World Health Organization, 2011, 2011 EST HIV AIDS EP; National Health and Family Planning Commission of the People's Republic of China, 2013, BACKGR HIV AIDS PREV; Qiu LJ, 2013, CHIN J AIDS STD, V19, P6; R Core Team, 2021, R LANGUAGE ENV STAT; Si Xue-feng, 2004, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V18, P308; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; Wang X, 2012, AIDS RES HUM RETROV, V28, P1637, DOI [10.1089/aid.2012.0164, 10.1089/AID.2012.0164]; Wheeler WH, 2010, AIDS, V24, P1203, DOI 10.1097/QAD.0b013e3283388742; WHO, 2012, WHO HIV DRUG RES REP; Wittkop L, 2011, LANCET INFECT DIS, V11, P363, DOI 10.1016/S1473-3099(11)70032-9; Wu YS, 2011, CHIN MED ASS 5 NAT A; Xing H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062408; [羊海涛 Yang Haitao], 2012, [南京医科大学学报. 自然科学版, Acta Universitatis Medicinalis Nanjing], V32, P1; Yang J, 2013, ARCH VIROL, V158, P839, DOI 10.1007/s00705-012-1557-7; Yin CY, 2011, CHIN J CLIN INFECT D, V4, P201; Zeng PB, 2012, TRANSFUSION, V52, P1041, DOI 10.1111/j.1537-2995.2011.03415.x; Zhang FJ, 2005, CELL RES, V15, P877, DOI 10.1038/sj.cr.7290362; Zhang FJ, 2006, CHINESE MED J-PEKING, V119, P1999, DOI 10.1097/00029330-200612010-00010; Zhang FJ, 2007, AIDS, V21, pS143, DOI 10.1097/01.aids.0000304710.10036.2b; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4; Zhang L, 2013, LANCET INFECT DIS, V13, P955, DOI 10.1016/S1473-3099(13)70245-7; Zhang XY, 2007, AIDS, V21, pS59, DOI 10.1097/01.aids.0000304698.47261.b1; Zhao B, 2011, AIDS RES HUM RETROV, V27, P1047, DOI [10.1089/aid.2010.0119, 10.1089/AID.2010.0119]; Zhao DC, 2012, CHINESE MED J-PEKING, V125, P3514, DOI 10.3760/cma.j.issn.0366-6999.2012.19.028; Zhao GL, 2009, CHIN J AIDS STD, V15, P589; Zhao Y, 2012, CHINESE MED J-PEKING, V125, P1331, DOI 10.3760/cma.j.issn.0366-6999.2012.07.025	48	8	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110652	10.1371/journal.pone.0110652	http://dx.doi.org/10.1371/journal.pone.0110652			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343483	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943500041
J	West, JA; Olsen, SL; Mitchell, JM; Priddle, RE; Luke, JM; Akefeldt, SO; Henter, JI; Turville, C; Kannourakis, G				West, Jennifer A.; Olsen, Sharon L.; Mitchell, Jenee M.; Priddle, Ross E.; Luke, Jennifer M.; Akefeldt, Selma Olsson; Henter, Jan-Inge; Turville, Christopher; Kannourakis, George			Polyclonal T-Cells Express CD1a in Langerhans Cell Histiocytosis (LCH) Lesions	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; GENE-EXPRESSION; DENDRITIC CELLS; DIFFERENTIATION; CYTOKINES; PROTEIN; INTERLEUKIN-3; LYMPHOCYTES; THYMOCYTES; MATURATION	Langerhans cell histiocytosis (LCH) is a complex and poorly understood disorder that has characteristics of both inflammatory and neoplastic disease. By using eight-colour flow cytometry, we have identified a previously unreported population of CD1a(+)/CD3(+) T-cells in LCH lesions. The expression of CD1a is regarded as a hallmark of this disease; however, it has always been presumed that it was only expressed by pathogenic Langerhans cells (LCs). We have now detected CD1a expression by a range of T-cell subsets within all of the LCH lesions that were examined, establishing that CD1a expression in these lesions is no longer restricted to pathogenic LCs. The presence of CD1a(+) T-cells in all of the LCH lesions that we have studied to date warrants further investigation into their biological function to determine whether these cells are important in the pathogenesis of LCH.	[West, Jennifer A.; Olsen, Sharon L.; Mitchell, Jenee M.; Priddle, Ross E.; Luke, Jennifer M.; Kannourakis, George] Fiona Elsey Canc Res Inst, Ballarat, Vic, Australia; [West, Jennifer A.; Olsen, Sharon L.; Mitchell, Jenee M.; Priddle, Ross E.; Kannourakis, George] Federat Univ, Sch Hlth Sci, Mt Helen, Vic, Australia; [Akefeldt, Selma Olsson; Henter, Jan-Inge] Karolinska Univ Hosp, Karolinska Inst, Dept Womens & Childrens Hlth, Childhood Canc Res Unit, Stockholm, Sweden; [Turville, Christopher] Federat Univ, Sch Sci Informat Technol & Engn, Mt Helen, Vic, Australia	Federation University Australia; Karolinska Institutet; Karolinska University Hospital; Federation University Australia	Kannourakis, G (corresponding author), Fiona Elsey Canc Res Inst, Ballarat, Vic, Australia.	George@fecri.org.au		, Jenee/0000-0002-1834-3699; Turville, Chris/0000-0001-9855-9838; Henter, Jan-Inge/0000-0002-0629-2126	Board of the Fiona Elsey Cancer Research Institute; Histiocytosis Association of America (HAA); Swedish Children's Cancer Foundation; Swedish Research Council; Stockholm County Council (ALF project)	Board of the Fiona Elsey Cancer Research Institute; Histiocytosis Association of America (HAA); Swedish Children's Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council (ALF project)(Stockholm County Council)	This work was supported by the Board of the Fiona Elsey Cancer Research Institute, the Histiocytosis Association of America (HAA), the Swedish Children's Cancer Foundation, the Swedish Research Council and the Stockholm County Council (ALF project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen HN, 2003, J MOL DIAGN, V5, P34, DOI 10.1016/S1525-1578(10)60449-7; Allen CE, 2007, DRUG TODAY, V43, P627, DOI 10.1358/dot.2007.43.9.1088823; Allen CE, 2010, J IMMUNOL, V184, P4557, DOI 10.4049/jimmunol.0902336; Allen CE, 2009, NAT MED, V15, P483, DOI 10.1038/nm0509-483; [Anonymous], 1987, Lancet, V1, P208; Arico M, 1998, HEMATOL ONCOL CLIN N, V12, P247, DOI 10.1016/S0889-8588(05)70508-6; Badalian-Very G, 2010, BLOOD, V116, P1919, DOI 10.1182/blood-2010-04-279083; Bechan GI, 2006, INT REV CYTOL, V254, P1, DOI 10.1016/S0074-7696(06)54001-X; Caux C, 1996, BLOOD, V87, P2376, DOI 10.1182/blood.V87.6.2376.bloodjournal8762376; Christie LJ, 2006, HUM PATHOL, V37, P32, DOI 10.1016/j.humpath.2005.08.024; CHU T, 1994, BRIT J CANCER, V70, pS4; Cortelazzo S, 2011, CRIT REV ONCOL HEMAT, V79, P330, DOI 10.1016/j.critrevonc.2010.12.003; Coury F, 2008, NAT MED, V14, P81, DOI 10.1038/nm1694; Coventry B, 2004, TRENDS IMMUNOL, V25, P242, DOI 10.1016/j.it.2004.03.002; Craig FE, 2008, BLOOD, V111, P3941, DOI 10.1182/blood-2007-11-120535; Crawford J M, 1989, Reg Immunol, V2, P91; da Costa CET, 2009, GENE CHROMOSOME CANC, V48, P239, DOI 10.1002/gcc.20634; De Filippi P, 2006, BRIT J HAEMATOL, V132, P784, DOI 10.1111/j.1365-2141.2005.05922.x; de Graaf JH, 1995, HISTIOCYTOSES CHILDH; Degar BA, 2009, DIS MODEL MECH, V2, P436, DOI 10.1242/dmm.004010; deGraaf JH, 1996, J PATHOL, V180, P400, DOI 10.1002/(SICI)1096-9896(199612)180:4<400::AID-PATH701>3.0.CO;2-W; Egeler RM, 2010, IMMUNOL REV, V234, P213, DOI 10.1111/j.0105-2896.2009.00883.x; Egeler RM, 1999, BLOOD, V94, P4195; FITHIAN E, 1981, P NATL ACAD SCI-BIOL, V78, P2541, DOI 10.1073/pnas.78.4.2541; Geissmann F, 2001, BLOOD, V97, P1241, DOI 10.1182/blood.V97.5.1241; Gogolak P, 2007, BLOOD, V109, P643, DOI 10.1182/blood-2006-04-016840; Gong L, 2010, J INT MED RES, V38, P1099, DOI 10.1177/147323001003800338; Han X, 2007, AM J CLIN PATHOL, V127, P528, DOI 10.1309/2QE3A6EKQ8UUDYRC; KANNOURAKIS G, 1994, BRIT J CANCER, V70, pS37; Kim WY, 2010, HUM PATHOL, V41, P129, DOI 10.1016/j.humpath.2009.05.014; Kohler T, 2000, STEM CELLS, V18, P139, DOI 10.1634/stemcells.18-2-139; Malpas JS, 1998, HEMATOL ONCOL CLIN N, V12, P259, DOI 10.1016/S0889-8588(05)70509-8; McClain Kenneth L, 2004, Hematology Am Soc Hematol Educ Program, P283; McClory S, 2012, J CLIN INVEST, V122, P1403, DOI 10.1172/JCI46125; Minkov M, 2007, PEDIATR BLOOD CANCER, V49, P694, DOI 10.1002/pbc.21227; Mittal A, 2003, PHOTOCHEM PHOTOBIOL, V77, P259, DOI 10.1562/0031-8655(2003)077<0259:CCATMS>2.0.CO;2; Mollah ZUA, 2003, J INVEST DERMATOL, V121, P1397, DOI 10.1111/j.1523-1747.2003.12641.x; NEZELOF C, 1973, BIOMEDICINE, V18, P365; Nezelof C, 2004, PEDIATR BLOOD CANCER, V42, P398, DOI 10.1002/pbc.10463; Peters TL, 2011, MOL THER, V19, P1433, DOI 10.1038/mt.2011.106; Pigozzi B, 2006, ONCOL REP, V15, P347; Res P, 1997, J EXP MED, V185, P141, DOI 10.1084/jem.185.1.141; Sahm F, 2012, BLOOD, V120, pE28, DOI 10.1182/blood-2012-06-429597; SALAMONE MD, 1992, IMMUNOL LETT, V33, P61, DOI 10.1016/0165-2478(92)90094-5; Satter EK, 2008, PEDIATR DERMATOL, V25, P291, DOI 10.1111/j.1525-1470.2008.00669.x; Schmitz L, 1998, HEMATOL ONCOL CLIN N, V12, P221, DOI 10.1016/S0889-8588(05)70507-4; Senechal B, 2007, PLOS MED, V4, P1374, DOI 10.1371/journal.pmed.0040253; SOTZIK F, 1993, IMMUNOL LETT, V36, P101, DOI 10.1016/0165-2478(93)90073-B; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Spandidos A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-633; SUMMERS KL, 1994, CLIN EXP IMMUNOL, V97, P39; Valladeau J, 1999, EUR J IMMUNOL, V29, P2695, DOI 10.1002/(SICI)1521-4141(199909)29:09<2695::AID-IMMU2695>3.0.CO;2-Q; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; WILLMAN CL, 1994, NEW ENGL J MED, V331, P154, DOI 10.1056/NEJM199407213310303; YU RC, 1994, LANCET, V343, P767, DOI 10.1016/S0140-6736(94)91842-2	55	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e109586	10.1371/journal.pone.0109586	http://dx.doi.org/10.1371/journal.pone.0109586			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343480	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943500017
J	Holzinger, A; Kaplan, F; Blaas, K; Zechmann, B; Komsic-Buchmann, K; Becker, B				Holzinger, Andreas; Kaplan, Franziska; Blaas, Kathrin; Zechmann, Bernd; Komsic-Buchmann, Karin; Becker, Burkhard			Transcriptomics of Desiccation Tolerance in the Streptophyte Green Alga Klebsormidium Reveal a Land Plant-Like Defense Reaction	PLOS ONE			English	Article							ANTIOXIDANTS; DEHYDRATION; TEMPERATURE; CULTURE; LICHEN; STRESS; ORIGIN; RNA; ULTRASTRUCTURE; CHAROPHYCEAE	Water loss has significant effects on physiological performance and survival rates of algae. However, despite the prominent presence of aeroterrestrial algae in terrestrial habitats, hardly anything is known about the molecular events that allow aeroterrestrial algae to survive harsh environmental conditions. We analyzed the transcriptome and physiology of a strain of the alpine aeroterrestrial alga Klebsormidium crenulatum under control and strong desiccation-stress conditions. Principal Findings: For comparison we first established a reference transcriptome. The high-coverage reference transcriptome includes about 24,183 sequences (1.5 million reads, 636 million bases). The reference transcriptome encodes for all major pathways (energy, carbohydrates, lipids, amino acids, sugars), nearly all deduced pathways are complete or missing only a few transcripts. Upon strong desiccation, more than 7000 transcripts showed changes in their expression levels. Most of the highest up-regulated transcripts do not show similarity to known viridiplant proteins, suggesting the existence of some genus-or species-specific responses to desiccation. In addition, we observed the up-regulation of many transcripts involved in desiccation tolerance in plants (e.g. proteins similar to those that are abundant in late embryogenesis (LEA), or proteins involved in early response to desiccation ERD), and enzymes involved in the biosynthesis of the raffinose family of oligosaccharides (RFO) known to act as osmolytes). Major physiological shifts are the up-regulation of transcripts for photosynthesis, energy production, and reactive oxygen species (ROS) metabolism, which is supported by elevated cellular glutathione content as revealed by immunoelectron microscopy as well as an increase in total antiradical power. However, the effective quantum yield of Photosystem II and CO2 fixation decreased sharply under the applied desiccation stress. In contrast, transcripts for cell integrative functions such as cell division, DNA replication, cofactor biosynthesis, and amino acid biosynthesis were down-regulated. Significance: This is the first study investigating the desiccation transcriptome of a streptophyte green alga. Our results indicate that the cellular response is similar to embryophytes, suggesting that embryophytes inherited a basic cellular desiccation tolerance from their streptophyte predecessors.	[Holzinger, Andreas; Kaplan, Franziska; Blaas, Kathrin] Univ Innsbruck, A-6020 Innsbruck, Austria; [Zechmann, Bernd] Baylor Univ, Ctr Microscopy & Imaging, Waco, TX 76798 USA; [Komsic-Buchmann, Karin; Becker, Burkhard] Univ Cologne, Bioctr, Inst Bot, D-50931 Cologne, Germany	University of Innsbruck; Baylor University; University of Cologne	Holzinger, A (corresponding author), Univ Innsbruck, A-6020 Innsbruck, Austria.	Andreas.Holzinger@uibk.ac.at	Holzinger, Andreas/A-6396-2008; Holzinger, Andreas/E-9530-2010; Holzinger, Andreas/Z-2659-2019; Becker, Burkhard/I-4022-2012	Holzinger, Andreas/0000-0002-7745-3978; Holzinger, Andreas/0000-0002-6786-5194; Holzinger, Andreas/0000-0002-7745-3978; Zechmann, Bernd/0000-0002-7702-2588; Becker, Burkhard/0000-0002-7965-1396	FWF [P24242-B16]; Austrian Science Fund (FWF) [P 22988, P 24242] Funding Source: researchfish	FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by FWF grant P24242-B16 (http://www.fwf.ac.at/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-109; Agrawal SC, 2012, FOLIA MICROBIOL, V57, P387, DOI 10.1007/s12223-012-0147-0; AGRAWAL SB, 1992, ENVIRON EXP BOT, V32, P137, DOI 10.1016/0098-8472(92)90038-4; Ahmad P., 2012, ENV ADAPTATIONS STRE, P297, DOI DOI 10.1007/978-1-4614-0815-4_14; Alpert P, 2006, J EXP BIOL, V209, P1575, DOI 10.1242/jeb.02179; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Atkin OK, 2009, ANN BOT-LONDON, V103, P581, DOI 10.1093/aob/mcn094; Becker B, 2013, TRENDS PLANT SCI, V18, P180, DOI 10.1016/j.tplants.2012.09.010; Becker B, 2009, ANN BOT-LONDON, V103, P999, DOI 10.1093/aob/mcp044; BERTSCH A, 1966, PLANTA, V70, P46, DOI 10.1007/BF00539910; Bolte S, 2004, J MICROSC-OXFORD, V214, P159, DOI 10.1111/j.0022-2720.2004.01348.x; BOROWITZKA MA, 1991, J APPL PHYCOL, V3, P295, DOI 10.1007/BF02392882; Chen HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078471; Cruces E, 2012, PHOTOCHEM PHOTOBIOL, V88, P58, DOI 10.1111/j.1751-1097.2011.01013.x; Deng YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039704; Dinakar C, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00482; Dinakar C, 2012, PLANT SCI, V182, P29, DOI 10.1016/j.plantsci.2011.01.018; Djilianov DL, 2013, J PLANT GROWTH REGUL, V32, P564, DOI 10.1007/s00344-013-9323-y; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; ElSayed AI, 2014, PLANT BIOLOGY, V16, P1, DOI 10.1111/plb.12053; Emans N, 2002, PLANT CELL, V14, P71, DOI 10.1105/tpc.010339; Gasulla F, 2013, PLANT J, V75, P726, DOI 10.1111/tpj.12241; Gasulla F, 2009, PLANTA, V231, P195, DOI 10.1007/s00425-009-1019-y; Gasulla F, 2013, PLANT CELL ENVIRON, V36, P1363, DOI 10.1111/pce.12065; Gray DW, 2007, PLANT CELL ENVIRON, V30, P1240, DOI 10.1111/j.1365-3040.2007.01704.x; Guarnieri MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025851; Haubner N, 2006, MICROB ECOL, V51, P285, DOI 10.1007/s00248-006-9016-1; Heinrich S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044342; Holzinger A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00327; Holzinger A, 2011, J PHYCOL, V47, P591, DOI 10.1111/j.1529-8817.2011.00980.x; Holzinger A, 2011, PHYCOL RES, V59, P221, DOI 10.1111/j.1440-1835.2011.00620.x; Kaplan F, 2012, PROTOPLASMA, V249, P789, DOI 10.1007/s00709-011-0324-z; Karsten U, 2014, J PHYCOL, V50, P804, DOI 10.1111/jpy.12210; Karsten Ulf, 2013, Algological Studies, V142, P45, DOI 10.1127/1864-1318/2013/0102; Karsten U, 2012, MICROB ECOL, V63, P51, DOI 10.1007/s00248-011-9924-6; Karsten U, 2010, J PHYCOL, V46, P1187, DOI 10.1111/j.1529-8817.2010.00921.x; Kranner I, 2005, INTEGR COMP BIOL, V45, P734, DOI 10.1093/icb/45.5.734; Kranner I, 2005, P NATL ACAD SCI USA, V102, P3141, DOI 10.1073/pnas.0407716102; LOKHORST GM, 1985, J PHYCOL, V21, P466; Luttge U, 2010, PLANT BIOLOGY, V12, P437, DOI 10.1111/j.1438-8677.2009.00249.x; Lunch CK, 2013, PHOTOSYNTH RES, V115, P139, DOI 10.1007/s11120-013-9846-x; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; MCFADDEN GI, 1986, PHYCOLOGIA, V25, P551, DOI 10.2216/i0031-8884-25-4-551.1; McIntyre LM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-293; Nagao M, 2008, PLANT CELL ENVIRON, V31, P872, DOI 10.1111/j.1365-3040.2008.01804.x; Nagao M, 2012, PLANTA, V235, P851, DOI 10.1007/s00425-011-1550-5; Nowrousian M, 2010, EUKARYOT CELL, V9, P1300, DOI 10.1128/EC.00123-10; Oliver MJ, 2010, METHODS MOL BIOL, V639, P3, DOI 10.1007/978-1-60761-702-0_1; OLIVER MJ, 1984, PLANT PHYSIOL, V74, P917, DOI 10.1104/pp.74.4.917; Osakabe Y, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00086; Plank DW, 2012, J AOAC INT, V95, P1562, DOI 10.5740/jaoacint.CS2012_04; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; RAPOPORT AI, 1986, MICROBIOLOGY+, V55, P689; Rindi F, 2011, MOL PHYLOGENET EVOL, V58, P218, DOI 10.1016/j.ympev.2010.11.030; Rindi F, 2008, J PHYCOL, V44, P1529, DOI 10.1111/j.1529-8817.2008.00593.x; Rodriguez MCS, 2010, PLANT J, V63, P212, DOI 10.1111/j.1365-313X.2010.04243.x; Rysanek D, 2015, ENVIRON MICROBIOL, V17, P689, DOI 10.1111/1462-2920.12501; Schreiber U., 1993, Progress in Botany, V54, P151; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Shiratake T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079630; Skaloud P, 2013, J EUKARYOT MICROBIOL, V60, P350, DOI 10.1111/jeu.12040; STARR RC, 1993, J PHYCOL, V29, P1, DOI 10.1111/j.0022-3646.1993.00001.x; Timme RE, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-96; Turmel M, 2013, GENOME BIOL EVOL, V5, P1817, DOI 10.1093/gbe/evt135; Usadel B, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00048; Weissman L, 2005, APPL ENVIRON MICROB, V71, P6508, DOI 10.1128/AEM.71.11.6508-6514.2005; Wieners PC, 2012, PHOTOSYNTH RES, V113, P239, DOI 10.1007/s11120-012-9771-4; Wodniok S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-104; Zechmann B, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-54; Zechmann B, 2010, PROTOPLASMA, V246, P15, DOI 10.1007/s00709-010-0111-2; Zhong BJ, 2014, MOL BIOL EVOL, V31, P177, DOI 10.1093/molbev/mst200	73	75	75	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110630	10.1371/journal.pone.0110630	http://dx.doi.org/10.1371/journal.pone.0110630			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340847	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662800044
J	Shen, SQ; Turro, E; Corbo, JC				Shen, Susan Q.; Turro, Ernest; Corbo, Joseph C.			Hybrid Mice Reveal Parent-of-Origin and Cis- and Trans-Regulatory Effects in the Retina	PLOS ONE			English	Article							GENE-EXPRESSION; HUMAN GENOME; MAMMALIAN RETINA; RNA-SEQ; DIFFERENTIAL EXPRESSION; LABORATORY MOUSE; IMPRINTED GRB10; PHOTORECEPTOR; CRX; MUTATIONS	A fundamental challenge in genomics is to map DNA sequence variants onto changes in gene expression. Gene expression is regulated by cis-regulatory elements (CREs, i. e., enhancers, promoters, and silencers) and the trans factors (e. g., transcription factors) that act upon them. A powerful approach to dissecting cis and trans effects is to compare F1 hybrids with F0 homozygotes. Using this approach and taking advantage of the high frequency of polymorphisms in wild-derived inbred Cast/EiJ mice relative to the reference strain C57BL/6J, we conducted allele-specific mRNA-seq analysis in the adult mouse retina, a disease-relevant neural tissue. We found that cis effects account for the bulk of gene regulatory divergence in the retina. Many CREs contained functional (i. e., activating or silencing) cis-regulatory variants mapping onto altered expression of genes, including genes associated with retinal disease. By comparing our retinal data with previously published liver data, we found that most of the cis effects identified were tissue-specific. Lastly, by comparing reciprocal F1 hybrids, we identified evidence of imprinting in the retina for the first time. Our study provides a framework and resource for mapping cis-regulatory variants onto changes in gene expression, and underscores the importance of studying cis-regulatory variants in the context of retinal disease.	[Shen, Susan Q.; Corbo, Joseph C.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Turro, Ernest] Univ Cambridge, Canc Res UK, Cambridge Inst, Cambridge, England; [Turro, Ernest] Univ Cambridge, Natl Hlth Serv Blood & Transplant, Dept Haematol, Cambridge, England	Washington University (WUSTL); Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; NHS Blood & Transplant (NHSBT); University of Cambridge	Corbo, JC (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	jcorbo@pathology.wustl.edu		Turro, Ernest/0000-0002-1820-6563; Shen, Susan/0000-0001-5558-294X; Corbo, Joseph/0000-0002-9323-7140	National Institutes of Health [5T32EY013360-14, R01HG006790, R01EY018826]; Cancer Research UK [C14303/ A10825]; Cambridge Biomedical Research Centre; Genome Technology Access Center at Washington University; National Cancer Institute Cancer Center Support Grant [P30 CA91842]; Institute of Clinical and Translational Sciences (ICTS)/Clinical & Translational Science Awards (CTSA) [UL1RR024992]; National Center for Research Resources (NCRR); NATIONAL EYE INSTITUTE [R01EY018826] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006790] Funding Source: NIH RePORTER; Cancer Research UK [19556] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); Cambridge Biomedical Research Centre(General Electric); Genome Technology Access Center at Washington University; National Cancer Institute Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Institute of Clinical and Translational Sciences (ICTS)/Clinical & Translational Science Awards (CTSA); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Cancer Research UK(Cancer Research UK)	This project was supported by the National Institutes of Health (NIH, http://www.nih.gov/) (grant numbers 5T32EY013360-14 to SQS, and R01HG006790 and R01EY018826 to JCC). ET was supported by Cancer Research UK (http://www.cancerresearchuk.org/) grant C14303/ A10825 and the Cambridge Biomedical Research Centre (http://cambridge-brc. org. uk/). The Genome Technology Access Center at Washington University was partially supported by National Cancer Institute (NCI, http://www.cancer.gov/) Cancer Center Support Grant P30 CA91842 to the Siteman Cancer Center and by Institute of Clinical and Translational Sciences (ICTS)/Clinical & Translational Science Awards (CTSA) Grant UL1RR024992 from the National Center for Research Resources (NCRR), a component of the NIH, and NIH Roadmap for Medical Research. This publication is solely the responsibility of the authors and does not necessarily represent the official view of NCRR or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Blake JA, 2014, NUCLEIC ACIDS RES, V42, pD810, DOI 10.1093/nar/gkt1225; Chadwick LH, 2006, GENETICS, V173, P2103, DOI 10.1534/genetics.105.054882; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Corbo JC, 2007, P NATL ACAD SCI USA, V104, P12069, DOI 10.1073/pnas.0705465104; Corbo JC, 2010, GENOME RES, V20, P1512, DOI 10.1101/gr.109405.110; Da Rocha ST, 2008, TRENDS GENET, V24, P306, DOI 10.1016/j.tig.2008.03.011; Daiger S. P., 1998, IOVS, V39, pS295; Dalke C, 2005, EXP EYE RES, V81, P503, DOI 10.1016/j.exer.2005.06.004; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Degner JF, 2009, BIOINFORMATICS, V25, P3207, DOI 10.1093/bioinformatics/btp579; Dejager L, 2009, TRENDS GENET, V25, P234, DOI 10.1016/j.tig.2009.03.007; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Emerson JJ, 2010, GENOME RES, V20, P826, DOI 10.1101/gr.101576.109; Erceg J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004060; Falls JG, 1999, AM J PATHOL, V154, P635, DOI 10.1016/S0002-9440(10)65309-6; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; FUCHS S, 1995, NAT GENET, V10, P360, DOI 10.1038/ng0795-360; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Gaffney DJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003501; Garfield AS, 2011, NATURE, V469, P534, DOI 10.1038/nature09651; Goncalves A, 2012, GENOME RES, V22, P2376, DOI 10.1101/gr.142281.112; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Grubb SC, 2014, NUCLEIC ACIDS RES, V42, pD825, DOI 10.1093/nar/gkt1159; Haider NB, 2008, MAMM GENOME, V19, P145, DOI 10.1007/s00335-008-9092-2; Hao H, 2012, PLOS GENET, V8, P380, DOI 10.1371/journal.pgen.1002649; Hsiau THC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000643; Jelcick AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021858; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Krueger F., TRIM GALORE; Kwasnieski JC, 2012, P NATL ACAD SCI USA, V109, P19498, DOI 10.1073/pnas.1210678109; Langmann T, 2010, AM J HUM GENET, V87, P376, DOI 10.1016/j.ajhg.2010.07.018; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Maurano MT, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002599; McManus CJ, 2014, GENOME RES, V24, P422, DOI 10.1101/gr.164996.113; McManus CJ, 2010, GENOME RES, V20, P816, DOI 10.1101/gr.102491.109; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Morison IM, 2001, NUCLEIC ACIDS RES, V29, P275, DOI 10.1093/nar/29.1.275; Mott R, 2014, CELL, V156, P332, DOI 10.1016/j.cell.2013.11.043; Nasonkin IO, 2011, J COMP NEUROL, V519, P1914, DOI 10.1002/cne.22613; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Oh ECT, 2008, BRAIN RES, V1236, P16, DOI 10.1016/j.brainres.2008.01.028; Ozgul RK, 2011, AM J HUM GENET, V89, P253, DOI 10.1016/j.ajhg.2011.07.005; Prickett AR, 2012, MOL GENET GENOMICS, V287, P621, DOI 10.1007/s00438-012-0708-6; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Sanz LA, 2008, EMBO J, V27, P2523, DOI 10.1038/emboj.2008.142; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Schulz R, 2008, EPIGENETICS-US, V3, P89, DOI 10.4161/epi.3.2.5900; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smith FM, 2007, MOL CELL BIOL, V27, P5871, DOI 10.1128/MCB.02087-06; Song X, 2011, NEUROSCIENCE, V174, P37, DOI 10.1016/j.neuroscience.2010.11.009; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; Tirosh I, 2009, SCIENCE, V324, P659, DOI 10.1126/science.1169766; Turro E, 2014, BIOINFORMATICS, V30, P180, DOI 10.1093/bioinformatics/btt624; Turro E, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r13; Wade CM, 2002, NATURE, V420, P574, DOI 10.1038/nature01252; White MA, 2013, P NATL ACAD SCI USA, V110, P11952, DOI 10.1073/pnas.1307449110; Wilkins JF, 2003, NAT REV GENET, V4, P359, DOI 10.1038/nrg1062; Williamson CM BA, 2014, MOUSEBOOK IMPRINTING; Wittkopp PJ, 2012, NAT REV GENET, V13, P59, DOI 10.1038/nrg3095; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035; Xu J, 1997, NATURE, V389, P505, DOI 10.1038/39068; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215	73	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e109382	10.1371/journal.pone.0109382	http://dx.doi.org/10.1371/journal.pone.0109382			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340786	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662800008
J	Alavanja, MCR; Hofmann, JN; Lynch, CF; Hines, CJ; Barry, KH; Barker, J; Buckman, DW; Thomas, K; Sandler, DP; Hoppin, JA; Koutros, S; Andreotti, G; Lubin, JH; Blair, A; Freeman, LEB				Alavanja, Michael C. R.; Hofmann, Jonathan N.; Lynch, Charles F.; Hines, Cynthia J.; Barry, Kathryn H.; Barker, Joseph; Buckman, Dennis W.; Thomas, Kent; Sandler, Dale P.; Hoppin, Jane A.; Koutros, Stella; Andreotti, Gabriella; Lubin, Jay H.; Blair, Aaron; Freeman, Laura E. Beane			Non-Hodgkin Lymphoma Risk and Insecticide, Fungicide and Fumigant se in the Agricultural Health Study	PLOS ONE			English	Article							OCCUPATIONAL-EXPOSURE; PESTICIDE EXPOSURE; CANCER-RISK; ADIPOSE-TISSUE; FARMERS; ORGANOCHLORINES; APPLICATORS	Farming and pesticide use have previously been linked to non-Hodgkin lymphoma (NHL), chronic lymphocytic leukemia (CLL) and multiple myeloma (MM). We evaluated agricultural use of specific insecticides, fungicides, and fumigants and risk of NHL and NHL-subtypes (including CLL and MM) in a U.S.-based prospective cohort of farmers and commercial pesticide applicators. A total of 523 cases occurred among 54,306 pesticide applicators from enrollment (1993-97) through December 31, 2011 in Iowa, and December 31, 2010 in North Carolina. Information on pesticide use, other agricultural exposures and other factors was obtained from questionnaires at enrollment and at follow-up approximately five years later (1999-2005). Information from questionnaires, monitoring, and the literature were used to create lifetime-days and intensity-weighted lifetime days of pesticide use, taking into account exposure-modifying factors. Poisson and polytomous models were used to calculate relative risks (RR) and 95% confidence intervals (CI) to evaluate associations between 26 pesticides and NHL and five NHL-subtypes, while adjusting for potential confounding factors. For total NHL, statistically significant positive exposure-response trends were seen with lindane and DDT. Terbufos was associated with total NHL in ever/never comparisons only. In subtype analyses, terbufos and DDT were associated with small cell lymphoma/chronic lymphocytic leukemia/marginal cell lymphoma, lindane and diazinon with follicular lymphoma, and permethrin with MM. However, tests of homogeneity did not show significant differences in exposure-response among NHL-subtypes for any pesticide. Because 26 pesticides were evaluated for their association with NHL and its subtypes, some chance finding could have occurred. Our results showed pesticides from different chemical and functional classes were associated with an excess risk of NHL and NHL subtypes, but not all members of any single class of pesticides were associated with an elevated risk of NHL or NHL subtypes. These findings are among the first to suggest links between DDT, lindane, permethrin, diazinon and terbufos with NHL subtypes.	[Alavanja, Michael C. R.; Hofmann, Jonathan N.; Barry, Kathryn H.; Koutros, Stella; Andreotti, Gabriella; Lubin, Jay H.; Blair, Aaron; Freeman, Laura E. Beane] NCI, Div Canc Epidemiol & Genet, Rockville, MD 20850 USA; [Lynch, Charles F.] Univ Iowa, Coll Publ Hlth, Iowa City, IA USA; [Hines, Cynthia J.] NIOSH, Cincinnati, OH 45226 USA; [Barker, Joseph; Buckman, Dennis W.] IMS Inc, Calverton, MD USA; [Thomas, Kent] US EPA, Natl Exposure Res Lab, Res Triangle Pk, NC 27711 USA; [Sandler, Dale P.; Hoppin, Jane A.] NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Iowa; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); United States Environmental Protection Agency; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Alavanja, MCR (corresponding author), NCI, Div Canc Epidemiol & Genet, Rockville, MD 20850 USA.	alavanjm@mail.nih.gov	Koutros, Stella/W-5788-2019; Hofmann, Jonathan/I-4168-2017; Freeman, Laura E. Beane/C-4468-2015	Koutros, Stella/0000-0001-5294-5485; Hofmann, Jonathan/0000-0002-1043-5812; Freeman, Laura E. Beane/0000-0003-1294-4124; Sandler, Dale/0000-0002-6776-0018; Hoppin, Jane/0000-0001-8456-0969	Intramural Research Program of the NIH, National Cancer Institute, Division of Cancer Epidemiology and Genetics [Z01CP010119]; National Institutes of Environmental Health Sciences [Z01ES049030]; IMS, Inc; NATIONAL CANCER INSTITUTE [ZIACP010119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES049030, ZIAES049028] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Cancer Institute, Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); National Institutes of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); IMS, Inc; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Intramural Research Program of the NIH, National Cancer Institute, Division of Cancer Epidemiology and Genetics (Z01CP010119) and The National Institutes of Environmental Health Sciences (Z01ES049030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. IMS, Inc, provided support in the form of salaries for authors Joseph Barker and Denis W Buckman, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alavanja MCR, 1996, ENVIRON HEALTH PERSP, V104, P362, DOI 10.2307/3432672; Alavanja MCR, 2003, AM J EPIDEMIOL, V157, P800, DOI 10.1093/aje/kwg040; Alavanja MCR, 2013, CA-CANCER J CLIN, V63, P120, DOI 10.3322/caac.21170; Alavanja MCR, 2012, J TOXICOL ENV HEAL B, V15, P238, DOI 10.1080/10937404.2012.632358; Ashizawa A, 2005, ATSDR TOXICOLOGICAL, P1; Baris D, 2004, SCAND J WORK ENV HEA, V30, P215, DOI 10.5271/sjweh.782; Baris D, 1998, OCCUP ENVIRON MED, V55, P522, DOI 10.1136/oem.55.8.522; Blair A, 1998, AM J IND MED, V33, P82, DOI 10.1002/(SICI)1097-0274(199801)33:1&lt;82::AID-AJIM9&gt;3.0.CO;2-Y; Blair A, 2002, EPIDEMIOLOGY, V13, P94, DOI 10.1097/00001648-200201000-00015; BLAIR A, 1985, SCAND J WORK ENV HEA, V11, P397, DOI 10.5271/sjweh.2208; Blair A, 2011, OCCUP ENVIRON MED, V68, P537, DOI 10.1136/oem.2010.059469; Brauner EV, 2012, ENVIRON HEALTH PERSP, V120, P105, DOI 10.1289/ehp.1103573; CANTOR KP, 1982, INT J CANCER, V29, P239, DOI 10.1002/ijc.2910290303; Coble J, 2011, INT J ENV RES PUB HE, V8, P4608, DOI 10.3390/ijerph8124608; Cocco P, 2008, OCCUP ENVIRON MED, V65, P132, DOI 10.1136/oem.2007.033548; Cocco P, 2013, OCCUP ENVIRON MED, V70, P91, DOI 10.1136/oemed-2012-100845; Cordes DH, 1991, HLTH HAZARDS FARMING, V3; De Roos AJ, 2003, OCCUP ENVIRON MED, V60, DOI 10.1136/oem.60.9.e11; Donalson D, 2002, EPA733R02001; Environmental Protection Agency, 2004, INT REG EL DEC DIAZ; EPA, 2006, RER EL DEC TERB; EPA, 2006, RER EL DEC PERM; EPA, 2012, DDT A BRIEF HIST STA; Freeman LEB, 2012, CANCER CAUSE CONTROL, V23, P663, DOI 10.1007/s10552-012-9921-1; Freeman LEB, 2005, AM J EPIDEMIOL, V162, P1070, DOI 10.1093/aje/kwi321; Heltshe SL, 2012, J EXPO SCI ENV EPID, V22, P409, DOI 10.1038/jes.2012.31; *IARC, 1991, IARC MON EV CARC RIS, V53; IARC,, 1987, IARC MON EV CARC RIS; McDuffie HH, 2001, CANCER EPIDEM BIOMAR, V10, P1155; Merhi M, 2007, CANCER CAUSE CONTROL, V18, P1209, DOI 10.1007/s10552-007-9061-1; MILHAM S, 1971, AM J EPIDEMIOL, V94, P307, DOI 10.1093/oxfordjournals.aje.a121324; Morton LM, 2007, BLOOD, V110, P695, DOI 10.1182/blood-2006-11-051672; Morton LM, 2014, J NATL CANC I MONOGR, V48, P130, DOI DOI 10.1093/JNCIM0N0GRAPHS/LGU013; Nanni O, 1996, OCCUP ENVIRON MED, V53, P652, DOI 10.1136/oem.53.10.652; NPIC, 2012, CHEM EV CARC POT; NTP, 2011, NAT TOX PROGR REP CA; PEARCE NE, 1985, AM J EPIDEMIOL, V121, P225, DOI 10.1093/oxfordjournals.aje.a113993; Percy C, 2001, CONVERSION NEOPLASMS; Piskac-Collier AL, 2009, J TOXICOL ENV HEAL A, V72, P1160, DOI 10.1080/15287390903091780; Purdue MP, 2007, INT J CANCER, V120, P642, DOI 10.1002/ijc.22258; Quintana PJE, 2004, ENVIRON HEALTH PERSP, V112, P854, DOI 10.1289/ehp.6726; Rothman N, 1997, LANCET, V350, P240, DOI 10.1016/S0140-6736(97)02088-6; RUPA DS, 1989, HUM GENET, V83, P271, DOI 10.1007/BF00285170; Rusiecki JA, 2009, ENVIRON HEALTH PERSP, V117, P581, DOI 10.1289/ehp.11318; Spinelli JJ, 2007, INT J CANCER, V121, P2767, DOI 10.1002/ijc.23005; Stockholm Convention, 2009, C PART STOCKH CONV P; Thomas KW, 2010, J EXPO SCI ENV EPID, V20, P559, DOI 10.1038/jes.2009.54; US Environmental Protection Agency, 2006, FED REGISTER, V71, P74905; Waddell BL, 2001, CANCER CAUSE CONTROL, V12, P509, DOI 10.1023/A:1011293208949	49	90	95	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e109332	10.1371/journal.pone.0109332	http://dx.doi.org/10.1371/journal.pone.0109332			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337994	gold, Green Submitted, Green Published			2022-12-27	WOS:000343674800010
J	Bijanki, KR; Hodis, B; Brumm, MC; Harlynn, EL; McCormick, LM				Bijanki, Kelly Rowe; Hodis, Brendan; Brumm, Michael C.; Harlynn, Emily L.; McCormick, Laurie M.			Hippocampal and Left Subcallosal Anterior Cingulate Atrophy in Psychotic Depression	PLOS ONE			English	Article							SUBGENUAL PREFRONTAL CORTEX; DEEP BRAIN-STIMULATION; ELECTROCONVULSIVE-THERAPY; VOLUME; ANTIDEPRESSANT; AMYGDALA; SCHIZOPHRENIA; ABNORMALITIES; NEUROGENESIS; REDUCTION	Background: Psychotic depression is arguably the most diagnostically stable subtype of major depressive disorder, and an attractive target of study in a famously heterogeneous mental illness. Previous imaging studies have identified abnormal volumes of the hippocampus, amygdala, and subcallosal region of the anterior cingulate cortex (scACC) in psychotic depression, though studies have not yet examined the role of family history of depression in these relationships. Methods: 20 participants with psychotic depression preparing to undergo electroconvulsive therapy and 20 healthy comparison participants (13 women and 7 men in each group) underwent structural brain imaging in a 1.5 T MRI scanner. 15 of the psychotic depression group had a first-degree relative with diagnosed affective disorders, while the healthy control group had no first-degree relatives with affective disorders. Depression severity was assessed with the Hamilton Depression Rating Scale and duration of illness was assessed in all patients. Automated neural nets were used to isolate the hippocampi and amygdalae in each scan, and an established manual method was used to parcellate the anterior cingulate cortex into dorsal, rostral, subcallosal, and subgenual regions. The volumes of these regions were compared between groups. Effects of laterality and family history of affective disorders were examined as well. Results: Patients with psychotic depression had significantly smaller left scACC and bilateral hippocampal volumes, while no group differences in other anterior cingulate cortex subregions or amygdala volumes were present. Hippocampal atrophy was found in all patients with psychotic depression, but reduced left scACC volume was found only in the patients with a family history of depression. Conclusions: Patients with psychotic depression showed significant reduction in hippocampal volume bilaterally, perhaps due to high cortisol states associated with this illness. Reduced left scACC volume may be a vulnerability factor related to family history of depression.	[Bijanki, Kelly Rowe; Hodis, Brendan; Brumm, Michael C.; Harlynn, Emily L.; McCormick, Laurie M.] Univ Iowa, Dept Psychiat, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa	Bijanki, KR (corresponding author), Univ Iowa, Dept Psychiat, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	kelly-rowe@uiowa.edu		Bijanki, Kelly/0000-0003-1624-8767; Brumm, Michael/0000-0002-3173-9989	University of Iowa College of Medicine; Nellie Ball Trust Foundation Grant	University of Iowa College of Medicine; Nellie Ball Trust Foundation Grant	Funding for this study was provided by a Collaborative Interdisciplinary Project Grant from the University of Iowa College of Medicine (LM) (http://obermann.uiowa.edu/programs/interdisciplinary-research-grants) and a Nellie Ball Trust Foundation Grant (LM) (https://research.uiowa.edu/grantbulletin/show.php/25137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen N. C., 1984, SCALE ASSESSMENT POS; ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P784; Asada H, 1999, NEUROSCI LETT, V274, P29, DOI 10.1016/S0304-3940(99)00679-5; Aylward EH, 2012, BIOL PSYCHIAT, V71, P822, DOI 10.1016/j.biopsych.2011.07.030; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Botteron KN, 2002, BIOL PSYCHIAT, V51, P342, DOI 10.1016/S0006-3223(01)01280-X; Broadway JM, 2012, NEUROPSYCHOPHARMACOL, V37, P1764, DOI 10.1038/npp.2012.23; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Campbell S, 2006, CURR OPIN PSYCHIATR, V19, P25, DOI 10.1097/01.yco.0000194371.47685.f2; CHARNEY DS, 1981, AM J PSYCHIAT, V138, P328; Coryell W, 2005, AM J PSYCHIAT, V162, P1706, DOI 10.1176/appi.ajp.162.9.1706; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; DUBOVSKY SL, 1991, BIOL PSYCHIAT, V30, P533; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; HELMS PM, 1983, J AFFECT DISORDERS, V5, P51, DOI 10.1016/0165-0327(83)90036-8; Hill SK, 2004, AM J PSYCHIAT, V161, P996, DOI 10.1176/appi.ajp.161.6.996; Hirayasu Y, 1999, AM J PSYCHIAT, V156, P1091; Ishii R, 1999, NEUROREPORT, V10, P675, DOI 10.1097/00001756-199903170-00003; Kates WR, 1997, PSYCHIAT RES-NEUROIM, V75, P31, DOI 10.1016/S0925-4927(97)00019-X; Keller J, 2008, AM J PSYCHIAT, V165, P872, DOI 10.1176/appi.ajp.2008.07081257; Keller J, 2007, SCHIZOPHRENIA BULL, V33, P877, DOI 10.1093/schbul/sbm065; Kronmuller KT, 2009, PSYCHIAT RES-NEUROIM, V174, P62, DOI 10.1016/j.pscychresns.2008.08.001; Lozano AM, 2012, J NEUROSURG, V116, P315, DOI 10.3171/2011.10.JNS102122; LYKOURAS E, 1986, ACTA PSYCHIAT SCAND, V73, P324, DOI 10.1111/j.1600-0447.1986.tb02692.x; MacQueen GM, 2003, P NATL ACAD SCI USA, V100, P1387, DOI 10.1073/pnas.0337481100; Magnotta VA, 2002, COMPUT MED IMAG GRAP, V26, P251, DOI 10.1016/S0895-6111(02)00011-3; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Mayberg HS, 2009, J CLIN INVEST, V119, P717, DOI 10.1172/JCI38454; McCormick LM, 2007, J ECT, V23, P265, DOI 10.1097/yct.0b013e318150d56d; McCormick LM, 2006, NEUROIMAGE, V32, P1167, DOI 10.1016/j.neuroimage.2006.04.227; McCormick LM, 2009, J PSYCHIATR RES, V43, P553, DOI 10.1016/j.jpsychires.2008.08.004; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Nordanskog P, 2010, J ECT, V26, P62, DOI 10.1097/YCT.0b013e3181a95da8; Ongur D, 1998, P NATL ACAD SCI USA, V95, P13290, DOI 10.1073/pnas.95.22.13290; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Pantel J, 2000, HIPPOCAMPUS, V10, P752, DOI 10.1002/1098-1063(2000)10:6<752::AID-HIPO1012>3.0.CO;2-Y; Petrides G, 2001, J ECT, V17, P244, DOI 10.1097/00124509-200112000-00003; Pizzagalli DA, 2011, NEUROPSYCHOPHARMACOL, V36, P183, DOI 10.1038/npp.2010.166; Powell HWR, 2008, J NEUROL NEUROSUR PS, V79, P686, DOI 10.1136/jnnp.2007.115139; ROTHSCHILD AJ, 1989, BIOL PSYCHIAT, V26, P565, DOI 10.1016/0006-3223(89)90081-4; Schumann CM, 2004, J NEUROSCI, V24, P6392, DOI 10.1523/JNEUROSCI.1297-04.2004; Scott BW, 2000, EXP NEUROL, V165, P231, DOI 10.1006/exnr.2000.7458; Sheline YI, 2003, BIOL PSYCHIAT, V54, P338, DOI 10.1016/S0006-3223(03)00347-0; Sheline YI, 1999, J NEUROSCI, V19, P5034; Vassilopoulou K, 2013, J AFFECT DISORDERS, V146, P197, DOI 10.1016/j.jad.2012.09.003; Videbech P, 2004, AM J PSYCHIAT, V161, P1957, DOI 10.1176/appi.ajp.161.11.1957; World Health Organization, 2008, GLOB BURD DIS 2004 U	49	17	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110770	10.1371/journal.pone.0110770	http://dx.doi.org/10.1371/journal.pone.0110770			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338068	Green Published, gold			2022-12-27	WOS:000343674800074
J	Chen, S; Wang, Q; Wu, ZY; Li, Y; Li, P; Sun, F; Zheng, WJ; Wu, QJ; Wu, CY; Deng, CW; Zhang, FC; Li, YZ				Chen, Si; Wang, Qian; Wu, Ziyan; Li, Yuan; Li, Ping; Sun, Fei; Zheng, Wenjie; Wu, Qingjun; Wu, Chanyuan; Deng, Chuiwen; Zhang, Fengchun; Li, Yongzhe			Genetic Association Study of TNFAIP3, IFIH1, IRF5 Polymorphisms with Polymyositis/Dermatomyositis in Chinese Han Population	PLOS ONE			English	Article							INFLAMMATORY MYOPATHY PATIENTS; GENOME-WIDE ASSOCIATION; NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; REGULATORY FACTOR; REVISED CRITERIA; RISK; JUVENILE; DISEASE; DERMATOMYOSITIS	Background: Single-nucleotide polymorphisms (SNPs) in the TNFAIP3, IFIH1, and IRF5 genes have been associated with several auto-inflammation diseases, while the susceptibility between these genes and idiopathic inflammatory myopathies (IIMs) were not reported. This study aimed to investigate whether TNFAIP3, IFIH1, and IRF5 gene polymorphisms confer susceptibility for the IIMs in Chinese Han population. Methods: A large case-control study of Chinese subjects with polymyositis (PM) (n = 298) and dermatomyositis (DM) (n = 530) was accomplished. 968 healthy and ethnically matched controls were available for comparison. Six SNPs in the TNFAIP3 region (rs2230926 and rs5029939), the IFIH1 gene (rs1990760 and rs3747517) and the IRF5 region (rs4728142 and rs729302) were assessed and genotyped using the Sequenom MassArray iPLEX platform. Results: Our study indicated a strong allele association was observed in PM/DM and PM patients for rs2230926 (OR: 1.61, 95% CI: 1.20-2.16, P-c = 7.5x10(-3); OR: 1.88, 95% CI: 1.30-2.74, P-c = 4.0x10(-3), respectively) and rs5029939 (OR: 1.64, 95% CI: 1.21-2.21, P-c = 6.0x10(-3); OR: 1.88, 95% CI: 1.28-2.76, P-c = 5.5x10(-3), respectively). And rs2230926 and rs5029939 were significantly associated with interstitial lung disease (ILD) in PM/DM and PM patients (P-c = 0.04 and P-c = 0.016; P-c = 0.02 and P-c = 0.03, respectively). In addition, rs4728142 allele and genotype had significant association with PM/DM patients (P-c = 0.026 and P-c = 0.048, respectively). Further analysis with three logistic regression genetic models revealed statistically significant difference in the genotypic distribution in the PM/DM, PM or DM patients when the additive and dominant models were used. Conclusions: This was the first study to reveal TNFAIP3 and IRF5 polymorphisms were associated with PM/DM patients or these patients with ILD, indicating that TNFAIP3 and IRF5 might be the susceptibility gene for PM/DM patients in Chinese Han population.	[Zhang, Fengchun] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol & Clin Immunol, Beijing 100730, Peoples R China; Peking Union Med Coll, Minist Educ, Key Lab Rheumatol & Clin Immunol, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhang, FC (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol & Clin Immunol, Beijing 100730, Peoples R China.	zhangfccra@aliyun.com; yongzhelipumch@126.com			Research Special Fund for Public Welfare Industry of Health [201202004]; National Natural Science Foundation of China [81172857, 81373188]; Chinese National High Technology Research and Development Program, Ministry of Science and Technology [2011AA02A113]; National Science Technology Pillar Program in the 12nd Five-year Plan [2014BAI07B00]	Research Special Fund for Public Welfare Industry of Health; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National High Technology Research and Development Program, Ministry of Science and Technology(National High Technology Research and Development Program of China); National Science Technology Pillar Program in the 12nd Five-year Plan	This work was supported by funding from the Research Special Fund for Public Welfare Industry of Health (201202004), and the National Natural Science Foundation of China Grants (81172857, 81373188), the Chinese National High Technology Research and Development Program, Ministry of Science and Technology Grants (2011AA02A113), and the National Science Technology Pillar Program in the 12nd Five-year Plan (2014BAI07B00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Barnes BJ, 2001, J BIOL CHEM, V276, P23382, DOI 10.1074/jbc.M101216200; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BOHAN A, 1975, NEW ENGL J MED, V292, P403, DOI 10.1056/NEJM197502202920807; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Cen H, 2013, AUTOIMMUNITY, V46, P455, DOI 10.3109/08916934.2013.796937; Chinoy H, 2008, ARTHRITIS RHEUM-US, V58, P3247, DOI 10.1002/art.23900; Chinoy H, 2007, RHEUMATOLOGY, V46, P1411, DOI 10.1093/rheumatology/kem145; Chinoy H, 2007, ANN RHEUM DIS, V66, P970, DOI 10.1136/ard.2006.068858; Chinoy H, 2012, RHEUMATOLOGY, V51, P794, DOI 10.1093/rheumatology/ker379; Chinoy H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3327; Chu YY, 2011, BLOOD, V117, P2227, DOI 10.1182/blood-2010-09-306019; Dayal NA, 2002, LUPUS, V11, P293, DOI 10.1191/0961203302lu186oa; de Padilla CML, 2007, ARTHRITIS RHEUM, V56, P1658, DOI 10.1002/art.22558; De Paepe B, 2007, ANN NY ACAD SCI, V1109, P441, DOI 10.1196/annals.1398.050; Dideberg V, 2007, HUM MOL GENET, V16, P3008, DOI 10.1093/hmg/ddm259; Dimachkie MM, 2014, NEUROL CLIN, V32, P595, DOI 10.1016/j.ncl.2014.04.007; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Ginn LR, 1998, ARTHRITIS RHEUM, V41, P400, DOI 10.1002/1529-0131(199803)41:3<400::AID-ART4>3.0.CO;2-5; Gono T, 2010, MOD RHEUMATOL, V20, P466, DOI 10.1007/s10165-010-0311-9; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Hassan AB, 2004, ARTHRITIS RHEUM, V50, P1013, DOI 10.1002/art.20208; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Izaguirre A, 2003, J LEUKOCYTE BIOL, V74, P1125, DOI 10.1189/jlb.0603255; Koumakis E, 2012, ARTHRITIS RHEUM-US, V64, P2746, DOI 10.1002/art.34490; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Mamyrova G, 2008, ARTHRITIS RHEUM-US, V58, P3941, DOI 10.1002/art.24039; Matmati M, 2011, NAT GENET, V43, P908, DOI 10.1038/ng.874; Miller FW, 2013, ARTHRITIS RHEUM-US, V65, P3239, DOI 10.1002/art.38137; MIMORI T, 1987, INT J DERMATOL, V26, P419, DOI 10.1111/j.1365-4362.1987.tb00580.x; Musone SL, 2011, GENES IMMUN, V12, P176, DOI 10.1038/gene.2010.64; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Niewold TB, 2011, PEDIATRICS, V127, pE1239, DOI 10.1542/peds.2010-3022; Pachman LM, 2000, ARTHRITIS RHEUM, V43, P2368, DOI 10.1002/1529-0131(200010)43:10<2368::AID-ANR26>3.0.CO;2-8; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Sharif R, 2012, ANN RHEUM DIS, V71, P1197, DOI 10.1136/annrheumdis-2011-200901; SHARP GC, 1972, AM J MED, V52, P148, DOI 10.1016/0002-9343(72)90064-2; Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Sontheimer RD, 2002, J AM ACAD DERMATOL, V46, P626, DOI 10.1067/mjd.2002.120621; Sugiura T, 2012, ANN RHEUM DIS, V71, P1646, DOI 10.1136/annrheumdis-2011-200839; Sutherland A, 2007, J CLIN ENDOCR METAB, V92, P3338, DOI 10.1210/jc.2007-0173; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Vereecke L, 2009, TRENDS IMMUNOL, V30, P383, DOI 10.1016/j.it.2009.05.007; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Walsh RJ, 2007, ARTHRITIS RHEUM, V56, P3784, DOI 10.1002/art.22928; Werth VP, 2002, J INVEST DERMATOL, V119, P1394, DOI 10.1046/j.1523-1747.2002.19608.x; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Zhou XD, 2004, MED SCI MONITOR, V10, pBR191	52	13	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110044	10.1371/journal.pone.0110044	http://dx.doi.org/10.1371/journal.pone.0110044			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337792	Green Published, gold, Green Submitted			2022-12-27	WOS:000343674800022
J	Gagnon, DD; Gagnon, SS; Rintamaki, H; Tormakangas, T; Puukka, K; Herzig, KH; Kyrolainen, H				Gagnon, Dominique D.; Gagnon, Sheila S.; Rintamaki, Hannu; Tormakangas, Timo; Puukka, Katri; Herzig, Karl-Heinz; Kyrolainen, Heikki			The Effects of Cold Exposure on Leukocytes, Hormones and Cytokines during Acute Exercise in Humans	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTION; ENDURANCE EXERCISE; IMMUNE-SYSTEM; NEUTROPHIL DEGRANULATION; EXERTIONAL HYPERTHERMIA; IMMUNOLOGICAL CHANGES; AUTONOMIC RESPONSES; SKELETAL-MUSCLE; HEAT-STRESS; TESTOSTERONE	The purpose of the study was to examine the effects of exercise on total leukocyte count and subsets, as well as hormone and cytokine responses in a thermoneutral and cold environment, with and without an individualized pre-cooling protocol inducing low-intensity shivering. Nine healthy young men participated in six experimental trials wearing shorts and t-shirts. Participants exercised for 60 min on a treadmill at low (LOW: 50% of peak VO2) and moderate (MOD: 70% VO2peak) exercise intensities in a climatic chamber set at 22 degrees C (NT), and in 0 degrees C (COLD) with and without a pre-exercise low-intensity shivering protocol (SHIV). Core and skin temperature, heart rate and oxygen consumption were collected continuously. Blood samples were collected before and at the end of exercise to assess endocrine and immunological changes. Core temperature in NT was greater than COLD and SHIV by 0.4 +/- 0.2 degrees C whereas skin temperature in NT was also greater than COLD and SHIV by 8.5 +/- 1.4 degrees C and 9.3 +/- 2.5 degrees C respectively in MOD. Total testosterone, adenocorticotropin and cortisol were greater in NT vs. COLD and SHIV in MOD. Norepinephrine was greater in NT vs. other conditions across intensities. Interleukin-2, IL-5, IL-7, IL-10, IL-17, IFN-gamma, Rantes, Eotaxin, IP-10, MIP-1 beta, MCP-1, VEGF, PDGF, and G-CSF were elevated in NT vs. COLD and/or SHIV. Furthermore, IFN-gamma, MIP-1 beta, MCP-1, IL-10, VEGF, and PDGF demonstrate greater concentrations in SHIV vs. COLD, mainly in the MOD condition. This study demonstrated that exercising in the cold can diminish the exercise-induced systemic inflammatory response seen in a thermoneutral environment. Nonetheless, prolonged cooling inducing shivering thermogenesis prior to exercise, may induce an immuno-stimulatory response following moderate intensity exercise. Performing exercise in cold environments can be a useful strategy in partially inhibiting the acute systemic inflammatory response from exercise but oppositely, additional body cooling may reverse this benefit.	[Gagnon, Dominique D.; Rintamaki, Hannu; Herzig, Karl-Heinz] Univ Oulu, Dept Physiol, Inst Biomed, Oulu, Finland; [Gagnon, Dominique D.; Rintamaki, Hannu; Herzig, Karl-Heinz] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Gagnon, Dominique D.; Kyrolainen, Heikki] Univ Jyvaskyla, Dept Biol Phys Act, SF-40100 Jyvaskyla, Finland; [Gagnon, Sheila S.] Univ Western Ontario, Dept Hlth & Rehabil Sci, London, ON, Canada; [Rintamaki, Hannu] Finnish Inst Occupat Hlth, Oulu, Finland; [Tormakangas, Timo] Univ Jyvaskyla, Dept Hlth Sci, Jyvaskyla, Finland; [Puukka, Katri] Univ Oulu, NordLab Oulu, Oulu Univ Hosp, Oulu, Finland; [Puukka, Katri] Univ Oulu, Dept Clin Chem, Oulu, Finland; [Herzig, Karl-Heinz] Med Res Ctr Oulu, Oulu, Finland; [Herzig, Karl-Heinz] Oulu Univ Hosp, Oulu, Finland	University of Oulu; University of Oulu; University of Jyvaskyla; Western University (University of Western Ontario); Finnish Institute of Occupational Health; University of Jyvaskyla; University of Oulu; University of Oulu; University of Oulu	Gagnon, DD (corresponding author), Univ Oulu, Dept Physiol, Inst Biomed, Oulu, Finland.	dominique.gagnon@oulu.fi		Kyrolainen, Heikki/0000-0003-3822-1733; Gagnon, Dominique/0000-0002-9051-0949; Tormakangas, Timo/0000-0001-7268-5297	Jenny and Antti Wihurin Foundation; Joint Motion Program - A CIHR training program in musculoskeletal health research and leadership	Jenny and Antti Wihurin Foundation; Joint Motion Program - A CIHR training program in musculoskeletal health research and leadership(Canadian Institutes of Health Research (CIHR))	Dominique D. Gagnon is supported by the Jenny and Antti Wihurin Foundation. Sheila S. Gagnon is supported in part by the Joint Motion Program - A CIHR training program in musculoskeletal health research and leadership. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beilin B, 1998, ANESTHESIOLOGY, V89, P1133, DOI 10.1097/00000542-199811000-00013; Brenner IKM, 1999, J APPL PHYSIOL, V87, P699, DOI 10.1152/jappl.1999.87.2.699; Carlson SL, 1989, J NEUROIMMUNOL, V24, P699; Castellani JW, 2002, MED SCI SPORT EXER, V34, P2013, DOI 10.1097/00005768-200212000-00023; Cross MC, 1996, J APPL PHYSIOL, V81, P822; Eyolfson DA, 2001, EUR J APPL PHYSIOL, V84, P100, DOI 10.1007/s004210000329; Fahrner CL, 1998, INT J SPORTS MED, V19, P12, DOI 10.1055/s-2007-971872; FIELDING RA, 1993, AM J PHYSIOL, V265, pR166, DOI 10.1152/ajpregu.1993.265.1.R166; Fragala MS, 2011, SPORTS MED, V41, P621, DOI 10.2165/11590430-000000000-00000; Fragala MS, 2011, NEUROIMMUNOMODULAT, V18, P156, DOI 10.1159/000321633; Frank SM, 1999, J APPL PHYSIOL, V86, P1588, DOI 10.1152/jappl.1999.86.5.1588; Gagnon DD, 2014, APPL PHYSIOL NUTR ME, V39, P282, DOI 10.1139/apnm-2013-0061; Gleeson M, 2007, J APPL PHYSIOL, V103, P693, DOI 10.1152/japplphysiol.00008.2007; Guevara Patino JA, 2000, EUR J IMMUNOL, V30, P2586; Hargreaves M, 1996, J APPL PHYSIOL, V81, P1594, DOI 10.1152/jappl.1996.81.4.1594; Jansky L, 1996, EUR J APPL PHYSIOL O, V72, P445, DOI 10.1007/BF00242274; JENSEN J, 1991, EUR J APPL PHYSIOL O, V63, P467, DOI 10.1007/BF00868080; JURANKOVA E, 1995, MOL CHEM NEUROPATHOL, V25, P213, DOI 10.1007/BF02960914; Klecha AJ, 2006, J ENDOCRINOL, V189, P45, DOI 10.1677/joe.1.06137; Laing SJ, 2005, AVIAT SPACE ENVIR MD, V76, P1068; Lander PJ, 2009, BRIT J SPORT MED, V43, P789, DOI 10.1136/bjsm.2008.056085; Lavoy ECP, 2011, WILD ENVIRON MED, V22, P343, DOI 10.1016/j.wem.2011.08.005; Lehto SM, 2010, PSYCHONEUROENDOCRINO, V35, P226, DOI 10.1016/j.psyneuen.2009.06.007; Leppaluoto J, 2005, ACTA PHYSIOL SCAND, V184, P255, DOI 10.1111/j.1365-201X.2005.01464.x; LEPPALUOTO J, 1988, ACTA PHYSIOL SCAND, V132, P543, DOI 10.1111/j.1748-1716.1988.tb08363.x; Malm C, 2000, J PHYSIOL-LONDON, V529, P243, DOI 10.1111/j.1469-7793.2000.00243.x; Matsukawa A, 2000, Rev Immunogenet, V2, P339; McFarlin BK, 2003, AVIAT SPACE ENVIR MD, V74, P1231; McMurray RW, 2001, PATHOBIOLOGY, V69, P44, DOI 10.1159/000048757; Mitchell JB, 2002, MED SCI SPORT EXER, V34, P1941, DOI 10.1097/00005768-200212000-00013; Morris PD, 2004, EUR J ENDOCRINOL, V151, P241, DOI 10.1530/eje.0.1510241; Myhrstad MCW, 2011, BRIT J NUTR, V106, P1826, DOI 10.1017/S0007114511002510; Nagatomi R, 2000, EXERC IMMUNOL REV, V6, P54; Nieman DC, 1997, J ATHL TRAINING, V32, P344; NIEMAN DC, 1994, MED SCI SPORT EXER, V26, P128, DOI 10.1249/00005768-199402000-00002; Nieman DC, 2009, MED SPORTIVA, V4, P189; Niess AM, 2003, EUR J APPL PHYSIOL, V89, P344, DOI 10.1007/s00421-003-0809-3; Ogilvie AC, 1996, J IMMUNOL, V156, P389; Olsen NJ, 1996, ENDOCR REV, V17, P369, DOI 10.1210/edrv-17-4-369; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; PALMES ED, 1947, FED PROC, V6, P175; Patterson S, 2008, J SPORT SCI, V26, P927, DOI 10.1080/02640410801885941; Peake JM, 2005, EUR J APPL PHYSIOL, V95, P514, DOI 10.1007/s00421-005-0035-2; Peake J, 2008, EUR J APPL PHYSIOL, V102, P391, DOI 10.1007/s00421-007-0598-1; Pedersen BK, 2000, BRIT J SPORT MED, V34, P246, DOI 10.1136/bjsm.34.4.246; Pedersen BK, 2000, PHYSIOL REV, V80, P1055, DOI 10.1152/physrev.2000.80.3.1055; Rhind SG, 1999, J APPL PHYSIOL, V87, P1178; Rhind SG, 2004, INT J HYPERTHER, V20, P503, DOI 10.1080/02656730410001670651; Rhind SG, 2001, AM J PHYSIOL-REG I, V281, pR66; Ribeiro MO, 2001, J CLIN INVEST, V108, P97, DOI 10.1172/JCI12584; Shephard RJ, 1998, CAN J PHYSIOL PHARM, V76, P828, DOI 10.1139/cjpp-76-9-828; Shinkai S, 1996, INT J SPORTS MED, V17, P597, DOI 10.1055/s-2007-972901; Steensberg A, 2003, AM J PHYSIOL-ENDOC M, V285, pE433, DOI 10.1152/ajpendo.00074.2003; Suzuki K, 2000, EUR J APPL PHYSIOL, V81, P281, DOI 10.1007/s004210050044; Suzuki K, 2002, EXERC IMMUNOL REV, V8, P6; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; Toner M.M., 1996, COMPR PHYSIOL, P379, DOI [10.1002/cphy.cp040117, DOI 10.1002/CPHY.CP040117, 10.1002/CPHY.CP040117]; Xu XJ, 2005, COMPUT BIOL MED, V35, P287, DOI 10.1016/j.compbiomed.2004.01.004; YIM CY, 1995, J IMMUNOL, V155, P4382	59	23	25	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110774	10.1371/journal.pone.0110774	http://dx.doi.org/10.1371/journal.pone.0110774			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338085	Green Published, Green Submitted, gold			2022-12-27	WOS:000343674800075
J	Chen, FF; Ren, P; Feng, Y; Liu, HY; Sun, Y; Liu, ZH; Ge, JY; Cui, XL				Chen, Fangfang; Ren, Ping; Feng, Ye; Liu, Haiyan; Sun, Yang; Liu, Zhonghui; Ge, Jingyan; Cui, Xueling			Follistatin Is a Novel Biomarker for Lung Adenocarcinoma in Humans	PLOS ONE			English	Article							CANCER CELL-LINES; ACTIVIN-A; PROSTATE-CANCER; TUMOR-MARKERS; SECRETION; APOPTOSIS; MACROPHAGES; REGULATORS; SURVIVAL; BINDING	Background: Follistatin (FST), a single chain glycoprotein, is originally isolated from follicular fluid of ovary. Previous studies have revealed that serum FST served as a biomarker for pregnancy and ovarian mucinous tumor. However, whether FST can serve as a biomarker for diagnosis in lung adenocarcinoma of humans remains unclear. Methods and Results: The study population consisted of 80 patients with lung adenocarcinoma, 40 patients with ovarian adenocarcinoma and 80 healthy subjects. Serum FST levels in patients and healthy subjects were measured using ELISA. The results showed that the positive ratio of serum FST levels was 51.3% (41/80), which was comparable to the sensitivity of FST in 40 patients with ovarian adenocarcinoma (60%, 24/40) using the 95th confidence interval for the healthy subject group as the cut-off value. FST expressions in lung adenocarcinoma were examined by immunohistochemical staining, we found that lung adenocarcinoma could produce FST and there was positive correlation between the level of FST expression and the differential degree of lung adenocarcinoma. Furthermore, the results showed that primary cultured lung adenocarcinoma cells could secrete FST, while cells derived from non-tumor lung tissues almost did not produce FST. In addition, the results of CCK8 assay and flow cytometry showed that using anti-FST monoclonal antibody to neutralize endogenous FST significantly augmented activin A-induced lung adenocarcinoma cells apoptosis. Conclusions: These data indicate that lung adenocarcinoma cells can secret FST into serum, which may be beneficial to the survival of adenocarcinoma cells by neutralizing activin A action. Thus, FST can serve as a promising biomarker for diagnosis of lung adenocarcinoma and a useful biotherapy target for lung adenocarcinoma.	[Chen, Fangfang; Feng, Ye] Jilin Univ, China Japan Union Hosp, Dept Gastrointestinal Surg, Changchun 130023, Peoples R China; [Ren, Ping] Jilin Univ, Hosp 1, Dept Thorac Surg, Changchun 130023, Peoples R China; [Liu, Haiyan; Sun, Yang; Liu, Zhonghui; Ge, Jingyan; Cui, Xueling] Jilin Univ, Coll Basic Med Sci, Dept Immunol, Changchun 130023, Peoples R China	Jilin University; Jilin University; Jilin University	Ge, JY (corresponding author), Jilin Univ, Coll Basic Med Sci, Dept Immunol, Changchun 130023, Peoples R China.	gejy@jlu.edu.cn; cxl@jlu.edu.cn	Ge, Jingyan/G-3184-2013		National Natural Science Foundation of China [31101039]; Project of Science and Technology of Jilin Province [20110754, 20130522041JH]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Science and Technology of Jilin Province	This work was supported by the National Natural Science Foundation of China (Grant No. 31101039) and the Project of Science and Technology of Jilin Province (Grant No. 20110754 and No. 20130522041JH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman-Muench GR, 2012, IMMUNOL CELL BIOL, V90, P137, DOI 10.1038/icb.2011.32; Ardizzoni A, 2006, CANCER-AM CANCER SOC, V107, P2842, DOI 10.1002/cncr.22330; Detterbeck FC, 2009, CHEST, V136, P260, DOI 10.1378/chest.08-0978; deWinter JP, 1996, MOL CELL ENDOCRINOL, V116, P105, DOI 10.1016/0303-7207(95)03705-5; Ejaz S, 2011, CANCER-AM CANCER SOC, V117, P4381, DOI 10.1002/cncr.26029; FARRELL WE, 1992, J CLIN INVEST, V90, P705, DOI 10.1172/JCI115941; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Florio P, 2010, REPROD SCI, V17, P320, DOI 10.1177/1933719109353205; Gao XW, 2010, J BIOL CHEM, V285, P36857, DOI 10.1074/jbc.M110.144477; Kim YI, 2009, ONCOL REP, V21, P491, DOI 10.3892/or_00000249; Kojima I, 2001, MOL CELL ENDOCRINOL, V180, P179, DOI 10.1016/S0303-7207(01)00511-1; LambertMesserlian G, 1997, BIOL REPROD, V57, P1211, DOI 10.1095/biolreprod57.5.1211; Li N, 2013, BIOCHEM BIOPH RES CO, V435, P222, DOI 10.1016/j.bbrc.2013.04.077; Licona-Limon P, 2009, BIOCHEM BIOPH RES CO, V381, P229, DOI 10.1016/j.bbrc.2009.02.029; Liu ZH, 1996, ENDOCR J, V43, P321, DOI 10.1507/endocrj.43.321; Maguer-Satta W, 2003, EXP CELL RES, V282, P110, DOI 10.1016/S0014-4827(02)00013-7; Morgillo F, 2011, BRIT J CANCER, V105, P382, DOI 10.1038/bjc.2011.244; NAKAMURA T, 1992, BIOCHIM BIOPHYS ACTA, V1135, P103, DOI 10.1016/0167-4889(92)90173-9; NISHIHARA T, 1993, BIOCHEM BIOPH RES CO, V197, P985, DOI 10.1006/bbrc.1993.2576; Ogino H, 2008, CLIN CANCER RES, V14, P660, DOI 10.1158/1078-0432.CCR-07-1221; Okamura K, 2013, LUNG CANCER, V80, P45, DOI 10.1016/j.lungcan.2013.01.002; Parkin DM, 2010, INT J CANCER, V127, P2918, DOI 10.1002/ijc.25517; Patella S, 2006, AM J PHYSIOL-GASTR L, V290, pG137, DOI 10.1152/ajpgi.00080.2005; Planque C, 2009, MOL CELL PROTEOMICS, V8, P2746, DOI 10.1074/mcp.M900134-MCP200; Ren P, 2012, J INT MED RES, V40, P877, DOI 10.1177/147323001204000306; ROBERTSON DM, 1987, BIOCHEM BIOPH RES CO, V149, P744, DOI 10.1016/0006-291X(87)90430-X; Rodrigues P, 2012, ARQ BRAS ENDOCRINOL, V56, P461, DOI 10.1590/S0004-27302012000700009; Sepporta MV, 2013, TARGET ONCOL, V8, P215, DOI 10.1007/s11523-013-0268-7; Thompson TB, 2005, DEV CELL, V9, P535, DOI 10.1016/j.devcel.2005.09.008; Tumminello FM, 2010, CLIN EXP METASTAS, V27, P549, DOI 10.1007/s10585-010-9344-x; VandeVoort CA, 2009, BIOL REPROD, V81, P1139, DOI 10.1095/biolreprod.109.077198; Wakatsuki M, 1996, J CLIN ENDOCR METAB, V81, P630, DOI 10.1210/jc.81.2.630; Wang BD, 2009, TOXICOLOGY, V258, P176, DOI 10.1016/j.tox.2009.01.023; Wang WJ, 2013, ASIAN PAC J CANCER P, V14, P4369, DOI 10.7314/APJCP.2013.14.7.4369; Wang YN, 2009, CELL MOL IMMUNOL, V6, P387, DOI 10.1038/cmi.2009.50; Ying XZ, 2011, BIOL TRACE ELEM RES, V144, P306, DOI 10.1007/s12011-011-9094-x	36	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111398	10.1371/journal.pone.0111398	http://dx.doi.org/10.1371/journal.pone.0111398			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347573	Green Published, gold, Green Submitted			2022-12-27	WOS:000347994900065
J	Kohr, MJ; Murphy, E; Steenbergen, C				Kohr, Mark J.; Murphy, Elizabeth; Steenbergen, Charles			Glyceraldehyde-3-Phosphate Dehydrogenase Acts as a Mitochondrial Trans-S-Nitrosylase in the Heart	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CYCLOPHILIN D; CELL-DEATH; PROTEIN; GAPDH; PHOSPHORYLATION; IDENTIFICATION; NITROSATION; MYOCARDIUM; ACTIVATION	Mitochondrial proteins have been shown to be common targets of S-nitrosylation (SNO), but the existence of a mitochondrial source of nitric oxide remains controversial. SNO is a nitric oxide-dependent thiol modification that can regulate protein function. Interestingly, trans-S-nitrosylation represents a potential pathway for the import of SNO into the mitochondria. The glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH), which has been shown to act as a nuclear trans-S-nitrosylase, has also been shown to enter mitochondria. However, the function of GAPDH in the mitochondria remains unknown. Therefore, we propose the hypothesis that S-nitrosylated GAPDH (SNO-GAPDH) interacts with mitochondrial proteins as a trans-S-nitrosylase. In accordance with this hypothesis, SNO-GAPDH should be detected in mitochondrial fractions, interact with mitochondrial proteins, and increase mitochondrial SNO levels. Our results demonstrate a four-fold increase in GAPDH levels in the mitochondrial fraction of mouse hearts subjected to ischemic preconditioning, which increases SNO-GAPDH levels. Co-immunoprecipitation studies performed in mouse hearts perfused with the S-nitrosylating agent S-nitrosoglutathione (GSNO), suggest that SNO promotes the interaction of GAPDH with mitochondrial protein targets. The addition of purified SNO-GAPDH to isolated mouse heart mitochondria demonstrated the ability of SNO-GAPDH to enter the mitochondrial matrix, and to increase SNO for many mitochondrial proteins. Further, the overexpression of GAPDH in HepG2 cells increased SNO for a number of different mitochondrial proteins, including heat shock protein 60, voltage-dependent anion channel 1, and acetyl-CoA acetyltransferase, thus supporting the role of GAPDH as a potential mitochondrial trans-S-nitrosylase. In further support of this hypothesis, many of the mitochondrial SNO proteins identified with GAPDH overexpression were no longer detected with GAPDH knock-down or mutation. Therefore, our results suggest that SNO-GAPDH can act as a mitochondrial trans-S-nitrosylase, thereby conferring the transfer of SNO from the cytosol to the mitochondria.	[Kohr, Mark J.; Steenbergen, Charles] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Kohr, Mark J.; Murphy, Elizabeth] NHLBI, Syst Biol Ctr, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Kohr, MJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.	mkohr1@jhmi.edu		Kohr, Mark/0000-0002-6034-5962	American Heart Association [12BGIA11780030]; National Heart, Lung and Blood Institute/National Institutes of Health [1K99HL114721, 5R01HL039752]; National Heart, Lung and Blood Institute/National Institutes of Health Intramural Program [ZO1HL006059, ZO1HL002066]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIGHL006020, R01HL039752, Z01HL002066, K99HL114721, R00HL114721, ZIAHL006059] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Heart, Lung and Blood Institute/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung and Blood Institute/National Institutes of Health Intramural Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the American Heart Association (12BGIA11780030, MK), National Heart, Lung and Blood Institute/National Institutes of Health grants 1K99HL114721 (MK) and 5R01HL039752 (CS), and the National Heart, Lung and Blood Institute/National Institutes of Health Intramural Program (ZO1HL006059 and ZO1HL002066, EM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brookes PS, 2004, MITOCHONDRION, V3, P187, DOI 10.1016/j.mito.2003.10.001; Brown GC, 2007, CARDIOVASC RES, V75, P283, DOI 10.1016/j.cardiores.2007.03.022; Brown GC, 2007, FRONT BIOSCI-LANDMRK, V12, P1024, DOI 10.2741/2122; Burwell LS, 2006, BIOCHEM J, V394, P627, DOI 10.1042/BJ20051435; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Ishitani R, 1998, MOL PHARMACOL, V53, P701, DOI 10.1124/mol.53.4.701; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Kohr MJ, 2014, J MOL CELL CARDIOL, V69, P67, DOI 10.1016/j.yjmcc.2014.01.010; Kohr MJ, 2012, CIRC RES, V111, P1308, DOI 10.1161/CIRCRESAHA.112.271320; Kohr MJ, 2011, AM J PHYSIOL-HEART C, V300, pH1327, DOI 10.1152/ajpheart.00997.2010; Kohr MJ, 2011, CIRC RES, V108, P418, DOI 10.1161/CIRCRESAHA.110.232173; Kornberg MD, 2010, NAT CELL BIOL, V12, P1094, DOI 10.1038/ncb2114; KUMAGAI H, 1983, J BIOCHEM-TOKYO, V93, P1259, DOI 10.1093/oxfordjournals.jbchem.a134260; Martinez-Ruiz A, 2005, P NATL ACAD SCI USA, V102, P8525, DOI 10.1073/pnas.0407294102; MEYERSIEGLER K, 1991, P NATL ACAD SCI USA, V88, P8460, DOI 10.1073/pnas.88.19.8460; Murphy E, 2014, J MOL CELL IN PRESS; Nguyen TT, 2011, J BIOL CHEM, V286, P40184, DOI 10.1074/jbc.M111.243469; Nguyen TTM, 2013, CIRC RES, V113, P1308, DOI 10.1161/CIRCRESAHA.113.301867; Ozawa K, 2008, MOL CELL, V31, P395, DOI 10.1016/j.molcel.2008.05.024; Qu J, 2007, NUCLEIC ACIDS RES, V35, P2522, DOI 10.1093/nar/gkl1163; Reiss N, 1996, BIOCHEM MOL BIOL INT, V40, P1191; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Sen N, 2009, NEURON, V63, P81, DOI 10.1016/j.neuron.2009.05.024; Sha YG, 2012, BBA-GEN SUBJECTS, V1820, P701, DOI 10.1016/j.bbagen.2011.05.008; Sun JH, 2007, CIRC RES, V101, P1155, DOI 10.1161/CIRCRESAHA.107.155879; Sun JH, 2012, ANTIOXID REDOX SIGN, V16, P45, DOI 10.1089/ars.2010.3844; Tarze A, 2007, ONCOGENE, V26, P2606, DOI 10.1038/sj.onc.1210074; Wang GH, 2006, J PROTEOME RES, V5, P1214, DOI 10.1021/pr050406g; Wang SB, 2011, CIRC RES, V109, P750, DOI 10.1161/CIRCRESAHA.111.246124; Yogalingam G, 2013, J BIOL CHEM, V288, P18947, DOI 10.1074/jbc.M113.466870	31	29	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111448	10.1371/journal.pone.0111448	http://dx.doi.org/10.1371/journal.pone.0111448			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347796	Green Published, gold, Green Submitted			2022-12-27	WOS:000347994900075
J	Montgomery, SE; Sepehry, AA; Wangsgaard, JD; Koenig, JE				Montgomery, Sarah E.; Sepehry, Amir A.; Wangsgaard, John D.; Koenig, Jeremy E.			The Effect of S-Adenosylmethionine on Cognitive Performance in Mice: An Animal Model Meta-Analysis	PLOS ONE			English	Article							N-ACETYL CYSTEINE; ALZHEIMERS-DISEASE; FOLIC-ACID; DIETARY SUPPLEMENTATION; ADENOSYL METHIONINE; LEVELS POTENTIATION; OXIDATIVE STRESS; FOLATE STATUS; HOMOCYSTEINE; DEFICIENCY	Background: Alzheimer's disease (AD) is the most frequently diagnosed form of dementia resulting in cognitive impairment. Many AD mouse studies, using the methyl donor S-adenosylmethionine (SAM), report improved cognitive ability, but conflicting results between and within studies currently exist. To address this, we conducted a meta-analysis to evaluate the effect of SAM on cognitive ability as measured by Y maze performance. As supporting evidence, we include further discussion of improvements in cognitive ability, by SAM, as measured by the Morris water maze (MWM). Methods: We conducted a comprehensive literature review up to April 2014 based on searches querying MEDLINE, EMBASE, Web of Science, the Cochrane Library and Proquest Theses and Dissertation databases. We identified three studies containing a total of 12 experiments that met our inclusion criteria and one study for qualitative review. The data from these studies were used to evaluate the effect of SAM on cognitive performance according to two scenarios: 1. SAM supplemented folate deficient (SFD) diet compared to a folate deficient (FD) diet and 2. SFD diet compared to a nutrient complete (NC) diet. Hedge's g was used to calculate effect sizes and mixed effects model meta-regression was used to evaluate moderating factors. Results: Our findings showed that the SFD diet was associated with improvements in cognitive performance. SFD diet mice also had superior cognitive performance compared to mice on an NC diet. Further to this, meta-regression analyses indicated a significant positive effect of study quality score and treatment duration on the effect size estimate for both the FD vs SFD analysis and the SFD vs NC analysis. Conclusion: The findings of this meta-analysis demonstrate efficacy of SAM in acting as a cognitive performance-enhancing agent. As a corollary, SAM may be useful in improving spatial memory in patients suffering from many dementia forms including AD.	[Montgomery, Sarah E.; Wangsgaard, John D.] Mt St Vincent Univ, Dept Appl Human Nutr, Halifax, NS B3M 2J6, Canada; [Sepehry, Amir A.] Univ British Columbia, Coll Interdisciplinary Studies, Grad Program Neurosci, Vancouver, BC V5Z 1M9, Canada; [Sepehry, Amir A.] Univ British Columbia, Dept Med, Div Neurol, Vancouver, BC V5Z 1M9, Canada; [Koenig, Jeremy E.] Dalhousie Univ, Fac Comp Sci, Halifax, NS, Canada	Mount Saint Vincent University; University of British Columbia; University of British Columbia; Dalhousie University	Montgomery, SE (corresponding author), Mt St Vincent Univ, Dept Appl Human Nutr, Halifax, NS B3M 2J6, Canada.	sarah.montgomery@msvu.ca	Sepehry, Amir Ali/AAH-6216-2019	Sepehry, Amir Ali/0000-0002-6055-4457	Mount Saint Vincent University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER	Mount Saint Vincent University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funding was provided by Mount Saint Vincent University (JK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres E, 2004, CAN MED ASSOC J, V171, P251, DOI 10.1503/cmaj.1031155; [Anonymous], 2012, NEW WAY LOOKING IMPA; Batsch N., 2012, WORLD ALZHEIMER REPO; Borenstein M., 2011, COMPREHENSIVE META A; BOTTIGLIERI T, 1990, J NEUROL NEUROSUR PS, V53, P1096, DOI 10.1136/jnnp.53.12.1096; Cavallaro RA, 2010, J ALZHEIMERS DIS, V20, P997, DOI 10.3233/JAD-2010-091666; Chan A, 2008, J NUTR HEALTH AGING, V12, P252, DOI 10.1007/BF02982630; Chan A, 2010, J NUTR HEALTH AGING, V14, P224, DOI 10.1007/s12603-010-0054-5; Chan A, 2009, J NEUROCHEM, V110, P831, DOI 10.1111/j.1471-4159.2009.06177.x; Chan A, 2009, J ALZHEIMERS DIS, V17, P483, DOI 10.3233/JAD-2009-1076; Coppede F, 2010, CURR GENOMICS, V11, P246, DOI 10.2174/138920210791233090; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Enquobahrie DA, 2012, PUBLIC HEALTH NUTR, V15, P1818, DOI 10.1017/S1368980012002984; Fuso A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.12.013; Graham NL, 2004, J NEUROL NEUROSUR PS, V75, P61; HEDGES LV, 1985, STAT METHODS METAANA, DOI [10.1016/C2009-0-03396-0, DOI 10.1016/C2009-0-03396-0]; Herrmann M, 2009, BONE, V44, P467, DOI 10.1016/j.bone.2008.10.051; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hooijmans C, 2011, LAB ANIM-UK, V45, P61, DOI 10.1258/la.2010.010130; Hooijmans CR, 2009, NEUROL SCI, V30, P439, DOI 10.1007/s10072-009-0110-2; Huang YD, 2011, BIOCHEM SOC T, V39, P924, DOI 10.1042/BST0390924; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1113/expphysiol.2010.053793, 10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Ordovas JM, 2010, NAT REV CARDIOL, V7, P510, DOI 10.1038/nrcardio.2010.104; Perel P, 2007, BMJ-BRIT MED J, V334, P197, DOI 10.1136/bmj.39048.407928.BE; Remington R, 2009, AM J ALZHEIMERS DIS, V24, P27, DOI 10.1177/1533317508325094; Rudolph ML, 2011, NEUROSCIENCE MED, V2, P222; Sener U, 2006, SEIZURE-EUR J EPILEP, V15, P79, DOI 10.1016/j.seizure.2005.11.002; Shea TB, 2007, NEUROMOL MED, V9, P264, DOI 10.1007/s12017-007-8005-y; Shuaibi AM, 2008, J AM DIET ASSOC, V108, P2090, DOI 10.1016/j.jada.2008.09.007; Stewart S, 2011, J ALZHEIMERS DIS, V26, P105, DOI 10.3233/JAD-2011-101827; Tchantchou F, 2004, NEUROMOL MED, V6, P93, DOI 10.1385/NMM:6:2-3:093; Thompson MA, 2009, J ALTERN COMPLEM MED, V15, P523, DOI 10.1089/acm.2008.0402; Veeranna V, 2011, J AM COLL CARDIOL, V58, P1025, DOI 10.1016/j.jacc.2011.05.028; Wani NA, 2008, IUBMB LIFE, V60, P834, DOI 10.1002/iub.133	35	22	23	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e107756	10.1371/journal.pone.0107756	http://dx.doi.org/10.1371/journal.pone.0107756			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347725	Green Published, Green Submitted, gold			2022-12-27	WOS:000347994900003
J	Murgan, S; Colabianchi, AMC; Monti, RJ; Lopez, LEB; Aguirre, CE; Stivala, EG; Carrasco, AE; Lopez, SL				Murgan, Sabrina; Castro Colabianchi, Aitana Manuela; Jose Monti, Renato; Boyadjian Lopez, Laura Elena; Aguirre, Cecilia E.; Gonzalez Stivala, Ernesto; Carrasco, Andres E.; Lopez, Silvia L.			FoxA4 Favours Notochord Formation by Inhibiting Contiguous Mesodermal Fates and Restricts Anterior Neural Development in Xenopus Embryos	PLOS ONE			English	Article							FORK-HEAD DOMAIN; FLOOR-PLATE; TRANSCRIPTION FACTORS; SPEMANN ORGANIZER; SONIC HEDGEHOG; CONVERGENT EXTENSION; LAEVIS EMBRYOS; RETINOIC ACID; HOMEOBOX GENE; BETA-CATENIN	In vertebrates, the embryonic dorsal midline is a crucial signalling centre that patterns the surrounding tissues during development. Members of the FoxA subfamily of transcription factors are expressed in the structures that compose this centre. Foxa2 is essential for dorsal midline development in mammals, since knock-out mouse embryos lack a definitive node, notochord and floor plate. The related gene foxA4 is only present in amphibians. Expression begins in the blastula - chordin and - noggin expressing centre (BCNE) and is later restricted to the dorsal midline derivatives of the Spemann's organiser. It was suggested that the early functions of mammalian foxa2 are carried out by foxA4 in frogs, but functional experiments were needed to test this hypothesis. Here, we show that some important dorsal midline functions of mammalian foxa2 are exerted by foxA4 in Xenopus. We provide new evidence that the latter prevents the respecification of dorsal midline precursors towards contiguous fates, inhibiting prechordal and paraxial mesoderm development in favour of the notochord. In addition, we show that foxA4 is required for the correct regionalisation and maintenance of the central nervous system. FoxA4 participates in constraining the prospective rostral forebrain territory during neural specification and is necessary for the correct segregation of the most anterior ectodermal derivatives, such as the cement gland and the pituitary anlagen. Moreover, the early expression of foxA4 in the BCNE (which contains precursors of the whole forebrain and most of the midbrain and hindbrain) is directly required to restrict anterior neural development.	[Murgan, Sabrina; Castro Colabianchi, Aitana Manuela; Jose Monti, Renato; Boyadjian Lopez, Laura Elena; Aguirre, Cecilia E.; Gonzalez Stivala, Ernesto; Carrasco, Andres E.; Lopez, Silvia L.] Univ Buenos Aires, Fac Med, Inst Biol Celular & Neurociencia, Lab Embriol Mol Prof Dr Andres E Carrasco, Buenos Aires, DF, Argentina	University of Buenos Aires	Lopez, SL (corresponding author), Univ Buenos Aires, Fac Med, Inst Biol Celular & Neurociencia, Lab Embriol Mol Prof Dr Andres E Carrasco, Buenos Aires, DF, Argentina.	slopez@fmed.uba.ar		Lopez, Silvia/0000-0002-3760-7549	Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 2005/6123, PIP 2012-2014/20110100508]; Universidad de Buenos Aires [M803/05]; Agencia Nacional de Promocion Cientifica y Tecnologica [BID PICT 2005/32024, BID PICT 2006/767, BID PICT 2011/1559, PME 2006/00319]	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This work was supported by grants from Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 2005/6123 and PIP 2012-2014/20110100508), Universidad de Buenos Aires (M803/05), and Agencia Nacional de Promocion Cientifica y Tecnologica (BID PICT 2005/32024, BID PICT 2006/767, BID PICT 2011/1559, and PME 2006/00319). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta H, 2011, DEVELOPMENT, V138, P2567, DOI 10.1242/dev.061143; ALTABA ARI, 1992, DEVELOPMENT, V116, P81; ALTABA ARI, 1993, P NATL ACAD SCI USA, V90, P8268, DOI 10.1073/pnas.90.17.8268; ALTABA ARI, 1993, MECH DEVELOP, V44, P91, DOI 10.1016/0925-4773(93)90060-B; Altaba ARI, 1998, DEVELOPMENT, V125, P2203; ANG SL, 1993, DEVELOPMENT, V119, P1301; ANG SL, 1994, CELL, V78, P561, DOI 10.1016/0092-8674(94)90522-3; Artinger M, 1997, MECH DEVELOP, V65, P187, DOI 10.1016/S0925-4773(97)00073-7; Benayoun BA, 2011, TRENDS GENET, V27, P224, DOI 10.1016/j.tig.2011.03.003; BLITZ IL, 1995, DEVELOPMENT, V121, P993; Britto J, 2002, NAT NEUROSCI, V5, P103, DOI 10.1038/nn797; Carron C, 2005, MECH DEVELOP, V122, P1234, DOI 10.1016/j.mod.2005.06.007; Charrier JB, 2005, INT J DEV BIOL, V49, P181, DOI 10.1387/ijdb.041962jc; Charrier JB, 2002, DEVELOPMENT, V129, P4785; Charrier JB, 2001, DEVELOPMENT, V128, P4011; Cleaver O, 2001, DEV BIOL, V234, P1, DOI 10.1006/dbio.2001.0214; Dal-Pra S, 2011, DEV BIOL, V350, P484, DOI 10.1016/j.ydbio.2010.12.018; DALE L, 1987, DEVELOPMENT, V99, P527; de-Leon SBT, 2011, DEV BIOL, V357, P21, DOI 10.1016/j.ydbio.2010.11.027; Dickinson A, 2007, SEMIN CELL DEV BIOL, V18, P525, DOI 10.1016/j.semcdb.2007.04.002; DIRKSEN ML, 1992, GENE DEV, V6, P599, DOI 10.1101/gad.6.4.599; EKKER SC, 1995, DEVELOPMENT, V121, P2337; Ermakova GV, 2007, DEV BIOL, V307, P483, DOI 10.1016/j.ydbio.2007.03.524; Ermakova GV, 1999, DEVELOPMENT, V126, P4513; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Franco PG, 1999, DEVELOPMENT, V126, P4257; GODSAVE S, 1994, DEV BIOL, V166, P465, DOI 10.1006/dbio.1994.1330; Hallonet M, 2002, DEV BIOL, V243, P20, DOI 10.1006/dbio.2001.0536; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; HEMMATIBRIVANLOU A, 1991, DEVELOPMENT, V111, P715; Hensey C, 1997, MECH DEVELOP, V69, P183, DOI 10.1016/S0925-4773(97)00191-3; Hogan KA, 2004, CURR TOP DEV BIOL, V62, P55; Holland LZ, 1999, CURR OPIN NEUROBIOL, V9, P596, DOI 10.1016/S0959-4388(99)00003-3; HOPWOOD ND, 1991, DEVELOPMENT, V111, P551; HOPWOOD ND, 1989, EMBO J, V8, P3409, DOI 10.1002/j.1460-2075.1989.tb08505.x; Ishibashi H, 2008, MECH DEVELOP, V125, P58, DOI 10.1016/j.mod.2007.10.005; Kablar B, 1996, MECH DEVELOP, V55, P145, DOI 10.1016/0925-4773(96)00497-2; Kaestner KH, 2000, GENE DEV, V14, P142; Kazanskaya OV, 1997, GENE, V200, P25, DOI 10.1016/S0378-1119(97)00326-0; Keller R, 2003, DIFFERENTIATION, V71, P171, DOI 10.1046/j.1432-0436.2003.710301.x; Keller R, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015007; Kimura-Yoshida C, 2007, P NATL ACAD SCI USA, V104, P5919, DOI 10.1073/pnas.0607779104; Kishi M, 2000, DEVELOPMENT, V127, P791; KNOCHEL S, 1992, MECH DEVELOP, V38, P157, DOI 10.1016/0925-4773(92)90007-7; Kuroda H, 2004, PLOS BIOL, V2, P623, DOI 10.1371/journal.pbio.0020092; Kwan KM, 2003, DEVELOPMENT, V130, P1961, DOI 10.1242/dev.00412; Latimer AJ, 2006, DEV BIOL, V298, P392, DOI 10.1016/j.ydbio.2006.05.039; Latinkic BV, 1999, DEVELOPMENT, V126, P1769; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; LOPEZ SL, 1992, MECH DEVELOP, V36, P153, DOI 10.1016/0925-4773(92)90066-S; Lopez SL, 2005, DEVELOPMENT, V132, P1035, DOI 10.1242/dev.01659; Luu O, 2008, DEV DYNAM, V237, P1307, DOI 10.1002/dvdy.21522; Martynova N, 2004, DEVELOPMENT, V131, P2329, DOI 10.1242/dev.01133; Mizuseki K, 1998, DEVELOPMENT, V125, P579; Monuki ES, 2007, J NEUROPATH EXP NEUR, V66, P566, DOI 10.1097/nen.0b013e3180986e1b; Morgan BA, 1996, P NATL ACAD SCI USA, V93, P2801, DOI 10.1073/pnas.93.7.2801; Muenke M, 2000, CURR OPIN GENET DEV, V10, P262, DOI 10.1016/S0959-437X(00)00084-8; Murato Y, 2007, DEV GENES EVOL, V217, P665, DOI 10.1007/s00427-007-0176-x; Nagatomo KI, 2007, DEV DYNAM, V236, P1475, DOI 10.1002/dvdy.21152; NIETO MA, 1991, DEVELOPMENT, P59; Norton WH, 2005, DEVELOPMENT, V132, P645, DOI 10.1242/dev.01611; Odenthal J, 1998, DEV GENES EVOL, V208, P245, DOI 10.1007/s004270050179; Pannese M, 1998, MECH DEVELOP, V73, P73, DOI 10.1016/S0925-4773(98)00034-3; PANNESE M, 1995, DEVELOPMENT, V121, P707; Papalopulu N, 1996, DEVELOPMENT, V122, P3409; Patten I, 2003, DEVELOPMENT, V130, P4809, DOI 10.1242/dev.00694; Pera EM, 2000, MECH DEVELOP, V96, P183, DOI 10.1016/S0925-4773(00)00394-4; Peres JN, 2006, MECH DEVELOP, V123, P321, DOI 10.1016/j.mod.2006.03.001; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Pizard A, 2004, CURR PROTOC MOL BIOL, V14, p14.9, DOI 10.1002/0471142727.mb1409-66; Pohl BS, 2005, GENE, V344, P21, DOI 10.1016/j.gene.2004.09.037; Reversade B, 2005, DEVELOPMENT, V132, P3381, DOI 10.1242/dev.01901; Revinski DR, 2010, DEV BIOL, V339, P477, DOI 10.1016/j.ydbio.2010.01.010; Saka Y, 2000, MECH DEVELOP, V93, P27, DOI 10.1016/S0925-4773(00)00260-4; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; SASAKI H, 1993, DEVELOPMENT, V118, P47; Schafer M, 2005, GENE DEV, V19, P897, DOI 10.1101/gad.336305; Sive H.L., 2000, EARLY DEV XENOPUS LA; SIVE HL, 1989, CELL, V58, P171, DOI 10.1016/0092-8674(89)90413-3; Strahle U, 2004, TRENDS GENET, V20, P155, DOI 10.1016/j.tig.2004.01.002; Tada M, 2000, DEVELOPMENT, V127, P2227; Teillet MA, 1998, P NATL ACAD SCI USA, V95, P11733, DOI 10.1073/pnas.95.20.11733; Theveneau E, 2011, GENESIS, V49, P164, DOI 10.1002/dvg.20700; Thibert C, 2003, SCIENCE, V301, P843, DOI 10.1126/science.1085405; Wallingford JB, 2001, DEVELOPMENT, V128, P2581; Wardle FC, 2002, DEVELOPMENT, V129, P4387; WEIGEL D, 1990, CELL, V63, P455, DOI 10.1016/0092-8674(90)90439-L; WEIGEL D, 1989, CELL, V57, P645, DOI 10.1016/0092-8674(89)90133-5; WEINSTEIN DC, 1994, CELL, V78, P575, DOI 10.1016/0092-8674(94)90523-1; Wessely O, 2004, DEV BIOL, V269, P552, DOI 10.1016/j.ydbio.2004.01.018; Wessely O, 2001, DEV BIOL, V234, P161, DOI 10.1006/dbio.2001.0258; Wijchers PJEC, 2006, BIOCHEM J, V397, P233, DOI 10.1042/BJ20060387; Wilson SW, 2004, DEV CELL, V6, P167, DOI 10.1016/S1534-5807(04)00027-9; Yamaguti M, 2005, DEV DYNAM, V234, P102, DOI 10.1002/dvdy.20523; Yang YP, 2006, DEV BIOL, V296, P458, DOI 10.1016/j.ydbio.2006.06.014; Yusuf F, 2006, ANAT EMBRYOL, V211, pS21, DOI 10.1007/s00429-006-0119-8; ZARAISKY AG, 1995, DEVELOPMENT, V121, P3839; Zhou XL, 2000, MECH DEVELOP, V91, P327, DOI 10.1016/S0925-4773(99)00270-1	98	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110559	10.1371/journal.pone.0110559	http://dx.doi.org/10.1371/journal.pone.0110559			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343614	Green Submitted, gold, Green Published			2022-12-27	WOS:000343943500036
J	Billis, K; Billini, M; Tripp, HJ; Kyrpides, NC; Mavromatis, K				Billis, Konstantinos; Billini, Maria; Tripp, H. James; Kyrpides, Nikos C.; Mavromatis, Konstantinos			Comparative Transcriptomics between Synechococcus PCC 7942 and Synechocystis PCC 6803 Provide Insights into Mechanisms of Stress Acclimation	PLOS ONE			English	Article							COMPARATIVE-ANALYSIS SYSTEM; SP STRAIN PCC-6803; BIOCONDUCTOR PACKAGE; ANTISENSE RNA; SALT STRESS; FRESH-WATER; EXPRESSION; GENE; PHOTOSYNTHESIS; ANTIPORTERS	Synechococcus sp. PCC 7942 and Synechocystis sp. PCC 6803 are model cyanobacteria from which the metabolism and adaptive responses of other cyanobacteria are inferred. Using stranded and 5' enriched libraries, we measured the gene expression response of cells transferred from reference conditions to stress conditions of decreased inorganic carbon, increased salinity, increased pH, and decreased illumination at 1-h and 24-h after transfer. We found that the specific responses of the two strains were by no means identical. Transcriptome profiles allowed us to improve the structural annotation of the genome i.e. identify possible missed genes (including anti-sense), alter gene coordinates and determine transcriptional units (operons). Finally, we predicted associations between proteins of unknown function and biochemical pathways by revealing proteins of known functions that are co-regulated with the unknowns. Future studies of these model organisms will benefit from the cataloging of their responses to environmentally relevant stresses, and improvements in their genome annotations found here.	[Billis, Konstantinos; Billini, Maria; Tripp, H. James; Kyrpides, Nikos C.; Mavromatis, Konstantinos] DOE Joint Genome Inst, Microbial Genome & Metagenome Program, Walnut Creek, CA USA; [Billini, Maria] Max Planck Inst Terr Microbiol, Grp Prokaryot Cell Biol, D-35043 Marburg, Germany; [Mavromatis, Konstantinos] Celgene Corp, Computat Biol Grp, San Francisco, CA USA; [Billis, Konstantinos] European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Cambridge, England; [Billis, Konstantinos] Aristotle Univ Thessaloniki, Dept Genet Dev & Mol Biol, GR-54006 Thessaloniki, Greece; [Kyrpides, Nikos C.] King Abdulaziz Univ, Fac Sci, Dept Biol Sci, Jeddah, Saudi Arabia; [Billini, Maria] Univ Marburg, Fac Biol, Marburg, Germany	United States Department of Energy (DOE); Max Planck Society; Bristol-Myers Squibb; Celgene Corporation; European Molecular Biology Laboratory (EMBL); Aristotle University of Thessaloniki; King Abdulaziz University; Philipps University Marburg	Billis, K (corresponding author), DOE Joint Genome Inst, Microbial Genome & Metagenome Program, Walnut Creek, CA USA.	kbillis@lbl.gov; kmavrommatis@lbl.gov	Billis, Konstantinos/ABE-6046-2021; Kyrpides, Nikos C./A-6305-2014	Billis, Konstantinos/0000-0001-8568-4306; Kyrpides, Nikos C./0000-0002-6131-0462; Mavrommatis, Konstantinos/0000-0003-4549-385X	Office of Science of the U. S. Department of Energy [DE-AC02-05CH11231]	Office of Science of the U. S. Department of Energy(United States Department of Energy (DOE))	The U.S. Department of Energy Joint Genome Institute is supported by the Office of Science of the U. S. Department of Energy under contract DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALGE D, 1994, GENE, V138, P127, DOI 10.1016/0378-1119(94)90794-3; ANDERSON SL, 1991, J BACTERIOL, V173, P2761, DOI 10.1128/JB.173.9.2761-2767.1991; Ardelean I, BIOENERGETIC PROCESS, P131; Billini M, 2008, J BACTERIOL, V190, P6318, DOI 10.1128/JB.00696-08; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Copeland A, 7942 PCC; Deshnium P, 1995, PLANT MOL BIOL, V29, P897, DOI 10.1007/BF00014964; Donlin Maureen J, 2007, Curr Protoc Bioinformatics, VChapter 9, DOI 10.1002/0471250953.bi0909s17; Duhring U, 2006, P NATL ACAD SCI USA, V103, P7054, DOI 10.1073/pnas.0600927103; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elanskaya IV, 2002, BIOCHEMISTRY-MOSCOW+, V67, P432, DOI 10.1023/A:1015281906254; Filiatrault MJ, CURRENT OPI IN PRESS; Georg J, 2011, MICROBIOL MOL BIOL R, V75, P286, DOI 10.1128/MMBR.00032-10; Haas BJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-734; Hess WR, 2011, CURR OPIN MICROBIOL, V14, P608, DOI 10.1016/j.mib.2011.07.024; Hovik H, 2012, J BACTERIOL, V194, P100, DOI 10.1128/JB.06385-11; Inaba M, 2001, J BACTERIOL, V183, P1376, DOI 10.1128/JB.183.4.1376-1384.2001; Kaneko T, 1996, DNA Res, V3, P109; Kanesaki Y, 2002, BIOCHEM BIOPH RES CO, V290, P339, DOI 10.1006/bbrc.2001.6201; KRATZ WA, 1955, PLANT PHYSIOL, V30, P275, DOI 10.1104/pp.30.3.275; Lasa I, 2011, P NATL ACAD SCI USA, V108, P20172, DOI 10.1073/pnas.1113521108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD560, DOI 10.1093/nar/gkt963; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P2124, DOI 10.1073/pnas.1015154108; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mulo P, 2009, CELL MOL LIFE SCI, V66, P3697, DOI 10.1007/s00018-009-0103-6; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; REED RH, 1985, MAR BIOL, V88, P1, DOI 10.1007/BF00393037; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sato N, 1997, J BACTERIOL, V179, P7063, DOI 10.1128/jb.179.22.7063-7071.1997; SCHOPF JW, 1993, SCIENCE, V260, P640, DOI 10.1126/science.260.5108.640; Schwarz D, 2011, PLANT PHYSIOL, V155, P1640, DOI 10.1104/pp.110.170225; Summerfield TC, 2008, APPL ENVIRON MICROB, V74, P5276, DOI 10.1128/AEM.00883-08; Vijayan V, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r47; Wang HL, 2002, MOL MICROBIOL, V44, P1493, DOI 10.1046/j.1365-2958.2002.02983.x; Wurtzel O, 2010, GENOME RES, V20, P133, DOI 10.1101/gr.100396.109; Yang SH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-336	39	31	33	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e109738	10.1371/journal.pone.0109738	http://dx.doi.org/10.1371/journal.pone.0109738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340743	Green Submitted, Green Published, gold			2022-12-27	WOS:000343662800015
J	Laulund, AS; Nybo, M; Brix, TH; Abrahamsen, B; Jorgensen, HL; Hegedus, L				Laulund, Anne Sofie; Nybo, Mads; Brix, Thomas Heiberg; Abrahamsen, Bo; Jorgensen, Henrik Lovendahl; Hegedus, Laszlo			Duration of Thyroid Dysfunction Correlates with All-Cause Mortality. The OPENTHYRO Register Cohort	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; POPULATION-BASED REGISTERS; AGED HOSPITALIZED-PATIENTS; FUNCTION TESTS; SUBCLINICAL HYPERTHYROIDISM; CARDIOVASCULAR EVENTS; EXCESS MORTALITY; CANCER-MORTALITY; ELDERLY-PEOPLE; GRAVES-DISEASE	Introduction and Aim: The association between thyroid dysfunction and mortality is controversial. Moreover, the impact of duration of thyroid dysfunction is unclarified. Our aim was to investigate the correlation between biochemically assessed thyroid function as well as dysfunction duration and mortality. Methods: Register-based follow-up study of 239,768 individuals with a serum TSH measurement from hospitals and/or general practice in Funen, Denmark. Measurements were performed at a single laboratory from January 1st 1995 to January 1st 2011. Cox regression was used for mortality analyses and Charlson Comorbidity Index (CCI) was used as comorbidity score. Results: Hazard ratios (HR) with 95% confidence intervals (CI) for mortality with decreased (<0.3 mIU/L) or elevated (>4.0 mIU/L) levels of TSH were 2.22; 2.14-2.30; P<0.0001 and 1.28; 1.22-1.35; P<0.0001, respectively. Adjusting for age, gender, CCI and diagnostic setting attenuated the risk estimates (HR 1.23; 95% CI: 1.19-1.28; P<0.0001, mean follow-up time 7.7 years, and HR 1.07; 95% CI: 1.02-1.13; P = 0.004, mean follow-up time 7.2 years) for decreased and elevated values of TSH, respectively. Mortality risk increased by a factor 1.09; 95% CI: 1.08-1.10; P<0.0001 or by a factor 1.03; 95% CI: 1.02-1.04; P<0.0001 for each six months a patient suffered from decreased or elevated TSH, respectively. Subdividing according to degree of thyroid dysfunction, overt hyperthyroidism (HRovert 1.12; 95% CI: 1.06-1.19; P<0.0001), subclinical hyperthyroidism (HRsubclinical 1.09; 95% CI: 1.02-1.17; P = 0.02) and overt hypothyroidism (HRovert 1.57; 95% CI: 1.34-1.83; P<0.0001), but not subclinical hypothyroidism (HRsubclinical 1.03; 95% CI: 0.97-1.09; P = 0.4) were associated with increased mortality. Conclusions and Relevance: In a large-scale, population-based cohort with long-term follow-up (median 7.4 years), overt and subclinical hyperthyroidism and overt but not subclinical hypothyroidism were associated with increased mortality. Excess mortality with increasing duration of decreased or elevated serum TSH suggests the importance of timely intervention in individuals with thyroid dysfunction.	[Laulund, Anne Sofie; Brix, Thomas Heiberg; Hegedus, Laszlo] Odense Univ Hosp, Dept Endocrinol & Metab, DK-5000 Odense, Denmark; [Nybo, Mads] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, DK-5000 Odense, Denmark; [Abrahamsen, Bo] Univ Southern Denmark, Odense Patient Data Explorat Network OPEN, Odense, Denmark; [Abrahamsen, Bo] Inst Clin Res, Odense, Denmark; [Abrahamsen, Bo] Glostrup Cty Hosp, Dept Med M, Res Ctr Ageing & Osteoporosis, Copenhagen, Denmark; [Jorgensen, Henrik Lovendahl] Bispebjerg Hosp, Dept Clin Biochem, DK-2400 Copenhagen, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital	Hegedus, L (corresponding author), Odense Univ Hosp, Dept Endocrinol & Metab, DK-5000 Odense, Denmark.	laszlo.hegedus@rsyd.dk	Jorgensen, Henrik/ABI-8236-2020; Nybo, Mads/J-6040-2019	Nybo, Mads/0000-0002-3029-2855; Jorgensen, Henrik Lovendahl/0000-0001-6374-761X; Abrahamsen, Bo/0000-0002-2730-6080	Novo Nordisk Foundation	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	The authors confirm that the study was funded by Novo Nordisk Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alevizaki M, 2006, CLIN ENDOCRINOL, V65, P369, DOI 10.1111/j.1365-2265.2006.02606.x; Bauer DC, 2007, AM J MED, V120, P343, DOI 10.1016/j.amjmed.2006.04.034; Biondi B, 2002, ANN INTERN MED, V137, P904, DOI 10.7326/0003-4819-137-11-200212030-00011; Biondi B, 2008, ENDOCR REV, V29, P76, DOI 10.1210/er.2006-0043; Biondi B, 2012, EUR J ENDOCRINOL, V167, P609, DOI 10.1530/EJE-12-0627; Brandt F, 2014, EUR J ENDOCRINOL, V170, P341, DOI 10.1530/EJE-13-0708; Brandt F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066711; Brandt F, 2013, THYROID, V23, P408, DOI 10.1089/thy.2012.0500; Brandt F, 2012, J CLIN ENDOCR METAB, V97, P4123, DOI 10.1210/jc.2012-2268; Brandt F, 2011, EUR J ENDOCRINOL, V165, P491, DOI 10.1530/EJE-11-0299; Brix TH, 2000, ARCH INTERN MED, V160, P661, DOI 10.1001/archinte.160.5.661; Brown-Borg HM, 2007, AGEING RES REV, V6, P28, DOI 10.1016/j.arr.2007.02.005; Cappola AR, 2006, JAMA-J AM MED ASSOC, V295, P1033, DOI 10.1001/jama.295.9.1033; Ceresini G, 2009, J AM GERIATR SOC, V57, P89, DOI 10.1111/j.1532-5415.2008.02080.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Coceani M, 2009, CLIN CARDIOL, V32, P380, DOI 10.1002/clc.20574; Collet TH, 2012, ARCH INTERN MED, V172, P799, DOI 10.1001/archinternmed.2012.402; Flynn RWV, 2006, J CLIN ENDOCR METAB, V91, P2159, DOI 10.1210/jc.2005-1833; Franklyn JA, 1998, NEW ENGL J MED, V338, P712, DOI 10.1056/NEJM199803123381103; Franklyn JA, 1999, J ROY COLL PHYS LOND, V33, P564; GOLDMAN MB, 1990, CANCER RES, V50, P2283; Gussekloo J, 2004, JAMA-J AM MED ASSOC, V292, P2591, DOI 10.1001/jama.292.21.2591; Haentjens P, 2008, EUR J ENDOCRINOL, V159, P329, DOI 10.1530/EJE-08-0110; HALL P, 1993, ACTA ENDOCRINOL-COP, V128, P230, DOI 10.1530/acta.0.1280230; HEGEDUS L, 1988, METABOLISM, V37, P229, DOI 10.1016/0026-0495(88)90100-X; Iglesias P, 2009, CLIN ENDOCRINOL, V70, P961, DOI 10.1111/j.1365-2265.2008.03421.x; Iglesias P, 2013, J CLIN ENDOCR METAB, V98, P4683, DOI 10.1210/jc.2012-3849; Jensen E, 2004, CLIN CHEM LAB MED, V42, P824, DOI 10.1515/CCLM.2004.136; Johannesdottir Sigrun Alba, 2012, Clin Epidemiol, V4, P303, DOI 10.2147/CLEP.S37587; Klein I, 2007, CIRCULATION, V116, P1725, DOI 10.1161/CIRCULATIONAHA.106.678326; LAURBERG P, 1991, J INTERN MED, V229, P415, DOI 10.1111/j.1365-2796.1991.tb00368.x; Laurberg P, 2010, BEST PRACT RES CL EN, V24, P13, DOI 10.1016/j.beem.2009.08.013; MALDONADO LS, 1992, THYROID, V2, P119, DOI 10.1089/thy.1992.2.119; McGue M, 2010, PERSPECT PSYCHOL SCI, V5, P546, DOI 10.1177/1745691610383511; McQuade C, 2011, THYROID, V21, P837, DOI 10.1089/thy.2010.0298; Metso S, 2007, J CLIN ENDOCR METAB, V92, P2190, DOI 10.1210/jc.2006-2321; Milla CE, 2012, PAEDIATR RESPIR REV, V13, P23, DOI 10.1016/j.prrv.2011.01.004; Mingote E, 2012, HORM-INT J ENDOCRINO, V11, P350, DOI 10.14310/horm.2002.1364; Nyirenda MJ, 2005, THYROID, V15, P718, DOI 10.1089/thy.2005.15.718; Ochs N, 2008, ANN INTERN MED, V148, P832, DOI 10.7326/0003-4819-148-11-200806030-00225; Osman F, 2007, J AM COLL CARDIOL, V49, P71, DOI 10.1016/j.jacc.2006.08.042; Osman Faizel, 2001, Current Opinion in Pharmacology, V1, P626, DOI 10.1016/S1471-4892(01)00107-2; Parle JV, 2001, LANCET, V358, P861, DOI 10.1016/S0140-6736(01)06067-6; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; PETERSEN K, 1990, ARCH INTERN MED, V150, P2077, DOI 10.1001/archinte.150.10.2077; Radacsi A, 2003, ENDOCRINE, V21, P133, DOI 10.1385/ENDO:21:2:133; Rodondi N, 2005, ARCH INTERN MED, V165, P2460, DOI 10.1001/archinte.165.21.2460; Singh S, 2008, INT J CARDIOL, V125, P41, DOI 10.1016/j.ijcard.2007.02.027; SLAG MF, 1981, JAMA-J AM MED ASSOC, V245, P43, DOI 10.1001/jama.245.1.43; Solanki A., 2013, INDIAN J ENDOCRINOL, V17, pS167, DOI [DOI 10.4103/2230-8210.119560, 10.4103/2230-8210.119560]; Sortso C, 2011, SCAND J PUBLIC HEALT, V39, P17, DOI 10.1177/1403494811399171; Stoving RK, 2001, INT J EAT DISORDER, V29, P230; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; Thvilum M, 2014, THYROID IN PRESS; Thvilum M, 2013, J CLIN ENDOCR METAB, V98, P1069, DOI 10.1210/jc.2012-3375; Thvilum M, 2012, NAT REV ENDOCRINOL, V8, P417, DOI 10.1038/nrendo.2012.29; Thygesen LC, 2011, SCAND J PUBLIC HEALT, V39, P8, DOI 10.1177/1403494811409654; Thygesen LC, 2011, SCAND J PUBLIC HEALT, V39, P12, DOI 10.1177/1403494811399956; van den Beld AW, 2005, J CLIN ENDOCR METAB, V90, P6403, DOI 10.1210/jc.2005-0872; Vanderpump MPJ, 1996, THYROID, V6, P155; Volzke H, 2007, J CLIN ENDOCR METAB, V92, P2421, DOI 10.1210/jc.2007-0179; Yang LB, 2012, EUR J ENDOCRINOL, V167, P75, DOI 10.1530/EJE-12-0015	62	43	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110437	10.1371/journal.pone.0110437	http://dx.doi.org/10.1371/journal.pone.0110437			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340819	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662800036
J	Pachulec, E; Siewering, K; Bender, T; Heller, EM; Salgado-Pabon, W; Schmoller, SK; Woodhams, KL; Dillard, JP; van der Does, C				Pachulec, Emilia; Siewering, Katja; Bender, Tobias; Heller, Eva-Maria; Salgado-Pabon, Wilmara; Schmoller, Shelly K.; Woodhams, Katelynn L.; Dillard, Joseph P.; van der Does, Chris			Functional Analysis of the Gonococcal Genetic Island of Neisseria gonorrhoeae	PLOS ONE			English	Article							IV SECRETION SYSTEM; T-PILUS BIOGENESIS; CHROMOSOMAL DNA; SUBSTRATE SELECTION; PROTEIN; MENINGITIDIS; MUTAGENESIS; DIVERSITY; HOMOLOG; VIRB9	Neisseria gonorrhoeae is an obligate human pathogen that is responsible for the sexually-transmitted disease gonorrhea. N. gonorrhoeae encodes a T4SS within the Gonococcal Genetic Island (GGI), which secretes ssDNA directly into the external milieu. Type IV secretion systems (T4SSs) play a role in horizontal gene transfer and delivery of effector molecules into target cells. We demonstrate that GGI-like T4SSs are present in other beta-proteobacteria, as well as in alpha- and gamma-proteobacteria. Sequence comparison of GGI-like T4SSs reveals that the GGI-like T4SSs form a highly conserved unit that can be found located both on chromosomes and on plasmids. To better understand the mechanism of DNA secretion by N. gonorrhoeae, we performed mutagenesis of all genes encoded within the GGI, and studied the effects of these mutations on DNA secretion. We show that genes required for DNA secretion are encoded within the yaa-atlA and parA-parB regions, while genes encoded in the yfeB-exp1 region could be deleted without any effect on DNA secretion. Genes essential for DNA secretion are encoded within at least four different operons.	[Pachulec, Emilia] Univ Groningen, Dept Microbiol, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands; [Siewering, Katja; Bender, Tobias; Heller, Eva-Maria; van der Does, Chris] Max Planck Inst Terr Microbiol, Dept Ecophysiol, D-35043 Marburg, Germany; [Salgado-Pabon, Wilmara; Schmoller, Shelly K.; Woodhams, Katelynn L.; Dillard, Joseph P.] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA	University of Groningen; Max Planck Society; University of Wisconsin System; University of Wisconsin Madison	van der Does, C (corresponding author), Max Planck Inst Terr Microbiol, Dept Ecophysiol, D-35043 Marburg, Germany.	does@mpi-marburg.mpg.de	Salgado-Pabon, Wilmara/N-9443-2018	Salgado-Pabon, Wilmara/0000-0003-0854-1568	University of Groningen; Max Planck Institute; US National Institutes of Health [AI047958]; NIH [T32 AI055397]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055397, R01AI047958] Funding Source: NIH RePORTER	University of Groningen; Max Planck Institute(Max Planck Society); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Work in the van der Does lab was funded by intramural funds of the University of Groningen and the Max Planck Institute. Work in the Dillard lab was supported by US National Institutes of Health grant AI047958 to JPD. WSP was also supported by a traineeship on NIH grant T32 AI055397. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atmakuri K, 2007, EMBO J, V26, P2540, DOI 10.1038/sj.emboj.7601696; Bhatty M, 2013, RES MICROBIOL, V164, P620, DOI 10.1016/j.resmic.2013.03.012; Bignell C, 2001, J BIOTECHNOL, V91, P1, DOI 10.1016/S0168-1656(01)00293-0; BOYLEVAVRA S, 1995, GENE, V155, P101, DOI 10.1016/0378-1119(94)00890-5; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; Clavel T, 1998, MOL MICROBIOL, V29, P359, DOI 10.1046/j.1365-2958.1998.00945.x; Dillard J. P., 2006, CURR PROTOC MICROBIO, V2; Dillard JP, 2001, MOL MICROBIOL, V41, P263, DOI 10.1046/j.1365-2958.2001.02520.x; Dominguez NM, 2011, J BACTERIOL, V193, P377, DOI 10.1128/JB.00948-10; Fronzes R, 2009, NAT REV MICROBIOL, V7, P703, DOI 10.1038/nrmicro2218; Garcillan-Barcia MP, 2009, FEMS MICROBIOL REV, V33, P657, DOI 10.1111/j.1574-6976.2009.00168.x; Guglielmini J, 2013, MOL BIOL EVOL, V30, P315, DOI 10.1093/molbev/mss221; Guglielmini J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002222; Hamilton HL, 2005, MOL MICROBIOL, V55, P1704, DOI 10.1111/j.1365-2958.2005.04521.x; Hamilton HL, 2001, J BACTERIOL, V183, P4718, DOI 10.1128/JB.183.16.4718-4726.2001; Jain S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035285; Jain S, 2011, J BIOL CHEM, V286, P43601, DOI 10.1074/jbc.M111.264028; Jakubowski SJ, 2009, MOL MICROBIOL, V71, P779, DOI 10.1111/j.1365-2958.2008.06565.x; Jakubowski SJ, 2005, J BACTERIOL, V187, P3486, DOI 10.1128/JB.187.10.3486-3495.2005; Jakubowski SJ, 2003, J BACTERIOL, V185, P2867, DOI 10.1128/JB.185.9.2867-2878.2003; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; Kohler PL, 2007, J BACTERIOL, V189, P5421, DOI 10.1128/JB.00531-07; Kohler PL, 2013, J BACTERIOL, V195, P1666, DOI 10.1128/JB.02098-12; MORSE SA, 1974, P SOC EXP BIOL MED, V145, P1418; Ramsey ME, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00061; Sagulenko E, 2001, J BACTERIOL, V183, P5813, DOI 10.1128/JB.183.20.5813-5825.2001; Salgado-Pabon W, 1912, J BACTERIOL, V192; Salgado-Pabon W, 2007, MOL MICROBIOL, V66, P930, DOI 10.1111/j.1365-2958.2007.05966.x; Salgado-Pabon W, 2010, J BACTERIOL, V192, P1912, DOI 10.1128/JB.01357-09; Snyder LAS, 2005, MICROBIOL-SGM, V151, P4005, DOI 10.1099/mic.0.27925-0; Wade JJ, 2007, FEMS MICROBIOL LETT, V273, P35, DOI 10.1111/j.1574-6968.2007.00776.x; Waksman G, 2010, TRENDS BIOCHEM SCI, V35, P691, DOI 10.1016/j.tibs.2010.06.002; Wallden K, 2010, CELL MICROBIOL, V12, P1203, DOI 10.1111/j.1462-5822.2010.01499.x; WEISS AA, 1993, P NATL ACAD SCI USA, V90, P2970, DOI 10.1073/pnas.90.7.2970; Woodhams KL, 2012, J BACTERIOL, V194, P2275, DOI 10.1128/JB.00094-12; Wozniak RAF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000786; Zechner EL, 2012, PHILOS T R SOC B, V367, P1073, DOI 10.1098/rstb.2011.0207; Zola TA, 2010, INFECT IMMUN, V78, P2429, DOI 10.1128/IAI.00228-10; Zweig MA, 2013, ENV MICROBIOL	39	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e109613	10.1371/journal.pone.0109613	http://dx.doi.org/10.1371/journal.pone.0109613			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340397	Green Submitted, gold, Green Published			2022-12-27	WOS:000343662800011
J	Padial, AA; Ceschin, F; Declerck, SAJ; De Meester, L; Bonecker, CC; Lansac-Toha, FA; Rodrigues, L; Rodrigues, LC; Train, S; Velho, LFM; Bini, LM				Padial, Andre A.; Ceschin, Fernanda; Declerck, Steven A. J.; De Meester, Luc; Bonecker, Claudia C.; Lansac-Toha, Fabio A.; Rodrigues, Liliana; Rodrigues, Luzia C.; Train, Sueli; Velho, Luiz F. M.; Bini, Luis M.			Dispersal Ability Determines the Role of Environmental, Spatial and Temporal Drivers of Metacommunity Structure	PLOS ONE			English	Article							RELATIVE IMPORTANCE; STREAM NETWORKS; BETA-DIVERSITY; AUTOCORRELATION; LIMITATION; TRAITS; RIVER; COMMUNITIES; ASSEMBLAGES; INCREASES	Recently, community ecologists are focusing on the relative importance of local environmental factors and proxies to dispersal limitation to explain spatial variation in community structure. Albeit less explored, temporal processes may also be important in explaining species composition variation in metacommunities occupying dynamic systems. We aimed to evaluate the relative role of environmental, spatial and temporal variables on the metacommunity structure of different organism groups in the Upper Parana River floodplain (Brazil). We used data on macrophytes, fish, benthic macroinvertebrates, zooplankton, periphyton, and phytoplankton collected in up to 36 habitats during a total of eight sampling campaigns over two years. According to variation partitioning results, the importance of predictors varied among biological groups. Spatial predictors were particularly important for organisms with comparatively lower dispersal ability, such as aquatic macrophytes and fish. On the other hand, environmental predictors were particularly important for organisms with high dispersal ability, such as microalgae, indicating the importance of species sorting processes in shaping the community structure of these organisms. The importance of watercourse distances increased when spatial variables were the main predictors of metacommunity structure. The contribution of temporal predictors was low. Our results emphasize the strength of a trait-based analysis and of better defining spatial variables. More importantly, they supported the view that "all-or- nothing" interpretations on the mechanisms structuring metacommunities are rather the exception than the rule.	[Padial, Andre A.] Univ Fed Parana, Dept Bot, BR-80060000 Curitiba, Parana, Brazil; [Padial, Andre A.; Ceschin, Fernanda] Univ Fed Parana, Programa Posgrad Ecol & Conservacao, BR-80060000 Curitiba, Parana, Brazil; [Declerck, Steven A. J.] Netherlands Inst Ecol NIOO KNAW, Dept Aquat Ecol, Wageningen, Netherlands; [De Meester, Luc] Univ Leuven, KU Leuven, Lab Aquat Ecol Evolut & Conservat, Leuven, Belgium; [Bonecker, Claudia C.; Lansac-Toha, Fabio A.; Rodrigues, Liliana; Rodrigues, Luzia C.; Train, Sueli; Velho, Luiz F. M.] Univ Estadual Maringa, Nucleo Pesquisa Limnol Ictiol & Aquicultura Nupel, Maringa, Parana, Brazil; [Bini, Luis M.] Univ Fed Goias, Dept Ecol, Goiania, Go, Brazil	Universidade Federal do Parana; Universidade Federal do Parana; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); KU Leuven; Universidade Estadual de Maringa; Universidade Federal de Goias	Padial, AA (corresponding author), Univ Fed Parana, Dept Bot, BR-80060000 Curitiba, Parana, Brazil.	aapadial@gmail.com	Bonecker, Claudia C/D-5946-2013; Rodrigues, Luzia C/B-7856-2017; Padial, Andre Andrian/H-8977-2012; De Meester, Luc/F-3832-2015; Lansac-Toha, Fábio A/I-3556-2016; Velho, Luiz Felipe Machado/I-9130-2016; Rodrigues, Luzia/AAB-2194-2021; Bini, Luis Mauricio/D-5865-2013; Declerck, Steven/E-4338-2010; KNAW, NIOO-KNAW/A-4320-2012	Bonecker, Claudia C/0000-0003-4338-9012; Rodrigues, Luzia C/0000-0002-0593-0931; Padial, Andre Andrian/0000-0002-8766-5974; De Meester, Luc/0000-0001-5433-6843; Velho, Luiz Felipe Machado/0000-0001-8111-4955; Rodrigues, Luzia/0000-0002-0593-0931; Bini, Luis Mauricio/0000-0003-3398-9399; Declerck, Steven/0000-0001-6179-667X; KNAW, NIOO-KNAW/0000-0002-3835-159X	CNPq; CAPES; KU Leuven [PF/2010/07]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); KU Leuven(KU Leuven)	CNPq (http://www.cnpq.br/) and CAPES (http://www.capes.gov.br/) provided scholarships. KU Leuven (http://www.kuleuven.be/) provided research fund grant PF/2010/07. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinho AA, 2004, REV FISH BIOL FISHER, V14, P11, DOI 10.1007/s11160-004-3551-y; Anderson MJ, 1998, AUST J ECOL, V23, P158, DOI 10.1111/j.1442-9993.1998.tb00713.x; Beisner BE, 2006, ECOLOGY, V87, P2985, DOI 10.1890/0012-9658(2006)87[2985:TROEAS]2.0.CO;2; Bellier E, 2013, ECOGRAPHY, V36; Bengtsson J, 1997, OIKOS, V78, P249, DOI 10.2307/3546291; Bini LM, 2014, ECOLOGY, V95, P1569, DOI 10.1890/13-0656.1; Bivand R., 2017, SPDEP SPATIAL DEPEND; Blanchet FG, 2008, ECOL MODEL, V215, P325, DOI 10.1016/j.ecolmodel.2008.04.001; Chang LW, 2013, ECOLOGY, V94, P2145, DOI 10.1890/12-2053.1; Chase JM, 2005, FUNCT ECOL, V19, P182, DOI 10.1111/j.0269-8463.2005.00937.x; Chase JM, 2010, SCIENCE, V328, P1388, DOI 10.1126/science.1187820; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; De Bie T, 2012, ECOL LETT, V15, P740, DOI 10.1111/j.1461-0248.2012.01794.x; Diniz JAF, 2012, OIKOS, V121, P201, DOI 10.1111/j.1600-0706.2011.19563.x; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Farjalla VF, 2012, ECOLOGY, V93, P1752, DOI 10.1890/11-1144.1; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Gronroos M, 2013, ECOL EVOL, V3, P4473, DOI 10.1002/ece3.834; Hajek M, 2011, J BIOGEOGR, V38, P1683, DOI 10.1111/j.1365-2699.2011.02503.x; Heino J, 2008, ECOL ENTOMOL, V33, P614, DOI 10.1111/j.1365-2311.2008.01012.x; Heino J, 2013, OECOLOGIA, V171, P971, DOI 10.1007/s00442-012-2451-4; Hubbell Stephen P., 2001, V32, pi; Jellyman PG, 2013, FRESHWATER BIOL, V58, P2614, DOI 10.1111/fwb.12238; Junk WJ, 1989, CANADIAN SPECIAL PUB, V106, P110, DOI DOI 10.1016/J.MATCHEMPHYS.2012.10.032; Landeiro VL, 2011, FRESHWATER BIOL, V56, P1184, DOI 10.1111/j.1365-2427.2010.02563.x; Landeiro VL, 2012, FRESHWATER BIOL, V57, P1554, DOI 10.1111/j.1365-2427.2012.02816.x; Langenheder S, 2012, ISME J, V6, P1107, DOI 10.1038/ismej.2011.177; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P, 2010, ECOLOGY, V91, P262, DOI 10.1890/09-0199.1; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Liu J, 2013, J BIOGEOGR, V40, P2238, DOI 10.1111/jbi.12160; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Padial AA, 2012, ECOL INDIC, V13, P55, DOI 10.1016/j.ecolind.2011.05.007; Padial AA, 2009, AQUAT SCI, V71, P389, DOI 10.1007/s00027-009-0109-z; Pavanelli CS., 2007, PEIXES PLANICIE INUN; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Peres-Neto PR, 2010, GLOBAL ECOL BIOGEOGR, V19, P174, DOI 10.1111/j.1466-8238.2009.00506.x; Peterson EE, 2006, ENVIRON MONIT ASSESS, V121, P615, DOI 10.1007/s10661-005-9163-8; R Core Team, 2021, R LANGUAGE ENV STAT; Roach KA, 2014, FRESHWATER BIOL, V59, P1278, DOI 10.1111/fwb.12347; Rouquette JR, 2013, DIVERS DISTRIB, V19, P1429, DOI 10.1111/ddi.12120; Shurin JB, 2009, OECOLOGIA, V159, P151, DOI 10.1007/s00442-008-1174-z; Stendera S, 2012, HYDROBIOLOGIA, V696, P1, DOI 10.1007/s10750-012-1183-0; Thomaz SM, 2007, HYDROBIOLOGIA, V579, P1, DOI 10.1007/s10750-006-0285-y; Thomaz SM, 2004, BIO INL WAT, P75; Thompson R, 2006, J ANIM ECOL, V75, P476, DOI 10.1111/j.1365-2656.2006.01068.x; Van der Gucht K, 2007, P NATL ACAD SCI USA, V104, P20404, DOI 10.1073/pnas.0707200104; Vanormelingen P, 2008, FRESHWATER BIOL, V53, P2170, DOI 10.1111/j.1365-2427.2008.02040.x; Wagner H., 2013, PACKAGE VEGAN COMMUN, V2, P1; Wetzel CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045071	50	184	193	5	144	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111227	10.1371/journal.pone.0111227	http://dx.doi.org/10.1371/journal.pone.0111227			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340577	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662800094
J	Poddighe, S; De Rose, F; Marotta, R; Ruffilli, R; Fanti, M; Secci, PP; Mostallino, MC; Setzu, MD; Zuncheddu, MA; Collu, I; Solla, P; Marrosu, F; Kasture, S; Acquas, E; Liscia, A				Poddighe, Simone; De Rose, Francescaelena; Marotta, Roberto; Ruffilli, Roberta; Fanti, Maura; Secci, Pietro Paolo; Mostallino, Maria Cristina; Setzu, Maria Dolores; Zuncheddu, Maria Antonietta; Collu, Ignazio; Solla, Paolo; Marrosu, Francesco; Kasture, Sanjay; Acquas, Elio; Liscia, Anna			Mucuna pruriens (Velvet bean) Rescues Motor, Olfactory, Mitochondrial and Synaptic Impairment in PINK1(B9) Drosophila melanogaster Genetic Model of Parkinson's Disease (Publication with Expression of Concern. See vol. 15, 2020)	PLOS ONE			English	Article; Publication with Expression of Concern							ANTIPARKINSON DRUG; DYSFUNCTION; NEURODEGENERATION; PATHOLOGY; DOPAMINE; EXTRACT; FRUIT	The fruit fly Drosophila melanogaster (Dm) mutant for PTEN-induced putative kinase 1 (PINK1(B9)) gene is a powerful tool to investigate physiopathology of Parkinson's disease (PD). Using PINK1(B9) mutant Dm we sought to explore the effects of Mucuna pruriens methanolic extract (Mpe), a L-Dopa-containing herbal remedy of PD. The effects of Mpe on PINK1(B9) mutants, supplied with standard diet to larvae and adults, were assayed on 3-6 (I), 10-15 (II) and 20-25 (III) days old flies. Mpe 0.1% significantly extended lifespan of PINK1(B9) and fully rescued olfactory response to 1-hexanol and improved climbing behavior of PINK1(B9) of all ages; in contrast, L-Dopa (0.01%, percentage at which it is present in Mpe 0.1%) ameliorated climbing of only PINK1(B9) flies of age step II. Transmission electron microscopy analysis of antennal lobes and thoracic ganglia of PINK1(B9) revealed that Mpe restored to wild type (WT) levels both T-bars and damaged mitochondria. Western blot analysis of whole brain showed that Mpe, but not L-Dopa on its own, restored bruchpilot (BRP) and tyrosine hydroxylase (TH) expression to age-matched WT control levels. These results highlight multiple sites of action of Mpe, suggesting that its effects cannot only depend upon its L-Dopa content and support the clinical observation of Mpe as an effective medication with intrinsic ability of delaying the onset of chronic L-Dopa-induced long-term motor complications. Overall, this study strengthens the relevance of using PINK1(B9) Dm as a translational model to study the properties of Mucuna pruriens for PD treatment.	[Poddighe, Simone; Fanti, Maura; Setzu, Maria Dolores] Univ Cagliari, Dept Biomed Sci, Cagliari, Italy; [De Rose, Francescaelena; Zuncheddu, Maria Antonietta; Collu, Ignazio; Acquas, Elio; Liscia, Anna] Univ Cagliari, Dept Life & Environm Sci, Cagliari, Italy; [Marotta, Roberto; Ruffilli, Roberta] Ist Italiano Tecnol, Nanochem Dept, Electron Microscopy Lab, Genoa, Italy; [Secci, Pietro Paolo; Mostallino, Maria Cristina] CNR, Inst Neurosci, Cagliari, Italy; [Solla, Paolo; Marrosu, Francesco] Univ Cagliari, Dept Publ Hlth Clin & Mol Med, Cagliari, Italy; [Kasture, Sanjay] Sanjivani Coll Pharmaceut Educ & Res, Ahmednagar, Maharashtra, India; [Acquas, Elio] Univ Cagliari, Ctr Excellence Study Neurobiol Addict, Cagliari, Italy; [Acquas, Elio] Univ Cagliari, Natl Inst Neurosci INN, Cagliari, Italy	University of Cagliari; University of Cagliari; Istituto Italiano di Tecnologia - IIT; Consiglio Nazionale delle Ricerche (CNR); University of Cagliari; University of Cagliari; University of Cagliari	Liscia, A (corresponding author), Univ Cagliari, Dept Life & Environm Sci, Cagliari, Italy.	liscia@unica.it	Marotta, Roberto/B-5382-2014; Solla, Paolo/R-5366-2016; Marotta, Roberto/HGV-1599-2022; Solla, Paolo/GQZ-7556-2022; Solla, Paolo/AAL-9671-2020	Solla, Paolo/0000-0002-2982-0665; Marotta, Roberto/0000-0003-0634-5483; Poddighe, Simone/0000-0002-7244-9240; Liscia, Anna/0000-0002-1629-2090; Acquas, Elio/0000-0002-4783-9319; Setzu, Maria Dolores/0000-0002-6934-4042				Bjorklund A, 2010, PROG BRAIN RES, V184, P3, DOI 10.1016/S0079-6123(10)84001-4; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brooks David J, 2008, Neuropsychiatr Dis Treat, V4, P39; Celotto AM, 2005, MOL INTERV, V5, P292, DOI 10.1124/mi.5.5.9; Chambers RP, 2013, BEHAV BRAIN RES, V253, P95, DOI 10.1016/j.bbr.2013.07.020; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Coulom H, 2004, J NEUROSCI, V24, P10993, DOI 10.1523/JNEUROSCI.2993-04.2004; Dekker T, 2006, CURR BIOL, V16, P101, DOI 10.1016/j.cub.2005.11.075; Dhanasekaran M, 2008, PHYTOTHER RES, V22, P6, DOI 10.1002/ptr.2109; Ferraris A, 2009, MOVEMENT DISORD, V24, P2350, DOI 10.1002/mds.22816; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Fox SH, 2013, DRUGS, V73, P1405, DOI 10.1007/s40265-013-0105-4; Gil S, 2010, CELL MOL NEUROBIOL, V30, P817, DOI 10.1007/s10571-010-9509-9; Haehner A, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/450939; Humphrey DM, 2012, HUM MOL GENET, V21, P2698, DOI 10.1093/hmg/dds096; Kasture S, 2013, ORIENTAL PHARM EXP M, V13, P165, DOI 10.1007/s13596-013-0126-2; Katzenschlager R, 2004, J NEUROL NEUROSUR PS, V75, P1672, DOI 10.1136/jnnp.2003.028761; Katzenschlager R, 2004, CURR OPIN NEUROL, V17, P417, DOI 10.1097/01.wco.0000137531.76491.c2; Katzenschlager Regina, 2002, J Neurol, V249 Suppl 2, pII19; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Knott A, 2009, ANN NY ACAD SCI, V1147, P283; Lieu CA, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/840247; Lieu CA, 2010, PARKINSONISM RELAT D, V16, P458, DOI 10.1016/j.parkreldis.2010.04.015; Liu Z, 2008, P NATL ACAD SCI USA, V105, P2693, DOI 10.1073/pnas.0708452105; Liu ZH, 2011, PHARMACOL RES, V63, P439, DOI 10.1016/j.phrs.2011.01.004; Manyam BV, 2004, PHYTOTHER RES, V18, P706, DOI 10.1002/ptr.1514; Mercuri NB, 2005, TRENDS PHARMACOL SCI, V26, P341, DOI 10.1016/j.tips.2005.05.002; Moisoi N, 2014, NEUROPHARMACOLOGY, V77, P350, DOI 10.1016/j.neuropharm.2013.10.009; Monastirioti M, 1999, MICROSC RES TECHNIQ, V45, P106, DOI 10.1002/(SICI)1097-0029(19990415)45:2<106::AID-JEMT5>3.3.CO;2-V; Morais VA, 2009, EMBO MOL MED, V1, P99, DOI 10.1002/emmm.200900006; Morelli Micaela, 2009, Handb Exp Pharmacol, P589, DOI 10.1007/978-3-540-89615-9_18; Obata T, 2001, BRAIN RES, V906, P170, DOI 10.1016/S0006-8993(01)02238-7; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Poddighe S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073156; Porras G, 2014, SCI REP-UK, V4, DOI 10.1038/srep03730; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Sharot T, 2009, CURR BIOL, V19, P2077, DOI 10.1016/j.cub.2009.10.025; Takao-Rikitsu E, 2004, J CELL BIOL, V164, P301, DOI 10.1083/jcb.200307101; Tufi R, 2014, NAT CELL BIOL, V16, P157, DOI 10.1038/ncb2901; Wagh DA, 2006, BRUCHPILOT PROTEIN; Wang J, 2011, AM J NEURORADIOL, V32, P677, DOI 10.3174/ajnr.A2350; Yadav SK, 2014, NEUROCHEM INT, V65, P1, DOI 10.1016/j.neuint.2013.12.001; Yadav SK, 2013, NEUROCHEM INT, V62, P1039, DOI 10.1016/j.neuint.2013.03.015; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Yellman C, 1997, P NATL ACAD SCI USA, V94, P4131, DOI 10.1073/pnas.94.8.4131	46	26	28	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110802	10.1371/journal.pone.0110802	http://dx.doi.org/10.1371/journal.pone.0110802			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340511	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662800057
J	Schaarschmidt, J; Huth, S; Meier, R; Paschke, R; Jaeschke, H				Schaarschmidt, Joerg; Huth, Sandra; Meier, Rene; Paschke, Ralf; Jaeschke, Holger			Influence of the Hinge Region and Its Adjacent Domains on Binding and Signaling Patterns of the Thyrotropin and Follitropin Receptor	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; EXTRACELLULAR DOMAIN; TSH RECEPTOR; LIGAND-BINDING; AMINO-ACIDS; ECTODOMAIN; RESIDUES; COMPLEX; MUTAGENESIS; ACTIVATION	Glycoprotein hormone receptors (GPHR) have a large extracellular domain (ECD) divided into the leucine rich repeat (LRR) domain for binding of the glycoprotein hormones and the hinge region (HinR), which connects the LRR domain with the transmembrane domain (TMD). Understanding of the activation mechanism of GPHRs is hindered by the unknown interaction of the ECD with the TMD and the structural changes upon ligand binding responsible for receptor activation. Recently, our group showed that the HinR of the thyrotropin receptor (TSHR) can be replaced by those of the follitropin (FSHR) and lutropin receptor (LHCGR) without effects on surface expression and hTSH signaling. However, differences in binding characteristics for bovine TSH at the various HinRs were obvious. To gain further insights into the interplay between LRR domain, HinR and TMD we generated chimeras between the TSHR and FSHR. Our results obtained by the determination of cell surface expression, ligand binding and G protein activation confirm the similar characteristics of GPHR HinRs but they also demonstrate an involvement of the HinR in ligand selectivity indicated by the observed promiscuity of some chimeras. While the TSHR HinR contributes to specific binding of TSH and its variants, no such contribution is observed for FSH and its analog TR4401 at the HinR of the FSHR. Furthermore, the charge distribution at the poorly characterized LRR domain/HinR transition affected ligand binding and signaling even though this area is not in direct contact with the ligand. In addition our results also demonstrate the importance of the TMD/HinR interface. Especially the combination of the TSHR HinR with the FSHR-TMD resulted in a loss of cell surface expression of the respective chimeras. In conclusion, the HinRs of GPHRs do not only share similar characteristics but also behave as ligand specific structural and functional entities.	[Schaarschmidt, Joerg; Huth, Sandra; Paschke, Ralf; Jaeschke, Holger] Univ Leipzig, Dept Internal Med Neurol & Dermatol, Div Endocrinol & Nephrol, D-04109 Leipzig, Germany; [Meier, Rene] Univ Leipzig, Inst Biochem, D-04109 Leipzig, Germany	Leipzig University; Leipzig University	Jaeschke, H (corresponding author), Univ Leipzig, Dept Internal Med Neurol & Dermatol, Div Endocrinol & Nephrol, D-04109 Leipzig, Germany.	holger.jaeschke@medizin.uni-leipzig.de	Schaarschmidt, Joerg/A-9449-2017	Schaarschmidt, Joerg/0000-0002-4389-2366; Meier, Rene/0000-0002-1501-1349	Deutsche Forschungsgemeinschaft (DFG) [Ja 1927/1-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG) Ja 1927/1-2. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarons EJ, 2001, VIROLOGY, V287, P382, DOI 10.1006/viro.2001.1046; Agrawal G, 2009, J BIOL CHEM, V284, P2636, DOI 10.1074/jbc.M808199200; Angelova K, 2010, J BIOL CHEM, V285, P34813, DOI 10.1074/jbc.M110.148221; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Ascoli M, 2002, ENDOCR REV, V23, P141, DOI 10.1210/er.23.2.141; Bonomi M, 2006, MOL ENDOCRINOL, V20, P3351, DOI 10.1210/me.2005-0521; Caltabiano G, 2008, CELL MOL LIFE SCI, V65, P2484, DOI 10.1007/s00018-008-8002-9; Chazenbalk GD, 1997, ENDOCRINOLOGY, V138, P2893, DOI 10.1210/en.138.7.2893; Chen CR, 2011, J BIOL CHEM, V286, P6219, DOI 10.1074/jbc.M110.211003; Chen CR, 2010, ENDOCRINOLOGY, V151, P1940, DOI 10.1210/en.2009-1430; Costagliola S, 2002, EMBO J, V21, P504, DOI 10.1093/emboj/21.4.504; Couet J, 1996, J BIOL CHEM, V271, P4545; de Bernard S, 1999, J BIOL CHEM, V274, P101, DOI 10.1074/jbc.274.1.101; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Jaeschke H, 2006, ENDOCRINOLOGY, V147, P1753, DOI 10.1210/en.2005-1138; Jaeschke H, 2011, ENDOCRINOLOGY, V152, P3986, DOI 10.1210/en.2011-1389; Jiang XL, 2012, P NATL ACAD SCI USA, V109, P12491, DOI 10.1073/pnas.1206643109; Kleinau G, 2008, FASEB J, V22, P2798, DOI 10.1096/fj.07-104711; Kleinau G, 2009, ENDOCR REV, V30, P133, DOI 10.1210/er.2008-0044; KOSUGI S, 1991, J BIOL CHEM, V266, P19413; Krause G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052920; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Miguel RN, 2008, J MOL ENDOCRINOL, V41, P145, DOI 10.1677/JME-08-0040; Montanelli L, 2004, MOL ENDOCRINOL, V18, P2061, DOI 10.1210/me.2004-0036; Mueller S, 2008, J BIOL CHEM, V283, P18048, DOI 10.1074/jbc.M800449200; Mueller S, 2010, METHOD ENZYMOL, V485, P421, DOI [10.1016/S0076-6879(10)85023-2, 10.1016/B978-0-12-381296-4.00023-3]; Mueller S, 2010, TRENDS ENDOCRIN MET, V21, P111, DOI 10.1016/j.tem.2009.09.001; Mueller S, 2009, J BIOL CHEM, V284, P16317, DOI 10.1074/jbc.M109.005710; NAGAYAMA Y, 1991, P NATL ACAD SCI USA, V88, P902, DOI 10.1073/pnas.88.3.902; NAGAYAMA Y, 1990, BIOCHEM BIOPH RES CO, V173, P1150, DOI 10.1016/S0006-291X(05)80906-4; Nakabayashi K, 2000, J BIOL CHEM, V275, P30264, DOI 10.1074/jbc.M005568200; Quellari M, 2003, EUR J BIOCHEM, V270, P3486, DOI 10.1046/j.1432-1033.2003.03718.x; Sanders J, 2007, THYROID, V17, P395, DOI 10.1089/thy.2007.0034; Sangkuhl K, 2002, J BIOL CHEM, V277, P47748, DOI 10.1074/jbc.M203491200; Simoni M, 1997, ENDOCR REV, V18, P739, DOI 10.1210/er.18.6.739; Smits G, 2003, NEW ENGL J MED, V349, P760, DOI 10.1056/NEJMoa030064; Szkudlinski MW, 2002, PHYSIOL REV, V82, P473, DOI 10.1152/physrev.00031.2001; Troppmann B, 2013, HUM REPROD UPDATE, V19, P583, DOI 10.1093/humupd/dmt023; VASSART G, 1992, ENDOCR REV, V13, P596, DOI 10.1210/er.13.3.596; Vassart G, 2004, TRENDS BIOCHEM SCI, V29, P119, DOI 10.1016/j.tibs.2004.01.006; Vischer HF, 2006, MOL ENDOCRINOL, V20, P1880, DOI 10.1210/me.2005-0202; Vlaeminck-Guillem V, 2002, MOL ENDOCRINOL, V16, P736, DOI 10.1210/me.16.4.736; WADSWORTH HL, 1990, SCIENCE, V249, P1423, DOI 10.1126/science.2169649; Zhang M, 2000, ENDOCRINOLOGY, V141, P3514, DOI 10.1210/en.141.9.3514	45	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							111570	10.1371/journal.pone.0111570	http://dx.doi.org/10.1371/journal.pone.0111570			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340405	Green Submitted, Green Published, gold			2022-12-27	WOS:000343662800110
J	Wiig, ME; Dahlin, LB; Friden, J; Hagberg, L; Larsen, SE; Wiklund, K; Mahlapuu, M				Wiig, Monica E.; Dahlin, Lars B.; Friden, Jan; Hagberg, Lars; Larsen, Soren E.; Wiklund, Kerstin; Mahlapuu, Margit			PXL01 in Sodium Hyaluronate for Improvement of Hand Recovery after Flexor Tendon Repair Surgery: Randomized Controlled Trial	PLOS ONE			English	Article							CONTROLLED CLINICAL-TRIAL; ZONE-II; HOSPITAL READMISSIONS; ADHESION FORMATION; AXONAL OUTGROWTH; GENE-EXPRESSION; PELVIC-SURGERY; SCIATIC-NERVE; PEPTIDE PXL01; HOST-DEFENSE	Background: Postoperative adhesions constitute a substantial clinical problem in hand surgery. Fexor tendon injury and repair result in adhesion formation around the tendon, which restricts the gliding function of the tendon, leading to decreased digit mobility and impaired hand recovery. This study evaluated the efficacy and safety of the peptide PXL01 in preventing adhesions, and correspondingly improving hand function, in flexor tendon repair surgery. Methods: This prospective, randomised, double-blind trial included 138 patients admitted for flexor tendon repair surgery. PXL01 in carrier sodium hyaluronate or placebo was administered around the repaired tendon. Efficacy was assessed by total active motion of the injured finger, tip-to-crease distance, sensory function, tenolysis rate and grip strength, and safety parameters were followed, for 12 months post-surgery. Results: The most pronounced difference between the treatment groups was observed at 6 months post-surgery. At this timepoint, the total active motion of the distal finger joint was improved in the PXL01 group (60 vs. 41 degrees for PXL01 vs. placebo group, p = 0.016 in PPAS). The proportion of patients with excellent/good digit mobility was higher in the PXL01 group (61% vs. 38%, p = 0.0499 in PPAS). Consistently, the PXL01 group presented improved tip-to-crease distance (5.0 vs. 15.5 mm for PXL01 vs. placebo group, p = 0.048 in PPAS). Sensory evaluation showed that more patients in the PXL01 group felt the thinnest monofilaments (FAS: 74% vs. 35%, p = 0.021; PPAS: 76% vs. 35%, p = 0.016). At 12 months post-surgery, more patients in the placebo group were considered to benefit from tenolysis (30% vs. 12%, p = 0.086 in PPAS). The treatment was safe, well tolerated, and did not increase the rate of tendon rupture. Conclusions: Treatment with PXL01 in sodium hyaluronate improves hand recovery after flexor tendon repair surgery. Further clinical trials are warranted to determine the most efficient dose and health economic benefits.	[Wiig, Monica E.] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; [Wiig, Monica E.] Univ Uppsala Hosp, Uppsala, Sweden; [Dahlin, Lars B.] Lund Univ, Skane Univ Hosp, Dept Clin Sci Malmo Hand Surg, Malmo, Sweden; [Friden, Jan] Sahlgrens Univ Hosp, Dept Hand Surg, Gothenburg, Sweden; [Hagberg, Lars] Karolinska Inst, Sodersjukhuset, Dept Clin Sci & Educ, Dept Hand Surg, Stockholm, Sweden; [Larsen, Soren E.] Odense Univ Hosp, Dept Orthopaed, Unit Hand Surg, DK-5000 Odense, Denmark; [Wiklund, Kerstin] Pharma Consulting Grp Solut AB, Uppsala, Sweden; [Mahlapuu, Margit] Pergamum AB, Stockholm, Sweden	Uppsala University; Uppsala University; Uppsala University Hospital; Lund University; Skane University Hospital; Sahlgrenska University Hospital; Karolinska Institutet; Sodersjukhuset Hospital; University of Southern Denmark; Odense University Hospital	Wiig, ME (corresponding author), Uppsala Univ, Dept Surg Sci, Uppsala, Sweden.	monica.wiig@akademiska.se		Mahlapuu, Margit/0000-0001-8740-8874	Pergamum AB	Pergamum AB	The study was financed by Pergamum AB. M. Mahlapuu is CSO of Pergamum, PhD. The funder provided support in the form of salary for author MM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section. Dr. K. Wiklund is employed by Pharma Consulting Group Solutions AB. Pharma Consulting Group Solutions AB provided support in the form of salary for author KW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	[Anonymous], 2010, SAF STUD INV LOC TOL; Bell-Krotoski JA, 1990, REHABILITATION HAND, P589; Cederlund RI, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-286; Dahlin LB, 2013, INT REV NEUROBIOL, V109, P151, DOI 10.1016/B978-0-12-420045-6.00007-9; Elliot D, 2002, J HAND SURG-BRIT EUR, V27B, P507, DOI 10.1054/jhsb.2002.0800; ELLIOT D, 1994, J HAND SURG-BRIT EUR, V19B, P607, DOI 10.1016/0266-7681(94)90126-0; Ellis H, 1999, LANCET, V353, P1476, DOI 10.1016/S0140-6736(98)09337-4; ELLIS J, 1990, BIOMATERIALS, V11, P379, DOI 10.1016/0142-9612(90)90090-D; FORRESTER JV, 1980, IMMUNOLOGY, V40, P435; Gelberman R H, 1985, Hand Clin, V1, P35; Golash A, 2003, J HAND SURG-BRIT EUR, V28B, P113, DOI 10.1016/S0266-7681(02)00249-8; GOULD AL, 1995, STAT MED, V14, P1039, DOI 10.1002/sim.4780140922; HAGBERG L, 1992, J HAND SURG-AM, V17A, P935, DOI 10.1016/0363-5023(92)90474-4; HAGBERG L, 1992, J HAND SURG-AM, V17A, P132, DOI 10.1016/0363-5023(92)90128-C; Hakansson J, 2012, J HAND SURG-AM, V37A, P2519, DOI 10.1016/j.jhsa.2012.09.019; Ikeda J, 2010, J BONE JOINT SURG AM, V92A, P388, DOI 10.2106/JBJS.H.01641; James R, 2008, J HAND SURG-AM, V33A, P102, DOI 10.1016/j.jhsa.2007.09.007; LARSEN NE, 1992, J ORTHOPAED RES, V10, P23, DOI 10.1002/jor.1100100104; Legrand D, 2004, BIOMETALS, V17, P225, DOI 10.1023/B:BIOM.0000027696.48707.42; Liew S H, 2001, Chir Main, V20, P384, DOI 10.1016/S1297-3203(01)00062-2; Lower AM, 2000, BRIT J OBSTET GYNAEC, V107, P855, DOI 10.1111/j.1471-0528.2000.tb11083.x; Mentzel M, 2000, J HAND SURG-BRIT EUR, V25B, P590, DOI 10.1054/jhsb.2000.0385; MEYERS SA, 1989, J ORTHOP RES, V7, P683, DOI 10.1002/jor.1100070508; Moreland LW, 2003, ARTHRITIS RES THER, V5, P54, DOI 10.1186/ar623; Nago M, 2010, J ORTHOP RES, V28, P726, DOI 10.1002/jor.21075; Nilsson A, 2005, MOL BRAIN RES, V136, P65, DOI 10.1016/j.molbrainres.2005.01.008; Nilsson E, 2009, ANN SURG, V250, P1021, DOI 10.1097/SLA.0b013e3181b246a7; Orkar KS, 2012, J HAND SURG-EUR VOL, V37E, P20, DOI 10.1177/1753193411413661; Rosberg HE, 2003, J HAND SURG-BRIT EUR, V28B, P106, DOI 10.1016/S0266-7681(02)00352-2; Saito H, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-88; Schreuders TAR, 2012, J HAND SURG-EUR VOL, V37E, P513, DOI 10.1177/1753193411430810; Sharma P., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P181; Siconolfi LB, 2001, J NEUROSCI, V21, P4336, DOI 10.1523/JNEUROSCI.21-12-04336.2001; STRICKLAND JW, 1980, J HAND SURG-AM, V5, P537, DOI 10.1016/S0363-5023(80)80101-8; Taguchi M, 2009, J HAND SURG-AM, V34A, P1276, DOI 10.1016/j.jhsa.2009.04.011; Takahashi K, 1999, OSTEOARTHR CARTILAGE, V7, P182, DOI 10.1053/joca.1998.0207; Tang JB, 2005, HAND CLIN, V21, P199, DOI 10.1016/j.hcl.2004.11.005; ten Broek RPG, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5588; Tsuda Y, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-12; Ward PP, 2002, BIOCHEM CELL BIOL, V80, P95, DOI 10.1139/o01-214; Wiig M, 2011, J HAND SURG-EUR VOL, V36E, P656, DOI 10.1177/1753193411410823; Zhao CF, 2013, J ORTHOP RES, V31, P969, DOI 10.1002/jor.22305; Zhao CF, 2010, J BONE JOINT SURG AM, V92A, P2817, DOI 10.2106/JBJS.I.01148; Zhao CF, 2010, J BONE JOINT SURG AM, V92A, P1453, DOI 10.2106/JBJS.I.00765	44	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110735	10.1371/journal.pone.0110735	http://dx.doi.org/10.1371/journal.pone.0110735			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340801	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662800053
J	Davis, SC; Burkle, LA; Cross, WF; Cutting, KA				Davis, Stacy C.; Burkle, Laura A.; Cross, Wyatt F.; Cutting, Kyle A.			The Effects of Timing of Grazing on Plant and Arthropod Communities in High-Elevation Grasslands	PLOS ONE			English	Article							VEGETATION STRUCTURE; SPECIES-DIVERSITY; SAGE GROUSE; ABUNDANCE; RESPONSES; HABITAT; HERBIVORY; HEMIPTERA; INVERTEBRATES; CONSERVATION	Livestock grazing can be used as a key management tool for maintaining healthy ecosystems. However, the effectiveness of using grazing to modify habitat for species of conservation concern depends on how the grazing regime is implemented. Timing of grazing is one grazing regime component that is less understood than grazing intensity and grazer identity, but is predicted to have important implications for plant and higher trophic level responses. We experimentally assessed how timing of cattle grazing affected plant and arthropod communities in high-elevation grasslands of southwest Montana to better evaluate its use as a tool for multi-trophic level management. We manipulated timing of grazing, with one grazing treatment beginning in mid-June and the other in mid-July, in two experiments conducted in different grassland habitat types (i.e., wet meadow and upland) in 2011 and 2012. In the upland grassland experiment, we found that both early and late grazing treatments reduced forb biomass, whereas graminoid biomass was only reduced with late grazing. Grazing earlier in the growing season versus later did not result in greater recovery of graminoid or forb biomass as expected. In addition, the density of the most ubiquitous grassland arthropod order (Hemiptera) was reduced by both grazing treatments in upland grasslands. A comparison of end-of-season plant responses to grazing in upland versus wet meadow grasslands revealed that grazing reduced graminoid biomass in the wet meadow and forb biomass in the upland, irrespective of timing of grazing. Both grazing treatments also reduced end-of-season total arthropod and Hemiptera densities and Hemiptera biomass in both grassland habitat types. Our results indicate that both early and late season herbivory affect many plant and arthropod characteristics in a similar manner, but grazing earlier may negatively impact species of conservation concern requiring forage earlier in the growing season.	[Davis, Stacy C.; Burkle, Laura A.; Cross, Wyatt F.] Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA; [Cutting, Kyle A.] US Fish & Wildlife Serv, Red Rock Lakes Natl Wildlife Refuge, Lima, MT USA	Montana State University System; Montana State University Bozeman; United States Department of the Interior; US Fish & Wildlife Service	Davis, SC (corresponding author), Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA.	stacy.davis1@msu.montana.edu		Simanonok, Stacy/0000-0002-0287-3871	Montana State University; U.S. Fish and Wildlife Service	Montana State University; U.S. Fish and Wildlife Service(US Fish & Wildlife Service)	The authors are grateful to Montana State University and the U.S. Fish and Wildlife Service for funding this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MT, 2003, J RANGE MANAGE, V56, P501, DOI 10.2307/4003843; [Anonymous], 1989, JMP VERS 10; Bai YF, 2012, J APPL ECOL, V49, P1204, DOI 10.1111/j.1365-2664.2012.02205.x; Bakker ES, 2006, ECOL LETT, V9, P780, DOI 10.1111/j.1461-0248.2006.00925.x; Bell JR, 2001, J ZOOL, V255, P377, DOI 10.1017/S0952836901001479; Brown JH, 1995, CONSERV BIOL, V9, P1644, DOI 10.1046/j.1523-1739.1995.09061644.x; Cagnolo L, 2002, BIODIVERS CONSERV, V11, P407, DOI 10.1023/A:1014861906082; Chase JM, 2000, ECOLOGY, V81, P2485, DOI 10.1890/0012-9658(2000)081[2485:TEOPHA]2.0.CO;2; Collins SL, 1998, SCIENCE, V280, P745, DOI 10.1126/science.280.5364.745; Davidson AD, 2010, ECOLOGY, V91, P3189, DOI 10.1890/09-1277.1; Davis SK, 2004, AUK, V121, P1130, DOI 10.1642/0004-8038(2004)121[1130:ASIGPE]2.0.CO;2; Dennis P, 1998, ECOL ENTOMOL, V23, P253, DOI 10.1046/j.1365-2311.1998.00135.x; Derner JD, 2009, RANGELAND ECOL MANAG, V62, P111, DOI 10.2111/08-008.1; Dion N, 2000, CONDOR, V102, P629, DOI 10.1650/0010-5422(2000)102[0629:IEOVAP]2.0.CO;2; DRUT MS, 1994, J RANGE MANAGE, V47, P90, DOI 10.2307/4002848; Frank DA, 2002, ECOLOGY, V83, P602, DOI 10.1890/0012-9658(2002)083[0602:CCOGPP]2.0.CO;2; GIBSON CWD, 1992, J APPL ECOL, V29, P132, DOI 10.2307/2404356; GIBSON CWD, 1992, ECOGRAPHY, V15, P166, DOI 10.1111/j.1600-0587.1992.tb00020.x; Gotelli NJ, 2013, ECOSIMR 1 00; Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.2307/177062; Horel J, 2002, B AM METEOROL SOC, V83, P211, DOI 10.1175/1520-0477(2002)083<0211:MCMITW>2.3.CO;2; Joern A, 2013, ANNU REV ENTOMOL, V58, P19, DOI 10.1146/annurev-ento-120811-153540; Korosi A, 2012, INSECT CONSERV DIVER, V5, P57, DOI 10.1111/j.1752-4598.2011.00153.x; Kruess A, 2002, BIOL CONSERV, V106, P293, DOI 10.1016/S0006-3207(01)00255-5; Lenoir L, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.1701; MASCHINSKI J, 1989, AM NAT, V134, P1, DOI 10.1086/284962; MCNAUGHTON SJ, 1986, AM NAT, V128, P937, DOI 10.1086/284615; MILCHUNAS DG, 1989, VEGETATIO, V80, P11, DOI 10.1007/BF00049137; MORRIS MG, 1979, J APPL ECOL, V16, P77, DOI 10.2307/2402730; MORRIS MG, 1973, J APPL ECOL, V10, P761, DOI 10.2307/2401868; MUEGGLER WF, 1967, ECOLOGY, V48, P942, DOI 10.2307/1934538; Mysterud A, 2005, J ZOOL, V266, P411, DOI 10.1017/S0952836905007107; Newlon K, 2007, STATUS REPORT 2006 B; Nickerson C., 2011, MAJOR USES LAND US; OESTERHELD M, 1991, OECOLOGIA, V85, P305, DOI 10.1007/BF00320604; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; PAQUETTE SR, 2013, ECOL APPL, V23, P122; Perez-Camacho L, 2012, FUNCT ECOL, V26, P740, DOI 10.1111/j.1365-2435.2012.01967.x; PETERSON J G, 1970, Journal of Wildlife Management, V34, P147, DOI 10.2307/3799502; Pillsbury FC, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00154.1; R Core Team, 2012, R LANG ENV STAT COMP; Rambo JL, 1999, CONSERV BIOL, V13, P1047, DOI 10.1046/j.1523-1739.1999.98504.x; ROGERS LE, 1977, ANN ENTOMOL SOC AM, V70, P51, DOI 10.1093/aesa/70.1.51; Rosenberg MS, 2000, METAWIN STAT SOFTWAR; Schmitz OJ, 2008, ANNU REV ECOL EVOL S, V39, P133, DOI 10.1146/annurev.ecolsys.39.110707.173418; SIMS PL, 1978, J ECOL, V66, P573, DOI 10.2307/2259152; Sjodin NE, 2008, J APPL ECOL, V45, P763, DOI 10.1111/j.1365-2664.2007.01443.x; Stewart KEJ, 2001, J APPL ECOL, V38, P1148, DOI 10.1046/j.1365-2664.2001.00658.x; Sullivan AT, 2009, ECOLOGY, V90, P1346, DOI 10.1890/08-0629.1; Sveum CM, 1998, GREAT BASIN NAT, V58, P344; United States Fish and Wildlife Service, 2009, COMPR CONS PLAN; WallisDeVries Michiel F., 1998, Conservation Biology Series, V11, P1; WIENS JA, 1987, OIKOS, V48, P132, DOI 10.2307/3565849	53	14	15	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110460	10.1371/journal.pone.0110460	http://dx.doi.org/10.1371/journal.pone.0110460			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338008	Green Published, gold, Green Submitted			2022-12-27	WOS:000343674800045
J	Meng, R; Dennison, PE; D'Antonio, CM; Moritz, MA				Meng, Ran; Dennison, Philip E.; D'Antonio, Carla M.; Moritz, Max A.			Remote Sensing Analysis of Vegetation Recovery following Short-Interval Fires in Southern California Shrublands	PLOS ONE			English	Article							COASTAL SAGE SCRUB; POSTFIRE RECOVERY; CLIMATE-CHANGE; PLANT DIVERSITY; BURN SEVERITY; TIME-SERIES; REGENERATION; SUCCESSION; WILDFIRES; DYNAMICS	Increased fire frequency has been shown to promote alien plant invasions in the western United States, resulting in persistent vegetation type change. Short interval fires are widely considered to be detrimental to reestablishment of shrub species in southern California chaparral, facilitating the invasion of exotic annuals and producing "type conversion". However, supporting evidence for type conversion has largely been at local, site scales and over short post-fire time scales. Type conversion has not been shown to be persistent or widespread in chaparral, and past range improvement studies present evidence that chaparral type conversion may be difficult and a relatively rare phenomenon across the landscape. With the aid of remote sensing data covering coastal southern California and a historical wildfire dataset, the effects of short interval fires (<8 years) on chaparral recovery were evaluated by comparing areas that burned twice to adjacent areas burned only once. Twelve pairs of once- and twice-burned areas were compared using normalized burn ratio (NBR) distributions. Correlations between measures of recovery and explanatory factors (fire history, climate and elevation) were analyzed by linear regression. Reduced vegetation cover was found in some lower elevation areas that were burned twice in short interval fires, where non-sprouting species are more common. However, extensive type conversion of chaparral to grassland was not evident in this study. Most variables, with the exception of elevation, were moderately or poorly correlated with differences in vegetation recovery.	[Meng, Ran; Dennison, Philip E.] Univ Utah, Dept Geog, Salt Lake City, UT 84112 USA; [D'Antonio, Carla M.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Moritz, Max A.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	Utah System of Higher Education; University of Utah; University of California System; University of California Santa Barbara; University of California System; University of California Berkeley	Meng, R (corresponding author), Univ Utah, Dept Geog, Salt Lake City, UT 84112 USA.	Ran.Meng@utah.edu	; Meng, Ran/Q-9436-2016	Dennison, Philip/0000-0002-0241-1917; Meng, Ran/0000-0003-4756-9934	California Energy Commission [500-10-045]	California Energy Commission	Funding for this research was provided by California Energy Commission grant 500-10-045. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batllori E, 2013, GLOBAL ECOL BIOGEOGR, V22, P1118, DOI 10.1111/geb.12065; Bentley JR, 1967, AGR HDB FOREST SERVI; Benz UC, 2004, ISPRS J PHOTOGRAMM, V58, P239, DOI 10.1016/j.isprsjprs.2003.10.002; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; BURCHAM L. T., 1955, JOUR RANGE MANAGEMENT, V8, P121, DOI 10.2307/3893999; CALLAWAY RM, 1993, ECOLOGY, V74, P1567, DOI 10.2307/1940084; Canty MJ, 2008, REMOTE SENS ENVIRON, V112, P1025, DOI 10.1016/j.rse.2007.07.013; Chen XX, 2011, INT J REMOTE SENS, V32, P7905, DOI 10.1080/01431161.2010.524678; Cooper W.S., 1922, BROAD SCLEROPHYLL VE; Dale VH, 2000, SCI TOTAL ENVIRON, V262, P201, DOI 10.1016/S0048-9697(00)00522-2; Dale VH, 2001, BIOSCIENCE, V51, P723, DOI 10.1641/0006-3568(2001)051[0723:CCAFD]2.0.CO;2; DALY C, 1994, J APPL METEOROL, V33, P140, DOI 10.1175/1520-0450(1994)033&lt;0140:ASTMFM&gt;2.0.CO;2; Dennison PE, 2003, REMOTE SENS ENVIRON, V87, P295, DOI 10.1016/j.rse.2003.07.001; Dennison PE, 2009, INT J WILDLAND FIRE, V18, P1021, DOI 10.1071/WF08055; Eidenshink J., 2007, FIRE ECOL, V3, P3, DOI [DOI 10.4996/FIREECOLOGY.0301003, 10.4996/fireecology.0301003]; Franklin J, 2004, J VEG SCI, V15, P701, DOI 10.1111/j.1654-1103.2004.tb02312.x; Fuhrmann K. N., 2001, Rangelands, V23, P13; Green RO, 2008, IEEE AER C; HANES TL, 1971, ECOL MONOGR, V41, P27, DOI 10.2307/1942434; Henry MC, 1998, INT J REMOTE SENS, V19, P3097, DOI 10.1080/014311698214208; Huesca M, 2013, INT J REMOTE SENS, V34, P4025, DOI 10.1080/01431161.2013.772313; HUNT ER, 1989, REMOTE SENS ENVIRON, V30, P43, DOI 10.1016/0034-4257(89)90046-1; Jacobsen AL, 2004, P 10 MEDECOS C, P1; KEELEY JE, 1981, AM J BOT, V68, P524, DOI 10.2307/2443028; Keeley JE, 2003, ECOL STU AN, V160, P218; Keeley JE, 2005, DIVERS DISTRIB, V11, P525, DOI 10.1111/j.1366-9516.2005.00200.x; Keeley JE, 2004, J FOREST, V102, P26; Keeley JE, 2003, ECOL APPL, V13, P1355, DOI 10.1890/02-5002; Keeley JE, 2002, J BIOGEOGR, V29, P303, DOI 10.1046/j.1365-2699.2002.00676.x; Keeley JE, 2001, CONSERV BIOL, V15, P1536, DOI 10.1046/j.1523-1739.2001.00097.x; Keeley JE, 2006, FIRE IN CALIFORNIA'S ECOSYSTEMS, P350; Keeley JE, 2012, OECOLOGIA, V169, P1043, DOI 10.1007/s00442-012-2253-8; Keeley JE, 2009, J FOREST, V107, P287; Keeley JE, 2007, TERRESTRIAL VEGETATION OF CALIFORNIA, 3RD EDITION, P339; Key C.H., 2006, LANDSCAPE ASSESSMENT; Kinoshita AM, 2011, CATENA, V87, P240, DOI 10.1016/j.catena.2011.06.005; Kirkman T. W., 1996, STAT USE; Krawchuk MA., 2012, FIRE CLIMATE CHANGE; Lentile LB, 2006, INT J WILDLAND FIRE, V15, P319, DOI 10.1071/WF05097; Lippitt CL, 2013, INT J WILDLAND FIRE, V22, P184, DOI 10.1071/WF10099; Lopez-Garcia M., 1991, GEOCARTO INT, V6, P31, DOI DOI 10.1080/10106049109354290; Love RM, 1960, CALIF AGR, V14, P2; McMichael CE, 2004, INT J REMOTE SENS, V25, P4743, DOI 10.1080/01431160410001726067; Mensing SA, 1999, QUATERNARY RES, V51, P295, DOI 10.1006/qres.1999.2035; Merriam KE, 2006, ECOLOGICAL APPL, V16, P527; Miller JD, 2007, REMOTE SENS ENVIRON, V109, P66, DOI 10.1016/j.rse.2006.12.006; Mitri GH, 2013, INT J APPL EARTH OBS, V20, P60, DOI 10.1016/j.jag.2011.09.001; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Moritz MA, 2013, ANN NY ACAD SCI, V1286, P92, DOI 10.1111/nyas.12104; Odion D, 2002, CONSERVATION ECOLOGY; Padgett PE, 1999, PLANT ECOL, V144, P93, DOI 10.1023/A:1009895720067; Pennypacker CR, 2013, REMOTE SENS-BASEL, V5, P5173, DOI 10.3390/rs5105173; Quinn R. D., 2006, INTRO CALIFORNIA CHA; Rodrigo A, 2004, ECOLOGY, V85, P716, DOI 10.1890/02-0492; Roder A, 2008, REMOTE SENS ENVIRON, V112, P259, DOI 10.1016/j.rse.2007.05.001; Saura S, 2002, INT J REMOTE SENS, V23, P4853, DOI 10.1080/01431160110114493; Schroeder M.J., 1964, SYNOPTIC WEATHER TYP; Schroeder W, 2014, REMOTE SENS ENVIRON, V143, P85, DOI 10.1016/j.rse.2013.12.008; Sugihara NG, 2006, FIRE IN CALIFORNIA'S ECOSYSTEMS, P58; Talluto MV, 2008, LANDSCAPE ECOL, V23, P803, DOI 10.1007/s10980-008-9238-3; van Leeuwen WJD, 2010, INT J WILDLAND FIRE, V19, P75, DOI 10.1071/WF08078; WELLS PV, 1962, ECOL MONOGR, V32, P79, DOI 10.2307/1942361; White JD, 1996, INT J WILDLAND FIRE, V6, P125, DOI 10.1071/WF9960125; WILLIAMS WILLIAM A., 1956, JOUR RANGE MANAGEMENT, V9, P28, DOI 10.2307/3894648; ZAMMIT CA, 1993, J ECOL, V81, P499, DOI 10.2307/2261528; ZEDLER PH, 1983, ECOLOGY, V64, P809, DOI 10.2307/1937204	66	34	34	2	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110637	10.1371/journal.pone.0110637	http://dx.doi.org/10.1371/journal.pone.0110637			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337785	gold, Green Submitted, Green Published			2022-12-27	WOS:000343674800064
J	Chien, LC; Lien, YJ; Yang, CH; Yu, HL				Chien, Lung-Chang; Lien, Yi-Jen; Yang, Chiang-Hsin; Yu, Hwa-Lung			Acute Increase of Children's Conjunctivitis Clinic Visits by Asian Dust Storms Exposure - A Spatiotemporal Study in Taipei, Taiwan	PLOS ONE			English	Article							LUNG-FUNCTION GROWTH; BAYESIAN P-SPLINES; AIR-POLLUTION; HOSPITAL ADMISSIONS; RESPIRATORY SYMPTOMS; PULMONARY-FUNCTION; EMERGENCY VISITS; EVENTS; HEALTH; ASTHMA	Adverse health impacts of Asian dust storms (ADS) have been widely investigated and discussed in respiratory disease, but no study has examined the association between ADS events and their impact on eye diseases, especially in children. The impact of ADS events on the incidence of children's conjunctivitis is examined by analyzing the data from children's clinic visits registered in the 41 districts of Taipei area in Taiwan during the period 2002-2007. The structural additive regression modeling approach was used to assess the association between ADS events and clinic visits for conjunctivitis in children with consideration of day-of-the-week effects, temperature, and air quality levels. This study identifies an acute increase in the relative rate for children's conjunctivitis clinic visits during ADS periods with 1.48% (95% CI = 0.79, 2.17) for preschool children (aged <6 years old) and 9.48% (95% CI = 9.03, 9.93) for schoolchildren (aged >= 6 years old), respectively. The relative rates during post-ADS periods were still statistically significant, but much lower than those during ADS periods. The spatial analysis presents geographic heterogeneity of children's conjunctivitis clinic visits where higher relative rates were more likely observed in the most populated districts Compared to previous ADS studies related to respiratory diseases, our results reveals significantly acute impacts on children's conjunctivitis during ADS periods, and much influence on schoolchildren. Vulnerable areas were also identified in high density population.	[Chien, Lung-Chang] Univ Texas San Antonio, Sch Publ Hlth, Div Biostat, San Antonio, TX USA; [Lien, Yi-Jen; Yu, Hwa-Lung] Natl Taiwan Univ, Dept Bioenvironm Syst Engn, Taipei 10764, Taiwan; [Yang, Chiang-Hsin] Natl Taipei Univ Nursing & Hlth Sci, Dept Hlth Care Management, Taipei, Taiwan	University of Texas System; University of Texas at San Antonio (UTSA); National Taiwan University; National Taipei University of Nursing & Health Science (NTUNHS)	Yu, HL (corresponding author), Natl Taiwan Univ, Dept Bioenvironm Syst Engn, Taipei 10764, Taiwan.	hlyu@ntu.edu.tw		Yu, Hwa Lung/0000-0001-9558-2100	National Science Council of Taiwan [NSC101-2628-E-002-017-MY3, NSC101-2628-E-002-003]; Environmental Protection Department of the New Taipei City Government (Taiwan)	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Environmental Protection Department of the New Taipei City Government (Taiwan)	This research and data collection was supported by funds from the National Science Council of Taiwan (NSC101-2628-E-002-017-MY3 and NSC101-2628-E-002-003) and the Environmental Protection Department of the New Taipei City Government (Taiwan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, 1974, AUTOMATIC CONTROL IE, V19, P716, DOI [DOI 10.1109/TAC.1974.1100705, 10.1109/tac.1974.1100705]; [Anonymous], 2012, BAYESX SOFTWARE BAYE; Belitz C, 2008, COMPUT STAT DATA AN, V53, P61, DOI 10.1016/j.csda.2008.05.032; Boezen HM, 1999, LANCET, V353, P874, DOI 10.1016/S0140-6736(98)06311-9; Bourcier T, 2003, BRIT J OPHTHALMOL, V87, P809, DOI 10.1136/bjo.87.7.809; Brezger A, 2008, STAT MODEL, V8, P141, DOI 10.1177/1471082X0800800202; Cakmak S, 2002, LANCET, V359, P947, DOI 10.1016/S0140-6736(02)08045-5; Chan CC, 2008, ENVIRON RES, V106, P393, DOI 10.1016/j.envres.2007.09.006; Chen PS, 2010, ENVIRON HEALTH PERSP, V118, P1211, DOI 10.1289/ehp.0901782; Chen YS, 2004, ENVIRON RES, V95, P151, DOI 10.1016/j.envres.2003.08.008; Cheng MF, 2008, J TOXICOL ENV HEAL A, V71, P1295, DOI 10.1080/15287390802114808; Chien L-C, 2012, ENVIRON HEALTH PERSP, V7; Chiu HF, 2008, INHAL TOXICOL, V20, P777, DOI 10.1080/08958370802005308 ; DASSEN W, 1986, JAPCA J AIR WASTE MA, V36, P1223, DOI 10.1080/00022470.1986.10466168; DOCKERY DW, 1982, JAPCA J AIR WASTE MA, V32, P937, DOI 10.1080/00022470.1982.10465494; Ezzati M, 2000, ENVIRON HEALTH PERSP, V108, P833, DOI 10.2307/3434990; Fahrmeir L, 2001, J ROY STAT SOC C-APP, V50, P201, DOI 10.1111/1467-9876.00229; Fromont A, 2010, BRAIN, V133, P1889, DOI 10.1093/brain/awq134; Horak F, 2002, EUR RESPIR J, V19, P838, DOI 10.1183/09031936.02.00512001; Jedrychowski W, 1999, ENVIRON HEALTH PERSP, V107, P669, DOI 10.2307/3434460; Kindermann R, 1980, MARKOV RANDOM FIELDS, Vix; Kuo HW, 2010, BUILD ENVIRON, V45, P610, DOI 10.1016/j.buildenv.2009.07.017; Lang S, 2004, J COMPUT GRAPH STAT, V13, P183, DOI 10.1198/1061860043010; Lee EC, 2008, EPIDEMIOLOGY, V19, pS145; Lee H., 2003, WATER AIR SOIL POLL, V3, P231, DOI DOI 10.1023/A:1023254910362; Liu Z, 2009, ACUTE CONJUNCTIVITIS, P443; Ma CJ, 2001, ATMOS ENVIRON, V35, P2707, DOI 10.1016/S1352-2310(00)00410-6; McConnell R, 1999, ENVIRON HEALTH PERSP, V107, P757, DOI 10.2307/3434662; Middleton N, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-39; NCU, 2005, TAIW WIND QUER SYST; Novaes P, 2007, ENVIRON HEALTH PERSP, V115, P1753, DOI 10.1289/ehp.10363; POPE CA, 1989, AM J PUBLIC HEALTH, V79, P623, DOI 10.2105/AJPH.79.5.623; Schwartz J, 2004, PEDIATRICS, V113, P1037; Stoss M, 2000, J ALTERN COMPLEM MED, V6, P499, DOI 10.1089/acm.2000.6.499; Tam WWS, 2011, RESPIROLOGY; Tuominen ISJ, 2003, INVEST OPHTH VIS SCI, V44, P2545, DOI 10.1167/iovs.02-1260; [TWDOH Department of Health EY], 2012, REGULATIONS GOVERNIN; TWEPA, 2011, AS DUST STORM MON NE; van der Zee SC, 1999, OCCUP ENVIRON MED, V56, P802, DOI 10.1136/oem.56.12.802; Yang CY, 2006, J TOXICOL ENV HEAL A, V69, P1673, DOI 10.1080/15287390600630096; Yang CY, 2009, J TOXICOL ENV HEAL A, V72, P324, DOI 10.1080/15287390802529880; Yang CY, 2005, INHAL TOXICOL, V17, P817, DOI 10.1080/08958370500241254; Yu HL, 2013, ENVIRON INT, V54, P35, DOI 10.1016/j.envint.2013.01.004; Yu HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041317	44	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e109175	10.1371/journal.pone.0109175	http://dx.doi.org/10.1371/journal.pone.0109175			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347189	Green Published, gold, Green Submitted			2022-12-27	WOS:000347994900006
J	Choi, AR; Shi, LC; Brown, LS; Jung, KH				Choi, Ah Reum; Shi, Lichi; Brown, Leonid S.; Jung, Kwang-Hwan			Cyanobacterial Light-Driven Proton Pump, Gloeobacter Rhodopsin: Complementarity between Rhodopsin-Based Energy Production and Photosynthesis	PLOS ONE			English	Article							ANABAENA SENSORY RHODOPSIN; PHOTOCHEMICAL-REACTION CYCLE; VIOLACEUS PCC-7421; SEQUENCE-ANALYSIS; LACKS THYLAKOIDS; PURPLE MEMBRANE; PROTEORHODOPSIN; BACTERIORHODOPSIN; BINDING; PROTEIN	A homologue of type I rhodopsin was found in the unicellular Gloeobacter violaceus PCC7421, which is believed to be primitive because of the lack of thylakoids and peculiar morphology of phycobilisomes. The Gloeobacter rhodopsin (GR) gene encodes a polypeptide of 298 amino acids. This gene is localized alone in the genome unlike cyanobacterium Anabaena opsin, which is clustered together with 14 kDa transducer gene. Amino acid sequence comparison of GR with other type I rhodopsin shows several conserved residues important for retinal binding and H+ pumping. In this study, the gene was expressed in Escherichia coli and bound all-trans retinal to form a pigment (lambda max = 544 nm at pH 7). The pK(a) of proton acceptor (Asp121) for the Schiff base, is approximately 5.9, so GR can translocate H+ under physiological conditions (pH 7.4). In order to prove the functional activity in the cell, pumping activity was measured in the sphaeroplast membranes of E. coli and one of Gloeobacter whole cell. The efficient proton pumping and rapid photocycle of GR strongly suggests that Gloeobacter rhodopsin functions as a proton pumping in its natural environment, probably compensating the shortage of energy generated by chlorophyll-based photosynthesis without thylakoids.	[Choi, Ah Reum; Jung, Kwang-Hwan] Sogang Univ, Dept Life Sci, Seoul, South Korea; [Choi, Ah Reum; Jung, Kwang-Hwan] Sogang Univ, Inst Biol Interfaces, Seoul, South Korea; [Shi, Lichi; Brown, Leonid S.] Univ Guelph, Dept Phys, Guelph, ON N1G 2W1, Canada	Sogang University; Sogang University; University of Guelph	Jung, KH (corresponding author), Sogang Univ, Dept Life Sci, Seoul, South Korea.	kjung@sogang.ac.kr	Brown, Leonid/X-7445-2019; Brown, Leonid/A-1050-2008	Brown, Leonid/0000-0002-5614-8317; Brown, Leonid/0000-0002-5614-8317	Research Foundation of Korea [2011-0012320, 2011-220-C00057]; National Nuclear R&D Program - Ministry of Science ICT & future planning [2012055325]; NSERC; PREA;  [NRF-2013R1A1A064883]	Research Foundation of Korea(National Research Foundation of Korea); National Nuclear R&D Program - Ministry of Science ICT & future planning; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); PREA; 	This work was supported by grants from the Research Foundation of Korea (2011-0012320 and 2011-220-C00057) and National Nuclear R&D Program funded by the Ministry of Science ICT & future planning (2012055325) to K.H. Jung, and grants from NSERC and PREA to L.S. Brown. A. R. Choi was supported by NRF-2013R1A1A064883. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balashov SP, 2010, BIOCHEMISTRY-US, V49, P9792, DOI 10.1021/bi1014166; Balashov SP, 2005, SCIENCE, V309, P2061, DOI 10.1126/science.1118046; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051; Bieszke JA, 1999, P NATL ACAD SCI USA, V96, P8034, DOI 10.1073/pnas.96.14.8034; BIRGE RR, 1990, BIOCHIM BIOPHYS ACTA, V1016, P293, DOI 10.1016/0005-2728(90)90163-X; BRYANT DA, 1981, ARCH MICROBIOL, V129, P190, DOI 10.1007/BF00425249; Chizhov I, 1996, BIOPHYS J, V71, P2329, DOI 10.1016/S0006-3495(96)79475-4; Choi AR, 2007, J MICROBIOL BIOTECHN, V17, P138; Dioumaev AK, 2002, BIOCHEMISTRY-US, V41, P5348, DOI 10.1021/bi025563x; FISCHER U, 1979, BIOPHYS J, V28, P211, DOI 10.1016/S0006-3495(79)85172-3; Friedrich T, 2002, J MOL BIOL, V321, P821, DOI 10.1016/S0022-2836(02)00696-4; GUGLIELMI G, 1981, ARCH MICROBIOL, V129, P181, DOI 10.1007/BF00425248; Hashimoto K, 2010, BIOCHEMISTRY-US, V49, P3343, DOI 10.1021/bi100184k; Hegemann P, 2008, ANNU REV PLANT BIOL, V59, P167, DOI 10.1146/annurev.arplant.59.032607.092847; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Honda D, 1999, J MOL EVOL, V48, P723, DOI 10.1007/PL00006517; Imasheva ES, 2009, BIOCHEMISTRY-US, V48, P10948, DOI 10.1021/bi901552x; Jung JY, 2008, FEBS LETT, V582, P1679, DOI 10.1016/j.febslet.2008.04.025; Jung KH, 2003, MOL MICROBIOL, V47, P1513, DOI 10.1046/j.1365-2958.2003.03395.x; Jung KH, 2007, PHOTOCHEM PHOTOBIOL, V83, P63, DOI 10.1562/2006-03-20-IR-853; Kelemen L, 1999, BIOPHYS J, V76, P1951, DOI 10.1016/S0006-3495(99)77354-6; Kim SY, 2008, BBA-BIOENERGETICS, V1777, P504, DOI 10.1016/j.bbabio.2008.03.010; KOENIG F, 1995, PHYSIOL PLANTARUM, V94, P621; Luecke H, 2008, P NATL ACAD SCI USA, V105, P16561, DOI 10.1073/pnas.0807162105; McCarren J, 2007, ENVIRON MICROBIOL, V9, P846, DOI 10.1111/j.1462-2920.2006.01203.x; Mimuro M, 2002, PLANT CELL PHYSIOL, V43, P587, DOI 10.1093/pcp/pcf070; Miranda MRM, 2009, BIOPHYS J, V96, P1471, DOI 10.1016/j.bpj.2008.11.026; MOWERY PC, 1979, BIOCHEMISTRY-US, V18, P4100, DOI 10.1021/bi00586a007; Nakamura Y, 2003, DNA RES, V10, P137, DOI 10.1093/dnares/10.4.137; Nelissen B, 1996, J MOL EVOL, V42, P194, DOI 10.1007/BF02198845; NELISSEN B, 1995, MOL BIOL EVOL, V12, P1166; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; OTTOLENGHI M, 1989, J MEMBRANE BIOL, V112, P193, DOI 10.1007/BF01870951; Ridge KD, 2007, J BIOL CHEM, V282, P9297, DOI 10.1074/jbc.R600032200; RIPPKA R, 1974, ARCH MICROBIOL, V100, P419, DOI 10.1007/BF00446333; Samuilov VD, 2001, BIOCHEMISTRY-MOSCOW+, V66, P640, DOI 10.1023/A:1010207314408; Sharma AK, 2006, TRENDS MICROBIOL, V14, P463, DOI 10.1016/j.tim.2006.09.006; Shi LC, 2006, J MOL BIOL, V358, P686, DOI 10.1016/j.jmb.2006.02.036; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; Sineshchevkov OA, 2005, J BIOL CHEM, V280, P14663, DOI 10.1074/jbc.m501416200; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; SPUDICH JL, 1980, J BIOL CHEM, V255, P5501; Spudich JL, 2006, TRENDS MICROBIOL, V14, P480, DOI 10.1016/j.tim.2006.09.005; Spudich JL, 2005, HANDBOOK OF PHOTOSENSORY RECEPTORS, P1, DOI 10.1002/352760510X.ch1; Varo G, 2003, BIOPHYS J, V84, P1202, DOI 10.1016/S0006-3495(03)74934-0; Vogt A, 2013, BIOPHYS J, V105, P2055, DOI 10.1016/j.bpj.2013.08.031; von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915; Wang WW, 2003, J BIOL CHEM, V278, P33985, DOI 10.1074/jbc.M305716200; XIE AH, 1987, BIOPHYS J, V51, P627, DOI 10.1016/S0006-3495(87)83387-8; Yamada M, 2005, J BACTERIOL, V187, P1702, DOI 10.1128/JB.187.5.1702-1709.2005	51	34	35	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e110643	10.1371/journal.pone.0110643	http://dx.doi.org/10.1371/journal.pone.0110643			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347537	gold, Green Published, Green Submitted			2022-12-27	WOS:000347994900025
J	Xu, J; Xu, L; Wang, YX; You, QS; Jonas, JB; Bin Wei, W				Xu, Jie; Xu, Liang; Wang, Ya Xing; You, Qi Sheng; Jonas, Jost B.; Bin Wei, Wen			Ten-Year Cumulative Incidence of Diabetic Retinopathy. The Beijing Eye Study 2001/2011	PLOS ONE			English	Article							CEREBROSPINAL-FLUID PRESSURE; RETINAL VESSEL DIAMETER; AXIAL LENGTH; VISION LOSS; PROGRESSION; POPULATION; PREVALENCE; RISK; ARTERIAL; CHINA	Objective: To assess the cumulative 10-year incidence of diabetic retinopathy (DR) and its associated factors in a population living in Greater Beijing. Methods: The population-based longitudinal Beijing Eye Study, which included 4439 subjects (age in 2001: 40+years) in 2001, was repeated in 2011 with 2695 subjects participating (66.4% of the survivors). The study participants underwent a detailed ophthalmic examination. Fundus photographs were examined for the new development of DR. Results: After excluding individuals with DR at baseline (n = 87) or no sufficient fundus photographs in 2011 (n = 6), the study included 2602 subjects with a mean age of 64.6 +/- 9.7 years (median: 64.0 years; range: 50 to 93 years). In the 10-year period, 109 subjects (39 men) developed new DR with an incidence of 4.2% (95% confidence interval (CI): 3.45,5.03). In multiple logistic regression analysis, incident DR was significantly associated with higher HbA1c value (P < 0.001; Odds Ratio (OR): 1.73; 95% Confidence Interval (CI): 1.35,2.21), longer duration of diabetes mellitus (P < 0.001; OR: 1.16; 95% CI: 1.10,1.22), higher serum concentration of creatinine (P = 0.02; OR: 1.01; 95% CI: 1.002,1.022), lower educational level (P = 0.049; OR: 0.74; 95% CI: 0.55,0.99), higher estimated cerebrospinal fluid pressure (P = 0.038; OR: 1.10; 95% CI: 1.01,1.22), and shorter axial length (P < 0.001; OR: 0.48; 95% CI: 0.33,0.71). Conclusions: The cumulative 10-year incidence (mean: 4.2%) of DR in a North Chinese population was significantly associated with a higher HbA1c value, longer known duration of diabetes mellitus, higher estimated CSFP and shorter axial length (P, 0.001). Shorter axial length (or hyperopia) and, potentially, higher CSFP may be additional risk factors to be taken into account when counseling and treating patients with diabetes mellitus.	[Xu, Jie; Xu, Liang; Wang, Ya Xing; You, Qi Sheng; Jonas, Jost B.] Capital Med Univ, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Heidelberg, Germany; [Bin Wei, Wen] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing, Peoples R China	Capital Medical University; Ruprecht Karls University Heidelberg; Capital Medical University	Bin Wei, W (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing, Peoples R China.	wenbing_wei@yahoo.com.cn	xu, jie/GQR-1913-2022; Dagdelen, Selcuk/A-9432-2017; wang, YA XING/K-9671-2016; Xu, Jie/AIE-0524-2022; You, Qisheng/AAG-7153-2020	xu, jie/0000-0002-2039-7055; Dagdelen, Selcuk/0000-0002-0513-1750; wang, YA XING/0000-0003-2749-7793; You, Qisheng/0000-0003-0743-7320	State Natural Sciences Fund [81041018]; Natural Sciences Fund of Beijing government [7092021, 7112031]	State Natural Sciences Fund(National Natural Science Foundation of China (NSFC)); Natural Sciences Fund of Beijing government	Supported by State Natural Sciences Fund (81041018) and the Natural Sciences Fund of Beijing government (7092021; 7112031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, OPHTHALMOLOGY, V98, P786; Bourne RRA, 2014, BRIT J OPHTHALMOL, V98, P629, DOI 10.1136/bjophthalmol-2013-304033; Bourne RRA, 2013, LANCET GLOB HEALTH, V1, pE339, DOI 10.1016/S2214-109X(13)70113-X; Cheung N, 2007, STROKE, V38, P398, DOI 10.1161/01.STR.0000254547.91276.50; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Cikamatana L, 2007, EYE, V21, P465, DOI 10.1038/sj.eye.6702771; DWYER MS, 1985, DIABETES CARE, V8, P316, DOI 10.2337/diacare.8.4.316; Grauslund J, 2009, DIABETOLOGIA, V52, P1829, DOI 10.1007/s00125-009-1450-4; HAYREH SS, 1971, BRIT J OPHTHALMOL, V55, P649, DOI 10.1136/bjo.55.10.649; Henricsson M, 2003, DIABETES CARE, V26, P349, DOI 10.2337/diacare.26.2.349; Ismail-Beigi F, 2010, LANCET, V376, P419, DOI 10.1016/S0140-6736(10)60576-4; Jonas JB, 2014, AM J HYPERTENS, V27, P1170, DOI 10.1093/ajh/hpu037; Jonas JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096273; Jonas JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082284; Jonas JB, 2013, DIABETES CARE, V36, pE69, DOI 10.2337/dc12-2377; Jonas JB, 2010, OPHTHALMOLOGY, V117, P2234, DOI 10.1016/j.ophtha.2009.12.006; Kawasaki R, 2011, DIABETOLOGIA, V54, P2288, DOI 10.1007/s00125-011-2199-0; Klein R, 2008, OPHTHALMOLOGY, V115, P1859, DOI 10.1016/j.ophtha.2008.08.023; Klein R, 2012, ARCH OPHTHALMOL-CHIC, V130, P749, DOI 10.1001/archophthalmol.2011.2560; Klein R, 2009, OPHTHALMOLOGY, V116, P497, DOI 10.1016/j.ophtha.2008.10.016; Leske MC, 2003, OPHTHALMOLOGY, V110, P941, DOI 10.1016/S0161-6420(03)00086-1; Lim LS, 2010, OPHTHALMOLOGY, V117, P524, DOI 10.1016/j.ophtha.2009.07.044; Man REK, 2012, OPHTHALMOLOGY, V119, P1754, DOI 10.1016/j.ophtha.2012.03.021; Mirshahi A, 2014, OPHTHALMOLOGY, V121, P2047, DOI 10.1016/j.ophtha.2014.04.017; Pan CW, 2013, OPHTHALMOLOGY, V120, P2058, DOI 10.1016/j.ophtha.2013.03.028; Pierro L, 1999, RETINA-J RET VIT DIS, V19, P401, DOI 10.1097/00006982-199909000-00005; Ren RJ, 2012, GRAEF ARCH CLIN EXP, V250, P445, DOI 10.1007/s00417-011-1746-1; Rogers SL, 2008, DIABETES CARE, V31, P761, DOI 10.2337/dc07-1622; Sjolie AK, 2008, LANCET, V372, P1385, DOI 10.1016/S0140-6736(08)61411-7; Stodtmeister R, 2013, INVEST OPHTH VIS SCI, V54, P4698, DOI 10.1167/iovs.12-10607; Tapp RJ, 2008, DIABETES CARE, V31, P1349, DOI 10.2337/dc07-1707; Tapp RJ, 2006, DIABETES RES CLIN PR, V73, P298, DOI 10.1016/j.diabres.2006.02.009; Varma R, 2010, AM J OPHTHALMOL, V149, P752, DOI 10.1016/j.ajo.2009.11.014; Wang Y, 2006, BRIT J OPHTHALMOL, V90, P353, DOI 10.1136/bjo.2005.081521; Wong TY, 2007, AM J OPHTHALMOL, V143, P970, DOI 10.1016/j.ajo.2007.02.020; Xie XB, 2013, CRIT CARE, V17, DOI 10.1186/cc12841; Xu L, 2006, BRIT J OPHTHALMOL, V90, P1087, DOI 10.1136/bjo.2006.096123; Xu L, 2010, GRAEF ARCH CLIN EXP, V248, P49, DOI 10.1007/s00417-009-1204-5; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909	39	44	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111320	10.1371/journal.pone.0111320	http://dx.doi.org/10.1371/journal.pone.0111320			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347072	Green Submitted, Green Published, gold			2022-12-27	WOS:000347994900061
J	Dong, B; Zhou, HL; Han, CH; Yao, JF; Xu, LM; Zhang, M; Fu, YW; Xia, Q				Dong, Biao; Zhou, Honglan; Han, Conghui; Yao, Jufang; Xu, Longmei; Zhang, Ming; Fu, Yaowen; Xia, Qiang			Ischemia/Reperfusion-Induced CHOP Expression Promotes Apoptosis and Impairs Renal Function Recovery: The Role of Acidosis and GPR4	PLOS ONE			English	Article							REPERFUSION INJURY; PH SENSOR; ISCHEMIA; PROTECTS; PATHWAY; DEATH; MICE	Endoplasmic reticulum (ER) stress-induced apoptosis is implicated in a wide range of diseases, including ischemia/reperfusion injury (IRI). As a common feature of ER stress, the role of CCAT/enhancer-binding protein homologous protein (CHOP) in renal IRI has not been thoroughly investigated. We found that IR led to renal CHOP expression, accompanied by apoptosis induction. Renal IRI was markedly alleviated in CHOP-/- mice. Observations from bone marrow chimeras showed that this was based on CHOP inactivation in renal parenchymal cells rather than inflammatory cells. In vivo and in vitro studies demonstrated that IRI induced CHOP expression in both endothelial and epithelial cells, which was responsible for apoptosis induction. These results were reinforced by the observation that CHOP knockout led to improvement of the postischemic microcirculatory recovery. In vitro studies revealed hypoxia-induced acidosis to be a major inducer of CHOP in endothelial cells, and neutralizing acidosis not only diminished CHOP protein, but also reduced apoptosis. Finally, knockdown of a proton-sensing G protein-coupled receptor GPR4 markedly reduced CHOP expression and endothelial cell apoptosis after hypoxia exposure. These results highlight the importance of hypoxia-acidosis in ER stress signaling regulation in ischemic kidneys and suggest that GPR4 inhibitors or agents targeting CHOP expression may be promising in the treatment of renal IRI.	[Dong, Biao; Zhang, Ming; Xia, Qiang] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Transplantat & Hepat Surg, Shanghai 200030, Peoples R China; [Dong, Biao; Zhou, Honglan; Fu, Yaowen] Jilin Univ, Hosp 1, Dept Urol, Changchun 130023, Peoples R China; [Dong, Biao; Zhou, Honglan; Fu, Yaowen] Xuzhou Cent Hosp, Xuzhou Med Coll, Affiliated Sch Clin Med, Dept Urol, Xuzhou, Peoples R China; [Yao, Jufang] Shanghai Jiao Tong Univ, Renji Hosp, Anim Facil, Shanghai 200030, Peoples R China; [Xu, Longmei] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Cent Lab, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Jilin University; Xuzhou Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Fu, YW (corresponding author), Jilin Univ, Hosp 1, Dept Urol, Changchun 130023, Peoples R China.	fuyaowenjdyy@163.com; xiaqiang@shsmu.edu.cn			National Natural Science Foundation of China [81270558, 81470895]; Shanghai Municipal Commission of Health and Family Planning [XBR2011029, 2013ZYJB0001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission of Health and Family Planning	This work was supported by grants from the National Natural Science Foundation of China (grant number: 81270558) to QX and (grant number: 81470895) to MZ, and grants from the Shanghai Municipal Commission of Health and Family Planning (XBR2011029, 2013ZYJB0001) to QX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blohmke CJ, 2012, J IMMUNOL, V189, P5467, DOI 10.4049/jimmunol.1103661; BONVENTRE JV, 1988, ANNU REV MED, V39, P531, DOI 10.1146/annurev.med.39.1.531; Chen AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027586; Chen CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040801; DeZwaan-McCabe D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003937; Dong LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061991; Engel T, 2013, BRAIN, V136, P577, DOI 10.1093/brain/aws337; Esposito V, 2013, AM J PHYSIOL-RENAL, V304, pF440, DOI 10.1152/ajprenal.00487.2011; Halterman MW, 2010, J BIOL CHEM, V285, P21329, DOI 10.1074/jbc.M109.095299; He K, 2014, KIDNEY INT, V85, P276, DOI 10.1038/ki.2013.342; Liu J, 2012, TRANSPLANTATION, V94, P211, DOI 10.1097/TP.0b013e318259d38e; Lozon TI, 2011, AM J PHYSIOL-LUNG C, V300, pL422, DOI 10.1152/ajplung.00166.2010; Malhi H, 2013, J BIOL CHEM, V288, P18624, DOI 10.1074/jbc.M112.442954; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Mehta RL, 2004, KIDNEY INT, V66, P1613, DOI 10.1111/j.1523-1755.2004.00927.x; Miyazaki Y, 2011, ARTERIOSCL THROM VAS, V31, P1124, DOI 10.1161/ATVBAHA.111.224519; Sun XM, 2010, J AM SOC NEPHROL, V21, P1745, DOI 10.1681/ASN.2009050477; Tajiri S, 2004, CELL DEATH DIFFER, V11, P403, DOI 10.1038/sj.cdd.4401365; Yang JR, 2014, AM J PHYSIOL-RENAL, V306, pF75, DOI 10.1152/ajprenal.00117.2013; Yang LV, 2007, MOL CELL BIOL, V27, P1334, DOI 10.1128/MCB.01909-06; Zhang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029876	21	38	43	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110944	10.1371/journal.pone.0110944	http://dx.doi.org/10.1371/journal.pone.0110944			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343248	Green Submitted, gold, Green Published			2022-12-27	WOS:000343943500068
J	Feng, L; Chen, Z; Ma, H; Chen, X; Li, Y; Wang, YY; Xiang, Y				Feng, Lin; Chen, Zhu; Ma, Hui; Chen, Xue; Li, Yuan; Wang, Yiyi; Xiang, Yan			The IQD Gene Family in Soybean: Structure, Phylogeny, Evolution and Expression	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; ARABIDOPSIS-THALIANA; TRANSCRIPTION FACTOR; CALCIUM; CALMODULIN; PROTEIN; POPULUS; DUPLICATION; SEQUENCE; SENSORS	Members of the plant-specific IQ67-domain (IQD) protein family are involved in plant development and the basal defense response. Although systematic characterization of this family has been carried out in Arabidopsis, tomato (Solanum lycopersicum), Brachypodium distachyon and rice (Oryza sativa), systematic analysis and expression profiling of this gene family in soybean (Glycine max) have not previously been reported. In this study, we identified and structurally characterized IQD genes in the soybean genome. A complete set of 67 soybean IQD genes (GmIQD1-67) was identified using Blast search tools, and the genes were clustered into four subfamilies (IQD I-IV) based on phylogeny. These soybean IQD genes are distributed unevenly across all 20 chromosomes, with 30 segmental duplication events, suggesting that segmental duplication has played a major role in the expansion of the soybean IQD gene family. Analysis of the Ka/Ks ratios showed that the duplicated genes of the GmIQD family primarily underwent purifying selection. Microsynteny was detected in most pairs: genes in clade 1-3 might be present in genome regions that were inverted, expanded or contracted after the divergence; most gene pairs in clade 4 showed high conservation with little rearrangement among these gene-residing regions. Of the soybean IQD genes examined, six were most highly expressed in young leaves, six in flowers, one in roots and two in nodules. Our qRT-PCR analysis of 24 soybean IQD III genes confirmed that these genes are regulated by MeJA stress. Our findings present a comprehensive overview of the soybean IQD gene family and provide insights into the evolution of this family. In addition, this work lays a solid foundation for further experiments aimed at determining the biological functions of soybean IQD genes in growth and development.	[Feng, Lin; Chen, Zhu; Ma, Hui; Chen, Xue; Li, Yuan; Wang, Yiyi; Xiang, Yan] Anhui Agr Univ, Sch Forestry & Landscape Architecture, Lab Modern Biotechnol, Hefei, Peoples R China; [Xiang, Yan] Anhui Agr Univ, Key Lab Crop Biol, Hefei, Peoples R China	Anhui Agricultural University; Anhui Agricultural University	Xiang, Y (corresponding author), Anhui Agr Univ, Sch Forestry & Landscape Architecture, Lab Modern Biotechnol, Hefei, Peoples R China.	xiangyanahau@sina.com	wang, yiyi/GWZ-5830-2022		National Natural Science Foundation of China [31370561]; Specialized research Fund for the Doctoral Program of Higher Education [20133418110005]; Anhui Provincial Natural Science Foundation [1308085MC36]; Anhui Agricultural University disciplinary construction Foundation [XKTS2013001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province); Anhui Agricultural University disciplinary construction Foundation	This work was supported by grants from the National Natural Science Foundation of China (No. 31370561), Specialized research Fund for the Doctoral Program of Higher Education(No. 20133418110005), Anhui Provincial Natural Science Foundation (No. 1308085MC36) and Anhui Agricultural University disciplinary construction Foundation(No. XKTS2013001) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-72; Abel S, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24369; Ali GS, 2003, PLANT MOL BIOL, V51, P803, DOI 10.1023/A:1023001403794; Anandalakshmi R, 2000, SCIENCE, V290, P142, DOI 10.1126/science.290.5489.142; Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Batistic O, 2004, PLANTA, V219, P915, DOI 10.1007/s00425-004-1333-3; Bhattacharya S, 2004, BBA-MOL CELL RES, V1742, P69, DOI 10.1016/j.bbamcr.2004.09.002; Boonburapong B, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-4; Bouche N, 2005, ANNU REV PLANT BIOL, V56, P435, DOI 10.1146/annurev.arplant.56.032604.144224; Brader G, 2001, PLANT PHYSIOL, V126, P849, DOI 10.1104/pp.126.2.849; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Bryfczynski S, 2009, ITICSE 2009: PROCEEDING OF THE 2009 ACM SIGSE ANNUAL CONFERENCE ON INNOVATION AND TECHNOLOGY IN COMPUTER SCIENCE EDUCATION, P389, DOI 10.1145/1595496.1563031; Burstenbinder K, 2013, J BIOL CHEM, V288, P1871, DOI 10.1074/jbc.M112.396200; Cannon SB, 2003, MOL GENET GENOMICS, V270, P347, DOI 10.1007/s00438-003-0928-x; Cannon SB, 2012, BREEDING SCI, V61; Chen X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087156; Cheng Q, 2006, PLANT SCI, V170, P1027, DOI 10.1016/j.plantsci.2005.12.012; Cipollini D, 2004, MOL ECOL, V13, P1643, DOI 10.1111/j.1365-294X.2004.02161.x; Clapperton JA, 2002, BIOCHEMISTRY-US, V41, P14669, DOI 10.1021/bi026660t; CREELMAN RA, 1992, P NATL ACAD SCI USA, V89, P4938, DOI 10.1073/pnas.89.11.4938; Day IS, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-10-research0056; DeFalco TA, 2010, BIOCHEM J, V425, P27, DOI 10.1042/BJ20091147; Dittmar K, 2011, EVOLUTION GENE DUPLI; Dodd AN, 2010, ANNU REV PLANT BIOL, V61, P593, DOI 10.1146/annurev-arplant-070109-104628; Du JC, 2012, PLANT CELL, V24, P21, DOI [10.1105/tpc.111.092759, 10.1105/tpc.112.103630]; Du LQ, 2009, NATURE, V457, P1154, DOI 10.1038/nature07612; Evans NH, 2001, CURR OPIN PLANT BIOL, V4, P415, DOI 10.1016/S1369-5266(00)00194-1; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Filiz E, 2013, PLANT OMICS, V6, P425; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fischer C, 2013, PLANT CELL PHYSIOL, V54, P573, DOI 10.1093/pcp/pct021; Gao F, 2012, PLANT J, V70, P1056, DOI 10.1111/j.1365-313X.2012.04969.x; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Grant D, 2010, NUCLEIC ACIDS RES, V38, pD843, DOI 10.1093/nar/gkp798; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Gutierrez N, 2011, MOL BREEDING, V28, P13, DOI 10.1007/s11032-010-9456-7; Hajduch M, 2005, PLANT PHYSIOL, V137, P1397, DOI 10.1104/pp.104.056614; Harada A, 2009, PLANT CELL PHYSIOL, V50, P360, DOI 10.1093/pcp/pcn203; Harper JF, 2001, TRENDS PLANT SCI, V6, P395, DOI 10.1016/S1360-1385(01)02023-4; Helfer S, 2014, NEW PHYTOL, V201, P770, DOI 10.1111/nph.12570; Hepler PK, 2001, ANNU REV CELL DEV BI, V17, P159, DOI 10.1146/annurev.cellbio.17.1.159; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; HU W-z, 2012, SCI TECHNOLOGY FOOD, V16; Huang ZJ, 2013, MOL GENET GENOMICS, V288, P111, DOI 10.1007/s00438-013-0733-0; Hyun TK, 2013, IND CROP PROD, V49, P864, DOI 10.1016/j.indcrop.2013.06.046; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Kamenetzky L, 2010, PLANT PHYSIOL, V152, P1772, DOI 10.1104/pp.109.150532; Le DT, 2011, DNA RES, V18, P17, DOI 10.1093/dnares/dsq032; Lecourieux D, 2006, NEW PHYTOL, V171, P249, DOI 10.1111/j.1469-8137.2006.01777.x; Lee TH, 2013, NUCLEIC ACIDS RES, V41, pD1152, DOI 10.1093/nar/gks1104; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Levy M, 2005, PLANT J, V43, P79, DOI 10.1111/j.1365-313X.2005.02435.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luan S, 2002, PLANT CELL, V14, pS389, DOI 10.1105/tpc.001115; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Miranda Vivian de Jesus, 2013, BMC Res Notes, V6, P196, DOI 10.1186/1756-0500-6-196; Nekrutenko A, 2002, GENOME RES, V12, P198, DOI 10.1101/gr.200901; Ng CKY, 2001, NEW PHYTOL, V151, P109, DOI 10.1046/j.1469-8137.2001.00152.x; Ohno S., 1970, EVOLUTION GENE DUPLI; Pauly N, 2000, NATURE, V405, P754, DOI 10.1038/35015671; Peng XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032997, 10.1371/journal.pone.0040120]; Perochon A, 2011, BIOCHIMIE, V93, P2048, DOI 10.1016/j.biochi.2011.07.012; Ranty B, 2006, PLANT SIGNAL BEHAV, V1, P96, DOI 10.4161/psb.1.3.2998; Reddy ASN, 2011, PLANT CELL, V23, P2010, DOI 10.1105/tpc.111.084988; Reddy ASN, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-7-research0024; Reddy ASN, 2001, PLANT SCI, V160, P381, DOI 10.1016/S0168-9452(00)00386-1; Schlueter JA, 2004, GENOME, V47, P868, DOI [10.1139/g04-047, 10.1139/G04-047]; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Shoemaker RC, 2006, CURR OPIN PLANT BIOL, V9, P104, DOI 10.1016/j.pbi.2006.01.007; Silva DCG, 2008, THEOR APPL GENET, V117, P57, DOI 10.1007/s00122-008-0752-0; Snedden WA, 2001, NEW PHYTOL, V151, P35, DOI 10.1046/j.1469-8137.2001.00154.x; Soto-Valdez H, 2012, FABRICATION PROPERTI, P206; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Team RC, 2012, R LANG ENV STAT COMP; Tian CG, 2014, CHINESE B BOT, V48, P447; Wang LQ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-282; Wei F, 2007, PLOS GENET, V3, P1254, DOI 10.1371/journal.pgen.0030123; Wei HY, 2008, PROG BIOCHEM BIOPHYS, V35, P703; Wittstock U, 2002, TRENDS PLANT SCI, V7, P263, DOI 10.1016/S1360-1385(02)02273-2; Wu S, 2011, PLANT PHYSIOL, V157, P1175, DOI 10.1104/pp.111.181065; Xiao H, 2008, SCIENCE, V319, P1527, DOI 10.1126/science.1153040; Xiong TC, 2004, PLANT J, V40, P12, DOI 10.1111/j.1365-313X.2004.02184.x; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yoo JH, 2005, J BIOL CHEM, V280, P3697, DOI 10.1074/jbc.M408237200; Yu YH, 2007, PLANT GROWTH REGUL, V52, P101, DOI 10.1007/s10725-007-9165-3; Zentella R, 2007, PLANT CELL, V19, P3037, DOI 10.1105/tpc.107.054999; Zhang CX, 2011, PLANT PHYSIOL BIOCH, V49, P1306, DOI 10.1016/j.plaphy.2011.08.010; Zhang HC, 2008, PLANT GROWTH REGUL, V56, P129, DOI 10.1007/s10725-008-9293-4; Zhang XH, 2011, MOL GENET GENOMICS, V285, P79, DOI 10.1007/s00438-010-0587-7; Zuo R, 2013, MOL BIOL REP, V40, P2645, DOI 10.1007/s11033-012-2351-z	95	63	68	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110896	10.1371/journal.pone.0110896	http://dx.doi.org/10.1371/journal.pone.0110896			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343341	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943500063
J	Gas-Pascual, E; Berna, A; Bach, TJ; Schaller, H				Gas-Pascual, Elisabet; Berna, Anne; Bach, Thomas J.; Schaller, Hubert			Plant Oxidosqualene Metabolism: Cycloartenol Synthase-Dependent Sterol Biosynthesis in Nicotiana benthamiana	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; ARABIDOPSIS-THALIANA; LANOSTEROL SYNTHASE; DIRECTED EVOLUTION; TRITERPENE; YEAST; PHYTOSTEROLS; PATHWAYS; CYCLASES; LEAVES	The plant sterol pathway exhibits a major biosynthetic difference as compared with that of metazoans. The committed sterol precursor is the pentacyclic cycloartenol (9 beta, 19-cyclolanost-24-en-3 beta-ol) and not lanosterol (lanosta-8,24-dien-3 beta-ol), as it was shown in the late sixties. However, plant genome mining over the last years revealed the general presence of lanosterol synthases encoding sequences (LAS1) in the oxidosqualene cyclase repertoire, in addition to cycloartenol synthases (CAS1) and to non-steroidal triterpene synthases that contribute to the metabolic diversity of C30H50O compounds on earth. Furthermore, plant LAS1 proteins have been unambiguously identified by peptidic signatures and by their capacity to complement the yeast lanosterol synthase deficiency. A dual pathway for the synthesis of sterols through lanosterol and cycloartenol was reported in the model Arabidopsis thaliana, though the contribution of a lanosterol pathway to the production of 24-alkyl-Delta(5) -sterols was quite marginal (Ohyama et al. (2009) PNAS 106, 725). To investigate further the physiological relevance of CAS1 and LAS1 genes in plants, we have silenced their expression in Nicotiana benthamiana. We used virus induced gene silencing (VIGS) based on gene specific sequences from a Nicotiana tabacum CAS1 or derived from the solgenomics initiative (http://solgenomics.net/) to challenge the respective roles of CAS1 and LAS1. In this report, we show a CAS1-specific functional sterol pathway in engineered yeast, and a strict dependence on CAS1 of tobacco sterol biosynthesis.	[Schaller, Hubert] CNRS, Inst Biol Mol Plantes, F-67084 Strasbourg, France; Univ Strasbourg, Inst Bot, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Schaller, H (corresponding author), CNRS, Inst Biol Mol Plantes, 12 Rue Gen Zimmer, F-67084 Strasbourg, France.	hubert.schaller@ibmp-cnrs.unistra.fr		Schaller, Hubert/0000-0002-4099-4447; Gas-Pascual, Elisabet/0000-0002-2643-6916	Centre National de la Recherche Scientifique; Universite de Strasbourg; Agence Nationale de la Recherche [BIOSIS ANR-06-BLAN-0291-02, TERPENE ANR-05-BLAN-0217-01, TERPENE ANR-05-BLAN-0217-02]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite de Strasbourg; Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the Centre National de la Recherche Scientifique, the Universite de Strasbourg, and the Agence Nationale de la Recherche (grant BIOSIS ANR-06-BLAN-0291-02 to TJB and TERPENE ANR-05-BLAN-0217-01 and 02 to HS and TJB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiychuk E, 2008, P NATL ACAD SCI USA, V105, P3163, DOI 10.1073/pnas.0712190105; BAULCOMBE DC, 1995, PLANT J, V7, P1045, DOI 10.1046/j.1365-313X.1995.07061045.x; BENVENISTE P, 1966, PHYTOCHEMISTRY, V5, P45, DOI 10.1016/S0031-9422(00)85080-3; Benveniste P, 2004, ANNU REV PLANT BIOL, V55, P429, DOI 10.1146/annurev.arplant.55.031903.141616; BLADOCHA M, 1983, PLANT PHYSIOL, V71, P756, DOI 10.1104/pp.71.4.756; Burger C, 2003, J EXP BOT, V54, P1675, DOI 10.1093/jxb/erg184; Buschhaus C, 2012, PLANT PHYSIOL, V160, P1120, DOI 10.1104/pp.112.198473; COREY EJ, 1993, P NATL ACAD SCI USA, V90, P11628, DOI 10.1073/pnas.90.24.11628; Cornforth JW, 2002, BIOCHEM BIOPH RES CO, V292, P1129, DOI 10.1006/bbrc.2001.2006; Darnet S, 2003, BBA-MOL CELL BIOL L, V1633, P106, DOI 10.1016/S1388-1981(03)00093-3; Gachotte D, 1999, P NATL ACAD SCI USA, V96, P12655, DOI 10.1073/pnas.96.22.12655; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Guhling O, 2005, J CHEM ECOL, V31, P2323, DOI 10.1007/s10886-005-7104-1; Hayward A, 2011, METHODS MOL BIOL, V678, P55, DOI 10.1007/978-1-60761-682-5_5; HEINTZ R, 1974, J BIOL CHEM, V249, P4267; Heupel RC, 1986, METABOLISM STRUCTURE; HEWLINS MJE, 1969, EUR J BIOCHEM, V8, P184, DOI 10.1111/j.1432-1033.1969.tb00513.x; Itkin M, 2013, SCIENCE, V341, P175, DOI 10.1126/science.1240230; Ito R, 2011, ORG LETT, V13, P2678, DOI 10.1021/ol200777d; Kolesnikova M, 2009, THESIS RICE U HOUSTO; Kolesnikova MD, 2006, ARCH BIOCHEM BIOPHYS, V447, P87, DOI 10.1016/j.abb.2005.12.010; Kushiro T, 1998, EUR J BIOCHEM, V256, P238, DOI 10.1046/j.1432-1327.1998.2560238.x; Lovato MA, 2000, J BIOL CHEM, V275, P13394, DOI 10.1074/jbc.275.18.13394; Men SZ, 2008, NAT CELL BIOL, V10, P237, DOI 10.1038/ncb1686; Meyer MM, 2002, ORG LETT, V4, P1395, DOI 10.1021/ol0257225; Milla P, 2002, LIPIDS, V37, P1171, DOI 10.1007/s11745-002-1017-9; Nes WD, 2011, CHEM REV, V111, P6423, DOI 10.1021/cr200021m; NES WD, 1993, ARCH BIOCHEM BIOPHYS, V300, P724, DOI 10.1006/abbi.1993.1100; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Ohyama K, 2009, P NATL ACAD SCI USA, V106, P725, DOI 10.1073/pnas.0807675106; Papadopoulou K, 1999, P NATL ACAD SCI USA, V96, P12923, DOI 10.1073/pnas.96.22.12923; Phillips DR, 2006, CURR OPIN PLANT BIOL, V9, P305, DOI 10.1016/j.pbi.2006.03.004; PONSINET G, 1967, PHYTOCHEMISTRY, V6, P1235, DOI 10.1016/S0031-9422(00)86086-0; Racolta S, 2012, PROTEINS, V80, P2009, DOI 10.1002/prot.24089; RAEDERSTORFF D, 1987, EUR J BIOCHEM, V164, P427, DOI 10.1111/j.1432-1033.1987.tb11075.x; Rahier A., 1989, ANAL STEROLS OTHER B, P223, DOI [10.1016/B978-0-12-515445-1.50016-1, DOI 10.1016/B978-0-12-515445-1.50016-1]; Vicente MRS, 2013, PLANTA, V237, P121, DOI 10.1007/s00425-012-1758-z; Sainsbury F, 2012, METHOD ENZYMOL, V517, P185, DOI 10.1016/B978-0-12-404634-4.00009-7; Sawai S, 2006, PLANT CELL PHYSIOL, V47, P673, DOI 10.1093/pcp/pcj032; SCHALLER H, 1991, PHYTOCHEMISTRY, V30, P2547, DOI 10.1016/0031-9422(91)85097-J; Schaller H, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 1: NATURAL PRODUCTS STRUCTURAL DIVERSITY-I: SECONDARY METABOLITES: ORGANIZATION AND BIOSYNTHESIS, P755; Segura MJR, 2002, ORG LETT, V4, P4459, DOI 10.1021/ol0269897; Venkatramesh M, 1995, ARCH BIOCHEM BIOPHYS, V324, P189, DOI 10.1006/abbi.1995.9912; Voutquenne-Nazabadioko L, 2013, PHYTOCHEMISTRY, V90, P114, DOI 10.1016/j.phytochem.2013.03.001; Wang KR, 2012, PLANT PHYSIOL, V158, P1789, DOI 10.1104/pp.111.189217; Wang ZH, 2011, PLANT PHYSIOL, V155, P540, DOI 10.1104/pp.110.162883; Wu TK, 2008, CHEM REC, V8, P302, DOI 10.1002/tcr.20157; Xu R, 2004, PHYTOCHEMISTRY, V65, P261, DOI 10.1016/j.phytochem.2003.11.014	48	39	43	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e109156	10.1371/journal.pone.0109156	http://dx.doi.org/10.1371/journal.pone.0109156			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343375	gold, Green Submitted, Green Published			2022-12-27	WOS:000343943500009
J	Gounarides, J; Cobb, JS; Zhou, J; Cook, F; Yang, XM; Yin, H; Meredith, E; Rao, C; Huang, Q; Xu, YY; Anderson, K; De Erkenez, A; Liao, SM; Crowley, M; Buchanan, N; Poor, S; Qiu, YB; Fassbender, E; Shen, SY; Woolfenden, A; Jensen, A; Cepeda, R; Etemad-Gilbertson, B; Giza, S; Mogi, M; Jaffee, B; Azarian, S				Gounarides, John; Cobb, Jennifer S.; Zhou, Jing; Cook, Frank; Yang, Xuemei; Yin, Hong; Meredith, Erik; Rao, Chang; Huang, Qian; Xu, YongYao; Anderson, Karen; De Erkenez, Andrea; Liao, Sha-Mei; Crowley, Maura; Buchanan, Natasha; Poor, Stephen; Qiu, Yubin; Fassbender, Elizabeth; Shen, Siyuan; Woolfenden, Amber; Jensen, Amy; Cepeda, Rosemarie; Etemad-Gilbertson, Bijan; Giza, Shelby; Mogi, Muneto; Jaffee, Bruce; Azarian, Sassan			Lack of Involvement of CEP Adducts in TLR Activation and in Angiogenesis	PLOS ONE			English	Article							MACULAR DEGENERATION; NEOVASCULARIZATION; INFLAMMATION; BIOMARKERS; COMPLEX; DAMAGE; CRB1	Proteins that are post-translationally adducted with 2-(omega-carboxyethyl) pyrrole (CEP) have been proposed to play a pathogenic role in age-related macular degeneration, by inducing angiogenesis in a Toll Like Receptor 2 (TLR2)-dependent manner. We have investigated the involvement of CEP adducts in angiogenesis and TLR activation, to assess the therapeutic potential of inhibiting CEP adducts and TLR2 for ocular angiogenesis. As tool reagents, several CEP-adducted proteins and peptides were synthetically generated by published methodology and adduction was confirmed by NMR and LC-MS/MS analyses. Structural studies showed significant changes in secondary structure in CEP-adducted proteins but not the untreated proteins. Similar structural changes were also observed in the treated unadducted proteins, which were treated by the same adduction method except for one critical step required to form the CEP group. Thus some structural changes were unrelated to CEP groups and were artificially induced by the synthesis method. In biological studies, the CEP-adducted proteins and peptides failed to activate TLR2 in cell-based assays and in an in vivo TLR2-mediated retinal leukocyte infiltration model. Neither CEP adducts nor TLR agonists were able to induce angiogenesis in a tube formation assay. In vivo, treatment of animals with CEP-adducted protein had no effect on laser-induced choroidal neovascularization. Furthermore, in vivo inactivation of TLR2 by deficiency in Myeloid Differentiation factor 88 (Myd88) had no effect on abrasion-induced corneal neovascularization. Thus the CEP-TLR2 axis, which is implicated in other wound angiogenesis models, does not appear to play a pathological role in a corneal wound angiogenesis model. Collectively, our data do not support the mechanism of action of CEP adducts in TLR2-mediated angiogenesis proposed by others.	[Gounarides, John; Cobb, Jennifer S.; Zhou, Jing; Cook, Frank; Yang, Xuemei; Yin, Hong; Meredith, Erik; Rao, Chang; Huang, Qian; Xu, YongYao; Anderson, Karen; De Erkenez, Andrea; Liao, Sha-Mei; Crowley, Maura; Buchanan, Natasha; Poor, Stephen; Qiu, Yubin; Fassbender, Elizabeth; Shen, Siyuan; Woolfenden, Amber; Jensen, Amy; Cepeda, Rosemarie; Etemad-Gilbertson, Bijan; Giza, Shelby; Mogi, Muneto; Jaffee, Bruce; Azarian, Sassan] Novartis Inst Biomed Res, Cambridge, MA 02139 USA	Novartis	Azarian, S (corresponding author), Novartis Inst Biomed Res, Cambridge, MA 02139 USA.	Sassan.Azarian@novartis.com		Giza, Shelby/0000-0002-0772-8200	Novartis Institutes for Biomedical Research	Novartis Institutes for Biomedical Research	This study was funded by the Novartis Institutes for Biomedical Research. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahmed N, 2002, BIOCHEM J, V364, P1; Alves CH, 2014, PROG RETIN EYE RES, V40, P35, DOI 10.1016/j.preteyeres.2014.01.001; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Cruz-Guilloty F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088201; Ebrahem Q, 2006, P NATL ACAD SCI USA, V103, P13480, DOI 10.1073/pnas.0601552103; Gu J, 2009, THESIS CASE W RESERV; Gu JY, 2009, MOL CELL PROTEOMICS, V8, P1338, DOI 10.1074/mcp.M800453-MCP200; Gu XR, 2003, J BIOL CHEM, V278, P42027, DOI 10.1074/jbc.M305460200; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Jang G-F, 2012, INVEST OPHTHALMOL, V53, P6478; Kuno Noriyuki, 2011, Curr Mol Pharmacol, V4, P196; Lu L, 2009, BIOORGAN MED CHEM, V17, P7548, DOI 10.1016/j.bmc.2009.09.009; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Miller JW, 2013, AM J OPHTHALMOL, V155, P1, DOI 10.1016/j.ajo.2012.10.018; Nguyen DH, 2013, DISCOV MED, V15, P343; Organisciak DT, 2013, MOL VIS, V19, P1433; Renganathan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076325; Saeed AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106421; Salomon RG, 2011, CHEM RES TOXICOL, V24, P1803, DOI 10.1021/tx200206v; Sivak JM, 2011, J BIOL CHEM, V286, P44965, DOI 10.1074/jbc.M111.294967; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; Yuan XL, 2010, MOL CELL PROTEOMICS, V9, P1031, DOI 10.1074/mcp.M900523-MCP200	22	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111472	10.1371/journal.pone.0111472	http://dx.doi.org/10.1371/journal.pone.0111472			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343517	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943500102
J	Harper, LD; West, DJ; Stevenson, E; Russell, M				Harper, Liam D.; West, Daniel J.; Stevenson, Emma; Russell, Mark			Technical Performance Reduces during the Extra-Time Period of Professional Soccer Match-Play	PLOS ONE			English	Article							FATIGUE; RELIABILITY; REDUCTION; PROFILES; VALIDITY; TESTS	Despite the importance of extra-time in determining progression in specific soccer tournament matches, few studies have profiled the demands of 120-minutes of soccer match-play. With a specific focus on the extra-time period, and using a within-match approach, we examined the influence of prolonged durations of professional soccer match-play on markers of technical (i.e., skilled) performance. In 18 matches involving professional European teams played between 2010 and 2014, this retrospective study quantified the technical actions observed during eight 15-minute epochs (E1: 00:00-14:59 min, E2: 15:00-29:59 min, E3: 30:00-44:59 min, E4: 45:00-59:59 min, E5: 60:00-74:59 min, E6: 75:00-89:59 min, E7: 90:00-104:59 min, E8: 105:00-119:59 min). Analysis of players who completed the demands of the full 120 min of match-play revealed that the cumulative number of successful passes observed during E8 (61 +/- 23) was lower than E1-4 (E1: 88 +/- 23, P = 0.001; E2: 77621, P = 0.005; E3: 79 +/- 18, P = 0.001; E4: 80 +/- 21, P = 0.001) and E7 (73 +/- 20, P = 0.002). Similarly, the total number of passes made in E8 (71 +/- 25) was reduced when compared to E1 (102 +/- 22, P = 0.001), E3 (91 +/- 19, P = 0.002), E4 (93 +/- 22, P <= 0.0005) and E7 (84 +/- 20, P = 0.001). The cumulative number of successful dribbles reduced in E8 (9 +/- 4) when compared to E1 (14 +/- 4, P = 0.001) and E3 (12 +/- 4, P <= 0.0005) and the total time the ball was in play was less in E8 (504 +/- 61 s) compared to E1 (598 +/- 70 s, P <= 0.0005). These results demonstrate that match-specific factors reduced particular indices of technical performance in the second half of extra-time. Interventions that seek to maintain skilled performance throughout extra-time warrant further investigation.	[Harper, Liam D.; West, Daniel J.; Stevenson, Emma; Russell, Mark] Northumbria Univ, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England	Northumbria University	Russell, M (corresponding author), Northumbria Univ, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England.	mark.russell@northumbria.ac.uk	Harper, Liam/I-7866-2019; Russell, Mark/M-1652-2019; West, Daniel/O-4127-2014	Harper, Liam/0000-0002-2089-4799; Russell, Mark/0000-0002-7305-1090; West, Daniel/0000-0003-2246-4925				Ali A, 2007, J SPORT SCI, V25, P1461, DOI 10.1080/02640410601150470; Aughey RJ, 2013, INT J SPORTS MED, V34, P282, DOI 10.1055/s-0032-1331776; Bradley PS, 2011, J SPORT SCI, V29, P821, DOI 10.1080/02640414.2011.561868; Carling C, 2011, J SPORT SCI, V29, P63, DOI 10.1080/02640414.2010.521945; Cohen J.E., 1988, STAT POWER ANAL BEHA; Di Salvo V, 2007, INT J SPORTS MED, V28, P222, DOI 10.1055/s-2006-924294; Edwards AM, 2009, SPORTS MED, V39, P1, DOI 10.2165/00007256-200939010-00001; Field A.P., 2020, DISCOVERING STAT USI, V4th; Lago-Penas C, 2010, J SPORT SCI MED, V9, P288; Mackenzie R, 2013, J SPORT SCI, V31, P639, DOI 10.1080/02640414.2012.746720; Mohr M, 2003, J SPORT SCI, V21, P519, DOI 10.1080/0264041031000071182; Rahnama N, 2003, J SPORT SCI, V21, P933, DOI 10.1080/0264041031000140428; Rampinini E, 2009, J SCI MED SPORT, V12, P227, DOI 10.1016/j.jsams.2007.10.002; Reilly T., 2003, SCI SOCCER, P59; Russell M, 2011, INT J SPORTS MED, V32, P511, DOI 10.1055/s-0031-1273742; Russell M, 2014, SPORTS MED, V44, P957, DOI 10.1007/s40279-014-0184-8; Russell M, 2013, J STRENGTH COND RES, V27, P2869, DOI 10.1519/JSC.0b013e318280cc13; Russell M, 2011, INT J SPORT PHYSIOL, V6, P221, DOI 10.1123/ijspp.6.2.221; Russell M, 2010, J SPORT SCI, V28, P1399, DOI 10.1080/02640414.2010.511247; Taylor JB, 2008, J SPORT SCI, V26, P885, DOI 10.1080/02640410701836887; Weston M, 2011, INT J SPORT PHYSIOL, V6, P174, DOI 10.1123/ijspp.6.2.174; Wilkinson M, 2013, INT J SPORTS MED, V34, P281, DOI 10.1055/s-0032-1331775	22	33	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110995	10.1371/journal.pone.0110995	http://dx.doi.org/10.1371/journal.pone.0110995			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343724	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000343943500073
J	Mollerstrom, J; Seim, D				Mollerstrom, Johanna; Seim, David			Cognitive Ability and the Demand for Redistribution	PLOS ONE			English	Article							RISK-AVERSION; PREFERENCES; ATTITUDES; FAIRNESS	Empirical research suggests that the cognitively able are politically more influential than the less able, by being more likely to vote and to assume leadership positions. This study asks whether this pattern matters for public policy by investigating what role a person's cognitive ability plays in determining his preferences for redistribution of income among citizens in society. To answer this question, we use a unique Swedish data set that matches responses to a tailor-made questionnaire to administrative tax records and to military enlistment records for men, with the latter containing a measure of cognitive ability. On a scale of 0 to 100 percent redistribution, a one-standard-deviation increase in cognitive ability reduces the willingness to redistribute by 5 percentage points, or by the same amount as a $35,000 increase in mean annual income. We find support for two channels mediating this economically strong and statistically significant relation. First, higher ability is associated with higher income. Second, ability is positively correlated with the view that economic success is the result of effort, rather than luck. Both these factors are, in turn, related to lower demand for redistribution.	[Mollerstrom, Johanna] George Mason Univ, Interdisciplinary Ctr Econ Sci, Fairfax, VA 22030 USA; [Mollerstrom, Johanna] George Mason Univ, Dept Econ, Fairfax, VA 22030 USA; [Mollerstrom, Johanna] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Seim, David] Univ Toronto, Dept Econ, Toronto, ON M5S 1A1, Canada; [Mollerstrom, Johanna; Seim, David] Res Inst Ind Econ, Stockholm, Sweden	George Mason University; George Mason University; Harvard University; University of Toronto; Research Institute of Industrial Economics (IFN)	Mollerstrom, J (corresponding author), George Mason Univ, Interdisciplinary Ctr Econ Sci, Fairfax, VA 22030 USA.	johanna.mollerstrom@gmail.com			Ragnar Soderberg Foundation [E56-10]; Kungliga VetenskapsAkademin [FOA10H-172]; Lab for Economics Applications and Policy at Harvard [370 31890 017599 619701 0012 50963]	Ragnar Soderberg Foundation; Kungliga VetenskapsAkademin; Lab for Economics Applications and Policy at Harvard	Financial support for this project is gratefully acknowledged from: the Ragnar Soderberg Foundation (http://ragnarsoderbergsstiftelse.se/, grant number: E56-10), Kungliga VetenskapsAkademin (http://www.kva.se/, grant number: FOA10H-172) and the Lab for Economics Applications and Policy at Harvard (http://leap.fas.harvard.edu/, grant number: 370 31890 017599 619701 0012 50963). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alesina A, 2005, AM ECON REV, V95, P960, DOI 10.1257/0002828054825655; Alesina A, 2004, J PUBLIC ECON, V88, P2009, DOI 10.1016/j.jpubeco.2003.07.006; Alesina A, 2005, J PUBLIC ECON, V89, P897, DOI 10.1016/j.jpubeco.2004.05.009; Alesina A., 2004, FIGHTING POVERTY US; Alesina A., 2011, HDB SOCIAL EC B, V1A; Benabou R, 2001, Q J ECON, V116, P447, DOI 10.1162/00335530151144078; Benjamin DJ, 2013, J EUR ECON ASSOC, V11, P1231, DOI 10.1111/jeea.12055; Burks SV, 2009, P NATL ACAD SCI USA, V106, P7745, DOI 10.1073/pnas.0812360106; Carlstedt B., 2000, THESIS GOTHENBURG U; Deary IJ, 2008, PSYCHOL SCI, V19, P1, DOI 10.1111/j.1467-9280.2008.02036.x; Deary IJ, 2008, INTELLIGENCE, V36, P548, DOI 10.1016/j.intell.2008.09.001; DeYoung CG, 2014, J PERS ASSESS, V96, P46, DOI 10.1080/00223891.2013.806327; Dohmen T, 2010, AM ECON REV, V100, P1238, DOI 10.1257/aer.100.3.1238; Falk A, 2013, EXPT VALIDATED PREFE; Fong C, 2001, J PUBLIC ECON, V82, P225, DOI 10.1016/S0047-2727(00)00141-9; Fong CM, 2011, J PUBLIC ECON, V95, P372, DOI 10.1016/j.jpubeco.2010.07.010; Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; Heckman JJ, 2006, J LABOR ECON, V24, P411, DOI 10.1086/504455; Hodson G, 2012, PSYCHOL SCI, V23, P187, DOI 10.1177/0956797611421206; Holt CA, 2002, AM ECON REV, V92, P1644, DOI 10.1257/000282802762024700; Judge TA, 2004, J APPL PSYCHOL, V89, P542, DOI 10.1037/0021-9010.89.3.542; Keiller SW, 2010, J HOMOSEXUAL, V57, P914, DOI 10.1080/00918369.2010.493442; Lindqvist E, 2011, AM ECON J-APPL ECON, V3, P101, DOI 10.1257/app.3.1.101; MacKinnon D.P., 2012, INTRO STAT MEDIATION; MELTZER AH, 1981, J POLIT ECON, V89, P914, DOI 10.1086/261013; Romer Thomas., 1975, J PUBLIC ECON, V4, P163, DOI DOI 10.1016/0047-2727(75)90016-X; Rustichini A., 2012, 6750 IZA WP DP; Schoon I, 2010, INTELLIGENCE, V38, P144, DOI 10.1016/j.intell.2009.09.005; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI [10.2307/270723, DOI 10.2307/270723]; SOBEL ME, 1985, SOCIOL METHODOL, P152	30	20	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e109955	10.1371/journal.pone.0109955	http://dx.doi.org/10.1371/journal.pone.0109955			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BL	25343713	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943500025
J	Wang, GQ; MacRaild, CA; Mohanty, B; Mobli, M; Cowieson, NP; Anders, RF; Simpson, JS; McGowan, S; Norton, RS; Scanlon, MJ				Wang, Geqing; MacRaild, Christopher A.; Mohanty, Biswaranjan; Mobli, Mehdi; Cowieson, Nathan P.; Anders, Robin F.; Simpson, Jamie S.; McGowan, Sheena; Norton, Raymond S.; Scanlon, Martin J.			Molecular Insights into the Interaction between Plasmodium falciparum Apical Membrane Antigen 1 and an Invasion-Inhibitory Peptide	PLOS ONE			English	Article							HOST-CELL INVASION; MALARIA PARASITE INVASION; DRUGGABLE HOT-SPOTS; NMR CHEMICAL-SHIFTS; ERYTHROCYTE INVASION; BINDING; AMA1; NONPEPTIDE; PROTEINS; ANTIBODY	Apical membrane antigen 1 (AMA1) of the human malaria parasite Plasmodium falciparum has been implicated in invasion of the host erythrocyte. It interacts with malarial rhoptry neck (RON) proteins in the moving junction that forms between the host cell and the invading parasite. Agents that block this interaction inhibit invasion and may serve as promising leads for anti-malarial drug development. The invasion-inhibitory peptide R1 binds to a hydrophobic cleft on AMA1, which is an attractive target site for small molecules that block parasite invasion. In this work, truncation and mutational analyses show that Phe5-Phe9, Phe12 and Arg15 in R1 are the most important residues for high affinity binding to AMA1. These residues interact with two well-defined binding hot spots on AMA1. Computational solvent mapping reveals that one of these hot spots is suitable for small molecule targeting. We also confirm that R1 in solution binds to AMA1 with 1:1 stoichiometry and adopts a secondary structure consistent with the major form of R1 observed in the crystal structure of the complex. Our results provide a basis for designing high affinity inhibitors of the AMA1-RON2 interaction.	[Wang, Geqing; MacRaild, Christopher A.; Mohanty, Biswaranjan; Simpson, Jamie S.; Norton, Raymond S.; Scanlon, Martin J.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia; [Mohanty, Biswaranjan; Scanlon, Martin J.] Monash Univ, Australian Res Council Ctr Excellence Coherent Xr, Parkville, Vic, Australia; [Mobli, Mehdi] Univ Queensland, Ctr Adv Imaging, St Lucia, Qld, Australia; [Cowieson, Nathan P.] Australian Synchrotron, Clayton, Vic, Australia; [Anders, Robin F.] La Trobe Univ, Dept Biochem, Bundoora, Vic 3083, Australia; [McGowan, Sheena] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia	Monash University; Monash University; University of Queensland; La Trobe University; Monash University	Norton, RS (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia.	ray.norton@monash.edu; martin.scanlon@monash.edu	McGowan, Sheena/C-4797-2014; Simpson, Jamie/ABC-7083-2020; Simpson, Jamie S/A-1700-2012; Mobli, Mehdi/O-7244-2014; Mohanty, Biswaranjan/E-2080-2018	McGowan, Sheena/0000-0001-6863-1106; Simpson, Jamie/0000-0002-8894-422X; Simpson, Jamie S/0000-0002-8894-422X; Mobli, Mehdi/0000-0003-2420-4262; Mohanty, Biswaranjan/0000-0002-6921-343X; Wang, Geqing/0000-0002-9419-8657; Norton, Raymond/0000-0001-8893-0584; Anders, Robin/0000-0002-0693-4547; MacRaild, Christopher/0000-0002-3694-3989; Scanlon, Martin/0000-0002-9230-7506	National Health and Medical Research Council of Australia [1025150]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The work was funded in part by a grant from the National Health and Medical Research Council of Australia (1025150). RSN is a research fellow of the National Health and Medical Research Council (1059060) (www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Bai T, 2005, P NATL ACAD SCI USA, V102, P12736, DOI 10.1073/pnas.0501808102; Bargieri DY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3552; Blackburn BK, 1997, J MED CHEM, V40, P717, DOI 10.1021/jm960652r; Brenke R, 2009, BIOINFORMATICS, V25, P621, DOI 10.1093/bioinformatics/btp036; Cabrita LD, 2007, PROTEIN SCI, V16, P2360, DOI 10.1110/ps.072822507; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Coley AM, 2006, INFECT IMMUN, V74, P2628, DOI 10.1128/IAI.74.5.2628-2636.2006; Coley AM, 2007, PLOS PATHOG, V3, P1308, DOI 10.1371/journal.ppat.0030138; Collins CR, 2007, J BIOL CHEM, V282, P7431, DOI 10.1074/jbc.M610562200; Collins CR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000273; Cortes A, 2003, INFECT IMMUN, V71, P1416, DOI 10.1128/IAI.71.3.1416-1426.2003; Damour D, 1996, BIOORG MED CHEM LETT, V6, P1667, DOI 10.1016/0960-894X(96)00289-2; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Giovannini D, 2011, CELL HOST MICROBE, V10, P591, DOI 10.1016/j.chom.2011.10.012; Han B, 2011, J BIOMOL NMR, V50, P43, DOI 10.1007/s10858-011-9478-4; Harris KS, 2009, J BIOL CHEM, V284, P9361, DOI 10.1074/jbc.M808762200; Harris KS, 2005, INFECT IMMUN, V73, P6981, DOI 10.1128/IAI.73.10.6981-6989.2005; Henderson KA, 2007, STRUCTURE, V15, P1452, DOI 10.1016/j.str.2007.09.011; HIRSCHMANN R, 1993, J AM CHEM SOC, V115, P12550, DOI 10.1021/ja00079a039; JAMES GL, 1993, SCIENCE, V260, P1937, DOI 10.1126/science.8316834; Keller R., 2004, COMPUTER AIDED RESON, V1; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozakov D, 2011, P NATL ACAD SCI USA, V108, P13528, DOI 10.1073/pnas.1101835108; Lamarque M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001276; Lamarque MH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5098; Lee EF, 2011, BIOPOLYMERS, V95, P354, DOI 10.1002/bip.21582; Li F, 2002, J BIOL CHEM, V277, P50303, DOI 10.1074/jbc.M207985200; Lim SS, 2013, AUST J CHEM, V66, P1530, DOI 10.1071/CH13266; MacRaild CA, 2011, CURR TOP MED CHEM, V11, P2039; MCDOWELL RS, 1994, J AM CHEM SOC, V116, P5069, DOI 10.1021/ja00091a007; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Miller LH, 2013, NAT MED, V19, P156, DOI 10.1038/nm.3073; Mital J, 2005, MOL BIOL CELL, V16, P4341, DOI 10.1091/mbc.E05-04-0281; Mobli M, 2007, NAT METHODS, V4, P467, DOI 10.1038/nmeth0607-467; Mobli M, 2010, J MAGN RESON, V204, P160, DOI 10.1016/j.jmr.2010.02.012; Ono K, 2014, ANGEW CHEM INT EDIT, V53, P2597, DOI 10.1002/anie.201310749; Polley SD, 2003, GENETICS, V165, P555; Richard D, 2010, J BIOL CHEM, V285, P14815, DOI 10.1074/jbc.M109.080770; Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003; Silvie O, 2004, J BIOL CHEM, V279, P9490, DOI 10.1074/jbc.M311331200; Sivashanmugam A, 2009, PROTEIN SCI, V18, P936, DOI 10.1002/pro.102; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; Srinivasan P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3261; Srinivasan P, 2011, P NATL ACAD SCI USA, V108, P13275, DOI 10.1073/pnas.1110303108; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tonkin ML, 2013, PROTEIN SCI, V22, P114, DOI 10.1002/pro.2193; Tonkin ML, 2011, SCIENCE, V333, P463, DOI 10.1126/science.1204988; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x; Vulliez-Le Normand B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002755; Whitten AE, 2008, J APPL CRYSTALLOGR, V41, P222, DOI 10.1107/S0021889807055136; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Yap A, 2014, CELL MICROBIOL, DOI [10.1111/cmi.122287, DOI 10.1111/CMI.122287]	54	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e109674	10.1371/journal.pone.0109674	http://dx.doi.org/10.1371/journal.pone.0109674			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343578	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943500019
J	Xu, Y; Hua, J; Ni, ZH; Chen, QL; Fan, YB; Ananiadou, S; Chang, EIC; Tsujii, J				Xu, Yan; Hua, Ji; Ni, Zhaoheng; Chen, Qinlang; Fan, Yubo; Ananiadou, Sophia; Chang, Eric I-Chao; Tsujii, Junichi			Anatomical Entity Recognition with a Hierarchical Framework Augmented by External Resources	PLOS ONE			English	Article							CLINICAL DOCUMENTS; FOUNDATIONAL MODEL; ONTOLOGY; TEXT	References to anatomical entities in medical records consist not only of explicit references to anatomical locations, but also other diverse types of expressions, such as specific diseases, clinical tests, clinical treatments, which constitute implicit references to anatomical entities. In order to identify these implicit anatomical entities, we propose a hierarchical framework, in which two layers of named entity recognizers (NERs) work in a cooperative manner. Each of the NERs is implemented using the Conditional Random Fields (CRF) model, which use a range of external resources to generate features. We constructed a dictionary of anatomical entity expressions by exploiting four existing resources, i.e., UMLS, MeSH, RadLex and BodyPart3D, and supplemented information from two external knowledge bases, i.e., Wikipedia and WordNet, to improve inference of anatomical entities from implicit expressions. Experiments conducted on 300 discharge summaries showed a micro-averaged performance of 0.8509 Precision, 0.7796 Recall and 0.8137 F1 for explicit anatomical entity recognition, and 0.8695 Precision, 0.6893 Recall and 0.7690 F1 for implicit anatomical entity recognition. The use of the hierarchical framework, which combines the recognition of named entities of various types (diseases, clinical tests, treatments) with information embedded in external knowledge bases, resulted in a 5.08% increment in F1. The resources constructed for this research will be made publicly available.	[Xu, Yan; Hua, Ji; Ni, Zhaoheng; Chen, Qinlang; Fan, Yubo] Beihang Univ, State Key Lab Software Dev Environm, Key Lab Biomech & Mechanobiol, Minist Educ, Beijing 100191, Peoples R China; [Chang, Eric I-Chao; Tsujii, Junichi] Microsoft Res Asia, Beijing, Peoples R China; [Ananiadou, Sophia] Univ Manchester, Natl Ctr Text Min, Sch Comp Sci, Manchester, Lancs, England	Beihang University; Microsoft; Microsoft Research Asia; University of Manchester	Chang, EIC (corresponding author), Microsoft Res Asia, Beijing, Peoples R China.	eric.chang@microsoft.com; jtsujii@microsoft.com			Microsoft Research Asia (MSR Asia); MSRA eHealth grant; National Science Foundation of China [61073077]; State Key Laboratory of Software Development Environment in Beihang University in China [SKLSDE-2011ZX-13]; Medical Research Council [MR/L01078X/1]; Defense Advanced Research Projects Agency [DARPA-BAA-14-14]; MRC [MR/L01078X/1] Funding Source: UKRI	Microsoft Research Asia (MSR Asia)(Microsoft); MSRA eHealth grant; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Software Development Environment in Beihang University in China; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Microsoft Research Asia (MSR Asia). The work was also supported by MSRA eHealth grant, Grant 61073077 from National Science Foundation of China and Grant SKLSDE-2011ZX-13 from State Key Laboratory of Software Development Environment in Beihang University in China. This work has been funded by the Medical Research Council (Supporting Evidence-based Public Health Interventions using Text Mining [Grant MR/L01078X/1]) and by the Defense Advanced Research Projects Agency (Big Mechanism [Grant DARPA-BAA-14-14]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananiadou S, 2014, BRIEFINGS F IN PRESS; Carletta J, 1996, COMPUT LINGUIST, V22, P249; Cucerzan Silviu, 2007, P 2007 JOINT C EMPIR; FRIEDMAN C, 1994, J AM MED INFORM ASSN, V1, P161, DOI 10.1136/jamia.1994.95236146; Friedman C, 2004, J AM MED INFORM ASSN, V11, P392, DOI 10.1197/jamia.M1552; HRIPCSAK G, 1995, ANN INTERN MED, V122, P681, DOI 10.7326/0003-4819-122-9-199505010-00007; Hripcsak G, 2002, RADIOLOGY, V224, P157, DOI 10.1148/radiol.2241011118; Jin-Dong K, 2004, P JNLPABA 2004; John L, 2001, P 18 INT C MACH LEAR; Junichi K, 2007, P 2007 JOINT C EMP M, P698; Li X, 2009, P 32 ACM SPEC INT GR; Martin G, 2010, BIONLP, P72; Meystre S, 2006, J BIOMED INFORM, V39, P589, DOI 10.1016/j.jbi.2005.11.004; Meystre Stephane M, 2005, AMIA Annu Symp Proc, P525; MX Zuo, 2009, HUMAN ANATOMY PHYSL; Naderi N, 2011, BIOINFORMATICS, V27, P2721, DOI 10.1093/bioinformatics/btr452; Powers D.M.W., 2011, J MACH LEARN TECHNOL, V2, P3763; Pyysalo S, 2014, BIOINFORMATICS, V30, P868, DOI 10.1093/bioinformatics/btt580; Rink B, 2011, J AM MED INFORM ASSN, V18, P594, DOI 10.1136/amiajnl-2011-000153; Rosse C, 2003, J BIOMED INFORM, V36, P478, DOI 10.1016/j.jbi.2003.11.007; Rosse C., 2007, COMPUT BIOL SER, V6, P59; SAGER N, 1994, J AM MED INFORM ASSN, V1, P142, DOI 10.1136/jamia.1994.95236145; Schwartz A.S., 2003, PACIFIC S BIOCOMPUTI, V8, P451; Spyns P, 1996, METHOD INFORM MED, V35, P285; Uzuner O, 2011, J AM MED INFORM ASSN, V18, P552, DOI 10.1136/amiajnl-2011-000203; Xu Y, 2012, J AM MED INFORM ASSN, V19, P897, DOI 10.1136/amiajnl-2011-000734; Yan X, 2012, BIOMED INFORM INSIGH, V5, P31	27	7	7	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e108396	10.1371/journal.pone.0108396	http://dx.doi.org/10.1371/journal.pone.0108396			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BL	25343498	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943500005
J	Diaz, N; Ribas, L; Piferrer, F				Diaz, Noelia; Ribas, Laia; Piferrer, Francesc			Effects of Changes in Food Supply at the Time of Sex Differentiation on the Gonadal Transcriptome of Juvenile Fish. Implications for Natural and Farmed Populations	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; DICENTRARCHUS-LABRAX L.; COD GADUS-MORHUA; GENE-EXPRESSION; ATLANTIC COD; BASS; GROWTH; TEMPERATURE; ENERGY; BIOINFORMATICS	Background: Food supply is a major factor influencing growth rates in animals. This has important implications for both natural and farmed fish populations, since food restriction may difficult reproduction. However, a study on the effects of food supply on the development of juvenile gonads has never been transcriptionally described in fish. Methods and Findings: This study investigated the consequences of growth on gonadal transcriptome of European sea bass in: 1) 4-month-old sexually undifferentiated fish, comparing the gonads of fish with the highest vs. the lowest growth, to explore a possible link between transcriptome and future sex, and 2) testis from 11-month-old juveniles where growth had been manipulated through changes in food supply. The four groups used were: i) sustained fast growth, ii) sustained slow growth, iii) accelerated growth, iv) decelerated growth. The transcriptome of undifferentiated gonads was not drastically affected by initial natural differences in growth. Further, changes in the expression of genes associated with protein turnover were seen, favoring catabolism in slow-growing fish and anabolism in fast-growing fish. Moreover, while fast-growing fish took energy from glucose, as deduced from the pathways affected and the analysis of protein-protein interactions examined, in slow-growing fish lipid metabolism and gluconeogenesis was favored. Interestingly, the highest transcriptomic differences were found when forcing initially fast-growing fish to decelerate their growth, while accelerating growth of initially slow-growing fish resulted in full transcriptomic convergence with sustained fast-growing fish. Conclusions: Food availability during sex differentiation shapes the juvenile testis transcriptome, as evidenced by adaptations to different energy balances. Remarkably, this occurs in absence of major histological changes in the testis. Thus, fish are able to recover transcriptionally their testes if they are provided with enough food supply during sex differentiation; however, an initial fast growth does not represent any advantage in terms of transcriptional fitness if later food becomes scarce.	[Diaz, Noelia; Ribas, Laia; Piferrer, Francesc] CSIC, Inst Ciencias Mar, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Piferrer, F (corresponding author), CSIC, Inst Ciencias Mar, Barcelona, Spain.	piferrer@icm.csic.es	Piferrer, Francesc/A-5634-2012; Ribas, Laia/E-1466-2013; Díaz, Noelia/AAZ-6001-2020	Piferrer, Francesc/0000-0003-0903-4736; Ribas, Laia/0000-0001-5538-6236; Díaz, Noelia/0000-0002-0319-3448	Spanish Ministry of Science [AGL2010-15939, CDS2007-0002]; Government of Spain [BES-2007-14273]; Epigen-Aqua project; Aquagenomics postdoctoral contract	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Government of Spain(Spanish Government); Epigen-Aqua project; Aquagenomics postdoctoral contract	Research was supported by the Spanish Ministry of Science projects "Epigen-Aqua'' (AGL2010-15939) and "Aquagenomics'' (CDS2007-0002) to FP. ND was supported by a scholarship from the Government of Spain (BES-2007-14273) and then by a contract by the Epigen-Aqua project. LR was supported by an Aquagenomics postdoctoral contract and Epigen-Aqua project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS SM, 1982, T AM FISH SOC, V111, P549, DOI 10.1577/1548-8659(1982)111<549:EPILBU>2.0.CO;2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blazquez M, 1995, AQUACULTURE, V135, P329, DOI 10.1016/0044-8486(95)01030-0; Blazquez M, 1999, J FISH BIOL, V55, P916, DOI 10.1111/j.1095-8649.1999.tb00730.x; Blazquez M, 2009, J EXP ZOOL PART B, V312B, P686, DOI 10.1002/jez.b.21286; Bolstad B, 2001, PROBE LEVEL QU UNPUB; Boshra H, 2004, J IMMUNOL, V173, P349, DOI 10.4049/jimmunol.173.1.349; Bozinovic G, 2011, ENVIRON TOXICOL CHEM, V30, P283, DOI 10.1002/etc.403; Calduch-Giner JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-470; Campos C, 2010, J EXP BIOL, V213, P200, DOI 10.1242/jeb.033126; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Castellano JM, 2009, PEPTIDES, V30, P139, DOI 10.1016/j.peptides.2008.06.007; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Craiu A, 1997, P NATL ACAD SCI USA, V94, P10850, DOI 10.1073/pnas.94.20.10850; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Diaz N, 2013, AQUACULTURE, V408, P191, DOI 10.1016/j.aquaculture.2013.05.032; Dobly A, 2004, COMP BIOCHEM PHYS A, V137, P75, DOI 10.1016/j.cbpb.2003.09.002; Drew RE, 2008, PHYSIOL GENOMICS, V35, P283, DOI 10.1152/physiolgenomics.90213.2008; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gabillard JC, 2006, J ENDOCRINOL, V191, P15, DOI 10.1677/joe.1.06869; Geay F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-522; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Higami Y, 2003, FASEB J, V17, P415, DOI 10.1096/fj.03-0678fje; Houlihan DF, 1995, PROTEIN SYNTHESIS FI; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jiang H, 2009, COMP BIOCHEM PHYS D, V4, P227, DOI 10.1016/j.cbd.2009.05.001; Kjaer MA, 2009, AQUACULTURE, V288, P325, DOI 10.1016/j.aquaculture.2008.12.022; KJESBU OS, 1994, J FISH BIOL, V45, P719, DOI 10.1006/jfbi.1994.1172; Koumoundouros G, 2002, J EXP ZOOL, V292, P573, DOI 10.1002/jez.10095; Marshall CT, 1999, NATURE, V402, P288, DOI 10.1038/46272; Martin B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004146; Martin P, 2007, NATURWISSENSCHAFTEN, V94, P843, DOI 10.1007/s00114-007-0260-0; Martin SAM, 2002, PFLUG ARCH EUR J PHY, V445, P257, DOI 10.1007/s00424-002-0916-8; Martin SA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-418; Moretti A, 1999, MANUAL HATCHERY PROD; Morgan MJ, 2013, FISH RES, V138, P42, DOI 10.1016/j.fishres.2012.02.019; Mylonas CC, 2005, J FISH BIOL, V67, P652, DOI 10.1111/j.0022-1112.2005.00766.x; Navarro-Martin L, 2009, AQUACULTURE, V296, P347, DOI 10.1016/j.aquaculture.2009.07.022; Overturf K, 2010, AQUACULTURE, V307, P111, DOI 10.1016/j.aquaculture.2010.06.010; Palstra AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053171; Papadaki M, 2005, J FISH BIOL, V66, P938, DOI 10.1111/j.0022-1112.2005.00639.x; Ravi P, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-5; Rescan PY, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-438; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; ROBLIN C, 1983, REPROD NUTR DEV, V23, P115, DOI 10.1051/rnd:19830110; Rolland AD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-546; Saillant E, 2003, J ZOOL, V260, P53, DOI 10.1017/S0952836903003467; Saillant E, 2003, AQUACULTURE, V221, P183, DOI 10.1016/S0044-8486(02)00539-2; Salas-Leiton E, 2010, FISH SHELLFISH IMMUN, V28, P296, DOI 10.1016/j.fsi.2009.11.006; Salem M, 2006, COMP BIOCHEM PHYS D, V1, P227, DOI 10.1016/j.cbd.2005.12.003; Schiller V, 2013, REPROD TOXICOL, V42, P210, DOI 10.1016/j.reprotox.2013.09.003; Schiller V, 2013, COMP BIOCHEM PHYS C, V157, P41, DOI 10.1016/j.cbpc.2012.09.005; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schneider JE, 2004, PHYSIOL BEHAV, V81, P289, DOI 10.1016/j.physbeh.2004.02.007; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sun FY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068452; Tacchi L, 2011, FISH SHELLFISH IMMUN, V31, P704, DOI 10.1016/j.fsi.2011.02.023; Tanaka K, 1998, GENES CELLS, V3, P499, DOI 10.1046/j.1365-2443.1998.00207.x; Tao WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063604; Vandeputte M, 2007, GENETICS, V176, P1049, DOI 10.1534/genetics.107.072140; Volkoff H, 2009, COMP BIOCHEM PHYS A, V153, P8, DOI 10.1016/j.cbpa.2008.12.001; Yi SK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-754; Yoneda M, 2005, J FISH BIOL, V67, P1225, DOI 10.1111/j.1095-8649.2005.00819.x	64	7	7	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111304	10.1371/journal.pone.0111304	http://dx.doi.org/10.1371/journal.pone.0111304			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340342	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662800100
J	Fumagalli, M; Rossiello, F; Mondello, C; di Fagagna, FD				Fumagalli, Marzia; Rossiello, Francesca; Mondello, Chiara; di Fagagna, Fabrizio d'Adda			Stable Cellular Senescence Is Associated with Persistent DDR Activation	PLOS ONE			English	Article							DNA-DAMAGE-RESPONSE; ONCOGENE-INDUCED SENESCENCE; STRESS-INDUCED SENESCENCE; HEMATOPOIETIC STEM-CELLS; HUMAN FIBROBLASTS; PREMATURE SENESCENCE; TRIGGERS SENESCENCE; AGING PRIMATES; P53; P16(INK4A)	The DNA damage response (DDR) is activated upon DNA damage generation to promote DNA repair and inhibit cell cycle progression in the presence of a lesion. Cellular senescence is a permanent cell cycle arrest characterized by persistent DDR activation. However, some reports suggest that DDR activation is a feature only of early cellular senescence that is then lost with time. This challenges the hypothesis that cellular senescence is caused by persistent DDR activation. To address this issue, we studied DDR activation dynamics in senescent cells. Here we show that normal human fibroblasts retain DDR markers months after replicative senescence establishment. Consistently, human fibroblasts from healthy aged donors display markers of DDR activation even three years in culture after entry into replicative cellular senescence. However, by extending our analyses to different human cell strains, we also observed an apparent DDR loss with time following entry into cellular senescence. This though correlates with the inability of these cell strains to survive in culture upon replicative or irradiation-induced cellular senescence. We propose a model to reconcile these results. Cell strains not suffering the prolonged in vitro culture stress retain robust DDR activation that persists for years, indicating that under physiological conditions persistent DDR is causally involved in senescence establishment and maintenance. However, cell strains unable to maintain cell viability in vitro, due to their inability to cope with prolonged cell culture-associated stress, show an only-apparent reduction in DDR foci which is in fact due to selective loss of the most damaged cells.	[Fumagalli, Marzia; Rossiello, Francesca; di Fagagna, Fabrizio d'Adda] FIRC Inst Mol Oncol Fdn, IFOM Fdn, Milan, Italy; [Mondello, Chiara; di Fagagna, Fabrizio d'Adda] CNR, Ist Genet Mol, I-27100 Pavia, Italy	IFOM - FIRC Institute of Molecular Oncology; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR)	di Fagagna, FD (corresponding author), FIRC Inst Mol Oncol Fdn, IFOM Fdn, Milan, Italy.	fabrizio.dadda@ifom.eu	d'Adda di Fagagna, Fabrizio/AAC-4683-2022; Rossiello, Francesca/AAA-8160-2022; Mondello, Chiara/B-8305-2015	d'Adda di Fagagna, Fabrizio/0000-0002-9603-5966; Rossiello, Francesca/0000-0002-6240-9907; Mondello, Chiara/0000-0002-8379-9246; DADDADIFAGAGNA, FABRIZIO/0000-0002-1976-3185	FIRC (Fondazione Italiana per la Ricerca sul Cancro) [12476]; AIRC (Associazione Italiana per la Ricerca sul Cancro) [8866]; HFSP (Human Frontier Science Program) [RGP 0014/2012]; AICR (Association for International Cancer Research) [14-1331]; FP7 PEOPLE ITN (CodeAge) [GA 316354]; Telethon [GGP12059]; Italian Ministry of Education, Universities, and Research (MIUR) [2010M4NEFY_006]; EPIGEN Project; European Research Council [322726]; Fondazione Cariplo [2011-0370]	FIRC (Fondazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); HFSP (Human Frontier Science Program)(Human Frontier Science Program); AICR (Association for International Cancer Research); FP7 PEOPLE ITN (CodeAge); Telethon(Fondazione Telethon); Italian Ministry of Education, Universities, and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); EPIGEN Project; European Research Council(European Research Council (ERC)European Commission); Fondazione Cariplo(Fondazione Cariplo)	F.R. is supported by FIRC (Fondazione Italiana per la Ricerca sul Cancro, code 12476, http://www.fondazionefirc.it); F.d'A.d.F. laboratory is supported by AIRC (Associazione Italiana per la Ricerca sul Cancro, grant number 8866, http://www.airc.it); HFSP (Human Frontier Science Program, contract number: RGP 0014/2012, http://www.hfsp.org); AICR (Association for International Cancer Research, 14-1331, http://www.aicr.org.uk); FP7 PEOPLE 2012 ITN (CodeAge, GA 316354, http://itn-codeage.uni-koeln.de); Telethon (GGP12059, http://www.telethon.it); PRIN 2010-2011, the Italian Ministry of Education, Universities, and Research (MIUR, 2010M4NEFY_006, http://prin.miur.it); EPIGEN Project (http://www.epigen.it); and European Research Council advanced grant (322726, http://erc.europa.eu). C.M. laboratory is supported by Fondazione Cariplo (grant n. 2011-0370, http://www.fondazionecariplo.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Bakkenist CJ, 2004, CANCER RES, V64, P3748, DOI 10.1158/0008-5472.CAN-04-0453; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Britt-Compton B, 2009, BIOGERONTOLOGY, V10, P683, DOI 10.1007/s10522-009-9216-4; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chen JH, 2006, FEBS LETT, V580, P6669, DOI 10.1016/j.febslet.2006.11.023; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; de Magalhaes JP, 2002, FEBS LETT, V523, P157, DOI 10.1016/S0014-5793(02)02973-3; Denchi EL, 2005, MOL CELL BIOL, V25, P2660, DOI 10.1128/MCB.25.7.2660-2672.2005; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Di Micco R, 2011, NAT CELL BIOL, V13, P292, DOI 10.1038/ncb2170; Drayton S, 2002, CURR OPIN GENET DEV, V12, P98, DOI 10.1016/S0959-437X(01)00271-4; Evan GI, 2009, CURR OPIN GENET DEV, V19, P25, DOI 10.1016/j.gde.2008.11.009; Falcone G, 2013, AGING CELL, V12, P312, DOI 10.1111/acel.12034; Forsyth NR, 2003, AGING CELL, V2, P235, DOI 10.1046/j.1474-9728.2003.00057.x; Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466; Gorbunova V, 2002, J BIOL CHEM, V277, P38540, DOI 10.1074/jbc.M202671200; Grandori C, 2003, GENE DEV, V17, P1569, DOI 10.1101/gad.1100303; Herbert BS, 2002, ONCOGENE, V21, P7897, DOI 10.1038/sj.onc.1205902; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; Johnson DG, 2006, CURR MOL MED, V6, P731; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Marusyk A, 2007, MOL CELL BIOL, V27, P5336, DOI 10.1128/MCB.01316-06; Meier A, 2007, EMBO J, V26, P2707, DOI 10.1038/sj.emboj.7601719; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Milyavsky M, 2003, CANCER RES, V63, P7147; Moiseeva O, 2006, MOL BIOL CELL, V17, P1583, DOI 10.1091/mbc.E05-09-0858; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Mondello C, 2003, BIOCHEM BIOPH RES CO, V308, P914, DOI 10.1016/S0006-291X(03)01484-0; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Ogrunc M, 2014, CELL DEATH DIFFER, V21, P998, DOI 10.1038/cdd.2014.16; Ramirez RD, 2001, GENE DEV, V15, P398, DOI 10.1101/gad.859201; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rube CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017487; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Suram A, 2012, EMBO J; Suzuki M, 2006, BIOCHEM BIOPH RES CO, V340, P145, DOI 10.1016/j.bbrc.2005.11.167; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; te Poele RH, 2002, CANCER RES, V62, P1876; von Zglinicki T, 2005, MECH AGEING DEV, V126, P111, DOI 10.1016/j.mad.2004.09.034; Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x; Zdanov S, 2006, FEBS LETT, V580, P6455, DOI 10.1016/j.febslet.2006.10.064; Zou Y, 2004, MOL BIOL CELL, V15, P3709, DOI 10.1091/mbc.E04-03-0207	58	78	81	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110969	10.1371/journal.pone.0110969	http://dx.doi.org/10.1371/journal.pone.0110969			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340529	gold, Green Published, Green Submitted			2022-12-27	WOS:000343662800075
J	Gonzalo, S; Llaneza, V; Pulido-Reyes, G; Fernandez-Pinas, F; Bonzongo, JC; Leganes, F; Rosal, R; Garcia-Calvo, E; Rodea-Palomares, I				Gonzalo, Soledad; Llaneza, Veronica; Pulido-Reyes, Gerardo; Fernandez-Pinas, Francisca; Bonzongo, Jean Claude; Leganes, Francisco; Rosal, Roberto; Garcia-Calvo, Eloy; Rodea-Palomares, Ismael			A Colloidal Singularity Reveals the Crucial Role of Colloidal Stability for Nanomaterials In-Vitro Toxicity Testing: nZVI-Microalgae Colloidal System as a Case Study	PLOS ONE			English	Article							SILVER NANOPARTICLES SNPS; VALENT IRON NANOPARTICLES; OXIDE NANOPARTICLES; BIOPHYSICOCHEMICAL INTERACTIONS; SILICA NANOPARTICLES; DNA FRAGMENTATION; ECOTOXICITY; CELL; CYTOTOXICITY; COAGULATION	Aggregation raises attention in Nanotoxicology due to its methodological implications. Aggregation is a physical symptom of a more general physicochemical condition of colloidal particles, namely, colloidal stability. Colloidal stability is a global indicator of the tendency of a system to reduce its net surface energy, which may be achieved by homo-aggregation or hetero-aggregation, including location at bio-interfaces. However, the role of colloidal stability as a driver of ENM bioactivity has received little consideration thus far. In the present work, which focuses on the toxicity of nanoscaled Fe nanoparticles (nZVI) towards a model microalga, we demonstrate that colloidal stability is a fundamental driver of ENM bioactivity, comprehensively accounting for otherwise inexplicable differential biological effects. The present work throws light on basic aspects of Nanotoxicology, and reveals a key factor which may reconcile contradictory results on the influence of aggregation in bioactivity of ENMs.	[Gonzalo, Soledad; Pulido-Reyes, Gerardo; Rosal, Roberto; Garcia-Calvo, Eloy] Univ Alcala de Henares, Dept Ingn Quim, Madrid, Spain; [Llaneza, Veronica; Bonzongo, Jean Claude] Univ Florida, Dept Environm Engn Sci, Gainesville, FL 32611 USA; [Pulido-Reyes, Gerardo; Fernandez-Pinas, Francisca; Leganes, Francisco; Rodea-Palomares, Ismael] Univ Autonoma Madrid, Fac Ciencias, Dept Biol, E-28049 Madrid, Spain; [Rosal, Roberto; Garcia-Calvo, Eloy] Inst Madrileno Estudios Avanzados IMDEA Agua, Madrid, Spain	Universidad de Alcala; State University System of Florida; University of Florida; Autonomous University of Madrid	Rodea-Palomares, I (corresponding author), Univ Autonoma Madrid, Fac Ciencias, Dept Biol, E-28049 Madrid, Spain.	ismael.rodea@uam.es	Fernandez-Piñas, Francisca/L-2450-2013; Bonzongo, Jean-Claude J/K-8271-2015; Rosal, Roberto/N-1231-2014; Calvo, Eloy García/K-3627-2017; Pulido-Reyes, Gerardo/AAA-4125-2022	Fernandez-Piñas, Francisca/0000-0002-7444-7601; Rosal, Roberto/0000-0003-0816-8775; Calvo, Eloy García/0000-0001-8795-3880; Pulido-Reyes, Gerardo/0000-0003-0853-9951; Rodea Palomares, Ismael Martin/0000-0002-4630-7345; BONZONGO, Jean-Claude/0000-0001-8431-7723	Comunidad de Madrid (Microambiente-CM) [S-0505/AMB/0321, S-2009/AMB/1511]; Spanish Ministry of Science and Innovation sub-program BOS [CGL2010-15675, CTM2008-04239/TECNO]; Spanish Ministry of Economy and Competitiveness (MINECO) [CTM2013-45775-C2-1-R, CTM2013-45775-C2-2-R]; US-National Science Foundation [CBET-0853347]	Comunidad de Madrid (Microambiente-CM)(Comunidad de Madrid); Spanish Ministry of Science and Innovation sub-program BOS(Ministry of Science and Innovation, Spain (MICINN)); Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); US-National Science Foundation(National Science Foundation (NSF))	This research was supported by the Comunidad de Madrid grants S-0505/AMB/0321 and S-2009/AMB/1511 (Microambiente-CM). The Spanish Ministry of Science and Innovation grants CGL2010-15675 sub-program BOS, and the CTM2008-04239/TECNO, and the Spanish Ministry of Economy and Competitiveness (MINECO) grants CTM2013-45775-C2-1-R, CTM2013-45775-C2-2-R and the US-National Science Foundation, grant number CBET-0853347.	[Anonymous], 2012, NAT NANOTECHNOL, V7, P545, DOI 10.1038/nnano.2012.150; [Anonymous], 1998, ORGANIC STRUCTURE AN; Auffan M, 2008, ENVIRON SCI TECHNOL, V42, P6730, DOI 10.1021/es800086f; BORTNER CD, 1995, TRENDS CELL BIOL, V5, P21, DOI 10.1016/S0962-8924(00)88932-1; Burhans WC, 2009, FREE RADICAL BIO MED, V47, P1282, DOI 10.1016/j.freeradbiomed.2009.05.026; Duan JM, 2003, ADV COLLOID INTERFAC, V100, P475, DOI 10.1016/S0001-8686(02)00067-2; Garside P, 2003, STUD CONSERV, V48, P269, DOI 10.1179/sic.2003.48.4.269; Gilbert B, 2009, J COLLOID INTERF SCI, V339, P285, DOI 10.1016/j.jcis.2009.07.058; Gong N, 2011, CHEMOSPHERE, V83, P510, DOI 10.1016/j.chemosphere.2010.12.059; Gregory J., 2006, PARTICLES WATER PROP; Grieger KD, 2010, J CONTAM HYDROL, V118, P165, DOI 10.1016/j.jconhyd.2010.07.011; Hadjoudja S, 2010, J COLLOID INTERF SCI, V342, P293, DOI 10.1016/j.jcis.2009.10.078; Handy RD, 2012, ENVIRON TOXICOL CHEM, V31, P15, DOI 10.1002/etc.706; Hartmann NB, 2013, NANOTOXICOLOGY, V7, P1082, DOI 10.3109/17435390.2012.710657; Henderson RK, 2010, WATER RES, V44, P3617, DOI 10.1016/j.watres.2010.04.016; Ivask A, 2014, ACS NANO, V8, P374, DOI 10.1021/nn4044047; Jiang W, 2010, LANGMUIR, V26, P18071, DOI 10.1021/la103738e; Kahru A, 2010, TOXICOLOGY, V269, P105, DOI 10.1016/j.tox.2009.08.016; Keller AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043983; Khan SS, 2011, J HAZARD MATER, V192, P299, DOI 10.1016/j.jhazmat.2011.05.024; Khan SS, 2011, COLLOID SURFACE B, V87, P129, DOI 10.1016/j.colsurfb.2011.05.012; Lee C, 2008, ENVIRON SCI TECHNOL, V42, P4927, DOI 10.1021/es800408u; Li HC, 2009, ECOTOX ENVIRON SAFE, V72, P684, DOI 10.1016/j.ecoenv.2008.09.027; Li ZQ, 2010, ENVIRON SCI TECHNOL, V44, P3462, DOI 10.1021/es9031198; Lin DH, 2012, WATER RES, V46, P4477, DOI 10.1016/j.watres.2012.05.035; Long ZF, 2012, ENVIRON SCI TECHNOL, V46, P8458, DOI 10.1021/es301802g; Lugo-Lugo V, 2012, J ENVIRON MANAGE, V112, P120, DOI 10.1016/j.jenvman.2012.07.009; Ma S, 2013, ENVIRON SCI-PROC IMP, V15, P145, DOI 10.1039/c2em30637a; Mace C, 2006, REMEDIATION, V16, P23, DOI 10.1002/rem.20079; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Nel A, 2013, ACCOUNTS CHEM RES, V46, P605, DOI 10.1021/ar400005v; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; OECD, 2006, 201 OECD TG; Pakrashi S, 2013, AQUAT TOXICOL, V132, P34, DOI 10.1016/j.aquatox.2013.01.018; Phenrat T, 2009, ENVIRON SCI TECHNOL, V43, P195, DOI 10.1021/es801955n; Phenrat T, 2007, ENVIRON SCI TECHNOL, V41, P284, DOI [10.1021/es061349a, 10.1021/es0614349a]; Pitre D, 2014, CHEM CENT J, V8, DOI 10.1186/1752-153X-8-8; Rabolli V, 2011, TOXICOL LETT, V206, P197, DOI 10.1016/j.toxlet.2011.07.013; Rodea-Palomares I, 2012, AQUAT TOXICOL, V122, P133, DOI 10.1016/j.aquatox.2012.06.005; Rodea-Palomares I, 2011, TOXICOL SCI, V119, P135, DOI 10.1093/toxsci/kfq311; Rosicka D, 2011, NANOSCALE RES LETT, V6, DOI 10.1007/s11671-010-9753-4; Sadiq IM, 2011, ECOTOX ENVIRON SAFE, V74, P1180, DOI 10.1016/j.ecoenv.2011.03.006; Schrand AM, 2010, NAT PROTOC, V5, P744, DOI 10.1038/nprot.2010.2; Schrurs F, 2012, NAT NANOTECHNOL, V7, P546, DOI 10.1038/nnano.2012.148; Sevcu A, 2011, MICROBES ENVIRON, V26, P271, DOI 10.1264/jsme2.ME11126; Stone V, 2006, NAT NANOTECHNOL, V1, P23, DOI 10.1038/nnano.2006.69; Sun YP, 2006, ADV COLLOID INTERFAC, V120, P47, DOI 10.1016/j.cis.2006.03.001; Thomas CR, 2011, ACS NANO, V5, P13, DOI 10.1021/nn1034857; Van Hoecke K, 2008, ENVIRON TOXICOL CHEM, V27, P1948, DOI 10.1897/07-634.1; Verma A, 2010, SMALL, V6, P12, DOI 10.1002/smll.200901158; von Moos N, 2014, NANOTOXICOLOGY, V8, P605, DOI 10.3109/17435390.2013.809810; Westerhoff P, 2013, ACCOUNTS CHEM RES, V46, P844, DOI 10.1021/ar300030n; Xia T, 2008, ACS NANO, V2, P2121, DOI 10.1021/nn800511k; Zhang JH, 2000, CELL RES, V10, P205, DOI 10.1038/sj.cr.7290049; Zheng RK, 2006, ADV MATER, V18, P2418, DOI 10.1002/adma.200600788; Zhu MT, 2013, ACCOUNTS CHEM RES, V46, P622, DOI 10.1021/ar300031y	56	23	24	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e109645	10.1371/journal.pone.0109645	http://dx.doi.org/10.1371/journal.pone.0109645			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340509	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662800012
J	Horm, SV; Mardy, S; Rith, S; Ly, S; Heng, S; Vong, S; Kitsutani, P; Ieng, V; Tarantola, A; Ly, S; Sar, B; Chea, N; Sokhal, B; Barr, I; Kelso, A; Horwood, PF; Timmermans, A; Hurt, A; Lon, C; Saunders, D; Ung, SA; Asgari, N; Roces, MC; Touch, S; Komadina, N; Buchy, P				Horm, Srey Viseth; Mardy, Sek; Rith, Sareth; Ly, Sovann; Heng, Seng; Vong, Sirenda; Kitsutani, Paul; Ieng, Vannra; Tarantola, Arnaud; Ly, Sowath; Sar, Borann; Chea, Nora; Sokhal, Buth; Barr, Ian; Kelso, Anne; Horwood, Paul F.; Timmermans, Ans; Hurt, Aeron; Lon, Chanthap; Saunders, David; Ung, Sam An; Asgari, Nima; Roces, Maria Concepcion; Touch, Sok; Komadina, Naomi; Buchy, Philippe			Epidemiological and Virological Characteristics of Influenza Viruses Circulating in Cambodia from 2009 to 2011	PLOS ONE			English	Article							ADAMANTANE RESISTANCE; SEASONAL INFLUENZA; ANTIVIRAL RESISTANCE; SURVEILLANCE; REASSORTMENT; MORTALITY; TAIWAN; HEMAGGLUTININ; INFECTIONS; EPIDEMICS	Background: The Cambodian National Influenza Center (NIC) monitored and characterized circulating influenza strains from 2009 to 2011. Methodology/Principal Findings: Sentinel and study sites collected nasopharyngeal specimens for diagnostic detection, virus isolation, antigenic characterization, sequencing and antiviral susceptibility analysis from patients who fulfilled case definitions for influenza-like illness, acute lower respiratory infections and event-based surveillance. Each year in Cambodia, influenza viruses were detected mainly from June to November, during the rainy season. Antigenic analysis show that A/H1N1pdm09 isolates belonged to the A/California/7/2009-like group. Circulating A/H3N2 strains were A/Brisbane/10/2007-like in 2009 before drifting to A/Perth/16/2009-like in 2010 and 2011. The Cambodian influenza B isolates from 2009 to 2011 all belonged to the B/Victoria lineage represented by the vaccine strains B/Brisbane/60/2008 and B/Malaysia/2506/2004. Sequences of the M2 gene obtained from representative 2009-2011 A/H3N2 and A/H1N1pdm09 strains all contained the S31N mutation associated with adamantanes resistance except for one A/H1N1pdm09 strain isolated in 2011 that lacked this mutation. No reduction in the susceptibility to neuraminidase inhibitors was observed among the influenza viruses circulating from 2009 to 2011. Phylogenetic analysis revealed that A/H3N2 strains clustered each year to a distinct group while most A/H1N1pdm09 isolates belonged to the S203T clade. Conclusions/Significance: In Cambodia, from 2009 to 2011, influenza activity occurred throughout the year with peak seasonality during the rainy season from June to November. Seasonal influenza epidemics were due to multiple genetically distinct viruses, even though all of the isolates were antigenically similar to the reference vaccine strains. The drug susceptibility profile of Cambodian influenza strains revealed that neuraminidase inhibitors would be the drug of choice for influenza treatment and chemoprophylaxis in Cambodia, as adamantanes are no longer expected to be effective.	[Horm, Srey Viseth; Mardy, Sek; Rith, Sareth; Vong, Sirenda; Tarantola, Arnaud; Ly, Sowath; Horwood, Paul F.; Buchy, Philippe] Reseau Int Inst Pasteur, Inst Pasteur Cambodge, Phnom Penh, Cambodia; [Mardy, Sek; Ieng, Vannra; Asgari, Nima; Roces, Maria Concepcion] WHO, Phnom Penh, Cambodia; [Ly, Sovann; Heng, Seng; Touch, Sok] Minist Hlth, Dept Communicable Dis Control, Phnom Penh, Cambodia; [Kitsutani, Paul] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, Atlanta, GA USA; [Sar, Borann; Chea, Nora] Ctr Dis Control & Prevent, Cambodia Off, Phnom Penh, Cambodia; [Sokhal, Buth; Ung, Sam An] Natl Inst Publ Hlth, Phnom Penh, Cambodia; [Barr, Ian; Kelso, Anne; Hurt, Aeron; Komadina, Naomi] WHO Collaborating Ctr Reference & Res Influenza, Melbourne, Vic, Australia; [Timmermans, Ans; Lon, Chanthap; Saunders, David] Armed Forces Res Inst Med Sci, Bangkok 10400, Thailand	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; World Health Organization; Centers for Disease Control & Prevention - USA; World Health Organization; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS)	Buchy, P (corresponding author), Reseau Int Inst Pasteur, Inst Pasteur Cambodge, Phnom Penh, Cambodia.	buchyphilippe@hotmail.com	Tarantola, Arnaud/D-2149-2015	Tarantola, Arnaud/0000-0002-6946-7958; Horwood, Paul/0000-0001-9622-0742; Kelso, Anne/0000-0002-3166-3267; Barr, Ian/0000-0002-7351-418X; Hurt, Aeron/0000-0003-1826-4314; BUCHY, Philippe/0000-0003-1372-3008	World Health Organization office in Cambodia; French Agency for Development (SISEA project); Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services	World Health Organization office in Cambodia; French Agency for Development (SISEA project); Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services	The study was funded by the World Health Organization office in Cambodia, the French Agency for Development (SISEA project) and by the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, Wkly Epidemiol Rec, V86, P61; [Anonymous], 2012, PLOS ONE, V7; [Anonymous], 2013, WPSAR, V4, DOI 10.5365; Barr IG, 2008, ANTIVIR RES, V80, P200, DOI 10.1016/j.antiviral.2008.06.008; Beckett CG, 2004, CLIN INFECT DIS, V39, P443, DOI 10.1086/422314; Blair PJ, 2010, EPIDEMIOL INFECT, V138, P199, DOI 10.1017/S095026880999063X; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; CDC, 2011, INFL ANT MED SUMM CL; Chittaganpitch M, 2012, INFLUENZA OTHER RESP, V6, P276, DOI 10.1111/j.1750-2659.2011.00302.x; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; DORAISINGHAM S, 1988, B WORLD HEALTH ORGAN, V66, P57; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Finkelman BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001296; Fourment M, 2010, J CLIN MICROBIOL, V48, P295, DOI 10.1128/JCM.01687-09; Glinsky GV, 2010, CELL CYCLE, V9, P958, DOI 10.4161/cc.9.5.10913; Nguyen HLK, 2007, J INFECTION, V55, P58, DOI 10.1016/j.jinf.2006.12.001; He GM, 2008, ANTIVIR RES, V77, P72, DOI 10.1016/j.antiviral.2007.08.007; Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300; HOPESIMPSON RE, 1981, J HYG-CAMBRIDGE, V86, P35, DOI 10.1017/S0022172400068728; Hurt AC, 2009, ANTIVIR RES, V83, P90, DOI 10.1016/j.antiviral.2009.03.003; Hurt AC, 2008, COMMUN DIS INTELL, V32, P57; Igarashi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008553; Ilyushina NA, 2005, VIROLOGY, V341, P102, DOI 10.1016/j.virol.2005.07.003; Jian JW, 2008, J CLIN MICROBIOL, V46, P1426, DOI 10.1128/JCM.01560-07; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leang SK, 2013, ANTIVIR RES, V97, P206, DOI 10.1016/j.antiviral.2012.12.016; Mardy S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-168; Maurer-Stroh Sebastian, 2010, PLoS Curr, V2, pRRN1162; McCullers JA, 1999, J VIROL, V73, P7343, DOI 10.1128/JVI.73.9.7343-7348.1999; McCullers JA, 2010, J INFECT DIS, V202, P1287, DOI 10.1086/656333; McKimm-Breschkin J, 2003, ANTIMICROB AGENTS CH, V47, P2264, DOI 10.1128/AAC.47.7.2264-2272.2003; Monto AS, 2006, ANTIMICROB AGENTS CH, V50, P2395, DOI 10.1128/AAC.01339-05; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; National Institute of Statistics, 2002, GEN POP CENS CAMB 19; Naughtin M, 2011, ANTIMICROB AGENTS CH, V55, P2004, DOI 10.1128/AAC.01773-10; Nelson M., 2009, PLOS CURR, V1, DOI [DOI 10.1371/CURRENTS.RRN1126, 10.1371/currents.RRN1126]; Nelson MI, 2007, PLOS PATHOG, V3, P1220, DOI 10.1371/journal.ppat.0030131; O'Brien KL, 2000, CLIN INFECT DIS, V30, P784, DOI 10.1086/313772; Pariani E, 2009, J Prev Med Hyg, V50, P113; Potdar VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009693; RAO BL, 1993, B WORLD HEALTH ORGAN, V71, P177; Shek LP, 2003, PAEDIATR RESPIR REV, V4, P104; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; Simonsen L, 2007, MOL BIOL EVOL, V24, P1811, DOI 10.1093/molbev/msm103; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Tsai HP, 2001, J CLIN MICROBIOL, V39, P111, DOI 10.1128/JCM.39.1.111-118.2001; Tsai HP, 2006, J CLIN MICROBIOL, V44, P2705, DOI 10.1128/JCM.02694-05; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WHO, 2007, REC LAB PROC DET AV; WHO, 2009, CDC PROT REALT RT PC; WHO, 2008, GUID EST EV BAS SURV; World Health Organization, 2010, WKLY EPIDEMIOL REC, V85, P61; World Health Organization, 2010, GLOB INFL PROGR INFL; World Health Organization, 2009, WKLY EPIDEMIOL REC, V84, P301	58	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110713	10.1371/journal.pone.0110713	http://dx.doi.org/10.1371/journal.pone.0110713			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340711	Green Published, gold, Green Accepted			2022-12-27	WOS:000343662800050
J	Kranitz, ML; Biffin, E; Clark, A; Hollingsworth, ML; Ruhsam, M; Gardner, MF; Thomas, P; Mill, RR; Ennos, RA; Gaudeul, M; Lowe, AJ; Hollingsworth, PM				Kranitz, Mai Lan; Biffin, Edward; Clark, Alexandra; Hollingsworth, Michelle L.; Ruhsam, Markus; Gardner, Martin F.; Thomas, Philip; Mill, Robert R.; Ennos, Richard A.; Gaudeul, Myriam; Lowe, Andrew J.; Hollingsworth, Peter M.			Evolutionary Diversification of New Caledonian Araucaria	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; AGATHIS ARAUCARIACEAE; FAMILY ARAUCARIACEAE; DIVERGENCE TIMES; CHLOROPLAST DNA; NEW-ZEALAND; SP NOV.; CONIFER; MACROFOSSILS; PLANTS	New Caledonia is a global biodiversity hotspot. Hypotheses for its biotic richness suggest either that the island is a 'museum' for an old Gondwana biota or alternatively it has developed following relatively recent long distance dispersal and in situ radiation. The conifer genus Araucaria (Araucariaceae) comprises 19 species globally with 13 endemic to this island. With a typically Gondwanan distribution, Araucaria is particularly well suited to testing alternative biogeographic hypotheses concerning the origins of New Caledonian biota. We derived phylogenetic estimates using 11 plastid and rDNA ITS2 sequence data for a complete sampling of Araucaria (including multiple accessions of each of the 13 New Caledonian Araucaria species). In addition, we developed a dataset comprising 4 plastid regions for a wider taxon sample to facilitate fossil based molecular dating. Following statistical analyses to identify a credible and internally consistent set of fossil constraints, divergence times estimated using a Bayesian relaxed clock approach were contrasted with geological scenarios to explore the biogeographic history of Araucaria. The phylogenetic data resolve relationships within Araucariaceae and among the main lineages in Araucaria, but provide limited resolution within the monophyletic New Caledonian species group. Divergence time estimates suggest a Late Cretaceous-Cenozoic radiation of extant Araucaria and a Neogene radiation of the New Caledonian lineage. A molecular timescale for the evolution of Araucariaceae supports a relatively recent radiation, and suggests that earlier (pre-Cenozoic) fossil types assigned to Araucaria may have affinities elsewhere in Araucariaceae. While additional data will be required to adequately resolve relationships among the New Caledonian species, their recent origin is consistent with overwater dispersal following Eocene emersion of New Caledonia but is too old to support a single dispersal from Australia to Norfolk Island for the radiation of the Pacific Araucaria sect. Eutacta clade.	[Kranitz, Mai Lan; Clark, Alexandra; Hollingsworth, Michelle L.; Ruhsam, Markus; Gardner, Martin F.; Thomas, Philip; Mill, Robert R.; Hollingsworth, Peter M.] Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland; [Ennos, Richard A.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Gaudeul, Myriam] Museum Natl Hist Nat, Inst Syst, CNRS, UMR MNHN UPMC EPHE 7205, F-75231 Paris, France; [Biffin, Edward; Lowe, Andrew J.] Univ Adelaide, Sch Earth & Environm Sci, Inst Environm, Australian Ctr Evolutionary Biol & Biodivers, Adelaide, SA, Australia	University of Edinburgh; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Adelaide	Biffin, E (corresponding author), Univ Adelaide, Sch Earth & Environm Sci, Inst Environm, Australian Ctr Evolutionary Biol & Biodivers, Adelaide, SA, Australia.	ed.biffin@adelaide.edu.au	Ruhsam, Markus/B-3608-2010; Ruhsam, Markus/N-6820-2019	Ruhsam, Markus/0000-0002-8457-345X; Lowe, Andrew/0000-0003-1139-2516; Hollingsworth, Peter/0000-0003-0602-0654; Hart, Michelle/0000-0001-9503-7786	Darwin Trust of Edinburgh; ANR project BIONEOCAL; PPF MNHN 'Structure et evolution des ecosystemes'; Australian Research Council through a Super Science Fellowship [FS1102 00051]; Discovery Grant [DP0665859]; Scottish Government's Rural and Environment Science and Analytical Services Division	Darwin Trust of Edinburgh; ANR project BIONEOCAL(French National Research Agency (ANR)); PPF MNHN 'Structure et evolution des ecosystemes'; Australian Research Council through a Super Science Fellowship(Australian Research Council); Discovery Grant; Scottish Government's Rural and Environment Science and Analytical Services Division	This work was supported by funds from the Darwin Trust of Edinburgh and the ANR project BIONEOCAL, the PPF MNHN 'Structure et evolution des ecosystemes' led by P. Grandcolas. The work of AJL and EB was supported by the Australian Research Council through a Super Science Fellowship (FS1102 00051) and Discovery Grant (DP0665859) awarded to AJL. The Royal Botanic Garden Edinburgh is supported by the Scottish Government's Rural and Environment Science and Analytical Services Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, TRACER V1 6; Axsmith BJ, 1998, AM J BOT, V85, P704, DOI 10.2307/2446541; Axsmith BJ, 2008, PALAEONTOL ELECTRON, V11; Biffin E, 2010, SYST BIOL, V59, P594, DOI 10.1093/sysbio/syq030; Bromham L, 2003, NAT REV GENET, V4, P216, DOI 10.1038/nrg1020; Cantrill DJ, 2006, INT J PLANT SCI, V167, P1259, DOI 10.1086/507608; CANTRILL DJ, 1992, INT J PLANT SCI, V153, P622, DOI 10.1086/297084; Chambers TC, 1998, INT J PLANT SCI, V159, P160, DOI 10.1086/297534; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Crisp MD, 2011, TRENDS ECOL EVOL, V26, P66, DOI 10.1016/j.tree.2010.11.005; Del Fueyo GM, 2002, CRETACEOUS RES, V23, P265, DOI 10.1006/cres.2002.1001; DEMESURE B, 1995, MOL ECOL, V4, P129, DOI 10.1111/j.1365-294X.1995.tb00201.x; Dettmann ME, 2012, ALCHERINGA, V36, P217, DOI 10.1080/03115518.2012.622155; Dornburg A, 2011, SYST BIOL, V60, P519, DOI 10.1093/sysbio/syr019; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Escapa I, 2008, REV PALAEOBOT PALYNO, V151, P110, DOI 10.1016/j.revpalbo.2008.03.002; Escapa IH, 2013, INT J PLANT SCI, V174, P1153, DOI 10.1086/672369; Francis J. E., 2008, ANTARCTICA KEYSTONE, P19, DOI [10.3133/of2007-1047, DOI 10.3133/OF2007-1047]; Gaudeul M, 2012, AM J BOT, V99, P68, DOI 10.3732/ajb.1100321; Grandcolas P, 2008, PHILOS T R SOC B, V363, P3309, DOI 10.1098/rstb.2008.0122; Grivet D, 2001, MOL ECOL NOTES, V1, P345, DOI 10.1046/j.1471-8278.2001.00107.x; Hall R, 2001, FAUNAL AND FLORAL MIGRATIONS AND EVOLUTION IN SE ASIA-AUSTRALASIA, P35; Hamilton MB, 1999, MOL ECOL, V8, P521; Heads M, 2008, J BIOGEOGR, V35, P2153, DOI 10.1111/j.1365-2699.2008.01977.x; Heads M, 2010, J BIOGEOGR, V37, P1179, DOI 10.1111/j.1365-2699.2010.02311.x; HILL R S, 1991, Australian Systematic Botany, V4, P449, DOI 10.1071/SB9910449; Hill RS, 2008, AUST SYST BOT, V21, P162, DOI 10.1071/SB08006; Hill RS, 1999, AUST J BOT, V47, P639, DOI 10.1071/BT98093; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; Kershaw P, 2001, ANNU REV ECOL SYST, V32, P397, DOI 10.1146/annurev.ecolsys.32.081501.114059; Knapp M, 2007, SYST BIOL, V56, P862, DOI 10.1080/10635150701636412; Kunzmann L, 2007, ZOOL ANZ, V246, P257, DOI 10.1016/j.jcz.2007.08.001; Ladiges PY, 2007, AUST SYST BOT, V20, P383, DOI 10.1071/SB07018; Lawver LA, 2003, PALAEOGEOGR PALAEOCL, V198, P11, DOI 10.1016/S0031-0182(03)00392-4; Lee DE, 2007, NEW ZEAL J BOT, V45, P565, DOI 10.1080/00288250709509739; Leslie AB, 2012, P NATL ACAD SCI USA, V109, P16217, DOI 10.1073/pnas.1213621109; Liu N, 2009, CHINESE SCI BULL, V54, P2648, DOI 10.1007/s11434-009-0373-2; Macphailm M, 2014, ALCHERINGA, V38, P135, DOI 10.1080/03115518.2014.843145; Marshall CR, 2008, AM NAT, V171, P726, DOI 10.1086/587523; McLean D, 2013, REV PALAEOBOT PALYNO, V190, P1, DOI 10.1016/j.revpalbo.2012.11.005; McLoughlin S, 2008, AM J BOT, V95, P465, DOI 10.3732/ajb.95.4.465; Meffre S, 2006, ASEG 18 GEOPH C MELB, V2006, P1, DOI DOI 10.1071/ASEG2006AB111; Miller CN, 1999, BOT REV, V65, P239, DOI 10.1007/BF02857631; Morat P., 1993, BIODIVERSITY LETT, V1, P72, DOI DOI 10.2307/2999750; Murienne J, 2009, J BIOGEOGR, V36, P1433, DOI 10.1111/j.1365-2699.2009.02143.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; OHSAWA T, 1995, J PLANT RES, V108, P25, DOI 10.1007/BF02344302; Pelletier B, 2006, DOCUMENTS SCI TECHNI, VII; Pillon Y, 2012, BOT J LINN SOC, V170, P288, DOI 10.1111/j.1095-8339.2012.01274.x; Pole M, 2008, ALCHERINGA, V32, P405, DOI 10.1080/03115510802417935; Pole M, 2009, CRETACEOUS RES, V30, P917, DOI 10.1016/j.cretres.2009.02.007; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruane S, 2011, J EVOLUTION BIOL, V24, P274, DOI 10.1111/j.1420-9101.2010.02164.x; Rutschmann F, 2007, SYST BIOL, V56, P591, DOI 10.1080/10635150701491156; Sanmartin I, 2004, SYST BIOL, V53, P216, DOI 10.1080/10635150490423430; Setoguchi H, 1998, AM J BOT, V85, P1507, DOI 10.2307/2446478; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Sinclair WT, 2002, PLANT SYST EVOL, V233, P79, DOI 10.1007/s00606-002-0199-8; STOCKEY RA, 1982, REV PALAEOBOT PALYNO, V37, P133, DOI 10.1016/0034-6667(82)90041-0; Stockler K, 2002, SYST BIOL, V51, P827, DOI 10.1080/10635150290102474; van der Ham RWJM, 2010, PALAEOGEOGR PALAEOCL, V291, P469, DOI 10.1016/j.palaeo.2010.03.017; van Waveren IM, 2008, NETH J GEOSCI, V87, P339, DOI 10.1017/S0016774600023398; VEEVERS JJ, 1991, AUST J EARTH SCI, V38, P373, DOI 10.1080/08120099108727979; Zwickl D. J, 2006, GENETIC ALGORITHM AP	67	31	33	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110308	10.1371/journal.pone.0110308	http://dx.doi.org/10.1371/journal.pone.0110308			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340350	gold, Green Published, Green Submitted			2022-12-27	WOS:000343662800028
J	Wei, J; Freytag, M; Schober, Y; Nockher, WA; Mautner, VF; Friedrich, RE; Manley, PW; Kluwe, L; Kurtz, A				Wei, Jiang; Freytag, Marcus; Schober, Yvonne; Nockher, Wolfgang A.; Mautner, Victor F.; Friedrich, Reinhard E.; Manley, Paul W.; Kluwe, Lan; Kurtz, Andreas			Nilotinib Is More Potent than Imatinib for Treating Plexiform Neurofibroma In Vitro and In Vivo	PLOS ONE			English	Article							KINASE INHIBITOR NILOTINIB; CHRONIC MYELOID-LEUKEMIA; TUMORS; TYPE-1; PATHOGENESIS; CELLS	In Plexiform neurofibromas (PNFs) are benign nerve sheath tumors mostly associated with neurofibromatosis type 1. They often extend through multiple layers of tissue and therefore cannot be treated satisfactorily by surgery. Nilotinib is a tyrosine kinase inhibitor used to treat leukemia, with advantages over the prototype imatinib in terms of potency and selectivity towards BCR-ABL, and the DDR, PDGFR, and KIT receptor kinases. In this study, we compared efficacies of the two drugs on cultured cells of PNF in vitro and on xenografted tumor fragments on sciatic nerve of athymic nude mice. Xenografts were monitored weekly using a high resolution ultrasound measurement. Treatment with nilotinib at a daily dose of 100 mg/kg for four weeks led to a reduction of the graft sizes(std) by 68(+/- 7)% in the 8 treated mice, significantly more than the 33(+/- 8)% reduction in the 8 untreated mice (P<0.05) and the 47(+/- 15)% in the 7 mice treated with imatinib (P<0.05). The peak plasma nilotinib concentration 6.6(+/- 1.1) mu M is within the pharmacological range of clinical application. Imatinib, but not nilotinib significantly hindered body weight increase of the mice and elevated cytotoxicity of mouse spleen cells (P<0.05). Our results suggest that nilotinib may be more potent than imatinib for treating PNFs and may also be better tolerated. Imatinib seems to have some off-target effect in elevating immunity.	[Wei, Jiang; Mautner, Victor F.; Kluwe, Lan] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Lab Tumor Genet, Hamburg, Germany; [Freytag, Marcus; Friedrich, Reinhard E.; Kluwe, Lan] Univ Med Ctr Hamburg Eppendorf, Dept Maxillofacial Surg, Hamburg, Germany; [Schober, Yvonne; Nockher, Wolfgang A.] Univ Marburg, Inst Lab Med & Pathobiochem, Marburg, Germany; [Manley, Paul W.] Novartis Inst Biomed Res, Basel, Switzerland; [Kurtz, Andreas] Charite, Berlin Brandenburg Ctr Regenerat Med, D-13353 Berlin, Germany; [Kurtz, Andreas] Seoul Natl Univ, Coll Vet Med, Seoul, South Korea; [Kurtz, Andreas] Seoul Natl Univ, Res Inst Vet Sci, Seoul, South Korea	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Philipps University Marburg; Novartis; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Seoul National University (SNU); Seoul National University (SNU)	Kurtz, A (corresponding author), Charite, Berlin Brandenburg Ctr Regenerat Med, D-13353 Berlin, Germany.	andreas.kurt@charite.de	manley, paul william/GVT-9482-2022	Kurtz, Andreas/0000-0003-3301-6546; Manley, Paul William/0000-0002-9722-7863	Novartis Pharmaceuticals AG of Switzerland	Novartis Pharmaceuticals AG of Switzerland	The study was funded by Novartis Pharmaceuticals AG of Switzerland. Novartis provided support in the form of salary for author Paul W. Manley, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions'' section.	Borg C, 2004, J CLIN INVEST, V114, P379, DOI 10.1172/jci20041102; Borrego-Diaz E, 2012, J NEURO-ONCOL, V108, P423, DOI 10.1007/s11060-012-0852-1; Brems H, 2009, LANCET ONCOL, V10, P508, DOI 10.1016/S1470-2045(09)70033-6; Demestre M, 2010, J NEURO-ONCOL, V98, P11, DOI 10.1007/s11060-009-0049-4; Evans DGR, 2002, J MED GENET, V39, P311, DOI 10.1136/jmg.39.5.311; Gambacorti-Passerini CB, 2002, BLOOD CELL MOL DIS, V28, P361, DOI 10.1006/bcmd.2002.0526; Gleiss J, 2013, IN VIVO, V27, P723; Gotze L, 2012, CLIN CHIM ACTA, V413, P143, DOI 10.1016/j.cca.2011.09.012; Cunha KSG, 2008, CLINICS, V63, P39, DOI 10.1590/S1807-59322008000100008; Gutmann DH, 1997, JAMA-J AM MED ASSOC, V278, P51, DOI 10.1001/jama.278.1.51; Jiang W, 2014, J NEURO-ONCOL, V116, P231, DOI 10.1007/s11060-013-1295-z; Kantarjian H, 2006, NEW ENGL J MED, V354, P2542, DOI 10.1056/NEJMoa055104; Kitamura M, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-2; Larson RA, 2012, LEUKEMIA, V26, P2197, DOI 10.1038/leu.2012.134; Laycock-van Spyk Sebastian, 2011, Human Genomics, V5, P623; Manley PW, 2010, BBA-PROTEINS PROTEOM, V1804, P445, DOI 10.1016/j.bbapap.2009.11.008; Oates EC, 2013, AM J MED GENET A, V161A, P659, DOI 10.1002/ajmg.a.35840; Plotkin SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035711; Rastogi MV, 2012, PEDIATR BLOOD CANCER, V59, P840, DOI 10.1002/pbc.24121; Saglio G, 2010, NEW ENGL J MED, V362, P2251, DOI 10.1056/NEJMoa0912614; Spyra M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021099; Tanaka C, 2010, CLIN PHARMACOL THER, V87, P197, DOI 10.1038/clpt.2009.208; Ward BA, 2005, PEDIATR NEUROL, V32, P221, DOI 10.1016/j.pediatrneurol.2004.11.002	23	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e107760	10.1371/journal.pone.0107760	http://dx.doi.org/10.1371/journal.pone.0107760			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340526	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662800003
J	Ardizzi, M; Sestito, M; Martini, F; Umilta, MA; Ravera, R; Gallese, V				Ardizzi, Martina; Sestito, Mariateresa; Martini, Francesca; Umilta, Maria Alessandra; Ravera, Roberto; Gallese, Vittorio			When Age Matters: Differences in Facial Mimicry and Autonomic Responses to Peers' Emotions in Teenagers and Adults	PLOS ONE			English	Article							FACE RECOGNITION; OWN-AGE; EMPATHY; BIAS; PATTERNS; DISPLAYS; INGROUP; YOUNG	Age-group membership effects on explicit emotional facial expressions recognition have been widely demonstrated. In this study we investigated whether Age-group membership could also affect implicit physiological responses, as facial mimicry and autonomic regulation, to observation of emotional facial expressions. To this aim, facial Electromyography (EMG) and Respiratory Sinus Arrhythmia (RSA) were recorded from teenager and adult participants during the observation of facial expressions performed by teenager and adult models. Results highlighted that teenagers exhibited greater facial EMG responses to peers' facial expressions, whereas adults showed higher RSA-responses to adult facial expressions. The different physiological modalities through which young and adults respond to peers' emotional expressions are likely to reflect two different ways to engage in social interactions with coetaneous. Findings confirmed that age is an important and powerful social feature that modulates interpersonal interactions by influencing low-level physiological responses.	[Ardizzi, Martina; Sestito, Mariateresa; Umilta, Maria Alessandra; Gallese, Vittorio] Univ Parma, Unit Physiol, Dept Neurosci, I-43100 Parma, Italy; [Martini, Francesca; Ravera, Roberto] ASL1 Imperiese, Dept Psychol, Clin Psychol Unit, Imperia, Italy	University of Parma	Ardizzi, M (corresponding author), Univ Parma, Unit Physiol, Dept Neurosci, I-43100 Parma, Italy.	martina.ardizzi@nemo.unipr.it	Ghiami, Zeinab/G-5492-2016; Gallese, Vittorio/ABD-5097-2021	Gallese, Vittorio/0000-0003-4815-3607; Ardizzi, Martina/0000-0001-9185-6784; Umilta', Maria Alessandra/0000-0003-0180-6818; sestito, mariateresa/0000-0002-7045-6850	EU grant TESIS; trans-border cooperation program "Alcotra"	EU grant TESIS; trans-border cooperation program "Alcotra"	This work was supported by the EU grant TESIS to V.G.; and by trans-border cooperation program "Alcotra" (2007 - 2013) to F.M., M.A., and R.R. (http://www.interreg-alcotra.org/2007-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JJB, 2007, BIOL PSYCHOL, V74, P243, DOI 10.1016/j.biopsycho.2006.08.005; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Beaupre MG, 2006, PERS SOC PSYCHOL B, V32, P16, DOI 10.1177/0146167205277097; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; Bourgeois P, 2008, BIOL PSYCHOL, V77, P343, DOI 10.1016/j.biopsycho.2007.11.008; Cohen J, 1988, PSYCHOLOGY; Critchley HD, 2000, J PHYSIOL-LONDON, V523, P259, DOI 10.1111/j.1469-7793.2000.t01-1-00259.x; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Diehl M, 2013, RES HUM DEV, V10, P1, DOI 10.1080/15427609.2013.760256; Dimberg U, 2002, COGNITION EMOTION, V16, P449, DOI 10.1080/02699930143000356; Ebner NC, 2011, COGNITION EMOTION, V25, P983, DOI 10.1080/02699931.2010.540817; Ebner NC, 2010, COGNITION EMOTION, V24, P1095, DOI 10.1080/02699930903128395; Elfenbein HA, 2002, EMOTION, V2, P75, DOI 10.1037/1528-3542.2.1.75; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ferri F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075758; Fischer H, 2010, CORTEX, V46, P490, DOI 10.1016/j.cortex.2009.05.011; Folster M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00030; FRIDLUND AJ, 1986, PSYCHOPHYSIOLOGY, V23, P567, DOI 10.1111/j.1469-8986.1986.tb00676.x; Harrison NA, 2010, SOC NEUROSCI-UK, V5, P393, DOI 10.1080/17470911003656330; Hofman D, 2012, P ROY SOC B-BIOL SCI, V279, P3535, DOI 10.1098/rspb.2012.0694; Hugenberg K, 2004, PSYCHOL SCI, V15, P342, DOI 10.1111/j.0956-7976.2004.00680.x; Iacoboni M, 2009, ANNU REV PSYCHOL, V60, P653, DOI 10.1146/annurev.psych.60.110707.163604; Lawrence EJ, 2004, PSYCHOL MED, V34, P911, DOI 10.1017/S0033291703001624; Lewin C, 2002, BRAIN COGNITION, V50, P121, DOI 10.1016/S0278-2626(02)00016-7; Loven J, 2011, EXP PSYCHOL, V58, P333, DOI 10.1027/1618-3169/a000100; MALPASS RS, 1969, J PERS SOC PSYCHOL, V13, P330, DOI 10.1037/h0028434; MCHUGO GJ, 1991, J NONVERBAL BEHAV, V15, P19, DOI 10.1007/BF00997765; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Porges S W, 1994, Monogr Soc Res Child Dev, V59, P167, DOI 10.2307/1166144; Porges Stephen W, 2009, Cleve Clin J Med, V76 Suppl 2, pS86, DOI 10.3949/ccjm.76.s2.17; Porges SW, 2003, ANN NY ACAD SCI, V1008, P31, DOI 10.1196/annals.1301.004; Raven J, 2000, COGNITIVE PSYCHOL, V41, P1, DOI 10.1006/cogp.1999.0735; Rhodes MG, 2012, PSYCHOL BULL, V138, P146, DOI 10.1037/a0025750; Riediger M, 2011, COGNITION EMOTION, V25, P968, DOI 10.1080/02699931.2010.540812; Rymarczyk K, 2011, INT J PSYCHOPHYSIOL, V79, P330, DOI 10.1016/j.ijpsycho.2010.11.001; Scherf KS, 2013, HORM BEHAV, V64, P298, DOI 10.1016/j.yhbeh.2013.05.011; Sebastian C, 2010, BRAIN COGNITION, V72, P134, DOI 10.1016/j.bandc.2009.06.008; Slessor G, 2014, EMOTION, V14, P532, DOI 10.1037/a0035825; Steinberg L, 2001, ANNU REV PSYCHOL, V52, P83, DOI 10.1146/annurev.psych.52.1.83; Thibault P, 2006, J EXP SOC PSYCHOL, V42, P676, DOI 10.1016/j.jesp.2005.10.006; Tiller W A, 1996, Altern Ther Health Med, V2, P52; Toichi M, 1997, J AUTONOM NERV SYST, V62, P79, DOI 10.1016/S0165-1838(96)00112-9; Van Boxtel A, 2001, PSYCHOPHYSIOLOGY, V38, P22, DOI 10.1017/S004857720199016X; van der Schalk J, 2011, EMOTION, V11, P286, DOI 10.1037/a0022582; Wang B, 2013, MEMORY, V21, P991, DOI 10.1080/09658211.2013.771273; Winkielman P, 2001, J PERS SOC PSYCHOL, V81, P989, DOI 10.1037//0022-3514.81.6.989; Wright DB, 2003, ACTA PSYCHOL, V114, P101, DOI 10.1016/S0001-6918(03)00052-0; Zotev V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079184	48	17	17	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110763	10.1371/journal.pone.0110763	http://dx.doi.org/10.1371/journal.pone.0110763			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6DY	25337916	gold, Green Published			2022-12-27	WOS:000343674800072
J	Castro, R; Abos, B; Pignatelli, J; Jorgensen, LV; Granja, AG; Buchmann, K; Tafalla, C				Castro, Rosario; Abos, Beatriz; Pignatelli, Jaime; Jorgensen, Louise von Gersdorff; Gonzalez Granja, Aitor; Buchmann, Kurt; Tafalla, Carolina			Early Immune Responses in Rainbow Trout Liver upon Viral Hemorrhagic Septicemia Virus (VHSV) Infection	PLOS ONE			English	Article							SINUSOIDAL ENDOTHELIAL-CELLS; ACUTE-PHASE RESPONSE; SERUM-AMYLOID-A; ONCORHYNCHUS-MYKISS; IMMUNOLOGICAL ORGAN; B-CELLS; FISH; EXPRESSION; INNATE; RECEPTOR	Among the essential metabolic functions of the liver, in mammals, a role as mediator of systemic and local innate immunity has also been reported. Although the presence of an important leukocyte population in mammalian liver is well documented, the characterization of leukocyte populations in the teleost liver has been only scarcely addressed. In the current work, we have confirmed the presence of IgM(+), IgD(+), IgT(+), CD8 alpha(+), CD3(+) cells, and cells expressing major histocompatibility complex (MHC-II) in rainbow trout (Oncorhynchus mykiss) liver by flow cytometry and/or immunohistochemistry analysis. Additionally, the effect of viral hemorrhagic septicemia virus (VHSV) on the liver immune response was assessed. First, we studied the effect of viral intraperitoneal injection on the transcription of a wide selection of immune genes at days 1, 2 and 5 post-infection. These included a group of leukocyte markers genes, pattern recognition receptors (PRRs), chemokines, chemokine receptor genes, and other genes involved in the early immune response and in acute phase reaction. Our results indicate that T lymphocytes play a key role in the initial response to VHSV in the liver, since CD3, CD8, CD4, perforin, Mx and interferon (IFN) transcription levels were up-regulated in response to VHSV. Consequently, flow cytometry analysis of CD8 alpha(+) cells in liver and spleen at day 5 post-infection revealed a decrease in the number of CD8 alpha(+) cells in the spleen and an increased population in the liver. No differences were found however in the percentages of B lymphocyte (IgM(+) or IgD(+)) populations. In addition, a strong up-regulation in the transcription levels of several PRRs and chemokines was observed from the second day of infection, indicating an important role of these factors in the response of the liver to viral infections.	[Castro, Rosario; Abos, Beatriz; Pignatelli, Jaime; Gonzalez Granja, Aitor; Tafalla, Carolina] Ctr Invest Sanidad Anim CISA INIA, Valdeolmos, Madrid, Spain; [Jorgensen, Louise von Gersdorff; Buchmann, Kurt] Univ Copenhagen, Dept Vet Dis Biol, Fac Hlth & Med Sci, Frederiksberg, Denmark	University of Copenhagen	Tafalla, C (corresponding author), Ctr Invest Sanidad Anim CISA INIA, Valdeolmos, Madrid, Spain.	tafalla@inia.es	Granja, Aitor/K-8102-2014; pignatelli, jaime/AAY-8734-2021; Pignatelli, Jaime/L-3122-2014; Tafalla, Carolina/J-8074-2014	pignatelli, jaime/0000-0002-8431-2241; Pignatelli, Jaime/0000-0002-8431-2241; Buchmann, Kurt/0000-0002-2747-237X; Jorgensen, Louise von Gersdorff/0000-0002-6005-3249; Tafalla, Carolina/0000-0002-0860-2976	European Research Council (ERC) [2011 280469]; European Commission under the 7th Framework Programme for Research and Technological Development (FP7) of the European Union [311993 TARGETFISH]	European Research Council (ERC)(European Research Council (ERC)); European Commission under the 7th Framework Programme for Research and Technological Development (FP7) of the European Union	This work was supported by the European Research Council (ERC Starting Grant 2011 280469) and by the European Commission under the 7th Framework Programme for Research and Technological Development (FP7) of the European Union (Grant Agreement 311993 TARGETFISH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abos B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082737; Agius C, 2003, J FISH DIS, V26, P499, DOI 10.1046/j.1365-2761.2003.00485.x; Ahmed M, 2009, J VIROL, V83, P2962, DOI 10.1128/JVI.02030-08; Ballesteros NA, 2014, DEV COMP IMMUNOL, V44, P195, DOI 10.1016/j.dci.2013.12.009; Bayne CJ, 2001, DEV COMP IMMUNOL, V25, P725, DOI 10.1016/S0145-305X(01)00033-7; Boardman T, 2012, VET IMMUNOL IMMUNOP, V145, P511, DOI 10.1016/j.vetimm.2011.11.017; Castro R, 2014, VACCINE, V32, P1160, DOI 10.1016/j.vaccine.2013.11.062; Castro R, 2014, J IMMUNOL, V192, P1257, DOI 10.4049/jimmunol.1302471; Castro R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003098; Crispe IN, 2009, ANNU REV IMMUNOL, V27, P147, DOI 10.1146/annurev.immunol.021908.132629; De Domenico I, 2010, J CLIN INVEST, V120, P2395, DOI 10.1172/JCI42011; DELUCA D, 1983, EUR J IMMUNOL, V13, P546, DOI 10.1002/eji.1830130706; Doherty DG, 2000, IMMUNOL REV, V174, P5, DOI 10.1034/j.1600-0528.2002.017416.x; Douglas SE, 2003, DEV COMP IMMUNOL, V27, P589, DOI 10.1016/S0145-305X(03)00036-3; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Gerwick L, 2002, FISH SHELLFISH IMMUN, V12, P229, DOI 10.1006/fsim.2001.0367; Gerwick L, 2007, FISH SHELLFISH IMMUN, V22, P157, DOI 10.1016/j.fsi.2006.04.003; Golden-Mason L, 2002, IMMUNOL CELL BIOL, V80, P45, DOI 10.1046/j.1440-1711.2002.01066.x; Gonzalez SF, 2007, VET IMMUNOL IMMUNOP, V115, P172, DOI 10.1016/j.vetimm.2006.09.007; HAMPTON JA, 1987, ANAT RECORD, V219, P338, DOI 10.1002/ar.1092190403; Hardy RR, 2006, J IMMUNOL, V177, P2749, DOI 10.4049/jimmunol.177.5.2749; HARDY RR, 1994, ADV IMMUNOL, V55, P297; Harmache A, 2006, J VIROL, V80, P3655, DOI 10.1128/JVI.80.7.3655-3659.2006; HINTON DE, 1976, J FISH BIOL, V8, P209, DOI 10.1111/j.1095-8649.1976.tb03944.x; Hsu MC, 2006, P NATL ACAD SCI USA, V103, P5905, DOI 10.1073/pnas.0601502103; Jensen LE, 1997, J IMMUNOL, V158, P384; Jorgensen LV, 2011, J FISH DIS, V34, P749, DOI 10.1111/j.1365-2761.2011.01291.x; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Knolle PA, 1998, CLIN EXP IMMUNOL, V114, P427; Knolle PA, 2000, IMMUNOL REV, V174, P21, DOI 10.1034/j.1600-0528.2002.017408.x; Knolle PA, 1999, GASTROENTEROLOGY, V116, P1428, DOI 10.1016/S0016-5085(99)70508-1; Krause A, 2003, PROTEIN SCI, V12, P143, DOI 10.1110/ps.0213603; Kurobe T, 2005, DEV COMP IMMUNOL, V29, P515, DOI 10.1016/j.dci.2004.10.005; Landreth KS, 2002, HUM EXP TOXICOL, V21, P493, DOI 10.1191/0960327102ht287oa; Lohse AW, 1996, GASTROENTEROLOGY, V110, P1175, DOI 10.1053/gast.1996.v110.pm8613007; Lynn DJ, 2003, VET IMMUNOL IMMUNOP, V93, P177, DOI 10.1016/S0165-2427(03)00058-8; Matsuo A, 2008, J IMMUNOL, V181, P3474, DOI 10.4049/jimmunol.181.5.3474; Moller AM, 2014, DEV COMP IMMUNOL, V46, P518, DOI 10.1016/j.dci.2014.03.020; Montero J, 2011, J VIROL, V85, P4046, DOI 10.1128/JVI.02519-10; Montero J, 2009, FISH SHELLFISH IMMUN, V27, P661, DOI 10.1016/j.fsi.2009.08.003; Nemeth E, 2009, SEMIN IMMUNOPATHOL, V31, P333, DOI 10.1007/s00281-009-0173-4; Norris S, 1998, J HEPATOL, V28, P84, DOI 10.1016/S0168-8278(98)80206-7; Ohmura K, 1999, J IMMUNOL, V163, P4788; Olsen MM, 2011, FISH SHELLFISH IMMUN, V30, P859, DOI 10.1016/j.fsi.2011.01.010; Parker GA, 2012, TOXICOL PATHOL, V40, P237, DOI 10.1177/0192623311428475; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Pietretti D, 2014, DEV COMP IMMUNOL, V43, P205, DOI 10.1016/j.dci.2013.08.010; Quillet E, 2001, DIS AQUAT ORGAN, V45, P171, DOI 10.3354/dao045171; Quillet E, 2007, DIS AQUAT ORGAN, V76, P7, DOI 10.3354/dao076007; Racanelli V, 2006, HEPATOLOGY, V43, pS54, DOI 10.1002/hep.21060; Raida MK, 2009, DEV COMP IMMUNOL, V33, P35, DOI 10.1016/j.dci.2008.07.001; Ramirez-Gomez F, 2012, J IMMUNOL, V188, P1341, DOI 10.4049/jimmunol.1101938; Rise ML, 2004, PHYSIOL GENOMICS, V20, P21, DOI 10.1152/physiolgenomics.00036.2004; ROCHA E, 1994, J ANAT, V185, P241; Shike H, 2002, EUR J BIOCHEM, V269, P2232, DOI 10.1046/j.1432-1033.2002.02881.x; Takizawa F, 2011, DEV COMP IMMUNOL, V35, P752, DOI 10.1016/j.dci.2011.02.008; Thorn CF, 2002, AMYLOID, V9, P229, DOI 10.3109/13506120209114098; Villarroel F, 2008, DEV COMP IMMUNOL, V32, P1160, DOI 10.1016/j.dci.2008.03.004; Weinstock D, 2010, TOXICOL PATHOL, V38, P1111, DOI 10.1177/0192623310382436; Zahl IH, 2012, FISH PHYSIOL BIOCHEM, V38, P201, DOI 10.1007/s10695-011-9565-1; Zhang YA, 2004, VET IMMUNOL IMMUNOP, V101, P259, DOI 10.1016/j.vetimm.2004.05.005; Zhang YA, 2010, NAT IMMUNOL, V11, P827, DOI 10.1038/ni.1913	62	49	50	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e111084	10.1371/journal.pone.0111084	http://dx.doi.org/10.1371/journal.pone.0111084			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338079	Green Submitted, Green Published, gold			2022-12-27	WOS:000343674800102
J	Drew, BJ; Harris, P; Zegre-Hemsey, JK; Mammone, T; Schindler, D; Salas-Boni, R; Bai, Y; Tinoco, A; Ding, Q; Hu, X				Drew, Barbara J.; Harris, Patricia; Zegre-Hemsey, Jessica K.; Mammone, Tina; Schindler, Daniel; Salas-Boni, Rebeca; Bai, Yong; Tinoco, Adelita; Ding, Quan; Hu, Xiao			Insights into the Problem of Alarm Fatigue with Physiologic Monitor Devices: A Comprehensive Observational Study of Consecutive Intensive Care Unit Patients	PLOS ONE			English	Article								Purpose: Physiologic monitors are plagued with alarms that create a cacophony of sounds and visual alerts causing "alarm fatigue'' which creates an unsafe patient environment because a life-threatening event may be missed in this milieu of sensory overload. Using a state-of-the-art technology acquisition infrastructure, all monitor data including 7 ECG leads, all pressure, SpO2, and respiration waveforms as well as user settings and alarms were stored on 461 adults treated in intensive care units. Using a well-defined alarm annotation protocol, nurse scientists with 95% inter-rater reliability annotated 12,671 arrhythmia alarms. Results: A total of 2,558,760 unique alarms occurred in the 31-day study period: arrhythmia, 1,154,201; parameter, 612,927; technical, 791,632. There were 381,560 audible alarms for an audible alarm burden of 187/bed/day. 88.8% of the 12,671 annotated arrhythmia alarms were false positives. Conditions causing excessive alarms included inappropriate alarm settings, persistent atrial fibrillation, and non-actionable events such as PVC's and brief spikes in ST segments. Low amplitude QRS complexes in some, but not all available ECG leads caused undercounting and false arrhythmia alarms. Wide QRS complexes due to bundle branch block or ventricular pacemaker rhythm caused false alarms. 93% of the 168 true ventricular tachycardia alarms were not sustained long enough to warrant treatment. Discussion: The excessive number of physiologic monitor alarms is a complex interplay of inappropriate user settings, patient conditions, and algorithm deficiencies. Device solutions should focus on use of all available ECG leads to identify non-artifact leads and leads with adequate QRS amplitude. Devices should provide prompts to aide in more appropriate tailoring of alarm settings to individual patients. Atrial fibrillation alarms should be limited to new onset and termination of the arrhythmia and delays for ST-segment and other parameter alarms should be configurable. Because computer devices are more reliable than humans, an opportunity exists to improve physiologic monitoring and reduce alarm fatigue.	[Drew, Barbara J.; Harris, Patricia; Schindler, Daniel; Salas-Boni, Rebeca; Bai, Yong; Tinoco, Adelita; Ding, Quan; Hu, Xiao] Univ Calif San Francisco, Dept Physiol Nursing, San Francisco, CA 94143 USA; [Zegre-Hemsey, Jessica K.] Univ N Carolina, Sch Nursing, Chapel Hill, NC USA; [Mammone, Tina] Univ Calif San Francisco, Med Ctr, Dept Nursing, San Francisco, CA USA	University of California System; University of California San Francisco; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Francisco	Drew, BJ (corresponding author), Univ Calif San Francisco, Dept Physiol Nursing, San Francisco, CA 94143 USA.	barbara.drew@nursing.ucsf.edu	Drew, Barbara/AAQ-7480-2020	Zegre-Hemsey, Jessica/0000-0002-5650-0464	General Electric (GE) Healthcare and entitled: Analysis of Patient Monitor Alarms in Adult Intensive Care Units [123.04-2012-GES-0003]	General Electric (GE) Healthcare and entitled: Analysis of Patient Monitor Alarms in Adult Intensive Care Units	Study was funded by General Electric (GE) Healthcare and entitled: Analysis of Patient Monitor Alarms in Adult Intensive Care Units; Study Number: 123.04-2012-GES-0003. The funder had minimal role in study design and no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Aboukhalil A, 2008, J BIOMED INFORM, V41, P442, DOI 10.1016/j.jbi.2008.03.003; [Anonymous], 1989, NEW ENGL J MED, V321, P406; Association for the Advancement of Medical Instrumentation, 2011, SIR CALL ACT PRIOR I; Association for the Advancement of Medical Instrumentation, 2008, EC132002R2007 ASS AD; Burgess LPA, 2009, J ADV NURS, V65, P1844, DOI 10.1111/j.1365-2648.2009.05048.x; Clifford GD, 2012, USER GUIDE DOCUMENTA; Crawford MH, 1999, J AM COLL CARDIOL, V34, P912, DOI 10.1016/S0735-1097(99)00354-X; Cvach MM, 2013, J NURS CARE QUAL, V28, P265, DOI 10.1097/NCQ.0b013e31827993bc; Drew BJ, 2010, CIRCULATION, V121, P1047, DOI 10.1161/CIRCULATIONAHA.109.192704; Drew BJ, 1998, J ELECTROCARDIOL S, V30, P174; European Heart Rhythm Association, 2006, J Am Coll Cardiol, V48, pe247, DOI 10.1016/j.jacc.2006.07.010; Gorges M, 2009, ANESTH ANALG, V108, P1546, DOI 10.1213/ane.0b013e31819bdfbb; Helfenbein E, 2014, J ELECTROCARDIOL; Keller JP, 2012, J ELECTROCARDIOL, V45, P588, DOI 10.1016/j.jelectrocard.2012.08.050; Kowalczyk L, 2010, MGH DEATH SPURS REV; Sgarbossa EB, 2004, J ELECTROCARDIOL, V37, P141, DOI 10.1016/j.jelectrocard.2004.04.002; Siebig S, 2010, CRIT CARE MED, V38, P451, DOI 10.1097/CCM.0b013e3181cb0888; The Joint Commission, 2014, JOINT COMM ANN 2014; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Welch J, 2011, BIOMED INSTRUM TECHN, V45, P46; Whalen DA, 2014, J CARDIOVASC NURS, V29, pE13, DOI 10.1097/JCN.0000000000000114	21	193	199	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110274	10.1371/journal.pone.0110274	http://dx.doi.org/10.1371/journal.pone.0110274			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338067	Green Published, gold			2022-12-27	WOS:000343674800032
J	Hu, YH; Wang, C; Huang, K; Xia, F; Parvin, JD; Mondal, N				Hu, Yiheng; Wang, Chao; Huang, Kun; Xia, Fen; Parvin, Jeffrey D.; Mondal, Neelima			Regulation of 53BP1 Protein Stability by RNF8 and RNF168 Is Important for Efficient DNA Double-Strand Break Repair	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; DAMAGE-RESPONSE; UBIQUITIN; BRCA1; RECRUITMENT; CHROMATIN; SITES; PROMOTES; ACETYLATION; DEGRADATION	53BP1 regulates DNA double-strand break (DSB) repair. In functional assays for specific DSB repair pathways, we found that 53BP1 was important in the conservative non-homologous end-joining (C-NHEJ) pathway, and this activity was dependent upon RNF8 and RNF168. We observed that 53BP1 protein was diffusely abundant in nuclei, and upon ionizing radiation, 53BP1 was everywhere degraded except at DNA damage sites. Depletion of RNF8 or RNF168 blocked the degradation of the diffusely localized nuclear 53BP1, and ionizing radiation induced foci (IRIF) did not form. Furthermore, when 53BP1 degradation was inhibited, a subset of 53BP1 was bound to DNA damage sites but bulk, unbound 53BP1 remained in the nucleoplasm, and localization of its downstream effector RIF1 at DSBs was abolished. Our data suggest a novel mechanism for responding to DSB that upon ionizing radiation, 53BP1 was divided into two populations, ensuring functional DSB repair: damage site-bound 53BP1 whose binding signal is known to be generated by RNF8 and RNF168; and unbound bulk 53BP1 whose ensuing degradation is regulated by RNF8 and RNF168.	[Hu, Yiheng; Wang, Chao; Huang, Kun; Parvin, Jeffrey D.] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Xia, Fen] Ohio State Univ, Dept Radiat Oncol, Columbus, OH 43210 USA; [Mondal, Neelima] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Jawaharlal Nehru University, New Delhi	Mondal, N (corresponding author), Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA.	Jeffrey.Parvin@osumc.edu; nmondal@mail.jnu.ac.in	Parvin, Jeffrey D/C-8955-2009; Huang, Kun/E-3272-2011		National Cancer Institute [CA141090]; DST-PURSE; UGC resource networking grant; NATIONAL CANCER INSTITUTE [R01CA141090] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DST-PURSE; UGC resource networking grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	CA141090 National Cancer Institute (JDP and KH) and DST-PURSE and UGC resource networking grant (NM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hakim A, 2010, DNA REPAIR, V9, P1229, DOI 10.1016/j.dnarep.2010.09.011; Asaithamby A, 2009, NUCLEIC ACIDS RES, V37, P3912, DOI 10.1093/nar/gkp237; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Bekker-Jensen S, 2011, FEBS LETT, V585, P2914, DOI 10.1016/j.febslet.2011.05.056; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Bohgaki M, 2013, P NATL ACAD SCI USA, V110, P20982, DOI 10.1073/pnas.1320302111; Bothmer A, 2011, MOL CELL, V42, P319, DOI 10.1016/j.molcel.2011.03.019; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Bunting SF, 2012, MOL CELL, V46, P125, DOI 10.1016/j.molcel.2012.02.015; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Butler LR, 2012, EMBO J, V31, P3918, DOI 10.1038/emboj.2012.232; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Coleman KA, 2011, J BIOL CHEM, V286, P13669, DOI 10.1074/jbc.M110.213728; Difilippantonio S, 2008, NATURE, V456, P529, DOI 10.1038/nature07476; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; FISHMANLOBELL J, 1992, MOL CELL BIOL, V12, P1292, DOI 10.1128/MCB.12.3.1292; Fradet-Turcotte A, 2013, NATURE, V499, P50, DOI 10.1038/nature12318; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Hu YH, 2014, J BIOL CHEM, V289, P21289, DOI 10.1074/jbc.C114.582122; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Iwabuchi K, 2003, J BIOL CHEM, V278, P36487, DOI 10.1074/jbc.M304066200; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lieber MR, 2010, CELL, V142, P496, DOI 10.1016/j.cell.2010.07.035; Lottersberger F, 2013, P NATL ACAD SCI USA, V110, P2146, DOI 10.1073/pnas.1222617110; Ma YM, 2005, CELL CYCLE, V4, P1193, DOI 10.4161/cc.4.9.1977; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mallette FA, 2012, CELL RES, V22, P1221, DOI 10.1038/cr.2012.58; Mallette FA, 2012, EMBO J, V31, P1865, DOI 10.1038/emboj.2012.47; Manis JP, 2004, NAT IMMUNOL, V5, P481, DOI 10.1038/ni1067; Meerang M, 2011, NAT CELL BIOL, V13, P1376, DOI 10.1038/ncb2367; Nakada S, 2012, CANCER RES, V72, P4974, DOI 10.1158/0008-5472.CAN-12-1057; Noon AT, 2010, NAT CELL BIOL, V12, P177, DOI 10.1038/ncb2017; Ogiwara H, 2011, ONCOGENE, V30, P2135, DOI [10.1038/onc.2010.592, 10.1038/onc.2010.592;]; Ransburgh DJR, 2010, CANCER RES, V70, P988, DOI 10.1158/0008-5472.CAN-09-2850; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Santos MA, 2010, J EXP MED, V207, P973, DOI 10.1084/jem.20092308; Silverman J, 2004, GENE DEV, V18, P2108, DOI 10.1101/gad.1216004; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Stewart GS, 2009, CELL CYCLE, V8, P1532, DOI 10.4161/cc.8.10.8351; Tang JB, 2013, NAT STRUCT MOL BIOL, V20, P317, DOI 10.1038/nsmb.2499; Towler WI, 2013, HUM MUTAT, V34, P439, DOI 10.1002/humu.22251; van Vugt MATM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000287; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Zhang F, 2012, J CELL SCI, V125, P6049, DOI 10.1242/jcs.111872; Zhong Q, 2002, J BIOL CHEM, V277, P28641, DOI 10.1074/jbc.M200748200; Zhuang J, 2009, J BIOL CHEM, V284, P30565, DOI 10.1074/jbc.M109.059444; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	52	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110522	10.1371/journal.pone.0110522	http://dx.doi.org/10.1371/journal.pone.0110522			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337968	Green Published, gold, Green Submitted			2022-12-27	WOS:000343674800052
J	Rohailla, S; Clarizia, N; Sourour, M; Sourour, W; Gelber, N; Wei, C; Li, J; Redington, AN				Rohailla, Sagar; Clarizia, Nadia; Sourour, Michel; Sourour, Wesam; Gelber, Nitai; Wei, Can; Li, Jing; Redington, Andrew N.			Acute, Delayed and Chronic Remote Ischemic Conditioning Is Associated with Downregulation of mTOR and Enhanced Autophagy Signaling	PLOS ONE			English	Article							REPERFUSION INJURY; PRECONDITIONING PROVIDES; LATE-PHASE; MECHANISMS; HEART; PROTECTION; CARDIOPROTECTION; DISEASE; KINASE; ROLES	Background: Remote ischemic conditioning (RIC), induced by brief periods of limb ischemia has been shown to decrease acute myocardial injury and chronic responses after acute coronary syndromes. While several signaling pathways have been implicated, our understanding of the cardioprotection and its underlying mediators and mechanisms remains incomplete. In this study we examine the effect of RIC on pro-autophagy signaling as a possible mechanism of benefit. Methods and Results: We examined the role of autophagy in the acute/first window (15 minutes after RIC), delayed/second window (24 hours after RIC) and chronic (24 hours after 9 days of repeated RIC) phases of cardioprotection. C57BL/6 mice (N = 69) were allocated to each treatment phase and further stratified to receive RIC, induced by four cycles of 5 minutes of limb ischemia followed by 5 minutes of reperfusion, or control treatment consisting solely of handling without transient ischemia. The groups included, group 1 (1W control), group 2 (1W RIC), group 3 (2W control), group 4 (2W RIC), group 5 (3W control) and group 6 (3W RIC). Hearts were isolated for assessment of cardiac function and infarct size after global ischemia using a Langendorff preparation. Infarct size was reduced in all three phases of cardioprotection, in association with improvements in post- ischemic left ventricular end diastolic pressure (LVEDP) and developed pressure (LVDP) (P, 0.05). The pattern of autophagy signaling varied; 1W RIC increased AMPK levels and decreased the activation of mammalian target of rapamycin (mTOR), whereas chronic RIC was associated with persistent mTOR suppression and increased levels of autophagosome proteins, LC3II/I and Atg5. Conclusions: Cardioprotection following transient ischemia exists in both the acute and delayed/chronic phases of conditioning. RIC induces pro-autophagy signaling but the pattern of responses varies depending on the phase, with the most complete portfolio of responses observed when RIC is administered chronically.	[Rohailla, Sagar; Clarizia, Nadia; Sourour, Michel; Sourour, Wesam; Gelber, Nitai; Wei, Can; Li, Jing; Redington, Andrew N.] Univ Toronto, Hosp Sick Children, Labatt Family Heart Ctr, Div Cardiol, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Redington, AN (corresponding author), Univ Toronto, Hosp Sick Children, Labatt Family Heart Ctr, Div Cardiol, Toronto, ON M5S 1A1, Canada.	andrew.redington@sickkids.ca						Bolli R, 2000, CIRC RES, V87, P972, DOI 10.1161/01.RES.87.11.972; Buss SJ, 2009, J AM COLL CARDIOL, V54, P2435, DOI 10.1016/j.jacc.2009.08.031; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; Depre C, 2010, AM J PHYSIOL-HEART C, V299, pH752, DOI 10.1152/ajpheart.00147.2010; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Gedik N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096567; Gottlieb RA, 2013, HEART FAIL REV, V18, P575, DOI 10.1007/s10741-012-9367-2; Gustafsson AB, 2009, CIRC RES, V104, P150, DOI 10.1161/CIRCRESAHA.108.187427; Hahn CD, 2011, STROKE, V42, P2960, DOI 10.1161/STROKEAHA.111.622340; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; Hassouna A, 2004, AM J PHYSIOL-CELL PH, V287, pC1418, DOI 10.1152/ajpcell.00144.2004; Hausenloy DJ, 2011, ANTIOXID REDOX SIGN, V14, P893, DOI 10.1089/ars.2010.3360; Hausenloy DJ, 2008, CARDIOVASC RES, V79, P377, DOI 10.1093/cvr/cvn114; Hausenloy DJ, 2005, AM J PHYSIOL-HEART C, V288, pH971, DOI 10.1152/ajpheart.00374.2004; Hougaard KD, 2014, STROKE, V45, P159, DOI 10.1161/STROKEAHA.113.001346; Jenkins DP, 1997, HEART, V77, P314, DOI 10.1136/hrt.77.4.314; Joo JD, 2006, J AM SOC NEPHROL, V17, P3115, DOI 10.1681/ASN.2006050424; Kanamori H, 2011, CARDIOVASC RES, V91, P330, DOI 10.1093/cvr/cvr073; Khan SA, 2006, J MOL CELL CARDIOL, V41, P256, DOI 10.1016/j.yjmcc.2006.04.014; Li J, 2011, CLIN SCI, V120, P451, DOI 10.1042/CS20100466; Loukogeorgakis SP, 2005, J AM COLL CARDIOL, V46, P450, DOI 10.1016/j.jacc.2005.04.044; Martinez-Lopez N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3799; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Mehrjerdi FZ, 2013, BRAIN RES, V1526, P94, DOI 10.1016/j.brainres.2013.06.018; Meng R, 2012, NEUROLOGY, V79, P1853, DOI 10.1212/WNL.0b013e318271f76a; Nishino Y, 2004, CARDIOVASC RES, V61, P610, DOI 10.1016/j.cardiores.2003.10.022; Przyklenk K, 2011, AUTOPHAGY, V7, P432, DOI 10.4161/auto.7.4.14395; Reid EA, 2005, AM J PHYSIOL-HEART C, V288, pH2253, DOI 10.1152/ajpheart.01009.2004; Romanque P, 2010, TRANSPL P, V42, P1569, DOI 10.1016/j.transproceed.2009.11.052; Shen YT, 2008, CIRCULATION, V118, P1961, DOI 10.1161/CIRCULATIONAHA.108.788240; Shimizu M, 2010, J SURG RES, V158, P155, DOI 10.1016/j.jss.2008.08.010; Thielmann M, 2010, BASIC RES CARDIOL, V105, P657, DOI 10.1007/s00395-010-0104-5; Venugopal V, 2009, HEART, V95, P1567, DOI 10.1136/hrt.2008.155770; Wei M, 2011, CIRC RES, V108, P1220, DOI 10.1161/CIRCRESAHA.110.236190; Yan L, 2005, P NATL ACAD SCI USA, V102, P13807, DOI 10.1073/pnas.0506843102; Yan WJ, 2013, ACTA PHARMACOL SIN, V34, P636, DOI 10.1038/aps.2013.18; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Zhou CH, 2014, J CARDIOVASC PHARM T, V19, P558, DOI 10.1177/1074248414524479; Zhou WW, 2010, PEDIATR CARDIOL, V31, P22, DOI 10.1007/s00246-009-9536-9	39	42	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111291	10.1371/journal.pone.0111291	http://dx.doi.org/10.1371/journal.pone.0111291			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347774	gold, Green Submitted, Green Published			2022-12-27	WOS:000347994900059
J	Sandor, B; Nagy, A; Toth, A; Rabai, M; Mezey, B; Csatho, A; Czuriga, I; Toth, K; Szabados, E				Sandor, Barbara; Nagy, Alexandra; Toth, Andras; Rabai, Miklos; Mezey, Bela; Csatho, Arpad; Czuriga, Istvan; Toth, Kalman; Szabados, Eszter			Effects of Moderate Aerobic Exercise Training on Hemorheological and Laboratory Parameters in Ischemic Heart Disease Patients	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; BODY-MASS INDEX; BLOOD-CELL AGGREGATION; CARDIAC REHABILITATION; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; SECONDARY PREVENTION; PHYSICAL-ACTIVITY; ESC GUIDELINES; RISK	Background and Design: In this study we set out to determine the effects of long-term physical training on hemorheological, laboratory parameters, exercise tolerability, psychological factors in cardiac patients participating in an ambulatory rehabilitation program. Methods: Before physical training, patients were examined by echocardiography, tested on treadmill by the Bruce protocol, and blood was drawn for laboratory tests. The enrolled 79 ischemic heart disease patients joined a 24-week cardiac rehabilitation training program. Blood was drawn to measure hematocrit (Hct), plasma and whole blood viscosity (PV, WBV), red blood cell (RBC) aggregation and deformability. Hemorheological, clinical chemistry and psychological measurements were repeated 12 and 24 weeks later, and a treadmill test was performed at the end of the program. Results: After 12 weeks Hct, PV, WBV and RBC aggregation were significantly decreased, RBC deformability exhibited a significant increase (p < 0.05). Laboratory parameters (triglyceride, uric acid, hsCRP and fibrinogen) were significantly decreased (p < 0.05). After 24 weeks the significant results were still observed. By the end of the study, IL-6 and TNF-alpha levels displayed decreasing trends (p < 0.06). There was a significant improvement in MET (p < 0.001), and the BMI decrease was also significant (p < 0.05). The vital exhaustion parameters measured on the fatigue impact scale indicated a significant improvement in two areas of the daily activities (p < 0.05). Conclusions: Regular physical training improved the exercise tolerability of patients with ischemic heart disease. Previous publications have demonstrated that decreases in Hct and PV may reduce cardiovascular risk, while a decrease in RBC aggregation and an increase in deformability improve the capillary flow. Positive changes in laboratory parameters and body weight may indicate better oxidative and inflammatory circumstances and an improved metabolic state. The psychological findings point to an improvement in the quality of life.	[Sandor, Barbara; Toth, Andras; Rabai, Miklos; Mezey, Bela; Czuriga, Istvan; Toth, Kalman; Szabados, Eszter] Univ Pecs, Sch Med, Dept Med 1, Pecs, Hungary; [Nagy, Alexandra; Csatho, Arpad] Univ Pecs, Sch Med, Dept Behav Sci, Pecs, Hungary	University of Pecs; University of Pecs	Szabados, E (corresponding author), Univ Pecs, Sch Med, Dept Med 1, Pecs, Hungary.	szabados.eszter@pte.hu	Csatho, Arpad/ABG-4329-2021; Csatho, Arpad/GNM-7312-2022	Csatho, Arpad/0000-0002-0284-654X				Aktas MK, 2004, JAMA-J AM MED ASSOC, V292, P1462, DOI 10.1001/jama.292.12.1462; Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; Antman EM, 2008, J AM COLL CARDIOL, V51, P2028, DOI [10.1016/j.jacc.2008.04.002, 10.1016/j.jacc.2007.10.001]; Baskurt OK, 2007, BIOMED HEALTH RES, V69, P170; Baskurt OK, 2013, CLIN HEMORHEOL MICRO, V54, P99, DOI 10.3233/CH-2012-1616; Bassand JP, 2007, EUR HEART J, V28, P1598, DOI 10.1093/eurheartj/ehm161; BAUERSACHS RM, 1989, CLIN HEMORHEOL, V9, P1; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Brun JF, 1998, CLIN HEMORHEOL MICRO, V19, P89; Bruna JF, 2013, CLIN HEMORHEOL MICRO, V55, P15, DOI 10.3233/CH-131686; Cakir-Atabek H, 2009, CLIN HEMORHEOL MICRO, V41, P251, DOI 10.3233/CH-2009-1176; CARTER C, 1983, AM HEART J, V105, P674, DOI 10.1016/0002-8703(83)90493-3; Church TS, 2002, AM HEART J, V143, P349, DOI 10.1067/mhj.2002.119758; Connes P, 2004, CLIN HEMORHEOL MICRO, V31, P311; Connes P, 2007, CLIN HEMORHEOL MICRO, V36, P319; Connes P, 2013, CLIN HEMORHEOL MICRO, V53, P187, DOI 10.3233/CH-2012-1643; Connes P, 2010, SCAND J MED SCI SPOR, V20, P48, DOI 10.1111/j.1600-0838.2010.01208.x; Cossette S, 2001, PSYCHOSOM MED, V63, P257, DOI 10.1097/00006842-200103000-00009; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Dobbe JGG, 2002, CYTOMETRY, V50, P313, DOI 10.1002/cyto.10171; Eckel RH, 2014, CIRCULATION, V129, pS76, DOI 10.1161/01.cir.0000437740.48606.d1; Ekman Inger, 2002, Eur J Cardiovasc Nurs, V1, P77, DOI 10.1016/S1474-5151(01)00016-0; ERNST E, 1987, EUR HEART J, V8, P59, DOI 10.1093/eurheartj/8.suppl_G.59; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Giannuzzi P, 2008, ARCH INTERN MED, V168, P2194, DOI 10.1001/archinte.168.20.2194; HUME R, 1966, J CLIN PATHOL, V19, P389, DOI 10.1136/jcp.19.4.389; Hunt SA, 2005, CIRCULATION, V112, P1825, DOI 10.1016/j.jacc.2005.08.023; KANNEL WB, 1987, AM HEART J, V113, P1006, DOI 10.1016/0002-8703(87)90063-9; Kesmarky G, 2001, CLIN HEMORHEOL MICRO, V24, P33; Kilic-Toprak E, 2012, MED SCI MONITOR, V18, pCR351, DOI 10.12659/MSM.882878; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Lee KW, 2005, HEART, V91, P1413, DOI 10.1136/hrt.2004.050005; LEVINE GN, 1995, AM J CARDIOL, V76, P80, DOI 10.1016/S0002-9149(99)80808-X; LOWE GDO, 1988, CLIN HEMORHEOL, V8, P517; Lowe G, 2011, MOD INSIGHTS DIS MOL, P235; Marton Z, 2003, CLIN HEMORHEOL MICRO, V29, P81; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Perk J, 2012, EUR HEART J, V33, P1635, DOI 10.1093/eurheartj/ehs092; Piepoli MF, 2010, EUR HEART J, V31, P1967, DOI 10.1093/eurheartj/ehq236; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sarwar N, 2007, CIRCULATION, V115, P450, DOI 10.1161/CIRCULATIONAHA.106.637793; Sarwar N, 2012, LANCET, V379, P1205, DOI 10.1016/S0140-6736(11)61931-4; Simmonds MJ, 2012, CLIN HEMORHEOL MICRO, V51, P87, DOI 10.3233/CH-2011-1514; Smith MM, 2015, CLIN HEMORHEOL MICRO, V60, P347, DOI 10.3233/CH-131708; Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009; Toth K, 2007, BIOMED HEALTH RES, V69, P392; Tripette J, 2011, CLIN HEMORHEOL MICRO, V47, P261, DOI 10.3233/CH-2011-1388; Van de Werf F, 2008, EUR HEART J, V29, P2909, DOI 10.1093/eurheartj/ehn416; Waltz X, 2015, CLIN HEMORHEOL MICRO, V59, P37, DOI 10.3233/CH-131742; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wood DA, 2008, LANCET, V371, P1999, DOI 10.1016/S0140-6736(08)60868-5; Yalcin O, 2003, J APPL PHYSIOL, V94, P997, DOI 10.1152/japplphysiol.00368.2002; Zhao G, 2013, ATHEROSCLEROSIS, V231, P61, DOI 10.1016/j.atherosclerosis.2013.08.023; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679; ZIJLSTRA WG, 1958, ACTA PHYSIOL PHARM N, V7, P153	58	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e110751	10.1371/journal.pone.0110751	http://dx.doi.org/10.1371/journal.pone.0110751			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347067	Green Published, gold, Green Submitted			2022-12-27	WOS:000347994900029
J	Tano, K; Yasuda, S; Kuroda, T; Saito, H; Umezawa, A; Sato, Y				Tano, Keiko; Yasuda, Satoshi; Kuroda, Takuya; Saito, Hirohisa; Umezawa, Akihiro; Sato, Yoji			A Novel In Vitro Method for Detecting Undifferentiated Human Pluripotent Stem Cells as Impurities in Cell Therapy Products Using a Highly Efficient Culture System	PLOS ONE			English	Article							HUMAN FIBROBLASTS; IPS CELLS; INDUCTION; SURVIVAL	Innovative applications of cell therapy products (CTPs) derived from human pluripotent stem cells (hPSCs) in regenerative medicine are currently being developed. The presence of residual undifferentiated hPSCs in CTPs is a quality concern associated with tumorigencity. However, no simple in vitro method for direct detection of undifferentiated hPSCs that contaminate CTPs has been developed. Here, we show a novel approach for direct and sensitive detection of a trace amount of undifferentiated human induced pluripotent stem cells (hiPSCs) using a highly efficient amplification method in combination with laminin-521 and Essential 8 medium. Essential 8 medium better facilitated the growth of hiPSCs dissociated into single cells on laminin-521 than in mTeSR1 medium. hiPSCs cultured on laminin-521 in Essential 8 medium were maintained in an undifferentiated state and they maintained the ability to differentiate into various cell types. Essential 8 medium allowed robust hiPSC proliferation plated on laminin-521 at low cell density, whereas mTeSR1 did not enhance the cell growth. The highly efficient culture system using laminin-521 and Essential 8 medium detected hiPSCs spiked into primary human mesenchymal stem cells (hMSCs) or human neurons at the ratio of 0.001%-0.01% as formed colonies. Moreover, this assay method was demonstrated to detect residual undifferentiated hiPSCs in cell preparations during the process of hMSC differentiation from hiPSCs. These results indicate that our highly efficient amplification system using a combination of laminin-521 and Essential 8 medium is able to detect a trace amount of undifferentiated hPSCs contained as impurities in CTPs and would contribute to quality assessment of hPSC-derived CTPs during the manufacturing process.	[Tano, Keiko; Umezawa, Akihiro] Natl Res Inst Child Hlth & Dev, Dept Reprod Biol, Tokyo, Japan; [Tano, Keiko; Yasuda, Satoshi; Kuroda, Takuya; Sato, Yoji] Natl Inst Hlth Sci, Div Cellular & Gene Therapy Prod, Tokyo, Japan; [Saito, Hirohisa] Natl Res Inst Child Hlth & Dev, Tokyo, Japan; [Sato, Yoji] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Qual Assurance Sci Pharmaceut, Nagoya, Aichi, Japan; [Sato, Yoji] Osaka Univ, Grad Sch Pharmaceut Sci, Dept Cellular & Gene Therapy Prod, Osaka, Japan; [Sato, Yoji] Kyushu Univ, Graduated Sch Pharmaceut Sci, Dept Translat Pharmaceut Sci, Fukuoka 812, Japan	National Center for Child Health & Development - Japan; National Institute of Health Sciences - Japan; National Center for Child Health & Development - Japan; Nagoya City University; Osaka University; Kyushu University	Sato, Y (corresponding author), Natl Inst Hlth Sci, Div Cellular & Gene Therapy Prod, Tokyo, Japan.	yoji@nihs.go.jp		YASUDA, Satoshi/0000-0002-1011-0815; Saito, Hirohisa/0000-0002-6630-8337	Japanese Ministry of Health, Labour and Welfare and Marketing Authorization Facilitation Program for Innovative Therapeutic Products [H23-SAISEI-IPPAN-004, H23-SAISEI-IPPAN-005, H24-IYAKU-SHITEI-027, H25-JITSUYOKA(SAISEI)-IPPAN-008]	Japanese Ministry of Health, Labour and Welfare and Marketing Authorization Facilitation Program for Innovative Therapeutic Products	This work was supported by Research Grants from the Japanese Ministry of Health, Labour and Welfare (H23-SAISEI-IPPAN-004, H23-SAISEI-IPPAN-005, H24-IYAKU-SHITEI-027, H25-JITSUYOKA(SAISEI)-IPPAN-008, and Marketing Authorization Facilitation Program for Innovative Therapeutic Products), http://www.mhlw.go.jp/english/policy/other/research-projects/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey AM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003685; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Chen YS, 2012, STEM CELL TRANSL MED, V1, P83, DOI 10.5966/sctm.2011-0022; Food and Drug Administration, 2008, CELL TISS GEN THER A; Hentze H, 2009, STEM CELL RES, V2, P198, DOI 10.1016/j.scr.2009.02.002; Jung YJ, 2012, STEM CELLS, V30, P42, DOI 10.1002/stem.727; Kajiwara M, 2012, P NATL ACAD SCI USA, V109, P12538, DOI 10.1073/pnas.1209979109; Kanemura H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02334; Kimbrel EA, 2014, STEM CELLS DEV, V23, P1611, DOI 10.1089/scd.2013.0554; Kuroda T, 2013, BIOL PHARM BULL, V36, P189, DOI 10.1248/bpb.b12-00970; Kuroda T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037342; Miyazaki T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2231; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Rodin S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4195; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Xu Y, 2010, P NATL ACAD SCI USA, V107, P8129, DOI 10.1073/pnas.1002024107	19	33	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e110496	10.1371/journal.pone.0110496	http://dx.doi.org/10.1371/journal.pone.0110496			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347300	gold, Green Submitted, Green Published			2022-12-27	WOS:000347994900023
J	Tran, US; Hofer, AA; Voracek, M				Tran, Ulrich S.; Hofer, Agnes A.; Voracek, Martin			Sex Differences in General Knowledge: Meta-Analysis and New Data on the Contribution of School-Related Moderators among High-School Students	PLOS ONE			English	Article							GENDER-DIFFERENCES; INDIVIDUAL-DIFFERENCES; PROGRESSIVE MATRICES; COGNITIVE-ABILITIES; DOMAIN KNOWLEDGE; SEMANTIC MEMORY; PERSONALITY; INTELLIGENCE; ACQUISITION; IQ	Research from various countries consistently reported an advantage of boys over girls in general knowledge and was also suggestive of some overall trends regarding specific domains of general knowledge that were speculated to stem from biologically differentiated interests. However, results were heterogeneous and, as of yet, had not been evaluated meta-analytically. Moreover, previous research drew on overly homogeneous high-school or undergraduate samples whose representativeness appears problematic; mostly, likely moderators, such as school type, student age or parental education, were also not directly investigated or controlled for. We provide a meta-analytical aggregation of available results regarding sex differences in general knowledge and present new data, investigating the psychometric properties of the General Knowledge Test (GKT), on which previous research primarily relied, and explored sex differences in a large and heterogeneous Austrian high-school student sample (N = 1088). The aggregated sex effect in general knowledge was of medium size in previous research, but differences in specific domains were heterogeneous across countries and only modest at best. Large sex differences in our data could be explained to a large part by school-related moderators (school type, school, student age, parental education) and selection processes. Boys had a remaining advantage over girls that was only small in size and that was consistent with the magnitude of sex differences in general intelligence. Analysis of the GKT yielded no evidence of biologically differentiated interests, but of a specific interest in the humanities among girls. In conclusion, previous research likely overestimated sex differences in general knowledge.	[Tran, Ulrich S.; Hofer, Agnes A.; Voracek, Martin] Univ Vienna, Sch Psychol, Dept Basic Psychol Res & Res Methods, Vienna, Austria	University of Vienna	Tran, US (corresponding author), Univ Vienna, Sch Psychol, Dept Basic Psychol Res & Res Methods, Vienna, Austria.	ulrich.tran@univie.ac.at	Voracek, Martin/S-5865-2016	Voracek, Martin/0000-0001-6109-6155; Tran, Ulrich/0000-0002-6589-3167				Ackerman PL, 2006, J EDUC PSYCHOL, V98, P366, DOI 10.1037/0022-0663.98.2.366; Ackerman PL, 1999, PSYCHOL AGING, V14, P314, DOI 10.1037/0882-7974.14.2.314; Ackerman PL, 2001, J EDUC PSYCHOL, V93, P797, DOI 10.1037//0022-0663.93.4.797; Asparouhov T, 2009, STRUCT EQU MODELING, V16, P397, DOI 10.1080/10705510903008204; Beier ME, 2005, PSYCHOL AGING, V20, P341, DOI 10.1037/0882-7974.20.2.341; Borenstein M., 2009, INTRO METAANALYSIS; Chamorro-Premuzic T, 2006, PERS INDIV DIFFER, V41, P419, DOI 10.1016/j.paid.2005.11.036; Deary IJ, 2012, ANNU REV PSYCHOL, V63, P453, DOI 10.1146/annurev-psych-120710-100353; Deary IJ, 2003, INTELLIGENCE, V31, P533, DOI 10.1016/S0160-2896(03)00053-9; Dykiert D, 2009, INTELLIGENCE, V37, P42, DOI 10.1016/j.intell.2008.06.002; Evans EM, 2002, SEX ROLES, V47, P153, DOI 10.1023/A:1021047122532; Forstmeier W, 2011, BEHAV ECOL SOCIOBIOL, V65, P47, DOI 10.1007/s00265-010-1038-5; Furnham A, 2007, PERS INDIV DIFFER, V43, P1563, DOI 10.1016/j.paid.2007.04.013; Furnham A, 2006, LEARN INDIVID DIFFER, V16, P79, DOI 10.1016/j.lindif.2005.07.002; Furnham A, 2009, BRIT J EDUC PSYCHOL, V79, P769, DOI 10.1348/978185409X412147; Furnham A, 2009, CURR PSYCHOL, V28, P225, DOI 10.1007/s12144-009-9064-z; Halpern D., 2013, SEX DIFFERENCES COGN, V4th; Hambrick DZ, 2008, INTELLIGENCE, V36, P261, DOI 10.1016/j.intell.2007.06.004; Hambrick DZ, 2010, LEARN INDIVID DIFFER, V20, P40, DOI 10.1016/j.lindif.2009.10.013; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hill NE, 2004, CHILD DEV, V75, P1491, DOI 10.1111/j.1467-8624.2004.00753.x; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hyde JS, 2009, P NATL ACAD SCI USA, V106, P8801, DOI 10.1073/pnas.0901265106; HYDE JS, 1988, PSYCHOL BULL, V104, P53, DOI 10.1037/0033-2909.104.1.53; Hyde JS, 2005, AM PSYCHOL, V60, P581, DOI 10.1037/0003-066X.60.6.581; Irwing P, 2006, NATURE, V442, pE1, DOI 10.1038/nature04966; Irwing P, 2005, BRIT J PSYCHOL, V96, P505, DOI 10.1348/000712605X53542; Irwing P, 2001, PERS INDIV DIFFER, V30, P857, DOI 10.1016/S0191-8869(00)00078-7; Irwing P, 2012, PERS INDIV DIFFER, V53, P126, DOI 10.1016/j.paid.2011.05.001; Johnson W, 2009, PERSPECT PSYCHOL SCI, V4, P598, DOI 10.1111/j.1745-6924.2009.01168.x; Keith TZ, 2008, INTELLIGENCE, V36, P502, DOI 10.1016/j.intell.2007.11.001; Lynn R, 2004, PERS INDIV DIFFER, V37, P1643, DOI 10.1016/j.paid.2004.02.018; Lynn R, 2004, INTELLIGENCE, V32, P481, DOI 10.1016/j.intell.2004.06.008; Lynn R, 2002, BRIT J PSYCHOL, V93, P545, DOI 10.1348/000712602761381394; Lynn R, 2002, INTELLIGENCE, V30, P27, DOI 10.1016/S0160-2896(01)00064-2; Lynn R, 2009, COLLEGIUM ANTROPOL, V33, P515; Madhyastha TM, 2009, INTELLIGENCE, V37, P422, DOI 10.1016/j.intell.2009.04.001; Marsh HW, 2010, PSYCHOL ASSESSMENT, V22, P471, DOI 10.1037/a0019227; Muthen L.K., 2012, MPLUS USERS GUIDE ST, DOI DOI 10.1111/J.1532-5415.2004.52225.X; OECD, 2009, EQ PREP LIF 15 YEAR; Reynolds MR, 2008, INTELLIGENCE, V36, P236, DOI 10.1016/j.intell.2007.06.003; Rhoten D, 2007, RES POLICY, V36, P56, DOI 10.1016/j.respol.2006.08.001; Rolfhus EL, 1999, J EDUC PSYCHOL, V91, P511, DOI 10.1037/0022-0663.91.3.511; Steinmayr R, 2010, INTELLIGENCE, V38, P101, DOI 10.1016/j.intell.2009.08.001; Voracek M, 2013, PSYCHOL REP, V112, P872, DOI 10.2466/03.PR0.112.3.872-886; Wong KC, 2002, BRIT EDUC RES J, V28, P827, DOI 10.1080/0141192022000019080; Zarevski P, 2007, SUVREM PSIHOL, V10, P213	47	7	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e110391	10.1371/journal.pone.0110391	http://dx.doi.org/10.1371/journal.pone.0110391			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ1JF	25347190	Green Published, gold, Green Submitted			2022-12-27	WOS:000347994900022
J	Wada, K; Matsushima, Y; Tada, T; Hasegawa, S; Obara, Y; Yoshizawa, Y; Takahashi, G; Hiai, H; Shimanuki, M; Suzuki, S; Saitou, J; Yamamoto, N; Ichikawa, M; Watanabe, K; Kikkawa, Y				Wada, Kenta; Matsushima, Yoshibumi; Tada, Tomoki; Hasegawa, Sayaka; Obara, Yo; Yoshizawa, Yasuhiro; Takahashi, Gou; Hiai, Hiroshi; Shimanuki, Midori; Suzuki, Sari; Saitou, Junichi; Yamamoto, Naoki; Ichikawa, Masumi; Watanabe, Kei; Kikkawa, Yoshiaki			Expression of Truncated PITX3 in the Developing Lens Leads to Microphthalmia and Aphakia in Mice	PLOS ONE			English	Article							HOMEOBOX GENE; CRYSTALLIN; MUTATIONS; DELETION; ANOPHTHALMIA; FAMILY; REGION; PAX6	Microphthalmia is a severe ocular disorder, and this condition is typically caused by mutations in transcription factors that are involved in eye development. Mice carrying mutations in these transcription factors would be useful tools for defining the mechanisms underlying developmental eye disorders. We discovered a new spontaneous recessive microphthalmos mouse mutant in the Japanese wild-derived inbred strain KOR1/Stm. The homozygous mutant mice were histologically characterized as microphthalmic by the absence of crystallin in the lens, a condition referred to as aphakia. By positional cloning, we identified the nonsense mutation c.444C>A outside the genomic region that encodes the homeodomain of the paired-like homeodomain transcription factor 3 gene (Pitx3) as the mutation responsible for the microphthalmia and aphakia. We examined Pitx3 mRNA expression of mutant mice during embryonic stages using RT-PCR and found that the expression levels are higher than in wild-type mice. Pitx3 over-expression in the lens during developmental stages was also confirmed at the protein level in the microphthalmos mutants via immunohistochemical analyses. Although lens fiber differentiation was not observed in the mutants, strong PITX3 protein signals were observed in the lens vesicles of the mutant lens. Thus, we speculated that abnormal PITX3, which lacks the C-terminus (including the OAR domain) as a result of the nonsense mutation, is expressed in mutant lenses. We showed that the expression of the downstream genes Foxe3, Prox1, and Mip was altered because of the Pitx3 mutation, with large reductions in the lens vesicles in the mutants. Similar profiles were observed by immunohistochemical analysis of these proteins. The expression profiles of crystallins were also altered in the mutants. Therefore, we speculated that the microphthalmos/aphakia in this mutant is caused by the expression of truncated PITX3, resulting in the abnormal expression of downstream targets and lens fiber proteins.	[Wada, Kenta; Tada, Tomoki; Hasegawa, Sayaka; Yoshizawa, Yasuhiro; Takahashi, Gou; Suzuki, Sari] Tokyo Univ Agr, Dept Bioprod, Abashiri, Japan; [Wada, Kenta; Matsushima, Yoshibumi; Obara, Yo; Suzuki, Sari; Saitou, Junichi; Watanabe, Kei; Kikkawa, Yoshiaki] Tokyo Metropolitan Inst Med Sci, Mammalian Genet Project, Tokyo 113, Japan; [Matsushima, Yoshibumi] Saitama Canc Ctr, Res Inst Clin Oncol, Saitama, Japan; [Obara, Yo; Saitou, Junichi; Watanabe, Kei] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Hiai, Hiroshi] Kyoto Univ, Grad Sch Med, Med Innovat Ctr, Kyoto, Japan; [Shimanuki, Midori; Ichikawa, Masumi] Tokyo Metropolitan Inst Med Sci, Basic Res Ctr, Tokyo 113, Japan; [Yamamoto, Naoki] Fujita Hlth Univ, Inst Joint Res, Toyoake, Aichi, Japan	Tokyo University of Agriculture; Tokyo Metropolitan Institute of Medical Science; University of Tsukuba; Kyoto University; Tokyo Metropolitan Institute of Medical Science; Fujita Health University	Kikkawa, Y (corresponding author), Tokyo Metropolitan Inst Med Sci, Mammalian Genet Project, Tokyo 113, Japan.	kikkawa-ys@igakuken.or.jp	Kikkawa, Yoshiaki/AAI-7229-2020; Yamamoto, Naoki/L-2603-2019	Takahashi, Gou/0000-0003-2277-7657; Kikkawa, Yoshiaki/0000-0001-8859-4998	Japan Society for the Promotion of Science [24700437]; Tokyo Metropolitan Institute of Medical Science; Tokyo University of Agriculture	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tokyo Metropolitan Institute of Medical Science; Tokyo University of Agriculture	This work was supported by a Grant-in-Aid of Scientific Research (Young Scientists (B), no. 24700437) from the Japan Society for the Promotion of Science. This study was also supported by Tokyo Metropolitan Institute of Medical Science, and Tokyo University of Agriculture. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2013, INT J DEV BIOL, V57, P741, DOI 10.1387/ijdb.130193jg; Aldahmesh MA, 2011, GENET MED, V13, P978, DOI 10.1097/GIM.0b013e31822623d5; Amendt BA, 1999, MOL CELL BIOL, V19, P7001; Baker KE, 2004, CURR OPIN CELL BIOL, V16, P293, DOI 10.1016/j.ceb.2004.03.003; Brouwer A, 2003, MECH DEVELOP, V120, P241, DOI 10.1016/S0925-4773(02)00416-1; Burgess D, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-13; Carmona FD, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-44; Chepelinsky Ana B, 2009, Handb Exp Pharmacol, P265, DOI 10.1007/978-3-540-79885-9_14; Gage PJ, 1999, MAMM GENOME, V10, P197, DOI 10.1007/s003359900970; Graw J, 2009, EXP EYE RES, V88, P173, DOI 10.1016/j.exer.2008.10.011; Grimm C, 1998, DEV GENET, V23, P299, DOI 10.1002/(SICI)1520-6408(1998)23:4&lt;299::AID-DVG5&gt;3.0.CO;2-G; Ho HY, 2009, MECH DEVELOP, V126, P18, DOI 10.1016/j.mod.2008.10.007; Matsushima Y, 2012, EXP ANIM TOKYO, V61, P25, DOI 10.1538/expanim.61.25; Medina-Martinez O, 2009, DEV DYNAM, V238, P2193, DOI 10.1002/dvdy.21924; Miyasaka Y, 2013, EXP ANIM TOKYO, V62, P333, DOI 10.1538/expanim.62.333; Morishita H, 2013, J BIOL CHEM, V288, P11436, DOI 10.1074/jbc.M112.437103; Morrison D, 2002, J MED GENET, V39, P16, DOI 10.1136/jmg.39.1.16; Ninkovic J, 2010, NEURON, V68, P682, DOI 10.1016/j.neuron.2010.09.030; Ravenscroft G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028699; Rieger DK, 2001, GENOMICS, V72, P61, DOI 10.1006/geno.2000.6464; Robinson ML, 1996, INVEST OPHTH VIS SCI, V37, P2276; Rosemann M, 2010, MAMM GENOME, V21, P13, DOI 10.1007/s00335-009-9235-0; Sakazume S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-84; Semina EV, 2000, HUM MOL GENET, V9, P1575, DOI 10.1093/hmg/9.11.1575; Semina EV, 1997, HUM MOL GENET, V6, P2109, DOI 10.1093/hmg/6.12.2109; Semina EV, 1998, NAT GENET, V19, P167, DOI 10.1038/527; Sorokina EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021122; Vadlamudi U, 2005, J CELL SCI, V118, P1129, DOI 10.1242/jcs.01706; Varadaraj K, 2007, DEV DYNAM, V236, P1319, DOI 10.1002/dvdy.21125; VARNUM DS, 1968, J HERED, V59, P147, DOI 10.1093/oxfordjournals.jhered.a107667; Voronina VA, 2004, HUM MOL GENET, V13, P315, DOI 10.1093/hmg/ddh025; Wada K, 2011, MAMM GENOME, V22, P693, DOI 10.1007/s00335-011-9358-y; Watanabe K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050737; Wistow G, 2012, HUM GENOMICS, V6, DOI 10.1186/1479-7364-6-26; Yan XH, 2014, HUM MOL GENET, V23, P5597, DOI 10.1093/hmg/ddu274	35	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111432	10.1371/journal.pone.0111432	http://dx.doi.org/10.1371/journal.pone.0111432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347445	gold, Green Published, Green Submitted			2022-12-27	WOS:000347994900072
J	Xiong, X; Mei, WJ; Xie, YY; Liu, JS; Lu, MM; Peng, XQ; Yang, CY; Zhang, X; Xie, MY; Luo, RN; Yuan, XN; Huang, L; Wu, L; Qin, J; Peng, Y; Jia, XJ; Hu, GY; Tang, DM; Tao, LJ				Xiong, Xuan; Mei, Wenjuan; Xie, Yanyun; Liu, Jishi; Lu, Miaomiao; Peng, Xiongqun; Yang, Congyin; Zhang, Xin; Xie, Mingyan; Luo, Renna; Yuan, Xiangning; Huang, Ling; Wu, Lin; Qin, Jiao; Peng, Yu; Jia, Xiujie; Hu, Gaoyun; Tang, Damu; Tao, Lijian			Fluorofenidone Offers Improved Renoprotection at Early Interventions during the Course of Diabetic Nephropathy in db/db Mice via Multiple Pathways	PLOS ONE			English	Article							MESANGIAL CELLS; KIDNEY-DISEASE; EXPRESSION; MODEL; FIBROSIS; PIRFENIDONE; PREVENTION; OXIDASE	Diabetic nephropathy (DN) remains the leading cause of end-stage renal disease (ESRD), a situation that is in part attributable to the lack of effective treatments. Fluorofenidone is a newly developed reagent with anti-fibrotic activity. While fluorofenidone was previously demonstrated to possess renoprotection from DN pathogenesis in db/db mice, the protective process and its underlying mechanisms have not been well studied. To characterize fluorofenidone-derived renoprotection, we treated 5, 8, or 12-week old db/db mice with daily doses of placebo, fluorofenidone, or losartan until 24 weeks of age; the time at which diabetes and DN were fully developed in placebo-treated animals. In comparison to db/db mice receiving fluorofenidone at 12-weeks old, those treated at 5-weeks had less glomerular expansion and better preservation of renal functions, judged by serum creatinine levels, albumin to creatinine ratio, and urinary albumin excretion (mg/24 hours). These benefits of early treatment were associated with significant reductions of multiple DN-promoting events, such as decreased expression of TGF-beta 1 and the p22(phox) subunit of NADPH oxidase as well as downregulated activation of protein kinase C-zeta (zeta), ERK and AKT. This improvement in renoprotection following early interventions is not a unique property of DN pathogenesis, as losartan does not apparently offer the same benefits and is not more renoprotective than fluorofenidone. Additionally, the enhanced renoprotection provided by fluorofenidone did not affect the diabetic process, as it did not alter serum levels of glycated serum proteins, glucose, triglyceride or cholesterol. Collectively, we provide evidence that fluorofenidone offers improved renoprotection at early stages of DN pathogenesis.	[Xiong, Xuan; Mei, Wenjuan; Xie, Yanyun; Lu, Miaomiao; Luo, Renna; Yuan, Xiangning; Huang, Ling; Wu, Lin; Qin, Jiao; Peng, Yu; Tao, Lijian] Cent S Univ, Xiangya Hosp, Div Nephrol, Changsha, Hunan, Peoples R China; [Xie, Yanyun; Tang, Damu] McMaster Univ, Dept Med, Div Nephrol, Hamilton, ON, Canada; [Liu, Jishi] Third Xiangya Hosp, Dept Nephrol, Changsha, Hunan, Peoples R China; [Peng, Xiongqun; Yang, Congyin; Zhang, Xin; Xie, Mingyan] Xiangya Hosp, Dept Gastroenterol, Changsha, Hunan, Peoples R China; [Jia, Xiujie] Second Xiangya Hosp, Dept Resp Med, Changsha, Hunan, Peoples R China; [Hu, Gaoyun] Cent S Univ, Sch Pharmaceut Sci, Dept Med Chem, Chem Sect, Changsha, Hunan, Peoples R China; [Tao, Lijian] Cent S Univ, State Key Lab Med Genet China, Changsha, Hunan, Peoples R China	Central South University; McMaster University; Central South University; Central South University; Central South University; Central South University	Tang, DM (corresponding author), McMaster Univ, Dept Med, Div Nephrol, Hamilton, ON, Canada.	damut@mcmaster.ca; taolj@mail.csu.edu.cn	TAO, Li/HIR-4254-2022; Tang, Damu/AAQ-1786-2021	Tang, Damu/0000-0002-3282-9521	NSFC [81061120524]; CIHR [CC1-10961]	NSFC(National Natural Science Foundation of China (NSFC)); CIHR(Canadian Institutes of Health Research (CIHR))	This research was supported by a NSFC grant (81061120524) to LT and a CIHR grant (CC1-10961) to DT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsaad KO, 2007, J CLIN PATHOL, V60, P18, DOI 10.1136/jcp.2005.035592; Balakumar P, 2009, J CARDIOVASC PHARM, V54, P129, DOI 10.1097/FJC.0b013e3181ad2190; Chiarelli F, 2009, HORM METAB RES, V41, P585, DOI 10.1055/s-0029-1220752; Cohen MP, 2001, METABOLISM, V50, P1435, DOI 10.1053/meta.2001.28074; Danesh FR, 2002, P NATL ACAD SCI USA, V99, P8301, DOI 10.1073/pnas.122228799; Forbes JM, 2003, FASEB J, V17, P1762, DOI 10.1096/fj.02-1102fje; Fujita H, 2004, AM J PHYSIOL-RENAL, V286, pF120, DOI 10.1152/ajprenal.00351.2002; GARTNER K, 1978, DIABETOLOGIA, V15, P59, DOI 10.1007/BF01219330; Gilbert RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047160; Ha TS, 2010, J MOL MED, V88, P391, DOI 10.1007/s00109-009-0575-8; Hudkins KL, 2010, J AM SOC NEPHROL, V21, P1533, DOI 10.1681/ASN.2009121290; Jefferson JA, 2008, KIDNEY INT, V74, P22, DOI 10.1038/ki.2008.128; Joo JD, 2007, AM J PHYSIOL-RENAL, V293, pF1847, DOI 10.1152/ajprenal.00336.2007; Kwon DS, 2006, EUR J CELL BIOL, V85, P1189, DOI 10.1016/j.ejcb.2006.06.001; Leiter LA, 2005, DIABETES RES CLIN PR, V68, pS3, DOI 10.1016/j.diabres.2005.03.015; Levin A, 2011, J AM SOC NEPHROL, V22, P992, DOI 10.1681/ASN.2011040402; Lewis Edmund J, 2003, Clin Exp Nephrol, V7, P1, DOI 10.1007/s101570300000; Lin X, 2013, CURR MED CHEM, V20, P3774, DOI 10.2174/09298673113209990183; Ma KL, 2014, INT J BIOL SCI, V10, P149, DOI 10.7150/ijbs.7875; Nicholas SB, 2010, KIDNEY INT, V77, P588, DOI 10.1038/ki.2009.518; Pan D, 2014, FOOD CHEM TOXICOL, V63, P111, DOI 10.1016/j.fct.2013.10.046; PARVING HH, 2004, DIABETIC NEPHROPATHY, P1777; Peng ZZ, 2009, NEPHROLOGY, V14, P565, DOI 10.1111/j.1440-1797.2009.01129.x; Pichaiwong W, 2013, J AM SOC NEPHROL, V24, P1088, DOI 10.1681/ASN.2012050445; Quaggin SE, 2007, J AM SOC NEPHROL, V18, P364, DOI 10.1681/ASN.2006121396; RamachandraRao SP, 2009, J AM SOC NEPHROL, V20, P1765, DOI 10.1681/ASN.2008090931; Reeves WB, 2000, P NATL ACAD SCI USA, V97, P7667, DOI 10.1073/pnas.97.14.7667; Remuzzi G, 2004, J AM SOC NEPHROL, V15, P3117, DOI 10.1097/01.ASN.0000146423.71226.0C; Ruggenenti P, 2004, NEW ENGL J MED, V351, P1941, DOI 10.1056/NEJMoa042167; Sharma K, 2011, J AM SOC NEPHROL, V22, P1144, DOI 10.1681/ASN.2010101049; Shimizu F, 2011, DIABETOLOGIA, V54, P1517, DOI 10.1007/s00125-011-2107-7; Stitt-Cavanagh E, 2009, THESCIENTIFICWORLDJO, V9, P1127, DOI 10.1100/tsw.2009.133; Susztak K, 2004, DIABETES, V53, P784, DOI 10.2337/diabetes.53.3.784; Tanios BY, 2012, NEPHRON EXTRA, V2, P278, DOI 10.1159/000343312; Taye A, 2013, N-S ARCH PHARMACOL, V386, P1071, DOI 10.1007/s00210-013-0904-x; Wang L, 2009, PHARMAZIE, V64, P680, DOI 10.1691/ph.2009.9525; Wang LH, 2011, PHARMACOLOGY, V88, P88, DOI 10.1159/000329419; Wu DC, 2009, J AM SOC NEPHROL, V20, P554, DOI 10.1681/ASN.2008040445; Xia L, 2007, AM J PHYSIOL-ENDOC M, V293, pE1280, DOI 10.1152/ajpendo.00223.2007; Xia L, 2008, AM J PHYSIOL-RENAL, V295, pF1705, DOI 10.1152/ajprenal.00043.2008; Zeng R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076836; Ziyadeh FN, 2000, P NATL ACAD SCI USA, V97, P8015, DOI 10.1073/pnas.120055097	42	10	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111242	10.1371/journal.pone.0111242	http://dx.doi.org/10.1371/journal.pone.0111242			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347392	Green Published, gold, Green Submitted			2022-12-27	WOS:000347994900056
J	Harriague, AC; Bavestrello, G; Bo, M; Borghini, M; Castellano, M; Majorana, M; Massa, F; Montella, A; Povero, P; Misic, C				Harriague, Anabella Covazzi; Bavestrello, Giorgio; Bo, Marzia; Borghini, Mireno; Castellano, Michela; Majorana, Margherita; Massa, Francesco; Montella, Alessandro; Povero, Paolo; Misic, Cristina			Linking Environmental Forcing and Trophic Supply to Benthic Communities in the Vercelli Seamount Area (Tyrrhenian Sea)	PLOS ONE			English	Article							ORGANIC-MATTER; BACTERIAL PRODUCTION; FLUXES; WATER; SIZE; ASSEMBLAGES; EXTRACTION; DIVERSITY; DYNAMICS; ECOLOGY	Seamounts and their influence on the surrounding environment are currently being extensively debated but, surprisingly, scant information is available for the Mediterranean area. Furthermore, although the deep Tyrrhenian Sea is characterised by a complex bottom morphology and peculiar hydrodynamic features, which would suggest a variable influence on the benthic domain, few studies have been carried out there, especially for soft-bottom macrofaunal assemblages. In order to fill this gap, the structure of the meio-and macrofaunal assemblages of the Vercelli Seamount and the surrounding deep area (northern Tyrrhenian Sea - western Mediterranean) were studied in relation to environmental features. Sediment was collected with a box-corer from the seamount summit and flanks and at two far-field sites in spring 2009, in order to analyse the metazoan communities, the sediment texture and the sedimentary organic matter. At the summit station, the heterogeneity of the habitat, the shallowness of the site and the higher trophic supply (water column phytopigments and macroalgal detritus, for instance) supported a very rich macrofaunal community, with high abundance, biomass and diversity. In fact, its trophic features resembled those observed in coastal environments next to seagrass meadows. At the flank and far-field stations, sediment heterogeneity and depth especially influenced the meiofaunal distribution. From a trophic point of view, the low content of the valuable sedimentary proteins that was found confirmed the general oligotrophy of the Tyrrhenian Sea, and exerted a limiting influence on the abundance and biomass of the assemblages. In this scenario, the rather refractory sedimentary carbohydrates became a food source for metazoans, which increased their abundance and biomass at the stations where the hydrolytic-enzyme-mediated turnover of carbohydrates was faster, highlighting high lability.	[Harriague, Anabella Covazzi; Bavestrello, Giorgio; Bo, Marzia; Castellano, Michela; Majorana, Margherita; Massa, Francesco; Montella, Alessandro; Povero, Paolo; Misic, Cristina] Univ Genoa, Dipartimento Sci Terra Ambiente & Vita DiSTAV, I-16126 Genoa, Italy; [Borghini, Mireno] CNR, Inst Marine Sci, CNR ISMAR, Sect La Spezia, Pozzuolo Di Lerici, Italy	University of Genoa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR)	Harriague, AC (corresponding author), Univ Genoa, Dipartimento Sci Terra Ambiente & Vita DiSTAV, I-16126 Genoa, Italy.	anabella7@hotmail.com	CNR, Ismar/P-1247-2014	CNR, Ismar/0000-0001-5351-1486; Castellano, Michela/0000-0001-6101-0112; COVAZZI HARRIAGUE, Sandra Anabella/0000-0003-0378-5395; MISIC, CRISTINA/0000-0002-2577-1800; Bo, Marzia/0000-0001-8400-6722; Massa, Francesco/0000-0001-9632-4939	Italian Ministry of Research and Instruction	Italian Ministry of Research and Instruction	This work was undertaken within the PRIN (Progetti di Rilevante Interesse Nazionale) project "Tyrrhenian Seamount Ecosystems: An Integrated Study (TySEc)'', financed by the Italian Ministry of Research and Instruction. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTALE V, 1994, J GEOPHYS RES-OCEANS, V99, P14127, DOI 10.1029/94JC00284; Bhaskar PV, 2008, ESTUAR COAST SHELF S, V80, P413, DOI 10.1016/j.ecss.2008.09.005; Bianchi A, 2002, OCEANOL ACTA, V25, P315, DOI 10.1016/S0399-1784(02)01205-7; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016357; Bongiorni L, 2013, DEEP-SEA RES PT II, V98, P75, DOI 10.1016/j.dsr2.2013.08.006; Bosc E, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002034; Buchanan J. B., 1971, P30; Caruso G, 2005, MAR FRESHWATER RES, V56, P173, DOI 10.1071/MF04049; Christiansen B, 2009, DEEP-SEA RES PT II, V56, P2579, DOI 10.1016/j.dsr2.2008.12.021; Clark MR, 2010, ANNU REV MAR SCI, V2, P253, DOI 10.1146/annurev-marine-120308-081109; Danovaro R, 1999, PROG OCEANOGR, V44, P287, DOI 10.1016/S0079-6611(99)00030-0; Danovaro R, 2010, METHODS STUDY DEEP S, P420; Danovaro R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011832; Danovaro R, 2009, DEEP-SEA RES PT II, V56, P738, DOI 10.1016/j.dsr2.2008.10.011; DOWER J, 1992, DEEP-SEA RES, V39, P1139, DOI 10.1016/0198-0149(92)90061-W; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; ETTER RJ, 1992, NATURE, V360, P576, DOI 10.1038/360576a0; Fonseca G, 2009, POLAR BIOL, V32, P1345, DOI 10.1007/s00300-009-0631-4; Gad G, 2004, ARCH FISH MAR RES, V51, P43; Galil Bella, 1998, Senckenbergiana Maritima, V28, P111; Galil Bella S., 1994, Senckenbergiana Maritima, V25, P41; George KH, 2004, ORG DIVERS EVOL, V4, P241, DOI 10.1016/j.ode.2004.02.003; Gooday AJ, 2002, J OCEANOGR, V58, P305, DOI 10.1023/A:1015865826379; Hansen H.P., 1983, METHODS SEAWATER ANA, V2nd ed., P347; Harriague AC, 2006, ESTUAR COAST SHELF S, V70, P251, DOI 10.1016/j.ecss.2005.10.017; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; HEDGES JI, 1984, LIMNOL OCEANOGR, V29, P657, DOI 10.4319/lo.1984.29.3.0657; Heinz P, 2004, MAR BIOL, V144, P985, DOI 10.1007/s00227-003-1257-7; HOLM-HANSEN OSMUND, 1965, J CONS CONS PERMS INTE EXPLOR MER, V30, P3; HOPPE HG, 1983, MAR ECOL PROG SER, V11, P299, DOI 10.3354/meps011299; Koroleff F., 1983, METHODS SEAWATER ANA, P125; Krivosheya V. G., 1983, Oceanology, V23, P166; Leduc D, 2012, DEEP-SEA RES PT I, V63, P164, DOI 10.1016/j.dsr.2011.10.009; MARSH JB, 1966, J LIPID RES, V7, P574; Misic C, 2012, DEEP-SEA RES PT I, V67, P1, DOI 10.1016/j.dsr.2012.04.012; Moen J, 1984, SR75; Mudryk ZJ, 2004, ESTUAR COAST SHELF S, V59, P59, DOI 10.1016/j.ecss.2003.08.001; Nair R, 1994, P 10 S IT ASS LIMN O, P65; Piepenburg D, 2004, ARCH FISH MAR RES, V51, P55; Psarra S, 2000, PROG OCEANOGR, V46, P187, DOI 10.1016/S0079-6611(00)00018-5; Pusceddu A, 2010, DEEP-SEA RES PT I, V57, P441, DOI 10.1016/j.dsr.2009.11.008; Pusceddu A, 2009, DEEP-SEA RES PT II, V56, P755, DOI 10.1016/j.dsr2.2008.10.012; Rex MA, 2006, MAR ECOL PROG SER, V317, P1, DOI 10.3354/meps317001; Rossi S, 2003, ESTUAR COAST SHELF S, V58, P423, DOI 10.1016/S0272-7714(03)00108-2; RUTTENBERG KC, 1992, LIMNOL OCEANOGR, V37, P1460, DOI 10.4319/lo.1992.37.7.1460; Sinsabaugh RL, 1997, LIMNOL OCEANOGR, V42, P29, DOI 10.4319/lo.1997.42.1.0029; Speicher EA, 2006, DEEP-SEA RES PT I, V53, P1810, DOI 10.1016/j.dsr.2006.08.005; Tamburini C, 2002, DEEP-SEA RES PT II, V49, P2109, DOI 10.1016/S0967-0645(02)00030-9; Tselepides A, 2000, PROG OCEANOGR, V46, P401, DOI 10.1016/S0079-6611(00)00027-6; Vakondios N, 2014, WATER RES, V63, P62, DOI 10.1016/j.watres.2014.06.011; Vetrano A, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005680; Wezel F.C., 1985, GEOLOGICAL EVOLUTION, P153; Wit R De, 1998, 3 MTP 2 WORKSH VAR M, P207; Zeppilli D, 2013, DEEP-SEA RES PT II, V98, P87, DOI 10.1016/j.dsr2.2013.08.009; ZOBRIST EC, 1992, MAR ECOL PROG SER, V88, P1, DOI 10.3354/meps088001	56	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110880	10.1371/journal.pone.0110880	http://dx.doi.org/10.1371/journal.pone.0110880			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343621	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943500061
J	Jackson, SR; Berrien-Elliott, M; Yuan, JY; Hsueh, EC; Teague, RM				Jackson, Stephanie R.; Berrien-Elliott, Melissa; Yuan, Jinyun; Hsueh, Eddy C.; Teague, Ryan M.			Neuropilin-1 Expression Is Induced on Tolerant Self-Reactive CD8(+) T Cells but Is Dispensable for the Tolerant Phenotype	PLOS ONE			English	Article							REGULATORY T; MEMBRANE-PROTEIN; DENDRITIC CELLS; RECEPTOR; PD-1; IMMUNOTHERAPY; VEGF; COMBINATION; DISRUPTION; INITIATION	Establishing peripheral CD8(+) T cell tolerance is vital to avoid immune mediated destruction of healthy self-tissues. However, it also poses a major impediment to tumor immunity since tumors are derived from self-tissue and often induce T cell tolerance and dysfunction. Thus, understanding the mechanisms that regulate T cell tolerance versus immunity has important implications for human health. Signals received from the tissue environment largely dictate whether responding T cells become activated or tolerant. For example, induced expression and subsequent ligation of negative regulatory receptors on the surface of self-reactive CD8(+) T cells are integral in the induction of tolerance. We utilized a murine model of T cell tolerance to more completely define the molecules involved in this process. We discovered that, in addition to other known regulatory receptors, tolerant self-reactive CD8(+) T cells distinctly expressed the surface receptor neuropilin-1 (Nrp1). Nrp1 was highly induced in response to self-antigen, but only modestly when the same antigen was encountered under immune conditions, suggesting a possible mechanistic link to T cell tolerance. We also observed a similar Nrp1 expression profile on human tumor infiltrating CD4(+) and CD8(+) T cells. Despite high expression on tolerant CD8(+) T cells, our studies revealed that Nrp1 had no detectable role in the tolerant phenotype. Specifically, Nrp1-deficient T cells displayed the same functional defects as wild-type self-reactive T cells, lacking in vivo cytolytic potential, IFN gamma production, and antitumor responses. While reporting mostly negative data, our findings have therapeutic implications, as Nrp1 is now being targeted for human cancer therapy in clinical trials, but the precise molecular pathways and immune cells being engaged during treatment remain incompletely defined.	[Jackson, Stephanie R.; Berrien-Elliott, Melissa; Yuan, Jinyun; Teague, Ryan M.] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA; [Hsueh, Eddy C.] St Louis Univ, Sch Med, Dept Surg, St Louis, MO 63103 USA; [Hsueh, Eddy C.; Teague, Ryan M.] St Louis Univ, Ctr Canc, St Louis, MO 63103 USA	Saint Louis University; Saint Louis University; Saint Louis University	Teague, RM (corresponding author), St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA.	rteague@slu.edu		Teague, Ryan/0000-0002-8426-2870; Jackson Cullison, Stephanie/0000-0002-5833-122X; Berrien-Elliott, Melissa/0000-0002-7319-9159	National Institute of Allergy and Infectious Disease/National Institutes of Health [R01AI087764]; Cancer Research Institute Investigator Award; National Cancer Institute/National Institutes of Health fellowship [F30CA180375]; NATIONAL CANCER INSTITUTE [F30CA180375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087764] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Cancer Research Institute Investigator Award; National Cancer Institute/National Institutes of Health fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institute of Allergy and Infectious Disease/National Institutes of Health (R01AI087764) to RMT, by a Cancer Research Institute Investigator Award to RMT, and by a National Cancer Institute/National Institutes of Health fellowship (F30CA180375) to SRJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battaglia A, 2008, IMMUNOLOGY, V123, P129, DOI 10.1111/j.1365-2567.2007.02737.x; Battaglia A, 2009, CANCER IMMUNOL IMMUN, V58, P1363, DOI 10.1007/s00262-008-0646-7; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Berrien-Elliott MM, 2013, CANCER RES, V73, P605, DOI 10.1158/0008-5472.CAN-12-2179; Bielenberg DR, 2006, EXP CELL RES, V312, P584, DOI 10.1016/j.yexcr.2005.11.024; Bottcher JP, 2013, CELL REP, V3, P779, DOI 10.1016/j.celrep.2013.02.008; Bouneaud C, 2000, IMMUNITY, V13, P829, DOI 10.1016/S1074-7613(00)00080-7; Bruder D, 2004, EUR J IMMUNOL, V34, P623, DOI 10.1002/eji.200324799; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Carrer A, 2012, CANCER RES, V72, P6371, DOI 10.1158/0008-5472.CAN-12-0762; Catalano A, 2010, J IMMUNOL, V185, P6373, DOI 10.4049/jimmunol.0903527; Chaudhary B, 2014, CANCER IMMUNOL IMMUN, V63, P81, DOI 10.1007/s00262-013-1500-0; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Delgoffe GM, 2013, NATURE, V501, P252, DOI 10.1038/nature12428; Fuh G, 2000, J BIOL CHEM, V275, P26690; Fujisawa H, 1995, DEV NEUROSCI-BASEL, V17, P343, DOI 10.1159/000111304; Glinka Y, 2008, J LEUKOCYTE BIOL, V84, P302, DOI 10.1189/jlb.0208090; Grosso JF, 2009, J IMMUNOL, V182, P6659, DOI 10.4049/jimmunol.0804211; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Hansen W, 2012, J EXP MED, V209, P2001, DOI 10.1084/jem.20111497; Jackson SR, 2014, IMMUNOTHERAPY; Jackson SR, 2014, J LEUKOC BIOL; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kawakami A, 1996, J NEUROBIOL, V29, P1, DOI 10.1002/(SICI)1097-4695(199601)29:1<1::AID-NEU1>3.0.CO;2-F; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Kitsukawa T, 1995, DEVELOPMENT, V121, P4309; Mamluk R, 2002, J BIOL CHEM, V277, P24818, DOI 10.1074/jbc.M200730200; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Ohlen C, 2001, J IMMUNOL, V166, P2863, DOI 10.4049/jimmunol.166.4.2863; Page DB, 2014, ANNU REV MED, V65, P185, DOI 10.1146/annurev-med-092012-112807; Pan Q, 2007, CANCER CELL, V11, P53, DOI 10.1016/j.ccr.2006.10.018; Patnaik A, 2014, CANCER CHEMOTH PHARM, V73, P951, DOI 10.1007/s00280-014-2426-8; Piechnik A, 2013, INT J CANCER, V133, P1489, DOI 10.1002/ijc.28135; Probst HC, 2005, NAT IMMUNOL, V6, P280, DOI 10.1038/ni1165; Rosenberg SA, 1999, IMMUNITY, V10, P281, DOI 10.1016/S1074-7613(00)80028-X; Sarris M, 2008, IMMUNITY, V28, P402, DOI 10.1016/j.immuni.2008.01.012; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Solomon BD, 2011, P NATL ACAD SCI USA, V108, P2040, DOI 10.1073/pnas.1008721108; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Tordjman R, 2002, NAT IMMUNOL, V3, P477, DOI 10.1038/ni789; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Weekes CD, 2014, INVEST NEW DRUGS; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822	45	10	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110707	10.1371/journal.pone.0110707	http://dx.doi.org/10.1371/journal.pone.0110707			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343644	gold, Green Submitted, Green Published			2022-12-27	WOS:000343943500049
J	Vivot, K; Langlois, A; Bietiger, W; Dal, S; Seyfritz, E; Pinget, M; Jeandidier, N; Maillard, E; Gies, JP; Sigrist, S				Vivot, Kevin; Langlois, Allan; Bietiger, William; Dal, Stephanie; Seyfritz, Elodie; Pinget, Michel; Jeandidier, Nathalie; Maillard, Elisa; Gies, Jean-Pierre; Sigrist, Severine			Pro-Inflammatory and Pro-Oxidant Status of Pancreatic Islet In Vitro Is Controlled by TLR-4 and HO-1 Pathways	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; EARLY GRAFT FAILURE; GENE-EXPRESSION; CARBON-MONOXIDE; TRANSPLANTED ISLETS; SIGNALING PATHWAYS; ALLOGENEIC ISLETS; CELL-DEATH; LANGERHANS; RAT	Since their isolation until implantation, pancreatic islets suffer a major stress leading to the activation of inflammatory reactions. The maintenance of controlled inflammation is essential to preserve survival and function of the graft. Identification and targeting of pathway(s) implicated in post-transplant detrimental inflammatory events, is mandatory to improve islet transplantation success. We sought to characterize the expression of the pro-inflammatory and pro-oxidant mediators during islet culture with a focus on Heme oxygenase (HO-1) and Toll-like receptors-4 signaling pathways. Rat pancreatic islets were isolated and pro-inflammatory and pro-oxidant status were evaluated after 0, 12, 24 and 48 hours of culture through TLR-4, HO-1 and cyclooxygenase-2 (COX-2) expression, CCL-2 and IL-6 secretion, ROS (Reactive Oxygen Species) production (Dihydroethidine staining, DHE) and macrophages migration. To identify the therapeutic target, TLR4 inhibition (CLI-095) and HO-1 activation (cobalt protoporphyrin, CoPP) was performed. Activation of NFkB signaling pathway was also investigated. After isolation and during culture, pancreatic islet exhibited a proinflammatory and prooxidant status (increase levels of TLR-4, COX-2, CCL-2, IL-6, and ROS). Activation of HO-1 or inhibition of TLR-4 decreased inflammatory status and oxidative stress of islets. Moreover, the overexpression of HO-1 induced NF kappa B phosphorylation while the inhibition of TLR-4 had no effect NF kappa B activation. Finally, inhibition of pro-inflammatory pathway induced a reduction of macrophages migration. These data demonstrated that the TLR-4 signaling pathway is implicated in early inflammatory events leading to a pro-inflammatory and pro-oxidant status of islets in vitro. Moreover, these results provide the mechanism whereby the benefits of HO-1 target in TLR-4 signaling pathway. HO-1 could be then an interesting target to protect islets before transplantation.	[Vivot, Kevin; Langlois, Allan; Bietiger, William; Dal, Stephanie; Seyfritz, Elodie; Pinget, Michel; Jeandidier, Nathalie; Maillard, Elisa; Sigrist, Severine] Univ Strasbourg, Ctr Europeen Etude Diabete, DIATHEC, EA 7294, Strasbourg, France; [Pinget, Michel; Jeandidier, Nathalie] HUS, Pole NUDE, Strasbourg, France; Univ Strasbourg, Fac Pharm, CNRS, UMR 7034, Illkirch Graffenstaden, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Sigrist, S (corresponding author), Univ Strasbourg, Ctr Europeen Etude Diabete, DIATHEC, EA 7294, Strasbourg, France.	s.sigrist@ceed-diabete.org	Vivot, Kevin/P-8329-2016	Vivot, Kevin/0000-0003-4617-0016	ASDIA (Assistance Service DIAbete); REUNICA Group; foundation "Vaincre le Diabete"	ASDIA (Assistance Service DIAbete); REUNICA Group; foundation "Vaincre le Diabete"	This work was supported by ASDIA (Assistance Service DIAbete), the REUNICA Group and the foundation "Vaincre le Diabete". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre ML, 2008, TRANSPLANTATION, V86, P1, DOI 10.1097/TP.0b013e31817c11e6; Arita S, 2002, TRANSPLANTATION, V73, P7, DOI 10.1097/00007890-200201150-00003; Armann B, 2007, AM J TRANSPLANT, V7, P38, DOI 10.1111/j.1600-6143.2006.01577.x; Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; Barshes NR, 2005, J LEUKOCYTE BIOL, V77, P587, DOI 10.1189/jlb.1104649; Biarnes M, 2002, DIABETES, V51, P66, DOI 10.2337/diabetes.51.1.66; Bottino R, 2004, DIABETES, V53, P2559, DOI 10.2337/diabetes.53.10.2559; Bottino R, 1998, DIABETES, V47, P316, DOI 10.2337/diabetes.47.3.316; BURKART V, 1993, CLIN EXP IMMUNOL, V93, P273; Chen X, 2010, J SURG RES, V164, P336, DOI 10.1016/j.jss.2009.08.016; Cowley MJ, 2012, CELL TRANSPLANT, V21, P2063, DOI 10.3727/096368911X627372; Dal-Ros S, 2010, GASTROENTEROLOGY, V138, P1574, DOI 10.1053/j.gastro.2009.10.040; Danner S, 2008, TRANSPL P, V40, P470, DOI 10.1016/j.transproceed.2008.01.002; Davalli AM, 1996, DIABETES, V45, P1161, DOI 10.2337/diabetes.45.9.1161; Forman K, 2011, J GERONTOL A-BIOL, V66, P823, DOI 10.1093/gerona/glr083; Gao Q, 2010, AM J TRANSPLANT, V10, P1588, DOI 10.1111/j.1600-6143.2010.03151.x; Goldberg A, 2007, FASEB J, V21, P2840, DOI 10.1096/fj.06-7910com; Gysemans C, 2003, DIABETOLOGIA, V46, P1115, DOI 10.1007/s00125-003-1154-0; HAKIM J, 1993, CR SOC BIOL, V187, P286; Heitmeier MR, 2004, J BIOL CHEM, V279, P53145, DOI 10.1074/jbc.M410978200; Hildebrand D, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-22; Ii M, 2006, MOL PHARMACOL, V69, P1288, DOI 10.1124/mol.105.019695; Itoh T, 2011, ISLETS, V3, P376, DOI 10.4161/isl.3.6.18159; Johansson U, 2003, BIOCHEM BIOPH RES CO, V308, P474, DOI 10.1016/S0006-291X(03)01392-5; Juang JH, 2010, TRANSPL P, V42, P4221, DOI 10.1016/j.transproceed.2010.09.086; Kawamoto T, 2008, EUR J PHARMACOL, V584, P40, DOI 10.1016/j.ejphar.2008.01.026; Kruger B, 2010, EUR J IMMUNOL, V40, P2914, DOI 10.1002/eji.201040601; Lee TS, 2002, NAT MED, V8, P240, DOI 10.1038/nm0302-240; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Matsuda T, 2005, AM J TRANSPLANT, V5, P484, DOI 10.1046/j.1600-6143.2004.00716.x; McCall M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007823; Melzi R, 2010, CELL TRANSPLANT, V19, P1031, DOI 10.3727/096368910X514639; Moberg L, 2005, CLIN EXP IMMUNOL, V142, P125, DOI 10.1111/j.1365-2249.2005.02883.x; Nakahira K, 2006, J EXP MED, V203, P2377, DOI 10.1084/jem.20060845; Nilsson B, 2011, CURR OPIN ORGAN TRAN, V16, P620, DOI 10.1097/MOT.0b013e32834c2393; Pepper Andrew R, 2013, World J Transplant, V3, P48, DOI 10.5500/wjt.v3.i4.48; Persaud SJ, 2004, DIABETES, V53, pS190, DOI 10.2337/diabetes.53.2007.S190; Piemonti L, 2002, DIABETES, V51, P55, DOI 10.2337/diabetes.51.1.55; Pileggi A, 2001, DIABETES, V50, P1983, DOI 10.2337/diabetes.50.9.1983; Remy S, 2009, J IMMUNOL, V182, P1877, DOI 10.4049/jimmunol.0802436; Rosenberg L, 1999, SURGERY, V126, P393, DOI 10.1067/msy.1999.98783; Ryan EA, 2006, DIABETES OBES METAB, V8, P1, DOI 10.1111/j.1463-1326.2004.00460.x; Ryan EA, 2002, DIABETES, V51, P2148, DOI 10.2337/diabetes.51.7.2148; Ryan EA, 2001, J INVEST MED, V49, P559, DOI 10.2310/6650.2001.33719; Ryan EA, 2001, DIABETES, V50, P710, DOI 10.2337/diabetes.50.4.710; SEIBERT K, 1994, RECEPTOR, V4, P17; Shapiro AMJ, 2011, CURR DIABETES REP, V11, P345, DOI 10.1007/s11892-011-0217-8; Shapiro AMJ, 2008, NAT CLIN PRACT NEPHR, V4, P662, DOI 10.1038/ncpneph0964; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Shen XD, 2005, AM J TRANSPLANT, V5, P1793, DOI 10.1111/j.1600-6143.2005.00932.x; Sigrist S, 2005, TRANSPL P, V37, P3516, DOI 10.1016/j.transproceed.2005.09.048; Sigrist S, 2004, IMMUNOLOGY, V111, P416, DOI 10.1111/j.1365-2567.2004.01828.x; Sklavos MM, 2010, DIABETES, V59, P1731, DOI 10.2337/db09-0588; Sorli CH, 1998, P NATL ACAD SCI USA, V95, P1788, DOI 10.1073/pnas.95.4.1788; SUTTON R, 1986, TRANSPLANTATION, V42, P689, DOI 10.1097/00007890-198612000-00022; Tran POT, 2002, DIABETES, V51, P1772, DOI 10.2337/diabetes.51.6.1772; Tsatsanis C, 2006, INT J BIOCHEM CELL B, V38, P1654, DOI 10.1016/j.biocel.2006.03.021; van der Windt DJ, 2007, XENOTRANSPLANTATION, V14, P288, DOI 10.1111/j.1399-3089.2007.00419.x; Vives-Pi M, 2003, CLIN EXP IMMUNOL, V133, P208, DOI 10.1046/j.1365-2249.2003.02211.x; Vivot K, 2011, TRANSPL P, V43, P3201, DOI 10.1016/j.transproceed.2011.09.096; Wang HJ, 2006, ENDOCRINOLOGY, V147, P762, DOI 10.1210/en.2005-0632; Wang HJ, 2005, DIABETES, V54, P1400, DOI 10.2337/diabetes.54.5.1400; Wang HJ, 2011, J TRANSPLANT, V2011, DOI 10.1155/2011/141898; WELSH N, 1995, MOL MED, V1, P806, DOI 10.1007/BF03401895; Wen L, 2004, J IMMUNOL, V172, P3173, DOI 10.4049/jimmunol.172.5.3173; XENOS ES, 1994, TRANSPLANTATION, V57, P1208, DOI 10.1097/00007890-199404270-00012; Ye J, 1998, ENDOCRINOLOGY, V139, P4155, DOI 10.1210/en.139.10.4155; Yin D, 2006, AM J TRANSPLANT, V6, P60, DOI 10.1111/j.1600-6143.2005.01157.x; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zhang YC, 2003, DIABETES, V52, P708, DOI 10.2337/diabetes.52.3.708; Ziolkowski AF, 2012, J CLIN INVEST, V122, P132, DOI 10.1172/JCI46177	74	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e107656	10.1371/journal.pone.0107656	http://dx.doi.org/10.1371/journal.pone.0107656			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343247	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943500002
J	Baier, PC; Brzozka, MM; Shahmoradi, A; Reinecke, L; Kroos, C; Wichert, SP; Oster, H; Wehr, MC; Taneja, R; Hirrlinger, J; Rossner, MJ				Baier, Paul C.; Brzozka, Magdalena M.; Shahmoradi, Ali; Reinecke, Lisa; Kroos, Christina; Wichert, Sven P.; Oster, Henrik; Wehr, Michael C.; Taneja, Reshma; Hirrlinger, Johannes; Rossner, Moritz J.			Mice Lacking the Circadian Modulators SHARP1 and SHARP2 Display Altered Sleep and Mixed State Endophenotypes of Psychiatric Disorders	PLOS ONE			English	Article							SPATIAL WORKING-MEMORY; BIPOLAR-I DISORDER; PREPULSE INHIBITION; FUNCTIONAL-ANALYSIS; STRAIN DIFFERENCES; GENE-EXPRESSION; MOOD DISORDERS; PHASE SYNDROME; ANIMAL-MODELS; CLOCK GENES	Increasing evidence suggests that clock genes may be implicated in a spectrum of psychiatric diseases, including sleep and mood related disorders as well as schizophrenia. The bHLH transcription factors SHARP1/DEC2/BHLHE41 and SHARP2/DEC1/ BHLHE40 are modulators of the circadian system and SHARP1/DEC2/BHLHE40 has been shown to regulate homeostatic sleep drive in humans. In this study, we characterized Sharp1 and Sharp2 double mutant mice (S1/2(-/-)) using online EEG recordings in living animals, behavioral assays and global gene expression profiling. EEG recordings revealed attenuated sleep/wake amplitudes and alterations of theta oscillations. Increased sleep in the dark phase is paralleled by reduced voluntary activity and cortical gene expression signatures reveal associations with psychiatric diseases. S1/2(-/-) mice display alterations in novelty induced activity, anxiety and curiosity. Moreover, mutant mice exhibit impaired working memory and deficits in prepulse inhibition resembling symptoms of psychiatric diseases. Network modeling indicates a connection between neural plasticity and clock genes, particularly for SHARP1 and PER1. Our findings support the hypothesis that abnormal sleep and certain (endo) phenotypes of psychiatric diseases may be caused by common mechanisms involving components of the molecular clock including SHARP1 and SHARP2.	[Baier, Paul C.] Univ Kiel, Dept Neurol, Kiel, Germany; [Baier, Paul C.] Univ Gottingen, Dept Clin Neurophysiol, D-37073 Gottingen, Germany; [Brzozka, Magdalena M.; Wichert, Sven P.; Wehr, Michael C.; Rossner, Moritz J.] Univ Munich, Dept Psychiat, D-80539 Munich, Germany; [Shahmoradi, Ali; Reinecke, Lisa; Kroos, Christina; Hirrlinger, Johannes; Rossner, Moritz J.] Max Planck Inst Expt Med, Res Grp Gene Express, D-37075 Gottingen, Germany; [Oster, Henrik] Max Planck Inst Biophys Chem, Circadian Rhythms Grp, D-37077 Gottingen, Germany; [Oster, Henrik] Med Univ Lubeck, Dept Med 1, D-23538 Lubeck, Germany; [Taneja, Reshma] Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore; [Hirrlinger, Johannes] Univ Leipzig, Carl Ludwig Inst Physiol, D-04109 Leipzig, Germany	University of Kiel; University of Gottingen; University of Munich; Max Planck Society; Max Planck Society; University of Lubeck; National University of Singapore; Leipzig University	Rossner, MJ (corresponding author), Univ Munich, Dept Psychiat, D-80539 Munich, Germany.	Moritz.Rossner@med.uni-muenchen.de	Brzózka, Magdalena Marta/ABH-2260-2021; Hirrlinger, Johannes/F-5984-2010; Wehr, Michael/J-7989-2019; Taneja, Reshma/F-9658-2014	Wehr, Michael/0000-0003-1770-8323; Taneja, Reshma/0000-0002-2151-2094; Reshma, Taneja/0000-0001-6214-6177; Brzozka, Magdalena M./0000-0001-8633-2855	Deutsche Forschungsgemeinschaft (CMPB); Klinische Forschergruppe [(KFO: RO 4076/1-1) 241]	Deutsche Forschungsgemeinschaft (CMPB)(German Research Foundation (DFG)); Klinische Forschergruppe	H. Oster is a Lichtenberg Fellow of the Volkswagen Foundation. This work was supported by the Deutsche Forschungsgemeinschaft (CMPB and grant Klinische Forschergruppe (KFO: RO 4076/1-1) 241). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari A, 2010, NEURON, V65, P257, DOI 10.1016/j.neuron.2009.12.002; Alamed J, 2006, NAT PROTOC, V1, P1671, DOI 10.1038/nprot.2006.275; Allen JA, 2011, P NATL ACAD SCI USA, V108, P18488, DOI 10.1073/pnas.1104807108; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Aston C, 2005, MOL PSYCHIATR, V10, P309, DOI 10.1038/sj.mp.4001565; Badcock JC, 2005, CORTEX, V41, P753, DOI 10.1016/S0010-9452(08)70294-6; BAIK JH, 1995, NATURE, V377, P424, DOI 10.1038/377424a0; Barnett JH, 2009, NEUROSCIENCE, V164, P331, DOI 10.1016/j.neuroscience.2009.03.080; Bello EP, 2011, NAT NEUROSCI, V14, P1033, DOI 10.1038/nn.2862; Benedetti F, 2011, NEUROPSYCHOBIOLOGY, V64, P141, DOI 10.1159/000328947; Bilkei-Gorzo A, 2004, PSYCHOPHARMACOLOGY, V176, P343, DOI 10.1007/s00213-004-1904-9; Bilkei-Gorzo A, 2010, BRIT J PHARMACOL, V160, P1443, DOI 10.1111/j.1476-5381.2010.00757.x; Bode B, 2011, J BIOL RHYTHM, V26, P530, DOI 10.1177/0748730411419782; Bode B, 2011, CHRONOBIOL INT, V28, P737, DOI 10.3109/07420528.2011.607374; Bodenmann S, 2012, BRIT J PHARMACOL, V165, P1904, DOI 10.1111/j.1476-5381.2011.01689.x; Boison D, 2012, NEUROPHARMACOLOGY, V62, P1527, DOI 10.1016/j.neuropharm.2011.01.048; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; BRAFF DL, 1990, ARCH GEN PSYCHIAT, V47, P181; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Brzozka MM, 2013, BEHAV BRAIN RES, V237, P348, DOI 10.1016/j.bbr.2012.10.001; Brzozka MM, 2010, BIOL PSYCHIAT, V68, P33, DOI 10.1016/j.biopsych.2010.03.015; Casamassima F, 2010, AM J MED GENET B, V153B, P1373, DOI 10.1002/ajmg.b.31122; Castner SA, 2004, PSYCHOPHARMACOLOGY, V174, P111, DOI 10.1007/s00213-003-1710-9; Chen JF, 2000, NEUROSCIENCE, V97, P195, DOI 10.1016/S0306-4522(99)00604-1; Cirelli C, 2004, NEURON, V41, P35, DOI 10.1016/S0896-6273(03)00814-6; Colgin LL, 2011, CURR OPIN NEUROBIOL, V21, P467, DOI 10.1016/j.conb.2011.04.006; Coogan AN, 2011, WORLD J BIOL PSYCHIA, V12, P40, DOI 10.3109/15622975.2011.598389; Dao DT, 2010, BIOL PSYCHIAT, V68, P801, DOI 10.1016/j.biopsych.2010.06.019; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Dezso Z, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-36; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Dudley CA, 2003, SCIENCE, V301, P379, DOI 10.1126/science.1082795; Duncan GE, 2006, PSYCHOPHARMACOLOGY, V184, P190, DOI 10.1007/s00213-005-0214-1; Dzirasa K, 2011, J NEUROSCI, V31, P6449, DOI 10.1523/JNEUROSCI.6144-10.2011; Einat H, 2007, NEUROSCI BIOBEHAV R, V31, P850, DOI 10.1016/j.neubiorev.2006.12.001; Fledrich R, 2012, BRAIN, V135, P72, DOI 10.1093/brain/awr322; Foster RG, 2005, NAT REV NEUROSCI, V6, P407, DOI 10.1038/nrn1670; Franken P, 2006, P NATL ACAD SCI USA, V103, P7118, DOI 10.1073/pnas.0602006103; Franken P, 2009, EUR J NEUROSCI, V29, P1820, DOI 10.1111/j.1460-9568.2009.06723.x; Franken P, 2000, J NEUROSCI, V20, P617, DOI 10.1523/JNEUROSCI.20-02-00617.2000; Glahn DC, 2006, BIPOLAR DISORD, V8, P117, DOI 10.1111/j.1399-5618.2006.00296.x; Harvey AG, 2008, AM J PSYCHIAT, V165, P820, DOI 10.1176/appi.ajp.2008.08010098; He Y, 2009, SCIENCE, V325, P866, DOI 10.1126/science.1174443; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Leussis MP, 2013, BIOL PSYCHIAT, V73, P683, DOI 10.1016/j.biopsych.2012.10.016; Mabrouk OS, 2011, J NEUROCHEM, V118, P24, DOI 10.1111/j.1471-4159.2011.07293.x; Mackiewicz M, 2007, PHYSIOL GENOMICS, V31, P441, DOI 10.1152/physiolgenomics.00275.2006; Mansour HA, 2009, BIPOLAR DISORD, V11, P701, DOI 10.1111/j.1399-5618.2009.00756.x; McOmish CE, 2008, MOL PSYCHIATR, V13, P661, DOI 10.1038/sj.mp.4002046; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Mukherjee S, 2010, BIOL PSYCHIAT, V68, P503, DOI 10.1016/j.biopsych.2010.04.031; Nakashima A, 2008, MOL CELL BIOL, V28, P4080, DOI 10.1128/MCB.02168-07; Naylor E, 2000, J NEUROSCI, V20, P8138; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Nicholas B, 2007, MOL PSYCHIATR, V12, P581, DOI 10.1038/sj.mp.4001953; Nievergelt CM, 2006, AM J MED GENET B, V141B, P234, DOI 10.1002/ajmg.b.30252; Nievergelt CM, 2005, PSYCHIAT GENET, V15, P45, DOI 10.1097/00041444-200503000-00008; Nikolsky Y, 2009, METHODS MOL BIOL, V563, P177, DOI 10.1007/978-1-60761-175-2_10; Nikonova EV, 2010, SLEEP, V33, P889, DOI 10.1093/sleep/33.7.889; PARK S, 1992, ARCH GEN PSYCHIAT, V49, P975; Perry W, 2001, BIOL PSYCHIAT, V50, P418, DOI 10.1016/S0006-3223(01)01184-2; Porcelli S, 2012, EUR NEUROPSYCHOPHARM, V22, P165, DOI 10.1016/j.euroneuro.2011.08.005; Postuma RB, 2012, NEUROBIOL DIS, V46, P553, DOI 10.1016/j.nbd.2011.10.003; Ramos A, 1998, NEUROSCI BIOBEHAV R, V22, P33; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Rossner MJ, 2006, J NEUROSCI, V26, P9956, DOI 10.1523/JNEUROSCI.0468-06.2006; Rossner MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002762; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Sato F, 2004, EUR J BIOCHEM, V271, P4409, DOI 10.1111/j.1432-1033.2004.04379.x; Scharf MT, 2008, PROG NEUROBIOL, V86, P264, DOI 10.1016/j.pneurobio.2008.08.003; Shi JJ, 2008, AM J MED GENET B, V147B, P1047, DOI 10.1002/ajmg.b.30714; Soria V, 2010, NEUROPSYCHOPHARMACOL, V35, P1279, DOI 10.1038/npp.2009.230; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun H, 2001, NAT IMMUNOL, V2, P1040, DOI 10.1038/ni721; Swerdlow NR, 2005, PHARMACOL BIOCHEM BE, V80, P203, DOI 10.1016/j.pbb.2004.11.002; Takahashi N, 2011, PROG NEUROBIOL, V93, P13, DOI 10.1016/j.pneurobio.2010.09.004; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; TRULLAS R, 1993, PSYCHOPHARMACOLOGY, V111, P323, DOI 10.1007/BF02244948; Vollenweider FX, 2006, BIOL PSYCHIAT, V60, P597, DOI 10.1016/j.biopsych.2006.03.058; Weber M, 2008, BEHAV PHARMACOL, V19, P786, DOI 10.1097/FBP.0b013e32831c3b2b; Wisorl JP, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-20; Wu JC, 2009, BIOL PSYCHIAT, V66, P298, DOI 10.1016/j.biopsych.2009.02.018; Wulff K, 2010, NAT REV NEUROSCI, V11, P589, DOI 10.1038/nrn2868; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; Young JW, 2010, PHARMACOL BIOCHEM BE, V96, P7, DOI 10.1016/j.pbb.2010.03.014; Zhu B, 2012, NEUROBIOL DIS, V48, P348, DOI 10.1016/j.nbd.2012.06.022; Zou YF, 2012, J AFFECT DISORDERS, V136, P229, DOI 10.1016/j.jad.2010.11.012	88	19	19	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110310	10.1371/journal.pone.0110310	http://dx.doi.org/10.1371/journal.pone.0110310			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340473	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662800029
J	Cai, QZ; Zhao, A; Yin, YT; Ma, LS; Jiao, ZZ; Zhi, HL; Lai, SH; Cheng, S; Yang, HM; Lu, YX; Siminovitch, KA; Gao, JM				Cai, Qinzhen; Zhao, Ai; Yin, Yuting; Ma, Lisha; Jiao, Zhenzhen; Zhi, Huilin; Lai, Shouhua; Cheng, Sha; Yang, Hongmei; Lu, Yinxiang; Siminovitch, Katherine A.; Gao, Jimin			Efficient Production of sTNFRII-gAD Fusion Protein in Large Quantity by Use of the Modified CHO-S Cell Expression System	PLOS ONE			English	Article							HAMSTER OVARY CELLS; LOW CULTURE TEMPERATURE; BATCH CULTURES; RECEPTORS; AGENTS; METABOLISM; ADIPOSE; GAMMA	TNF alpha is one of the initial and important mediators to activate downstream signaling pathways by binding to trimerized TNF alpha receptors (TNFR), and thus is an ideal drug target for cancer therapy. Taking advantage of intrinsic homotimerization of the globular domain of adiponectin (gAD), we have developed a novel TNF alpha antagonist, the trimerized fusion protein named sTNFRII-gAD. However, our previously-used CHO expression system yielded less than 10 mg/L of sTNFRII-gAD. To produce large quantities of sTNFRII-gAD efficiently, we used a modified CHO-S cell expression system, which is based on a pMH3 vector with non-coding GC-rich DNA fragments for high-level gene expression. We obtained stable clones that produced 75 mg/L of sTNFRII-gAD in the 96-well plate, adapted the clones to 40 ml suspension serum-free batch culture, then optimized the culturing conditions to scale up the fed-batch culture in a 3 L shake-flask and finally in a 5 L AP30 bioreactor. We achieved a final yield of 52 mg/L of sTNFRII-gAD. The trimerized sTNFRII-gAD exhibited the higher affinity to TNF alpha with a dissociation constant (Kd) of 5.63 nM than the dimerized sTNFRII-Fc with a Kd of 13.4 nM, and further displayed the higher TNF alpha-neutralizing activity than sTNFRII-Fc (p<0.05) in a L929 cytotoxicity assay. Therefore, the strategy employed in this study may provide an efficient avenue for large-scale production of other recombinant proteins by use of the modified CHO-S cell expression system.	[Cai, Qinzhen; Zhao, Ai; Yin, Yuting; Ma, Lisha; Jiao, Zhenzhen; Zhi, Huilin; Lai, Shouhua; Cheng, Sha; Yang, Hongmei; Lu, Yinxiang; Gao, Jimin] Wenzhou Med Univ, Sch Lab Med & Life Sci, Zhejiang Prov Key Lab Technol & Applicat Model Or, Wenzhou, Zhejiang, Peoples R China; [Siminovitch, Katherine A.] Univ Toronto, Mt Sinai Hosp, Dept Immunol, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Siminovitch, Katherine A.] Univ Toronto, Mt Sinai Hosp, Dept Mol Genet, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Siminovitch, Katherine A.] Toronto Gen Res Inst, Toronto, ON, Canada	Wenzhou Medical University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Lu, YX (corresponding author), Wenzhou Med Univ, Sch Lab Med & Life Sci, Zhejiang Prov Key Lab Technol & Applicat Model Or, Wenzhou, Zhejiang, Peoples R China.	18905856000@189.com; ksimin@mshri.on.ca; jimingao@yahoo.com	Siminovitch, Katherine/K-1475-2013		National Major Specific Project for Innovation of New Pharmaceuticals [2009ZX09103-649]; Chinese National 863 plan [2012AA02A407]; Scientific Research Fund of Ministry of Public Health [201231029]; Zhejiang Provincial Major Research Program [2010C13007]; Key Science and Technology Innovation Team of Zhejiang Province; Natural Science Foundation of Zhejiang Province [Y2110580, LY12C07001, LY13H100003, LZ14H260001]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents; Science & Technology Innovation Program for College/University Students in Zhejiang Province [2012R413039, 2012R413041]; Wenzhou Municipal Research Program [Y20100183, Y20100274]	National Major Specific Project for Innovation of New Pharmaceuticals; Chinese National 863 plan; Scientific Research Fund of Ministry of Public Health; Zhejiang Provincial Major Research Program; Key Science and Technology Innovation Team of Zhejiang Province; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents; Science & Technology Innovation Program for College/University Students in Zhejiang Province; Wenzhou Municipal Research Program	The authors would like to thank Dr. Mizhou Hui at AmProtein China, Hangzhou for his technical support. This work was sponsored partly by National Major Specific Project for Innovation of New Pharmaceuticals (2009ZX09103-649), Chinese National 863 plan (2012AA02A407), The Scientific Research Fund of Ministry of Public Health (201231029), Zhejiang Provincial Major Research Program (2010C13007), Key Science and Technology Innovation Team of Zhejiang Province, the Natural Science Foundation of Zhejiang Province (Y2110580, LY12C07001, LY13H100003, LZ14H260001), Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents, Science & Technology Innovation Program for College/University Students in Zhejiang Province (2012R413039, 2012R413041), and Wenzhou Municipal Research Program (Y20100183, Y20100274). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen ML, 2007, EPIGENETICS-US, V2, P227, DOI 10.4161/epi.2.4.5231; Bollati-Fogolin M, 2005, BIOTECHNOL PROGR, V21, P17, DOI 10.1021/bp049825t; Chen Suyun, 2010, Sheng Wu Gong Cheng Xue Bao, V26, P207; Combs TP, 2002, ENDOCRINOLOGY, V143, P998, DOI 10.1210/endo.143.3.8662; Fernandez-Botran R, 2000, EXPERT OPIN INV DRUG, V9, P497, DOI 10.1517/13543784.9.3.497; Fox SR, 2005, BIOTECHNOL APPL BIOC, V41, P255, DOI 10.1042/BA20040066; Furukawa K, 1999, CYTOTECHNOLOGY, V31, P85, DOI 10.1023/A:1008059803038; Gambhir A, 1999, J BIOSCI BIOENG, V87, P805, DOI 10.1016/S1389-1723(99)80157-1; Heiker JT, 2010, BIOL CHEM, V391, P1005, DOI 10.1515/BC.2010.104; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Huang SS, 2013, ACTA CARDIOL SIN, V29, P115; Jia Q, 2010, SCI CHINA LIFE SCI, V53, P94, DOI 10.1007/s11427-010-0003-x; Kim NS, 1998, BIOTECHNOL BIOENG, V60, P679, DOI 10.1002/(SICI)1097-0290(19981220)60:6<679::AID-BIT5>3.0.CO;2-Q; Lai TF, 2013, PHARMACEUTICALS, V6, P579, DOI 10.3390/ph6050579; Landry Y, 2008, FUND CLIN PHARMACOL, V22, P1, DOI 10.1111/j.1472-8206.2007.00548.x; Li F, 2006, BIOTECHNOL PROGR, V22, P696, DOI 10.1021/bp0504041; Luo MS, 2012, INT IMMUNOPHARMACOL, V13, P88, DOI 10.1016/j.intimp.2012.03.013; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Maranga L, 2006, BIOTECHNOL BIOENG, V94, P139, DOI 10.1002/bit.20890; MOHLER KM, 1993, J IMMUNOL, V151, P1548; Moore A, 1997, CYTOTECHNOLOGY, V23, P47, DOI 10.1023/A:1007919921991; REUVENY S, 1993, APPL MICROBIOL BIOT, V38, P619, DOI 10.1007/BF00182800; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Toussirot E, 2004, EXPERT OPIN PHARMACO, V5, P581, DOI 10.1517/14656566.5.3.581; Wlaschin KF, 2006, ADV BIOCHEM ENG BIOT, V101, P43, DOI 10.1007/10_015; Xie LZ, 1996, BIOTECHNOL BIOENG, V51, P725, DOI 10.1002/(SICI)1097-0290(19960920)51:6<725::AID-BIT12>3.0.CO;2-C; Yoon SK, 2004, BIOTECHNOL PROGR, V20, P1683, DOI 10.1021/bp049847f; Yoon SK, 2003, BIOTECHNOL BIOENG, V82, P289, DOI 10.1002/bit.10566	29	2	2	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111229	10.1371/journal.pone.0111229	http://dx.doi.org/10.1371/journal.pone.0111229			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340707	Green Submitted, Green Published, gold			2022-12-27	WOS:000343662800095
J	Eticha, T; Kidane, F				Eticha, Tadele; Kidane, Feven			The Prevalence of and Factors Associated with Current Smoking among College of Health Sciences Students, Mekelle University in Northern Ethiopia	PLOS ONE			English	Article							CIGARETTE-SMOKING; TOBACCO USE; EASTERN ETHIOPIA; ADDIS-ABABA; DETERMINANTS; PREDICTORS; BEHAVIOR; TUNISIA; SMOKERS; YOUTH	Background: Tobacco smoking is one of the greatest causes of preventable morbidity and mortality globally, and is responsible for many causes of untimely deaths. This survey was aimed to determine prevalence and factors associated with current smoking among the students of College of Health Sciences, Mekelle University, Ethiopia. Methods: A cross-sectional study was employed using a structured self-administered questionnaire among College of Health Sciences students in March 2013. A stratified random sampling method was employed to select study participants. Data were entered and analysed using of Statistical Package for Social Sciences (SPSS) version 20.0. Results: Of the 193 students, 57 (29.5%) of the students were current smokers. Most of the current smokers (89.4%) smoked between 1-10 sticks of cigarette per day. The two main reasons cited for smoking cigarettes were peer pressure (43.9%) and to relieve stress (36.8%). Being female (adjusted OR [AOR] = 0.49; 95% CI: 0.25, 0.95) and Tigre by ethnicity (AOR = 0.32; 95% CI: 0.14, 0.74) were significantly less associated with current smoking. On the other hand, being second year students (AOR = 3.84; 95% CI: 1.41, 10.46), khat chewing (AOR = 8.36; 95% CI: 2.60, 26.85) and taking illicit drugs (AOR = 10.59; 95% CI: 2.77, 40.51) were positively associated with current smoking cigarettes. Conclusions: The current smoking prevalence among students in College of Health Sciences, Mekelle University is high and therefore, effective smoking prevention and cessation intervention programs are required to reduce smoking among university students.	[Eticha, Tadele; Kidane, Feven] Mekelle Univ, Coll Hlth Sci, Dept Pharm, Mekelle, Ethiopia	Mekelle University	Eticha, T (corresponding author), Mekelle Univ, Coll Hlth Sci, Dept Pharm, Mekelle, Ethiopia.	td.eticha@gmail.com						Ahmed Rashid, 2008, J Pak Med Assoc, V58, P597; Aklog T, 2013, GJMR, V13, P5; Akpinar E, 2006, W INDIAN MED J, V55, P414; Ali SA, 2010, MED J BASHAR U, V28, P85; Ali Sajid, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P1054; Aryal UR, 2010, ASIAN J MED SCI, V1, P53; Aslan D, 2006, TURK J CANC, V36, P49; Babatunde O. A., 2012, Journal of Asian Scientific Research, V2, P62; Bogdanovica I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023889; Chkhaidze I, 2013, J BRAS PNEUMOL, V39, P579, DOI 10.1590/S1806-37132013000500008; Christophi CA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-190; Deressa W, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-660; El Mhamdi S., 2011, Eastern Mediterranean Health Journal, V17, P523; Fakhfakh R, 2002, B WORLD HEALTH ORGAN, V80, P350; Fawibe AE, 2011, NIGER J CLIN PRACT, V14, P201, DOI 10.4103/1119-3077.84016; Kebede Y, 2005, ETHIOP PUBLIC HLTH T, V81; Kegler MC, 1999, FAM COMMUNITY HEALTH, V22, P31, DOI 10.1097/00003727-199907000-00005; Khader Y. S., 2008, Eastern Mediterranean Health Journal, V14, P897; Kumar GS, 2011, KATHMANDU U MED J, V36, P233; Nazemi S., 2012, J BASIC APPL SCI RES, V2, P9161; Ngahane BHM, 2013, INT J TUBERC LUNG D, V17, P270, DOI 10.5588/ijtld.12.0377; Reda AA, 2012, HARM REDUCT J, V9, DOI 10.1186/1477-7517-9-39; Reda AA, 2013, HARM REDUCT J, V10, DOI 10.1186/1477-7517-10-28; RIGOTTI NA, 2002, TOBACCO CONTROL, V0011; Rigotti NA, 2000, JAMA-J AM MED ASSOC, V284, P699, DOI 10.1001/jama.284.6.699; Rudatsikira E, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-176; Schoenmaker N., 2005, Ethiopian Journal of Health Development, V19, P182; Thompson B, 2007, NICOTINE TOB RES, V9, P429, DOI 10.1080/14622200701188844; Townsend L, 2006, DRUG ALCOHOL DEPEN, V84, P14, DOI 10.1016/j.drugalcdep.2005.12.008; Von Ah Diane, 2005, Tob Induc Dis, V3, P27, DOI 10.1186/1617-9625-3-1-27; Yahya S J, 2010, Niger J Med, V19, P275; Yigzaw Kebede, 2002, Ethiopian Journal of Health Development, V16, P9	32	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111033	10.1371/journal.pone.0111033	http://dx.doi.org/10.1371/journal.pone.0111033			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340844	Green Submitted, Green Published, gold			2022-12-27	WOS:000343662800080
J	da Silva, MDS; Paula, TD; Moreira, BC; Carolino, M; Cruz, C; Bazzolli, DMS; Silva, CC; Kasuya, MCM				Soares da Silva, Marliane de Cassia; Paula, Thiago de Almeida; Moreira, Bruno Coutinho; Carolino, Manuela; Cruz, Cristina; Bazzolli, Denise Mara Soares; Silva, Cynthia Canedo; Megumi Kasuya, Maria Catarina			Nitrogen-Fixing Bacteria in Eucalyptus globulus Plantations	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; DIAZOTROPHIC BACTERIA; COMMUNITY STRUCTURE; DIVERSITY; SOIL; MICROORGANISMS; BIODIVERSITY; RHIZOSPHERE; WASTELANDS; DGGE	Eucalypt cultivation is an important economic activity worldwide. In Portugal, Eucalyptus globulus plantations account for one-third of the total forested area. The nutritional requirements of this crop have been well studied, and nitrogen (N) is one of the most important elements required for vegetal growth. N dynamics in soils are influenced by microorganisms, such as diazotrophic bacteria (DB) that are responsible for biological nitrogen fixation (BNF), so the aim of this study was to evaluate and identity the main groups of DB in E. globulus plantations. Samples of soil and root systems were collected in winter and summer from three different Portuguese regions (Penafiel, Gaviao and Odemira). We observed that DB communities were affected by season, N fertilization and moisture. Furthermore Bradyrhizobium and Burkholderia were the most prevalent genera in these three regions. This is the first study describing the dynamic of these bacteria in E. globulus plantations, and these data will likely contribute to a better understanding of the nutritional requirements of eucalypt cultivation and associated organic matter turnover.	[Soares da Silva, Marliane de Cassia; Paula, Thiago de Almeida; Moreira, Bruno Coutinho; Bazzolli, Denise Mara Soares; Silva, Cynthia Canedo; Megumi Kasuya, Maria Catarina] Univ Fed Vicosa, Dept Microbiol, Vicosa, MG, Brazil; [Carolino, Manuela; Cruz, Cristina] Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, Lisbon, Campo Grande, Portugal	Universidade Federal de Vicosa; Universidade de Lisboa	Kasuya, MCM (corresponding author), Univ Fed Vicosa, Dept Microbiol, Vicosa, MG, Brazil.	mkasuya@ufv.br	Cruz, Cristina/H-7026-2019; Cruz, Cristina/F-2643-2011; Moreira, Bruno C/H-8516-2018; de Cássia S da Silva, Marliane/G-4068-2012; Kasuya, Maria Catarina Megumi/E-1123-2013; Bazzolli, Denise Mara Soares/AAR-7924-2021; Carolino, Manuela/K-7876-2017	Cruz, Cristina/0000-0003-3100-463X; de Cássia S da Silva, Marliane/0000-0003-4678-7876; Kasuya, Maria Catarina Megumi/0000-0002-9539-9370; Bazzolli, Denise Mara Soares/0000-0002-0371-6966; Moreira, Bruno Coutinho/0000-0002-6290-9282; Carolino, Manuela/0000-0001-8237-6834	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do estado de Minas Gerais (FAPEMIG)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	The authors thank Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao de Amparo a Pesquisa do estado de Minas Gerais (FAPEMIG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAF, 2010, AN EST ABRAF 2010 AN; [Anonymous], [No title captured]; Baudoin E, 2003, SOIL BIOL BIOCHEM, V35, P1183, DOI 10.1016/S0038-0717(03)00179-2; Castro-Gonzalez R, 2011, PLANT SOIL, V345, P155, DOI 10.1007/s11104-011-0768-0; Coelho MRR, 2009, APPL SOIL ECOL, V42, P48, DOI 10.1016/j.apsoil.2009.01.010; Coelho MRR, 2008, FEMS MICROBIOL LETT, V279, P15, DOI 10.1111/j.1574-6968.2007.00975.x; Costa R, 2006, SOIL BIOL BIOCHEM, V38, P2434, DOI 10.1016/j.soilbio.2006.03.003; da Silva K, 2012, SYST APPL MICROBIOL, V35, P253, DOI 10.1016/j.syapm.2012.04.001; Direito I. C. N., 2002, Revista Universidade Rural. Serie Ciencias da Vida, V22, P123; DOBEREINER J, 1988, PLANT SOIL, V110, P207, DOI 10.1007/BF02226800; Estrada-De los Santos P, 2001, APPL ENVIRON MICROB, V67, P2790, DOI 10.1128/AEM.67.6.2790-2798.2001; GAMA-RODRIGUES E. F. D., 2005, REV BRAS CIENC SOLO, V29, P893; Gobert A, 2008, MYCORRHIZA, P209, DOI DOI 10.1007/978-3-540-78826-3_11; Hayat R, 2010, ANN MICROBIOL, V60, P579, DOI 10.1007/s13213-010-0117-1; Hong YY, 2012, MICROBIOL RES, V167, P596, DOI 10.1016/j.micres.2012.05.003; James EK, 2000, FIELD CROP RES, V65, P197, DOI 10.1016/S0378-4290(99)00087-8; Kahindi JHP, 1997, APPL SOIL ECOL, V6, P55, DOI 10.1016/S0929-1393(96)00151-5; KANDELER E, 1988, BIOL FERT SOILS, V6, P68, DOI 10.1007/BF00257924; Kozdroj J, 2000, SOIL BIOL BIOCHEM, V32, P1405, DOI 10.1016/S0038-0717(00)00058-4; Mulvaney R. L., 1996, Methods of soil analysis. Part 3 - chemical methods., P1123; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; Nicolaisen MH, 2002, J MICROBIOL METH, V50, P189, DOI 10.1016/S0167-7012(02)00026-X; OBANDO CASTELLANOS DOLLY MELISSA, 2010, Acta biol.Colomb., V15, P107; Raymond J, 2004, MOL BIOL EVOL, V21, P541, DOI 10.1093/molbev/msh047; Rosado AS, 1998, APPL ENVIRON MICROB, V64, P2770; Rosch C, 2002, APPL ENVIRON MICROB, V68, P3818, DOI 10.1128/AEM.68.8.3818-3829.2002; Schulte EE, 1987, WINCONSIN PROCEDURES; Silva TF, 2011, REV BRAS CIENC SOLO, V35, P359, DOI 10.1590/S0100-06832011000200007; Smerthurst P, 2004, FOREST ECOL MANAG, V193, P63; Smith H, 1996, FOREST ECOL MANAG, V89, P189, DOI 10.1016/S0378-1127(96)03847-9; UEDA T, 1995, J BACTERIOL, V177, P1414, DOI 10.1128/jb.177.5.1414-1417.1995; Vitousek PM, 2002, AMBIO, V31, P97, DOI 10.1639/0044-7447(2002)031[0097:NAN]2.0.CO;2; Wartiainen I, 2008, APPL SOIL ECOL, V39, P65, DOI 10.1016/j.apsoil.2007.11.008; Zehr JP, 2003, ENVIRON MICROBIOL, V5, P539, DOI 10.1046/j.1462-2920.2003.00451.x; Zhan J, 2012, MICROBIOL RES, V167, P157, DOI 10.1016/j.micres.2011.05.006; Zhan J, 2011, J ENVIRON SCI-CHINA, V23, P476, DOI 10.1016/S1001-0742(10)60433-0	37	7	7	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111313	10.1371/journal.pone.0111313	http://dx.doi.org/10.1371/journal.pone.0111313			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340502	gold, Green Published, Green Submitted			2022-12-27	WOS:000343662800102
J	Zeraik, ML; Petronio, MS; Coelho, D; Regasini, LO; Silva, DHS; da Fonseca, LM; Machado, SAS; Bolzani, VS; Ximenes, VF				Zeraik, Maria Luiza; Petronio, Maicon S.; Coelho, Dyovani; Regasini, Luis Octavio; Silva, Dulce H. S.; da Fonseca, Luiz Marcos; Machado, Sergio A. S.; Bolzani, Vanderlan S.; Ximenes, Valdecir F.			Improvement of Pro-Oxidant Capacity of Protocatechuic Acid by Esterification	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; NADPH OXIDASE; GALLIC ACID; HORSERADISH-PEROXIDASE; HYDROXYCINNAMIC ACIDS; PHENOXYL RADICALS; CARCINOMA-CELLS; FATTY-ACID; OXIDATION; CURCUMIN	Pro-oxidant effects of phenolic compounds are usually correlated to the one-electron redox potential of the phenoxyl radicals. Here we demonstrated that, besides their oxidizability, hydrophobicity can also be a decisive factor. We found that esterification of protocatechuic acid (P0) provoked a profound influence in its pro-oxidant capacity. The esters bearing alkyl chains containing two (P2), four (P4) and seven (P7) carbons, but not the acid precursor (P0), were able to exacerbate the oxidation of trolox, alpha-tocopherol and rifampicin. This effect was also dependent on the catechol moiety, since neither gallic acid nor butyl gallate showed any pro-oxidant effects. A comparison was also made with apocynin, which is well-characterized regarding its pro-oxidant properties. P7 was more efficient than apocynin regarding co-oxidation of trolox. However, P7 was not able to co-oxidize glutathione and NADH, which are targets of the apocynin radical. A correlation was found between pro-oxidant capacity and the stability of the radicals, as suggested by the intensity of the peak current in the differential pulse voltammetry experiments. In conclusion, taking into account that hydroquinone and related moieties are frequently found in biomolecules and quinone-based chemotherapeutics, our demonstration that esters of protocatechuic acid are specific and potent co-catalysts in their oxidations may be very relevant as a pathway to exacerbate redox cycling reactions, which are usually involved in their biological and pharmacological mechanisms of action.	[Zeraik, Maria Luiza; Ximenes, Valdecir F.] Sao Paulo State Univ, UNESP, Fac Sci, Dept Chem, Sao Paulo, Brazil; [Zeraik, Maria Luiza; Regasini, Luis Octavio; Silva, Dulce H. S.; Bolzani, Vanderlan S.] Sao Paulo State Univ, UNESP, Nuclei Bioassays Ecophysiol & Biosynth Nat Prod N, Dept Organ Chem,Inst Chem, Sao Paulo, Brazil; [Petronio, Maicon S.; da Fonseca, Luiz Marcos] Sao Paulo State Univ, UNESP, Sch Pharmaceut Sci, Dept Clin Anal, Sao Paulo, Brazil; [Coelho, Dyovani; Machado, Sergio A. S.] Univ Sao Paulo, Inst Chem Sao Carlos, Sao Carlos, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade de Sao Paulo	Ximenes, VF (corresponding author), Sao Paulo State Univ, UNESP, Fac Sci, Dept Chem, Sao Paulo, Brazil.	vfximenes@fc.unesp.br	Bolzani, Vanderlan S/C-2111-2012; Regasini, Luis O/B-1985-2012; Zeraik, Maria Luiza/I-8072-2014; Silva, Dulce H S/F-2626-2012; Ximenes, Valdecir/A-5323-2008; SILVA, DULCE/AAZ-5978-2020; Petrônio, Maicon Segalla/B-8581-2015; Coelho, Dyovani/G-8293-2016; Machado, Sergio/M-9384-2013; Zeraik, Maria Luiza/AAB-8302-2020; Bolzani, Vanderlan/C-2111-2012	Bolzani, Vanderlan S/0000-0003-0615-8776; Zeraik, Maria Luiza/0000-0002-0559-8502; Silva, Dulce H S/0000-0002-1516-7765; Ximenes, Valdecir/0000-0003-2636-3080; SILVA, DULCE/0000-0002-1516-7765; Coelho, Dyovani/0000-0002-1652-7144; Machado, Sergio/0000-0001-8946-8467; Zeraik, Maria Luiza/0000-0002-0559-8502; Bolzani, Vanderlan/0000-0001-7019-5825	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2013/08784-0, 010/52327-5, 2011/03017-6, 2013/07600-3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors gratefully acknowledge financial support from FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) grants #2013/08784-0, #010/52327-5, #2011/03017-6 and #2013/07600-3; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggeli IK, 2013, J EXP ZOOL PART A, V319A, P328, DOI 10.1002/jez.1797; Cavaliere V, 2014, TARGET ONCOL, V9, P25, DOI 10.1007/s11523-013-0256-y; Chan T, 1999, CHEM-BIOL INTERACT, V122, P15, DOI 10.1016/S0009-2797(99)00103-9; de Faria CMQG, 2012, CURR MED CHEM, V19, P4885; Delicado EN, 1997, BBA-GEN SUBJECTS, V1335, P127, DOI 10.1016/S0304-4165(96)00130-4; dos Santos FJN, 2005, BIOL PHARM BULL, V28, P1822; Du Q, 2013, ONCOL REP, V29, P1851, DOI 10.3892/or.2013.2310; Fan GJ, 2009, CHEM-EUR J, V15, P12889, DOI 10.1002/chem.200901627; Galati G, 2002, TOXICOLOGY, V177, P91, DOI 10.1016/S0300-483X(02)00198-1; Galato D, 2001, REDOX REP, V6, P243, DOI 10.1179/135100001101536391; Gandhy SU, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-564; Gaspar A, 2009, EUR J MED CHEM, V44, P2092, DOI 10.1016/j.ejmech.2008.10.027; Ghosh A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-241; Gilloteaux J, 2010, ULTRASTRUCT PATHOL, V34, P140, DOI 10.3109/01913121003662304; Castor LRG, 2010, FREE RADICAL BIO MED, V48, P1636, DOI 10.1016/j.freeradbiomed.2010.03.010; Gunckel S, 1998, CHEM-BIOL INTERACT, V114, P45, DOI 10.1016/S0009-2797(98)00041-6; Kagan VE, 2001, CANCER RES, V61, P7777; Kapiotis S, 1997, ARTERIOSCL THROM VAS, V17, P2855, DOI 10.1161/01.ATV.17.11.2855; Lende Amol B., 2011, Inflammopharmacology, V19, P255, DOI 10.1007/s10787-011-0086-4; Ligeret H, 2004, FREE RADICAL BIO MED, V36, P919, DOI 10.1016/j.freeradbiomed.2003.12.018; Locatelli C, 2008, BIOORGAN MED CHEM, V16, P3791, DOI 10.1016/j.bmc.2008.01.049; Martins-Maciel ER, 2013, TOXICOL LETT, V217, P82, DOI 10.1016/j.toxlet.2012.11.021; Martins LAM, 2014, CELL BIOCHEM BIOPHYS, V68, P247, DOI 10.1007/s12013-013-9703-8; Metzler M, 2013, BIOFACTORS, V39, P14, DOI 10.1002/biof.1042; Murias M, 2005, BIOCHEM PHARMACOL, V69, P903, DOI 10.1016/j.bcp.2004.12.001; Park WH, 2013, ONCOL REP, V30, P513, DOI 10.3892/or.2013.2447; Petronio MS, 2013, MOLECULES, V18, P2821, DOI 10.3390/molecules18032821; Porter NA, 2013, J ORG CHEM, V78, P3511, DOI 10.1021/jo4001433; Putchala MC, 2013, ARCH ORAL BIOL, V58, P563, DOI 10.1016/j.archoralbio.2013.01.016; Reis B, 2010, J AGR FOOD CHEM, V58, P6986, DOI 10.1021/jf100569j; Russell LH, 2012, ANTICANCER RES, V32, P1595; Saito S, 2006, HELV CHIM ACTA, V89, P1395, DOI 10.1002/hlca.200690139; Senejoux F, 2013, FUND CLIN PHARMACOL, V27, P262, DOI 10.1111/j.1472-8206.2011.01025.x; Simic A, 2007, MOLECULES, V12, P2327, DOI 10.3390/12102327; Simonyi Agnes, 2012, Front Biosci (Elite Ed), V4, P2183; Sukalovic VHT, 2008, J PLANT RES, V121, P115, DOI 10.1007/s10265-007-0124-x; Tafazoli S, 2005, CHEM RES TOXICOL, V18, P1567, DOI 10.1021/tx0500575; THOMAS MJ, 1989, J AM CHEM SOC, V111, P3315, DOI 10.1021/ja00191a031; Veitch NC, 2004, PHYTOCHEMISTRY, V65, P249, DOI 10.1016/j.phytochem.2003.10.022; Wondrak GT, 2009, ANTIOXID REDOX SIGN, V11, P3013, DOI [10.1089/ars.2009.2541, 10.1089/ARS.2009.2541]; Ximenes VF, 2007, ARCH BIOCHEM BIOPHYS, V457, P134, DOI 10.1016/j.abb.2006.11.010; Ximenes VF, 2010, J AGR FOOD CHEM, V58, P5355, DOI 10.1021/jf100233y; Ximenes VF, 2009, BBA-GEN SUBJECTS, V1790, P787, DOI 10.1016/j.bbagen.2009.03.021; Zeraik ML, 2012, CURR MED CHEM, V19, P5405, DOI 10.2174/092986712803833344; Zou LN, 2012, ANALYST, V137, P414, DOI 10.1039/c1an15720e	45	26	28	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110277	10.1371/journal.pone.0110277	http://dx.doi.org/10.1371/journal.pone.0110277			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340774	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662800025
J	Gong, C; Pan, D; Qiu, FW; Sun, P; Zhang, YH				Gong, Cheng; Pan, Deng; Qiu, Fengwu; Sun, Pei; Zhang, Yu-Hui			Selective DNA Delivery to Tumor Cells Using an Oligoarginine-LTVSPWY Peptide	PLOS ONE			English	Article							GENE-DELIVERY; VIRAL VECTORS; IN-VIVO; MECHANISM; NANOPARTICLES; THERAPEUTICS; OCTAARGININE; EXPRESSION; THERAPY; DESIGN	DNA therapy for cancer requires efficient, selective and safe DNA delivery systems. Compared with other non-viral methods such as lipid or polymer-based DNA delivery vectors, peptide-based DNA delivery systems are biocompatible and biodegradable, which leads to lower immunogenicity and lower toxicity. Moreover, peptide vectors are easier to produce and their compositions easier to control because solid-phase peptide synthesis has been extensively developed. However, peptide-based systems for DNA delivery toward special tumor cells or tissues are still lacking. In this study, we constructed a non-viral 9rR-LTVSPWY peptide-based DNA delivery system and showed that it is able to efficiently and selectively transfect DNA into targeted tumor cells. This work presents a novel strategy for tumor cell-specific DNA delivery and a reference for designing more efficient DNA delivery systems targeted towards various types of cancer.	[Gong, Cheng; Pan, Deng; Qiu, Fengwu; Sun, Pei; Zhang, Yu-Hui] Huazhong Univ Sci & Technol, Britton Chance Ctr Biomed Photon, Wuhan Natl Lab Optoelect, Wuhan 430074, Hubei, Peoples R China; [Gong, Cheng; Pan, Deng; Qiu, Fengwu; Sun, Pei; Zhang, Yu-Hui] Huazhong Univ Sci & Technol, Dept Biomed Engn, Minist Educ, Key Lab Biomed Photon, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zhang, YH (corresponding author), Huazhong Univ Sci & Technol, Britton Chance Ctr Biomed Photon, Wuhan Natl Lab Optoelect, Wuhan 430074, Hubei, Peoples R China.	zhangyh@mail.hust.edu.cn			Science Fund for Creative Research Group of China [61121004]; National Natural Science Foundation of China [31270906]; seed project of Wuhan National Laboratory for Optoelectronics	Science Fund for Creative Research Group of China(Science Fund for Creative Research Groups); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); seed project of Wuhan National Laboratory for Optoelectronics	This work was supported by the Science Fund for Creative Research Group of China (Grant No. 61121004), the National Natural Science Foundation of China (Grant No. 31270906), and the seed project of Wuhan National Laboratory for Optoelectronics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chi EY, 2003, PHARM RES-DORDR, V20, P1325, DOI 10.1023/A:1025771421906; Choi HS, 2007, NAT BIOTECHNOL, V25, P1165, DOI 10.1038/nbt1340; El-Sayed A, 2008, J BIOL CHEM, V283, P23450, DOI 10.1074/jbc.M709387200; Fonseca SB, 2009, ADV DRUG DELIVER REV, V61, P953, DOI 10.1016/j.addr.2009.06.001; Gong C, 2012, BIOMATERIALS, V33, P3456, DOI 10.1016/j.biomaterials.2011.12.017; He H, 2011, J INNOV OPT HEAL SCI, V4, P113, DOI 10.1142/S179354581100123X; Henriques ST, 2006, BIOCHEM J, V399, P1, DOI 10.1042/BJ20061100; Huang SH, 2013, BIOTECHNOL ADV, V31, P208, DOI 10.1016/j.biotechadv.2012.10.001; Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30; Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324; Khalil IA, 2004, GENE THER, V11, P636, DOI 10.1038/sj.gt.3302128; Kim PH, 2010, BIOMATERIALS, V31, P1865, DOI 10.1016/j.biomaterials.2009.11.043; Lehrman S, 1999, NATURE, V401, P517, DOI 10.1038/43977; Liu L, 2012, BIOCONJUGATE CHEM, V23, P1211, DOI 10.1021/bc300025d; Luo HM, 2011, FASEB J, V25, P1865, DOI 10.1096/fj.10-174318; Lv HT, 2006, J CONTROL RELEASE, V114, P100, DOI 10.1016/j.jconrel.2006.04.014; Ma Y, 2012, J CONTROL RELEASE, V162, P286, DOI 10.1016/j.jconrel.2012.07.022; Martin ME, 2007, AAPS J, V9, pE18, DOI 10.1208/aapsj0901003; Minko T, 2012, ADV DEL SCI TECHNOL, P329, DOI 10.1007/978-1-4614-0881-9_12; Munch RC, 2013, MOL THER, V21, P109, DOI 10.1038/mt.2012.186; Nakase I, 2012, ACCOUNTS CHEM RES, V45, P1132, DOI 10.1021/ar200256e; Ruoslahti E, 2012, ADV MATER, V24, P3747, DOI 10.1002/adma.201200454; Sadatmousavi P, 2011, CURR PHARM BIOTECHNO, V12, P1089, DOI 10.2174/138920111796117409; Seow WY, 2009, NUCLEIC ACIDS RES, V37, P6276, DOI 10.1093/nar/gkp651; Seow WY, 2009, ADV MATER, V21, P86, DOI 10.1002/adma.200800928; Shadidi M, 2002, FASEB J, V16, P256, DOI 10.1096/fj.02-0280fje; Song Li-bing, 2002, Ai Zheng, V21, P158; Standley SM, 2010, CANCER RES, V70, P3020, DOI 10.1158/0008-5472.CAN-09-3267; Wang HY, 2011, J CONTROL RELEASE, V155, P26, DOI 10.1016/j.jconrel.2010.12.009; Wang S, 2009, NANOTECHNOLOGY, V20; Wang XF, 2007, CANCER RES, V67, P3337, DOI 10.1158/0008-5472.CAN-06-2480; Wender PA, 2008, ADV DRUG DELIVER REV, V60, P452, DOI 10.1016/j.addr.2007.10.016; Won YW, 2010, MOL THER, V18, P734, DOI 10.1038/mt.2009.297; Zhang Y, 2012, MOL THER, V20, P1298, DOI 10.1038/mt.2012.79	34	10	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110632	10.1371/journal.pone.0110632	http://dx.doi.org/10.1371/journal.pone.0110632			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337703	Green Submitted, Green Published, gold			2022-12-27	WOS:000343674800063
J	Guo, XY; Kang, HJ; Etienne-Cummings, R; Boctor, EM				Guo, Xiaoyu; Kang, Hyun-Jae; Etienne-Cummings, Ralph; Boctor, Emad M.			Active Ultrasound Pattern Injection System (AUSPIS) for Interventional Tool Guidance	PLOS ONE			English	Article							GUIDED PERCUTANEOUS PROCEDURES; TRACKING; BIOPSY	Accurate tool tracking is a crucial task that directly affects the safety and effectiveness of many interventional medical procedures. Compared to CT and MRI, ultrasound-based tool tracking has many advantages, including low cost, safety, mobility and ease of use. However, surgical tools are poorly visualized in conventional ultrasound images, thus preventing effective tool tracking and guidance. Existing tracking methods have not yet provided a solution that effectively solves the tool visualization and mid-plane localization accuracy problem and fully meets the clinical requirements. In this paper, we present an active ultrasound tracking and guiding system for interventional tools. The main principle of this system is to establish a bi-directional ultrasound communication between the interventional tool and US imaging machine within the tissue. This method enables the interventional tool to generate an active ultrasound field over the original imaging ultrasound signals. By controlling the timing and amplitude of the active ultrasound field, a virtual pattern can be directly injected into the US machine B mode display. In this work, we introduce the time and frequency modulation, mid-plane detection, and arbitrary pattern injection methods. The implementation of these methods further improves the target visualization and guiding accuracy, and expands the system application beyond simple tool tracking. We performed ex vitro and in vivo experiments, showing significant improvements of tool visualization and accurate localization using different US imaging platforms. An ultrasound image mid-plane detection accuracy of +/- 0.3 mm and a detectable tissue depth over 8.5 cm was achieved in the experiment. The system performance is tested under different configurations and system parameters. We also report the first experiment of arbitrary pattern injection to the B mode image and its application in accurate tool tracking.	[Guo, Xiaoyu; Etienne-Cummings, Ralph] Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA; [Kang, Hyun-Jae; Boctor, Emad M.] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA; [Boctor, Emad M.] Johns Hopkins Univ, Dept Radiol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Guo, XY (corresponding author), Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA.	xguo9@jhu.edu			Johns Hopkins University	Johns Hopkins University(Johns Hopkins University)	This work is supported by the internal funding of the Johns Hopkins University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BREYER B, 1984, MED BIOL ENG COMPUT, V22, P268, DOI 10.1007/BF02442755; Chan C, 2005, ULTRASOUND MED BIOL, V31, P1469, DOI 10.1016/j.ultrasmedbio.2005.07.014; Cheung S, 2004, ULTRASOUND MED BIOL, V30, P617, DOI 10.1016/j.ultrasmedbio.2004.02.001; Dodd GD, 2000, RADIOGRAPHICS, V20, P9, DOI 10.1148/radiographics.20.1.g00ja019; Fishman JE, 2003, RADIOLOGY, V226, P779, DOI 10.1148/radiol.2263011622; Harvey CJ, 2001, EUR RADIOL, V11, P1578, DOI 10.1007/s003300101002; Krucker J, 2007, J VASC INTERV RADIOL, V18, P1141, DOI 10.1016/j.jvir.2007.06.014; Merdes CL, 2001, IEEE T BIOMEDICAL EN, V48; Mung J, 2011, LECT NOTES COMPUT SC, V6891, P153, DOI 10.1007/978-3-642-23623-5_20; Simonetti F., 2009, P SOC PHOTO-OPT INS, V7261; Stoll J, 2005, LECT NOTES COMPUT SC, V3750, P41, DOI 10.1007/11566489_6; Vilkomerson D, 1997, IEEE T ULTRASONICS F, V44	12	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e104262	10.1371/journal.pone.0104262	http://dx.doi.org/10.1371/journal.pone.0104262			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337784	Green Submitted, Green Published, gold			2022-12-27	WOS:000343674800001
J	May, M; Dunne, DW; Brown, DR				May, Meghan; Dunne, Dylan W.; Brown, Daniel R.			A Sialoreceptor Binding Motif in the Mycoplasma synoviae Adhesin VlhA	PLOS ONE			English	Article							BROILER-CHICKENS; GALLISEPTICUM; PROTEIN; HEMAGGLUTININ; STRAIN; GENE; CYTADHERENCE; PREDICTION; MEMBRANE; POULTRY	Mycoplasma synoviae depends on its adhesin VlhA to mediate cytadherence to sialylated host cell receptors. Allelic variants of VlhA arise through recombination between an assemblage of promoterless vlhA pseudogenes and a single transcription promoter site, creating lineages of M. synoviae that each express a different vlhA allele. The predicted full-length VlhA sequences adjacent to the promoter of nine lineages of M. synoviae varying in avidity of cytadherence were aligned with that of the reference strain MS53 and with a 60-a.a. hemagglutinating VlhA C-terminal fragment from a Tunisian lineage of strain WVU1853(T). Seven different sequence variants of an imperfectly conserved, single-copy, 12-a.a. candidate cytadherence motif were evident amid the flanking variable residues of the 11 total sequences examined. The motif was predicted to adopt a short hairpin structure in a low-complexity region near the C-terminus of VlhA. Biotinylated synthetic oligopeptides representing four selected variants of the 12-a.a. motif, with the whole synthesized 60-a.a. fragment as a positive control, differed (P<0.01) in the extent they bound to chicken erythrocyte membranes. All bound to a greater extent (P<0.01) than scrambled or irrelevant VlhA domain negative control peptides did. Experimentally introduced branched-chain amino acid (BCAA) substitutions Val3Ile and Leu7Ile did not significantly alter binding, whereas fold-destabilizing substitutions Thr4Gly and Ala9Gly tended to reduce it (P<0.05). Binding was also reduced to background levels (P<0.01) when the peptides were exposed to desialylated membranes, or were pre-saturated with free sialic acid before exposure to untreated membranes. From this evidence we conclude that the motif P-X-(BCAA)-X-F-X-(BCAA)-X-A-K-X-G binds sialic acid and likely mediates VlhA-dependent M. synoviae attachment to host cells. This conserved mechanism retains the potential for fine-scale rheostasis in binding avidity, which could be a general characteristic of pathogens that depend on analogous systems of antigenically variable adhesins. The motif may be useful to identify previously unrecognized adhesins.	[May, Meghan] Univ New England, Coll Osteopath Med, Dept Biomed Sci, Biddeford, ME 04005 USA; [Dunne, Dylan W.] Towson Univ, Jess & Mildred Fisher Coll Sci & Math, Dept Biol Sci, Towson, MD USA; [Brown, Daniel R.] Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL USA	University of New England - Maine; University System of Maryland; Towson University; State University System of Florida; University of Florida	May, M (corresponding author), Univ New England, Coll Osteopath Med, Dept Biomed Sci, Biddeford, ME 04005 USA.	mmay3@une.edu			Robert M. Fisher Foundation (MM)	Robert M. Fisher Foundation (MM)	This work was supported by the Robert M. Fisher Foundation (MM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boguslavsky S, 2000, INFECT IMMUN, V68, P3956, DOI 10.1128/IAI.68.7.3956-3964.2000; Brown DR, 2010, BERGEYS MANUAL SYSTE, V4; Brylinski M, 2013, J COMPUT AID MOL DES, V27, P551, DOI 10.1007/s10822-013-9663-5; CHIN RP, 1991, AVIAN DIS, V35, P631, DOI 10.2307/1591233; Citti C, 2005, MYCOPLASMAS MOL BIOL; Feinstein WP, 2014, MOL INFORM, V33, P135, DOI 10.1002/minf.201300143; FORSYTH MH, 1992, MOL MICROBIOL, V6, P2099, DOI 10.1111/j.1365-2958.1992.tb01383.x; Glew MD, 1998, INFECT IMMUN, V66, P5833, DOI 10.1128/IAI.66.12.5833-5841.1998; Goh MS, 1998, MICROBIOL-SGM, V144, P2971, DOI 10.1099/00221287-144-11-2971; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Jenkins C, 2007, MICROBIOL-SGM, V153, P1455, DOI 10.1099/mic.0.2006/004937-0; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Khiari AB, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-6; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lockaby SB, 1998, VET PATHOL, V35, P178, DOI 10.1177/030098589803500303; MANCHEE RJ, 1969, J BACTERIOL, V98, P914, DOI 10.1128/JB.98.3.914-919.1969; May M, 2006, INFECT IMMUN, V74, P1777, DOI 10.1128/IAI.74.3.1777-1785.2006; May M, 2011, J BACTERIOL, V193, P2116, DOI 10.1128/JB.00022-11; May M, 2009, J BACTERIOL, V191, P3588, DOI 10.1128/JB.00142-09; Noormohammadi AH, 1997, INFECT IMMUN, V65, P2542, DOI 10.1128/IAI.65.7.2542-2547.1997; Noormohammadi AH, 2000, MOL MICROBIOL, V35, P911, DOI 10.1046/j.1365-2958.2000.01766.x; Noormohammadi AH, 1998, INFECT IMMUN, V66, P3470, DOI 10.1128/IAI.66.7.3470-3475.1998; Pang SS, 2014, J BIOL CHEM, V289, P6332, DOI 10.1074/jbc.M113.513135; Papazisi L, 2002, INFECT IMMUN, V70, P6839, DOI 10.1128/IAI.70.12.6839-6845.2002; Senties-Cue G, 2005, AVIAN PATHOL, V34, P137, DOI 10.1080/03079450500058646; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stipkovits L, 1996, REV SCI TECH OIE, V15, P1495, DOI 10.20506/rst.15.4.986; Szczepanek SM, 2010, INFECT IMMUN, V78, P1760, DOI 10.1128/IAI.01172-09; Tharakaraman K, 2013, CELL, V153, P1486, DOI 10.1016/j.cell.2013.05.034; Vasconcelos ATR, 2005, J BACTERIOL, V187, P5568, DOI 10.1128/JB.187.16.5568-5577.2005; Worth CL, 2011, NUCLEIC ACIDS RES, V39, pW215, DOI 10.1093/nar/gkr363; Zimmerman C-U, 2014, MOLLICUTES MOL BIOL	32	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e0110360	10.1371/journal.pone.0110360	http://dx.doi.org/10.1371/journal.pone.0110360			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338071	Green Published, Green Submitted, gold			2022-12-27	WOS:000343674800039
J	Sherley, RB; Waller, LJ; Strauss, V; Geldenhuys, D; Underhill, LG; Parsons, NJ				Sherley, Richard B.; Waller, Lauren J.; Strauss, Venessa; Geldenhuys, Deon; Underhill, Les G.; Parsons, Nola J.			Hand-Rearing, Release and Survival of African Penguin Chicks Abandoned Before Independence by Moulting Parents	PLOS ONE			English	Article							TREASURE OIL-SPILL; SPHENISCUS-DEMERSUS; BREEDING SUCCESS; ROBBEN ISLAND; SOUTH-AFRICA; REHABILITATION; AGE; ESTABLISHMENT; AVAILABILITY; PELECANOIDES	The African penguin Spheniscus demersus has an 'Endangered' conservation status and a decreasing population. Following abandonment, 841 African penguin chicks in 2006 and 481 in 2007 were admitted to SANCCOB (Southern African Foundation for the Conservation of Coastal Birds) for hand-rearing from colonies in the Western Cape, South Africa, after large numbers of breeding adults commenced moult with chicks still in the nest. Of those admitted, 91% and 73% respectively were released into the wild. There were veterinary concerns about avian malaria, airsacculitis and pneumonia, feather-loss and pododermatitis (bumblefoot). Post-release juvenile (0.32, s.e. = 0.08) and adult (0.76, s.e. = 0.10) survival rates were similar to African penguin chicks reared after oil spills and to recent survival rates recorded for naturally-reared birds. By December 2012, 12 birds had bred, six at their colony of origin, and the apparent recruitment rate was 0.11 (s.e. = 0.03). Hand-rearing of abandoned penguin chicks is recommended as a conservation tool to limit mortality and to bolster the population at specific colonies. The feasibility of conservation translocations for the creation of new colonies for this species using hand-reared chicks warrants investigation. Any such programme would be predicated on adequate disease surveillance programmes established to minimise the risk of disease introduction to wild birds.	[Sherley, Richard B.; Waller, Lauren J.; Underhill, Les G.] Univ Cape Town, Anim Demog Unit, ZA-7700 Rondebosch, Western Cape, South Africa; [Sherley, Richard B.; Waller, Lauren J.; Underhill, Les G.] Univ Cape Town, Marine Res Inst, ZA-7700 Rondebosch, Western Cape, South Africa; [Sherley, Richard B.] Bristol Zoo Gardens, Bristol Zool Soc, Bristol, Avon, England; [Waller, Lauren J.; Geldenhuys, Deon] CapeNature, Hermanus, Western Cape, South Africa; [Strauss, Venessa; Parsons, Nola J.] Southern African Fdn Conservat Coastal Birds, Bloubergrant, Western Cape, South Africa	University of Cape Town; University of Cape Town	Sherley, RB (corresponding author), Univ Cape Town, Anim Demog Unit, ZA-7700 Rondebosch, Western Cape, South Africa.	richard.sherley@gmail.com	Sherley, Richard B/D-7507-2012	Sherley, Richard B/0000-0001-7367-9315; Underhill, Les/0000-0002-8758-1527	SeaChange Programme of the National Research Foundation; Earthwatch Institute; Norway South Africa Fisheries Agreement (NORSA); Leiden Conservation Foundation; Dyer Island Conservation Trust; IFAW	SeaChange Programme of the National Research Foundation; Earthwatch Institute; Norway South Africa Fisheries Agreement (NORSA); Leiden Conservation Foundation; Dyer Island Conservation Trust; IFAW	The authors acknowledge financial support from our institutes, the SeaChange Programme of the National Research Foundation, the Earthwatch Institute, Dyer Island Conservation Trust, the Norway South Africa Fisheries Agreement (NORSA), IFAW and the Leiden Conservation Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, AVIAN MED PRINCIPLES; Barham PJ, 2008, BIRD CONSERV INT, V18, P144, DOI 10.1017/S0959270908000142; Barham PJ, 2007, EMU, V107, P7, DOI 10.1071/MU06028; Brossy J.-J., 1999, Marine Ornithology, V27, P185; BROSSY JJ, 1992, OSTRICH, V63, P10, DOI 10.1080/00306525.1992.9634174; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carlile N, 2012, BIRD CONSERV INT, V22, P46, DOI 10.1017/S0959270911000372; Choquet R, 2009, ENVIRON ECOL STAT SE, V3, P845, DOI 10.1007/978-0-387-78151-8_39; Cooper J., 1978, International Zoo Yearbook, V18, P22, DOI 10.1111/j.1748-1090.1978.tb00211.x; Crawford RJM, 2008, AFR J MAR SCI, V30, P167, DOI 10.2989/AJMS.2008.30.1.17.467; Crawford RJM, 2011, AFR J MAR SCI, V33, P139, DOI 10.2989/1814232X.2011.572377; Crawford RJM, 1995, S AFR J MARINE SCI, V16, P101; Crawford RJM., 2006, ACTA ZOOL SINICA, V52, P444; Crawford RJM, 2006, BIOL CONSERV, V132, P119, DOI 10.1016/j.biocon.2006.03.019; Crawford RJM, 2014, OSTRICH, V85, P111, DOI 10.2989/00306525.2014.955141; Croxall JP, 2012, BIRD CONSERV INT, V22, P1, DOI 10.1017/S0959270912000020; Deguchi T, 2012, BIRD CONSERV INT, V22, P66, DOI 10.1017/S0959270911000438; DUFFY DC, 1987, NATL GEOGR RES, V3, P480; Durant JM, 2010, MAR ECOL PROG SER, V420, P263, DOI 10.3354/meps08857; Erikstad KE, 1998, ECOLOGY, V79, P1781; Gimenez O, 2012, THEOR POPUL BIOL, V82, P307, DOI 10.1016/j.tpb.2012.02.001; GRACZYK TK, 1995, J HELMINTHOL SOC W, V62, P135; Grim KC, 2003, J ZOO WILDLIFE MED, V34, P250, DOI 10.1638/02-070; GUMMER H, 2003, DOC SCI INTERNAL SER, V150; Hansen W., 1999, FIELD MANUAL WILDLIF, P163; Jones Carl G., 2012, P33; Jones HI, 1999, MAR ORNITHOL; Jones HP, 2012, J WILDLIFE MANAGE, V76, P2, DOI 10.1002/jwmg.240; Kane OJ, 2012, J WILDLIFE DIS, V48, P790, DOI 10.7589/0090-3558-48.3.790; Kane OJ, 2010, WATERBIRDS, V33, P415, DOI 10.1675/063.033.0321; Kemper J, 2008, AUK, V125, P809, DOI 10.1525/auk.2008.06262; Lebreton JD, 2009, ADV ECOL RES, V41, P87, DOI 10.1016/S0065-2504(09)00403-6; Lewison R., 2012, Endangered Species Research, V17, P93, DOI 10.3354/esr00419; Lubbe A, 2014, AFR J MAR SCI, V36, P143, DOI 10.2989/1814232X.2014.915232; Ludynia K, 2014, AFR J MAR SCI, V36, P253, DOI 10.2989/1814232X.2014.929027; Miskelly CM, 2004, EMU, V104, P205, DOI 10.1071/MU03062; Miskelly CM, 2009, BIOL CONSERV, V142, P1965, DOI 10.1016/j.biocon.2009.03.027; Oro D, 2011, BIOL CONSERV, V144, P851, DOI 10.1016/j.biocon.2010.11.018; Parsons NJ, 2005, AFR J MAR SCI, V27, P289, DOI 10.2989/18142320509504087; Payne RB, 1972, AVIAN BIOL, V2, P104; Peirce M.A., 1989, International Council for Bird Preservation Technical Publication, P69; PETERSEN SL, 2005, MARINE ORNITHOLOGY, V33, pE1; Pichegru L, 2012, BIOL CONSERV, V156, P117, DOI 10.1016/j.biocon.2011.12.013; Randall R.M., 1989, P244; Robinson WML, 2013, THESIS U CAPE TOWN C; Schwitzer C, 2013, WAZA MAG, V14, P23; SEDDON PJ, 1993, OSTRICH, V64, P8, DOI 10.1080/00306525.1993.9634188; Sherley, 2010, THESIS U BRISTOL BRI; Sherley RB, 2014, IBIS, V156, P716, DOI 10.1111/ibi.12189; Sherley RB, 2013, ENDANGER SPECIES RES, V21, P89, DOI 10.3354/esr00510; Sherley RB, 2013, MAR ECOL PROG SER, V473, P291, DOI 10.3354/meps10070; Sherley RB, 2012, EMU, V112, P97, DOI 10.1071/MU11055; Turner Wendy A., 1998, Penguin Conservation, V11, P2; Underhill LG, 1999, IBIS, V141, P29; Waller L., 2011, THESIS U CAPE TOWN C; Whittington P, 2005, OSTRICH, V76, P14, DOI 10.2989/00306520509485468; Whittington PA, 2005, AFR J MAR SCI, V27, P205, DOI 10.2989/18142320509504079; WHITTINGTON PA, 2002, THESIS U CAPE TOWN C; Wilson D, 2009, AUK, V126, P688, DOI 10.1525/auk.2009.9709; Wolfaardt AC, 2009, AFR J MAR SCI, V31, P19, DOI 10.2989/AJMS.2009.31.1.2.773	60	19	19	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110794	10.1371/journal.pone.0110794	http://dx.doi.org/10.1371/journal.pone.0110794			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337698	Green Submitted, gold, Green Published			2022-12-27	WOS:000343674800077
J	Zhao, L; Chen, F; Dai, J; Hua, T; Lu, CT; Ramakrishnan, N				Zhao, Liang; Chen, Feng; Dai, Jing; Hua, Ting; Lu, Chang-Tien; Ramakrishnan, Naren			Unsupervised Spatial Event Detection in Targeted Domains with Applications to Civil Unrest Modeling	PLOS ONE			English	Article							MEDIA; SCAN	Twitter has become a popular data source as a surrogate for monitoring and detecting events. Targeted domains such as crime, election, and social unrest require the creation of algorithms capable of detecting events pertinent to these domains. Due to the unstructured language, short-length messages, dynamics, and heterogeneity typical of Twitter data streams, it is technically difficult and labor-intensive to develop and maintain supervised learning systems. We present a novel unsupervised approach for detecting spatial events in targeted domains and illustrate this approach using one specific domain, viz. civil unrest modeling. Given a targeted domain, we propose a dynamic query expansion algorithm to iteratively expand domain-related terms, and generate a tweet homogeneous graph. An anomaly identification method is utilized to detect spatial events over this graph by jointly maximizing local modularity and spatial scan statistics. Extensive experiments conducted in 10 Latin American countries demonstrate the effectiveness of the proposed approach.	[Zhao, Liang; Hua, Ting; Lu, Chang-Tien; Ramakrishnan, Naren] Virginia Tech, Dept Comp Sci, Falls Church, VA 22043 USA; [Chen, Feng] SUNY Albany, Dept Comp Sci, Albany, NY 12222 USA; [Dai, Jing] Google, New York, NY USA	Virginia Polytechnic Institute & State University; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Google Incorporated	Zhao, L (corresponding author), Virginia Tech, Dept Comp Sci, Falls Church, VA 22043 USA.	liangz8@vt.edu			Intelligence Advanced Research Projects Activity (IARPA) via Department of Interior National Business Center (DoI/NBC) [D12PC000337]	Intelligence Advanced Research Projects Activity (IARPA) via Department of Interior National Business Center (DoI/NBC)	This work is supported by the Intelligence Advanced Research Projects Activity (IARPA) via Department of Interior National Business Center (DoI/NBC) contract number D12PC000337. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal C. C., 2012, P 2012 SIAM INT C DA, P624, DOI DOI 10.1137/1.9781611972825.54; Chakrabarti D., 2011, P 5 INT AAAI C WEBL, V11, P66; Golub G. H., 2012, MATRIX COMPUTATIONS, V3; Haveliwala TH, 2003, IEEE T KNOWL DATA EN, V15, P784, DOI 10.1109/TKDE.2003.1208999; Jinxi Xu, 1996, SIGIR Forum, P4; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kumaran G., 2004, Proceedings of Sheffield SIGIR 2004. The Twenty-Seventh Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P297, DOI 10.1145/1008992.1009044; Lappas T, 2012, PROC VLDB ENDOW, V5, P836, DOI 10.14778/2311906.2311911; Li R, 2013, PROC VLDB ENDOW, V6, P1966, DOI 10.14778/2556549.2556577; Li R, 2012, PROC INT CONF DATA, P1273, DOI 10.1109/ICDE.2012.125; Liu TT, 2010, LECT N BIOINFORMAT, V6254, P148; Mandelzis Lea, 2008, PEACE POLICY, P62; Massoudi K, 2011, LECT NOTES COMPUT SC, V6611, P362, DOI 10.1007/978-3-642-20161-5_36; Muff S, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056107; Neill DB, 2012, J R STAT SOC B, V74, P337, DOI 10.1111/j.1467-9868.2011.01014.x; Ramakrishnan N, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P1799, DOI 10.1145/2623330.2623373; Ritter Alan, 2012, P 18 ACM SIGKDD INT, P1104, DOI DOI 10.1145/2339530.2339704; Sakaki T., 2010, P 19 INT C WORLD WID, P851, DOI [10.1145/1772690.1772777, DOI 10.1145/1772690.1772777, 10.1145/1772690.1772777.]; Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467; Tufekci Z, 2012, J COMMUN, V62, P363, DOI 10.1111/j.1460-2466.2012.01629.x; Weng J., 2011, P 4 INT AAAI C WEBL, V11, P401; Wilson C, 2011, INT J COMMUN-US, V5, P1248; Yin Z., 2011, P 20 INT C WORLD WID, P247, DOI DOI 10.1145/1963405.1963443	23	36	40	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110206	10.1371/journal.pone.0110206	http://dx.doi.org/10.1371/journal.pone.0110206			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350136	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943100022
J	Bozza, G; Capitani, M; Montanari, P; Benucci, B; Biancucci, M; Nardi-Dei, V; Caproni, E; Barrile, R; Picciani, B; Savino, S; Arico, B; Rappuoli, R; Pizza, M; Luini, A; Sallese, M; Merola, M				Bozza, Giuseppe; Capitani, Mirco; Montanari, Paolo; Benucci, Barbara; Biancucci, Marco; Nardi-Dei, Vincenzo; Caproni, Elena; Barrile, Riccardo; Picciani, Benedetta; Savino, Silvana; Arico, Beatrice; Rappuoli, Rino; Pizza, Mariagrazia; Luini, Alberto; Sallese, Michele; Merola, Marcello			Role of ARF6, Rab11 and External Hsp90 in the Trafficking and Recycling of Recombinant-Soluble Neisseria meningitidis Adhesin A (rNadA) in Human Epithelial Cells	PLOS ONE			English	Article							CLATHRIN-INDEPENDENT ENDOCYTOSIS; TRIMERIC AUTOTRANSPORTER ADHESINS; CAVEOLAE-MEDIATED ENDOCYTOSIS; PROTEIN-KINASE-C; MORAXELLA-CATARRHALIS; MOLECULAR CHAPERONE; NADA; ACTIVATION; MECHANISMS; BARTONELLA	Neisseria meningitidis adhesin A (NadA) is a meningococcus surface protein thought to assist in the adhesion of the bacterium to host cells. We have previously shown that NadA also promotes bacterial internalization in a heterologous expression system. Here we have used the soluble recombinant NadA (rNadA) lacking the membrane anchor region to characterize its internalization route in Chang epithelial cells. Added to the culture medium, rNadA internalizes through a PI3K-dependent endocytosis process not mediated by the canonical clathrin or caveolin scaffolds, but instead follows an ARF6-regulated recycling pathway previously described for MHC-I. The intracellular pool of rNadA reaches a steady state level within one hour of incubation and colocalizes in endocytic vesicles with MHC-I and with the extracellularly labeled chaperone Hsp90. Treatment with membrane permeated and impermeable Hsp90 inhibitors 17-AAG and FITC-GA respectively, lead to intracellular accumulation of rNadA, strongly suggesting that the extracellular secreted pool of the chaperone is involved in rNadA intracellular trafficking. A significant number of intracellular vesicles containing rNadA recruit Rab11, a small GTPase associated to recycling endosomes, but do not contain transferrin receptor (TfR). Interestingly, cell treatment with Hsp90 inhibitors, including the membrane-impermeable FITC-GA, abolished Rab11-rNadA colocalization but do not interfere with Rab11-TfR colocalization. Collectively, these results are consistent with a model whereby rNadA internalizes into human epithelial cells hijacking the recycling endosome pathway and recycle back to the surface of the cell via an ARF6-dependent, Rab11 associated and Hsp90-regulated mechanism. The present study addresses for the first time a meningoccoccal adhesin mechanism of endocytosis and suggests a possible entry pathway engaged by N. meningitidis in primary infection of human epithelial cells.	[Bozza, Giuseppe; Montanari, Paolo; Benucci, Barbara; Biancucci, Marco; Nardi-Dei, Vincenzo; Caproni, Elena; Barrile, Riccardo; Savino, Silvana; Arico, Beatrice; Rappuoli, Rino; Pizza, Mariagrazia; Merola, Marcello] Novartis Vaccines, Siena, Italy; [Capitani, Mirco; Picciani, Benedetta; Sallese, Michele] Fdn Mario Negri Sud, Unit Genom Approaches Membrane Traff, Santa Maria Imbaro, CH, Italy; [Luini, Alberto] CNR, Inst Prot Biochem, I-80125 Naples, Italy; [Merola, Marcello] Univ Naples Federico II, Dept Biol, Naples, Italy	Novartis; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); University of Naples Federico II	Sallese, M (corresponding author), Fdn Mario Negri Sud, Unit Genom Approaches Membrane Traff, Santa Maria Imbaro, CH, Italy.	sallese@negrisud.it; marcello.merola@novartis.com	Sallese, Michele/J-5347-2016; Luini, Alberto/L-1372-2013	Sallese, Michele/0000-0002-2555-3571; Luini, Alberto/0000-0002-8729-2549; Picciani, Benedetta/0000-0002-4023-5547	Novartis Vaccines	Novartis Vaccines	This work is entirely funded by Novartis Vaccines; no external entities have contributed to cover project expenses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvi F, 2007, CELL MOL LIFE SCI, V64, P263, DOI 10.1007/s00018-006-6363-5; Amiri A, 2007, MOL CANCER RES, V5, P933, DOI 10.1158/1541-7786.MCR-06-0362; Amyere M, 2000, MOL BIOL CELL, V11, P3453, DOI 10.1091/mbc.11.10.3453; Araki N, 2007, EXP CELL RES, V313, P1496, DOI 10.1016/j.yexcr.2007.02.012; Binder RJ, 2004, TISSUE ANTIGENS, V64, P442, DOI 10.1111/j.1399-0039.2004.00299.x; BIRKNESS KA, 1995, INFECT IMMUN, V63, P402, DOI 10.1128/IAI.63.2.402-409.1995; Bowe F, 2004, INFECT IMMUN, V72, P4052, DOI 10.1128/IAI.72.7.4052-4060.2004; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Capecchi B, 2005, MOL MICROBIOL, V55, P687, DOI 10.1111/j.1365-2958.2004.04423.x; Carbonnelle E, 2009, VACCINE, V27, pB78, DOI 10.1016/j.vaccine.2009.04.069; Cecchini P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025089; Cha SK, 2008, AM J PHYSIOL-RENAL, V294, pF1212, DOI 10.1152/ajprenal.00007.2008; Comanducci M, 2004, INFECT IMMUN, V72, P4217, DOI 10.1128/IAI.72.7.4217-4223.2004; Comanducci M, 2002, J EXP MED, V195, P1445, DOI 10.1084/jem.20020407; Cortese K, 2013, MOL BIOL CELL, V24, P129, DOI 10.1091/mbc.E12-04-0282; Cotter SE, 2005, TRENDS MICROBIOL, V13, P199, DOI 10.1016/j.tim.2005.03.004; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Dautin N, 2007, ANNU REV MICROBIOL, V61, P89, DOI 10.1146/annurev.micro.61.080706.093233; Delom Frederic, 2011, Int J Cell Biol, V2011, P246954, DOI 10.1155/2011/246954; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Donaldson JG, 2009, CELL SIGNAL, V21, P1, DOI 10.1016/j.cellsig.2008.06.020; El Tahir Y, 2001, INT J MED MICROBIOL, V291, P209, DOI 10.1078/1438-4221-00119; Emonts M, 2003, LANCET INFECT DIS, V3, P565, DOI 10.1016/S1473-3099(03)00740-0; Eyster CA, 2011, MOL BIOL CELL, V22, P3218, DOI 10.1091/mbc.E10-11-0874; Eyster CA, 2009, TRAFFIC, V10, P590, DOI 10.1111/j.1600-0854.2009.00894.x; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Franzoso S, 2008, J LEUKOCYTE BIOL, V83, P1100, DOI 10.1189/jlb.1207810; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Hill DJ, 2010, CLIN SCI, V118, P547, DOI 10.1042/CS20090513; Hill DJ, 2003, MOL MICROBIOL, V48, P117, DOI 10.1046/j.1365-2958.2003.03433.x; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Jean S, 2012, NAT REV MOL CELL BIO, V13, P463, DOI 10.1038/nrm3379; Kobayashi Hotaka, 2013, Commun Integr Biol, V6, pe25036, DOI 10.4161/cib.25036; Kumari S, 2010, CELL RES, V20, P256, DOI 10.1038/cr.2010.19; Laarmann S, 2002, MOL MICROBIOL, V46, P731, DOI 10.1046/j.1365-2958.2002.03189.x; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Li W, 2012, BBA-MOL CELL RES, V1823, P730, DOI 10.1016/j.bbamcr.2011.09.009; Linke D, 2006, TRENDS MICROBIOL, V14, P264, DOI 10.1016/j.tim.2006.04.005; Litt DJ, 2004, J INFECT DIS, V190, P1488, DOI 10.1086/424464; Lyskowski A, 2011, ADV EXP MED BIOL, V715, P143, DOI 10.1007/978-94-007-0940-9_9; Magagnoli C, 2009, VACCINE, V27, P2156, DOI 10.1016/j.vaccine.2009.01.099; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Mazzon C, 2007, J IMMUNOL, V179, P3904, DOI 10.4049/jimmunol.179.6.3904; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; McMichael JC, 1998, INFECT IMMUN, V66, P4374; Montanari P, 2012, CELL MICROBIOL, V14, P368, DOI 10.1111/j.1462-5822.2011.01722.x; Nagele V, 2011, J BIOL CHEM, V286, P20536, DOI 10.1074/jbc.M110.188326; Naslavsky N, 2003, MOL BIOL CELL, V14, P417, DOI 10.1091/mbc.02-04-0053; O'Rourke F, 2011, ADV EXP MED BIOL, V715, P51, DOI 10.1007/978-94-007-0940-9_4; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; Powers MV, 2006, ENDOCR-RELAT CANCER, V13, pS125, DOI 10.1677/erc.1.01324; Pujol C, 1997, INFECT IMMUN, V65, P4836, DOI 10.1128/IAI.65.11.4836-4842.1997; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Riess T, 2004, J EXP MED, V200, P1267, DOI 10.1084/jem.20040500; Roggenkamp A, 2003, J BACTERIOL, V185, P3735, DOI 10.1128/JB.185.13.3735-3744.2003; Rojas R, 2008, J CELL BIOL, V183, P513, DOI 10.1083/jcb.200804048; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Sandvig K, 2011, CURR OPIN CELL BIOL, V23, P413, DOI 10.1016/j.ceb.2011.03.007; Scarselli M, 2006, MOL MICROBIOL, V61, P631, DOI 10.1111/j.1365-2958.2006.05261.x; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Schweitzer JK, 2011, SEMIN CELL DEV BIOL, V22, P39, DOI 10.1016/j.semcdb.2010.09.002; Serruto D, 2009, CELL MICROBIOL, V11, P1044, DOI 10.1111/j.1462-5822.2009.01306.x; Shajahan AN, 2004, J BIOL CHEM, V279, P48055, DOI 10.1074/jbc.M405837200; Sharma DK, 2004, MOL BIOL CELL, V15, P3114, DOI 10.1091/mbc.E04-03-0189; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stephens DS, 2009, VACCINE, V27, pB71, DOI 10.1016/j.vaccine.2009.04.070; STEPHENS DS, 1983, J INFECT DIS, V148, P369, DOI 10.1093/infdis/148.3.369; Surana NK, 2004, J BIOL CHEM, V279, P14679, DOI 10.1074/jbc.M311496200; Sutherland TC, 2010, INFECT IMMUN, V78, P3832, DOI 10.1128/IAI.01377-09; Takahashi S, 2012, J CELL SCI, V125, P4049, DOI 10.1242/jcs.102913; Tsutsumi S, 2007, CANCER SCI, V98, P1536, DOI 10.1111/j.1349-7006.2007.00561.x; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Virji M, 2009, NAT REV MICROBIOL, V7, P274, DOI 10.1038/nrmicro2097; Yang W, 2004, BIOCHEM J, V382, P199, DOI 10.1042/BJ20040623; YANG YX, 1993, INFECT IMMUN, V61, P3907, DOI 10.1128/IAI.61.9.3907-3913.1993; Zagorac GB, 2012, J CELL PHYSIOL, V227, P2953, DOI 10.1002/jcp.23042; Zhang P, 2004, P NATL ACAD SCI USA, V101, P13630, DOI 10.1073/pnas.0405284101; Zhao XH, 2001, J CELL SCI, V114, P353	80	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e110047	10.1371/journal.pone.0110047	http://dx.doi.org/10.1371/journal.pone.0110047			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347845	gold, Green Published, Green Submitted			2022-12-27	WOS:000347994900020
J	Yu, D; Feng, Y; Yang, L; Da, M; Fan, CF; Wang, S; Mo, XM				Yu, Di; Feng, Yu; Yang, Lei; Da, Min; Fan, Changfeng; Wang, Song; Mo, Xuming			Maternal Socioeconomic Status and the Risk of Congenital Heart Defects in Offspring: A Meta-Analysis of 33 Studies	PLOS ONE			English	Article							ATRIOVENTRICULAR-CANAL DEFECTS; VENTRICULAR SEPTAL-DEFECTS; PARENTAL CIGARETTE-SMOKING; BIRTH-DEFECTS; CARDIOVASCULAR-DISEASE; PSYCHOSOCIAL FACTORS; DOWN-SYNDROME; HEALTH; MALFORMATIONS; EPIDEMIOLOGY	Background: We conducted this meta-analysis to address the open question of a possible association between maternal socioeconomic status and congenital heart defects (CHDs). Methods: We searched MEDLINE and EMBASE from their inception to January 1, 2014 for case-control and cohort studies that assessed the association between maternal socioeconomic status and the risk of CHDs. Study-specific relative risk estimates were polled according to random-effect or fixed-effect models. Results: From 3343 references, a total of 31 case-control studies and 2 cohort studies were enrolled in this meta-analysis, including more than 50,000 cases. We observed that maternal educational attainment, family income and maternal occupation were negatively associated with an 11% (pooled RR = 1.11, 95% CI: 1.03, 1.21), 5% (pooled RR = 1.05, 95% CI: 1.01, 1.09) and 51% (pooled RR = 1.51, 95% CI: 1.02, 2.24) increased risk of CHDs, respectively. In a subgroup analysis by geographic region, the results were inconsistent for the European region (RR = 1.29, 95% CI: 0.99-1.69) and USA/Canada region (RR = 1.06, 95% CI: 0.97, 1.16) in maternal educational attainment. Conclusion: In summary, this meta-analysis suggests that a lower degree of maternal socioeconomic status is modestly associated with an increased risk of CHDs. However, further investigations are needed to confirm the association.	[Yu, Di; Feng, Yu; Yang, Lei; Da, Min; Fan, Changfeng; Wang, Song; Mo, Xuming] Nanjing Med Univ, Nanjing Childrens Hosp, Dept Cardiothorac Surg, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Mo, XM (corresponding author), Nanjing Med Univ, Nanjing Childrens Hosp, Dept Cardiothorac Surg, Nanjing, Jiangsu, Peoples R China.	mohsuming15@sina.com						ADLER NE, 1994, AM PSYCHOL, V49, P15, DOI 10.1037/0003-066X.49.1.15; Agha MM, 2011, BIRTH DEFECTS RES A, V91, P1011, DOI 10.1002/bdra.22857; Agopian AJ, 2012, PAEDIATR PERINAT EP, V26, P515, DOI 10.1111/ppe.12006; Alverson CJ, 2011, PEDIATRICS, V127, pE647, DOI 10.1542/peds.2010-1399; Ariza-Montes A, 2013, INT J ENV RES PUB HE, V10, P3121, DOI 10.3390/ijerph10083121; Bassili A, 2000, EUR J EPIDEMIOL, V16, P805, DOI 10.1023/A:1007601919164; Batra M, 2007, ARCH PEDIAT ADOL MED, V161, P89, DOI 10.1001/archpedi.161.1.89; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Boneva RS, 2001, CIRCULATION, V103, P2376; Botto LD, 2000, AM J EPIDEMIOL, V151, P878, DOI 10.1093/oxfordjournals.aje.a010291; Brent RL, 2004, PEDIATRICS, V113, P957; Carmichael SL, 2003, PAEDIATR PERINAT EP, V17, P264, DOI 10.1046/j.1365-3016.2003.00498.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fixler DE, 1998, TERATOLOGY, V58, P6, DOI 10.1002/(SICI)1096-9926(199807)58:1<6::AID-TERA4>3.0.CO;2-0; Gonzalez MA, 1998, INT J EPIDEMIOL, V27, P350, DOI 10.1093/ije/27.3.350; Grewal J, 2008, BIRTH DEFECTS RES A, V82, P519, DOI 10.1002/bdra.20461; Hackshaw A, 2011, HUM REPROD UPDATE, V17, P589, DOI 10.1093/humupd/dmr022; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hobbs CA, 2010, OBSTET GYNECOL, V116, P316, DOI 10.1097/AOG.0b013e3181e80979; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Huisman M, 2012, EUR J PUBLIC HEALTH, V22, P238, DOI 10.1093/eurpub/ckr039; Jenkins KJ, 2007, CIRCULATION, V115, P2995, DOI 10.1161/CIRCULATIONAHA.106.183216; KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973; Karatza AA, 2011, INT J CARDIOL, V148, P295, DOI 10.1016/j.ijcard.2009.11.008; Kavanagh A, 2010, SOC SCI MED, V71, P1150, DOI 10.1016/j.socscimed.2010.05.038; Kuciene R, 2010, MED LITH, V46, P635, DOI 10.3390/medicina46090090; Lee LJ, 2013, PEDIATR CARDIOL, V34, P398, DOI 10.1007/s00246-012-0470-x; Lisowski LA, 2010, HERZ, V35, P19, DOI 10.1007/s00059-010-3244-3; Liu SW, 2009, J EPIDEMIOL, V19, P122, DOI 10.2188/jea.JE20080039; Long J, 2010, BIRTH DEFECTS RES A, V88, P971, DOI 10.1002/bdra.20724; Lupo PJ, 2012, BIRTH DEFECTS RES A, V94, P875, DOI 10.1002/bdra.23071; Malik S, 2008, PEDIATRICS, V121, pE810, DOI 10.1542/peds.2007-1519; Manrique-Garcia E, 2011, J EPIDEMIOL COMMUN H, V65, P301, DOI 10.1136/jech.2009.104075; Mateja WA, 2012, J WOMENS HEALTH, V21, P26, DOI 10.1089/jwh.2010.2582; Materna-Kiryluk A, 2011, PAEDIATR PERINAT EP, V25, P135, DOI 10.1111/j.1365-3016.2010.01186.x; McBride KL, 2005, BIRTH DEFECTS RES A, V73, P555, DOI 10.1002/bdra.20169; Padula AM, 2013, PAEDIATR PERINAT EP, V27, P329, DOI 10.1111/ppe.12055; Patel SS, 2012, AM J MED GENET A, V158A, P2447, DOI 10.1002/ajmg.a.35555; PRADAT P, 1993, INT ARCH OCC ENV HEA, V65, P13, DOI 10.1007/BF00586052; Smedts HPM, 2009, BJOG-INT J OBSTET GY, V116, P416, DOI 10.1111/j.1471-0528.2008.01957.x; STOLL C, 1989, EUR J EPIDEMIOL, V5, P382, DOI 10.1007/BF00144842; Strike PC, 2004, PROG CARDIOVASC DIS, V46, P337, DOI 10.1016/j.pcad.2003.09.001; Tamayo T, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-525; TIKKANEN J, 1992, INT ARCH OCC ENV HEA, V64, P59, DOI 10.1007/BF00625952; Torfs CP, 1999, EPIDEMIOLOGY, V10, P264, DOI 10.1097/00001648-199905000-00013; Tusting LS, 2013, LANCET, V382, P963, DOI 10.1016/S0140-6736(13)60851-X; van Beynum IM, 2010, EUR HEART J, V31, P464, DOI 10.1093/eurheartj/ehp479; van Driel LMJW, 2008, EUR HEART J, V29, P1424, DOI 10.1093/eurheartj/ehn170; Vereczkey A, 2013, BIRTH DEFECTS RES A, V97, P217, DOI 10.1002/bdra.23124; Vereczkey A, 2012, J MATERN-FETAL NEO M, V25, P2536, DOI 10.3109/14767058.2012.712568; Wasserman CR, 1996, TERATOLOGY, V53, P261, DOI 10.1002/(SICI)1096-9926(199604)53:4<261::AID-TERA9>3.3.CO;2-8; Williams LJ, 2004, BIRTH DEFECTS RES A, V70, P59, DOI 10.1002/bdra.10145; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; Yang J, 2008, AM J EPIDEMIOL, V167, P145, DOI 10.1093/aje/kwm283	54	23	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111056	10.1371/journal.pone.0111056	http://dx.doi.org/10.1371/journal.pone.0111056			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ1JF	25347676	Green Submitted, Green Published, gold			2022-12-27	WOS:000347994900042
J	Salanki, R; Hos, C; Orgovan, N; Peter, B; Sandor, N; Bajtay, Z; Erdei, A; Horvath, R; Szabo, B				Salanki, Rita; Hos, Csaba; Orgovan, Norbert; Peter, Beatrix; Sandor, Noemi; Bajtay, Zsuzsa; Erdei, Anna; Horvath, Robert; Szabo, Balint			Single Cell Adhesion Assay Using Computer Controlled Micropipette	PLOS ONE			English	Article							FLUID SLIP; SURFACE; DEPENDENCE; INTEGRINS; FORCE; SERUM; FLOW; STRENGTH; AVIDITY; DESIGN	Cell adhesion is a fundamental phenomenon vital for all multicellular organisms. Recognition of and adhesion to specific macromolecules is a crucial task of leukocytes to initiate the immune response. To gain statistically reliable information of cell adhesion, large numbers of cells should be measured. However, direct measurement of the adhesion force of single cells is still challenging and today's techniques typically have an extremely low throughput (5-10 cells per day). Here, we introduce a computer controlled micropipette mounted onto a normal inverted microscope for probing single cell interactions with specific macromolecules. We calculated the estimated hydrodynamic lifting force acting on target cells by the numerical simulation of the flow at the micropipette tip. The adhesion force of surface attached cells could be accurately probed by repeating the pick-up process with increasing vacuum applied in the pipette positioned above the cell under investigation. Using the introduced methodology hundreds of cells adhered to specific macromolecules were measured one by one in a relatively short period of time (similar to 30 min). We blocked nonspecific cell adhesion by the protein non-adhesive PLL-g-PEG polymer. We found that human primary monocytes are less adherent to fibrinogen than their in vitro differentiated descendants: macrophages and dendritic cells, the latter producing the highest average adhesion force. Validation of the here introduced method was achieved by the hydrostatic step-pressure micropipette manipulation technique. Additionally the result was reinforced in standard microfluidic shear stress channels. Nevertheless, automated micropipette gave higher sensitivity and less side-effect than the shear stress channel. Using our technique, the probed single cells can be easily picked up and further investigated by other techniques; a definite advantage of the computer controlled micropipette. Our experiments revealed the existence of a sub-population of strongly fibrinogen adherent cells appearing in macrophages and highly represented in dendritic cells, but not observed in monocytes.	[Salanki, Rita; Peter, Beatrix] Univ Pannonia, Doctoral Sch Mol & Nanotechnol, Veszprem, Hungary; [Salanki, Rita; Orgovan, Norbert; Peter, Beatrix; Horvath, Robert; Szabo, Balint] Res Ctr Nat Sci, Inst Tech Phys & Mat Sci, Nanobiosensor Grp, Budapest, Hungary; [Salanki, Rita; Orgovan, Norbert; Szabo, Balint] Eotvos Lorand Univ, Dept Biol Phys, Budapest, Hungary; [Hos, Csaba] Budapest Univ Technol & Econ, Dept Hydrodynam Syst, Budapest, Hungary; [Sandor, Noemi; Erdei, Anna] Eotvos Lorand Univ, MTA ELTE Immunol Res Grp, Budapest, Hungary; [Bajtay, Zsuzsa; Erdei, Anna] Eotvos Lorand Univ, Dept Immunol, Budapest, Hungary; [Szabo, Balint] CellSorter Co Innovat, Budapest, Hungary	University of Pannonia; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Eotvos Lorand University; Budapest University of Technology & Economics; Eotvos Lorand University; Eotvos Lorand University	Szabo, B (corresponding author), Res Ctr Nat Sci, Inst Tech Phys & Mat Sci, Nanobiosensor Grp, Budapest, Hungary.	balintszabo1@gmail.com	Horvath, Robert/C-4602-2008; Sándor, Noémi/AAG-1715-2021; Erdei, Anna/AAN-5988-2020; bajtay, zsuzsa/AAI-1267-2020; Hos, Csaba/E-7089-2013; Hos, Csaba/J-5881-2019; Horvath, Robert/AAW-9031-2020	Horvath, Robert/0000-0001-8617-2302; Hos, Csaba/0000-0002-1930-515X; Hos, Csaba/0000-0002-0233-9759; Horvath, Robert/0000-0001-8617-2302; Erdei, Anna/0000-0002-3622-6680	Lendulet Program of the Hungarian Academy of Sciences; project Social Renewal Operational Programme [4.2.2/B-10/1-2010-0025]; Hungarian Scientific Research Fund: Funding Basic Research in Hungary, Hungarian national research grant [K104838]; Bolyai Scholarship of the Hungarian Academy of Sciences	Lendulet Program of the Hungarian Academy of Sciences; project Social Renewal Operational Programme; Hungarian Scientific Research Fund: Funding Basic Research in Hungary, Hungarian national research grant; Bolyai Scholarship of the Hungarian Academy of Sciences	This work was supported by the Lendulet Program of the Hungarian Academy of Sciences for R. H. (http://mta.hu/english/); the project Social Renewal Operational Programme-4.2.2/B-10/1-2010-0025 for R. S.; The Hungarian Scientific Research Fund: Funding Basic Research in Hungary K104838 Hungarian national research grant for Z.B. (http://www.otka.hu/en); and Bolyai Scholarship of the Hungarian Academy of Sciences for B. S. (http://mta.hu/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 1994, MOL BIOL CELL, P966; Ammon C, 2000, IMMUNOLOGY, V100, P364, DOI 10.1046/j.1365-2567.2000.00056.x; [Anonymous], 2012, ANSYS CFX 14 0 THEOR; Christ KV, 2010, J ADHES SCI TECHNOL, V24, P2027, DOI 10.1163/016942410X507911; Cottier K, 2008, APPL PHYS B-LASERS O, V91, P319, DOI 10.1007/s00340-008-2994-6; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; Faraasen S, 2003, PHARMACEUT RES, V20, P237, DOI 10.1023/A:1022366921298; Gahmberg CG, 1997, CURR OPIN CELL BIOL, V9, P643, DOI 10.1016/S0955-0674(97)80117-2; Garcia AJ, 1997, BIOMATERIALS, V18, P1091, DOI 10.1016/S0142-9612(97)00042-2; Gupta R, 2013, HOUILLE BLANCHE, P60, DOI 10.1051/lhb/2013017; Helenius J, 2008, J CELL SCI, V121, P1785, DOI 10.1242/jcs.030999; Hochmuth RM, 2000, J BIOMECH, V33, P15, DOI 10.1016/S0021-9290(99)00175-X; Hogg N, 2002, IMMUNOL REV, V186, P164, DOI 10.1034/j.1600-065X.2002.18614.x; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Huang NP, 2001, LANGMUIR, V17, P489, DOI 10.1021/la000736+; KAPLANSKI G, 1993, BIOPHYS J, V64, P1922, DOI 10.1016/S0006-3495(93)81563-7; Karimi S, 2014, J NON-NEWTON FLUID, V207, P42, DOI 10.1016/j.jnnfm.2014.03.007; Kazemzadeh A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073002; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; KLEBE RJ, 1974, NATURE, V250, P248, DOI 10.1038/250248a0; Kornyei Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep01088; Lauga E, 2005, MICROFLUIDICS NO SLI, P2; Michel R, 2005, LANGMUIR, V21, P12327, DOI 10.1021/la051726h; Mohanty S, 2008, LECT NOTES ENG COMP, P68; Neto C, 2005, REP PROG PHYS, V68, P2859, DOI 10.1088/0034-4885/68/12/R05; Ogaki R, 2012, BIOMACROMOLECULES, V13, P3668, DOI 10.1021/bm301125g; Orgovan N, 2014, ADV COLLOID INTERFAC, V211, P1, DOI 10.1016/j.cis.2014.03.011; Orgovan N, 2014, SCI REP-UK, V4, DOI 10.1038/srep04034; Orgovan N, 2014, BIOSENS BIOELECTRON, V54, P339, DOI 10.1016/j.bios.2013.10.076; Park H, 2014, INT J HEAT MASS TRAN, V73, P511, DOI 10.1016/j.ijheatmasstransfer.2014.02.038; Potthoff E, 2014, NANO LETT, V14, P1069, DOI 10.1021/nl4047398; Potthoff E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052712; Puech PH, 2006, ULTRAMICROSCOPY, V106, P637, DOI 10.1016/j.ultramic.2005.08.003; Ramsden JJ, 2009, J RECEPT SIG TRANSD, V29, P211, DOI 10.1080/10799890903064119; ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83; Sagvolden G, 1999, P NATL ACAD SCI USA, V96, P471, DOI 10.1073/pnas.96.2.471; Salanki R, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4893922; Sandor N, 2013, IMMUNOBIOLOGY, V218, P652, DOI 10.1016/j.imbio.2012.07.031; Sandor N, 2009, MOL IMMUNOL, V47, P438, DOI 10.1016/j.molimm.2009.08.025; Schurpf T, 2011, EMBO J; Shao JY, 2004, FRONT BIOSCI-LANDMRK, V9, P2183, DOI 10.2741/1386; SUNG KLP, 1986, SCIENCE, V234, P1405, DOI 10.1126/science.3491426; Toth E, 2013, BIOMED CIRC SYST C, P266, DOI 10.1109/BioCAS.2013.6679690; Tretheway DC, 2004, PHYS FLUIDS, V16, P1509, DOI 10.1063/1.1669400; USAMI S, 1993, ANN BIOMED ENG, V21, P77, DOI 10.1007/BF02368167; van Kooyk Y, 2000, CURR OPIN CELL BIOL, V12, P542, DOI 10.1016/S0955-0674(00)00129-0; Voronov RS, 2008, IND ENG CHEM RES, V47, P2455, DOI 10.1021/ie0712941; Wei D, 2014, J WIND ENG IND AEROD, V126, P118, DOI 10.1016/j.jweia.2014.01.008; Xu JL, 2007, INT J HEAT MASS TRAN, V50, P2571, DOI 10.1016/j.ijheatmasstransfer.2006.11.031; Zhang H, 2008, J R SOC INTERFACE, V5, P671, DOI 10.1098/rsif.2008.0052; Zhu Y, 2001, PHYS REV LETT, V87; Zhu YX, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.106102	53	27	27	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111450	10.1371/journal.pone.0111450	http://dx.doi.org/10.1371/journal.pone.0111450			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343359	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000343943500099
J	Siragam, V; Cui, XZ; Masse, S; Ackerley, C; Aafaqi, S; Strandberg, L; Tropak, M; Fridman, MD; Nanthakumar, K; Liu, J; Su, B; Wang, C; Liu, XR; Yan, YQ; Mendlowitz, A; Hamilton, RM				Siragam, Vinayakumar; Cui, Xuezhi; Masse, Stephane; Ackerley, Cameron; Aafaqi, Shabana; Strandberg, Linn; Tropak, Michael; Fridman, Michael D.; Nanthakumar, Kumaraswamy; Liu, Jun; Su, Bin; Wang, Caroline; Liu, Xiaoru; Yan, Yuqing; Mendlowitz, Ariel; Hamilton, Robert M.			TMEM43 Mutation p.S358L Alters Intercalated Disc Protein Expression and Reduces Conduction Velocity in Arrhythmogenic Right Ventricular Cardiomyopathy	PLOS ONE			English	Article							LUMINAL CA2+ ACTIVATION; INNER NUCLEAR-MEMBRANE; SUDDEN-DEATH; CONNEXIN PHOSPHORYLATION; RYANODINE RECEPTOR; JUNCTIONAL COMMUNICATION; HL-1 CARDIOMYOCYTES; ACTIN CYTOSKELETON; CARDIAC MYOCYTES; TIGHT JUNCTION	Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a myocardial disease characterized by fibro-fatty replacement of myocardium in the right ventricular free wall and frequently results in life-threatening ventricular arrhythmias and sudden cardiac death. A heterozygous missense mutation in the transmembrane protein 43 (TMEM43) gene, p. S358L, has been genetically identified to cause autosomal dominant ARVC type 5 in a founder population from the island of Newfoundland, Canada. Little is known about the function of the TMEM43 protein or how it leads to the pathogenesis of ARVC. We sought to determine the distribution of TMEM43 and the effect of the p. S358L mutation on the expression and distribution of various intercalated (IC) disc proteins as well as functional effects on IC disc gap junction dye transfer and conduction velocity in cell culture. Through Western blot analysis, transmission electron microscopy (TEM), immunofluorescence (IF), and electrophysiological analysis, our results showed that the stable expression of p. S358L mutation in the HL-1 cardiac cell line resulted in decreased Zonula Occludens (ZO-1) expression and the loss of ZO-1 localization to cell-cell junctions. Junctional Plakoglobin (JUP) and a-catenin proteins were redistributed to the cytoplasm with decreased localization to cell-cell junctions. Connexin-43 (Cx43) phosphorylation was altered, and there was reduced gap junction dye transfer and conduction velocity in mutant TMEM43-transfected cells. These observations suggest that expression of the p. S358L mutant of TMEM43 found in ARVC type 5 may affect localization of proteins involved in conduction, alter gap junction function and reduce conduction velocity in cardiac tissue.	[Siragam, Vinayakumar; Cui, Xuezhi; Aafaqi, Shabana; Strandberg, Linn; Tropak, Michael; Fridman, Michael D.; Su, Bin; Wang, Caroline; Liu, Xiaoru; Yan, Yuqing; Mendlowitz, Ariel; Hamilton, Robert M.] Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Siragam, Vinayakumar; Cui, Xuezhi; Ackerley, Cameron; Aafaqi, Shabana; Strandberg, Linn; Tropak, Michael; Fridman, Michael D.; Su, Bin; Wang, Caroline; Liu, Xiaoru; Yan, Yuqing; Mendlowitz, Ariel; Hamilton, Robert M.] Res Inst, Toronto, ON, Canada; [Masse, Stephane; Nanthakumar, Kumaraswamy] Univ Hlth Network, Div Cardiol, Toronto, ON, Canada; [Ackerley, Cameron] Hosp Sick Children, Div Pathol, Toronto, ON M5G 1X8, Canada; [Liu, Jun; Su, Bin] Univ Toronto, Dept Mech & Ind Engn, Adv Micro & Nanosyst Lab, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Hamilton, RM (corresponding author), Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	robert.hamilton@sickkids.ca	Liu, Jun/K-2919-2019; , Nanthakumar/AAA-9943-2020	Liu, Jun/0000-0002-5815-2483; Sun, Yu/0000-0001-7895-0741	Heart and Stroke Foundation of Canada [NA 6379]; CIHR Emerging Team Grant in ARVC; Caitlin Elizabeth Morris Fund of the Hospital for Sick Children Foundation; Alex Corrance Memorial Fund	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); CIHR Emerging Team Grant in ARVC; Caitlin Elizabeth Morris Fund of the Hospital for Sick Children Foundation; Alex Corrance Memorial Fund	This work was supported by the Heart and Stroke Foundation of Canada (#NA 6379), a CIHR Emerging Team Grant in ARVC, the Caitlin Elizabeth Morris Fund of the Hospital for Sick Children Foundation and the Alex Corrance Memorial Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JM, 1995, BIOCHEM SOC T, V23, P470, DOI 10.1042/bst0230470; Asimaki A, 2007, AM J HUM GENET, V81, P964, DOI 10.1086/521633; Asimaki A, 2009, NEW ENGL J MED, V360, P1075, DOI 10.1056/NEJMoa0808138; Awad MM, 2006, AM J HUM GENET, V79, P136, DOI 10.1086/504393; Baskin B, 2013, HUMAN GENETICS; Beffagna G, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-65; Bengtsson L, 2008, J CELL SCI, V121, P536, DOI 10.1242/jcs.019281; Cerrone M., 2013, HEART RHYTHM, V10, P1743, DOI [10.1016/j.hrthm.2013.09.019, DOI 10.1016/J.HRTHM.2013.09.019]; Christensen AH, 2011, CLIN GENET, V80, P256, DOI 10.1111/j.1399-0004.2011.01623.x; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Coonar AS, 1998, CIRCULATION, V97, P2049, DOI 10.1161/01.CIR.97.20.2049; DAVIS LM, 1995, J CARDIOVASC ELECTR, V6, P103, DOI 10.1111/j.1540-8167.1995.tb00762.x; Dreger M, 2001, P NATL ACAD SCI USA, V98, P11943, DOI 10.1073/pnas.211201898; Fidler LM, 2009, J CELL MOL MED, V13, P4219, DOI 10.1111/j.1582-4934.2008.00438.x; Franke WW, 2014, CELL TISSUE RES, V357, P159, DOI 10.1007/s00441-014-1865-1; George CH, 2006, CIRC RES, V98, P88, DOI 10.1161/01.RES.0000199296.70534.7c; George CH, 2003, CIRC RES, V93, P531, DOI 10.1161/01.RES.0000091335.07574.86; George CH, 2007, CIRC RES, V100, P874, DOI 10.1161/01.RES.0000260804.77807.cf; Gerull B, 2004, NAT GENET, V36, P1162, DOI 10.1038/ng1461; Gizurarson S, 2012, CELL PHYSIOL BIOCHEM, V30, P477, DOI 10.1159/000339029; Gonzalez-Mariscal L, 2003, PROG BIOPHYS MOL BIO, V81, P1, DOI 10.1016/S0079-6107(02)00037-8; Goodchild RE, 2005, J CELL BIOL, V168, P855, DOI 10.1083/jcb.200411026; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Heuser A, 2006, AM J HUM GENET, V79, P1081, DOI 10.1086/509044; Jiang D, 2007, P NATL ACAD SCI USA, V104, P18309, DOI 10.1073/pnas.0706573104; Jiang DW, 2005, CIRC RES, V97, P1173, DOI 10.1161/01.RES.0000192146.85173.4b; Kim JC, 2010, PROG BIOPHYS MOL BIO, V103, P59, DOI 10.1016/j.pbiomolbio.2010.02.002; Laird DW, 2005, BBA-BIOMEMBRANES, V1711, P172, DOI 10.1016/j.bbamem.2004.09.009; Lampe PD, 2004, INT J BIOCHEM CELL B, V36, P1171, DOI 10.1016/S1357-2725(03)00264-4; Liang WC, 2011, ANN NEUROL, V69, P1005, DOI 10.1002/ana.22338; Marquez-Rosado L, 2012, BBA-BIOMEMBRANES, V1818, P1985, DOI 10.1016/j.bbamem.2011.07.028; Meinke P, 2011, BIOCHEM SOC T, V39, P1693, DOI 10.1042/BST20110658; Merner ND, 2008, AM J HUM GENET, V82, P809, DOI 10.1016/j.ajhg.2008.01.010; Milting H, 2014, EUR HEART J; Moreno AP, 2007, PROG BIOPHYS MOL BIO, V94, P107, DOI 10.1016/j.pbiomolbio.2007.03.004; MUSIL LS, 1991, J CELL BIOL, V115, P1357, DOI 10.1083/jcb.115.5.1357; MUSIL LS, 1990, J CELL BIOL, V111, P2077, DOI 10.1083/jcb.111.5.2077; Nekrasova OE, 2011, J CELL BIOL, V195, P1185, DOI 10.1083/jcb.201106057; Norgett EE, 2000, HUM MOL GENET, V9, P2761, DOI 10.1093/hmg/9.18.2761; Oxford EM, 2007, CIRC RES, V101, P703, DOI 10.1161/CIRCRESAHA.107.154252; Pilichou K, 2006, CIRCULATION, V113, P1171, DOI 10.1161/CIRCULATIONAHA.105.583674; Pilmer CM, 2013, HEART RHYTHM, V10, P517, DOI 10.1016/j.hrthm.2012.12.003; Pilmer CM, 2013, HEART RHYTHM; Platonov PG, 2011, J ELECTROCARDIOL, V44, P237, DOI 10.1016/j.jelectrocard.2010.08.008; Rajkumar R, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-21; Rhett JM, 2011, MOL BIOL CELL, V22, P1516, DOI 10.1091/mbc.E10-06-0548; Saffitz JE, 2000, AM J PHYSIOL-HEART C, V278, pH1662, DOI 10.1152/ajpheart.2000.278.5.H1662; Saffitz JE, 1999, CARDIOVASC RES, V42, P309, DOI 10.1016/S0008-6363(99)00023-1; Saffitz JE, 2009, HEART RHYTHM, V6, pS62, DOI 10.1016/j.hrthm.2009.03.003; Sato PY, 2009, CIRC RES, V105, P523, DOI 10.1161/CIRCRESAHA.109.201418; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Smyth JW, 2012, CIRC RES, V110, P978, DOI 10.1161/CIRCRESAHA.111.257964; Solan JL, 2005, BBA-BIOMEMBRANES, V1711, P154, DOI 10.1016/j.bbamem.2004.09.013; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Syrris P, 2006, AM J HUM GENET, V79, P978, DOI 10.1086/509122; Tabib A, 2003, CIRCULATION, V108, P3000, DOI 10.1161/01.CIR.0000108396.65446.21; Takemura N, 2008, J CARDIOL, V51, P205, DOI 10.1016/j.jjcc.2008.03.003; Tandri H, 2008, J CARDIOVASC ELECTR, V19, P1212, DOI 10.1111/j.1540-8167.2008.01207.x; Tang YJ, 2012, CIRC RES, V110, P968, DOI 10.1161/CIRCRESAHA.111.256560; THIENE G, 1988, NEW ENGL J MED, V318, P129, DOI 10.1056/NEJM198801213180301; Toyofuku T, 1998, J BIOL CHEM, V273, P12725, DOI 10.1074/jbc.273.21.12725; Toyofuku T, 2001, J BIOL CHEM, V276, P1780, DOI 10.1074/jbc.M005826200; Umapathy K, 2008, HEART RHYTHM, V5, P1029, DOI 10.1016/j.hrthm.2008.03.022; Vanpoucke G, 2004, NUCLEIC ACIDS RES, V32, P4155, DOI 10.1093/nar/gkh727; White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003; Wu JC, 2003, J CELL BIOCHEM, V88, P823, DOI 10.1002/jcb.10390	66	27	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e109128	10.1371/journal.pone.0109128	http://dx.doi.org/10.1371/journal.pone.0109128			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343256	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943500008
J	Sun, DJY; Li, SX; Zhang, XT; Fernandez, C; Chen, W; Srinivasan, SR; Berenson, GS				Sun, Dianjianyi; Li, Shengxu; Zhang, Xiaotao; Fernandez, Camilo; Chen, Wei; Srinivasan, Sathanur R.; Berenson, Gerald S.			Uric Acid Is Associated with Metabolic Syndrome in Children and Adults in a Community: The Bogalusa Heart Study	PLOS ONE			English	Article							BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; SCIENTIFIC STATEMENT; CELL-PROLIFERATION; INSULIN-RESISTANCE; YOUNG ADULTHOOD; SYNDROME-X; RISK; ADOLESCENTS; CHILDHOOD	Background: Elevated serum uric acid (UA) is commonly found in subjects with metabolic syndrome (MetS). This study examined the association of UA with levels of individual MetS components and the degree of their clustering patterns in both children and adults. Methods: The study sample consisted of 2614 children aged 4-18 years and 2447 adults aged 19-54 years. MetS components included body mass index (BMI), mean arterial pressure (MAP), triglycerides to high-density lipoprotein cholesterol ratio (TG/HDLC), and homeostasis model assessment of insulin resistance (HOMA). Observed/expected (O/E) ratio and intra-class correlation coefficient (ICC) were used as a measure of the degree of clustering of categorical and continuous MetS variables, respectively. Results: UA was positively and significantly associated only with BMI in children but with all four components in adults. The odds ratio for MetS associated with 1 mg/dL increase of UA was 1.74 (p<0.001) in children and 1.92 (p<0.001) in adults. O/E ratios showed a significant, increasing trend with increasing UA quartiles in both children and adults for 3- and 4-variable clusters with p-values for trend <0.001, except for BMI-MAP-TG/HDLC and MAP-TG/HDLC-HOMA clusters in children and MAP-TG/HDLC-HOMA cluster in adults. ICCs of 3 and 4 components increased with increasing UA quartiles in children and adults. Conclusions: These results indicate that UA may play a role in the development of MetS in both pediatric and adult populations alike, which may aid in the identification and treatment of high risk individuals for MetS and related clinical disorders in early life.	[Sun, Dianjianyi] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100871, Peoples R China; [Sun, Dianjianyi; Li, Shengxu; Zhang, Xiaotao; Fernandez, Camilo; Chen, Wei; Srinivasan, Sathanur R.; Berenson, Gerald S.] Tulane Univ, Dept Epidemiol, New Orleans, LA 70118 USA	Peking University; Tulane University	Berenson, GS (corresponding author), Tulane Univ, Dept Epidemiol, New Orleans, LA 70118 USA.	berenson@tulane.edu	Zhang, Xiaotao/K-1581-2019	Zhang, Xiaotao/0000-0002-3968-5030; Sun, Dianjianyi/0000-0003-3651-6693	National Institute of Environmental Health Science [5R01ES021724]; National Institute on Aging [2R01AG016592]; American Heart Association [13SDG14650068]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016592] Funding Source: NIH RePORTER	National Institute of Environmental Health Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants 5R01ES021724 from National Institute of Environmental Health Science, 2R01AG016592 from the National Institute on Aging and 13SDG14650068 from American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper AB, 2005, HYPERTENSION, V45, P34, DOI 10.1161/01.HYP.0000150783.79172.bb; Alvarez-Lario B, 2011, QJM-INT J MED, V104, P1015, DOI 10.1093/qjmed/hcr159; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; BAO WH, 1994, ARCH INTERN MED, V154, P1842; Berenson GS., 1980, CARDIOVASCULAR RISK; Borges RL, 2010, CURR HYPERTENS REP, V12, P113, DOI 10.1007/s11906-010-0098-2; Chen W, 2000, DIABETES, V49, P1042, DOI 10.2337/diabetes.49.6.1042; Chen W, 2007, AM J EPIDEMIOL, V166, P527, DOI 10.1093/aje/kwm105; Chen W, 2011, EVOLUTION OF CARDIO-METABOLIC RISK FROM BIRTH TO MIDDLE AGE: THE BOGALUSA HEART STUDY, P35, DOI 10.1007/978-94-007-1451-9_4; Chiou WK, 2010, J EPIDEMIOL, V20, P219, DOI 10.2188/jea.JE20090078; Choi HK, 2007, AM J MED, V120, P442, DOI 10.1016/j.amjmed.2006.06.040; Cohen E, 2012, ISR MED ASSOC J, V14, P676; Corry DB, 2008, J HYPERTENS, V26, P269, DOI 10.1097/HJH.0b013e3282f240bf; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; Dehghan A, 2008, DIABETES CARE, V31, P361, DOI 10.2337/dc07-1276; Ford ES, 2008, J PEDIATR-US, V152, P160, DOI 10.1016/j.jpeds.2007.07.056; Ford ES, 2007, CIRCULATION, V115, P2526, DOI 10.1161/CIRCULATIONAHA.106.657627; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; GINSBERG MH, 1977, J CLIN INVEST, V60, P999, DOI 10.1172/JCI108880; Girillo P, 2006, J AM SOC NEPHROL, V17, pS165, DOI 10.1681/ASN.2006080909; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Ishiro M, 2013, ANN NUTR METAB, V62, P169, DOI 10.1159/000346227; Ishizaka N, 2005, ARTERIOSCL THROM VAS, V25, P1038, DOI 10.1161/01.ATV.0000161274.87407.26; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; Koga M, 2009, ACTA DIABETOL, V46, P141, DOI 10.1007/s00592-008-0072-5; Kuzuya M, 2002, J GERONTOL A-BIOL, V57, pM660, DOI 10.1093/gerona/57.10.M660; LEE J, 1995, AM J EPIDEMIOL, V142, P288, DOI 10.1093/oxfordjournals.aje.a117634; MACLACHLAN MJ, 1967, AM J MED, V42, P38, DOI 10.1016/0002-9343(67)90005-8; Masuo K, 2003, HYPERTENSION, V42, P474, DOI 10.1161/01.HYP.0000091371.53502.D3; Nakagawa T, 2006, AM J PHYSIOL-RENAL, V290, pF625, DOI 10.1152/ajprenal.00140.2005; NICHOLLS A, 1973, BRIT MED J, V1, P449, DOI 10.1136/bmj.1.5851.449; Nieto FJ, 2000, ATHEROSCLEROSIS, V148, P131, DOI 10.1016/S0021-9150(99)00214-2; Osgood K, 2013, METAB SYNDR RELAT D, V11, P157, DOI 10.1089/met.2012.0151; ROSNER B, 2000, FUNDAMENTALS BIOSTAT, P211; Sautin YY, 2007, AM J PHYSIOL-CELL PH, V293, pC584, DOI 10.1152/ajpcell.00600.2006; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Soltani Z, 2013, CURR HYPERTENS REP, V15, P175, DOI 10.1007/s11906-013-0344-5; Steinberger J, 2009, CIRCULATION, V119, P628, DOI 10.1161/CIRCULATIONAHA.108.191394; Sui XM, 2008, METABOLISM, V57, P845, DOI 10.1016/j.metabol.2008.01.030; Sundstrom J, 2005, HYPERTENSION, V45, P28, DOI 10.1161/01.HYP.0000150784.92944.9a; Wang JY, 2012, J PEDIATR-US, V161, P753, DOI 10.1016/j.jpeds.2012.03.036; Wheeler JG, 2005, PLOS MED, V2, P236, DOI 10.1371/journal.pmed.0020076; Yoo TW, 2005, CIRC J, V69, P928, DOI 10.1253/circj.69.928	44	35	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e89696	10.1371/journal.pone.0089696	http://dx.doi.org/10.1371/journal.pone.0089696			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343690	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943500001
J	Tittarelli, E; Mistchenko, AS; Barrero, PR				Tittarelli, Estefania; Mistchenko, Alicia S.; Barrero, Paola R.			Dengue Virus 1 in Buenos Aires from 1999 to 2010: Towards Local Spread	PLOS ONE			English	Article							POPULATION-DYNAMICS; ARGENTINA; INFERENCE; AMERICA; TYPE-3; MODELS; GENOME; BRAZIL	Dengue virus (DENV) is a public health problem representing the most important arthropod-borne viral disease in humans. In Argentina, Northern provinces have reported autochthonous cases since 1997, though these outbreaks have originated in bordering countries, where co-circulation of more than one serotype has been reported. In the last decade, imported dengue cases have been reported in Buenos Aires, the urban area of Argentina with the highest population density. In 2009, a dengue outbreak affected Buenos Aires and, for the first time, local transmission was detected. All cases of this outbreak were caused by DENV-1. In this report, we present the full-length sequences of 27 DENV-1 isolates, corresponding to imported cases of 1999-2000, as well as local and imported cases of the 2009 and 2010 outbreaks. We analyzed their phylogenetic and phylodynamic relationships and their global and local spread. Additionally, we characterized their genomic and phenotypic features. All cases belonged to DENV-1 genotype V. The most recent ancestor for this genotype was dated similar to 1934, whereas that for the 2009 outbreak was dated similar to 2007. The mean rates of nucleotide substitution were 4.98E-4 and 8.53E-4 subs./site/yr, respectively. We inferred an introduction from Paraguay in 1999-2000 and mainly from Venezuela during 2009-2010. Overall, the number of synonymous substitutions per synonymous site significantly exceeded the number of non-synonymous substitutions per site and 12 positively selected sites were detected. These analyses could contribute to a better understanding regarding spread and evolution of this pathogen in the Southern Cone of South America.	[Tittarelli, Estefania; Mistchenko, Alicia S.; Barrero, Paola R.] Hosp Ninos Dr Ricardo Gutierrez, Virol Lab, Buenos Aires, DF, Argentina; [Tittarelli, Estefania; Barrero, Paola R.] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Mistchenko, Alicia S.] Comis Invest Cient Prov Buenos Aires, Buenos Aires, DF, Argentina	Hospital de Ninos Doctor Ricardo Gutierrez; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Comision de Investigaciones Cientificas	Tittarelli, E (corresponding author), Hosp Ninos Dr Ricardo Gutierrez, Virol Lab, Buenos Aires, DF, Argentina.	estefaniatittarelli@conicet.gov.ar			ANPCYT, Ministerio de Ciencia, Tecnologia e Innovacion Productiva de la Nacion, Argentina [PICT2244/10]	ANPCYT, Ministerio de Ciencia, Tecnologia e Innovacion Productiva de la Nacion, Argentina(ANPCyT)	This work was supported by ANPCYT, Ministerio de Ciencia, Tecnologia e Innovacion Productiva de la Nacion, Argentina (grant PICT2244/10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Allicock OM, 2012, MOL BIOL EVOL, V29, P1533, DOI 10.1093/molbev/msr320; Barrero PR, 2004, VIRUS RES, V101, P135, DOI 10.1016/j.virusres.2003.12.033; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Butrapet S, 2000, J VIROL, V74, P3011, DOI 10.1128/JVI.74.7.3011-3019.2000; Chen RB, 2011, VIRUSES-BASEL, V3, P1562, DOI 10.3390/v3091562; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Di Rienzo J.A., INFOSTAT, VVersion 2020; Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770; Ding XX, 2011, CLIN VACCINE IMMUNOL, V18, P430, DOI 10.1128/CVI.00462-10; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Drumond BP, 2012, ARCH VIROL, V157, P2061, DOI 10.1007/s00705-012-1393-9; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; de Araujo JMG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001784; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108; Johansen MB, 2006, GLYCOBIOLOGY, V16, P844, DOI 10.1093/glycob/cwl009; Leparc-Goffart I, 2009, J CLIN VIROL, V45, P61, DOI 10.1016/j.jcv.2009.02.010; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Ludert JE, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-51; Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09; Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Resch W, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-65; Rico-Hesse R, 2003, ADV VIRUS RES, V59, P315, DOI 10.1016/S0065-3527(03)59009-1; Roca Y, 2009, VECTOR-BORNE ZOONOT, V9, P337, DOI 10.1089/vbz.2008.0187; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Barrero PR, 2008, VIRUS RES, V135, P83, DOI 10.1016/j.virusres.2008.02.013; Seijo A, 2001, MEDICINA-BUENOS AIRE, V61, P137; Seijo A, 2009, MEDICINA-BUENOS AIRE, V69, P593; Tcherepanov V, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-150; Villabona-Arenas CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062649; Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003; Zhang CL, 2005, J VIROL, V79, P15123, DOI 10.1128/JVI.79.24.15123-15130.2005	37	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111017	10.1371/journal.pone.0111017	http://dx.doi.org/10.1371/journal.pone.0111017			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343372	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943500075
J	Venugopalan, A; Ghorpade, RP; Chopra, A				Venugopalan, Anuradha; Ghorpade, Ravi P.; Chopra, Arvind			Cytokines in Acute Chikungunya	PLOS ONE			English	Article							VIRUS-INFECTION; INNATE IMMUNITY; EPIDEMIC; CHEMOKINES; DISEASE; PHASE; CELLS	Introduction: Acute chikungunya (CHIKV) is predominantly an acute onset of excruciatingly painful, self-limiting musculoskeletal (MSK) arbovirus illness and this was further reported by us during the 2006 Indian epidemic [Chopra et al. Epidemiol Infect 2012]. Selected serum cytokines profile in subjects within one month of onset of illness is being presented. Methods: Out of 509 clinical CHIKV cases (43% population) identified during a rural population survey, 225 subjects consented blood investigations. 132 examined within 30 days of febrile onset are the study cohort. Anti-CHIKV IgM and IgG antibodies tested by immunochromatography and indirect immunofluorescence respectively. Interferons (IFN)-alpha, -beta and -gamma, Interferon Gamma-Induced Protein-10 (CXCL-10/IP-10), Tumor Necrosis Factor-alpha (TNF-alpha), Interleukin-1 beta (IL-1 beta), Interleukin-6 (IL-6), Interleukin-13 (IL-13), Monocyte Chemoattractant Protein-1 (MCP-1), Interleukin-4 (IL-4) and Interleukin-10 (IL-10) performed by ELISA. Samples collected from neighboring community a year prior to the epidemic used as healthy controls. Results: Seropositivity for anti-CHIKV IgM and IgG was 65% and 52% respectively. IFN-alpha, IFN-beta, IFN-gamma, CXCL10/IP-10 and IL-1 beta showed intense response in early acute phase. Cytokines (particularly TNF-alpha, MCP-1, IL-4, IL-6 and IL-10) was maximum in extended symptomatic phase and remained elevated in recovered subjects. Higher (p<0.05) IFN and IL-4 seen in patients seropositive for anti-CHIKV IgG. Elderly cases (>= 65 years) showed elevated cytokines (except IFN) and anti-CHIKV antibodies near similar to younger subjects. Significant correlations (p<0.05) found between cytokines and clinical features (fatigue, low back ache, myalgia) and anti-CHIKV antibodies. Conclusion: An intense cytokine milieu was evident in the early and immediate persistent symptomatic phase and in recovered subjects. Early persistent IgM and lower IgG to anti-CHKV and intense Th2 cytokine phenotype seem to be associated with delay in resolution of MSK symptoms. Intriguingly, maximum TNF-alpha, IL-6 and IL-13 with low anti-CHIKV IgM response found in subjects recovered from CHIKV within one month of illness.	[Venugopalan, Anuradha; Ghorpade, Ravi P.; Chopra, Arvind] Ctr Rheumat Dis, Pune, Maharashtra, India		Venugopalan, A (corresponding author), Ctr Rheumat Dis, Pune, Maharashtra, India.	venugopalan_anuradha@hotmail.com			Indian Council of Medical Research (Government of India) [5/8/7/20/2006-ECD-I]; Arthritis Research Care Foundation (CRD, Pune)	Indian Council of Medical Research (Government of India)(Indian Council of Medical Research (ICMR)); Arthritis Research Care Foundation (CRD, Pune)	This project was funded by Indian Council of Medical Research (Government of India, 5/8/7/20/2006-ECD-I) and Arthritis Research Care Foundation (CRD, Pune). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliprantis AO, 2007, P NATL ACAD SCI USA, V104, P2827, DOI 10.1073/pnas.0700021104; Barr TA, 2009, J IMMUNOL, V183, P1005, DOI 10.4049/jimmunol.0803706; BRIGHTON SW, 1983, S AFR MED J, V63, P313; Broom AK, 2003, MANSONS TROPICAL DIS, P737; Chaaitanya IK, 2011, VIRAL IMMUNOL, V24, P265, DOI 10.1089/vim.2010.0123; Chopra A, 2012, EPIDEMIOL INFECT, V140, P842, DOI 10.1017/S0950268811001300; Chopra A., 2009, INDIAN J RHEUMATOL, V4, P119, DOI [10.1016/S0973-3698(10)60192-6, DOI 10.1016/S0973-3698(10)60192-6]; Chopra A, 2011, INDIAN J RHEUMATOL, V6, P5; Chopra A, 2008, ARTHRITIS RHEUM, V58, P2921, DOI 10.1002/art.23753; Chopra A, 2014, ARTHRITIS RHEUMATOL, V66, P319, DOI 10.1002/art.38221; Chow A, 2011, J INFECT DIS, V203, P149, DOI 10.1093/infdis/jiq042; Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029; Dupuis-Maguiraga L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001446; El-Gabalawy HS, 2012, ARTHRITIS RHEUM-US, V64, P1720, DOI 10.1002/art.34449; GIFFORD GE, 1963, NATURE, V200, P50, DOI 10.1038/200050a0; Hapuarachchi H. A. C., 2008, CEYLON MEDICAL JOURNAL, V53, P104; Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200; Kalantri SP, 2006, NATL MED J INDIA, V19, P315; Kam YW, 2009, MICROBES INFECT, V11, P1186, DOI 10.1016/j.micinf.2009.09.003; Kelvin AA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001279; Kokkonen H, 2010, ARTHRITIS RHEUM-US, V62, P383, DOI 10.1002/art.27186; Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104; Lakshmi V, 2008, CLIN INFECT DIS, V46, P1436, DOI 10.1086/529444; Leo YS, 2009, EMERG INFECT DIS, V15, P836, DOI 10.3201/eid1505.081390; Lum FM, 2013, J IMMUNOL, V190, P6295, DOI 10.4049/jimmunol.1300304; Morceau F, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/405016; Ng LFP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004261; Noridah O, 2007, Med J Malaysia, V62, P323; Ozden S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000527; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Schilte C, 2010, J EXP MED, V207, P429, DOI 10.1084/jem.20090851; Suhrbier A, 2009, PHARMACOL THERAPEUT, V124, P301, DOI 10.1016/j.pharmthera.2009.09.005; Wauquier N, 2011, J INFECT DIS, V204, P115, DOI 10.1093/infdis/jiq006; Yergolkar PN, 2006, EMERG INFECT DIS, V12, P1580, DOI 10.3201/eid1210.060529; Ziegler SA, 2008, AM J TROP MED HYG, V79, P133, DOI 10.4269/ajtmh.2008.79.133	35	55	57	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111305	10.1371/journal.pone.0111305	http://dx.doi.org/10.1371/journal.pone.0111305			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343623	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943500097
J	Freeman, A; Bridge, JA; Maruthayanar, P; Overgaard, NH; Jung, JW; Simpson, F; Prow, TW; Soyer, HP; Frazer, IH; Freeman, M; Wells, JW				Freeman, Andrew; Bridge, Jennifer A.; Maruthayanar, Pirashanthini; Overgaard, Nana H.; Jung, Ji-Won; Simpson, Fiona; Prow, Tarl W.; Soyer, H. Peter; Frazer, Ian H.; Freeman, Michael; Wells, James W.			Comparative Immune Phenotypic Analysis of Cutaneous Squamous Cell Carcinoma and Intraepidermal Carcinoma in Immune-Competent Individuals: Proportional Representation of CD8(+) T-Cells but Not FoxP3(+) Regulatory T-Cells Is Associated with Disease Stage	PLOS ONE			English	Article							ORGAN TRANSPLANT RECIPIENTS; INVARIANT NKT CELLS; SKIN-CANCER; ACTINIC KERATOSES; MAST-CELLS; PROGRESSION; IMIQUIMOD; TUMORS; EXPRESSION; REGRESSION	Squamous Cell Carcinoma (SCC) is a type of non-melanoma skin cancer prevalent in immune-suppressed transplant recipients and older individuals with a history of chronic sun-exposure. SCC itself is believed to be a late-stage manifestation that can develop from premalignant lesions including Intraepidermal Carcinoma (IEC). Notably, while SCC regression is rare, IEC typically regresses in response to immune modifying topical treatments, however the underlying immunological reasons for these differential responses remain unclear. This study aimed to define whether IEC and SCC are associated with distinct immune profiles. We investigated the immune cell infiltrate of photo-damaged skin, IEC, and SCC tissue using 10-colour flow cytometry following fresh lesion digest. We found that IEC lesions contain higher percentages of CD3(+) T-cells than photo-damaged skin, however, the abundance of CD3(-)CD56(+) Natural Killer (NK) cells, CD11c(+)HLA-DR+ conventional Dendritic Cells (cDC), BDCA-2(+)HLA-DR+ plasmacytoid DC (pDC), FoxP3(+) Regulatory T-cells (T-reg), V alpha 24(+)V beta 11(+) invariant NKT-cells, and gamma delta Tcells did not alter with disease stage. Within the total T-cell population, high percentages of CD4(+) T-cells were associated with SCC, yet CD8(+) T-cells were less abundant in SCC compared with IEC. Our study demonstrates that while IEC lesions contain a higher proportion of T-cells than SCC lesions in general, SCC lesions specifically display a lower abundance of CD8(+) T-cells than IEC. We propose that differences in CD8(+) T-cell abundance contribute critically to the different capacity of SCC and IEC to regress in response to immune modifying topical treatments. Our study also suggests that a high ratio of CD4(+) T-cells to CD8(+) T-cells may be a immunological diagnostic indicator of late-stage SCC development in immune-competent patients.	[Freeman, Andrew; Freeman, Michael] Pindara Private Hosp, Skin Ctr, Gold Coast, Australia; [Freeman, Andrew; Prow, Tarl W.; Soyer, H. Peter; Freeman, Michael] Univ Queensland, Sch Med, Dermatol Res Ctr, Translat Res Inst, Brisbane, Qld, Australia; [Bridge, Jennifer A.; Maruthayanar, Pirashanthini; Overgaard, Nana H.; Jung, Ji-Won; Simpson, Fiona; Frazer, Ian H.; Wells, James W.] Univ Queensland, Translat Res Inst, Univ Queensland Diamantina Inst, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Wells, JW (corresponding author), Univ Queensland, Translat Res Inst, Univ Queensland Diamantina Inst, Brisbane, Qld, Australia.	j.wells3@uq.edu.au	Simpson, Fiona/J-2721-2012; Overgaard, Nana/A-3733-2016; Overgaard, Nana Haahr/P-2923-2019; Wells, James W./C-7480-2011; Simpson, Fiona/ABE-1276-2020; Soyer, H. Peter/W-3791-2017; Prow, Tarl/AAB-8359-2019; Soyer, H. Peter/E-6000-2010; Frazer, Ian/A-1137-2007	Simpson, Fiona/0000-0002-0271-781X; Overgaard, Nana/0000-0001-6916-9566; Overgaard, Nana Haahr/0000-0001-6916-9566; Wells, James W./0000-0002-9618-6940; Simpson, Fiona/0000-0002-0271-781X; Soyer, H. Peter/0000-0002-4770-561X; Prow, Tarl/0000-0003-2892-6238; Soyer, H. Peter/0000-0002-4770-561X; Frazer, Ian/0000-0002-8002-4680	University of Queensland New Staff Research Start-Up Fund; Perpetual Trustees Fellowship; Cancer Council Queensland project grant	University of Queensland New Staff Research Start-Up Fund(University of Queensland); Perpetual Trustees Fellowship; Cancer Council Queensland project grant(Cancer Council Queensland)	This work was supported by The University of Queensland New Staff Research Start-Up Fund (J.W.W), a Perpetual Trustees Fellowship (J.W.W) and a Cancer Council Queensland project grant (J.W.W and I.H.F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkilic-Materna M, 2011, ACTA DERM-VENEREOL, V91, P432, DOI 10.2340/00015555-1099; Anwar J, 2004, CLIN DERMATOL, V22, P189, DOI 10.1016/j.clindermatol.2003.12.006; Beham A, 1998, Adv Anat Pathol, V5, P269, DOI 10.1097/00125480-199809000-00001; Berhane T, 2002, BRIT J DERMATOL, V146, P810, DOI 10.1046/j.1365-2133.2002.04720.x; Bier H, 1998, CANCER IMMUNOL IMMUN, V46, P167, DOI 10.1007/s002620050475; Bluth MJ, 2009, J INVEST DERMATOL, V129, P2451, DOI 10.1038/jid.2009.96; Carroll RP, 2010, J AM SOC NEPHROL, V21, P713, DOI 10.1681/ASN.2009060669; Chu PG, 2001, HISTOPATHOLOGY, V39, P9, DOI 10.1046/j.1365-2559.2001.01105.x; Clark RA, 2008, J EXP MED, V205, P2221, DOI 10.1084/jem.20071190; Clark RA, 2006, J INVEST DERMATOL, V126, P1059, DOI 10.1038/sj.jid.5700199; DODSON JM, 1991, ARCH DERMATOL, V127, P1029, DOI 10.1001/archderm.127.7.1029; Fukunaga A, 2010, J IMMUNOL, V185, P4633, DOI 10.4049/jimmunol.1000246; Parizi ACG, 2010, AN BRAS DERMATOL, V85, P811, DOI 10.1590/S0365-05962010000600006; HALLIDAY GM, 1995, WORLD J SURG, V19, P352, DOI 10.1007/BF00299157; Hanke CW, 2011, J DRUGS DERMATOL, V10, P165; Harnden P, 1997, J CLIN PATHOL, V50, P1032, DOI 10.1136/jcp.50.12.1032; Hope CM, 2014, KIDNEY INT; Hussein MR, 2005, CANCER BIOL THER, V4, P819, DOI 10.4161/cbt.4.8.1864; Jang TJ, 2008, YONSEI MED J, V49, P942, DOI 10.3349/ymj.2008.49.6.942; Junankar SR, 2006, J INVEST DERM SYMP P, V11, P36, DOI 10.1038/sj.jidsymp.5650024; Kirshenbaum AS, 1999, BLOOD, V94, P2333, DOI 10.1182/blood.V94.7.2333.419k30_2333_2342; Kosmidis M, 2010, J IMMUNOTHER, V33, P538, DOI 10.1097/CJI.0b013e3181cc2615; Love WE, 2009, ARCH DERMATOL, V145, P1431, DOI 10.1001/archdermatol.2009.291; MARKS R, 1986, BRIT J DERMATOL, V115, P649, DOI 10.1111/j.1365-2133.1986.tb06644.x; Mattarollo SR, 2011, J IMMUNOL, V187, P1601, DOI 10.4049/jimmunol.1100756; Mattarollo SR, 2010, J IMMUNOL, V184, P1242, DOI 10.4049/jimmunol.0902191; Moodycliffe AM, 2000, NAT IMMUNOL, V1, P521, DOI 10.1038/82782; Muhleisen B, 2009, HISTOPATHOLOGY, V55, P67, DOI 10.1111/j.1365-2559.2009.03324.x; PATEL A, 1995, J DERMATOL SCI, V9, P12, DOI 10.1016/0923-1811(94)00344-E; Peguillet I, 2014, CANCER RES, V74, P2204, DOI 10.1158/0008-5472.CAN-13-2269; Sarchio SNE, 2014, J INVEST DERMATOL, V134, P1091, DOI 10.1038/jid.2013.424; SMOLLE J, 1987, BRIT J DERMATOL, V116, P823, DOI 10.1111/j.1365-2133.1987.tb04901.x; Ulrich C, 2003, BRIT J DERMATOL, V149, P40, DOI 10.1046/j.0366-077X.2003.05633.x; Ulrich C, 2010, EUR J DERMATOL, V20, P482, DOI 10.1684/ejd.2010.1010; Vajdic CM, 2009, INT J CANCER, V125, P1747, DOI 10.1002/ijc.24439; Watarai H, 2008, NAT PROTOC, V3, P70, DOI 10.1038/nprot.2007.515; Zhang SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062154; ZIEGLER A, 1994, NATURE, V372, P773, DOI 10.1038/372773a0	38	30	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110928	10.1371/journal.pone.0110928	http://dx.doi.org/10.1371/journal.pone.0110928			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340823	Green Submitted, Green Published, gold			2022-12-27	WOS:000343662800072
J	Kivuyo, HS; Mbazi, PH; Kisika, DS; Munga, S; Rumisha, SF; Urasa, FM; Kweka, EJ				Kivuyo, Happiness S.; Mbazi, Paschal H.; Kisika, Denis S.; Munga, Stephen; Rumisha, Susan F.; Urasa, Felister M.; Kweka, Eliningaya J.			Performance of Five Food Regimes on Anopheles gambiae Senso Stricto Larval Rearing to Adult Emergence in Insectary	PLOS ONE			English	Article							MALARIA VECTOR MOSQUITOS; WESTERN KENYA; QUADRIMACULATUS DIPTERA; LABORATORY CONDITIONS; HABITAT PRODUCTIVITY; DEVELOPMENT RATES; AEDES-AEGYPTI; MICHIGAN POND; MAIZE POLLEN; CULICIDAE	Background: Rearing of Anopheles gambiae s.s mosquitoes in insectary with quality cheap food sources is of paramount importance for better and healthy colony. This study evaluated larval survival and the development rate of aquatic stages of An. gambiae s.s under five food regimes; tetramin fish food (a standard insectary larval food), maize pollen, Cerelac, green filamentous algae and dry powdered filamentous algae. Methods: Food materials were obtained from different sources, cerelac was made locally, fresh filamentous algae was taken from water bodies, dry filamentous algae was ground to powder after it was dried under shade, and maize pollen was collected from the flowering maize. Each food source type was used to feed three densities of mosquito larvae 20, 60, and 100 in six replicates each. Larval age structure was monitored daily until pupation and subsequently adult emergence. Tetramin was used and taken as a standard food source for An. gambiae s.s. larvae feeding in Insectary. Results: Larval survivorship using maize pollen and Tetramin fish food was statistically insignificant (P = 0.564). However when compared to other food regime survivorship was significantly different with Tetramin fish food performing better than cerelac (P<0.001), dry algae (P<0.001) and fresh algae (P<0.001). The pupation rates and sex ratio of emerging adults had significant differences among the food regimes. Conclusion: The findings of this study have shown that maize pollen had closely similar nutritional value for larval survivorship to tetramin fish food, a standard larvae food in insectary. Further studies are required to assess the effect of food sources on various life traits of the emerged adults.	[Kivuyo, Happiness S.; Mbazi, Paschal H.; Kisika, Denis S.; Urasa, Felister M.] Univ Dar Es Salaam, Coll Nat & Appl Sci, Dept Zool & Wildlife Conservat, Dar Es Salaam, Tanzania; [Munga, Stephen] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Rumisha, Susan F.] Natl Inst Med Res, Dar Es Salaam, Tanzania; [Kweka, Eliningaya J.] Trop Pesticides Res Inst, Div Livestock & Human Dis Vector Control, Mosquito Sect, Arusha, Tanzania; [Kweka, Eliningaya J.] Catholic Univ Hlth & Allied Sci, Dept Med Parasitol & Entomol, Mwanza, Tanzania	University of Dar es Salaam; Kenya Medical Research Institute; National Institute of Medical Research	Kweka, EJ (corresponding author), Trop Pesticides Res Inst, Div Livestock & Human Dis Vector Control, Mosquito Sect, Arusha, Tanzania.	pat.kweka@gmail.com		Kweka, Eliningaya/0000-0002-8891-758X				Araujo MD, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-261; Coetzee M, 2000, PARASITOL TODAY, V16, P74, DOI 10.1016/S0169-4758(99)01563-X; Coetzee M, 2004, AM J TROP MED HYG, V70, P103, DOI 10.4269/ajtmh.2004.70.103; DADD RH, 1978, ANN ENTOMOL SOC AM, V71, P794, DOI 10.1093/aesa/71.5.794; Das S., 2007, J VIS EXP, V221; Fish D., 2008, VECTOR BORNE DIS UND; Frouz J, 2009, AQUAT ECOL, V43, P487, DOI 10.1007/s10452-008-9178-7; Garros C, 2008, MOL ECOL RESOUR, V8, P512, DOI 10.1111/j.1471-8286.2007.02013.x; Gilbreath TM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-353; Gimnig JE, 2002, J MED ENTOMOL, V39, P162, DOI 10.1603/0022-2585-39.1.162; Gouagna LC, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-96; Juliano SA, 2004, OECOLOGIA, V139, P583, DOI 10.1007/s00442-004-1532-4; KARANJA DMS, 1994, ACTA TROP, V56, P365, DOI 10.1016/0001-706X(94)90107-4; Kebede A, 2005, AM J TROP MED HYG, V73, P676, DOI 10.4269/ajtmh.2005.73.676; Kweka EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052084; Kweka EJ, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-33; Kweka EJ, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-110; LYIMO EO, 1992, ENTOMOL EXP APPL, V63, P265, DOI 10.1007/BF00192775; MCCRAE AWR, 1984, ANN TROP MED PARASIT, V78, P307, DOI 10.1080/00034983.1984.11811821; MCCRAE AWR, 1983, ANN TROP MED PARASIT, V77, P615, DOI 10.1080/00034983.1983.11811761; MERRITT RW, 1992, ANNU REV ENTOMOL, V37, P349, DOI 10.1146/annurev.en.37.010192.002025; Moribayashi Atsuko, 2004, Medical Entomology and Zoology, V55, P59; Mutuku FM, 2006, AM J TROP MED HYG, V74, P54, DOI 10.4269/ajtmh.2006.74.54; Ng'habi KR, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-49; Schneider JR, 2004, J MED ENTOMOL, V41, P634, DOI 10.1603/0022-2585-41.4.634; Shawa ST, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-299; Takken W, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-345; Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x; Vrzal EM, 2010, J INSECT PHYSIOL, V56, P1659, DOI 10.1016/j.jinsphys.2010.06.011; Wallace JR, 2004, J MED ENTOMOL, V41, P853, DOI 10.1603/0022-2585-41.5.853; Wallace JR, 1999, ENVIRON ENTOMOL, V28, P233, DOI 10.1093/ee/28.2.233; Yang GJ, 2008, ECOL APPL, V18, P2028, DOI 10.1890/07-1209.1; Ye-Ebiyo Y, 2003, J MED ENTOMOL, V40, P860, DOI 10.1603/0022-2585-40.6.860; Ye-Ebiyo Y, 2003, AM J TROP MED HYG, V68, P748, DOI 10.4269/ajtmh.2003.68.748; Ye-Ebiyo Y, 2000, AM J TROP MED HYG, V63, P90, DOI 10.4269/ajtmh.2000.63.90	35	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110671	10.1371/journal.pone.0110671	http://dx.doi.org/10.1371/journal.pone.0110671			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340408	Green Submitted, Green Published, gold			2022-12-27	WOS:000343662800047
J	Aiba, I; Shuttleworth, CW				Aiba, Isamu; Shuttleworth, C. William			Characterization of Inhibitory GABA-A Receptor Activation during Spreading Depolarization in Brain Slice	PLOS ONE			English	Article							RAT HIPPOCAMPAL SLICES; DEPRESSION-LIKE DEPOLARIZATIONS; INTRINSIC OPTICAL SIGNALS; AMINO-ACIDS; CEREBRAL-CORTEX; ISCHEMIA; NEURONS; PROPOFOL; RELEASE; MIGRAINE	Spreading depolarization (SD) is a slowly propagating wave of near complete depolarizations of neurons and glia. Previous studies have reported large GABA releases during SD, but there is limited understanding of how GABA release and receptor activation are regulated and influence the propagating SD wavefront, as well as an excitatory phase immediately following the passage of SD. The present study characterized GABA-A type receptor (GABA(A)R) currents during SD generated by KCl microinjection in acute hippocampal slices from adult mice. Spontaneous GABA(A)R- mediated currents (sIPSCs) were initially enhanced, and were followed by a large outward current at the wavefront. sIPSC were then transiently supressed during the late SD phase, resulting in a significant reduction of the sIPSC/sEPSC ratio. The large outward current generated during SD was eliminated by the GABA(A)R antagonist gabazine, but the channel potentiator/agonist propofol failed to potentiate the current, likely because of a ceiling effect. Extracellular Cl- decreases recorded during SD were reduced by the antagonist but were not increased by the potentiator. Together with effects of GABA(A)R modulators on SD propagation rate, these results demonstrate a significant inhibitory role of the initial GABA(A)R activation and suggest that intracellular Cl- loading is insufficient to generate excitatory GABA(A)R responses during SD propagation. These results provide a mechanistic explanation for facilitating effects of GABA(A)R antagonists, and the lack of inhibitory effect of GABA(A)R potentiators on SD propagation. In addition, selective suppression of GABA transmission in the late SD period and the lack of effect of GABA(A) modulators on the duration of SD suggests that GABA modulation may not be effective approach to protect neurons during the vulnerable phase of SD.	[Aiba, Isamu; Shuttleworth, C. William] Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA	University of New Mexico	Shuttleworth, CW (corresponding author), Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA.	bshuttleworth@salud.unm.edu			National Institutes of Health [NS051288]; American Heart Association [11PRE4870002]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant #NS051288 (CWS), nih.gov; and American Heart Association Grant #11PRE4870002 (IA), www.heart.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addae JI, 2011, EUR J PHARMACOL, V653, P41, DOI 10.1016/j.ejphar.2010.11.021; Aiba I, 2012, J PHYSIOL-LONDON, V590, P5877, DOI 10.1113/jphysiol.2012.234476; Aiba I, 2012, J NEUROPHYSIOL, V107, P1032, DOI 10.1152/jn.00453.2011; AKAIKE N, 1987, J PHYSIOL-LONDON, V391, P219, DOI 10.1113/jphysiol.1987.sp016735; Allen NJ, 2004, J PHYSIOL-LONDON, V561, P485, DOI 10.1113/jphysiol.2004.070490; BEKKERS JM, 1995, J NEUROPHYSIOL, V73, P1145, DOI 10.1152/jn.1995.73.3.1145; Brager DH, 2003, J NEUROSCI, V23, P10475; Charles AC, 2013, NAT REV NEUROL, V9, P637, DOI 10.1038/nrneurol.2013.192; CHEN QX, 1995, J PHYSIOL-LONDON, V482, P353, DOI 10.1113/jphysiol.1995.sp020522; CLARK RM, 1976, J PHYSIOL-LONDON, V262, P383, DOI 10.1113/jphysiol.1976.sp011600; CONGAR P, 1995, J NEUROPHYSIOL, V73, P421, DOI 10.1152/jn.1995.73.1.421; DAM M, 1990, ANESTHESIOLOGY, V73, P499, DOI 10.1097/00000542-199009000-00021; Dhir A, 2012, NEUROSCI LETT, V514, P67, DOI 10.1016/j.neulet.2012.02.058; Dietz RM, 2008, J NEUROSCI, V28, P8014, DOI 10.1523/JNEUROSCI.0765-08.2008; Dreier JP, 2012, BRAIN, V135, P259, DOI 10.1093/brain/awr303; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Eickhoff M, 2014, EXP NEUROL, V253, P1, DOI 10.1016/j.expneurol.2013.12.008; FABRICIUS M, 1993, BRAIN RES, V612, P61, DOI 10.1016/0006-8993(93)91644-8; Fayuk D, 2002, J NEUROPHYSIOL, V87, P1924, DOI 10.1152/jn.00231.2001; Fordsmann JC, 2013, J NEUROSCI, V33, P2562, DOI 10.1523/JNEUROSCI.2308-12.2013; Galeffi F, 2004, J NEUROSCI, V24, P4478, DOI 10.1523/JNEUROSCI.0755-04.2004; Gniel HM, 2010, J NEUROPHYSIOL, V104, P3203, DOI 10.1152/jn.00922.2009; HANSEN AJ, 1981, ACTA PHYSIOL SCAND, V113, P437, DOI 10.1111/j.1748-1716.1981.tb06920.x; HARA M, 1993, ANESTHESIOLOGY, V79, P781, DOI 10.1097/00000542-199310000-00021; Hertle DN, 2012, BRAIN, V135, P2390, DOI 10.1093/brain/aws152; Houston CM, 2012, J NEUROSCI, V32, P3887, DOI 10.1523/JNEUROSCI.5406-11.2012; HUGUENARD JR, 1986, J NEUROPHYSIOL, V56, P1; INOUE M, 1986, NATURE, V324, P156, DOI 10.1038/324156a0; JANIGRO D, 1987, BRAIN RES, V404, P189, DOI 10.1016/0006-8993(87)91370-9; Kimelberg HK, 2006, GLIA, V54, P747, DOI 10.1002/glia.20423; Kitahara Y, 2001, J NEUROSURG ANESTH, V13, P26, DOI 10.1097/00008506-200101000-00005; Kohling R, 2003, BRAIN RES, V975, P129, DOI 10.1016/S0006-8993(03)02600-3; KOROLEVA VI, 1983, EXP BRAIN RES, V51, P291, DOI 10.1007/BF00237205; Kruger H, 1996, NEUROREPORT, V7, P2733; Krusz JC, 2000, HEADACHE, V40, P224, DOI 10.1046/j.1526-4610.2000.00032.x; Kudo C, 2008, EXP NEUROL, V212, P201, DOI 10.1016/j.expneurol.2008.03.026; Kudo C, 2013, NEUROPHARMACOLOGY, V67, P32, DOI 10.1016/j.neuropharm.2012.10.018; Kunkler PE, 2004, HIPPOCAMPUS, V14, P356, DOI 10.1002/hipo.10181; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Lee HHC, 2011, NAT NEUROSCI, V14, P736, DOI 10.1038/nn.2806; Madl JE, 2000, NEUROSCIENCE, V96, P657, DOI 10.1016/S0306-4522(99)00548-5; Mendez P, 2012, J NEUROSCI, V32, P16616, DOI 10.1523/JNEUROSCI.1720-12.2012; Molchanova S, 2004, NEUROCHEM RES, V29, P1519, DOI 10.1023/B:NERE.0000029564.98905.5c; Muller M, 1999, J NEUROPHYSIOL, V82, P1818, DOI 10.1152/jn.1999.82.4.1818; NICHOLSON C, 1993, J NEUROSCI METH, V48, P199, DOI 10.1016/0165-0270(93)90092-6; Pietrobon D, 2014, NAT REV NEUROSCI, V15, P379, DOI 10.1038/nrn3770; PSARROPOULOU C, 1993, NEUROSCIENCE, V55, P57, DOI 10.1016/0306-4522(93)90454-N; Sheridan David C, 2012, Pediatr Emerg Care, V28, P1293, DOI 10.1097/PEC.0b013e3182768a6b; Shimizu-Sasamata M, 1998, J NEUROSCI, V18, P9564; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; STELZER A, 1994, NEUROSCIENCE, V62, P813, DOI 10.1016/0306-4522(94)90479-0; Vandesteene A, 1988, Anaesthesia, V43 Suppl, P42, DOI 10.1111/j.1365-2044.1988.tb09067.x; Vanlersberghe C., 2008, V182, P227, DOI 10.1007/978-3-540-74806-9_11; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Windmuller O, 2005, BRAIN, V128, P2042, DOI 10.1093/brain/awh545; Zhang ZJ, 2012, J NEUROSCI, V32, P2499, DOI 10.1523/JNEUROSCI.4247-11.2012	56	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110849	10.1371/journal.pone.0110849	http://dx.doi.org/10.1371/journal.pone.0110849			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338191	Green Published, Green Submitted, gold			2022-12-27	WOS:000343674800083
J	Franchin, C; Cesaro, L; Pinna, LA; Arrigoni, G; Salvi, M				Franchin, Cinzia; Cesaro, Luca; Pinna, Lorenzo A.; Arrigoni, Giorgio; Salvi, Mauro			Identification of the PLK2-Dependent Phosphopeptidome by Quantitative Proteomics	PLOS ONE			English	Article							POLO-LIKE KINASES; ALPHA-SYNUCLEIN; CENTRIOLE DUPLICATION; ENRICHMENT ANALYSIS; IN-VIVO; PLK2; PHOSPHORYLATION; SPECIFICITY; FAMILY; MOUSE	Polo-like kinase 2 (PLK2) has been recently recognized as the major enzyme responsible for phosphorylation of alpha-synuclein at S129 in vitro and in vivo, suggesting that this kinase may play a key role in the pathogenesis of Parkinson's disease and other synucleinopathies. Moreover PLK2 seems to be implicated in cell division, oncogenesis, and synaptic regulation of the brain. However little is known about the phosphoproteome generated by PLK2 and, consequently the overall impact of PLK2 on cellular signaling. To fill this gap we exploited an approach based on in vitro kinase assay and quantitative phosphoproteomics. A proteome-derived peptide library obtained by digestion of undifferentiated human neuroblastoma cell line was exhaustively dephosphorylated by lambda phosphatase followed by incubation with or without PLK2 recombinant kinase. Stable isotope labeling based quantitative phosphoproteomics was applied to identify the phosphosites generated by PLK2. A total of 98 unique PLK2-dependent phosphosites from 89 proteins were identified by LC-MS/MS. Analysis of the primary structure of the identified phosphosites allowed the detailed definition of the kinase specificity and the compilation of a list of potential PLK2 targets among those retrieved in PhosphositePlus, a curated database of in cell/vivo phosphorylation sites.	[Franchin, Cinzia; Cesaro, Luca; Pinna, Lorenzo A.; Arrigoni, Giorgio; Salvi, Mauro] Univ Padua, Dept Biomed Sci, Padua, Italy; [Franchin, Cinzia; Arrigoni, Giorgio] Univ Padua, Prote Ctr, Padua, Italy; [Pinna, Lorenzo A.] CNR, Inst Neurosci, Padua, Italy	University of Padua; University of Padua; Consiglio Nazionale delle Ricerche (CNR)	Arrigoni, G (corresponding author), Univ Padua, Dept Biomed Sci, Padua, Italy.	giorgio.arrigoni@unipd.it; mauro.salvi@unipd.it	Franchin, Cinzia/AAM-1196-2021; Arrigoni, Giorgio/A-3535-2014; Franchin, Cinzia/AHE-4689-2022	Franchin, Cinzia/0000-0001-9223-117X; Arrigoni, Giorgio/0000-0002-4103-2733; Franchin, Cinzia/0000-0001-9223-117X; Cesaro, Luca/0000-0002-6707-2282; Pinna, Lorenzo A./0000-0002-8856-4956; Salvi, Mauro/0000-0003-3448-6048	Associazione Italiana per la Ricerca sul Cancro, AIRC [IG10312]	Associazione Italiana per la Ricerca sul Cancro, AIRC(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Associazione Italiana per la Ricerca sul Cancro, AIRC (grant number IG10312) (to LAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Bergeron M, 2014, NEUROSCIENCE, V256, P72, DOI 10.1016/j.neuroscience.2013.09.061; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Burns TF, 2003, MOL CELL BIOL, V23, P5556, DOI 10.1128/MCB.23.16.5556-5571.2003; Cholewa BD, 2013, CANCER RES, V73, P6848, DOI 10.1158/0008-5472.CAN-13-2197; de Carcer G, 2011, CELL CYCLE, V10, P2255, DOI 10.4161/cc.10.14.16494; Fingas CD, 2013, HEPATOLOGY, V58, P1362, DOI 10.1002/hep.26484; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Inglis KJ, 2009, J BIOL CHEM, V284, P2598, DOI 10.1074/jbc.C800206200; Johnson EF, 2007, BIOCHEMISTRY-US, V46, P9551, DOI 10.1021/bi7008745; Kettenbach AN, 2012, CHEM BIOL, V19, P608, DOI 10.1016/j.chembiol.2012.04.011; Krause A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009849; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lee KJ, 2011, NEURON, V69, P957, DOI 10.1016/j.neuron.2011.02.004; Looyenga BD, 2013, P NATL ACAD SCI USA, V110, P16293, DOI 10.1073/pnas.1315622110; Massimino ML, 2004, INT J BIOCHEM CELL B, V36, P2016, DOI 10.1016/j.biocel.2004.03.002; Mbefo MK, 2010, J BIOL CHEM, V285, P2807, DOI 10.1074/jbc.M109.081950; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Oueslati A, 2013, P NATL ACAD SCI USA, V110, pE3945, DOI 10.1073/pnas.1309991110; Salvi M, 2012, BBA-PROTEINS PROTEOM, V1824, P1366, DOI 10.1016/j.bbapap.2012.07.003; Salvi M, 2012, BIOTECHNIQUES, P1; Salvi M, 2012, BIOCHEM BIOPH RES CO, V418, P156, DOI 10.1016/j.bbrc.2011.12.152; Salvi M, 2009, BBA-MOL CELL RES, V1793, P847, DOI 10.1016/j.bbamcr.2009.01.013; Schwarz J, 2014, J BIOL CHEM, V289, P3080, DOI 10.1074/jbc.M113.536847; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Toppo S, 2010, CURR BIOINFORM, V5, P141, DOI 10.2174/157489310791268432; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Valenti F, 2011, CELL CYCLE, V10, P4330, DOI 10.4161/cc.10.24.18682; Venerando A, 2014, BIOCHEM J, V460, P141, DOI 10.1042/BJ20140178; Venerando A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074232; Villegas E, 2014, DEVELOPMENT, V141, P1562, DOI 10.1242/dev.108258; Wang CL, 2013, J PROTEOME RES, V12, P3813, DOI 10.1021/pr4002965; Warnke S, 2004, CURR BIOL, V14, P1200, DOI 10.1016/j.cub.2004.06.059; Zimmerman WC, 2007, CELL CYCLE, V6, P1314, DOI 10.4161/cc.6.11.4275	36	7	9	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e111018	10.1371/journal.pone.0111018	http://dx.doi.org/10.1371/journal.pone.0111018			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338102	gold, Green Published			2022-12-27	WOS:000343674800096
J	Pimiento, C; Clements, CF				Pimiento, Catalina; Clements, Christopher F.			When Did Carcharocles megalodon Become Extinct? A New Analysis of the Fossil Record	PLOS ONE			English	Article							CONFIDENCE-INTERVALS; SIGHTING RECORD; SHARKS; MYSTICETI; ACCURACY; CETACEA; RANGES; WHALE; RAYS	Carcharocles megalodon ("Megalodon") is the largest shark that ever lived. Based on its distribution, dental morphology, and associated fauna, it has been suggested that this species was a cosmopolitan apex predator that fed on marine mammals from the middle Miocene to the Pliocene (15.9-2.6 Ma). Prevailing theory suggests that the extinction of apex predators affects ecosystem dynamics. Accordingly, knowing the time of extinction of C. megalodon is a fundamental step towards understanding the effects of such an event in ancient communities. However, the time of extinction of this important species has never been quantitatively assessed. Here, we synthesize the most recent records of C. megalodon from the literature and scientific collections and infer the date of its extinction by making a novel use of the Optimal Linear Estimation (OLE) model. Our results suggest that C. megalodon went extinct around 2.6 Ma. Furthermore, when contrasting our results with known ecological and macroevolutionary trends in marine mammals, it became evident that the modern composition and function of modern gigantic filter-feeding whales was established after the extinction of C. megalodon. Consequently, the study of the time of extinction of C. megalodon provides the basis to improve our understanding of the responses of marine species to the removal of apex predators, presenting a deep-time perspective for the conservation of modern ecosystems.	[Pimiento, Catalina] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Pimiento, Catalina] Univ Florida, Dept Biol, Gainesville, FL USA; [Pimiento, Catalina] Smithsonian Trop Res Inst, Balboa, Panama; [Clements, Christopher F.] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Zurich	Pimiento, C (corresponding author), Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA.	pimientoc@ufl.edu	Pimiento, Catalina/ABF-1204-2020	Pimiento, Catalina/0000-0002-5320-7246; Clements, Christopher/0000-0001-5677-5401	National Science Foundation NSF [EAR 0418042, PIRE 0966884]; Office Of The Director [0966884] Funding Source: National Science Foundation	National Science Foundation NSF(National Science Foundation (NSF)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This project was funded by the National Science Foundation NSF EAR 0418042, PIRE 0966884 (http://www.nsf.gov/funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Applegate SP, 1996, GREAT WHITE SHARKS, P19, DOI 10.1016/B978-012415031-7/50005-7; Boessenecker RW, 2013, NATURWISSENSCHAFTEN, V100, P365, DOI 10.1007/s00114-013-1037-2; Bouetel V, 2005, J MAMMAL, V86, P139, DOI 10.1644/1545-1542(2005)086<0139:PIOSSA>2.0.CO;2; CAPPETTA H, 2012, HDB PALEOICHTHYOLO E, V3; Clements CF, 2014, CONSERV BIOL, V28, P971, DOI 10.1111/cobi.12329; Clements CF, 2013, J ANIM ECOL, V82, P345, DOI 10.1111/1365-2656.12005; Collen B, 2010, DIVERS DISTRIB, V16, P755, DOI 10.1111/j.1472-4642.2010.00689.x; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; El Adli JJ, 2014, ZOOL J LINN SOC-LOND, V170, P400, DOI 10.1111/zoj.12108; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Gottfried MD, 1996, GREAT WHITE SHARKS, P55, DOI 10.1016/B978-012415031-7/50008-2; Lambert O, 2010, NATURE, V466, P105, DOI 10.1038/nature09067; Marshall CR, 1997, PALEOBIOLOGY, V23, P165, DOI 10.1017/S0094837300016766; Marx FG, 2010, SCIENCE, V327, P993, DOI 10.1126/science.1185581; Micheli F, 1999, SCIENCE, V285, P1396, DOI 10.1126/science.285.5432.1396; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Pimiento C, 2013, J PALEONTOL, V87, P755, DOI 10.1666/12-117; Pimiento C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010552; Purdy RW, 1996, GREAT WHITE SHARKS, P67, DOI 10.1016/B978-012415031-7/50009-4; Purdy RW, 2001, SM C PALEOB, V90, P71; Pyenson ND, 2011, J MAMM EVOL, V18, P269, DOI 10.1007/s10914-011-9170-1; R Development Core Team, 2012, R LANG ENV STAT COMP; Rivadeneira MM, 2009, ECOLOGY, V90, P1291, DOI 10.1890/08-0316.1; Roberts DL, 2003, NATURE, V426, P245, DOI 10.1038/426245a; ROBSON DS, 1964, BIOMETRIKA, V51, P33, DOI 10.2307/2334193; Solow AR, 2006, P NATL ACAD SCI USA, V103, P7351, DOI 10.1073/pnas.0509480103; Solow AR, 2005, MATH BIOSCI, V195, P47, DOI 10.1016/j.mbs.2005.02.001; Steadman DW, 2005, P NATL ACAD SCI USA, V102, P11763, DOI 10.1073/pnas.0502777102; STRAUSS D, 1989, MATH GEOL, V21, P411, DOI 10.1007/BF00897326; Terborgh J., 2010, TROPHIC CASCADES PRE; Turney CSM, 2008, P NATL ACAD SCI USA, V105, P12150, DOI 10.1073/pnas.0801360105	32	43	45	3	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e111086	10.1371/journal.pone.0111086	http://dx.doi.org/10.1371/journal.pone.0111086			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338197	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000343674800104
J	Pletzer, D; Lafon, C; Braun, Y; Kohler, T; Page, MGP; Mourez, M; Weingart, H				Pletzer, Daniel; Lafon, Corinne; Braun, Yvonne; Koehler, Thilo; Page, Malcolm G. P.; Mourez, Michael; Weingart, Helge			High-Throughput Screening of Dipeptide Utilization Mediated by the ABC Transporter DppBCDF and Its Substrate-Binding Proteins DppA1-A5 in Pseudomonas aeruginosa	PLOS ONE			English	Article							ESCHERICHIA-COLI; OLIGOPEPTIDE PERMEASE; PEPTIDE-TRANSPORT; ANTIBIOTIC-RESISTANCE; BORRELIA-BURGDORFERI; EXPRESSION ANALYSIS; SALMONELLA-TYPHIMURIUM; 5-AMINOLEVULINIC ACID; GENE; SYSTEM	In this study, we show that the dppBCDF operon of Pseudomonas aeruginosa PA14 encodes an ABC transporter responsible for the utilization of di/tripeptides. The substrate specificity of ABC transporters is determined by its associated substrate-binding proteins (SBPs). Whereas in E. coli only one protein, DppA, determines the specificity of the transporter, five orthologous SBPs, DppA1-A5 are present in P. aeruginosa. Multiple SBPs might broaden the substrate specificity by increasing the transporter capacity. We utilized the Biolog phenotype MicroArray technology to investigate utilization of di/tripeptides in mutants lacking either the transport machinery or all of the five SBPs. This high-throughput method enabled us to screen hundreds of dipeptides with various side-chains, and subsequently, to determine the substrate profile of the dipeptide permease. The substrate spectrum of the SBPs was elucidated by complementation of a penta mutant, deficient of all five SBPs, with plasmids carrying individual SBPs. It became apparent that some dipeptides were utilized with different affinity for each SBP. We found that DppA2 shows the highest flexibility on substrate recognition and that DppA2 and DppA4 have a higher tendency to utilize tripeptides. DppA5 was not able to complement the penta mutant under our screening conditions. Phaseolotoxin, a toxic tripeptide inhibiting the enzyme ornithine carbamoyltransferase, is also transported into P. aeruginosa via the DppBCDF permease. The SBP DppA1, and with much greater extend DppA3, are responsible for delivering the toxin to the permease. Our results provide a first overview of the substrate pattern of the ABC dipeptide transport machinery in P. aeruginosa.	[Pletzer, Daniel; Braun, Yvonne; Weingart, Helge] Jacobs Univ Bremen, Sch Sci & Engn, D-28759 Bremen, Germany; [Lafon, Corinne; Mourez, Michael] Sanofi Aventis R&D, Infect Dis Therapeut Unit, Toulouse, France; [Koehler, Thilo] Univ Hosp Geneva, Dept Microbiol & Mol Med, Geneva, Switzerland; [Koehler, Thilo] Univ Hosp Geneva, Infect Dis Serv, Geneva, Switzerland; [Page, Malcolm G. P.] Basilea Pharmaceut Int Ltd, Basel, Switzerland	Jacobs University; Sanofi-Aventis; Sanofi France; University of Geneva; University of Geneva; Basilea Pharmaceutica Ltd.	Weingart, H (corresponding author), Jacobs Univ Bremen, Sch Sci & Engn, D-28759 Bremen, Germany.	h.weingart@jacobs-university.de	Köhler, Thilo/AAN-9498-2021; Pletzer, Daniel/G-5737-2013	Pletzer, Daniel/0000-0001-5750-7505	Innovative Medicines Joint Undertaking [115525]; European Union's seventh framework program (FP7); EFPIA	Innovative Medicines Joint Undertaking; European Union's seventh framework program (FP7); EFPIA	The research leading to these results was conducted as part of the Translocation consortium (www.imi.europa.eu/content/translocation) and has received support from the Innovative Medicines Joint Undertaking under Grant Agreement No. 115525, resources which are composed of financial contribution from the European Union's seventh framework program (FP7/2007-2013) and EFPIA companies in kind contribution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUHAMAD WN, 1994, MOL MICROBIOL, V14, P1077, DOI 10.1111/j.1365-2958.1994.tb01340.x; ABOUHAMAD WN, 1991, MOL MICROBIOL, V5, P1035, DOI 10.1111/j.1365-2958.1991.tb01876.x; Arndt H, 1989, ARCH PHYTOPATHOL, P247; Bardoel BW, 2012, J MOL BIOL, V415, P573, DOI 10.1016/j.jmb.2011.11.039; Bender CL, 1999, MICROBIOL MOL BIOL R, V63, P266, DOI 10.1128/MMBR.63.2.266-292.1999; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; BODEY GP, 1983, REV INFECT DIS, V5, P279; Bono JL, 1998, MICROBIOL-UK, V144, P1033, DOI 10.1099/00221287-144-4-1033; Bonomo RA, 2006, CLIN INFECT DIS, V43, pS49, DOI 10.1086/504477; Breidenstein EBM, 2012, ANTIMICROB AGENTS CH, V56, P2879, DOI 10.1128/AAC.06014-11; Cahan R, 2001, J BIOL CHEM, V276, P43645, DOI 10.1074/jbc.M106950200; Cai HJ, 2007, EUKARYOT CELL, V6, P1805, DOI 10.1128/EC.00257-06; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; de Jong A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-299; Doeven MK, 2008, BIOPHYS J, V94, P3956, DOI 10.1529/biophysj.107.120964; DUNTEN P, 1995, PROTEIN SCI, V4, P2327, DOI 10.1002/pro.5560041110; ELLIOTT T, 1993, J BACTERIOL, V175, P325, DOI 10.1128/JB.175.2.325-331.1993; Engel LS, 1998, J BIOL CHEM, V273, P16792, DOI 10.1074/jbc.273.27.16792; Fuerst John A, 2010, Commun Integr Biol, V3, P572, DOI 10.4161/cib.3.6.13061; Gonnet GH, 2000, BIOINFORMATICS, V16, P101, DOI 10.1093/bioinformatics/16.2.101; GUYER CA, 1986, J BACTERIOL, V168, P775, DOI 10.1128/jb.168.2.775-779.1986; Hancock REW, 2000, DRUG RESIST UPDATE, V3, P247, DOI 10.1054/drup.2000.0152; He JX, 2004, P NATL ACAD SCI USA, V101, P2530, DOI 10.1073/pnas.0304622101; Higgins CF, 2001, RES MICROBIOL, V152, P205, DOI 10.1016/S0923-2508(01)01193-7; HILES ID, 1987, J MOL BIOL, V195, P125, DOI 10.1016/0022-2836(87)90332-9; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Homann OR, 2005, PLOS GENET, V1, P715, DOI 10.1371/journal.pgen.0010080; HULEN C, 1988, FEMS MICROBIOL LETT, V49, P167, DOI 10.1016/0378-1097(88)90453-3; KELLYWINTENBERG K, 1994, APPL ENVIRON MICROB, V60, P363, DOI 10.1128/AEM.60.1.363-367.1994; KESSLER E, 1993, J BIOL CHEM, V268, P7503; Kiely PD, 2008, MICROBIOL-SGM, V154, P2209, DOI 10.1099/mic.0.2007/015032-0; Kohler T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087814; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lamarque M, 2011, MICROBIOL-SGM, V157, P1612, DOI 10.1099/mic.0.048173-0; Letoffe S, 2008, J BACTERIOL, V190, P1866, DOI 10.1128/JB.01636-07; Letoffe S, 2006, P NATL ACAD SCI USA, V103, P12891, DOI 10.1073/pnas.0605440103; Lin B, 2001, BBA-MOL CELL RES, V1499, P222, DOI 10.1016/S0167-4889(00)00121-X; Lister PD, 2009, CLIN MICROBIOL REV, V22, P582, DOI 10.1128/CMR.00040-09; Luckett JCA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002854; MANSON MD, 1986, NATURE, V321, P253, DOI 10.1038/321253a0; Marquart ME, 2005, INVEST OPHTH VIS SCI, V46, P3761, DOI 10.1167/iovs.04-1483; MATTHEWS DM, 1980, CURR TOP MEMBR TRANS, V14, P331; Medrano MS, 2007, J BACTERIOL, V189, P2653, DOI 10.1128/JB.01760-06; Microsoft, 2007, MICR ACC 2007; MILLER RV, 1978, J BACTERIOL, V133, P165, DOI 10.1128/JB.133.1.165-171.1978; Mistry A, 2013, ANTIMICROB AGENTS CH, V57, P5565, DOI 10.1128/AAC.01198-13; MORIHARA K, 1995, METHOD ENZYMOL, V248, P242; Nickitenko AV, 1995, BIOCHEMISTRY-US, V34, P16585, DOI 10.1021/bi00051a006; Ochsner UA, 2002, MOL MICROBIOL, V45, P1277, DOI 10.1046/j.1365-2958.2002.03084.x; PAYNE JW, 1994, ADV MICROB PHYSIOL, V36, P1, DOI 10.1016/S0065-2911(08)60176-9; Peltoniemi K, 2002, ARCH MICROBIOL, V177, P457, DOI 10.1007/s00203-002-0411-9; PERRY D, 1984, J BACTERIOL, V160, P943, DOI 10.1128/JB.160.3.943-948.1984; Ringrose PS, 1980, MICROORGANISMS NITRO, P641; Rubio-Aliaga I, 2008, XENOBIOTICA, V38, P1022, DOI [10.1080/00498250701875254, 10.1080/00498250701875254 ]; Saier MH, 2014, NUCLEIC ACIDS RES, V42, pD251, DOI 10.1093/nar/gkt1097; Salunkhe P, 2005, J BACTERIOL, V187, P4908, DOI 10.1128/JB.187.14.4908-4920.2005; Schenk A, 2008, MOL PLANT PATHOL, V9, P227, DOI 10.1111/J.1364-3703.2007.00452.X; SCHWEIZER HP, 1995, GENE, V158, P15, DOI 10.1016/0378-1119(95)00055-B; SHUMAN HA, 1982, ANN INST PASTEUR MIC, VA133, P153; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SMITH MW, 1990, FEMS MICROBIOL LETT, V70, P311, DOI 10.1016/S0378-1097(05)80014-X; Smith MW, 1999, MICROBIOL-SGM, V145, P2891, DOI 10.1099/00221287-145-10-2891; Stacey G, 2002, TRENDS PLANT SCI, V7, P257, DOI 10.1016/S1360-1385(02)02249-5; STASKAWICZ BJ, 1980, J BACTERIOL, V142, P474, DOI 10.1128/JB.142.2.474-479.1980; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Tamber S, 2006, J BACTERIOL, V188, P45, DOI 10.1128/JB.188.1.45-54.2006; Thoma S, 2009, FEMS MICROBIOL LETT, V294, P127, DOI 10.1111/j.1574-6968.2009.01556.x; Torchilin Vladimir, 2008, Drug Discov Today Technol, V5, pe95, DOI 10.1016/j.ddtec.2009.01.002; van der Heide T, 2002, EMBO REP, V3, P938, DOI 10.1093/embo-reports/kvf201; VERKAMP E, 1993, J BACTERIOL, V175, P1452, DOI 10.1128/JB.175.5.1452-1456.1993; Wang XG, 2004, J BACTERIOL, V186, P51, DOI 10.1128/JB.186.1.51-60.2004; Wang XG, 2002, J BACTERIOL, V184, P6198, DOI 10.1128/JB.184.22.6198-6206.2002; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weinberg MV, 2007, J BACTERIOL, V189, P3392, DOI 10.1128/JB.01636-06; Wensing A, 2010, APPL ENVIRON MICROB, V76, P2704, DOI 10.1128/AEM.02979-09; Wilderman PJ, 2001, INFECT IMMUN, V69, P5385, DOI 10.1128/IAI.69.9.5385-5394.2001; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Wu TK, 2007, J BACTERIOL, V189, P8215, DOI 10.1128/JB.01039-07; Wurtzel O, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002945; Zumaquero A, 2010, J BACTERIOL, V192, P4474, DOI 10.1128/JB.00260-10	84	34	44	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e111311	10.1371/journal.pone.0111311	http://dx.doi.org/10.1371/journal.pone.0111311			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338022	Green Published, Green Submitted, gold			2022-12-27	WOS:000343674800116
J	Saxena, N; Kumar, V				Saxena, Nehul; Kumar, Vijay			The HBx Oncoprotein of Hepatitis B Virus Deregulates the Cell Cycle by Promoting the Intracellular Accumulation and Re-Compartmentalization of the Cellular Deubiquitinase USP37	PLOS ONE			English	Article							TRCP UBIQUITIN LIGASE; X-PROTEIN; BETA-CATENIN; DEPENDENT PROTEOLYSIS; DEGRADATION; EXPRESSION; TRANSACTIVATION; DESTRUCTION; CHECKPOINT; COMPLEX	The HBx oncoprotein of hepatitis B Virus has been accredited as one of the protagonists in driving hepatocarcinogenesis. HBx exerts its influence over the cell cycle progression by potentiating the activity of cyclin A/E CDK2 complex, the Cyclin A partner of which is a well-known target of cellular deubiquitinase USP37. In the present study, we observed the intracellular accumulation of cyclin A and USP37 proteins under the HBx microenvironment. Flow cytometry analysis of the HBx-expressing cells showed deregulation of cell cycle apparently due to the enhanced gene expression and stabilization of USP37 protein and deubiquitination of Cyclin A by USP37. Our co-immunoprecipitation and confocal microscopic studies suggested a direct interaction between USP37 and HBx. This interaction promoted the translocation of USP37 outside the nucleus and prevented its association and ubiquitination by E3 ubiquitin ligases - APC/CDH1 and SCF/beta-TrCP. Thus, HBx seems to control the cell cycle progression via the cyclin A-CDK2 complex by regulating the intracellular distribution and stability of deubiquitinase USP37.	[Saxena, Nehul; Kumar, Vijay] Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Kumar, V (corresponding author), Int Ctr Genet Engn & Biotechnol, Virol Grp, Aruna Asaf Ali Marg, New Delhi, India.	vijay@icgeb.res.in			Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India [BT/PR12658/BRB/10/712/2009]	Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	This work was supported by grant no. BT/PR12658/BRB/10/712/2009 of the Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India (to VK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja R, 2014, CURR SCI IN PRESS; BENN J, 1995, P NATL ACAD SCI USA, V92, P11215, DOI 10.1073/pnas.92.24.11215; Bianchi F, 2007, J CLIN INVEST, V117, P3436, DOI 10.1172/JCI32007; Burrows AC, 2012, J BIOL CHEM, V287, P39021, DOI 10.1074/jbc.M112.390328; Chae S, 2013, CARCINOGENESIS, V34, P1680, DOI 10.1093/carcin/bgt105; Da Silva-Ferrada E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025397; Das CM, 2013, ONCOGENE, V32, P1691, DOI 10.1038/onc.2012.182; Daubeuf S, 2009, BLOOD, V113, P3264, DOI 10.1182/blood-2008-07-168203; Davis M, 2002, GENE DEV, V16, P439, DOI 10.1101/gad.218702; Forgues M, 2001, J BIOL CHEM, V276, P22797, DOI 10.1074/jbc.M101259200; Fukushima H, 2013, CELL REP, V4, P803, DOI 10.1016/j.celrep.2013.07.031; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hsieh JK, 1997, GENE DEV, V11, P1840, DOI 10.1101/gad.11.14.1840; Huang XD, 2011, MOL CELL, V42, P511, DOI 10.1016/j.molcel.2011.03.027; Hung L, 2004, FEBS LETT, V560, P210, DOI 10.1016/S0014-5793(04)00113-9; Jacobs HW, 2001, EMBO J, V20, P2376, DOI 10.1093/emboj/20.10.2376; Jung JK, 2007, J GEN VIROL, V88, P2144, DOI 10.1099/vir.0.82836-0; Kapoor NR, 2012, P NATL A SCI INDIA B, V82, P31, DOI 10.1007/s40011-011-0003-z; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kumar V, 1996, P NATL ACAD SCI USA, V93, P5647, DOI 10.1073/pnas.93.11.5647; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; Lin RK, 2010, J CLIN INVEST, V120, P521, DOI 10.1172/JCI40706; Machida YJ, 2007, GENE DEV, V21, P184, DOI 10.1101/gad.1495007; Margottin-Goguet F, 2003, DEV CELL, V4, P813, DOI 10.1016/S1534-5807(03)00153-9; Mukherji A, 2007, BIOCHEM J, V401, P247, DOI 10.1042/BJ20061091; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; Pandey V, 2012, J BIOL CHEM, V287, P20545, DOI 10.1074/jbc.M112.359760; Saxena N, 2013, VIROL DISCOV, V1, P5, DOI DOI 10.7243/2052-6202-1-5; Schippers IJ, 1997, CELL BIOL TOXICOL, V13, P375, DOI 10.1023/A:1007404028681; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schnell JD, 2003, J BIOL CHEM, V278, P35857, DOI 10.1074/jbc.R300018200; Sidhu K, 2014, MASS SPECTR IN PRESS; Studach L, 2010, J BIOL CHEM, V285, P30282, DOI 10.1074/jbc.M109.093963; Tanno H, 2014, J BIOL CHEM, V289, P2415, DOI 10.1074/jbc.M113.528372; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; von Mikecz A, 2006, J CELL SCI, V119, P1977, DOI 10.1242/jcs.03008; Weissman AM, 2011, NAT REV MOL CELL BIO, V12, P605, DOI 10.1038/nrm3173; Yang WC, 2013, ONCOGENE, V32, P5167, DOI 10.1038/onc.2012.537; Zhang M, 2010, J BIOL CHEM, V285, P8703, DOI 10.1074/jbc.M109.093526; Zhao YH, 2013, HUM PATHOL, V44, P365, DOI 10.1016/j.humpath.2012.03.030; Zhou Y, 2003, BIOCHEM J, V374, P349, DOI 10.1042/BJ20030600	43	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111256	10.1371/journal.pone.0111256	http://dx.doi.org/10.1371/journal.pone.0111256			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347529	Green Published, Green Submitted, gold			2022-12-27	WOS:000347994900057
J	Ammar, ED; Richardson, ML; Abdo, Z; Hall, DG; Shatters, RG				Ammar, El-Desouky; Richardson, Matthew L.; Abdo, Zaid; Hall, David G.; Shatters, Robert G., Jr.			Differences in Stylet Sheath Occurrence and the Fibrous Ring (Sclerenchyma) between xCitroncirus Plants Relatively Resistant or Susceptible to Adults of the Asian Citrus Psyllid Diaphorina citri (Hemiptera: Liviidae)	PLOS ONE			English	Article							FEEDING-BEHAVIOR; DISEASE; APHIDIDAE	The Asian citrus psyllid (ACP, Diaphorina citri, Hemiptera: Liviidae), is the principal vector of the phloem-limited bacteria strongly associated with huanglongbing (HLB), the world's most serious disease of citrus. Host plant resistance may provide an environmentally safe and sustainable method of controlling ACP and/or HLB. Two xCitroncirus accessions (hybrids of Poncirus trifoliata and Citrus spp.), that are relatively resistant (UN-3881) or relatively susceptible (Troyer-1459) to ACP adults with regard to adult longevity, were compared in relation to ACP feeding behavior and some structural features of the leaf midrib. The settling (putative feeding/probing) sites of ACP adults on various parts of the leaf were not influenced primarily by plant accession. However, fewer ACP stylet sheaths were found in the midrib and fewer stylet sheath termini reached the vascular bundle (phloem and/or xylem) in UN-3881 compared to Troyer-1459 plants. Furthermore, in midribs of UN-3881 leaves the fibrous ring (sclerenchyma) around the phloem was significantly wider (thicker) compared to that in midribs of Troyer-1459 leaves. Our data indicate that feeding and/or probing by ACP adults into the vascular bundle is less frequent in the more resistant (UN-3881) than in the more susceptible (Troyer-1459) accessions. Our results also suggest that the thickness of the fibrous ring may be a barrier to stylet penetration into the vascular bundle, which is important for successful ACP feeding on the phloem and for transmitting HLB-associated bacteria. These results may help in the development of citrus plants resistant to ACP, which in turn could halt or slow the spread of the HLB-associated bacteria by this vector.	[Ammar, El-Desouky; Richardson, Matthew L.; Hall, David G.; Shatters, Robert G., Jr.] USDA ARS, Hort Res Lab, Ft Pierce, FL 34945 USA; [Abdo, Zaid] USDA ARS, South Atlantic Area, Athens, GA USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Ammar, ED (corresponding author), USDA ARS, Hort Res Lab, Ft Pierce, FL 34945 USA.	desoukyammar@gmail.com	Abdo, Zaid/E-5176-2017	Abdo, Zaid/0000-0002-8272-7734; Shatters, Robert/0000-0002-3903-772X	USDA-ARS	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This study was funded by USDA-ARS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammar ED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059914; Ammar ED, 2012, ANN ENTOMOL SOC AM, V105, P731, DOI 10.1603/AN12056; Bonani JP, 2010, ENTOMOL EXP APPL, V134, P35, DOI 10.1111/j.1570-7458.2009.00937.x; Bove JM, 2006, J PLANT PATHOL, V88, P7; Cen YJ, 2012, ENTOMOL EXP APPL, V143, P13, DOI 10.1111/j.1570-7458.2012.01222.x; Chandran P, 2013, J ECON ENTOMOL, V106, P2234, DOI 10.1603/EC13126; Civolani S, 2013, J APPL ENTOMOL, V137, P365, DOI 10.1111/jen.12003; Crompton DS, 2010, J ECON ENTOMOL, V103, P648, DOI 10.1603/EC09370; Folimonova SY, 2010, PHYTOPATHOLOGY, V100, P949, DOI 10.1094/PHYTO-100-9-0949; Folimonova SY, 2009, PHYTOPATHOLOGY, V99, P1346, DOI 10.1094/PHYTO-99-12-1346; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Hall DG, 2007, J ECON ENTOMOL, V100, P847, DOI 10.1603/0022-0493(2007)100[847:EOAPFO]2.0.CO;2; Hall DG, 2013, HORTSCIENCE, V48, P330, DOI 10.21273/HORTSCI.48.3.330; Hall DG, 2013, ENTOMOL EXP APPL, V146, P207, DOI 10.1111/eea.12025; Hewer A, 2011, J EXP BIOL, V214, P3868, DOI 10.1242/jeb.060913; Lei H, 1999, ENTOMOL EXP APPL, V92, P299, DOI 10.1023/A:1003806417443; MESFIN T, 1995, B ENTOMOL RES, V85, P387, DOI 10.1017/S0007485300036129; Morgan JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062444; R Core Team, 2021, R LANGUAGE ENV STAT; Rangasamy M, 2009, J ECON ENTOMOL, V102, P432, DOI 10.1603/029.102.0156; Richardson M. L., 2013, Crop Science, V53, P183, DOI 10.2135/cropsci2012.02.0091; Richardson ML, 2011, HORTSCIENCE, V46, P1260, DOI 10.21273/HORTSCI.46.9.1260; Richter S, 2011, PLANTA, V233, P763, DOI 10.1007/s00425-010-1338-z; Ripley B. D, 2002, MODERN APPL STAT S, P4, DOI DOI 10.1007/978-0-387-21706-2; Schliephake E, 2013, ENTOMOL EXP APPL, V146, P347, DOI 10.1111/eea.12033; Smith CM, 2012, ANNU REV ENTOMOL, V57, P309, DOI 10.1146/annurev-ento-120710-100642; Stover E, 2010, PROC FL STATE HORTIC, V123, P115; Westbrook CJ, 2011, HORTSCIENCE, V46, P997, DOI 10.21273/HORTSCI.46.7.997; Will T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046903	31	18	18	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110919	10.1371/journal.pone.0110919	http://dx.doi.org/10.1371/journal.pone.0110919			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343712	Green Submitted, gold, Green Published			2022-12-27	WOS:000343943500067
J	Tomassini, A; Solomon, JA; Morgan, MJ				Tomassini, Alessandro; Solomon, Joshua Adam; Morgan, Michael John			Which Way Is Down? Positional Distortion in the Tilt Illusion	PLOS ONE			English	Article							INDUCED EYE TORSION; VISUAL-CORTEX; HEAD TILT; ORIENTATION; PERCEPTION; ADAPTATION; BODY; CONTRAST; NEURONS; FRAME	Contextual information can have a huge impact on our sensory experience. The tilt illusion is a classic example of contextual influence exerted by an oriented surround on a target's perceived orientation. Traditionally, the tilt illusion has been described as the outcome of inhibition between cortical neurons with adjacent receptive fields and a similar preference for orientation. An alternative explanation is that tilted contexts could produce a re-calibration of the subjective frame of reference. Although the distinction is subtle, only the latter model makes clear predictions for unoriented stimuli. In the present study, we tested one such prediction by asking four naive subjects to estimate three positions (4, 6, and 8 o'clock) on an imaginary clock face within a tilted surround. To indicate their estimates, they used either an unoriented dot or a line segment, with one endpoint at fixation in the middle of the surround. The surround's tilt was randomly chosen from a set of orientations (+/- 75 degrees, +/- 65 degrees, +/- 55 degrees, +/- 45 degrees, +/- 35 degrees, +/- 25 degrees, +/- 15 degrees, +/- 5 degrees with respect to vertical) across trials. Our results showed systematic biases consistent with the tilt illusion in both conditions. Biases were largest when observers attempted to estimate the 4 and 8 o'clock positions, but there was no significant difference between data gathered with the dot and data gathered with the line segment. A control experiment confirmed that biases were better accounted for by a local coordinate shift than to torsional eye movements induced by the tilted context. This finding supports the idea that tilted contexts distort perceived positions as well as perceived orientations and cannot be readily explained by lateral interactions between orientation selective cells in V1.	[Tomassini, Alessandro] UCL, Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London, England; [Tomassini, Alessandro; Solomon, Joshua Adam; Morgan, Michael John] City Univ London, Appl Vis Res Ctr, Optometry Div, London EC1V 0HB, England; [Morgan, Michael John] Max Planck Inst Neurol Res, D-50931 Cologne, Germany	University of London; University College London; City University London; Max Planck Society	Tomassini, A (corresponding author), UCL, Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London, England.	a.tomassini@ucl.ac.uk		Tomassini, Alessandro/0000-0001-5645-6910	EPSRC [EP/E064604]; Engineering and Physical Sciences Research Council [EP/E064604/1] Funding Source: researchfish; EPSRC [EP/E064604/1] Funding Source: UKRI	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by EPSRC with the grant number EP/E064604. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson E. H., 2000, NEW COGNITIVE NEUROS; ADELSON EH, 1993, SCIENCE, V262, P2042, DOI 10.1126/science.8266102; ANDREWS DP, 1964, Q J EXP PSYCHOL, V16, P104, DOI 10.1080/17470216408416355; APPELLE S, 1972, PSYCHOL BULL, V78, P266, DOI 10.1037/h0033117; ASCH SE, 1948, J EXP PSYCHOL, V38, P325, DOI 10.1037/h0057855; Aubert H., 1861, ARCH PATHOL ANAT PH, V20, P381, DOI [10.1007/BF02355256, DOI 10.1007/BF02355256]; Barlow H.B., 1961, SENSORY COMMUNICATIO, V1; BLAKEMORE C, 1970, J PHYSIOL-LONDON, V210, P727, DOI 10.1113/jphysiol.1970.sp009238; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BUCHANANSMITH HM, 1993, PERCEPTION, V22, P1389, DOI 10.1068/p221389; CHUBB C, 1989, P NATL ACAD SCI USA, V86, P9631, DOI 10.1073/pnas.86.23.9631; Clifford C.W.G., 2005, FITTING MIND WORLD A; Clifford CWG, 1996, VISION RES, V36, P2595, DOI 10.1016/0042-6989(95)00301-0; CRONE RA, 1975, A GRAEF ARCH KLIN EX, V196, P1, DOI 10.1007/BF00410021; Daddaoua N, 2008, J VISION, V8, DOI 10.1167/8.3.19; DAY RH, 1969, PSYCHOL BULL, V71, P33, DOI 10.1037/h0026872; Dichgans J, 1974, PSYCHOPHYSICS VISUAL; DILORENZO JR, 1982, J EXP PSYCHOL HUMAN, V8, P536, DOI 10.1037/0096-1523.8.4.536; EBBINGHAUS H, 1897, Z PSYCHOL, V13, P401; EBENHOLTZ SM, 1977, PERCEPT PSYCHOPHYS, V22, P491, DOI 10.3758/BF03199516; GEISLER WS, 1992, VISION RES, V32, P1409, DOI 10.1016/0042-6989(92)90196-P; Gibson JJ, 1937, J EXP PSYCHOL, V20, P453, DOI 10.1037/h0059826; Gibson JJ, 1933, J EXP PSYCHOL, V16, P1, DOI 10.1037/h0074626; GILBERT CD, 1990, VISION RES, V30, P1689, DOI 10.1016/0042-6989(90)90153-C; GOODENOUGH DR, 1979, VISION RES, V19, P1177, DOI 10.1016/0042-6989(79)90015-4; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; HENN V, 1974, BRAIN RES, V71, P144, DOI 10.1016/0006-8993(74)90198-X; Hering E., 1878, LEHRE LICHTSINN; HORN G, 1969, NATURE, V221, P186, DOI 10.1038/221186a0; HOWARD IP, 1964, VISION RES, V4, P433, DOI 10.1016/0042-6989(64)90015-X; Kohn A, 2004, NAT NEUROSCI, V7, P764, DOI 10.1038/nn1267; Krekelberg B, 2006, TRENDS NEUROSCI, V29, P250, DOI 10.1016/j.tins.2006.02.008; Lewis RF, 2005, ANN NY ACAD SCI, V1039, P294, DOI 10.1196/annals.1325.028; Lipshits M, 1999, NEUROREPORT, V10, P1085, DOI 10.1097/00001756-199904060-00033; Luyat M, 2001, PERCEPT PSYCHOPHYS, V63, P541, DOI 10.3758/BF03194419; Luyat M, 2005, NEUROSCI LETT, V385, P215, DOI 10.1016/j.neulet.2005.05.044; Luyat M, 2002, J EXP PSYCHOL HUMAN, V28, P1002, DOI 10.1037//0096-1523.28.4.1002; MACH E., 1865, SB AKAD WISS WIEN MN, V52, P303; Milner D, 2003, TRENDS COGN SCI, V7, P10, DOI 10.1016/S1364-6613(02)00004-9; Muller GE, 1916, Z SINNESPHYSIOL, V49; OTOOLE B, 1977, VISION RES, V17, P367, DOI 10.1016/0042-6989(77)90025-6; PARKER DE, 1983, PERCEPT PSYCHOPHYS, V33, P139, DOI 10.3758/BF03202831; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Purves D, 2011, P NATL ACAD SCI USA, V108, P15588, DOI 10.1073/pnas.1012178108; Sauvan XM, 1999, VIS COGN, V6, P43, DOI 10.1080/713756803; Schwartz O, 2007, NAT REV NEUROSCI, V8, P522, DOI 10.1038/nrn2155; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; Trousselard M, 2003, PERCEPT PSYCHOPHYS, V65, P1179, DOI 10.3758/BF03194843; van Beuzekom AD, 2000, J NEUROPHYSIOL, V84, P11, DOI 10.1152/jn.2000.84.1.11; Watson AB, 1997, SPATIAL VISION, V10, P447, DOI 10.1163/156856897X00384; WENDEROTH P, 1988, VISION RES, V28, P301, DOI 10.1016/0042-6989(88)90158-7	51	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110729	10.1371/journal.pone.0110729	http://dx.doi.org/10.1371/journal.pone.0110729			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BL	25343463	Green Published, Green Accepted, gold			2022-12-27	WOS:000343943500052
J	Sumrall, ET; Gallo, EB; Aboderin, AO; Lamikanra, A; Okeke, IN				Sumrall, Eric T.; Gallo, Elizabeth B.; Aboderin, Aaron Oladipo; Lamikanra, Adebayo; Okeke, Iruka N.			Dissemination of the Transmissible Quinolone-Resistance Gene qnrS1 by IncX Plasmids in Nigeria	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; ANTIMICROBIAL RESISTANCE; REFERENCE STRAIN; GENOME SEQUENCE; IDENTIFICATION; TOPOISOMERASES	The plasmid-encoded quinolone resistance gene qnrS1 was recently found to be commonly associated with ciprofloxacin resistance in Nigeria. We mapped the qnrS1 gene from an Escherichia coli isolate obtained in Nigeria to a 43.5 Kb IncX2 plasmid. The plasmid, pEBG1, was sufficient to confer ciprofloxacin non-susceptibility, as well as tetracycline and trimethoprim resistance, on E. coli K-12. Deletion analysis confirmed that qnrS1 accounted for all the ciprofloxacin non-suceptibility conferred by pEBG1 and tetracycline and trimethoprim resistance could be attributed to tetAR and dfrA14 genes respectively. While it contained a complete IncX conjugation system, pEBG1 was not self-transmissible likely due to an IS3 element inserted between the pilX5 and pilX6 genes. The plasmid was however efficiently mobilizable. pEBG1 was most similar to another qnrS1-bearing IncX2 plasmid from Nigeria, but both plasmids acquired qnrS1 independently and differ in their content of other resistance genes. Screening qnrS1-positive isolates from other individuals in Nigeria revealed that they carried neither pEBG1 nor pNGX2-QnrS1 but that IncX plasmids were prevalent. This study demonstrates that the IncX backbone is a flexible platform that has contributed to qnrS1 dissemination in Nigeria.	[Sumrall, Eric T.; Gallo, Elizabeth B.; Okeke, Iruka N.] Haverford Coll, Dept Biol, Haverford, PA 19041 USA; [Aboderin, Aaron Oladipo] Obafemi Awolowo Univ, Dept Med Microbiol & Parasitol, Ife, Osun State, Nigeria; [Lamikanra, Adebayo] Obafemi Awolowo Univ, Dept Pharmaceut, Ife, Osun State, Nigeria	Haverford College; Obafemi Awolowo University; Obafemi Awolowo University	Okeke, IN (corresponding author), Haverford Coll, Dept Biol, Haverford, PA 19041 USA.	iokeke@haverford.edu	Okeke, Iruka N/N-1595-2019; Aboderin, Aaron/V-8025-2019	Okeke, Iruka N/0000-0002-1694-7587; Aboderin, Aaron/0000-0002-4280-2218; Sumrall, Eric/0000-0001-9181-6918	Society-in-Science, ETHZ, Zurich; Haverford College	Society-in-Science, ETHZ, Zurich(ETH Zurich); Haverford College	This work was supported by a Branco Weiss Fellowship to INO from the Society-in-Science, ETHZ, Zurich and intramural funding from Haverford College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; APPLEYARD RK, 1954, GENETICS, V39, P440; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Carattoli A, 2010, J ANTIMICROB CHEMOTH, V65, P2070, DOI 10.1093/jac/dkq269; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Chah KF, 2010, J BASIC MICROB, V50, pS18, DOI 10.1002/jobm.200900325; Clinical and Laboratory Standards (CLSI), 2009, METHODS DILUTION ANT, Veighth; Doyle M, 2007, SCIENCE, V315, P251, DOI 10.1126/science.1137550; Du XX, 2013, J MED MICROBIOL, V62, P1332, DOI 10.1099/jmm.0.057091-0; Fields PI, 1997, J CLIN MICROBIOL, V35, P1066, DOI 10.1128/JCM.35.5.1066-1070.1997; Garcia-Fernandez A, 2009, J ANTIMICROB CHEMOTH, V63, P274, DOI 10.1093/jac/dkn470; Gay K, 2006, CLIN INFECT DIS, V43, P297, DOI 10.1086/505397; Grudniak AM, 2007, CURR MICROBIOL, V55, P549, DOI 10.1007/s00284-007-9032-5; Gunell M, 2009, ANTIMICROB AGENTS CH, V53, P3832, DOI 10.1128/AAC.00121-09; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hata M, 2005, ANTIMICROB AGENTS CH, V49, P801, DOI 10.1128/AAC.49.2.801-803.2005; Huang SY, 2012, FOODBORNE PATHOG DIS, V9, P896, DOI 10.1089/fpd.2012.1131; Johnson TJ, 2012, PLASMID, V68, P43, DOI 10.1016/j.plasmid.2012.03.001; Jun L, 2002, PLASMID, V48, P24, DOI 10.1016/S0147-619X(02)00007-0; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Kehrenberg C, 2007, J ANTIMICROB CHEMOTH, V60, P903, DOI 10.1093/jac/dkm283; Labar AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038142; Lamikanra A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-312; Le TMV, 2011, ANTIMICROB AGENTS CH, V55, P1798, DOI 10.1128/AAC.01200-10; Lescat M, 2009, ANTIMICROB AGENTS CH, V53, P2283, DOI 10.1128/AAC.00123-09; Literak I, 2010, APPL ENVIRON MICROB, V76, P8126, DOI 10.1128/AEM.01446-10; Martinez-Martinez L, 1998, LANCET, V351, P797, DOI 10.1016/S0140-6736(97)07322-4; MOLLET B, 1983, NUCLEIC ACIDS RES, V11, P6319, DOI 10.1093/nar/11.18.6319; NCCLS, 2003, M2A8 NCCLS; Nunez B, 1997, MOL MICROBIOL, V24, P1157, DOI 10.1046/j.1365-2958.1997.4111778.x; Nwaneshiudu AI, 2007, J BACTERIOL, V189, P6074, DOI 10.1128/JB.00349-07; OBRIEN TF, 1995, EMERG INFECT DIS, V1, P66, DOI 10.3201/eid0102.950209; Partridge SR, 2011, ANTIMICROB AGENTS CH, V55, P5933, DOI 10.1128/AAC.00639-11; Robicsek A, 2006, NAT MED, V12, P83, DOI 10.1038/nm1347; Robicsek A, 2006, LANCET INFECT DIS, V6, P629, DOI 10.1016/S1473-3099(06)70599-0; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sambrook J., 2001, MOL CLONING LAB MANU; Sandegren L, 2012, J ANTIMICROB CHEMOTH, V67, P74, DOI 10.1093/jac/dkr405; Schluter A, 2003, MICROBIOL-SGM, V149, P3139, DOI 10.1099/mic.0.26570-0; SIMONSEN CC, 1983, J BACTERIOL, V155, P1001, DOI 10.1128/JB.155.3.1001-1008.1983; Strahilevitz J, 2009, CLIN MICROBIOL REV, V22, P664, DOI 10.1128/CMR.00016-09; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tran JH, 2002, P NATL ACAD SCI USA, V99, P5638, DOI 10.1073/pnas.082092899; Usongo V, 2013, J BACTERIOL, V195, P1758, DOI 10.1128/JB.02001-12; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wu JJ, 2007, ANTIMICROB AGENTS CH, V51, P1223, DOI 10.1128/AAC.01195-06; Yi H, 2012, J BACTERIOL, V194, P3742, DOI 10.1128/JB.00641-12	49	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110279	10.1371/journal.pone.0110279	http://dx.doi.org/10.1371/journal.pone.0110279			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340787	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662800026
J	Cheng, HC; Liu, JH; Lee, SM; Lin, PK				Cheng, Hui-Chen; Liu, Jorn-Hon; Lee, Shui-Mei; Lin, Po-Kang			Hyperhomocysteinemia in Patients with Polypoidal Choroidal Vasculopathy: A Case Control Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; MACULAR DEGENERATION; PLASMA HOMOCYSTEINE; CLINICAL CHARACTERISTICS; INFLAMMATORY MARKERS; RISK FACTOR; AGE; DISEASE; METAANALYSIS; FOLATE	Purpose: To determine whether elevated plasma homocysteine and serum high sensitivity C-reactive protein (hsCRP) levels, two established risk factors of vascular diseases, are associated with polypoidal choroidal vasculopathy (PCV). Design: Retrospective case-control study. Methods: One hundred and nineteen consecutive patients with PCV and 119 matched controls were enrolled in a tertiary hospital from September 2008 to June 2013. Plasma homocysteine and serum hsCRP levels were measured. Associations among plasma homocysteine, serum hsCRP levels and PCV were further evaluated using multivariable logistic regression analysis. Results: The median plasma homocysteine level was significantly higher in patients with PCV than in the controls (12.20 mu mol/L vs. 9.80 mu mol/ L, p<0.001). The median serum hsCRP level was slightly higher in the PCV group (0.16 mg/dl vs. 0.11 mg/dl in control group, p = 0.07). After multivariable logistic regression analysis, each 1 mmol/ L increase of plasma homocysteine was associated with a 1.5-fold increase in likelihood of having PCV (OR, 1.54; 95% confidence interval (CI), 1.33-1.79, p<0.001). Conclusions: Hyperhomocysteinemia was associated with PCV and might play a role in the pathogenesis of PCV.	[Cheng, Hui-Chen; Liu, Jorn-Hon; Lee, Shui-Mei; Lin, Po-Kang] Natl Yang Ming Univ, Sch Med, Dept Ophthalmol, Taipei 112, Taiwan; [Cheng, Hui-Chen; Liu, Jorn-Hon; Lee, Shui-Mei; Lin, Po-Kang] Taipei Vet Gen Hosp, Dept Ophthalmol, Taipei, Taiwan; [Liu, Jorn-Hon] Cheng Hsin Rehabil Med Ctr, Dept Ophthalmol, Taipei, Taiwan; [Lin, Po-Kang] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Lin, Po-Kang] Natl Chiao Tung Univ, Biomed Elect Translat Res Ctr, Hsinchu, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Taiwan University; National Yang Ming Chiao Tung University	Lin, PK (corresponding author), Natl Yang Ming Univ, Sch Med, Dept Ophthalmol, Taipei 112, Taiwan.	pklin123@hotmail.com			National Science Council of the Republic of China, Taiwan [NSC101-2220-E-010-001]; "Aim for the Top University Plan" of the National Chiao Tung University; Ministry of Education, Taiwan, R. O. C	National Science Council of the Republic of China, Taiwan(Ministry of Science and Technology, Taiwan); "Aim for the Top University Plan" of the National Chiao Tung University; Ministry of Education, Taiwan, R. O. C(Ministry of Education, Taiwan)	The authors would like to thank the National Science Council of the Republic of China, Taiwan, for supporting this research under Contract No. NSC101-2220-E-010-001. This work was also supported by the "Aim for the Top University Plan" of the National Chiao Tung University and Ministry of Education, Taiwan, R. O. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, NIPPON GANKA GAKKAI, V109, P417; [Anonymous], 2002, JAMA, V288, P2015; [Anonymous], 2005, AM J CLIN NUTR, V82, P806; Aydemir O, 2008, RETINA-J RET VIT DIS, V28, P741, DOI 10.1097/IAE.0b013e31816079fb; Cackett P, 2009, RETINA-J RET VIT DIS, V29, P187, DOI 10.1097/IAE.0b013e318188c839; Cahill MT, 2003, AM J OPHTHALMOL, V136, P1136, DOI 10.1016/S0002-9394(03)00571-3; Ciardella Antonio P, 2002, Ophthalmol Clin North Am, V15, P537, DOI 10.1016/S0896-1549(02)00053-6; CLARKE R, 1991, NEW ENGL J MED, V324, P1149, DOI 10.1056/NEJM199104253241701; Hoh BL, 2004, ACTA NEUROCHIR, V146, P705, DOI 10.1007/s00701-004-0276-6; Karnik SK, 2003, DEVELOPMENT, V130, P411, DOI 10.1242/dev.00223; Kikuchi M, 2007, OPHTHALMOLOGY, V114, P1722, DOI 10.1016/j.ophtha.2006.12.021; Kondo N, 2008, INVEST OPHTH VIS SCI, V49, P1101, DOI 10.1167/iovs.07-1145; Kuroiwa S, 2004, CLIN EXP OPHTHALMOL, V32, P297, DOI 10.1111/j.1442-9071.2004.00827.x; Laude A, 2010, PROG RETIN EYE RES, V29, P19, DOI 10.1016/j.preteyeres.2009.10.001; Liu Y, 2007, GRAEF ARCH CLIN EXP, V245, P1441, DOI 10.1007/s00417-007-0575-8; Maruko I, 2007, AM J OPHTHALMOL, V144, P15, DOI 10.1016/j.ajo.2007.03.047; McCully KS, 2009, ANN CLIN LAB SCI, V39, P219; McGimpsey SJ, 2009, OPHTHALMOLOGY, V116, P1778, DOI 10.1016/j.ophtha.2009.02.033; Nakajima M, 2004, JPN J OPHTHALMOL, V48, P249, DOI 10.1007/s10384-003-0057-4; Nakashizuka H, 2008, INVEST OPHTH VIS SCI, V49, P4729, DOI 10.1167/iovs.08-2134; Ng MKC, 2002, ARTERIOSCL THROM VAS, V22, P1136, DOI 10.1161/01.ATV.0000022167.80130.A6; Okubo A, 2002, BRIT J OPHTHALMOL, V86, P1093, DOI 10.1136/bjo.86.10.1093; Refsum H, 2004, CLIN CHEM, V50, P3, DOI 10.1373/clinchem.2003.021634; Ridker PM, 2001, CIRCULATION, V103, P1813, DOI 10.1161/01.CIR.103.13.1813; Rochtchina E, 2007, AM J OPHTHALMOL, V143, P344, DOI 10.1016/j.ajo.2006.08.032; Rosa RH, 2002, ARCH OPHTHALMOL-CHIC, V120, P502; Ross RD, 1996, RETINA-J RET VIT DIS, V16, P105, DOI 10.1097/00006982-199616020-00003; Russo GT, 2003, J NUTR, V133, P3416, DOI 10.1093/jn/133.11.3416; Scassellati-Sforzolini B, 2001, RETINA-J RET VIT DIS, V21, P121, DOI 10.1097/00006982-200104000-00004; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; Sho K, 2003, ARCH OPHTHALMOL-CHIC, V121, P1392, DOI 10.1001/archopht.121.10.1392; SPAIDE RF, 1995, RETINA-J RET VIT DIS, V15, P100, DOI 10.1097/00006982-199515020-00003; Tewari PC, 2004, CLIN CHIM ACTA, V342, P171, DOI 10.1016/j.cccn.2003.12.025; Turgut B, 2010, CLIN INTERV AGING, V5, P133; Wu KHC, 2007, INVEST OPHTH VIS SCI, V48, P1983, DOI 10.1167/iovs.06-0223; Yannuzzi LA, 1999, ARCH OPHTHALMOL-CHIC, V117, P1503; YANNUZZI LA, 1990, RETINA-J RET VIT DIS, V10, P1, DOI 10.1097/00006982-199001010-00001	37	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110818	10.1371/journal.pone.0110818	http://dx.doi.org/10.1371/journal.pone.0110818			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337797	gold, Green Submitted, Green Published			2022-12-27	WOS:000343674800078
J	Kicinska, A; Leluk, J; Jarmuszkiewicz, W				Kicinska, Anna; Leluk, Jacek; Jarmuszkiewicz, Wieslawa			Acanthamoeba castellanii STAT Protein	PLOS ONE			English	Article							DICTYOSTELIUM STAT; UNCOUPLING PROTEIN; IDENTIFICATION; EVOLUTION; GENOME; ALIGNMENT; HOMOLOGY; KINASE; GENES; DNA	STAT (signal transducers and activators of transcription) proteins are one of the important mediators of phosphotyrosine-regulated signaling in metazoan cells. We described the presence of STAT protein in a unicellular, free-living amoebae with a simple life cycle, Acanthamoeba castellanii. A. castellanii is the only, studied to date, Amoebozoan that does not belong to Mycetozoa but possesses STATs. A sequence of the A. castellanii STAT protein includes domains similar to those of the Dictyostelium STAT proteins: a coiled coil (characteristic for Dictyostelium STAT coiled coil), a STAT DNA-binding domain and a Src-homology domain. The search for protein sequences homologous to A. castellanii STAT revealed 17 additional sequences from lower eukaryotes. Interestingly, all of these sequences come from Amoebozoa organisms that belong to either Mycetozoa (slime molds) or Centramoebida. We showed that there are four separated clades within the slime mold STAT proteins. The A. castellanii STAT protein branches next to a group of STATc proteins from Mycetozoa. We also demonstrate that Amoebozoa form a distinct monophyletic lineage within the STAT protein world that is well separated from the other groups.	[Kicinska, Anna; Jarmuszkiewicz, Wieslawa] Adam Mickiewicz Univ, Dept Bioenerget, Poznan, Poland; [Leluk, Jacek] Univ Zielona Gora, Dept Mol Biol, Zielona Gora, Poland	Adam Mickiewicz University; University of Zielona Gora	Kicinska, A (corresponding author), Adam Mickiewicz Univ, Dept Bioenerget, Poznan, Poland.	anias@amu.edu.pl	Leluk, Jacek/G-2839-2015	Leluk, Jacek/0000-0002-4410-4317; Kicinska, Anna/0000-0003-4293-762X; Jarmuszkiewicz, Wieslawa/0000-0001-8550-8337	PARENT/BRIDGE programme by Foundation for Polish Science [2010-1/3]; European Union within Action 1.2 "Strengthening the personnel potential of science" POIG; KNOW Poznan RNA Centre [01/KNOW2/2014]	PARENT/BRIDGE programme by Foundation for Polish Science; European Union within Action 1.2 "Strengthening the personnel potential of science" POIG; KNOW Poznan RNA Centre	This work was supported by the PARENT/BRIDGE programme 2010-1/3 grant by Foundation for Polish Science, co-financed by the European Union from structural funds within Action 1.2 "Strengthening the personnel potential of science" POIG 2007-2013 to AK and partially supported by KNOW Poznan RNA Centre, 01/KNOW2/2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 1997, INT J BIOCHEM CELL B, V29, P1401, DOI 10.1016/S1357-2725(97)00063-0; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Araki T, 2003, J CELL SCI, V116, P2907, DOI 10.1242/jcs.00501; Araki T, 2012, P NATL ACAD SCI USA, V109, pE1931, DOI 10.1073/pnas.1202715109; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Clarke M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r11; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fogtman A, 2005, BIOALGORITHMS MED SY, V1, P117; Fukuzawa M, 2000, DEVELOPMENT, V127, P2705; Fukuzawa M, 2001, MOL CELL, V7, P779, DOI 10.1016/S1097-2765(01)00222-2; Gajewska E, 2005, BIOALGORITHMS MED SY, V1, P121; Gonzalez-Robles A, 2008, EXP PARASITOL, V119, P411, DOI 10.1016/j.exppara.2008.04.004; Gorissen M, 2011, J ENDOCRINOL, V209, P175, DOI 10.1530/JOE-11-0033; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Higgins D G, 1994, Methods Mol Biol, V25, P307; Hino K, 2003, DEV GENES EVOL, V213, P264, DOI 10.1007/s00427-003-0318-8; Jarmuszkiewicz W, 1997, FEBS LETT, V411, P110, DOI 10.1016/S0014-5793(97)00676-5; Kawata T, 1997, CELL, V89, P909, DOI 10.1016/S0092-8674(00)80276-7; Kawata T, 2011, DEV GROWTH DIFFER, V53, P548, DOI 10.1111/j.1440-169X.2010.01243.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leluk J, 2000, BIOSYSTEMS, V56, P83, DOI 10.1016/S0303-2647(00)00074-5; Leluk J, 1998, COMPUT CHEM, V22, P123, DOI 10.1016/S0097-8485(97)00035-1; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Liu BA, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002105; Le L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022970; Madden TL, 1996, METHOD ENZYMOL, V266, P131; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Na JB, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-123; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ruiz-Trillo I, 2007, TRENDS GENET, V23, P113, DOI 10.1016/j.tig.2007.01.005; Scala C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046150; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Soler-Lopez M, 2004, MOL CELL, V13, P791, DOI 10.1016/S1097-2765(04)00130-3; Swida A, 2008, BIOCHEM J, V413, P359, DOI 10.1042/BJ20080333; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wang Y, 2006, FASEB J, V20, P1641, DOI 10.1096/fj.06-6051com; Wojciak JM, 2009, EMBO J, V28, P948, DOI 10.1038/emboj.2009.30; Woyda-Ploszczyca A, 2013, BIOL CHEM, V394, P649, DOI 10.1515/hsz-2012-0326	40	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e111345	10.1371/journal.pone.0111345	http://dx.doi.org/10.1371/journal.pone.0111345			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338074	Green Published, gold, Green Submitted			2022-12-27	WOS:000343674800117
J	Nouvenne, A; Ticinesi, A; Lauretani, F; Maggio, M; Lippi, G; Guida, L; Morelli, I; Ridolo, E; Borghi, L; Meschi, T				Nouvenne, Antonio; Ticinesi, Andrea; Lauretani, Fulvio; Maggio, Marcello; Lippi, Giuseppe; Guida, Loredana; Morelli, Ilaria; Ridolo, Erminia; Borghi, Loris; Meschi, Tiziana			Comorbidities and Disease Severity as Risk Factors for Carbapenem-Resistant Klebsiella pneumoniae Colonization: Report of an Experience in an Internal Medicine Unit	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; BLOOD-STREAM INFECTION; K.-PNEUMONIAE; ACTIVE SURVEILLANCE; OUTBREAK; ENTEROBACTERIACEAE; IMPACT; EPIDEMIOLOGY; PREDICTORS; MORTALITY	Background: Carbapenem-resistant Klebsiella pneumoniae (CRKP) is an emerging multidrug-resistant nosocomial pathogen, spreading to hospitalized elderly patients. Risk factors in this setting are unclear. Our aims were to explore the contribution of multi-morbidity and disease severity in the onset of CRKP colonization/infection, and to describe changes in epidemiology after the institution of quarantine-ward managed by staff-cohorting. Methods and Findings: With a case-control design, we evaluated 133 CRKP-positive patients (75 M, 58 F; mean age 79610 years) and a control group of 400 CRKP-negative subjects (179 M, 221 F; mean age 79612 years) admitted to Internal Medicine and Critical Subacute Care Unit of Parma University Hospital, Italy, during a 10-month period. Information about comorbidity type and severity, expressed through Cumulative Illness Rating Scale-CIRS, was collected in each patient. During an overall 5-month period, CRKP-positive patients were managed in an isolation ward with staff cohorting. A contact-bed isolation approach was established in the other 5 months. The effects of these strategies were evaluated with a cross-sectional study design. CRKP-positive subjects had higher CIRS comorbidity index (12.0 +/- 3.6 vs 9.1 +/- 3.5, p<0.0001) and CIRS severity index (3.2 +/- 0.4 vs 2.9 +/- 0.5, p<0.0001), along with higher cardiovascular, respiratory, renal and neurological disease burden than control group. CIRS severity index was associated with a higher risk for CRKP-colonization (OR 13.3, 95% CI6.88-25.93), independent of comorbidities. Isolation ward activation was associated with decreased monthly incidence of CRKP-positivity (from 16.9% to 1.2% of all admissions) and infection (from 36.6% to 22.5% of all positive cases; p = 0.04 derived by Wilcoxon signed-rank test). Mortality rate did not differ between cases and controls (21.8% vs 15.2%, p = 0.08). The main limitations of this study are observational design and lack of data about prior antibiotic exposure. Conclusions: Comorbidities and disease severity are relevant risk factors for CRKP-colonization/infection in elderly frail patients. Sanitary measures may have contributed to limit epidemic spread and rate of infection also in internal medicine setting.	[Nouvenne, Antonio; Ticinesi, Andrea; Guida, Loredana; Morelli, Ilaria; Ridolo, Erminia; Borghi, Loris; Meschi, Tiziana] Parma Univ Hosp, Internal Med & Crit Subacute Care Unit, Parma, Italy; [Nouvenne, Antonio; Ticinesi, Andrea; Maggio, Marcello; Ridolo, Erminia; Borghi, Loris; Meschi, Tiziana] Univ Parma, Dept Clin & Expt Med, I-43100 Parma, Italy; [Lauretani, Fulvio] Parma Univ Hosp, Geriatr Unit, Parma, Italy; [Lippi, Giuseppe] Parma Univ Hosp, Lab Clin Chem & Hematol, Parma, Italy	University of Parma; University Hospital of Parma; University of Parma; University Hospital of Parma; University of Parma; University Hospital of Parma; University of Parma; University Hospital of Parma	Nouvenne, A (corresponding author), Parma Univ Hosp, Internal Med & Crit Subacute Care Unit, Parma, Italy.	antonio.nouvenne@alice.it	Meschi, Tiziana/K-5032-2016; Ticinesi, Andrea/K-5017-2016; Lauretani, Fulvio/K-5115-2016; Lippi, Giuseppe/X-7198-2018	Meschi, Tiziana/0000-0002-7538-6863; Ticinesi, Andrea/0000-0001-9171-8592; Lauretani, Fulvio/0000-0002-5287-9972; Lippi, Giuseppe/0000-0001-9523-9054; Nouvenne, Antonio/0000-0002-2680-2242				Agodi A, 2011, J CLIN MICROBIOL, V49, P3986, DOI 10.1128/JCM.01242-11; Al-Hasan MN, 2010, MAYO CLIN PROC, V85, P139, DOI 10.4065/mcp.2009.0410; Anderson DJ, 2008, J INFECT DIS, V197, P752, DOI 10.1086/527486; Armand-Lefevre L, 2013, ANTIMICROB AGENTS CH, V57, P1488, DOI 10.1128/AAC.01823-12; Aschbacher R, 2013, DIAGN MICR INFEC DIS, V77, P354, DOI 10.1016/j.diagmicrobio.2013.08.029; Chen Luke F, 2012, Infect Drug Resist, V5, P133, DOI 10.2147/IDR.S26613; Chitnis AS, 2012, INFECT CONT HOSP EP, V33, P984, DOI 10.1086/667738; Cornaglia G, 2011, LANCET INFECT DIS, V11, P381, DOI 10.1016/S1473-3099(11)70056-1; Daikos GL, 2011, CLIN MICROBIOL INFEC, V17, P1135, DOI 10.1111/j.1469-0691.2011.03553.x; Gagliotti C, 2013, J HOSP INFECT, V83, P330, DOI 10.1016/j.jhin.2012.11.024; Gagliotti C, 2013, INDICAZIONI PRATICHE; Gaibani P, 2011, EURO SURVEILL, V12; Gasink LB, 2009, INFECT CONT HOSP EP, V30, P1180, DOI 10.1086/648451; Giani T, 2013, EURO SURVEILL, V18; Giani T, 2009, J CLIN MICROBIOL, V47, P3793, DOI 10.1128/JCM.01773-09; Giuffre M, 2013, J HOSP INFECT, V85, P233, DOI 10.1016/j.jhin.2013.08.004; Hirsch EB, 2013, J INFECT DIS, V207, P786, DOI 10.1093/infdis/jis766; Jochimsen EM, 1999, INFECT CONT HOSP EP, V20, P106, DOI 10.1086/501598; Livermore DM, 2011, INT J ANTIMICROB AG, V37, P415, DOI 10.1016/j.ijantimicag.2011.01.012; Lomaestro BM, 2006, CLIN INFECT DIS, V43, pE26, DOI 10.1086/505598; MILLER MD, 1992, PSYCHIAT RES, V41, P237, DOI 10.1016/0165-1781(92)90005-N; Mouloudi E, 2010, INFECT CONT HOSP EP, V31, P1250, DOI 10.1086/657135; Munoz-Price LS, 2013, LANCET INFECT DIS, V13, P785, DOI 10.1016/S1473-3099(13)70190-7; Munoz-Price LS, 2010, INFECT CONT HOSP EP, V31, P1074, DOI 10.1086/656243; Munoz-Price LS, 2010, INFECT CONT HOSP EP, V31, P341, DOI 10.1086/651097; Nordmann P, 2012, CLIN MICROBIOL INFEC, V18, P432, DOI 10.1111/j.1469-0691.2012.03815.x; Nordmann P, 2002, CLIN MICROBIOL INFEC, V8, P321, DOI 10.1046/j.1469-0691.2002.00401.x; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; Papadimitriou-Olivgeris M, 2012, J ANTIMICROB CHEMOTH, V67, P2976, DOI 10.1093/jac/dks316; Poulou A, 2012, J CLIN MICROBIOL, V50, P2618, DOI 10.1128/JCM.00459-12; Sypsa V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041068; Tumbarello M, 2012, CLIN INFECT DIS, V55, P943, DOI 10.1093/cid/cis588; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001; Zarkotou O, 2011, CLIN MICROBIOL INFEC, V17, P1798, DOI 10.1111/j.1469-0691.2011.03514.x	34	26	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110001	10.1371/journal.pone.0110001	http://dx.doi.org/10.1371/journal.pone.0110001			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25335100	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766200073
J	Risco, D; Serrano, E; Fernandez-Llario, P; Cuesta, JM; Goncalves, P; Garcia-Jimenez, WL; Martinez, R; Cerrato, R; Velarde, R; Gomez, L; Segales, J; de Mendoza, JH				Risco, David; Serrano, Emmanuel; Fernandez-Llario, Pedro; Cuesta, Jesus M.; Goncalves, Pilar; Garcia-Jimenez, Waldo L.; Martinez, Remigio; Cerrato, Rosario; Velarde, Roser; Gomez, Luis; Segales, Joaquim; Hermoso de Mendoza, Javier			Severity of Bovine Tuberculosis Is Associated with Co-Infection with Common Pathogens in Wild Boar	PLOS ONE			English	Article							CIRCOVIRUS TYPE-2 INFECTIONS; SUS-SCROFA; MYCOBACTERIUM-TUBERCULOSIS; SPECIES COOCCURRENCE; PREVALENCE; IDENTIFICATION; CONSEQUENCES; ANTIBODIES; PARASITES; INVASION	Co-infections with parasites or viruses drive tuberculosis dynamics in humans, but little is known about their effects in other non-human hosts. This work aims to investigate the relationship between Mycobacterium bovis infection and other pathogens in wild boar (Sus scrofa), a recognized reservoir of bovine tuberculosis (bTB) in Mediterranean ecosystems. For this purpose, it has been assessed whether contacts with common concomitant pathogens are associated with the development of severe bTB lesions in 165 wild boar from mid-western Spain. The presence of bTB lesions affecting only one anatomic location (cervical lymph nodes), or more severe patterns affecting more than one location (mainly cervical lymph nodes and lungs), was assessed in infected animals. In addition, the existence of contacts with other pathogens such as porcine circovirus type 2 (PCV2), Aujeszky's disease virus (ADV), swine influenza virus, porcine reproductive and respiratory syndrome virus, Mycoplasma hyopneumoniae, Actinobacillus pleuropneumoniae, Haemophilus parasuis and Metastrongylus spp, was evaluated by means of serological, microbiological and parasitological techniques. The existence of contacts with a structured community of pathogens in wild boar infected by M. bovis was statistically investigated by null models. Association between this community of pathogens and bTB severity was examined using a Partial Least Squares regression approach. Results showed that adult wild boar infected by M. bovis had contacted with some specific, non-random pathogen combinations. Contact with PCV2, ADV and infection by Metastrongylus spp, was positively correlated to tuberculosis severity. Therefore, measures against these concomitant pathogens such as vaccination or deworming, might be useful in tuberculosis control programmes in the wild boar. However, given the unexpected consequences of altering any community of organisms, further research should evaluate the impact of such measures under controlled conditions. Furthermore, more research including other important pathogens, such as gastro-intestinal nematodes, will be necessary to complete this picture.	[Risco, David; Fernandez-Llario, Pedro; Cuesta, Jesus M.; Goncalves, Pilar; Garcia-Jimenez, Waldo L.; Martinez, Remigio; Cerrato, Rosario; Gomez, Luis; Hermoso de Mendoza, Javier] Univ Extremadura, Fac Vet, Red Grp Invest Recursos Faunist, Caceres, Spain; [Serrano, Emmanuel] Univ Aveiro, Ctr Environm & Marine Studies CESAM, Dept Biol, P-3800 Aveiro, Portugal; [Serrano, Emmanuel; Velarde, Roser] Univ Autonoma Barcelona, Dept Med & Cirurgia Anim, Serv Ecopatol Fauna Salvatge SEFaS, Bellaterra, Spain; [Segales, Joaquim] Univ Autonoma Barcelona, Inst Recerca & Tecnol Agroalimentaries, Ctr Recerca Sanitat Anim CReSA, Bellaterra, Spain; [Segales, Joaquim] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, Bellaterra, Spain	Universidad de Extremadura; Universidade de Aveiro; Autonomous University of Barcelona; Autonomous University of Barcelona; IRTA; Autonomous University of Barcelona	Risco, D (corresponding author), Univ Extremadura, Fac Vet, Red Grp Invest Recursos Faunist, Caceres, Spain.	driscope@gmail.com	Velarde, Roser/M-1614-2014; Segalés, Joaquim/A-4933-2011; Hermoso-de-Mendoza, Javier/N-7808-2013; Segalés, Joaquim/AAB-4815-2020; Pérez, Remigio Martínez/A-2414-2009; SERRANO-FERRON, Emmanuel/J-4489-2013	Velarde, Roser/0000-0003-3332-6405; Segalés, Joaquim/0000-0002-1539-7261; Hermoso-de-Mendoza, Javier/0000-0002-5574-4432; Segalés, Joaquim/0000-0002-1539-7261; Pérez, Remigio Martínez/0000-0002-5908-9447; SERRANO-FERRON, Emmanuel/0000-0002-9799-9804	Ministerio de Ciencia e Innovacion (Gobierno de Espana) [PS0900513]; Junta de Extremadura [PDT09A046, GRU10142]; Ministerio de Ciencia e Innovacion; Fundacao para a Ciencia ea Tecnologia, Portugal [SFRH/BPD/96637/2013]	Ministerio de Ciencia e Innovacion (Gobierno de Espana)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Extremadura; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacao para a Ciencia ea Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This study was supported by Ministerio de Ciencia e Innovacion (Gobierno de Espana) PS0900513 and Junta de Extremadura (PDT09A046 and GRU10142). D. Risco has a Formacion Profesorado Universitario (FPU) grant from the Ministerio de Ciencia e Innovacion (https://sede.educacion.gob.es). E. Serrano was supported by the postdoctoral program (SFRH/BPD/96637/2013) of the Fundacao para a Ciencia ea Tecnologia, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2007, ENCY MEASUREMENT STA, P741; Acevedo-Whitehouse K, 2005, MOL ECOL, V14, P3209, DOI 10.1111/j.1365-294X.2005.02656.x; Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; Black Thomas C., 1946, SOUTHERN MED JOUR, V39, P881, DOI 10.1097/00007611-194611000-00007; BOITANI L, 1992, ONGULES / UNGULATES 91, P419; Bollo E, 2000, J VET MED B, V47, P337, DOI 10.1046/j.1439-0450.2000.00354.x; Bordes Frederic, 2011, Infect Ecol Epidemiol, V1, DOI 10.3402/iee.v1i0.7346; Borkow G, 2004, CLIN MICROBIOL REV, V17, P1012, DOI 10.1128/CMR.17.4.1012-1030.2004; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; Calero-Bernal R, 2013, J WILDLIFE DIS, V49, P1019, DOI 10.7589/2013-01-024; Cho WS, 2003, LETT APPL MICROBIOL, V37, P56, DOI 10.1046/j.1472-765X.2003.01347.x; CORNER LA, 1988, VET MICROBIOL, V18, P127, DOI 10.1016/0378-1135(88)90058-2; COUSINS DV, 1991, VET MICROBIOL, V27, P187, DOI 10.1016/0378-1135(91)90010-D; Diedrich CR, 2011, INFECT IMMUN, V79, P1407, DOI 10.1128/IAI.01126-10; Elias D, 2005, CLIN EXP IMMUNOL, V139, P398, DOI 10.1111/j.1365-2249.2004.02719.x; Elias D, 2005, VACCINE, V23, P1326, DOI 10.1016/j.vaccine.2004.09.038; Elias D, 2001, CLIN EXP IMMUNOL, V123, P219, DOI 10.1046/j.1365-2249.2001.01446.x; Ezenwa VO, 2011, INTEGR COMP BIOL, V51, P540, DOI 10.1093/icb/icr058; Ezenwa VO, 2010, AM NAT, V176, P613, DOI 10.1086/656496; Fenton A, 2013, PARASITOLOGY, V140, P1119, DOI 10.1017/S0031182013000590; Fitzgerald SD, 2013, VET PATHOL, V50, P488, DOI 10.1177/0300985812467472; Garrido JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024905; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; Gortazar C, 2013, EPIDEMIOL INFECT, V141, P1339, DOI 10.1017/S0950268813000599; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Gotelli NJ, 2002, ECOLOGY, V83, P2091, DOI 10.2307/3072040; Gotelli NJ, 2002, ECOL LETT, V5, P86, DOI 10.1046/j.1461-0248.2002.00288.x; Gottschalk M, 2006, DIS SWINE, P563; Graham AL, 2007, TRENDS PARASITOL, V23, P284, DOI 10.1016/j.pt.2007.04.005; Haenlein M., 2004, UNDERSTANDING STAT, V3, P283, DOI [10.1207/s15328031us0304_4, DOI 10.1207/S15328031US0304_4]; Hammer R, 2012, J WILDLIFE DIS, V48, P87, DOI 10.7589/0090-3558-48.1.87; Hatcher M. J., 2011, PARASITES ECOLOGICAL; Jolles AE, 2008, ECOLOGY, V89, P2239, DOI 10.1890/07-0995.1; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Lass S, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0588; Li XX, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-79; Garcia-Gonzalez AM, 2013, J WILDLIFE DIS, V49, P157, DOI 10.7589/2011-07-217; Martin-Hernando MP, 2007, TUBERCULOSIS, V87, P360, DOI 10.1016/j.tube.2007.02.003; Menin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053884; Moller AP, 2002, OECOLOGIA, V132, P492, DOI 10.1007/s00442-002-0952-2; Navarro-Gonzalez N, 2013, VET PARASITOL, V196, P114, DOI 10.1016/j.vetpar.2013.02.019; Oliveira S, 2001, J VET DIAGN INVEST, V13, P495, DOI 10.1177/104063870101300607; Olsen CW, 2006, DIS SWINE, V9, P469; Pathak AK, 2012, INT J PARASITOL, V42, P647, DOI 10.1016/j.ijpara.2012.04.011; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; Pejsak ZK, 2006, DIS SWINE, P419; Perez JM, 2006, BIODIVERS CONSERV, V15, P2033, DOI 10.1007/s10531-005-0773-9; Rafi W, 2012, CURR OPIN HIV AIDS, V7, P239, DOI 10.1097/COH.0b013e3283524dc5; Rapp-Gabrielson VJ, 2006, DIS SWINE, P681; Reich NG, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0414; Risco D, 2013, TRANSBOUND EMERG DIS, V60, P121, DOI 10.1111/tbed.12112; Risco D, 2013, T EMERG DIS IN PRESS; Roic B, 2012, J WILDLIFE DIS, V48, P131, DOI 10.7589/0090-3558-48.1.131; SANCHEZ G, 2010, PLSPM PARTIAL LEAST; Santos N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012663; Segales J, 2006, DIS SWINE, P299; Serrano E, 2014, EPIDEMIOL INFECT, V142, P1533, DOI 10.1017/S0950268813002100; Serrano E, 2014, EPIDEMIOL INFECT, V142, P530, DOI 10.1017/S0950268813001295; STONE L, 1990, OECOLOGIA, V85, P74, DOI 10.1007/BF00317345; Stukelj M, 2014, SLOV VET RES, V51, P21; Supali T, 2010, INT J PARASITOL, V40, P1171, DOI 10.1016/j.ijpara.2010.05.003; Team RDC, 2014, R LANG ENV STAT COMP; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333; Thacker EL, 2006, DIS SWINE, P701; Thakar J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002345; Yacob HT, 2006, VET PARASITOL, V137, P184, DOI 10.1016/j.vetpar.2006.01.020; Zimmerman J., 2006, DIS SWINE, P387	67	34	34	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110123	10.1371/journal.pone.0110123	http://dx.doi.org/10.1371/journal.pone.0110123			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350002	Green Submitted, gold, Green Published			2022-12-27	WOS:000343943100021
J	Lim, SL; Bruce, AS; Aupperle, RL				Lim, Seung-Lark; Bruce, Amanda S.; Aupperle, Robin L.			The Influence of a Working Memory Task on Affective Perception of Facial Expressions	PLOS ONE			English	Article							COOPERATIVE COMPUTER GAME; BEHAVIORAL ACTIVATION; INCREASES SENSITIVITY; EMOTIONAL FACES; NEURAL SYSTEMS; HUMAN AMYGDALA; MODULATION; CONTRAST; CONTEXT; RECOGNITION	In a dual-task paradigm, participants performed a spatial location working memory task and a forced two-choice perceptual decision task (neutral vs. fearful) with gradually morphed emotional faces (neutral, fearful). Task-irrelevant word distractors (negative, neutral, and control) were experimentally manipulated during spatial working memory encoding. We hypothesized that, if affective perception is influenced by concurrent cognitive load using a working memory task, task-irrelevant emotional distractors would bias subsequent perceptual decision-making on ambiguous facial expression. We found that when either neutral or negative emotional words were presented as task-irrelevant working-memory distractors, participants more frequently reported fearful face perception - but only at the higher emotional intensity levels of morphed faces. Also, the affective perception bias due to negative emotional distractors correlated with a decrease in working memory performance. Taken together, our findings suggest that concurrent working memory load by task-irrelevant distractors has an impact on affective perception of facial expressions.	[Lim, Seung-Lark; Aupperle, Robin L.] Univ Missouri Kansas City, Dept Psychol, Kansas City, MO 64110 USA; [Bruce, Amanda S.] Univ Kansas, Med Ctr, Dept Pediat, Kansas City, KS 66103 USA; [Bruce, Amanda S.] Childrens Mercy Hosp, Ctr Childrens Hlth Lifestyle & Nutr, Kansas City, MO 64108 USA	University of Missouri System; University of Missouri Kansas City; University of Kansas; University of Kansas Medical Center; Children's Mercy Hospital	Lim, SL (corresponding author), Univ Missouri Kansas City, Dept Psychol, Kansas City, MO 64110 USA.	limse@umkc.edu	Lim, Seung-Lark/D-2664-2011; Aupperle, Robin/AAU-8550-2020	Lim, Seung-Lark/0000-0002-0360-6361	National Cancer Institute of the National Institutes of Health [R21CA184834 (PI: Lim)]; NATIONAL CANCER INSTITUTE [R21CA184834] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by the National Cancer Institute (http://www.cancer.gov/) of the National Institutes of Health under Award Number R21CA184834 (PI: Lim). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; Aviezer H, 2011, EMOTION, V11, P1406, DOI 10.1037/a0023578; Balconi M, 2009, INT J PSYCHOPHYSIOL, V74, P158, DOI 10.1016/j.ijpsycho.2009.08.006; Barrett LF, 2007, TRENDS COGN SCI, V11, P327, DOI 10.1016/j.tics.2007.06.003; Beaver JD, 2008, J NEUROSCI, V28, P2719, DOI 10.1523/JNEUROSCI.0033-08.2008; Bishop SJ, 2007, TRENDS COGN SCI, V11, P307, DOI 10.1016/j.tics.2007.05.008; Calder AJ, 2011, PHILOS T R SOC B, V366, P1684, DOI 10.1098/rstb.2010.0362; Carrasco M, 2006, PROG BRAIN RES, V154, P33; Carver CS, 2004, EMOTION, V4, P3, DOI 10.1037/1528-3542.4.1.3; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Clark L, 2004, NEUROCASE, V10, P398, DOI 10.1080/13554790490882799; Davidoff J, 2001, TRENDS COGN SCI, V5, P382, DOI 10.1016/S1364-6613(00)01726-5; Davis FC, 2011, EMOTION, V11, P647, DOI 10.1037/a0021625; Davis FC, 2010, CEREB CORTEX, V20, P612, DOI 10.1093/cercor/bhp126; de Gelder B, 2000, COGNITION EMOTION, V14, P289, DOI 10.1080/026999300378824; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Egner T, 2008, CEREB CORTEX, V18, P1475, DOI 10.1093/cercor/bhm179; Ekman P., 1976, PICTURES FACIAL AFFE; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Haxby JV, 2002, BIOL PSYCHIAT, V51, P59, DOI 10.1016/S0006-3223(01)01330-0; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Huang LQ, 2005, VISION RES, V45, P1201, DOI 10.1016/j.visres.2004.10.024; Hugenberg K, 2004, PSYCHOL SCI, V15, P342, DOI 10.1111/j.0956-7976.2004.00680.x; Iidaka T, 2010, J COGNITIVE NEUROSCI, V22, P2074, DOI 10.1162/jocn.2009.21347; Jack RE, 2012, P NATL ACAD SCI USA, V109, P7241, DOI 10.1073/pnas.1200155109; Kim H, 2004, J COGNITIVE NEUROSCI, V16, P1730, DOI 10.1162/0898929042947865; Lee TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032987; Lee TH, 2009, NEUROREPORT, V20, P750, DOI 10.1097/WNR.0b013e32832a5cfa; Lim SL, 2008, NEUROPSYCHOLOGIA, V46, P1267, DOI 10.1016/j.neuropsychologia.2007.12.003; Lim SL, 2008, EMOTION, V8, P96, DOI 10.1037/1528-3542.8.1.96; Lundqvist D., 1998, KAROLINSKA DIRECTED; Mandal MK, 2004, BEHAV NEUROL, V15, P23, DOI 10.1155/2004/786529; MATHEWS A, 1989, J ABNORM PSYCHOL, V98, P236, DOI 10.1037/0021-843X.98.3.236; McKinnon MC, 2007, COGNITION, V102, P179, DOI 10.1016/j.cognition.2005.12.011; Mobbs D, 2006, SOC COGN AFFECT NEUR, V1, P95, DOI 10.1093/scan/nsl014; Muller VI, 2011, NEUROIMAGE, V54, P2257, DOI 10.1016/j.neuroimage.2010.10.047; Pessoa L, 2005, NEUROIMAGE, V28, P249, DOI 10.1016/j.neuroimage.2005.05.048; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; Pessoa Luiz, 2010, Dialogues Clin Neurosci, V12, P433; Phelps EA, 2006, ANNU REV PSYCHOL, V57, P27, DOI 10.1146/annurev.psych.56.091103.070234; Phillips LH, 2008, EMOTION, V8, P184, DOI 10.1037/1528-3542.8.2.184; Posamentier MT, 2003, NEUROPSYCHOL REV, V13, P113, DOI 10.1023/A:1025519712569; Ravaja N, 2004, BIOL PSYCHOL, V65, P163, DOI 10.1016/S0301-0511(03)00078-4; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Righart R, 2008, COGN AFFECT BEHAV NE, V8, P264, DOI 10.3758/CABN.8.3.264; Righart R, 2008, SOC COGN AFFECT NEUR, V3, P270, DOI 10.1093/scan/nsn021; Rolls ET, 2007, NEUROPSYCHOLOGIA, V45, P124, DOI 10.1016/j.neuropsychologia.2006.04.019; RUSSELL JA, 1994, PSYCHOL BULL, V115, P102, DOI 10.1037/0033-2909.115.1.102; Said CP, 2011, PHILOS T R SOC B, V366, P1660, DOI 10.1098/rstb.2010.0351; Schwarz KA, 2013, SOC COGN AFFECT NEUR, V8, P438, DOI 10.1093/scan/nss013; SCLAR G, 1990, VISION RES, V30, P1, DOI 10.1016/0042-6989(90)90123-3; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Viskontas IV, 2007, ANN NY ACAD SCI, V1121, P528, DOI 10.1196/annals.1401.025; Wieser MJ, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00471; Wingrove J, 1999, NEUROPSYCHOPHARMACOL, V21, P755, DOI 10.1016/S0893-133X(99)00078-0; Wingrove J, 1998, AGGRESSIVE BEHAV, V24, P27, DOI 10.1002/(SICI)1098-2337(1998)24:1<27::AID-AB3>3.0.CO;2-P	59	9	9	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111074	10.1371/journal.pone.0111074	http://dx.doi.org/10.1371/journal.pone.0111074			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ1JF	25347772	Green Submitted, Green Published, gold			2022-12-27	WOS:000347994900043
J	Yang, Y; Jiang, XT; Zhang, T				Yang, Ying; Jiang, Xiao-Tao; Zhang, Tong			Evaluation of a Hybrid Approach Using UBLAST and BLASTX for Metagenomic Sequences Annotation of Specific Functional Genes	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE GENES; SIMILARITY SEARCH TOOL; ACTIVATED-SLUDGE; WATER TREATMENT; GENERATION; DATABASE	The fast development of next generation sequencing (NGS) has dramatically increased the application of metagenomics in various aspects. Functional annotation is a major step in the metagenomics studies. Fast annotation of functional genes has been a challenge because of the deluge of NGS data and expanding databases. A hybrid annotation pipeline proposed previously for taxonomic assignments was evaluated in this study for metagenomic sequences annotation of specific functional genes, such as antibiotic resistance genes, arsenic resistance genes and key genes in nitrogen metabolism. The hybrid approach using UBLAST and BLASTX is 44-177 times faster than direct BLASTX in the annotation using the small protein database for the specific functional genes, with the cost of missing a small portion (<1.8%) of target sequences compared with direct BLASTX hits. Different from direct BLASTX, the time required for specific functional genes annotation using the hybrid annotation pipeline depends on the abundance for the target genes. Thus this hybrid annotation pipeline is more suitable in specific functional genes annotation than in comprehensive functional genes annotation.	[Yang, Ying; Jiang, Xiao-Tao; Zhang, Tong] Univ Hong Kong, Dept Civil Engn, Environm Biotechnol Lab, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Zhang, T (corresponding author), Univ Hong Kong, Dept Civil Engn, Environm Biotechnol Lab, Hong Kong, Hong Kong, Peoples R China.	zhangt@hku.hk	Zhang, Tong/HGC-1090-2022; 張彤, Tong Zhang/C-6786-2008	Zhang, Tong/0000-0003-1148-4322; JIANG, Xiao-Tao/0000-0003-1804-5314	National Science Foundation of China (NSFC) [21277113]	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was financially supported by the National Science Foundation of China (NSFC 21277113). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Cai L, 2013, APPL MICROBIOL BIOT, V97, P9579, DOI 10.1007/s00253-012-4678-8; Chao YQ, 2013, SCI REP-UK, V3, DOI 10.1038/srep03550; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; MacDonald NJ, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks335; McArthur AG, 2013, ANTIMICROB AGENTS CH, V57, P3348, DOI 10.1128/AAC.00419-13; Pennisi E, 2011, SCIENCE, V331, P666, DOI 10.1126/science.331.6018.666; Sboner A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-125; Scholz MB, 2012, CURR OPIN BIOTECH, V23, P9, DOI 10.1016/j.copbio.2011.11.013; Thomas Torsten, 2012, Microb Inform Exp, V2, P3, DOI 10.1186/2042-5783-2-3; Yang Y, 2014, APPL MICROBIOL BIOT, V98, P5709, DOI 10.1007/s00253-014-5648-0; Yang Y, 2013, ENVIRON SCI TECHNOL, V47, P10197, DOI 10.1021/es4017365; Ye YZ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-159; Yu K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059831; Zhao YA, 2012, BIOINFORMATICS, V28, P125, DOI 10.1093/bioinformatics/btr595	19	29	32	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e110947	10.1371/journal.pone.0110947	http://dx.doi.org/10.1371/journal.pone.0110947			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347677	Green Published, Green Submitted, gold			2022-12-27	WOS:000347994900034
J	Chua, SK; Lo, HM; Chiu, CZ; Shyu, KG				Chua, Su-Kiat; Lo, Huey-Ming; Chiu, Chiung-Zuan; Shyu, Kou-Gi			Use of CHADS(2) and CHA(2)DS(2)-VASc Scores to Predict Subsequent Myocardial Infarction, Stroke, and Death in Patients with Acute Coronary Syndrome: Data from Taiwan Acute Coronary Syndrome Full Spectrum Registry	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; ATRIAL-FIBRILLATION; CARDIOVASCULAR EVENTS; TERM SURVIVAL; RISK; MANAGEMENT; STRATIFICATION; MORTALITY; HISTORY; TRENDS	Background: Acute coronary syndrome (ACS) patients have a wide spectrum of risks for subsequent cardiovascular events and death. However, there is no simple, convenience scoring system to identify risk of adverse outcomes. We investigated whether CHADS(2) and CHA(2)DS(2)-VASc scores were useful tools to assess the risk for adverse events among ACS patients. Methods: This observational prospective study was conducted at 39 hospitals. Totally 3,183 patients with ACS were enrolled, and CHADS(2) and CHA(2)DS(2)-VASc scores were calculated. The primary endpoint was occurrence of adverse event, including subsequent myocardial infarction, stroke, or death, within 1 year of discharge. Results: CHADS(2) and CHA(2)DS(2)-VASc scores were significant predictors of adverse events in separate multivariate regression analyses. A Kaplan-Meier analysis of CHADS(2) and CHA(2)DS(2)-VASc scores of >= 2 showed a higher rate of adverse events as compared with scores of <2 (P<0.001; log-rank test). CHA(2)DS(2)-VASc score was better than CHADS(2) score in predicting subsequent adverse events; the area under the receiver operating characteristic curve increased from 0.66 to 0.70 (p<0.001). Patients with CHADS(2) scores of 0 or 1 were further classified according to CHA(2)DS(2)-VASc score, using a cutoff value of 2. The rate of adverse events significantly differed between those with a score of <2 and those with a score of >= 2 (4.1% vs. 10.7%, P<0.001). Conclusions: CHADS(2) and CHA(2)DS(2)-VASc scores were useful predictors of subsequent adverse events in ACS patients.	[Chua, Su-Kiat; Shyu, Kou-Gi] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Chua, Su-Kiat; Lo, Huey-Ming; Chiu, Chiung-Zuan; Shyu, Kou-Gi] Shin Kong Wu Ho Su Mem Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Chua, Su-Kiat] Shin Kong Wu Ho Su Mem Hosp, Dept Gen Med, Taipei, Taiwan; [Lo, Huey-Ming; Chiu, Chiung-Zuan] Fu Jen Cathol Univ, Sch Med, New Taipei City, Taiwan	Taipei Medical University; Shin Kong Wu Ho Su Memorial Hospital; Shin Kong Wu Ho Su Memorial Hospital; Fu Jen Catholic University	Shyu, KG (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan.	shyukg@ms12.hinet.net			Sanofi-Aventis Taiwan Co. Ltd.; Bristol-Myers Squibb (Taiwan) Ltd.	Sanofi-Aventis Taiwan Co. Ltd.; Bristol-Myers Squibb (Taiwan) Ltd.(Bristol-Myers Squibb)	This study was supported by the Sanofi-Aventis Taiwan Co. Ltd. and Bristol-Myers Squibb (Taiwan) Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Thani HA, 2011, INT J VASC MED, V2011, DOI 10.1155/2011/815902; Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Armstrong PW, 1998, CIRCULATION, V98, P1860, DOI 10.1161/01.CIR.98.18.1860; Avezum A, 2005, AM HEART J, V149, P67, DOI 10.1016/j.ahj.2004.06.003; Boden H, 2012, J INTERN MED, V271, P521, DOI 10.1111/j.1365-2796.2012.02533.x; Boersma E, 2000, CIRCULATION, V101, P2557, DOI 10.1161/01.CIR.101.22.2557; Camm AJ, 2013, J INTERN MED, V273, P31, DOI 10.1111/joim.12001; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Chao TF, 2011, HEART RHYTHM, V8, P1155, DOI 10.1016/j.hrthm.2011.03.016; Crandall MA, 2009, PACE, V32, P981, DOI 10.1111/j.1540-8159.2009.02427.x; Daida H, 2013, CIRC J, V77, P934, DOI 10.1253/circj.CJ-13-0174; Das RR, 2008, STROKE, V39, P2929, DOI 10.1161/STROKEAHA.108.516575; Dormandy J, 1999, Semin Vasc Surg, V12, P118; Dormandy J, 1999, Semin Vasc Surg, V12, P123; Fox KAA, 2006, BMJ-BRIT MED J, V333, P1091, DOI 10.1136/bmj.38985.646481.55; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Fuster V, 2011, J AM COLL CARDIOL, V57, pE101, DOI 10.1016/j.jacc.2010.09.013; Goldberg RJ, 1998, AM J CARDIOL, V82, P1311, DOI 10.1016/S0002-9149(98)00633-X; Gustafsson F, 1998, EUR HEART J, V19, P588, DOI 10.1053/euhj.1997.0822; Henriksson KM, 2010, INT J CARDIOL, V141, P18, DOI 10.1016/j.ijcard.2008.11.122; Herman B, 1997, EUR HEART J, V18, P963; Hochman JS, 1999, NEW ENGL J MED, V341, P226, DOI 10.1056/NEJM199907223410402; Hochman JS, 1997, J AM COLL CARDIOL, V30, P141, DOI 10.1016/S0735-1097(97)00107-1; Leng GC, 1996, BMJ-BRIT MED J, V313, P1440, DOI 10.1136/bmj.313.7070.1440; Leng GC, 1996, INT J EPIDEMIOL, V25, P1172, DOI 10.1093/ije/25.6.1172; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Nakatani D, 2013, CIRC J, V77, P439, DOI 10.1253/circj.CJ-11-1059; Park JH, 2011, EUROPACE, V13, P1541, DOI 10.1093/europace/eur135; Poci D, 2012, CHEST, V141, P1431, DOI 10.1378/chest.11-0435; Roger VL, 2002, ANN INTERN MED, V136, P341, DOI 10.7326/0003-4819-136-5-200203050-00005; Rouleau JL, 1996, J AM COLL CARDIOL, V27, P1119, DOI 10.1016/0735-1097(95)00599-4; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Shyu KG, 2011, ACTA CARDIOL SIN, V27, P135	33	58	58	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111167	10.1371/journal.pone.0111167	http://dx.doi.org/10.1371/journal.pone.0111167			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343586	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943500084
J	Nie, XH; Pan, ZM; Zhang, DS; Zhou, H; Chen, M; Zhang, WN				Nie, Xinhua; Pan, Zhongming; Zhang, Dasha; Zhou, Han; Chen, Min; Zhang, Wenna			Energy Detection Based on Undecimated Discrete Wavelet Transform and Its Application in Magnetic Anomaly Detection	PLOS ONE			English	Article								Magnetic anomaly detection (MAD) is a passive approach for detection of a ferromagnetic target, and its performance is often limited by external noises. In consideration of one major noise source is the fractal noise (or called 1/f noise) with a power spectral density of 1/f(a) (0<a<2), which is non-stationary, self-similarity and long-range correlation. Meanwhile the orthonormal wavelet decomposition can play the role of a Karhunen-Loeve-type expansion to the 1/f-type signal by its decorrelation abilities, an effective energy detection method based on undecimated discrete wavelet transform (UDWT) is proposed in this paper. Firstly, the foundations of magnetic anomaly detection and UDWT are introduced in brief, while a possible detection system based on giant magneto-impedance (GMI) magnetic sensor is also given out. Then our proposed energy detection based on UDWT is described in detail, and the probabilities of false alarm and detection for given the detection threshold in theory are presented. It is noticeable that no a priori assumptions regarding the ferromagnetic target or the magnetic noise probability are necessary for our method, and different from the discrete wavelet transform (DWT), the UDWT is shift invariant. Finally, some simulations are performed and the results show that the detection performance of our proposed detector is better than that of the conventional energy detector even utilized in the Gaussian white noise, especially when the spectral parameter alpha is less than 1.0. In addition, a real-world experiment was done to demonstrate the advantages of the proposed method.	[Nie, Xinhua; Pan, Zhongming; Zhang, Dasha; Zhou, Han; Chen, Min; Zhang, Wenna] Natl Univ Def Technol, Coll Mechatron Engn & Automat, Changsha, Hunan, Peoples R China	National University of Defense Technology - China	Pan, ZM (corresponding author), Natl Univ Def Technol, Coll Mechatron Engn & Automat, Changsha, Hunan, Peoples R China.	chungmingpan@163.com			National Natural Science Foundation of China [91320202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China, NO. 91320202. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A., 2005, FDN ANALOG DIGITAL E, V1st; [Anonymous], 1999, WAVELET TOUR SIGNAL, DOI DOI 10.1016/B978-012466606-1/50016-7; Bahoura M, 2012, CIRC SYST SIGNAL PR, V31, P987, DOI 10.1007/s00034-011-9355-0; Bankhead P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032435; DAUBECHIES I, 1998, COMMUN PURE APPL MAT, V41, P909; Emanuele VA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048103; FLANDRIN P, 1992, IEEE T INFORM THEORY, V38, P910, DOI 10.1109/18.119751; Ginzburg B, 2002, SENSOR ACTUAT A-PHYS, V102, P67, DOI 10.1016/S0924-4247(02)00351-5; Guan T, 2014, IEEE MULTIMEDIA, V21, P32, DOI 10.1109/MMUL.2013.31; Guan T, 2013, IEEE T MULTIMEDIA, V15, P1688, DOI 10.1109/TMM.2013.2265674; He D, 2013, CIRC SYST SIGNAL PR, V32, P1891, DOI 10.1007/s00034-013-9552-0; He YZ, 2010, NDT&E INT, V43, P409, DOI 10.1016/j.ndteint.2010.03.007; Hirchoren GA, 1998, IEEE T SIGNAL PROCES, V46, P1624, DOI 10.1109/78.678478; Ji RR, 2012, ACM T INTEL SYST TEC, V3, DOI 10.1145/2168752.2168758; Kay, 1998, FUNDAMENTALS STAT SI; Kim WH, 1999, EL CIRC SYST C BRAT, P251; Meng XD, 2013, CIRC SYST SIGNAL PR, V32, P2003, DOI 10.1007/s00034-013-9549-8; Nie Xinhua, 2014, Journal of National University of Defense Technology, V36, P181; Nimgaonkar S, 2013, CIRC SYST SIGNAL PR, V32, P2581, DOI 10.1007/s00034-013-9621-4; Phan MH, 2008, PROG MATER SCI, V53, P323, DOI 10.1016/j.pmatsci.2007.05.003; Sheinker A, 2007, SENSOR ACTUAT A-PHYS, V138, P105, DOI 10.1016/j.sna.2007.04.018; Sheinker A, 2012, IEEE T GEOSCI REMOTE, V50, P1095, DOI 10.1109/TGRS.2011.2164086; Sheinker A, 2008, MEAS SCI TECHNOL, V19, DOI 10.1088/0957-0233/19/4/045205; Uchiyama T, 2012, IEEE T MAGN, V48, P3833, DOI 10.1109/TMAG.2012.2198627; WORNELL GW, 1993, P IEEE, V81, P1428, DOI 10.1109/5.241506; WORNELL GW, 1990, IEEE T INFORM THEORY, V36, P859, DOI 10.1109/18.53745; Yu GL, 2011, IEEE SENS J, V11, DOI 10.1109/JSEN.2011.2134084; Zhang L, 2013, T I MEAS CONTROL, V35, P625, DOI 10.1177/0142331212463026; Zhao W, 2012, J MAGN MAGN MATER, V324, P3073, DOI 10.1016/j.jmmm.2012.05.004	29	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110829	10.1371/journal.pone.0110829	http://dx.doi.org/10.1371/journal.pone.0110829			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343484	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943500059
J	Vetter, BN; Orlowski, V; Fransen, K; Niederhauser, C; Aubert, V; Brandenberger, M; Ciardo, D; Dollenmaier, G; Klimkait, T; Regenass, S; Schmid, P; Schottstedt, V; Suter-Riniker, F; Yerly, S; Shah, C; Boni, J; Schupbach, J				Vetter, Beatrice N.; Orlowski, Vanessa; Fransen, Katrien; Niederhauser, Christoph; Aubert, Vincent; Brandenberger, Marcel; Ciardo, Diana; Dollenmaier, Guenter; Klimkait, Thomas; Regenass, Stephan; Schmid, Patrick; Schottstedt, Volkmar; Suter-Riniker, Franziska; Yerly, Sabine; Shah, Cyril; Boeni, Juerg; Schuepbach, Joerg			Generation of a Recombinant Gag Virus-Like-Particle Panel for the Evaluation of p24 Antigen Detection by Diagnostic HIV Tests	PLOS ONE			English	Article							HEAT-DENATURED PLASMA; AG/AB COMBO ASSAY; ANTIRETROVIRAL THERAPY; SENSITIVE DETECTION; TYPE-1 INFECTION; SCREENING ASSAYS; ANTIBODY; RNA; TRANSMISSION; SEROCONVERSION	Background: Detection of HIV-1 p24 antigen permits early identification of primary HIV infection and timely intervention to limit further spread of the infection. Principally, HIV screening should equally detect all viral variants, but reagents for a standardised test evaluation are limited. Therefore, we aimed to create an inexhaustible panel of diverse HIV-1 p24 antigens. Methods: We generated a panel of 43 recombinantly expressed virus-like particles (VLPs), containing the structural Gag proteins of HIV-1 subtypes A-H and circulating recombinant forms (CRF) CRF01_AE, CRF02_AG, CRF12_BF, CRF20_BG and group O. Eleven 4th generation antigen/antibody tests and five antigen-only tests were evaluated for their ability to detect VLPs diluted in human plasma to p24 concentrations equivalent to 50, 10 and 2 IU/ml of the WHO p24 standard. Three tests were also evaluated for their ability to detect p24 after heat-denaturation for immune-complex disruption, a pre-requisite for ultrasensitive p24 detection. Results: Our VLP panel exhibited an average intra-clade p24 diversity of 6.7%. Among the 4th generation tests, the Abbott Architect and Siemens Enzygnost Integral 4 had the highest sensitivity of 97.7% and 93%, respectively. Alere Determine Combo and BioRad Access were least sensitive with 10.1% and 40.3%, respectively. Antigen-only tests were slightly more sensitive than combination tests. Almost all tests detected the WHO HIV-1 p24 standard at a concentration of 2 IU/ml, but their ability to detect this input for different subtypes varied greatly. Heat-treatment lowered overall detectability of HIV-1 p24 in two of the three tests, but only few VLPs had a more than 3-fold loss in p24 detection. Conclusions: The HIV-1 Gag subtype panel has a broad diversity and proved useful for a standardised evaluation of the detection limit and breadth of subtype detection of p24 antigen-detecting tests. Several tests exhibited problems, particularly with non-B subtypes.	[Vetter, Beatrice N.; Orlowski, Vanessa; Shah, Cyril; Boeni, Juerg; Schuepbach, Joerg] Univ Zurich, Inst Med Virol, SNCR, Zurich, Switzerland; [Fransen, Katrien] Inst Trop Med, B-2000 Antwerp, Belgium; [Niederhauser, Christoph] BSDSRK, Swiss Red Cross Bern, Blood Transfus Serv, Bern, Switzerland; [Aubert, Vincent] CHU Vaudois, Univ Hosp, Serv Immunol & Allergy, Lausanne, Switzerland; [Brandenberger, Marcel] Labor Synlab Luzern, Luzern, Switzerland; [Ciardo, Diana] Viollier AG, Allschwil, Switzerland; [Dollenmaier, Guenter] ZLMSG, Ctr Lab Med, St Gallen, Switzerland; [Klimkait, Thomas] Univ Basel, Dept Biomed, Basel, Switzerland; [Regenass, Stephan] Univ Hosp, Clin Immunol, Zurich, Switzerland; [Schmid, Patrick] KSSG, Cantonal Hosp St Gallen, Dept Infect Dis, St Gallen, Switzerland; [Schottstedt, Volkmar] DRK, German Red Cross Blood Transfus Serv West, Hagen, Germany; [Suter-Riniker, Franziska] Univ Bern, Inst Infect Dis, Bern, Switzerland; [Yerly, Sabine] HUG, Univ Hosp, Geneva, Switzerland	University of Zurich; Institute of Tropical Medicine (ITM); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Basel; University of Zurich; University Zurich Hospital; Kantonsspital St. Gallen; University of Bern; University of Geneva	Vetter, BN (corresponding author), Univ Zurich, Inst Med Virol, SNCR, Zurich, Switzerland.	vetter.beatrice@virology.uzh.ch	Boeni, Juerg/B-8386-2015; Schüpbach, Jörg/G-4209-2016	Schüpbach, Jörg/0000-0002-8074-5891; Klimkait, Thomas/0000-0003-4945-6511	Merck Sharp Dohme; Gilead	Merck Sharp Dohme(Merck & Company); Gilead(Gilead Sciences)	The authors have read the journal's policy and one author of this manuscript has the following competing interests: SY has received educational grants from Merck Sharp & Dohme and Gilead. The following authors were associated with private companies when this work was done: MB with Labor Synlab Luzern and DC with Viollier AG. Both companies are commercial diagnostic laboratories. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. All other authors have declared that no competing interests exist.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; BESNIER JM, 1990, LANCET, V335, P798, DOI 10.1016/0140-6736(90)90920-Z; Boni J, 1997, AIDS, V11, pF47, DOI 10.1097/00002030-199706000-00001; Branson BM, 2010, JAIDS-J ACQ IMM DEF, V55, pS102, DOI 10.1097/QAI.0b013e3181fbca44; Brennan CA, 2013, J CLIN VIROL, V57, P169, DOI 10.1016/j.jcv.2013.01.017; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Brinkhof MWG, 2006, JAIDS-J ACQ IMM DEF, V41, P557, DOI 10.1097/01.qai.0000209824.77784.2c; Busch Michael P., 1997, American Journal of Medicine, V102, P117, DOI 10.1016/S0002-9343(97)00077-6; BUSCH MP, 1995, TRANSFUSION, V35, P91, DOI 10.1046/j.1537-2995.1995.35295125745.x; Christiansen CB, 1996, VOX SANG, V70, P144, DOI 10.1111/j.1423-0410.1996.tb01312.x; Conway DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094062; Eshleman SH, 2009, JAIDS-J ACQ IMM DEF, V52, P121, DOI 10.1097/QAI.0b013e3181ab61e1; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Fiscus SA, 2007, J CLIN MICROBIOL, V45, P2274, DOI 10.1128/JCM.00813-07; Foley B., 2013, HIV SEQUENCE COMPEND; George E, 2007, J CLIN MICROBIOL, V45, P3416, DOI 10.1128/JCM.01314-07; Gottlieb GS, 2002, J INFECT DIS, V185, P905, DOI 10.1086/339295; Gueudin M, 2007, JAIDS-J ACQ IMM DEF, V44, P500, DOI 10.1097/QAI.0b013e31803260df; Hecht FM, 2006, J INFECT DIS, V194, P725, DOI 10.1086/506616; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Holmes H, 2008, J VIROL METHODS, V154, P86, DOI 10.1016/j.jviromet.2008.08.014; Kilembe W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037154; Le T, 2013, NEW ENGL J MED, V368, P218, DOI 10.1056/NEJMoa1110187; Ly TD, 2007, J VIROL METHODS, V143, P86, DOI 10.1016/j.jviromet.2007.02.013; Ly TD, 2012, J CLIN VIROL, V55, P121, DOI 10.1016/j.jcv.2012.06.012; Miedouge M, 2011, J CLIN VIROL, V50, P57, DOI 10.1016/j.jcv.2010.09.003; Muhlbacher A, 2013, MED MICROBIOL IMMUN, V202, P77, DOI 10.1007/s00430-012-0250-5; Pandori MW, 2009, J CLIN MICROBIOL, V47, P2639, DOI 10.1128/JCM.00119-09; RITTER J, 1990, VOX SANG, V59, P244, DOI 10.1111/j.1423-0410.1990.tb00246.x; Rosenberg NE, 2012, J INFECT DIS, V205, P528, DOI 10.1093/infdis/jir789; Schupbach J, 2006, J MED VIROL, V78, P1003, DOI 10.1002/jmv.20655; SCHUPBACH J, 1994, J INFECT DIS, V170, P318, DOI 10.1093/infdis/170.2.318; Schupbach J, 2005, JAIDS-J ACQ IMM DEF, V40, P250, DOI 10.1097/01.qai.0000181281.75670.56; SCHUPBACH J, 1993, J VIROL METHODS, V43, P247, DOI 10.1016/0166-0934(93)90080-B; Schupbach J, 1996, AIDS, V10, P1085; Schupbach Jorg, 2002, AIDS Reviews, V4, P83; Song EY, 2012, J MED VIROL, V84, P1884, DOI 10.1002/jmv.23423; Tao CM, 2013, J CLIN VIROL, V58, P221, DOI 10.1016/j.jcv.2013.05.012; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Torrecilla E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088099; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Weber B, 1998, J CLIN MICROBIOL, V36, P2235, DOI 10.1128/JCM.36.8.2235-2239.1998; World Health Organization, 2010, WHO REC DIAGN HIV IN; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	45	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111552	10.1371/journal.pone.0111552	http://dx.doi.org/10.1371/journal.pone.0111552			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343245	gold, Green Accepted, Green Published			2022-12-27	WOS:000343943500104
J	Zeng, W; Zeng, A; Liu, H; Shang, MS; Zhang, YC				Zeng, Wei; Zeng, An; Liu, Hao; Shang, Ming-Sheng; Zhang, Yi-Cheng			Similarity from Multi-Dimensional Scaling: Solving the Accuracy and Diversity Dilemma in Information Filtering	PLOS ONE			English	Article							RECOMMENDATION	Recommender systems are designed to assist individual users to navigate through the rapidly growing amount of information. One of the most successful recommendation techniques is the collaborative filtering, which has been extensively investigated and has already found wide applications in e-commerce. One of challenges in this algorithm is how to accurately quantify the similarities of user pairs and item pairs. In this paper, we employ the multidimensional scaling (MDS) method to measure the similarities between nodes in user-item bipartite networks. The MDS method can extract the essential similarity information from the networks by smoothing out noise, which provides a graphical display of the structure of the networks. With the similarity measured from MDS, we find that the item-based collaborative filtering algorithm can outperform the diffusion-based recommendation algorithms. Moreover, we show that this method tends to recommend unpopular items and increase the global diversification of the networks in long term.	[Zeng, Wei; Shang, Ming-Sheng; Zhang, Yi-Cheng] Univ Elect Sci & Technol China, Web Sci Ctr, Sch Comp Sci & Engn, Chengdu 610054, Peoples R China; [Zeng, Wei; Shang, Ming-Sheng] State Key Lab Networking & Switching Technol, Beijing, Peoples R China; [Zeng, Wei; Zeng, An; Liu, Hao; Zhang, Yi-Cheng] Univ Fribourg, Dept Phys, CH-1700 Fribourg, Switzerland; [Zhang, Yi-Cheng] Hangzhou Normal Univ, Inst Informat Econ, Hangzhou, Zhejiang, Peoples R China; [Zeng, An] Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China	University of Electronic Science & Technology of China; Beijing University of Posts & Telecommunications; University of Fribourg; Hangzhou Normal University; Beijing Normal University	Zeng, A (corresponding author), Univ Fribourg, Dept Phys, CH-1700 Fribourg, Switzerland.	an.zeng@unifr.ch; shang.mingsheng@gmail.com	Zeng, Wei/O-4804-2017		National Natural Science Foundation of China [61370150, 91324002]; Open Foundation of State Key Laboratory of Networking and Switching Technology [SKLNST-2013-1-18]; Program of Outstanding Ph.D. Candidate in Academic Research by UESTC [YBXSZC20131029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Foundation of State Key Laboratory of Networking and Switching Technology; Program of Outstanding Ph.D. Candidate in Academic Research by UESTC	This work is supported by the National Natural Science Foundation of China (Grant Nos. 61370150 and 91324002) and the Open Foundation of State Key Laboratory of Networking and Switching Technology (SKLNST-2013-1-18). W.Z. acknowledges support from the Program of Outstanding Ph.D. Candidate in Academic Research by UESTC (YBXSZC20131029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adomavicius G, 2005, IEEE T KNOWL DATA EN, V17, P734, DOI 10.1109/TKDE.2005.99; Becavin C, 2011, BIOINFORMATICS, V27, P1413, DOI 10.1093/bioinformatics/btr143; Berry MW, 1995, SIAM REV, V37, P573, DOI 10.1137/1037127; Breese J. S., 1998, Uncertainty in Artificial Intelligence. Proceedings of the Fourteenth Conference (1998), P43; Cremonesi P., 2010, RECSYS, P39, DOI [10.1145/1864708.1864721, DOI 10.1145/1864708.1864721]; Fouss F, 2007, IEEE T KNOWL DATA EN, V19, P355, DOI 10.1109/TKDE.2007.46; Herlocker JL, 2004, ACM T INFORM SYST, V22, P5, DOI 10.1145/963770.963772; Jamali Mohsen, 2010, P 4 ACM C REC SYST, P135, DOI DOI 10.1145/1864708.1864736; Kinoshita K, 2009, BIOINFORMATICS, V25, P2677, DOI 10.1093/bioinformatics/btp442; Koren Y, 2009, COMPUTER, V42, P30, DOI 10.1109/MC.2009.263; Koren Yehuda, 2008, KDD, P426, DOI DOI 10.1145/1401890.1401944; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Linden G, 2003, IEEE INTERNET COMPUT, V7, P76, DOI 10.1109/MIC.2003.1167344; Liu JG, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.037101; Lu L, 2011, PHYSICA A, V390; Lu LY, 2012, PHYS REP, V519, P1, DOI 10.1016/j.physrep.2012.02.006; Lu LY, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066119; Lu LY, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046122; Maslov S, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.248701; Qiu T, 2011, EPL-EUROPHYS LETT, V95, DOI 10.1209/0295-5075/95/58003; Sarwar B., 2001, PROC 10 INT WORLD WI, P285, DOI 10.1145/371920.372071; Schafer J. B., 1999, P 1 ACM C EL COMM, P158, DOI DOI 10.1145/336992.337035; Shang MS, 2009, EPL-EUROPHYS LETT, V88, DOI 10.1209/0295-5075/88/68008; Wang J., 2006, Proceedings of the Twenty-Ninth Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P501, DOI 10.1145/1148170.1148257; Zeng A, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/18005; Zeng W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079354; Zeng W, 2010, INT J MOD PHYS C, V21, P1217, DOI 10.1142/S0129183110015786; Zhang FG, 2012, EPL-EUROPHYS LETT, V100, DOI 10.1209/0295-5075/100/58005; Zhang YC, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.154301; Zhao DD, 2013, CHINESE PHYS LETT, V30, DOI 10.1088/0256-307X/30/11/118901; Zhou T, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046115; Zhou T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020648; Zhou T, 2009, EUR PHYS J B, V71, P623, DOI 10.1140/epjb/e2009-00335-8	37	6	6	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111005	10.1371/journal.pone.0111005	http://dx.doi.org/10.1371/journal.pone.0111005			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343243	Green Published, gold			2022-12-27	WOS:000343943500074
J	Choi, M; Wang, SE; Ko, SY; Kang, HJ; Chae, SY; Lee, SH; Kim, YS; Duman, RS; Son, H				Choi, Miyeon; Wang, Sung Eun; Ko, Seung Yeon; Kang, Hyo Jung; Chae, Seung Yeun; Lee, Seung Hoon; Kim, Yong-Seok; Duman, Ronald S.; Son, Hyeon			Overexpression of Human GATA-1 and GATA-2 Interferes with Spine Formation and Produces Depressive Behavior in Rats	PLOS ONE			English	Article							ANTIDEPRESSANT ACTIONS; TRANSCRIPTION FACTORS; DENDRITIC SPINES; GENE; EXPRESSION; PROMOTER; BRAIN; IDENTIFICATION; PLASTICITY; REGULATOR	Functional consequences to which vertebrate GATA transcription factors contribute in the adult brain remain largely an open question. The present study examines how human GATA-1 and GATA-2 (hGATA-1 and hGATA-2) are linked to neuronal differentiation and depressive behaviors in rats. We investigated the effects of adeno-associated viral expression of hGATA-1 and hGATA-2 (AAV-hGATA1 and AAV-hGATA2) in the dentate gyrus (DG) of the dorsal hippocampus on dendrite branching and spine number. We also examined the influence of AAV-hGATA1 and AAV-hGATA2 infusions into the dorsal hippocampus on rodent behavior in models of depression. Viral expression of hGATA-1 and hGATA-2 cDNA in rat hippocampal neurons impaired dendritic outgrowth and spine formation. Moreover, viral-mediated expression of hGATA-1 and hGATA-2 in the dorsal hippocampus caused depressive-like deficits in the forced swim test and learned helplessness models of depression, and decreased the expression of several synapse-related genes as well as spine number in hippocampal neurons. Conversely, shRNA knockdown of GATA-2 increased synapse-related gene expression, spine number, and dendrite branching. The results demonstrate that hGATA-1 and hGATA-2 expression in hippocampus is sufficient to cause depressive like behaviors that are associated with reduction in spine synapse density and expression of synapserelated genes.	[Choi, Miyeon; Kim, Yong-Seok; Son, Hyeon] Hanyang Univ, Coll Med, Dept Biochem & Mol Biol, Seoul 133791, South Korea; [Wang, Sung Eun; Ko, Seung Yeon; Chae, Seung Yeun; Lee, Seung Hoon; Kim, Yong-Seok; Son, Hyeon] Hanyang Univ, Grad Sch Biomed Sci & Engn, Seoul 133791, South Korea; [Kang, Hyo Jung] Chung Ang Univ, Dept Life Sci, Seoul 156756, South Korea; [Duman, Ronald S.] Yale Univ, Sch Med, Dept Psychiat, Lab Mol Psychiat,Ctr Genes & Behav, New Haven, CT USA; [Duman, Ronald S.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Duman, Ronald S.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA	Hanyang University; Hanyang University; Chung Ang University; Yale University; Yale University; Yale University	Son, H (corresponding author), Hanyang Univ, Coll Med, Dept Biochem & Mol Biol, Seoul 133791, South Korea.	hyeonson@hanyang.ac.kr	Kim, Yongseok/P-7501-2015	Kim, Yongseok/0000-0001-5062-7408; Wang, Sung Eun/0000-0002-0526-588X	National Research Foundation grant of Korea - Korea government [2011-0028317]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH105910, R01MH093897] Funding Source: NIH RePORTER	National Research Foundation grant of Korea - Korea government; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by National Research Foundation grant of Korea (No. 2011-0028317) funded by Korea government awarded to HS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banasr M, 2010, MOL PSYCHIATR, V15, P501, DOI 10.1038/mp.2008.106; Banasr M, 2008, BIOL PSYCHIAT, V64, P863, DOI 10.1016/j.biopsych.2008.06.008; Beauquis J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013993; Begley CG, 1999, BLOOD, V93, P2760; Craven SE, 2004, DEVELOPMENT, V131, P1165, DOI 10.1242/dev.01024; Denny JB, 2006, CURR NEUROPHARMACOL, V4, P293, DOI 10.2174/157015906778520782; Duric V, 2010, NAT MED, V16, P1328, DOI 10.1038/nm.2219; El Wakil A, 2006, DEVELOPMENT, V133, P2155, DOI 10.1242/dev.02377; Eyre H, 2012, PSYCHONEUROENDOCRINO, V37, P1397, DOI 10.1016/j.psyneuen.2012.03.019; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; GONG QH, 1991, MOL CELL BIOL, V11, P2558, DOI 10.1128/MCB.11.5.2558; Gumina RJ, 1997, BLOOD, V89, P1260, DOI 10.1182/blood.V89.4.1260; Gutierrez H, 2011, TRENDS NEUROSCI, V34, P316, DOI 10.1016/j.tins.2011.03.001; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Hommel JD, 2003, NAT MED, V9, P1539, DOI 10.1038/nm964; Hunsberger JG, 2007, NAT MED, V13, P1476, DOI 10.1038/nm1669; Kang HJ, 2012, NAT MED, V18, P1413, DOI 10.1038/nm.2886; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Keith D, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.004.2008; Kim JS, 2004, J NEUROCHEM, V89, P324, DOI 10.1046/j.1471-4159.2004.02329.x; Kumari J, 2009, MOL IMMUNOL, V46, P3099, DOI 10.1016/j.molimm.2009.06.008; Li NX, 2011, BIOL PSYCHIAT, V69, P754, DOI 10.1016/j.biopsych.2010.12.015; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; MELIA KR, 1994, J NEUROSCI, V14, P5929; MERIKA M, 1993, MOL CELL BIOL, V13, P3999, DOI 10.1128/MCB.13.7.3999; Minegishi N, 1998, J BIOL CHEM, V273, P3625, DOI 10.1074/jbc.273.6.3625; Morceau F, 2004, ANN NY ACAD SCI, V1030, P537, DOI 10.1196/annals.1329.064; Nardelli J, 1999, DEV BIOL, V210, P305, DOI 10.1006/dbio.1999.9278; Pan XQ, 2000, J BIOCHEM, V127, P105, DOI 10.1093/oxfordjournals.jbchem.a022570; Santarelli L, 2001, P NATL ACAD SCI USA, V98, P1912, DOI 10.1073/pnas.041596398; Shivdasani RA, 1996, BLOOD, V87, P4025, DOI 10.1182/blood.V87.10.4025.bloodjournal87104025; SHOLL DA, 1953, J ANAT, V87, P387; Son H, 2012, P NATL ACAD SCI USA, V109, P11378, DOI 10.1073/pnas.1201191109; Wallach I, 2009, PEDIATR RES, V65, P619, DOI 10.1203/PDR.0b013e31819ea3b8; Zhou YH, 2000, DEVELOPMENT, V127, P3829	37	13	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e109253	10.1371/journal.pone.0109253	http://dx.doi.org/10.1371/journal.pone.0109253			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340772	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662800007
J	Jones, AG; Shields, BM; Hyde, CJ; Henley, WE; Hattersley, AT				Jones, Angus G.; Shields, Beverley M.; Hyde, Christopher J.; Henley, William E.; Hattersley, Andrew T.			Identifying Good Responders to Glucose Lowering Therapy in Type 2 Diabetes: Implications for Stratified Medicine	PLOS ONE			English	Article							EFFICACY; ADJUSTMENT; INSULIN; TRIALS; MODELS	Aims: Defining responders to glucose lowering therapy can be important for both clinical care and for the development of a stratified approach to diabetes management. Response is commonly defined by either HbA1c change after treatment or whether a target HbA1c is achieved. We aimed to determine the extent to which the individuals identified as responders and non-responders to glucose lowering therapy, and their characteristics, depend on the response definition chosen. Methods: We prospectively studied 230 participants commencing GLP-1 agonist therapy. We assessed participant characteristics at baseline and repeated HbA1c after 3 months treatment. We defined responders (best quartile of response) based on HbA1c change or HbA1c achieved. We assessed the extent to which these methods identified the same individuals and how this affected the baseline characteristics associated with treatment response. Results: Different definitions of response identified different participants. Only 39% of responders by one definition were also good responders by the other. Characteristics associated with good response depend on the response definition chosen: good response by HbA1c achieved was associated with low baseline HbA1c (p<0.001), high C-peptide (p<0.001) and shorter diabetes duration (p = 0.01) whereas response defined by HbA1c change was associated with high HbA1c (p<0.001) only. We describe a simple novel method of defining treatment response based on a combination of HbA1c change and HbA1c achieved that defines response groups with similar baseline glycaemia. Conclusions: The outcome of studies aiming to identify predictors of treatment response to glucose lowering therapy may depend on how response is defined. Alternative definitions of response should be considered which minimise influence of baseline glycaemia.	[Jones, Angus G.; Shields, Beverley M.; Hattersley, Andrew T.] Univ Exeter, Sch Med, NIHR Exeter Clin Res Facil, Exeter, Devon, England; [Hyde, Christopher J.] Univ Exeter, Sch Med, Exeter, Devon, England; [Henley, William E.] Univ Exeter, Sch Med, Inst Hlth Res, Exeter, Devon, England	University of Exeter; University of Exeter; University of Exeter	Jones, AG (corresponding author), Univ Exeter, Sch Med, NIHR Exeter Clin Res Facil, Exeter, Devon, England.	angus.jones@exeter.ac.uk		Jones, Angus/0000-0002-0883-7599; Hattersley, Andrew/0000-0001-5620-473X; Christopher, Hyde/0000-0002-7349-0616	National Institute of Health Research (NIHR) (UK); NIHR; National Institute for Health Research (NIHR); MRC [MR/K005707/1] Funding Source: UKRI; Medical Research Council [MR/K005707/1] Funding Source: researchfish; National Institute for Health Research [DRF-2010-03-72, NF-SI-0611-10219, CL-2014-23-001] Funding Source: researchfish	National Institute of Health Research (NIHR) (UK)(National Institute for Health Research (NIHR)); NIHR(National Institute for Health Research (NIHR)); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The PRIBA study was funded by the National Institute of Health Research (NIHR) (UK). AGJ is funded by an NIHR Doctoral Research Fellowship. ATH is an NIHR Senior Investigator and a Wellcome Trust Senior Investigator. ATH and BMS are core staff members of the NIHR Exeter Clinical Research Facility. WEH is partially supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) for the South West Peninsula. The views given in this paper do not necessarily represent those of NIHR, the NHS or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anichini R, 2013, DIABETES METAB SYNDR, V6, P123, DOI 10.2147/DMSO.S42729; Bloomgarden ZT, 2006, DIABETES CARE, V29, P2137, DOI 10.2337/dc06-1120; DeFronzo RA, 2010, DIABETIC MED, V27, P309, DOI 10.1111/j.1464-5491.2010.02941.x; Esposito K, 2012, DIABETES OBES METAB, V14, P228, DOI 10.1111/j.1463-1326.2011.01512.x; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Gale Edwin A M, 2007, Diabetes Care, V30, P2989, DOI 10.2337/dc07-0155; Glymour MM, 2005, AM J EPIDEMIOL, V162, P267, DOI 10.1093/aje/kwi187; Hall GC, 2013, DIABETIC MED, V30, P681, DOI 10.1111/dme.12137; Hopewell JC, 2013, EUR HEART J, V34, P982, DOI 10.1093/eurheartj/ehs344; Mokwe E, 2004, HYPERTENSION, V43, P1202, DOI 10.1161/01.HYP.0000127924.67353.86; Pencek R, 2012, INT J CLIN PRACT; Penformis Martinez S, 2013, DIABETOLOGIA S1, V56; ROBINSON LD, 1991, INT STAT REV, V59, P227, DOI 10.2307/1403444; Rosenstock J, 2012, DIABETES CARE, V35, P955, DOI 10.2337/dc11-1434; Yanez ND, 1998, STAT MED, V17, P2597, DOI 10.1002/(SICI)1097-0258(19981130)17:22<2597::AID-SIM940>3.0.CO;2-G	15	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111235	10.1371/journal.pone.0111235	http://dx.doi.org/10.1371/journal.pone.0111235			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340784	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662800097
J	Perlikowski, D; Wisniewska, H; Goral, T; Kwiatek, M; Majka, M; Kosmala, A				Perlikowski, Dawid; Wisniewska, Halina; Goral, Tomasz; Kwiatek, Michal; Majka, Maciej; Kosmala, Arkadiusz			Identification of Kernel Proteins Associated with the Resistance to Fusarium Head Blight in Winter Wheat (Triticum aestivum L.)	PLOS ONE			English	Article							ALPHA-AMYLASE ACTIVITY; DEOXYNIVALENOL ACCUMULATION; INFECTION; GRAIN; GRAMINEARUM; TRICHOTHECENES; CONTAMINATION; GENOTYPE; PROTEOME; CULMORUM	Numerous potential components involved in the resistance to Fusarium head blight (FHB) in cereals have been indicated, however, our knowledge regarding this process is still limited and further work is required. Two winter wheat (Triticum aestivum L.) lines differing in their levels of resistance to FHB were analyzed to identify the most crucial proteins associated with resistance in this species. The presented work involved analysis of protein abundance in the kernel bulks of more resistant and more susceptible wheat lines using two-dimensional gel electrophoresis and mass spectrometry identification of proteins, which were differentially accumulated between the analyzed lines, after inoculation with F. culmorum under field conditions. All the obtained two-dimensional patterns were demonstrated to be well-resolved protein maps of kernel proteomes. Although, 11 proteins were shown to have significantly different abundance between these two groups of plants, only two are likely to be crucial and have a potential role in resistance to FHB. Monomeric alpha-amylase and dimeric alpha-amylase inhibitors, both highly accumulated in the more resistant line, after inoculation and in the control conditions. Fusarium pathogens can use hydrolytic enzymes, including amylases to colonize kernels and acquire nitrogen and carbon from the endosperm and we suggest that the inhibition of pathogen amylase activity could be one of the most crucial mechanisms to prevent infection progress in the analyzed wheat line with a higher resistance. Alpha-amylase activity assays confirmed this suggestion as it revealed the highest level of enzyme activity, after F. culmorum infection, in the line more susceptible to FHB.	[Perlikowski, Dawid; Wisniewska, Halina; Kwiatek, Michal; Majka, Maciej; Kosmala, Arkadiusz] Polish Acad Sci, Inst Plant Genet, Poznan, Poland; [Goral, Tomasz] Natl Res Inst, Plant Breeding & Acclimatizat Inst, Radzikow, Blonie, Poland	Polish Academy of Sciences; Institute of Plant Genetics of the Polish Academy of Sciences; Institute of Plant Breeding & Acclimatization	Kosmala, A (corresponding author), Polish Acad Sci, Inst Plant Genet, Poznan, Poland.	akos@igr.poznan.pl	Góral, Tomasz/I-4887-2019; Perlikowski, Dawid/ABA-1345-2020; Majka, Maciej/ABG-2805-2020; Kwiatek, Michał T./ABG-5673-2020; Kosmala, Arkadiusz/R-6737-2019	Góral, Tomasz/0000-0001-9130-6109; Perlikowski, Dawid/0000-0001-5532-5118; Majka, Maciej/0000-0002-5039-9465; Kwiatek, Michał T./0000-0001-9442-3124; Kosmala, Arkadiusz/0000-0002-1760-1334	Polish Ministry of Agriculture and Rural Development [HOR hn-078/PB/18/14 no. 6]	Polish Ministry of Agriculture and Rural Development	The study was supported by the Polish Ministry of Agriculture and Rural Development (HOR hn-078/PB/18/14 no. 6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bottalico A, 2002, EUR J PLANT PATHOL, V108, P611, DOI 10.1023/A:1020635214971; Bottalico A., 1998, MYCOTOXINS AGR FOOD, P65; Buerstmayr H, 2009, PLANT BREEDING, V128, P1, DOI 10.1111/j.1439-0523.2008.01550.x; Champeil A, 2004, PLANT SCI, V166, P1389, DOI 10.1016/j.plantsci.2004.02.004; Chelkowski J, 2001, OCCURRENCE TOXIGENIC, P111; Comeau A, 2008, CEREAL RES COMMUN, V36, P91; Cowger C, 2010, PHYTOPATHOLOGY, V100, P719, DOI 10.1094/PHYTO-100-7-0719; Ding LN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019008; Edwards SG, 2004, TOXICOL LETT, V153, P29, DOI 10.1016/j.toxlet.2004.04.022; Eggert K, 2011, PLANT PATHOL, V60, P918, DOI 10.1111/j.1365-3059.2011.02442.x; Eggert K, 2011, PROTEOMICS, V11, P972, DOI 10.1002/pmic.201000322; Foroud NA, 2009, INT J MOL SCI, V10, P147, DOI 10.3390/ijms10010147; Golinski P, 2010, FOOD ADDIT CONTAM A, V27, P1015, DOI 10.1080/19440041003702208; Gottwald S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-369; HURKMAN WJ, 1986, PLANT PHYSIOL, V81, P802, DOI 10.1104/pp.81.3.802; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Jackowiak H, 2005, INT J FOOD MICROBIOL, V98, P113, DOI 10.1016/j.ijfoodmicro.2004.05.014; Kiecana I, 2004, AGRONOMIJAS VESTIS L, V7, P165; Kosmala A, 2012, J EXP BOT, V63, P6161, DOI 10.1093/jxb/ers265; Langevin F, 2004, EUR J PLANT PATHOL, V110, P735, DOI 10.1023/B:EJPP.0000041568.31778.ad; Lunn GD, 2001, J CEREAL SCI, V33, P313, DOI 10.1006/jcrs.2001.0369; Mardi M, 2006, PLANT BREEDING, V125, P313, DOI 10.1111/j.1439-0523.2006.01228.x; Mares D, 2008, J CEREAL SCI, V47, P6, DOI 10.1016/j.jcs.2007.01.005; Masojc P, 2013, J APPL GENET, V54, P11, DOI 10.1007/s13353-012-0127-8; Masojc P, 2012, MOL BREEDING, V30, P1355, DOI 10.1007/s11032-012-9721-z; McCleary BV, 2002, J AOAC INT, V85, P1096; Mesterhazy A, 1995, PLANT BREEDING, V114, P377, DOI 10.1111/j.1439-0523.1995.tb00816.x; Miedaner T, 2001, PLANT BREEDING, V120, P97, DOI 10.1046/j.1439-0523.2001.00580.x; Mielniczuk E, 2004, BIOLOGIA, V59, P809; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Packa D, 2013, EJPAU, V16, p#06; Packa D., 2008, SEED SCI BIOTECHNOL, V2, P27; Paillard S, 2003, THEOR APPL GENET, V107, P1235, DOI 10.1007/s00122-003-1361-6; Perlikowski D, 2014, PLANT BIOLOGY, V16, P385, DOI 10.1111/plb.12074; Pirgozliev SR, 2003, EUR J PLANT PATHOL, V109, P731, DOI 10.1023/A:1026034509247; Pritsch C, 2000, MOL PLANT MICROBE IN, V13, P159, DOI 10.1094/MPMI.2000.13.2.159; Roberts TH, 2008, FUNCT INTEGR GENOMIC, V8, P1, DOI 10.1007/s10142-007-0059-2; SNIJDERS CHA, 1990, PHYTOPATHOLOGY, V80, P566, DOI 10.1094/Phyto-80-566; Svensson B, 2004, BBA-PROTEINS PROTEOM, V1696, P145, DOI 10.1016/j.bbapap.2003.07.004; Thitisaksakul M, 2012, J CEREAL SCI, V56, P67, DOI 10.1016/j.jcs.2012.04.002; Veronese P, 2003, PLANT PHYSIOL, V131, P1580, DOI 10.1104/pp.102.013417; Wang JH, 2005, J AGR FOOD CHEM, V53, P5818, DOI 10.1021/jf050525g; Wisniewska H, 2004, J PHYTOPATHOL, V152, P613, DOI 10.1111/j.1439-0434.2004.00904.x; Xu XM, 2007, PLANT PATHOL, V56, P943, DOI 10.1111/j.1365-3059.2007.01650.x; Yang F, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00037; Yang F, 2010, PROTEOMICS, V10, P3748, DOI 10.1002/pmic.201000243; Yang F, 2010, J PROTEOMICS, V73, P743, DOI 10.1016/j.jprot.2009.10.010; Zhang XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082079; Zhou WC, 2005, GENOME, V48, P770, DOI 10.1139/g05-041; Zhou WC, 2006, PROTEOMICS, V6, P4599, DOI 10.1002/pmic.200600052	50	14	14	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110822	10.1371/journal.pone.0110822	http://dx.doi.org/10.1371/journal.pone.0110822			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340555	Green Submitted, Green Published, gold			2022-12-27	WOS:000343662800058
J	Shen, JM; Feng, L; Feng, C				Shen, Jin-Ming; Feng, Lei; Feng, Chun			Role of mtDNA Haplogroups in the Prevalence of Osteoarthritis in Different Geographic Populations: A Meta-Analysis	PLOS ONE			English	Article							MITOCHONDRIAL-DNA HAPLOGROUPS; KNEE OSTEOARTHRITIS; OA CHONDROCYTES; SERUM-LEVELS; DISEASES; APOPTOSIS; CLASSIFICATION; EPIDEMIOLOGY; DYSFUNCTION; SELECTION	Background: Osteoarthritis (OA) is the most common form of arthritis and has become an increasingly important publichealth problem. However, the pathogenesis of OA is still unclear. In recent years, its correlation with mtDNA haplogroups attracts much attention. We aimed to perform a meta-analysis to investigate the association between mtDNA haplogroups and OA. Methods: Published English or Chinese literature from PubMed, Web of Science, SDOS, and CNKI was retrieved up until April 15, 2014. Case-control or cohort studies that detected the frequency of mtDNA haplogroups in OA patients and controls were included. The quality of the included studies was evaluated by the Newcastle-Ottawa Scale (NOS) assessment. A metaanalysis was conducted to calculate pooled odds ratio (OR) with 95% confidence interval (CI) through the random or fixed effect model, which was selected based on the between-study heterogeneity assessed by Q test and l(2) test. Subgroup analysis was performed to explore the origin of heterogeneity. Results: A total of 6 case-control studies (10590 cases and 7161 controls) with an average NOS score of 6.9 were involved. For the analysis between mtDNA haplogroup J and OA, random model was selected due to high heterogeneity. No significant association was found initially (OR = 0.73, 95% CI: 0.52-1.03), however, once any study from UK population was removed the association emerged. Further subgroup analysis demonstrated that there was a significant association in Spain population (OR = 0.57, 95% CI: 0.46-0.71), but not in UK population. Also, subgroup analysis revealed that there was a significant correlation between cluster TJ and OA in Spain population (OR = 0.70, 95% CI: 0.58-0.84), although not in UK population. No significant correlation was found between haplogroup T/cluster HV/cluster KU and OA. Conclusions: Our current meta-analysis suggests that mtDNA haplogroup J and cluster TJ correlate with the risk of OA in Spanish population, but the associations in other populations require further investigation.	[Shen, Jin-Ming; Feng, Lei] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Dept Orthoped, Hangzhou, Zhejiang, Peoples R China; [Feng, Chun] Zhejiang Univ, Sch Med, Womens Hosp, Dept Reprod Endocrinol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang Chinese Medical University; Zhejiang University	Shen, JM (corresponding author), Zhejiang Chinese Med Univ, Affiliated Hosp 1, Dept Orthoped, Hangzhou, Zhejiang, Peoples R China.	shenjinmg@gmail.com			Natural Science Foundation of China [81200446k]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of China, No. 81200446k, CF (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Blanco FJ, 2011, NAT REV RHEUMATOL, V7, P161, DOI 10.1038/nrrheum.2010.213; Carelli V, 2003, TRENDS GENET, V19, P257, DOI 10.1016/S0168-9525(03)00072-6; Chinnery PF, 2012, INT J EPIDEMIOL, V41, P177, DOI 10.1093/ije/dyr232; Cross M, 2014, ANN RHEUM DIS, V73, P1323, DOI 10.1136/annrheumdis-2013-204763; de Moura MB, 2010, ENVIRON MOL MUTAGEN, V51, P391, DOI 10.1002/em.20575; Dieppe PA, 2005, LANCET, V365, P965, DOI 10.1016/S0140-6736(05)71086-2; Fang HZ, 2014, INT J MOL SCI, V15, P2646, DOI 10.3390/ijms15022646; Fernandez-Moreno M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00129; Fernandez-Moreno M, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-283; Fernandez-Moreno M, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-264; Gavriilidis C, 2013, ARTHRITIS RHEUM-US, V65, P378, DOI 10.1002/art.37782; Grishko VI, 2009, OSTEOARTHR CARTILAGE, V17, P107, DOI 10.1016/j.joca.2008.05.009; Grishko V, 2009, J BIOL CHEM, V284, P9132, DOI 10.1074/jbc.M804178200; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hudson G, 2013, ANN RHEUM DIS, V72, P136, DOI 10.1136/annrheumdis-2012-201932; Kim J, 2010, OSTEOARTHR CARTILAGE, V18, P424, DOI 10.1016/j.joca.2009.09.008; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Lu Hong-bin, 2006, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V31, P640; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P2410, DOI 10.1002/1529-0131(200011)43:11<2410::AID-ANR6>3.0.CO;2-E; McDonnell SM, 2007, J BONE JOINT SURG BR, V89B, P901, DOI 10.1302/0301-620X.89B7.18915; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Pala M, 2012, AM J HUM GENET, V90, P915, DOI 10.1016/j.ajhg.2012.04.003; Reddy PH, 2012, BBA-MOL BASIS DIS, V1822, P101, DOI 10.1016/j.bbadis.2011.10.016; Rego I, 2010, ANN RHEUM DIS, V69, P210, DOI 10.1136/ard.2008.105254; Rego I, 2008, OSTEOARTHRITIS CA S4, V16, pS159; Rego-Perez I, 2011, ANN RHEUM DIS, V70, P646, DOI 10.1136/ard.2010.133637; Rego-Perez I, 2010, ANN RHEUM DIS, V69, P910, DOI 10.1136/ard.2009.117416; Rego-Perez I, 2008, ARTHRITIS RHEUM-US, V58, P2387, DOI 10.1002/art.23659; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Sangha O, 2000, RHEUMATOLOGY, V39, P3, DOI 10.1093/rheumatology/39.suppl_2.3; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; Soto-Hermida A, 2014, MITOCHONDRION, V15, P18, DOI 10.1016/j.mito.2014.03.001; Terkeltaub R, 2002, MITOCHONDRION, V1, P301, DOI 10.1016/S1567-7249(01)00037-X; Torroni A, 1996, GENETICS, V144, P1835; Vilaca ST, 2014, J BIOGEOGR, V41, P987, DOI 10.1111/jbi.12268; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wells GA., 2015, NEWCASTLE OTTAWA SCA; Yan MH, 2013, FREE RADICAL BIO MED, V62, P90, DOI 10.1016/j.freeradbiomed.2012.11.014	40	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e108896	10.1371/journal.pone.0108896	http://dx.doi.org/10.1371/journal.pone.0108896			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340756	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662800006
J	Zhou, ZW; Zhang, BC; Guo, K; Li, W; Zhang, R; Zhang, PP; Li, YG				Zhou, Zhi-Wen; Zhang, Bu-Chun; Guo, Kai; Li, Wei; Zhang, Rui; Zhang, Peng-Pai; Li, Yi-Gang			Acute Impact of Pacing at Different Cardiac Sites on Left Ventricular Rotation and Twist in Dogs	PLOS ONE			English	Article							HEART-FAILURE; RESYNCHRONIZATION THERAPY; TISSUE-DOPPLER; SYNCHRONY; DYSSYNCHRONY; ACTIVATION; DURATION; TORSION; MODEL; APEX	Objectives: We evaluated the acute impact of different cardiac pacing sites on two-dimensional speckle-tracking echocardiography (STE) derived left ventricular (LV) rotation and twist in healthy dogs. Methods: Twelve dogs were used in this study. The steerable pacing electrodes were positioned into right heart through the superior or inferior vena cava, into LV through aorta across the aortic valve. The steerable pacing electrodes were positioned individually in the right atrium (RA), right ventricular apex (RVA), RV outflow tract (RVOT), His bundle (HB), LV apex (LVA) and LV high septum (LVS), individual pacing mode was applied at 10 minutes interval for at least 5 minutes from each position under fluoroscopy and ultrasound guidance and at stabilized hemodynamic conditions. LV short-axis images at the apical and basal levels were obtained during sinus rhythm and pacing. Offline STE analysis was performed. Rotation, twist, time to peak rotation (TPR), time to peak twist (TPT), and apical-basal rotation delay (rotational synchronization index, RSI) values were compared at various conditions. LV pressure was monitored simultaneously. Results: Anesthetic death occurred in 1 dog, and another dog was excluded because of bad imaging quality. Data from 10 dogs were analyzed. RVA, RVOT, HB, LVA, LVS, RARV (RA+RVA) pacing resulted in significantly reduced apical and basal rotation and twist, significantly prolonged apical TPR, TPT and RSI compared to pre-pacing and RA pacing (all P<0.05). The apical and basal rotation and twist values were significantly higher during HB pacing than during pacing at ventricular sites (all P<0.05, except basal rotation at RVA pacing). The apical TPR during HB pacing was significantly shorter than during RVOT and RVA pacing (both P<0.05). The LV end systolic pressure (LVESP) was significantly lower during ventricular pacing than during pre-pacing and RA pacing. Conclusions: Our results show that RA and HB pacing results in less acute reduction on LV twist, rotation and LVESP compared to ventricular pacing.	[Zhou, Zhi-Wen; Guo, Kai; Li, Wei; Zhang, Rui; Zhang, Peng-Pai; Li, Yi-Gang] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Dept Cardiol, Shanghai 200030, Peoples R China; [Zhou, Zhi-Wen] Shanghai Xuhui Cent Hosp, Dept Cardiol, Shanghai, Peoples R China; [Zhang, Bu-Chun] Xuzhou Med Coll, Affiliated Hosp, Dept Cardiol, Xuzhou, Jiangsu, Peoples R China	Shanghai Jiao Tong University; Xuzhou Medical University	Li, YG (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Dept Cardiol, Shanghai 200030, Peoples R China.	drliyigang@outlook.com			China Postdoctoral Science Foundation [2012M511114]; National Natural Science Foundation of China [81070154, 81270258]; Shanghai Committee of Science and Technology [11JC1408200]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	This work was supported by China Postdoctoral Science Foundation (NO: 2012M511114), the National Natural Science Foundation of China (No: 81070154 and 81270258), and the Shanghai Committee of Science and Technology (NO: 11JC1408200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen AE, 2008, EUROPACE, V10, P127, DOI 10.1093/europace/eum279; Barba-Pichardo R, 2008, REV ESP CARDIOL, V61, P1096; Barba-Pichardo R, 2013, EUROPACE, V15, P83, DOI 10.1093/europace/eus228; Barba-Pichardo R, 2010, EUROPACE, V12, P527, DOI 10.1093/europace/euq038; Burns AT, 2008, HEART, V94, P978, DOI 10.1136/hrt.2007.120410; Burns AT, 2009, JACC-CARDIOVASC IMAG, V2, P709, DOI 10.1016/j.jcmg.2009.01.015; Burns KV, 2011, J CARD FAIL, V17, P495, DOI 10.1016/j.cardfail.2011.02.011; Catanzariti D, 2013, EUROPACE, V15, P546, DOI 10.1093/europace/eus313; Delgado V, 2009, CIRC-ARRHYTHMIA ELEC, V2, P135, DOI 10.1161/CIRCEP.108.814608; Deshmukh PM, 2004, PACE, V27, P862, DOI 10.1111/j.1540-8159.2004.00548.x; Domenichini G, 2012, EUR J INTERN MED, V23, P621, DOI 10.1016/j.ejim.2012.03.012; Friedberg MK, 2006, AM J CARDIOL, V97, P101, DOI 10.1016/j.amjcard.2005.07.127; Hara M, 2011, ECHOCARDIOGR-J CARD, V28, P69, DOI 10.1111/j.1540-8175.2010.01257.x; Hu K, 1998, CARDIOVASC RES, V39, P401, DOI 10.1016/S0008-6363(98)00090-X; Hu K, 2013, EUR HEART J-CARD IMG, V14, P205, DOI 10.1093/ehjci/jes240; Ji L, 2010, ECHOCARDIOGR-J CARD, V27, P1219, DOI 10.1111/j.1540-8175.2010.01221.x; Johnson L, 2007, AM J PHYSIOL-HEART C, V293, pH3046, DOI 10.1152/ajpheart.00728.2007; Kavanagh KM, 2008, CARDIOVASC RES, V77, P81, DOI 10.1093/cvr/cvm036; Kim WJ, 2009, CIRC-CARDIOVASC IMAG, V2, P123, DOI 10.1161/CIRCIMAGING.108.794719; Manolis AS, 2006, PACE, V29, P298, DOI 10.1111/j.1540-8159.2006.00338.x; Matsuoka K, 2009, J AM SOC ECHOCARDIOG, V22, P914, DOI 10.1016/j.echo.2009.05.001; Neilan TG, 2008, AM J PHYSIOL-HEART C, V294, pH2106, DOI 10.1152/ajpheart.01128.2007; Nielsen JC, 2011, EUR HEART J, V32, P686, DOI 10.1093/eurheartj/ehr022; Occhetta Eraldo, 2007, Indian Pacing Electrophysiol J, V7, P110; Padeletti L, 2007, AM J CARDIOL, V100, P1556, DOI 10.1016/j.amjcard.2007.06.055; Peschar M, 2003, J AM COLL CARDIOL, V41, P1218, DOI 10.1016/S0735-1097(03)00091-3; Poerner TC, 2007, ULTRASOUND MED BIOL, V33, P699, DOI 10.1016/j.ultrasmedbio.2006.11.014; RADEMAKERS FE, 1992, CIRCULATION, V85, P1572, DOI 10.1161/01.CIR.85.4.1572; Russel IK, 2009, JACC-CARDIOVASC IMAG, V2, P648, DOI 10.1016/j.jcmg.2009.03.001; Sade LE, 2008, AM J CARDIOL, V101, P1163, DOI 10.1016/j.amjcard.2007.11.069; Simantirakis EN, 2009, EUROPACE, V11, P77, DOI 10.1093/europace/eup277; Smith JJ, 1990, CIRCULATORY PHYSL ES, P40; Sweeney MO, 2003, CIRCULATION, V107, P2932, DOI 10.1161/01.CIR.0000072769.17295.B1; Takeuchi M, 2007, EUR HEART J, V28, P2756, DOI 10.1093/eurheartj/ehm440; Tanabe M, 2008, J AM SOC ECHOCARDIOG, V21, P1382, DOI 10.1016/j.echo.2008.09.012; van Deursen C, 2009, CIRC-ARRHYTHMIA ELEC, V2, P580, DOI 10.1161/CIRCEP.108.846022; Vanerio G, 2008, J INTERV CARD ELECTR, V21, P195, DOI 10.1007/s10840-008-9238-x; Varma N, 2012, J ELECTROCARDIOL, V45, P660, DOI 10.1016/j.jelectrocard.2012.07.003; Yoon HJ, 2009, ECHOCARDIOGR-J CARD, V26, P665, DOI 10.1111/j.1540-8175.2008.00855.x	39	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111231	10.1371/journal.pone.0111231	http://dx.doi.org/10.1371/journal.pone.0111231			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340769	gold, Green Published, Green Submitted			2022-12-27	WOS:000343662800096
J	Al-Safadi, S; Al-Safadi, A; Branchaud, M; Rutherford, S; Dayanandan, A; Robinson, B; Amir, S				Al-Safadi, Sherin; Al-Safadi, Aya; Branchaud, Marie; Rutherford, Spencer; Dayanandan, Arun; Robinson, Barry; Amir, Shimon			Stress-Induced Changes in the Expression of the Clock Protein PERIOD1 in the Rat Limbic Forebrain and Hypothalamus: Role of Stress Type, Time of Day, and Predictability	PLOS ONE			English	Article							CHRONIC UNPREDICTABLE STRESS; MAMMALIAN CIRCADIAN CLOCK; CENTRAL EXTENDED AMYGDALA; SUPRACHIASMATIC NUCLEUS; MESSENGER-RNA; PSYCHOSOCIAL STRESS; STRIA TERMINALIS; OVAL NUCLEUS; BED NUCLEUS; HPA AXIS	Stressful events can disrupt circadian rhythms in mammals but mechanisms underlying this disruption remain largely unknown. One hypothesis is that stress alters circadian protein expression in the forebrain, leading to functional dysregulation of the brain circadian network and consequent disruption of circadian physiological and behavioral rhythms. Here we characterized the effects of several different stressors on the expression of the core clock protein, PER1 and the activity marker, FOS in select forebrain and hypothalamic nuclei in rats. We found that acute exposure to processive stressors, restraint and forced swim, elevated PER1 and FOS expression in the paraventricular and dorsomedial hypothalamic nuclei and piriform cortex but suppressed PER1 and FOS levels exclusively in the central nucleus of the amygdala (CEAI) and oval nucleus of the bed nucleus of the stria terminalis (BNSTov). Conversely, systemic stressors, interleukin-1 beta and 2-Deoxy-D-glucose, increased PER1 and FOS levels in all regions studied, including the CEAI and BNSTov. PER1 levels in the suprachiasmatic nucleus (SCN), the master pacemaker, were unaffected by any of the stress manipulations. The effect of stress on PER1 and FOS was modulated by time of day and, in the case of daily restraint, by predictability. These results demonstrate that the expression of PER1 in the forebrain is modulated by stress, consistent with the hypothesis that PER1 serves as a link between stress and the brain circadian network. Furthermore, the results show that the mechanisms that control PER1 and FOS expression in CEAI and BNSTov are uniquely sensitive to differences in the type of stressor. Finally, the finding that the effect of stress on PER1 parallels its effect on FOS supports the idea that Per1 functions as an immediate-early gene. Our observations point to a novel role for PER1 as a key player in the interface between stress and circadian rhythms.	[Al-Safadi, Sherin; Dayanandan, Arun; Amir, Shimon] Concordia Univ, Dept Biol, 1455 De Maisonneuve Blvd W, Montreal, PQ H3G 1M8, Canada; [Al-Safadi, Sherin; Al-Safadi, Aya; Branchaud, Marie; Rutherford, Spencer; Dayanandan, Arun; Robinson, Barry; Amir, Shimon] Concordia Univ, Dept Psychol, Ctr Studies Behav Neurobiol, Montreal, PQ H3G 1M8, Canada	Concordia University - Canada; Concordia University - Canada	Amir, S (corresponding author), Concordia Univ, Dept Biol, 1455 De Maisonneuve Blvd W, Montreal, PQ H3G 1M8, Canada.	shimon.amir@concordia.ca	Rutherford, Spencer/GPS-9422-2022; Amir, Shimon/AAE-4635-2022		Natural Sciences and Engineering Research Council of Canada [37358]; le Fonds de la recherche en sante Quebec; Concordia University Research Chair Program	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); le Fonds de la recherche en sante Quebec; Concordia University Research Chair Program	Supported by grants from the Natural Sciences and Engineering Research Council of Canada (Grant # 37358), le Fonds de la recherche en sante Quebec and the Concordia University Research Chair Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca C, 2002, P NATL ACAD SCI USA, V99, P9026, DOI 10.1073/pnas.142039099; Akashi M, 2000, GENE DEV, V14, P645; Akhisaroglu M, 2004, PHARMACOL BIOCHEM BE, V79, P37, DOI 10.1016/j.pbb.2004.06.014; Albrecht U, 2012, NEURON, V74, P246, DOI 10.1016/j.neuron.2012.04.006; Amir S, 2004, J NEUROSCI, V24, P781, DOI 10.1523/JNEUROSCI.4488-03.2004; Anisman H, 2005, CURR PHARM DESIGN, V11, P963, DOI 10.2174/1381612053381701; Anisman H, 2001, BEHAV NEUROSCI, V115, P443, DOI 10.1037/0735-7044.115.2.443; Araujo APN, 2003, BEHAV BRAIN RES, V139, P75, DOI 10.1016/S0166-4328(02)00088-8; Babb JA, 2014, STRESS, V17, P224, DOI 10.3109/10253890.2014.905534; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Bartlang MS, 2014, CHRONOBIOL INT, V31, P996, DOI 10.3109/07420528.2014.940085; Bartlang MS, 2012, J ENDOCRINOL, V215, P425, DOI 10.1530/JOE-12-0267; Beaule C, 2001, NEUROSCIENCE, V106, P249, DOI 10.1016/S0306-4522(01)00313-X; Braga ANG, 2002, AM J PHYSIOL-REG I, V282, pR1663, DOI 10.1152/ajpregu.00583.2001; Cheon S, 2013, NUCLEIC ACIDS RES, V41, P6161, DOI 10.1093/nar/gkt307; Chung S, 2011, BBA-MOL BASIS DIS, V1812, P581, DOI 10.1016/j.bbadis.2011.02.003; Daskalakis NP, 2014, PSYCHONEUROENDOCRINO, V39, P39, DOI 10.1016/j.psyneuen.2013.09.021; Day HEW, 2005, EUR J NEUROSCI, V21, P441, DOI 10.1111/j.1460-9568.2005.03865.x; Day HEW, 2004, BRAIN RES, V1025, P139, DOI 10.1016/j.brainres.2004.07.079; Dayas CV, 2001, EUR J NEUROSCI, V14, P1143, DOI 10.1046/j.0953-816x.2001.01733.x; Dickmeis T, 2009, J ENDOCRINOL, V200, P3, DOI 10.1677/JOE-08-0415; Dong L, 2011, AM J PSYCHIAT, V168, P1090, DOI 10.1176/appi.ajp.2011.10111579; Emmert MH, 1999, BRAIN RES, V845, P60, DOI 10.1016/S0006-8993(99)01931-9; Fuchs E, 2003, PHYSIOL BEHAV, V79, P417, DOI 10.1016/S0031-9384(03)00161-6; Gadek-Michalska A, 2013, PHARMACOL REP, V65, P1163; Gattermann R, 1996, J EXP ANIM SCI, V38, P66; Gery S, 2007, CLIN CANCER RES, V13, P1399, DOI 10.1158/1078-0432.CCR-06-1730; Gibb J, 2013, BRAIN BEHAV IMMUN, V28, P149, DOI 10.1016/j.bbi.2012.11.004; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Haile CN, 2001, PSYCHOPHARMACOLOGY, V154, P213, DOI 10.1007/s002130000650; Hammen C, 2009, DEPRESS ANXIETY, V26, P718, DOI 10.1002/da.20571; Harbour VL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076391; Hastings MH, 2004, J BIOL RHYTHM, V19, P400, DOI 10.1177/0748730404268786; Herman JP, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00061; Herman JP, 2012, ALCOHOL RES-CURR REV, V34, P441; Herzog ED, 1998, NAT NEUROSCI, V1, P708, DOI 10.1038/3708; HOFFMAN GE, 1993, FRONT NEUROENDOCRIN, V14, P173, DOI 10.1006/frne.1993.1006; Ishida A, 2005, CELL METAB, V2, P297, DOI 10.1016/j.cmet.2005.09.009; Jang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049993; Jiang WG, 2011, BRAIN RES, V1399, P25, DOI 10.1016/j.brainres.2011.05.001; Kalsbeek A, 2012, MOL CELL ENDOCRINOL, V349, P20, DOI 10.1016/j.mce.2011.06.042; Kario K, 2002, HYPERTENS RES, V25, P543; Kinoshita C, 2012, NEUROREPORT, V23, P98, DOI 10.1097/WNR.0b013e32834e7ec2; Koresh O, 2012, EUR NEUROPSYCHOPHARM, V22, P205, DOI 10.1016/j.euroneuro.2011.07.012; Kosobud Ann E K, 2007, ScientificWorldJournal, V7, P203; Kudielka BM, 2004, PSYCHONEUROENDOCRINO, V29, P983, DOI 10.1016/j.psyneuen.2003.08.009; Lamont EW, 2005, P NATL ACAD SCI USA, V102, P4180, DOI 10.1073/pnas.0500901102; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Matsui Daisuke, 2005, Kobe Journal of Medical Sciences, V51, P85; Meerlo P, 2002, STRESS, V5, P15, DOI 10.1080/102538902900012323; Meijer JH, 1998, J NEUROSCI, V18, P9078; Miller ES, 1998, PHYSIOL BEHAV, V65, P535, DOI 10.1016/S0031-9384(98)00199-1; Minami Y, 2002, FEBS LETT, V526, P115, DOI 10.1016/S0014-5793(02)03159-9; Nader N, 2010, TRENDS ENDOCRIN MET, V21, P277, DOI 10.1016/j.tem.2009.12.011; O'Callaghan EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047087; Paladino N, 2010, J NEUROIMMUNOL, V225, P62, DOI 10.1016/j.jneuroim.2010.04.015; Perreau-Lenz S, 2008, DRUG NEWS PERSPECT, V21, P211, DOI 10.1358/dnp.2008.21.4.1213350; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Roeser K, 2012, PHYSIOL BEHAV, V106, P151, DOI 10.1016/j.physbeh.2012.01.023; Sage D, 2001, AM J PHYSIOL-ENDOC M, V280, pE260, DOI 10.1152/ajpendo.2001.280.2.E260; Segall LA, 2006, NEUROSCIENCE, V140, P753, DOI 10.1016/j.neuroscience.2006.03.037; Segall LA, 2009, NEUROSCI LETT, V457, P58, DOI 10.1016/j.neulet.2009.03.083; Segall LA, 2010, J MOL NEUROSCI, V42, P168, DOI 10.1007/s12031-010-9341-1; Segall LA, 2010, J MOL NEUROSCI, V42, P176, DOI 10.1007/s12031-010-9375-4; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Smale L, 2001, BRAIN RES, V899, P101, DOI 10.1016/S0006-8993(01)02205-3; Spencer S, 2013, EUR J NEUROSCI, V37, P242, DOI 10.1111/ejn.12010; Strausbaugh HJ, 1999, P NATL ACAD SCI USA, V96, P14629, DOI 10.1073/pnas.96.25.14629; Swanson LW., 2004, BRAIN MAPS STRUCTURE, V3rd edition; Takahashi S, 2001, ENDOCRINOLOGY, V142, P4910, DOI 10.1210/en.142.11.4910; Tasker JG, 2006, ENDOCRINOLOGY, V147, P5549, DOI 10.1210/en.2006-0981; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Verwey M, 2009, EUR J NEUROSCI, V29, P2217, DOI 10.1111/j.1460-9568.2009.06766.x; Wong CCP, 2012, J NEURAL TRANSM, V119, P1111, DOI 10.1007/s00702-012-0829-4; Yamamoto T, 2005, J BIOL CHEM, V280, P42036, DOI 10.1074/jbc.M509600200; Yang XM, 2009, CHRONOBIOL INT, V26, P1323, DOI 10.3109/07420520903431301; Zhang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016212; Zucchi FCR, 2009, BEHAV BRAIN RES, V205, P67, DOI 10.1016/j.bbr.2009.06.030	78	20	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e111166	10.1371/journal.pone.0111166	http://dx.doi.org/10.1371/journal.pone.0111166			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338089	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000343674800109
J	Kim, J; Moon, SH; Kim, BT; Chae, CH; Lee, JY; Kim, SH				Kim, Jiyeon; Moon, Seong-Hee; Kim, Bum Tae; Chae, Chong Hak; Lee, Joo Yun; Kim, Seong Hwan			A Novel Aminothiazole KY-05009 with Potential to Inhibit Traf2-and Nck-Interacting Kinase (TNIK) Attenuates TGF-beta 1-Mediated Epithelial-to-Mesenchymal Transition in Human Lung Adenocarcinoma A549 Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; FOCAL-ADHESION KINASE; BREAST-CANCER; E-CADHERIN; PANCREATIC-CANCER; INVASION; PAXILLIN; CATENIN; PHOSPHORYLATION; METASTASIS	Transforming growth factor (TGF)-beta triggers the epithelial-to-mesenchymal transition (EMT) of cancer cells via well-orchestrated crosstalk between Smad and non-Smad signaling pathways, including Wnt/beta-catenin. Since EMT-induced motility and invasion play a critical role in cancer metastasis, EMT-related molecules are emerging as novel targets of anticancer therapies. Traf2- and Nck-interacting kinase (TNIK) has recently been considered as a first-in-class anti-cancer target molecule to regulate Wnt signaling pathway, but pharmacologic inhibition of its EMT activity has not yet been studied. Here, using 5-(4-methylbenzamido)-2-(phenylamino) thiazole-4-carboxamide (KY-05009) with TNIK-inhibitory activity, its efficacy to inhibit EMT in cancer cells was validated. The molecular docking/binding study revealed the binding of KY-05009 in the hinge region of TNIK, and the inhibitory activity of KY-05009 against TNIK was confirmed by an ATP competition assay (K-i, 100 nM). In A549 cells, KY-05009 significantly and strongly inhibited the TGF-beta-activated EMT through the attenuation of Smad and non-Smad signaling pathways, including the Wnt, NF-kappa B, FAK-Src-paxillin-related focal adhesion, and MAP kinases (ERK and JNK) signaling pathways. Continuing efforts to identify and validate potential therapeutic targets associated with EMT, such as TNIK, provide new and improved therapies for treating and/or preventing EMT-based disorders, such as cancer metastasis and fibrosis.	[Kim, Jiyeon] Eulji Univ, Sch Med, Dept Biomed Lab Sci, Taejon, South Korea; [Moon, Seong-Hee; Kim, Seong Hwan] Korea Res Inst Chem Technol, Lab Translat Therapeut, Taejon 305606, South Korea; [Kim, Bum Tae] Korea Res Inst Chem Technol, Div Drug Discovery Res, Taejon 305606, South Korea; [Chae, Chong Hak; Lee, Joo Yun] Korea Res Inst Chem Technol, Drug Discovery Platform Technol Team, Taejon 305606, South Korea	Eulji University; Korea Research Institute of Chemical Technology (KRICT); Korea Research Institute of Chemical Technology (KRICT); Korea Research Institute of Chemical Technology (KRICT)	Kim, J (corresponding author), Eulji Univ, Sch Med, Dept Biomed Lab Sci, Taejon, South Korea.	yeon@eulji.ac.kr; hwan@krict.re.kr			KRICT's project [SI-1304]; Ministry of Knowledge Economy of Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2014002349]	KRICT's project; Ministry of Knowledge Economy of Korea(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning(National Research Foundation of Korea)	This work was supported by KRICT's project, SI-1304 funded by the Ministry of Knowledge Economy of Korea and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2014002349). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn JF, 2008, J CELL SCI, V121, P1036, DOI 10.1242/jcs.019455; Avizienyte E, 2002, NAT CELL BIOL, V4, P632, DOI 10.1038/ncb829; Barcellos-Hoff MH, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2224; Barker N, 2001, TRENDS MOL MED, V7, P535, DOI 10.1016/S1471-4914(01)02215-8; BEHRENS J, 1989, J CELL BIOL, V108, P2435, DOI 10.1083/jcb.108.6.2435; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Brunton VG, 2005, CANCER RES, V65, P1335, DOI 10.1158/0008-5472.CAN-04-1949; Buck MB, 2006, ANN NY ACAD SCI, V1089, P119, DOI 10.1196/annals.1386.024; Cance WG, 2000, CLIN CANCER RES, V6, P2417; Chen J, 2012, CANCER RES, V72, P4130, DOI 10.1158/0008-5472.CAN-12-0655; Chen XF, 2012, MOL BIOL REP, V39, P3549, DOI 10.1007/s11033-011-1128-0; Cicchini C, 2008, EXP CELL RES, V314, P143, DOI 10.1016/j.yexcr.2007.09.005; Drabsch Y, 2012, CANCER METAST REV, V31, P553, DOI 10.1007/s10555-012-9375-7; Fu CA, 1999, J BIOL CHEM, V274, P30729, DOI 10.1074/jbc.274.43.30729; Galliher Amy J, 2006, Future Oncol, V2, P743, DOI 10.2217/14796694.2.6.743; Galliher AJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1524; Gui JH, 2011, HUM CELL, V24, P121, DOI 10.1007/s13577-011-0023-2; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Ivaska Johanna, 2011, Small GTPases, V2, P51; Jagadeeswaran R, 2008, CANCER RES, V68, P132, DOI 10.1158/0008-5472.CAN-07-1998; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kaneko S, 2011, P NATL ACAD SCI USA, V108, P11127, DOI 10.1073/pnas.1104128108; Kim J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074342; Kim Y, 2009, J CELL BIOL, V184, P309, DOI 10.1083/jcb.200806067; Labbe E, 2000, P NATL ACAD SCI USA, V97, P8358, DOI 10.1073/pnas.150152697; Liu QH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; Mahmoudi T, 2009, EMBO J, V28, P3329, DOI 10.1038/emboj.2009.285; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Medici D, 2008, MOL BIOL CELL, V19, P4875, DOI 10.1091/mbc.E08-05-0506; Nagathihalli NS, 2012, FRONT BIOSCI-LANDMRK, V17, P2059, DOI 10.2741/4037; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Polakis P, 2000, GENE DEV, V14, P1837; Romero D, 2008, CARCINOGENESIS, V29, P1070, DOI 10.1093/carcin/bgn054; Santibanez JF, 2006, FEBS LETT, V580, P5385, DOI 10.1016/j.febslet.2006.09.003; Serra R, 2005, ENDOCR-RELAT CANCER, V12, P749, DOI 10.1677/erc.1.00936; Shitashige M, 2010, CANCER RES, V70, P5024, DOI 10.1158/0008-5472.CAN-10-0306; Shkoda A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001376; Suzuki K, 2007, CANCER RES, V67, P3673, DOI 10.1158/0008-5472.CAN-06-3211; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tumbarello DA, 2005, J CELL SCI, V118, P4849, DOI 10.1242/jcs.02615; Velden J L AJ, 2011, AM J RESP CELL MOL B, V44, P571, DOI DOI 10.1165/RCMB.2009-02820C; Wang JH, 2010, MOL CANCER RES, V8, P266, DOI 10.1158/1541-7786.MCR-09-0221; Wei JC, 2008, ANTICANCER RES, V28, P327; Wei W, 2013, PANCREATOLOGY, V13, P384, DOI 10.1016/j.pan.2013.05.008; Wu Y, 2010, BRIT J CANCER, V102, P639, DOI 10.1038/sj.bjc.6605530; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yamada T, 2010, TNIK inhibitor and its use. Google Patents, Patent No. [US20100216795 A1, 20100216795]; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200	53	21	25	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110180	10.1371/journal.pone.0110180	http://dx.doi.org/10.1371/journal.pone.0110180			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337707	Green Published, Green Submitted, gold			2022-12-27	WOS:000343674800028
J	Koh, XH; Liu, XY; Teo, YY				Koh, Xuan-Han; Liu, Xuanyao; Teo, Yik-Ying			Can Evidence from Genome-Wide Association Studies and Positive Natural Selection Surveys Be Used to Evaluate the Thrifty Gene Hypothesis in East Asians?	PLOS ONE			English	Article							SUSCEPTIBILITY LOCI; INSULIN-RESISTANCE; EVOLUTIONARY ORIGINS; TYPE-2; GENOTYPES; OBESITY; DIFFERENTIATION; INSIGHTS; CELLS; PAX4	Body fat deposition and distribution differ between East Asians and Europeans, and for the same level of obesity, East Asians are at higher risks of Type 2 diabetes (T2D) and other metabolic disorders. This observation has prompted the reclassifications of body mass index thresholds for the definitions of "overweight'' and "obese'' in East Asians. However, the question remains over what evolutionary mechanisms have driven the differences in adiposity morphology between two population groups that shared a common ancestor less than 80,000 years ago. The Thrifty Gene hypothesis has been suggested as a possible explanation, where genetic factors that allowed for efficient food-energy conversion and storage are evolutionarily favoured by conferring increased chances of survival and fertility. Here, we leveraged on the existing findings from genome-wide association studies and large-scale surveys of positive natural selection to evaluate whether there is currently any evidence to support the Thrifty Gene hypothesis. We first assess whether the existing genetic associations with obesity and T2D are located in genomic regions that are reported to be under positive selection, and if so, whether the risk alleles sit on the extended haplotype forms. In addition, we interrogate whether these risk alleles are the derived forms that differ from the ancestral alleles, and whether there is significant evidence of population differentiation at these SNPs between East Asian and European populations. Our systematic survey did not yield conclusive evidence to support the Thrifty Gene hypothesis as a possible explanation for the differences observed between East Asians and Europeans.	[Koh, Xuan-Han] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Liu, Xuanyao; Teo, Yik-Ying] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Liu, Xuanyao; Teo, Yik-Ying] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Teo, Yik-Ying] Natl Univ Singapore, Inst Life Sci, Singapore 117548, Singapore; [Teo, Yik-Ying] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Teo, Yik-Ying] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Teo, YY (corresponding author), Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore.	statyy@nus.edu.sg			Saw Swee Hock School of Public Health from the National University of Singapore; National Research Foundation Singapore [NRF-RF-2010-05]; Life Sciences Institute, National University of Singapore	Saw Swee Hock School of Public Health from the National University of Singapore(National University of Singapore); National Research Foundation Singapore(National Research Foundation, Singapore); Life Sciences Institute, National University of Singapore(National University of Singapore)	XHK, XYL and YYT acknowledge support from the Saw Swee Hock School of Public Health from the National University of Singapore and the National Research Foundation Singapore (NRF-RF-2010-05). YYT also acknowledges the support from the Life Sciences Institute, National University of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Benyshek DC, 2006, AM J PHYS ANTHROPOL, V131, P120, DOI 10.1002/ajpa.20334; Blyszczuk P, 2003, P NATL ACAD SCI USA, V100, P998, DOI 10.1073/pnas.0237371100; Bouchard C, 2007, INT J OBESITY, V31, P1337, DOI 10.1038/sj.ijo.0803610; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Diamond J, 2003, NATURE, V423, P599, DOI 10.1038/423599a; Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Li H, 2012, DIABETES RES CLIN PR, V98, P226, DOI 10.1016/j.diabres.2012.05.010; Liu X, 2013, AM J HUM GENET; Ma RCW, 2013, DIABETOLOGIA, V56, P1291, DOI 10.1007/s00125-013-2874-4; Ma RCW, 2013, ANN NY ACAD SCI, V1281, P64, DOI 10.1111/nyas.12098; Perry JRB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002741; Prentice AM, 2008, INT J OBESITY, V32, P1607, DOI 10.1038/ijo.2008.147; Prentice AM, 2005, P NUTR SOC, V64, P153, DOI 10.1079/PNS2005421; Prentice AM, 2005, PHYSIOL BEHAV, V86, P640, DOI 10.1016/j.physbeh.2005.08.055; Prentice AM, 2005, MECH AGEING DEV, V126, P976, DOI 10.1016/j.mad.2005.03.018; Qian W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054224; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Simonis-Bik AM, 2010, DIABETES, V59, P293, DOI 10.2337/db09-1048; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; Southam L, 2009, DIABETOLOGIA, V52, P1846, DOI 10.1007/s00125-009-1419-3; Speakman JR, 2008, INT J OBESITY, V32, P1611, DOI 10.1038/ijo.2008.161; SWINBURN BA, 1991, J CLIN INVEST, V88, P168, DOI 10.1172/JCI115274; Takeuchi F, 2009, DIABETES, V58, P1690, DOI 10.2337/db08-1494; Teo YY, 2009, GENOME RES, V19, P2154, DOI 10.1101/gr.095000.109; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Watve MG, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-61; Wells JCK, 2009, INT J OBESITY, V33, P1331, DOI 10.1038/ijo.2009.175; WENDORF M, 1991, DIABETES, V40, P161, DOI 10.2337/diabetes.40.2.161; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	37	7	8	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110974	10.1371/journal.pone.0110974	http://dx.doi.org/10.1371/journal.pone.0110974			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337808	Green Published, gold, Green Submitted			2022-12-27	WOS:000343674800092
J	Israely, T; Melamed, S; Achdout, H; Erez, N; Politi, B; Waner, T; Lustig, S; Paran, N				Israely, Tomer; Melamed, Sharon; Achdout, Hagit; Erez, Noam; Politi, Boaz; Waner, Trevor; Lustig, Shlomo; Paran, Nir			TLR3 and TLR9 Agonists Improve Postexposure Vaccination Efficacy of Live Smallpox Vaccines	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; ADAPTIVE IMMUNE-RESPONSE; VIRUS-INFECTION; INTERFERON-GAMMA; MONKEYPOX VIRUS; RECOGNITION RECEPTORS; POXVIRUS INFECTION; ECTROMELIA-VIRUS; INNATE IMMUNITY; PROTECTS MICE	Eradication of smallpox and discontinuation of the vaccination campaign resulted in an increase in the percentage of unvaccinated individuals, highlighting the need for postexposure efficient countermeasures in case of accidental or deliberate viral release. Intranasal infection of mice with ectromelia virus (ECTV), a model for human smallpox, is curable by vaccination with a high vaccine dose given up to 3 days postexposure. To further extend this protective window and to reduce morbidity, mice were vaccinated postexposure with Vaccinia-Lister, the conventional smallpox vaccine or Modified Vaccinia Ankara, a highly attenuated vaccine in conjunction with TLR3 or TLR9 agonists. We show that co-administration of the TLR3 agonist poly(I:C) even 5 days postexposure conferred protection, avoiding the need to increase the vaccination dose. Efficacious treatments prevented death, ameliorated disease symptoms, reduced viral load and maintained tissue integrity of target organs. Protection was associated with significant elevation of serum IFN alpha and anti-vaccinia IgM antibodies, modulation of IFN gamma response, and balanced activation of NK and T cells. TLR9 agonists (CpG ODNs) were less protective than the TLR3 agonist poly(I:C). We show that activation of type 1 IFN by poly(I:C) and protection is achievable even without co-vaccination, requiring sufficient amount of the viral antigens of the infective agent or the vaccine. This study demonstrated the therapeutic potential of postexposure immune modulation by TLR activation, allowing to alleviate the disease symptoms and to further extend the protective window of postexposure vaccination.	[Israely, Tomer; Melamed, Sharon; Achdout, Hagit; Erez, Noam; Politi, Boaz; Waner, Trevor; Lustig, Shlomo; Paran, Nir] Israel Inst Biol Res, Dept Infect Dis, IL-70450 Ness Ziona, Israel		Paran, N (corresponding author), Israel Inst Biol Res, Dept Infect Dis, IL-70450 Ness Ziona, Israel.	nirp@iibr.gov.il	Erez, Noam/AAW-4953-2021; Paran, Nir/AAC-1036-2020	Erez, Noam/0000-0001-5241-8028	Israel Institute for Biological Research	Israel Institute for Biological Research	This work was supported by internal institute (Israel Institute for Biological Research) funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpaia N, 2011, CURR OPIN VIROL, V1, P447, DOI 10.1016/j.coviro.2011.10.006; Belyakov IM, 2003, P NATL ACAD SCI USA, V100, P9458, DOI 10.1073/pnas.1233578100; Buchman GW, 2010, VACCINE, V28, P6627, DOI 10.1016/j.vaccine.2010.07.030; Coban C, 2010, EXPERT REV VACCINES, V9, P775, DOI 10.1586/ERV.10.60; Cross J, 1821, HIST VARIOLOUS EPIDE; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; Earl PL, 2012, J VIROL, V86, P9105, DOI 10.1128/JVI.00162-12; Esteban David, 2012, Methods Mol Biol, V890, P177, DOI 10.1007/978-1-61779-876-4_11; Esteban DJ, 2005, J GEN VIROL, V86, P2645, DOI 10.1099/vir.0.81090-0; FENNER F, 1982, REV INFECT DIS, V4, P916; Fogg CN, 2007, VACCINE, V25, P2787, DOI 10.1016/j.vaccine.2006.12.037; Golden JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042353; Goulding J, 2012, J IMMUNOL, V189, P2432, DOI 10.4049/jimmunol.1200799; Hanagata N, 2012, INT J NANOMED, V7, P2181, DOI 10.2147/IJN.S30197; Henderson DA, 1999, SCIENCE, V283, P1279, DOI 10.1126/science.283.5406.1279; Holechek SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077879; Ichinohe T, 2005, J VIROL, V79, P2910, DOI 10.1128/JVI.79.5.2910-2919.2005; Israely T, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-119; Jahrling PB, 2004, P NATL ACAD SCI USA, V101, P15196, DOI 10.1073/pnas.0405954101; JURADO A, 1989, EXPERIENTIA, V45, P521, DOI 10.1007/BF01990501; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; KNOPF HLS, 1971, INVEST OPHTH VISUAL, V10, P750; Kremer M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002557; Kundi M, 2007, EXPERT REV VACCINES, V6, P133, DOI 10.1586/14760584.6.2.133; Lau YF, 2009, VACCINE, V27, P1354, DOI 10.1016/j.vaccine.2008.12.048; Lester SN, 2014, J MOL BIOL, V426, P1246, DOI 10.1016/j.jmb.2013.11.024; LEVY HB, 1978, J INFECT DIS, V137, P78, DOI 10.1093/infdis/137.1.78; Liu G, 2004, FEMS IMMUNOL MED MIC, V40, P201, DOI 10.1016/S0928-8244(03)00358-4; Lustig S, 2009, VACCINE, V27, P1691, DOI 10.1016/j.vaccine.2009.01.038; Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005; Mortimer PP, 2003, CLIN INFECT DIS, V36, P622, DOI 10.1086/374054; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Paran N, 2009, J INFECT DIS, V199, P39, DOI 10.1086/595565; Paran N, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-229; Parker S, 2008, ANTIVIR RES, V77, P39, DOI 10.1016/j.antiviral.2007.08.003; Quenelle DC, 2007, ANTIMICROB AGENTS CH, V51, P689, DOI 10.1128/AAC.00879-06; RAMSHAW I, 1992, IMMUNOL REV, V127, P157, DOI 10.1111/j.1600-065X.1992.tb01413.x; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409; REYNOLDS DS, 1987, J IMMUNOL, V139, P767; Samuelsson C, 2008, J CLIN INVEST, V118, P1776, DOI 10.1172/JCI33940; Sasai M, 2013, INT REV IMMUNOL, V32, P116, DOI 10.3109/08830185.2013.774391; Skountzou I, 2010, VACCINE, V28, P4103, DOI 10.1016/j.vaccine.2009.07.058; Smith GL, 2013, J GEN VIROL, V94, P2367, DOI 10.1099/vir.0.055921-0; Stabenow J, 2010, J VIROL, V84, P3909, DOI 10.1128/JVI.02012-09; Stahl-Hennig C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000373; Steinhagen F, 2011, VACCINE, V29, P3341, DOI 10.1016/j.vaccine.2010.08.002; Tatematsu M, 2014, BIOCHEM J, V458, P195, DOI 10.1042/BJ20131492; Taylor DN, 2011, VACCINE, V29, P4897, DOI 10.1016/j.vaccine.2011.05.001; Tougan T, 2013, HUM VACCIN IMMUNOTHE, V9; Vilaysane A, 2009, SEMIN IMMUNOL, V21, P208, DOI 10.1016/j.smim.2009.05.006; Volz A, 2014, J VIROL; Walsh KB, 2014, J VIROL; Xiao YH, 2007, VACCINE, V25, P1214, DOI 10.1016/j.vaccine.2006.10.009; Xiao YH, 2013, VACCINE, V31, P319, DOI 10.1016/j.vaccine.2012.11.007; Xu RH, 2008, J EXP MED, V205, P981, DOI 10.1084/jem.20071854; Xu RH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002475; Zhang SY, 2013, CURR OPIN IMMUNOL, V25, P19, DOI 10.1016/j.coi.2012.11.001	58	10	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110545	10.1371/journal.pone.0110545	http://dx.doi.org/10.1371/journal.pone.0110545			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350003	gold, Green Submitted, Green Published			2022-12-27	WOS:000343943100030
J	Kosidou, K; Dalman, C; Fredlund, P; Magnusson, C				Kosidou, Kyriaki; Dalman, Christina; Fredlund, Peeter; Magnusson, Cecilia			School Performance and the Risk of Suicidal Thoughts in Young Adults: Population-Based Study	PLOS ONE			English	Article							PUBLIC-HEALTH COHORT; SELF-HARM; IQ; BEHAVIORS	Although low school performance is related to attempted and completed suicide, its relationship with suicidal thoughts has been less clear. We conducted a population-based study including 10081 individuals aged 18-29 years in Stockholm, Sweden, and found a clear positive gradient in the risk of lifetime suicidal thoughts with decreasing levels of compulsory school leaving grades. This relationship was somewhat attenuated but remained significant in multivariate models accounting for family background, severe adult psychopathology and adult socioeconomic conditions. School failure is associated with an increased risk of experiencing suicidal thoughts and may also increase the tendency of acting upon them.	[Kosidou, Kyriaki] Stockholm Cty Council, Ctr Epidemiol & Community Med, Stockholm, Sweden; Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden	Stockholm County Council; Karolinska Institutet	Kosidou, K (corresponding author), Stockholm Cty Council, Ctr Epidemiol & Community Med, Stockholm, Sweden.	kyriaki.kosidou@sll.se		Magnusson, Cecilia/0000-0002-8567-6725; Dalman, Christina/0000-0002-3579-2357	Stockholm County Council; Swedish Council for Working Life and Social Research [DNR 2007-2064]	Stockholm County Council(Stockholm County Council); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	This study was supported by a grant by the Stockholm County Council, Swedish Council for Working Life and Social Research (DNR 2007-2064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alati R, 2009, SUICIDE LIFE-THREAT, V39, P282, DOI 10.1521/suli.2009.39.3.282; Chang SS, 2014, J AFFECT DISORDERS, V152, P175, DOI 10.1016/j.jad.2013.09.005; Fanous AH, 2004, PSYCHOL MED, V34, P301, DOI 10.1017/S0033291703008857; Fergusson DM, 2003, PSYCHOL MED, V33, P61, DOI 10.1017/S0033291702006748; Furnham A, 2009, BRIT J EDUC PSYCHOL, V79, P769, DOI 10.1348/978185409X412147; Gunnell D, 2011, J AFFECT DISORDERS, V131, P104, DOI 10.1016/j.jad.2011.01.002; Gunnell D, 2009, SOC PSYCH PSYCH EPID, V44, P34, DOI 10.1007/s00127-008-0404-3; Jablonska B, 2009, INT J EPIDEMIOL, V38, P1334, DOI 10.1093/ije/dyp236; Kang EH, 2014, AUST NZ J PSYCHIAT; Kosidou K, 2013, PSYCHOL MED, V24, P1; Kosidou K, 2011, J AFFECT DISORDERS, V134, P160, DOI 10.1016/j.jad.2011.05.024; Lundstrom Sixten., 1999, J OFF STAT, V15, P305, DOI DOI 10.1002/SIM.1903.; Richardson Angela S, 2005, Arch Suicide Res, V9, P163, DOI 10.1080/13811110590904016; Svensson AC, 2013, INT J EPIDEMIOL, V42, P1263, DOI 10.1093/ije/dys126	14	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e109958	10.1371/journal.pone.0109958	http://dx.doi.org/10.1371/journal.pone.0109958			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ1JF	25347404	Green Published, gold			2022-12-27	WOS:000347994900016
J	Tejada, MA; Stople, K; Bomholtz, SH; Meinild, AK; Poulsen, AN; Klaerke, DA				Tejada, Maria A.; Stople, Kathleen; Bomholtz, Sofia Hammami; Meinild, Anne-Kristine; Poulsen, Asser Nyander; Klaerke, Dan A.			Cell Volume Changes Regulate Slick (Slo2.1), but Not Slack (Slo2.2) K+ Channels	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNEL; ATP RELEASE; EPITHELIAL-CELLS; NA+; TRAFFICKING; INHIBITION; MECHANISM; SURFACE	Slick (Slo2.1) and Slack (Slo2.2) channels belong to the family of high-conductance K+ channels and have been found widely distributed in the CNS. Both channels are activated by Na+ and Cl- and, in addition, Slick channels are regulated by ATP. Therefore, the roles of these channels in regulation of cell excitability as well as ion transport processes, like regulation of cell volume, have been hypothesized. It is the aim of this work to evaluate the sensitivity of Slick and Slack channels to small, fast changes in cell volume and to explore mechanisms, which may explain this type of regulation. For this purpose Slick and Slack channels were co-expressed with aquaporin 1 in Xenopus laevis oocytes and cell volume changes of around 5% were induced by exposure to hypotonic or hypertonic media. Whole-cell currents were measured by two electrode voltage clamp. Our results show that Slick channels are dramatically stimulated (196% of control) by cell swelling and inhibited (57% of control) by a decrease in cell volume. In contrast, Slack channels are totally insensitive to similar cell volume changes. The mechanism underlining the strong volume sensitivity of Slick channels needs to be further explored, however we were able to show that it does not depend on an intact actin cytoskeleton, ATP release or vesicle fusion. In conclusion, Slick channels, in contrast to the similar Slack channels, are the only high-conductance K+ channels strongly sensitive to small changes in cell volume.	[Tejada, Maria A.; Stople, Kathleen; Bomholtz, Sofia Hammami; Poulsen, Asser Nyander; Klaerke, Dan A.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Physiol & Biochem IKVH, Copenhagen, Denmark; [Bomholtz, Sofia Hammami; Meinild, Anne-Kristine] Univ Copenhagen, Fac Sci, Dept Biol, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Tejada, MA (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Physiol & Biochem IKVH, Copenhagen, Denmark.	tejada@sund.ku.dk		Bomholtz, Sofia Hammami/0000-0001-7221-4532	Danish Medical Research Council [0602-00021B]; Novonordisk Foundation; Lundbeck Foundation (Lucens); Fouger_Hartmann Foundation; Danish National Foundation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novonordisk Foundation(Novo Nordisk Foundation); Lundbeck Foundation (Lucens)(Lundbeckfonden); Fouger_Hartmann Foundation; Danish National Foundation	The work was supported by grants from the Danish Medical Research Council (Grant 0602-00021B), the Novonordisk Foundation, The Lundbeck Foundation (Lucens), The Fouger_Hartmann Foundation and Danish National Foundation for Advanced Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharjee A, 2005, TRENDS NEUROSCI, V28, P422, DOI 10.1016/j.tins.2005.06.003; Bhattacharjee A, 2003, J NEUROSCI, V23, P11681; Chen HJ, 2009, J NEUROSCI, V29, P5654, DOI 10.1523/JNEUROSCI.5978-08.2009; DRYER SE, 1989, J PHYSIOL-LONDON, V410, P283, DOI 10.1113/jphysiol.1989.sp017533; DRYER SE, 1994, TRENDS NEUROSCI, V17, P155, DOI 10.1016/0166-2236(94)90093-0; Franco R, 2008, J CELL PHYSIOL, V216, P14, DOI 10.1002/jcp.21406; Grunnet M, 2003, J PHYSIOL-LONDON, V549, P419, DOI 10.1113/jphysiol.2003.038455; Grunnet M, 2002, PFLUG ARCH EUR J PHY, V444, P167, DOI 10.1007/s00424-002-0782-4; Hammami S, 2013, ACTA PHYSIOL, V207, P503, DOI 10.1111/j.1748-1716.2012.02460.x; Hammami S, 2009, J PHYSIOL-LONDON, V587, P2225, DOI 10.1113/jphysiol.2008.163550; Hayashi M, 2012, AM J PHYSIOL-CELL PH, V303, pC151, DOI 10.1152/ajpcell.00089.2012; Hazama A, 1998, PFLUG ARCH EUR J PHY, V437, P31, DOI 10.1007/s004240050742; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Joiner WJ, 1998, NAT NEUROSCI, V1, P462, DOI 10.1038/2176; Joseph SM, 2003, J BIOL CHEM, V278, P23331, DOI 10.1074/jbc.M302680200; KAMEYAMA M, 1984, NATURE, V309, P354, DOI 10.1038/309354a0; Lee TH, 1999, MOL BIOL CELL, V10, P1445, DOI 10.1091/mbc.10.5.1445; Leung YM, 2007, ENDOCR REV, V28, P653, DOI 10.1210/er.2007-0010; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; MCCARTY NA, 1992, PHYSIOL REV, V72, P1037, DOI 10.1152/physrev.1992.72.4.1037; Musante L, 1999, J BIOL CHEM, V274, P11701, DOI 10.1074/jbc.274.17.11701; Piron J, 2010, J PHYSIOL-LONDON, V588, P3471, DOI 10.1113/jphysiol.2010.195313; Rizoli SB, 2000, AM J PHYSIOL-CELL PH, V279, pC619, DOI 10.1152/ajpcell.2000.279.3.C619; Santacroce M, 2006, J MICROSC-OXFORD, V223, P57, DOI 10.1111/j.1365-2818.2006.01596.x; Stutzin A, 2006, ACTA PHYSIOL, V187, P27, DOI 10.1111/j.1748-1716.2006.01537.x; Tejada MD, 2012, BIOL-TARGETS THER, V6, P465, DOI 10.2147/BTT.S33827; Tejada MD, 2012, BIOCHEM BIOPH RES CO, V424, P208, DOI 10.1016/j.bbrc.2012.06.038; Vessey JP, 2004, BIOCHEM CELL BIOL, V82, P708, DOI 10.1139/O04-107; Wang Y, 1996, P NATL ACAD SCI USA, V93, P12020, DOI 10.1073/pnas.93.21.12020; Yang B, 2007, J NEUROSCI, V27, P2617, DOI 10.1523/JNEUROSCI.5308-06.2007; Yuan A, 2003, NEURON, V37, P765, DOI 10.1016/S0896-6273(03)00096-5; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9	32	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e110833	10.1371/journal.pone.0110833	http://dx.doi.org/10.1371/journal.pone.0110833			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347289	Green Submitted, gold, Green Published			2022-12-27	WOS:000347994900031
J	Dieleman, JL; Templin, T				Dieleman, Joseph L.; Templin, Tara			Random-Effects, Fixed-Effects and the within-between Specification for Clustered Data in Observational Health Studies: A Simulation Study	PLOS ONE			English	Article							RANDOM-EFFECT MODELS; LINEAR MIXED MODELS; COMPLEX SURVEY DATA; MULTILEVEL MODELS; CONTEXT; ISSUES; GEE	Background: When unaccounted-for group-level characteristics affect an outcome variable, traditional linear regression is inefficient and can be biased. The random-and fixed-effects estimators (RE and FE, respectively) are two competing methods that address these problems. While each estimator controls for otherwise unaccounted-for effects, the two estimators require different assumptions. Health researchers tend to favor RE estimation, while researchers from some other disciplines tend to favor FE estimation. In addition to RE and FE, an alternative method called within-between (WB) was suggested by Mundlak in 1978, although is utilized infrequently. Methods: We conduct a simulation study to compare RE, FE, and WB estimation across 16,200 scenarios. The scenarios vary in the number of groups, the size of the groups, within-group variation, goodness-of-fit of the model, and the degree to which the model is correctly specified. Estimator preference is determined by lowest mean squared error of the estimated marginal effect and root mean squared error of fitted values. Results: Although there are scenarios when each estimator is most appropriate, the cases in which traditional RE estimation is preferred are less common. In finite samples, the WB approach outperforms both traditional estimators. The Hausman test guides the practitioner to the estimator with the smallest absolute error only 61% of the time, and in many sample sizes simply applying the WB approach produces smaller absolute errors than following the suggestion of the test. Conclusions: Specification and estimation should be carefully considered and ultimately guided by the objective of the analysis and characteristics of the data. The WB approach has been underutilized, particularly for inference on marginal effects in small samples. Blindly applying any estimator can lead to bias, inefficiency, and flawed inference.	[Dieleman, Joseph L.; Templin, Tara] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Dieleman, JL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.	dieleman@uw.edu			Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This research was supported by funding from the Bill & Melinda Gates Foundation (http://www.gatesfoundation.org/). The funders had no role in study design, data collection and analysis, interpretation of data, decision to publish, or preparation of the manuscript.	Allison PD, 2009, FIXED EFFECT REGRESS; [Anonymous], 2001, ECONOMETRIC ANAL CRO; Asparouhov T, 2006, COMMUN STAT-THEOR M, V35, P439, DOI 10.1080/03610920500476598; Bartels B., 2008, WORKING PAPER; Begg MD, 2003, STAT MED, V22, P2591, DOI 10.1002/sim.1524; Bell A, 2015, POLIT SCI RES METH, V3, P133, DOI 10.1017/psrm.2014.7; Berlin JA, 1999, BIOMETRICS, V55, P470, DOI 10.1111/j.0006-341X.1999.00470.x; Bingenheimer JB, 2004, ANNU REV PUBL HEALTH, V25, P53, DOI 10.1146/annurev.publhealth.25.050503.153925; Brumback BA, 2013, STAT MED, V32, P1313, DOI 10.1002/sim.5624; Carle AC, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-49; CHAMBERLAIN G, 1980, REV ECON STUD, V47, P225, DOI 10.2307/2297110; Chu R, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-21; Clark TS, 2014, WORKING PAPER; Debarsy N, 2012, SPAT ECON ANAL, V7, P109, DOI 10.1080/17421772.2011.647059; Desai M, 2008, AM J PUBLIC HEALTH, V98, P1425, DOI 10.2105/AJPH.2006.108233; Duncan C, 1998, SOC SCI MED, V46, P97, DOI 10.1016/S0277-9536(97)00148-2; Gardiner JC, 2009, STAT MED, V28, P221, DOI 10.1002/sim.3478; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; Greene William, 2007, ECONOMETRIC ANAL; Greenland S, 2002, STAT MED, V21, P389, DOI 10.1002/sim.1024; Hahn J, 2011, ECON LETT, V112, P293, DOI 10.1016/j.econlet.2011.05.018; HAUSMAN JA, 1978, ECONOMETRICA, V46, P1251, DOI 10.2307/1913827; Hubbard AE, 2010, EPIDEMIOLOGY, V21, P467, DOI 10.1097/EDE.0b013e3181caeb90; Kennedy P., 2003, GUIDE ECONOMETRICS; Kravdal O, 2010, J EPIDEMIOL COMMUN H, V64, P1029, DOI 10.1136/jech.2008.081034; Lee ES., 2006, ANAL COMPLEX SURVEY, P50, DOI 10.4135/9781412983341.n6; Leyland AH, 2010, J EPIDEMIOL COMMUN H, V64, P1027, DOI 10.1136/jech.2009.102236; Litiere S, 2007, BIOMETRICS, V63, P1038, DOI 10.1111/j.1541-0420.2007.00782.x; Localio AR, 2002, HLTH SERV OUTCOMES R, V3, P195; MUNDLAK Y, 1978, ECONOMETRICA, V46, P69, DOI 10.2307/1913646; Neuhaus JM, 1998, BIOMETRICS, V54, P638, DOI 10.2307/3109770; Pfeffermann D, 1998, J ROY STAT SOC B, V60, P23, DOI 10.1111/1467-9868.00106; Quan H, 2014, STAT MED, V33, P2191, DOI 10.1002/sim.6108; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Rabe-Hesketh S, 2006, J R STAT SOC A STAT, V169, P805, DOI 10.1111/j.1467-985X.2006.00426.x; Roux AVD, 2002, J EPIDEMIOL COMMUN H, V56, P588, DOI 10.1136/jech.56.8.588; Schempf AH, 2012, ANN EPIDEMIOL, V22, P683, DOI 10.1016/j.annepidem.2012.06.105; Setodji CM, 2013, MED CARE, V51, P25, DOI 10.1097/MLR.0b013e31827a8bb0; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; Wooldridge J. M., 2010, WORKING PAPER	40	92	92	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110257	10.1371/journal.pone.0110257	http://dx.doi.org/10.1371/journal.pone.0110257			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BL	25343620	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943500030
J	Fernandez-de-las-Penas, C; Palacios-Cena, D; Salom-Moreno, J; Lopez-de-Andres, A; Hernandez-Barrera, V; Jimenez-Trujillo, I; Jimenez-Garcia, R; Gallardo-Pino, C; Garcia-Gomez-de-las-Heras, MS; Carrasco-Garrido, P				Fernandez-de-las-Penas, Cesar; Palacios-Cena, Domingo; Salom-Moreno, Jaime; Lopez-de-Andres, Ana; Hernandez-Barrera, Valentin; Jimenez-Trujillo, Isabel; Jimenez-Garcia, Rodrigo; Gallardo-Pino, Carmen; Garcia-Gomez-de-las-Heras, Maria S.; Carrasco-Garrido, Pilar			Has the Prevalence of Migraine Changed over the Last Decade (2003-2012)? A Spanish Population-Based Survey	PLOS ONE			English	Article							NORD-TRONDELAG HEALTH; UNITED-STATES; HEADACHE; EPIDEMIOLOGY; COMORBIDITY; HUNT; DISABILITY; CAUSATION; DIAGNOSIS; BURDEN	Introduction: Information on temporal trends can identify groups of people at risk for any particular condition; however information on temporal trends on migraine headache at population levels is scarce. Our aim was to estimate the time trends in the prevalence of migraine from 2003 to 2012 in Spain. Methods: A population-based national study was conducted. We analyzed data using individualized information taken from national surveys conducted in 2003/4, 2006/7, 2009/10 and 2011/12. A total of 94,158 Spanish adults participated. We considered the presence of self-rated and diagnosed migraine, and we analyzed socio-demographic features, lifestyle habits, self-rated health status, and comorbid diseases using logistic regressions. Results: The prevalence of migraine increased from 6.54% in 2003 to 9.69% in 2012 with significant time trends (adj. OR 1.65; 95% CI 1.50-1.81). The probability of women of suffering migraine was 3 times higher than for men (adj. OR 3.08; 2.82-3.37). There was a declining trend in migraine prevalence as age increased (adj. OR 0.42; 0.35-0.51). Demographic variables associated with migraine were lower educational level (adj. OR 1.32; 1.13-1.54) and not being an immigrant (adj. OR 1.37; 1.15-1.64). A worse self-reported health status was related to higher prevalence of migraine (adj. OR 2.83; 2.59-3.09). The prevalence of migraine also increased as the number of comorbid conditions increased (adj. OR 2.42; 2.05-2.86). Conclusion: The prevalence of migraine has increased in the first decade of the 21st century in Spain. Migraine was associated with being female, mid-age, low educational level, not being an immigrant, worse self-rated health status and presence of comorbid conditions.	[Fernandez-de-las-Penas, Cesar; Salom-Moreno, Jaime] Univ Rey Juan Carlos, Dept Phys Therapy Occupat Therapy Rehabil & Phys, Alcorcon, Spain; [Fernandez-de-las-Penas, Cesar; Palacios-Cena, Domingo; Salom-Moreno, Jaime] Univ Rey Juan Carlos, Esthesiol Lab, Alcorcon, Spain; [Lopez-de-Andres, Ana; Hernandez-Barrera, Valentin; Jimenez-Trujillo, Isabel; Jimenez-Garcia, Rodrigo; Gallardo-Pino, Carmen; Carrasco-Garrido, Pilar] Univ Rey Juan Carlos, Dept Prevent Med & Publ Hlth, Alcorcon, Spain; [Garcia-Gomez-de-las-Heras, Maria S.] Univ Rey Juan Carlos, Dept Human Histol, Alcorcon, Spain	Universidad Rey Juan Carlos; Universidad Rey Juan Carlos; Universidad Rey Juan Carlos; Universidad Rey Juan Carlos	Fernandez-de-las-Penas, C (corresponding author), Univ Rey Juan Carlos, Dept Phys Therapy Occupat Therapy Rehabil & Phys, Alcorcon, Spain.	cesar.fernandez@urjc.es	Lopez-de-Andres, Ana/D-4498-2019; Jimenez-Garcia, Rodrigo/D-4953-2019; Jimenez-Trujillo, Isabel/AAP-7746-2021; PALACIOS-CEÑA, DOMINGO/B-6944-2015; Lopez-de-Andres, Ana/AAD-8703-2019	Lopez-de-Andres, Ana/0000-0001-5551-5181; Jimenez-Garcia, Rodrigo/0000-0001-5906-9393; Jimenez-Trujillo, Isabel/0000-0002-9394-6799; PALACIOS-CEÑA, DOMINGO/0000-0003-0669-6339; Lopez-de-Andres, Ana/0000-0001-5551-5181; Hernandez-Barrera, Valentin/0000-0001-5790-1959; Fernandez-de-las-Penas, Cesar/0000-0003-3772-9690				Anttila P, 2006, PEDIATRICS, V117, pE1197, DOI 10.1542/peds.2005-2274; Dahlof C, 2001, CEPHALALGIA, V21, P664, DOI 10.1046/j.1468-2982.2001.00218.x; Fernandez-de-las-Penas C, 2010, J HEADACHE PAIN, V11, P97, DOI 10.1007/s10194-009-0176-5; Galanis P, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-350; Henry P, 2002, NEUROLOGY, V59, P232, DOI 10.1212/WNL.59.2.232; *INE, 2003, ENC NAC SAL ESP 2003; Instituto Nacional de Estadistica, 2011, ENC NAC SAL 2011; Instituto Nacional de Estadistica, 2009, ENC EUR SAL ESP 2009; Instituto Nacional de Estadistica (INE), 2006, ENC NAC SAL ESP 2006; Jensen R, 2008, LANCET NEUROL, V7, P354, DOI 10.1016/S1474-4422(08)70062-0; Jette N, 2008, HEADACHE, V48, P501, DOI 10.1111/j.1526-4610.2007.00993.x; Jimenez-Sanchez S, 2010, J PAIN, V11, P612, DOI 10.1016/j.jpain.2009.09.015; Lanteri-Minet M, 2011, CEPHALALGIA, V31, P837, DOI 10.1177/0333102411398400; Linde M, 2011, CEPHALALGIA, V31, P585, DOI 10.1177/0333102410391488; Lipton RB, 2002, NEUROLOGY, V58, P885, DOI 10.1212/WNL.58.6.885; LIPTON RB, 1992, ARCH INTERN MED, V152, P1273, DOI 10.1001/archinte.152.6.1273; Lyngberg AC, 2005, EUR J EPIDEMIOL, V20, P243, DOI 10.1007/s10654-004-6519-2; McBeth J, 2007, BEST PRACT RES CL RH, V21, P403, DOI 10.1016/j.berh.2007.03.003; Peterlin BL, 2013, NEUROLOGY, V81, P942, DOI 10.1212/WNL.0b013e3182a43ea7; RASMUSSEN BK, 1991, HEADACHE, V31, P290, DOI 10.1111/j.1526-4610.1991.hed3105290.x; Robberstad L, 2010, NEUROLOGY, V75, P712, DOI 10.1212/WNL.0b013e3181eee244; Rozen TD, 1999, NEUROLOGY, V53, P1468, DOI 10.1212/WNL.53.7.1468; Sauro KM, 2009, HEADACHE, V49, P1378, DOI [10.1111/j.1526-4610.2009.01486.x, 10.1111/j.1526-4610.2009.01476.x]; Scher AI, 2005, CURR OPIN NEUROL, V18, P305, DOI 10.1097/01.wco.0000169750.52406.a2; Sjogren P, 2009, EUR J PAIN, V13, P287, DOI 10.1016/j.ejpain.2008.04.007; Stewart WF, 2013, NEUROLOGY, V81, P948, DOI 10.1212/WNL.0b013e3182a43b32; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; Stovner LJ, 2010, J HEADACHE PAIN, V30, P1082; Strine TW, 2006, HEADACHE, V46, P223, DOI 10.1111/j.1526-4610.2006.00340.x; Varkey E, 2008, CEPHALALGIA, V28, P1292, DOI 10.1111/j.1468-2982.2008.01678.x; Wang SJ, 2000, CEPHALALGIA, V20, P566, DOI 10.1046/j.1468-2982.2000.00085.x	31	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110530	10.1371/journal.pone.0110530	http://dx.doi.org/10.1371/journal.pone.0110530			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343495	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943500035
J	Hassani, M; Kivimaki, M; Elbaz, A; Shipley, M; Singh-Manoux, A; Sabia, S				Hassani, Maliheh; Kivimaki, Mika; Elbaz, Alexis; Shipley, Martin; Singh-Manoux, Archana; Sabia, Severine			Non-Consent to a Wrist-Worn Accelerometer in Older Adults: The Role of Socio-Demographic, Behavioural and Health Factors	PLOS ONE			English	Article							ASSESSED PHYSICAL-ACTIVITY; SEDENTARY BEHAVIOR; QUESTIONNAIRE; ASSOCIATIONS; VALIDITY; INACTIVITY; COGNITION; WOMEN; SCALE; TIME	Background: Accelerometers, initially waist-worn but increasingly wrist-worn, are used to assess physical activity free from reporting-bias. However, its acceptability by study participants is unclear. Our objective is to assess factors associated with non-consent to a wrist-mounted accelerometer in older adults. Methods: Data are from 4880 Whitehall II study participants (1328 women, age range = 60-83), requested to wear a wrist-worn accelerometer 24 h every day for 9 days in 2012/13. Sociodemographic, behavioral, and health-related factors were assessed by questionnaire and weight, height, blood pressure, cognitive and motor function were measured during a clinical examination. Results: 210 participants had contraindications and 388 (8.3%) of the remaining 4670 participants did not consent. Women, participants reporting less physical activity and less favorable general health were more likely not to consent. Among the clinical measures, cognitive impairment (Odds Ratio = 2.21, 95% confidence interval: 1.22-4.00) and slow walking speed (Odds Ratio = 1.38, 95% confidence interval: 1.02-1.86) were associated with higher odds of non-consent. Conclusions: The rate of non-consent in our study of older adults was low. However, key markers of poor health at older ages were associated with non-consent, suggesting some selection bias in the accelerometer data.	[Hassani, Maliheh; Kivimaki, Mika; Shipley, Martin; Singh-Manoux, Archana; Sabia, Severine] UCL, Dept Epidemiol & Publ Hlth, London, England; [Elbaz, Alexis; Singh-Manoux, Archana] INSERM, Ctr Res Epidemiol & Populat Hlth, U1018, Villejuif, France; [Elbaz, Alexis; Singh-Manoux, Archana] Univ Paris 11, Villejuif, France; [Singh-Manoux, Archana] Univ Versailles St Quentin, Boulogne, France; [Singh-Manoux, Archana] Hop Ste Perine, AP HP, Ctr Gerontol, Paris, France	University of London; University College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Sainte-Perine - APHP	Sabia, S (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	s.sabia@ucl.ac.uk	Sabia, Séverine/G-2966-2017; El-Baz, Ayman/AAC-6689-2019; Elbaz, Alexis/F-8952-2017; Kivimaki, Mika/B-3607-2012; Singh-Manoux, Archana/F-6804-2013	Sabia, Séverine/0000-0003-3109-9720; El-Baz, Ayman/0000-0001-7264-1323; Elbaz, Alexis/0000-0001-9724-5490; Kivimaki, Mika/0000-0002-4699-5627; Singh-Manoux, Archana/0000-0002-1244-5037	US National Institutes of Health [R01AG013196, R01AG034454, R01HL036310]; UK Medical Research Council [K013351]; British Heart Foundation; Economic and Social Research Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034454, R01AG013196] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the US National Institutes of Health (R01AG013196 to ASM; R01AG034454 to ASM and MK, R01HL036310 to MK) and the UK Medical Research Council (K013351 to MK). MJS is partly supported by the British Heart Foundation. MK is supported by a professorial fellowship from the Economic and Social Research Council. The study sponsor had no role in study design, collection, analysis, and interpretation of data, writing the report, and decision to submit the report for publication.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Barnes DE, 2008, J AM GERIATR SOC, V56, P1658, DOI 10.1111/j.1532-5415.2008.01841.x; Brach JS, 2003, ARCH INTERN MED, V163, P2565, DOI 10.1001/archinte.163.21.2565; Buchman AS, 2012, NEUROLOGY, V78, P1323, DOI 10.1212/WNL.0b013e3182535d35; Buchman AS, 2008, AM J GERIAT PSYCHIAT, V16, P697, DOI 10.1097/JGP.0b013e31817945f6; Buman MP, 2010, AM J EPIDEMIOL, V172, P1155, DOI 10.1093/aje/kwq249; Cust AE, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-33; Ferrari P, 2007, AM J EPIDEMIOL, V166, P832, DOI 10.1093/aje/kwm148; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freedson PS, 2013, MED SCI SPORT EXER, V45, P962, DOI 10.1249/MSS.0b013e31827f024d; Friedenreich CM, 2006, AM J EPIDEMIOL, V163, P959, DOI 10.1093/aje/kwj112; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hagstromer M, 2007, MED SCI SPORT EXER, V39, P1502, DOI 10.1249/mss.0b013e3180a76de5; Head J, 2013, PSYCHOL MED, V43, P2649, DOI 10.1017/S0033291713000342; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Henson J, 2013, DIABETOLOGIA, V56, P1012, DOI 10.1007/s00125-013-2845-9; Jedrziewski AK, 2007, ALZHEIMERS DEMENT, V3, P98, DOI 10.1016/j.jalz.2007.01.009; JENKINS CD, 1988, J CLIN EPIDEMIOL, V41, P313, DOI 10.1016/0895-4356(88)90138-2; KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1_Part_1.20; Kim Y, 2013, PUBLIC HEALTH NUTR, V16, P440, DOI 10.1017/S1368980012002996; King AC, 2010, JAMA-J AM MED ASSOC, V304, P1944, DOI 10.1001/jama.2010.1577; Kozakova M, 2010, EUR HEART J, V31, P1511, DOI 10.1093/eurheartj/ehq092; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lee IM, 2014, BRIT J SPORT MED, V48, P197, DOI 10.1136/bjsports-2013-093154; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lee PH, 2013, GAIT POSTURE, V38, P912, DOI 10.1016/j.gaitpost.2013.04.018; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-81; Loprinzi PD, 2013, J PHYS ACT HEALTH, V10, P79, DOI 10.1123/jpah.10.1.79; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Ottevaere C, 2011, J SCI MED SPORT, V14, P317, DOI 10.1016/j.jsams.2011.02.008; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Roth MA, 2013, J PHYS ACT HEALTH, V10, P70, DOI 10.1123/jpah.10.1.70; Sabia S, 2014, AM J EPIDEMIOL, V179, P781, DOI 10.1093/aje/kwt330; Singh-Manoux A, 2011, AGE, V33, P385, DOI 10.1007/s11357-010-9189-x; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Vallance JK, 2011, PREV MED, V53, P284, DOI 10.1016/j.ypmed.2011.07.013; Ware J., 1993, SF 36 HLTH SURVEY MA	38	10	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110816	10.1371/journal.pone.0110816	http://dx.doi.org/10.1371/journal.pone.0110816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BL	25343453	Green Published, gold			2022-12-27	WOS:000343943500058
J	Lois, G; Linke, J; Wessa, M				Lois, Giannis; Linke, Julia; Wessa, Michele			Altered Functional Connectivity between Emotional and Cognitive Resting State Networks in Euthymic Bipolar I Disorder Patients	PLOS ONE			English	Article							DEFAULT MODE NETWORK; LARGE-SCALE NETWORKS; PREFRONTAL CORTEX; NEURONAL DYNAMICS; GROUP PICA; AMYGDALA; BRAIN; SCHIZOPHRENIA; ACTIVATION; DEPRESSION	Bipolar disorder is characterized by a functional imbalance between hyperactive ventral/limbic areas and hypoactive dorsal/cognitive brain regions potentially contributing to affective and cognitive symptoms. Resting-state studies in bipolar disorder have identified abnormal functional connectivity between these brain regions. However, most of these studies used a seed-based approach, thus restricting the number of regions that were analyzed. Using data-driven approaches, researchers identified resting state networks whose spatial maps overlap with frontolimbic areas such as the default mode network, the frontoparietal networks, the salient network, and the meso/paralimbic network. These networks are specifically engaged during affective and cognitive tasks and preliminary evidence suggests that functional connectivity within and between some of these networks is impaired in bipolar disorder. The present study used independent component analysis and functional network connectivity approaches to investigate functional connectivity within and between these resting state networks in bipolar disorder. We compared 30 euthymic bipolar I disorder patients and 35 age-and gender-matched healthy controls. Inter-network connectivity analysis revealed increased functional connectivity between the meso/paralimbic and the right frontoparietal network in bipolar disorder. This abnormal connectivity pattern did not correlate with variables related to the clinical course of the disease. The present finding may reflect abnormal integration of affective and cognitive information in ventral-emotional and dorsal-cognitive networks in euthymic bipolar patients. Furthermore, the results provide novel insights into the role of the meso/paralimbic network in bipolar disorder.	[Lois, Giannis; Linke, Julia; Wessa, Michele] Johannes Gutenberg Univ Mainz, Inst Psychol, Dept Clin Psychol & Neuropsychol, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz	Wessa, M (corresponding author), Johannes Gutenberg Univ Mainz, Inst Psychol, Dept Clin Psychol & Neuropsychol, D-55122 Mainz, Germany.	wessa@uni-mainz.de	Linke, Julia Olivia/GPF-3605-2022; Linke, Julia/ABD-9110-2020; Wessa, Michele/F-7010-2014	Linke, Julia Olivia/0000-0003-0466-2194; Wessa, Michele/0000-0002-3216-7214	Deutsche Forschungsgemeinschaft [SFB 636/C6]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was funded by the Deutsche Forschungsgemeinschaft (SFB 636/C6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Elseoud A, 2010, HUM BRAIN MAPP, V31, P1207, DOI 10.1002/hbm.20929; Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Anand A, 2009, PSYCHIAT RES-NEUROIM, V171, P189, DOI 10.1016/j.pscychresns.2008.03.012; Anticevic A, 2013, BIOL PSYCHIAT, V73, P565, DOI 10.1016/j.biopsych.2012.07.031; Assaf M, 2010, NEUROIMAGE, V53, P247, DOI 10.1016/j.neuroimage.2010.05.067; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Chai XQJ, 2011, NEUROPSYCHOPHARMACOL, V36, P2009, DOI 10.1038/npp.2011.88; Chen CH, 2011, BIPOLAR DISORD, V13, P1, DOI 10.1111/j.1399-5618.2011.00893.x; Chepenik LG, 2010, PSYCHIAT RES-NEUROIM, V182, P207, DOI 10.1016/j.pscychresns.2010.04.002; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Das P, 2014, NEUROIMAGE; Erhardt EB, 2011, HUM BRAIN MAPP, V32, P2075, DOI 10.1002/hbm.21170; Foland LC, 2008, PSYCHIAT RES-NEUROIM, V162, P27, DOI 10.1016/j.pscychresns.2007.04.007; Gardner DM, 2010, AM J PSYCHIAT, V167, P686, DOI 10.1176/appi.ajp.2009.09060802; Greicius MD, 2003, CURR OPIN NEUROL, V16, P143, DOI 10.1097/00019052-200304000-00004; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Houenou J, 2011, J AFFECT DISORDERS, V132, P344, DOI 10.1016/j.jad.2011.03.016; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Khadka S, 2013, BIOL PSYCHIAT; Kiviniemi V, 2009, HUM BRAIN MAPP, V30, P3865, DOI 10.1002/hbm.20813; Laird AR, 2011, J COGNITIVE NEUROSCI, V23, P4022, DOI 10.1162/jocn_a_00077; Linke J, 2011, BIPOLAR DISORD, V13, P638, DOI 10.1111/j.1399-5618.2011.00956.x; Mamah D, 2013, J AFFECT DISORD; Mann-Wrobel MC, 2011, BIPOLAR DISORD, V13, P334, DOI 10.1111/j.1399-5618.2011.00935.x; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; Meda SA, 2012, BIOL PSYCHIAT, V71, P881, DOI 10.1016/j.biopsych.2012.01.025; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Ongur D, 2010, PSYCHIAT RES-NEUROIM, V183, P59, DOI 10.1016/j.pscychresns.2010.04.008; Perlman SB, 2012, BIPOLAR DISORD, V14, P162, DOI 10.1111/j.1399-5618.2012.00999.x; Phillips M, 2008, MOL PSYCHIATR, V13, P833, DOI 10.1038/mp.2008.65; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Pompei F, 2011, NEUROIMAGE, V57, P576, DOI 10.1016/j.neuroimage.2011.04.055; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Sackeim HA, 2001, J CLIN PSYCHIAT, V62, pS10; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sole B, 2012, CNS NEUROSCI THER, V18, P194, DOI 10.1111/j.1755-5949.2011.00262.x; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Strakowski SM, 2005, AM J PSYCHIAT, V162, P1697, DOI 10.1176/appi.ajp.162.9.1697; Strakowski SM, 2012, BIPOLAR DISORD, V14, P313, DOI 10.1111/j.1399-5618.2012.01022.x; Torrisi S, 2013, BIPOLAR DISORD, V15, P156, DOI 10.1111/bdi.12047; Townsend JD, 2013, BIOL PSYCHIAT, V73, P127, DOI 10.1016/j.biopsych.2012.06.030; Uhlhaas PJ, 2013, CURR OPIN NEUROBIOL, V23, P283, DOI 10.1016/j.conb.2012.11.004; Uhlhaas PJ, 2012, NEURON, V75, P963, DOI 10.1016/j.neuron.2012.09.004; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Versace A, 2010, BIOL PSYCHIAT, V67, P422, DOI 10.1016/j.biopsych.2009.11.025; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Vizueta N, 2012, AM J PSYCHIAT, V169, P831, DOI 10.1176/appi.ajp.2012.11030349; von dem Hagen EAH, 2013, SOC COGN AFFECT NEUR, V8, P694, DOI 10.1093/scan/nss053; Wessa M., 2013, RESTOR NEUROL NEUROS; Wessa M, 2009, INT REV PSYCHIATR, V21, P357, DOI 10.1080/09540260902962156; Wright KA, 2008, J ABNORM PSYCHOL, V117, P838, DOI 10.1037/a0013598	58	48	48	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e107829	10.1371/journal.pone.0107829	http://dx.doi.org/10.1371/journal.pone.0107829			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BL	25343370	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943500003
J	Scholten, AC; Haagsma, JA; Panneman, MJM; van Beeck, EF; Polinder, S				Scholten, Annemieke C.; Haagsma, Juanita A.; Panneman, Martien J. M.; van Beeck, Ed F.; Polinder, Suzanne			Traumatic Brain Injury in the Netherlands: Incidence, Costs and Disability-Adjusted Life Years	PLOS ONE			English	Article							QUALITY-OF-LIFE; HEAD-INJURIES; ECONOMIC BURDEN; HEALTH; WORK; PREVENTION; DISORDERS; MORTALITY; DISEASES; OUTCOMES	Objective: Traumatic brain injury (TBI) is a major cause of death and disability, leading to great personal suffering and huge costs to society. Integrated knowledge on epidemiology, economic consequences and disease burden of TBI is scarce but essential for optimizing healthcare policy and preventing TBI. This study aimed to estimate incidence, cost-of-illness and disability-adjusted life years (DALYs) of TBI in the Netherlands. Methods: This study included data on all TBI patients who were treated at an Emergency Department (ED - National Injury Surveillance System), hospitalized (National Medical Registration), or died due to their injuries in the Netherlands between 2010-2012. Direct healthcare costs and indirect costs were determined using the incidence-based Dutch Burden of Injury Model. Disease burden was assessed by calculating years of life lost (YLL) owing to premature death, years lived with disability (YLD) and DALYs. Incidence, costs and disease burden were stratified by age and gender. Results: TBI incidence was 213.6 per 100,000 person years. Total costs were (sic)314.6 (USD $433.8) million per year and disease burden resulted in 171,200 DALYs (on average 7.1 DALYs per case). Men had highest mean costs per case ((sic)19,540 versus (sic)14,940), driven by indirect costs. 0-24-year-olds had high incidence and disease burden but low economic costs, whereas 25-64-year-olds had relatively low incidence but high economic costs. Patients aged 65+ had highest incidence, leading to considerable direct healthcare costs. 0-24-year-olds, men aged 25-64 years, traffic injury victims (especially bicyclists) and home and leisure injury victims (especially 0-5-year-old and elderly fallers) are identified as risk groups in TBI. Conclusions: The economic and health consequences of TBI are substantial. The integrated approach of assessing incidence, costs and disease burden enables detection of important risk groups in TBI, development of prevention programs that target these risk groups and assessment of the benefits of these programs.	[Scholten, Annemieke C.; Haagsma, Juanita A.; van Beeck, Ed F.; Polinder, Suzanne] Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Panneman, Martien J. M.] Consumer & Safety Inst, Res Dept, Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Scholten, AC (corresponding author), Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands.	a.scholten@erasmusmc.nl						Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; [Anonymous], 2014, US INFLATION CALCULA; [Anonymous], 1996, GLOBAL BURDEN DIS CO; [Anonymous], 2008, NEUR DIS PUBL HLTH C, V65, P154, DOI 10.1001/archneurol.2007.19; Baguley IJ, 2012, MED J AUSTRALIA, V196, P40, DOI 10.5694/mja11.10090; Berg J, 2005, EUR J NEUROL, V12, P85, DOI 10.1111/j.1468-1331.2005.01200.x; Boake C, 2005, NEUROSURGERY, V56, P994, DOI 10.1227/01.NEU.0000158319.38230.C3; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Consumer and Safety Institute, 2011, FACT SHEET SPORTS IN; Consumer and Safety Institute, 2011, FACT SHEET BIC ACC; Consumer and Safety Institute, 2013, FACT SHEET TRAUM BRA; Consumer and Safety Institute, 2012, FACT SHEET SPORTS IN; Consumer Safety Institute, 2005, DUTCH BURD INJ MOD; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Eurostat, 2014, HICP INFL RAT; Farhad K, 2013, J NEUROTRAUM, V30, P84, DOI 10.1089/neu.2011.2283; Faul M, 2010, TRAUMATIC BRAIN INJU, P2; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Gommer A, 2010, YEARS LIFE LOST MORB; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Haagsma JA, 2012, B WORLD HEALTH ORGAN, V90, P513, DOI 10.2471/BLT.11.095109; Haagsma JA, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-1; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Hartholt KA, 2011, J NEUROTRAUM, V28, P739, DOI 10.1089/neu.2010.1488; Hoang Hanh T M, 2008, Cost Eff Resour Alloc, V6, P17, DOI 10.1186/1478-7547-6-17; Holtslag HR, 2007, CLIN REHABIL, V21, P373, DOI 10.1177/0269215507072084; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kannus P, 2007, INJURY, V38, P81, DOI 10.1016/j.injury.2006.08.027; Kayani NA, 2009, PUBLIC HEALTH REP, V124, P551, DOI 10.1177/003335490912400412; MACKENZIE EJ, 1988, J TRAUMA, V28, P281, DOI 10.1097/00005373-198803000-00003; Macpherson AK, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.5.e60; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; McGregor K, 1997, SOC SCI MED, V45, P295, DOI 10.1016/S0277-9536(96)00345-0; McMillan TM, 2007, BRAIN, V130, P2520, DOI 10.1093/brain/awm185; Meerding WJ, 2006, EUR J PUBLIC HEALTH, V16, P271, DOI 10.1093/eurpub/ckl006; Meerding WJ, 2010, INT J INJ CONTROL SA, V17, P13, DOI 10.1080/17457300903523237; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mulder S, 2002, INJURY PREV, V8, P74, DOI 10.1136/ip.8.1.74; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; Nielen M, 2014, INCIDENCE PREVALENCE; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Olesen J, 2003, EUR J NEUROL, V10, P471, DOI 10.1046/j.1468-1331.2003.00682.x; Oostenbrink JB, 2002, PHARMACOECONOMICS, V20, P443, DOI 10.2165/00019053-200220070-00002; Polinder S, 2005, J TRAUMA, V59, P1283, DOI 10.1097/01.ta.0000195998.11304.5b; Polinder S, 2004, SURVEILLANCE BASED A; Polinder S, 2007, J TRAUMA, V62, P133, DOI 10.1097/TA.0b013e31802b71c9; Polinder S, 2007, B WORLD HEALTH ORGAN, V85, P27, DOI 10.2471/BLT.06.030973; Radford K, 2013, BRAIN INJURY, V27, P507, DOI 10.3109/02699052.2013.766929; Rivara FP, 1998, ANNU REV PUBL HEALTH, V19, P293, DOI 10.1146/annurev.publhealth.19.1.293; Schootman M, 2003, BRAIN INJURY, V17, P983, DOI 10.1080/0269905031000110427; Schulman J, 2002, INJ PREV, V8, P47, DOI 10.1136/ip.8.1.47; Statistics Netherlands (CBS), 2014, POP DAT; Statistics Netherlands (CBS), 2014, MOB NETH; Statistics Netherlands (CBS), 2014, CONS PRIC INFL 1963; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101; Thurman DJ., 1995, GUIDELINES SURVEILLA; Van der Stegen R, 2009, DISCRIPTION METHODS; World Health Organization, 2004, WORLD REPORT ROAD TR	63	68	68	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110905	10.1371/journal.pone.0110905	http://dx.doi.org/10.1371/journal.pone.0110905			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BL	25343447	gold, Green Published			2022-12-27	WOS:000343943500064
J	Shridhar, K; Dhillon, PK; Bowen, L; Kinra, S; Bharathi, AV; Prabhakaran, D; Reddy, KS; Ebrahim, S				Shridhar, Krithiga; Dhillon, Preet Kaur; Bowen, Liza; Kinra, Sanjay; Bharathi, Ankalmadugu Venkatsubbareddy; Prabhakaran, Dorairaj; Reddy, Kolli Srinath; Ebrahim, Shah		Indian Migration Study Grp	The Association between a Vegetarian Diet and Cardiovascular Disease (CVD) Risk Factors in India: The Indian Migration Study	PLOS ONE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; ISCHEMIC-HEART-DISEASE; BLOOD-PRESSURE; EPIC-OXFORD; BRITISH VEGETARIANS; RURAL INDIA; MORTALITY; HYPERTENSION; HEALTH; NUTRITION	Background: Studies in the West have shown lower cardiovascular disease (CVD) risk among people taking a vegetarian diet, but these findings may be confounded and only a minority selects these diets. We evaluated the association between vegetarian diets (chosen by 35%) and CVD risk factors across four regions of India. Methods: Study participants included urban migrants, their rural siblings and urban residents, of the Indian Migration Study from Lucknow, Nagpur, Hyderabad and Bangalore (n = 6555, mean age-40.9 yrs). Information on diet (validated interviewer-administered semi-quantitative food frequency questionnaire), tobacco, alcohol, physical history, medical history, as well as blood pressure, fasting blood and anthropometric measurements were collected. Vegetarians ate no eggs, fish, poultry or meat. Using robust standard error multivariate linear regression models, we investigated the association of vegetarian diets with blood cholesterol, low density lipoprotein (LDL), high density lipoprotein (HDL), triglycerides, fasting blood glucose (FBG), systolic (SBP) and diastolic blood pressure (DBP). Results: Vegetarians (32.8% of the study population) did not differ from non-vegetarians with respect to age, use of smokeless tobacco, body mass index, and prevalence of diabetes or hypertension. Vegetarians had a higher standard of living and were less likely to smoke, drink alcohol (p<0.0001) and were less physically active (p = 0.04). In multivariate analysis, vegetarians had lower levels of total cholesterol (beta = -0.1 mmol/L (95% CI: -0.03 to -0.2), p = 0.006), triglycerides (beta = -0.05 mmol/L (95% CI: -0.007 to -0.01), p = 0.02), LDL (beta = -0.06 mmol/L (95% CI: -0.005 to -0.1), p = 0.03) and lower DBP (beta = -0.7 mmHg (95% CI: -1.2 to -0.07), p = 0.02). Vegetarians also had decreases in SBP (beta = -0.9 mmHg (95% CI: -1.9 to 0.08), p = 0.07) and FBG level (beta = -0.07 mmol/L (95% CI: -0.2 to 0.01), p = 0.09) when compared to nonvegetarians. Conclusion: We found beneficial association of vegetarian diet with cardiovascular risk factors compared to non-vegetarian diet.	[Shridhar, Krithiga; Dhillon, Preet Kaur; Prabhakaran, Dorairaj] Publ Hlth Fdn India, Ctr Chron Condit & Injuries, New Delhi, India; [Bowen, Liza; Kinra, Sanjay; Ebrahim, Shah] London Sch Hyg & Trop Med, London WC1, England; [Bharathi, Ankalmadugu Venkatsubbareddy] Just Right Obes Clin, Bangalore, Karnataka, India; [Prabhakaran, Dorairaj] Ctr Chron Dis Control, New Delhi, India; [Reddy, Kolli Srinath] Publ Hlth Fdn India, New Delhi, India	Public Health Foundation of India; University of London; London School of Hygiene & Tropical Medicine; Public Health Foundation of India	Shridhar, K (corresponding author), Publ Hlth Fdn India, Ctr Chron Condit & Injuries, New Delhi, India.	g.krithiga@phfi.org	Prabhakaran, Dorairaj/B-4147-2011; Bowen, Liza/AAA-5502-2019	Prabhakaran, Dorairaj/0000-0002-3172-834X; Reddy, K Srinath/0000-0003-3416-3548; Bowen, Liza/0000-0001-8318-8421	Wellcome Trust [GR070797MF]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by Wellcome Trust project grant GR070797MF. SE received the funding. Wellcome Trust had no role in the design, data collection, analysis or preparation or publication of the manuscript.	Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1326; Appleby PN, 2002, PUBLIC HEALTH NUTR, V5, P645, DOI 10.1079/PHN2002332; Arnold F, 2005, NUTR INDIA NATL FAMI; Ashavaid TF, 2005, INDIAN J CLIN BIOCHE, V20, P72, DOI 10.1007/BF02893046; BEILIN LJ, 1988, AM J CLIN NUTR, V48, P806, DOI 10.1093/ajcn/48.3.806; Berkow SE, 2005, NUTR REV, V63, P1, DOI [10.1301/nr.janr.1-8, 10.1111/j.1753-4887.2005.tb00104.x]; Bowen L, 2012, ASIA PAC J CLIN NUTR, V21, P355; Bowen L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014822; BURR ML, 1981, J HUM NUTR, V35, P437; Chiplonkar SA, 2004, J AM COLL NUTR, V23, P239, DOI 10.1080/07315724.2004.10719367; Crowe FL, 2013, AM J CLIN NUTR, V97, P597, DOI 10.3945/ajcn.112.044073; Daniel CR, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-12; Das Shyamal Kumar, 2005, Int J Med Sci, V2, P70; Dhillon PK, 2012, INT J EPIDEMIOL, V41, P847, DOI 10.1093/ije/dys046; Ebrahim S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000268; Fraser GE, 2009, AM J CLIN NUTR, V89, pS1607, DOI 10.3945/ajcn.2009.26736K; Fraser GE, 1999, AM J CLIN NUTR, V70, p532S, DOI 10.1093/ajcn/70.3.532s; Ganguli D, 2011, BRIT J NUTR, V105, P1520, DOI 10.1017/S0007114510005131; Gopalan C., 1971, NUTR VALUE INDIAN FO; Gupta R, 2006, INT J CARDIOL, V108, P291, DOI 10.1016/j.ijcard.2005.05.044; Gupta R, 2012, J EPIDEMIOL COMMUN H, V66, P881, DOI 10.1136/jech-2011-200101; Gupta Rajeev, 2012, J Assoc Physicians India, V60, P11; Gupta R, 2010, INDIAN J MED RES, V132, P531; Huang T, 2012, ANN NUTR METAB, V60, P233, DOI 10.1159/000337301; Jayanthi V, 2001, PERITON DIALYSIS INT, V21, pS322; Jhala C I, 1998, Indian J Clin Biochem, V13, P1, DOI 10.1007/BF02873435; Joshi R, 2006, INT J EPIDEMIOL, V35, P1522, DOI 10.1093/ije/dyl168; Juraschek SP, 2012, AM J CLIN NUTR, V95, P1079, DOI 10.3945/ajcn.111.027995; Key TIJ, 2003, AM J CLIN NUTR, V78, p533S, DOI 10.1093/ajcn/78.3.533S; Key TJ, 2009, AM J CLIN NUTR, V89, pS1613, DOI 10.3945/ajcn.2009.26736L; Key TJ, 2006, P NUTR SOC, V65, P35, DOI 10.1079/PNS2005481; Key TJ, 1999, AM J CLIN NUTR, V70, p516S, DOI 10.1093/ajcn/70.3.516s; Key TJ, 1999, P NUTR SOC, V58, P271, DOI 10.1017/S0029665199000373; Kuriyan R, 1998, INDIAN J MED RES, V107, P37; Marchioni DML, 2007, CAD SAUDE PUBLICA, V23, P2187, DOI 10.1590/S0102-311X2007000900026; Lyngdoh T, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-2; Millett C, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001459; Misra A, 2009, BRIT J NUTR, V101, P465, DOI 10.1017/S0007114508073649; Mozaffarian D, 2011, CIRCULATION, V123, P2870, DOI 10.1161/CIRCULATIONAHA.110.968735; Parr CL, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-4; Radhika G, 2007, J Assoc Physicians India, V55, P405; Radhika G, 2008, BRIT J NUTR, V99, P398, DOI 10.1017/S0007114507803965; Radhika G, 2011, PUBLIC HEALTH NUTR, V14, P591, DOI 10.1017/S136898001000203X; Rastogi T, 2004, AM J CLIN NUTR, V79, P582; Reddy KS, 2006, B WORLD HEALTH ORGAN, V84, P461, DOI 10.2471/BLT.05.027037; Reddy KS, 2004, PUBLIC HEALTH NUTR, V7, P167, DOI 10.1079/PHN2003587; Shetty PS, 2002, PUBLIC HEALTH NUTR, V5, P175, DOI 10.1079/PHN2001291; Sullivan R, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-13; THOROGOOD M, 1987, BMJ-BRIT MED J, V295, P351, DOI 10.1136/bmj.295.6594.351; Tonstad S, 2009, DIABETES CARE, V32, P791, DOI 10.2337/dc08-1886; U.S. Department of Agriculture USDA National Nutrient Database for Standard Reference, 2001, USDA NAT NUTR DAT ST; Vellakkal S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068219; Welch AU., 1995, MCCANCE WIDDOWSONS C; WEST RO, 1968, AM J CLIN NUTR, V21, P853, DOI 10.1093/ajcn/21.8.853; Whitton C, 2011, BRIT J NUTR, V106, P1899, DOI 10.1017/S0007114511002340; Yadav D, 2013, CLIN CHIM ACTA, V426, P145, DOI 10.1016/j.cca.2013.06.004; Zaman MJ, 2012, INT J EPIDEMIOL, V41, P1302, DOI 10.1093/ije/dyr226	57	41	44	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110586	10.1371/journal.pone.0110586	http://dx.doi.org/10.1371/journal.pone.0110586			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343719	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000343943500037
J	Lin, LJ; Piao, JJ; Ma, YB; Jin, TF; Quan, CS; Kong, JN; Li, YL; Lin, ZH				Lin, Lijuan; Piao, Junjie; Ma, Yibing; Jin, Tiefeng; Quan, Chengshi; Kong, Jienan; Li, Yulin; Lin, Zhenhua			Mechanisms Underlying Cancer Growth and Apoptosis by DEK Overexpression in Colorectal Cancer	PLOS ONE			English	Article							BCL-2 FAMILY; EXPRESSION; P53; ONCOPROTEIN; PROTOONCOGENE; CARCINOMA; CHROMATIN; PROTEIN; CHEMORESISTANCE; TRANSCRIPTION	Our previous study indicated that DEK protein was overexpressed in colorectal carcinoma (CRC) compared with the normal colorectal mucosa. DEK was also significantly correlated with the prognostic characteristics of patients with CRC, demonstrating that DEK played an important role in CRC progression. In this work, we evaluate the effects of DEK on biological behaviors in CRC and explore the related molecular mechanisms. The results showed that DEK was overexpressed in human CRC tissues, and was correlated with the Ki-67 index and the apoptotic index. DEK depletion by RNAi in SW-620 and HCT116 cells significantly decreased cell proliferation, but increased cell apoptosis. Upregulation of DEK was involved in the p53/MDM, Bcl-2 family, and caspase pathways. Our study demonstrates that DEK promotes the growth of CRC, and could be a therapeutic target in CRC.	[Lin, Lijuan; Piao, Junjie; Jin, Tiefeng; Kong, Jienan; Lin, Zhenhua] Yanbian Univ, Dept Pathol, Coll Med, Yanji, Peoples R China; [Lin, Lijuan; Piao, Junjie; Jin, Tiefeng; Kong, Jienan; Lin, Zhenhua] Yanbian Univ, Canc Res Ctr, Coll Med, Yanji, Peoples R China; [Lin, Lijuan] Eastern Liaoning Univ, Dept Med Imaging, Coll Med, Dandong, Peoples R China; [Ma, Yibing] Dandong Ctr Hosp, Dept Pathol, Dandong, Peoples R China; [Quan, Chengshi; Li, Yulin] Jilin Univ, Bethune Med Coll, Key Lab Pathobiol, Minist Educ, Changchun 130023, Peoples R China	Yanbian University; Yanbian University; Liaodong University; Jilin University	Li, YL (corresponding author), Yanbian Univ, Dept Pathol, Coll Med, Yanji, Peoples R China.	ylli@jlu.edu.cn; zhlin720@ybu.edu.cn		Ma, Yibing/0000-0002-9340-8181	National Ministry of Science & Technology of China [2014CB560708]; National Natural Science Funds of China [61371067]; Basic Scientific Research Fund of Jilin University in China [2013-01]	National Ministry of Science & Technology of China; National Natural Science Funds of China(National Natural Science Foundation of China (NSFC)); Basic Scientific Research Fund of Jilin University in China	This study was supported by the Special Fund of 973 Prophase Research from the National Ministry of Science & Technology of China (2014CB560708), the grants from the National Natural Science Funds of China (61371067), and Basic Scientific Research Fund of Jilin University in China (2013-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autret A, 2009, MOL CELL, V36, P355, DOI 10.1016/j.molcel.2009.10.011; Beroud C, 2003, HUM MUTAT, V21, P176, DOI 10.1002/humu.10187; Borralho PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023787; Carro MS, 2006, CELL CYCLE, V5, P1202, DOI 10.4161/cc.5.11.2801; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Datta A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-234; Gamble MJ, 2007, NAT STRUCT MOL BIOL, V14, P548, DOI 10.1038/nsmb1248; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Huang LY, 2012, ONCOL REP, V27, P917, DOI 10.3892/or.2011.1598; Jeong KE, 2013, HEALTH ECON REV, V3, DOI 10.1186/2191-1991-3-20; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Jin AH, 2014, EXP MOL PATHOL, V96, P54, DOI 10.1016/j.yexmp.2013.11.003; Kang MH, 2009, CLIN CANCER RES, V15, P1126, DOI 10.1158/1078-0432.CCR-08-0144; Kappes F, 2008, MOL CELL BIOL, V28, P3245, DOI 10.1128/MCB.01921-07; Karam M, 2014, NEOPLASIA, V16, P21, DOI 10.1593/neo.131658; Khan R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056020; Khodadoust MS, 2009, CANCER RES, V69, P6405, DOI 10.1158/0008-5472.CAN-09-1063; Kim DW, 2009, J CELL BIOCHEM, V106, P1048, DOI 10.1002/jcb.22083; Kourennyi DE, 2002, ANN BIOMED ENG, V30, P1196, DOI 10.1114/1.1521415; Kubbutat MHG, 1998, MOL MED TODAY, V4, P250, DOI 10.1016/S1357-4310(98)01260-X; Kurokawa H, 2005, J ORAL PATHOL MED, V34, P602, DOI 10.1111/j.1600-0714.2005.00358.x; Lin LJ, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-366; Liu Y, 2012, INT J NONLIN SCI NUM, V13, P1; Marine JC, 2006, CELL DEATH DIFFER, V13, P927, DOI 10.1038/sj.cdd.4401912; Merkel CA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-316; Ohno K, 2013, INT J MOL SCI, V14, P13129, DOI 10.3390/ijms140713129; Riveiro-Falkenbach E, 2010, CLIN CANCER RES, V16, P2932, DOI 10.1158/1078-0432.CCR-09-2330; Saito S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054881; Sammons M, 2006, J BIOL CHEM, V281, P26802, DOI 10.1074/jbc.M600915200; Scovassi AI, 1999, MOL CELL BIOCHEM, V199, P125; Secchiero P, 2010, CLIN CANCER RES, V16, P1824, DOI 10.1158/1078-0432.CCR-09-3031; Shi MD, 2008, CHEM-BIOL INTERACT, V174, P201, DOI 10.1016/j.cbi.2008.06.006; Shibata T, 2010, ONCOGENE, V29, P4671, DOI 10.1038/onc.2010.217; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Vinnedge LMP, 2015, ONCOGENE, V34, P2325, DOI 10.1038/onc.2014.173; Vinnedge LMP, 2013, CELL CYCLE, V12, P51, DOI 10.4161/cc.23121; VONLINDERN M, 1992, MOL CELL BIOL, V12, P3346, DOI 10.1128/MCB.12.8.3346; Wang JF, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053400, 10.1371/journal.pone.0070519]; Wise-Draper TM, 2005, J VIROL, V79, P14309, DOI 10.1128/JVI.79.22.14309-14317.2005; Wise-Draper TM, 2006, MOL CELL BIOL, V26, P7506, DOI 10.1128/MCB.00430-06; Wise-Draper TM, 2009, CANCER RES, V69, P1792, DOI 10.1158/0008-5472.CAN-08-2304; Wise-Draper TM, 2009, AM J PATHOL, V174, P71, DOI 10.2353/ajpath.2009.080330; Wu QY, 2008, PATHOL INT, V58, P378, DOI 10.1111/j.1440-1827.2008.02239.x; Xiao CX, 2013, CANCER LETT, V330, P67, DOI 10.1016/j.canlet.2012.11.030; Zheng BB, 2013, BIOL PHARM BULL, V36, P1118, DOI 10.1248/bpb.b13-00058	45	20	21	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111260	10.1371/journal.pone.0111260	http://dx.doi.org/10.1371/journal.pone.0111260			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340858	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662800099
J	Picoche, C; Le Gendre, R; Flye-Sainte-Marie, J; Francoise, S; Maheux, F; Simon, B; Gangnery, A				Picoche, Coralie; Le Gendre, Romain; Flye-Sainte-Marie, Jonathan; Francoise, Sylvaine; Maheux, Frank; Simon, Benjamin; Gangnery, Aline			Towards the Determination of Mytilus edulis Food Preferences Using the Dynamic Energy Budget (DEB) Theory	PLOS ONE			English	Article							ENGLISH-CHANNEL; SPATIOTEMPORAL VARIABILITY; PHYTOPLANKTON COMPOSITION; REPRODUCTIVE OUTPUT; SEASONAL-VARIATION; MUSSEL; GROWTH; L.; FLOW; PARAMETERS	The blue mussel, Mytilus edulis, is a commercially important species, with production based on both fisheries and aquaculture. Dynamic Energy Budget (DEB) models have been extensively applied to study its energetics but such applications require a deep understanding of its nutrition, from filtration to assimilation. Being filter feeders, mussels show multiple responses to temporal fluctuations in their food and environment, raising questions that can be investigated by modeling. To provide a better insight into mussel-environment interactions, an experiment was conducted in one of the main French growing zones (Utah Beach, Normandy). Mussel growth was monitored monthly for 18 months, with a large number of environmental descriptors measured in parallel. Food proxies such as chlorophyll a, particulate organic carbon and phytoplankton were also sampled, in addition to non-nutritious particles. High-frequency physical data recording (e. g., water temperature, immersion duration) completed the habitat description. Measures revealed an increase in dry flesh mass during the first year, followed by a high mass loss, which could not be completely explained by the DEB model using raw external signals. We propose two methods that reconstruct food from shell length and dry flesh mass variations. The former depends on the inversion of the growth equation while the latter is based on iterative simulations. Assemblages of food proxies are then related to reconstructed food input, with a special focus on plankton species. A characteristic contribution is attributed to these sources to estimate nutritional values for mussels. M. edulis shows no preference between most plankton life history traits. Selection is based on the size of the ingested particles, which is modified by the volume and social behavior of plankton species. This finding reveals the importance of diet diversity and both passive and active selections, and confirms the need to adjust DEB models to different populations and sites.	[Picoche, Coralie; Le Gendre, Romain; Francoise, Sylvaine; Maheux, Frank; Simon, Benjamin; Gangnery, Aline] IFREMER, Lab Environm Ressources Normandie, Port En Bessin, France; [Flye-Sainte-Marie, Jonathan] Univ Bretagne Occidentale, Inst Univ Europeen Mer, Lab Sci Environnement Marin LEMAR, UMR 6539,CNRS,UBO,IRD,IFREMER, Plouzane, France	Ifremer; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale	Picoche, C (corresponding author), IFREMER, Lab Environm Ressources Normandie, Port En Bessin, France.	cpicoche@gmail.com		Le Gendre, Romain/0000-0001-7015-8290; Flye-Sainte-Marie, Jonathan/0000-0002-6462-0677	BlueDEB project; OGIVE project; French Norwegian Foundation; Basse Normandie region; Hordaland County Council; European Fund for Fisheries; Seine-Normandie Water Agency; departments of Manche and Calvados	BlueDEB project; OGIVE project; French Norwegian Foundation; Basse Normandie region(Region Normandie); Hordaland County Council; European Fund for Fisheries; Seine-Normandie Water Agency; departments of Manche and Calvados	This work was achieved with the financial fundings of BlueDEB and OGIVE projects. BlueDEB was supported by the French Norwegian Foundation, Basse Normandie region and Hordaland County Council. OGIVE is supported by the European Fund for Fisheries, Seine-Normandie Water Agency, Basse Normandie region and the departments of Manche and Calvados. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminot A., 2007, DOSAGE AUTOMATIQUE N; Aminot A., 2004, HYDROLOGIE ECOSYSTEM; [Anonymous], 2012, ISRN ZOOL, DOI DOI 10.5402/2012/902152; BAYNE BL, 1980, MAR ECOL PROG SER, V3, P317, DOI 10.3354/meps003317; BAYNE BL, 1973, J MAR BIOL ASSOC UK, V53, P39, DOI 10.1017/S0025315400056629; Beadman HA, 2002, HELGOLAND MAR RES, V56, P76, DOI 10.1007/s10152-001-0092-9; Behrenfeld MJ, 2008, PHILOS T R SOC B, V363, P2687, DOI 10.1098/rstb.2008.0019; Bougrier S, 1997, AQUACULTURE, V150, P123, DOI 10.1016/S0044-8486(96)01457-3; Bourles Y, 2009, J SEA RES, V62, P62, DOI 10.1016/j.seares.2009.03.002; Bracken MES, 2012, MAR ECOL PROG SER, V459, P53, DOI 10.3354/meps09764; BRAND LE, 1984, ESTUAR COAST SHELF S, V18, P543, DOI 10.1016/0272-7714(84)90089-1; Cardoso Joana F. M. E., 2007, Senckenbergiana Maritima, V37, P83; Cardoso JFMF, 2006, J SEA RES, V56, P182, DOI 10.1016/j.seares.2006.03.011; Dabrowski T, 2013, J SEA RES, V76, P5, DOI 10.1016/j.seares.2012.10.012; DARE PJ, 1975, J EXP MAR BIOL ECOL, V18, P89, DOI 10.1016/0022-0981(75)90066-0; De Zwaan A., 1972, Comparative Biochem Physiol (A), V43, P53, DOI 10.1016/0300-9629(72)90468-9; Doherty SD, 2009, J EXP MAR BIOL ECOL, V378, P1, DOI 10.1016/j.jembe.2009.04.022; Duarte P, 2012, J SEA RES, V67, P44, DOI 10.1016/j.seares.2011.09.002; Dueri S, 2012, ECOL MODEL, V245, P55, DOI 10.1016/j.ecolmodel.2012.02.008; Faugeras B, 2003, J MARINE SYST, V40, P99, DOI 10.1016/S0924-7963(03)00015-0; Fearman JA, 2009, J SHELLFISH RES, V28, P305, DOI 10.2983/035.028.0212; Fennel K, 2001, J MARINE SYST, V28, P45, DOI 10.1016/S0924-7963(00)00083-X; Flye Sainte Marie J, 2009, AQUACULTURE EUROPE; Freitas V, 2009, J SEA RES, V62, P75, DOI 10.1016/j.seares.2009.07.004; Garen P, 2004, AQUACULTURE, V232, P511, DOI 10.1016/S0044-8486(03)00535-0; Gillikin DP, 2006, ORG GEOCHEM, V37, P1371, DOI 10.1016/j.orggeochem.2006.03.008; Grangere K, 2009, J SEA RES, V62, P147, DOI 10.1016/j.seares.2009.02.002; Guilloux L, 2013, CAH BIOL MAR, V54, P247; Hagger JA, 2010, ECOTOXICOLOGY, V19, P953, DOI 10.1007/s10646-010-0477-0; Handa A, 2011, J SEA RES, V66, P297, DOI 10.1016/j.seares.2011.05.005; HILBISH TJ, 1986, J EXP MAR BIOL ECOL, V96, P103, DOI 10.1016/0022-0981(86)90236-4; Horner R.A, 2002, TAXONOMIC GUIDE SOME; Hui JA, 1996, J BIOGEOGR, V23, P129; Jouenne F, 2005, ESTUAR COAST SHELF S, V65, P421, DOI 10.1016/j.ecss.2005.05.023; Jouenne F, 2007, MAR BIOL, V151, P805, DOI 10.1007/s00227-006-0440-z; KAUTSKY N, 1982, MAR BIOL, V68, P143, DOI 10.1007/BF00397601; Kooijman S. A. L. M., 2010, DYNAMIC ENERGY BUDGE; Lauringson V, 2014, MAR ECOL-EVOL PERSP, V35, P56, DOI 10.1111/maec.12120; Leblanc K, 2012, EARTH SYST SCI DATA, V4, P149, DOI 10.5194/essd-4-149-2012; Lefebvre S, 2009, MAR ECOL PROG SER, V390, P27, DOI 10.3354/meps08187; Lehane C, 2006, ESTUAR COAST SHELF S, V67, P645, DOI 10.1016/j.ecss.2005.12.015; Leonardos N, 2000, AQUACULTURE, V182, P301, DOI 10.1016/S0044-8486(99)00269-0; Li W, 2009, OR INSIGHT, V46, P44; Maloy AP, 2013, MAR BIOL, V160, P479, DOI 10.1007/s00227-012-2105-4; Marie D, 1997, APPL ENVIRON MICROB, V63, P186, DOI 10.1128/AEM.63.1.186-193.1997; Marshall HG, 2006, ESTUAR COAST SHELF S, V69, P10, DOI 10.1016/j.ecss.2006.03.019; Marshall HG, 2004, CASTANEA, V69, P272, DOI 10.2179/0008-7475(2004)069<0272:PCWTTF>2.0.CO;2; Masquelier S, 2011, J SEA RES, V66, P111, DOI 10.1016/j.seares.2011.05.004; NEWELL RIE, 1982, BIOL BULL, V162, P299, DOI 10.2307/1540985; PALMER AR, 1981, NATURE, V292, P150, DOI 10.1038/292150a0; Pernet F, 2012, J SEA RES, V68, P20, DOI 10.1016/j.seares.2011.11.004; Pronker AE, 2008, AQUACULT INT, V16, P297, DOI 10.1007/s10499-007-9143-9; RIISGARD H. U., 2011, J MAR BIOL, DOI [DOI 10.1155/2011/312459, 10.1155/2011/312459]; RODHOUSE PG, 1984, J MAR BIOL ASSOC UK, V64, P513, DOI 10.1017/S0025315400030204; Rosland R, 2009, J SEA RES, V62, P49, DOI 10.1016/j.seares.2009.02.007; Rouillon G, 2005, J SHELLFISH RES, V24, P5; Saraiva S, 2012, MAR ECOL PROG SER, V463, P141, DOI 10.3354/meps09801; Saraiva S, 2011, J SEA RES, V66, P289, DOI 10.1016/j.seares.2011.06.002; Saurel C, 2007, LIMNOL OCEANOGR, V52, P1919, DOI 10.4319/lo.2007.52.5.1919; Smaal AC, 1997, MAR ECOL PROG SER, V153, P167, DOI 10.3354/meps153167; Smaal AC, 1997, J EXP MAR BIOL ECOL, V209, P33, DOI 10.1016/S0022-0981(96)02695-0; SPRUNG M, 1983, HELGOLANDER MEERESUN, V36, P243, DOI 10.1007/BF01983629; Strohmeier T, 2012, J EXP MAR BIOL ECOL, V412, P96, DOI 10.1016/j.jembe.2011.11.006; STROMGREN T, 1984, J EXP MAR BIOL ECOL, V76, P23, DOI 10.1016/0022-0981(84)90014-5; Sun J, 2003, J PLANKTON RES, V25, P1331, DOI 10.1093/plankt/fbg096; TANAKA N, 1986, NATURE, V320, P520, DOI 10.1038/320520a0; THACKER WC, 1989, J GEOPHYS RES-OCEANS, V94, P6177, DOI 10.1029/JC094iC05p06177; Thomas Y, 2011, J SEA RES, V66, P308, DOI 10.1016/j.seares.2011.04.015; Thorarinsdottir GG, 2003, POLAR RES, V22, P217, DOI 10.1111/j.1751-8369.2003.tb00108.x; Toro JE, 2002, MAR BIOL, V141, P897, DOI 10.1007/s00227-002-0897-3; Toupoint N, 2012, BIOFOULING, V28, P985, DOI 10.1080/08927014.2012.725202; Toupoint N, 2012, ECOLOGY, V93, P1922, DOI 10.1890/11-1292.1; Troost TA, 2010, PHILOS T R SOC B, V365, P3567, DOI 10.1098/rstb.2010.0074; Trottet A, 2008, J EXP MAR BIOL ECOL, V365, P103, DOI 10.1016/j.jembe.2008.08.001; Ubertini M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044155; Uthermol H., 1958, MITTEILINGEN INTERNA, V9, P1, DOI [10.1080/0 5384680.1958.11904091, DOI 10.1080/05384680.1958.11904091]; van der Veer HW, 2006, J SEA RES, V56, P107, DOI 10.1016/j.seares.2006.03.005; VAULOT D, 1989, CYTOMETRY, V10, P629, DOI 10.1002/cyto.990100519; WIDDOWS J, 1979, MAR BIOL, V50, P195, DOI 10.1007/BF00394201	79	17	18	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e109796	10.1371/journal.pone.0109796	http://dx.doi.org/10.1371/journal.pone.0109796			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340793	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662800018
J	Rutebemberwa, A; Stevens, MJ; Perez, MJ; Smith, LP; Sanders, L; Cosgrove, G; Robertson, CE; Tuder, RM; Harris, JK				Rutebemberwa, Alleluiah; Stevens, Mark J.; Perez, Mario J.; Smith, Lynelle P.; Sanders, Linda; Cosgrove, Gregory; Robertson, Charles E.; Tuder, Rubin M.; Harris, J. Kirk			Novosphingobium and Its Potential Role in Chronic Obstructive Pulmonary Diseases: Insights from Microbiome Studies	PLOS ONE			English	Article							ACUTE EXACERBATIONS; CYSTIC-FIBROSIS; SPHINGOMONAS-PAUCIMOBILIS; AIRWAY MICROBIOTA; BARCODED PRIMERS; EMPHYSEMA; LUNG; MICE; INFLAMMATION; COPD	Bacterial infection of lung airways underlies some of the main complications of COPD, significantly impacting disease progression and outcome. Colonization by bacteria may further synergize, amplify, or trigger pathways of tissue damage started by cigarette smoke, contributing to the characteristic airway inflammation and alveolar destruction of COPD. We sought to elucidate the presence and types of lung bacterial populations in different stages of COPD, aimed at revealing important insights into the pathobiology of the disease. Sequencing of the bacterial small subunit ribosomal RNA gene in 55 well-characterized clinical lung samples, revealed the presence of Novosphingobium spp. (>2% abundance) in lungs of patients with GOLD 3-GOLD 4 COPD, cystic fibrosis and a subset of control individuals. Novosphingobium-specific quantitative PCR was concordant with the sequence data and high levels of Novosphingobium spp. were quantifiable in advanced COPD, but not from other disease stages. Using a mouse model of subacute lung injury due to inhalation of cigarette smoke, bronchoalveolar lavage neutrophil and macrophage counts were significantly higher in mice challenged intratracheally with N. panipatense compared to control mice (p<0.01). Frequencies of neutrophils and macrophages in lung tissue were increased in mice challenged with N. panipatense at room air compared to controls. However, we did not observe an interaction between N. panipatense and subacute cigarette smoke exposure in the mouse. In conclusion, Novosphingobium spp. are present in more severe COPD disease, and increase inflammation in a mouse model of smoke exposure.	[Rutebemberwa, Alleluiah; Perez, Mario J.; Smith, Lynelle P.; Sanders, Linda; Tuder, Rubin M.] Univ Colorado, Sch Med, Program Translat Lung Res, Div Pulm Sci & Crit Care Med, Aurora, CO 80045 USA; [Stevens, Mark J.; Harris, J. Kirk] Univ Colorado, Sch Med, Dept Pediat,Childrens Hosp Colorado, Mucosal & Vaccine Res Colorado,Microbiome Res Col, Aurora, CO USA; [Cosgrove, Gregory] Natl Jewish Hlth, Dept Med, Aurora, CO USA; [Cosgrove, Gregory] Univ Colorado, Sch Med, Div Pulm Sci & Crit Care Med, Aurora, CO USA; [Robertson, Charles E.] Univ Colorado, Dept Mol Cellular & Dev Biol, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Tuder, RM (corresponding author), Univ Colorado, Sch Med, Program Translat Lung Res, Div Pulm Sci & Crit Care Med, Anschutz Med Campus, Aurora, CO 80045 USA.	Rubin.Tuder@ucdenver.edu; Jonathan.Harris@ucdenver.edu		Harris, Jonathan/0000-0002-2378-4202; ROBERTSON, CHARLES/0000-0002-4136-4121	NIH [R21 HL110721, R03 HL 097009, R01 ES016285]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R03HL097009, R21HL110721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016285] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The work included in this manuscript was financially supported through the following NIH grants: R21 HL110721 and R03 HL 097009 (to RMT and JKH) and R01 ES016285 (to RMT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALL P, 1995, CHEST, V108, pS43, DOI 10.1378/chest.108.2_Supplement.43S; BAUGHMAN RP, 1987, CHEST, V91, P233, DOI 10.1378/chest.91.2.233; Blainey PC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004458; Cabrera-Rubio R, 2012, J CLIN MICROBIOL, V50, P3562, DOI 10.1128/JCM.00767-12; Cosio MG, 2009, NEW ENGL J MED, V360, P2445, DOI 10.1056/NEJMra0804752; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Field TR, 2010, ANAEROBE, V16, P337, DOI 10.1016/j.anaerobe.2010.04.002; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Guerassimov A, 2004, AM J RESP CRIT CARE, V170, P974, DOI 10.1164/rccm.200309-1270oc; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Han MK, 2012, THORAX, V67, P456, DOI 10.1136/thoraxjnl-2011-201183; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Harris JK, 2010, APPL ENVIRON MICROB, V76, P3863, DOI 10.1128/AEM.02585-09; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Huang YJ, 2013, AM J RESP CRIT CARE, V187, P1382, DOI 10.1164/rccm.201303-0488WS; Huang YJ, 2011, EXPERT REV RESP MED, V5, P809, DOI [10.1586/ERS.11.76, 10.1586/ers.11.76]; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Huang YJ, 2010, OMICS, V14, P9, DOI 10.1089/omi.2009.0100; Kaplan MM, 2004, AM J GASTROENTEROL, V99, P2147, DOI 10.1111/j.1572-0241.2004.41121.x; Kelley ST, 2004, APPL ENVIRON MICROB, V70, P4187, DOI 10.1128/AEM.70.7.4187-4192.2004; Lemaitre D, 1996, J HOSP INFECT, V32, P199, DOI 10.1016/S0195-6701(96)90146-2; MacIntyre Neil, 2008, Proc Am Thorac Soc, V5, P530, DOI 10.1513/pats.200707-088ET; Mannino David M, 2006, Int J Chron Obstruct Pulmon Dis, V1, P219; Martinez Fernando J, 2007, Proc Am Thorac Soc, V4, P647, DOI 10.1513/pats.200707-097TH; Mattner J, 2008, CELL HOST MICROBE, V3, P304, DOI 10.1016/j.chom.2008.03.009; Morris A, 2013, AM J RESP CRIT CARE, V187, P1067, DOI 10.1164/rccm.201210-1913OC; Murphy TF, 2006, CURR OPIN INFECT DIS, V19, P225, DOI 10.1097/01.qco.0000224815.89363.15; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; National Heart Lung and Blood Institute, 2000, COPD ARE YOU RISK; Patrone JB, 2006, J IMMUNOL, V177, P1314, DOI 10.4049/jimmunol.177.2.1314; Pauwels RA, 2004, LANCET, V364, P613, DOI 10.1016/S0140-6736(04)16855-4; Pragman AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047305; Proctor LM, 2011, CELL HOST MICROBE, V10, P287, DOI 10.1016/j.chom.2011.10.001; Rajendrasozhan S, 2010, AM J PHYSIOL-LUNG C, V298, pL197, DOI 10.1152/ajplung.00265.2009; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Retamales I, 2001, AM J RESP CRIT CARE, V164, P469, DOI 10.1164/ajrccm.164.3.2007149; Robertson CE, 2013, BIOINFORMATICS; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Ryan MP, 2010, J HOSP INFECT, V75, P153, DOI 10.1016/j.jhin.2010.03.007; Sapkota AR, 2010, ENVIRON HEALTH PERSP, V118, P351, DOI 10.1289/ehp.0901201; Seemungal T, 2001, AM J RESP CRIT CARE, V164, P1618, DOI 10.1164/ajrccm.164.9.2105011; Sethi S, 2000, CHEST, V117, p286S, DOI 10.1378/chest.117.5_suppl_1.286S; Shi T, 2001, J IND MICROBIOL BIOT, V26, P283, DOI 10.1038/sj.jim.7000130; Sze MA, 2012, AM J RESP CRIT CARE, V185, P1073, DOI 10.1164/rccm.201111-2075OC; Takeuchi M, 2001, INT J SYST EVOL MICR, V51, P1405, DOI 10.1099/00207713-51-4-1405; Veeramachaneni Sateesh B, 2006, COPD, V3, P109; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wedzicha JA, 2000, THROMB HAEMOSTASIS, V84, P210; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8; Yao HW, 2008, AM J PHYSIOL-LUNG C, V294, pL1174, DOI 10.1152/ajplung.00439.2007; Yoshida T, 2010, NAT MED, V16, P767, DOI 10.1038/nm.2157; Zemanick ET, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062917; Zemanick ET, 2011, CURR OPIN PEDIATR, V23, P319, DOI 10.1097/MOP.0b013e32834604f2	55	14	16	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111150	10.1371/journal.pone.0111150	http://dx.doi.org/10.1371/journal.pone.0111150			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340840	Green Submitted, Green Published, gold			2022-12-27	WOS:000343662800089
J	Smart, HC; Mast, FD; Chilije, MFJ; Tavassoli, M; Dacks, JB; Zaremberg, V				Smart, Heather C.; Mast, Fred D.; Chilije, Maxwell F. J.; Tavassoli, Marjan; Dacks, Joel B.; Zaremberg, Vanina			Phylogenetic Analysis of Glycerol 3-Phosphate Acyltransferases in Opisthokonts Reveals Unexpected Ancestral Complexity and Novel Modern Biosynthetic Components	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; PHOSPHATIDIC-ACID; GLYCEROL-3-PHOSPHATE ACYLTRANSFERASES; DIHYDROXYACETONEPHOSPHATE ACYLTRANSFERASE; TRIACYLGLYCEROL SYNTHESIS; MAXIMUM-LIKELIHOOD; ESCHERICHIA-COLI; MEMBRANE-PROTEIN; INITIAL STEP; IDENTIFICATION	Glycerolipid synthesis represents a central metabolic process of all forms of life. In the last decade multiple genes coding for enzymes responsible for the first step of the pathway, catalyzed by glycerol 3-phosphate acyltransferase (GPAT), have been described, and characterized primarily in model organisms like Saccharomyces cerevisiae and mice. Notoriously, the fungal enzymes share low sequence identity with their known animal counterparts, and the nature of their homology is unclear. Furthermore, two mitochondrial GPAT isoforms have been described in animal cells, while no such enzymes have been identified in Fungi. In order to determine if the yeast and mammalian GPATs are representative of the set of enzymes present in their respective groups, and to test the hypothesis that metazoan orthologues are indeed absent from the fungal clade, a comparative genomic and phylogenetic analysis was performed including organisms spanning the breadth of the Opisthokonta supergroup. Surprisingly, our study unveiled the presence of 'fungal' orthologs in the basal taxa of the holozoa and 'animal' orthologues in the basal holomycetes. This includes a novel clade of fungal homologues, with putative peroxisomal targeting signals, of the mitochondrial/peroxisomal acyltransferases in Metazoa, thus potentially representing an undescribed metabolic capacity in the Fungi. The overall distribution of GPAT homologues is suggestive of high relative complexity in the ancestors of the opisthokont clade, followed by loss and sculpting of the complement in the descendent lineages. Divergence from a general versatile metabolic model, present in ancestrally deduced GPAT complements, points to distinctive contributions of each GPAT isoform to lipid metabolism and homeostasis in contemporary organisms like humans and their fungal pathogens.	[Smart, Heather C.; Chilije, Maxwell F. J.; Tavassoli, Marjan; Zaremberg, Vanina] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Mast, Fred D.; Dacks, Joel B.] Univ Alberta, Dept Cell Biol, Edmonton, AB, Canada	University of Calgary; University of Alberta	Dacks, JB (corresponding author), Univ Alberta, Dept Cell Biol, Edmonton, AB, Canada.	dacks@ualberta.ca; vzarembe@ucalgary.ca	Mast, Fred/AAM-2426-2021; Mast, Fred/A-6507-2011; Dacks, Joel/AAE-3308-2021	Mast, Fred/0000-0002-2177-6647; Mast, Fred/0000-0002-2177-6647; Dacks, Joel/0000-0003-4520-5694	National Sciences and Engineering Research Council (NSERC); New Faculty Award from Alberta Innovates Technology Futures	National Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); New Faculty Award from Alberta Innovates Technology Futures	This work was supported by operating grants from the National Sciences and Engineering Research Council (NSERC) to JBD and VZ. Work in the Dacks lab is also funded by a New Faculty Award from Alberta Innovates Technology Futures. JBD is the Canada Research Chair in Evolutionary Cell Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasland R, 2002, FEBS LETT, V513, P141, DOI 10.1016/S0014-5793(01)03295-1; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Athenstaedt K, 1999, J BACTERIOL, V181, P1458, DOI 10.1128/JB.181.5.1458-1463.1999; Bertolesi GE, 2012, GENE EXPR PATTERNS, V12, P219, DOI 10.1016/j.gep.2012.04.002; Bratschi MW, 2009, EUKARYOT CELL, V8, P1184, DOI 10.1128/EC.00085-09; Cao JS, 2006, P NATL ACAD SCI USA, V103, P19695, DOI 10.1073/pnas.0609140103; Coleman RA, 2007, CELL METAB, V5, P87, DOI 10.1016/j.cmet.2007.01.004; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Daum G, 2011, BIOCH BIOPHYS ACTA M, V1811, P1165, DOI [10.1016/j.bbalip.2011.07.015, DOI 10.1016/J.BBALIP.2011.07.015]; De Smet CH, 2012, MOL BIOL CELL, V23, P1146, DOI 10.1091/mbc.E11-07-0624; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Fairn GD, 2008, SCIENCE, V320, P458, DOI 10.1126/science.1158173; Fares MA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003176; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Foster DA, 2013, TRENDS ENDOCRIN MET, V24, P272, DOI 10.1016/j.tem.2013.02.003; Gimeno RE, 2008, J LIPID RES, V49, P2079, DOI 10.1194/jlr.R800013-JLR200; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hammond LE, 2005, J BIOL CHEM, V280, P25629, DOI 10.1074/jbc.M503181200; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Kuruma Y, 2009, BBA-BIOMEMBRANES, V1788, P567, DOI 10.1016/j.bbamem.2008.10.017; Lewin TM, 1999, BIOCHEMISTRY-US, V38, P5764, DOI 10.1021/bi982805d; LIGHTNER VA, 1983, J BIOL CHEM, V258, P856; Liu DL, 2005, J LIPID RES, V46, P727, DOI 10.1194/jlr.M400364-JLR200; Luisi PL, 2011, NAT CHEM, V3, P755, DOI 10.1038/nchem.1156; Maddison WP, 2011, MESQUITE MODULAR SYS; Marr N, 2012, J BIOL CHEM, V287, P10251, DOI 10.1074/jbc.M111.314112; Mast FD, 2012, MOL BIOL EVOL, V29, P975, DOI 10.1093/molbev/msr264; MINSKOFF SA, 1994, J LIPID RES, V35, P2254; Mohanty A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00268; Neuberger G, 2003, J MOL BIOL, V328, P567, DOI 10.1016/S0022-2836(03)00318-8; OFMAN R, 1994, BBA-PROTEIN STRUCT M, V1206, P27, DOI 10.1016/0167-4838(94)90068-X; Ohba Y, 2013, EMBO J, V32, P1265, DOI 10.1038/emboj.2013.77; Patil VA, 2013, ADV EXP MED BIOL, V991, P195, DOI 10.1007/978-94-007-6331-9_11; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Santiago TC, 2004, J BIOL CHEM, V279, P9222, DOI 10.1074/jbc.M310502200; Shen YQ, 2009, FUNCT INTEGR GENOMIC, V9, P145, DOI 10.1007/s10142-008-0095-6; SHIN DH, 1991, J BIOL CHEM, V266, P23834; Shiromoto Y, 2013, RNA, V19, P803, DOI 10.1261/rna.038521.113; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suga H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3325; Takeuchi K, 2009, AM J PHYSIOL-ENDOC M, V296, pE1195, DOI 10.1152/ajpendo.90958.2008; Wang Z, 2009, GENOME BIOL EVOL, V1, P23, DOI 10.1093/gbe/evp002; Wendel AA, 2013, J BIOL CHEM, V288, P27299, DOI 10.1074/jbc.M113.485219; Wendel AA, 2009, BBA-MOL CELL BIOL L, V1791, P501, DOI 10.1016/j.bbalip.2008.10.010; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Wood V, 2012, NUCLEIC ACIDS RES, V40, pD695, DOI 10.1093/nar/gkr853; Zaremberg V, 2002, J BIOL CHEM, V277, P39035, DOI 10.1074/jbc.M207753200; Zhang CB, 2012, P NATL ACAD SCI USA, V109, P1667, DOI 10.1073/pnas.1110730109; Zheng ZF, 2001, J BIOL CHEM, V276, P41710, DOI 10.1074/jbc.M104749200	52	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110684	10.1371/journal.pone.0110684	http://dx.doi.org/10.1371/journal.pone.0110684			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340523	Green Submitted, Green Published, gold			2022-12-27	WOS:000343662800048
J	Cardenosa, D; Hyde, J; Caballero, S				Cardenosa, Diego; Hyde, John; Caballero, Susana			Genetic Diversity and Population Structure of the Pelagic Thresher Shark (Alopias pelagicus) in the Pacific Ocean: Evidence for Two Evolutionarily Significant Units	PLOS ONE			English	Article							SHORTFIN MAKO; WHALE SHARK; FISH; DIFFERENTIATION; G(ST)	There has been an increasing concern about shark overexploitation in the last decade, especially for open ocean shark species, where there is a paucity of data about their life histories and population dynamics. Little is known regarding the population structure of the pelagic thresher shark, Alopias pelagicus. Though an earlier study using mtDNA control region data, showed evidence for differences between eastern and western Pacific populations, the study was hampered by low sample size and sparse geographic coverage, particularly a lack of samples from the central Pacific. Here, we present the population structure of Alopias pelagicus analyzing 351 samples from six different locations across the Pacific Ocean. Using data from mitochondrial DNA COI sequences and seven microsatellite loci we found evidence of strong population differentiation between western and eastern Pacific populations and evidence for reciprocally monophyly for organelle haplotypes and significant divergence of allele frequencies at nuclear loci, suggesting the existence of two Evolutionarily Significant Units (ESU) in the Pacific Ocean. Interestingly, the population in Hawaii appears to be composed of both ESUs in what seems to be clear sympatry with reproductive isolation. These results may indicate the existence of a new cryptic species in the Pacific Ocean. The presence of these distinct ESUs highlights the need for revised management plans for this highly exploited shark throughout its range.	[Cardenosa, Diego; Caballero, Susana] Univ Los Andes, Lab Ecol Mol Vertebrados Acuat, Dept Ciencias Biol, Bogota, Colombia; [Hyde, John] Natl Marine Fisheries Serv, SW Fisheries Sci Ctr, La Jolla, CA 92038 USA	Universidad de los Andes (Colombia); National Oceanic Atmospheric Admin (NOAA) - USA	Caballero, S (corresponding author), Univ Los Andes, Lab Ecol Mol Vertebrados Acuat, Dept Ciencias Biol, Bogota, Colombia.	sj.caballero26@uniandes.edu.co		Cardenosa, Diego/0000-0001-9414-7385; Cardenosa, Diego/0000-0001-9535-997X	Universidad d elos Andes (Proyecto semilla Profesor Asociado y Proyecto semilla estudiante); NOAA	Universidad d elos Andes (Proyecto semilla Profesor Asociado y Proyecto semilla estudiante); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA)	Funding for this project was provided by Universidad d elos Andes (Proyecto semilla Profesor Asociado y Proyecto semilla estudiante) and NOAA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caballero S, 2012, MOL ECOL RESOUR, V12, P233, DOI 10.1111/j.1755-0998.2011.03089.x; Caldas JP, 2010, PLAN ACCION NACL CON; CAMHI MD, 2008, SHARKS OPEN OCEAN; Castro ALF, 2007, MOL ECOL, V16, P5183, DOI 10.1111/j.1365-294X.2007.03597.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Daly-Engel TS, 2012, PLOS ONE, V7, P279, DOI 10.1371/journal.pone.0029986; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eitner BJ, 1995, COPEIA, P562, DOI 10.2307/1446753; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gerlach G, 2010, MOL ECOL, V19, P3845, DOI 10.1111/j.1365-294X.2010.04784.x; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hyde JR, 2005, MAR ECOL PROG SER, V286, P269, DOI 10.3354/meps286269; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Liu KM, 1999, COPEIA, P68; Maddison D. R., 2000, MACCLADE ANAL PHYLOG; MARTIN AP, 1995, MOL BIOL EVOL, V12, P1114; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Ovenden JR, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-40; Pardini AT, 2000, MOL ECOL, V9, P1176, DOI 10.1046/j.1365-294x.2000.00954-4.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Hoelzel AR, 2006, BIOL LETTERS, V2, P639, DOI 10.1098/rsbl.2006.0513; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; Schmidt JV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004988; Schrey AW, 2003, CAN J FISH AQUAT SCI, V60, P670, DOI 10.1139/F03-064; Schrey AW, 2002, CONSERV GENET, V3, P459, DOI 10.1023/A:1020583609967; Trejo T, 2005, THESIS STATE U MONTE, P1; Tsai WP, 2010, MAR FRESHWATER RES, V61, P1056, DOI 10.1071/MF09303; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Westemeier RL, 1998, SCIENCE, V282, P1695, DOI 10.1126/science.282.5394.1695	33	29	29	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110193	10.1371/journal.pone.0110193	http://dx.doi.org/10.1371/journal.pone.0110193			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337814	Green Submitted, Green Published, gold			2022-12-27	WOS:000343674800029
J	Krief, S; Cibot, M; Bortolamiol, S; Seguya, A; Krief, JM; Masi, S				Krief, Sabrina; Cibot, Marie; Bortolamiol, Sarah; Seguya, Andrew; Krief, Jean-Michel; Masi, Shelly			Wild Chimpanzees on the Edge: Nocturnal Activities in Croplands	PLOS ONE			English	Article							KIBALE NATIONAL-PARK; PAN-TROGLODYTES; CATHEMERAL ACTIVITY; FOOD AVAILABILITY; ACTIVITY PATTERNS; BEHAVIOR; FOREST; DECLINE; POPULATION; PRIMATES	In a rapidly changing landscape highly impacted by anthropogenic activities, the great apes are facing new challenges to coexist with humans. For chimpanzee communities inhabiting encroached territories, not bordered by rival conspecifics but by human agricultural fields, such boundaries are risky areas. To investigate the hypothesis that they use specific strategies for incursions out of the forest into maize fields to prevent the risk of detection by humans guarding their field, we carried out video recordings of chimpanzees at the edge of the forest bordered by a maize plantation in Kibale National Park, Uganda. Contrary to our expectations, large parties are engaged in crop-raids, including vulnerable individuals such as females with clinging infants. More surprisingly chimpanzees were crop-raiding during the night. They also stayed longer in the maize field and presented few signs of vigilance and anxiety during these nocturnal crop-raids. While nocturnal activities of chimpanzees have been reported during full moon periods, this is the first record of frequent and repeated nocturnal activities after twilight, in darkness. Habitat destruction may have promoted behavioural adjustments such as nocturnal exploitation of open croplands.	[Krief, Sabrina; Cibot, Marie; Bortolamiol, Sarah; Masi, Shelly] Museum Natl Hist Nat, UMR CNRS MNHN P7 7206, F-75231 Paris, France; [Krief, Sabrina; Cibot, Marie; Bortolamiol, Sarah; Krief, Jean-Michel] Kibale Natl Pk, Projet Conservat Grands Singes, Ft Portal, Uganda; [Cibot, Marie] Museum Natl Hist Nat, UMR CNRS MNHN 7179, F-75231 Paris, France; [Bortolamiol, Sarah] Paris Diderot Univ, UMR 7533, Paris, France; [Seguya, Andrew] Uganda Wildlife Author, Kampala, Uganda	Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); UDICE-French Research Universities; Universite Paris Cite	Krief, S (corresponding author), Museum Natl Hist Nat, UMR CNRS MNHN P7 7206, F-75231 Paris, France.	krief@mnhn.fr			National Museum of Natural History/ATM [16]; LabEx BCDIV; Projet pour la Conservation des Grands Singes funds; ANR JC-JC SAFAPE	National Museum of Natural History/ATM; LabEx BCDIV; Projet pour la Conservation des Grands Singes funds; ANR JC-JC SAFAPE(French National Research Agency (ANR))	SK received funds from National Museum of Natural History/ATM 16, ANR JC-JC SAFAPE to design and conduct the study. MC received funds from LabEx BCDIV for her field study. Projet pour la Conservation des Grands Singes funds the Ugandan field team and support logistic management. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aureli F, 1997, AM J PRIMATOL, V41, P213, DOI 10.1002/(SICI)1098-2345(1997)41:3<213::AID-AJP4>3.0.CO;2-#; Bates LA, 2009, BEHAV ECOL SOCIOBIOL, V64, P247, DOI 10.1007/s00265-009-0841-3; BOESCH C, 1994, ANIM BEHAV, V48, P653, DOI 10.1006/anbe.1994.1285; Boesch Christophe, 1993, P158; Bortolamiol S, 2014, PLOS ONE IN PRESS; Campbell G, 2008, CURR BIOL, V18, pR903, DOI 10.1016/j.cub.2008.08.015; Chapman CA, 1996, INT J PRIMATOL, V17, P31, DOI 10.1007/BF02696157; Colquhoun IC, 2006, FOLIA PRIMATOL, V77, P143, DOI 10.1159/000089701; Conklin-Brittain Nancy Lou, 2006, P445; Conklin-Brittain NL, 1998, 14 ICAES C; Curtis DJ, 2002, EVOL ANTHROPOL, V11, P83, DOI 10.1002/evan.10064; Curtis DJ, 1999, AM J PRIMATOL, V75, P201; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; Dewar RE, 2007, P NATL ACAD SCI USA, V104, P13723, DOI 10.1073/pnas.0704346104; Donati G, 2006, FOLIA PRIMATOL, V77, P104, DOI 10.1159/000089698; Donati G, 1999, NEW DIRECTIONS IN LEMUR STUDIES, P119; Donati G, 2009, ANIM BEHAV, V77, P317, DOI 10.1016/j.anbehav.2008.09.033; ENGQVIST A, 1991, FOLIA PRIMATOL, V57, P169, DOI 10.1159/000156581; Erkert HG, 2008, BIOL RHYTHM RES, V39, P229, DOI 10.1080/09291010701683391; Erkert Hans G., 2003, P252; Fernandez-Duque E, 2003, BEHAV ECOL SOCIOBIOL, V54, P431, DOI 10.1007/s00265-003-0637-9; FRA, 2010, 147 FAO; Goodall J., 1986, CHIMPANZEES GOMBE PA; Greene D, 2003, LIGHT DARK EXPLORATI; Gursky S, 2003, INT J PRIMATOL, V24, P351, DOI 10.1023/A:1023053301059; Halle S., 2000, ACTIVITY PATTERNS SM; HAMILTON A, 1986, NATURE, V320, P164, DOI 10.1038/320164a0; Hardus ME, 2012, BIOL CONSERV, V146, P177, DOI 10.1016/j.biocon.2011.12.014; Hartter J., 2009, Human Dimensions of Wildlife, V14, P433, DOI 10.1080/10871200902911834; Hartter J, 2010, P IUFRO LANDSC EC IN; HAYNE DW, 1949, J MAMMAL, V30, P1, DOI 10.2307/1375189; Head JS, 2011, INT J PRIMATOL, V32, P755, DOI 10.1007/s10764-011-9499-6; Herbinger I, 2001, INT J PRIMATOL, V22, P143, DOI 10.1023/A:1005663212997; Hockings K., 2009, BEST PRACTICE GUIDEL; Hockings KJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000886; Hockings Kimberley J., 2013, Primate Conservation, V26, P57; Hockings KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033391; Hockings KJ, 2012, ANIM BEHAV, V83, P801, DOI 10.1016/j.anbehav.2012.01.002; Hockings KJ, 2010, AM J PRIMATOL, V72, P887, DOI 10.1002/ajp.20784; Hockings KJ, 2011, PRIMATOL MONOGR, P221, DOI 10.1007/978-4-431-53921-6_24; HORROCKS JA, 1986, INT J PRIMATOL, V7, P31, DOI 10.1007/BF02692308; HUFFMAN MA, 1989, PRIMATES, V30, P51, DOI 10.1007/BF02381210; Humle T, 2009, ANIM COGN, V12, pS37, DOI 10.1007/s10071-009-0272-6; Hyeroba D, 2011, VET REC, V169, DOI 10.1136/vr.d4680; Janmaat KRL, 2013, ANIM COGN, V16, P851, DOI 10.1007/s10071-013-0617-z; Junker J, 2012, DIVERS DISTRIB, V18, P1077, DOI 10.1111/ddi.12005; Kappeler PM, 2003, BEHAV ECOL SOCIOBIOL, V54, P359, DOI 10.1007/s00265-003-0652-x; Krief S, 2006, AM J PRIMATOL, V68, P51, DOI 10.1002/ajp.20206; Krief S, 2004, ANTIMICROB AGENTS CH, V48, P3196, DOI 10.1128/AAC.48.8.3196-3199.2004; Krief S, 2014, J MED PRIMATOL, V43, P280, DOI 10.1111/jmp.12129; Linkie M, 2007, ANIM CONSERV, V10, P127, DOI 10.1111/j.1469-1795.2006.00083.x; Masi S, 2011, J BIOL RES, V1, P293; Masi S, 2012, PHYSIOL BEHAV, V105, P337, DOI 10.1016/j.physbeh.2011.08.012; Matthews A, 2004, PRIMATES, V45, P15, DOI 10.1007/s10329-003-0058-4; McLennan MR, 2012, J NAT CONSERV, V20, P219, DOI 10.1016/j.jnc.2012.03.002; McLennan Matthew R., 2008, Primate Conservation, V23, P45, DOI 10.1896/052.023.0105; Mitani JC, 2005, ANIM BEHAV, V70, P1079, DOI 10.1016/j.anbehav.2005.02.012; Morgan D., 2007, BEST PRACTICE GUIDEL; Nakamura M, 2011, PRIMATOL MONOGR, P251, DOI 10.1007/978-4-431-53921-6_27; Naughton-Treves L, 1997, GEOGR REV, V87, P27, DOI 10.2307/215656; Naughton-Treves L, 1998, J APPL ECOL, V35, P596, DOI 10.1046/j.1365-2664.1998.3540596.x; Naughton-Treves L, 1999, LAND DEGRAD DEV, V10, P311, DOI 10.1002/(SICI)1099-145X(199907/08)10:4<311::AID-LDR362>3.0.CO;2-3; Nishida T., 1996, CHIMPANZEE CULTURES, P373; Nyhus PJ, 2000, ORYX, V34, P262, DOI 10.1017/S0030605300031331; Overdorff DJ, 1995, CREATURES OF THE DARK, P61; Pruetz Jill D., 2009, Paleoanthropology, V2009, P252; Rasmussen MA, 2005, CAM S BIO EVOL ANTHR, V44, P105, DOI 10.1017/CBO9780511542343.005; Sitati NW, 2003, J APPL ECOL, V40, P667, DOI 10.1046/j.1365-2664.2003.00828.x; Starr C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036396; STRUHSAKER T. T., 1997, ECOLOGY AFRICAN RAIN; Treves A, 2010, BIOL CONSERV, V143, P521, DOI 10.1016/j.biocon.2009.11.025; Turner PL, 2010, SLEEP MED REV, V14, P269, DOI 10.1016/j.smrv.2009.11.002; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; Watts DP, 2008, J HUM EVOL, V54, P125, DOI 10.1016/j.jhevol.2007.07.008; Watts DP, 2001, BEHAVIOUR, V138, P299, DOI 10.1163/15685390152032488; Wilson ML, 2007, BEHAVIOUR, V144, P1621, DOI 10.1163/156853907782512137; Wilson ML, 2003, ANNU REV ANTHROPOL, V32, P363, DOI 10.1146/annurev.anthro.32.061002.120046; Wittemyer G, 2008, SCIENCE, V321, P123, DOI 10.1126/science.1158900; WRANGHAM R W, 1983, Primates, V24, P276, DOI 10.1007/BF02381090; Zamma K, 2014, PRIMATES, V55, P51, DOI 10.1007/s10329-013-0367-1	80	65	66	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e109925	10.1371/journal.pone.0109925	http://dx.doi.org/10.1371/journal.pone.0109925			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338066	Green Published, gold, Green Submitted			2022-12-27	WOS:000343674800018
J	Ou, CB; Shi, NN; Yang, QH; Zhang, Y; Wu, ZX; Wang, BZ; Compans, RW; He, C				Ou, Changbo; Shi, Ningning; Yang, Qunhui; Zhang, Yu; Wu, Zongxue; Wang, Baozhong; Compans, Richard W.; He, Cheng			Protocatechuic Acid, a Novel Active Substance against Avian Influenza Virus H9N2 Infection	PLOS ONE			English	Article							A H5N1 VIRUS; CELLS; OSELTAMIVIR; PATHOGENESIS; COMBINATION; RESISTANCE; EFFICACY; HUMATE; MICE	Influenza virus H9N2 subtype has triggered co-infection with other infectious agents, resulting in huge economical losses in the poultry industry. Our current study aims to evaluate the antiviral activity of protocatechuic acid (PCA) against a virulent H9N2 strain in a mouse model. 120 BALB/c mice were divided into one control group, one untreated group, one 50 mg/kg amantadine hydrochloride-treated group and three PCA groups treated 12 hours post-inoculation with 40, 20 or 10 mg/kg PCA for 7 days. All the infected animals were inoculated intranasally with 0.2 ml of a A/Chicken/Hebei/4/2008(H9N2) inoculum. A significant body weight loss was found in the 20 mg/kg and 40 mg/kg PCA-treated and amantadine groups as compared to the control group. The 14 day survivals were 94.4%, 100% and 95% in the PCA-treated groups and 94.4% in the amantadine hydrochloride group, compared to less than 60% in the untreated group. Virus loads were less in the PCA-treated groups compared to the amantadine-treated or the untreated groups. Neutrophil cells in BALF were significantly decreased while IFN-gamma, IL-2, TNF-alpha and IL-6 decreased significantly at days 7 in the PCA-treated groups compared to the untreated group. Furthermore, a significantly decreased CD4+/CD8+ ratio and an increased proportion of CD19 cells were observed in the PCA-treated groups and amantadine-treated group compared to the untreated group. Mice administered with PCA exhibited a higher survival rate and greater viral clearance associated with an inhibition of inflammatory cytokines and activation of CD8+ T cell subsets. PCA is a promising novel agent against bird flu infection in the poultry industry.	[Ou, Changbo] Henan Inst Sci & Technol, Coll Anim Sci, Xinxiang, Peoples R China; [Ou, Changbo; Yang, Qunhui; Zhang, Yu; Wu, Zongxue; He, Cheng] China Agr Univ, Coll Vet Med, Minist Agr, Key Lab Anim Epidemiol & Zoonosis, Beijing 100094, Peoples R China; [Shi, Ningning] Agr Univ Hebei, Coll Life Sci, Baoding, Peoples R China; [Wang, Baozhong; Compans, Richard W.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Wang, Baozhong; Compans, Richard W.] Emory Univ, Sch Med, Yerkes Vaccine Ctr, Atlanta, GA USA	Henan Institute of Science & Technology; China Agricultural University; Ministry of Agriculture & Rural Affairs; Hebei Agricultural University; Emory University; Emory University	He, C (corresponding author), China Agr Univ, Coll Vet Med, Minist Agr, Key Lab Anim Epidemiol & Zoonosis, Beijing 100094, Peoples R China.	hecheng@cau.edu.cn	Compans, Richard W/I-4087-2013; Ou, Changbo/E-2423-2013	Compans, Richard W/0000-0003-2360-335X; Ou, Changbo/0000-0001-9912-5740	National Hi-tech Research and Development Program [2006AA10A208-3-2]; National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01AI101047]; National Natural Science Foundation of China [31402169]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101047] Funding Source: NIH RePORTER	National Hi-tech Research and Development Program(National High Technology Research and Development Program of China); National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Hi-tech Research and Development Program (No. 2006AA10A208-3-2) to CH, National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number R01AI101047 to BW, and National Natural Science Foundation of China (No. 31402169) to CO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado-Esquivel C, 2006, J ANTIMICROB CHEMOTH, V57, P221, DOI 10.1093/jac/dki457; Barbour EK, 2006, INT J APPL RES VET M, V4, P8; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Cheng VCC, 2011, J INFECTION, V62, P394, DOI 10.1016/j.jinf.2011.02.007; Ciftci O, 2013, TOXICOL IND HEALTH, V29, P806, DOI 10.1177/0748233712442735; Deng GC, 2010, ARCH VIROL, V155, P187, DOI 10.1007/s00705-009-0560-0; Doherty PC, 2008, J CLIN INVEST, V118, P3273, DOI 10.1172/JCI37232; Hagau N, 2010, CRIT CARE, V14, DOI 10.1186/cc9324; Hamada H, 2013, J IMMUNOL, V190, P296, DOI 10.4049/jimmunol.1200571; He CQ, 2009, MOL BIOL EVOL, V26, P177, DOI 10.1093/molbev/msn238; HILS J, 1986, BIOMED BIOCHIM ACTA, V45, P1173; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Kishimoto T, 2005, CLIN REV ALLERG IMMU, V28, P177, DOI 10.1385/CRIAI:28:3:177; Lan Y, 2010, ANTIVIR THER, V15, P853, DOI 10.3851/IMP1656; Lende Amol B., 2011, Inflammopharmacology, V19, P255, DOI 10.1007/s10787-011-0086-4; Lin CY, 2009, J AGR FOOD CHEM, V57, P6661, DOI 10.1021/jf9015202; Lin YP, 2000, P NATL ACAD SCI USA, V97, P9654, DOI 10.1073/pnas.160270697; Liu Z, 2009, EUR J PHARM SCI, V38, P215, DOI 10.1016/j.ejps.2009.07.004; Lu FJ, 2002, ARCH VIROL, V147, P273, DOI 10.1007/s705-002-8319-5; Nguyen JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009332; Ortega E, 1999, J ANTIMICROB CHEMOTH, V44, P561, DOI 10.1093/jac/44.4.561; Ou CB, 2012, POULTRY SCI, V91, P1604, DOI 10.3382/ps.2011-02069; Ou CB, 2011, J ANIMAL VET ADV, V10, P5; Rimmelzwaan GF, 2001, J VIROL, V75, P6687, DOI 10.1128/JVI.75.14.6687-6691.2001; Shang Ruo-feng, 2010, Virologica Sinica, V25, P145, DOI 10.1007/s12250-010-3082-8; Simeonova L, 2012, ANTIVIR RES, V95, P172, DOI 10.1016/j.antiviral.2012.05.004; Smee DF, 2012, ANTIVIR RES, V96, P13, DOI 10.1016/j.antiviral.2012.07.002; Sood R, 2012, INDIAN J EXP BIOL, V50, P179; Sturlan S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004122; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Sun YP, 2012, VET MICROBIOL, V156, P193, DOI 10.1016/j.vetmic.2011.10.003; TANAKA T, 1993, CANCER RES, V53, P3908; Tohid T, 2010, VET RES COMMUN, V34, P709, DOI 10.1007/s11259-010-9444-8; Tosh C, 2011, VIRUS GENES, V42, P10, DOI 10.1007/s11262-010-0534-z; Wang GZ, 2012, J TRAUMA ACUTE CARE, V73, P1130, DOI 10.1097/TA.0b013e318265d069; Wei MM, 2012, INFLAMMATION, V35, P1169, DOI 10.1007/s10753-011-9425-2; Xu T, 2006, AM J RESP CRIT CARE, V174, P1011, DOI 10.1164/rccm.200511-1751OC; Yip ECH, 2006, CELL BIOL TOXICOL, V22, P293, DOI 10.1007/s10565-006-0082-4; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029347; Zhao Y, 2012, AM J RESP CRIT CARE, V186, P1292, DOI 10.1164/rccm.201207-1245OC; Zitzow LA, 2002, J VIROL, V76, P4420, DOI 10.1128/JVI.76.9.4420-4429.2002	41	18	21	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e111004	10.1371/journal.pone.0111004	http://dx.doi.org/10.1371/journal.pone.0111004			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337912	Green Published, gold, Green Submitted			2022-12-27	WOS:000343674800093
J	Resto, YA; Robledo, JAF				Resto, Yesmalie Aleman; Robledo, Jose A. Fernandez			Identification of MMV Malaria Box Inhibitors of Perkinsus marinus Using an ATP-Based Bioluminescence Assay	PLOS ONE			English	Article							OYSTER CRASSOSTREA-VIRGINICA; IN-VITRO-PROPAGATION; RIBOSOMAL-RNA LOCUS; EASTERN OYSTER; PROTISTAN PARASITE; PROTOZOAN PARASITE; OSTREA-EDULIS; N-SP; CULTURE; MEDITERRANEUS	''Dermo'' disease caused by the protozoan parasite Perkinsus marinus (Perkinsozoa) is one of the main obstacles to the restoration of oyster populations in the USA. Perkinsus spp. are also a concern worldwide because there are limited approaches to intervention against the disease. Based on the phylogenetic affinity between the Perkinsozoa and Apicomplexa, we exposed Perkinsus trophozoites to the Medicines for Malaria Venture Malaria Box, an open access compound library comprised of 200 drug-like and 200 probe-like compounds that are highly active against the erythrocyte stage of Plasmodium falciparum. Using a final concentration of 20 mu M, we found that 4 days after exposure 46% of the compounds were active against P. marinus trophozoites. Six compounds with IC50 in the mu M range were used to compare the degree of susceptibility in vitro of eight P. marinus strains from the USA and five Perkinsus species from around the world. The three compounds, MMV666021, MMV665807 and MMV666102, displayed a uniform effect across Perkinsus strains and species. Both Perkinsus marinus isolates and Perkinsus spp. presented different patterns of response to the panel of compounds tested, supporting the concept of strain/species variability. Here, we expanded the range of compounds available for inhibiting Perkinsus proliferation in vitro and characterized Perkinsus phenotypes based on their resistance to six compounds. We also discuss the implications of these findings in the context of oyster management. The Perkinsus system offers the potential for investigating the mechanism of action of the compounds of interest.	[Robledo, Jose A. Fernandez] Bigelow Lab Ocean Sci, Boothbay, ME 04544 USA; [Resto, Yesmalie Aleman] Bigelow Lab Ocean Sci, Res Experiences Undergrad REU NSF Program 2013, Boothbay, ME USA	Bigelow Laboratory for Ocean Sciences; Bigelow Laboratory for Ocean Sciences	Robledo, JAF (corresponding author), Bigelow Lab Ocean Sci, Boothbay, ME 04544 USA.	jfernandez-robledo@bigelow.org			Bigelow Laboratory for Ocean Sciences; National Science Foundation [OCE0755142]; National Institute of Health [1R21AI076797-01A2]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076797] Funding Source: NIH RePORTER	Bigelow Laboratory for Ocean Sciences; National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by institutional funds from Bigelow Laboratory for Ocean Sciences, grant OCE0755142 (REU Program) from the National Science Foundation, and grant 1R21AI076797-01A2 from the National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bessoff K, 2014, ANTIMICROB AGENTS CH, V58, P2731, DOI 10.1128/AAC.02641-13; Blackbourn J, 1998, CAN J ZOOL, V76, P942, DOI 10.1139/cjz-76-5-942; Bowman JD, 2014, ANTIMICROB AGENTS CH, V58, P811, DOI 10.1128/AAC.01500-13; Brown GD, 2003, DIS AQUAT ORGAN, V57, P117, DOI 10.3354/dao057117; Bushek D, 1996, MAR ECOL PROG SER, V139, P127, DOI 10.3354/meps139127; Bushek D, 1996, J SHELLFISH RES, V15, P103; Caceres-Martinez J, 2008, J INVERTEBR PATHOL, V99, P66, DOI 10.1016/j.jip.2008.03.005; Carrasco N, 2014, J INVERTEBR PATHOL, V117, P56, DOI 10.1016/j.jip.2014.01.009; Casas SM, 2008, J EUKARYOT MICROBIOL, V55, P34, DOI 10.1111/j.1550-7408.2008.00301.x; Casas SM, 2013, EUR J PROTISTOL, V49, P201, DOI 10.1016/j.ejop.2012.07.004; Casas SM, 2004, DIS AQUAT ORGAN, V58, P231, DOI 10.3354/dao058231; Chen CZ, 2011, ANTIMICROB AGENTS CH, V55, P667, DOI 10.1128/AAC.00618-10; Coss CA, 2001, J EUKARYOT MICROBIOL, V48, P52, DOI 10.1111/j.1550-7408.2001.tb00415.x; Coss CA, 2001, J EUKARYOT MICROBIOL, V48, P38, DOI 10.1111/j.1550-7408.2001.tb00414.x; Duffy S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-408; Dungan CF, 2006, J EUKARYOT MICROBIOL, V53, P316, DOI 10.1111/j.1550-7408.2006.00120.x; Faisal M, 1999, COMP BIOCHEM PHYS B, V123, P417, DOI 10.1016/S0305-0491(99)00088-7; Feng CG, 2013, J BIOL CHEM, V288, P24394, DOI 10.1074/jbc.M113.476531; Fernandez-Robledo JA, 2008, MOL BIOCHEM PARASIT, V157, P44, DOI 10.1016/j.molbiopara.2007.09.007; Fichera ME, 1997, NATURE, V390, P407, DOI 10.1038/37132; Ford SE, 2007, MAR BIOL, V151, P119, DOI 10.1007/s00227-006-0454-6; Ford SE, 2006, J EXP MAR BIOL ECOL, V339, P226, DOI 10.1016/j.jembe.2006.08.004; Garreis KA, 1996, FISH SHELLFISH IMMUN, V6, P581, DOI 10.1006/fsim.1996.0054; GAUTHIER JD, 1993, J INVERTEBR PATHOL, V62, P321, DOI 10.1006/jipa.1993.1122; GAUTHIER JD, 1995, J EUKARYOT MICROBIOL, V42, P307, DOI 10.1111/j.1550-7408.1995.tb01585.x; Goodman CD, 2007, MOL BIOCHEM PARASIT, V152, P181, DOI 10.1016/j.molbiopara.2007.01.005; Grimberg BT, 2011, PHARMACEUTICALS, V4, P681, DOI 10.3390/ph4050681; He Y, 2012, FISH SHELLFISH IMMUN, V33, P411, DOI 10.1016/j.fsi.2012.05.028; Hohwy M, 2008, J MED CHEM, V51, P2178, DOI 10.1021/jm701509k; Joseph SJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-228; Keeling PJ, 2010, PHILOS T R SOC B, V365, P729, DOI 10.1098/rstb.2009.0103; KLEINSCHUSTER SJ, 1993, NAUTILUS, V107, P76; LAPEYRE JF, 1993, J EUKARYOT MICROBIOL, V40, P304, DOI 10.1111/j.1550-7408.1993.tb04920.x; Leite RB, 2011, HERBICIDES, THEORY AND APPLICATIONS, P567; Lucantoni L, 2013, ANTIMICROB AGENTS CH, V57, P6050, DOI 10.1128/AAC.00870-13; MACKIN JG, 1950, SCIENCE, V111, P328, DOI 10.1126/science.111.2883.328; Menzel W., 1966, P NATIONAL SHELLFISH, V56, P23; Monzote Lianet, 2011, Open Med Chem J, V5, P1, DOI 10.2174/1874104501105010001; Moss JA, 2008, J EUKARYOT MICROBIOL, V55, P117, DOI 10.1111/j.1550-7408.2008.00314.x; Na BK, 2007, EXP PARASITOL, V116, P414, DOI 10.1016/j.exppara.2007.02.005; Njuguna JT, 2014, BIOORGAN MED CHEM, V22, P4338, DOI 10.1016/j.bmc.2014.05.007; Panko C, 2006, J SHELLFISH RES, V25, P760; Pecher WT, 2008, J PARASITOL, V94, P410, DOI 10.1645/GE-1282.1; Reece KS, 2001, MAR BIOL, V139, P1047, DOI 10.1007/s002270100657; Robledo JAF, 1999, J PARASITOL, V85, P650, DOI 10.2307/3285738; Robledo JAF, 2002, J EUKARYOT MICROBIOL, V49, P414, DOI 10.1111/j.1550-7408.2002.tb00221.x; Robledo JAF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100872; Robledo JAF, 2011, INT J PARASITOL, V41, P1217, DOI 10.1016/j.ijpara.2011.07.008; Rojpibulstit P., 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P292; Schott EJ, 2003, EXP PARASITOL, V105, P232, DOI 10.1016/j.exppara.2003.12.012; Shridhar S, 2013, INT J PARASITOL-DRUG, V3, P85, DOI 10.1016/j.ijpddr.2013.03.001; Sibley LD, 2002, PHILOS T R SOC B, V357, P81, DOI 10.1098/rstb.2001.1017; Smolowitz R, 2013, VET PATHOL, V50, P404, DOI 10.1177/0300985813480806; Spangenberg T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062906; Stelter K, 2007, PROTIST, V158, P119, DOI 10.1016/j.protis.2006.09.003; Tasumi S, 2007, J IMMUNOL, V179, P3086, DOI 10.4049/jimmunol.179.5.3086; Thompson PC, 2011, INFECT GENET EVOL, V11, P598, DOI 10.1016/j.meegid.2011.01.008; Yu HY, 2011, FISH SHELLFISH IMMUN, V30, P757, DOI 10.1016/j.fsi.2010.12.015	58	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e111051	10.1371/journal.pone.0111051	http://dx.doi.org/10.1371/journal.pone.0111051			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337810	Green Published, gold			2022-12-27	WOS:000343674800099
J	Chen, SH; Chang, S; Huang, QJ; He, J; Wang, H; Huang, QG				Chen, Suhang; Chang, Sheng; Huang, Qijun; He, Jin; Wang, Hao; Huang, Qiangui			SVM-Based Synthetic Fingerprint Discrimination Algorithm and Quantitative Optimization Strategy	PLOS ONE			English	Article								Synthetic fingerprints are a potential threat to automatic fingerprint identification systems (AFISs). In this paper, we propose an algorithm to discriminate synthetic fingerprints from real ones. First, four typical characteristic factors-the ridge distance features, global gray features, frequency feature and Harris Corner feature-are extracted. Then, a support vector machine (SVM) is used to distinguish synthetic fingerprints from real fingerprints. The experiments demonstrate that this method can achieve a recognition accuracy rate of over 98% for two discrete synthetic fingerprint databases as well as a mixed database. Furthermore, a performance factor that can evaluate the SVM's accuracy and efficiency is presented, and a quantitative optimization strategy is established for the first time. After the optimization of our synthetic fingerprint discrimination task, the polynomial kernel with a training sample proportion of 5% is the optimized value when the minimum accuracy requirement is 95%. The radial basis function (RBF) kernel with a training sample proportion of 15% is a more suitable choice when the minimum accuracy requirement is 98%.	[Chen, Suhang; Chang, Sheng; Huang, Qijun; He, Jin; Wang, Hao; Huang, Qiangui] Wuhan Univ, Sch Phys & Technol, Wuhan 430072, Peoples R China	Wuhan University	Chang, S (corresponding author), Wuhan Univ, Sch Phys & Technol, Wuhan 430072, Peoples R China.	changsheng@whu.edu.cn			National Natural Science Foundation of China [61204096, J1210061]; Fundamental Research Funds for the Central Universities, Wuhan University [2042014kf0238]; Specialised Research Fund for the Doctoral Program of Higher Education [20110141120074]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities, Wuhan University; Specialised Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was funded by the National Natural Science Foundation of China (grant nos 61204096 and J1210061), the Fundamental Research Funds for the Central Universities, Wuhan University (grant no 2042014kf0238) and the Specialised Research Fund for the Doctoral Program of Higher Education (grant no 20110141120074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli A, 2006, IEEE T INF FOREN SEC, V1, P360, DOI 10.1109/TIFS.2006.879289; Cappelli R, 2004, I C CONT AUTOMAT ROB, P1250; Cappelli R, 2002, INT C PATT RECOG, P744, DOI 10.1109/ICPR.2002.1048096; Cappelli R, 2000, INT C PATT RECOG, P471, DOI 10.1109/ICPR.2000.903586; Cappelli R, 2007, IEEE T PATTERN ANAL, V29, P1489, DOI 10.1109/TPAMI.2007.1087; Capplli R, 2004, INT WORKSH BIOM TECH, P147; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Derakhshani R, 2003, PATTERN RECOGN, V36, P383, DOI 10.1016/S0031-3203(02)00038-9; Feng JJ, 2011, IEEE T PATTERN ANAL, V33, P209, DOI 10.1109/TPAMI.2010.77; Fingerprint Verification Competition (FVC2004), 2004, FVC2004 DAT; Galbally J, 2012, FUTURE GENER COMP SY, V28, P311, DOI 10.1016/j.future.2010.11.024; Harris C., 1988, P ALVEY VISION C, DOI DOI 10.5244/C.2.23; Hsu C.W., 2003, PRACTICAL GUIDE SUPP; Hu Jin, 2007, Journal of Software, V18, P517, DOI 10.1360/jos180517; Jain AK, 2005, LECT NOTES COMPUT SC, V3617, P19, DOI 10.1007/11553595_3; Jianjiang Feng, 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P1622, DOI 10.1109/ICPR.2010.401; Kovacs-Vajna ZM, 2000, PATTERN RECOGN, V33, P69, DOI 10.1016/S0031-3203(99)00040-0; Pereira LFA, 2012, IEEE INT JOINT C NEU, P1; Ratha NK, 2001, LECT NOTES COMPUT SC, V2091, P223; Sandstrom M, 2004, LIVENESS DETECTION F, P39; Soweon Yoon, 2012, 2012 5th IAPR International Conference on Biometrics (ICB), P222, DOI 10.1109/ICB.2012.6199812; Uludag U, 2004, P IEEE, V92, P948, DOI 10.1109/JPROC.2004.827372; Vapnik V. N., 2000, NATURE STAT LEARNING, DOI DOI 10.1007/978-1-4757-3264-1_1; Wong WT, 2006, EUR J OPER RES, V173, P938, DOI 10.1016/j.ejor.2005.08.002; Yoon S, 2012, IEEE T PATTERN ANAL, V34, P451, DOI 10.1109/TPAMI.2011.161; Zhao Q, 2012, IEEE INT C AUTOMAT L, P277, DOI 10.1109/ICAL.2012.6308211	26	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111099	10.1371/journal.pone.0111099	http://dx.doi.org/10.1371/journal.pone.0111099			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347063	Green Submitted, Green Published, gold			2022-12-27	WOS:000347994900045
J	Imbrosci, B; Neitz, A; Mittmann, T				Imbrosci, Barbara; Neitz, Angela; Mittmann, Thomas			Focal Cortical Lesions Induce Bidirectional Changes in the Excitability of Fast Spiking and Non Fast Spiking Cortical Interneurons	PLOS ONE			English	Article							PYRAMIDAL NEURONS; LASER-LESIONS; PARVALBUMIN; INHIBITION; CORTEX; CELLS; SYNCHRONIZATION; DEPOLARIZATION; EXCITOTOXICITY; SOMATOSTATIN	A physiological brain function requires neuronal networks to operate within a well-defined range of activity. Indeed, alterations in neuronal excitability have been associated with several pathological conditions, ranging from epilepsy to neuropsychiatric disorders. Changes in inhibitory transmission are known to play a key role in the development of hyperexcitability. However it is largely unknown whether specific interneuronal subpopulations contribute differentially to such pathological condition. In the present study we investigated functional alterations of inhibitory interneurons embedded in a hyperexcitable cortical circuit at the border of chronically induced focal lesions in mouse visual cortex. Interestingly, we found opposite alterations in the excitability of non fast-spiking (Non Fs) and fast-spiking (Fs) interneurons in acute cortical slices from injured animals. Non Fs interneurons displayed a depolarized membrane potential and a higher frequency of spontaneous excitatory postsynaptic currents (sEPSCs). In contrast, Fs interneurons showed a reduced sEPSCs amplitude. The observed downscaling of excitatory synapses targeting Fs interneurons may prevent the recruitment of this specific population of interneurons to the hyperexcitable network. This mechanism is likely to seriously affect neuronal network function and to exacerbate hyperexcitability but it may be important to protect this particular vulnerable population of GABAegic neurons from excitotoxicity.	[Imbrosci, Barbara; Neitz, Angela; Mittmann, Thomas] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz	Imbrosci, B (corresponding author), Charite, Neurowissensch Forschungszentrum, Campus Charite Mitte,Charitepl 1, D-13353 Berlin, Germany.	barbara.imbrosci@charite.de; mittmann@uni-mainz.de	Mittmann, Thomas/AAM-9047-2020		German Research Foundation (DFG) [CRC 1080, TP-A7]; MAIFOR	German Research Foundation (DFG)(German Research Foundation (DFG)); MAIFOR	This work is supported by the German Research Foundation (DFG, CRC 1080, TP-A7) to T.M. and by a MAIFOR grant to B.I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Silva LFA, 2011, J NEUROL SCI, V308, P35, DOI 10.1016/j.jns.2011.06.030; Badawy RAB, 2012, NEUROSCIENCE, V222, P89, DOI 10.1016/j.neuroscience.2012.07.015; Barmashenko G, 2001, NEUROREPORT, V12, P3023, DOI 10.1097/00001756-200110080-00009; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Bartos M, 2012, J PHYSIOL-LONDON, V590, P669, DOI 10.1113/jphysiol.2011.226175; BuchkremerRatzmann I, 1996, STROKE, V27, P1105, DOI 10.1161/01.STR.27.6.1105; Buhl EH, 1998, J PHYSIOL-LONDON, V513, P117, DOI 10.1111/j.1469-7793.1998.117by.x; Cabungcal JH, 2013, P NATL ACAD SCI USA, V110, P9130, DOI 10.1073/pnas.1300454110; CHURN SB, 1993, STROKE, V24, P271, DOI 10.1161/01.STR.24.2.271; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; Dong XX, 2009, ACTA PHARMACOL SIN, V30, P379, DOI 10.1038/aps.2009.24; EYSEL UT, 1991, NEUROSCI LETT, V131, P45, DOI 10.1016/0304-3940(91)90333-O; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; Imbrosci B, 2013, NEUROSCIENCE, V250, P208, DOI 10.1016/j.neuroscience.2013.06.063; Imbrosci B, 2014, BRAIN STRUCT FUNCT; Imbrosci B, 2013, PFLUG ARCH EUR J PHY, V465, P879, DOI 10.1007/s00424-012-1191-y; Imbrosci B, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/614329; Jin XM, 2006, J NEUROSCI, V26, P4891, DOI 10.1523/JNEUROSCI.4361-05.2006; Jin XM, 2005, J NEUROPHYSIOL, V93, P2117, DOI 10.1152/jn.00728.2004; Lee S, 2013, NAT NEUROSCI, V16, P1662, DOI 10.1038/nn.3544; Li HF, 2002, J NEUROPHYSIOL, V88, P2, DOI 10.1152/jn.00507.2001; Malarkey EB, 2008, NEUROCHEM INT, V52, P142, DOI 10.1016/j.neuint.2007.06.005; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Merchant H, 2012, PROG NEUROBIOL, V99, P163, DOI 10.1016/j.pneurobio.2012.08.005; MITTMANN T, 1994, NEUROSCIENCE, V60, P891, DOI 10.1016/0306-4522(94)90270-4; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Prince DA, 2009, EPILEPSIA, V50, P30, DOI 10.1111/j.1528-1167.2008.02008.x; Ross ST, 2000, J NEUROPHYSIOL, V83, P2916, DOI 10.1152/jn.2000.83.5.2916; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Schiene K, 1996, J CEREBR BLOOD F MET, V16, P906, DOI 10.1097/00004647-199609000-00014; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Tan ZJ, 2008, P NATL ACAD SCI USA, V105, P2187, DOI 10.1073/pnas.0710628105; Tavalin SJ, 1997, J NEUROPHYSIOL, V77, P632, DOI 10.1152/jn.1997.77.2.632; Thomson AM, 2000, TRENDS NEUROSCI, V23, P305, DOI 10.1016/S0166-2236(00)01580-0; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Witte OW, 2000, J CEREBR BLOOD F MET, V20, P1149, DOI 10.1097/00004647-200008000-00001; Xu H, 2013, NEURON, V77, P155, DOI 10.1016/j.neuron.2012.11.004; Yan L, 2012, CEREB CORTEX, V22, P2392, DOI 10.1093/cercor/bhr318	41	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111105	10.1371/journal.pone.0111105	http://dx.doi.org/10.1371/journal.pone.0111105			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347396	Green Published, gold, Green Submitted			2022-12-27	WOS:000347994900048
J	Leppin, AL; Bora, PR; Tilburt, JC; Gionfriddo, MR; Zeballos-Palacios, C; Dulohery, MM; Sood, A; Erwin, PJ; Brito, JP; Boehmer, KR; Montori, VM				Leppin, Aaron L.; Bora, Pavithra R.; Tilburt, Jon C.; Gionfriddo, Michael R.; Zeballos-Palacios, Claudia; Dulohery, Megan M.; Sood, Amit; Erwin, Patricia J.; Brito, Juan Pablo; Boehmer, Kasey R.; Montori, Victor M.			The Efficacy of Resiliency Training Programs: A Systematic Review and Meta-Analysis of Randomized Trials	PLOS ONE			English	Review							STRESS-MANAGEMENT; INTERVENTION; DEPRESSION; HEALTH	Importance: Poor mental health places a burden on individuals and populations. Resilient persons are able to adapt to life's challenges and maintain high quality of life and function. Finding effective strategies to bolster resilience in individuals and populations is of interest to many stakeholders. Objectives: To synthesize the evidence for resiliency training programs in improving mental health and capacity in 1) diverse adult populations and 2) persons with chronic diseases. Data Sources: Electronic databases, clinical trial registries, and bibliographies. We also contacted study authors and field experts. Study Selection: Randomized trials assessing the efficacy of any program intended to enhance resilience in adults and published after 1990. No restrictions were made based on outcome measured or comparator used. Data Extraction and Synthesis: Reviewers worked independently and in duplicate to extract study characteristics and data. These were confirmed with authors. We conducted a random effects meta-analysis on available data and tested for interaction in planned subgroups. Main Outcomes: The standardized mean difference (SMD) effect of resiliency training programs on 1) resilience/hardiness, 2) quality of life/well-being, 3) self-efficacy/activation, 4) depression, 5) stress, and 6) anxiety. Results: We found 25 small trials at moderate to high risk of bias. Interventions varied in format and theoretical approach. Random effects meta-analysis showed a moderate effect of generalized stress-directed programs on enhancing resilience [pooled SMD 0.37 (95% CI 0.18, 0.57) p = .0002; I-2 = 41%] within 3 months of follow up. Improvement in other outcomes was favorable to the interventions and reached statistical significance after removing two studies at high risk of bias. Trauma-induced stress-directed programs significantly improved stress [-0.53 (-1.04, -0.03) p = .03; I-2 = 73%] and depression [-0.51 (-0.92, -0.10) p = .04; I-2 = 61%]. Conclusions: We found evidence warranting low confidence that resiliency training programs have a small to moderate effect at improving resilience and other mental health outcomes. Further study is needed to better define the resilience construct and to design interventions specific to it.	[Leppin, Aaron L.; Bora, Pavithra R.; Gionfriddo, Michael R.; Zeballos-Palacios, Claudia; Brito, Juan Pablo; Boehmer, Kasey R.; Montori, Victor M.] Mayo Clin, Knowledge & Evaluat Res Unit, Rochester, MN 55902 USA; [Leppin, Aaron L.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Tilburt, Jon C.; Sood, Amit] Mayo Clin, Div Gen Internal Med, Integrat Med Program, Rochester, MN USA; [Gionfriddo, Michael R.] Mayo Clin, Mayo Grad Sch, Rochester, MN USA; [Dulohery, Megan M.] Mayo Clin, Div Pulm & Crit Care Med, Rochester, MN USA; [Erwin, Patricia J.] Mayo Clin, Mayo Clin Libraries, Rochester, MN USA; [Brito, Juan Pablo; Montori, Victor M.] Mayo Clin, Div Metab Endocrinol & Nutr, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Leppin, AL (corresponding author), Mayo Clin, Knowledge & Evaluat Res Unit, Rochester, MN 55902 USA.	leppin.aaron@mayo.edu	Gionfriddo, Michael R./S-8359-2016	Gionfriddo, Michael R./0000-0003-1391-7072; Montori, Victor/0000-0003-0595-2898	CTSA Grant from the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH) [UL1 TR000135]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135] Funding Source: NIH RePORTER	CTSA Grant from the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The authors received no specific funding for this work. However, this publication was made possible by CTSA Grant Number UL1 TR000135 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NIH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, REV MAN REVMAN; Bohlmeijer E, 2010, J PSYCHOSOM RES, V68, P539, DOI 10.1016/j.jpsychores.2009.10.005; Bradshaw BG, 2007, DIABETES EDUCATOR, V33, P650, DOI 10.1177/0145721707303809; Brunwasser SM, 2009, J CONSULT CLIN PSYCH, V77, P1042, DOI 10.1037/a0017671; Burton NW, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-427; Earvolino-Ramirez M, 2007, NURS FORUM, V42, P73, DOI 10.1111/j.1744-6198.2007.00070.x; Farchi M, 2010, J NERV MENT DIS, V198, P382, DOI 10.1097/NMD.0b013e3181da4b67; Friedli L., 2009, MENTAL HLTH; Goyal M, 2014, JAMA INTERN MED, V174, P357, DOI 10.1001/jamainternmed.2013.13018; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Kent M, 2011, J TRAUMA STRESS, V24, P591, DOI 10.1002/jts.20685; Keyes CLM, 2007, AM PSYCHOL, V62, P95, DOI 10.1037/0003-066X.62.2.95; Kim SH, 2013, J INVEST MED, V61, P827, DOI [10.2310/JIM.0b013e3182906862, 10.231/JIM.0b013e3182906862]; Kuptniratsaikul V, 1997, STUDY CTR EPIDEMIOLO; Lazarus R. S., 1984, STRESS APPRAISAL COP; Lazarus RS, 1978, STRESS RELATED T PER, P287, DOI DOI 10.1007/978-1-4613-3997-7_12; Leppin A, 2014, SYSTEMATIC REV, V3; Loprinzi CE, 2011, CLIN BREAST CANCER, V11, P364, DOI 10.1016/j.clbc.2011.06.008; Luthans F, 2008, ACAD MANAG LEARN EDU, V7, P209, DOI 10.5465/AMLE.2008.32712618; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Petree RD, 2012, AM J HEALTH PROMOT, V26, P217, DOI 10.4278/ajhp.091001-QUAN-321; Rose RD, 2013, BEHAV RES THER, V51, P106, DOI 10.1016/j.brat.2012.11.003; Sahler OJZ, 2013, J CLIN ONCOL, V31, P1329, DOI 10.1200/JCO.2011.39.1870; Schachman KA, 2004, NURS RES, V53, P107, DOI 10.1097/00006199-200403000-00006; Scherbaum CA, 2006, EDUC PSYCHOL MEAS, V66, P1047, DOI 10.1177/0013164406288171; Songprakun W, 2012, J PSYCHIATR MENT HLT, V19, P647, DOI 10.1111/j.1365-2850.2011.01861.x; Songprakun W, 2012, J ADV NURS, V68, P2674, DOI 10.1111/j.1365-2648.2012.05966.x; Sood A, 2011, J GEN INTERN MED, V26, P858, DOI 10.1007/s11606-011-1640-x; Steinhardt M, 2008, J AM COLL HEALTH, V56, P445, DOI 10.3200/JACH.56.44.445-454; Stewart DE, 2011, PSYCHOSOMATICS, V52, P199, DOI 10.1016/j.psym.2011.01.036; Varker T, 2012, J ANXIETY DISORD, V26, P696, DOI 10.1016/j.janxdis.2012.01.009; Wagnild G, 2009, J NURS MEAS, V17, P105, DOI 10.1891/1061-3749.17.2.105; WHO, 2001, WORLD HLTH REP MENT; Windle G, 2012, PERSPECT PUBLIC HEAL, V132, P159, DOI 10.1177/1757913912449572; Windle G, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-8; Windle G, 2011, REV CLIN GERONTOL, V21, P152, DOI 10.1017/S0959259810000420	37	180	181	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111420	10.1371/journal.pone.0111420	http://dx.doi.org/10.1371/journal.pone.0111420			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ1JF	25347713	gold, Green Published, Green Submitted			2022-12-27	WOS:000347994900066
J	Qiu, X; Liang, YX; Sellers, RS; Perez-Soler, R; Zou, YY				Qiu, Xuan; Liang, Yuanxin; Sellers, Rani S.; Perez-Soler, Roman; Zou, Yiyu			Aerosol Azacytidine Inhibits Orthotopic Lung Cancers in Mice through Its DNA Demethylation and Gene Reactivation Effects	PLOS ONE			English	Article							ABERRANT PROMOTER METHYLATION; POOR-PROGNOSIS; HYPERMETHYLATION; 5-AZACYTIDINE; EXPRESSION; RASSF1A; P16; CHEMOPREVENTION; ASSOCIATION; EPIGENETICS	We devised an aerosol based demethylation therapy to achieve therapeutic efficacy in premalignant or in situ lesions of lung cancer, without systemic toxicity. Optimum regimens of aerosolized azacytidine (Aza) were designed and used in orthotopic human non- small cell lung cancer xenograft models. The therapeutic efficacy and toxicity of aerosol Aza were compared with intravenously administered Aza. We observed that 80% of the droplets of the aerosol Aza measured similar to 0.1-5 microns, which resulted in deposition in the lower bronchial airways. An animal model that phenocopies field carcinogeneisis in humans was developed by intratracheal inoculation of the human lung cancer cells in mice, thus resulting in their distribution throughout the entire airway space. Aerosolized Aza significantly prolonged the survival of mice bearing endo-bronchial lung tumors. The aerosol treatment did not cause any detectable lung toxicity or systemic toxicity. A pre-pharmacokinetic study in mice demonstrated that lung deposition of aerosolized Aza was significantly higher than the intravenous route. Lung tumors were resected after aerosol treatment and the methylation levels of 24 promoters of tumor-suppresser genes related to lung cancer were analyzed. Aerosol Aza significantly reduced the methylation level in 9 of these promoters and reexpressed several genes tested. In conclusion, aerosol Aza at non-cytotoxic doses appears to be effective and results in DNA demethylation and tumor suppressor gene re-expression. The therapeutic index of aerosol Aza is >100-fold higher than that of intravenous Aza. These results provide a preclinical rationale for a phase I clinical trial of aerosol Aza to be initiated at our Institution.	[Qiu, Xuan; Liang, Yuanxin; Perez-Soler, Roman; Zou, Yiyu] Albert Einstein Coll Med, Dept Med, Div Med Oncol, Bronx, NY 10467 USA; [Sellers, Rani S.] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Zou, YY (corresponding author), Albert Einstein Coll Med, Dept Med, Div Med Oncol, Bronx, NY 10467 USA.	yiyu.zou@einstein.yu.edu			NIH [5R01CA154755]; NATIONAL CANCER INSTITUTE [R01CA154755] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study is supported by a NIH grant 5R01CA154755. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040024; Bates D V, 1966, Health Phys, V12, P173; Bauman J, 2012, CANCER CHEMOTH PHARM, V69, P547, DOI 10.1007/s00280-011-1729-2; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Belinsky SA, 2004, NAT REV CANCER, V4, P707, DOI 10.1038/nrc1432; Belinsky SA, 2011, COMBINATION THERAPY; Ben-Avraham D, 2012, EPIGENOMICS-UK, V4, P503, DOI [10.2217/EPI.12.41, 10.2217/epi.12.41]; BENNER SE, 1995, CHEST, V107, pS316, DOI 10.1378/chest.107.6_Supplement.316S; CAVALIERE A, 1987, CANCER LETT, V37, P51, DOI 10.1016/0304-3835(87)90145-5; Cecener G, 2008, TUMORI, V94, P845; Cui Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002990; Daskalos A, 2011, CANCER LETT, V300, P79, DOI 10.1016/j.canlet.2010.09.009; DAVIES DS, 1979, SCAND J RESPIR DIS, P44; Digel W, 2005, CRIT REV ONCOL HEMAT, V55, P1, DOI 10.1016/j.critrevonc.2005.02.002; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Fischer JR, 2006, LUNG CANCER, V54, P109, DOI 10.1016/j.lungcan.2006.06.017; Fukui T, 2005, ONCOGENE, V24, P6323, DOI 10.1038/sj.onc.1208777; Georgiou E, 2007, EUR J CANCER PREV, V16, P396, DOI 10.1097/01.cej.0000236260.26265.d6; Guo MZ, 2004, CLIN CANCER RES, V10, P5131, DOI 10.1158/1078-0432.CCR-03-0763; Jaspers I, 2010, AM J RESP CELL MOL, V43, P368, DOI 10.1165/rcmb.2009-0254OC; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Katayama H, 2007, ASIAN PAC J CANCER P, V8, P221; Kaye FJ, 2002, ONCOGENE, V21, P6908, DOI 10.1038/sj.onc.1205834; Keating GM, 2012, DRUGS, V72, P1111, DOI 10.2165/11209430-000000000-00000; Khuri FR, 2004, CLIN CANCER RES, V10, p4249S, DOI 10.1158/1078-0432.CCR-040019; Kim JS, 2006, CANCER RES, V66, P4049, DOI 10.1158/0008-5472.CAN-05-3813; Koga T, 2011, INT J CANCER, V128, P1009, DOI 10.1002/ijc.25447; Kontic M, 2012, CLIN LUNG CANCER, V13, P297, DOI 10.1016/j.cllc.2011.11.003; Lee SM, 2012, MOL MED REP, V5, P239, DOI 10.3892/mmr.2011.608; Lichter P, 2008, INT J CANCER, V123, pIX, DOI 10.1002/ijc.23636; Lin RK, 2007, LUNG CANCER, V55, P205, DOI 10.1016/j.lungcan.2006.10.022; Lippman SM, 2001, JNCI-J NATL CANCER I, V93, P605, DOI 10.1093/jnci/93.8.605; Mahesh S, 2010, CLIN LUNG CANCER, V11, P405, DOI 10.3816/CLC.2010.n.052; Mahesh Sameer, 2008, Proceedings of the American Association for Cancer Research Annual Meeting, V49, P666; Miyamoto K, 2005, JPN J CLIN ONCOL, V35, P293, DOI 10.1093/jjco/hyi088; Miyazu YM, 2005, CANCER RES, V65, P9623, DOI 10.1158/0008-5472.CAN-05-0976; Mufti Ghulam, 2003, Hematology Am Soc Hematol Educ Program, P176; Perez-Soler R, 2009, ONCOGENE, V28, pS38, DOI 10.1038/onc.2009.200; Reed MD, 2013, BRIT J CANCER, V109, P1775, DOI 10.1038/bjc.2013.575; Safar AM, 2007, ARCH PATHOL LAB MED, V131, P936; Sawan C, 2008, MUTAT RES-FUND MOL M, V642, P1, DOI 10.1016/j.mrfmmm.2008.03.002; Seng TJ, 2008, BRIT J CANCER, V99, P375, DOI 10.1038/sj.bjc.6604452; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Spira A, 2004, P NATL ACAD SCI USA, V101, P10143, DOI 10.1073/pnas.0401422101; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wakelee H, 2008, SEMIN THORAC CARDIOV, V20, P198, DOI 10.1053/j.semtcvs.2008.09.001; Wang GY, 2008, LUNG CANCER, V62, P162, DOI 10.1016/j.lungcan.2008.03.023; Wu JY, 2008, ANN SURG ONCOL, V15, P3272, DOI 10.1245/s10434-008-0078-9; Zhao M, 2004, J CHROMATOGR B, V813, P81, DOI 10.1016/j.jchromb.2004.09.012; Zhong Y, 2001, CLIN CANCER RES, V7, P1683; Zochbauer-Muller S, 2002, ONCOLOGIST, V7, P451, DOI 10.1634/theoncologist.7-5-451; Zou YY, 2007, CLIN CANCER RES, V13, P4900, DOI 10.1158/1078-0432.CCR-07-0395; Zou YY, 1998, J NATL CANCER I, V90, P1130, DOI 10.1093/jnci/90.15.1130; ZOU YY, 1994, CANCER RES, V54, P1479	55	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e109874	10.1371/journal.pone.0109874	http://dx.doi.org/10.1371/journal.pone.0109874			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347303	Green Published, gold, Green Submitted			2022-12-27	WOS:000347994900015
J	Shi, AM; Liu, HZ; Liu, L; Hu, H; Wang, Q; Adhikari, B				Shi, Aimin; Liu, Hongzhi; Liu, Li; Hu, Hui; Wang, Qiang; Adhikari, Benu			Isolation, Purification and Molecular Mechanism of a Peanut Protein-Derived ACE-Inhibitory Peptide	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; ANTIHYPERTENSIVE DRUGS; BIOACTIVE PEPTIDES; CRYSTAL-STRUCTURE; BLOOD-PRESSURE; HYDROLYSATE; BINDING; IDENTIFICATION; METABOLISM; STABILITY	Although a number of bioactive peptides are capable of angiotensin I-converting enzyme (ACE) inhibitory effects, little is known regarding the mechanism of peanut peptides using molecular simulation. The aim of this study was to obtain ACE inhibiting peptide from peanut protein and provide insight on the molecular mechanism of its ACE inhibiting action. Peanut peptides having ACE inhibitory activity were isolated through enzymatic hydrolysis and ultrafiltration. Further chromatographic fractionation was conducted to isolate a more potent peanut peptide and its antihypertensive activity was analyzed through in vitro ACE inhibitory tests and in vivo animal experiments. MALDI-TOF/TOF-MS was used to identify its amino acid sequence. Mechanism of ACE inhibition of P8 was analyzed using molecular docking and molecular dynamics simulation. A peanut peptide (P8) having Lys-Leu-Tyr-Met-Arg-Pro amino acid sequence was obtained which had the highest ACE inhibiting activity of 85.77% (half maximal inhibitory concentration (IC50): 0.0052 mg/ml). This peanut peptide is a competitive inhibitor and show significant short term (12 h) and long term (28 days) antihypertensive activity. Dynamic tests illustrated that P8 can be successfully docked into the active pocket of ACE and can be combined with several amino acid residues. Hydrogen bond, electrostatic bond and Pi-bond were found to be the three main interaction contributing to the structural stability of ACE-peptide complex. In addition, zinc atom could form metal-carboxylic coordination bond with Tyr, Met residues of P8, resulting into its high ACE inhibiting activity. Our finding indicated that the peanut peptide (P8) having a Lys-Leu-Tyr-Met-Arg-Pro amino acid sequence can be a promising candidate for functional foods and prescription drug aimed at control of hypertension.	[Shi, Aimin; Liu, Hongzhi; Liu, Li; Hu, Hui; Wang, Qiang] Chinese Acad Agr Sci, Inst Agroprod Proc Sci & Technol, Key Lab Agroprod Proc, Minist Agr, Beijing 100193, Peoples R China; [Adhikari, Benu] RMIT Univ, Sch Appl Sci, Melbourne, Vic, Australia	Chinese Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Royal Melbourne Institute of Technology (RMIT)	Wang, Q (corresponding author), Chinese Acad Agr Sci, Inst Agroprod Proc Sci & Technol, Key Lab Agroprod Proc, Minist Agr, Beijing 100193, Peoples R China.	wangqiang06@caas.cn	SHI, AIMIN/L-7480-2019; shi, aimin/N-4618-2017; Adhikari, Benu P/K-6192-2017	SHI, AIMIN/0000-0001-8275-3185; shi, aimin/0000-0001-8275-3185; Adhikari, Benu P/0000-0002-7571-7968	Key Program for International S&T Cooperation Projects of China [2012DFA31400]; Agricultural Science and Technology Innovation Program in CAAS; National Nature Science Foundation of China [31201458]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2012BAD29B00]; Special Fund for Basic Scientific Research and Operational Costs of Central-level Public Welfare Scientific Research Institutes of CP in CAAS	Key Program for International S&T Cooperation Projects of China; Agricultural Science and Technology Innovation Program in CAAS; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Special Fund for Basic Scientific Research and Operational Costs of Central-level Public Welfare Scientific Research Institutes of CP in CAAS	Funding Support was provided by the Key Program for International S&T Cooperation Projects of China (no. 2012DFA31400), the Agricultural Science and Technology Innovation Program in CAAS, the National Nature Science Foundation of China (no. 31201458), the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (no. 2012BAD29B00) and the Special Fund for Basic Scientific Research and Operational Costs of Central-level Public Welfare Scientific Research Institutes of CP in CAAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn CB, 2012, PROCESS BIOCHEM, V47, P2240, DOI 10.1016/j.procbio.2012.08.019; Bamdad F, 2013, MOL NUTR FOOD RES, V57, P493, DOI 10.1002/mnfr.201200252; Chen JW, 2012, PEPTIDES, V33, P52, DOI 10.1016/j.peptides.2011.11.006; CHEUNG HS, 1973, BIOCHIM BIOPHYS ACTA, V293, P451, DOI 10.1016/0005-2744(73)90352-5; Chibale K., 2012, DRUG DISCOVERY AFRIC, Vfirst; CUSHMAN DW, 1971, BIOCHEM PHARMACOL, V20, P1637, DOI 10.1016/0006-2952(71)90292-9; FAMULOK M, 1994, J AM CHEM SOC, V116, P1698, DOI 10.1021/ja00084a010; Girgih AT, 2014, J AGR FOOD CHEM, V62, P4135, DOI 10.1021/jf5002606; Gobbetti M, 2004, INT J DAIRY TECHNOL, V57, P173, DOI 10.1111/j.1471-0307.2004.00139.x; Guang C, 2009, J AGR FOOD CHEM, V57, P10102, DOI 10.1021/jf901787e; Guy JL, 2003, BIOCHEMISTRY-US, V42, P13185, DOI 10.1021/bi035268s; He R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091051; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Huang SY, 2007, PROTEINS, V66, P399, DOI 10.1002/prot.21214; Huang WH, 2011, FOOD CHEM, V128, P968, DOI 10.1016/j.foodchem.2011.03.127; Jacques H, 2010, BRIT J NUTR, V103, P1331, DOI 10.1017/S0007114509993278; Jamdar SN, 2010, FOOD CHEM, V121, P178, DOI 10.1016/j.foodchem.2009.12.027; Jimsheena VK, 2011, FOOD CHEM, V125, P561, DOI 10.1016/j.foodchem.2010.09.048; Jimsheena VK, 2010, PEPTIDES, V31, P1165, DOI 10.1016/j.peptides.2010.02.022; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Korhonen H, 2006, INT DAIRY J, V16, P945, DOI 10.1016/j.idairyj.2005.10.012; KRITCHEVSKY D, 1982, ATHEROSCLEROSIS, V41, P429, DOI 10.1016/0021-9150(82)90208-8; Lee JK, 2009, BIORESOURCE TECHNOL, V100, P5255, DOI 10.1016/j.biortech.2009.05.057; Leoncini G, 2010, J HYPERTENS, V28, P156, DOI 10.1097/HJH.0b013e328332038c; Li CH, 2002, J PEPT SCI, V8, P267, DOI 10.1002/psc.387; Li GH, 2004, NUTR RES, V24, P469, DOI [10.1016/S0271-5317(04)00058-2, 10.1016/j.nutres.2003.10.014]; Li GH, 2006, J PEPT SCI, V12, P509, DOI 10.1002/psc.758; MATSUFUJI H, 1994, BIOSCI BIOTECH BIOCH, V58, P2244, DOI 10.1271/bbb.58.2244; Meisel H, 2005, CURR MED CHEM, V12, P1905, DOI 10.2174/0929867054546618; Miguel M, 2010, MOL NUTR FOOD RES, V54, P1422, DOI 10.1002/mnfr.200900448; Moitessier N, 2008, BRIT J PHARMACOL, V153, pS7, DOI 10.1038/sj.bjp.0707515; Natesh R, 2004, BIOCHEMISTRY-US, V43, P8718, DOI 10.1021/bi049480n; Natesh R, 2003, NATURE, V421, P551, DOI 10.1038/nature01370; Oxtoby D. W., 2012, PRINCIPLES MODERN CH; Park PJ, 2001, J AM OIL CHEM SOC, V78, P651, DOI 10.1007/s11746-001-0321-0; Pihlanto-Leppala A, 2000, TRENDS FOOD SCI TECH, V11, P347, DOI 10.1016/S0924-2244(01)00003-6; Politi A, 2010, J MOL GRAPH MODEL, V29, P425, DOI 10.1016/j.jmgm.2010.08.003; Quist EE, 2005, THESIS U GEORGIA ATH; Ronquist G, 2004, PROSTATE, V58, P50, DOI 10.1002/pros.10294; Rosivall L, 2009, MOL CELL ENDOCRINOL, V302, P185, DOI 10.1016/j.mce.2008.09.033; Ruiz JAG, 2004, INT DAIRY J, V14, P1075, DOI 10.1016/j.idairyj.2004.04.007; Ruiz-Gimenez P, 2012, FOOD CHEM, V131, P266, DOI 10.1016/j.foodchem.2011.08.076; Sakkiah S, 2012, J BIOMOL STRUCT DYN, V30, P235, DOI 10.1080/07391102.2012.680026; Sheih IC, 2009, FOOD CHEM, V115, P279, DOI 10.1016/j.foodchem.2008.12.019; Sica D.A., 2005, J CLIN HYPERTENS, V7, P17, DOI [10.1111/j.1524-6175.2005.04556.x, DOI 10.1111/J.1524-6175.2005.04556.X]; Su CC, 2011, NATURE, V470, P558, DOI 10.1038/nature09743; Tavares T, 2012, MOL NUTR FOOD RES, V56, P316, DOI 10.1002/mnfr.201100381; Vercruysse L, 2008, PROCESS BIOCHEM, V43, P900, DOI 10.1016/j.procbio.2008.04.014; Wang CY, 2011, EUR FOOD RES TECHNOL, V232, P549, DOI 10.1007/s00217-010-1411-7; Wang CY, 2010, INT J MOL SCI, V11, P4952, DOI 10.3390/ijms11124952; Wu HW, 2009, FOOD RES INT, V42, P343, DOI 10.1016/j.foodres.2008.12.006; Wu JP, 2002, FOOD RES INT, V35, P367, DOI 10.1016/S0963-9969(01)00131-4; Xu Y, 2004, BIOORGAN MED CHEM, V12, P6193, DOI 10.1016/j.bmc.2004.08.045; Yamamoto D, 2007, BIOCHEM BIOPH RES CO, V354, P981, DOI 10.1016/j.bbrc.2007.01.088; YAMAMOTO K, 1992, HYPERTENSION, V19, P692, DOI 10.1161/01.HYP.19.6.692; Yang NC, 2012, FOOD CHEM, V132, P1796, DOI 10.1016/j.foodchem.2011.11.143; Yergey AL, 2002, J AM SOC MASS SPECTR, V13, P784, DOI 10.1016/S1044-0305(02)00393-8; Zhao GL, 2011, FOOD CHEM, V127, P1438, DOI 10.1016/j.foodchem.2011.01.046	58	33	34	4	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111188	10.1371/journal.pone.0111188	http://dx.doi.org/10.1371/journal.pone.0111188			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347076	gold, Green Published, Green Submitted			2022-12-27	WOS:000347994900053
J	Boutou, AK; Nair, A; Douraghi-Zadeh, D; Sandhu, R; Hansell, DM; Wells, AU; Polkey, MI; Hopkinson, NS				Boutou, Afroditi K.; Nair, Arjun; Douraghi-Zadeh, Dariush; Sandhu, Ranbir; Hansell, David M.; Wells, Athol U.; Polkey, Michael I.; Hopkinson, Nicholas S.			A Combined Pulmonary Function and Emphysema Score Prognostic Index for Staging in Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; PREDICT MORTALITY; CO-MORBIDITY; LUNG; CT; ARTERIAL; SURVIVAL; HYPERTENSION	Introduction: Chronic Obstructive Pulmonary Disease (COPD) is characterized by high morbidity and mortality. Lung computed tomography parameters, individually or as part of a composite index, may provide more prognostic information than pulmonary function tests alone. Aim: To investigate the prognostic value of emphysema score and pulmonary artery measurements compared with lung function parameters in COPD and construct a prognostic index using a contingent staging approach. Material-Methods: Predictors of mortality were assessed in COPD outpatients whose lung computed tomography, spirometry, lung volumes and gas transfer data were collected prospectively in a clinical database. Univariate and multivariate Cox proportional hazard analysis models with bootstrap techniques were used. Results: 169 patients were included (59.8% male, 61.1 years old; Forced Expiratory Volume in 1 second % predicted: 40.5 +/- 19.2). 20.1% died; mean survival was 115.4 months. Age (HR = 1.098, 95% Cl = 1.04-1.252) and emphysema score (HR = 1.034, 95% CI = 1.007-1.07) were the only independent predictors of mortality. Pulmonary artery dimensions were not associated with survival. An emphysema score of 55% was chosen as the optimal threshold and 30% and 65% as suboptimals. Where emphysema score was between 30% and 65% (intermediate risk) the optimal lung volume threshold, a functional residual capacity of 210% predicted, was applied. This contingent staging approach separated patients with an intermediate risk based on emphysema score alone into high risk (Functional Residual Capacity >= 210% predicted) or low risk (Functional Residual Capacity <210% predicted). This approach was more discriminatory for survival (HR = 3.123; 95% CI = 1.094-10.412) than either individual component alone. Conclusion: Although to an extent limited by the small sample size, this preliminary study indicates that the composite Emphysema score-Functional Residual Capacity index might provide a better separation of high and low risk patients with COPD, than other individual predictors alone.	[Boutou, Afroditi K.; Nair, Arjun; Hansell, David M.; Wells, Athol U.; Polkey, Michael I.; Hopkinson, Nicholas S.] Royal Brompton & Harefield NHS Fdn Trust, NIHR Resp Biomed Res Unit, London, England; [Boutou, Afroditi K.; Nair, Arjun; Hansell, David M.; Wells, Athol U.; Polkey, Michael I.; Hopkinson, Nicholas S.] Univ London Imperial Coll Sci Technol & Med, London, England; [Douraghi-Zadeh, Dariush] Chelsea & Westminster NHS Fdn Trust, Dept Radiol, London, England; [Sandhu, Ranbir] Imperial Coll Healthcare NHS Trust, Dept Radiol, London, England	Royal Brompton & Harefield NHS Foundation Trust; Imperial College London; Imperial College London; Imperial College London	Hopkinson, NS (corresponding author), Royal Brompton & Harefield NHS Fdn Trust, NIHR Resp Biomed Res Unit, London, England.	n.hopkinson@imperial.ac.uk			European Respiratory Society Fellowship [STRF 2012-258]; NIHR Respiratory Biomedical Research Unit at Royal Brompton; Harefield NHS Foundation Trust and Imperial College, London, UK; National Institute for Health Research [NF-SI-0512-10157] Funding Source: researchfish	European Respiratory Society Fellowship; NIHR Respiratory Biomedical Research Unit at Royal Brompton; Harefield NHS Foundation Trust and Imperial College, London, UK; National Institute for Health Research(National Institute for Health Research (NIHR))	Dr. Boutou is the recipient of a European Respiratory Society Fellowship (STRF 2012-258). The study was supported by NIHR Respiratory Biomedical Research Unit at Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTHONISEN NR, 1986, AM REV RESPIR DIS, V133, P14, DOI 10.1164/arrd.1986.133.1.14; Barker BL, 2013, CLIN SCI, V124, P371, DOI 10.1042/CS20120340; Boutou AK, 2013, EUR RESPIR J, V42, P616, DOI 10.1183/09031936.00146012; Boutou AK, 2013, RESPIRATION, V85, P126, DOI 10.1159/000338792; Budweiser S, 2007, CHEST, V131, P1650, DOI 10.1378/chest.06-2124; Celli BR, 2008, RESP MED, V102, pS27, DOI 10.1016/S0954-6111(08)70005-2; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CLARK EH, 1978, CLIN SCI MOL MED, V54, P627, DOI 10.1042/cs0540627; Cote Claudia G, 2009, Pneumonol Alergol Pol, V77, P305; Dawkins PA, 2003, THORAX, V58, P1020, DOI 10.1136/thorax.58.12.1020; Devaraj A, 2010, RADIOLOGY, V254, P609, DOI 10.1148/radiol.09090548; Goh NSL, 2008, AM J RESP CRIT CARE, V177, P1248, DOI 10.1164/rccm.200706-877OC; Hackx M, 2012, RADIOLOGY, V265, P34, DOI 10.1148/radiol.12111270; Haimovici JBA, 1997, ACAD RADIOL, V4, P327; Haruna A, 2010, CHEST, V138, P635, DOI 10.1378/chest.09-2836; HODGKIN JE, 1990, CLIN CHEST MED, V11, P555; Incalzi RA, 1997, EUR RESPIR J, V10, P2794, DOI 10.1183/09031936.97.10122794; Johannessen A, 2013, AM J RESP CRIT CARE, V187, P602, DOI 10.1164/rccm.201209-1722OC; Jones RC, 2009, AM J RESP CRIT CARE, V180, P1189, DOI 10.1164/rccm.200902-0271OC; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Martinez FJ, 2006, AM J RESP CRIT CARE, V173, P1326, DOI 10.1164/rccm.200510-1677OC; Moore AJ, 2010, RESP MED, V104, P1319, DOI 10.1016/j.rmed.2010.03.001; Nakano Y, 2000, AM J RESP CRIT CARE, V162, P1102, DOI 10.1164/ajrccm.162.3.9907120; Ng CS, 1999, J THORAC IMAG, V14, P270, DOI 10.1097/00005382-199910000-00007; Oga T, 2011, INT J CHRONIC OBSTR, V6, P521, DOI 10.2147/COPD.S24420; Pedone C, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-35; Puhan MA, 2009, LANCET, V374, P704, DOI 10.1016/S0140-6736(09)61301-5; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Saitoh T, 2000, INVEST RADIOL, V35, P235, DOI 10.1097/00004424-200004000-00004; Sciurba FC, 2010, NEW ENGL J MED, V363, P1233, DOI 10.1056/NEJMoa0900928; Swallow EB, 2007, THORAX, V62, P115, DOI 10.1136/thx.2006.062026; Ueda K, 2006, CLIN CANCER RES, V12, P6730, DOI 10.1158/1078-0432.CCR-06-1196; Waschki B, 2011, CHEST, V140, P331, DOI 10.1378/chest.10-2521; Wells JM, 2012, NEW ENGL J MED, V367, P913, DOI 10.1056/NEJMoa1203830; Zavorsky GS, 2007, RESP PHYSIOL NEUROBI, V155, P268, DOI 10.1016/j.resp.2006.07.002; Zulueta JJ, 2012, CHEST, V141, P1216, DOI 10.1378/chest.11-0101	38	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111109	10.1371/journal.pone.0111109	http://dx.doi.org/10.1371/journal.pone.0111109			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343258	gold, Green Submitted, Green Published			2022-12-27	WOS:000343943500080
J	Lau, HY; Palanisamy, R; Trau, M; Botella, JR				Lau, Han Yih; Palanisamy, Ramkumar; Trau, Matt; Botella, Jose R.			Molecular Inversion Probe: A New Tool for Highly Specific Detection of Plant Pathogens	PLOS ONE			English	Article							REAL-TIME PCR; MULTIPLEX DETECTION; PADLOCK PROBES; DNA; QUANTIFICATION; IDENTIFICATION; INFECTION; UNIVERSAL; ASSAY; OLIGONUCLEOTIDES	Highly specific detection methods, capable of reliably identifying plant pathogens are crucial in plant disease management strategies to reduce losses in agriculture by preventing the spread of diseases. We describe a novel molecular inversion probe (MIP) assay that can be potentially developed into a robust multiplex platform to detect and identify plant pathogens. A MIP has been designed for the plant pathogenic fungus Fusarium oxysporum f.sp. conglutinans and the proof of concept for the efficiency of this technology is provided. We demonstrate that this methodology can detect as little as 2.5 ng of pathogen DNA and is highly specific, being able to accurately differentiate Fusarium oxysporum f.sp. conglutinans from other fungal pathogens such as Botrytis cinerea and even pathogens of the same species such as Fusarium oxysporum f.sp. lycopersici. The MIP assay was able to detect the presence of the pathogen in infected Arabidopsis thaliana plants as soon as the tissues contained minimal amounts of pathogen. MIP methods are intrinsically highly multiplexable and future development of specific MIPs could lead to the establishment of a diagnostic method that could potentially screen infected plants for hundreds of pathogens in a single assay.	[Lau, Han Yih; Botella, Jose R.] Univ Queensland, Sch Agr & Food Sci, Plant Genet Engn Lab, Brisbane, Qld, Australia; [Lau, Han Yih; Palanisamy, Ramkumar; Trau, Matt] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Trau, M (corresponding author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia.	m.trau@uq.edu.au; j.botella@uq.edu.au	LAU, HAN YIH/HGE-7086-2022; Botella, Jose R/D-9766-2011; Trau, Matt/E-3944-2015	Botella, Jose R/0000-0002-4446-3432; Trau, Matt/0000-0001-5516-1280	Malaysian Agricultural Research and Development Institute (MARDI); National Breast Cancer Foundation of Australia [CG-08-07, CG-12-07]	Malaysian Agricultural Research and Development Institute (MARDI); National Breast Cancer Foundation of Australia	Special thanks to Malaysian Agricultural Research and Development Institute (MARDI) for providing the PhD scholarship of HYL. Although not directly funding this work, the Trau laboratory acknowledges funding received from the National Breast Cancer Foundation of Australia (CG-08-07 and CG-12-07). These grants have significantly contributed to creating the environment to enable the research described here. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrios G. N., 2005, PLANT PATHOL; Akhras MS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000223; Araujo R, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-154; Cazzonelli CI, 1998, AUST J PLANT PHYSIOL, V25, P513, DOI 10.1071/PP98013; Cherepanov A, 2001, J BIOCHEM-TOKYO, V129, P61, DOI 10.1093/oxfordjournals.jbchem.a002837; Chillali M, 1998, MYCOL RES, V102, P533, DOI 10.1017/S0953756297005315; Clark JS, 2009, BAYESIAN ANAL, V4, P337, DOI 10.1214/09-BA413; COMSTOCK JC, 1992, PLANT DIS, V76, P1033, DOI 10.1094/PD-76-1033; Dai J, 2013, J APPL MICROBIOL, V114, P502, DOI 10.1111/jam.12071; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Diep D, 2012, NAT METHODS, V9, P270, DOI [10.1038/nmeth.1871, 10.1038/NMETH.1871]; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; FRANKEN AAJM, 1992, NETH J PLANT PATHOL, V98, P81, DOI 10.1007/BF01996321; Ge Z, 2013, CLIN MICROBIOL INFEC, V19, P1042, DOI 10.1111/1469-0691.12149; Hardenbol P, 2003, NAT BIOTECHNOL, V21, P673, DOI 10.1038/nbt821; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hirani R, 2011, ANAL CHEM, V83, P8215, DOI 10.1021/ac2019409; Horsfall J.G., 1977, PLANT DIS ADV TREATI; Hyman RW, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-29; Klosterman SJ, 2012, METHODS MOL BIOL, V835, P121, DOI 10.1007/978-1-61779-501-5_8; Kokoskova Blanka, 2009, V508, P75, DOI 10.1007/978-1-59745-062-1_7; Lee, 2000, J MICROBIOL, V38, P66; Li JB, 2009, GENOME RES, V19, P1606, DOI 10.1101/gr.092213.109; Lievens B, 2006, PLANT SCI, V171, P155, DOI 10.1016/j.plantsci.2006.03.009; Lin SR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-712; Lin YH, 2013, EUR J PLANT PATHOL, V135, P395, DOI 10.1007/s10658-012-0096-0; MALIN EM, 1983, PLANT DIS, V67, P645, DOI 10.1094/PD-67-645; Markoulatos P, 2002, J CLIN LAB ANAL, V16, P47, DOI 10.1002/jcla.2058; MAUCHMANI B, 1994, MOL PLANT MICROBE IN, V7, P378, DOI 10.1094/MPMI-7-0378; Miedaner T, 1996, PLANT DIS, V80, P500, DOI 10.1094/PD-80-0500; NILSSON M, 1994, SCIENCE, V265, P2085, DOI 10.1126/science.7522346; Novais RC, 2008, J MICROBIOL METH, V72, P60, DOI 10.1016/j.mimet.2007.10.009; Novakova S, 2006, J VIROL METHODS, V137, P229, DOI 10.1016/j.jviromet.2006.06.020; Palanisamy R, 2011, ANAL CHEM, V83, P2631, DOI 10.1021/ac103016n; Price JA, 2010, J VIROL METHODS, V165, P198, DOI 10.1016/j.jviromet.2010.01.019; Punja ZK, 2007, BIOTECHNOLOGY AND PLANT DISEASE MANAGEMENT, P1, DOI 10.1079/9781845932886.0000; Sikora K, 2012, PHYTOPATHOLOGY, V102, P635, DOI 10.1094/PHYTO-11-11-0309; Sint D, 2012, METHODS ECOL EVOL, V3, P898, DOI 10.1111/j.2041-210X.2012.00215.x; Szemes M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni069; Tooley PW, 1997, APPL ENVIRON MICROB, V63, P1467, DOI 10.1128/AEM.63.4.1467-1475.1997; Trusov Y, 2013, METHODS MOL BIOL, V1043, P67, DOI 10.1007/978-1-62703-532-3_7; Turner EH, 2009, ANNU REV GENOM HUM G, V10, P263, DOI 10.1146/annurev-genom-082908-150112; van Doorn R, 2009, APPL ENVIRON MICROB, V75, P4185, DOI 10.1128/AEM.00071-09; van Doorn R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-276; Vincelli P, 2008, PLANT DIS, V92, P660, DOI 10.1094/PDIS-92-5-0660; Wang Y, 2005, CHEM RES CHINESE U, V21, P183; Ward E, 2004, ANN APPL BIOL, V145, P1, DOI 10.1111/j.1744-7348.2004.tb00354.x; WU DY, 1989, GENE, V76, P245, DOI 10.1016/0378-1119(89)90165-0; Xu YZ, 1999, NUCLEIC ACIDS RES, V27, P875, DOI 10.1093/nar/27.3.875; Yamazaki W, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-94	50	5	5	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111182	10.1371/journal.pone.0111182	http://dx.doi.org/10.1371/journal.pone.0111182			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343255	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943500086
J	Rashidi, MM; Kavyani, N; Abelman, S; Uddin, MJ; Freidoonimehr, N				Rashidi, Mohammad M.; Kavyani, Neda; Abelman, Shirley; Uddin, Mohammed J.; Freidoonimehr, Navid			Double Diffusive Magnetohydrodynamic (MHD) Mixed Convective Slip Flow along a Radiating Moving Vertical Flat Plate with Convective Boundary Condition	PLOS ONE			English	Article							DIFFERENTIAL-EQUATIONS; THERMAL-RADIATION; TRANSFORM METHOD; SOLID-SURFACES; HEAT-TRANSFER; MASS-TRANSFER; POROUS-MEDIUM; LAYER	In this study combined heat and mass transfer by mixed convective flow along a moving vertical flat plate with hydrodynamic slip and thermal convective boundary condition is investigated. Using similarity variables, the governing nonlinear partial differential equations are converted into a system of coupled nonlinear ordinary differential equations. The transformed equations are then solved using a semi-numerical/analytical method called the differential transform method and results are compared with numerical results. Close agreement is found between the present method and the numerical method. Effects of the controlling parameters, including convective heat transfer, magnetic field, buoyancy ratio, hydrodynamic slip, mixed convective, Prandtl number and Schmidt number are investigated on the dimensionless velocity, temperature and concentration profiles. In addition effects of different parameters on the skin friction factor, Cf-x, local Nusselt number, Nu(x), and local Sherwood number Sh(x) are shown and explained through tables.	[Rashidi, Mohammad M.] Bu Ali Sina Univ, Fac Engn, Dept Mech Engn, Hamadan, Iran; [Rashidi, Mohammad M.] Shanghai Jiao Tong Univ, Univ Michigan, Joint Inst, Shanghai 200030, Peoples R China; [Kavyani, Neda] Islamic Azad Univ, Sama Tech & Vocat Training Coll, Malayer Branch, Malayer, Iran; [Abelman, Shirley] Univ Witwatersrand, Sch Computat & Appl Math, Ctr Differential Equat Continuum Mech & Applicat, Johannesburg, South Africa; [Uddin, Mohammed J.] Amer Int Univ Bangladesh, Dept Math, Dhaka, Bangladesh; [Freidoonimehr, Navid] Islamic Azad Univ, Hamedan Branch, Young Res & Elite Club, Hamadan, Iran	Bu Ali Sina University; Shanghai Jiao Tong University; Islamic Azad University; University of Witwatersrand; American International University Bangladesh (AIUB); Islamic Azad University	Rashidi, MM (corresponding author), Bu Ali Sina Univ, Fac Engn, Dept Mech Engn, Hamadan, Iran.	mm_rashidi@yahoo.com; Shirley.Abelman@wits.ac.za	Rashidi, Mohammad Mehdi/P-2692-2014; Freidoonimehr, Navid/I-2308-2014	Rashidi, Mohammad Mehdi/0000-0002-6309-8688; Freidoonimehr, Navid/0000-0002-2850-7861; Uddin, Dr. Md. Jashim/0000-0002-3243-3455	NRF, Pretoria, South Africa	NRF, Pretoria, South Africa	SA acknowledges support from the NRF, Pretoria, South Africa.	Abd El-Aziz M, 2013, J EGYPT MAT IN PRESS; Ascher U. M., 1995, NUMERICAL SOLUTION B; Ayaz F, 2004, APPL MATH COMPUT, V147, P547, DOI 10.1016/S0096-3003(02)00794-4; Aziz A, 2009, COMMUN NONLINEAR SCI, V14, P1064, DOI 10.1016/j.cnsns.2008.05.003; Baker G.A., 1975, ESSENTIALS PADE APPR; Baker GA, 1981, ENCY MATH ITS APPL 2; Baker Jr. George A., 1981, ENCY MATH ITS APPL 1, V13; Beg O., 2013, INT J APPL MATH MECH, V9, P37; Beg OA, 2014, J ENG THERMOPHYS-RUS, V23, P79, DOI 10.1134/S1810232814020015; Broyden CG, 2000, MATH PROGRAM, V87, P209, DOI 10.1007/s101070050111; BROYDEN CG, 1965, MATH COMPUT, V19, P557; Chen CH, 2004, ACTA MECH, V172, P219, DOI 10.1007/s00707-004-0155-5; Chen CH, 2009, INT J NONLIN MECH, V44, P596, DOI 10.1016/j.ijnonlinmec.2009.02.004; Chen CK, 1999, APPL MATH COMPUT, V106, P171, DOI 10.1016/S0096-3003(98)10115-7; Damseh R. A., 2006, Turkish Journal of Engineering and Environmental Sciences, V30, P83; Emam T., 2012, J EGYPT MATH SOC, V20, P215, DOI [10.1016/j.joems.2012.08.016, DOI 10.1016/J.JOEMS.2012.08.016]; He J, 1997, COMMUN NONLINEAR SCI, V2, P235, DOI DOI 10.1016/S1007-5704(97)90007-1; He JH, 1999, COMPUT METHOD APPL M, V178, P257, DOI 10.1016/S0045-7825(99)00018-3; Ishak A, 2010, APPL MATH COMPUT, V217, P837, DOI 10.1016/j.amc.2010.06.026; Karmishin A.V., 1990, METHODS DYNAMICS CAL; Karniadakis G, 2005, MICROFLOWS NANOFLOWS; Kaya A, 2012, ISI BILIM TEK DERG, V32, P9; Keller H.B., 1992, NUMERICAL METHODS 2; Kim BH, 2010, MICROFLUID NANOFLUID, V9, P31, DOI 10.1007/s10404-009-0515-5; KUZNETSOV AV, 2010, TRANSPORT POROUS MED, V85, P657; Li D., 2008, ENCY MICROFLUIDICS N; Liao S, 2004, APPL MATH COMPUT, V147, P499, DOI [10.1016/S0096-3003(02)00790-7, 10.1016/50096-3003(02)00790-7]; Lyapunov A. M., 1992, GEN PROBLEM STABILIT; Magyari E, 2011, COMMUN NONLINEAR SCI, V16, P599, DOI 10.1016/j.cnsns.2010.03.020; Martin MJ, 2006, J THERMOPHYS HEAT TR, V20, P710, DOI 10.2514/1.22968; NATH O, 1991, ASTROPHYS SPACE SCI, V183, P135, DOI 10.1007/BF00643022; Nguyen NT, 2009, FUNDAMENTALS APPL MI; Noor NFM, 2012, INT J HEAT MASS TRAN, V55, P2122, DOI 10.1016/j.ijheatmasstransfer.2011.12.015; Pal D, 2011, COMMUN NONLINEAR SCI, V16, P1329, DOI 10.1016/j.cnsns.2010.06.008; Rahman MM, 2009, INT J THERM SCI, V48, P2331, DOI 10.1016/j.ijthermalsci.2009.05.003; Rashidi MM, 2010, HEAT TRANSF-ASIAN RE, V39, P575, DOI 10.1002/htj.20317; Rashidi M. M., 2010, MATH PROBL ENG, P1; Rashidi MM, 2013, INT J ENERGY TECH, V5, P1; Rashidi MM, 2010, INT J ENG, V23, P267; Rashidi MM, 2010, INT J THERM SCI, V49, P2405, DOI 10.1016/j.ijthermalsci.2010.07.005; Rashidi MM, 2009, COMMUN NONLINEAR SCI, V14, P2999, DOI 10.1016/j.cnsns.2008.10.030; Rohni AM, 2013, INT J THERM SCI, V64, P264, DOI 10.1016/j.ijthermalsci.2012.08.016; SAKIADIS BC, 1961, AICHE J, V7, P26, DOI 10.1002/aic.690070108; SPREITER JR, 1974, ACTA ASTRONAUT, V1, P15, DOI 10.1016/0094-5765(74)90006-X; Thompson PA, 1997, NATURE, V389, P360, DOI 10.1038/38686; Zhou J.K., 1986, DIFFERENTIAL TRANSFO	46	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e109404	10.1371/journal.pone.0109404	http://dx.doi.org/10.1371/journal.pone.0109404			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343360	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943500015
J	Xue, TC; Ge, NL; Zhang, L; Cui, JF; Chen, RX; You, Y; Ye, SL; Ren, ZG				Xue, Tong-Chun; Ge, Ning-Ling; Zhang, Lan; Cui, Jie-Feng; Chen, Rong-Xin; You, Yang; Ye, Sheng-Long; Ren, Zheng-Gang			Goosecoid Promotes the Metastasis of Hepatocellular Carcinoma by Modulating the Epithelial-Mesenchymal Transition	PLOS ONE			English	Article							COLLECTIVE CELL-MIGRATION; NEURAL CREST DELAMINATION; EXTRAHEPATIC METASTASIS; TUMOR-METASTASIS; GENE; GASTRULATION; EXPRESSION; CANCER; MORPHOGENESIS; ORGANIZER	The homeobox gene, goosecoid (GSC), is a transcription factor that participates in cell migration during embryonic development. Because cell migration during development has characteristics similar to cell invasion during metastasis, we evaluated the potential role of GSC in the metastasis of hepatocellular carcinoma (HCC). GSC expression in HCC cell lines and tissues was evaluated, and its effects on the migration potential of HCC cells were determined by GSC knock-down and overexpression methods. In addition, the prognostic role of GSC expression in the metastasis of cancer cells in HCC patients was determined. Our data showed that GSC was highly expressed in several HCC cell lines, particularly in a highly metastatic HCC cell line. Overexpression of GSC promoted cell migration and invasion of HCC cells in vitro. Gain-of-function induced the epithelial-mesenchymal transition but not collective cell migration, whereas loss-of-function induced the reverse change. High-level expression of GSC correlated closely with poor survival and lung metastasis in HCC patients; lung metastases showed more upregulated GSC expression than the primary tumor. We conclude that GSC promotes metastasis of HCC potentially through initiating the epithelial-mesenchymal transition. GSC is also a prognostic factor for poor survival and metastasis of HCC, which suggests its potential as a therapeutic target for metastatic HCC.	[Xue, Tong-Chun; Ge, Ning-Ling; Zhang, Lan; Cui, Jie-Feng; Chen, Rong-Xin; You, Yang; Ye, Sheng-Long; Ren, Zheng-Gang] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai 200433, Peoples R China; [Xue, Tong-Chun; Ge, Ning-Ling; Zhang, Lan; Cui, Jie-Feng; Chen, Rong-Xin; You, Yang; Ye, Sheng-Long; Ren, Zheng-Gang] Fudan Univ, Key Lab Carcinogenesis & Canc Invas, Minist Educ, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Ren, ZG (corresponding author), Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai 200433, Peoples R China.	ren.zhenggang@zs-hospital.sh.cn			National Clinical Key Special Subject of China; National Natural Science Foundation of China [81172275, 21272565]; National Basic Research Program of China (973 Program) [2009CB521700]	National Clinical Key Special Subject of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This study was supported by The National Clinical Key Special Subject of China, The National Natural Science Foundation of China (81172275 and 21272565) and The National Basic Research Program of China (973 Program, 2009CB521700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; BLUM M, 1992, CELL, V69, P1097, DOI 10.1016/0092-8674(92)90632-M; Carmona-Fontaine C, 2008, NATURE, V456, P957, DOI 10.1038/nature07441; Chuai M, 2012, CURR GENOMICS, V13, P267, DOI 10.2174/138920212800793357; Clouthier DE, 1998, DEVELOPMENT, V125, P813; Farooqui R, 2005, J CELL SCI, V118, P51, DOI 10.1242/jcs.01577; Friedl P, 2004, INT J DEV BIOL, V48, P441, DOI 10.1387/ijdb.041821pf; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gritsman K, 2000, DEVELOPMENT, V127, P921; Hartwell KA, 2006, P NATL ACAD SCI USA, V103, P18969, DOI 10.1073/pnas.0608636103; Locascio A, 2001, CURR OPIN GENET DEV, V11, P464, DOI 10.1016/S0959-437X(00)00218-5; Lugli A, 2005, CLIN CANCER RES, V11, P6450, DOI 10.1158/1078-0432.CCR-04-2458; Luu O, 2008, DEV DYNAM, V237, P1307, DOI 10.1002/dvdy.21522; Nabeshima K, 1998, INT J CANCER, V78, P750, DOI 10.1002/(SICI)1097-0215(19981209)78:6<750::AID-IJC13>3.0.CO;2-#; Nakaya Y, 2008, DEV GROWTH DIFFER, V50, P755, DOI 10.1111/j.1440-169X.2008.01070.x; NIEHRS C, 1993, CELL, V72, P491, DOI 10.1016/0092-8674(93)90069-3; Ogunwobi OO, 2011, CLIN EXP METASTAS, V28, P721, DOI 10.1007/s10585-011-9404-x; Ozen E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042717; Shoval I, 2012, DEV DYNAM, V241, P1155, DOI 10.1002/dvdy.23799; Simon R, 2010, METHODS MOL BIOL, V664, P113, DOI 10.1007/978-1-60761-806-5_12; Tang ZY, 2004, J CANCER RES CLIN, V130, P187, DOI 10.1007/s00432-003-0511-1; Theveneau E, 2012, DEV BIOL, V366, P34, DOI 10.1016/j.ydbio.2011.12.041; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Xue TC, 2011, ASIAN PAC J CANCER P, V12, P657; Xue TC, 2013, ONCOL REP, V30, P105, DOI 10.3892/or.2013.2442; Xue TC, 2012, EXP THER MED, V3, P117, DOI 10.3892/etm.2011.358; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yasuo H, 2001, DEVELOPMENT, V128, P3783; Zhou Xin-Da, 2002, Hepatobiliary Pancreat Dis Int, V1, P35	29	18	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e109695	10.1371/journal.pone.0109695	http://dx.doi.org/10.1371/journal.pone.0109695			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343336	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943500021
J	d'Ettorre, G; Baroncelli, S; Micci, L; Ceccarelli, G; Andreotti, M; Sharma, P; Fanello, G; Fiocca, F; Cavallari, EN; Giustini, N; Mallano, A; Galluzzo, CM; Vella, S; Mastroianni, CM; Silvestri, G; Paiardini, M; Vullo, V				d'Ettorre, Gabriella; Baroncelli, Silvia; Micci, Luca; Ceccarelli, Giancarlo; Andreotti, Mauro; Sharma, Prachi; Fanello, Gianfranco; Fiocca, Fausto; Cavallari, Eugenio Nelson; Giustini, Noemi; Mallano, Alessandra; Galluzzo, Clementina M.; Vella, Stefano; Mastroianni, Claudio M.; Silvestri, Guido; Paiardini, Mirko; Vullo, Vincenzo			Reconstitution of Intestinal CD4 and Th17 T Cells in Antiretroviral Therapy Suppressed HIV-Infected Subjects: Implication for Residual Immune Activation from the Results of a Clinical Trial	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NATURAL SIV HOSTS; MICROBIAL TRANSLOCATION; LYMPHOID-TISSUE; HIV-1-INFECTED PATIENTS; POSITIVE PATIENTS; GUT MUCOSA; RESTORATION; AIDS; DEPLETION	Introduction: During HIV infection the severe depletion of intestinal CD4(+) T-cells is associated with microbial translocation, systemic immune activation, and disease progression. This study examined intestinal and peripheral CD4(+) T-cell subsets reconstitution under combined antiretroviral therapy (cART), and systemic immune activation markers. Methods: This longitudinal single-arm pilot study evaluates CD4(+) T cells, including Th1 and Th17, in gut and blood and soluble markers for inflammation in HIV-infected individuals before (M0) and after eight (M8) months of cART. From January 2010 to December 2011, 10 HIV-1 naive patients were screened and 9 enrolled. Blood and gut CD4(+) T-cells subsets and cellular immune activation were determined by flow-cytometry and plasma soluble CD14 by ELISA. CD4(+) Th17 cells were detected in gut biopsies by immunohistochemistry. Microbial translocation was measured by limulus-amebocyte-lysate assay to detect bacterial lipopolysaccharide (LPS) and PCR Real Time to detect plasma bacterial 16S rDNA. Results: Eight months of cART increased intestinal CD4(+) and Th17 cells and reduced levels of T-cell activation and proliferation. The magnitude of intestinal CD4(+) T-cell reconstitution correlated with the reduction of plasma LPS. Importantly, the magnitude of Th17 cells reconstitution correlated directly with blood CD4(+) T-cell recovery. Conclusion: Short-term antiretroviral therapy resulted in a significant increase in the levels of total and Th17 CD4(+) T-cells in the gut mucosa and in decline of T-cell activation. The observation that pre-treatment levels of CD4(+) and of CD8(+) T-cell activation are predictors of the magnitude of Th17 cell reconstitution following cART provides further rationale for an early initiation of cART in HIV-infected individuals.	[d'Ettorre, Gabriella; Ceccarelli, Giancarlo; Cavallari, Eugenio Nelson; Giustini, Noemi; Vullo, Vincenzo] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Ist Pasteur Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Baroncelli, Silvia; Andreotti, Mauro; Mallano, Alessandra; Galluzzo, Clementina M.; Vella, Stefano] Ist Super Sanita, Dept Therapeut Res & Med Evaluat, I-00161 Rome, Italy; [Micci, Luca; Silvestri, Guido; Paiardini, Mirko] Yerkes Natl Primate Res Ctr, Div Microbiol & Immunol, Atlanta, GA USA; [Sharma, Prachi] Yerkes Natl Primate Res Ctr, Div Pathol, Atlanta, GA USA; [Fanello, Gianfranco; Fiocca, Fausto] Univ Roma La Sapienza, Policlin Umberto I, Dept Emergency Surg, Emergency Endoscop Unit, I-00185 Rome, Italy; [Mastroianni, Claudio M.] Sapienza Univ, Infect Dis Unit, Fdn Eleonora Lorillard Spencer Cenci, Latina, Italy; [Silvestri, Guido; Paiardini, Mirko] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	Fondazione Cenci Bolognetti; Sapienza University Rome; Istituto Superiore di Sanita (ISS); Sapienza University Rome; University Hospital Sapienza Rome; Sapienza University Rome; Emory University	d'Ettorre, G (corresponding author), Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Ist Pasteur Fdn Cenci Bolognetti, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	gabriella.dettorre@uniroma1.it	MASTROIANNI, Claudio Maria/O-9741-2019; Ceccarelli, Giancarlo/K-6454-2016; Sharma, Prachi/HGD-0637-2022; andreotti, mauro/K-1436-2016; Ceccarelli, Giancarlo/ABD-8347-2020; Cavallari, Eugenio Nelson/ABF-1968-2020; VELLA, STEFANO/ABI-3368-2020; MALLANO, ALESSANDRA/D-7959-2016; andreotti, mauro/ABA-8513-2021; Vella, Stefano/GZM-0519-2022; d'Ettorre, Gabriella/K-4511-2016; Fiocca, Fausto/AAI-4702-2020; galluzzo, clementina maria/M-8912-2017	MASTROIANNI, Claudio Maria/0000-0002-1286-467X; Ceccarelli, Giancarlo/0000-0001-5921-3180; andreotti, mauro/0000-0001-5168-8624; Ceccarelli, Giancarlo/0000-0001-5921-3180; Cavallari, Eugenio Nelson/0000-0002-6021-484X; MALLANO, ALESSANDRA/0000-0003-2392-0769; andreotti, mauro/0000-0001-5168-8624; d'Ettorre, Gabriella/0000-0002-3571-5677; galluzzo, clementina maria/0000-0003-1392-6569; Fiocca, Fausto/0000-0002-7787-1766	ISS "Programma Italia Usa"; National Institutes of Health [R01-AI-084836]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084836] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	ISS "Programma Italia Usa"; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by ISS "Programma Italia Usa" (to AM) and by National Institutes of Health grant R01-AI-084836 (to MP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancuta P, 2010, CURR OPIN HIV AIDS, V5, P158, DOI 10.1097/COH.0b013e3283364733; Baroncelli S, 2009, J CLIN VIROL, V46, P367, DOI 10.1016/j.jcv.2009.09.011; Bhaskaran K, 2008, JAMA-J AM MED ASSOC, V300, P51, DOI 10.1001/jama.300.1.51; Brandt L, 2011, JAIDS-J ACQ IMM DEF, V57, P101, DOI 10.1097/QAI.0b013e318215a991; Brenchley JM, 2008, BLOOD, V112, P2826, DOI 10.1182/blood-2008-05-159301; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Cassol E, 2013, J INFECT DIS, V208, P1113, DOI 10.1093/infdis/jit249; Cecchinato V, 2008, MUCOSAL IMMUNOL, V1, P279, DOI 10.1038/mi.2008.14; Chahroudi A, 2012, SCIENCE, V335, P1188, DOI 10.1126/science.1217550; Chege D, 2011, AIDS, V25, P741, DOI 10.1097/QAD.0b013e328344cefb; Ciccone EJ, 2010, MUCOSAL IMMUNOL, V3, P172, DOI 10.1038/mi.2009.129; Ciccone EJ, 2011, J VIROL, V85, P5880, DOI 10.1128/JVI.02643-10; Costiniuk CT, 2012, MUCOSAL IMMUNOL, V5, P596, DOI 10.1038/mi.2012.82; d'Ettorre G, 2011, AIDS RES HUM RETROV, V27, P355, DOI 10.1089/aid.2010.0342; d'Ettorre G, 2011, CURR HIV RES, V9, P148, DOI 10.2174/157016211795945296; Dandekar S, 2010, CURR OPIN HIV AIDS, V5, P173, DOI 10.1097/COH.0b013e328335eda3; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; El Hed A, 2010, J INFECT DIS, V201, P843, DOI 10.1086/651021; Estes JD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001052; Favre D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000295; Gaardbo JC, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/670957; George MD, 2005, J VIROL, V79, P2709, DOI 10.1128/JVI.79.5.2709-2719.2005; Gordon SN, 2010, J IMMUNOL, V185, P5169, DOI 10.4049/jimmunol.1001801; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Guadalupe M, 2006, J VIROL, V80, P8236, DOI 10.1128/JVI.00120-06; Guglani L, 2010, CURR OPIN HIV AIDS, V5, P120, DOI 10.1097/COH.0b013e328335c2f6; Hartigan-O'Connor DJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003941; Hartigan-O'Connor DJ, 2011, CURR OPIN HIV AIDS, V6, P221, DOI 10.1097/COH.0b013e32834577b3; Hayes TL, 2013, AIDS, V27, P867, DOI 10.1097/QAD.0b013e32835d85b4; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Hunt PW, 2010, CURR OPIN HIV AIDS, V5, P189, DOI 10.1097/COH.0b013e32833647d9; Jain V, 2013, J INFECT DIS, V208, P1202, DOI 10.1093/infdis/jit311; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Kanwar B, 2010, CURR OPIN HIV AIDS, V5, P151, DOI 10.1097/COH.0b013e328335c0c1; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lambotte O, 2006, PATHOL BIOL, V54, P566, DOI 10.1016/j.patbio.2006.07.035; Lok JJ, 2012, BIOMETRICS, V68, P745, DOI 10.1111/j.1541-0420.2011.01738.x; Macal M, 2008, MUCOSAL IMMUNOL, V1, P475, DOI 10.1038/mi.2008.35; Marchetti G, 2013, CLIN MICROBIOL REV, V26, P2, DOI 10.1128/CMR.00050-12; Mavigner M, 2012, J CLIN INVEST, V122, P62, DOI 10.1172/JCI59011; Mehandru S, 2006, PLOS MED, V3, P2335, DOI 10.1371/journal.pmed.0030484; Merlini E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018580; Micci L, 2012, BLOOD, V120, P3925, DOI 10.1182/blood-2012-04-420240; Noma Takeshi, 2010, Nihon Rinsho Meneki Gakkai Kaishi, V33, P262; Paiardini M, 2010, CURR OPIN HIV AIDS, V5, P166, DOI 10.1097/COH.0b013e328335c161; Papasavvas E, 2009, AIDS, V23, P369, DOI 10.1097/QAD.0b013e32831e9c76; Pelletier M, 2010, BLOOD, V115, P335, DOI 10.1182/blood-2009-04-216085; Piconi S, 2010, AIDS, V24, P1991, DOI 10.1097/QAD.0b013e32833c93ce; Pinzone MR, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/515962; Prendergast A, 2010, AIDS, V24, P491, DOI 10.1097/QAD.0b013e3283344895; Raffatellu M, 2008, NAT MED, V14, P421, DOI 10.1038/nm1743; Salgado M, 2011, CLIN IMMUNOL, V139, P110, DOI 10.1016/j.clim.2011.02.008; Sheth PM, 2008, MUCOSAL IMMUNOL, V1, P382, DOI 10.1038/mi.2008.23; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Tesmer LA, 2008, IMMUNOL REV, V223, P87, DOI 10.1111/j.1600-065X.2008.00628.x; Tincati C, 2009, ANTIVIR THER, V14, P321; Wallet MA, 2010, AIDS, V24, P1281, DOI 10.1097/QAD.0b013e328339e228; Westrop SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005474; Yukl SA, 2010, J INFECT DIS, V202, P1553, DOI 10.1086/656722	60	26	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e109791	10.1371/journal.pone.0109791	http://dx.doi.org/10.1371/journal.pone.0109791			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340778	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662800017
J	Li, WW; Wang, G; Liang, WL; Kang, K; Guo, KK; Zhang, YM				Li, Weiwei; Wang, Gang; Liang, Wulong; Kang, Kai; Guo, Kangkang; Zhang, Yanming			Integrin beta 3 Is Required in Infection and Proliferation of Classical Swine Fever Virus	PLOS ONE			English	Article							MOUTH-DISEASE VIRUS; VASCULAR ENDOTHELIAL-CELLS; HERPES-SIMPLEX-VIRUS; SIN-NOMBRE-VIRUS; WEST-NILE-VIRUS; IN-VIVO; ALPHA(V)BETA(3) INTEGRIN; VITRONECTIN RECEPTOR; HEPARAN-SULFATE; HUMAN PARECHOVIRUS-1	Classical Swine Fever (CSF) is a highly infectious fatal pig disease, resulting in huge economic loss to the swine industry. Integrins are membrane- bound signal mediators, expressed on a variety of cell surfaces and are known as receptors or coreceptors for many viruses. However, the role of integrin beta 3 in CSFV infection is unknown. Here, through quantitive PCR, immunofluorescence (IFC) and immunocytohistochemistry (ICC), we revealed that ST (swine testicles epithelial) cells have a prominent advantage in CSFV proliferation as compared to EC (swine umbilical vein endothelial cell), IEC (swine intestinal epithelial cell) and PK (porcine kidney epithelial) cells. Meanwhile, ST cells had remarkably more integrin beta 3 expression as compared to EC, IEC and PK cells, which was positively correlated with CSFV infection and proliferation. Integrin beta 3 was upregulated post CSFV infection in all the four cell lines, while the CSFV proliferation rate was decreased in integrin beta 3 function- blocked cells. ShRNA1755 dramatically decreased integrin beta 3, with a deficiency of 96% at the mRNA level and 80% at the protein level. CSFV proliferation was dramatically reduced in integrin beta 3 constantly- defected cells (ICDC), with the deficiencies of 92.6%, 99% and 81.7% at 24 h, 48 h and 72 h post CSFV infection, respectively. These results demonstrate that integrin b3 is required in CSFV infection and proliferation, which provide a new insight into the mechanism of CSFV infection.	[Li, Weiwei; Liang, Wulong; Kang, Kai; Guo, Kangkang; Zhang, Yanming] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China; [Wang, Gang] Xuzhou Med Coll, Jiangsu Key Lab Biol Canc Therapy, Xuzhou, Jiangsu, Peoples R China	Northwest A&F University - China; Xuzhou Medical University	Zhang, YM (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China.	zhangym@nwsuaf.edu.cn			National Natural Science Foundation of China [31172339]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project is supported by the National Natural Science Foundation of China (No. 31172339). URL:http://www.nsfc.gov.cn/nsfc/cen/xmzn/2014xmzn/ index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bensaude E, 2004, J GEN VIROL, V85, P1029, DOI 10.1099/vir.0.19637-0; BERINSTEIN A, 1995, J VIROL, V69, P2664, DOI 10.1128/JVI.69.4.2664-2666.1995; Bernard-Trifilo JA, 2006, CURR PROTOC CELL BIO; Blacksell SD, 2006, TROP ANIM HEALTH PRO, V38, P467, DOI 10.1007/s11250-006-4434-0; Bogachek MV, 2010, BIOCHEMISTRY-MOSCOW+, V75, P472, DOI 10.1134/S0006297910040115; Butler B, 2005, J BIOL CHEM, V280, P14556, DOI 10.1074/jbc.M411765200; Campadelli-Fiume G, 2012, CURR OPIN VIROL, V2, P28, DOI 10.1016/j.coviro.2011.12.001; Cayrol C, 2011, WORLD J GASTROENTERO, V17, P4488, DOI 10.3748/wjg.v17.i40.4488; Chiodelli P, 2012, J BIOL CHEM, V287, P20456, DOI 10.1074/jbc.M111.337139; Choi C, 2003, J VET DIAGN INVEST, V15, P35, DOI 10.1177/104063870301500108; Croyle M A, 1998, Pharm Dev Technol, V3, P365, DOI 10.3109/10837459809009864; Croyle MA, 1998, GENE THER, V5, P645, DOI 10.1038/sj.gt.3300645; Dreier S, 2007, J VIROL METHODS, V140, P95, DOI 10.1016/j.jviromet.2006.11.013; Duque H, 2003, J VIROL, V77, P2500, DOI 10.1128/JVI.77.4.2500-2511.2003; Fernandez Catherine, 1998, Frontiers in Bioscience, V3, pD684; Gavrilovskaya IN, 1999, J VIROL, V73, P3951, DOI 10.1128/JVI.73.5.3951-3959.1999; Gianni T, 2012, P NATL ACAD SCI USA, V109, P19792, DOI 10.1073/pnas.1212597109; Gianni T, 2012, J VIROL, V86, P2850, DOI 10.1128/JVI.06689-11; Greiser-Wilke I, 2000, VET MICROBIOL, V77, P17, DOI 10.1016/S0378-1135(00)00253-4; Guerrero CA, 2012, ACTA VIROL, V56, P63, DOI 10.4149/av_2012_01_63; Guerrero CA, 2000, P NATL ACAD SCI USA, V97, P14644, DOI 10.1073/pnas.250299897; Hamilton TE, 1997, J PEDIATR SURG, V32, P1695, DOI 10.1016/S0022-3468(97)90508-X; He L, 2012, VIRUS GENES, V45, P274, DOI 10.1007/s11262-012-0773-2; Husser L, 2011, VIRUS RES, V159, P9, DOI 10.1016/j.virusres.2011.04.005; Hulst MM, 2000, J VIROL, V74, P9553, DOI 10.1128/JVI.74.20.9553-9561.2000; Hulst MM, 2001, J VIROL, V75, P9585, DOI 10.1128/JVI.75.20.9585-9595.2001; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jackson T, 1997, J VIROL, V71, P8357, DOI 10.1128/JVI.71.11.8357-8361.1997; Ji P, 1999, BBA-MOL CELL RES, V1448, P543, DOI 10.1016/S0167-4889(98)00160-8; Joki-Korpela P, 2001, J VIROL, V75, P1958, DOI 10.1128/JVI.75.4.1958-1967.2001; Lafrenie RM, 2002, VIROLOGY, V297, P31, DOI 10.1006/viro.2002.1399; Lanthier J, 2006, BIOCHEM CELL BIOL, V84, P684, DOI 10.1139/O06-055; Larson RS, 2005, J VIROL, V79, P7319, DOI 10.1128/JVI.79.12.7319-7326.2005; Larson RS, 2005, BIOCHEMISTRY-US, V44, P4322, DOI 10.1021/bi048187k; Lei HY, 2001, J BIOMED SCI, V8, P377, DOI 10.1007/BF02255946; Majhen D, 2011, LIFE SCI, V89, P241, DOI 10.1016/j.lfs.2011.06.009; Medina RA, 2007, J GEN VIROL, V88, P493, DOI 10.1099/vir.0.82459-0; Naik MU, 2011, J CELL BIOCHEM, V112, P3289, DOI 10.1002/jcb.23255; Neff S, 2000, NEUROSURGERY, V47, P794, DOI 10.1097/00006123-200009000-00065; Neff S, 1998, J VIROL, V72, P3587, DOI 10.1128/JVI.72.5.3587-3594.1998; Neff S, 2001, J VIROL, V75, P527, DOI 10.1128/JVI.75.1.527-532.2001; Nelsen-Salz B, 1999, J GEN VIROL, V80, P2311, DOI 10.1099/0022-1317-80-9-2311; O'Donnell V, 2005, J VIROL, V79, P8506, DOI 10.1128/JVI.79.13.8506-8518.2005; Pfaff M, 2001, J CELL SCI, V114, P2775; Raman S, 2009, J VIROL, V83, P2831, DOI 10.1128/JVI.02368-08; ROIVAINEN M, 1994, VIROLOGY, V203, P357, DOI 10.1006/viro.1994.1494; Ruiz-Saenz J, 2009, INTERVIROLOGY, V52, P201, DOI 10.1159/000226121; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Song JW, 2005, EXP MOL MED, V37, P121, DOI 10.1038/emm.2005.16; Stegeman A, 2000, VET MICROBIOL, V73, P183, DOI 10.1016/S0378-1135(00)00144-9; Stegeman JA, 2002, EPIDEMIOL INFECT, V128, P285, DOI 10.1017/S0950268801006483; Sun DS, 2005, J BIOMED SCI, V12, P937, DOI 10.1007/s11373-005-9016-z; Sun DS, 2005, J BIOMED SCI, V12, P321, DOI 10.1007/s11373-005-0979-6; Tang QH, 2010, VET IMMUNOL IMMUNOP, V133, P237, DOI 10.1016/j.vetimm.2009.07.005; Triantafilou K, 2001, J CELL BIOCHEM, V80, P373, DOI 10.1002/1097-4644(20010301)80:3<373::AID-JCB110>3.0.CO;2-C; Triantafilou K, 2000, J VIROL, V74, P5856, DOI 10.1128/JVI.74.13.5856-5862.2000; Tu CC, 2001, VIRUS RES, V81, P29, DOI 10.1016/S0168-1702(01)00366-5; Wang J, 2014, J VIROL METHODS, V202, P87, DOI 10.1016/j.jviromet.2014.03.007; Wang T, 2001, J IMMUNOL, V167, P5273, DOI 10.4049/jimmunol.167.9.5273; Wang W, 2012, ARCH VIROL, V157, P1051, DOI 10.1007/s00705-012-1245-7; Xu H, 2007, INTERVIROLOGY, V50, P433, DOI 10.1159/000113467; Zarate S, 2004, J VIROL, V78, P10839, DOI 10.1128/JVI.78.20.10839-10847.2004; Zarate S, 2000, VIROLOGY, V278, P50, DOI 10.1006/viro.2000.0660; Zhang JL, 2007, BIOCHEM BIOPH RES CO, V356, P763, DOI 10.1016/j.bbrc.2007.03.051; Zhang X, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-31; Zhang ZS, 2007, J VIROL METHODS, V143, P125, DOI 10.1016/j.jviromet.2007.02.012; Zhu Y, 2009, VIRUS RES, V142, P169, DOI 10.1016/j.virusres.2009.02.011	68	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110911	10.1371/journal.pone.0110911	http://dx.doi.org/10.1371/journal.pone.0110911			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340775	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662800070
J	Tholking, G; Fortmann, C; Koch, R; Gerth, HU; Pabst, D; Pavenstadt, H; Kabar, I; Husing, A; Wolters, H; Reuter, S; Suwelack, B				Thoelking, Gerold; Fortmann, Christian; Koch, Raphael; Gerth, Hans Ulrich; Pabst, Dirk; Pavenstaedt, Hermann; Kabar, Iyad; Huesing, Anna; Wolters, Heiner; Reuter, Stefan; Suwelack, Barbara			The Tacrolimus Metabolism Rate Influences Renal Function After Kidney Transplantation	PLOS ONE			English	Article							CALCINEURIN INHIBITOR NEPHROTOXICITY; CYTOCHROME-P450 3A5; RECIPIENTS; CYP3A5; PHARMACOKINETICS; POLYMORPHISMS; ABSORPTION; EXPRESSION; EVOLUTION; EXPOSURE	The effective calcineurin inhibitor (CNI) tacrolimus (Tac) is an integral part of the standard immunosuppressive regimen after renal transplantation (RTx). However, as a potent CNI it has nephrotoxic potential leading to impaired renal function in some cases. Therefore, it is of high clinical impact to identify factors which can predict who is endangered to develop CNI toxicity. We hypothesized that the Tac metabolism rate expressed as the blood concentration normalized by the dose (C/D ratio) is such a simple predictor. Therefore, we analyzed the impact of the C/D ratio on kidney function after RTx. Renal function was analyzed 1, 2, 3, 6, 12 and 24 months after RTx in 248 patients with an immunosuppressive regimen including basiliximab, tacrolimus, mycophenolate mofetil and prednisolone. According to keep the approach simple, patients were split into three C/D groups: fast, intermediate and slow metabolizers. Notably, compared with slow metabolizers fast metabolizers of Tac showed significantly lower estimated glomerular filtration rate (eGFR) values at all the time points analyzed. Moreover, fast metabolizers underwent more indication renal biopsies (p = 0.006) which revealed a higher incidence of CNI nephrotoxicity (p = 0.015) and BK nephropathy (p = 0.024) in this group. We herein identified the C/D ratio as an easy calculable risk factor for the development of CNI nephrotoxicity and BK nephropathy after RTx. We propose that the simple C/D ratio should be taken into account early in patient's risk management strategies.	[Thoelking, Gerold; Fortmann, Christian; Gerth, Hans Ulrich; Pabst, Dirk; Pavenstaedt, Hermann; Reuter, Stefan; Suwelack, Barbara] Univ Hosp Munster, Div Gen Internal Med Nephrol & Rheumatol, Dept Med D, Munster, Germany; [Koch, Raphael] Univ Munster, Inst Biostat & Clin Res, D-48149 Munster, Germany; [Kabar, Iyad; Huesing, Anna] Univ Hosp Munster, Dept Transplant Med, Munster, Germany; [Wolters, Heiner] Univ Hosp Munster, Dept Gen Surg, Munster, Germany	University of Munster; University of Munster; University of Munster; University of Munster	Tholking, G (corresponding author), Univ Hosp Munster, Div Gen Internal Med Nephrol & Rheumatol, Dept Med D, Munster, Germany.	Gerold.Thoelking@ukmuenster.de	Koch, Raphael/A-7857-2013; Pabst, Dirk/M-6258-2019	Koch, Raphael/0000-0002-5581-5122; 	Deutsche Forschungsgemeinschaft; Open Access Publication Fund of University of Munster	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Fund of University of Munster	We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publication Fund of University of Munster.	Acott P, 2012, ANN TRANSPL, V17, P86; Anglicheau D, 2003, NEPHROL DIAL TRANSPL, V18, P2409, DOI 10.1093/ndt/gfg381; Borni-Duval C, 2013, TRANSPLANTATION, V95, P1498, DOI 10.1097/TP.0b013e3182921995; Ekberg H, 2009, AM J TRANSPLANT, V9, P1876, DOI 10.1111/j.1600-6143.2009.02726.x; Ekberg H, 2007, NEW ENGL J MED, V357, P2562, DOI 10.1056/NEJMoa067411; Gijsen V, 2011, J HEART LUNG TRANSPL, V30, P1352, DOI 10.1016/j.healun.2011.08.001; Jacobson PA, 2012, TRANSPLANTATION, V93, P624, DOI 10.1097/TP.0b013e3182461288; Ji E, 2012, TRANSPLANTATION, V94, P866, DOI 10.1097/TP.0b013e318263700a; Joy MS, 2007, NEPHROL DIAL TRANSPL, V22, P1963, DOI 10.1093/ndt/gfm133; Karamperis N, 2003, TRANSPLANT P, V35, P1314, DOI 10.1016/S0041-1345(03)00481-0; Kim IW, 2012, BASIC CLIN PHARMACOL, V111, P217, DOI 10.1111/j.1742-7843.2012.00892.x; Kuypers DRJ, 2007, CLIN PHARMACOL THER, V82, P711, DOI 10.1038/sj.clpt.6100216; Kuypers DR, 2008, ANN TRANSPL, V13, P11; Kuypers DRJ, 2004, DRUG METAB DISPOS, V32, P1421, DOI 10.1124/dmd.104.001503; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Metalidis C, 2011, TRANSPLANTATION, V91, P1098, DOI 10.1097/TP.0b013e3182177502; Mourad M, 2006, CLIN CHEM LAB MED, V44, P1192, DOI 10.1515/CCLM.2006.229; Naesens M, 2007, AM J TRANSPLANT, V7, P2504, DOI 10.1111/j.1600-6143.2007.01949.x; Nankivell BJ, 2004, TRANSPLANTATION, V78, P461, DOI 10.1097/01.TP.0000128612.75163.26; Nankivell Brian J., 2003, New England Journal of Medicine, V349, P2326, DOI 10.1056/NEJMoa020009; Sis B, 2010, AM J TRANSPLANT, V10, P464, DOI 10.1111/j.1600-6143.2009.02987.x; Stratta P, 2012, EUR J CLIN PHARMACOL, V68, P671, DOI 10.1007/s00228-011-1150-0; Tavira B, 2011, CLIN CHEM LAB MED, V49, P825, DOI 10.1515/CCLM.2011.143; Tsuchiya T, 2013, TRANSPLANTATION, V96, P198, DOI 10.1097/TP.0b013e318296c9d5; Watanabe Y, 1998, TRANSPL P, V30, P3777, DOI 10.1016/S0041-1345(98)01233-0	25	64	65	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111128	10.1371/journal.pone.0111128	http://dx.doi.org/10.1371/journal.pone.0111128			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340655	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662800086
J	Rashid, A; Ab Manan, A; Yahya, N; Ibrahim, L				Rashid, Abdul; Ab Manan, Azizah; Yahya, Noorlia; Ibrahim, Lailanor			The Support for Smoke Free Policy and How It Is Influenced by Tolerance to Smoking - Experience of a Developing Country	PLOS ONE			English	Article							TOBACCO CONTROL POLICY; CLEAN INDOOR AIR; PUBLIC PLACES; CIGARETTE CONSUMPTION; SOCIAL ACCEPTABILITY; REPORTED COMPLIANCE; FREE WORKPLACES; ATTITUDES; CALIFORNIA; BEHAVIOR	This cross sectional survey was conducted to determine the support in making Penang UNESCO World Heritage Site (GTWHS) smoke free and to determine the influence of tolerance towards smoking on this support. This is the first phase in making Penang, Malaysia a smoke free state. A multistage sampling process was done to select a sample of respondents to represent the population of GTWHS. Attitude towards smoking was assessed using tolerance as a proxy. A total of 3,268 members of the community participated in the survey. A big majority (n = 2969; 90.9%) of the respondents supported the initiative. Support was lowest among the owners and residents/tenants, higher age groups, the Chinese, men, respondents who had poor knowledge of the places gazetted as smoke free, and respondents with poor knowledge of the health effects on smokers and on passive smokers. The odds (both adjusted and unadjusted) of not supporting the initiative was high among those tolerant to smoking in public areas. Tolerance towards smoking was associated with 80.3% risk of non-support in the respondents who were tolerant to smoking and a 57.2% risk in the population. Health promotion and education concerning the harm of tobacco smoke in Malaysia, which has mainly targeted smokers, must change. Health education concerning the risks of second hand smoke must also be given to non-smokers and efforts should be made to denormalize smoking.	[Rashid, Abdul] Penang Med Coll, Dept Publ Hlth Med, Georgetown, Penang, Malaysia; [Ab Manan, Azizah; Yahya, Noorlia; Ibrahim, Lailanor] Penang State Hlth Dept, Georgetown, Penang, Malaysia		Rashid, A (corresponding author), Penang Med Coll, Dept Publ Hlth Med, Georgetown, Penang, Malaysia.	drrashid10@gmail.com		rashid, abdul/0000-0003-1520-8480				Ashley MJ, 2000, CAN J PUBLIC HEALTH, V91, P376, DOI 10.1007/BF03404811; Ashley MJ, 2003, TOB CONTROL, V12, P396, DOI 10.1136/tc.12.4.396; Bakhturidze GD, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003461; Bayer R, 2008, SOC SCI MED, V67, P463, DOI 10.1016/j.socscimed.2008.03.017; Blanco-Marquizo A, 2010, TOB CONTROL, V19, P231, DOI 10.1136/tc.2009.034769; Borland R, 2006, TOB CONTROL, V15, P34, DOI 10.1136/tc.2004.008748; Borland R, 2006, TOB CONTROL, V15, P42, DOI 10.1136/tc.2005.012492; Callinan JE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005992.pub2; Chapman S, 2008, TOB CONTROL, V17, P25, DOI 10.1136/tc.2007.021386; Chapman S, 1999, AM J PUBLIC HEALTH, V89, P1018, DOI 10.2105/AJPH.89.7.1018; Cohen JE, 2002, SOC SCI MED, V55, P1069, DOI 10.1016/S0277-9536(01)00244-1; Cummings KM, 2002, ONCOGENE, V21, P7349, DOI 10.1038/sj.onc.1205810; Danishevski K, 2008, TOB CONTROL, V17, DOI 10.1136/tc.2008.025759; Department of Health and Human Services, 2014, HLTH CONS SMOK 50 YE; Diethelm PA, 2005, LANCET, V366, P86, DOI 10.1016/S0140-6736(05)66474-4; Dinno A, 2007, PREV MED, V45, P9, DOI 10.1016/j.ypmed.2007.03.013; Doucet JM, 2007, ADDICT BEHAV, V32, P148, DOI 10.1016/j.addbeh.2006.04.003; European Commission, 2009, ATT EUR TOB; European Medicines Agency, 2012, ASS REP FORX DAP, P1; Fichtenberg CM, 2002, BMJ-BRIT MED J, V325, P188, DOI 10.1136/bmj.325.7357.188; Fong GT, 2006, TOB CONTROL, V15, P51, DOI 10.1136/tc.2005.013649; Frieden TR, 2014, JAMA-J AM MED ASSOC, V311, P133, DOI 10.1001/jama.2013.284534; Gilpin EA, 2004, TOB CONTROL, V13, P38, DOI 10.1136/tc.2003.004739; Gilpin EA, 2002, AM J PUBLIC HEALTH, V92, P785, DOI 10.2105/AJPH.92.5.785; Glantz SA, 2000, PEDIATRICS, V106, part. no., DOI 10.1542/peds.106.6.e82; Goodman PG, 2009, INT J PUBLIC HEALTH, V54, P367, DOI 10.1007/s00038-009-0089-8; Gutman M, 2011, SOCIAL NORMS ATTIDUE; Hammond D, 2006, AM J PREV MED, V31, P225, DOI 10.1016/j.amepre.2006.04.004; Holford TR, 2014, JAMA-J AM MED ASSOC, V311, P164, DOI 10.1001/jama.2013.285112; Hublet A, 2009, ADDICTION, V104, P1918, DOI 10.1111/j.1360-0443.2009.02686.x; Hyland A, 2004, NICOTINE TOB RES, V6, P363, DOI 10.1080/14622200412331320761; Hyland A, 2009, NICOTINE TOB RES, V11, P642, DOI 10.1093/ntr/ntp063; Institute for Public Health, 2012, REP GLOB AD TOB SURV; Jha P, 2014, NEW ENGL J MED, V370, P60, DOI 10.1056/NEJMra1308383; Koh HK, 2011, TOB CONTROL, V20, P219, DOI 10.1136/tc.2010.038885; Maguire Rachel Loflin, 2010, N C Med J, V71, P511; Malaysia MoH, 2006, ANN REPORT; Malone RE, 2012, TOB CONTROL, V21, P162, DOI 10.1136/tobaccocontrol-2011-050200; Ng M, 2014, JAMA-J AM MED ASSOC, V311, P183, DOI 10.1001/jama.2013.284692; Markham WA, 2009, BIOMED CENTRAL PUBLI, V9, P1471; Martinez-Sanchez JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013881; Ministry of Education, 2018, DRAFT DIS LEARN SUPP; PIERCE JP, 1990, AM J PUBLIC HEALTH, V80, P565, DOI 10.2105/AJPH.80.5.565; Poland BD, 2000, TOB CONTROL, V9, P364, DOI 10.1136/tc.9.4.364; Rennen E, 2014, HEALTH EDUC RES, V29, P72, DOI 10.1093/her/cyt073; Rosenberg M, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000784; Scollo M, 2003, TOB CONTROL, V12, P13, DOI 10.1136/tc.12.1.13; Siahpush M, 2007, TOB CONTROL, V16, DOI 10.1136/tc.2006.016279; Thomson G, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2806; Thrasher JF, 2013, HEALTH POLICY PLANN, V28, P789, DOI 10.1093/heapol/czs118; Thrasher JF, 2009, NICOTINE TOB RES, V11, P591, DOI 10.1093/ntr/ntp039; Thyrian Jochen R., 2010, Central European Journal of Public Health, V18, P87; Totten JW, 2012, ATLANTIC MARKETING J, V1, P73; Unger JB, 1999, HEALTH EDUC RES, V14, P751, DOI 10.1093/her/14.6.751; Viswanathan B, 2011, TOB CONTROL, V20, P427, DOI 10.1136/tc.2010.041590; Walsh RA, 2008, AUST NZ J PUBL HEAL, V32, P482, DOI 10.1111/j.1753-6405.2008.00284.x; Yong HH, 2010, ASIA-PAC J PUBLIC HE, V22, P98, DOI 10.1177/1010539509351303; Zlatev M, 2008, PSYCHOL HEALTH, V25, P167	58	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e109429	10.1371/journal.pone.0109429	http://dx.doi.org/10.1371/journal.pone.0109429			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6DY	25338116	gold, Green Published, Green Submitted			2022-12-27	WOS:000343674800013
J	Shved, N; Haas, C; Papageorgopoulou, C; Akguel, G; Paulsen, K; Bouwman, A; Warinner, C; Ruhli, F				Shved, Natallia; Haas, Cordula; Papageorgopoulou, Christina; Akguel, Guelfirde; Paulsen, Katja; Bouwman, Abigail; Warinner, Christina; Ruehli, Frank			Post Mortem DNA Degradation of Human Tissue Experimentally Mummified in Salt	PLOS ONE			English	Article							ANCIENT DNA; LINDOW MAN; IDENTIFICATION; MUMMIFICATION; SEQUENCE; MUMMIES; REMAINS; SAMPLES; NUMBER	Mummified human tissues are of great interest in forensics and biomolecular archaeology. The aim of this study was to analyse post mortem DNA alterations in soft tissues in order to improve our knowledge of the patterns of DNA degradation that occur during salt mummification. In this study, the lower limb of a female human donor was amputated within 24 h post mortem and mummified using a process designed to simulate the salt dehydration phase of natural or artificial mummification. Skin and skeletal muscle were sampled at multiple time points over a period of 322 days and subjected to genetic analysis. Patterns of genomic fragmentation, miscoding lesions, and overall DNA degradation in both nuclear and mitochondrial DNA was assessed by different methods: gel electrophoresis, multiplex comparative autosomal STR length amplification, cloning and sequence analysis, and PCR amplification of different fragment sizes using a damage sensitive recombinant polymerase. The study outcome reveals a very good level of DNA preservation in salt mummified tissues over the course of the experiment, with an overall slower rate of DNA fragmentation in skin compared to muscle.	[Shved, Natallia; Papageorgopoulou, Christina; Akguel, Guelfirde; Bouwman, Abigail; Warinner, Christina; Ruehli, Frank] Univ Zurich, Inst Evolutionary Med, Zurich, Switzerland; [Haas, Cordula] Univ Zurich, Dept Forens Genet, Inst Legal Med, Zurich, Switzerland; [Paulsen, Katja] Univ Zurich, Div Cell & Neurobiol, Inst Anat, Zurich, Switzerland	University of Zurich; University of Zurich; University of Zurich	Shved, N (corresponding author), Univ Zurich, Inst Evolutionary Med, Zurich, Switzerland.	natallia.shved@uzh.ch	Haas, Cordula/GWM-7074-2022; Bouwman, Abigail/G-6154-2016	Haas, Cordula/0000-0001-8122-1427; Warinner, Christina/0000-0002-4528-5877; papageorgopoulou, Christina/0000-0002-4145-950X	Swiss National Science Foundation, Maxi Stiftung [120662]	Swiss National Science Foundation, Maxi Stiftung	Funding provided by Swiss National Science Foundation (120662) http://www.snf.ch/de/Seiten/default.aspx, Maxi Stiftung (FR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aali A., 2012, ANTIQUITY, V86; AALI A, 2005, SALT MEN, P35; Aali A, 2012, ARCHAOL KORRESPONDEN, V42, P61; ALLISON MJ, 1985, NAT HIST, V94, P74; AMBACH E, 1992, FORENSIC SCI INT, V54, P191, DOI 10.1016/0379-0738(92)90164-R; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; [Anonymous], 1979, MANCHESTER MUSEUM MU; Arriaza BT., 1998, MUMMIES, P190; ASCENZI A., 1998, MUMMIES DIS ANCIENT, P263; Aufderheide A.C., 2003, SCI STUDY MUMMIES; BOGENHAGEN D, 1974, J BIOL CHEM, V249, P7991; Brier B, 1997, Z AGYPT SPRACHE ALT, V124, P89; Brier B, 1995, Paleopathol Newsl, P7; Brier B., 1998, ENCY MUMMIES; Cardenas-Arroyo F., 2003, VIEW LIFE CONTEXT DE, P150; Clifford W., 2004, KMT, V15, P64; Cooper A, 2000, SCIENCE, V289, P1139; Fisher C, 1998, MUMMIES DIS ANCIENT, P237; Frey B, 1995, BIOCHEMICA, V2, P34; Fricker EJ, 1997, LETT APPL MICROBIOL, V24, P351, DOI 10.1046/j.1472-765X.1997.00066.x; Gilbert MTP, 2005, AM J PHYS ANTHROPOL, V128, P110, DOI 10.1002/ajpa.20045; Guillen SE, 2004, COLLEGIUM ANTROPOL, V28, P141; Guillen SE, 1992, CHINCHORRO CULTURE M; Hansen AJ, 2001, MOL BIOL EVOL, V18, P262, DOI 10.1093/oxfordjournals.molbev.a003800; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Ikram S, 1998, MUMMY ANCIENT EGYPT; Ikram S, 2005, MANUFACTURING DIVINI; Ikram S, 2014, EXPT EXPERIENCE; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Lalueza-Fox C, 2011, CURR BIOL, V21, pR1002, DOI 10.1016/j.cub.2011.11.021; Leek F.F., 1984, EVIDENCE EMBALMED MO, P104; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lucas A., 1914, J EGYPT ARCHAEOL, V1, P119; Lucas A., 1932, J EGYPT ARCHAEOL, V18, P62, DOI DOI 10.1177/030751333201800109; Lucas A., 1932, J EGYPT ARCHEOL, V18, P125, DOI [10.2307/3854973., DOI 10.2307/3854973]; Mekota AM, 2005, INT J OSTEOARCHAEOL, V15, P51, DOI 10.1002/oa.747; Notman D, 1992, EXPT MUMMIFICATION C, P821; PAINTER TJ, 1991, CARBOHYD POLYM, V15, P123, DOI 10.1016/0144-8617(91)90028-B; Papageorgopoulou C, 2013, ANATOMICAL IN PRESS; PECK WH, 1998, MUMMIES DIS ANCIENT, P336; Rameckers J, 1997, NATURWISSENSCHAFTEN, V84, P259, DOI 10.1007/s001140050393; Spindler K, 1994, MAN ICE; Swango KL, 2007, FORENSIC SCI INT, V170, P35, DOI 10.1016/j.forsciint.2006.09.002; Vass AA, 2002, J FORENSIC SCI, V47, P542; VASS AA, 1992, J FORENSIC SCI, V37, P1236; Wang Y, 2004, NUCLEIC ACIDS RES, V32, P1197, DOI 10.1093/nar/gkh271; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; Wilson AS, 2007, FORENSIC SCI INT, V169, P6, DOI 10.1016/j.forsciint.2006.07.023; ZHENG G, 1979, SCI SINICA, V22, P1095; Zink A, 2003, AM J PHYS ANTHROPOL, V121, P109, DOI 10.1002/ajpa.10213; Zink AR, 2005, AM J PHYS ANTHROPOL, V126, P32, DOI 10.1002/ajpa.10409	52	15	16	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110753	10.1371/journal.pone.0110753	http://dx.doi.org/10.1371/journal.pone.0110753			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337822	Green Published, gold, Green Accepted			2022-12-27	WOS:000343674800071
J	Wang, ZT; Wu, YP; Duan, GQ; Cao, HJ; Liu, JC; Wang, KX; Wang, D				Wang, Zhitao; Wu, Yuping; Duan, Guoqin; Cao, Hanjiang; Liu, Jianchang; Wang, Kexiong; Wang, Ding			Assessing the Underwater Acoustics of the World's Largest Vibration Hammer (OCTA-KONG) and Its Potential Effects on the Indo-Pacific Humpbacked Dolphin (Sousa chinensis)	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; WHALES ORCINUS-ORCA; TURSIOPS-TRUNCATUS; RIVER ESTUARY; HEARING-LOSS; HONG-KONG; NOISE; SOUND; CONSERVATION; AUDIOGRAM	Anthropogenic noise in aquatic environments is a worldwide concern due to its potential adverse effects on the environment and aquatic life. The Hongkong-Zhuhai-Macao Bridge is currently under construction in the Pearl River Estuary, a hot spot for the Indo-Pacific humpbacked dolphin (Sousa chinensis) in China. The OCTA-KONG, the world's largest vibration hammer, is being used during this construction project to drive or extract steel shell piles 22 m in diameter. This activity poses a substantial threat to marine mammals, and an environmental assessment is critically needed. The underwater acoustic properties of the OCTA-KONG were analyzed, and the potential impacts of the underwater acoustic energy on Sousa, including auditory masking and physiological impacts, were assessed. The fundamental frequency of the OCTA-KONG vibration ranged from 15 Hz to 16 Hz, and the noise increments were below 20 kHz, with a dominant frequency and energy below 10 kHz. The resulting sounds are most likely detectable by Sousa over distances of up to 3.5 km from the source. Although Sousa clicks do not appear to be adversely affected, Sousa whistles are susceptible to auditory masking, which may negatively impact this species' social life. Therefore, a safety zone with a radius of 500 m is proposed. Although the zero-to-peak source level (SL) of the OCTA-KONG was lower than the physiological damage level, the maximum root-mean-square SL exceeded the cetacean safety exposure level on several occasions. Moreover, the majority of the unweighted cumulative source sound exposure levels (SSELs) and the cetacean auditory weighted cumulative SSELs exceeded the acoustic threshold levels for the onset of temporary threshold shift, a type of potentially recoverable auditory damage resulting from prolonged sound exposure. These findings may aid in the identification and design of appropriate mitigation methods, such as the use of air bubble curtains, "soft start" and "power down" techniques.	[Wang, Zhitao; Wang, Kexiong; Wang, Ding] Chinese Acad Sci, Key Lab Aquat Biodivers & Conservat, Inst Hydrobiol, Wuhan, Peoples R China; [Wang, Zhitao] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wu, Yuping] Sun Yat Sen Univ, Sch Marine Sci, Guangzhou 510275, Guangdong, Peoples R China; [Duan, Guoqin; Cao, Hanjiang] Hongkong Zhuhai Macao Bridge Author, Guangzhou, Guangdong, Peoples R China; [Liu, Jianchang] Minist Transport, Transport Planning & Res Inst, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Sun Yat Sen University; Ministry of Transport of the People's Republic of China	Wang, KX (corresponding author), Chinese Acad Sci, Key Lab Aquat Biodivers & Conservat, Inst Hydrobiol, Wuhan, Peoples R China.	wangk@ihb.ac.cn; wangd@ihb.ac.cn	Wang, Zhi-Tao/F-1176-2015	Wang, Zhi-Tao/0000-0002-5734-7385	Ministry of Science and Technology of China [2011BAG07B05-3]; National Natural Science Foundation of China [31170501, 31070347]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-Z-4]; State Oceanic Administration of China [201105011-3]; Special Fund for Agro-scientific Research in the Public Interest of the Ministry of Agriculture of China [201203086]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); State Oceanic Administration of China; Special Fund for Agro-scientific Research in the Public Interest of the Ministry of Agriculture of China	The research was supported by grants from the Ministry of Science and Technology of China (2011BAG07B05-3), the National Natural Science Foundation of China (31170501 and 31070347), the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-Z-4), the State Oceanic Administration of China (201105011-3) and the Special Fund for Agro-scientific Research in the Public Interest of the Ministry of Agriculture of China (201203086). The funders had no role in designing the study, collecting data, analyzing data, preparing the manuscript or deciding where to publish the manuscript.	Au W.W.L., 2008, PRINCIPLES MARINE BI; Au WWL, 2013, J ACOUST SOC AM, V133, P3119, DOI 10.1121/1.4798360; Bailey H, 2010, MAR POLLUT BULL, V60, P888, DOI 10.1016/j.marpolbul.2010.01.003; Barros NB., 1987, J ACOUST SOC AM, V82(Suppl. 1, P65, DOI [10.1121/1.2024924, DOI 10.1121/1.2024924]; Blackwell SB, 2004, J ACOUST SOC AM, V115, P2346, DOI 10.1121/1.1701899; Brandt MJ, 2011, MAR ECOL PROG SER, V421, P205, DOI 10.3354/meps08888; Buckstaff KC, 2004, MAR MAMMAL SCI, V20, P709, DOI 10.1111/j.1748-7692.2004.tb01189.x; Casper BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073844; Casper BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039593; Chen BY, 2009, INTEGR ZOOL, V4, P240, DOI 10.1111/j.1749-4877.2009.00160.x; Chen T, 2010, MAMMALIA, V74, P117, DOI 10.1515/MAMM.2010.024; Cheung E, 2009, J PROP INVEST FINANC, V27, P290, DOI 10.1108/14635780910951984; Codarin A, 2009, MAR POLLUT BULL, V58, P1880, DOI 10.1016/j.marpolbul.2009.07.011; David JA, 2006, WATER ENVIRON J, V20, P48, DOI 10.1111/j.1747-6593.2005.00023.x; Erbe C, 2002, MAR MAMMAL SCI, V18, P394, DOI 10.1111/j.1748-7692.2002.tb01045.x; Finneran J. J., 2012, CRITERIA THRESHOLDS; Finneran JJ, 2013, J ACOUST SOC AM, V133, P1819, DOI 10.1121/1.4776211; Finneran JJ, 2011, J ACOUST SOC AM, V130, P3124, DOI 10.1121/1.3641449; Finneran JJ, 2010, J ACOUST SOC AM, V128, P567, DOI 10.1121/1.3458814; Finneran JJ, 2002, J ACOUST SOC AM, V112, P322, DOI 10.1121/1.1488652; Finneran JJ, 2002, J ACOUST SOC AM, V111, P2929, DOI 10.1121/1.1479150; FISHER FH, 1977, J ACOUST SOC AM, V62, P558, DOI 10.1121/1.381574; Foote AD, 2004, NATURE, V428, P910, DOI 10.1038/428910a; Gannon DP, 2005, ANIM BEHAV, V69, P709, DOI 10.1016/j.anbehav.2004.06.020; Halvorsen MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038968; HAMILTON EL, 1976, J ACOUST SOC AM, V59, P528, DOI 10.1121/1.380910; Hawkins ER, 2010, J ACOUST SOC AM, V127, P2652, DOI 10.1121/1.3308465; Hildebrand JA, 2009, MAR ECOL PROG SER, V395, P5, DOI 10.3354/meps08353; Holt MM, 2009, J ACOUST SOC AM, V125, pEL27, DOI 10.1121/1.3040028; Houser DS, 2008, MAR MAMMAL SCI, V24, P28, DOI 10.1111/j.1748-7692.2007.00148.x; JNCC, 2008, DRAFT GUID MIN AC DI; Jonker G, 1987, P 19 ANN OFFSH TECHN, P549; Knobles DP, 2003, J ACOUST SOC AM, V113, P205, DOI 10.1121/1.1521930; Lesage V, 1999, MAR MAMMAL SCI, V15, P65, DOI 10.1111/j.1748-7692.1999.tb00782.x; Li SH, 2013, J EXP BIOL, V216, P4144, DOI 10.1242/jeb.091504; Li SH, 2012, J EXP BIOL, V215, P3055, DOI 10.1242/jeb.070904; Madsen PT, 2006, MAR ECOL PROG SER, V309, P279, DOI 10.3354/meps309279; Morisaka T, 2005, J MAMMAL, V86, P541, DOI 10.1644/1545-1542(2005)86[541:EOANOT]2.0.CO;2; NMFS, 2000, FED REGISTER, V65, P34014; NOAA, 2013, FED REGISTER, V78, P75488; NOAA,, 2013, DRAFT GUID ASS EFF A; Nowacek DP, 2007, MAMMAL REV, V37, P81, DOI 10.1111/j.1365-2907.2007.00104.x; Pirotta E, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.1090; Popov Vladimir V., 2007, Aquatic Mammals, V33, P24, DOI 10.1578/AM.33.1.2007.24; Popper A.N., 2012, EFFECTS NOISE AQUATI; Popper AN, 2009, INTEGR ZOOL, V4, P43, DOI 10.1111/j.1749-4877.2008.00134.x; Preen A, 2004, BIOL CONSERV, V118, P205, DOI 10.1016/j.biocon.2003.08.014; Reeves RR, 2008, SOUSA CHINENSIS IUCN; Reyff JA, 2005, TRANSPORT RES REC, V11, P481; Richardson WJ, 1997, MAR FRESHW BEHAV PHY, V29, P183, DOI 10.1080/10236249709379006; RICHARDSON WJ, 1986, J ACOUST SOC AM, V79, P1117, DOI 10.1121/1.393384; Richardson WJ, 1995, MARINE MAMMALS NOISE, V1st; ROBINSON DW, 1956, BRIT J APPL PHYS, V7, P166, DOI 10.1088/0508-3443/7/5/302; Scheifele PM, 2005, J ACOUST SOC AM, V117, P1486, DOI 10.1121/1.1835508; Sims P.Q., 2012, J MAR BIOL, V2012, DOI [10.1155/2012/169103, DOI 10.1155/2012/169103]; Sims PQ, 2012, J ACOUST SOC AM, V131, pEL48, DOI 10.1121/1.3663281; Southall Brandon L., 2007, Aquatic Mammals, V33, pI; Sun M., 2008, PAN PEARL RIVER DELT, P241; Suzuki Y, 2004, J ACOUST SOC AM, V116, P918, DOI 10.1121/1.1763601; Urick RJ., 1983, PRINCIPLES UNDERWATE, V3; Vasconcelos RO, 2007, J EXP BIOL, V210, P2104, DOI 10.1242/jeb.004317; Wahlberg M, 2005, MAR ECOL PROG SER, V288, P295, DOI 10.3354/meps288295; Wang ZT, 2015, INTEGR ZOOL, V10, P122, DOI 10.1111/1749-4877.12102; Wang ZT, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0097907, 10.1371/journal.pone.0114792, 10.1371/journal.pone.0103645, 10.1371/journal.pone.0089948, 10.1371/journal.pone.0087381, 10.1371/journal.pone.0091755, 10.1371/journal.pone.0109571, 10.1371/journal.pone.0104657]; Wang ZT, 2013, J ACOUST SOC AM, V133, P2479, DOI 10.1121/1.4794390; Wursig B, 2000, MAR ENVIRON RES, V49, P79, DOI 10.1016/S0141-1136(99)00050-1; Zar JH, 1999, BIOSTATISTICAL ANAL	67	18	19	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110590	10.1371/journal.pone.0110590	http://dx.doi.org/10.1371/journal.pone.0110590			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338113	Green Submitted, gold, Green Published			2022-12-27	WOS:000343674800061
J	Mishra, S; Alavilli, H; Lee, BH; Panda, SK; Sahoo, L				Mishra, Sagarika; Alavilli, Hemasundar; Lee, Byeong-Ha; Panda, Sanjib Kumar; Sahoo, Lingaraj			Cloning and Functional Characterization of a Vacuolar Na+/H+ Antiporter Gene from Mungbean (VrNHX1) and Its Ectopic Expression Enhanced Salt Tolerance in Arabidopsis thaliana	PLOS ONE			English	Article							SODIUM-TRANSPORT; MOLECULAR-CLONING; SUAEDA-SALSA; STRESS; YEAST; SALINITY; K+; OVEREXPRESSION; TRANSFORMATION; HOMEOSTASIS	Plant vacuolar NHX exchangers play a significant role in adaption to salt stress by compartmentalizing excess cytosolic Na+ into vacuoles and maintaining cellular homeostasis and ionic equilibrium. We cloned an orthologue of the vacuolar Na+/H+ antiporter gene, VrNHX1 from mungbean (Vigna radiata), an important Asiatic grain legume. The VrNHX1 (Genbank Accession number JN656211.1) contains 2095 nucleotides with an open reading frame of 1629 nucleotides encoding a predicted protein of 542 amino acids with a deduced molecular mass of 59.6 kDa. The consensus amiloride binding motif ((LFFIYLLPPI93)-L-84) was observed in the third putative transmembrane domain of VrNHX1. Bioinformatic and phylogenetic analysis clearly suggested that VrNHX1 had high similarity to those of orthologs belonging to Class-I clade of plant NHX exchangers in leguminous crops. VrNHX1 could be strongly induced by salt stress in mungbean as the expression in roots significantly increased in presence of 200 mM NaCl with concomitant accumulation of total [Na+]. Induction of VrNHX1 was also observed under cold and dehydration stress, indicating a possible cross talk between various abiotic stresses. Heterologous expression in salt sensitive yeast mutant AXT3 complemented for the loss of yeast vacuolar NHX1 under NaCl, KCl and LiCl stress indicating that VrNHX1 was the orthologue of ScNHX1. Further, AXT3 cells expressing VrNHX1 survived under low pH environment and displayed vacuolar alkalinization analyzed using pH sensitive fluorescent dye BCECF-AM. The constitutive and stress inducible expression of VrNHX1 resulted in enhanced salt tolerance in transgenic Arabidopsis thaliana lines. Our work suggested that VrNHX1 was a salt tolerance determinant in mungbean.	[Mishra, Sagarika; Sahoo, Lingaraj] Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati, India; [Alavilli, Hemasundar; Lee, Byeong-Ha] Sogang Univ, Dept Life Sci, Seoul, South Korea; [Panda, Sanjib Kumar] Assam Univ, Dept Life Sci & Bioinformat, Silchar, India; [Panda, Sanjib Kumar] Oklahoma State Univ, Noble Res Ctr, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati; Sogang University; Assam University; Oklahoma State University System; Oklahoma State University - Stillwater	Sahoo, L (corresponding author), Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati, India.	ls@iitg.ernet.in	Mishra, Sagarika/W-6314-2019; Mishra, Sagarika/ABF-5875-2021; Lee, Byeong-ha/B-8478-2009	Mishra, Sagarika/0000-0003-1123-2483; Mishra, Sagarika/0000-0003-1123-2483; Lee, Byeong-ha/0000-0001-7633-3264; Panda, Sanjib Kumar/0000-0001-5131-9693	Department of Biotechnology, Government of India [BT/PR10818/AGR/02/591/2008]; Rural Development Administration, Republic of Korea [PJ009104]; MHRD	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); MHRD	LS is grateful to Department of Biotechnology, Government of India for partial support from the grant (BT/PR10818/AGR/02/591/2008) to this work. BhL is grateful to Rural Development Administration, Republic of Korea for its support by Next-Generation BioGreen 21 Program (PJ009104). SM is grateful to MHRD for Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali R, 2004, J BIOL CHEM, V279, P4498, DOI 10.1074/jbc.M307446200; An BaoYan, 2008, Acta Agronomica Sinica, V34, P557, DOI 10.3724/SP.J.1006.2008.00557; Baltierra F, 2013, BIOCHEM BIOPH RES CO, V430, P535, DOI 10.1016/j.bbrc.2012.11.118; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Blumwald E, 2000, CURR OPIN CELL BIOL, V12, P431, DOI 10.1016/S0955-0674(00)00112-5; Blumwald E, 2000, BBA-BIOMEMBRANES, V1465, P140, DOI 10.1016/S0005-2736(00)00135-8; Bor M, 2003, PLANT SCI, V164, P77, DOI 10.1016/S0168-9452(02)00338-2; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Darley CP, 2000, BIOCHEM J, V351, P241, DOI 10.1042/0264-6021:3510241; Dernetriou G, 2007, BBA-BIOENERGETICS, V1767, P272, DOI 10.1016/j.bbabio.2007.02.020; Du YH, 2010, J PLANT BIOL, V53, P251, DOI 10.1007/s12374-010-9107-x; Fukuda A, 2004, PLANT CELL PHYSIOL, V45, P146, DOI 10.1093/pcp/pch014; Gattiker Alexandre, 2002, Appl Bioinformatics, V1, P107; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gouiaa S, 2012, PLANT MOL BIOL, V79, P137, DOI 10.1007/s11103-012-9901-6; Guan B, 2011, MOL BIOL REP, V38, P1889, DOI 10.1007/s11033-010-0307-8; Hamada A, 2001, PLANT MOL BIOL, V46, P35, DOI 10.1023/A:1010603222673; Harris C, 1999, INT J MOL MED, V3, P315; Hasanuzzaman M, 2013, INT CURR PHARM J, V2, P92; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Jacoby B., 1999, HDB PLANT CROP STRES, V2, P97; Kinclova-Zimmermannova O, 2004, FOLIA MICROBIOL, V49, P519, DOI 10.1007/BF02931527; Kronzucker HJ, 2011, NEW PHYTOL, V189, P54, DOI 10.1111/j.1469-8137.2010.03540.x; Li JY, 2007, PLANT CELL TISS ORG, V90, P41, DOI 10.1007/s11240-007-9246-z; Li WYF, 2006, PLANT CELL ENVIRON, V29, P1122, DOI 10.1111/j.1365-3040.2005.01487.x; LICHTENTHALER HK, 1987, J PLANT PHYSIOL, V131, P101, DOI 10.1016/S0176-1617(87)80271-7; Ma XL, 2004, BIOL PLANTARUM, V48, P219, DOI 10.1023/B:BIOP.0000033448.96998.44; Maathuis FJM, 1999, ANN BOT-LONDON, V84, P123, DOI 10.1006/anbo.1999.0912; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Munns R, 2010, METHODS MOL BIOL, V639, P371, DOI 10.1007/978-1-60761-702-0_23; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nair RM, 2013, J SCI FOOD AGR, V93, P1805, DOI 10.1002/jsfa.6110; Pardo JM, 2006, J EXP BOT, V57, P1181, DOI 10.1093/jxb/erj114; Rodriguez-Rosales M, 2009, PLANT SIGNAL BEHAV, V4, P265, DOI 10.4161/psb.4.4.7919; Qiao WH, 2007, PLANT CELL REP, V26, P1663, DOI 10.1007/s00299-007-0354-3; Quintero FJ, 2000, FEBS LETT, V471, P224, DOI 10.1016/S0014-5793(00)01412-5; Rajagopal D, 2007, MOL BREEDING, V19, P137, DOI 10.1007/s11032-006-9052-z; Schroeder JI, 2013, NATURE, V497, P60, DOI 10.1038/nature11909; Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197; Shi HZ, 2002, PLANT MOL BIOL, V50, P543, DOI 10.1023/A:1019859319617; Shi HZ, 2002, PLANT CELL, V14, P465, DOI 10.1105/tpc.010371; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang R, 2010, PLANT MOL BIOL REP, V28, P102, DOI 10.1007/s11105-009-0135-y; Teakle NL, 2010, PHYSIOL PLANTARUM, V139, P358, DOI 10.1111/j.1399-3054.2010.01373.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Venema K, 2003, J BIOL CHEM, V278, P22453, DOI 10.1074/jbc.M210794200; Wu C, 2009, PLANT MOL BIOL REP, V27, P1, DOI 10.1007/s11105-008-0048-1; Wu GQ, 2011, J PLANT PHYSIOL, V168, P758, DOI 10.1016/j.jplph.2010.10.015; Yang DH, 2012, BIOCHEM BIOPH RES CO, V417, P732, DOI 10.1016/j.bbrc.2011.12.023; Yokoi S, 2002, PLANT J, V30, P529, DOI 10.1046/j.1365-313X.2002.01309.x; Zhang GH, 2008, PLANT PHYSIOL BIOCH, V46, P117, DOI 10.1016/j.plaphy.2007.10.022; Zhang H, 2012, PLANT CELL TISS ORG, V110, DOI 10.1007/s11240-012-0142-9; Zhang HX, 2001, NAT BIOTECHNOL, V19, P765, DOI 10.1038/90824; Zorb C, 2005, J PLANT PHYSIOL, V162, P55, DOI 10.1016/j.jplph.2004.03.010	58	18	24	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e106678	10.1371/journal.pone.0106678	http://dx.doi.org/10.1371/journal.pone.0106678			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350285	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943100005
J	Finger, A; Kaiser-Bunbury, CN; Kettle, CJ; Valentin, T; Ghazoul, J				Finger, Aline; Kaiser-Bunbury, Christopher N.; Kettle, Chris J.; Valentin, Terence; Ghazoul, Jaboury			Genetic Connectivity of the Moth Pollinated Tree Glionnetia sericea in a Highly Fragmented Habitat	PLOS ONE			English	Article							POLLEN FLOW; REPRODUCTIVE SUCCESS; SEED DISPERSAL; TROPICAL TREES; DRY FOREST; POPULATION; PLANTS; CONSEQUENCES; METAANALYSIS; DISRUPTION	Long-distance gene flow is thought to be one prerequisite for the persistence of plant species in fragmented environments. Human influences have led to severe fragmentation of native habitats in the Seychelles islands, with many species surviving only in small and isolated populations. The endangered Seychelles endemic tree Glionnetia sericea is restricted to altitudes between 450 m and 900 m where the native forest vegetation has been largely lost and replaced with exotic invasives over the last 200 years. This study explores the genetic and ecological consequences of population fragmentation in this species by analysing patterns of genetic diversity in a sample of adults, juveniles and seeds, and by using controlled pollination experiments. Our results show no decrease in genetic diversity and no increase in genetic structuring from adult to juvenile cohorts. Despite significant inbreeding in some populations, there is no evidence of higher inbreeding in juvenile cohorts relative to adults. A Bayesian structure analysis and a tentative paternity analysis indicate extensive historical and contemporary gene flow among remnant populations. Pollination experiments and a paternity analysis show that Glionnetia sericea is self-compatible. Nevertheless, outcrossing is present with 7% of mating events resulting from pollen transfer between populations. Artificial pollination provided no evidence for pollen limitation in isolated populations. The highly mobile and specialized hawkmoth pollinators (Agrius convolvuli and Cenophodes tamsi; Sphingidae) appear to promote extensive gene flow, thus mitigating the potential negative ecological and genetic effects of habitat fragmentation in this species. We conclude that contemporary gene flow is sufficient to maintain genetic connectivity in this rare and restricted Seychelles endemic, in contrast to other island endemic tree species with limited contemporary gene flow.	[Finger, Aline; Kettle, Chris J.; Ghazoul, Jaboury] Swiss Fed Inst Technol, Zurich, Switzerland; [Kaiser-Bunbury, Christopher N.] Tech Univ Darmstadt, Dept Biol, Darmstadt, Germany; [Valentin, Terence] Natl Pk Author, Victoria, Mahe, Seychelles	Swiss Federal Institutes of Technology Domain; ETH Zurich; Technical University of Darmstadt	Finger, A (corresponding author), Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland.	a.finger@rbge.ac.uk	Kaiser-Bunbury, Christopher/C-5038-2012; Ghazoul, Jaboury/B-2121-2018	Kaiser-Bunbury, Christopher/0000-0001-7254-3491; 	ETH Zurich [ETH-07 08-01]	ETH Zurich(ETH Zurich)	This research was funded under grant number ETH-07 08-01, ETH Zurich (https://www.ethz.ch/en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, P NATL ACAD SCI USA, V106, P20342, DOI 10.1073/pnas.0902213106; Aizen MA, 2002, J VEG SCI, V13, P885, DOI 10.1111/j.1654-1103.2002.tb02118.x; Angeloni F, 2011, BIOL CONSERV, V144, P35, DOI 10.1016/j.biocon.2010.08.016; [Anonymous], 2014, R LANG ENV STAT COMP; Ashworth L, 2004, J ECOL, V92, P717, DOI 10.1111/j.0022-0477.2004.00910.x; Bates D, 2005, R NEWS, V5, P27, DOI DOI 10.1111/J.1523-1739.2005.00280.X; BAWA KS, 1990, ANNU REV ECOL SYST, V21, P399, DOI 10.1146/annurev.es.21.110190.002151; Bittencourt JVM, 2007, HEREDITY, V99, P580, DOI 10.1038/sj.hdy.6801019; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; BOND WJ, 1994, PHILOS T R SOC B, V344, P83, DOI 10.1098/rstb.1994.0055; Buschbom J, 2011, J HERED, V102, P464, DOI 10.1093/jhered/esr023; Chase MR, 1996, NATURE, V383, P398, DOI 10.1038/383398a0; Chybicki IJ, 2009, J HERED, V100, P106, DOI 10.1093/jhered/esn088; Daehler CC, 2004, CONSERV BIOL, V18, P360, DOI 10.1111/j.1523-1739.2004.00066.x; Dafni A, 1998, SEX PLANT REPROD, V11, P177, DOI 10.1007/s004970050138; Dick CW, 2001, P ROY SOC B-BIOL SCI, V268, P2391, DOI 10.1098/rspb.2001.1781; Diels L, 1922, WISSENSCHAFTLICHE ER; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Finger A, 2012, MOL ECOL, V21, P2369, DOI 10.1111/j.1365-294X.2012.05543.x; Finger A, 2011, MOL ECOL, V20, P3773, DOI 10.1111/j.1365-294X.2011.05228.x; Finger A, 2012, CONSERV GENET RESOUR, V4, P239, DOI 10.1007/s12686-011-9515-3; Fleischer-Dogley F, 2011, DIVERS DISTRIB, V17, P235, DOI 10.1111/j.1472-4642.2010.00732.x; Fleischmann K, 1997, J VEG SCI, V8, P5, DOI 10.2307/3237236; Ghazoul J, 2005, BIOL REV, V80, P413, DOI 10.1017/S1464793105006731; Ghazoul J, 2004, BIOTROPICA, V36, P156, DOI 10.1111/j.1744-7429.2004.tb00308.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; HABER WA, 1989, BIOTROPICA, V21, P155, DOI 10.2307/2388706; Ismail S, 2011, IUCN RED LIST THREAT; Ismail SA, 2012, MOL ECOL, V21, P5484, DOI 10.1111/mec.12054; JANZEN DH, 1994, TRENDS ECOL EVOL, V9, P365, DOI 10.1016/0169-5347(94)90053-1; Robledo-Arnuncio JJ, 2011, NEW PHYTOL, V190, P222, DOI 10.1111/j.1469-8137.2010.03588.x; Kaiser-Bunbury CN, 2011, J ECOL, V99, P202, DOI 10.1111/j.1365-2745.2010.01732.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kettle CJ, 2007, MOL ECOL, V16, P3581, DOI 10.1111/j.1365-294X.2007.03419.x; Kueffer C, 2010, PERSPECT PLANT ECOL, V12, P145, DOI 10.1016/j.ppees.2009.06.002; Lander TA, 2010, BIOL CONSERV, V143, P2583, DOI 10.1016/j.biocon.2010.06.028; Morales CL, 2009, ECOL LETT, V12, P716, DOI 10.1111/j.1461-0248.2009.01319.x; Liepelt S, 2002, P NATL ACAD SCI USA, V99, P14590, DOI 10.1073/pnas.212285399; LINHART YB, 1977, BIOTROPICA, V9, P143, DOI 10.2307/2387672; Lourmas M, 2007, HEREDITY, V99, P151, DOI 10.1038/sj.hdy.6800976; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; MOULDS M S, 1981, General and Applied Entomology, V13, P69; Munoz AA, 2008, J ECOL, V96, P459, DOI 10.1111/j.1365-2745.2008.01361.x; Nason JD, 1998, NATURE, V391, P685, DOI 10.1038/35607; Ottewell KM, 2009, BIOL CONSERV, V142, P888, DOI 10.1016/j.biocon.2008.12.019; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Ritland K, 2002, HEREDITY, V88, P221, DOI 10.1038/sj.hdy.6800029; Sork VL, 2006, LANDSCAPE ECOL, V21, P821, DOI 10.1007/s10980-005-5415-9; Traveset A, 2006, TRENDS ECOL EVOL, V21, P208, DOI 10.1016/j.tree.2006.01.006; Van Geert A, 2008, CONSERV GENET, V9, P845, DOI 10.1007/s10592-007-9409-9; White GM, 2002, P NATL ACAD SCI USA, V99, P2038, DOI 10.1073/pnas.042649999	53	16	17	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111111	10.1371/journal.pone.0111111	http://dx.doi.org/10.1371/journal.pone.0111111			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347541	Green Published, gold, Green Submitted			2022-12-27	WOS:000347994900049
J	Lakin, MR; Brown, CW; Horwitz, EK; Fanning, ML; West, HE; Stefanovic, D; Graves, SW				Lakin, Matthew R.; Brown, Carl W., III; Horwitz, Eli K.; Fanning, M. Leigh; West, Hannah E.; Stefanovic, Darko; Graves, Steven W.			Biophysically Inspired Rational Design of Structured Chimeric Substrates for DNAzyme Cascade Engineering	PLOS ONE			English	Article							DNA STRAND-DISPLACEMENT; LOGIC GATES; IN-VITRO; MOLECULAR AUTOMATON; AMPLIFIED DETECTION; LIGASE ACTIVITY; RNA; DEOXYRIBOZYME; ENZYME; HYDROLYSIS	The development of large-scale molecular computational networks is a promising approach to implementing logical decision making at the nanoscale, analogous to cellular signaling and regulatory cascades. DNA strands with catalytic activity (DNAzymes) are one means of systematically constructing molecular computation networks with inherent signal amplification. Linking multiple DNAzymes into a computational circuit requires the design of substrate molecules that allow a signal to be passed from one DNAzyme to another through programmed biochemical interactions. In this paper, we chronicle an iterative design process guided by biophysical and kinetic constraints on the desired reaction pathways and use the resulting substrate design to implement heterogeneous DNAzyme signaling cascades. A key aspect of our design process is the use of secondary structure in the substrate molecule to sequester a downstream effector sequence prior to cleavage by an upstream DNAzyme. Our goal was to develop a concrete substrate molecule design to achieve efficient signal propagation with maximal activation and minimal leakage. We have previously employed the resulting design to develop high-performance DNAzyme-based signaling systems with applications in pathogen detection and autonomous theranostics.	[Lakin, Matthew R.; Fanning, M. Leigh; Stefanovic, Darko] Univ New Mexico, Dept Comp Sci, Albuquerque, NM 87131 USA; [Brown, Carl W., III; Horwitz, Eli K.; West, Hannah E.; Stefanovic, Darko; Graves, Steven W.] Univ New Mexico, Ctr Biomed Engn, Albuquerque, NM 87131 USA; [Graves, Steven W.] Univ New Mexico, Dept Chem & Biol Engn, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico; University of New Mexico	Stefanovic, D (corresponding author), Univ New Mexico, Dept Comp Sci, Albuquerque, NM 87131 USA.	darko@cs.unm.edu; graves@unm.edu		Brown III, Ph.D., Carl W./0000-0002-6524-4140	National Science Foundation [1027877, 1028238, 1318833, DGE-0549500]; New Mexico Cancer Nanoscience and Microsystems Training Center under National Institutes of Health [5R25CA153825]; NATIONAL CANCER INSTITUTE [R25CA153825] Funding Source: NIH RePORTER; Direct For Computer & Info Scie & Enginr [1318833] Funding Source: National Science Foundation; Div Of Chem, Bioeng, Env, & Transp Sys [1026592] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); New Mexico Cancer Nanoscience and Microsystems Training Center under National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This material is based upon work supported by the National Science Foundation (http://nsf. gov/) under grant numbers 1027877, 1028238, and 1318833, which supported M.R.L., C.W.B., D.S., and S.W.G. C.W.B. gratefully acknowledges support from an Integrative Graduate Education and Research Traineeship in Integrating Nanotechnology with Cell Biology and Neuroscience from the National Science Foundation (http://nsf.gov/) under grant number DGE-0549500. M.R.L. gratefully acknowledges support from the New Mexico Cancer Nanoscience and Microsystems Training Center (http://cntc.unm.edu/) under National Institutes of Health (http://www.nih.gov/) grant number 5R25CA153825. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bath J, 2009, SMALL, V5, P1513, DOI 10.1002/smll.200900078; Baum DA, 2008, CELL MOL LIFE SCI, V65, P2156, DOI 10.1007/s00018-008-8029-y; Bois JS, 2005, NUCLEIC ACIDS RES, V33, P4090, DOI 10.1093/nar/gki721; Bonaccio M, 2004, NUCLEIC ACIDS RES, V32, P916, DOI 10.1093/nar/gkh250; Bonnet G, 1998, P NATL ACAD SCI USA, V95, P8602, DOI 10.1073/pnas.95.15.8602; BREAKER RR, 1995, CHEM BIOL, V2, P655, DOI 10.1016/1074-5521(95)90028-4; Brown CW, 2014, ANGEW CHEM INT EDIT, V53, P7183, DOI 10.1002/anie.201402691; Brown CW, 2014, CHEMBIOCHEM, V15, P950, DOI 10.1002/cbic.201400047; Cairns MJ, 2000, ANTISENSE NUCLEIC A, V10, P323, DOI 10.1089/oli.1.2000.10.323; Chandra M, 2009, NAT CHEM BIOL, V5, P718, DOI 10.1038/nchembio.201; CUENOUD B, 1995, NATURE, V375, P611, DOI 10.1038/375611a0; Dass CR, 2002, ANTISENSE NUCLEIC A, V12, P289, DOI 10.1089/108729002761381276; Dirks RM, 2003, J COMPUT CHEM, V24, P1664, DOI 10.1002/jcc.10296; Dirks RM, 2007, SIAM REV, V49, P65, DOI 10.1137/060651100; Eckhoff G., 2010, J SYST CHEM, V1, P13, DOI DOI 10.1186/1759-2208-1-13; Elbaz J, 2012, NANO LETT, V12, P6049, DOI 10.1021/nl300051g; Elbaz J, 2010, NAT NANOTECHNOL, V5, P417, DOI [10.1038/NNANO.2010.88, 10.1038/nnano.2010.88]; Elbaz J, 2009, CHEM-EUR J, V15, P3411, DOI 10.1002/chem.200802004; Emilsson GM, 2003, RNA, V9, P907, DOI 10.1261/rna.5680603; Fanning Leigh M, 2011, P 2 ACM C BIOINF COM, p404 ; Fanning ML, 2014, THESIS U NEW MEXICO; Flynn-Charlebois A, 2003, J AM CHEM SOC, V125, P5346, DOI 10.1021/ja0340331; Flynn-Charlebois A, 2003, J AM CHEM SOC, V125, P2444, DOI 10.1021/ja028774y; Gerasimova YV, 2013, CHEMBIOCHEM, V14, P2087, DOI 10.1002/cbic.201300471; Gu HZ, 2013, J AM CHEM SOC, V135, P9121, DOI 10.1021/ja403585e; Gu HZ, 2010, NATURE, V465, P202, DOI 10.1038/nature09026; Han DR, 2011, SCIENCE, V332, P342, DOI 10.1126/science.1202998; Katz E., 2012, BIOMOLECULAR INFORM; Katz E, 2012, ANAL CHEM, V84, P5463, DOI 10.1021/ac3007076; Katz E, 2010, CHEM SOC REV, V39, P1835, DOI 10.1039/b806038j; Ke YG, 2012, SCIENCE, V338, P1177, DOI 10.1126/science.1227268; Lakin MR, 2012, J R SOC INTERFACE, V9, P1470, DOI 10.1098/rsif.2011.0800; Lakin MR, 2012, J R SOC INTERFACE, V9, P470, DOI 10.1098/rsif.2011.0343; Lederman H, 2006, BIOCHEMISTRY-US, V45, P1194, DOI 10.1021/bi051871u; Lee CS, 2011, NUCLEIC ACIDS RES, V39, P269, DOI 10.1093/nar/gkq753; Li J, 2000, NUCLEIC ACIDS RES, V28, P481, DOI 10.1093/nar/28.2.481; Li YF, 1999, CURR OPIN STRUC BIOL, V9, P315, DOI 10.1016/S0959-440X(99)80042-6; Li YF, 1999, P NATL ACAD SCI USA, V96, P2746, DOI 10.1073/pnas.96.6.2746; Lu CH, 2012, J AM CHEM SOC, V134, P10651, DOI 10.1021/ja3037838; Lund K, 2010, NATURE, V465, P206, DOI 10.1038/nature09012; Macdonald J, 2006, NANO LETT, V6, P2598, DOI 10.1021/nl0620864; Martin CH, 2009, CHEM BIOL, V16, P277, DOI 10.1016/j.chembiol.2009.01.010; Ouldridge TE, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3552946; Parker DJ, 2013, J AM CHEM SOC, V135, P8472, DOI 10.1021/ja4032488; Pei R, 2006, J AM CHEM SOC, V128, P12693, DOI 10.1021/ja058394n; Pei RJ, 2010, NAT NANOTECHNOL, V5, P773, DOI [10.1038/nnano.2010.194, 10.1038/NNANO.2010.194]; Purtha WE, 2005, J AM CHEM SOC, V127, P13124, DOI 10.1021/ja0533702; Qian L, 2011, J R SOC INTERFACE, V8, P1281, DOI 10.1098/rsif.2010.0729; Qian L, 2011, NATURE, V475, P368, DOI 10.1038/nature10262; Rothemund PWK, 2004, PLOS BIOL, V2, P2041, DOI 10.1371/journal.pbio.0020424; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; Schlosser K, 2010, CHEMBIOCHEM, V11, P866, DOI 10.1002/cbic.200900786; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; Srinivas N, 2013, NUCLEIC ACIDS RES, V41, P10641, DOI 10.1093/nar/gkt801; Stojanovic MN, 2002, J AM CHEM SOC, V124, P3555, DOI 10.1021/ja016756v; Stojanovic MN, 2003, J SERB CHEM SOC, V68, P321, DOI 10.2298/JSC0305321S; Stojanovic MN, 2003, J AM CHEM SOC, V125, P6673, DOI 10.1021/ja0296632; Stojanovic MN, 2003, NAT BIOTECHNOL, V21, P1069, DOI 10.1038/nbt862; Sulc P, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4754132; Tian C, 2014, LANGMUIR, V30, P5859, DOI 10.1021/la402326b; Walsh SM, 2013, J AM CHEM SOC, V135, P14928, DOI 10.1021/ja407586u; Wang FA, 2012, J AM CHEM SOC, V134, P5504, DOI 10.1021/ja300616w; Wang FA, 2011, ANGEW CHEM INT EDIT, V50, P295, DOI 10.1002/anie.201005246; Wang YM, 2005, ANGEW CHEM INT EDIT, V44, P5863, DOI 10.1002/anie.200501643; Wei B, 2012, NATURE, V485, P623, DOI 10.1038/nature11075; Willner I, 2008, CHEM SOC REV, V37, P1153, DOI 10.1039/b718428j; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Woo S, 2011, NAT CHEM, V3, P620, DOI [10.1038/NCHEM.1070, 10.1038/nchem.1070]; Xiao Y, 2012, NUCLEIC ACIDS RES, V40, P1778, DOI 10.1093/nar/gkr860; Yin P, 2004, ANGEW CHEM INT EDIT, V43, P4906, DOI 10.1002/anie.200460522; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; Zadeh JN, 2011, J COMPUT CHEM, V32, P439, DOI 10.1002/jcc.21633; Zadeh JN, 2011, J COMPUT CHEM, V32, P170, DOI 10.1002/jcc.21596; Zhang DY, 2008, J AM CHEM SOC, V130, P13921, DOI 10.1021/ja803318t; Zhang DY, 2007, SCIENCE, V318, P1121, DOI 10.1126/science.1148532; Zhang DY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2965; Zhang DY, 2011, NAT CHEM, V3, P103, DOI [10.1038/nchem.957, 10.1038/NCHEM.957]; Zhang DY, 2009, J AM CHEM SOC, V131, P17303, DOI 10.1021/ja906987s; Zhou J, 2009, J PHYS CHEM B, V113, P16065, DOI 10.1021/jp9079052	80	6	6	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e110986	10.1371/journal.pone.0110986	http://dx.doi.org/10.1371/journal.pone.0110986			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347066	Green Published, gold, Green Submitted			2022-12-27	WOS:000347994900037
J	Choong, ML; Tan, SH; Tan, TZ; Manesh, S; Ngo, A; Yong, JWY; Yang, HH; Lee, MA				Choong, Meng Ling; Tan, Shan Ho; Tan, Tuan Zea; Manesh, Sravanthy; Ngo, Anna; Yong, Jacklyn W. Y.; Yang, Henry He; Lee, May Ann			Molecular Integrative Clustering of Asian Gastric Cell Lines Revealed Two Distinct Chemosensitivity Clusters	PLOS ONE			English	Article							GENE-EXPRESSION; KINASE 1; CANCER; INHIBITION; CARCINOMA; PROTEIN; INACTIVATION; BORTEZOMIB; SIGNATURES; PATTERNS	Cell lines recapitulate cancer heterogeneity without the presence of interfering tissue found in primary tumor. Their heterogeneous characteristics are reflected in their multiple genetic abnormalities and variable responsiveness to drug treatments. In order to understand the heterogeneity observed in Asian gastric cancers, we have performed array comparative genomic hybridization (aCGH) on 18 Asian gastric cell lines. Hierarchical clustering and single-sample Gene Set Enrichment Analysis were performed on the aCGH data together with public gene expression data of the same cell lines obtained from the Cancer Cell Line Encyclopedia. We found a large amount of genetic aberrations, with some cell lines having 13 fold more aberrations than others. Frequently mutated genes and cellular pathways are identified in these Asian gastric cell lines. The combined analyses of aCGH and expression data demonstrate correlation of gene copy number variations and expression profiles in human gastric cancer cells. The gastric cell lines can be grouped into 2 integrative clusters (ICs). Gastric cells in IC1 are enriched with gene associated with mitochondrial activities and oxidative phosphorylation while cells in IC2 are enriched with genes associated with cell signaling and transcription regulations. The two clusters of cell lines were shown to have distinct responsiveness towards several chemotherapeutics agents such as PI3 K and proteosome inhibitors. Our molecular integrative clustering provides insight into critical genes and pathways that may be responsible for the differences in survival in response to chemotherapy.	[Choong, Meng Ling; Tan, Shan Ho; Manesh, Sravanthy; Ngo, Anna; Yong, Jacklyn W. Y.; Lee, May Ann] Agcy Sci Technol & Res, Ctr Expt Therapeut, Singapore, Singapore; [Tan, Tuan Zea; Yang, Henry He] Natl Univ Singapore, Canc Sci Inst Singapore, Bioinformat Core, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Experimental Drug Development Centre (EDDC); Experimental Therapeutics Centre; National University of Singapore	Lee, MA (corresponding author), Agcy Sci Technol & Res, Ctr Expt Therapeut, Singapore, Singapore.	malee@etc.a-star.edu.sg	Tan, Tuan Zea/I-9227-2019	Tan, Tuan Zea/0000-0001-6624-1593; Choong, Meng Ling/0000-0002-1818-1597				Acland A, 2014, NUCLEIC ACIDS RES, V42, pD7, DOI 10.1093/nar/gkt1146; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Boussioutas A, 2003, CANCER RES, V63, P2569; Chen X, 2003, MOL BIOL CELL, V14, P3208, DOI 10.1091/mbc.E02-12-0833; Cheng XX, 2005, CLIN EXP METASTAS, V22, P85, DOI 10.1007/s10585-005-4578-8; Dicken BJ, 2005, ANN SURG, V241, P27, DOI 10.1097/01.sla.0000149300.28588.23; Fan BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029824; Gao M, 2013, ASIAN PAC J TROP MED, V6, P260, DOI 10.1016/S1995-7645(13)60054-1; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gough DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083395; Hitosugi T, 2011, MOL CELL, V44, P864, DOI 10.1016/j.molcel.2011.10.015; Hoshida Y, 2010, SEMIN LIVER DIS, V30, P35, DOI 10.1055/s-0030-1247131; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Kaji T, 2010, BIOCHEM BIOPH RES CO, V395, P213, DOI 10.1016/j.bbrc.2010.03.164; Kim B, 2003, CANCER RES, V63, P8248; Kim HE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043223; KITADAI Y, 1993, CELL GROWTH DIFFER, V4, P291; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X; Li LH, 2012, ONCOL REP, V27, P1435, DOI 10.3892/or.2012.1664; Li QY, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0793-3; Ling YH, 2003, J BIOL CHEM, V278, P33714, DOI 10.1074/jbc.M302559200; Macdonald JS, 2009, J CLIN ONCOL, V27; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mao P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081803; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Philchenkov A, 2004, EXP ONCOL, V26, P82; Porta C, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00064; Rao R, 2010, CLIN CANCER RES, V16, P4742, DOI 10.1158/1078-0432.CCR-10-0529; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Siegelin MD, 2013, CANCER LETT, V333, P133, DOI 10.1016/j.canlet.2013.01.045; Singapore Cancer Registry, 2011, CANC SURV SING 1968; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-659; Tan IB, 2011, GASTROENTEROLOGY, V141, P476, DOI 10.1053/j.gastro.2011.04.042; Tay ST, 2003, CANCER RES, V63, P3309; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Verhaak RGW, 2013, J CLIN INVEST, V123, P517, DOI 10.1172/JCI65833; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170; Wu WKK, 2010, CANCER LETT, V295, P144, DOI 10.1016/j.canlet.2010.04.025; Ye B, 2012, INT J IMMUNOPATH PH, V25, P627, DOI 10.1177/039463201202500309	43	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111146	10.1371/journal.pone.0111146	http://dx.doi.org/10.1371/journal.pone.0111146			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343454	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943500082
J	Ito, M; Hayashi, K; Adachi, E; Minamisawa, T; Homma, S; Koido, S; Shiba, K				Ito, Masaki; Hayashi, Kazumi; Adachi, Eru; Minamisawa, Tamiko; Homma, Sadamu; Koido, Shigeo; Shiba, Kiyotaka			Combinatorial Contextualization of Peptidic Epitopes for Enhanced Cellular Immunity	PLOS ONE			English	Article							MHC CLASS-I; DENDRITIC CELLS; CROSS-PRESENTATION; ARTIFICIAL PROTEINS; VACCINE; ANTIGEN; VIVO; ENDOTOXIN; INTERLEUKIN-2; ACTIVATION	Invocation of cellular immunity by epitopic peptides remains largely dependent on empirically developed protocols, such as interfusion of aluminum salts or emulsification using terpenoids and surfactants. To explore novel vaccine formulation, epitopic peptide motifs were co-programmed with structural motifs to produce artificial antigens using our "motif-programming'' approach. As a proof of concept, we used an ovalbumin (OVA) system and prepared an artificial protein library by combinatorially polymerizing MHC class I and II sequences from OVA along with a sequence that tends to form secondary structures. The purified endotoxin-free proteins were then examined for their ability to activate OVA-specific T-cell hybridoma cells after being processed within dendritic cells. One clone, F37A (containing three MHC I and two MHC II OVA epitopes), possessed a greater ability to evoke cellular immunity than the native OVA or the other artificial antigens. The sensitivity profiles of drugs that interfered with the F37A uptake differed from those of the other artificial proteins and OVA, suggesting that alteration of the cross-presentation pathway is responsible for the enhanced immunogenicity. Moreover, F37A, but not an epitopic peptide, invoked cellular immunity when injected together with monophosphoryl lipid A (MPL), and retarded tumor growth in mice. Thus, an artificially synthesized protein antigen induced cellular immunity in vivo in the absence of incomplete Freund's adjuvant or aluminum salts. The method described here could be potentially used for developing vaccines for such intractable ailments as AIDS, malaria and cancer, ailments in which cellular immunity likely play a crucial role in prevention and treatment.	[Ito, Masaki; Hayashi, Kazumi; Homma, Sadamu] Jikei Univ, Sch Med, Dept Oncol, Tokyo, Japan; [Ito, Masaki; Adachi, Eru; Minamisawa, Tamiko; Shiba, Kiyotaka] Japanese Fdn Canc Res, Inst Canc, Div Prot Engn, Tokyo 170, Japan; [Koido, Shigeo] Jikei Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan	Jikei University; Japanese Foundation for Cancer Research; Jikei University	Ito, M (corresponding author), Jikei Univ, Sch Med, Dept Oncol, Tokyo, Japan.	mito@jikei.ac.jp; kshiba@jfcr.or.jp	Shiba, Kiyotaka/I-9588-2014	Shiba, Kiyotaka/0000-0001-6459-0204	JST A-STEP [AS221Z01237G]; Jikei University Research Fund;  [22650231];  [12936891]; Grants-in-Aid for Scientific Research [26430172] Funding Source: KAKEN	JST A-STEP; Jikei University Research Fund(Jikei University); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Grant-in Aid for Exploratory Research # 22650231 (MI), JST A-STEP #AS221Z01237G (MI), The Jikei University Research Fund (MI), and Grant-in-Aid for Scientific Research (A) # 12936891 (KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accapezzato D, 2005, J EXP MED, V202, P817, DOI 10.1084/jem.20051106; AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Awate S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00114; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Billiau A, 2001, J LEUKOCYTE BIOL, V70, P849; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Casella CR, 2008, CELL MOL LIFE SCI, V65, P3231, DOI 10.1007/s00018-008-8228-6; Dubensky TW, 2010, SEMIN IMMUNOL, V22, P155, DOI 10.1016/j.smim.2010.04.007; EROSHKIN AM, 1995, PROTEIN ENG, V8, P167, DOI 10.1093/protein/8.2.167; Fox CB, 2009, MOLECULES, V14, P3286, DOI 10.3390/molecules14093286; Garulli B, 2008, CLIN VACCINE IMMUNOL, V15, P1497, DOI 10.1128/CVI.00166-08; GRANT EP, 1992, J IMMUNOL, V148, P13; Hailemichael Y, 2013, NAT MED, V19, P465, DOI 10.1038/nm.3105; Jackson DC, 2004, P NATL ACAD SCI USA, V101, P15440, DOI 10.1073/pnas.0406740101; Jin JO, 2009, BLOOD, V113, P5839, DOI 10.1182/blood-2008-10-184796; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; Kjerrulf M, 1997, MOL IMMUNOL, V34, P599, DOI 10.1016/S0161-5890(97)00078-3; Koff WC, 2013, SCIENCE, V340, DOI 10.1126/science.1232910; Lai YP, 2011, ISRN IMMUNOLOGY, V2011, P1, DOI DOI 10.1166/JNAN.2011.1007; Lechmann M, 2002, TRENDS IMMUNOL, V23, P273, DOI 10.1016/S1471-4906(02)02214-7; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; Murshid A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00063; Palena C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/380697; Reichelt P, 2006, PROTEIN EXPRES PURIF, V46, P483, DOI 10.1016/j.pep.2005.09.027; Rock KL, 2010, J IMMUNOL, V184, P9, DOI 10.4049/jimmunol.0903399; Rock KL, 2005, IMMUNOL REV, V207, P166, DOI 10.1111/j.0105-2896.2005.00301.x; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Rosenberg SA, 2010, J IMMUNOTHER, V33, P626, DOI 10.1097/CJI.0b013e3181dac9de; Saito H, 2004, CHEM BIOL, V11, P765, DOI 10.1016/j.chembiol.2004.03.032; Saito H, 2008, CANCER SCI, V99, P398, DOI 10.1111/j.1349-7006.2007.00697.x; Schwartzentruber DJ, 2011, NEW ENGL J MED, V364, P2119, DOI 10.1056/NEJMoa1012863; Shanmugam A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030839; Shen ZH, 1997, J IMMUNOL, V158, P2723; Shiba K, 1997, P NATL ACAD SCI USA, V94, P3805, DOI 10.1073/pnas.94.8.3805; Shiba K, 2004, J MOL CATAL B-ENZYM, V28, P145, DOI 10.1016/j.molcatb.2003.12.027; Shiba K, 2002, J MOL BIOL, V320, P833, DOI 10.1016/S0022-2836(02)00567-3; Toes REM, 1996, P NATL ACAD SCI USA, V93, P7855, DOI 10.1073/pnas.93.15.7855; Tsuji T, 2008, P NATL ACAD SCI USA, V105, P16866, DOI 10.1073/pnas.0804277105	40	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110425	10.1371/journal.pone.0110425	http://dx.doi.org/10.1371/journal.pone.0110425			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343355	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943500033
J	Koblinger, K; Fuzesi, T; Ejdrygiewicz, J; Krajacic, A; Bains, JS; Whelan, PJ				Koblinger, Kathrin; Fuezesi, Tamas; Ejdrygiewicz, Jillian; Krajacic, Aleksandra; Bains, Jaideep S.; Whelan, Patrick J.			Characterization of A11 Neurons Projecting to the Spinal Cord of Mice	PLOS ONE			English	Article							AMINO-ACID DECARBOXYLASE; DIENCEPHALIC DOPAMINE NEURONS; CENTRAL-NERVOUS-SYSTEM; RESTLESS LEGS SYNDROME; RAT DORSAL-HORN; IMMUNOCYTOCHEMICAL LOCALIZATION; TYROSINE-HYDROXYLASE; DEPENDENT MODULATION; RENSHAW CELLS; ACTIVATION	The hypothalamic A11 region has been identified in several species including rats, mice, cats, monkeys, zebrafish, and humans as the primary source of descending dopamine (DA) to the spinal cord. It has been implicated in the control of pain, modulation of the spinal locomotor network, restless leg syndrome, and cataplexy, yet the A11 cell group remains an understudied dopaminergic (DAergic) nucleus within the brain. It is unclear whether A11 neurons in the mouse contain the full complement of enzymes consistent with traditional DA neuronal phenotypes. Given the abundance of mouse genetic models and tools available to interrogate specific neural circuits and behavior, it is critical first to fully understand the phenotype of A11 cells. We provide evidence that, in addition to tyrosine hydroxylase (TH) that synthesizes L-DOPA, neurons within the A11 region of the mouse contain aromatic L-amino acid decarboxylase (AADC), the enzyme that converts L-DOPA to dopamine. Furthermore, we show that the A11 neurons contain vesicular monoamine transporter 2 (VMAT2), which is necessary for packaging DA into vesicles. On the contrary, A11 neurons in the mouse lack the dopamine transporter (DAT). In conclusion, our data suggest that A11 neurons are DAergic. The lack of DAT, and therefore the lack of a DA reuptake mechanism, points to a longer time of action compared to typical DA neurons.	[Koblinger, Kathrin; Fuezesi, Tamas; Ejdrygiewicz, Jillian; Krajacic, Aleksandra; Bains, Jaideep S.; Whelan, Patrick J.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Bains, Jaideep S.; Whelan, Patrick J.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Ejdrygiewicz, Jillian; Krajacic, Aleksandra; Whelan, Patrick J.] Univ Calgary, Dept Comparat Biol & Expt Med, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary	Whelan, PJ (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada.	whelan@ucalgary.ca		Whelan, Patrick/0000-0002-1234-5415; Bains, Jaideep/0000-0002-3634-6463	Canadian Institutes of Health Research [MOP-130528]; Alberta Innovates [201100359] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates	This study was supported by the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca) MOP-130528. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDOYAMAMOTO M, 1987, J BIOCHEM-TOKYO, V101, P405, DOI 10.1093/oxfordjournals.jbchem.a121925; Barraud Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013306; Barriere G, 2004, EUR J NEUROSCI, V19, P1325, DOI 10.1111/j.1460-9568.2004.03210.x; BJORKLUND A, 1979, BRAIN RES, V177, P170, DOI 10.1016/0006-8993(79)90927-2; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P185, DOI 10.1016/j.tins.2007.03.004; BLESSING WW, 1979, NEUROSCI LETT, V11, P35, DOI 10.1016/0304-3940(79)90052-1; Borgkvist A, 2012, INT J NEUROPSYCHOPH, V15, P531, DOI 10.1017/S1461145711000812; Charbit AR, 2009, J NEUROSCI, V29, P12532, DOI 10.1523/JNEUROSCI.2887-09.2009; Christie KJ, 2005, J NEUROPHYSIOL, V94, P1554, DOI 10.1152/jn.00299.2005; Ciliax BJ, 1999, J COMP NEUROL, V409, P38, DOI 10.1002/(SICI)1096-9861(19990621)409:1<38::AID-CNE4>3.0.CO;2-1; CILIAX BJ, 1995, J NEUROSCI, V15, P1714, DOI 10.1523/JNEUROSCI.15-03-01714.1995; Clemens S, 2004, J NEUROSCI, V24, P11337, DOI 10.1523/JNEUROSCI.3698-04.2004; Clemens S, 2012, J NEUROPHYSIOL, V107, P2250, DOI 10.1152/jn.00366.2011; Clemens S, 2006, NEUROLOGY, V67, P125, DOI 10.1212/01.wnl.0000223316.53428.c9; DAHLSTROM A, 1964, ACTA PHYSIOL SCAND, V62, P1; Feenstra MGP, 2002, NEUROPHARMACOLOGY, V42, P752, DOI 10.1016/S0028-3908(02)00029-1; FLEETWOODWALKER SM, 1988, J PHYSIOL-LONDON, V399, P335; Ford CP, 2014, NEUROSCIENCE, V282, P13, DOI 10.1016/j.neuroscience.2014.01.025; Fuxe K, 2010, PROG NEUROBIOL, V90, P82, DOI 10.1016/j.pneurobio.2009.10.012; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; Gerin C, 1998, BRAIN RES, V794, P169, DOI 10.1016/S0006-8993(98)00278-9; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Gordon IT, 2006, J NEUROPHYSIOL, V96, P3122, DOI 10.1152/jn.00606.2006; Gozal EA, 2008, EFFECTS TRACE AMINES; Han P, 2009, NEUROSCIENCE, V158, P1699, DOI 10.1016/j.neuroscience.2008.11.040; HOKFELT T, 1979, ACTA PHYSIOL SCAND, V107, P393, DOI 10.1111/j.1748-1716.1979.tb06491.x; Howland JG, 2002, J NEUROSCI, V22, P1137, DOI 10.1523/JNEUROSCI.22-03-01137.2002; Humphreys JM, 2012, J NEUROPHYSIOL, V108, P3370, DOI 10.1152/jn.00482.2012; JAEGER CB, 1983, SCIENCE, V219, P1233, DOI 10.1126/science.6131537; Jiang ZY, 1999, BRAIN RES, V816, P493, DOI 10.1016/S0006-8993(98)01199-8; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; Kagan R, 2013, NEUROSCIENCE, V248, P359, DOI 10.1016/j.neuroscience.2013.06.014; Karasawa N, 2007, ACTA HISTOCHEM CYTOC, V40, P83, DOI 10.1267/ahc.06019; Kawano M, 2006, J COMP NEUROL, V498, P581, DOI 10.1002/cne.21054; Kiehn O, 1996, J NEUROPHYSIOL, V75, P1472, DOI 10.1152/jn.1996.75.4.1472; Koblinger K, 2012, CHARACTERIZATION ALL; KOMORI K, 1992, NEUROSCI LETT, V147, P197, DOI 10.1016/0304-3940(92)90594-W; Lambert AM, 2012, J NEUROSCI, V32, P13488, DOI 10.1523/JNEUROSCI.1638-12.2012; Lapointe NP, 2009, J PHYSIOL-LONDON, V587, P1499, DOI 10.1113/jphysiol.2008.166314; LINDVALL O, 1983, ANN NEUROL, V14, P255, DOI 10.1002/ana.410140302; LORANG D, 1994, J NEUROSCI, V14, P4903; Madriaga MA, 2004, J NEUROPHYSIOL, V92, P1566, DOI 10.1152/jn.01181.2003; MAITRA KK, 1993, ACTA PHYSIOL SCAND, V148, P101, DOI 10.1111/j.1748-1716.1993.tb09538.x; McCrea AE, 1997, DEV BRAIN RES, V100, P130, DOI 10.1016/S0165-3806(97)00027-8; Moron JA, 2002, J NEUROSCI, V22, P389, DOI 10.1523/JNEUROSCI.22-02-00389.2002; Pappas SS, 2008, BRAIN RES, V1214, P1, DOI 10.1016/j.brainres.2008.03.010; Pappas SS, 2011, NEUROPHARMACOLOGY, V61, P614, DOI 10.1016/j.neuropharm.2011.05.002; Pappas SS, 2010, J COMP NEUROL, V518, P2423, DOI 10.1002/cne.22340; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Peyron C, 1995, NEUROREPORT, V6, P2527, DOI 10.1097/00001756-199512150-00019; Qu S, 2006, EXP BRAIN RES, V168, P152, DOI 10.1007/s00221-005-0075-1; RIDET JL, 1993, NEUROSCIENCE, V52, P143, DOI 10.1016/0306-4522(93)90189-M; RIDET JL, 1994, J NEUROSCI RES, V38, P109, DOI 10.1002/jnr.490380114; Ridet JL, 2000, TRENDS NEUROSCI, V23, P58, DOI 10.1016/S0166-2236(99)01523-4; SETH P, 1993, NEUROSCI LETT, V158, P217, DOI 10.1016/0304-3940(93)90268-P; SICKLES AE, 1992, DEV BRAIN RES, V68, P17, DOI 10.1016/0165-3806(92)90243-P; SKAGERBERG G, 1985, BRAIN RES, V342, P340, DOI 10.1016/0006-8993(85)91134-5; SKAGERBERG G, 1982, BRAIN RES BULL, V9, P237, DOI 10.1016/0361-9230(82)90136-8; Thorpe AJ, 2011, EUR NEUROL, V66, P18, DOI 10.1159/000328431; Ugrumov MV, 2009, J CHEM NEUROANAT, V38, P241, DOI 10.1016/j.jchemneu.2009.08.004; Whelan P, 2000, J NEUROPHYSIOL, V84, P2821, DOI 10.1152/jn.2000.84.6.2821	62	66	66	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e109636	10.1371/journal.pone.0109636	http://dx.doi.org/10.1371/journal.pone.0109636			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343491	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943500018
J	Soma, T; Hayashi, R; Sugiyama, H; Tsujikawa, M; Kanayama, S; Oie, Y; Nishida, K				Soma, Takeshi; Hayashi, Ryuhei; Sugiyama, Hiroaki; Tsujikawa, Motokazu; Kanayama, Shintaro; Oie, Yoshinori; Nishida, Kohji			Maintenance and Distribution of Epithelial Stem/Progenitor Cells after Corneal Reconstruction Using Oral Mucosal Epithelial Cell Sheets	PLOS ONE			English	Article							OCULAR SURFACE DISORDERS; STEM-CELLS; ENDOTHELIAL-CELLS; PROGENITOR CELLS; SELF-RENEWAL; LIMBAL; TRANSPLANTATION; DIFFERENTIATION; DEFICIENCY; EXPRESSION	We assessed the maintenance and distribution of epithelial stem/progenitor cells after corneal reconstruction using tissue-engineered oral mucosal cell sheets in a rat model. Oral mucosal biopsy specimens were excised from green fluorescent protein (GFP) rats and enzymatically treated with Dispase II. These cells were cultured on inserts with mitomycin C-treated NIH/3T3 cells, and the resulting cell sheets were harvested. These tissue-engineered cell sheets from GFP rats were transplanted onto the eyes of a nude rat limbal stem cell deficiency model. Eight weeks after surgery, ocular surfaces were completely covered by the epithelium with GFP-positive cells. Transplanted corneas expressed p63 in the basal layers and K14 in all epithelial layers. Epithelial cells harvested from the central and peripheral areas of reconstructed corneas were isolated for a colony-forming assay, which showed that the colony-forming efficiency of the peripheral epithelial cells was significantly higher than that of the central epithelial cells 8 weeks after corneal reconstruction. Thus, in this rat model, the peripheral cornea could maintain more stem/progenitor cells than the central cornea after corneal reconstruction using oral mucosal epithelial cell sheets.	[Soma, Takeshi; Hayashi, Ryuhei; Sugiyama, Hiroaki; Tsujikawa, Motokazu; Kanayama, Shintaro; Oie, Yoshinori; Nishida, Kohji] Osaka Univ, Grad Sch Med, Dept Ophthalmol, Suita, Osaka, Japan	Osaka University	Nishida, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Ophthalmol, Suita, Osaka, Japan.	knishida@ophthal.med.osaka-u.ac.jp	Hayashi, Ryuhei/AAW-4737-2020	Nishida, Kohji/0000-0001-9069-3610; Hayashi, Ryuhei/0000-0002-4699-8617	High-Tech Research Center Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan [16300161]; Center of Excellence Program for the 21st Century from the Ministry of Education, Culture, Sports, Science, and Technology of Japan [16300161]; JSPS KAKENHI Grant [15390530]	High-Tech Research Center Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Center of Excellence Program for the 21st Century from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the High-Tech Research Center Program and the Center of Excellence Program for the 21st Century from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (16300161; http://www.mext.go.jp/a_menu/koutou/coe/main6_a3.htm), and JSPS KAKENHI Grant (15390530; http://kaken.nii.ac.jp/d/p/15390530/2003/3/ja.ja.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen HCJ, 2009, INVEST OPHTH VIS SCI, V50, P4660, DOI 10.1167/iovs.09-3377; Chen WS, 2007, EXP EYE RES, V84, P626, DOI 10.1016/j.exer.2006.11.006; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Ilari L, 2002, OPHTHALMOLOGY, V109, P1278, DOI 10.1016/S0161-6420(02)01081-3; Inatomi T, 2006, AM J OPHTHALMOL, V141, P267, DOI 10.1016/j.ajo.2005.09.003; Kanayama S, 2007, EXP EYE RES, V85, P772, DOI 10.1016/j.exer.2007.08.011; Kobayashi H, 2010, NAT CELL BIOL, V12, P1046, DOI 10.1038/ncb2108; Lane SW, 2009, BLOOD, V114, P1150, DOI 10.1182/blood-2009-01-202606; Li GG, 2012, INVEST OPHTH VIS SCI, V53, P3357, DOI 10.1167/iovs.11-9414; Nakamura T, 2004, BRIT J OPHTHALMOL, V88, P1280, DOI 10.1136/bjo.2003.038497; Nakamura T, 2007, OPHTHALMOLOGY, V114, P1080, DOI 10.1016/j.ophtha.2006.09.034; Nakamura T, 2011, BRIT J OPHTHALMOL, V95, P942, DOI 10.1136/bjo.2010.188714; Nishida K, 2004, TRANSPLANTATION, V77, P379, DOI 10.1097/01.TP.0000110320.45678.30; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Samson CM, 2002, OPHTHALMOLOGY, V109, P862, DOI 10.1016/S0161-6420(02)00994-6; Santos MS, 2005, AM J OPHTHALMOL, V140, P223, DOI 10.1016/j.ajo.2005.03.022; Satake Y, 2011, OPHTHALMOLOGY, V118, P1524, DOI 10.1016/j.ophtha.2011.01.039; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; Sekiyama E, 2006, EXP EYE RES, V83, P741, DOI 10.1016/j.exer.2006.02.015; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; THOFT RA, 1983, INVEST OPHTH VIS SCI, V24, P1442; TSAI RJF, 1990, OPHTHALMOLOGY, V97, P446, DOI 10.1016/S0161-6420(90)32575-7; TSENG SCG, 1989, EYE, V3, P141, DOI 10.1038/eye.1989.22	27	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110987	10.1371/journal.pone.0110987	http://dx.doi.org/10.1371/journal.pone.0110987			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343456	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943500070
J	Magnusdottir, OK; Landberg, R; Gunnarsdottir, I; Cloetens, L; Akesson, B; Rosqvist, F; Schwab, U; Herzig, KH; Hukkanen, J; Savolainen, MJ; Brader, L; Hermansen, K; Kolehmainen, M; Poutanen, K; Uusitupa, M; Riserus, U; Thorsdottir, I				Magnusdottir, Ola Kally; Landberg, Rikard; Gunnarsdottir, Ingibjorg; Cloetens, Lieselotte; Akesson, Bjorn; Rosqvist, Fredrik; Schwab, Ursula; Herzig, Karl-Heinz; Hukkanen, Janne; Savolainen, Markku J.; Brader, Lea; Hermansen, Kjeld; Kolehmainen, Marjukka; Poutanen, Kaisa; Uusitupa, Matti; Riserus, Ulf; Thorsdottir, Inga			Whole Grain Rye Intake, Reflected by a Biomarker, Is Associated with Favorable Blood Lipid Outcomes in Subjects with the Metabolic Syndrome - A Randomized Study	PLOS ONE			English	Article							INSULIN SENSITIVITY; PLASMA ALKYLRESORCINOLS; CARDIOVASCULAR-DISEASE; LDL CHOLESTEROL; BREAD; WHEAT; FIBER; GLUCOSE; MARKERS; PRESSURE	Background and Aim: Few studies have explored the possible plasma cholesterol lowering effects of rye consumption. The aim of this secondary analysis in the SYSDIET study was to investigate the association between plasma alkylresorcinols (AR), a biomarker for whole grain wheat and rye intake, and blood lipid concentrations in a population with metabolic syndrome. Furthermore, we analyzed the associations between the AR C17:0/C21:0 ratio, a suggested marker of the relative intake of whole grain/bran rye, and blood lipid concentrations. Methods: Participants were 30-65 years of age, with body mass index (BMI) 27-40 kg/m(2) and had metabolic syndrome. Individuals were recruited through six centers in the Nordic countries and randomized either to a healthy Nordic diet (ND, n = 93), rich in whole grain rye and wheat, as well as berries, fruits and vegetables, rapeseed oil, three fish meals per week and low-fat dairy products, or a control diet (n = 65) for 18/24 weeks. Associations between total plasma AR concentration and C17:0/C21:0 homologue ratio and blood lipids were investigated in pooled (ND + control group) regression analyses at 18/24 weeks adjusted for baseline value for the dependent variable, age, BMI and statin use. Results: When adjusted for confounders, total plasma AR at 18/24 weeks was not significantly associated with blood lipids but the AR ratio C17:0/C21:0 was inversely associated with LDL cholesterol concentrations (B (95% Cl): -0.41 (-0.80 to -0.02)), log LDL/HDL cholesterol ratio (-0.20 (-0.37 to -0.03)), log non-HDL cholesterol (-0.20 (-0.37 to -0.03)), log apolipoprotein B (-0.12 (-0.24 to 0.00)) and log triglyceride concentrations (-0.35 (-0.59 to -0.12)). Discussion: Increased proportion of whole grain rye, reflected by a biomarker, in the diet is associated with favorable blood lipid outcomes, a relationship that should be further investigated.	[Magnusdottir, Ola Kally; Gunnarsdottir, Ingibjorg; Thorsdottir, Inga] Univ Iceland, Landspitali Natl Univ Hosp Iceland, Unit Nutr Res, Reykjavik, Iceland; [Magnusdottir, Ola Kally; Gunnarsdottir, Ingibjorg; Thorsdottir, Inga] Univ Iceland, Sch Hlth Sci, Fac Food Sci & Nutr, Reykjavik, Iceland; [Landberg, Rikard] Swedish Univ Agr Sci, Dept Food Sci, BioCtr, Uppsala, Sweden; [Landberg, Rikard] Karolinska Inst, Inst Environm Med, Div Nutr Epidemiol, S-10401 Stockholm, Sweden; [Cloetens, Lieselotte; Akesson, Bjorn] Lund Univ, Lund, Sweden; [Akesson, Bjorn] Skane Univ Hosp, Dept Clin Nutr, Lund, Sweden; [Rosqvist, Fredrik; Riserus, Ulf] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden; [Schwab, Ursula] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Schwab, Ursula] Kuopio Univ Hosp, Inst Clin Med, SF-70210 Kuopio, Finland; [Herzig, Karl-Heinz] Oulu Univ, Dept Physiol, Inst Biomed, Oulu, Finland; [Herzig, Karl-Heinz] Oulu Univ, Bioctr, Oulu, Finland; [Herzig, Karl-Heinz] Kuopio Univ Hosp, Dept Psychiat, SF-70210 Kuopio, Finland; [Hukkanen, Janne; Savolainen, Markku J.] Univ Oulu, Inst Clin Med, Dept Internal Med, Oulu, Finland; [Hukkanen, Janne; Savolainen, Markku J.] Univ Oulu, Inst Clin Med, Bioctr, Oulu, Finland; [Hukkanen, Janne; Savolainen, Markku J.] Oulu Univ Hosp, Clin Res Ctr, Oulu, Finland; [Brader, Lea; Hermansen, Kjeld] Aarhus Univ Hosp, Dept Endocrinol & Internal Med, DK-8000 Aarhus, Denmark; [Kolehmainen, Marjukka; Poutanen, Kaisa] VTT Tech Res Ctr Finland, Espoo, Finland; [Kolehmainen, Marjukka; Poutanen, Kaisa] VTT Tech Res Ctr Finland, Kuopio, Finland; [Uusitupa, Matti] Kuopio Univ Hosp, Res Unit, SF-70210 Kuopio, Finland	University of Iceland; University of Iceland; Swedish University of Agricultural Sciences; Karolinska Institutet; Lund University; Lund University; Skane University Hospital; Uppsala University; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Oulu; University of Oulu; Kuopio University Hospital; University of Eastern Finland; University of Oulu; University of Oulu; University of Oulu; Aarhus University; VTT Technical Research Center Finland; VTT Technical Research Center Finland; Kuopio University Hospital; University of Eastern Finland	Magnusdottir, OK (corresponding author), Univ Iceland, Landspitali Natl Univ Hosp Iceland, Unit Nutr Res, Reykjavik, Iceland.	olakally@landspitali.is	Uusitupa, Matti Ilmari Julius/AAX-4929-2020; hermansen, kjeld/AAY-4241-2021; Hukkanen, Janne/C-7292-2013; Gunnarsdottir, Ingibjorg/L-9371-2015; Rosqvist, Fredrik/K-8975-2019; Akesson, Bjorn/Q-9163-2017; Thorsdottir, Inga/M-3260-2015	Hukkanen, Janne/0000-0003-4981-0525; Thorsdottir, Inga/0000-0002-2946-287X; Gunnarsdottir, Ingibjorg/0000-0001-9447-8627; Magnusdottir, Ola Kally/0000-0003-4074-7451	NordForsk NCoE in Food Nutrition and Health SYSDIET (Systems biology in controlled dietary interventions and cohort studies) [070014]; Academy of Finland; Finnish Diabetes Research Foundation; Finnish Foundation for Cardiovascular Research; Sigrid Juselius Foundation; Kuopio University Hospital (Finland); Druvan Foundation; ESPEN; Skane County Council Research and Development Foundation; Swedish Research Council for Health, Working Life and Welfare; EXODIAB (Excellence of Diabetes Research in Sweden); Heart-Lung Foundation; Diabetesfonden; Foundation Cerealia (Sweden)	NordForsk NCoE in Food Nutrition and Health SYSDIET (Systems biology in controlled dietary interventions and cohort studies); Academy of Finland(Academy of Finland); Finnish Diabetes Research Foundation; Finnish Foundation for Cardiovascular Research; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Kuopio University Hospital (Finland); Druvan Foundation; ESPEN; Skane County Council Research and Development Foundation; Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); EXODIAB (Excellence of Diabetes Research in Sweden); Heart-Lung Foundation(Swedish Heart-Lung Foundation); Diabetesfonden; Foundation Cerealia (Sweden)	The study was supported by NordForsk NCoE in Food Nutrition and Health: Project 070014 SYSDIET (Systems biology in controlled dietary interventions and cohort studies. http://www.nordforsk.org/en?set_language=en. This study was also funded by the Academy of Finland, Finnish Diabetes Research Foundation, Finnish Foundation for Cardiovascular Research, The Sigrid Juselius Foundation, and EVO funding from Kuopio University Hospital (Finland: US, KHH, JH, MJS, MK, KP, MU); the Druvan Foundation, ESPEN, Skane County Council Research and Development Foundation, Swedish Research Council for Health, Working Life and Welfare, EXODIAB (Excellence of Diabetes Research in Sweden), The Heart-Lung Foundation, Diabetesfonden and Foundation Cerealia (Sweden: RL, LC, BA, FR, UR); The Danish Obesity Research Centre (DanORC, www.danorc.dk), The Danish Council for Strategic Research (DairyHealth, BioFunCarb) (Denmark: LB, KH), The Agricultural Productivity Fund (Iceland: IG, OKM, IT) and the Icelandic Research Fund for graduate students (1206880061) http://rannis.is/ (OKM). The following companies provided food products for the study participants: Kesko Food Ltd, Raisio Group, Bunge Finland Ltd (Finland); Belico Food AB, Fazer Bageri Sverige, Lantmannen, Oatly AB, Olle Svensson AB, Procordia Food AB, Pagen AB, Unilever, Wasabrod AB (Sweden); Lantmannen Food R& D, Jan Import A/S,Ardo A/S, Scandic Food A/S, WASA, Glyngore Limfjord A/S, Royal Greenland A/S, Arla Foods (Denmark); The Mother Earth Farm at Vallanes (Iceland); and Unilever Nordic (Sweden, Denmark, Iceland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostoni C, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1885; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Andersson U, 2010, NUTRITION, V26, P230, DOI 10.1016/j.nut.2009.06.007; Behall KM, 2006, J AM DIET ASSOC, V106, P1445, DOI 10.1016/j.jada.2006.06.010; Bresson JL, 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.1254; Chen Y, 2004, J AGR FOOD CHEM, V52, P8242, DOI 10.1021/jf049726v; de Munter JSL, 2007, PLOS MED, V4, P1385, DOI 10.1371/journal.pmed.0040261; Fardet A, 2010, NUTR RES REV, V23, P65, DOI 10.1017/S0954422410000041; Giacco R, 2010, NUTR METAB CARDIOVAS, V20, P186, DOI 10.1016/j.numecd.2009.03.025; Hansen HB, 2003, J SCI FOOD AGR, V83, P76, DOI 10.1002/jsfa.1284; HealthyPeople.gov, 2020, NUTR PHYS ACT; Jenkins DJA, 1999, J AM COLL NUTR, V18, P159, DOI 10.1080/07315724.1999.10718844; Juntunen KS, 2003, AM J CLIN NUTR, V77, P385; Landberg R, 2009, ANAL BIOCHEM, V385, P7, DOI 10.1016/j.ab.2008.10.031; Landberg R, 2008, AM J CLIN NUTR, V87, P832, DOI 10.1093/ajcn/87.4.832; Landberg R, 2009, AM J CLIN NUTR, V89, P290, DOI 10.3945/ajcn.2008.26709; Leinonen K, 1999, EUR J CLIN NUTR, V53, P262, DOI 10.1038/sj.ejcn.1600716; Leinonen KS, 2000, J NUTR, V130, P164, DOI 10.1093/jn/130.2.164; Linko-Parvinen AM, 2007, J NUTR, V137, P1137, DOI 10.1093/jn/137.5.1137; LUND EK, 1993, J NUTR, V123, P1834, DOI 10.1093/jn/123.11.1834; Lundin EA, 2004, EUR J CLIN NUTR, V58, P1410, DOI 10.1038/sj.ejcn.1601985; Ma JT, 2012, J NUTR, V142, P1859, DOI 10.3945/jn.112.163253; Magnusdottir OK, 2014, EUR J CLIN NUTR, V68, P453, DOI 10.1038/ejcn.2014.12; Magnusdottir OK, 2013, J NUTR; Magnusdottir OK, 2014, EUR J CLIN NUTR; McKeown NM, 2002, AM J CLIN NUTR, V76, P390, DOI 10.1093/ajcn/76.2.390; Mellen PB, 2008, NUTR METAB CARDIOVAS, V18, P283, DOI 10.1016/j.numecd.2006.12.008; Moazzami AA, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-88; Montonen J, 2010, EUR J CLIN NUTR, V64, P698, DOI 10.1038/ejcn.2010.71; Othman RA, 2011, NUTR REV, V69, P299, DOI 10.1111/j.1753-4887.2011.00401.x; Pereira MA, 2002, AM J CLIN NUTR, V75, P848, DOI 10.1093/ajcn/75.5.848; Rakha A, 2010, FOOD CHEM, V119, P859, DOI 10.1016/j.foodchem.2009.09.090; Ross AB, 2004, NUTR REV, V62, P81, DOI [10.1111/j.1753-4887.2004.tb00029.x, 10.1301/nr.2004.mar.81-95]; Ross AB, 2003, J AGR FOOD CHEM, V51, P4111, DOI 10.1021/jf0340456; Ross AB, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/462967; Ross AB, 2012, AM J CLIN NUTR, V95, P204, DOI 10.3945/ajcn.110.008508; Ross AB, 2011, BRIT J NUTR, V105, P1492, DOI 10.1017/S0007114510005209; Sahyoun NR, 2006, AM J CLIN NUTR, V83, P124; Slavin JL, 2001, J AM DIET ASSOC, V101, P780, DOI 10.1016/S0002-8223(01)00194-8; Tighe P, 2010, AM J CLIN NUTR, V92, P733, DOI 10.3945/ajcn.2010.29417; Tiwari U, 2011, NUTRITION, V27, P1008, DOI 10.1016/j.nut.2010.11.006; Uusitupa M, 2013, J INTERN MED, V274, P52, DOI 10.1111/joim.12044; Wolever TMS, 2010, AM J CLIN NUTR, V92, P723, DOI 10.3945/ajcn.2010.29174; ZHANG JX, 1994, BRIT J NUTR, V71, P861, DOI 10.1079/BJN19940192	44	26	27	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110827	10.1371/journal.pone.0110827	http://dx.doi.org/10.1371/journal.pone.0110827			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340768	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662800061
J	Zhang, Z; Martiny, V; Lagorce, D; Ikeguchi, Y; Alexov, E; Miteva, MA				Zhang, Zhe; Martiny, Virginie; Lagorce, David; Ikeguchi, Yoshihiko; Alexov, Emil; Miteva, Maria A.			Rational Design of Small-Molecule Stabilizers of Spermine Synthase Dimer by Virtual Screening and Free Energy-Based Approach	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; SINGLE NUCLEOTIDE POLYMORPHISMS; SNYDER-ROBINSON SYNDROME; DRUG DISCOVERY; IN-SILICO; POLYAMINE METABOLISM; MENTAL-RETARDATION; MISSENSE MUTATION; C2 DOMAIN; BINDING	Snyder-Robinson Syndrome (SRS) is a rare mental retardation disorder which is caused by the malfunctioning of an enzyme, the spermine synthase (SMS), which functions as a homo-dimer. The malfunctioning of SMS in SRS patients is associated with several identified missense mutations that occur away from the active site. This investigation deals with a particular SRS-causing mutation, the G56S mutation, which was shown computationally and experimentally to destabilize the SMS homo-dimer and thus to abolish SMS enzymatic activity. As a proof-of-concept, we explore the possibility to restore the enzymatic activity of the malfunctioning SMS mutant G56S by stabilizing the dimer through small molecule binding at the mutant homo-dimer interface. For this purpose, we designed an in silico protocol that couples virtual screening and a free binding energy-based approach to identify potential small-molecule binders on the destabilized G56S dimer, with the goal to stabilize it and thus to increase SMS G56S mutant activity. The protocol resulted in extensive list of plausible stabilizers, among which we selected and tested 51 compounds experimentally for their capability to increase SMS G56S mutant enzymatic activity. In silico analysis of the experimentally identified stabilizers suggested five distinctive chemical scaffolds. This investigation suggests that druggable pockets exist in the vicinity of the mutation sites at protein-protein interfaces which can be used to alter the disease-causing effects by small molecule binding. The identified chemical scaffolds are druglike and can serve as original starting points for development of lead molecules to further rescue the disease-causing effects of the Snyder-Robinson syndrome for which no efficient treatment exists up to now.	[Zhang, Zhe; Martiny, Virginie; Lagorce, David; Miteva, Maria A.] Univ Paris Diderot, Sorbonne Paris Cite, INSERM, UMR S 973, Paris, France; [Zhang, Zhe; Martiny, Virginie; Lagorce, David; Miteva, Maria A.] INSERM, U973, Paris, France; [Zhang, Zhe; Alexov, Emil] Clemson Univ, Dept Phys & Astron, Clemson, SC 29634 USA; [Ikeguchi, Yoshihiko] Josai Univ, Fac Pharmaceut Sci, Togane, Japan	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Clemson University; Josai University	Alexov, E (corresponding author), Clemson Univ, Dept Phys & Astron, Clemson, SC 29634 USA.	ealexov@clemson.edu; maria.miteva@univ-paris-diderot.fr	Miteva, Maria M/N-2419-2018; Zhang, Zhe/J-9434-2014	Miteva, Maria M/0000-0001-6895-1214; Zhang, Zhe/0000-0002-1952-5726; Zhang, Zhe/0000-0002-0744-1314	NIH [NLM R03LM009748]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093937] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R03LM009748] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Z.Z. and E. A. were supported by a grant from NIH, NLM R03LM009748. Z.Z. thanks the French Embassy in Washington for the Chateaubriand fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexov EG, 1999, BIOCHEMISTRY-US, V38, P8253, DOI 10.1021/bi982700a; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Ballester PJ, 2014, J CHEM INF MODEL, V54, P944, DOI 10.1021/ci500091r; Basse MJ, 2013, NUCLEIC ACIDS RES, V41, pD824, DOI 10.1093/nar/gks1002; Basse N, 2010, CHEM BIOL, V17, P46, DOI 10.1016/j.chembiol.2009.12.011; Becerra-Solano LE, 2009, AM J MED GENET A, V149A, P328, DOI 10.1002/ajmg.a.32641; Block P, 2007, PROTEINS, V68, P170, DOI 10.1002/prot.21296; Boeckler FM, 2008, P NATL ACAD SCI USA, V105, P10360, DOI 10.1073/pnas.0805326105; Bowman AL, 2007, J AM CHEM SOC, V129, P3634, DOI 10.1021/ja068256d; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Cason AL, 2003, EUR J HUM GENET, V11, P937, DOI 10.1038/sj.ejhg.5201072; Chettiar SN, 2013, BIOORG MED CHEM LETT, V23, P5429, DOI 10.1016/j.bmcl.2013.07.034; de Alencastro G, 2008, J MED GENET, V45, P539, DOI 10.1136/jmg.2007.056713; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Engin HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081035; Gautier B, 2011, CHEM BIOL, V18, P1631, DOI 10.1016/j.chembiol.2011.10.016; Geerts D, 2010, INT J CANCER, V126, P2012, DOI 10.1002/ijc.25074; Georgescu RE, 2002, BIOPHYS J, V83, P1731, DOI 10.1016/S0006-3495(02)73940-4; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Grant BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025711; Haberthur U, 2008, J COMPUT CHEM, V29, P701, DOI 10.1002/jcc.20832; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Heikamp K, 2013, CHEM BIOL DRUG DES, V81, P33, DOI 10.1111/cbdd.12054; Ikeguchi Y, 2006, J BIOCHEM, V139, P1, DOI 10.1093/jb/mvj019; Ikeguchi Y, 2003, BIOCHEM J, V373, P885, DOI 10.1042/BJ20030246; Jain AN, 2007, J COMPUT AID MOL DES, V21, P281, DOI 10.1007/s10822-007-9114-2; Johnson DK, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002951; Jones R, 2007, CANCER RES, V67, P9134, DOI 10.1158/0008-5472.CAN-07-1528; Kouranov A, 2006, NUCLEIC ACIDS RES, V34, pD302, DOI 10.1093/nar/gkj120; Labbe CM, 2013, DRUG DISCOV TODAY, V18, P958, DOI 10.1016/j.drudis.2013.05.003; Lagorce D, 2011, BIOINFORMATICS; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Martiny VY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073587; Metz A, 2012, J CHEM INF MODEL, V52, P120, DOI 10.1021/ci200322s; Miroy GJ, 1996, P NATL ACAD SCI USA, V93, P15051, DOI 10.1073/pnas.93.26.15051; Morelli X, 2011, CURR OPIN CHEM BIOL, V15, P475, DOI 10.1016/j.cbpa.2011.05.024; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nervall M, 2008, J MED CHEM, V51, P2657, DOI 10.1021/jm701218j; Nicolaes GAF, 2014, BLOOD, V123, P113, DOI 10.1182/blood-2013-05-503227; Ortiz MA, 1999, P NATL ACAD SCI USA, V96, P2740, DOI 10.1073/pnas.96.6.2740; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Proctor EA, 2012, BIOPHYS J, V102, P144, DOI 10.1016/j.bpj.2011.11.4008; Ray SS, 2005, P NATL ACAD SCI USA, V102, P3639, DOI 10.1073/pnas.0408277102; Rechfeld F, 2011, CURR TOP MED CHEM, V11, P1305; Ryan CJ, 2013, NAT REV GENET, V14, P865, DOI 10.1038/nrg3574; Sackett DL, 2009, NAT CHEM, V1, P596, DOI 10.1038/nchem.427; Scior T, 2012, J CHEM INF MODEL, V52, P867, DOI 10.1021/ci200528d; Segers K, 2007, P NATL ACAD SCI USA, V104, P12697, DOI 10.1073/pnas.0701051104; SHIRAHATA A, 1993, BIOCHEM PHARMACOL, V45, P1897, DOI 10.1016/0006-2952(93)90449-7; SNYDER RD, 1969, CLIN PEDIATR, V8, P669, DOI 10.1177/000992286900801114; Song YF, 2009, J COMPUT CHEM, V30, P2231, DOI 10.1002/jcc.21222; Sousa SF, 2013, CURR MED CHEM, V20, P2296, DOI 10.2174/0929867311320180002; Soussi T, 2006, NAT REV CANCER, V6, P83, DOI 10.1038/nrc1783; Sperandio O, 2014, THROMB RES; Sperandio O, 2012, CURR PHARM DES; Sperandio O, 2010, EUR BIOPHYS J BIOPHY, V39, P1365, DOI 10.1007/s00249-010-0592-0; Teague SJ, 2003, NAT REV DRUG DISCOV, V2, P527, DOI 10.1038/nrd1129; Teng S, 2008, CURR PHARM BIOTECHNO, V9, P123, DOI 10.2174/138920108783955164; Teng SL, 2009, BIOPHYS J, V96, P2178, DOI 10.1016/j.bpj.2008.12.3904; Thiel P, 2012, ANGEW CHEM INT EDIT, V51, P2012, DOI 10.1002/anie.201107616; Tiede S, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9443; Tomar D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043522; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Venkatesan RN, 2007, MOL CELL BIOL, V27, P7669, DOI 10.1128/MCB.00002-07; Viaud J, 2007, P NATL ACAD SCI USA, V104, P10370, DOI 10.1073/pnas.0700773104; Villoutreix BO, 2008, CURR PHARM BIOTECHNO, V9, P103, DOI 10.2174/138920108783955218; Villoutreix BO, 2013, DRUG DISCOV TODAY, V18, P1081, DOI 10.1016/j.drudis.2013.06.013; Villoutreix BO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021117; Volkamer A, 2012, J CHEM INF MODEL, V52, P360, DOI 10.1021/ci200454v; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Wendt MD, 2007, BIOORG MED CHEM LETT, V17, P3122, DOI 10.1016/j.bmcl.2007.03.042; Wu H, 2008, J BIOL CHEM, V283, P16135, DOI 10.1074/jbc.M710323200; Xiang ZX, 2001, J MOL BIOL, V311, P421, DOI 10.1006/jmbi.2001.4865; Yamazaki K, 2012, ANAL SCI, V28, P621, DOI 10.2116/analsci.28.621; Yates CM, 2013, J MOL BIOL, V425, P3949, DOI 10.1016/j.jmb.2013.07.012; Zhang QC, 2013, NUCLEIC ACIDS RES, V41, pD828, DOI 10.1093/nar/gks1231; Zhang Z, 2013, J AM MED INFORM ASS; Zhang Z, 2013, HUM MOL GENET, V22, P3789, DOI 10.1093/hmg/ddt229; Zhang Z, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/805827; Zhang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020373; Zhang Z, 2010, HUM MUTAT, V31, P1043, DOI 10.1002/humu.21310; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816	83	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110884	10.1371/journal.pone.0110884	http://dx.doi.org/10.1371/journal.pone.0110884			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340632	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662800067
J	Hormann, AM; vom Saal, FS; Nagel, SC; Stahlhut, RW; Moyer, CL; Ellersieck, MR; Welshons, WV; Toutain, PL; Taylor, JA				Hormann, Annette M.; vom Saal, Frederick S.; Nagel, Susan C.; Stahlhut, Richard W.; Moyer, Carol L.; Ellersieck, Mark R.; Welshons, Wade V.; Toutain, Pierre-Louis; Taylor, Julia A.			Holding Thermal Receipt Paper and Eating Food after Using Hand Sanitizer Results in High Serum Bioactive and Urine Total Levels of Bisphenol A (BPA)	PLOS ONE			English	Article							HUMAN EXPOSURE; ETHINYL ESTRADIOL; RHESUS-MONKEYS; VARIABILITY; ABSORPTION; HEALTH; PHARMACOKINETICS; MECHANISMS; CHEMICALS; DISEASE	Bisphenol A (BPA) is an endocrine disrupting environmental contaminant used in a wide variety of products, and BPA metabolites are found in almost everyone's urine, suggesting widespread exposure from multiple sources. Regulatory agencies estimate that virtually all BPA exposure is from food and beverage packaging. However, free BPA is applied to the outer layer of thermal receipt paper present in very high (similar to 20 mg BPA/g paper) quantities as a print developer. Not taken into account when considering thermal paper as a source of BPA exposure is that some commonly used hand sanitizers, as well as other skin care products, contain mixtures of dermal penetration enhancing chemicals that can increase by up to 100 fold the dermal absorption of lipophilic compounds such as BPA. We found that when men and women held thermal receipt paper immediately after using a hand sanitizer with penetration enhancing chemicals, significant free BPA was transferred to their hands and then to French fries that were eaten, and the combination of dermal and oral BPA absorption led to a rapid and dramatic average maximum increase (Cmax) in unconjugated (bioactive) BPA of similar to 7 ng/mL in serum and similar to 20 mu g total BPA/g creatinine in urine within 90 min. The default method used by regulatory agencies to test for hazards posed by chemicals is intra-gastric gavage. For BPA this approach results in less than 1% of the administered dose being bioavailable in blood. It also ignores dermal absorption as well as sublingual absorption in the mouth that both bypass first-pass liver metabolism. The elevated levels of BPA that we observed due to holding thermal paper after using a product containing dermal penetration enhancing chemicals have been related to an increased risk for a wide range of developmental abnormalities as well as diseases in adults.	[Hormann, Annette M.; vom Saal, Frederick S.; Stahlhut, Richard W.; Moyer, Carol L.; Taylor, Julia A.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Nagel, Susan C.] Univ Missouri, Dept Obstet Gynecol & Womens Hlth, Columbia, MO 65211 USA; [Ellersieck, Mark R.] Univ Missouri, Dept Stat, Columbia, MO 65211 USA; [Welshons, Wade V.] Univ Missouri, Dept Biomed Sci, Columbia, MO 65211 USA; [Toutain, Pierre-Louis] Univ Toulouse, INPT, ENVT, UPS,UMR1331, F-31062 Toulouse, France; [Toutain, Pierre-Louis] INRA, UMR1331, Toxalim, Res Ctr Food Toxicol, F-31027 Toulouse, France	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Taylor, JA (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	TaylorJA@missouri.edu	Toutain, Pierre Louis/G-4540-2011	Toutain, Pierre Louis/0000-0002-8846-8892; Nagel, Susan C./0000-0003-4703-7604	The Passport Foundation; NIEHS [ES018764]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [RC2ES018764] Funding Source: NIH RePORTER	The Passport Foundation; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by a grant from The Passport Foundation (no URL available) and by NIEHS grant ES018764 to FvS (NIEHS website http://www.niehs.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brand RM, 2007, CUTAN OCUL TOXICOL, V26, P15, DOI 10.1080/15569520601182791; Braun JM, 2011, ENVIRON HEALTH PERSP, V119, P131, DOI 10.1289/ehp.1002366; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Churchwell MI, 2014, TOXICOL SCI, V139, P4, DOI 10.1093/toxsci/kfu021; ECHA, 2017, US BISPH A ITS ALT T; EFSA (European Food Safety Authority), 2008, TOX BISPH A SCI OP P; Ehrlich S, 2014, JAMA-J AM MED ASSOC, V311, P859, DOI 10.1001/jama.2013.283735; *ENVIRONMENTCANA, 2008, SCREEN ASS CHALL PHE; *FDA, 2008, FOOD DRUG ADM DRAFT; Fitzmaurice S, 2010, TXB AGING SKIN, P999; Funke AP, 2002, PHARMACEUT RES, V19, P661, DOI 10.1023/A:1015314314796; Gayrard V, 2013, ENVIRON HEALTH PERSP, V121, pA323, DOI 10.1289/ehp.1307424R; Gayrard V, 2013, ENVIRON HEALTH PERSP, V121, P951, DOI 10.1289/ehp.1206339; Goldzieher JW, 2008, CONTRACEPTION, V78, P4, DOI 10.1016/j.contraception.2008.02.020; *GRANDVIEWRESEAR, 2014, GLOB BISPH A BPA MAR; Heffernan AL, 2014, ENVIRON INT, V68, P139, DOI 10.1016/j.envint.2014.03.027; *IBISWORLD, 2012, HAND SAN MAN US MARK; Karande P, 2009, BBA-BIOMEMBRANES, V1788, P2362, DOI 10.1016/j.bbamem.2009.08.015; Krieter DH, 2013, ARTIF ORGANS, V37, P283, DOI 10.1111/j.1525-1594.2012.01556.x; Lambre C., 2021, EFSA J, V19, P38, DOI [10.2903/j.efsa.2021.7010, DOI 10.2903/J.EFSA.2021.7010]; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Levitt David G, 2004, BMC Clin Pharmacol, V4, P2, DOI 10.1186/1472-6904-4-2; Liao CY, 2012, ENVIRON SCI TECHNOL, V46, P6860, DOI 10.1021/es301334j; Liao CY, 2012, ENVIRON SCI TECHNOL, V46, P5003, DOI 10.1021/es300115a; Liao CY, 2011, ENVIRON SCI TECHNOL, V45, P9372, DOI 10.1021/es202507f; Liao CY, 2011, ENVIRON SCI TECHNOL, V45, P6761, DOI 10.1021/es200977t; Melzer D, 2012, CIRCULATION, V125, P1482, DOI 10.1161/CIRCULATIONAHA.111.069153; Mendum T, 2011, GREEN CHEM LETT REV, V4, P81, DOI 10.1080/17518253.2010.502908; Patterson TA, 2013, TOXICOL APPL PHARM, V267, P41, DOI 10.1016/j.taap.2012.12.006; Polak S, 2012, J PHARM SCI-US, V101, P2584, DOI 10.1002/jps.23155; Rochester JR, 2013, REPROD TOXICOL, V42, P132, DOI 10.1016/j.reprotox.2013.08.008; Singh I, 2011, INT J PHARM INVESTIG, V1, P4, DOI 10.4103/2230-973X.76721; *STATISTICSBRAIN, 2014, FAST FOOD STAT; Trasande L, 2014, HEALTH AFFAIR, V33, P316, DOI 10.1377/hlthaff.2013.0686; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Vandenberg LN, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-46; Vandenberg LN, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-25; Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716; Vandenberg LN, 2013, ENDOCRINE DISRUPTION, V1, pE1; Vanderford BJ, 2014, ANAL CHEM, V86, P774, DOI 10.1021/ac403274a; Vinas R, 2013, ENVIRON HEALTH PERSP, V121, P352, DOI 10.1289/ehp.1205826; Vokel W, 2002, CHEM RES TOXICOL, V15, P1281, DOI 10.1021/tx025548t; vom Saal FS, 2014, REPROD TOXICOL, V45, P105, DOI 10.1016/j.reprotox.2014.01.007; Welshons WV, 2006, ENDOCRINOLOGY, V147, pS56, DOI 10.1210/en.2005-1159; Welshons WV, 2003, ENVIRON HEALTH PERSP, V111, P994, DOI 10.1289/ehp.5494; Xue JP, 2007, RISK ANAL, V27, P411, DOI 10.1111/j.1539-6924.2007.00893.x; Ye XY, 2013, ENVIRON HEALTH PERSP, V121, P283, DOI 10.1289/ehp.1206093; You L, 2011, ENVIRON HEALTH PERSP, V119, P527, DOI 10.1289/ehp.1002572; Zalko D, 2011, CHEMOSPHERE, V82, P424, DOI 10.1016/j.chemosphere.2010.09.058	49	133	135	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110509	10.1371/journal.pone.0110509	http://dx.doi.org/10.1371/journal.pone.0110509			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337790	Green Submitted, Green Published, gold			2022-12-27	WOS:000343674800050
J	Joyce, AL; White, WH; Nuessly, GS; Solis, MA; Scheffer, SJ; Lewis, ML; Medina, RF				Joyce, Andrea L.; White, William H.; Nuessly, Gregg S.; Solis, M. Alma; Scheffer, Sonja J.; Lewis, Matthew L.; Medina, Raul F.			Geographic Population Structure of the Sugarcane Borer, Diatraea saccharalis (F.) (Lepidoptera: Crambidae), in the Southern United States	PLOS ONE			English	Article							LIRIOMYZA-HUIDOBRENSIS DIPTERA; APANTELES-FLAVIPES; MITOCHONDRIAL-DNA; PYRALIDAE; PHEROMONE; MOTH; ESTABLISHMENT; INDIVIDUALS; BRACONIDAE; RESISTANCE	The sugarcane borer moth, Diatraea saccharalis, is widespread throughout the Western Hemisphere, and is considered an introduced species in the southern United States. Although this moth has a wide distribution and is a pest of many crop plants including sugarcane, corn, sorghum and rice, it is considered one species. The objective was to investigate whether more than one introduction of D. saccharalis had occurred in the southern United States and whether any cryptic species were present. We field collected D. saccharalis in Texas, Louisiana and Florida in the southern United States. Two molecular markers, AFLPs and mitochondrial COI, were used to examine genetic variation among these regional populations and to compare the sequences with those available in GenBank and BOLD. We found geographic population structure in the southern United States which suggests two introductions and the presence of a previously unknown cryptic species. Management of D. saccharalis would likely benefit from further investigation of population genetics throughout the range of this species.	[Joyce, Andrea L.] Univ Calif Merced, SNRI, Merced, CA 95343 USA; [White, William H.] USDA ARS, Sugarcane Res Unit, Houma, LA 70361 USA; [Nuessly, Gregg S.] Univ Florida, Everglades Res & Educ Ctr, Belle Glade, FL 33430 USA; [Solis, M. Alma] USDA, Natl Museum Nat Hist, Washington, DC 20250 USA; [Scheffer, Sonja J.; Lewis, Matthew L.] USDA ARS, Systemat Entomol Lab, Beltsville, MD USA; [Medina, Raul F.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	University of California System; University of California Merced; United States Department of Agriculture (USDA); State University System of Florida; University of Florida; Smithsonian Institution; Smithsonian National Museum of Natural History; United States Department of Agriculture (USDA); Smithsonian Institution; United States Department of Agriculture (USDA); Texas A&M University System; Texas A&M University College Station	Joyce, AL (corresponding author), Univ Calif Merced, SNRI, Merced, CA 95343 USA.	ajoyce2@ucmerced.edu	Medina, Raul F/S-8294-2016	Medina, Raul F/0000-0002-8697-8901				Avequin JB, 1857, J PHARM CHEM PARIS, V32, P335; Avequin JB, 1857, J PHARM CHEM, V32, P338; Bennett FD, 1990, I FOOD AGR SCI SER, V355; BESSIN RT, 1990, ENVIRON ENTOMOL, V19, P635, DOI 10.1093/ee/19.3.635; Bleszynski S., 1969, PESTS SUGAR CANE, P11; BOX HAROLD E., 1931, BULL ENT RES [LONDON], V22, P1, DOI 10.1017/S0007485300029709; BOX HE, 1951, B ENTOMOL RES, V42, P379, DOI 10.1017/S0007485300025402; Box HE, 1935, FOOD PLANTS AM DIATR, P1; Bravo JP, 2008, GENET MOL RES, V7, P741, DOI 10.4238/vol7-3gmr470; Burns JM, 2008, P NATL ACAD SCI USA, V105, P6350, DOI 10.1073/pnas.0712181105; CAB International, 1989, AGR MAP A, V5; Cherry R. H., 1993, INSECT MANAGEMENT SU; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; DYAR HARRISON G., 1927, PROC U S NATION MM, V71, P1; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FLYNN JL, 1984, J ECON ENTOMOL, V77, P691, DOI 10.1093/jee/77.3.691; FUCHS TW, 1979, ENTOMOPHAGA, V24, P109, DOI 10.1007/BF02375123; FULLER BW, 1988, J ECON ENTOMOL, V81, P349, DOI 10.1093/jee/81.1.349; GIFFORD JR, 1967, J ECON ENTOMOL, V60, P44, DOI 10.1093/jee/60.1.44; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Goolsby JA, 2006, MOL ECOL, V15, P287, DOI 10.1111/j.1365-294X.2005.02788.x; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; HALL DG, 1988, FLA ENTOMOL, V71, P138, DOI 10.2307/3495361; Hartfield EA, 2010, ENTOMOL EXP APPL, V137, P11, DOI 10.1111/j.1570-7458.2010.01033.x; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hemmerter S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-100; Hufbauer RA, 1999, EVOLUTION, V53, P1435, DOI 10.1111/j.1558-5646.1999.tb05408.x; Joyce AL, 2010, ENTOMOL EXP APPL, V137, P153, DOI 10.1111/j.1570-7458.2010.01048.x; Kalinova B, 2005, J APPL ENTOMOL, V129, P70, DOI 10.1111/j.1439-0418.2005.00927.x; Lange CL, 2004, B ENTOMOL RES, V94, P457, DOI 10.1079/BER2004320; Li JH, 2006, EUR J ENTOMOL, V103, P605, DOI 10.14411/eje.2006.081; LONG WH, 1972, ANNU REV ENTOMOL, V17, P149, DOI 10.1146/annurev.en.17.010172.001053; Marti A., 1988, A Working conference for Users of Simulation Hardware, Software and Intelliware. Proceedings of the User 1 Working Conference, P83; Meagher RL, 1998, ENVIRON ENTOMOL, V27, P759, DOI 10.1093/ee/27.3.759; Medina RF, 2006, MOL ECOL NOTES, V6, P1010, DOI 10.1111/j.1471-8286.2006.01476.x; Milton M., 2013, BAR CODE LIFE DATASY; Nagoshi RN, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.15401; Cortes AMP, 2010, J INSECT PHYSIOL, V56, P1624, DOI 10.1016/j.jinsphys.2010.06.005; PASHLEY DP, 1990, ANN ENTOMOL SOC AM, V83, P1048, DOI 10.1093/aesa/83.6.1048; Pindell J., 1990, GEOLOGY N AM, VH, P405, DOI DOI 10.1130/DNAG-GNA-H.405; Pritchard JK, 2000, GENETICS, V155, P945; PRITCHARD JK, 2007, DOCUMENTATION STRUCT; Qiagen, 2006, DNEASY TISS HDB; ROBINSON G S, 1976, Entomologist's Gazette, V27, P127; Rodriguez LM, 2001, J ECON ENTOMOL, V94, P1464, DOI 10.1603/0022-0493-94.6.1464; Roe AD, 2007, MOL ECOL, V16, P3617, DOI 10.1111/j.1365-294X.2007.03412.x; SAUNDERS JA, 2001, USE AFLP TECHNIQUES, P1; Scheffer SJ, 2000, J ECON ENTOMOL, V93, P1146, DOI 10.1603/0022-0493-93.4.1146; Scheffer SJ, 2001, ANN ENTOMOL SOC AM, V94, P648, DOI 10.1603/0013-8746(2001)094[0648:TNGCME]2.0.CO;2; Solis M. A., 2004, TALLER INT BARRENADO, P6; SPERLING FAH, 1994, MOL BIOL EVOL, V11, P656; Symonds MRE, 2008, TRENDS ECOL EVOL, V23, P220, DOI 10.1016/j.tree.2007.11.009; Vargas G, 2013, FLA ENTOMOL, V96, P1198, DOI 10.1653/024.096.0367; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; WALTER GH, 2003, INSECT PEST MANAGEME, P115; White WH, 2008, CROP PROT, V27, P1256, DOI 10.1016/j.cropro.2008.03.011; White WH, 2004, ENVIRON ENTOMOL, V33, P627, DOI 10.1603/0046-225X-33.3.627; White WH, 2001, CROP SCI, V41, P1706, DOI 10.2135/cropsci2001.1706; Yang ZF, 2012, SYST ENTOMOL, V37, P686, DOI 10.1111/j.1365-3113.2012.00637.x	59	32	33	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110036	10.1371/journal.pone.0110036	http://dx.doi.org/10.1371/journal.pone.0110036			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337705	Green Published, gold, Green Submitted			2022-12-27	WOS:000343674800021
J	Lamas, NJ; Johnson-Kerner, B; Roybon, L; Kim, YA; Garcia-Diaz, A; Wichterle, H; Henderson, CE				Lamas, Nuno Jorge; Johnson-Kerner, Bethany; Roybon, Laurent; Kim, Yoon A.; Garcia-Diaz, Alejandro; Wichterle, Hynek; Henderson, Christopher E.			Neurotrophic Requirements of Human Motor Neurons Defined Using Amplified and Purified Stem Cell-Derived Cultures	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; IN-VITRO; ROCK INHIBITION; SPINAL-CORD; PHARMACOLOGICAL INHIBITION; AXONAL REGENERATION; KINASE INHIBITOR; SURVIVAL; RHO; MOTONEURONS	Human motor neurons derived from embryonic and induced pluripotent stem cells (hESCs and hiPSCs) are a potentially important tool for studying motor neuron survival and pathological cell death. However, their basic survival requirements remain poorly characterized. Here, we sought to optimize a robust survival assay and characterize their response to different neurotrophic factors. First, to increase motor neuron yield, we screened a small-molecule collection and found that the Rho-associated kinase (ROCK) inhibitor Y-27632 enhances motor neuron progenitor proliferation up to 4-fold in hESC and hiPSC cultures. Next, we FACS-purified motor neurons expressing the Hb9::GFP reporter from Y-27632-amplified embryoid bodies and cultured them in the presence of mitotic inhibitors to eliminate dividing progenitors. Survival of these purified motor neurons in the absence of any other cell type was strongly dependent on neurotrophic support. GDNF, BDNF and CNTF all showed potent survival effects (EC50 1-2 pM). The number of surviving motor neurons was further enhanced in the presence of forskolin and IBMX, agents that increase endogenous cAMP levels. As a demonstration of the ability of the assay to detect novel neurotrophic agents, Y-27632 itself was found to support human motor neuron survival. Thus, purified human stem cell-derived motor neurons show survival requirements similar to those of primary rodent motor neurons and can be used for rigorous cell-based screening.	[Lamas, Nuno Jorge; Johnson-Kerner, Bethany; Roybon, Laurent; Kim, Yoon A.; Garcia-Diaz, Alejandro; Wichterle, Hynek; Henderson, Christopher E.] Project ALS Jenifer Estess Lab Stem Cell Res, New York, NY 10032 USA; [Lamas, Nuno Jorge; Johnson-Kerner, Bethany; Roybon, Laurent; Wichterle, Hynek; Henderson, Christopher E.] Columbia Univ, Med Ctr, Ctr Motor Neuron Biol & Dis, New York, NY USA; [Lamas, Nuno Jorge; Johnson-Kerner, Bethany; Roybon, Laurent; Wichterle, Hynek; Henderson, Christopher E.] Columbia Univ, Med Ctr, Dept Rehabil & Regenerat Med, New York, NY USA; [Lamas, Nuno Jorge; Johnson-Kerner, Bethany; Roybon, Laurent; Wichterle, Hynek; Henderson, Christopher E.] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY USA; [Lamas, Nuno Jorge; Johnson-Kerner, Bethany; Roybon, Laurent; Wichterle, Hynek; Henderson, Christopher E.] Columbia Univ, Dept Neurol, Med Ctr, New York, NY USA; [Lamas, Nuno Jorge; Johnson-Kerner, Bethany; Roybon, Laurent; Wichterle, Hynek; Henderson, Christopher E.] Columbia Univ, Dept Neurosci, Med Ctr, New York, NY USA; [Lamas, Nuno Jorge; Johnson-Kerner, Bethany; Roybon, Laurent; Wichterle, Hynek; Henderson, Christopher E.] Columbia Univ, Columbia Stem Cell Initiat, Med Ctr, New York, NY USA; [Lamas, Nuno Jorge; Johnson-Kerner, Bethany; Roybon, Laurent; Wichterle, Hynek; Henderson, Christopher E.] Columbia Univ, Columbia Translat Neurosci Initiat, Med Ctr, New York, NY USA; [Lamas, Nuno Jorge] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst, Braga, Minho, Portugal; [Lamas, Nuno Jorge] ICVS 3Bs PT, Govt Associate Lab, Braga, Minho, Portugal	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Universidade do Minho	Henderson, CE (corresponding author), Project ALS Jenifer Estess Lab Stem Cell Res, New York, NY 10032 USA.	ch2331@columbia.edu	MD/PhD, Nuno Jorge Lamas/T-6210-2018	MD/PhD, Nuno Jorge Lamas/0000-0002-4648-136X; Wichterle, Hynek/0000-0002-7817-0080	A.L.S.; P2ALS; NYSTEM [CO24415]; Portuguese Foundation for Science and Technology [SFRH/BD/33421/2008]; Luso-American Development Foundation; National Institute of Neurological Disorders and Stroke (NINDS); Swedish Brain Foundation/Hjarnfonden	A.L.S.; P2ALS; NYSTEM; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Luso-American Development Foundation; National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Swedish Brain Foundation/Hjarnfonden	This work was funded by Project A.L.S., P2ALS and NYSTEM grant number CO24415. The work of N.J.L. was supported by the Portuguese Foundation for Science and Technology SFRH/BD/33421/2008 and the Luso-American Development Foundation. B.J.-K. was supported by the National Institute of Neurological Disorders and Stroke (NINDS). L.R. was supported by the Swedish Brain Foundation/Hjarnfonden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman J, 2001, DEV HUMAN SPINAL COR; Amoroso MW, 2013, J NEUROSCI, V33, P574, DOI 10.1523/JNEUROSCI.0906-12.2013; Bayer S. A., 2002, ATLAS HUMAN CENTRAL; Beck M, 2001, AMYOTROPH LATERAL SC, V2, pS55, DOI 10.1080/146608201300079454; Bordet T, 2007, J PHARMACOL EXP THER, V322, P709, DOI 10.1124/jpet.107.123000; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Bowerman M, 2010, HUM MOL GENET, V19, P1468, DOI 10.1093/hmg/ddq021; Bueno C, 2010, STEM CELL REV REP, V6, P215, DOI 10.1007/s12015-010-9118-5; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Claassen DA, 2009, MOL REPROD DEV, V76, P722, DOI 10.1002/mrd.21021; Dasen JS, 2008, CELL, V134, P304, DOI 10.1016/j.cell.2008.06.019; Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; Dergham P, 2002, J NEUROSCI, V22, P6570; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Fournier AE, 2003, J NEUROSCI, V23, P1416, DOI 10.1523/JNEUROSCI.23-04-01416.2003; Gauthaman K, 2010, STEM CELL REV REP, V6, P86, DOI [10.1007/s12015-010-9166-x, 10.1007/s12015-009-9107-8]; Gisselsson L, 2010, BRAIN RES, V1316, P92, DOI 10.1016/j.brainres.2009.11.087; Gould TW, 2011, BRAIN RES REV, V67, P1, DOI 10.1016/j.brainresrev.2010.10.003; Gould TW, 2009, NEUROSCIENTIST, V15, P105, DOI 10.1177/1073858408324787; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Han SSW, 2011, NEURON, V70, P626, DOI 10.1016/j.neuron.2011.05.003; Hanson MG, 1998, J NEUROSCI, V18, P7361; HENDERSON CE, 1993, NATURE, V363, P266, DOI 10.1038/363266a0; Henderson CE, 1996, CURR OPIN NEUROBIOL, V6, P64, DOI 10.1016/S0959-4388(96)80010-9; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Iwamoto H, 2000, J HEPATOL, V32, P762, DOI 10.1016/S0168-8278(00)80245-7; Julien S, 2008, J NEUROSCI RES, V86, P531, DOI 10.1002/jnr.21511; Kanning KC, 2010, ANNU REV NEUROSCI, V33, P409, DOI 10.1146/annurev.neuro.051508.135722; Kiskinis E., 2014, CELL STEM CELL; Kiskinis E, 2014, CELL STEM CELL, V14, P781, DOI 10.1016/j.stem.2014.03.004; KOLIATSOS VE, 1993, NEURON, V10, P359, DOI 10.1016/0896-6273(93)90326-M; LI LX, 1995, P NATL ACAD SCI USA, V92, P9771, DOI 10.1073/pnas.92.21.9771; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Lingor P, 2008, BRAIN, V131, P250, DOI 10.1093/brain/awm284; Lingor P, 2007, J NEUROCHEM, V103, P181, DOI 10.1111/j.1471-4159.2007.04756.x; MAGAL E, 1991, DEV BRAIN RES, V63, P141, DOI 10.1016/0165-3806(91)90074-S; METTLING C, 1995, J NEUROSCI, V15, P3128; METTLING C, 1993, DEVELOPMENT, V118, P1149; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Okumura N, 2009, INVEST OPHTH VIS SCI, V50, P3680, DOI 10.1167/iovs.08-2634; OPPENHEIM RW, 1992, NATURE, V360, P755, DOI 10.1038/360755a0; OPPENHEIM RW, 1991, SCIENCE, V251, P1616, DOI 10.1126/science.2011743; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Peljto M, 2010, CELL STEM CELL, V7, P355, DOI 10.1016/j.stem.2010.07.013; Pennica D, 1996, NEURON, V17, P63, DOI 10.1016/S0896-6273(00)80281-0; Raoul C, 2006, P NATL ACAD SCI USA, V103, P6007, DOI 10.1073/pnas.0508774103; Rees RW, 2003, J UROLOGY, V170, P2517, DOI 10.1097/01.ju.0000085024.47406.6c; Routhier A, 2010, ONCOL REP, V23, P861, DOI 10.3892/or_00000708; Roy NS, 2005, EXP NEUROL, V196, P224, DOI 10.1016/j.expneurol.2005.06.021; SENDTNER M, 1992, NATURE, V358, P502, DOI 10.1038/358502a0; Sendtner M, 2000, CELL TISSUE RES, V301, P71, DOI 10.1007/s004410000217; Street CA, 2010, INT J ONCOL, V37, P1297, DOI 10.3892/ijo_00000781; Tonges L, 2014, GLIA, V62, P217, DOI 10.1002/glia.22601; Ullian EM, 2004, MOL CELL NEUROSCI, V25, P241, DOI 10.1016/j.mcn.2003.10.011; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; YAN Q, 1995, NATURE, V373, P341, DOI 10.1038/373341a0; Yang YM, 2013, CELL STEM CELL, V12, P713, DOI 10.1016/j.stem.2013.04.003; Yu ZY, 2012, NEUROCHEM INT, V61, P1114, DOI 10.1016/j.neuint.2012.08.003; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7	63	37	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110324	10.1371/journal.pone.0110324	http://dx.doi.org/10.1371/journal.pone.0110324			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337699	Green Published, gold, Green Submitted			2022-12-27	WOS:000343674800035
J	Shirasawa, M; Sakamoto, T; Terasaki, H; Yamashita, T; Uchino, E; Sonoda, S				Shirasawa, Makoto; Sakamoto, Taiji; Terasaki, Hiroto; Yamashita, Takehiro; Uchino, Eisuke; Sonoda, Shozo			Objective Determination of Optimal Number of Spectral-Domain Optical Coherence Tomographic Images of Retina to Average	PLOS ONE			English	Article							REDUCTION; SYSTEMS; NOISE; OCT	Purpose: To determine by objective methods the minimum number of spectral-domain optical coherence tomographic (SD-OCT) images to average to obtain the clearest retinal image. Methods: SD-OCT Images were obtained from 9 healthy eyes and also from a phantom eye model. The SD-OCT images were obtained by averaging 1, 5, 20, 60, and 100 B-scan images. The reflectivity (mean gray value) of the different retinal layers was evaluated in these images. The image quality was evaluated by the size of the standard deviations (SDs) and the contrast-to-noise ratios (CNRs). A phantom eye model made by TiO2 silicone plates was also examined. Results: The SDs decreased significantly when the number of images averaged increased from 1 to 5 and also from 5 to 20 (P<0.05, post hoc Tukey's honestly significant difference tests). The SD of the automatic real time averaging of 1 (ART = 1) and ART = 5 were significantly larger than the SD of ART = 100 (P<0.05). The SDs of all other averaged numbers were not significantly larger than that of ART = 100. The CNR increased with an increase in the number of images averaged, and there was a significant increase between ART = 1 to 5 and between ART = 5 to 20 (P<0.05). No significant differences in the CNR was observed between ART = 5, ART = 20 and ART = 60. Similar results were obtained with the phantom eye model. Conclusions: Although the image quality of the SD-OCT images of the retina improved with an increase in the number of images averaged, it does not improve significantly by averaging more than 20 images.	[Shirasawa, Makoto; Sakamoto, Taiji; Terasaki, Hiroto; Yamashita, Takehiro; Uchino, Eisuke; Sonoda, Shozo] Kagoshima Univ, Dept Ophthalmol, Grad Sch Med & Dent Sci, Kagoshima 890, Japan	Kagoshima University	Sakamoto, T (corresponding author), Kagoshima Univ, Dept Ophthalmol, Grad Sch Med & Dent Sci, Kagoshima 890, Japan.	tsakamot@m3.kufm.kagoshima-u.ac.jp			Research Committee on Chorioretinal Degeneration and Optic Atrophy; Ministry of Education, Science, and Culture of the Japanese Government; Ministry of Health, Labor, and Welfare, Tokyo, Japan	Research Committee on Chorioretinal Degeneration and Optic Atrophy; Ministry of Education, Science, and Culture of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare, Tokyo, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a grant from the Research Committee on Chorioretinal Degeneration and Optic Atrophy, Ministry of Health, Labor, and Welfare, Tokyo, Japan, and by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture of the Japanese Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhi M, 2013, CURR OPIN OPHTHALMOL, V24, P213, DOI 10.1097/ICU.0b013e32835f8bf8; American National Standards Institute, 2007, AM NAT STAND SAF US; Chen XJ, 2013, INVEST OPHTH VIS SCI, V54, P6846, DOI 10.1167/iovs.13-12062; de Bruin DM, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3369003; de Kinkelder R, 2013, J BIOPHOTONICS, V6, P314, DOI 10.1002/jbio.201200018; El-Ashry M, 2006, CURR EYE RES, V31, P409, DOI 10.1080/02713680600646882; Leibu R, 1999, GRAEF ARCH CLIN EXP, V237, P991, DOI 10.1007/s004170050335; Maldonado RS, 2010, INVEST OPHTH VIS SCI, V51, P2678, DOI 10.1167/iovs.09-4403; Mrejen S, 2013, SURV OPHTHALMOL, V58, P387, DOI 10.1016/j.survophthal.2012.12.001; Pappuru RR, 2012, OPHTHAL SURG LAS IM, V43, P63, DOI 10.3928/15428877-20110908-02; Sakamoto A, 2008, OPHTHALMOLOGY, V115, P1071, DOI 10.1016/j.ophtha.2007.09.001; Seitz J, 2000, INVEST RADIOL, V35, P380, DOI 10.1097/00004424-200006000-00007; SPRAWLS P, 1992, RADIOGRAPHICS, V12, P1041, DOI 10.1148/radiographics.12.5.1529128; SWINDELL W, 1995, MED PHYS, V22, P1405, DOI 10.1118/1.597618; Wu W, 2013, OSLI RETINA, V44, P168, DOI 10.3928/23258160-20130313-09; Yannuzzi LA, 2004, AM J OPHTHALMOL, V137, P511, DOI 10.1016/j.ajo.2003.12.035; Youssef PN, 2011, EYE, V25, P1, DOI 10.1038/eye.2010.149	17	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110550	10.1371/journal.pone.0110550	http://dx.doi.org/10.1371/journal.pone.0110550			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337716	Green Published, Green Submitted, gold			2022-12-27	WOS:000343674800056
J	Palmer, KS; Agoritsas, T; Martin, D; Scott, T; Mulla, SM; Miller, AP; Agarwal, A; Bresnahan, A; Hazzan, AA; Jeffery, RA; Merglen, A; Negm, A; Siemieniuk, RA; Bhatnagar, N; Dhalla, IA; Lavis, JN; You, JJ; Duckett, SJ; Guyatt, GH				Palmer, Karen S.; Agoritsas, Thomas; Martin, Danielle; Scott, Taryn; Mulla, Sohail M.; Miller, Ashley P.; Agarwal, Arnav; Bresnahan, Andrew; Hazzan, Afeez Abiola; Jeffery, Rebecca A.; Merglen, Arnaud; Negm, Ahmed; Siemieniuk, Reed A.; Bhatnagar, Neera; Dhalla, Irfan A.; Lavis, John N.; You, John J.; Duckett, Stephen J.; Guyatt, Gordon H.			Activity-Based Funding of Hospitals and Its Impact on Mortality, Readmission, Discharge Destination, Severity of Illness, and Volume of Care: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							PROSPECTIVE-PAYMENT SYSTEM; MEDICARE PROSPECTIVE-PAYMENT; POST-ACUTE CARE; LENGTH-OF-STAY; HIP FRACTURE; ELDERLY-PATIENTS; GENERAL HOSPITALS; HEART-FAILURE; HEALTH-CARE; QUALITY	Background: Activity-based funding (ABF) of hospitals is a policy intervention intended to re-shape incentives across health systems through the use of diagnosis-related groups. Many countries are adopting or actively promoting ABF. We assessed the effect of ABF on key measures potentially affecting patients and health care systems: mortality (acute and post-acute care); readmission rates; discharge rate to post-acute care following hospitalization; severity of illness; volume of care. Methods: We undertook a systematic review and meta-analysis of the worldwide evidence produced since 1980. We included all studies reporting original quantitative data comparing the impact of ABF versus alternative funding systems in acute care settings, regardless of language. We searched 9 electronic databases (OVID MEDLINE, EMBASE, OVID Healthstar, CINAHL, Cochrane CENTRAL, Health Technology Assessment, NHS Economic Evaluation Database, Cochrane Database of Systematic Reviews, and Business Source), hand-searched reference lists, and consulted with experts. Paired reviewers independently screened for eligibility, abstracted data, and assessed study credibility according to a pre-defined scoring system, resolving conflicts by discussion or adjudication. Results: Of 16,565 unique citations, 50 US studies and 15 studies from 9 other countries proved eligible (i.e. Australia, Austria, England, Germany, Israel, Italy, Scotland, Sweden, Switzerland). We found consistent and robust differences between ABF and no-ABF in discharge to post-acute care, showing a 24% increase with ABF (pooled relative risk = 1.24, 95% CI 1.18-1.31). Results also suggested a possible increase in readmission with ABF, and an apparent increase in severity of illness, perhaps reflecting differences in diagnostic coding. Although we found no consistent, systematic differences in mortality rates and volume of care, results varied widely across studies, some suggesting appreciable benefits from ABF, and others suggesting deleterious consequences. Conclusions: Transitioning to ABF is associated with important policy-and clinically-relevant changes. Evidence suggests substantial increases in admissions to post-acute care following hospitalization, with implications for system capacity and equitable access to care. High variability in results of other outcomes leaves the impact in particular settings uncertain, and may not allow a jurisdiction to predict if ABF would be harmless. Decision-makers considering ABF should plan for likely increases in post-acute care admissions, and be aware of the large uncertainty around impacts on other critical outcomes.	[Palmer, Karen S.] Simon Fraser Univ, Fac Sci, Burnaby, BC V5A 1S6, Canada; [Agoritsas, Thomas; Scott, Taryn; Mulla, Sohail M.; Agarwal, Arnav; Hazzan, Afeez Abiola; Lavis, John N.; You, John J.; Guyatt, Gordon H.] McMaster Univ, Fac Hlth Sci, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Agoritsas, Thomas] Univ Hosp Geneva, Div Gen Internal Med, Geneva, Switzerland; [Agoritsas, Thomas] Univ Hosp Geneva, Div Clin Epidemiol, Geneva, Switzerland; [Agoritsas, Thomas; Merglen, Arnaud] Univ Geneva, Fac Med, Geneva, Switzerland; [Martin, Danielle] Univ Toronto, Dept Family & Community Med, Dept Hlth Policy Management & Evaluat, Toronto, ON M5S 1A1, Canada; [Martin, Danielle] Med Affairs & Hlth Syst Solut Womens Coll Hosp, Womens Coll Hosp, Toronto, ON, Canada; [Miller, Ashley P.] Mem Univ Newfoundland, St John, NF, Canada; [Bresnahan, Andrew] McMaster Univ, Michael G DeGroote Sch Med, Hamilton, ON, Canada; [Jeffery, Rebecca A.] Dalhousie Univ, Fac Med, Halifax, NS, Canada; [Merglen, Arnaud] Hosp Sick Children, Paediat Outcome Res Team, Toronto, ON M5G 1X8, Canada; [Merglen, Arnaud] Univ Hosp Geneva, Div Gen Pediat, Geneva, Switzerland; [Negm, Ahmed] McMaster Univ, Rehabil Sch, Hamilton, ON, Canada; [Siemieniuk, Reed A.] Sunnybrook Hlth Sci Ctr, Dept Gen Internal Med, Toronto, ON M4N 3M5, Canada; [Bhatnagar, Neera] McMaster Univ, Hlth Sci Lib, Hamilton, ON, Canada; [Dhalla, Irfan A.] Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON, Canada; [Dhalla, Irfan A.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Lavis, John N.] McMaster Univ, Dept Polit Sci, McMaster Hlth Forum, Ctr Hlth Econ & Policy Anal, Hamilton, ON, Canada; [Lavis, John N.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Duckett, Stephen J.] Grattan Inst, Carlton, Vic, Australia	Simon Fraser University; McMaster University; University of Geneva; University of Geneva; University of Geneva; University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; Memorial University Newfoundland; McMaster University; Dalhousie University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Geneva; McMaster University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; McMaster University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; McMaster University; Harvard University; Harvard T.H. Chan School of Public Health	Palmer, KS (corresponding author), Simon Fraser Univ, Fac Sci, Burnaby, BC V5A 1S6, Canada.	kpalmer@sfu.ca	Martin, Danielle/GWQ-9731-2022; Agarwal, Arnav/J-1553-2014; Duckett, Stephen/U-7182-2017; Agoritsas, Thomas/F-4321-2014; Negm, Ahmed/Z-1108-2018	Agarwal, Arnav/0000-0002-0931-7851; Duckett, Stephen/0000-0002-2096-5905; Agoritsas, Thomas/0000-0002-6182-9969; Negm, Ahmed/0000-0001-5849-1402; Miller, Ashley P/0000-0001-8976-3431	Canadian Institute for Health Research	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR))	KSP, DM, IAD, GHG received funds from the Canadian Institute for Health Research through a Knowledge Synthesis Grant, Priority Area: Evidence Informed Healthcare Renewal (http://www.cihr-irsc.gc.ca/e/193.html). The research was independent of any involvement from the sponsors of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abler S, 2011, ARCH DIS CHILD-FETAL, V96, pF186, DOI 10.1136/adc.2010.192500; Ackerly DC, 2014, NEW ENGL J MED, V370, P689, DOI 10.1056/NEJMp1315350; [Anonymous], 1983, Fed Regist, V48, P39752; Averill RF, 2009, HEALTH CARE FINANC R, V30, P1; Berta P, 2009, MUNICH PERSONAL REPE, V17671, P1; Biorn E, 2010, HEALTH CARE MANAG SC, V13, P1, DOI 10.1007/s10729-009-9106-y; Brereton L, 2010, IMPACT NHS MARKET OV; Bresnick J, 2013, KNEE HIP REPLACEMENT; Brizioli E, 1996, ARCH GERONTOL GERIAT, V23, P347, DOI 10.1016/S0167-4943(96)00741-8; Buntin MB, 2009, HEALTH SERV RES, V44, P1188, DOI 10.1111/j.1475-6773.2009.00968.x; Busato A, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-31; Busse R, 2011, WORLD HLTH ORG BEHAL; Canadian Institute for Health Information, 2013, EV IMP ACT BAS FUND; Canadian Institute for Health Information, 2009, HLTH CAR CAN 2009 DE; Canadian Institute for Health Information, 2013, WHY WHAT ACT BAS FUN; Canadian Institute for Health Information Activity-Based Funding Unit, 2010, PRIM ACT BAS FUND; CARROLL NV, 1987, MED CARE, V25, P1161, DOI 10.1097/00005650-198712000-00005; CARROLL NV, 1990, AM J HOSP PHARM, V47, P2251, DOI 10.1093/ajhp/47.10.2251; Center for Public Integrity, 2013, CRACK COD; Centers for Medicare & Medicaid Services, 2013, READM RED PROGR; Chulis G S, 1991, Med Care Rev, V48, P167, DOI 10.1177/002570879104800203; Cohen M, 2013, HOSP WALLS ACTIVITY; Coulam R F, 1991, Health Care Financ Rev Annu Suppl, P45; CUTLER DM, 1995, ECONOMETRICA, V63, P29, DOI 10.2307/2951696; Dafny LS, 2005, AM ECON REV, V95, P1525, DOI 10.1257/000282805775014236; Day B, 2007, COMMUNICATION; DeJong G, 2010, PHYS THER, V90, P658, DOI 10.2522/ptj.2010.90.5.658; DESHARNAIS S, 1987, INQUIRY-J HEALTH CAR, V24, P7; DESHARNAIS S, 1991, EVAL HEALTH PROF, V14, P228, DOI 10.1177/016327879101400206; DESHARNAIS S, 1988, INQUIRY-J HEALTH CAR, V25, P374; DesHarnais S I, 1991, QRB Qual Rev Bull, V17, P261; DESHARNAIS SI, 1990, INQUIRY-J HEALTH CAR, V27, P382; Dishonest Hospitals Sidestep Medicare Readmission Penalties by Submitting Claims for Inappropriate Observation Stays, 2013, MED FRAUD BLOG; DRAPER D, 1990, JAMA-J AM MED ASSOC, V264, P1956, DOI 10.1001/jama.264.15.1956; Easton L S, 1991, Appl Nurs Res, V4, P107; Eggers P W, 1987, Health Care Financ Rev, VSpec No, P29; Eijkenaar F, 2013, HEALTH POLICY, V110, P115, DOI 10.1016/j.healthpol.2013.01.008; Ellis RP, 1998, J HEALTH ECON, V17, P537, DOI 10.1016/S0167-6296(97)00042-8; ENTHOVEN AC, 1991, HEALTH AFFAIR, V10, P60, DOI 10.1377/hlthaff.10.3.60; EPSTEIN AM, 1991, INQUIRY-J HEALTH CAR, V28, P19; Ettelt S, 2006, REIMBURSING HIGHLY S; Farrar S, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3047; FITZGERALD JF, 1988, NEW ENGL J MED, V319, P1392, DOI 10.1056/NEJM198811243192106; FITZGERALD JF, 1987, JAMA-J AM MED ASSOC, V258, P218; Fleiss J L, 1993, Stat Methods Med Res, V2, P121, DOI 10.1177/096228029300200202; Frick U, 2001, PSYCHIAT PRAX, V28, pS55; FRIEDMAN B, 1995, HEALTH SERV RES, V30, P467; FUCHS PC, 1986, INFECT CONT HOSP EP, V7, P506, DOI 10.1017/S0195941700065139; GAUMER GL, 1992, HEALTH SERV RES, V26, P725; Gay E G, 1994, Home Health Care Serv Q, V14, P49, DOI 10.1300/J027v14n04_05; GAY EG, 1990, SOC SCI MED, V31, P1103; GERETY MB, 1989, J GEN INTERN MED, V4, P388, DOI 10.1007/BF02599687; Gianfrancesco F D, 1990, Health Care Financ Rev, V12, P37; Guterman S, 1988, Health Care Financ Rev, V9, P67; HELMS CM, 1987, AM J PUBLIC HEALTH, V77, P1331, DOI 10.2105/AJPH.77.10.1331; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hing E, 1989, Vital Health Stat 13, P1; Hussey PS, 2011, HEALTH AFFAIR, V30, P2116, DOI 10.1377/hlthaff.2011.0784; Jauss M, 2010, NERVENARZT, V81, P218, DOI 10.1007/s00115-009-2910-2; KAHN KL, 1990, JAMA-J AM MED ASSOC, V264, P1984, DOI 10.1001/jama.264.15.1984; KANDA K, 1991, GERONTOLOGIST, V31, P318, DOI 10.1093/geront/31.3.318; KANE JT, 1987, ARCH PHYS MED REHAB, V68, P833; KEELER EB, 1992, JAMA-J AM MED ASSOC, V268, P1709, DOI 10.1001/jama.268.13.1709; Kerr GD, 1998, MED J AUSTRALIA, V168, P57, DOI 10.5694/j.1326-5377.1998.tb126711.x; Laderman M, 2013, COMMONWEALTH FUND; LEIBSON C, 1990, GERONTOLOGIST, V30, P316, DOI 10.1093/geront/30.3.316; LEIBSON CL, 1991, J AM GERIATR SOC, V39, P895, DOI 10.1111/j.1532-5415.1991.tb04457.x; LEWIS MA, 1987, AM J PUBLIC HEALTH, V77, P819, DOI 10.2105/AJPH.77.7.819; LOGERFO JP, 1990, JAMA-J AM MED ASSOC, V264, P1995, DOI 10.1001/jama.264.15.1995; Long M J, 1990, Health Care Financ Rev, V11, P69; Long M J, 1993, Health Serv Manage Res, V6, P61; LONG MJ, 1987, MED CARE, V25, P528, DOI 10.1097/00005650-198706000-00007; LONG MJ, 1989, HEALTH SERV RES, V24, P615; Louis DZ, 1999, HEALTH SERV RES, V34, P405; Manton K G, 1990, Health Care Financ Rev, V11, P51; Manton K G, 1990, J Aging Health, V2, P131, DOI 10.1177/089826439000200201; MANTON KG, 1993, HEALTH SERV RES, V28, P269; MAYEROAKES SA, 1988, JAMA-J AM MED ASSOC, V260, P3146, DOI 10.1001/jama.260.21.3146; Mayes R, 2007, J HIST MED ALL SCI, V62, P21, DOI 10.1093/jhmas/jrj038; Moreno-Serra R, 2010, J HEALTH ECON, V29, P585, DOI 10.1016/j.jhealeco.2010.05.007; MORRISEY MA, 1988, MED CARE, V26, P685, DOI 10.1097/00005650-198807000-00004; Murkofsky RL, 2003, JAMA-J AM MED ASSOC, V289, P2841, DOI 10.1001/jama.289.21.2841; Newhouse J P, 1989, Health Care Financ Rev, V11, P33; O'Reilly J, 2012, HEALTH ECON POLICY L, V7, P73, DOI 10.1017/S1744133111000314; Office of Inspector General, TOP MAN PERF CHALL; Onder G, 2001, ARCH INTERN MED, V161, P1918, DOI 10.1001/archinte.161.15.1918; Palmer Karen S, 2013, Open Med, V7, pe94; PALMER RM, 1989, ARCH INTERN MED, V149, P2237, DOI 10.1001/archinte.149.10.2237; Pfeiffer D, 1987, J Health Hum Resour Adm, V10, P115; Qian XF, 2011, B ECON RES, V63, P1, DOI 10.1111/j.1467-8586.2010.00369.x; RAY WA, 1990, ARCH INTERN MED, V150, P2109, DOI 10.1001/archinte.150.10.2109; Researchers of the Italian Group of Pharmaco-epidemiology in the Aged (GIFA), 1996, ANN ITAL MED INT, V11, P220; RICH MW, 1988, AM J PUBLIC HEALTH, V78, P680, DOI 10.2105/AJPH.78.6.680; ROGERS WH, 1990, JAMA-J AM MED ASSOC, V264, P1989, DOI 10.1001/jama.264.15.1989; Roland M, 2011, NEW ENGL J MED, V364, P1360, DOI 10.1056/NEJMhpr1009757; Schmidt SM, 2002, ARCH PHYS MED REHAB, V83, P894, DOI 10.1053/apmr.2002.33219; Schuetz P, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13228; Shmueli A, 2002, SOC SCI MED, V55, P981, DOI 10.1016/S0277-9536(01)00233-7; SLOAN FA, 1988, AM J PUBLIC HEALTH, V78, P553, DOI 10.2105/AJPH.78.5.553; South M, 1997, MED J AUSTRALIA, V167, P11, DOI 10.5694/j.1326-5377.1997.tb138755.x; Street A, 2007, 030CHERP U YORK CTR; Stromberg L, 1997, ACTA ORTHOP SCAND, V68, P6, DOI 10.3109/17453679709003967; Sutherland JM, 2011, CHSRF SERIES COST DR, V4; Sutherland JM, 2012, REV POTENTIAL ROLES; Tan SS, 2010, EURO OBSERVER, V12, P7; Tan SS, 2011, WORLD HLTH ORG BEHAL; Thuilliez J, 2011, DIAGNOSIS RELATED GR, P37; U.S. Department of Health and Human Services (HHS) Office of Inspector General, 2014, OEI061100370 HHS OFF; U.S. Department of Health & Human Services, 2013, MED FRAUD STRIK FORC; US Congress Office of Technology Assessment, 1995, OTABPH148 US GOV PRI, P139; Van Gelder S, 1986, Pride Inst J Long Term Home Health Care, V5, P3; von Eiff W, 2011, REHABILITATION, V50, P214, DOI 10.1055/s-0031-1275720; WEINBERGER M, 1988, MED CARE, V26, P77, DOI 10.1097/00005650-198801000-00008; Welch WP, 1998, HEALTH AFFAIR, V17, P69, DOI 10.1377/hlthaff.17.6.69; WELLS KB, 1993, AM J PSYCHIAT, V150, P1799; Xiao J, 2000, Aust Health Rev, V23, P122; Yin J, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-172; Carlson Joe, 2013, Mod Healthc, V43, P8	118	62	65	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e109975	10.1371/journal.pone.0109975	http://dx.doi.org/10.1371/journal.pone.0109975			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ1JF	25347697	Green Published, Green Submitted, gold			2022-12-27	WOS:000347994900018
J	Stewart, DS; Pierce, DW; Hotta, M; Stern, AT; Forman, SA				Stewart, Deirdre S.; Pierce, David W.; Hotta, Mayo; Stern, Alex T.; Forman, Stuart A.			Mutations at Beta N265 in gamma-Aminobutyric Acid Type A Receptors Alter Both Binding Affinity and Efficacy of Potent Anesthetics	PLOS ONE			English	Article							GATED ION CHANNELS; GABA(A) RECEPTOR; GENERAL-ANESTHETICS; ETOMIDATE BINDING; GLYCINE RECEPTORS; SUBUNIT INTERFACE; CROSS-LINKING; AMINO-ACID; SITES; MODULATION	Etomidate and propofol are potent general anesthetics that act via GABAA receptor allosteric co-agonist sites located at transmembrane beta+/alpha- inter-subunit interfaces. Early experiments in heteromeric receptors identified beta N265 (M2-15') on beta 2 and beta 3 subunits as an important determinant of sensitivity to these drugs. Mechanistic analyses suggest that substitution with serine, the beta 1 residue at this position, primarily reduces etomidate efficacy, while mutation to methionine eliminates etomidate sensitivity and might prevent drug binding. However, the beta N265 residue has not been photolabeled with analogs of either etomidate or propofol. Furthermore, substituted cysteine modification studies find no propofol protection at this locus, while etomidate protection has not been tested. Thus, evidence of contact between beta N265 and potent anesthetics is lacking and it remains uncertain how mutations alter drug sensitivity. In the current study, we first applied heterologous alpha 1 beta 2N265C gamma 2L receptor expression in Xenopus oocytes, thiol-specific aqueous probe modification, and voltage-clamp electrophysiology to test whether etomidate inhibits probe reactions at the beta-265 sidechain. Using up to 300 mu M etomidate, we found both an absence of etomidate effects on alpha 1 beta 2N265C gamma 2L receptor activity and no inhibition of thiol modification. To gain further insight into anesthetic insensitive beta N265M mutants, we applied indirect structurefunction strategies, exploiting second mutations in alpha 1 beta 2/3 gamma 2L GABAA receptors. Using alpha 1M236C as a modifiable and anesthetic-protectable site occupancy reporter in beta+/alpha- interfaces, we found that beta N265M reduced apparent anesthetic affinity for receptors in both resting and GABA-activated states. beta N265M also impaired the transduction of gating effects associated with alpha 1M236W, a mutation that mimics beta+/alpha- anesthetic site occupancy. Our results show that beta N265M mutations dramatically reduce the efficacy/transduction of anesthetics bound in beta+/alpha- sites, and also significantly reduce anesthetic affinity for resting state receptors. These findings are consistent with a role for beta N265 in anesthetic binding within the beta+/alpha- transmembrane sites.	[Stewart, Deirdre S.; Pierce, David W.; Hotta, Mayo; Stern, Alex T.; Forman, Stuart A.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Forman, SA (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA.	saforman@partners.org	Forman, Stuart/Q-6590-2019	Forman, Stuart/0000-0001-6340-2478	National Institutes of General Medical Sciences Grant [R01GM089745]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089745, P01GM058448] Funding Source: NIH RePORTER	National Institutes of General Medical Sciences Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of General Medical Sciences Grant R01GM089745 to SAF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atucha E, 2009, BIOORG MED CHEM LETT, V19, P4284, DOI 10.1016/j.bmcl.2009.05.065; Bali M, 2004, MOL PHARMACOL, V65, P68, DOI 10.1124/mol.65.1.68; Bali M, 2012, J BIOL CHEM, V287, P27762, DOI 10.1074/jbc.M112.363341; Bali M, 2009, J NEUROSCI, V29, P3083, DOI 10.1523/JNEUROSCI.6090-08.2009; Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Baumann SW, 2001, J BIOL CHEM, V276, P36275, DOI 10.1074/jbc.M105240200; Belelli D, 1997, P NATL ACAD SCI USA, V94, P11031, DOI 10.1073/pnas.94.20.11031; Bertaccini EJ, 2013, ANESTHESIOLOGY, V119, P1087, DOI 10.1097/ALN.0b013e31829e47e3; Borghese CM, 2014, J NEUROCHEM, V128, P363, DOI 10.1111/jnc.12476; Borghese CM, 2012, ANESTHESIOLOGY, V117, P765, DOI 10.1097/ALN.0b013e31826a0d93; Chiara DC, 2013, J BIOL CHEM, V288, P19343, DOI 10.1074/jbc.M113.479725; Chiara DC, 2012, BIOCHEMISTRY-US, V51, P836, DOI 10.1021/bi201772m; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Desai R, 2009, ANESTHESIOLOGY, V111, P774, DOI 10.1097/ALN.0b013e3181b55fae; Foadi N, 2010, N-S ARCH PHARMACOL, V381, P477, DOI 10.1007/s00210-010-0506-9; Forman SA, 2012, METHODS MOL BIOL, V796, P317, DOI 10.1007/978-1-61779-334-9_17; Forman SA, 2011, CAN J ANESTH, V58, P191, DOI 10.1007/s12630-010-9419-9; Galzi JL, 1996, P NATL ACAD SCI USA, V93, P1853, DOI 10.1073/pnas.93.5.1853; GODEFROI EF, 1965, J MED CHEM, V8, P220, DOI 10.1021/jm00326a017; Guitchounts G, 2012, ANESTHESIOLOGY, V116, P1235, DOI 10.1097/ALN.0b013e3182567df3; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; HillVenning C, 1997, BRIT J PHARMACOL, V120, P749, DOI 10.1038/sj.bjp.0700927; Husain SS, 2006, J MED CHEM, V49, P4818, DOI 10.1021/jm051207b; Husain SS, 2010, J MED CHEM, V53, P6432, DOI 10.1021/jm100498u; Husain SS, 2003, J MED CHEM, V46, P1257, DOI 10.1021/jm020465v; Jansen M, 2006, J NEUROSCI, V26, P4492, DOI 10.1523/JNEUROSCI.0224-06.2006; Jayakar SS, 2014, J BIOL CHEM, V289, P27456, DOI 10.1074/jbc.M114.581728; Jurd R, 2002, FASEB J, V16, P250, DOI 10.1096/fj.02-0611fje; Kaur KH, 2009, J BIOL CHEM, V284, P7889, DOI 10.1074/jbc.M806484200; Krasowski MD, 2001, NEUROPHARMACOLOGY, V41, P952, DOI 10.1016/S0028-3908(01)00141-1; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Li GD, 2010, J BIOL CHEM, V285, P8615, DOI 10.1074/jbc.M109.074708; Li JN, 2011, PROTEINS, V79, P2794, DOI 10.1002/prot.23106; Lynagh T, 2014, J NEUROSCI, V34, P2155, DOI 10.1523/JNEUROSCI.4307-13.2014; Lynagh T, 2012, TRENDS PHARMACOL SCI, V33, P432, DOI 10.1016/j.tips.2012.05.002; McCracken ML, 2010, J PHARMACOL EXP THER, V335, P600, DOI 10.1124/jpet.110.170472; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Miller PS, 2014, NATURE, DOI [10.1038/nature13293:1-8, DOI 10.1038/NATURE13293:1-8]; Nishikawa K, 2002, NEUROPHARMACOLOGY, V42, P337, DOI 10.1016/S0028-3908(01)00189-7; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Pejo E, 2014, ANESTHESIOLOGY, V121, P290, DOI 10.1097/ALN.0000000000000268; Ruesch D, 2012, ANESTHESIOLOGY, V116, P47, DOI 10.1097/ALN.0b013e31823d0c36; Rusch D, 2004, J BIOL CHEM, V279, P20982, DOI 10.1074/jbc.M400472200; Sauguet L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2682; Savechenkov PY, 2012, J MED CHEM, V55, P6554, DOI 10.1021/jm300631e; Siegwart R, 2002, J NEUROCHEM, V80, P140, DOI 10.1046/j.0022-3042.2001.00682.x; Siegwart Roberta, 2003, BMC Pharmacol, V3, P13, DOI 10.1186/1471-2210-3-13; Spurny R, 2013, J BIOL CHEM, V288, P8355, DOI 10.1074/jbc.M112.424507; Stewart D, 2008, MOL PHARMACOL, V74, P1687, DOI 10.1124/mol.108.050500; Stewart DS, 2013, J BIOL CHEM, V288, P30373, DOI 10.1074/jbc.M113.494583; Stewart DS, 2013, MOL PHARMACOL, V83, P1200, DOI 10.1124/mol.112.084558; Yip GMS, 2013, NAT CHEM BIOL, V9, P715, DOI [10.1038/NCHEMBIO.1340, 10.1038/nchembio.1340]; Zeller Anja, 2007, BMC Pharmacology, V7, P2, DOI 10.1186/1471-2210-7-2	54	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111470	10.1371/journal.pone.0111470	http://dx.doi.org/10.1371/journal.pone.0111470			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347186	gold, Green Published, Green Submitted			2022-12-27	WOS:000347994900078
J	Huang, S; Rossi, S; Hamalainen, M; Ahveninen, J				Huang, Samantha; Rossi, Stephanie; Haemaelaeinen, Matti; Ahveninen, Jyrki			Auditory Conflict Resolution Correlates with Medial-Lateral Frontal Theta/Alpha Phase Synchrony	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; PREFRONTAL CORTEX; COGNITIVE CONTROL; NEURONAL SYNCHRONIZATION; RESPONSE CONFLICT; VISUAL-ATTENTION; THETA; GAMMA; TASK; OSCILLATIONS	When multiple persons speak simultaneously, it may be difficult for the listener to direct attention to correct sound objects among conflicting ones. This could occur, for example, in an emergency situation in which one hears conflicting instructions and the loudest, instead of the wisest, voice prevails. Here, we used cortically-constrained oscillatory MEG/EEG estimates to examine how different brain regions, including caudal anterior cingulate (cACC) and dorsolateral prefrontal cortices (DLPFC), work together to resolve these kinds of auditory conflicts. During an auditory flanker interference task, subjects were presented with sound patterns consisting of three different voices, from three different directions (45 degrees left, straight ahead, 45 degrees right), sounding out either the letters "A'' or "O''. They were asked to discriminate which sound was presented centrally and ignore the flanking distracters that were phonetically either congruent (50%) or incongruent (50%) with the target. Our cortical MEG/EEG oscillatory estimates demonstrated a direct relationship between performance and brain activity, showing that efficient conflict resolution, as measured with reduced conflict-induced RT lags, is predicted by theta/alpha phase coupling between cACC and right lateral frontal cortex regions intersecting the right frontal eye fields (FEF) and DLPFC, as well as by increased pre-stimulus gamma (60-110 Hz) power in the left inferior fontal cortex. Notably, cACC connectivity patterns that correlated with behavioral conflict-resolution measures were found during both the pre-stimulus and the pre-response periods. Our data provide evidence that, instead of being only transiently activated upon conflict detection, cACC is involved in sustained engagement of attentional resources required for effective sound object selection performance.	[Huang, Samantha; Rossi, Stephanie; Haemaelaeinen, Matti; Ahveninen, Jyrki] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Athinoula A Martinos Ctr Biomed Imaging,Dept Radi, Charlestown, MA 02129 USA; [Haemaelaeinen, Matti] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT)	Huang, S (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Athinoula A Martinos Ctr Biomed Imaging,Dept Radi, Charlestown, MA 02129 USA.	samhuang@nmr.mgh.harvard.edu	Hamalainen, Matti S/C-8507-2013		National Institutes of Health [R01MH083744, R21DC010060, R21DC014134, R01HD040712, R01NS037462, 5R01EB009048]; National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health; National Center for Research Resources Shared Instrumentation Grants [S10RR014978, S10RR021110, S10RR019307, S10RR014798, S10RR023401]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040712] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013218, S10RR014798, S10RR021110, S10RR002340, S10RR019307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015896, R01EB009048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC010060, R21DC014134] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Center for Research Resources Shared Instrumentation Grants; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health Awards R01MH083744, R21DC010060, R21DC014134, R01HD040712, R01NS037462, and 5R01EB009048. This research was carried out at the Athinoula A. Martinos Center for Biomedical Imaging at the Massachusetts General Hospital, using resources provided by the Center for Functional Neuroimaging Technologies, P41EB015896, and a P41 Biotechnology Resource Grant supported by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health. The research environment was additionally supported by National Center for Research Resources Shared Instrumentation Grants S10RR014978, S10RR021110, S10RR019307, S10RR014798, and S10RR023401. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahveninen J, 2013, J COGNITIVE NEUROSCI, V25, P1926, DOI 10.1162/jocn_a_00452; Ahveninen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038511; Alain C, 2000, FRONT BIOSCI-LANDMRK, V5, pD202, DOI 10.2741/Alain; Algazi VR, 2001, IEEE WORKSH APPL SIG, V2001, P99, DOI [DOI 10.1109/ASPAA.2001.969552, 10.1155/S1463924601000141]; Badre D, 2005, NEURON, V47, P907, DOI 10.1016/j.neuron.2005.07.023; Badre D, 2004, NEURON, V41, P473, DOI 10.1016/S0896-6273(03)00851-1; Bar M, 2004, NAT REV NEUROSCI, V5, P617, DOI 10.1038/nrn1476; Barbas H, 2000, BRAIN RES BULL, V52, P319, DOI 10.1016/S0361-9230(99)00245-2; Benedict RHB, 2002, J COGNITIVE NEUROSCI, V14, P637, DOI 10.1162/08989290260045765; Benes FM, 2009, CINGULATE NEUROBIOLO, P679; Bibbig A, 2002, J NEUROPHYSIOL, V88, P1634, DOI 10.1152/jn.2002.88.4.1634; Biehl SC, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-107; Bland JM, 1996, BRIT MED J, V312, P770; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Casey BJ, 2000, P NATL ACAD SCI USA, V97, P8728, DOI 10.1073/pnas.97.15.8728; Chan JS, 2005, ACTA ACUST UNITED AC, V91, P554; Christoffels IK, 2007, HUM BRAIN MAPP, V28, P868, DOI 10.1002/hbm.20315; Cohen MX, 2013, J NEUROPHYSIOL, V110, P2752, DOI 10.1152/jn.00479.2013; Cohen MX, 2014, ISS CLIN COGN NEUROP, P15; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; DeWitt I, 2012, P NATL ACAD SCI USA, V109, pE505, DOI 10.1073/pnas.1113427109; Doesburg SM, 2012, BRAIN RES, V1431, P77, DOI 10.1016/j.brainres.2011.11.005; Doesburg SM, 2009, BRAIN RES, V1303, P97, DOI 10.1016/j.brainres.2009.09.069; Durston S, 2003, NEUROIMAGE, V20, P2135, DOI 10.1016/j.neuroimage.2003.08.004; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Espinoza-Varas B, 2011, PSYCHOL RES-PSYCH FO, V75, P159, DOI 10.1007/s00426-010-0295-2; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fan J, 2003, NEUROIMAGE, V18, P42, DOI 10.1006/nimg.2002.1319; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Fries P, 2008, J NEUROSCI, V28, P4823, DOI 10.1523/JNEUROSCI.4499-07.2008; Ghosh SS, 2010, NEUROIMAGE, V53, P85, DOI 10.1016/j.neuroimage.2010.05.075; Gramfort A, 2013, NEUROIMAGE; Gross J, 2004, P NATL ACAD SCI USA, V101, P13050, DOI 10.1073/pnas.0404944101; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hamalainen M. S., 2010, MEG INTRO METHODS, P186, DOI [10.1093/acprof:oso/9780195307238.003., DOI 10.1093/ACPROF:OSO/9780195307238.003, DOI 10.1093/ACPROF:OSO/9780195307238.003.0008]; Haupt S, 2009, HUM BRAIN MAPP, V30, P3043, DOI 10.1002/hbm.20731; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Huang S, 2014, NEUROIMAGE, V86, P461, DOI 10.1016/j.neuroimage.2013.10.043; Huang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044062; Jaaskelainen IP, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/216731; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Johansen-Berg H, 2004, P NATL ACAD SCI USA, V101, P13335, DOI 10.1073/pnas.0403743101; Johnston K, 2007, NEURON, V53, P453, DOI 10.1016/j.neuron.2006.12.023; Jonides J, 1998, P NATL ACAD SCI USA, V95, P8410, DOI 10.1073/pnas.95.14.8410; Kaiser J, 2003, NEUROIMAGE, V20, P816, DOI 10.1016/S1053-8119(03)00350-1; Kenet T, 2012, NEUROIMAGE, V61, P1226, DOI 10.1016/j.neuroimage.2012.03.010; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Klauschen F, 2009, HUM BRAIN MAPP, V30, P1310, DOI 10.1002/hbm.20599; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Kopp B, 1996, PSYCHOPHYSIOLOGY, V33, P282, DOI 10.1111/j.1469-8986.1996.tb00425.x; Larson E, 2013, NEUROIMAGE, V64, P365, DOI 10.1016/j.neuroimage.2012.09.006; Larson MJ, 2014, INT J PSYCHOPHYSIOL, V93, P283, DOI 10.1016/j.ijpsycho.2014.06.007; Lesh TA, 2013, NEUROIMAGE-CLIN, V2, P590, DOI 10.1016/j.nicl.2013.04.010; Liu X, 2004, NEUROIMAGE, V22, P1097, DOI 10.1016/j.neuroimage.2004.02.033; Luks TL, 2007, NEUROIMAGE, V35, P949, DOI 10.1016/j.neuroimage.2006.11.041; LUPPINO G, 1993, J COMP NEUROL, V338, P114, DOI 10.1002/cne.903380109; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Machado L, 2013, Q J EXP PSYCHOL, V66, P138, DOI 10.1080/17470218.2012.701651; Mainy N, 2007, HUM BRAIN MAPP, V28, P183, DOI 10.1002/hbm.20264; Mayr U, 2003, NAT NEUROSCI, V6, P450, DOI 10.1038/nn1051; Miller EK, 2013, CURR OPIN NEUROBIOL, V23, P216, DOI 10.1016/j.conb.2012.11.011; Moore RA, 2006, INT J PSYCHOPHYSIOL, V60, P260, DOI 10.1016/j.ijpsycho.2005.06.003; Morris R, 1999, J COMP NEUROL, V407, P183, DOI 10.1002/(SICI)1096-9861(19990503)407:2<183::AID-CNE3>3.0.CO;2-N; Nigbur R, 2012, J COGNITIVE NEUROSCI, V24, P1264, DOI 10.1162/jocn_a_00128; Orr JM, 2009, CEREB CORTEX, V19, P703, DOI 10.1093/cercor/bhn119; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Percival Donald B., 1993, SPECTRAL ANAL PHYS A; PETRIDES M, 1984, J COMP NEUROL, V228, P105, DOI 10.1002/cne.902280110; Roberts KL, 2008, J COGNITIVE NEUROSCI, V20, P1063, DOI 10.1162/jocn.2008.20074; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Sauseng P, 2007, EUR J NEUROSCI, V25, P587, DOI 10.1111/j.1460-9568.2006.05286.x; Schack B, 2005, INT J PSYCHOPHYSIOL, V57, P105, DOI 10.1016/j.ijpsycho.2005.03.016; Sharon D, 2007, NEUROIMAGE, V36, P1225, DOI 10.1016/j.neuroimage.2007.03.066; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Shinn-Cunningham BG, 2008, TRENDS COGN SCI, V12, P182, DOI 10.1016/j.tics.2008.02.003; SIMON JR, 1967, J APPL PSYCHOL, V51, P300, DOI 10.1037/h0020586; Soutschek A, 2013, J NEUROSCI, V33, P5647, DOI 10.1523/JNEUROSCI.4768-12.2013; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Szmalec A, 2008, NEUROSCI LETT, V435, P158, DOI 10.1016/j.neulet.2008.02.023; Szucs D, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-35; Taulu S, 2005, IEEE T SIGNAL PROCES, V53, P3359, DOI 10.1109/TSP.2005.853302; Totah NKB, 2012, CEREBRAL CORTEX; van Driel J, 2012, J NEUROSCI, V32, P16795, DOI 10.1523/JNEUROSCI.0802-12.2012; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vinck M, 2011, NEUROIMAGE, V55, P1548, DOI 10.1016/j.neuroimage.2011.01.055; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Weissman DH, 2005, CEREB CORTEX, V15, P229, DOI 10.1093/cercor/bhh125; Westerhausen R, 2010, NEUROPSYCHOLOGIA, V48, P2075, DOI 10.1016/j.neuropsychologia.2010.03.028; Womelsdorf T, 2007, CURR OPIN NEUROBIOL, V17, P154, DOI 10.1016/j.conb.2007.02.002; Womelsdorf T, 2010, P NATL ACAD SCI USA, V107, P5248, DOI 10.1073/pnas.0906194107; Yendiki A, 2010, NEUROIMAGE, V53, P119, DOI 10.1016/j.neuroimage.2010.02.084; Yoncheva YN, 2010, CEREB CORTEX, V20, P622, DOI 10.1093/cercor/bhp129	109	9	9	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110989	10.1371/journal.pone.0110989	http://dx.doi.org/10.1371/journal.pone.0110989			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BL	25343503	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943500071
J	Komulainen, E; Meskanen, K; Lipsanen, J; Lahti, JM; Jylha, P; Melartin, T; Wichers, M; Isometsa, E; Ekelund, J				Komulainen, Emma; Meskanen, Katarina; Lipsanen, Jari; Lahti, Jari Marko; Jylha, Pekka; Melartin, Tarja; Wichers, Marieke; Isometsa, Erkki; Ekelund, Jesper			The Effect of Personality on Daily Life Emotional Processes	PLOS ONE			English	Article							ECOLOGICAL MOMENTARY ASSESSMENT; POPULATION-BASED TWIN; MAJOR DEPRESSION; INTERNALIZING DISORDERS; MENTAL-DISORDERS; 5-FACTOR MODEL; EVERYDAY LIFE; NEUROTICISM; EXTROVERSION; REACTIVITY	Personality features are associated with individual differences in daily emotional life, such as negative and positive affectivity, affect variability and affect reactivity. The existing literature is somewhat mixed and inconclusive about the nature of these associations. The aim of this study was to shed light on what personality features represent in daily life by investigating the effect of the Five Factor traits on different daily emotional processes using an ecologically valid method. The Experience Sampling Method was used to collect repeated reports of daily affect and experiences from 104 healthy university students during one week of their normal lives. Personality traits of the Five Factor model were assessed using NEO Five Factor Inventory. Hierarchical linear modeling was used to analyze the effect of the personality traits on daily emotional processes. Neuroticism predicted higher negative and lower positive affect, higher affect variability, more negative subjective evaluations of daily incidents, and higher reactivity to stressors. Conscientiousness, by contrast, predicted lower average level, variability, and reactivity of negative affect. Agreeableness was associated with higher positive and lower negative affect, lower variability of sadness, and more positive subjective evaluations of daily incidents. Extraversion predicted higher positive affect and more positive subjective evaluations of daily activities. Openness had no effect on average level of affect, but predicted higher reactivity to daily stressors. The results show that the personality features independently predict different aspects of daily emotional processes. Neuroticism was associated with all of the processes. Identifying these processes can help us to better understand individual differences in daily emotional life.	[Komulainen, Emma; Meskanen, Katarina; Ekelund, Jesper] Univ Helsinki, Dept Psychiat, SF-00180 Helsinki, Finland; [Lipsanen, Jari; Lahti, Jari Marko] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Meskanen, Katarina; Melartin, Tarja; Isometsa, Erkki] Univ Helsinki, Dept Psychiat, Cent Hosp, Hosp Dist Helsinki & Uusimaa, SF-00180 Helsinki, Finland; [Jylha, Pekka] Univ Helsinki, Dept Psychiat, Cent Hosp, Hosp Dist Helsinki & Uusimaa,Jorvi Hosp, SF-00180 Helsinki, Finland; [Lahti, Jari Marko] Folkhalsan Res Ctr, Helsinki, Finland; [Ekelund, Jesper] Vaasa Hosp Dist, Dept Psychiat, Vaasa, Finland; [Jylha, Pekka] Natl Inst Hlth & Welf, Dept Mental Hlth & Substance, Abuse Serv, Helsinki, Finland; [Wichers, Marieke] Maastricht Univ, Dept Psychiat & Psychol, Sch Mental Hlth & Neurosci, Maastricht, Netherlands	University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; Finland National Institute for Health & Welfare; Maastricht University	Ekelund, J (corresponding author), Univ Helsinki, Dept Psychiat, SF-00180 Helsinki, Finland.	jesper.ekelund@helsinki.fi	Wichers, Marieke/N-6667-2014; Lahti, Jari/P-2283-2019; Lahti, Jari/P-7987-2018; Isometsa, Erkki/K-8579-2014	Wichers, Marieke/0000-0001-5024-9064; Lahti, Jari/0000-0002-4310-5297; Lahti, Jari/0000-0002-4310-5297; Isometsa, Erkki/0000-0001-5956-2399; Lipsanen, Jari Olavi/0000-0003-0746-2745	Academy of Finland [250935]	Academy of Finland(Academy of Finland)	This research was supported by Academy of Finland (grant number 250935). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOLGER N, 1991, J PERS, V59, P355, DOI 10.1111/j.1467-6494.1991.tb00253.x; BOLGER N, 1995, J PERS SOC PSYCHOL, V69, P890, DOI 10.1037/0022-3514.69.5.890; Broderick Joan E, 2008, Pharmaceut Med, V22, P69; Canli T, 2002, SCIENCE, V296, P2191, DOI 10.1126/science.1068749; Chan SWY, 2007, PSYCHOL MED, V37, P1281, DOI 10.1017/S0033291707000669; Claridge G, 2001, PERS INDIV DIFFER, V31, P383, DOI 10.1016/S0191-8869(00)00144-6; CLARK LA, 1994, J ABNORM PSYCHOL, V103, P103, DOI 10.1037/0021-843X.103.1.103; Costa P.T., 2008, SAGE HDB PERSONALITY, P179, DOI [10.4135/9781849200479.n9, DOI 10.4135/9781849200479.N9, 10.4135/9781849200479.N9]; COSTA PT, 1980, J PERS SOC PSYCHOL, V38, P668, DOI 10.1037/0022-3514.38.4.668; CSIKSZENTMIHALYI M, 1987, J NERV MENT DIS, V175, P526, DOI 10.1097/00005053-198709000-00004; David JP, 1997, J PERS SOC PSYCHOL, V73, P149, DOI 10.1037/0022-3514.73.1.149; DeNeve KM, 1998, PSYCHOL BULL, V124, P197, DOI 10.1037/0033-2909.124.2.197; Fanous AH, 2007, PSYCHOL MED, V37, P1163, DOI 10.1017/S0033291707000244; First MB, 2002, STRUCTURED CLIN INTE; Gomez R, 2000, PERS INDIV DIFFER, V29, P351, DOI 10.1016/S0191-8869(99)00198-1; Griffith JW, 2010, PSYCHOL MED, V40, P1125, DOI 10.1017/S0033291709991449; Hamalainen M, 1994, NESTA PERSOONALLISUU; Hektner JM, 2007, EXPERIENCE SAMPLING; Hettema JM, 2006, AM J PSYCHIAT, V163, P857, DOI 10.1176/appi.ajp.163.5.857; Jacobs N, 2011, BRIT J CLIN PSYCHOL, V50, P19, DOI 10.1348/014466510X491397; Jylha P, 2006, DEPRESS ANXIETY, V23, P281, DOI 10.1002/da.20167; Kendler KS, 2014, PSYCHOL MED, V44, P647, DOI 10.1017/S0033291713000585; Kendler KS, 2006, ARCH GEN PSYCHIAT, V63, P1113, DOI 10.1001/archpsyc.63.10.1113; Kendler KS, 2004, AM J PSYCHIAT, V161, P631, DOI 10.1176/appi.ajp.161.4.631; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P853; Kessler RC, 2011, ARCH GEN PSYCHIAT, V68, P90, DOI 10.1001/archgenpsychiatry.2010.180; Klein DN, 2011, ANNU REV CLIN PSYCHO, V7, P269, DOI 10.1146/annurev-clinpsy-032210-104540; Kotov R, 2010, PSYCHOL BULL, V136, P768, DOI 10.1037/a0020327; Kramer MD, 2008, PSYCHOL MED, V38, P51, DOI 10.1017/S0033291707001572; Krueger RF, 2001, PERS INDIV DIFFER, V30, P1245, DOI 10.1016/S0191-8869(00)00106-9; Krueger RF, 1999, ARCH GEN PSYCHIAT, V56, P921, DOI 10.1001/archpsyc.56.10.921; Kuppens P, 2007, EMOTION, V7, P262, DOI 10.1037/1528-3542.7.2.262; Larsen R. J., 1992, EMOTION, P25; Longua J, 2009, J RES PERS, V43, P547, DOI 10.1016/j.jrp.2009.02.006; Lucas RE, 2000, J PERS SOC PSYCHOL, V79, P1039, DOI 10.1037//0022-3514.79.6.1039; Lucas RE, 2004, J PERS SOC PSYCHOL, V86, P473, DOI 10.1037/0022-3514.86.3.473; McConville C, 1999, PERS INDIV DIFFER, V26, P65; MCCRAE RR, 1992, J PERS, V60, P175, DOI 10.1111/j.1467-6494.1992.tb00970.x; MCCRAE RR, 1987, J PERS SOC PSYCHOL, V52, P81, DOI 10.1037/0022-3514.52.1.81; MCFATTER RM, 1994, J PERS SOC PSYCHOL, V66, P570, DOI 10.1037/0022-3514.66.3.570; Miller DJ, 2009, PERS INDIV DIFFER, V47, P873, DOI 10.1016/j.paid.2009.07.007; Miller JD, 2006, AM J PSYCHIAT, V163, P839, DOI 10.1176/appi.ajp.163.5.839; Mroczek DK, 2004, J PERS, V72, P355, DOI 10.1111/j.0022-3506.2004.00265.x; ORMEL J, 1991, J PERS SOC PSYCHOL, V60, P744, DOI 10.1037/0022-3514.60.5.744; Ormel J, 2004, ARCH GEN PSYCHIAT, V61, P990, DOI 10.1001/archpsyc.61.10.990; Ormel J, 2001, AM J PSYCHIAT, V158, P885, DOI 10.1176/appi.ajp.158.6.885; Ormel J, 2004, SOC PSYCH PSYCH EPID, V39, P906, DOI 10.1007/s00127-004-0873-y; Ormel J, 2013, NEUROSCI BIOBEHAV R, V37, P59, DOI 10.1016/j.neubiorev.2012.09.004; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Schwartz JE, 1998, HEALTH PSYCHOL, V17, P6, DOI 10.1037/0278-6133.17.1.6; Shiffman S, 2008, ANNU REV CLIN PSYCHO, V4, P1, DOI 10.1146/annurev.clinpsy.3.022806.091415; Smillie LD, 2012, J PERS SOC PSYCHOL, V103, P306, DOI 10.1037/a0028372; Steel P, 2008, PSYCHOL BULL, V134, P138, DOI 10.1037/0033-2909.134.1.138; Sullivan LM, 1999, STAT MED, V18, P855, DOI 10.1002/(SICI)1097-0258(19990415)18:7<855::AID-SIM117>3.0.CO;2-7; Suls J, 1998, PERS SOC PSYCHOL B, V24, P127, DOI 10.1177/0146167298242002; Tong EMW, 2006, PERS INDIV DIFFER, V41, P513, DOI 10.1016/j.paid.2006.01.018; Tong EMW, 2010, J PERS, V78, DOI 10.1111/j.1467-6494.2010.00620.x; Watson D, 1999, J PERS SOC PSYCHOL, V76, P820, DOI 10.1037/0022-3514.76.5.820; WATSON D, 1984, PSYCHOL BULL, V96, P465, DOI 10.1037/0033-2909.96.3.465; Wichers M, 2010, J AFFECT DISORDERS, V124, P191, DOI 10.1016/j.jad.2009.11.010; Wichers MC, 2009, NEUROPSYCHOPHARMACOL, V34, P923, DOI 10.1038/npp.2008.66; Wichers MC, 2007, ACTA PSYCHIAT SCAND, V115, P451, DOI 10.1111/j.1600-0447.2006.00924.x; Yuan JJ, 2012, COGN AFFECT BEHAV NE, V12, P175, DOI 10.3758/s13415-011-0064-8; Zautra AJ, 2005, J PERS, V73, P1511, DOI 10.1111/j.0022-3506.2005.00357.x	64	50	50	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110907	10.1371/journal.pone.0110907	http://dx.doi.org/10.1371/journal.pone.0110907			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BL	25343494	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943500065
J	Ehman, M; Flood, J; Barry, PM				Ehman, Melissa; Flood, Jennifer; Barry, Pennan M.			Tuberculosis Treatment Managed by Providers outside the Public Health Department: Lessons for the Affordable Care Act	PLOS ONE			English	Article							SURVEILLANCE DATA; DRUG-RESISTANCE; UNITED-STATES; CALIFORNIA; OUTCOMES; ASSOCIATION; REGRESSION; IMPACT; DELAYS; RATES	Introduction: Tuberculosis (TB) requires at least six months of multidrug treatment and necessitates monitoring for response to treatment. Historically, public health departments (HDs) have cared for most TB patients in the United States. The Affordable Care Act (ACA) provides coverage for uninsured persons and may increase the proportion of TB patients cared for by private medical providers and other providers outside HDs (PMPs). We sought to determine whether there were differences in care provided by HDs and PMPs to inform public health planning under the ACA. Methods: We conducted a retrospective, cross-sectional analysis of California TB registry data. We included adult TB patients with culture-positive, pulmonary TB reported in California during 2007-2011. We examined trends, described case characteristics, and created multivariate models measuring two standards of TB care in PMP- and HD-managed patients: documented culture conversion within 60 days, and use of directly observed therapy (DOT). Results: The proportion of PMP-managed TB patients increased during 2007-2011 (p = 0.002). On univariable analysis (N = 4,606), older age, white, black or Asian/Pacific Islander race, and birth in the United States were significantly associated with PMP care (p < 0.05). Younger age, Hispanic ethnicity, homelessness, drug or alcohol use, and cavitary and/or smear-positive TB disease, were associated with HD care. Multivariable analysis showed PMP care was associated with lack of documented culture conversion (adjusted relative risk [aRR] = 1.37, confidence interval [CI] 1.25-1.51) and lack of DOT (aRR = 8.56, CI 6.59-11.1). Conclusion: While HDs cared for TB cases with more social and clinical complexities, patients under PMP care were less likely to receive DOT and have documented culture conversion. This indicates a need for close collaboration between PMPs and HDs to ensure that optimal care is provided to all TB patients and TB transmission is halted. Strategies to enhance collaboration between HDs and PMPs should be included in ACA implementation.	[Ehman, Melissa; Flood, Jennifer; Barry, Pennan M.] Calif Dept Publ Hlth, Ctr Infect Dis, Div Communicable Dis Control, TB Control Branch, Richmond, CA 94804 USA; [Ehman, Melissa] Univ Calif San Francisco, Inst Global Hlth, San Francisco, CA 94143 USA	California Department of Public Health; University of California System; University of California San Francisco	Ehman, M (corresponding author), Calif Dept Publ Hlth, Ctr Infect Dis, Div Communicable Dis Control, TB Control Branch, Richmond, CA 94804 USA.	Melissa.Ehman@cdph.ca.gov						American Thoracic Society, 2003, MMWR Recomm Rep, V52, P1; [Anonymous], 2012, SAS VERS 9 3; Binkin NJ, 1999, INT J TUBERC LUNG D, V3, P663; California Department of Health Services (CDHS), 2013, MED RAT; California Department of Public Health California Tuberculosis Controller's Association, 2011, GUID DIR OBS THER PR; Cass Anne, 2013, Public Health Rep, V128, P367, DOI 10.1177/003335491312800507; Centers for Disease Control and Prevention, 2009, 729A CDCP; Centers for Disease Control and Prevention, 2003, 729A CDCP; Centers for Disease Control and Prevention (CDC), 2012, REP TUB US 2011; Curry International Tuberculosis Center, 2012, ENG PRIV SECT TB PRE; Davidow AL, 2009, PUBLIC HEALTH REP, V124, P391, DOI 10.1177/003335490912400308; Ehman M, 2013, J PUBLIC HEALTH MAN, V19, pE29, DOI 10.1097/PHH.0b013e3182751d6f; Erwin PC, 2011, AM J PUBLIC HEALTH, V101, P609, DOI 10.2105/AJPH.2009.177451; Golub JE, 2005, INT J TUBERC LUNG D, V9, P992; Handford CD, 2012, AIDS CARE, V24, P267, DOI 10.1080/09540121.2011.608419; Honda H, 2010, AM J MED, V123, P631, DOI 10.1016/j.amjmed.2010.01.015; Hughes S., 2010, Morbidity and Mortality Weekly Report, V59, P295; *I MED, 2000, END NEGL EL TUB US; Jenkins TC, 2008, CLIN INFECT DIS, V46, P1000, DOI 10.1086/529190; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Kong DG, 2013, J PUBLIC HEALTH MAN, V19, P169, DOI 10.1097/PHH.0b013e3182550a83; Liu ZY, 1998, CHEST, V113, P1446, DOI 10.1378/chest.113.6.1446; Liu ZY, 1999, ARCH INTERN MED, V159, P1110, DOI 10.1001/archinte.159.10.1110; Mays Glen P, 2004, J Public Health Manag Pract, V10, P435; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Moonan PK, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-19; National Cancer Institute, 2013, JOINP REGR PROGR VER; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Porco TC, 2013, CLIN INFECT DIS, V56, P761, DOI 10.1093/cid/cis989; Rao SN, 2000, CHEST, V117, P734, DOI 10.1378/chest.117.3.734; Richardson N L, 2000, J Contin Educ Health Prof, V20, P146, DOI 10.1002/chp.1340200303; SBARBARO JA, 1970, AM REV RESPIR DIS, V101, P463; Schmitt S, 2014, CLIN INFECT DIS, V58, P22, DOI 10.1093/cid/cit610; Silin M, 2010, J PUBLIC HEALTH MAN, V16, pE9, DOI 10.1097/PHH.0b013e3181c87ae5; Sprinson JE, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-217; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; Tuberculosis Control Branch, 2013, REP TUB CAL 2012; WEIS SE, 1994, NEW ENGL J MED, V330, P1179, DOI 10.1056/NEJM199404283301702; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	40	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110645	10.1371/journal.pone.0110645	http://dx.doi.org/10.1371/journal.pone.0110645			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR5ZY	25340876	gold, Green Published, Green Submitted			2022-12-27	WOS:000343662800045
J	Huang, YC; Tsai, YH; Lee, JD; Weng, HH; Lin, LC; Lin, YH; Wu, CY; Huang, YC; Hsu, HL; Lee, M; Yang, HT; Hsu, CY; Pan, YT; Yang, JT				Huang, Yen-Chu; Tsai, Yuan-Hsiung; Lee, Jiann-Der; Weng, Hsu-Huei; Lin, Leng-Chieh; Lin, Ya-Hui; Wu, Chih-Ying; Huang, Ying-Chih; Hsu, Huan-Lin; Lee, Meng; Yang, Hsin-Ta; Hsu, Chia-Yu; Pan, Yi-Ting; Yang, Jen-Tsung			Hemodynamic Factors May Play a Critical Role in Neurological Deterioration Occurring within 72 hrs after Lacunar Stroke	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; SMALL VESSEL DISEASE; PROGRESSIVE MOTOR DEFICITS; LENTICULOSTRIATE ARTERY; DIFFUSION; INFARCTION; THROMBOLYSIS; PREDICTION; TERRITORY; ASPIRIN	Background: Whether a perfusion defect exists in lacunar infarct and whether it is related to early neurological deterioration (END) is still under debate. The aim of this study was to evaluate whether END in lacunar infarct is related to a perfusion defect using diffusion-weighted imaging (DWI), diffusion tensor imaging (DTI) and perfusion MR imaging. Methods: One hundred and forty-one consecutive patients had an MRI scan within 30 hours after onset of symptoms and 43 patients with acute lacunar infarct and classic lacunar syndrome were recruited. The MRI sequences included DWI, DTI and cerebral blood flow (CBF) maps to respectively represent the topographic locations of acute infarcts, the corticospinal tract and perfusion defects. The END was defined in reference to the National Institute of Health Stroke Scale (NIHSS) as an increase >= 2 within 72 hours. Cohen's Kappa coefficient was used to examine the reliability between the 2 image readers. A multivariate logistic regression model was constructed adjusting for baseline variables. Results: Ten out of the 43 patients had END. Patients having END was significantly associated with lower chances of favorable and good outcomes at 3 months (p = 0.01 and p = 0.002, respectively). END was predicted when the non-core hypoperfused area overlapped on the corticospinal tract, which is defined as the expected END profile. Cohen's Kappa coefficient between the 2 image readers to define images of expected END profiles was 0.74. In 15 patients with expected END profile, 9 had END clinically, whereas 28 patients had no expected END profile, and only 1 patient had END (p<0.0001). After adjusting for sex, the expected END profile was still associated with END (odds ratio, 42.2; p = 0.002). Conclusion: Our study demonstrated that the END in acute lacunar stroke is likely related to the transformation of non-core hypoperfused area into infarction in the anatomy of corticospinal tracts.	[Huang, Yen-Chu; Lee, Jiann-Der; Lin, Ya-Hui; Wu, Chih-Ying; Huang, Ying-Chih; Hsu, Huan-Lin; Lee, Meng; Yang, Hsin-Ta; Hsu, Chia-Yu; Pan, Yi-Ting] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp Chiayi, Dept Neurol, Chiayi, Taiwan; [Tsai, Yuan-Hsiung; Weng, Hsu-Huei] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp Chiayi, Dept Diagnost Radiol, Chiayi, Taiwan; [Yang, Jen-Tsung] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp Chiayi, Dept Neurosurg, Chiayi, Taiwan; [Lin, Leng-Chieh] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp Chiayi, Dept Emergency Med, Chiayi, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Yang, JT (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp Chiayi, Dept Neurosurg, Chiayi, Taiwan.	jents716@ms32.hinet.net	Huang, Yenchu/AAO-1140-2020; Weng, Hsu-Huei/N-8329-2014	Weng, Hsu-Huei/0000-0002-2020-8912	Chang Gung Memorial Hospital [CMRPG690451, CMRPG690452, CORPG690453]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by Chang Gung Memorial Hospital grants CMRPG690451, CMRPG690452 and CORPG690453. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Alawneh JA, 2011, BRAIN, V134, P1765, DOI 10.1093/brain/awr100; Alawneh JA, 2009, STROKE, V40, pE443, DOI 10.1161/STROKEAHA.108.532465; Arenillas JF, 2002, STROKE, V33, P2197, DOI 10.1161/01.STR.0000027861.75884.DF; Cocho D, 2006, EUR NEUROL, V55, P70, DOI 10.1159/000091982; Del BA, 2012, INT J STROKE, V7, P321; FISHER CM, 1982, NEUROLOGY, V32, P871, DOI 10.1212/WNL.32.8.871; Fuentes B, 2012, EUR J NEUROL, V19, P1568, DOI 10.1111/j.1468-1331.2012.03790.x; Gerraty RP, 2002, STROKE, V33, P2019, DOI 10.1161/01.STR.0000020841.74704.5B; Huang YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069085; Hwang YH, 2008, CEREBROVASC DIS, V26, P355, DOI 10.1159/000151638; Lai C, 2007, BRIT J RADIOL, V80, P782, DOI 10.1259/bjr/99366083; Lee JS, 2005, NEUROIMAGE, V26, P771, DOI 10.1016/j.neuroimage.2005.02.036; Mustanoja S, 2011, STROKE, V42, P102, DOI 10.1161/STROKEAHA.110.597534; Nakamura T, 2012, J NEUROL SCI, V313, P22, DOI 10.1016/j.jns.2011.09.038; Ohara T, 2010, J NEUROL SCI, V293, P87, DOI 10.1016/j.jns.2010.02.027; Ois A, 2008, CEREBROVASC DIS, V25, P151, DOI 10.1159/000113732; Poppe AY, 2009, CEREBROVASC DIS, V28, P151, DOI 10.1159/000225908; Siegler JE, 2011, INT J STROKE, V6, P211, DOI 10.1111/j.1747-4949.2011.00596.x; Steinke W, 2002, STROKE, V33, P1510, DOI 10.1161/01.STR.0000016326.78014.FE; Takase K, 2011, EUR NEUROL, V65, P355, DOI 10.1159/000327980; Terasawa Y, 2008, J NEUROL SCI, V269, P35, DOI 10.1016/j.jns.2007.12.014; Wang QS, 2012, ARCH NEUROL-CHICAGO, V69, P1454, DOI 10.1001/archneurol.2012.1633; Wang YJ, 2013, NEW ENGL J MED, V369, P11, DOI 10.1056/NEJMoa1215340; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Wardlaw JM, 2013, LANCET NEUROL, V12, P483, DOI 10.1016/S1474-4422(13)70060-7; Yamada M, 2004, AM J NEURORADIOL, V25, P402; Yamamoto Y, 2011, J NEUROL SCI, V304, P78, DOI 10.1016/j.jns.2011.02.006	28	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e108395	10.1371/journal.pone.0108395	http://dx.doi.org/10.1371/journal.pone.0108395			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340713	Green Submitted, Green Published, gold			2022-12-27	WOS:000343662800005
J	Lee, PH				Lee, Paul H.			Association between Adolescents' Physical Activity and Sedentary Behaviors with Change in BMI and Risk of Type 2 Diabetes	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; BODY-MASS INDEX; SYSTEMATIC ANALYSIS; GLOBAL BURDEN; CARDIOVASCULAR-DISEASE; METABOLIC RISK; 21 REGIONS; CHILDREN; OBESITY; POPULATION	This study aims at identifying the association between physical activity (PA) and sedentary behavior (SB) patterns during adolescents on the future increase in BMI and risk of diabetes during young adulthood. A total of 3,717 participants aged 11 to 21 at baseline who completed Waves I (1994-1995), II (1996), III (2001-2002), and IV (2008) surveys of the National Longitudinal Study of Adolescent Health (Add Health) were analyzed. Physical activity and sedentary behavior patterns were assessed using an interviewer-administered questionnaire at Waves I, II, and III. A participant was classified as having diabetes at Wave IV according to WHO guidelines. The k-means cluster analysis was used to identify the number of PA and SB patterns assessed using interviewer-administered questionnaire. The k-means cluster analysis identified three clusters; 575 (15.5%), 2,140 (57.6%), and 1,002 (27.0%) participants belonged to the low PA high SB (LPAHSB), the LPALSB, and the HPALSB cluster respectively. Relative to the LPALSB cluster, the HPALSB cluster had lower increase in BMI from Wave III to Wave IV (P = 0.03), whereas the difference between LPAHSB cluster and LPALSB cluster was not significant (P = 0.09). The odds of developing diabetes at Wave IV was significant for the LPAHSB cluster (OR = 1.69, 95% CI = 1.04, 2.75) but not significant for the HPALSB cluster (OR = 0.87, 95% CI = 0.52, 1.47) relative to the LPALSB cluster. To conclude, PA but not SB during adolescence predicted change in BMI during young adulthood. SB but not PA during adolescence predicted type 2 diabetes during young adulthood.	Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Hong Kong, Peoples R China	Hong Kong Polytechnic University	Lee, PH (corresponding author), Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Hong Kong, Peoples R China.	paul.h.lee@polyu.edu.hk	Lee, Paul H/F-2549-2010	Lee, Paul H/0000-0002-5729-6450	Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01-HD31921]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD031921] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research uses data from Add Health, a program project directed by Kathleen Mullan Harris and designed by J. Richard Udry, Peter S. Bearman, and Kathleen Mullan Harris at the University of North Carolina at Chapel Hill, and funded by grant P01-HD31921 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, with cooperative funding from 23 other federal agencies and foundations. Special acknowledgment is due Ronald R. Rindfuss and Barbara Entwisle for assistance in the original design. Information on how to obtain the Add Health data files is available on the Add Health website (http://www.cpc.unc.edu/addhealth). No direct support was received from grant P01-HD31921 for this analysis.	Atlantis E, 2014, CIRC J, V78, P1066, DOI 10.1253/circj.CJ-14-0324; BARANOWSKI T, 1988, RES Q EXERCISE SPORT, V59, P314, DOI 10.1080/02701367.1988.10609379; CDC, 2012, MMWR-MORBID MORTAL W, V61, pSS; Christensen DL, 2012, AM J HUM BIOL, V24, P558, DOI 10.1002/ajhb.22239; Chu AHY, 2013, PREV MED, V57, pS14, DOI 10.1016/j.ypmed.2012.12.011; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; Gordon-Larsen P, 2004, AM J PREV MED, V27, P277, DOI 10.1016/j.amepre.2004.07.006; Grontved A, 2011, JAMA-J AM MED ASSOC, V305, P2448, DOI 10.1001/jama.2011.812; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Healy GN, 2008, MED SCI SPORT EXER, V40, P639, DOI 10.1249/MSS.0b013e3181607421; Hennig C, 2004, J COMPUT GRAPH STAT, V13, P930, DOI 10.1198/106186004X12740; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; Jakes RW, 2003, EUR J CLIN NUTR, V57, P1089, DOI 10.1038/sj.ejcn.1601648; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115; LEE PH, 2013, PUBLIC HEALTH NUTR, V16, P1436; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Magee CA, 2013, J DEV BEHAV PEDIATR, V34, P165, DOI [10.1097/DBP.0b013e318289aa51., 10.1097/DBP.0b013e318289aa51]; Maher CA, 2013, OBESITY, V21, pE730, DOI 10.1002/oby.20430; Marshall SJ, 2004, INT J OBESITY, V28, P1238, DOI 10.1038/sj.ijo.0802706; Monda KL, 2005, OBES RES, V13, P1042, DOI 10.1038/oby.2005.122; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Paulozzi Leonard, 2012, Morbidity and Mortality Weekly Report, V61, P10; Reis JP, 2011, ANN INTERN MED, V155, P292, DOI 10.7326/0003-4819-155-5-201109060-00006; Sinha R, 2002, NEW ENGL J MED, V346, P802, DOI 10.1056/NEJMoa012578; Thorndike R. L., 1953, PSYCHOMETRIKA, V18, P267, DOI [10.1007/BF02289263, DOI 10.1007/BF02289263]; Tremblay MS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-98; van der Ploeg HP, 2012, ARCH INTERN MED, V172, P494, DOI 10.1001/archinternmed.2011.2174; van Poppel MNM, 2010, SPORTS MED, V40, P565, DOI 10.2165/11531930-000000000-00000; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wiecha JL, 2006, ARCH PEDIAT ADOL MED, V160, P436, DOI 10.1001/archpedi.160.4.436; World Health Organization, 2006, DEF DIAGN DIAB MELL; Zabinski MF, 2007, HEALTH PSYCHOL, V26, P113, DOI 10.1037/0278-6133.26.1.113	36	15	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110732	10.1371/journal.pone.0110732	http://dx.doi.org/10.1371/journal.pone.0110732			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR5ZY	25340773	Green Submitted, Green Published, gold			2022-12-27	WOS:000343662800052
J	Moller, AT; Backstrom, T; Sondergaard, HP; Helstrom, L				Moller, Anna Tiihonen; Backstrom, Torbjorn; Sondergaard, Hans Peter; Helstrom, Lotti			Identifying Risk Factors for PTSD in Women Seeking Medical Help after Rape	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; SEXUAL ASSAULT VICTIMS; FEMALE CRIME VICTIMS; PSYCHIATRIC-DISORDERS; EARLY INTERVENTION; MAJOR DEPRESSION; NATIONAL-SURVEY; ABUSE; COMORBIDITY; EXPERIENCES	Objectives: Rape has been found to be the trauma most commonly associated with Posttraumatic Stress Disorder (PTSD) among women. It is therefore important to be able to identify those women at greatest risk of developing PTSD. The aims of the present study were to analyze the PTSD prevalence six months after sexual assaults and identify the major risk factors for developing PTSD. Methods: Participants were 317 female victims of rape who sought help at the Emergency Clinic for Raped Women at Stockholm South Hospital, Sweden. Baseline assessments of mental health were carried out and followed up after six months. Results: Thirty-nine percent of the women had developed PTSD at the six month assessment, and 47% suffered from moderate or severe depression. The major risk factors for PTSD were having been sexually assaulted by more than one person, suffering from acute stress disorder (ASD) shortly after the assault, having been exposed to several acts during the assault, having been injured, having co-morbid depression, and having a history of more than two earlier traumas. Further, ASD on its own was found to be a poor predictor of PTSD because of the substantial ceiling effect after sexual assaults. Conclusions: Development of PTSD is common in the aftermath of sexual assaults. Increased risk of developing PTSD is caused by a combination of victim vulnerability and the extent of the dramatic nature of the current assault. By identifying those women at greatest risk of developing PTSD appropriate therapeutic resources can be directed.	[Moller, Anna Tiihonen; Sondergaard, Hans Peter; Helstrom, Lotti] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Moller, Anna Tiihonen; Helstrom, Lotti] Stockholm South Hosp, Dept Obstet & Gynecol, Stockholm, Sweden; [Backstrom, Torbjorn] Umea Univ, Dept Clin Sci Obstet & Gynecol, Umea, Sweden	Karolinska Institutet; Umea University	Moller, AT (corresponding author), Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden.	anna.moller@ki.se		Sondergaard, Hans Peter/0000-0002-1676-2670	Swedish Research Council [90418601]; Stockholm County Council, Sweden ("ALF-medel") [20110192]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council, Sweden ("ALF-medel")(Stockholm County Council)	The study was funded by grants from the Swedish Research Council (project number 90418601), and supported by grants provided by the Stockholm County Council, Sweden ("ALF-medel", number 20110192). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acierno R, 1999, J ANXIETY DISORD, V13, P541, DOI 10.1016/S0887-6185(99)00030-4; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Beck AT, 1996, PSYCHOL ASSESS; BOWNES IT, 1991, ACTA PSYCHIAT SCAND, V83, P27, DOI 10.1111/j.1600-0447.1991.tb05507.x; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Brewin CR, 1999, AM J PSYCHIAT, V156, P360; Bryant RA, 2012, J PSYCHIATR RES, V46, P168, DOI 10.1016/j.jpsychires.2011.10.007; Cardena E, 2000, J TRAUMA STRESS, V13, P719, DOI 10.1023/A:1007822603186; Cougle JR, 2009, BEHAV RES THER, V47, P1012, DOI 10.1016/j.brat.2009.07.014; Dancu CV, 1996, J TRAUMA STRESS, V9, P253, DOI 10.1007/BF02110659; Darves-Bornoz JM, 1998, EUR PSYCHIAT, V13, P281, DOI 10.1016/S0924-9338(98)80045-X; Elklit A, 2010, J INTERPERS VIOLENCE, V25, P1470, DOI 10.1177/0886260509354587; Epstein JN, 1997, J TRAUMA STRESS, V10, P573, DOI 10.1023/A:1024841718677; Filipas HH, 2006, J INTERPERS VIOLENCE, V21, P652, DOI 10.1177/0886260506286879; Fletcher RH, 2014, CLIN EPIDEMIOLOGY ES, V5; Foa Jaycox L, 1997, PSYCHOL ASSESSMENT, V9, P445; Horsmer DW LS, 1980, COMMUNICATIONS STA A, VA10, P1043; Kaysen D, 2006, J TRAUMA STRESS, V19, P399, DOI 10.1002/jts.20122; Kaysen DL, 2010, J TRAUMA STRESS, V23, P523, DOI 10.1002/jts.20542; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2000, J CLIN PSYCHIAT, V61, P4; Kilpatrick DG, 2003, J CONSULT CLIN PSYCH, V71, P692, DOI 10.1037/0022-006X.71.4.692; Masho SW, 2007, J WOMENS HEALTH, V16, P262, DOI 10.1089/jwh.2006.M076; Moller AS, 2012, J INTERPERS VIOLENCE, V27, P3131, DOI 10.1177/0886260512441261; Nishith P, 2000, J ABNORM PSYCHOL, V109, P20, DOI 10.1037/0021-843X.109.1.20; Resnick H, 2005, BEHAV MODIF, V29, P156, DOI 10.1177/0145445504270883; Rothbaum BO, 2012, BIOL PSYCHIAT, V72, P957, DOI 10.1016/j.biopsych.2012.06.002; Rothbaum BO, 1992, J TRAUMATIC STRESS, V5; Swahnberg IMK, 2003, EUR J PUBLIC HEALTH, V13, P361, DOI 10.1093/eurpub/13.4.361; Temple JR, 2007, VIOLENCE AGAINST WOM, V13, P285, DOI 10.1177/1077801206297437; Ullman SE, 2006, J INTERPERS VIOLENCE, V21, P798, DOI 10.1177/0886260506288590; Ullman SE, 2001, J TRAUMA STRESS, V14, P369, DOI 10.1023/A:1011125220522; Zinzow HM, 2012, SOC PSYCH PSYCH EPID, V47, P893, DOI 10.1007/s00127-011-0397-1; Zinzow HM, 2010, DEPRESS ANXIETY, V27, P708, DOI 10.1002/da.20719	34	48	48	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111136	10.1371/journal.pone.0111136	http://dx.doi.org/10.1371/journal.pone.0111136			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR5ZY	25340763	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662800088
J	Rotheram-Borus, MJ; Tomlinson, M; le Roux, IM; Harwood, JM; Comulada, S; O'Connor, MJ; Weiss, RE; Worthman, CM				Rotheram-Borus, Mary Jane; Tomlinson, Mark; le Roux, Ingrid M.; Harwood, Jessica M.; Comulada, Scott; O'Connor, Mary J.; Weiss, Robert E.; Worthman, Carol M.			A Cluster Randomised Controlled Effectiveness Trial Evaluating Perinatal Home Visiting among South African Mothers/Infants	PLOS ONE			English	Article							COMMUNITY-HEALTH WORKERS; SUB-SAHARAN AFRICA; NEWBORN CARE; OUTCOMES; INFANTS; PARAPROFESSIONALS; DEPRESSION; PROGRAMS; PACKAGE; NURSES	Background: Interventions are needed to reduce poor perinatal health. We trained community health workers (CHWs) as home visitors to address maternal/infant risks. Methods: In a cluster randomised controlled trial in Cape Town townships, neighbourhoods were randomised within matched pairs to 1) the control, healthcare at clinics (n = 12 neighbourhoods; n = 594 women), or 2) a home visiting intervention by CBW trained in cognitive-behavioural strategies to address health risks (by the Philani Maternal, Child Health and Nutrition Programme), in addition to clinic care (n = 12 neighbourhoods; n = 644 women). Participants were assessed during pregnancy (2% refusal) and 92% were reassessed at two weeks post-birth, 88% at six months and 84% at 18 months later. We analysed 32 measures of maternal/infant well-being over the 18 month follow-up period using longitudinal random effects regressions. A binomial test for correlated outcomes evaluated overall effectiveness over time. The 18 month post-birth assessment outcomes also were examined alone and as a function of the number of home visits received. Results: Benefits were found on 7 of 32 measures of outcomes, resulting in significant overall benefits for the intervention compared to the control when using the binomial test (p = 0.008); nevertheless, no effects were observed when only the 18 month outcomes were analyzed. Benefits on individual outcomes were related to the number of home visits received. Among women living with HIV, intervention mothers were more likely to implement the PMTCT regimens, use condoms during all sexual episodes (OR = 1.25; p = 0.014), have infants with healthy weight-for-age measurements (OR = 1.42; p = 0.045), height-for-age measurements (OR = 1.13, p<0.001), breastfeed exclusively for six months (OR = 3.59; p<0.001), and breastfeed longer (OR = 3.08; p<0.001). Number of visits was positively associated with infant birth weight >= 2500 grams (OR = 1.07; p = 0.012), healthy head-circumference-for-age measurements at 6 months (OR = 1.09, p = 0.017), and improved cognitive development at 18 months (OR = 1.02, p = 0.048). Conclusions: Home visits to neighbourhood mothers by CHWs may be a feasible strategy for enhancing maternal/child outcomes. However, visits likely must extend over several years for persistent benefits.	[Rotheram-Borus, Mary Jane; Harwood, Jessica M.; Comulada, Scott; O'Connor, Mary J.] Univ Calif Los Angeles, Semel Inst, Dept Psychiat & Biobehav Med, Los Angeles, CA 90095 USA; [Tomlinson, Mark] Univ Stellenbosch, Dept Psychol, ZA-7600 Stellenbosch, South Africa; [le Roux, Ingrid M.] Philani Maternal Child Hlth & Nutr Programme, Cape Town, South Africa; [Worthman, Carol M.] Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA; [Weiss, Robert E.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Biostat, Los Angeles, CA USA	University of California System; University of California Los Angeles; Stellenbosch University; Emory University; University of California System; University of California Los Angeles	Rotheram-Borus, MJ (corresponding author), Univ Calif Los Angeles, Semel Inst, Dept Psychiat & Biobehav Med, Los Angeles, CA 90095 USA.	CCHPublications@mednet.ucla.edu		Worthman, Carol M/0000-0002-5397-2298	NIAAA grant [R01 AA017104]; Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) NIMH grant [P30 MH58107]; UCLA Center for AIDS Research (CFAR) grant [P30 AI028697]; National Center for Advancing Translational Sciences through UCLA CSTI Grant [UL1 TR000124]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH058107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017104, R24AA022919] Funding Source: NIH RePORTER	NIAAA grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) NIMH grant; UCLA Center for AIDS Research (CFAR) grant; National Center for Advancing Translational Sciences through UCLA CSTI Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by NIAAA grant R01 AA017104, the Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) NIMH grant P30 MH58107; the UCLA Center for AIDS Research (CFAR) grant P30 AI028697; and the National Center for Advancing Translational Sciences through UCLA CSTI Grant UL1 TR000124. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamo S, 2012, AIDS PATIENT CARE ST, V26, P101, DOI 10.1089/apc.2011.0279; Bayley N, 2003, BAYLEY SCALES INFANT; Berggren WL., 2002, FOOD NUTR BULL, V23, P7; Chibanda D, 2010, ARCH WOMEN MENT HLTH, V13, P201, DOI 10.1007/s00737-009-0073-6; Cogill B, 2003, ANTHROPOMETRIC INDIC; Cooper PJ, 1999, BRIT J PSYCHIAT, V175, P554, DOI 10.1192/bjp.175.6.554; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Dawson DA, 2005, COMPR PSYCHIAT, V46, P405, DOI 10.1016/j.comppsych.2005.01.006; Flay BR, 2005, PREV SCI, V6, P151, DOI 10.1007/s11121-005-5553-y; Grantham-McGregor S, 2007, LANCET, V369, P824, DOI 10.1016/S0140-6736(07)60404-8; GROSS RT, 1990, JAMA-J AM MED ASSOC, V263, P3035; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Kirkwood BR, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-58; Langer A, 2011, SUPPORT PREGNANCY WO; le Roux IM, 2013, AIDS, V27, P1461, DOI 10.1097/QAD.0b013e3283601b53; Lewin S., 2006, LAY HLTH WORKERS PRI; May PA, 2009, DEV DISABIL RES REV, V15, P176, DOI 10.1002/ddrr.68; Narman N, 2007, SAMJ S AFR MED J, V97, P733; Olds D, 1998, JUVENILE JUSTICE B; Olds DL, 2002, PEDIATRICS, V110, P486, DOI 10.1542/peds.110.3.486; Olds DL, 2004, PEDIATRICS, V114, P1560, DOI 10.1542/peds.2004-0961; Peacock S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-17; Rotheram-Borus MJ, 2012, INT J TELEMED APPL, V2012, DOI 10.1155/2012/973237; Rotheram-Borus MJ, 2014, J CLIN CHILD ADOLESC, V43, P229, DOI 10.1080/15374416.2013.836453; Rotheram-Borus MJ, 2012, AM PSYCHOL, V67, P463, DOI 10.1037/a0028180; Rotheram-Borus MJ, 2011, PREV SCI, V12, P372, DOI 10.1007/s11121-011-0238-1; Singh P, 2013, LANCET, V382, P363, DOI 10.1016/S0140-6736(12)62002-9; Sprague C, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-10; Stein AD, 2013, J PEDIATR-US, V163, P1740, DOI 10.1016/j.jpeds.2013.08.012; Suri A, 2007, J INFECT DIS, V196, pS505, DOI 10.1086/521122; Sweet MA, 2004, CHILD DEV, V75, P1435, DOI 10.1111/j.1467-8624.2004.00750.x; Tomlinson M, 2014, TROP MED INT HEALTH, V19, P256, DOI 10.1111/tmi.12257; Tomlinson M, 2013, S AFR J INFORM MANAG, V15, DOI 10.4102/sajim.v15i1.528; Tylleskar T, 2011, LANCET, V378, P420, DOI 10.1016/S0140-6736(11)60738-1; USAID, MAT HLTH S AFR; World Health Organization, 2011, WORK WHO AFR REG 201	37	52	52	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e105934	10.1371/journal.pone.0105934	http://dx.doi.org/10.1371/journal.pone.0105934			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR5ZY	25340337	gold, Green Published, Green Submitted			2022-12-27	WOS:000343662800001
J	Tanaka, R; Hino, A; Tsai, IJ; Palomares-Rius, JE; Yoshida, A; Ogura, Y; Hayashi, T; Maruyama, H; Kikuchi, T				Tanaka, Ryusei; Hino, Akina; Tsai, Isheng J.; Palomares-Rius, Juan Emilio; Yoshida, Ayako; Ogura, Yoshitoshi; Hayashi, Tetsuya; Maruyama, Haruhiko; Kikuchi, Taisei			Assessment of Helminth Biodiversity in Wild Rats Using 18S rDNA Based Metagenomics	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; PHYLOGENETIC-RELATIONSHIPS; DIVERSITY; PARASITES; RARE; RESOLUTION; SEQUENCES; SELECTION; REGIONS; PROJECT	Parasite diversity has important implications in several research fields including ecology, evolutionary biology and epidemiology. Wide-ranging analysis has been restricted because of the difficult, highly specialised and time-consuming processes involved in parasite identification. In this study, we assessed parasite diversity in wild rats using 18S rDNA-based metagenomics. 18S rDNA PCR products were sequenced using an Illumina MiSeq sequencer and the analysis of the sequences using the QIIME software successfully classified them into several parasite groups. The comparison of the results with those obtained using standard methods including microscopic observation of helminth parasites in the rat intestines and PCR amplification/sequencing of 18S rDNA from isolated single worms suggests that this new technique is reliable and useful to investigate parasite diversity.	[Tanaka, Ryusei; Hino, Akina; Palomares-Rius, Juan Emilio; Yoshida, Ayako; Maruyama, Haruhiko; Kikuchi, Taisei] Miyazaki Univ, Fac Med, Div Parasitol, Miyazaki, Japan; [Tsai, Isheng J.] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Ogura, Yoshitoshi; Hayashi, Tetsuya] Miyazaki Univ, Frontier Sci Res Ctr, Dept Genom & Bioenvirom Sci, Div Microbial Genom, Miyazaki, Japan	University of Miyazaki; Academia Sinica - Taiwan; University of Miyazaki	Kikuchi, T (corresponding author), Miyazaki Univ, Fac Med, Div Parasitol, Miyazaki, Japan.	taisei_kikuchi@med.miyazaki-u.ac.jp	Hayashi, Tetsuya/ABA-1074-2020; Palomares-Rius, Juan/K-8004-2015; Tsai, Isheng Jason/ABB-8273-2021	Palomares-Rius, Juan/0000-0003-1776-8131; Tsai, Isheng Jason/0000-0002-2123-5058; Kikuchi, Taisei/0000-0003-2759-9167	JSPS KAKENHI [24780044, 24659190, 26460510, 26292178]; Project of Establishing Medical Research Base Networks against Infectious Diseases in Okinawa [CBB13001]; Integrated Research Project for Human and Veterinary Medicine of the University of Miyazaki	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Project of Establishing Medical Research Base Networks against Infectious Diseases in Okinawa; Integrated Research Project for Human and Veterinary Medicine of the University of Miyazaki	This work was supported in part by JSPS KAKENHI (grants numbers 24780044, 24659190, 26460510 and 26292178), the Project of Establishing Medical Research Base Networks against Infectious Diseases in Okinawa (grants number CBB13001), and the Integrated Research Project for Human and Veterinary Medicine of the University of Miyazaki. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; Amir A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt1070; Bik HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078230; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; COMBES C, 1990, TRENDS ECOL EVOL, V5, P334, DOI 10.1016/0169-5347(90)90181-C; Desai N, 2012, CURR OPIN BIOTECH, V23, P72, DOI 10.1016/j.copbio.2011.12.017; Hadziavdic K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087624; Hatcher M. J., 2011, PARASITES ECOLOGICAL; Holterman M, 2006, MOL BIOL EVOL, V23, P1792, DOI 10.1093/molbev/msl044; Hugerth LW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095567; Jumpponen A, 2009, NEW PHYTOL, V184, P438, DOI 10.1111/j.1469-8137.2009.02990.x; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Korallo NP, 2007, DIVERS DISTRIB, V13, P353, DOI 10.1111/j.1472-4642.2007.00332.x; Logares R, 2014, CURR BIOL, V24, P813, DOI 10.1016/j.cub.2014.02.050; Porazinska DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044641; Porazinska DL, 2009, MOL ECOL RESOUR, V9, P1439, DOI 10.1111/j.1755-0998.2009.02611.x; Poulin R, 2000, Q REV BIOL, V75, P277, DOI 10.1086/393500; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sukhdeo MVK, 1996, INT J PARASITOL, V26, P483, DOI 10.1016/0020-7519(96)89378-7; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Vestheim H, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-12; Waeschenbach A, 2007, MOL PHYLOGENET EVOL, V45, P311, DOI 10.1016/j.ympev.2007.03.019; WATERS AP, 1991, P NATL ACAD SCI USA, V88, P3140, DOI 10.1073/pnas.88.8.3140; WEBSTER JP, 1995, PARASITOLOGY, V111, P247, DOI 10.1017/S0031182000081804; Weinstock GM, 2012, NATURE, V489, P250, DOI 10.1038/nature11553; Yamaguti S., 1961, NEMATODES VERTEBRATE; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhao XM, 2001, INT J PARASITOL, V31, P715, DOI 10.1016/S0020-7519(01)00136-9	32	34	34	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110769	10.1371/journal.pone.0110769	http://dx.doi.org/10.1371/journal.pone.0110769			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340824	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662800054
J	Kadic, AJ; Zanic, M; Skaricic, N; Marusic, A				Kadic, Antonia Jelicic; Zanic, Maja; Skaricic, Natasa; Marusic, Ana			Using the WHO Essential Medicines List to Assess the Appropriateness of Insurance Coverage Decisions: A Case Study of the Croatian National Medicine Reimbursement List	PLOS ONE			English	Article							CARE; SYSTEM	Purpose: To investigate the use of the WHO EML as a tool with which to evaluate the evidence base for the medicines on the national insurance coverage list of the Croatian Institute of Health Insurance (CIHI). Methods: Medicines from 9 ATC categories with highest expenditures from 2012 CIHI Basic List (n = 509) were compared with 2011 WHO EML for adults (n = 359). For medicines with specific indication listed only in CIHI Basic List we assessed whether there was evidence in Cochrane Database of Systematic Reviews questioning their efficacy and safety. Results: The two lists shared 188 medicines (52.4% of WHO EML and 32.0% of CIHI list). CIHI Basic List had 254 medicines and 33 combinations of these medicines which were not on the WHO EML, plus 14 medicines rejected and 20 deleted from WHO EML by its Evaluation Committee. For deleted medicines, we could obtain data that showed 2,965,378 prescriptions issued to 617,684 insured patients, and the cost of approximately (sic) 41.2 million for 2012 and the first half of 2013, when the CIHI Basic List was in effect. For CIHI List-only medicines with a specific indication (n = 164 or 57.1% of the analyzed set), fewer benefits or more serious side-effects than other medicines were found for 17 (10.4%) and not enough evidence for recommendations for specific indication for 21 (12.8%) medicines in Cochrane systematic reviews. Conclusions: National health care policy should use high-quality evidence in deciding on adding new medicines and reassessing those already present on national medicines lists, in order to rationalize expenditures and ensure wider and better access to medicines. The WHO EML and recommendations from its Evaluation Committee may be useful tools in this quality assurance process.	[Kadic, Antonia Jelicic; Marusic, Ana] Univ Split, Sch Med, Dept Anat, Split, Croatia; [Zanic, Maja] Univ Split, Ctr Hosp, Dept Obstet & Gynaecol, Split, Croatia; [Skaricic, Natasa] Univ Zagreb, Sch Humanities & Social Sci, Zagreb 41000, Croatia; [Marusic, Ana] Univ Split, Sch Med, Dept Res Biomed & Hlth, Split, Croatia	University of Split; University of Split; University of Zagreb; University of Split	Marusic, A (corresponding author), Univ Split, Sch Med, Dept Anat, Split, Croatia.	ana.marusic@mefst.hr	Marusic, Ana/E-7683-2013	Marusic, Ana/0000-0001-6272-0917	Ministry of Science and Technology of the Republic of Croatia [216-1080314-0245]	Ministry of Science and Technology of the Republic of Croatia	The study was supported by the research grant from the Ministry of Science and Technology of the Republic of Croatia, No. 216-1080314-0245. The funder had no role in the study, including data collection and analysis, manuscript preparation or authorization for publication.	Agency for Medicines and Medicinal Products, 2011, 2011 CHARTB MED MARK; [Anonymous], 2013, WHO GLOBAL HLTH OBSE; Barber SL, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010303; Croatian Agency for Medicines and Medical Devices, 2012, TOT EXP MED PER MAIN; Croatian Institute for Health Insurance, MED LISTS; Gustafsson LL, 2011, BASIC CLIN PHARMACOL, V108, P224, DOI 10.1111/j.1742-7843.2011.00682.x; Hebrang A, 2003, HEALTH POLICY PLANN, V18, P421, DOI 10.1093/heapol/czg050; Hill S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038055; Laing R, 2003, LANCET, V361, P1723, DOI 10.1016/S0140-6736(03)13375-2; Millar TP, 2011, AM J PUBLIC HEALTH, V101, P1444, DOI 10.2105/AJPH.2010.300054; Ministry of Health and Social Care of the Republic of Croatia, 2009, PUBL B, V155, P3832; Moja LP, 2005, BMJ-BRIT MED J, V330, P1053, DOI 10.1136/bmj.38414.515938.8F; Moten A, 2014, J GLOB HEALTH, V4, DOI 10.7189/jogh.04.010304; Oreskovic S, 1998, Croat Med J, V39, P225; Republic of Croatia, 2009, PUBL B, V43, P985; Republic of Croatia, 2013, PUBL B, V137, P2944; Rico-Alba I, 2013, EUR J CLIN PHARMACOL, V69, P949, DOI 10.1007/s00228-012-1421-4; The Organization for Economic Co-operation and Development, 2010, VAL MON HLTH SPEND; The World Bank, 2013, DAT CROAT; Vitezic D, 2012, INT J CLIN PHARM TH, V50, P483, DOI 10.5414/CP201686; WHO, ESS MED; WHO, 2013, SEL US ESS MED; WHO Collaborating Centre for Drug Statistics Methodology, AN THER CHEM ATC DEF; World Health Organization, 2013, NAT MED LISTS; World Health Organization, 2013, CROAT COUNTR PROF MO; World Health Organization, SPEC PHARM PREP; World Health Organization, INT NONPR NAM	27	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e111474	10.1371/journal.pone.0111474	http://dx.doi.org/10.1371/journal.pone.0111474			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6DY	25337860	Green Published, gold, Green Submitted			2022-12-27	WOS:000343674800121
J	Mohan, AM; Bibby, KJ; Lipus, D; Hammack, RW; Gregory, KB				Mohan, Arvind Murali; Bibby, Kyle J.; Lipus, Daniel; Hammack, Richard W.; Gregory, Kelvin B.			The Functional Potential of Microbial Communities in Hydraulic Fracturing Source Water and Produced Water from Natural Gas Extraction Characterized by Metagenomic Sequencing	PLOS ONE			English	Article							SHALE GAS; OIL; DIVERSITY; GALAXY; FLUIDS; WELLS; TEXAS	Microbial activity in produced water from hydraulic fracturing operations can lead to undesired environmental impacts and increase gas production costs. However, the metabolic profile of these microbial communities is not well understood. Here, for the first time, we present results from a shotgun metagenome of microbial communities in both hydraulic fracturing source water and wastewater produced by hydraulic fracturing. Taxonomic analyses showed an increase in anaerobic/facultative anaerobic classes related to Clostridia, Gammaproteobacteria, Bacteroidia and Epsilonproteobacteria in produced water as compared to predominantly aerobic Alphaproteobacteria in the fracturing source water. The metabolic profile revealed a relative increase in genes responsible for carbohydrate metabolism, respiration, sporulation and dormancy, iron acquisition and metabolism, stress response and sulfur metabolism in the produced water samples. These results suggest that microbial communities in produced water have an increased genetic ability to handle stress, which has significant implications for produced water management, such as disinfection.	[Mohan, Arvind Murali; Bibby, Kyle J.; Lipus, Daniel; Hammack, Richard W.; Gregory, Kelvin B.] Natl Energy Technol Lab, Pittsburgh, PA 15236 USA; [Mohan, Arvind Murali; Gregory, Kelvin B.] Carnegie Mellon Univ, Dept Civil & Environm Engn, Pittsburgh, PA 15213 USA; [Bibby, Kyle J.; Lipus, Daniel] Univ Pittsburgh, Dept Civil & Environm Engn, Pittsburgh, PA USA; [Bibby, Kyle J.] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA USA	United States Department of Energy (DOE); National Energy Technology Laboratory - USA; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gregory, KB (corresponding author), Natl Energy Technol Lab, Pittsburgh, PA 15236 USA.	kelvin@cmu.edu	Lipus, Daniel/ABH-3450-2020; Bibby, Kyle J/C-6189-2018	Bibby, Kyle J/0000-0003-3142-6090; Lipus, Daniel/0000-0002-5706-9143; Gregory, Kelvin/0000-0001-5488-2297	National Energy Technology Laboratory's Regional University Alliance (NETL-RUA); RES [DE-FE0004000]; NETL	National Energy Technology Laboratory's Regional University Alliance (NETL-RUA); RES; NETL	Work was supported by the National Energy Technology Laboratory's Regional University Alliance (NETL-RUA), a collaborative initiative of the NETL, this technical effort was performed under the RES contract DE-FE0004000 (http://www.netl.doe.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An DS, 2013, ENVIRON SCI TECHNOL, V47, P10708, DOI 10.1021/es4020184; Arthur JD, 2009, SPE AM ENV SAF C SAN; Barbot E, 2013, ENVIRON SCI TECHNOL, V47, P2562, DOI 10.1021/es304638h; Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]; Dahle H, 2008, ANTON LEEUW INT J G, V93, P37, DOI 10.1007/s10482-007-9177-z; David G., 2004, NE GEOL ENVIRON SCI, V26, P57; Davis JP, 2012, MICROB ECOL, V64, P942, DOI 10.1007/s00248-012-0073-3; Delmont TO, 2012, ISME J, V6, P1677, DOI 10.1038/ismej.2011.197; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Dong YR, 2014, ENVIRON MICROBIOL, V16, P1695, DOI 10.1111/1462-2920.12325; Driscoll F.G., 1986, GROUNDWATER WELLS, V2nd ed; Fichter JK, 2008, P 40 ANN M CHIC LING, P1; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Gilbert JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003042; Gittel A, 2009, APPL ENVIRON MICROB, V75, P7086, DOI 10.1128/AEM.01123-09; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Grabowski A, 2005, FEMS MICROBIOL ECOL, V54, P427, DOI 10.1016/j.femsec.2005.05.007; Green Tringe Susannah, 2005, Nature Reviews Genetics, V6, P805, DOI 10.1038/nrg1709; Gregory KB, 2011, ELEMENTS, V7, P181, DOI 10.2113/gselements.7.3.181; Hendrickson H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000335; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kermani MB, 1996, SPE PROD FACIL, V11, P186, DOI 10.2118/29784-PA; Kogure K, 1998, CURR OPIN BIOTECH, V9, P278, DOI 10.1016/S0958-1669(98)80059-1; Lamendella R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-103; Little BJ., 2007, MICROBIOLOGICALLY IN; Lu J, 2009, J BIOL CHEM, V284, P723, DOI 10.1074/jbc.R800045200; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mohan AM, 2013, ENVIRON SCI TECHNOL, V47, P13141, DOI 10.1021/es402928b; Mohan AM, 2013, FEMS MICROBIOL ECOL, V86, P567, DOI 10.1111/1574-6941.12183; Moore SL, 2010, 137010 CSUGSPE, P1; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pham VD, 2009, ENVIRON MICROBIOL, V11, P176, DOI 10.1111/j.1462-2920.2008.01751.x; Roberge PR., 2000, HDB CORROSION ENG; Sandy M, 2009, CHEM REV, V109, P4580, DOI 10.1021/cr9002787; Schmieder R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-341; SETLOW P, 1992, J BACTERIOL, V174, P2737, DOI 10.1128/JB.174.9.2737-2741.1992; Shi YM, 2011, ISME J, V5, P999, DOI 10.1038/ismej.2010.189; Struchtemeyer CG, 2012, INT BIODETER BIODEGR, V71, P15, DOI 10.1016/j.ibiod.2012.01.013; Struchtemeyer CG, 2012, FEMS MICROBIOL ECOL, V81, P13, DOI 10.1111/j.1574-6941.2011.01196.x; Tovchigrechko A, MGTAXA FREE SOFTWARE; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Valavanidis A, 2006, ECOTOX ENVIRON SAFE, V64, P178, DOI 10.1016/j.ecoenv.2005.03.013; van der Kraan GM, 2010, FEMS MICROBIOL ECOL, V71, P428, DOI 10.1111/j.1574-6941.2009.00813.x; Veil JA, 2010, ANLEVSR103 NAT EN TE; Wegley L, 2007, ENVIRON MICROBIOL, V9, P2707, DOI 10.1111/j.1462-2920.2007.01383.x; Williams TM, 2010, NACE INT CORR C EXP, P1; Yergeau E, 2010, ISME J, V4, P1206, DOI 10.1038/ismej.2010.41; Yu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038183; Zerbino D. R, 2010, CURR PROTOC BIOINFOR, V31, DOI DOI 10.1002/0471250953.BI1105S31	50	36	38	3	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e107682	10.1371/journal.pone.0107682	http://dx.doi.org/10.1371/journal.pone.0107682			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338024	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000343674800004
J	Schneider, M; Brock, O				Schneider, Michael; Brock, Oliver			Combining Physicochemical and Evolutionary Information for Protein Contact Prediction	PLOS ONE			English	Article							SEQUENCE; RECONSTRUCTION	We introduce a novel contact prediction method that achieves high prediction accuracy by combining evolutionary and physicochemical information about native contacts. We obtain evolutionary information from multiple-sequence alignments and physicochemical information from predicted ab initio protein structures. These structures represent low-energy states in an energy landscape and thus capture the physicochemical information encoded in the energy function. Such low-energy structures are likely to contain native contacts, even if their overall fold is not native. To differentiate native from non-native contacts in those structures, we develop a graph-based representation of the structural context of contacts. We then use this representation to train an support vector machine classifier to identify most likely native contacts in otherwise non-native structures. The resulting contact predictions are highly accurate. As a result of combining two sources of information-evolutionary and physicochemical-we maintain prediction accuracy even when only few sequence homologs are present. We show that the predicted contacts help to improve ab initio structure prediction.	[Schneider, Michael; Brock, Oliver] Tech Univ Berlin, Robot & Biol Lab, Dept Elect Engn & Comp Sci, Berlin, Germany	Technical University of Berlin	Brock, O (corresponding author), Tech Univ Berlin, Robot & Biol Lab, Dept Elect Engn & Comp Sci, Berlin, Germany.	oliver.brock@tu-berlin.de			Alexander-von-Humboldt Foundation through an Alexander-von-Humboldt professorship; NIH Grant [1 R01 GM076706]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076706] Funding Source: NIH RePORTER	Alexander-von-Humboldt Foundation through an Alexander-von-Humboldt professorship; NIH Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Alexander-von-Humboldt Foundation through an Alexander-von-Humboldt professorship, http://www.humboldtfoundation. de/web/start.html, and a NIH Grant (1 R01 GM076706), http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Bjorkholm P, 2009, BIOINFORMATICS, V25, P1264, DOI 10.1093/bioinformatics/btp149; Blum B, 2010, PROTEINS, V78, P1583, DOI 10.1002/prot.22677; Cavallo L, 2003, NUCLEIC ACIDS RES, V31, P3364, DOI 10.1093/nar/gkg601; Cheng JL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-113; Di Lena P, 2012, BIOINFORMATICS, V28, P2449, DOI 10.1093/bioinformatics/bts475; Eickholt J, 2012, BIOINFORMATICS, V28, P3066, DOI 10.1093/bioinformatics/bts598; Eickholt J, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-38; Fischer JD, 2008, BIOINFORMATICS, V24, P613, DOI 10.1093/bioinformatics/btm626; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Geng Li, 2012, Statistical Analysis and Data Mining, V5, P265, DOI 10.1002/sam.11153; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Hagberg A, 2008, 7 PYTH SCI C SCIPY20, V7, P11, DOI DOI 10.25080/ISSN.2575-9752; Hamilton Nicholas, 2008, V453, P87, DOI 10.1007/978-1-60327-429-6_3; He HB, 2009, IEEE T KNOWL DATA EN, V21, P1263, DOI 10.1109/TKDE.2008.239; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Kamisetty H, 2013, P NATL ACAD SCI USA, V110, P15674, DOI 10.1073/pnas.1314045110; Karakas M, 2010, J COMPUT BIOL, V17, P153, DOI 10.1089/cmb.2009.0030; Karplus K, 2009, NUCLEIC ACIDS RES, V37, pW492, DOI 10.1093/nar/gkp403; Kosciolek T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092197; Li W, 2004, BIOPHYS J, V87, P1241, DOI 10.1529/biophysj.104.044750; Li YQ, 2011, BIOINFORMATICS, V27, P3379, DOI 10.1093/bioinformatics/btr579; Marks DS, 2012, NAT BIOTECHNOL, V30, P1072, DOI 10.1038/nbt.2419; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Monastyrskyy B, 2014, PROTEINS, V82, P138, DOI 10.1002/prot.24340; Monastyrskyy B, 2011, PROTEINS, V79, P119, DOI 10.1002/prot.23160; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Platt JC, 2000, ADV NEUR IN, P61; Punta M, 2005, BIOINFORMATICS, V21, P2960, DOI 10.1093/bioinformatics/bti454; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Samudrala R, 1999, PROTEINS, P194; Sathyapriya R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000584; Tegge AN, 2009, NUCLEIC ACIDS RES, V37, pW515, DOI 10.1093/nar/gkp305; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Tyka MD, 2012, J COMPUT CHEM, V33, P2483, DOI 10.1002/jcc.23069; Vassura M, 2008, IEEE ACM T COMPUT BI, V5, P357, DOI 10.1109/TCBB.2008.27; Vassura M, 2008, BIOINFORMATICS, V24, P1313, DOI 10.1093/bioinformatics/btn115; Vullo A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-180; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wang SJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep01086; Wang ZY, 2013, BIOINFORMATICS, V29, P266, DOI 10.1093/bioinformatics/btt211; Wu S, 2008, BIOINFORMATICS, V24, P924, DOI 10.1093/bioinformatics/btn069; Wu ST, 2011, STRUCTURE, V19, P1182, DOI 10.1016/j.str.2011.05.004; Zadrozny B., 2001, ICML, V1, P609; Zhao F, 2012, STRUCTURE, V20, P1118, DOI 10.1016/j.str.2012.04.003; Zhu J, 2003, PROTEINS, V52, P598, DOI 10.1002/prot.10444	47	14	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e108438	10.1371/journal.pone.0108438	http://dx.doi.org/10.1371/journal.pone.0108438			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338092	Green Published, Green Submitted, gold			2022-12-27	WOS:000343674800005
J	Li, M; Pang, ZY; Xiao, W; Liu, XY; Zhang, Y; Yu, DS; Yang, MJ; Yang, Y; Hu, JS; Luo, KJ				Li, Ming; Pang, Zunyu; Xiao, Wei; Liu, Xinyi; Zhang, Yan; Yu, Dongshuai; Yang, Minjun; Yang, Yang; Hu, Jiansheng; Luo, Kaijun			A Transcriptome Analysis Suggests Apoptosis-Related Signaling Pathways in Hemocytes of Spodoptera litura After Parasitization by Microplitis bicoloratus	PLOS ONE			English	Article							POLYDNAVIRUS INDUCES APOPTOSIS; DNA-DAMAGE; PSEUDOPLUSIA-INCLUDENS; IMMUNE-RESPONSE; GENE-EXPRESSION; CELL-DEATH; RNA-SEQ; PROTEIN; P53; BRACOVIRUS	Microplitis bicoloratus parasitism induction of apoptotic DNA fragmentation of host Spodoptera litura hemocytes has been reported. However, how M. bicoloratus parasitism regulates the host signaling pathways to induce DNA fragmentation during apoptosis remains unclear. To address this question, we performed a new RNAseq-based comparative analysis of the hemocytes transcriptomes of non-parasitized and parasitized S. litura. We were able to assemble a total of more than 11.63 Gbp sequence, to yield 20,571 unigenes. At least six main protein families encoded by M. bicoloratus bracovirus are expressed in the parasitized host hemocytes: Ankyrin-repeat, Ben domain, C-type lectin, Egf-like and Mucin-like, protein tyrosine phosphatase. The analysis indicated that during DNA fragmentation and cell death, 299 genes were up-regulated and 2,441 genes were down-regulated. Data on five signaling pathways related with cell death, the gap junctions, Ca2+, PI3K/Akt, NF-kappa B, ATM/p53 revealed that CypD, which is involved in forming a Permeability Transition Pore Complex (PTPC) to alter mitochondrial membrane permeabilization (MMP), was dramatically up-regulated. The qRT-PCR also provided that the key genes for cell survival were down-regulated under M. bicoloratus parasitism, including those encoding Inx1, Inx2 and Inx3 of the gap junction signaling pathway, p110 subunit of the PI3K/Akt signaling pathway, and the p50 and p65 subunit of the NF-kappa B signaling pathway. These findings suggest that M. bicoloratus parasitism may regulate host mitochondria to trigger internucleosomal DNA fragmentation. This study will facilitate the identification of immunosuppression-related genes and also improves our understanding of molecular mechanisms underlying polydnavirus-parasitoid-host interaction.	[Li, Ming; Pang, Zunyu; Xiao, Wei; Liu, Xinyi; Zhang, Yan; Yu, Dongshuai; Yang, Yang; Hu, Jiansheng; Luo, Kaijun] Yunnan Univ, Sch Life Sci, Kunming, Peoples R China; [Li, Ming; Pang, Zunyu; Xiao, Wei; Liu, Xinyi; Zhang, Yan; Yu, Dongshuai; Yang, Yang; Hu, Jiansheng; Luo, Kaijun] Yunnan Univ, Key Lab Anim Genet Divers & Evolut High Educ Yunn, Kunming, Peoples R China; [Yang, Minjun] Chinese Natl Human Genome Ctr, Shanghai Minist Sci & Technol, Key Lab Hlth & Dis Genom, Shanghai, Peoples R China	Yunnan University; Yunnan University	Luo, KJ (corresponding author), Yunnan Univ, Sch Life Sci, Kunming, Peoples R China.	kaijun_luo@ynu.edu.cn	Luo, Kaijun/AGL-3479-2022; Yang, Minjun/AGJ-3201-2022; liu, xinyi/GWZ-8739-2022	Yang, Minjun/0000-0002-3324-1498	National Natural Science Foundation of China [31260448, 31060251, 31360454]; Major State Basic Research Development Program [2013CB127600]; Yunnan Department of Science and Technology [2013FA003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program(National Basic Research Program of China); Yunnan Department of Science and Technology	This study was supported in part by a grant (31260448; 31060251) from National Natural Science Foundation of China, a grant (2013CB127600) from Major State Basic Research Development Program and a grant (2013FA003) from Yunnan Department of Science and Technology to KL, and a grant (31360454) from National Natural Science Foundation of China to ML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaya KE, 2005, J INSECT PHYSIOL, V51, P505, DOI 10.1016/j.jinsphys.2004.11.019; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Beck MH, 2011, J VIROL, V85, P11685, DOI 10.1128/JVI.05726-11; Bensimon A, 2011, FEBS LETT, V585, P1625, DOI 10.1016/j.febslet.2011.05.013; Bitra K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002722; Borner C, 2003, MOL IMMUNOL, V39, P615, DOI 10.1016/S0161-5890(02)00252-3; Bouaziz C, 2008, TOXICOLOGY, V254, P19, DOI 10.1016/j.tox.2008.08.020; Brodsky MH, 2004, MOL CELL BIOL, V24, P1219, DOI 10.1128/MCB.24.3.1219-1231.2004; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Chen YF, 2011, VIROLOGY, V414, P42, DOI 10.1016/j.virol.2011.03.009; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cregan SP, 2004, ONCOGENE, V23, P2785, DOI 10.1038/sj.onc.1207517; Demaurex N, 2003, SCIENCE, V300, P65, DOI 10.1126/science.1083628; Desjardins CA, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-61; Desjardins CA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r183; Espagne E, 2004, SCIENCE, V306, P286, DOI 10.1126/science.1103066; Eum JH, 2010, INSECT BIOCHEM MOLEC, V40, P690, DOI 10.1016/j.ibmb.2010.07.003; Fuhrman LE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000657; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; Gonzalez-Rodriguez A, 2007, J CELL PHYSIOL, V212, P76, DOI 10.1002/jcp.21004; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gu JJ, 1999, J BIOL CHEM, V274, P20759, DOI 10.1074/jbc.274.30.20759; Gupta S, 2002, FEBS LETT, V532, P61, DOI 10.1016/S0014-5793(02)03628-1; Halle M, 2007, CELL CYCLE, V6, P2773, DOI 10.4161/cc.6.22.4926; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hsu MJ, 2010, VIRUS RES, V153, P36, DOI 10.1016/j.virusres.2010.07.002; Ishikawa M, 2011, J CELL BIOL, V193, P1257, DOI 10.1083/jcb.201101050; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Lee S, 2008, COMP BIOCHEM PHYS A, V149, P351, DOI 10.1016/j.cbpa.2008.01.007; Li Guanghong, 1998, Acta Scientiarum Naturalium Universitatis Sunyatseni, V37, P1; Liu T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070456; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loeffler M, 2000, EXP CELL RES, V256, P19, DOI 10.1006/excr.2000.4833; Luo KJ, 2006, ACTA BIOCH BIOPH SIN, V38, P577, DOI 10.1111/j.1745-7270.2006.00195.x; Luo KJ, 2007, BIOCONTROL, V52, P309, DOI 10.1007/s10526-006-9030-8; Luo KJ, 2006, J INSECT PHYSIOL, V52, P795, DOI 10.1016/j.jinsphys.2006.04.007; Luo KJ, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.0106; Luo Kaijun, 2008, P93; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakamura M, 2007, GENES CELLS, V12, P997, DOI 10.1111/j.1365-2443.2007.01111.x; Ninios YP, 2010, APOPTOSIS, V15, P128, DOI 10.1007/s10495-009-0418-7; Okamura K, 2010, DEV CELL, V18, P692, DOI [10.1016/j.devcel.2010.05.004, 10.1016/j.devce1.2010.05.004]; Prabagar MG, 2013, CELL DEATH DIFFER, V20, P535, DOI 10.1038/cdd.2012.160; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sathyan KM, 2011, J CELL SCI, V124, P3149, DOI 10.1242/jcs.086603; Schumacher B, 2005, CELL, V120, P357, DOI 10.1016/j.cell.2004.12.009; Sharma S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001310; Stambolsky P, 2006, CELL DEATH DIFFER, V13, P2140, DOI 10.1038/sj.cdd.4401965; STRAND MR, 1995, J GEN VIROL, V76, P283, DOI 10.1099/0022-1317-76-2-283; Strand MR, 2012, PLOS PATHOG, V8, DOI [10.1372/journal.ppat.1002757, DOI 10.1372/JOURNAL.PPAT.1002757]; Suderman RJ, 2008, J GEN VIROL, V89, P1411, DOI 10.1099/vir.0.2008/000307-0; Thoetkiattikul H, 2005, P NATL ACAD SCI USA, V102, P11426, DOI 10.1073/pnas.0505240102; Webb BA, 2006, VIROLOGY, V347, P160, DOI 10.1016/j.virol.2005.11.010; Widlak P, 2000, J BIOL CHEM, V275, P8226, DOI 10.1074/jbc.275.11.8226; Xiao W, 2009, VIROLOGY, V391, P83, DOI 10.1016/j.virol.2009.06.007; Yousefi S, 2003, SEMIN IMMUNOL, V15, P195, DOI 10.1016/S1044-5323(03)00033-2; Zhang JH, 2002, TRENDS CELL BIOL, V12, P84, DOI 10.1016/S0962-8924(01)02206-1; Zhou P, 2001, P NATL ACAD SCI USA, V98, P6051, DOI 10.1073/pnas.111145098	59	23	30	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110967	10.1371/journal.pone.0110967	http://dx.doi.org/10.1371/journal.pone.0110967			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350281	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943100050
J	Carvalho, GA; Vieira, JL; Haro, MM; Correa, AS; Ribon, AOB; de Oliveira, LO; Guedes, RNC				Carvalho, Gislaine A.; Vieira, Juliana L.; Haro, Marcelo M.; Correa, Alberto S.; Ribon, Andrea Oliveira B.; de Oliveira, Luiz Orlando; Guedes, Raul Narciso C.			Pleiotropic Impact of Endosymbiont Load and Co-Occurrence in the Maize Weevil Sitophilus zeamais	PLOS ONE			English	Article							SYMBIOTIC BACTERIA; INSECTICIDE RESISTANCE; BRAZILIAN POPULATIONS; ORYZAE COLEOPTERA; GUT BACTERIA; RICE WEEVIL; CURCULIONIDAE; APHIDS; MITOCHONDRIAL; WOLBACHIA	Individual traits vary among and within populations, and the co-occurrence of different endosymbiont species within a host may take place under varying endosymbiont loads in each individual host. This makes the recognition of the potential impact of such endosymbiont associations in insect species difficult, particularly in insect pest species. The maize weevil, Sitophilus zeamais Motsch. (Coleoptera: Curculionidae), a key pest species of stored cereal grains, exhibits associations with two endosymbiotic bacteria: the obligatory endosymbiont SZPE ("Sitophilus zeamais Primary Endosymbiont'') and the facultative endosymbiont Wolbachia. The impact of the lack of SZPE in maize weevil physiology is the impairment of nutrient acquisition and energy metabolism, while Wolbachia is an important factor in reproductive incompatibility. However, the role of endosymbiont load and co-occurrence in insect behavior, grain consumption, body mass and subsequent reproductive factors has not yet been explored. Here we report on the impacts of co-occurrence and varying endosymbiont loads achieved via thermal treatment and antibiotic provision via ingested water in the maize weevil. SZPE exhibited strong effects on respiration rate, grain consumption and weevil body mass, with observed effects on weevil behavior, particularly flight activity, and potential consequences for the management of this pest species. Wolbachia directly favored weevil fertility and exhibited only mild indirect effects, usually enhancing the SZPE effect. SZPE suppression delayed weevil emergence, which reduced the insect population growth rate, and the thermal inactivation of both symbionts prevented insect reproduction. Such findings are likely important for strain divergences reported in the maize weevil and their control, aspects still deserving future attention.	[Carvalho, Gislaine A.; Ribon, Andrea Oliveira B.; de Oliveira, Luiz Orlando] Univ Fed Vicosa, Dept Bioquim & Biol Mol, Vicosa, MG, Brazil; [Vieira, Juliana L.; Haro, Marcelo M.; Guedes, Raul Narciso C.] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil; [Correa, Alberto S.] Univ Sao Paulo, Escola Super Agr Luiz Queiroz, Dept Entomol & Acarol, Piracicaba, SP, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade de Sao Paulo	Guedes, RNC (corresponding author), Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil.	guedes@ufv.br	Ribon, Andrea O. B./C-8318-2017; Correa, Alberto S/C-4683-2014; de Haro, Marcelo Mendes/V-5823-2017; de Haro, Marcelo Mendes/AAK-6570-2021; Carvalho, Gislaine/P-4107-2015; Guedes, Raul Narciso Carvalho/L-3924-2013; Oliveira, Luiz/D-6435-2013	Ribon, Andrea O. B./0000-0001-8485-3075; Correa, Alberto S/0000-0002-3788-7480; de Haro, Marcelo Mendes/0000-0001-7572-532X; Guedes, Raul Narciso Carvalho/0000-0001-6229-7549; Oliveira, Luiz/0000-0002-5578-2260; Vieira, Juliana/0000-0002-6586-2117	National Council of Scientific and Technological Development (CNPq, Brazilian Ministry of Science and Technology); CAPES Foundation (Brazilian Ministry of Education); Minas Gerais State Foundation of Research Aid (FAPEMIG)	National Council of Scientific and Technological Development (CNPq, Brazilian Ministry of Science and Technology)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES Foundation (Brazilian Ministry of Education)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Minas Gerais State Foundation of Research Aid (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	The financial support was provided by the National Council of Scientific and Technological Development (CNPq, Brazilian Ministry of Science and Technology), CAPES Foundation (Brazilian Ministry of Education), and Minas Gerais State Foundation of Research Aid (FAPEMIG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselme C, 2006, APPL ENVIRON MICROB, V72, P6766, DOI 10.1128/AEM.00942-06; Araujo RA, 2008, B ENTOMOL RES, V98, P417, DOI 10.1017/S0007485308005737; Bourtzis K, 2008, ADV EXP MED BIOL, V627, P104, DOI 10.1007/978-0-387-78225-6_9; Brankatschk R, 2012, APPL ENVIRON MICROB, V78, P4481, DOI 10.1128/AEM.07878-11; Carvalho GA, 2014, J STORED PROD RES, V59, P61, DOI 10.1016/j.jspr.2014.05.004; Chiel E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004767; Clark TL, 2001, INSECT MOL BIOL, V10, P303, DOI 10.1046/j.0962-1075.2001.00269.x; Correa AS, 2014, ANN APPL BIOL, V165, P137, DOI 10.1111/aab.12127; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Fragoso DB, 2005, J STORED PROD RES, V41, P271, DOI 10.1016/j.jspr.2004.03.008; GASNIERFAUCHET F, 1987, INSECT BIOCHEM, V17, P17, DOI 10.1016/0020-1790(87)90138-7; Gil R, 2008, INT MICROBIOL, V11, P41, DOI 10.2436/20.1501.01.43; GRENIER AM, 1994, ENTOMOL EXP APPL, V70, P201, DOI 10.1007/BF02380553; Guedes NMP, 2015, J STORED PR IN PRESS; Guedes RNC, 2006, PHYSIOL ENTOMOL, V31, P30, DOI 10.1111/j.1365-3032.2005.00479.x; GUEDES RNC, 1995, J STORED PROD RES, V31, P145, DOI 10.1016/0022-474X(94)00043-S; Heddi A, 1998, J MOL EVOL, V47, P52, DOI 10.1007/PL00006362; HEDDI A, 1993, INSECT BIOCHEM MOLEC, V23, P403, DOI 10.1016/0965-1748(93)90024-M; Heddi A, 2001, RES MICROBIOL, V152, P431, DOI 10.1016/S0923-2508(01)01216-5; Heddi A, 1999, P NATL ACAD SCI USA, V96, P6814, DOI 10.1073/pnas.96.12.6814; Le Clec'h W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060232; Lopes KVG, 2010, J INSECT PHYSIOL, V56, P1050, DOI 10.1016/j.jinsphys.2010.02.020; Mansour K, 1930, Q J MICROSC SCI, V73, P421; Mitchell Randall J., 1993, P211; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Morales JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067283; Moran NA, 2006, CURR BIOL, V16, pR866, DOI 10.1016/j.cub.2006.09.019; Nardon P, 2002, SYMBIOSIS, V33, P227; Nardon P., 1988, CELL CELL SIGNALS PL, P255; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Pilon FM, 2013, J COMP PHYSIOL B, V183, P735, DOI 10.1007/s00360-013-0744-5; Ribeiro BM, 2003, J STORED PROD RES, V39, P21, DOI 10.1016/S0022-474X(02)00014-0; Rio RVM, 2003, APPL ENVIRON MICROB, V69, P6825, DOI 10.1128/AEM.69.11.6825-6832.2003; Russell JA, 2006, P ROY SOC B-BIOL SCI, V273, P603, DOI 10.1098/rspb.2005.3348; Saridaki A, 2010, CURR OPIN MICROBIOL, V13, P67, DOI 10.1016/j.mib.2009.11.005; SAS Institute, 2008, SAS STAT US GUID; Toju H, 2013, ISME J, V7, P1378, DOI 10.1038/ismej.2013.27; Tome HVV, 2015, CHEMOSPHERE IN PRESS; Trematerra P, 1996, J STORED PROD RES, V32, P315, DOI 10.1016/S0022-474X(96)00035-5; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vigneron A, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S14; Visotto LE, 2009, ENVIRON ENTOMOL, V38, P1078, DOI 10.1603/022.038.0415; Visotto LE, 2009, J INSECT PHYSIOL, V55, P185, DOI 10.1016/j.jinsphys.2008.10.017; Wernegreen JJ, 2002, NAT REV GENET, V3, P850, DOI 10.1038/nrg931; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; WICKER C, 1983, COMP BIOCHEM PHYS A, V76, P177, DOI 10.1016/0300-9629(83)90311-0; Xue X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048148; Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544	50	17	17	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111396	10.1371/journal.pone.0111396	http://dx.doi.org/10.1371/journal.pone.0111396			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347417	Green Published, Green Submitted, gold			2022-12-27	WOS:000347994900064
J	Stacchiotti, A; Favero, G; Giugno, L; Lavazza, A; Reiter, RJ; Rodella, LF; Rezzani, R				Stacchiotti, Alessandra; Favero, Gaia; Giugno, Lorena; Lavazza, Antonio; Reiter, Russel J.; Rodella, Luigi Fabrizio; Rezzani, Rita			Mitochondrial and Metabolic Dysfunction in Renal Convoluted Tubules of Obese Mice: Protective Role of Melatonin	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; OXIDATIVE STRESS; SKELETAL-MUSCLE; OB/OB MICE; ENDOPLASMIC-RETICULUM; INTRINSIC PATHWAY; RAT-KIDNEY; APOPTOSIS; DYNAMICS; BAK	Obesity is a common and complex health problem, which impacts crucial organs; it is also considered an independent risk factor for chronic kidney disease. Few studies have analyzed the consequence of obesity in the renal proximal convoluted tubules, which are the major tubules involved in reabsorptive processes. For optimal performance of the kidney, energy is primarily provided by mitochondria. Melatonin, an indoleamine and antioxidant, has been identified in mitochondria, and there is considerable evidence regarding its essential role in the prevention of oxidative mitochondrial damage. In this study we evaluated the mechanism(s) of mitochondrial alterations in an animal model of obesity (ob/ob mice) and describe the beneficial effects of melatonin treatment on mitochondrial morphology and dynamics as influenced by mitofusin-2 and the intrinsic apoptotic cascade. Melatonin dissolved in 1% ethanol was added to the drinking water from postnatal week 5-13; the calculated dose of melatonin intake was 100 mg/kg body weight/day. Compared to control mice, obesity-related morphological alterations were apparent in the proximal tubules which contained round mitochondria with irregular, short cristae and cells with elevated apoptotic index. Melatonin supplementation in obese mice changed mitochondria shape and cristae organization of proximal tubules, enhanced mitofusin-2 expression, which in turn modulated the progression of the mitochondria-driven intrinsic apoptotic pathway. These changes possibly aid in reducing renal failure. The melatonin-mediated changes indicate its potential protective use against renal morphological damage and dysfunction associated with obesity and metabolic disease.	[Stacchiotti, Alessandra; Favero, Gaia; Giugno, Lorena; Rodella, Luigi Fabrizio; Rezzani, Rita] Univ Brescia, Dept Clin & Expt Sci, Anat & Physiopathol Div, Brescia, Italy; [Lavazza, Antonio] Ist Zooprofilatt Sperimentale Lombardia & Emilia, OIE Reference Lab RHD, Brescia, Italy; [Reiter, Russel J.] UT Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX USA	University of Brescia; IZS Lombardia e Emilia; University of Texas System; University of Texas Health San Antonio	Rezzani, R (corresponding author), Univ Brescia, Dept Clin & Expt Sci, Anat & Physiopathol Div, Brescia, Italy.	rita.rezzani@unibs.it	Stacchiotti, Alessandra/AAA-2193-2019; Lavazza, Antonio/G-8182-2011; Stacchiotti, Alessandra/AAL-7239-2021	Lavazza, Antonio/0000-0002-7646-3592; stacchiotti, alessandra/0000-0002-6767-6617; Rodella, Luigi Fabrizio/0000-0002-9497-4708; Favero, Gaia/0000-0001-6895-7106				Acuna-Castroviejo D., 2014, CELL MOL LIFE SCI; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Brady NR, 2004, BIOPHYS J, V87, P2022, DOI 10.1529/biophysj.103.035097; Brezniceanu ML, 2008, DIABETES, V57, P451, DOI 10.2337/db07-0013; Brooks C, 2007, P NATL ACAD SCI USA, V104, P11649, DOI 10.1073/pnas.0703976104; Cano P, 2008, ENDOCRINE, V33, P118, DOI 10.1007/s12020-008-9066-x; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chen J, 2004, ANN INTERN MED, V140, P167, DOI 10.7326/0003-4819-140-3-200402030-00007; Cheng ZY, 2014, CELL CYCLE, V13, P890, DOI 10.4161/cc.28189; Cosson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046293; D'Elia JA, 2009, INT J NEPHROL RENOV, V2, P39; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Dong F, 2006, J ENDOCRINOL, V188, P25, DOI 10.1677/joe.1.06241; Favero G, 2013, ACTA HISTOCHEM, V115, P783, DOI 10.1016/j.acthis.2013.02.014; Galano A, 2013, J PINEAL RES, V54, P245, DOI 10.1111/jpi.12010; Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x; Gall J, 2013, PLOS ONE, V7; Galloway CA, 2012, J GEN PHYSIOL, V139, P455, DOI 10.1085/jgp.201210771; Garcia-Ruiz I, 2007, HEPATOLOGY, V46, P414, DOI 10.1002/hep.21687; Ghibelli L, 2010, MITOCHONDRION, V10, P604, DOI 10.1016/j.mito.2010.08.003; Hall AM, 2009, J AM SOC NEPHROL, V20, P1293, DOI 10.1681/ASN.2008070759; Hsiao CW, 2013, J PINEAL RES, V54, P107, DOI 10.1111/jpi.12004; Hu ZP, 2013, J PINEAL RES, V55, P388, DOI 10.1111/jpi.12085; Jheng HF, 2012, MOL CELL BIOL, V32, P309, DOI 10.1128/MCB.05603-11; Jimenez-Aranda A, 2013, J PINEAL RES, V55, P416, DOI 10.1111/jpi.12089; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Kelly KJ, 2008, AM J PHYSIOL-RENAL, V294, pF1136, DOI 10.1152/ajprenal.00396.2007; Kurella M, 2005, J AM SOC NEPHROL, V16, P2134, DOI 10.1681/ASN.2005010106; Lanoix D, 2013, MOL CELL ENDOCRINOL, V381, P35, DOI 10.1016/j.mce.2013.07.010; Leoncini G, 2012, J NEPHROL, V25, P63, DOI 10.5301/JN.2011.7752; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Martin-Cano FE, 2014, J PINEAL RES, V56, P163, DOI 10.1111/jpi.12109; Mendes C, 2013, J PINEAL RES, V55, P229, DOI 10.1111/jpi.12065; Molpeceres V, 2007, J GERONTOL A-BIOL, V62, P687, DOI 10.1093/gerona/62.7.687; Paradies G, 2010, J PINEAL RES, V48, P297, DOI 10.1111/j.1600-079X.2010.00759.x; Quigley JE, 2009, CLIN EXP PHARMACOL P, V36, P724, DOI 10.1111/j.1440-1681.2009.05139.x; Radogna F, 2008, J PINEAL RES, V44, P316, DOI 10.1111/j.1600-079X.2007.00532.x; Raskind MA, 2007, NEUROPSYCHOPHARMACOL, V32, P284, DOI 10.1038/sj.npp.1301093; Reiter Russel J, 2008, Interdiscip Toxicol, V1, P137, DOI 10.2478/v10102-010-0030-2; Rezzani R, 2013, LIFE SCI, V92, P875, DOI 10.1016/j.lfs.2012.11.011; Rodella LF, 2013, AGE, V35, P103, DOI 10.1007/s11357-011-9336-z; Runkel ED, 2014, EXP GERONTOL, V56, P194, DOI 10.1016/j.exger.2014.02.013; Sebastian D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109; Solis-Munoz P, 2011, J PINEAL RES, V51, P113, DOI 10.1111/j.1600-079X.2011.00868.x; Stacchiotti A, 2006, J HISTOCHEM CYTOCHEM, V54, P1149, DOI 10.1369/jhc.6A6932.2006; Stacchiotti A, 2009, FOOD CHEM TOXICOL, V47, P2834, DOI 10.1016/j.fct.2009.09.003; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Tan DX, 2013, J PINEAL RES, V54, P127, DOI 10.1111/jpi.12026; Tan DX, 1993, ENDOCR J, V1, P57; Tang WX, 2012, ENDOCRINE, V41, P236, DOI 10.1007/s12020-011-9555-1; Tobar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075547; Ulivieri C, 2010, TISSUE CELL, V42, P339, DOI 10.1016/j.tice.2010.10.004; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Wickman C, 2013, SEMIN NEPHROL, V33, P14, DOI 10.1016/j.semnephrol.2012.12.006; Yamaguchi R, 2008, MOL CELL, V31, P557, DOI 10.1016/j.molcel.2008.07.010; Zhai XY, 2003, J AM SOC NEPHROL, V14, P611, DOI 10.1097/01.ASN.0000051725.00406.0C; Zhan M, 2013, KIDNEY INT, V83, P568, DOI 10.1038/ki.2012.441; Zorzano A, 2009, INT J BIOCHEM CELL B, V41, P1846, DOI 10.1016/j.biocel.2009.02.004	58	38	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111141	10.1371/journal.pone.0111141	http://dx.doi.org/10.1371/journal.pone.0111141			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347680	Green Published, gold, Green Submitted			2022-12-27	WOS:000347994900050
J	Galli, R; Uckermann, O; Andresen, EF; Geiger, KD; Koch, E; Schackert, G; Steiner, G; Kirsch, M				Galli, Roberta; Uckermann, Ortrud; Andresen, Elisabeth F.; Geiger, Kathrin D.; Koch, Edmund; Schackert, Gabriele; Steiner, Gerald; Kirsch, Matthias			Intrinsic Indicator of Photodamage during Label-Free Multiphoton Microscopy of Cells and Tissues	PLOS ONE			English	Article							RAMAN SCATTERING MICROSCOPY; INFRARED LASER-PULSES; 2ND-HARMONIC GENERATION; BIOLOGICAL TISSUES; FEMTOSECOND LASER; CARS MICROSCOPY; FLUORESCENCE; NANOSURGERY; MECHANISMS; EXCITATION	Multiphoton imaging has evolved as an indispensable tool in cell biology and holds prospects for clinical applications. When addressing endogenous signals such as coherent anti-Stokes Raman scattering (CARS) or second harmonic generation, it requires intense laser irradiation that may cause photodamage. We report that increasing endogenous fluorescence signal upon multiphoton imaging constitutes a marker of photodamage. The effect was studied on mouse brain in vivo and ex vivo, on ex vivo human brain tissue samples, as well as on glioblastoma cells in vitro, demonstrating that this phenomenon is common to a variety of different systems, both ex vivo and in vivo. CARS microscopy and vibrational spectroscopy were used to analyze the photodamage. The development of a standard easy-to-use model that employs rehydrated cryosections allowed the characterization of the irradiation-induced fluorescence and related it to nonlinear photodamage. In conclusion, the monitoring of endogenous two-photon excited fluorescence during label-free multiphoton microscopy enables to estimate damage thresholds ex vivo as well as detect photodamage during in vivo experiments.	[Galli, Roberta; Koch, Edmund; Steiner, Gerald] Tech Univ Dresden, Fac Med Carl Gustav Carus, Dresden, Germany; [Uckermann, Ortrud; Andresen, Elisabeth F.; Schackert, Gabriele; Kirsch, Matthias] Tech Univ Dresden, Carl Gustav Carus Univ Hosp, Dresden, Germany; [Geiger, Kathrin D.] Tech Univ Dresden, Carl Gustav Carus Univ Hosp, Inst Pathol, Dresden, Germany; [Andresen, Elisabeth F.; Kirsch, Matthias] CRTD, DFG, Cluster Excellence, Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; German Research Foundation (DFG); Technische Universitat Dresden	Steiner, G (corresponding author), Tech Univ Dresden, Fac Med Carl Gustav Carus, Dresden, Germany.	Gerald.Steiner@tu-dresden.de; Matthias.Kirsch@uniklinikum-dresden.de		Koch, Edmund/0000-0003-0554-2178	German Federal Ministry of Education and Research (MediCARS project) [A.Z. 13N10777]	German Federal Ministry of Education and Research (MediCARS project)	This work was funded by the German Federal Ministry of Education and Research (MediCARS project, A.Z. 13N10777). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begin S, 2011, BIOMED OPT EXPRESS, V2, P1296, DOI 10.1364/BOE.2.001296; Bennett BD, 1996, J BIOL CHEM, V271, P3647; Campagnola PJ, 2003, NAT BIOTECHNOL, V21, P1356, DOI 10.1038/nbt894; Carriles R, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3184828; Chung SH, 2009, J BIOPHOTONICS, V2, P557, DOI 10.1002/jbio.200910053; Colombelli J, 2006, M S-MED SCI, V22, P651, DOI 10.1051/medsci/20062267651; Dunn KW, 2006, NEPHRON EXP NEPHROL, V103, pE33, DOI 10.1159/000090614; Evans CL, 2008, ANNU REV ANAL CHEM, V1, P883, DOI 10.1146/annurev.anchem.1.031207.112754; Ferrari AC, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.155306; Fischer F, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2960016; Galbraith JA, 2003, MOL BIOL CELL, V14, P1808, DOI 10.1091/mbc.E02-03-0163; Galli R, 2012, ANAL CHEM, V84, P8707, DOI 10.1021/ac301938m; Gao L, 2011, BIOMED OPT EXPRESS, V2, P915, DOI 10.1364/BOE.2.000915; Girotti AW, 2001, J PHOTOCH PHOTOBIO B, V63, P103, DOI 10.1016/S1011-1344(01)00207-X; Harnett MT, 2012, NATURE, V491, P599, DOI 10.1038/nature11554; Hopt A, 2001, BIOPHYS J, V80, P2029, DOI 10.1016/S0006-3495(01)76173-5; Hovhannisyan V, 2008, OPT EXPRESS, V16, P7958, DOI 10.1364/OE.16.007958; Hovhannisyan V, 2010, OPT EXPRESS, V18, P24037, DOI 10.1364/OE.18.024037; Ji N, 2008, NAT METHODS, V5, P197, DOI 10.1038/NMETH.1175; KIKUGAWA K, 1986, ADV FREE RADICAL BIO, V2, P389, DOI 10.1016/S8755-9668(86)80020-5; Kirkpatrick ND, 2007, CANCER EPIDEM BIOMAR, V16, P2048, DOI 10.1158/1055-9965.EPI-07-0009; Koester HJ, 1999, BIOPHYS J, V77, P2226, DOI 10.1016/S0006-3495(99)77063-3; Kohli V, 2009, WIRES NANOMED NANOBI, V1, P11, DOI 10.1002/wnan.29; Konig K, 2000, J MICROSC-OXFORD, V200, P83, DOI 10.1046/j.1365-2818.2000.00738.x; Konig K, 1999, OPT LETT, V24, P113, DOI 10.1364/OL.24.000113; KONIG K, 1995, NATURE, V377, P20, DOI 10.1038/377020a0; Konig K, 1996, J MICROSC-OXFORD, V183, P197; Konig K, 1996, HUM REPROD, V11, P2162; Leppert J, 2006, NEUROSURGERY, V58, P759, DOI 10.1227/01.NEU.0000204885.45644.22; Meyer T, 2013, ANAL CHEM, V85, P6703, DOI 10.1021/ac400570w; Mohler W, 2003, METHODS, V29, P97, DOI 10.1016/S1046-2023(02)00292-X; Movasaghi Z, 2008, APPL SPECTROSC REV, V43, P134, DOI 10.1080/05704920701829043; Movasaghi Z, 2007, APPL SPECTROSC REV, V42, P493, DOI 10.1080/05704920701551530; Nan XL, 2006, BIOPHYS J, V91, P728, DOI 10.1529/biophysj.105.074534; Orzekowsky-Schroeder R, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3655587; Pestov D, 2010, J OPTICS-UK, V12, DOI 10.1088/2040-8978/12/8/084006; Pezacki JP, 2011, NAT CHEM BIOL, V7, P137, DOI 10.1038/NCHEMBIO.525; Pohling C, 2011, BIOMED OPT EXPRESS, V2, P2110, DOI 10.1364/BOE.2.002110; Ronchi P, 2012, BIOL CHEM, V393, P235, DOI 10.1515/hsz-2011-0237; Saytashev I, 2012, J PHOTOCH PHOTOBIO B, V115, P42, DOI 10.1016/j.jphotobiol.2012.06.009; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Straub M, 1998, BIOIMAGING, V6, P177, DOI 10.1002/1361-6374(199812)6:4<177::AID-BIO3>3.0.CO;2-R; SUTHERLAND JC, 1981, RADIAT RES, V86, P399, DOI 10.2307/3575456; Tiede LM, 2006, PHOTOCHEM PHOTOBIOL, V82, P656, DOI 10.1562/2005-09-19-RA-689; Tinevez JY, 2012, METHOD ENZYMOL, V506, P291, DOI 10.1016/B978-0-12-391856-7.00039-1; Veberg A, 2006, LWT-FOOD SCI TECHNOL, V39, P562, DOI 10.1016/j.lwt.2005.03.009; Vogel A, 2005, APPL PHYS B-LASERS O, V81, P1015, DOI 10.1007/s00340-005-2036-6; Vogel A, 2003, CHEM REV, V103, P577, DOI 10.1021/cr010379n; Xu C, 1996, P NATL ACAD SCI USA, V93, P10763, DOI 10.1073/pnas.93.20.10763; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899; Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100; Zoumi A, 2002, P NATL ACAD SCI USA, V99, P11014, DOI 10.1073/pnas.172368799	53	52	52	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110295	10.1371/journal.pone.0110295	http://dx.doi.org/10.1371/journal.pone.0110295			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343251	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943500032
J	Gresner, P; Gromadzinska, J; Jablonska, E; Stepnik, M; Quispe, OZ; Twardowska, E; Wasowicz, W				Gresner, Peter; Gromadzinska, Jolanta; Jablonska, Ewa; Stepnik, Maciej; Quispe, Oscar Zambrano; Twardowska, Ewa; Wasowicz, Wojciech			Single Nucleotide Polymorphisms in Noncoding Regions of Rad51C Do Not Change the Risk of Unselected Breast Cancer but They Modulate the Level of Oxidative Stress and the DNA Damage Characteristics: A Case-Control Study	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; GERMLINE MUTATIONS; FANCONI-ANEMIA; SUSCEPTIBILITY GENE; OVARIAN; MAINTENANCE; PROTEIN; REPAIR; ROLES; BRIP1	Deleterious and missense mutations of RAD51C have recently been suggested to modulate the individual susceptibility to hereditary breast and ovarian cancer and unselected ovarian cancer, but not unselected breast cancer (BrC). We enrolled 132 unselected BrC females and 189 cancer-free female subjects to investigate whether common single nucleotide polymorphisms (SNPs) in non-coding regions of RAD51C modulate the risk of BrC, and whether they affect the level of oxidative stress and the extent/characteristics of DNA damage. Neither SNPs nor reconstructed haplotypes were found to significantly affect the unselected BrC risk. Contrary to this, carriers of rs12946522, rs16943176, rs12946397 and rs17222691 rare-alleles were found to present significantly increased level of blood plasma TBARS compared to respective wild-type homozygotes (p<0.05). Furthermore, these carriers showed significantly decreased fraction of oxidatively generated DNA damage (34% of total damaged DNA) in favor of DNA strand breakage, with no effect on total DNA damage, unlike respective wild-types, among which more evenly distributed proportions between oxidatively damaged DNA (48% of total DNA damage) and DNA strand breakage was found (p<0.0005 for the difference). Such effects were found among both the BrC cases and healthy subjects, indicating that they cannot be assumed as causal factors contributing to BrC development.	[Gresner, Peter; Gromadzinska, Jolanta; Jablonska, Ewa; Stepnik, Maciej; Twardowska, Ewa; Wasowicz, Wojciech] Nofer Inst Occupat Med, Dept Toxicol & Carcinogenesis, Lodz, Poland; [Quispe, Oscar Zambrano] Herlev Hosp, Dept Oncol, DK-2730 Herlev, Denmark	Nofer Institute of Occupational Medicine; University of Copenhagen; Herlev & Gentofte Hospital	Gresner, P (corresponding author), Nofer Inst Occupat Med, Dept Toxicol & Carcinogenesis, Lodz, Poland.	pgresner@imp.lodz.pl	Jablonska, Ewa/F-6005-2010; Grešner, Peter/G-5905-2010; Stepnik, Maciej/F-6093-2010	Jablonska, Ewa/0000-0002-3946-3964; Stepnik, Maciej/0000-0003-1586-2482; Wasowicz, Wojciech/0000-0002-2991-9040; Gresner, Peter/0000-0002-7008-396X; Gromadzinska, Jolanta/0000-0001-6878-2297	Nofer Institute of Occupational Medicine fund [IMP1.5/2011]	Nofer Institute of Occupational Medicine fund	The study was supported by the Nofer Institute of Occupational Medicine fund no. IMP1.5/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari MR, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2619; Badie S, 2009, J CELL BIOL, V185, P587, DOI 10.1083/jcb.200811079; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Clague J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025632; COLLINS AR, 1993, CARCINOGENESIS, V14, P1733, DOI 10.1093/carcin/14.9.1733; De Leeneer K, 2012, BREAST CANCER RES TR, V133, P393, DOI 10.1007/s10549-012-1998-4; Fackenthal JD, 2007, NAT REV CANCER, V7, P937, DOI 10.1038/nrc2054; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gresner P, 2014, MUTAT RES-FUND MOL M, V762, P47, DOI 10.1016/j.mrfmmm.2014.02.007; Gresner P, 2012, GENE, V504, P166, DOI 10.1016/j.gene.2012.05.030; Halliwell B, 2002, FREE RADICAL BIO MED, V32, P968, DOI 10.1016/S0891-5849(02)00808-0; Halliwell B, 2007, BIOCHEM J, V401, P1, DOI 10.1042/BJ20061131; Johnson RD, 2001, BIOCHEM SOC T, V29, P196, DOI 10.1042/BST0290196; Levy-Lahad E, 2010, NAT GENET, V42, P368, DOI 10.1038/ng0510-368; LEWONTIN RC, 1995, GENETICS, V140, P377; Liochev SI, 2013, FREE RADICAL BIO MED, V60, P1, DOI 10.1016/j.freeradbiomed.2013.02.011; Liu YL, 2004, SCIENCE, V303, P243, DOI 10.1126/science.1093037; Loveday C, 2012, NAT GENET, V44, P475, DOI 10.1038/ng.2224; Macintyre G, 2010, BIOINFORMATICS, V26, pi524, DOI 10.1093/bioinformatics/btq378; Masson JY, 2001, GENE DEV, V15, P3296, DOI 10.1101/gad.947001; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; MCKELVEYMARTIN VJ, 1993, MUTAT RES, V288, P47, DOI 10.1016/0027-5107(93)90207-V; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Mena S, 2009, MUTAT RES-GEN TOX EN, V674, P36, DOI 10.1016/j.mrgentox.2008.09.017; Nakabeppu Y, 2004, FREE RADICAL RES, V38, P423, DOI 10.1080/10715760410001688348; Osorio A, 2012, HUM MOL GENET, V21, P2889, DOI 10.1093/hmg/dds115; Pang ZY, 2011, BREAST CANCER RES TR, V129, P1019, DOI 10.1007/s10549-011-1574-3; Pelttari LM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-552; Pelttari LM, 2011, HUM MOL GENET, V20, P3278, DOI 10.1093/hmg/ddr229; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Ripperger T, 2009, EUR J HUM GENET, V17, P722, DOI 10.1038/ejhg.2008.212; Romero A, 2011, BREAST CANCER RES TR, V129, P939, DOI 10.1007/s10549-011-1543-x; Sage JM, 2010, J BIOL CHEM, V285, P18984, DOI 10.1074/jbc.M109.099846; Saleh-Gohari N, 2005, MOL CELL BIOL, V25, P7158, DOI 10.1128/MCB.25.16.7158-7169.2005; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Somyajit K, 2012, J BIOL CHEM, V287, P3366, DOI 10.1074/jbc.M111.311241; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Thompson ER, 2012, HUM MUTAT, V33, P95, DOI 10.1002/humu.21625; Turnbull C, 2008, ANNU REV GENOM HUM G, V9, P321, DOI 10.1146/annurev.genom.9.081307.164339; Vuorela M, 2011, BREAST CANCER RES TR, V130, P1003, DOI 10.1007/s10549-011-1677-x; WASOWICZ W, 1993, CLIN CHEM, V39, P2522; Wong MW, 2011, BREAST CANCER RES TR, V127, P853, DOI 10.1007/s10549-011-1443-0; Zheng YL, 2010, BREAST CANCER RES TR, V124, P857, DOI 10.1007/s10549-010-1095-5	48	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110696	10.1371/journal.pone.0110696	http://dx.doi.org/10.1371/journal.pone.0110696			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343521	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943500048
J	Fernandez, H; Prandoni, N; Fernandez-Pascual, M; Fajardo, S; Morcillo, C; Diaz, E; Carmona, M				Fernandez, Helga; Prandoni, Nicolas; Fernandez-Pascual, Mercedes; Fajardo, Susana; Morcillo, Cesar; Diaz, Eduardo; Carmona, Manuel			Azoarcus sp CIB, an Anaerobic Biodegrader of Aromatic Compounds Shows an Endophytic Lifestyle	PLOS ONE			English	Article							PHOSPHATE SOLUBILIZING BACTERIA; SP STRAIN BH72; PLANT-GROWTH; SP-NOV; NITROGEN-FIXATION; IAA BIOSYNTHESIS; LUPINUS-ALBUS; COLONIZATION; RICE; IDENTIFICATION	Background: Endophytic bacteria that have plant growth promoting traits are of great interest in green biotechnology. The previous thought that the Azoarcus genus comprises bacteria that fit into one of two major eco-physiological groups, either free-living anaerobic biodegraders of aromatic compounds or obligate endophytes unable to degrade aromatics under anaerobic conditions, is revisited here. Methodology/Principal Findings: Light, confocal and electron microscopy reveal that Azoarcus sp. CIB, a facultative anaerobe beta-proteobacterium able to degrade aromatic hydrocarbons under anoxic conditions, is also able to colonize the intercellular spaces of the rice roots. In addition, the strain CIB displays plant growth promoting traits such nitrogen fixation, uptake of insoluble phosphorus and production of indoleacetic acid. Therefore, this work demonstrates by the first time that a free-living bacterium able to degrade aromatic compounds under aerobic and anoxic conditions can share also an endophytic lifestyle. The phylogenetic analyses based on the 16S rDNA and nifH genes confirmed that obligate endophytes of the Azoarcus genus and facultative endophytes, such as Azoarcus sp. CIB, locate into different evolutionary branches. Conclusions/Significance: This is the first report of a bacterium, Azoarcus sp. CIB, able to degrade anaerobically a significant number of aromatic compounds, some of them of great environmental concern, and to colonize the rice as a facultative endophyte. Thus, Azoarcus sp. CIB becomes a suitable candidate for a more sustainable agricultural practice and phytoremediation technology.	[Fernandez, Helga; Prandoni, Nicolas; Diaz, Eduardo; Carmona, Manuel] CSIC, Ctr Invest Biol, Dept Environm Biol, Madrid, Spain; [Fernandez-Pascual, Mercedes; Fajardo, Susana; Morcillo, Cesar] CSIC, Inst Ciencias Agr, Dept Plant Protect, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias Agrarias (ICA)	Carmona, M (corresponding author), CSIC, Ctr Invest Biol, Dept Environm Biol, Madrid, Spain.	mcarmona@cib.csic.es	Diaz, Eduardo/F-8605-2016	Diaz, Eduardo/0000-0002-9731-6524; Carmona, Manuel/0000-0002-1591-7618	Ministry of Economy and Competitiveness of Spain [BIO2009-10438, CSD2007-00005, BIO2012-3950, AGL2009-10371]; Castilla-La Mancha Autonomous Community [POII10-0211-5015]; Madrid Autonomous Community Grant [S2009/AMB-1511]; European Union FP7 Grant [311815]	Ministry of Economy and Competitiveness of Spain(Spanish Government); Castilla-La Mancha Autonomous Community; Madrid Autonomous Community Grant; European Union FP7 Grant	This work was supported by Ministry of Economy and Competitiveness of Spain Grants BIO2009-10438, CSD2007-00005, BIO2012-3950, AGL2009-10371, Castilla-La Mancha Autonomous Community Grant POII10-0211-5015, Madrid Autonomous Community Grant S2009/AMB-1511 and European Union FP7 Grant 311815. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERS HJ, 1995, INT J SYST BACTERIOL, V45, P327, DOI 10.1099/00207713-45-2-327; Anzai Y, 2000, INT J SYST EVOL MICR, V50, P1563, DOI 10.1099/00207713-50-4-1563; Bacon C. W., 2000, MICROBIAL ENDOPHYTES, DOI 10.1201/9781482277302; Barac T, 2004, NAT BIOTECHNOL, V22, P583, DOI 10.1038/nbt960; Barragan MJL, 2004, J BACTERIOL, V186, P5762, DOI 10.1128/JB.186.17.5762-5774.2004; BEDMAR EJ, 1979, CURR MICROBIOL, V2, P11, DOI 10.1007/BF02601725; Boll M, 2014, ENVIRON MICROBIOL, V16, P612, DOI 10.1111/1462-2920.12328; BRENT R, 1980, P NATL ACAD SCI-BIOL, V77, P1932, DOI 10.1073/pnas.77.4.1932; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Camerini S, 2008, ARCH MICROBIOL, V190, P67, DOI 10.1007/s00203-008-0365-7; Carmona M, 2009, MICROBIOL MOL BIOL R, V73, P71, DOI 10.1128/MMBR.00021-08; Chappell J, 1998, PHYTOREMEDIATION TCE; Chen YP, 2006, APPL SOIL ECOL, V34, P33, DOI 10.1016/j.apsoil.2005.12.002; de Lorenzo CA, 1998, PROTOPLASMA, V201, P71, DOI 10.1007/BF01280713; de Maria N, 2005, PLANT PHYSIOL BIOCH, V43, P985, DOI 10.1016/j.plaphy.2005.09.001; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Ebenau-Jehle C, 2012, J BACTERIOL, V194, P2894, DOI 10.1128/JB.00250-12; Egener T, 1998, MOL PLANT MICROBE IN, V11, P71, DOI 10.1094/MPMI.1998.11.1.71; Elbeltagy A, 2001, APPL ENVIRON MICROB, V67, P5285, DOI 10.1128/AEM.67.11.5285-5293.2001; Engelhard M, 2000, ENVIRON MICROBIOL, V2, P131, DOI 10.1046/j.1462-2920.2000.00078.x; Fedorova E, 2005, MOL PLANT MICROBE IN, V18, P405, DOI 10.1094/MPMI-18-0405; FERNANDEZPASCUAL M, 1988, J PLANT PHYSIOL, V133, P288, DOI 10.1016/S0176-1617(88)80202-5; Germaine K, 2004, FEMS MICROBIOL ECOL, V48, P109, DOI 10.1016/j.femsec.2003.12.009; GLICK BR, 1995, CAN J MICROBIOL, V41, P109, DOI 10.1139/m95-015; GLICKMANN E, 1995, APPL ENVIRON MICROB, V61, P793, DOI 10.1128/AEM.61.2.793-796.1995; Goldstein A., 1986, American Journal of Alternative Agriculture, V1, P51; GORDON SA, 1951, PLANT PHYSIOL, V26, P192, DOI 10.1104/pp.26.1.192; Gyaneshwar P, 2001, J BACTERIOL, V183, P2634, DOI 10.1128/JB.183.8.2634-2645.2001; Harms G, 1999, APPL ENVIRON MICROB, V65, P999; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; HUREK T, 1995, MOL MICROBIOL, V18, P225, DOI 10.1111/j.1365-2958.1995.mmi_18020225.x; Hurek T, 1997, APPL ENVIRON MICROB, V63, P4331, DOI 10.1128/AEM.63.11.4331-4339.1997; Hurek T, 1997, J BACTERIOL, V179, P4172, DOI 10.1128/jb.179.13.4172-4178.1997; HUREK T, 1995, APPL ENVIRON MICROB, V61, P2257, DOI 10.1128/AEM.61.6.2257-2261.1995; Hurek T, 2003, J BIOTECHNOL, V106, P169, DOI 10.1016/j.jbiotec.2003.07.010; HUREK T, 1994, J BACTERIOL, V176, P1913, DOI 10.1128/jb.176.7.1913-1923.1994; Juarez JF, 2013, ENVIRON MICROBIOL, V15, P148, DOI 10.1111/j.1462-2920.2012.02818.x; Karg T, 1996, J BACTERIOL, V178, P5748, DOI 10.1128/jb.178.19.5748-5754.1996; KLEMENT Z, 1963, NATURE, V199, P299, DOI 10.1038/199299b0; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lewis RS, 2007, GENET RESOUR CROP EV, V54, P727, DOI 10.1007/s10722-006-0024-2; Li LP, 1999, FEMS MICROBIOL LETT, V179, P141, DOI 10.1111/j.1574-6968.1999.tb08719.x; Mano H, 2008, MICROBES ENVIRON, V23, P109, DOI 10.1264/jsme2.23.109; Mitter B, 2013, TRENDS PLANT SCI, V4, P1; Patten CL, 2013, CRIT REV MICROBIOL, V39, P395, DOI 10.3109/1040841X.2012.716819; Phi QT, 2008, J MICROBIOL BIOTECHN, V18, P1235; Porter AW, 2014, ADV APPL MICROBIOL, V88, P167, DOI 10.1016/B978-0-12-800260-5.00005-X; Rabus R, 2005, APPL MICROBIOL BIOT, V68, P580, DOI 10.1007/s00253-005-0030-x; RABUS R, 1995, ARCH MICROBIOL, V163, P96, DOI 10.1007/BF00381782; Rabus R, 2014, APPL MICROBIOL BIOT, V98, P3371, DOI 10.1007/s00253-013-5466-9; Rajkumar M, 2009, CHEMOSPHERE, V77, P153, DOI 10.1016/j.chemosphere.2009.06.047; Ramos C, 2000, APPL ENVIRON MICROB, V66, P801, DOI 10.1128/AEM.66.2.801-809.2000; REINHOLD B, 1986, APPL ENVIRON MICROB, V52, P520, DOI 10.1128/AEM.52.3.520-526.1986; Reinhold-Hurek B, 2000, INT J SYST EVOL MICR, V50, P649, DOI 10.1099/00207713-50-2-649; Reinhold-Hurek B, 1998, TRENDS MICROBIOL, V6, P139, DOI 10.1016/S0966-842X(98)01229-3; REINHOLDHUREK B, 1993, INT J SYST BACTERIOL, V43, P574, DOI 10.1099/00207713-43-3-574; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rhine ED, 2006, ENVIRON MICROBIOL, V8, P899, DOI 10.1111/j.1462-2920.2005.00977.x; Rodriguez H, 1999, BIOTECHNOL ADV, V17, P319, DOI 10.1016/S0734-9750(99)00014-2; Rodriguez H, 2000, J BIOTECHNOL, V84, P155, DOI 10.1016/S0168-1656(00)00347-3; Rosenblueth M, 2006, MOL PLANT MICROBE IN, V19, P827, DOI 10.1094/MPMI-19-0827; Ruiz-Diez B, 2012, APPL MICROBIOL BIOT, V96, P543, DOI 10.1007/s00253-011-3832-z; Salkowski E., 1885, Z PHYSL CHEM, V9, P23; Sambrook J., 2001, MOL CLONING LAB MANU; Sessitsch A, 2002, FEMS MICROBIOL ECOL, V39, P23, DOI 10.1111/j.1574-6941.2002.tb00903.x; Silva-Rocha R, 2013, NUCLEIC ACIDS RES, V41, pD666, DOI 10.1093/nar/gks1119; Singh OV, 2003, APPL MICROBIOL BIOT, V63, P128, DOI 10.1007/s00253-003-1425-1; Tsavkelova E, 2012, FUNGAL GENET BIOL, V49, P48, DOI 10.1016/j.fgb.2011.10.005; Verma SC, 2001, J BIOTECHNOL, V91, P127, DOI 10.1016/S0168-1656(01)00333-9; WICHNER S, 1968, PHYSIOL PLANTARUM, V21, P227, DOI 10.1111/j.1399-3054.1968.tb07246.x	71	33	33	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110771	10.1371/journal.pone.0110771	http://dx.doi.org/10.1371/journal.pone.0110771			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340341	Green Submitted, Green Published, gold			2022-12-27	WOS:000343662800055
J	Lu, HL; Wamba, PCF; Lapointe, M; Poirier, P; Martin, J; Bastien, M; Cianflone, K				Lu, HuiLing; Wamba, Ponce Cedric Fouejeu; Lapointe, Marc; Poirier, Paul; Martin, Julie; Bastien, Marjorie; Cianflone, Katherine			Increased Vaspin Levels Are Associated with Beneficial Metabolic Outcome Pre- and Post-Bariatric Surgery	PLOS ONE			English	Article							INSULIN SENSITIVITY; ADIPOSE-TISSUE; ADIPOKINE VASPIN; GENE-EXPRESSION; SERUM-LEVELS; WEIGHT-LOSS; OBESITY; INHIBITOR; LIGAND; FAT	Purpose: Vaspin (visceral-adipose-tissue-derived-serine-protease-inhibitor) is a recently identified adipokine with putative insulin-sensitizing properties. Plasma vaspin responses to surgery-induced weight loss are sparse and contradictory. Design and Participants: We evaluated changes in vaspin levels and relationship to post-operative outcomes in men (n = 22) and women (n = 55) undergoing biliopancreatic-diversion/duodenal-switch bariatric surgery. Body composition and plasma parameters were measured at baseline, acutely (1 and 5 days) and medium-term (6 and 12 months) post-surgery. Results: Fasting preoperative vaspin concentrations were comparable in men vs women. The distribution was biphasic (both men and women) with a nadir of 2.5 ng/ml. Subjects were divided into high (>= 2.5 ng/mL, HI-group) and low (<2.5 ng/mL, LO-group) vaspin level. Both groups had comparable sex distribution, age and BMI, but the HI-vaspin group had lower insulin, HOMA, and triglyceride and higher HDL-cholesterol, acylation stimulating protein (ASP) and IL-6 levels (all p, <0.05). Post-operatively, both groups decreased BMI comparably over 12 months; the HI-vaspin group maintained high vaspin levels, while the LO-vaspin group gradually increased their levels with weight loss over 12 months. The HI-vaspin group maintained a better glucose, insulin, HOMA, fructosamine, HDL-cholesterol, and triglyceride profile throughout. The HI-vaspin group also had higher gamma-glutamyltransferase and ASP profiles. Finally, baseline vaspin level inversely correlated significantly with baseline and 12-month insulin, HOMA, triglyceride and positively correlated with HDL and ASP. Twelve-month vaspin also correlated similarly, including an inverse correlation with BMI. Conclusion: Globally, this study supports the concept of vaspin as a beneficial adipokine in obesity, which may potentially lead to possible therapeutic targets.	[Lu, HuiLing; Wamba, Ponce Cedric Fouejeu; Lapointe, Marc; Poirier, Paul; Martin, Julie; Bastien, Marjorie; Cianflone, Katherine] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Quebec City, PQ, Canada; [Cianflone, Katherine] Univ Laval, Fac Med, Quebec City, PQ G1K 7P4, Canada; [Poirier, Paul; Martin, Julie; Bastien, Marjorie] Univ Laval, Fac Pharm, Quebec City, PQ, Canada; [Lu, HuiLing] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Pediat, Wuhan 430074, Hubei, Peoples R China; [Wamba, Ponce Cedric Fouejeu] Univ Yaounde, Fac Sci, Lab Nut & Biochim Nutr, Yaounde, Cameroon	Laval University; Laval University; Laval University; Huazhong University of Science & Technology; University of Yaounde I	Cianflone, K (corresponding author), Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Quebec City, PQ, Canada.	katherine.cianflone@criucpq.ulaval.ca		Lapointe, Marc/0000-0003-0461-2576	Canadian Institutes of Health Research (CIHR); National Natural Science Foundation of China (NSFC) [81270949]; Canadian Commonwealth Scholarship Program	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Canadian Commonwealth Scholarship Program	This study was supported by a grant from Canadian Institutes of Health Research (CIHR) to KC and a grant from National Natural Science Foundation of China (NSFC) #81270949 to HLL.K. Cianflone holds a Canada Research Chair in Adipose Tissue. PC Fouejeu Wamba was supported by a Canadian Commonwealth Scholarship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbarzadeh S, 2012, DIABETES RES CLIN PR, V95, P132, DOI 10.1016/j.diabres.2011.10.004; Bluher M, 2012, ENDOCRINE, V41, P176, DOI 10.1007/s12020-011-9572-0; Bluher M, 2012, DIABETES CARE, V35, P342, DOI 10.2337/dc11-1267; Cao HM, 2014, J ENDOCRINOL, V220, pT47, DOI 10.1530/JOE-13-0339; Cinar N, 2011, EUR J ENDOCRINOL, V165, P563, DOI 10.1530/EJE-11-0180; DeClercq V., 2013, Cardiovascular & Hematological Disorders - Drug Targets, V13, P59; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Goktas Zeynep, 2013, Front Endocrinol (Lausanne), V4, P69, DOI 10.3389/fendo.2013.00069; Golpaie A, 2011, EUR CYTOKINE NETW, V22, P181, DOI 10.1684/ecn.2011.0295; Goralski KB, 2007, CAN J PHYSIOL PHARM, V85, P113, DOI 10.1139/Y06-092; Guidone C, 2006, DIABETES, V55, P2025, DOI 10.2337/db06-0068; Handisurya A, 2010, OBES SURG, V20, P198, DOI 10.1007/s11695-009-9882-y; Heiker JT, 2013, CELL MOL LIFE SCI, V70, P2569, DOI 10.1007/s00018-013-1258-8; Heiker JT, 2014, J PEPT SCI; Hida K, 2005, P NATL ACAD SCI USA, V102, P10610, DOI 10.1073/pnas.0504703102; Isbell JM, 2010, DIABETES CARE, V33, P1438, DOI 10.2337/dc09-2107; Kadoglou NPE, 2011, REGUL PEPTIDES, V170, P57, DOI 10.1016/j.regpep.2011.05.008; Kim SM, 2011, METABOLISM, V60, P1294, DOI 10.1016/j.metabol.2011.01.013; Kloting N, 2006, BIOCHEM BIOPH RES CO, V339, P430, DOI 10.1016/j.bbrc.2005.11.039; Koiou E, 2011, ENDOCR J, V58, P237, DOI 10.1507/endocrj.K10E-330; Lee JA, 2011, ENDOCR J, V58, P639, DOI 10.1507/endocrj.K11E-073; Marceau P, 2009, SURG OBES RELAT DIS, V5, P43, DOI 10.1016/j.soard.2008.03.244; Maslowska M, 2006, J LIPID RES, V47, P643, DOI 10.1194/jlr.M500500-JLR200; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; Munkonda MN, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.13; Nakatsuka A, 2013, CIRC RES, V112, P771, DOI 10.1161/CIRCRESAHA.111.300049; Nakatsuka A, 2012, DIABETES, V61, P2823, DOI 10.2337/db12-0232; Oberbach A, 2010, OBESITY FACTS, V3, P328, DOI 10.1159/000321637; Phalitakul S, 2011, PHARMACOL RES, V64, P493, DOI 10.1016/j.phrs.2011.06.001; Poirier P, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-013-0444-5; Schultz S, 2013, CHEMMEDCHEM, V8, P549, DOI 10.1002/cmdc.201200448; Seeger J, 2008, J CLIN ENDOCR METAB, V93, P247, DOI 10.1210/jc.2007-1853; Tan BK, 2008, DIABETES, V57, P1501, DOI 10.2337/db08-0127; von Loeffelholz C, 2010, EUR J ENDOCRINOL, V162, P507, DOI 10.1530/EJE-09-0737; You BS, 2008, DIABETES, V57, P372, DOI 10.2337/db07-1045	35	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111002	10.1371/journal.pone.0111002	http://dx.doi.org/10.1371/journal.pone.0111002			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340725	gold, Green Published, Green Submitted			2022-12-27	WOS:000343662800077
J	Bliss, CA; Danforth, CM; Dodds, PS				Bliss, Catherine A.; Danforth, Christopher M.; Dodds, Peter Sheridan			Estimation of Global Network Statistics from Incomplete Data	PLOS ONE			English	Article							SCALE-FREE; SIZE	Complex networks underlie an enormous variety of social, biological, physical, and virtual systems. A profound complication for the science of complex networks is that in most cases, observing all nodes and all network interactions is impossible. Previous work addressing the impacts of partial network data is surprisingly limited, focuses primarily on missing nodes, and suggests that network statistics derived from subsampled data are not suitable estimators for the same network statistics describing the overall network topology. We generate scaling methods to predict true network statistics, including the degree distribution, from only partial knowledge of nodes, links, or weights. Our methods are transparent and do not assume a known generating process for the network, thus enabling prediction of network statistics for a wide variety of applications. We validate analytical results on four simulated network classes and empirical data sets of various sizes. We perform subsampling experiments by varying proportions of sampled data and demonstrate that our scaling methods can provide very good estimates of true network statistics while acknowledging limits. Lastly, we apply our techniques to a set of rich and evolving large-scale social networks, Twitter reply networks. Based on 100 million tweets, we use our scaling techniques to propose a statistical characterization of the Twitter Interactome from September 2008 to November 2008. Our treatment allows us to find support for Dunbar's hypothesis in detecting an upper threshold for the number of active social contacts that individuals maintain over the course of one week.	[Bliss, Catherine A.] Univ Vermont, Dept Math & Stat, Vermont Complex Syst Ctr, Computat Story Lab, Burlington, VT 05405 USA; Univ Vermont, Vermont Adv Comp Core, Burlington, VT 05405 USA	University of Vermont; University of Vermont	Bliss, CA (corresponding author), Univ Vermont, Dept Math & Stat, Vermont Complex Syst Ctr, Computat Story Lab, Burlington, VT 05405 USA.	Catherine.Bliss@uvm.edu	Dodds, Peter S/C-9119-2014	Dodds, Peter S/0000-0003-1973-8614	NASA at the University of Vermont [NNX-08AO96G]; NSF CAREER Award [0846668]; MITRE Corporation	NASA at the University of Vermont; NSF CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); MITRE Corporation	The authors acknowledge the Vermont Advanced Computing Core and support by NASA (NNX-08AO96G) at the University of Vermont for Providing High Performance Computing resources that have contributed to the research results reported within this paper. CAB and PSD were funded by an NSF CAREER Award to PSD (\# 0846668). CMD and PSD were funded by a grant from the MITRE Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagrow J. P., 2013, ARXIV13126122; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; BIERNACKI P, 1981, SOCIOL METHOD RES, V10, P141, DOI 10.1177/004912418101000205; Bliss C. A., 2014, J COMPUTATIONAL SCI; Bliss CA, 2012, J COMPUT SCI-NETH, V3, P388, DOI 10.1016/j.jocs.2012.05.001; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cohen R, 2000, PHYS REV LETT, V85, P4626, DOI 10.1103/PhysRevLett.85.4626; Costenbader E, 2003, SOC NETWORKS, V25, P283, DOI 10.1016/S0378-8733(03)00012-1; Cotilla-Sanchez E, 2012, IEEE T SMART GRID, V3, P1832, DOI 10.1109/TSG.2012.2213848; de Silva E, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-39; DUNBAR RIM, 1995, J HUM EVOL, V28, P287, DOI 10.1006/jhev.1995.1021; ERDOS P, 1960, B INT STATIST INST, V38, P343; FRANK O, 1978, SOC NETWORKS, V1, P91, DOI 10.1016/0378-8733(78)90015-1; FRANK O, 1980, J STAT PLAN INFER, V4, P45, DOI 10.1016/0378-3758(80)90032-4; Frank O, 1994, J OFF STAT, V10, P53; Frantz TL, 2009, COMPUT MATH ORGAN TH, V15, P303, DOI 10.1007/s10588-009-9063-5; Goldstein ML, 2004, EUR PHYS J B, V41, P255, DOI 10.1140/epjb/e2004-00316-5; Goncalves B, 2011, PLOS ONE, V6; Grindrod P, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.066702; Han JDJ, 2005, NAT BIOTECHNOL, V23, P839, DOI 10.1038/nbt1116; Hines P, 2009, IEEE POTENTIALS, V28, P24, DOI 10.1109/MPOT.2009.933498; Holme P, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066109; Kolaczyk ED, 2009, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-88146-1_1; Kossinets G, 2006, SOC NETWORKS, V28, P247, DOI 10.1016/j.socnet.2005.07.002; Lakhina A, 2003, P IEEE INFOCOM; Lee SH, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.016102; Leskovec J, 2006, P 12 ACM SIGKDD INT, P631; Lusseau D, 2003, BEHAV ECOL SOCIOBIOL, V54, P396, DOI 10.1007/s00265-003-0651-y; Martin S, 2006, PHYSICA A, V371, P870, DOI 10.1016/j.physa.2006.04.046; Morstatter F, 2013, P ICWSM; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Pahwa Sakshi, 2014, Sci Rep, V4, P3694, DOI 10.1038/srep03694; Platig J, 2013, B AM PHYS SOC, V58; PRICE DJD, 1976, J AM SOC INFORM SCI, V27, P292, DOI 10.1002/asi.4630270505; PRICE DJD, 1965, SCIENCE, V149, P510; SIMON HA, 1955, BIOMETRIKA, V42, P425; Stumpf MPH, 2008, P NATL ACAD SCI USA, V105, P6959, DOI 10.1073/pnas.0708078105; Stumpf MPH, 2005, LECT NOTES COMPUT SC, V3737, P65; Stumpf MPH, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.036118; Stumpf MPH, 2005, P NATL ACAD SCI USA, V102, P4221, DOI 10.1073/pnas.0501179102; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weng L, 2013, SCI REP-UK, V3, DOI [10.1038/srep02304, 10.1038/srep02522]; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wiuf C, 2006, P ROY SOC A-MATH PHY, V462, P1181, DOI 10.1098/rspa.2005.1622; Woolley-Meza O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069829; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752	50	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e108471	10.1371/journal.pone.0108471	http://dx.doi.org/10.1371/journal.pone.0108471			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6DY	25338183	Green Submitted, Green Published, gold			2022-12-27	WOS:000343674800006
J	Emde, S; Kochmann, J; Kuhn, T; Plath, M; Klimpel, S				Emde, Sebastian; Kochmann, Judith; Kuhn, Thomas; Plath, Martin; Klimpel, Sven			Getting What Is Served? Feeding Ecology Influencing Parasite-Host Interactions in Invasive Round Goby Neogobius melanostomus	PLOS ONE			English	Article							BIOTIC HOMOGENIZATION; METAZOAN PARASITES; ALIEN PREDATORS; GREAT-LAKES; FISH; PALLAS; RHINE; GOBIIDAE; INVADER; LAEVIS	Freshwater ecosystems are increasingly impacted by alien invasive species which have the potential to alter various ecological interactions like predator-prey and host-parasite relationships. Here, we simultaneously examined predator-prey interactions and parasitization patterns of the highly invasive round goby (Neogobius melanostomus) in the rivers Rhine and Main in Germany. A total of 350 N. melanostomus were sampled between June and October 2011. Gut content analysis revealed a broad prey spectrum, partly reflecting temporal and local differences in prey availability. For the major food type (amphipods), species compositions were determined. Amphipod fauna consisted entirely of non-native species and was dominated by Dikerogammarus villosus in the Main and Echinogammarus trichiatus in the Rhine. However, the availability of amphipod species in the field did not reflect their relative abundance in gut contents of N. melanostomus. Only two metazoan parasites, the nematode Raphidascaris acus and the acanthocephalan Pomphorhynchus sp., were isolated from N. melanostomus in all months, whereas unionid glochidia were only detected in June and October in fish from the Main. To analyse infection pathways, we examined 17,356 amphipods and found Pomphorhynchus sp. larvae only in D. villosus in the river Rhine at a prevalence of 0.15%. Dikerogammarus villosus represented the most important amphipod prey for N. melanostomus in both rivers but parasite intensities differed between rivers, suggesting that final hosts (large predatory fishes) may influence host-parasite dynamics of N. melanostomus in its introduced range.	[Emde, Sebastian; Kuhn, Thomas; Klimpel, Sven] Goethe Univ Frankfurt, Inst Ecol Evolut & Divers, D-60054 Frankfurt, Hesse, Germany; [Kochmann, Judith; Klimpel, Sven] Senckenberg Gesell Nat Forsch, Biodivers & Climate Res Ctr, Frankfurt, Hesse, Germany; [Plath, Martin] Northwest Agr & Forestry Univ, Coll Anim Sci & Technol, Yangling, Shaanxi Provinc, Peoples R China	Goethe University Frankfurt; Senckenberg Gesellschaft fur Naturforschung (SGN); Northwest A&F University - China	Kochmann, J (corresponding author), Senckenberg Gesell Nat Forsch, Biodivers & Climate Res Ctr, Frankfurt, Hesse, Germany.	judith.kochmann@senckenberg.de	Kochmann, Judith/AAG-3574-2021	Kochmann, Judith/0000-0001-6312-7859	Hesse's Ministry of Higher Education, Research, and the Arts	Hesse's Ministry of Higher Education, Research, and the Arts	The present study was financially supported by the research funding programme "LOEWE -Landes-Offensive zur Entwicklung Wissenschaftlichokonomischer Exzellenz" of Hesse's Ministry of Higher Education, Research, and the Arts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundsen PA, 1996, J FISH BIOL, V48, P607, DOI 10.1111/j.1095-8649.1996.tb01455.x; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 1994, PARASITIC NEMATODES; Baldauf SA, 2007, INT J PARASITOL, V37, P61, DOI 10.1016/j.ijpara.2006.09.003; Bernauer Dietmar, 2006, Aquatic Invasions, V1, P55, DOI 10.3391/ai.2006.1.2.2; Boets P, 2012, BIOINVASIONS REC, V1, P115, DOI 10.3391/bir.2012.1.2.06; Borcherding J, 2011, J APPL ICHTHYOL, V27, P153, DOI 10.1111/j.1439-0426.2010.01662.x; Borcherding J, 2013, LIMNOLOGICA, V43, P49, DOI 10.1016/j.limno.2012.08.003; Brandner J, 2013, J FISH BIOL, V82, P2063, DOI 10.1111/jfb.12137; Brandner J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073036; Brandner J, 2013, HYDROBIOLOGIA, V703, P113, DOI 10.1007/s10750-012-1349-9; Brodniewicz I., 1968, Acta Palaeontologica Polonica, V13, P619; Busch Markus Wilhelm, 2012, P329; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; Campbell LM, 2009, J GREAT LAKES RES, V35, P224, DOI 10.1016/j.jglr.2009.02.002; Carlsson NOL, 2009, FRONT ECOL ENVIRON, V7, P525, DOI 10.1890/080093; CARLTON JT, 1993, SCIENCE, V261, P78, DOI 10.1126/science.261.5117.78; Charlebois PM, 1997, INHS SPECIAL PUBLICA, V20, P1; Chen Wei, 2012, BioInvasions Records, V1, P263, DOI 10.3391/bir.2012.1.4.04; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Corkum LD, 2004, BIOL INVASIONS, V6, P173, DOI 10.1023/B:BINV.0000022136.43502.db; Crawley M. J., 1987, COLONIZATION SUCCESS, V26, P429; Dezfuli BS, 2011, PARASITE IMMUNOL, V33, P116, DOI 10.1111/j.1365-3024.2010.01266.x; Dick JTA, 2000, P ROY SOC B-BIOL SCI, V267, P977, DOI 10.1098/rspb.2000.1099; Dick JTA, 2002, CAN J FISH AQUAT SCI, V59, P1078, DOI 10.1139/F02-074; Douda K, 2013, DIVERS DISTRIB, V19, P933, DOI 10.1111/ddi.12044; Eggers Thomas Ols, 2001, Lauterbornia, V42, P1; Eggers Thomas Ols, 2004, Lauterbornia, V50, P1; Emde S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053218; Francova K, 2011, J APPL ICHTHYOL, V27, P879, DOI 10.1111/j.1439-0426.2010.01582.x; Gendron AD, 2012, BIOL INVASIONS, V14, P367, DOI 10.1007/s10530-011-0083-y; Go Nan YJ, 1969, MEMOIRES MUSEUM NA A, V57; Grabowski Michal, 2007, Aquatic Invasions, V2, P25; Haas G, 2002, INVASIVE AQUATIC SPECIES OF EUROPE: DISTRIBUTION, IMPACTS AND MANAGEMENT, P426; HINE PM, 1974, J FISH BIOL, V6, P521, DOI 10.1111/j.1095-8649.1974.tb04569.x; HYSLOP EJ, 1980, J FISH BIOL, V17, P411, DOI 10.1111/j.1095-8649.1980.tb02775.x; IKSR, 2002, 128D IKSR; Karlson AML, 2007, ICES J MAR SCI, V64, P479, DOI 10.1093/icesjms/fsl049; Kats LB, 2003, DIVERS DISTRIB, V9, P99, DOI 10.1046/j.1472-4642.2003.00013.x; Kelly DW, 2009, ECOLOGY, V90, P2047, DOI 10.1890/08-1085.1; Kohler A, 2011, BEHAV ECOL SOCIOBIOL, V65, P1513, DOI 10.1007/s00265-011-1161-y; Kopp K, 2007, OIKOS, V116, P295, DOI [10.1111/j.2006.0030-1299.15290.x, 10.1111/j.0030-1299.2007.15290.x]; Kornis MS, 2012, J FISH BIOL, V80, P235, DOI 10.1111/j.1095-8649.2011.03157.x; Kvach Y, 2008, J GREAT LAKES RES, V34, P23, DOI 10.3394/0380-1330(2008)34[23:MPOIRA]2.0.CO;2; Kvach Yuriy, 2005, Acta Ichthyologica et Piscatoria, V35, P103; Kvach Y, 2007, PARASITOL RES, V100, P767, DOI 10.1007/s00436-006-0311-z; Leprieur F, 2008, PLOS BIOL, V6, P404, DOI 10.1371/journal.pbio.0060028; Locke SA, 2014, OECOLOGIA, V175, P315, DOI 10.1007/s00442-014-2898-6; Machida Y, 2013, HYDROBIOLOGIA, V720, P145, DOI 10.1007/s10750-013-1665-8; Martin CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014395; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Moravec F, 2013, ACAD PRAHA, P264; Nachev M, 2010, TAGUNGSBAND DTSCH GE; Ondrackova M, 2005, J APPL ICHTHYOL, V21, P345, DOI 10.1111/j.1439-0426.2005.00682.x; Ondrackova M, 2010, ECOL RES, V25, P857, DOI 10.1007/s11284-010-0716-0; Paolucci EM, 2013, DIVERS DISTRIB, V19, P988, DOI 10.1111/ddi.12073; Paterson RA, 2011, J ANIM ECOL, V80, P990, DOI 10.1111/j.1365-2656.2011.01834.x; Pinkas L., 1971, CALIF DEP FISH GAME, V152, P1, DOI DOI 10.1201/B18714-2; Podraza Petra, 2001, Lauterbornia, V41, P129; Poulin R, 1996, INT J PARASITOL, V26, P1311, DOI 10.1016/S0020-7519(96)00108-7; Prenter J, 2004, TRENDS ECOL EVOL, V19, P385, DOI 10.1016/j.tree.2004.05.002; QUIGLEY MA, 1989, HYDROBIOLOGIA, V171, P255, DOI 10.1007/BF00008147; Rakauskas Vytautas, 2008, Acta Zoologica Lituanica, V18, P180, DOI 10.2478/v10043-008-0030-z; Ricciardi A, 1996, CAN J FISH AQUAT SCI, V53, P1434, DOI 10.1139/cjfas-53-6-1434; Ricciardi A, 2011, FIFTY YEARS OF INVASION ECOLOGY: THE LEGACY OF CHARLES ELTON, P211; Riemann F., 1988, P293; Robinson SA, 2010, WATERBIRDS, V33, P307, DOI 10.1675/063.033.0306; Roche KF, 2013, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2013066; Rohde K, 2005, MARINE PARASITOLOGY, P1; Salo P, 2007, P ROY SOC B-BIOL SCI, V274, P1237, DOI 10.1098/rspb.2006.0444; Schaperclaus W., 1991, FISH DIS, V1; Scharnweber Kristin, 2011, Bulletin of Fish Biology, V13, P11; Sih A, 2001, ANIM BEHAV, V61, P379, DOI 10.1006/anbe.2000.1592; Vitule JRS, 2009, FISH FISH, V10, P98, DOI 10.1111/j.1467-2979.2008.00312.x; Skora KE, 2001, J GREAT LAKES RES, V27, P290, DOI 10.1016/S0380-1330(01)70644-2; Spakulova M, 2011, HELMINTHOLOGIA, V48, P268, DOI 10.2478/s11687-011-0038-y; STOREY AW, 1991, HYDROBIOLOGIA, V211, P111, DOI 10.1007/BF00037367; Strayer DL, 2012, ECOL LETT, V15, P1199, DOI 10.1111/j.1461-0248.2012.01817.x; Taeubert JE, 2012, AQUAT CONSERV, V22, P36, DOI 10.1002/aqc.1245; Telfer S, 2005, PARASITOLOGY, V130, P661, DOI 10.1017/S0031182005007250; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; Van Riel MC, 2003, CRUSTACEANA, V76, P241, DOI 10.1163/156854003321824585; Vanderploeg HA, 2002, CAN J FISH AQUAT SCI, V59, P1209, DOI 10.1139/F02-087; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WITTE F, 1992, ENVIRON BIOL FISH, V34, P1, DOI 10.1007/BF00004782; Woo PTK, 2012, FISH PARASITES: PATHOBIOLOGY AND PROTECTION, P1, DOI 10.1079/9781845938062.0000; Zieritz A, 2012, ECOL EVOL, V2, P740, DOI 10.1002/ece3.220	87	15	15	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e109971	10.1371/journal.pone.0109971	http://dx.doi.org/10.1371/journal.pone.0109971			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338158	Green Submitted, Green Published, gold			2022-12-27	WOS:000343674800020
J	Kim, SW; Shin, HJ; Kay, CS; Son, SH				Kim, Shin-Wook; Shin, Hun-Joo; Kay, Chul Seung; Son, Seok Hyun			A Customized Bolus Produced Using a 3-Dimensional Printer for Radiotherapy	PLOS ONE			English	Article							ELECTRON-BEAMS; AIR-GAP; PERTURBATION; PATIENT; PHOTON	Objective: Boluses are used in high-energy radiotherapy in order to overcome the skin sparing effect. In practice though, commonly used flat boluses fail to make a perfect contact with the irregular surface of the patient's skin, resulting in air gaps. Hence, we fabricated a customized bolus using a 3-dimensional (3D) printer and evaluated its feasibility for radiotherapy. Methods: We designed two kinds of bolus for production on a 3D printer, one of which was the 3D printed flat bolus for the Blue water phantom and the other was a 3D printed customized bolus for the RANDO phantom. The 3D printed flat bolus was fabricated to verify its physical quality. The resulting 3D printed flat bolus was evaluated by assessing dosimetric parameters such as D-1.5 cm, D-5 cm, and D-10 cm. The 3D printed customized bolus was then fabricated, and its quality and clinical feasibility were evaluated by visual inspection and by assessing dosimetric parameters such as D-max, D-min, D-mean, D-90%, and V-90%. Results: The dosimetric parameters of the resulting 3D printed flat bolus showed that it was a useful dose escalating material, equivalent to a commercially available flat bolus. Analysis of the dosimetric parameters of the 3D printed customized bolus demonstrated that it is provided good dose escalation and good contact with the irregular surface of the RANDO phantom. Conclusions: A customized bolus produced using a 3D printer could potentially replace commercially available flat boluses.	[Kim, Shin-Wook; Shin, Hun-Joo; Kay, Chul Seung; Son, Seok Hyun] Catholic Univ Korea, Coll Med, Incheon St Marys Hosp, Seoul, South Korea	Catholic University of Korea	Son, SH (corresponding author), Catholic Univ Korea, Coll Med, Incheon St Marys Hosp, Seoul, South Korea.	sonshyun@catholic.ac.kr			Catholic Medical Center Research Foundation [5-2013-B0001-00243]	Catholic Medical Center Research Foundation	The authors wish to acknowledge the financial support of the Catholic Medical Center Research Foundation made in the program year of 2014 (5-2013-B0001-00243). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, 62 ICRU, P357; Benoit J, 2009, VET RADIOL ULTRASOUN, V50, P555, DOI 10.1111/j.1740-8261.2009.01573.x; Butson MJ, 2000, RADIAT MEAS, V32, P201, DOI 10.1016/S1350-4487(99)00276-0; Ju SG, 2014, INT J RADIAT ONCOL, V88, P453, DOI 10.1016/j.ijrobp.2013.10.024; Khan F M, 2010, PHYS RAD THERAPY; Khan Y., 2013, J CANC THER, V04, P1251, DOI [10.4236/jct.2013.47147, DOI 10.4236/JCT.2013.47147]; Kong M, 2007, AUSTRALAS PHYS ENG S, V30, P111, DOI 10.1007/BF03178415; Schubert C, 2014, BRIT J OPHTHALMOL, V98, P159, DOI 10.1136/bjophthalmol-2013-304446; SHARMA SC, 1993, MED PHYS, V20, P377, DOI 10.1118/1.597079; Vyas V, 2013, MED DOSIM, V38, P268, DOI 10.1016/j.meddos.2013.02.007	10	46	48	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110746	10.1371/journal.pone.0110746	http://dx.doi.org/10.1371/journal.pone.0110746			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337700	Green Submitted, Green Published, gold			2022-12-27	WOS:000343674800070
J	Miao, WB; Zheng, S; Dai, HJ; Wang, F; Jin, XN; Zhu, ZH; Jia, B				Miao, Weibing; Zheng, Shan; Dai, Haojie; Wang, Feng; Jin, Xiaona; Zhu, Zhaohui; Jia, Bing			Comparison of Tc-99m-3PRGD2 Integrin Receptor Imaging with Tc-99m-MDP Bone Scan in Diagnosis of Bone Metastasis in Patients with Lung Cancer: A Multicenter Study	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CYCLIC RGD DIMERS; BREAST-CANCER; TUMOR UPTAKE; ALPHA(V)BETA(3); ANGIOGENESIS; PHARMACOKINETICS; F-18-GALACTO-RGD; BIODISTRIBUTION; TC-99M-NC100692	Purpose: Tc-99m-3PRGD2, a promising tracer targeting integrin receptor, may serve as a novel tumor-specific agent for single photon emission computed tomography (SPECT). A multi-center study was prospectively designed to evaluate the diagnostic accuracy of Tc-99m-3PRGD2 imaging for bone metastasis in patients with lung cancer in comparison with the conventional Tc-99m-MDP bone scan. Methods: The patients underwent whole-body scan and chest tomography successively at both 1 h and 4 h after intravenous injection of 11.1 MBq/Kg Tc-99m-3PRGD2. Tc-99m-MDP whole-body bone scan was routinely performed within 1 week for comparison. Three experienced nuclear medicine physicians blindly read the Tc-99m-3PRGD2 and Tc-99m-MDP images. The final diagnosis was established based on the comprehensive assessment of all available data. Results: A total of 44 patients (29 male, 59 +/- 10 years old) with suspected lung cancer were recruited from 4 centers. Eighty-nine bone lesions in 18 patients were diagnosed as metastases and 23 bone lesions in 9 patients were benign. In a lesion-based analysis, Tc-99m-3PRGD2 imaging demonstrated a sensitivity, specificity, and accuracy of 92.1%, 91.3%, and 92.0%, respectively. The corresponding diagnostic values for Tc-99m-MDP bone scan were 87.6%, 60.9%, and 82.1%, respectively in the same patients. Tc-99m-MDP bone scan had better contrast in most lesions, whereas the Tc-99m-3PRGD2 imaging seemed to be more effective to exclude pseudo-positive lesions and detect bone metastases without osteogenesis. Conclusion: Tc-99m-3PRGD2 is a novel tumor-specific agent based on SPECT technology with a promising value in diagnosis of bone metastasis in patients with lung cancer.	[Miao, Weibing; Zheng, Shan] Fujian Med Univ, Affiliated Hosp 1, Dept Nucl Med, Fuzhou, Peoples R China; [Dai, Haojie] Beijing Tongren Hosp, Dept Nucl Med, Beijing, Peoples R China; [Wang, Feng] Nanjing Med Univ, Affiliated Hosp 1, Dept Nucl Med, Nanjing, Jiangsu, Peoples R China; [Jin, Xiaona; Zhu, Zhaohui] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Nucl Med, Beijing 100730, Peoples R China; [Jin, Xiaona; Zhu, Zhaohui] Peking Union Med Coll, Beijing 100021, Peoples R China; [Jia, Bing] Peking Univ, Med Isotopes Res Ctr, Beijing 100871, Peoples R China	Fujian Medical University; Capital Medical University; Nanjing Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking University	Miao, WB (corresponding author), Fujian Med Univ, Affiliated Hosp 1, Dept Nucl Med, Fuzhou, Peoples R China.	miaoweibing@126.com; zhuzhh@pumch.cn	Zhu, Zhaohui/CAA-1003-2022; jin, xiaona/AGC-9610-2022; Jia, Bing/C-3796-2008		Fujian Provincial Natural Science Foundation [2010J01154]; Capital Special Project for Featured Clinical Application [Z111107058811096]; National Natural Science Foundation of China (NSFC) projects [81171369, 81171370, 81271614, 81071189, 81000625, 30900373, 30930030, 30870728, 30870725]; Outstanding Youth Fund [81125011]; "973" project [2011CB707703]; Ministry of Science and Technology of China [2011YQ030114, 2012ZX09102301-018]	Fujian Provincial Natural Science Foundation; Capital Special Project for Featured Clinical Application; National Natural Science Foundation of China (NSFC) projects(National Natural Science Foundation of China (NSFC)); Outstanding Youth Fund; "973" project(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was financially supported, in part, by the Fujian Provincial Natural Science Foundation (2010J01154), the Capital Special Project for Featured Clinical Application (Z111107058811096), the National Natural Science Foundation of China (NSFC) projects (81171369, 81171370, 81271614, 81071189, 81000625, 30900373, 30930030, 30870728, and 30870725), the Outstanding Youth Fund (81125011), a "973" project (2011CB707703), and grants from the Ministry of Science and Technology of China (2011YQ030114 and 2012ZX09102301-018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelsson R, 2010, ACTA RADIOL, V51, P40, DOI 10.3109/02841850903273974; Bach-Gansmo T, 2006, J NUCL MED, V47, P1434; Beer AJ, 2005, J NUCL MED, V46, P1333; Beer AJ, 2006, CLIN CANCER RES, V12, P3942, DOI 10.1158/1078-0432.CCR-06-0266; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; Costouros NG, 2002, J CELL BIOCHEM, P72, DOI 10.1002/jcb.10426; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Haubner R, 2005, PLOS MED, V2, P244, DOI 10.1371/journal.pmed.0020070; Haubner R, 2001, CANCER RES, V61, P1781; Haubner R, 2004, CURR PHARM DESIGN, V10, P1439, DOI 10.2174/1381612043384745; Higgins MJ, 2009, EXPERT REV ANTICANC, V9, P1365, DOI [10.1586/era.09.115, 10.1586/ERA.09.115]; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Jia B, 2011, MOL IMAGING BIOL, V13, P730, DOI 10.1007/s11307-010-0385-y; Kenny LM, 2008, J NUCL MED, V49, P879, DOI 10.2967/jnumed.107.049452; Liu S, 2005, TOP CURR CHEM, V252, P117, DOI 10.1007/b101226; Liu ZF, 2010, BIOCONJUGATE CHEM, V21, P548, DOI 10.1021/bc900547d; Liu ZF, 2009, EUR J NUCL MED MOL I, V36, P947, DOI 10.1007/s00259-008-1045-1; Liu ZF, 2009, EUR J NUCL MED MOL I, V36, P1296, DOI 10.1007/s00259-009-1112-2; McDonald DM, 2003, NAT MED, V9, P713, DOI 10.1038/nm0603-713; McParland BJ, 2008, J NUCL MED, V49, P1664, DOI 10.2967/jnumed.108.052126; Nishino M, 2011, ACAD RADIOL, V18, P424, DOI 10.1016/j.acra.2010.10.020; Pasqualini R, 1997, NAT BIOTECHNOL, V15, P542, DOI 10.1038/nbt0697-542; Pichler BJ, 2005, J NUCL MED, V46, P184; Ruoslahti E, 2002, NAT REV CANCER, V2, P83, DOI 10.1038/nrc724; Sengupta S, 2001, J EXP CLIN CANC RES, V20, P585; Shi JY, 2009, EUR J NUCL MED MOL I, V36, P1874, DOI 10.1007/s00259-009-1166-1; Shi JY, 2009, BIOCONJUGATE CHEM, V20, P1559, DOI 10.1021/bc9001739; Wang LJ, 2009, MOL PHARMACEUT, V6, P231, DOI 10.1021/mp800150r; Zhu ZH, 2012, J NUCL MED, V53, P716, DOI 10.2967/jnumed.111.098988; Zitzmann S, 2002, CANCER RES, V62, P5139	30	14	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e111221	10.1371/journal.pone.0111221	http://dx.doi.org/10.1371/journal.pone.0111221			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338281	gold, Green Published, Green Submitted			2022-12-27	WOS:000343674800111
J	Orban, JC; Maiziere, EM; Ghaddab, A; Van Obberghen, E; Ichai, C				Orban, Jean-Christophe; Maiziere, Eve-Marie; Ghaddab, Anis; Van Obberghen, Emmanuel; Ichai, Carole			Incidence and Characteristics of Acute Kidney Injury in Severe Diabetic Ketoacidosis	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; INTERNATIONAL CONSENSUS CONFERENCE; HYPERGLYCEMIC CRISES; ADULT PATIENTS; MANAGEMENT; MORTALITY; THERAPY; ADMISSIONS	Aims: Acute kidney injury is a classical complication of diabetic ketoacidosis. However, to the best of our knowledge, no study has reported the incidence and characteristics of acute kidney injury since the consensus definition was issued. Methods: Retrospective study of all cases of severe diabetic ketoacidosis hospitalised consecutively in a medical surgical tertiary ICU during 10 years. Patients were dichotomised in with AKI and without AKI on admission according to the RIFLE classification. Clinical and biological parameters were compared in these populations. Risk factors of presenting AKI on admission were searched for. Results: Ninety-four patients were included in the study. According to the RIFLE criteria, 47 patients (50%) presented acute kidney injury on admission; most of them were in the risk class (51%). At 12 and 24 hours, the percentage of AKI patients decreased to 26% and 27% respectively. During the first 24 hours, 3 patients needed renal replacement therapy. Acute renal failure on admission was associated with a more advanced age, SAPS 2 and more severe biological impairments. Treatments were not different between groups except for insulin infusion. Logistic regression found 3 risk factors of presenting AKI on admission: age (odds ratio 1.060 [1.020-1.100], p<0.01), blood glucose (odds ratio 1.101 [1.039-1.166], p<0.01) and serum protein (odds ratio 0.928 [0.865-0.997], p = 0.04). Conclusions: Acute kidney injury is frequently associated with severe diabetic ketoacidosis on admission in ICU. Most of the time, this AKI is transient and characterised by a volume-responsiveness to fluid infusion used in DKA treatment. Age, blood glucose and serum protein are associated to the occurrence of AKI on ICU admission.	[Orban, Jean-Christophe; Maiziere, Eve-Marie; Ghaddab, Anis; Ichai, Carole] CHU Nice, Hop St Roch, F-06202 Nice, France; [Orban, Jean-Christophe; Van Obberghen, Emmanuel; Ichai, Carole] Univ Nice Sophia Antipolis, Fac Med, IRCAN, F-06189 Nice, France; [Van Obberghen, Emmanuel] CHU Nice, Biochim Lab, F-06202 Nice, France	CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice	Orban, JC (corresponding author), CHU Nice, Hop St Roch, F-06202 Nice, France.	orban.jc@chu-nice.fr						Abdulrahman GO, 2013, DIABETES RES CLIN PR, V100, pE7, DOI 10.1016/j.diabres.2013.01.009; ADROGUE HJ, 1982, NEW ENGL J MED, V307, P1603, DOI 10.1056/NEJM198212233072603; Barski L, 2012, ISR MED ASSOC J, V14, P299; Basi S, 2005, AM J PHYSIOL-RENAL, V289, pF259, DOI 10.1152/ajprenal.00002.2005; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Brochard L, 2010, AM J RESP CRIT CARE, V181, P1128, DOI 10.1164/rccm.200711-1664ST; Bull SV, 2007, CRIT CARE MED, V35, P41, DOI 10.1097/01.CCM.0000249825.18677.D2; Efstathiou SP, 2002, CLIN ENDOCRINOL, V57, P595, DOI 10.1046/j.1365-2265.2002.01636.x; Ezeani IU, 2013, DIABET METAB SYND OB, V6, P303, DOI 10.2147/DMSO.S44477; FISHER JN, 1983, J CLIN ENDOCR METAB, V57, P177, DOI 10.1210/jcem-57-1-177; Gershengorn HB, 2012, CRIT CARE MED, V40, P2009, DOI 10.1097/CCM.0b013e31824e9eae; Glassock RJ, 2012, KIDNEY INT, V82, P270, DOI 10.1038/ki.2012.65; Himmelfarb J, 2008, CLIN J AM SOC NEPHRO, V3, P962, DOI 10.2215/CJN.04971107; Hoste EAJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4915; Kitabchi AE, 2009, DIABETES CARE, V32, P1335, DOI 10.2337/dc09-9032; Kitabchi AE, 2001, DIABETES CARE, V24, P131, DOI 10.2337/diacare.24.1.131; Leone M, 2012, CRIT CARE MED, V40, P3189, DOI 10.1097/CCM.0b013e31826571f2; Lombardo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063675; Mahler SA, 2011, AM J EMERG MED, V29, P670, DOI 10.1016/j.ajem.2010.02.004; Marinac JS, 2000, CRIT CARE MED, V28, P2238, DOI 10.1097/00003246-200007000-00009; Mehta RL, 2007, J AM SOC NEPHROL, V18, P2623, DOI 10.1681/ASN.2007010109; Mehta RL, 2004, KIDNEY INT, V66, P1613, DOI 10.1111/j.1523-1755.2004.00927.x; Rocktaeschel J, 2003, CRIT CARE, V7, pR60, DOI 10.1186/cc2333; Shen T, 2012, INTERN MED J, V42, P1347, DOI 10.1111/imj.12001; Singh RK, 1997, DIABETIC MED, V14, P482, DOI 10.1002/(SICI)1096-9136(199706)14:6<482::AID-DIA371>3.3.CO;2-1; Taylor D, 2006, INTENS CARE MED, V32, P295, DOI 10.1007/s00134-005-0009-1; Uchino S, 2010, NEPHROL DIAL TRANSPL, V25, P1833, DOI 10.1093/ndt/gfp624; Vallon V, 2012, ANNU REV PHYSIOL, V74, P351, DOI 10.1146/annurev-physiol-020911-153333; Verny C, 2007, DIABETES METAB, V33, pS32, DOI 10.1016/S1262-3636(07)80055-3; von Bibra H, 2010, DIABETOLOGIA, V53, P1033, DOI 10.1007/s00125-010-1682-3; Wagner A, 1999, DIABETES CARE, V22, P674, DOI 10.2337/diacare.22.5.674; WOODROW G, 1994, POSTGRAD MED J, V70, P192, DOI 10.1136/pgmj.70.821.192; Yunos NM, 2012, JAMA-J AM MED ASSOC, V308, P1566, DOI 10.1001/jama.2012.13356; Zhang ZH, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-235	34	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110925	10.1371/journal.pone.0110925	http://dx.doi.org/10.1371/journal.pone.0110925			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338064	Green Published, gold, Green Submitted			2022-12-27	WOS:000343674800088
J	Wireen, S; Drevin, L; Akre, O; Robinson, D; Stattin, P				Wiren, Sara; Drevin, Linda; Akre, Olof; Robinson, David; Stattin, Par			Fathering of Dizygotic Twins and Risk of Prostate Cancer: Nationwide, Population-Based Case-Control Study	PLOS ONE			English	Article							FATHERHOOD STATUS; MEN; INFERTILITY; FECUNDITY; ANDROGENS	Background: An association between male fertility and risk of prostate cancer has been suggested, possibly through lower androgen levels in subfertile men. We evaluated male fertility in relation to risk of prostate cancer by assessing the frequency of fathering of dizygotic twins, a marker of high fertility, among cases of prostate cancer and controls. Methods: We performed a case-control study in Prostate Cancer data Base Sweden (PCBaSe), a nationwide, population-based cohort. PCBaSe was linked to the Swedish twin register for information on zygosity for same-sex twins and to other nationwide health care registers and demographic databases for information on socioeconomic factors, comorbidity, and tumor characteristics for 96 301 prostate cancer cases and 378 583 matched controls. To account for the influence of in vitro fertilization on dizygotic twinning, analyses were restricted to men who had fathered children before 1991, when in vitro fertilization was still uncommon in Sweden. Results: 1 112 cases and 4 538 controls had fathered dizygotic twins. Men with dizygotic twins had no increased risk of prostate cancer compared to fathers of singletons; neither for total prostate cancer odds ratio (OR) 0.95(95% CI 0.89-1.02), nor for any risk category, OR 0.97 (95% CI 0.84-1.12) for low-risk disease, and OR 1.04 (95% CI 0.90-1.22) for metastatic disease. Conclusion: The lack of association between fathering of dizygotic twins and prostate cancer risk give no support for an association between male fertility and prostate cancer risk.	[Wiren, Sara; Stattin, Par] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden; [Drevin, Linda] Univ Uppsala Hosp, Reg Canc Ctr, Uppsala, Sweden; [Akre, Olof] Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit, Stockholm, Sweden; [Robinson, David] Ryhov Cty Hosp, Dept Urol, Jonkoping, Sweden	Umea University; Uppsala University; Uppsala University Hospital; Karolinska Institutet	Stattin, P (corresponding author), Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden.	par.stattin@umu.se			Swedish Research Council [825-2010-5950]; Swedish Cancer Society [11 0471]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society)	This study was supported by the Swedish Research Council (www.vr.se)(grant nr 825-2010-5950) and the Swedish Cancer Society (www.cancerfonden.se) 11 0471. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson J, 2007, SCAND J UROL NEPHROL, V41, P456, DOI 10.1080/00365590701673625; Andersson AM, 2004, J CLIN ENDOCR METAB, V89, P3161, DOI 10.1210/jc.2003-031786; Asklund C, 2007, HUM REPROD, V22, P751, DOI 10.1093/humrep/del449; Basso O, 2004, HUM REPROD, V19, P2222, DOI 10.1093/humrep/deh437; Bermejo JL, 2007, JNCI-J NATL CANCER I, V99, P901, DOI 10.1093/jnci/djk208; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Collins J, 2001, HUM REPROD, V16, P1518; Crawford ED, 2009, UROLOGY, V73, P4, DOI 10.1016/j.urology.2009.03.001; Dennis LK, 2002, EPIDEMIOLOGY, V13, P72, DOI 10.1097/00001648-200201000-00012; Derom C, 2011, HUM REPROD, V26, P2247, DOI 10.1093/humrep/der180; Dohle GR, 2003, WORLD J UROL, V21, P341, DOI 10.1007/s00345-003-0365-9; Eisenberg ML, 2010, INT J EPIDEMIOL; Ekbom A, 2011, METHODS MOL BIOL, V675, P215, DOI 10.1007/978-1-59745-423-0_10; Giwercman A, 2005, INT J CANCER, V115, P994, DOI 10.1002/ijc.20963; Hagel E, 2009, SCAND J UROL NEPHROL, P1; Harlap S, 2007, JNCI-J NATL CANCER I, V99, P77, DOI [10.1093/jnci/djk007, 10.1093/jnci/djk210]; Hsing AW, 2008, CANCER EPIDEM BIOMAR, V17, P2525, DOI 10.1158/1055-9965.EPI-08-0448; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; Jorgensen KT, 2008, CANCER-AM CANCER SOC, V112, P919, DOI 10.1002/cncr.23230; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Lundqvist E, 2012, GRAVIDITETER FORLOSS; Magnusson PKE, 2013, TWIN RES HUM GENET, V16, P317, DOI 10.1017/thg.2012.104; Mohler J, 2010, J NATL COMPR CANC NE, V8, P162, DOI 10.6004/jnccn.2010.0012; Negri E, 2006, INT J CANCER, V118, P786, DOI 10.1002/ijc.21369; Richiardi L, 2004, J NATL CANCER I, V96, P145, DOI 10.1093/jnci/djh012; Ruhayel Y, 2010, CANCER CAUSE CONTROL, V21, P1635, DOI 10.1007/s10552-010-9592-8; Tong S, 1997, LANCET, V349, P843, DOI 10.1016/S0140-6736(96)10003-9; Van Hemelrijck M, 2012, INT J EPIDEMIOL; Walsh TJ, 2010, CANCER-AM CANCER SOC, V116, P2140, DOI 10.1002/cncr.25075; Wiren S, 2008, BEST PRACT RES CL EN, V22, P601, DOI 10.1016/j.beem.2008.06.002; Wiren SM, 2013, INT J CANCER, V133, P937, DOI 10.1002/ijc.28057; Zhu JL, 2007, HUM REPROD, V22, P1086, DOI 10.1093/humrep/del495	33	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110506	10.1371/journal.pone.0110506	http://dx.doi.org/10.1371/journal.pone.0110506			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337702	Green Submitted, Green Published, gold			2022-12-27	WOS:000343674800049
J	So, JH; Kim, JD; Yoo, KW; Kim, HT; Jung, SH; Choi, JH; Lee, MS; Jin, SW; Kim, CH				So, Ju-Hoon; Kim, Jun-Dae; Yoo, Kyeong-Won; Kim, Hyun-Taek; Jung, Seung-Hyun; Choi, Jung-Hwa; Lee, Mi-Sun; Jin, Suk-Won; Kim, Cheol-Hee			FIH-1, a Novel Interactor of Mindbomb, Functions as an Essential Anti-Angiogenic Factor during Zebrafish Vascular Development	PLOS ONE			English	Article							HIF-ALPHA; HYPOXIA; NOTCH; VEGF; ACTIVATION; PROTEIN; VHL; RESPONSES; GRIDLOCK; RECEPTOR	Objective: It has been shown that Mindbomb (Mib), an E3 Ubiquitin ligase, is an essential modulator of Notch signaling during development. However, its effects on vascular development remain largely unknown. Approaches and Results: We identified a number of novel proteins that physically interact with Mib, including the Factor Inhibiting Hypoxia Inducible Factor 1 (FIH-1, also known as HIF1AN) from a yeast two hybrid screen, as previously reported. In cultured cells, FIH-1 colocalizes with Mib1, corroborating their potential interaction. In zebrafish embryos, FIH-1 appears to modulate VEGF-A signaling activity; depletion of fih-1 induces ectopic expression of vascular endothelial growth factor-alpha (vegfa) and leads to exuberant ectopic sprouts from intersegmental vessels (ISVs). Conversely, over-expression of fih-1 substantially attenuates the formation of ISVs, which can be rescued by concurrent over-expression of vegfa, indicating that FIH-1/HIF1AN may fine tune VEGF-A signaling. Conclusions: Taken together, our data suggest that FIH-1 interacts with Mib E3 Ubiquitin ligase and modulates vascular development by attenuating VEGF-A signaling activity.	[So, Ju-Hoon; Yoo, Kyeong-Won; Kim, Hyun-Taek; Jung, Seung-Hyun; Choi, Jung-Hwa; Lee, Mi-Sun; Kim, Cheol-Hee] Chungnam Natl Univ, Dept Biol, Taejon, South Korea; [So, Ju-Hoon] Univ Pittsburgh, Dept Dev Biol, Pittsburgh, PA USA; [Kim, Jun-Dae; Jin, Suk-Won] Yale Univ, Sch Med, Dept Internal Med, Yale Cardiovasc Res Ctr,Sect Cardiovascul Med, New Haven, CT 06510 USA; [Jin, Suk-Won] Gwangju Inst Sci & Technol, Sch Biol Sci, Kwangju, South Korea	Chungnam National University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yale University; Gwangju Institute of Science & Technology (GIST)	Jin, SW (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Yale Cardiovasc Res Ctr,Sect Cardiovascul Med, New Haven, CT 06510 USA.	suk-won.jin@yale.edu; zebrakim@cnu.ac.kr	Choi, Jung-Hwa/GQQ-6280-2022	Kim, Jun-dae/0000-0002-9747-6288; Kim, Cheol-Hee/0000-0002-3019-0699	KRIBB Research Initiative Program [KGM4611411]; NIH [HL090960, HL119345]; American Heart Association [11POST7440010]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090960] Funding Source: NIH RePORTER	KRIBB Research Initiative Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work has been supported by grants from the KRIBB Research Initiative Program (KGM4611411) to CHK, the NIH to S-WJ (HL090960 and HL119345), American Heart Association post-doctoral fellowship to J-DK (11POST7440010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Gnarra JR, 1997, P NATL ACAD SCI USA, V94, P9102, DOI 10.1073/pnas.94.17.9102; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hawighorst T, 2002, AM J PATHOL, V160, P1381, DOI 10.1016/S0002-9440(10)62565-5; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jensen LD, 2012, CELL REP, V2, P231, DOI 10.1016/j.celrep.2012.07.005; Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087; Kim JD, 2012, DEV CELL, V23, P441, DOI 10.1016/j.devcel.2012.07.007; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koo BK, 2005, DEVELOPMENT, V132, P3459, DOI 10.1242/dev.01922; Koo BK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001221; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Lee PJ, 1997, J BIOL CHEM, V272, P5375, DOI 10.1074/jbc.272.9.5375; Liang D, 1998, BBA-GENE STRUCT EXPR, V1397, P14, DOI 10.1016/S0167-4781(97)00233-9; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; So JH, 2010, GENES CELLS, V15, P1099, DOI 10.1111/j.1365-2443.2010.01448.x; Stolze IP, 2004, J BIOL CHEM, V279, P42719, DOI 10.1074/jbc.M406713200; Tammela T, 2005, CARDIOVASC RES, V65, P550, DOI 10.1016/j.cardiores.2004.12.002; Tseng LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093394; van Rooijen E, 2010, DIS MODEL MECH, V3, P343, DOI 10.1242/dmm.004036; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; WEINSTEIN BM, 1995, NAT MED, V1, P1143, DOI 10.1038/nm1195-1143; Wiley DM, 2011, NAT CELL BIOL, V13, P686, DOI 10.1038/ncb2232; Yoo KW, 2006, FEBS LETT, V580, P4409, DOI 10.1016/j.febslet.2006.07.009; Zhang N, 2010, CELL METAB, V11, P364, DOI 10.1016/j.cmet.2010.03.001; Zhong TP, 2001, NATURE, V414, P216, DOI 10.1038/35102599	36	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e109517	10.1371/journal.pone.0109517	http://dx.doi.org/10.1371/journal.pone.0109517			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347788	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000347994900011
J	Wang, LZ; Zhou, HH; Han, J; Milne, RI; Wang, MY; Liu, BB				Wang, Lizhong; Zhou, Haihong; Han, Jin; Milne, Richard I.; Wang, Mingyu; Liu, Bingbing			Genome-Scale Transcriptome Analysis of the Alpine "Glasshouse'' Plant Rheum nobile (Polygonaceae) with Special Translucent Bracts	PLOS ONE			English	Article							PARALLEL EVOLUTION; CELLULAR-RESPONSE; PHOTOSYSTEM-II; HOOK-F; PROTEIN; GENE; BIOSYNTHESIS; RADIATION; PHOSPHORYLATION; RECONSTRUCTION	Background: Rheum nobile is an alpine plant with translucent bracts concealing the inflorescence which produce a "glasshouse'' effect promoting the development of fertile pollen grains in such conditions. The current understanding of the adaptation of such bracts to alpine environments mainly focuses on the phenotypic and physiological changes while the genetic basis is very limited. By sequencing the upper bract and the lower rosulate leaf from the same R. nobile stem, we identified candidate genes that may be involved in alpine adaption of the translucent bract in "glasshouse'' plants and illustrated the changes in gene expression underlying the adaptive and complex evolution of the bracts phenotype. Results: A total of 174.2 million paired-end reads from each transcriptome were assembled into 25,249 unigenes. By comparing the gene expression profiles, we identified 1,063 and 786 genes up-regulated respectively in the upper bract and the lower leaf. Functional enrichment analyses of these genes recovered a number of differential important pathways, including flavonoid biosynthesis, mismatch repair and photosynthesis related pathways. These pathways are mainly involved in three types of functions: 9 genes in the UV protective process, 9 mismatch repair related genes and 88 genes associated with photosynthesis. Conclusions: This study provides the first comprehensive dataset characterizing Rheum nobile gene expression at the transcriptomic scale, and provides novel insights into the gene expression profiles associated with the adaptation of the "glasshouse'' plant bracts. The dataset will be served as a public genetic resources for further functional and evolutionary studies of "glasshouse'' plants.	[Wang, Lizhong; Han, Jin; Liu, Bingbing] Lanzhou Univ, Sch Life Sci, State Key Lab Grassland Agroecosyst, Lanzhou, Gansu, Peoples R China; [Zhou, Haihong; Wang, Mingyu] Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Act & Stress Adaptat, Lanzhou, Gansu, Peoples R China; [Milne, Richard I.] Univ Edinburgh, Sch Biol Sci, Inst Mol Plant Sci, Edinburgh, Midlothian, Scotland; [Milne, Richard I.] Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland	Lanzhou University; Lanzhou University; University of Edinburgh	Wang, MY (corresponding author), Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Act & Stress Adaptat, Lanzhou, Gansu, Peoples R China.	wangmy09@lzu.cn; liubb2013@gmail.com	liu, bb/GXA-2527-2022	wang, lizhong/0000-0002-3571-8771	Key Project of International Collaboration Program; Ministry of Science and Technology of China [2010DFB63500]; Fundamental Research Funds for the Central Universities [lzujbky-2009-k05, lzujbky-2012-112]; International Collaboration 111 Projects of China	Key Project of International Collaboration Program; Ministry of Science and Technology of China(Ministry of Science and Technology, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); International Collaboration 111 Projects of China	This work was funded by the Key Project of International Collaboration Program, the Ministry of Science and Technology of China (research grant 2010DFB63500), the Fundamental Research Funds for the Central Universities (lzujbky-2009-k05 and lzujbky-2012-112) and the International Collaboration 111 Projects of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Armbruster WS, 1997, ECOLOGY, V78, P1661; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benjamini Y, 2001, CONTROL FALSE DISCOV; BILLINGS WD, 1968, BIOL REV, V43, P481, DOI 10.1111/j.1469-185X.1968.tb00968.x; Binz SK, 2004, DNA REPAIR, V3, P1015, DOI 10.1016/j.dnarep.2004.03.028; Booij-James IS, 2000, PLANT PHYSIOL, V124, P1275, DOI 10.1104/pp.124.3.1275; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; CALDWELL MM, 1983, PHYSIOL PLANTARUM, V58, P445, DOI 10.1111/j.1399-3054.1983.tb04206.x; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Cline SD, 2003, NAT REV MOL CELL BIO, V4, P361, DOI 10.1038/nrm1101; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cong B, 2002, P NATL ACAD SCI USA, V99, P13606, DOI 10.1073/pnas.172520999; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; Friend A.D., 1990, ADV ECOL RES, V20, P59, DOI [10.1016/S0065-2504(08)60053-7, DOI 10.1016/S0065-2504(08)60053-7]; Gao Y, 2013, PLANT MOL BIOL, V81, P363, DOI 10.1007/s11103-013-0009-4; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902; Hankamer B, 1997, ANNU REV PLANT PHYS, V48, P641, DOI 10.1146/annurev.arplant.48.1.641; Hanson MA, 1996, GENETICS, V143, P1395; HELLER W, 1980, ARCH BIOCHEM BIOPHYS, V200, P617, DOI 10.1016/0003-9861(80)90395-1; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Iwashina T, 2004, J PLANT RES, V117, P101, DOI 10.1007/s10265-003-0134-2; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; KUHLBRANDT W, 1984, NATURE, V307, P478, DOI 10.1038/307478a0; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; LANDRY LG, 1995, PLANT PHYSIOL, V109, P1159, DOI 10.1104/pp.109.4.1159; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu BB, 2013, J SYST EVOL, V51, P134, DOI 10.1111/j.1759-6831.2012.00225.x; Liu RR, 2010, CARYOLOGIA, V63, P82; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ohba H., 1988, HIMALAYAN PLANTS, Vvol. 1, P19; Omori Y, 1996, BOT J LINN SOC, V122, P269, DOI 10.1111/j.1095-8339.1996.tb02076.x; Omori Y, 2000, BOT J LINN SOC, V132, P19, DOI 10.1111/j.1095-8339.2000.tb01852.x; Quattrocchio F, 1999, PLANT CELL, V11, P1433, DOI 10.1105/tpc.11.8.1433; Ralston L, 2005, PLANT PHYSIOL, V137, P1375, DOI 10.1104/pp.104.054502; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Robinson PN, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-144; Schofield MJ, 2003, ANNU REV MICROBIOL, V57, P579, DOI 10.1146/annurev.micro.57.030502.090847; Shao HB, 2007, COLLOID SURFACE B, V54, P37, DOI 10.1016/j.colsurfb.2006.07.002; Shao RG, 1999, EMBO J, V18, P1397, DOI 10.1093/emboj/18.5.1397; Smith NGC, 2002, NATURE, V415, P1022, DOI 10.1038/4151022a; Song B, 2012, OECOLOGIA, P1; Sun YS, 2012, MOL PHYLOGENET EVOL, V63, P150, DOI 10.1016/j.ympev.2012.01.002; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; TERASHIMA I, 1993, OECOLOGIA, V95, P194, DOI 10.1007/BF00323490; Tsukaya H, 2002, J PLANT RES, V115, P59, DOI 10.1007/s102650200009; Uchiyama I, 2010, NUCLEIC ACIDS RES, V38, pD361, DOI 10.1093/nar/gkp948; Wan DS, 2011, BIOCHEM SYST ECOL, V39, P651, DOI 10.1016/j.bse.2011.05.016; Wang AL, 2005, ANN BOT-LONDON, V96, P489, DOI 10.1093/aob/mci201; Winkel-Shirley B, 2002, CURR OPIN PLANT BIOL, V5, P218, DOI 10.1016/S1369-5266(02)00256-X; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Yang MH, 2001, NORD J BOT, V21, P411, DOI 10.1111/j.1756-1051.2001.tb00789.x; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zenoni S, 2010, PLANT PHYSIOL, V152, P1787, DOI 10.1104/pp.109.149716; Zhang DY, 2010, PLANTA, V231, P1505, DOI 10.1007/s00425-010-1133-x; Zhu ZF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3200	64	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110712	10.1371/journal.pone.0110712	http://dx.doi.org/10.1371/journal.pone.0110712			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343261	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943500050
J	Costa, L; Pinheiro, RO; Dutra, PML; Santos, RF; Cunha, EF; Torres-Santos, EC; da Silva, AJM; Costa, PRR; Da-Silva, SAG				Costa, Luciana; Pinheiro, Roberta O.; Dutra, Patricia M. L.; Santos, Rosiane F.; Cunha-Junior, Edezio F.; Torres-Santos, Eduardo C.; da Silva, Alcides J. M.; Costa, Paulo R. R.; Da-Silva, Silvia A. G.			Pterocarpanquinone LQB-118 Induces Apoptosis in Leishmania (Viannia) braziliensis and Controls Lesions in Infected Hamsters	PLOS ONE			English	Article							MUCOSAL LEISHMANIASIS; DIMETHYL-SULFOXIDE; CURRENT SCENARIO; EFFICACY	Previous results demonstrate that the hybrid synthetic pterocarpanquinone LQB-118 presents antileishmanial activity against Leishmania amazonensis in a mouse model. The aim of the present study was to use a hamster model to investigate whether LQB-118 presents antileishmanial activity against Leishmania (Viannia) braziliensis, which is the major Leishmania species related to American tegumentary leishmaniasis. The in vitro antileishmanial activity of LQB-118 on L. braziliensis was tested on the promastigote and intracellular amastigote forms. The cell death induced by LQB-118 in the L. braziliensis promastigotes was analyzed using an annexin V-FITC/PI kit, the oxidative stress was evaluated by 2',7'-dichlorodihydro-fluorescein diacetate (H(2)DCFDA) and the ATP content by luminescence. In situ labeling of DNA fragments by terminal deoxyribonucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) was used to investigate apoptosis in the intracellular amastigotes. L. braziliensis-infected hamsters were treated from the seventh day of infection with LQB-118 administered intralesionally (26 mu g/kg/day, three times a week) or orally (4,3 mg/kg/day, five times a week) for eight weeks. LQB-118 was active against the L. braziliensis promastigotes and intracellular amastigotes, producing IC50 (50% inhibitory concentration) values of 3,4 +/- 0,1 and 7,5 +/- 0,8 mu M, respectively. LQB-118 induced promastigote phosphatidylserine externalization accompanied by increased reactive oxygen species production and ATP depletion. Intracellular amastigote DNA fragmentation was also observed, without affecting the viability of macrophages. The treatment of L. braziliensis-infected hamsters with LQB-118, either orally or intralesionally, was effective in the control of lesion size, parasite load and increase intradermal reaction to parasite antigen. Taken together, these results show that the antileishmanial effect of LQB-118 extends to L. braziliensis in the hamster model, involves the induction of parasite apoptosis and shows promising therapeutic option by oral or local routes in leishmaniasis.	[Costa, Luciana; Santos, Rosiane F.; Da-Silva, Silvia A. G.] Univ Estado Rio de Janeiro, Lab Imunofarmacol Parasitaria, Dept Microbiol Imunol & Parasitol, BR-20550011 Rio De Janeiro, Brazil; [Pinheiro, Roberta O.] Fiocruz MS, Inst Oswaldo Cruz, Lab Hanseniase, BR-21045900 Rio De Janeiro, Brazil; [Dutra, Patricia M. L.] Univ Estado Rio de Janeiro, Lab Bioquim Protozoarios & Imunofisiol Exercicio, Dept Microbiol Imunol & Parasitol, BR-20550011 Rio De Janeiro, Brazil; [Cunha-Junior, Edezio F.; Torres-Santos, Eduardo C.] Fiocruz MS, Inst Oswaldo Cruz, Lab Bioquim Tripanosomatideos, BR-21045900 Rio De Janeiro, Brazil; [da Silva, Alcides J. M.] Univ Fed Rio de Janeiro, Lab Catalise Organ, Nucleo Pesquisas Prod Nat, Rio De Janeiro, Brazil; [Costa, Paulo R. R.] Univ Fed Rio de Janeiro, Lab Quim Bioorgan, Nucleo Pesquisas Prod Nat, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Da-Silva, SAG (corresponding author), Univ Estado Rio de Janeiro, Lab Imunofarmacol Parasitaria, Dept Microbiol Imunol & Parasitol, BR-20550011 Rio De Janeiro, Brazil.	silvasag@gmail.com	SAG, Da-Silva/K-3091-2014; Da-Silva, Silvia/AAV-4808-2020; Costa, Paulo Roberto Ribeiro/AAH-4777-2021; Dutra, Patricia M L/J-6431-2014; Torres-Santos, Eduardo Caio/J-9908-2014; da Silva, Alcides José/AAV-6031-2020; Cunha-Junior, Edezio/E-1043-2015; Cunha-Junior, Edezio/F-5200-2018; Costa, Paulo Roberto Ribeiro/F-1153-2013; Pinheiro, R O/A-2525-2013	SAG, Da-Silva/0000-0003-1600-1238; Da-Silva, Silvia/0000-0003-1600-1238; Costa, Paulo Roberto Ribeiro/0000-0001-9541-1707; Torres-Santos, Eduardo Caio/0000-0003-2240-4519; da Silva, Alcides José/0000-0002-3200-0318; Cunha-Junior, Edezio/0000-0002-2833-1771; Costa, Paulo Roberto Ribeiro/0000-0001-9541-1707; Pinheiro, R O/0000-0001-8471-4227; Dutra, Patricia Maria Lourenco/0000-0002-2494-6912	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). PMLD ECTS AJMS PRRC SAGS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Amato VS, 2008, ACTA TROP, V105, P1, DOI 10.1016/j.actatropica.2007.08.003; Ameen M, 2010, CLIN EXP DERMATOL, V35, P699, DOI 10.1111/j.1365-2230.2010.03851.x; Bacelar TD, 2013, ANTI-CANCER DRUG, V24, P73, DOI 10.1097/CAD.0b013e3283592da8; Colucci M, 2008, PHARMACOL RES, V57, P419, DOI 10.1016/j.phrs.2008.04.004; Creek DJ, 2008, ANTIMICROB AGENTS CH, V52, P1291, DOI 10.1128/AAC.01033-07; Croft SL, 2006, INDIAN J MED RES, V123, P399; da Cunha EF, 2011, J ANTIMICROB CHEMOTH, V66, P1555, DOI 10.1093/jac/dkr158; Guerra JAD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000980; DeKrey GK, 1998, INFECT IMMUN, V66, P827, DOI 10.1128/IAI.66.2.827-829.1998; Fonseca-Silva F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014666; Gomes-Silva A, 2013, PARASITOLOGY, V140, P771, DOI 10.1017/S0031182012002156; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; GRIMALDI G, 1989, AM J TROP MED HYG, V41, P687, DOI 10.4269/ajtmh.1989.41.687; Joshi J, 2014, PARASITOL INT, V63, P612, DOI 10.1016/j.parint.2014.04.002; Maia RC, 2011, INVEST NEW DRUG, V29, P1143, DOI 10.1007/s10637-010-9453-z; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Netto CD, 2009, EUR J MED CHEM, V44, P920, DOI 10.1016/j.ejmech.2008.01.027; O'Daly Jose A, 2013, J Parasitol Res, V2013, P657016, DOI 10.1155/2013/657016; Pham TTH, 2013, INT J PHARMACEUT, V454, P539, DOI 10.1016/j.ijpharm.2013.07.035; Reers M, 1995, METHOD ENZYMOL, V260, P406, DOI 10.1016/0076-6879(95)60154-6; Ribeiro GA, 2013, J ANTIMICROB CHEMOTH, V68, P789, DOI 10.1093/jac/dks498; Rocha FJS, 2007, INFECT IMMUN, V75, P3823, DOI 10.1128/IAI.01335-06; Santos NC, 2003, BIOCHEM PHARMACOL, V65, P1035, DOI 10.1016/S0006-2952(03)00002-9; Sinagra A, 1997, AM J TROP MED HYG, V57, P115, DOI 10.4269/ajtmh.1997.57.115; Soto J, 2008, AM J TROP MED HYG, V78, P210, DOI 10.4269/ajtmh.2008.78.210; Weingartner A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042070	27	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e109672	10.1371/journal.pone.0109672	http://dx.doi.org/10.1371/journal.pone.0109672			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340550	Green Published, gold			2022-12-27	WOS:000343662800013
J	de Ridder, D; Kroese, F; Adriaanse, M; Evers, C				de Ridder, Denise; Kroese, Floor; Adriaanse, Marieke; Evers, Catharine			Always Gamble on an Empty Stomach: Hunger Is Associated with Advantageous Decision Making	PLOS ONE			English	Article							SELF-CONTROL; VISCERAL INFLUENCES; FUTURE CONSEQUENCES; PREFRONTAL CORTEX; RISK-TAKING; HEALTH; INSENSITIVITY; PERSONALITY; IMPULSIVITY; PERCEPTION	Three experimental studies examined the counterintuitive hypothesis that hunger improves strategic decision making, arguing that people in a hot state are better able to make favorable decisions involving uncertain outcomes. Studies 1 and 2 demonstrated that participants with more hunger or greater appetite made more advantageous choices in the Iowa Gambling Task compared to sated participants or participants with a smaller appetite. Study 3 revealed that hungry participants were better able to appreciate future big rewards in a delay discounting task; and that, in spite of their perception of increased rewarding value of both food and monetary objects, hungry participants were not more inclined to take risks to get the object of their desire. Together, these studies for the first time provide evidence that hot states improve decision making under uncertain conditions, challenging the conventional conception of the detrimental role of impulsivity in decision making.	[de Ridder, Denise; Kroese, Floor; Adriaanse, Marieke; Evers, Catharine] Univ Utrecht, Dept Clin & Hlth Psychol, Utrecht, Netherlands	Utrecht University	de Ridder, D (corresponding author), Univ Utrecht, Dept Clin & Hlth Psychol, Utrecht, Netherlands.	d.t.d.deridder@uu.nl	Adriaanse, Marieke/AFQ-8371-2022	Adriaanse, Marieke/0000-0002-2218-4723				Apfelbaum EP, 2009, PSYCHOL SCI, V20, P139, DOI 10.1111/j.1467-9280.2009.02266.x; Ariely D, 2006, J BEHAV DECIS MAKING, V19, P87, DOI 10.1002/bdm.501; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Briers B, 2006, PSYCHOL SCI, V17, P939, DOI 10.1111/j.1467-9280.2006.01808.x; BRUNER JS, 1947, J ABNORM SOC PSYCH, V42, P33, DOI 10.1037/h0058484; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Crone EA, 2003, PERS INDIV DIFFER, V35, P1625, DOI 10.1016/S0191-8869(02)00386-0; Damasio A.R., 2005, DESCARTES ERROR EMOT; Davis C, 2007, PERS INDIV DIFFER, V42, P279, DOI 10.1016/j.paid.2006.07.006; De Ridder DTD, 2011, PSYCHOL HEALTH, V26, P501, DOI 10.1080/08870440903564332; De Witt Huberts JC, 2012, LICENSE SIN SELF LIC; den Daas C, 2013, SOC PSYCHOL PERS SCI, V4, P362, DOI 10.1177/1948550612456046; DICKMAN SJ, 1990, J PERS SOC PSYCHOL, V58, P95, DOI 10.1037/0022-3514.58.1.95; Dijksterhuis A, 2006, PERSPECT PSYCHOL SCI, V1, P95, DOI 10.1111/j.1745-6916.2006.00007.x; Ditto PH, 2006, J BEHAV DECIS MAKING, V19, P99, DOI 10.1002/bdm.520; Duckworth AL, 2011, J RES PERS, V45, P259, DOI 10.1016/j.jrp.2011.02.004; Dunn BD, 2006, NEUROSCI BIOBEHAV R, V30, P239, DOI 10.1016/j.neubiorev.2005.07.001; Fennis BM, 2009, J CONSUM RES, V35, P906, DOI 10.1086/593291; Hofmann W, 2012, J PERS SOC PSYCHOL, V102, P1318, DOI 10.1037/a0026545; Huberts JCD, 2014, PERS SOC PSYCHOL REV, V18, P119, DOI 10.1177/1088868313507533; Kacelnik A, 2003, TIME DECISION EC PSY, P115; Kirby KN, 1999, J EXP PSYCHOL GEN, V128, P78, DOI 10.1037/0096-3445.128.1.78; Kuijer R, 2008, APPETITE, V51, P506, DOI 10.1016/j.appet.2008.03.014; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; Loewenstein G, 1996, ORGAN BEHAV HUM DEC, V65, P272, DOI 10.1006/obhd.1996.0028; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Maridakis V, 2009, INT J NEUROSCI, V119, P975, DOI 10.1080/00207450802333995; Metcalfe J, 1999, PSYCHOL REV, V106, P3, DOI 10.1037/0033-295X.106.1.3; Nordgren LF, 2008, HEALTH PSYCHOL, V27, P722, DOI 10.1037/0278-6133.27.6.722; Nordgren LF, 2009, J CONSUM RES, V36, P39, DOI 10.1086/596306; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pinel JPJ, 2000, AM PSYCHOL, V55, P1105, DOI 10.1037//0003-066X.55.10.1105; Rawn CD, 2011, PERS SOC PSYCHOL REV, V15, P267, DOI 10.1177/1088868310381084; Salmon SJ, 2014, HEALTH PSYCHOL, V33, P103, DOI 10.1037/a0031785; Seo MG, 2007, ACAD MANAGE J, V50, P923, DOI 10.2307/20159897; Tangney JP, 2004, J PERS, V72, P271, DOI 10.1111/j.0022-3506.2004.00263.x; Toplak ME, 2010, CLIN PSYCHOL REV, V30, P562, DOI 10.1016/j.cpr.2010.04.002; Tuk MA, 2011, PSYCHOL SCI, V22, P627, DOI 10.1177/0956797611404901; Turnbull OH, 2005, BRAIN COGNITION, V57, P244, DOI 10.1016/j.bandc.2004.08.053; Van den Bergh B, 2008, J CONSUM RES, V35, P85, DOI 10.1086/525505; van Koningsbruggen GM, 2011, J EXP SOC PSYCHOL, V47, P293, DOI 10.1016/j.jesp.2010.10.012; Veltkamp M, 2008, SOC COGNITION, V26, P720, DOI 10.1521/soco.2008.26.6.720; WMO, 2012, CENTR COMM RES INV H; Zermatten A, 2005, J NERV MENT DIS, V193, P647, DOI 10.1097/01.nmd.0000180777.41295.65	46	27	28	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111081	10.1371/journal.pone.0111081	http://dx.doi.org/10.1371/journal.pone.0111081			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR5ZY	25340399	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662800083
J	Sugawara, Y; Yutani, M; Amatsu, S; Matsumura, T; Fujinaga, Y				Sugawara, Yo; Yutani, Masahiro; Amatsu, Sho; Matsumura, Takuhiro; Fujinaga, Yukako			Functional Dissection of the Clostridium botulinum Type B Hemagglutinin Complex: Identification of the Carbohydrate and E-Cadherin Binding Sites	PLOS ONE			English	Article							C PROGENITOR TOXIN; EPITHELIAL BARRIER; CRYSTAL-STRUCTURE; HA PROTEINS; NEUROTOXIN; ERYTHROCYTES; SUBCOMPONENT; DISRUPTION; ABSORPTION; MECHANISM	Botulinum neurotoxin (BoNT) inhibits neurotransmitter release in motor nerve endings, causing botulism, a condition often resulting from ingestion of the toxin or toxin-producing bacteria. BoNTs are always produced as large protein complexes by associating with a non-toxic protein, non-toxic non-hemagglutinin (NTNH), and some toxin complexes contain another nontoxic protein, hemagglutinin (HA), in addition to NTNH. These accessory proteins are known to increase the oral toxicity of the toxin dramatically. NTNH has a protective role against the harsh conditions in the digestive tract, while HA is considered to facilitate intestinal absorption of the toxin by intestinal binding and disruption of the epithelial barrier. Two specific activities of HA, carbohydrate and E-cadherin binding, appear to be involved in these processes; however, the exact roles of these activities in the pathogenesis of botulism remain unclear. The toxin is conventionally divided into seven serotypes, designated A through G. In this study, we identified the amino acid residues critical for carbohydrate and E-cadherin binding in serotype B HA. We constructed mutants defective in each of these two activities and examined the relationship of these activities using an in vitro intestinal cell culture model. Our results show that the carbohydrate and E-cadherin binding activities are functionally and structurally independent. Carbohydrate binding potentiates the epithelial barrier-disrupting activity by enhancing cell surface binding, while E-cadherin binding is essential for the barrier disruption.	[Sugawara, Yo; Yutani, Masahiro; Amatsu, Sho; Matsumura, Takuhiro; Fujinaga, Yukako] Osaka Univ, Microbial Dis Res Inst, Lab Infect Cell Biol, Int Res Ctr Infect Dis, Suita, Osaka 565, Japan	Osaka University	Fujinaga, Y (corresponding author), Osaka Univ, Microbial Dis Res Inst, Lab Infect Cell Biol, Int Res Ctr Infect Dis, Suita, Osaka 565, Japan.	yukafuji@biken.osaka-u.ac.jp		Amatsu, Sho/0000-0003-0692-264X	Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology of Japan [20790336, 21390128]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding provided by the Funding Program for Next Generation World-Leading Researchers (NEXT Program) from the Japan Society for the Promotion of Science (JSPS) and grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (20790336, 21390128). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatsu S, 2013, J BIOL CHEM, V288, P35617, DOI 10.1074/jbc.M113.521179; Arimitsu H, 2008, MICROB PATHOGENESIS, V45, P142, DOI 10.1016/j.micpath.2008.04.007; Barash JR, 2014, J INFECT DIS, V209, P183, DOI 10.1093/infdis/jit449; Benefield DA, 2013, P NATL ACAD SCI USA, V110, P5630, DOI [10.1073/pnas.1222139110, 10.1073/pnas.12222139110]; Fujinaga Y, 2004, MICROBIOL-SGM, V150, P1529, DOI 10.1099/mic.0.26805-0; Fujinaga Y, 1997, MICROBIOL-UK, V143, P3841, DOI 10.1099/00221287-143-12-3841; Fujinaga Y, 2000, FEBS LETT, V467, P179, DOI 10.1016/S0014-5793(00)01147-9; Fujinaga Y, 2013, CURR TOP MICROBIOL, V364, P45, DOI 10.1007/978-3-642-33570-9_3; Harrison OJ, 2011, STRUCTURE, V19, P244, DOI 10.1016/j.str.2010.11.016; Hasegawa K, 2007, J BIOL CHEM, V282, P24777, DOI 10.1074/jbc.M703446200; Inoue K, 2003, MICROBIOL-SGM, V149, P3361, DOI 10.1099/mic.0.26586-0; Inoue K, 1996, INFECT IMMUN, V64, P1589, DOI 10.1128/IAI.64.5.1589-1594.1996; Jin YJ, 2009, MICROBIOL-SGM, V155, P35, DOI 10.1099/mic.0.021246-0; Johnson EA, 2014, J INFECT DIS, V210, P992, DOI 10.1093/infdis/jiu211; Lee K, 2014, SCIENCE, V344, P1405, DOI 10.1126/science.1253823; Lee K, 2014, BIOCHEM BIOPH RES CO, V446, P568, DOI 10.1016/j.bbrc.2014.03.008; Lee K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003690; Lommel M, 2013, P NATL ACAD SCI USA, V110, P21024, DOI 10.1073/pnas.1316753110; Matsumura T, 2008, CELL MICROBIOL, V10, P355, DOI 10.1111/j.1462-5822.2007.01048.x; Nakamura T, 2008, J MOL BIOL, V376, P854, DOI 10.1016/j.jmb.2007.12.031; Nakamura T, 2007, BBA-GEN SUBJECTS, V1770, P551, DOI 10.1016/j.bbagen.2006.11.006; Oguma K, 1999, J TOXICOL-TOXIN REV, V18, P17, DOI 10.3109/15569549909036015; Pinho SS, 2011, CELL MOL LIFE SCI, V68, P1011, DOI 10.1007/s00018-010-0595-0; Poulain B, 2008, BOTULINUM J, V1, P14, DOI DOI 10.1504/TBJ.2008.018951; SAKAGUCHI G, 1982, PHARMACOL THERAPEUT, V19, P165, DOI 10.1016/0163-7258(82)90061-4; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Sugawara Y, 2010, J CELL BIOL, V189, P691, DOI 10.1083/jcb.200910119; SUGII S, 1977, INFECT IMMUN, V16, P910, DOI 10.1128/IAI.16.3.910-914.1977; Yamashita S, 2012, FEBS LETT, V586, P2404, DOI 10.1016/j.febslet.2012.05.055	30	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111170	10.1371/journal.pone.0111170	http://dx.doi.org/10.1371/journal.pone.0111170			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340348	Green Submitted, Green Published, gold			2022-12-27	WOS:000343662800091
J	Scherf, JM; Hu, XS; Tepp, WH; Ichtchenko, K; Johnson, EA; Pellett, S				Scherf, Jacob M.; Hu, Xiaoyang Serene; Tepp, William H.; Ichtchenko, Konstantin; Johnson, Eric A.; Pellett, Sabine			Analysis of Gene Expression in Induced Pluripotent Stem Cell-Derived Human Neurons Exposed to Botulinum Neurotoxin A Subtype 1 and a Type A Atoxic Derivative	PLOS ONE			English	Article							MOTOR-NERVE TERMINALS; NEUROMUSCULAR-JUNCTIONS; TOXIN; TRANSLOCATION; ASTROCYTES; ASSAY; MICROGLIA; MEMBRANES; SYNAPSES; DELIVERY	Botulinum neurotoxin type A1 (BoNT/A1) is a potent protein toxin responsible for the potentially fatal human illness botulism. Notwithstanding, the long-lasting flaccid muscle paralysis caused by BoNT/A has led to its utility as a powerful and versatile bio-pharmaceutical. The flaccid paralysis is due to specific cleavage of neuronal SNAREs by BoNTs. However, actions of BoNTs on intoxicated neurons besides the cleavage of SNAREs have not been studied in detail. In this study we investigated by microarray analysis the effects of BoNT/A and a catalytically inactive derivative (BoNT/A ad) on the transcriptome of human induced pluripotent stem cell (hiPSC)-derived neurons at 2 days and 2 weeks after exposure. While there were only minor changes in expression levels at 2 days post exposure, at 2 weeks post exposure 492 genes were differentially expressed more than 2-fold in BoNT/A1-exposed cells when compared to non-exposed populations, and 682 genes were differentially expressed in BoNT/A ad-exposed cells. The vast majority of genes were similarly regulated in BoNT/A1 and BoNT/A ad-exposed neurons, and the few genes differentially regulated between BoNT/A1 and BoNT/A ad-exposed neurons were differentially expressed less than 3.5 fold. These data indicate a similar response of neurons to BoNT/A1 and BoNT/A ad exposure. The most highly regulated genes in cells exposed to either BoNT/A1 or BoNT/A ad are involved in neurite outgrowth and calcium channel sensitization.	[Scherf, Jacob M.; Hu, Xiaoyang Serene; Tepp, William H.; Johnson, Eric A.; Pellett, Sabine] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Ichtchenko, Konstantin] NYU, Sch Med, Dept Pharmacol, New York, NY USA	University of Wisconsin System; University of Wisconsin Madison; New York University	Pellett, S (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	sludwig@wisc.edu		Ichtchenko, Konstantin/0000-0002-2198-1325	National Institute of Allergy and Infectious Diseases [R01 AI093504]; University of Wisconsin-Madison Food Research Institute (FRI); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093504] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Wisconsin-Madison Food Research Institute (FRI); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases Award Number R01 AI093504 and the University of Wisconsin-Madison Food Research Institute (FRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGAUTPETIT D, 1990, NEUROSCIENCE, V37, P799, DOI 10.1016/0306-4522(90)90109-H; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Bade S, 2004, J NEUROCHEM, V91, P1461, DOI 10.1111/j.1471-4159.2004.02844.x; Band PA, 2010, PROTEIN EXPRES PURIF, V71, P62, DOI 10.1016/j.pep.2009.12.013; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; BERNARD M, 1988, J BIOL CHEM, V263, P17159; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; Bolz H, 2001, BBA-GENE STRUCT EXPR, V1522, P221, DOI 10.1016/S0167-4781(01)00329-3; BONNER PH, 1994, DEV BRAIN RES, V79, P39, DOI 10.1016/0165-3806(94)90047-7; Brashear A, 2010, DRUG TODAY, V46, P671, DOI 10.1358/dot.2010.46.9.1524356; Carmignoto G, 2000, PROG NEUROBIOL, V62, P561, DOI 10.1016/S0301-0082(00)00029-0; Chaddock JA, 2006, CELL MOL LIFE SCI, V63, P540, DOI 10.1007/s00018-005-5505-5; Cheng YC, 2012, MOL NEUROBIOL, V45, P536, DOI 10.1007/s12035-012-8275-8; Coffield JA, 2009, J PHARMACOL EXP THER, V330, P352, DOI 10.1124/jpet.108.147744; DIAZ J, 1989, NEUROSCI LETT, V96, P127, DOI 10.1016/0304-3940(89)90045-1; Dressler D, 2012, CURR OPIN MICROBIOL, V15, P325, DOI 10.1016/j.mib.2012.05.012; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; FINKBEINER S, 1992, NEURON, V8, P1101, DOI 10.1016/0896-6273(92)90131-V; Fischer A, 2007, J BIOL CHEM, V282, P29604, DOI 10.1074/jbc.M703619200; Fischer A, 2007, P NATL ACAD SCI USA, V104, P10447, DOI 10.1073/pnas.0700046104; Foran PG, 2003, J BIOL CHEM, V278, P1363, DOI 10.1074/jbc.M209821200; Fujikawa R, 2008, J PHYSIOL SCI, V58, P419, DOI 10.2170/physiolsci.RP000908; GIMENEZ DF, 1995, INT J FOOD MICROBIOL, V27, P1, DOI 10.1016/0168-1605(94)00144-U; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Harrison SJ, 2008, J COMP NEUROL, V507, P1780, DOI 10.1002/cne.21650; Hashimoto T, 2009, CELL BIOCHEM FUNCT, V27, P496, DOI 10.1002/cbf.1600; Hatheway C.L., 1988, LAB DIAGNOSIS INFECT, P111; HOLLAND RL, 1981, NEUROSCIENCE, V6, P1167, DOI 10.1016/0306-4522(81)90081-6; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huh JW, 2009, MOL CELLS, V28, P111, DOI 10.1007/s10059-009-0106-z; Johnson EA, 2005, TOPLEY WILSONS MICRO, V8, P1035; Johnson Eric A, 2008, Handb Clin Neurol, V91, P333, DOI 10.1016/S0072-9752(07)01511-4; Juzans P, 1996, NEUROMUSCULAR DISORD, V6, P177, DOI 10.1016/0960-8966(96)00041-7; Kahler AK, 2008, AM J MED GENET B, V147B, P1089, DOI 10.1002/ajmg.b.30726; Keller JE, 2004, BIOCHEMISTRY-US, V43, P526, DOI 10.1021/bi0356698; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Krug A, 2013, SCHIZOPHRENIA BULL, V39, P141, DOI 10.1093/schbul/sbr076; Lee SA, 2011, J BIOL CHEM, V286, P13550, DOI 10.1074/jbc.M110.181065; Lin HJ, 2012, INVEST OPHTH VIS SCI, V53, P6519, DOI 10.1167/iovs.11-9031; Malizio CJ, 2000, METH MOL B, V145, P27; MOLGO J, 1990, J PHYSIOLOGY PARIS, V84, P152; Mukund K, 2014, MUSCLE NERVE; MURAGAKI Y, 1991, EUR J BIOCHEM, V197, P615, DOI 10.1111/j.1432-1033.1991.tb15951.x; NEDERGAARD M, 1994, SCIENCE, V263, P1768, DOI 10.1126/science.8134839; Neely GG, 2010, CELL, V143, P628, DOI 10.1016/j.cell.2010.09.047; Noonan EJ, 2007, CELL STRESS CHAPERON, V12, P393, DOI 10.1379/CSC-278e.1; Noureddini M, 2012, CELL BIOL INT, V36, P961, DOI 10.1042/CBI20110610; Pantano S, 2014, CELL MOL LIFE SCI, V71, P793, DOI 10.1007/s00018-013-1380-7; Pellett S, 2007, FEBS LETT, V581, P4803, DOI 10.1016/j.febslet.2007.08.078; Pellett S, 2011, BIOCHEM BIOPH RES CO, V405, P673, DOI 10.1016/j.bbrc.2011.01.093; Pellett S, 2010, J PHARMACOL TOX MET, V61, P304, DOI 10.1016/j.vascn.2010.01.003; Peterziel H, 2011, MOL CELL NEUROSCI, V46, P483, DOI 10.1016/j.mcn.2010.12.001; Pirone A, 2014, J NEUROSCI, V34, P434, DOI 10.1523/JNEUROSCI.3085-13.2014; Pozzi D, 2008, P NATL ACAD SCI USA, V105, P323, DOI 10.1073/pnas.0706211105; Rossert J, 2000, NEPHROL DIAL TRANSPL, V15, P66, DOI 10.1093/ndt/15.suppl_6.66; Rummel A, 2013, CURR TOP MICROBIOL, V364, P61, DOI 10.1007/978-3-642-33570-9_4; SCHANTZ EJ, 1978, J ASSOC OFF ANA CHEM, V61, P96; Siegenthaler JA, 2009, CELL, V139, P597, DOI 10.1016/j.cell.2009.10.004; Smith TJ, 2005, INFECT IMMUN, V73, P5450, DOI 10.1128/IAI.73.9.5450-5457.2005; Tafoya LCR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-105; Takita J, 2011, CANCER SCI, V102, P1645, DOI 10.1111/j.1349-7006.2011.01995.x; Thirunavukkarasu N, 2011, BIOCHEM BIOPH RES CO, V405, P684, DOI 10.1016/j.bbrc.2011.01.102; van Scheltinga AFT, 2013, NEUROSCIENTIST, V19, P479, DOI 10.1177/1073858412472399; Wang XX, 2014, AESTHET SURG J, V34, P154, DOI 10.1177/1090820X13482938; Whitemarsh RCM, 2012, TOXICOL SCI, V126, P426, DOI 10.1093/toxsci/kfr354; Whitemarsh RCM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090252; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	69	5	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e111238	10.1371/journal.pone.0111238	http://dx.doi.org/10.1371/journal.pone.0111238			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337697	gold, Green Submitted, Green Published			2022-12-27	WOS:000343674800112
J	Picard, FA; Gueret, P; Laissy, JP; Champagne, S; Leclercq, F; Carrie, D; Juliard, JM; Henry, P; Niarra, R; Chatellier, G; Steg, PG				Picard, Fabien A.; Gueret, Pascal; Laissy, Jean-Pierre; Champagne, Stephane; Leclercq, Florence; Carrie, Didier; Juliard, Jean-Michel; Henry, Patrick; Niarra, Ralph; Chatellier, Gilles; Steg, Philippe Gabriel			Epicardial Adipose Tissue Thickness Correlates with the Presence and Severity of Angiographic Coronary Artery Disease in Stable Patients with Chest Pain	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; PERICARDIAL FAT; INDEPENDENT PREDICTOR; COMPUTED-TOMOGRAPHY; ASSOCIATION; INFLAMMATION; CALCIFICATION	Objective: Epicardial adipose tissue (EAT) is suggested to correlate with metabolic risk factors and to promote plaque development in the coronary arteries. We sought to determine whether EAT thickness was associated or not with the presence and extent of angiographic coronary artery disease (CAD). Methods: We measured epicardial fat thickness by computed tomography and assessed the presence and extent of CAD by coronary angiography in participants from the prospective EVASCAN study. The association of EAT thickness with cardiovascular risk factors, coronary artery calcification scoring and angiographic CAD was assessed using multivariate regression analysis. Results: Of 970 patients (age 60.9 years, 71% male), 75% (n = 731) had CAD. Patients with angiographic CAD had thicker EAT on the left ventricle lateral wall when compared with patients without CAD (2.74 +/- 2.4 mm vs. 2.08 +/- 2.1 mm; p = 0.0001). The adjusted odds ratio (OR) for a patient with a LVLW EAT value >= 2.8 mm to have CAD was OR = 1.46 [1.03-2.08], p = 0.0326 after adjusting for risk factors. EAT also correlated with the number of diseased vessels (p = 0.0001 for trend). By receiver operating characteristic curve analysis, an EAT value >= 2.8 mm best predicted the presence of >50% diameter coronary artery stenosis, with a sensitivity and specificity of 46.1% and 66.5% respectively (AUC:0.58). Coronary artery calcium scoring had an AUC of 0.76. Conclusion: Although left ventricle lateral wall EAT thickness correlated with the presence and extent of angiographic CAD, it has a low performance for the diagnosis of CAD.	[Picard, Fabien A.; Juliard, Jean-Michel; Steg, Philippe Gabriel] Univ Paris Diderot, Hop Bichat, AP HP, Dept Cardiol,Sorbonne Paris Cite, Paris, France; [Gueret, Pascal; Champagne, Stephane] Univ Paris Est Creteil, Hop Henri Mondor, AP HP, Dept Cardiol, Creteil, France; [Laissy, Jean-Pierre] Univ Paris Diderot, Hop Bichat, AP HP, Dept Radiol, Paris, France; [Laissy, Jean-Pierre; Steg, Philippe Gabriel] Univ Paris Diderot, Hop Bichat, AP HP, INSERM,Dept Hosp Univ FIRE,U 1148, Paris, France; [Leclercq, Florence] Ctr Hosp Univ Arnaud Villeneuve, Dept Cardiol, Montpellier, France; [Carrie, Didier] CHU Rangueil, Dept Cardiol, F-31054 Toulouse, France; [Henry, Patrick] Univ Paris Diderot, Hop Lariboisiere, AP HP, Dept Cardiol,Sorbonne Paris Cite, Paris, France; [Niarra, Ralph; Chatellier, Gilles] Hop Europe Georges Pompidou, AP HP, Epidemiol & Clin Res Unit, Paris, France; [Niarra, Ralph; Chatellier, Gilles] Ctr Invest Epidemiol, Unite INSERM, Paris, France; [Chatellier, Gilles] Univ Paris 05, Fac Med, Sorbonne Paris Cite, Paris, France; [Steg, Philippe Gabriel] Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, ICMS, NHLI, London, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Montpellier; CHU de Montpellier; CHU de Toulouse; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Imperial College London; Royal Brompton Hospital	Steg, PG (corresponding author), Univ Paris Diderot, Hop Bichat, AP HP, Dept Cardiol,Sorbonne Paris Cite, Paris, France.	gabriel.steg@bch.aphp.fr	STEG, Philippe Gabriel/Z-1567-2019; Picard, Fabien/AAM-4602-2021	STEG, Philippe Gabriel/0000-0001-6896-2941; CARRIE, didier/0000-0003-2479-8144				Albuquerque FN, 2012, AM J CARDIOL, V110, P1100, DOI 10.1016/j.amjcard.2012.06.003; Alexopoulos N, 2010, ATHEROSCLEROSIS, V210, P150, DOI 10.1016/j.atherosclerosis.2009.11.020; Austen W G, 1975, Circulation, V51, P5; Baker AR, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-1; Bettencourt N, 2012, INT J CARDIOL, V158, P26, DOI 10.1016/j.ijcard.2010.12.085; Broedl UC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004733; Chaowalit N, 2006, ATHEROSCLEROSIS, V186, P354, DOI 10.1016/j.atherosclerosis.2005.08.004; de Vos AM, 2008, EUR HEART J, V29, P777, DOI 10.1093/eurheartj/ehm564; Ding JZ, 2008, OBESITY, V16, P1914, DOI 10.1038/oby.2008.278; Eroglu S, 2009, NUTR METAB CARDIOVAS, V19, P211, DOI 10.1016/j.numecd.2008.05.002; Fandino-Vaquero R, 2014, ATHEROSCLEROSIS, V235, P281, DOI 10.1016/j.atherosclerosis.2014.05.921; Gorter PM, 2008, ATHEROSCLEROSIS, V197, P896, DOI 10.1016/j.atherosclerosis.2007.08.016; Greif M, 2009, ARTERIOSCL THROM VAS, V29, P781, DOI 10.1161/ATVBAHA.108.180653; Gueret P, 2013, AM J CARDIOL, V111, P471, DOI 10.1016/j.amjcard.2012.10.029; Hirata Y, 2011, INT HEART J, V52, P139, DOI 10.1536/ihj.52.139; Mahabadi AA, 2013, J AM COLL CARDIOL, V61, P1388, DOI 10.1016/j.jacc.2012.11.062; Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5; Menzel HG, 2000, 16262EN EUR; Oka T, 2012, INT J CARDIOL, V161, P45, DOI 10.1016/j.ijcard.2011.04.021; Pracon R, 2011, CIRC J, V75, P391, DOI 10.1253/circj.CJ-10-0441; Rabkin SW, 2007, OBES REV, V8, P253, DOI 10.1111/j.1467-789X.2006.00293.x; Rosito GA, 2008, CIRCULATION, V117, P605, DOI 10.1161/CIRCULATIONAHA.107.743062; Sacks HS, 2007, AM HEART J, V153, P907, DOI 10.1016/j.ahj.2007.03.019; Smith SC, 2006, J AM COLL CARDIOL, V47, P216, DOI 10.1016/j.jacc.2005.11.025; Taguchi R, 2001, ATHEROSCLEROSIS, V157, P203, DOI 10.1016/S0021-9150(00)00709-7; Tok D, 2012, TURK KARDIYOL DERN A, V40, P690, DOI 10.5543/tkda.2012.60207; Wang TD, 2010, ATHEROSCLEROSIS, V213, P279, DOI 10.1016/j.atherosclerosis.2010.07.055; Xu Y, 2012, CORONARY ARTERY DIS, V23, P227, DOI 10.1097/MCA.0b013e328351ab2c	28	36	39	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110005	10.1371/journal.pone.0110005	http://dx.doi.org/10.1371/journal.pone.0110005			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25335187	Green Submitted, Green Published, gold			2022-12-27	WOS:000343731200025
J	Sun, Y; Hou, R; Fu, XT; Sun, CS; Wang, S; Wang, C; Li, N; Zhang, LL; Bao, ZM				Sun, Yan; Hou, Rui; Fu, Xiaoteng; Sun, Changsen; Wang, Shi; Wang, Chen; Li, Ning; Zhang, Lingling; Bao, Zhenmin			Genome-Wide Analysis of DNA Methylation in Five Tissues of Zhikong Scallop, Chlamys farreri	PLOS ONE			English	Article							GENE-EXPRESSION; CPG METHYLATION; AMPLIFICATION; PATTERNS; 5-METHYLCYTOSINE; CONSERVATION; EPIGENETICS; DIVERGENCE; WIDESPREAD; PLANTS	DNA methylation plays a vital role in tissue development and differentiation in eukaryotes. Epigenetic studies have been seldom conducted in the extremely diverse and evolutionarily highly successful bilaterian lineage Mollusca. In the present study, we conducted the genome-wide profiling of DNA methylation for five tissues of a bivalve mollusc, Chlamys farreri using the methylation-sensitive amplification polymorphism (MSAP) technique. The methylation levels were quite similar among tissues, ranging from 20.9% to 21.7%. CG methylation was the dominant type (14.9%-16.5%) in the C. farreri genome, but CHG methylation also accounted for a substantial fraction of total methylation (5.1%-6.3%). Relatively high methylation diversity was observed within tissues. Methylation differentiation between tissues was evaluated and 460 tissue-specific epiloci were identified. Kidney differs from the other tissues in DNA methylation profiles. Our study presents the first look at the tissue-specific DNA methylation patterns in a bivalve mollusc and represents an initial step towards understanding of epigenetic regulatory mechanism underlying tissue development and differentiation in bivalves.	[Sun, Yan; Hou, Rui; Fu, Xiaoteng; Wang, Shi; Wang, Chen; Li, Ning; Zhang, Lingling; Bao, Zhenmin] Ocean Univ China, Coll Marine Life Sci, Minist Educ, Key Lab Marine Genet & Breeding MGB, Qingdao, Peoples R China; [Sun, Changsen] Taizhou Univ, Sch Life Sci, Taizhou, Peoples R China	Ocean University of China; Taizhou University	Zhang, LL (corresponding author), Ocean Univ China, Coll Marine Life Sci, Minist Educ, Key Lab Marine Genet & Breeding MGB, Qingdao, Peoples R China.	lingling80@ouc.edu.cn	zhang, lingling/HDM-2189-2022	sun, Yongjun/0000-0002-5266-3645; Zheng, Huaili/0000-0001-8544-6033; Zhai, Jun/0000-0002-4378-0604; zhao, chun/0000-0002-9118-9990	National High Technology Research and Development Program of China [2012AA10A401]; National Basic Research Program of China (973 Program) [2010CB126406]; Natural Science Foundation for Distinguished Young Scholars of Shandong Province [JQ201308]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation for Distinguished Young Scholars of Shandong Province	This work is supported by National High Technology Research and Development Program of China (2012AA10A401), National Basic Research Program of China (973 Program, 2010CB126406), and Natural Science Foundation for Distinguished Young Scholars of Shandong Province (JQ201308). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; BIRD AP, 1979, CELL, V17, P889, DOI 10.1016/0092-8674(79)90329-5; Boks MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006767; Bossdorf O, 2008, ECOL LETT, V11, P106, DOI 10.1111/j.1461-0248.2007.01130.x; Cervera MT, 2002, MOL GENET GENOMICS, V268, P543, DOI 10.1007/s00438-002-0772-4; De Montera B, 2004, CLONING STEM CELLS, V6, P133, DOI 10.1089/1536230041372382; EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709; Elango N, 2009, P NATL ACAD SCI USA, V106, P11206, DOI 10.1073/pnas.0900301106; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; GAMASOSA MA, 1983, NUCLEIC ACIDS RES, V11, P3087, DOI 10.1093/nar/11.10.3087; Gavery MR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-483; Gowher H, 2000, EMBO J, V19, P6918, DOI 10.1093/emboj/19.24.6918; Jiao WQ, 2014, DNA RES, V21, P85, DOI 10.1093/dnares/dst043; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lu YL, 2008, J GENET GENOMICS, V35, P41, DOI 10.1016/S1673-8527(08)60006-5; Nabel CS, 2012, NAT CHEM BIOL, V8, P751, DOI [10.1038/NCHEMBIO.1042, 10.1038/nchembio.1042]; Peraza-Echeverria S, 2001, PLANT SCI, V161, P359, DOI 10.1016/S0168-9452(01)00421-6; ReynaLopez GE, 1997, MOL GEN GENET, V253, P703, DOI 10.1007/s004380050374; Sambrook J, 1989, MOL CLONING; Schalkwyk LC, 2010, AM J HUM GENET, V86, P196, DOI 10.1016/j.ajhg.2010.01.014; Schrey AW, 2013, INTEGR COMP BIOL, V53, P340, DOI 10.1093/icb/ict012; Schulz B, 2013, MOL ECOL RESOUR, V13, P642, DOI 10.1111/1755-0998.12100; SIMPSON VJ, 1986, NUCLEIC ACIDS RES, V14, P6711, DOI 10.1093/nar/14.16.6711; Su ZX, 2011, EPIGENETICS-US, V6, P134, DOI 10.4161/epi.6.2.13875; Suzuki MM, 2007, GENOME RES, V17, P625, DOI 10.1101/gr.6163007; Wang Y, 2006, SCIENCE, V314, P645, DOI 10.1126/science.1135213; Xiong LZ, 1999, MOL GEN GENET, V261, P439, DOI 10.1007/s004380050986; Xu Q, 2007, ANIM BIOTECHNOL, V18, P231, DOI 10.1080/10495390701574838; Yang C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016229; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zhang DD, 2010, AM J HUM GENET, V86, P411, DOI 10.1016/j.ajhg.2010.02.005	36	69	74	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e86232	10.1371/journal.pone.0086232	http://dx.doi.org/10.1371/journal.pone.0086232			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	25347394	gold, Green Published, Green Submitted			2022-12-27	WOS:000329925800057
J	Dvorak, K; Stritesky, J; Petrtyl, J; Vitek, L; Sroubkova, R; Lenicek, M; Smid, V; Haluzik, M; Bruha, R				Dvorak, Karel; Stritesky, Jan; Petrtyl, Jaromir; Vitek, Libor; Sroubkova, Renata; Lenicek, Martin; Smid, Vaclav; Haluzik, Martin; Bruha, Radan			Use of Non-Invasive Parameters of Non-Alcoholic Steatohepatitis and Liver Fibrosis in Daily Practice - An Exploratory Case-Control Study	PLOS ONE			English	Article							FATTY LIVER; HYALURONIC-ACID; SCORING SYSTEM; SERUM MARKERS; DISEASE; BIOPSY; CYTOKERATIN-18; METAANALYSIS; VALIDATION; APOPTOSIS	Background: Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of a metabolic syndrome. To date, liver biopsy has been the gold standard used to differentiate between simple steatosis and steatohepatitis/fibrosis. Our aim was to compare the relevance of serum non-invasive parameters and scoring systems in the staging of liver fibrosis and nonalcoholic steatohepatitis (NASH) in patients with NAFLD. Methods and Findings: A total of 112 consecutive patients diagnosed with NAFLD were included. A liver biopsy was performed on 56 patients. The Kleiner score was used for the staging and grading of the histology. Non-invasive parameters for fibrosis (hyaluronic acid; AST/ALT; fibrosis scoring indexes OELF, ELF, BARD score, APRI, NAFLD fibrosis score); and inflammation (M30 and M65 cytokeratin-18 fragments) were measured and calculated. The same analyses were performed in 56 patients diagnosed with NAFLD, who were not indicated for liver biopsy. Based on the liver histology, NASH was diagnosed in 38 patients; simple steatosis in 18 patients. A cut-off value of 750 U/L of serum M65 discriminated patients with and without NASH with a 80% sensitivity and 82% specificity (95% CI: 57-95). Fibrosis stage F0-F2 was present in 39 patients; F3-F4 in 17 patients. Serum concentrations of hyaluronic acid were higher in patients with advanced fibrosis (p<0.01); a cut-off value of 25 mg/l discriminated patients with F3-F4 with a 90% sensitivity and 84% specificity from those with F0-F2 (95% CI: 59-99). When applying the non-invasive criteria to those patients without a liver biopsy, NASH could only be diagnosed in 16%; however, advanced fibrosis could be diagnosed in 35% of them. Conclusions: In patients with NAFLD, non-invasive serum parameters with a high accuracy can differentiate those patients with NASH and/or advanced fibrosis from those with simple steatosis. A substantial portion of those patients not indicated for liver biopsy might have undiagnosed advanced fibrosis.	[Dvorak, Karel; Petrtyl, Jaromir; Vitek, Libor; Sroubkova, Renata; Smid, Vaclav; Bruha, Radan] Charles Univ Prague, Fac Med 1, Dept Internal Med 4, Prague, Czech Republic; [Stritesky, Jan] Charles Univ Prague, Fac Med 1, Dept Pathol, Prague, Czech Republic; [Vitek, Libor; Lenicek, Martin] Charles Univ Prague, Fac Med 1, Inst Med Biochem & Lab Diagnost, Prague, Czech Republic; [Vitek, Libor; Lenicek, Martin] Charles Univ Prague, Fac Med 1, Diagnost Lab, Prague, Czech Republic; [Haluzik, Martin] Charles Univ Prague, Fac Med 1, Dept Internal Med 3, Prague, Czech Republic	Charles University Prague; Charles University Prague; Charles University Prague; Charles University Prague; Charles University Prague	Bruha, R (corresponding author), Charles Univ Prague, Fac Med 1, Dept Internal Med 4, Prague, Czech Republic.	bruha@cesnet.cz	Sroubkova, Renata/P-4561-2016; Stritesky, Jan/N-3787-2017; Petrtýl, Jaromír/AFY-0958-2022; Smid, Vaclav/B-7724-2017; Haluzik, Martin/I-8190-2017; Bruha, Radan/A-4432-2008; Dvorak, Karel/AAD-8111-2020; Vitek, Libor/A-2645-2008; Lenicek, Martin/A-5495-2009	Sroubkova, Renata/0000-0003-3758-361X; Stritesky, Jan/0000-0002-8200-7155; Petrtýl, Jaromír/0000-0002-1271-5367; Smid, Vaclav/0000-0002-8664-7918; Haluzik, Martin/0000-0002-0201-6888; Bruha, Radan/0000-0001-9924-4301; Vitek, Libor/0000-0002-5318-0151; Lenicek, Martin/0000-0001-6242-3488	Internal Grant Agency, Czech Ministry of Health (IGA MZCR) [NT 11247-4, NT 12290-4]; Charles University in Prague [SVV 260032-2014]	Internal Grant Agency, Czech Ministry of Health (IGA MZCR); Charles University in Prague	This work was supported by: 1) NT 11247-4 and NT 12290-4 given by Internal Grant Agency, Czech Ministry of Health (IGA MZCR)(http://iga.mzcr.cz/publicWeb/) to RB and KD; and 2) SVV 260032-2014 given by Charles University in Prague (http://www.cuni.cz/UKEN-1.html) to LV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Brunt EM, 2004, SEMIN LIVER DIS, V24, P3; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Chen J, 2013, HEPATOL RES; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Feldstein AE, 2009, HEPATOLOGY, V50, P1072, DOI 10.1002/hep.23050; Guha IN, 2008, HEPATOLOGY, V47, P455, DOI 10.1002/hep.21984; Harrison SA, 2008, GUT, V57, P1441, DOI 10.1136/gut.2007.146019; Hernaez R, 2011, HEPATOLOGY, V54, P1082, DOI 10.1002/hep.24452; Joka D, 2012, HEPATOLOGY, V55, P455, DOI 10.1002/hep.24734; Kalambokis G, 2007, J HEPATOL, V47, P284, DOI 10.1016/j.jhep.2007.05.001; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kwok R, 2014, ALIMENT PHARM THER, V39, P254, DOI 10.1111/apt.12569; Lebensztejn DM, 2011, ACTA BIOCHIM POL, V58, P563; Lichtinghagen R, 2013, J HEPATOL, V59, P236, DOI 10.1016/j.jhep.2013.03.016; Machado MV, 2013, J HEPATOL, V58, P1007, DOI 10.1016/j.jhep.2012.11.021; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Merriman RB, 2006, HEPATOLOGY, V44, P874, DOI 10.1002/hep.21346; Nobili V, 2009, GASTROENTEROLOGY, V136, P160, DOI 10.1053/j.gastro.2008.09.013; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742; Rosenberg WMC, 2004, GASTROENTEROLOGY, V127, P1704, DOI 10.1053/j.gastro.2004.08.052; Schuppan D, 2013, J GASTROEN HEPATOL, V28, P68, DOI 10.1111/jgh.12212; Shimada M, 2002, HEPATOL RES, V24, P429, DOI 10.1016/S1386-6346(02)00246-2; Sowa JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062439; Sumida Y, 2014, WORLD J GASTROENTERO, V20, P475, DOI 10.3748/wjg.v20.i2.475; Suzuki A, 2005, LIVER INT, V25, P779, DOI 10.1111/j.1478-3231.2005.01064.x; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Wieckowska A, 2006, HEPATOLOGY, V44, P27, DOI 10.1002/hep.21223; Yilmaz Y, 2007, WORLD J GASTROENTERO, V13, P837, DOI 10.3748/wjg.v13.i6.837	33	27	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111551	10.1371/journal.pone.0111551	http://dx.doi.org/10.1371/journal.pone.0111551			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350286	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943100077
J	Ichijo, T; Izumi, Y; Nakamoto, S; Yamaguchi, N; Nasu, M				Ichijo, Tomoaki; Izumi, Yoko; Nakamoto, Sayuri; Yamaguchi, Nobuyasu; Nasu, Masao			Distribution and Respiratory Activity of Mycobacteria in Household Water System of Healthy Volunteers in Japan	PLOS ONE			English	Article							FREE-LIVING AMEBAS; NONTUBERCULOUS MYCOBACTERIA; DRINKING-WATER; OPPORTUNISTIC PATHOGENS; ACANTHAMOEBA-POLYPHAGA; PULMONARY-DISEASE; RIBOSOMAL-RNA; ASIAN DUST; AVIUM; INTRACELLULARE	The primary infectious source of nontuberculous mycobacteria (NTM), which are known as opportunistic pathogens, appears to be environmental exposure, and it is important to reduce the frequency of exposure from environmental sources for preventing NTM infections. In order to achieve this, the distribution and respiratory activity of NTM in the environments must be clarified. In this study, we determined the abundance of mycobacteria and respiratory active mycobacteria in the household water system of healthy volunteers using quantitative PCR and a fluorescent staining method, because household water has been considered as one of the possible infectious sources. We chose healthy volunteer households in order to lessen the effect of possible residential contamination from an infected patient. We evaluated whether each sampling site (bathroom drain, kitchen drain, bath heater pipe and showerhead) have the potential to be the sources of NTM infections. Our results indicated that drains in the bathroom and kitchen sink are the niche for Mycobacterium spp. and M. avium cells were only detected in the bathtub inlet. Both physicochemical and biologic selective pressures may affect the preferred habitat of Mycobacterium spp. Regional differences also appear to exist as demonstrated by the presence (US) or absence (Japan) of Mycobacterium spp. on showerheads. Understanding of the country specific human activities and water usage will help to elucidate the infectious source and route of nontuberculous mycobacterial disease.	[Ichijo, Tomoaki; Izumi, Yoko; Nakamoto, Sayuri; Yamaguchi, Nobuyasu; Nasu, Masao] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka, Japan; [Ichijo, Tomoaki] Res Inst Humanity & Nat, Kyoto, Japan	Osaka University; Research Institute for Humanity & Nature (RIHN)	Yamaguchi, N (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka, Japan.	yamaguti@phs.osaka-u.ac.jp		Yamaguchi, Nobuyasu/0000-0003-1201-076X; Ichijo, Tomoaki/0000-0001-6922-2793	JSPS KAKENHI [20249007]; Ohyama Health Foundation; RIHN [C-06]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ohyama Health Foundation; RIHN	This research project was funded by the JSPS KAKENHI (grant number 20249007), Ohyama Health Foundation and the RIHN C-06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekambi T, 2006, APPL ENVIRON MICROB, V72, P5974, DOI 10.1128/AEM.03075-05; Aoki M, 2008, FUKUJUJI, V320; Dailloux M, 1999, WATER RES, V33, P2219, DOI 10.1016/S0043-1354(98)00466-7; Delafont V, 2013, WATER RES, V47, P6958, DOI 10.1016/j.watres.2013.07.047; Falkinham JO, 2009, J APPL MICROBIOL, V107, P356, DOI 10.1111/j.1365-2672.2009.04161.x; Falkinham JO, 2003, APPL ENVIRON MICROB, V69, P5685, DOI 10.1128/AEM.69.9.5685-5689.2003; Falkinham JO, 2001, APPL ENVIRON MICROB, V67, P1225, DOI 10.1128/AEM.67.3.1225-1231.2001; Falkinham JO, 2008, J WATER HEALTH, V6, P209, DOI [10.2166/wh.2008.232, 10.2166/wh.2008.032]; Falkinham JO, 2010, FUTURE MICROBIOL, V5, P951, DOI 10.2217/FMB.10.53; Feazel LM, 2009, P NATL ACAD SCI USA, V106, P16393, DOI 10.1073/pnas.0908446106; Glassroth J, 2008, CHEST, V133, P243, DOI 10.1378/chest.07-0358; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Ichijo T, 2010, J MICROBIOL METH, V82, P327, DOI 10.1016/j.mimet.2010.06.010; Jacobs J, 2009, APPL ENVIRON MICROB, V75, P7378, DOI 10.1128/AEM.01900-09; Lachnik J, 2002, J CLIN MICROBIOL, V40, P3364, DOI 10.1128/JCM.40.9.3364-3373.2002; Le Dantec C, 2002, APPL ENVIRON MICROB, V68, P5318, DOI 10.1128/AEM.68.11.5318-5325.2002; Lee ZMP, 2009, NUCLEIC ACIDS RES, V37, pD489, DOI 10.1093/nar/gkn689; Marras TK, 2007, THORAX, V62, P661, DOI 10.1136/thx.2006.070797; Mullis SN, 2013, J APPL MICROBIOL, V115, P908, DOI 10.1111/jam.12272; Mura M, 2006, APPL ENVIRON MICROB, V72, P854, DOI 10.1128/AEM.72.1.854-859.2006; Nishimura Y, 2010, MICROBES ENVIRON, V25, P22, DOI 10.1264/jsme2.ME09166; Nishiuchi Y, 2007, CLIN INFECT DIS, V45, P347, DOI 10.1086/519383; Nishiuchi Y, 2009, JPN J INFECT DIS, V62, P182; Ovrutsky AR, 2013, APPL ENVIRON MICROB, V79, P3185, DOI 10.1128/AEM.03823-12; Radomski N, 2010, APPL ENVIRON MICROB, V76, P7348, DOI 10.1128/AEM.00942-10; Radomski N, 2010, APPL ENVIRON MICROB, V76, P3514, DOI 10.1128/AEM.02659-09; Richardson ET, 2009, J CLIN MICROBIOL, V47, P1497, DOI 10.1128/JCM.01868-08; SCHULZEROBBECKE R, 1992, APPL ENVIRON MICROB, V58, P1869; Schuster FL, 2004, INT J PARASITOL, V34, P1001, DOI 10.1016/j.ijpara.2004.06.004; Simons S, 2011, EMERG INFECT DIS, V17, P343, DOI 10.3201/eid1703.100604; Torvinen E, 2004, APPL ENVIRON MICROB, V70, P1973, DOI 10.1128/AEM.70.4.1973-1981.2004; TSAI YL, 1991, APPL ENVIRON MICROB, V57, P1070, DOI 10.1128/AEM.57.4.1070-1074.1991; van der Wielen PWJJ, 2013, APPL ENVIRON MICROB, V79, P825, DOI 10.1128/AEM.02748-12; Wang H, 2012, APPL ENVIRON MICROB, V78, P6285, DOI 10.1128/AEM.01492-12; Yamaguchi N, 1997, J APPL MICROBIOL, V83, P43, DOI 10.1046/j.1365-2672.1997.00165.x; Yamaguchi N, 2004, BIOIMAGES, V12, P1, DOI [10.11169/bioimages.12.1, DOI 10.11169/BIOIMAGES.12.1]; Yamaguchi N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00525; Yamaguchi N, 2011, ECOL RES, V26, P893, DOI 10.1007/s11284-010-0707-1	38	16	16	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110554	10.1371/journal.pone.0110554	http://dx.doi.org/10.1371/journal.pone.0110554			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350137	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943100031
J	Li, JW; Xie, XX; Liu, J; Yu, H; Zhang, SH; Zhan, Y; Zhang, HL; Logothetis, DE; An, HL				Li, Junwei; Xie, Xiaoxiao; Liu, Jun; Yu, Hui; Zhang, Suhua; Zhan, Yong; Zhang, Hailin; Logothetis, Diomedes E.; An, Hailong			Lack of Negatively Charged Residues at the External Mouth of Kir2.2 Channels Enable the Voltage-Dependent Block by External Mg2+	PLOS ONE			English	Article							RECTIFIER K+ CHANNELS; PARTICLE MESH EWALD; POTASSIUM CHANNEL; EXTRACELLULAR CATIONS; SWISS-MODEL; INWARD RECTIFICATION; MOLECULAR-DYNAMICS; ENDOTHELIAL-CELLS; CRYSTAL-STRUCTURE; ION SELECTIVITY	Kir channels display voltage-dependent block by cytosolic cations such as Mg2+ and polyamines that causes inward rectification. In fact, cations can regulate K channel activity from both the extracellular and intracellular sides. Previous studies have provided insight into the up-regulation of Kir channel activity by extracellular K+ concentration. In contrast, extracellular Mg2+ has been found to reduce the amplitude of the single-channel current at milimolar concentrations. However, little is known about the molecular mechanism of Kir channel blockade by external Mg2+ and the relationship between the Mg2+ blockade and activity potentiation by permeant K+ ions. In this study, we applied an interactive approach between theory and experiment. Electrophysiological recordings on Kir2.2 and its mutants were performed by heterologous expression in Xenopus laevis oocytes. Our results confirmed that extracellular Mg2+ could reduce heterologously expressed WT Kir2.2 currents in a voltage dependent manner. The kinetics of inhibition and recovery of Mg2+ exhibit a 3 similar to 4s time constant. Molecular dynamics simulation results revealed a Mg2+ binding site located at the extracellular mouth of Kir2.2 that showed voltage-dependent Mg2+ binding. The mutants, G119D, Q126E and H128D, increased the number of permeant K+ ions and reduced the voltage-dependent blockade of Kir2.2 by extracellular Mg2+.	[Li, Junwei; Xie, Xiaoxiao; Liu, Jun; Yu, Hui; Zhang, Suhua; Zhan, Yong; An, Hailong] Hebei Univ Technol, Inst Biophys, Tianjin, Peoples R China; [Zhang, Hailin] Hebei Med Univ, Dept Pharmacol, Key Lab Pharmacol & Toxicol New Drug, Key Lab Neural & Vasc Biol,Minist Educ, Shijiazhuang, Hebei Province, Peoples R China; [Logothetis, Diomedes E.] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA USA	Hebei University of Technology; Hebei Medical University; Virginia Commonwealth University	Zhan, Y (corresponding author), Hebei Univ Technol, Inst Biophys, Tianjin, Peoples R China.	zhany@hebut.edu.cn; hailong_an@hebut.edu.cn	Li, Junwei/B-6936-2019	Li, Junwei/0000-0002-1724-4752	Natural Science Foundation of the Hebei Province of China [C2012202079]; National Natural Science Foundation of China [11247010, 11175055, 11342002]; NIH R01 grant [HL059949]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059949] Funding Source: NIH RePORTER	Natural Science Foundation of the Hebei Province of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH R01 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Natural Science Foundation of the Hebei Province of China (Grant No. C2012202079 to HA), the National Natural Science Foundation of China (Grant No. 11247010 to HA, 11175055 to YZ, 11342002 to SZ) and NIH R01 grant HL059949 to DEL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APELL HJ, 1977, J MEMBRANE BIOL, V31, P171, DOI 10.1007/BF01869403; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; Berneche S, 2003, P NATL ACAD SCI USA, V100, P8644, DOI 10.1073/pnas.1431750100; BIERMANS G, 1987, PFLUG ARCH EUR J PHY, V410, P604, DOI 10.1007/BF00581320; Claydon TW, 2004, BIOPHYS J, V87, P2407, DOI 10.1529/biophysj.103.039073; D'Avanzo N, 2005, J GEN PHYSIOL, V125, P493, DOI 10.1085/jgp.200409175; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Doi T, 1996, J BIOL CHEM, V271, P17261, DOI 10.1074/jbc.271.29.17261; DOUPNIK CA, 1995, CURR OPIN NEUROBIOL, V5, P268, DOI 10.1016/0959-4388(95)80038-7; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; ELAM TR, 1995, J GEN PHYSIOL, V105, P463, DOI 10.1085/jgp.105.4.463; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FICKER E, 1994, SCIENCE, V266, P1068, DOI 10.1126/science.7973666; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; KONNO T, 1991, P ROY SOC B-BIOL SCI, V244, P69, DOI 10.1098/rspb.1991.0053; Kubo Y, 1996, RECEPTOR CHANNEL, V4, P73; Leung YM, 2000, CAN J PHYSIOL PHARM, V78, P751, DOI 10.1139/cjpp-78-9-751; Liu TA, 2011, BBA-BIOMEMBRANES, V1808, P1772, DOI 10.1016/j.bbamem.2011.02.016; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MACKINNON R, 1989, BIOCHEMISTRY-US, V28, P8092, DOI 10.1021/bi00446a020; MATSUDA H, 1991, ANNU REV PHYSIOL, V53, P289, DOI 10.1146/annurev.ph.53.030191.001445; Murata Y, 2002, J PHYSIOL-LONDON, V544, P665, DOI 10.1113/jphysiol.2002.030650; Nichols CG, 1996, CIRC RES, V78, P1, DOI 10.1161/01.RES.78.1.1; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Owen JM, 1999, EXP PHYSIOL, V84, P471, DOI 10.1017/S0958067099018060; PARDO LA, 1992, P NATL ACAD SCI USA, V89, P2466, DOI 10.1073/pnas.89.6.2466; PENNEFATHER P, 1992, BIOPHYS J, V61, P448, DOI 10.1016/S0006-3495(92)81850-7; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Sackin H, 2001, BIOPHYS J, V80, P683, DOI 10.1016/S0006-3495(01)76048-1; Sackin H, 2012, BIOPHYS J, V102, P2742, DOI 10.1016/j.bpj.2012.05.018; Sackin H, 2011, BIOPHYS J, V100, P1207, DOI 10.1016/j.bpj.2011.01.032; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; VANDENBERG CA, 1987, P NATL ACAD SCI USA, V84, P2560, DOI 10.1073/pnas.84.8.2560; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; WORLEY JF, 1986, J GEN PHYSIOL, V87, P327, DOI 10.1085/jgp.87.2.327; Xiao J, 2003, NAT NEUROSCI, V6, P811, DOI 10.1038/nn1090; Yang L, 2012, J GEN PHYSIOL, V139, P145, DOI 10.1085/jgp.201110727; Yang L, 2010, J AM SOC NEPHROL, V21, P2109, DOI 10.1681/ASN.2010060617; Zhang YY, 2006, BIOPHYS J, V91, P2901, DOI 10.1529/biophysj.106.087700; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	48	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111372	10.1371/journal.pone.0111372	http://dx.doi.org/10.1371/journal.pone.0111372			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350118	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943100067
J	Penicaud, C; Landaud, S; Jamme, F; Talbot, P; Bouix, M; Ghorbal, S; Fonseca, F				Penicaud, Caroline; Landaud, Sophie; Jamme, Frederic; Talbot, Pauline; Bouix, Marielle; Ghorbal, Sarrah; Fonseca, Fernanda			Physiological and Biochemical Responses of Yarrowia lipolytica to Dehydration Induced by Air-Drying and Freezing	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; INFRARED-SPECTROSCOPY; FTIR MICROSPECTROSCOPY; PLASMA-MEMBRANE; FLOW-CYTOMETRY; CELLS; STRESS; IDENTIFICATION; SURVIVAL; BACTERIA	Organisms that can withstand anhydrobiosis possess the unique ability to temporarily and reversibly suspend their metabolism for the periods when they live in a dehydrated state. However, the mechanisms underlying the cell's ability to tolerate dehydration are far from being fully understood. The objective of this study was to highlight, for the first time, the cellular damage to Yarrowia lipolytica as a result of dehydration induced by drying/rehydration and freezing/thawing. Cellular response was evaluated through cell cultivability determined by plate counts, esterase activity and membrane integrity assessed by flow cytometry, and the biochemical composition of cells as determined by FT-IR spectroscopy. The effects of the harvesting time (in the log or stationary phase) and of the addition of a protective molecule, trehalose, were investigated. All freshly harvested cells exhibited esterase activity and no alteration of membrane integrity. Cells freshly harvested in the stationary phase presented spectral contributions suggesting lower nucleic acid content and thicker cell walls, as well as longer lipid chains than cells harvested in the log phase. Moreover, it was found that drying/rehydration induced cell plasma membrane permeabilization, loss of esterase activity with concomitant protein denaturation, wall damage and oxidation of nucleic acids. Plasma membrane permeabilization and loss of esterase activity could be reduced by harvesting in the stationary phase and/or with trehalose addition. Protein denaturation and wall damage could be reduced by harvesting in the stationary phase. In addition, it was shown that measurements of loss of membrane integrity and preservation of esterase activity were suitable indicators of loss and preservation of cultivability, respectively. Conversely, no clear effect of freezing/thawing could be observed, probably because of the favorable operating conditions applied. These results give insights into Y. lipolytica mechanisms of cellular response to dehydration and provide a basis to better understand its ability to tolerate anhydrobiosis.	[Penicaud, Caroline; Landaud, Sophie; Talbot, Pauline; Bouix, Marielle; Ghorbal, Sarrah; Fonseca, Fernanda] INRA, UMR782 Genie & Microbiol Proc Alimentaires, F-78850 Thiverval Grignon, France; [Penicaud, Caroline; Landaud, Sophie; Talbot, Pauline; Bouix, Marielle; Ghorbal, Sarrah; Fonseca, Fernanda] AgroParisTech, UMR782 Genie & Microbiol Proc Alimentaires, F-78850 Thiverval Grignon, France; [Jamme, Frederic] Synchrotron SOLEIL, Gif Sur Yvette, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; SOLEIL Synchrotron	Penicaud, C (corresponding author), INRA, UMR782 Genie & Microbiol Proc Alimentaires, F-78850 Thiverval Grignon, France.	caroline.penicaud@grignon.inra.fr	Fonseca, Fernanda/AAR-9094-2020; FONSECA, FERNANDA/HDN-9451-2022; JAMME, Frederic/E-2170-2011	Fonseca, Fernanda/0000-0003-3394-182X; FONSECA, FERNANDA/0000-0002-0315-6479; JAMME, Frederic/0000-0002-7398-7868; Penicaud, Caroline/0000-0002-1161-0272	National Institute of Agronomic Research (Paris, France)	National Institute of Agronomic Research (Paris, France)	This study was supported by the National Institute of Agronomic Research (Paris, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adt I, 2010, CAN J MICROBIOL, V56, P793, DOI [10.1139/W10-062, 10.1139/w10-062]; Ando A, 2007, FEMS YEAST RES, V7, P244, DOI 10.1111/j.1567-1364.2006.00162.x; Andrus PGL, 1998, BIOSPECTROSCOPY, V4, P37, DOI 10.1002/(SICI)1520-6343(1998)4:1<37::AID-BSPY4>3.0.CO;2-P; Attfield PV, 2001, MOL MICROBIOL, V40, P1000, DOI 10.1046/j.1365-2958.2001.02444.x; Attfield PV, 2000, J APPL MICROBIOL, V89, P207, DOI 10.1046/j.1365-2672.2000.01100.x; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Barth G, 1997, FEMS MICROBIOL REV, V19, P219, DOI 10.1016/S0168-6445(97)00002-8; Beker MJ, 1987, ADV BIOCH ENG BIOTEC, V35, P127, DOI DOI 10.1007/BFB0004428; Beney L, 2001, APPL MICROBIOL BIOT, V57, P34; Beopoulos A, 2011, APPL MICROBIOL BIOT, V90, P1193, DOI 10.1007/s00253-011-3212-8; Beopoulos A, 2009, PROG LIPID RES, V48, P375, DOI 10.1016/j.plipres.2009.08.005; Boydston-White S, 1999, BIOSPECTROSCOPY, V5, P219, DOI 10.1002/(SICI)1520-6343(1999)5:4<219::AID-BSPY2>3.0.CO;2-O; Burattini E, 2008, VIB SPECTROSC, V47, P139, DOI 10.1016/j.vibspec.2008.04.007; Casaregola S, 2000, FEBS LETT, V487, P95, DOI 10.1016/S0014-5793(00)02288-2; Chalmers J.M., 2002, HDB VIBRATIONAL SPEC, V2; Chiriboga L, 2000, APPL SPECTROSC, V54, P1, DOI 10.1366/0003702001948204; Correa-Garcia S, 2014, ANAL METHODS-UK, V6, P1855, DOI 10.1039/c3ay42322k; Corte L, 2011, ANALYST, V136, P2339, DOI 10.1039/c0an00515k; Corte L, 2010, ANAL CHIM ACTA, V659, P258, DOI 10.1016/j.aca.2009.11.035; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.ph.54.030192.003051; Diaz M, 2010, BIOCHEM ENG J, V48, P385, DOI 10.1016/j.bej.2009.07.013; Dupont S, 2010, BBA-BIOMEMBRANES, V1798, P975, DOI 10.1016/j.bbamem.2010.01.015; Ede SM, 2004, APPL SPECTROSC, V58, P317, DOI 10.1366/000370204322886672; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Espindola AD, 2003, CRYOBIOLOGY, V47, P236, DOI 10.1016/j.cryobiol.2003.10.003; Fickers P, 2005, FEMS YEAST RES, V5, P527, DOI 10.1016/j.femsyr.2004.09.004; Fickers P, 2011, BIOTECHNOL ADV, V29, P632, DOI 10.1016/j.biotechadv.2011.04.005; Finogenova TV, 2005, APPL BIOCHEM MICRO+, V41, P418, DOI 10.1007/s10438-005-0076-7; Franca MB, 2007, COMP BIOCHEM PHYS A, V146, P621, DOI 10.1016/j.cbpa.2006.02.030; Fu N, 2011, FOOD RES INT, V44, P1127, DOI 10.1016/j.foodres.2011.03.053; Gabier AC, 2005, INT J FOOD MICROBIOL, V105, P97, DOI 10.1016/j.ijfoodmicro.2005.02.005; Galichet A, 2001, FEMS MICROBIOL LETT, V197, P179, DOI 10.1016/S0378-1097(01)00101-X; Gan L, 2014, BBA-MOL BASIS DIS, V1842, P1208, DOI 10.1016/j.bbadis.2013.12.011; Garre E, 2010, INT J FOOD MICROBIOL, V136, P295, DOI 10.1016/j.ijfoodmicro.2009.10.018; Guyot S, 2006, J AGR FOOD CHEM, V54, P8450, DOI 10.1021/jf0620158; Harrick N.J., 1967, INTERNAL REFLECTION; HELM D, 1991, J GEN MICROBIOL, V137, P69, DOI 10.1099/00221287-137-1-69; Hohmann S, 2010, YEAST STRESS RESPONS; Huleihel M, 2002, J BIOCHEM BIOPH METH, V50, P111, DOI 10.1016/S0165-022X(01)00177-4; Jamme F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074421; Kardeh S, 2014, EUR J PHARMACOL, V735, P150, DOI 10.1016/j.ejphar.2014.04.023; Krafft C, 2004, ANALYST, V129, P921, DOI 10.1039/b408934k; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P927, DOI 10.1016/B978-0-444-52149-1.00082-3; Lemetais G, 2012, APPL MICROBIOL BIOT, V96, P471, DOI 10.1007/s00253-012-4014-3; Levin DE, 2011, GENETICS, V189, P1145, DOI 10.1534/genetics.111.128264; Lopez-Martinez G, 2013, YEAST, V30, P319, DOI 10.1002/yea.2952; Madzak C, 2004, J BIOTECHNOL, V109, P63, DOI 10.1016/j.jbiotec.2003.10.027; MALINS DC, 1995, CANCER, V75, P503, DOI 10.1002/1097-0142(19950115)75:2<503::AID-CNCR2820750213>3.0.CO;2-0; MAZUR P, 1968, CRYOBIOLOGY, V5, P1, DOI 10.1016/S0011-2240(68)80138-5; Mordechai S, 2001, PROC SPIE, V4491, P243, DOI 10.1117/12.450167; Movasaghi Z, 2008, APPL SPECTROSC REV, V43, P134, DOI 10.1080/05704920701829043; NAUMANN D, 1991, NATURE, V351, P81, DOI 10.1038/351081a0; NAUMANN D, 1988, J MOL STRUCT, V174, P165, DOI 10.1016/0022-2860(88)80152-2; Naumova ES, 2010, MICROBIOLOGY+, V79, P229, DOI 10.1134/S0026261710020153; Pacifico A, 2003, VIB SPECTROSC, V32, P107, DOI 10.1016/S0924-2031(03)00051-1; Papanikolaou S, 2010, EUR J LIPID SCI TECH, V112, P639, DOI 10.1002/ejlt.200900197; Pereira ED, 2003, CELL STRESS CHAPERON, V8, P120; Poirier I, 1999, J APPL MICROBIOL, V86, P87, DOI 10.1046/j.1365-2672.1999.00638.x; Polomska X, 2012, POL J FOOD NUTR SCI, V62, P143, DOI 10.2478/v10222-011-0045-1; PRESTRELSKI SJ, 1993, BIOPHYS J, V65, P661, DOI 10.1016/S0006-3495(93)81120-2; R Core Team, 2012, R LANG ENV STAT COMP; Rodriguez-Porrata B, 2008, INT J FOOD MICROBIOL, V126, P116, DOI 10.1016/j.ijfoodmicro.2008.05.016; Roscini L, 2010, ANALYST, V135, P2099, DOI 10.1039/c0an00127a; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Seki S, 2009, CRYOBIOLOGY, V58, P157, DOI 10.1016/j.cryobiol.2008.11.011; Simonin H, 2007, BBA-BIOMEMBRANES, V1768, P1600, DOI 10.1016/j.bbamem.2007.03.017; Singh J, 2005, APPL ENVIRON MICROB, V71, P8752, DOI 10.1128/AEM.71.12.8752-8763.2005; Smith AE, 2000, P NATL ACAD SCI USA, V97, P9871, DOI 10.1073/pnas.97.18.9871; Swennen D, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-219; ZEROUAL W, 1994, BBA-MOL CELL RES, V1222, P171, DOI 10.1016/0167-4889(94)90166-X; Zheng DQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085022	71	14	14	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111138	10.1371/journal.pone.0111138	http://dx.doi.org/10.1371/journal.pone.0111138			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350121	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943100058
J	Shamu, S; Zarowsky, C; Shefer, T; Temmerman, M; Abrahams, N				Shamu, Simukai; Zarowsky, Christina; Shefer, Tamara; Temmerman, Marleen; Abrahams, Naeemah			Intimate Partner Violence after Disclosure of HIV Test Results among Pregnant Women in Harare, Zimbabwe	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; SEROSTATUS DISCLOSURE; SOUTH-AFRICA; PREVENTION; CONTEXT; RISK; PREVALENCE; INFECTION; SETTINGS; PROGRAMS	Background: HIV status disclosure is a central strategy in HIV prevention and treatment but in high prevalence settings women test disproportionately and most often during pregnancy. This study reports intimate partner violence (IPV) following disclosure of HIV test results by pregnant women. Methods: In this cross sectional study we interviewed 1951 postnatal women who tested positive and negative for HIV about IPV experiences following HIV test disclosure, using an adapted WHO questionnaire. Multivariate regression models assessed factors associated with IPV after disclosure and controlled for factors such as previous IPV and other known behavioural factors associated with IPV. Results: Over 93% (1817) disclosed the HIV results to their partners (96.5% HIV- vs. 89.3% HIV+, p<0.0001). Overall HIV prevalence was 15.3%, (95% CI: 13.7-16.9), 35.2% among non-disclosers and 14.3% among disclosers. Overall 32.8% reported IPV (40.5% HIV+; 31.5% HIV- women, p = 0.004). HIV status was associated with IPV (partially adjusted 1.43: (95%CI: 1.00-2.05 as well as reporting negative reactions by male partners immediately after disclosure (adjusted OR 5.83, 95%CI: 4.31-7.80). Factors associated with IPV were gender inequity, past IPV, risky sexual behaviours and living with relatives. IPV after HIV disclosure in pregnancy is high but lower than and is strongly related with IPV before pregnancy (adjusted OR 6.18, 95%CI: 3.84-9.93). Conclusion: The study demonstrates the interconnectedness of IPV, HIV status and its disclosure with IPV which was a common experience post disclosure of both an HIV positive and HIV negative result. Health services must give attention to the gendered nature and consequences of HIV disclosure such as enskilling women on how to determine and respond to the risks associated with disclosure. Efforts to involve men in antenatal care must also be strengthened.	[Shamu, Simukai; Abrahams, Naeemah] MRC, Gender & Hlth Res Unit, Cape Town, South Africa; [Temmerman, Marleen] Univ Ghent, Int Ctr Reprod Hlth, B-9000 Ghent, Belgium; [Shamu, Simukai; Zarowsky, Christina; Abrahams, Naeemah] Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa; [Shefer, Tamara] Univ Western Cape, Womens & Gender Studies, Cape Town, South Africa; [Zarowsky, Christina] Univ Montreal, Hosp Res Ctr CR CHUM, Montreal, PQ, Canada	Ghent University; University of the Western Cape; University of the Western Cape; Universite de Montreal	Shamu, S (corresponding author), MRC, Gender & Hlth Res Unit, Cape Town, South Africa.	shamuts@yahoo.com	Abrahams, Naeemah/AAF-1144-2020	Zarowsky, Christina/0000-0002-0850-6212; Abrahams, Naeemah/0000-0002-6138-6256; Shamu, Simukai/0000-0002-2290-0515	Flemish Inter-University cooperation (VLIR-UOS); University of the Western Cape (UWC); African Population and Heath Research Centre; International Development Research Centre; South African Medical Research Council (MRC)	Flemish Inter-University cooperation (VLIR-UOS); University of the Western Cape (UWC); African Population and Heath Research Centre; International Development Research Centre; South African Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	SS received funding for PhD studies, towards which this paper contributed, from the Flemish Inter-University cooperation (VLIR-UOS) with the University of the Western Cape (UWC). SS received fieldwork support from the African Doctoral Dissertation Research Fellowship provided by the African Population and Heath Research Centre in partnership with the International Development Research Centre and additional support from the South African Medical Research Council (MRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chandisarewa W, 2007, B WORLD HEALTH ORGAN, V85, P843, DOI 10.2471/BLT.06.035188; Chandra PS, 2003, AIDS CARE, V15, P207, DOI 10.1080/0954012031000068353; Colombini M, 2008, B WORLD HEALTH ORGAN, V86, P635, DOI 10.2471/BLT.07.045906; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Farid M, 2008, INT J GYNECOL OBSTET, V101, P141, DOI 10.1016/j.ijgo.2007.11.015; Gaillard P, 2002, AIDS, V16, P937, DOI 10.1097/00002030-200204120-00019; Harling G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014257; Hatcher AM, 2013, CULT HEALTH SEX, V15, P404, DOI 10.1080/13691058.2012.760205; Jasseron C, 2011, AIDS BEHAV, P1; Jewkes R, 2010, SCIENCE, V329, P145, DOI 10.1126/science.1193794; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Kissinger PJ, 2003, SEX TRANSM DIS, V30, P75, DOI 10.1097/00007435-200301000-00015; Maman S, 2003, AIDS BEHAV, V7, P373, DOI 10.1023/B:AIBE.0000004729.89102.d4; Maman S, 2003, GENDER DIMENSIONS HI; Medley A, 2004, B WORLD HEALTH ORGAN, V82, P299; Muhajarine N, 1999, CAN MED ASSOC J, V160, P1007; Nebie Y, 2001, J ACQ IMMUN DEF SYND, V28, P367, DOI 10.1097/00126334-200112010-00010; Obermeyer CM, 2007, AM J PUBLIC HEALTH, V97, P1762, DOI 10.2105/AJPH.2006.096263; Obermeyer CM, 2011, AM J PUBLIC HEALTH, V101, P1011, DOI 10.2105/AJPH.2010.300102; Shamu S, 2011, PLOS ONE, V8, P6; Shamu S, 2013, TROP MED INT HEALTH, V18, P696, DOI 10.1111/tmi.12078; Shamu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043148; Simoni Jane M, 2004, Top HIV Med, V12, P109; Taillieu TL, 2010, AGGRESS VIOLENT BEH, V15, P14, DOI 10.1016/j.avb.2009.07.013; TEMMERMAN M, 1995, LANCET, V345, P969, DOI 10.1016/S0140-6736(95)90707-6; Tsai AC, 2012, AIDS, V26, P381, DOI 10.1097/QAD.0b013e32834e1ccb; Varga CA, 2006, AIDS CARE, V18, P952, DOI 10.1080/09540120500356906; Were E, 2011, AIDS, V25, P2009, DOI 10.1097/QAD.0b013e32834b005d; WHO, 2005, MULT STUD WOM HLTH D; Williams R, 2006, STATA J, V6, P58, DOI 10.1177/1536867X0600600104; World Health Organization, 2001, WHOFCHGWH011; Yount KM, 2009, J MARRIAGE FAM, V71, P1125, DOI 10.1111/j.1741-3737.2009.00659.x; ZIMSTAT ICF, 2012, ZIMB DEM HLTH SURV 2	33	76	76	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e109447	10.1371/journal.pone.0109447	http://dx.doi.org/10.1371/journal.pone.0109447			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BH	25350001	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943100012
J	Munguia-Rosas, MA; Montiel, S				Munguia-Rosas, Miguel A.; Montiel, Salvador			Patch Size and Isolation Predict Plant Species Density in a Naturally Fragmented Forest	PLOS ONE			English	Article							HABITAT FRAGMENTATION; ISLAND BIOGEOGRAPHY; EQUILIBRIUM-THEORY; DIVERSITY; AREA; CONSERVATION; RICHNESS; EVOLUTIONARY; LANDSCAPE; PATTERNS	Studies of the effects of patch size and isolation on plant species density have yielded contrasting results. However, much of the available evidence comes from relatively recent anthropogenic forest fragments which have not reached equilibrium between extinction and immigration. This is a critical issue because the theory clearly states that only when equilibrium has been reached can the number of species be accurately predicted by habitat size and isolation. Therefore, species density could be better predicted by patch size and isolation in an ecosystem that has been fragmented for a very long time. We tested whether patch area, isolation and other spatial variables explain variation among forest patches in plant species density in an ecosystem where the forest has been naturally fragmented for long periods of time on a geological scale. Our main predictions were that plant species density will be positively correlated with patch size, and negatively correlated with isolation (distance to the nearest patch, connectivity, and distance to the continuous forest). We surveyed the vascular flora (except lianas and epiphytes) of 19 forest patches using five belt transects (50x4 m each) per patch (area sampled per patch = 0.1 ha). As predicted, plant species density was positively associated (logarithmically) with patch size and negatively associated (linearly) with patch isolation (distance to the nearest patch). Other spatial variables such as patch elevation and perimeter, did not explain among-patch variability in plant species density. The power of patch area and isolation as predictors of plant species density was moderate (together they explain 43% of the variation), however, a larger sample size may improve the explanatory power of these variables. Patch size and isolation may be suitable predictors of long-term plant species density in terrestrial ecosystems that are naturally and anthropogenically fragmented.	[Munguia-Rosas, Miguel A.; Montiel, Salvador] Inst Politecn Nacl CINVESTAV, Ctr Invest & Estudios Avanzados, Dept Ecol Humana, Merida, Yucatan, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Munguia-Rosas, MA (corresponding author), Inst Politecn Nacl CINVESTAV, Ctr Invest & Estudios Avanzados, Dept Ecol Humana, Merida, Yucatan, Mexico.	munguiarma@mda.cinvestav.mx	Montiel, Salvador/A-4738-2008; Munguia-Rosas, Miguel/H-9364-2019	Munguia-Rosas, Miguel A./0000-0003-2319-1666	Consejo NacionaL de Ciencia y Tecnologia [CB-2012-177680]	Consejo NacionaL de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This study was funded by Consejo NacionaL de Ciencia y Tecnologia (project CB-2012-177680), funds to MAM-R. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Arroyo-Rodriguez V, 2013, J ECOL, V101, P1449, DOI 10.1111/1365-2745.12153; Arroyo-Rodriguez V, 2012, J ECOL, V100, P702, DOI 10.1111/j.1365-2745.2011.01952.x; Arroyo-Rodriguez V, 2009, CONSERV BIOL, V23, P729, DOI 10.1111/j.1523-1739.2008.01120.x; Barragan F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017976; Barrera A, 1982, BIOTICA, V2, P163; BOECKLEN WJ, 1984, BIOL CONSERV, V29, P63, DOI 10.1016/0006-3207(84)90014-4; Brokaw N, 2011, ARBOLES MUNDO MAYA; Castillo-Campos G, 2008, BIODIVERS CONSERV, V17, P1701, DOI 10.1007/s10531-008-9375-7; Collins CD, 2009, ECOLOGY, V90, P2577, DOI 10.1890/08-1405.1; CONANP-SEMARNAT, 2006, RES BIOF LOS PET; CONNOR EF, 1979, AM NAT, V113, P791, DOI 10.1086/283438; Cook WM, 2002, ECOL LETT, V5, P619, DOI 10.1046/j.1461-0248.2002.00366.x; Costa-Lugo E, 2010, PLAN CONSERVACION EC; Crawley MJ, 2013, R BOOK, P557; DEBINSKI DM, 2000, CONSERV BIOL, V14, P342, DOI DOI 10.1046/j.1523-1739.2000.98081.x; Duran R, 1987, BIOTICA, V12, P191; DURAN R., 1987, BIOTICA, V12, P199; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fahrig L, 2013, J BIOGEOGR, V40, P1649, DOI 10.1111/jbi.12130; Farmilo BJ, 2014, AUSTRAL ECOL, V39, P416, DOI 10.1111/aec.12099; GILBERT FS, 1980, J BIOGEOGR, V7, P209, DOI 10.2307/2844629; Gotelli Nicholas J., 2011, P39; Grace James B., 1999, Perspectives in Plant Ecology Evolution and Systematics, V2, P1, DOI 10.1078/1433-8319-00063; Haila Y, 2002, ECOL APPL, V12, P321, DOI 10.1890/1051-0761(2002)012[0321:ACGOFR]2.0.CO;2; Heaney LR, 2000, GLOBAL ECOL BIOGEOGR, V9, P59, DOI 10.1046/j.1365-2699.2000.00163.x; Helm A, 2006, ECOL LETT, V9, P72, DOI 10.1111/j.1461-0248.2005.00841.x; Hu G, 2013, PLOS ONE, V7; JANZEN DH, 1968, AM NAT, V102, P592, DOI 10.1086/282574; Johansson V, 2013, OECOLOGIA, V172, P607, DOI 10.1007/s00442-012-2509-3; Laurance WF, 2008, BIOL CONSERV, V141, P1731, DOI 10.1016/j.biocon.2008.05.011; MAC ARTHUR ROBERT H., 1967; MACARTHUR RH, 1963, EVOLUTION, V17, P373, DOI 10.2307/2407089; Martinez-Ramos M, 1998, TRENDS PLANT SCI, V3, P400, DOI 10.1016/S1360-1385(98)01313-2; Mas J-F., 2000, INVESTIG GEOGR FICAS, V6, P42; Moller AP, 2002, OECOLOGIA, V132, P492, DOI 10.1007/s00442-002-0952-2; Montiel S, 2006, J TROP ECOL, V22, P267, DOI 10.1017/S026646740500307X; Munguia-Rosas MA, 2014, J TROP ECOL, V30, P323, DOI 10.1017/S0266467414000194; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Palacios-Rios, 1996, ACTA BOT MEX, V34, P53, DOI DOI 10.21829/ABM34.1996.950; Pennington TD, 2005, ARBOLES TROPICALES X; Prugh LR, 2009, ECOL APPL, V19, P1300, DOI 10.1890/08-1524.1; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; RICO-GRAY V, 1982, Biotica (Mexico), V7, P171; ROBINSON GR, 1992, SCIENCE, V257, P524, DOI 10.1126/science.257.5069.524; Rosati L, 2010, PLANT BIOSYST, V144, P38, DOI 10.1080/11263500903429213; Santos BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012625; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Walter HS, 2004, J BIOGEOGR, V31, P177, DOI 10.1046/j.0305-0270.2003.00989.x; Wettstein W, 1999, J APPL ECOL, V36, P363, DOI 10.1046/j.1365-2664.1999.00404.x; Yamaura Y, 2008, CONSERV BIOL, V22, P1513, DOI 10.1111/j.1523-1739.2008.01024.x	51	33	34	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111742	10.1371/journal.pone.0111742	http://dx.doi.org/10.1371/journal.pone.0111742			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347818	Green Published, Green Submitted, gold			2022-12-27	WOS:000347994900084
J	Kumar, NP; Sridhar, R; Hanna, LE; Banurekha, VV; Nutman, TB; Babu, S				Kumar, Nathella Pavan; Sridhar, Rathinam; Hanna, Luke E.; Banurekha, Vaithilingam V.; Nutman, Thomas B.; Babu, Subash			Decreased Frequencies of Circulating CD4(+) T Follicular Helper Cells Associated with Diminished Plasma IL-21 in Active Pulmonary Tuberculosis	PLOS ONE			English	Article							FH CELLS	Background: Circulating T follicular helper (Tfh) cells represent a distinct subset of CD4(+) T cells and are important in immunity to infections. Although they have been shown to play a role in experimental models of tuberculosis infection, their role in human tuberculosis remains unexplored. Aims/Methodology: To determine the distribution of circulating Tfh cells in human TB, we measured the frequencies of Tfh cells ex vivo and following TB - antigen or polyclonal stimulation in pulmonary TB (PTB; n = 30) and latent TB (LTB; n = 20) individuals, using the markers CXCR5, PD-1 and ICOS. Results: We found that both ex vivo and TB - antigen induced frequencies of Tfh cell subsets was significantly lower in PTB compared to LTB individuals. Similarly, antigen induced frequencies of Tfh cells expressing IL-21 was also significantly lower in PTB individuals and this was reflected in diminished circulating levels of IL-21 and IFN gamma. This was not accompanied by diminished frequencies of activated or memory B cell subsets. Finally, the diminution in frequency of Tfh cells in PTB individuals was dependent on IL-10, CTLA-4 and PD-L1 in vitro. Conclusions: Thus, PTB is characterized by adiminution in the frequency of Tfh cell subsets.	[Kumar, Nathella Pavan; Babu, Subash] Int Ctr Excellence Res, Natl Inst Hlth, Madras, Tamil Nadu, India; [Kumar, Nathella Pavan; Hanna, Luke E.; Banurekha, Vaithilingam V.] Natl Inst Res TB, Madras, Tamil Nadu, India; [Sridhar, Rathinam] Govt Stanley Med Hosp, Madras, Tamil Nadu, India; [Nutman, Thomas B.; Babu, Subash] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Babu, S (corresponding author), Int Ctr Excellence Res, Natl Inst Hlth, Madras, Tamil Nadu, India.	sbabu@mail.nih.gov	Kumar, Nathella Pavan/AAU-2328-2021; Babu, Subash/GXG-4746-2022		Division of Intramural Research, NIAID, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001065] Funding Source: NIH RePORTER	Division of Intramural Research, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the Division of Intramural Research, NIAID, NIH. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bentebibel SE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005191; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; CS Ma, 2013, IMMUNOL CELL BIOL; Ernst JD, 2012, NAT REV IMMUNOL, V12, P581, DOI 10.1038/nri3259; Feng JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021698; Hams E, 2011, J IMMUNOL, V186, P5648, DOI 10.4049/jimmunol.1003161; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Kozakiewicz L, 2013, ADV EXP MED BIOL, V783, P225, DOI 10.1007/978-1-4614-6111-1_12; Lindqvist M, 2012, J CLIN INVEST, V122, P3271, DOI 10.1172/JCI64314; Locci M, 2013, IMMUNITY; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Odorizzi PM, 2012, J IMMUNOL, V188, P2957, DOI 10.4049/jimmunol.1100038; Pallikkuth S, 2012, BLOOD, V120, P985, DOI 10.1182/blood-2011-12-396648; Phuah JY, 2012, AM J PATHOL, V181, P508, DOI 10.1016/j.ajpath.2012.05.009; Slight SR, 2013, J CLIN INVEST, V123, P712, DOI 10.1172/JCI65728; Tangye SG, 2013, NAT REV IMMUNOL, V13, P412, DOI 10.1038/nri3447; Tsai LM, 2014, IMMUNOL CELL BIOL, V92, P57, DOI 10.1038/icb.2013.68; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960	21	20	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111098	10.1371/journal.pone.0111098	http://dx.doi.org/10.1371/journal.pone.0111098			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343703	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000343943500079
J	Liu, Y; Nie, L; Zhao, H; Zhang, W; Zhang, YQ; Wang, SS; Cheng, L				Liu, Yi; Nie, Lin; Zhao, Hua; Zhang, Wen; Zhang, Yuan-Qiang; Wang, Shuai-Shuai; Cheng, Lei			Conserved Dopamine Neurotrophic Factor-Transduced Mesenchymal Stem Cells Promote Axon Regeneration and Functional Recovery of Injured Sciatic Nerve	PLOS ONE			English	Article							BRAIN-INJURY; FACTOR CDNF; TRANSPLANTATION; LESIONS; REPAIR	Peripheral nerve injury (PNI) is a common disease that often results in axonal degeneration and the loss of neurons, ultimately leading to limited nerve regeneration and severe functional impairment. Currently, there are no effective treatments for PNI. In the present study, we transduced conserved dopamine neurotrophic factor (CDNF) into mesenchymal stem cells (MSCs) in collagen tubes to investigate their regenerative effects on rat peripheral nerves in an in vivo transection model. Scanning electron microscopy of the collagen tubes demonstrated their ability to be resorbed in vivo. We observed notable overexpression of the CDNF protein in the distal sciatic nerve after application of CDNF-MSCs. Quantitative analysis of neurofilament 200 (NF200) and S100 immunohistochemistry showed significant enhancement of axonal and Schwann cell regeneration in the group receiving CDNF-MSCs (CDNF-MSCs group) compared with the control groups. Myelination thickness, axon diameter and the axon-to fiber diameter ratio (G-ratio) were significantly higher in the CDNF-MSCs group at 8 and 12 weeks after nerve transection surgery. After surgery, the sciatic functional index, target muscle weight, wet weight ratio of gastrocnemius muscle and horseradish peroxidase (HRP) tracing demonstrated functional recovery. Light and electron microscopy confirmed successful regeneration of the sciatic nerve. The greater numbers of HRP-labeled neuron cell bodies and increased sciatic nerve index values (SFI) in the CDNF-MSCs group suggest that CDNF exerts neuroprotective effects in vivo. We also observed higher target muscle weights and a significant improvement in muscle atrophism in the CDNF-MSCs group. Collectively, these findings indicate that CDNF gene therapy delivered by MSCs is capable of promoting nerve regeneration and functional recovery, likely because of the significant neuroprotective and neurotrophic effects of CDNF and the superior environment offered by MSCs and collagen tubes.	[Liu, Yi; Nie, Lin; Zhao, Hua; Zhang, Wen; Zhang, Yuan-Qiang; Wang, Shuai-Shuai; Cheng, Lei] Shandong Univ, Qilu Hosp, Dept Spine Surg, Jinan 250100, Peoples R China; [Liu, Yi; Zhao, Hua] Shandong Univ, Qilu Hosp, Res Ctr Cell Therapy, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250100, Peoples R China	Shandong University; Shandong University	Cheng, L (corresponding author), Shandong Univ, Qilu Hosp, Dept Spine Surg, Jinan 250100, Peoples R China.	chengleiyx@126.com		Zhang, Yuanqiang/0000-0002-4592-4966	Ph.D. Programs Foundation of the Ministry of Education of China [20110131120079]; Natural Science Foundation of Shandong Province [ZR2013HM095]	Ph.D. Programs Foundation of the Ministry of Education of China(Ministry of Education, China); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	The study was supported by a grant from the Ph.D. Programs Foundation of the Ministry of Education of China (20110131120079) and Natural Science Foundation of Shandong Province (ZR2013HM095). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airavaara M, 2009, J COMP NEUROL, V515, P116, DOI 10.1002/cne.22039; BAIN JR, 1989, PLAST RECONSTR SURG, V83, P129, DOI 10.1097/00006534-198901000-00024; Bhagavati S, 2004, BIOCHEM BIOPH RES CO, V318, P119, DOI 10.1016/j.bbrc.2004.03.192; Cao JN, 2013, BIOMATERIALS, V34, P1302, DOI 10.1016/j.biomaterials.2012.10.031; Cheng L, 2013, BIOCH BIOPHYS RES CO; Cheng L, 2013, BIOCHEM BIOPH RES CO, V435, P34, DOI 10.1016/j.bbrc.2013.04.029; Cuevas P, 2004, NEUROL RES, V26, P230, DOI 10.1179/016164104225013897; Deumens R, 2010, PROG NEUROBIOL, V92, P245, DOI 10.1016/j.pneurobio.2010.10.002; Guan JJ, 2011, BIOMATERIALS, V32, P5568, DOI 10.1016/j.biomaterials.2011.04.038; Hellman M, 2010, BIOMOLECULAR NMR ASS, V2010; Ichihara S, 2008, INJURY, V39, pS29, DOI 10.1016/j.injury.2008.08.029; Kemp SWP, 2007, J NEUROSCI METH, V165, P83, DOI 10.1016/j.jneumeth.2007.05.032; Kretschmer T, 2001, J NEUROSURG, V94, P905, DOI 10.3171/jns.2001.94.6.0905; Li Y, 2001, NEUROSCI LETT, V316, P67, DOI 10.1016/S0304-3940(01)02384-9; Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006; Lindholm P, 2010, DEV NEUROBIOL, V70, P360, DOI 10.1002/dneu.20760; Lindholm P, 2007, NATURE, V448, P73, DOI 10.1038/nature05957; MACKINNON SE, 1992, PLAST RECONSTR SURG, V90, P695, DOI 10.1097/00006534-199210000-00024; Madduri S, 2012, J CONTROL RELEASE, V161, P274, DOI 10.1016/j.jconrel.2011.11.036; Mahmood A, 2001, J NEUROSURG, V94, P589, DOI 10.3171/jns.2001.94.4.0589; ORTIGUELA ME, 1987, J HAND SURG-AM, V12A, P1119, DOI 10.1016/S0363-5023(87)80129-6; Palgi M, 2009, P NATL ACAD SCI USA, V106, P2429, DOI 10.1073/pnas.0810996106; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Secer HI, 2008, SURG NEUROL, V69, P143, DOI 10.1016/j.surneu.2007.01.032; Wei L, 2012, NEUROBIOL DIS, V46, P635, DOI 10.1016/j.nbd.2012.03.002; Zhao H, 2013, J MOL NEUROSCI	26	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110993	10.1371/journal.pone.0110993	http://dx.doi.org/10.1371/journal.pone.0110993			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343619	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943500072
J	Xu, J; Lu, ZG; Xu, MM; Rossi, GC; Kest, B; Waxman, AR; Pasternak, GW; Pan, YX				Xu, Jin; Lu, Zhigang; Xu, Mingming; Rossi, Grace C.; Kest, Benjamin; Waxman, Amanda R.; Pasternak, Gavril W.; Pan, Ying-Xian			Differential Expressions of the Alternatively Spliced Variant mRNAs of the mu Opioid Receptor Gene, OPRM1, in Brain Regions of Four Inbred Mouse Strains	PLOS ONE			English	Article							IMMUNOHISTOCHEMICAL LOCALIZATION; OPIATE RECEPTORS; RAT-BRAIN; AUTORADIOGRAPHIC LOCALIZATION; PHARMACOLOGICAL CHARACTERIZATION; MORPHINE; MOR-1; ANALGESIA; HEROIN; TOLERANCE	The mu opioid receptor gene, OPRM1, undergoes extensive alternative pre-mRNA splicing in rodents and humans, with dozens of alternatively spliced variants of the OPRM1 gene. The present studies establish a SYBR green quantitative PCR (qPCR) assay to more accurately quantify mouse OPRM1 splice variant mRNAs. Using these qPCR assays, we examined the expression of OPRM1 splice variant mRNAs in selected brain regions of four inbred mouse strains displaying differences in mu opioid-induced tolerance and physical dependence: C56BL/6J, 129P3/J, SJL/J and SWR/J. The complete mRNA expression profiles of the OPRM1 splice variants reveal marked differences of the variant mRNA expression among the brain regions in each mouse strain, suggesting region-specific alternative splicing of the OPRM1 gene. The expression of many variants was also strain-specific, implying a genetic influence on OPRM1 alternative splicing. The expression levels of a number of the variant mRNAs in certain brain regions appear to correlate with strain sensitivities to morphine analgesia, tolerance and physical dependence in four mouse strains.	[Xu, Jin; Lu, Zhigang; Xu, Mingming; Pasternak, Gavril W.; Pan, Ying-Xian] Mem Sloan Kettering Canc Ctr, Dept Neurol & Mol Pharmacol, New York, NY 10021 USA; [Xu, Jin; Lu, Zhigang; Xu, Mingming; Pasternak, Gavril W.; Pan, Ying-Xian] Mem Sloan Kettering Canc Ctr, Chem Program, New York, NY 10021 USA; [Rossi, Grace C.] Long Isl Univ, Dept Psychol, Brookville, NY USA; [Kest, Benjamin; Waxman, Amanda R.] CUNY, Dept Psychol, Staten Isl, NY USA; [Kest, Benjamin; Waxman, Amanda R.] CUNY, Ctr Dev Neurosci, Staten Isl, NY USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; City University of New York (CUNY) System; City University of New York (CUNY) System	Pan, YX (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Neurol & Mol Pharmacol, 1275 York Ave, New York, NY 10021 USA.	pany@mskcc.org	Rossi, Grace/AIC-2739-2022		National Institute on Drug Abuse [DA13997, DA029244, DA02615, DA06241, DA07242]; National Cancer Institute [CA08748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA002615, R21DA029244, R01DA006241, R01DA013997, R56DA002615, R01DA007242, R37DA007242] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in part, by research grants DA13997 & DA029244 (to YXP) and DA02615, DA06241 and DA07242 (to GWP) from the National Institute on Drug Abuse and a core grant from the National Cancer Institute to MSKCC (CA08748). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbadie C, 2000, NEUROSCIENCE, V100, P141, DOI 10.1016/S0306-4522(00)00248-7; Abbadie C, 2000, J COMP NEUROL, V419, P244, DOI 10.1002/(SICI)1096-9861(20000403)419:2<244::AID-CNE8>3.0.CO;2-R; Abbadie C, 2001, NEUROREPORT, V12, P3069, DOI 10.1097/00001756-200110080-00017; ARVIDSSON U, 1995, J NEUROSCI, V15, P3328; ATWEH SF, 1983, BRIT MED BULL, V39, P47, DOI 10.1093/oxfordjournals.bmb.a071789; ATWEH SF, 1977, BRAIN RES, V134, P393, DOI 10.1016/0006-8993(77)90817-4; ATWEH SF, 1977, BRAIN RES, V129, P1, DOI 10.1016/0006-8993(77)90965-9; ATWEH SF, 1977, BRAIN RES, V124, P53, DOI 10.1016/0006-8993(77)90863-0; BELKNAP JK, 1995, LIFE SCI, V57, pPL117, DOI 10.1016/0024-3205(95)02040-P; Belknap JK, 1998, PHARMACOL BIOCHEM BE, V59, P353, DOI 10.1016/S0091-3057(97)00421-8; Bolan EA, 2004, SYNAPSE, V51, P11, DOI 10.1002/syn.10277; Chang A, 1998, EUR J PHARMACOL, V351, P189, DOI 10.1016/S0014-2999(98)00366-5; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; CHEN Y, 1993, MOL PHARMACOL, V44, P8; Ding YQ, 1996, J COMP NEUROL, V367, P375; Foley KM, 1985, CANC PRINCIPLES PRAC, P1940; GIROS B, 1995, LIFE SCI, V56, pPL369, DOI 10.1016/0024-3205(95)00119-Q; HONDA CN, 1995, NEUROREPORT, V6, P1025, DOI 10.1097/00001756-199505090-00019; KAUFMAN DL, 1995, J BIOL CHEM, V270, P15877, DOI 10.1074/jbc.270.26.15877; Kest B, 2002, NEUROSCIENCE, V115, P463, DOI 10.1016/S0306-4522(02)00458-X; Kest B, 2002, PHARMACOL BIOCHEM BE, V73, P821, DOI 10.1016/S0091-3057(02)00908-5; Klein G, 2008, PHARMACOL BIOCHEM BE, V90, P447, DOI 10.1016/j.pbb.2008.03.030; Koch T, 1998, J BIOL CHEM, V273, P13652, DOI 10.1074/jbc.273.22.13652; Kolesnikov Y, 1998, J PHARMACOL EXP THER, V284, P455; KOZAK CA, 1994, GENOMICS, V21, P659, DOI 10.1006/geno.1994.1331; Leipzig J, 2004, NUCLEIC ACIDS RES, V32, P3977, DOI 10.1093/nar/gkh731; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; LING GSF, 1985, J PHARMACOL EXP THER, V232, P149; LING GSF, 1984, SCIENCE, V226, P462, DOI 10.1126/science.6541807; Liu XY, 2011, CELL, V147, P447, DOI 10.1016/j.cell.2011.08.043; Majumdar S, 2011, P NATL ACAD SCI USA, V108, P19778, DOI 10.1073/pnas.1115231108; MANSOUR A, 1994, REGUL PEPTIDES, V54, P179, DOI 10.1016/0167-0115(94)90449-9; MANSOUR A, 1987, J NEUROSCI, V7, P2445; MANSOUR A, 1995, TRENDS NEUROSCI, V18, P22, DOI 10.1016/0166-2236(95)93946-U; MANSOUR A, 1994, BRAIN RES, V643, P245, DOI 10.1016/0006-8993(94)90031-0; MANSOUR A, 1995, J CHEM NEUROANAT, V8, P283, DOI 10.1016/0891-0618(95)00055-C; MANSOUR A, 1994, J COMP NEUROL, V350, P412, DOI 10.1002/cne.903500307; Metten P, 2009, DRUG ALCOHOL DEPEN, V99, P123, DOI 10.1016/j.drugalcdep.2008.07.006; Moriwaki A, 1996, NEUROCHEM RES, V21, P1315, DOI 10.1007/BF02532373; MOULIN DE, 1988, PAIN, V33, P233, DOI 10.1016/0304-3959(88)90095-4; Pan L, 2005, NEUROSCIENCE, V133, P209, DOI 10.1016/j.neuroscience.2004.12.033; Pan YX, 2011, RECEPT SER, P121, DOI 10.1007/978-1-60761-993-2_6; Pan YX, 2009, P NATL ACAD SCI USA, V106, P4917, DOI 10.1073/pnas.0811586106; Pan YX, 1999, MOL PHARMACOL, V56, P396, DOI 10.1124/mol.56.2.396; Pan YX, 2001, P NATL ACAD SCI USA, V98, P14084, DOI 10.1073/pnas.241296098; Pan YX, 2000, FEBS LETT, V466, P337, DOI 10.1016/S0014-5793(00)01095-4; Pan YX, 2005, DNA CELL BIOL, V24, P736, DOI 10.1089/dna.2005.24.736; Pasternak GW, 2013, PHARMACOL REV, V65, P1257, DOI 10.1124/pr.112.007138; Pasternak GW, 2004, NEUROPHARMACOLOGY, V47, P312, DOI 10.1016/j.neuropharm.2004.07.004; PASTERNAK GW, 1993, CLIN NEUROPHARMACOL, V16, P1, DOI 10.1097/00002826-199302000-00001; Paxinos G, 2000, MOUSE BRAIN STEREOTA; Payne R, 1992, PRINCIPLES DRUG THER, P268; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Portenoy RK, 1996, PAIN MANAGEMENT THEO, P248; ROSSI GC, 1995, FEBS LETT, V369, P192, DOI 10.1016/0014-5793(95)00757-Z; Rossi GC, 1997, J PHARMACOL EXP THER, V281, P109; Schlussman SD, 2008, NEUROSCI LETT, V440, P284, DOI 10.1016/j.neulet.2008.05.103; Tanowitz M, 2008, J BIOL CHEM, V283, P35614, DOI 10.1074/jbc.M806588200; THOMPSON RC, 1993, NEURON, V11, P903, DOI 10.1016/0896-6273(93)90120-G; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang H, 1997, NEUROSCIENCE, V81, P757, DOI 10.1016/S0306-4522(97)00253-4; WANG JB, 1993, P NATL ACAD SCI USA, V90, P10230, DOI 10.1073/pnas.90.21.10230; WANG JB, 1994, FEBS LETT, V338, P217, DOI 10.1016/0014-5793(94)80368-4; Xu J, 2009, SOC NEUROSCI; Xu J, 2014, J NEUROSCI, V34, P11048, DOI 10.1523/JNEUROSCI.3986-13.2014; Xu J, 2013, J BIOL CHEM, V288, P21211, DOI 10.1074/jbc.M113.458687	67	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111267	10.1371/journal.pone.0111267	http://dx.doi.org/10.1371/journal.pone.0111267			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343478	Green Published, gold			2022-12-27	WOS:000343943500089
J	Chung, MH; Huang, CC; Vong, SC; Yang, TM; Chen, KT; Lin, HJ; Chen, JH; Su, SB; Guo, HR; Hsu, CC				Chung, Min-Hsien; Huang, Chien-Cheng; Vong, Si-Chon; Yang, Tzu-Meng; Chen, Kuo-Tai; Lin, Hung-Jung; Chen, Jiann-Hwa; Su, Shih-Bin; Guo, How-Ran; Hsu, Chien-Chin			Geriatric Fever Score: A New Decision Rule for Geriatric Care	PLOS ONE			English	Article							INFECTIOUS-DISEASES SOCIETY; MANAGEMENT; EMERGENCY; GUIDELINES; ADULTS	Background: Evaluating geriatric patients with fever is time-consuming and challenging. We investigated independent mortality predictors of geriatric patients with fever and developed a prediction rule for emergency care, critical care, and geriatric care physicians to classify patients into mortality risk and disposition groups. Materials and Methods: Consecutive geriatric patients (>= 65 years old) visiting the emergency department (ED) of a university-affiliated medical center between June 1 and July 21, 2010, were enrolled when they met the criteria of fever: a tympanic temperature >= 37.2 degrees C or a baseline temperature elevated >= 1.3 degrees C. Thirty-day mortality was the primary endpoint. Internal validation with bootstrap re-sampling was done. Results: Three hundred thirty geriatric patients were enrolled. We found three independent mortality predictors: Leukocytosis (WBC > 12,000 cells/mm(3)), Severe coma (GCS <= 8), and Thrombocytopenia (platelets < 150 10(3)/mm(3)) (LST). After assigning weights to each predictor, we developed a Geriatric Fever Score that stratifies patients into two mortality-risk and disposition groups: low (4.0%) (95% CI: 2.3-6.9%): a general ward or treatment in the ED then discharge and high (30.3%) (95% CI: 17.4-47.3%): consider the intensive care unit. The area under the curve for the rule was 0.73. Conclusions: We found that the Geriatric Fever Score is a simple and rapid rule for predicting 30-day mortality and classifying mortality risk and disposition in geriatric patients with fever, although external validation should be performed to confirm its usefulness in other clinical settings. It might help preserve medical resources for patients in greater need.	[Chung, Min-Hsien; Huang, Chien-Cheng; Vong, Si-Chon; Yang, Tzu-Meng; Chen, Kuo-Tai; Lin, Hung-Jung; Hsu, Chien-Chin] Chi Mei Med Ctr, Dept Emergency Med, Tainan, Taiwan; [Huang, Chien-Cheng; Guo, How-Ran] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Huang, Chien-Cheng] Southern Taiwan Univ Sci & Technol, Dept Child Care & Educ, Tainan, Taiwan; [Huang, Chien-Cheng] Kuo Gen Hosp, Dept Emergency Med, Tainan, Taiwan; [Chen, Kuo-Tai; Lin, Hung-Jung] Taipei Med Univ, Dept Emergency Med, Taipei, Taiwan; [Lin, Hung-Jung; Hsu, Chien-Chin] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan; [Chen, Jiann-Hwa] Cathay Gen Hosp, Dept Emergency Med, Taipei, Taiwan; [Chen, Jiann-Hwa] Fu Jen Catholic Univ, Sch Med, Taipei, Taiwan; [Su, Shih-Bin] Chi Mei Med Ctr, Dept Occupat Med, Tainan, Taiwan; [Su, Shih-Bin] Southern Taiwan Univ Sci & Technol, Dept Leisure Recreat & Tourism Management, Tainan, Taiwan; [Su, Shih-Bin] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Guo, How-Ran] Natl Cheng Kung Univ Hosp, Dept Occupat & Environm Med, Tainan 70428, Taiwan	Chi Mei Hospital; National Cheng Kung University; Southern Taiwan University of Science & Technology; Taipei Medical University; Southern Taiwan University of Science & Technology; Cathay General Hospital; Fu Jen Catholic University; Chi Mei Hospital; Southern Taiwan University of Science & Technology; Chi Mei Hospital; National Cheng Kung University; National Cheng Kung University Hospital	Guo, HR (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan.	hrguo@mail.ncku.edu.tw; nych2525@gmail.com	Guo, How-Ran/AAK-9063-2020	Guo, How-Ran/0000-0003-3343-3446	Chi-Mei Medical Center [CMNCKU10305]	Chi-Mei Medical Center	This study was supported by grant CMNCKU10305 from the Chi-Mei Medical Center. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminzadeh F, 2002, ANN EMERG MED, V39, P238, DOI 10.1067/mem.2002.121523; [Anonymous], 2004, PLAT COUNT AKA THROM; Cagatay AA, 2010, J AGING RES, V2010; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Department of Statistics Ministry of Interior Taiwan, TABL ELD POP COUNT R; FONTANAROSA PB, 1992, ANN EMERG MED, V21, P842, DOI 10.1016/S0196-0644(05)81032-7; Harper SA, 2009, CLIN INFECT DIS, V48, P1003, DOI 10.1086/598513; High KP, 2009, J AM GERIATR SOC, V57, P375, DOI 10.1111/j.1532-5415.2009.02175.x; Karnofsky D, 1949, EVALUATION CHEMOTHER, P196; Katz ED, 2004, GERIATRIC EMERGENCY, P55; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; MARCO CA, 1995, ANN EMERG MED, V26, P18, DOI 10.1016/S0196-0644(95)70232-6; NORMAN DC, 1985, J AM GERIATR SOC, V33, P859, DOI 10.1111/j.1532-5415.1985.tb05441.x; Norman DC, 2000, CLIN INFECT DIS, V31, P148, DOI 10.1086/313896; O'Sullivan SB, 2007, PHYS REHABILITATION, P385; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; OUSLANDER JG, 1994, ANN INTERN MED, V120, P584, DOI 10.7326/0003-4819-120-7-199404010-00010; Samaras N, 2010, ANN EMERG MED, V56, P261, DOI 10.1016/j.annemergmed.2010.04.015; Smith PW, 1997, INFECT CONT HOSP EP, V18, P831; TEASDALE G, 1974, LANCET, V2, P81; WASSERMAN M, 1989, J AM GERIATR SOC, V37, P537, DOI 10.1111/j.1532-5415.1989.tb05686.x	21	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110927	10.1371/journal.pone.0110927	http://dx.doi.org/10.1371/journal.pone.0110927			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340811	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662800071
J	Malairaman, U; Dandapani, K; Katyal, A				Malairaman, Udayabanu; Dandapani, Kumaran; Katyal, Anju			Effect of Ca(2)EDTA on Zinc Mediated Inflammation and Neuronal Apoptosis in Hippocampus of an In Vivo Mouse Model of Hypobaric Hypoxia	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; GLOBAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; NADPH OXIDASE; INDUCIBLE FACTOR-1-ALPHA; OXIDATIVE STRESS; RAT HIPPOCAMPUS; REPERFUSION INJURY; MEMORY IMPAIRMENT; CORTICAL-NEURONS	Background: Calcium overload has been implicated as a critical event in glutamate excitotoxicity associated neurodegeneration. Recently, zinc accumulation and its neurotoxic role similar to calcium has been proposed. Earlier, we reported that free chelatable zinc released during hypobaric hypoxia mediates neuronal damage and memory impairment. The molecular mechanism behind hypobaric hypoxia mediated neuronal damage is obscure. The role of free zinc in such neuropathological condition has not been elucidated. In the present study, we investigated the underlying role of free chelatable zinc in hypobaric hypoxia-induced neuronal inflammation and apoptosis resulting in hippocampal damage. Methods: Adult male Balb/c mice were exposed to hypobaric hypoxia and treated with saline or Ca(2)EDTA (1.25 mM/kg i.p) daily for four days. The effects of Ca(2)EDTA on apoptosis (caspases activity and DNA fragmentation), pro-inflammatory markers (iNOS, TNF-alpha and COX-2), NADPH oxidase activity, poly(ADP ribose) polymerase (PARP) activity and expressions of Bax, Bcl-2, HIF-1 alpha, metallothionein-3, ZnT-1 and ZIP-6 were examined in the hippocampal region of brain. Results: Hypobaric hypoxia resulted in increased expression of metallothionein-3 and zinc transporters (ZnT-1 and ZIP-6). Hypobaric hypoxia elicited an oxidative stress and inflammatory response characterized by elevated NADPH oxidase activity and up-regulation of iNOS, COX-2 and TNF-alpha. Furthermore, hypobaric hypoxia induced HIF-1 alpha protein expression, PARP activation and apoptosis in the hippocampus. Administration of Ca(2)EDTA significantly attenuated the hypobaric hypoxia induced oxidative stress, inflammation and apoptosis in the hippocampus. Conclusion: We propose that hypobaric hypoxia/reperfusion instigates free chelatable zinc imbalance in brain associated with neuroinflammation and neuronal apoptosis. Therefore, zinc chelating strategies which block zinc mediated neuronal damage linked with cerebral hypoxia and other neurodegenerative conditions can be designed in future.	[Malairaman, Udayabanu; Dandapani, Kumaran; Katyal, Anju] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India	University of Delhi	Katyal, A (corresponding author), Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India.	anju_katyal@yahoo.com		Malairaman, Udayabanu/0000-0001-7118-1070	Indian Council of Medical Research, India; University Grants Commission India	Indian Council of Medical Research, India(Indian Council of Medical Research (ICMR)); University Grants Commission India(University Grants Commission, India)	The authors AK, DK and UM are thankful to the Indian Council of Medical Research, India for providing research fellowship and University Grants Commission India for funding the project. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barhwal K, 2007, EUR J PHARMACOL, V570, P97, DOI 10.1016/j.ejphar.2007.05.063; Brown GC, 2010, NITRIC OXIDE-BIOL CH, V23, P153, DOI 10.1016/j.niox.2010.06.001; Brown GC, 2010, MOL NEUROBIOL, V41, P242, DOI 10.1007/s12035-010-8105-9; Brune B, 2003, CURR MED CHEM, V10, P845, DOI 10.2174/0929867033457746; Capasso M, 2005, J ALZHEIMERS DIS, V8, P93; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chao WH, 1999, J NUTR, V129, P2009, DOI 10.1093/jn/129.11.2009; CHOI DW, 1988, NEUROSCIENCE, V24, P67, DOI 10.1016/0306-4522(88)90312-0; Chun YS, 2000, BIOCHEM BIOPH RES CO, V268, P652, DOI 10.1006/bbrc.2000.2180; Cross AR, 2004, BBA-BIOENERGETICS, V1657, P1, DOI 10.1016/j.bbabio.2004.03.008; Cuajungco MP, 1997, NEUROBIOL DIS, V4, P137, DOI 10.1006/nbdi.1997.0163; GLOWINSKI J, 1966, J NEUROCHEM, V13, P655, DOI 10.1111/j.1471-4159.1966.tb09873.x; Godzich M, 2006, FASEB J, V20, P1519, DOI 10.1096/fj.05-4708fje; Green SP, 2001, J CEREBR BLOOD F MET, V21, P374, DOI 10.1097/00004647-200104000-00006; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; Guzik TJ, 2003, J PHYSIOL PHARMACOL, V54, P469; Haddad JJ, 2001, FEBS LETT, V505, P269, DOI 10.1016/S0014-5793(01)02833-2; Hidalgo J, 2001, BRAIN RES BULL, V55, P133, DOI 10.1016/S0361-9230(01)00452-X; Hota SK, 2008, NEUROBIOL LEARN MEM, V89, P522, DOI 10.1016/j.nlm.2008.01.003; Hota SK, 2007, NEUROCHEM INT, V51, P384, DOI 10.1016/j.neuint.2007.04.003; Hu RC, 2002, CHINESE MED J-PEKING, V115, P1833; Khurana P, 2002, NEUROCHEM RES, V27, P931, DOI 10.1023/A:1020347732741; Kim I, 2008, NEUROREPORT, V19, P1063, DOI 10.1097/WNR.0b013e328304d9ac; Koh JY, 2001, MOL NEUROBIOL, V24, P99, DOI 10.1385/MN:24:1-3:099; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Kondoh M, 2001, LIFE SCI, V69, P2137, DOI 10.1016/S0024-3205(01)01294-2; Kumaran D, 2008, BEHAV BRAIN RES, V192, P178, DOI 10.1016/j.bbr.2008.03.043; LEES GJ, 1990, NEUROSCI LETT, V120, P155, DOI 10.1016/0304-3940(90)90026-6; Li RC, 2004, NEUROBIOL DIS, V17, P44, DOI 10.1016/j.nbd.2004.05.006; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Maiti P, 2010, ACTA HISTOCHEM, V112, P222, DOI 10.1016/j.acthis.2008.10.005; Maiti P, 2008, J CHEM NEUROANAT, V36, P227, DOI 10.1016/j.jchemneu.2008.07.003; Martinez-Romero R, 2008, J CELL BIOCHEM, V104, P2248, DOI 10.1002/jcb.21781; Maulik N, 2002, J CELL MOL MED, V6, P13, DOI 10.1111/j.1582-4934.2002.tb00308.x; Maxwell PH, 2001, CURR OPIN GENET DEV, V11, P293, DOI 10.1016/S0959-437X(00)00193-3; Mazumdar T, 2005, J IMMUNOL, V174, P2314, DOI 10.4049/jimmunol.174.4.2314; Mishra OP, 2006, NEUROSCI LETT, V401, P81, DOI 10.1016/j.neulet.2006.02.070; Moller P, 2001, FASEB J, V15, P1181, DOI 10.1096/fj.00-0703com; Mori K, 2001, BEHAV BRAIN RES, V120, P159, DOI 10.1016/S0166-4328(00)00371-5; Mura M, 2004, J APPL PHYSIOL, V97, P1605, DOI 10.1152/japplphysiol.00202.2004; Noh KM, 2000, J NEUROSCI, V20; Nouette-Gaulain K, 2011, CAN J PHYSIOL PHARM, V89, P58, DOI [10.1139/Y10-105, 10.1139/y10-105]; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Semenov DG, 2009, B EXP BIOL MED+, V147, P185, DOI 10.1007/s10517-009-0467-5; Stork CJ, 2006, J NEUROSCI, V26, P10430, DOI 10.1523/JNEUROSCI.1588-06.2006; Strosznajder R, 2006, ACTA NEUROBIOL EXP, V66, P15; Strosznajder RP, 2003, J MOL NEUROSCI, V20, P61, DOI 10.1385/JMN:20:1:61; Suschek CV, 2004, CURR MOL MED, V4, P763, DOI 10.2174/1566524043359908; Szabo C, 2003, TOXICOL LETT, V140, P105, DOI 10.1016/S0378-4274(02)00507-6; Tejada-Simon MV, 2005, MOL CELL NEUROSCI, V29, P97, DOI 10.1016/j.mcn.2005.01.007; Tran MH, 2001, FASEB J, V15, P1407, DOI 10.1096/fj.00-0719fje; Udayabanu M, 2008, BRAIN RES, V1230, P138, DOI 10.1016/j.brainres.2008.06.081; Udayabanu M, 2012, NEUROSCIENCE, V202, P434, DOI 10.1016/j.neuroscience.2011.11.022; VALLEE BL, 1995, NEUROCHEM INT, V27, P23, DOI 10.1016/0197-0186(94)00165-Q; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Wang Q, 2006, BRAIN RES, V1090, P182, DOI 10.1016/j.brainres.2006.03.060; Wang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011888; Yamada K, 1999, NEUROSCIENCE, V88, P281, DOI 10.1016/S0306-4522(98)00237-1; Yi XY, 2006, AM J PHYSIOL-HEART C, V290, pH1136, DOI 10.1152/ajpheart.00296.2005; YOKOYAMA M, 1986, NEUROSCI LETT, V71, P351, DOI 10.1016/0304-3940(86)90646-4; Yun YJ, 2010, PROSTATE, V70, P1179, DOI 10.1002/pros.21152	61	22	23	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110253	10.1371/journal.pone.0110253	http://dx.doi.org/10.1371/journal.pone.0110253			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340757	gold, Green Published, Green Submitted			2022-12-27	WOS:000343662800024
J	Stahl, P; Ruppert, V; Schwarz, RT; Meyer, T				Stahl, Philipp; Ruppert, Volker; Schwarz, Ralph T.; Meyer, Thomas			Trypanosoma cruzi Evades the Protective Role of Interferon-Gamma-Signaling in Parasite-Infected Cells	PLOS ONE			English	Article							IFN-GAMMA; CHAGAS-DISEASE; PROINFLAMMATORY CYTOKINES; ALPHA/BETA-INTERFERON; GENE-EXPRESSION; KAPPA-B; STAT1; TRANSCRIPTION; MACROPHAGES; ACTIVATION	The protozoan parasite Trypanosoma cruzi is responsible for the zoonotic Chagas disease, a chronic and systemic infection in humans and warm-blooded animals typically leading to progressive dilated cardiomyopathy and gastrointestinal manifestations. In the present study, we report that the transcription factor STAT1 (signal transducer and activator of transcription 1) reduces the susceptibility of human cells to infection with T. cruzi. Our in vitro data demonstrate that interferon -gamma (IFN gamma) pre-treatment causes T. cruzi-infected cells to enter an anti-parasitic state through the activation of the transcription factor STAT1. Whereas stimulation of STAT1-expressing cells with IFN gamma significantly impaired intracellular replication of parasites, no protective effect of IFN gamma was observed in STAT1-deficient U3A cells. The gene encoding indoleamine 2, 3-dioxygenase (ido) was identified as a STAT1-regulated target gene engaged in parasite clearance. Exposure of cells to T. cruzi trypomastigotes in the absence of IFN gamma resulted in both sustained tyrosine and serine phosphorylation of STAT1 and its increased DNA binding. Furthermore, we found that in response to T. cruzi the total amount of intracellular STAT1 increased in an infectious dose-dependent manner, both at the mRNA and protein level. While STAT1 activation is a potent strategy of the host in the fight against the invading pathogen, amastigotes replicating intracellularly antagonize this pathway by specifically promoting the dephosphorylation of STAT1 serine 727, thereby partially circumventing its protective effects. These findings point to the crucial role of the IFN gamma/STAT1 signal pathway in the evolutionary combat between T. cruzi parasites and their host.	[Stahl, Philipp; Schwarz, Ralph T.] Univ Marburg, Inst Virol, AG Parasitol, D-35032 Marburg, Germany; [Ruppert, Volker] Univ Marburg, Kardiol Klin, Marburg, Germany; [Meyer, Thomas] Univ Gottingen, Klin Psychosomat Med & Psychotherapie, D-37073 Gottingen, Germany; [Schwarz, Ralph T.] Univ Lille 1 Sci & Technol, UMR CNRS USTL 8576, Unite Glycobiol Struct & Fonct, Villeneuve Dascq, France	Philipps University Marburg; Philipps University Marburg; University of Gottingen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Meyer, T (corresponding author), Univ Gottingen, Klin Psychosomat Med & Psychotherapie, D-37073 Gottingen, Germany.	thomas.meyer@med.uni-goettingen.de			Deutsche Forschungsgemeinschaft; Studienstiftung des Deutschen Volkes; Deutsche Gesellschaft fur Kardiologie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Studienstiftung des Deutschen Volkes; Deutsche Gesellschaft fur Kardiologie	The authors gratefully acknowledge the excellent technical assistance of Anke Gregus from the University of Gottingen and Nancy Mounogou Kouassi from the University of Marburg. The research on this subject was funded by a grant from the Deutsche Forschungsgemeinschaft to TM, a scholarship from the Studienstiftung des Deutschen Volkes to PS and a grant from the Deutsche Gesellschaft fur Kardiologie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliberti JCS, 1996, INFECT IMMUN, V64, P1961, DOI 10.1128/IAI.64.6.1961-1967.1996; Almeida IC, 2000, EMBO J, V19, P1476, DOI 10.1093/emboj/19.7.1476; Andrejeva J, 2002, J VIROL, V76, P2159, DOI 10.1128/JVI.76.5.2159-2167.2002; Antunez MI, 2000, IMMUNOL LETT, V71, P103, DOI 10.1016/S0165-2478(99)00172-8; Bastos KRB, 2007, J INTERF CYTOK RES, V27, P399, DOI 10.1089/jir.2007.0128; Begitt A, 2000, P NATL ACAD SCI USA, V97, P10418, DOI 10.1073/pnas.190318397; Bergeron M, 2006, J IMMUNOL, V177, P6271, DOI 10.4049/jimmunol.177.9.6271; Boscardin SB, 2010, J CELL MOL MED, V14, P1373, DOI 10.1111/j.1582-4934.2010.01007.x; Camargo MM, 1997, J IMMUNOL, V158, P5890; Campos MA, 2004, J IMMUNOL, V172, P1711, DOI 10.4049/jimmunol.172.3.1711; Ceravolo IP, 1999, INFECT IMMUN, V67, P2233; Chatterjee-Kishore M, 2000, EMBO J, V19, P4111, DOI 10.1093/emboj/19.15.4111; Cheon H, 2011, J INTERF CYTOK RES, V31, P33, DOI 10.1089/jir.2010.0100; Chessler ADC, 2008, J IMMUNOL, V181, P7917, DOI 10.4049/jimmunol.181.11.7917; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DAUBENER W, 1994, J IMMUNOL METHODS, V168, P39, DOI 10.1016/0022-1759(94)90207-0; de Avalos SV, 2002, J BIOL CHEM, V277, P639, DOI 10.1074/jbc.M109037200; Epting CL, 2010, EXP PARASITOL, V126, P283, DOI 10.1016/j.exppara.2010.06.023; Forget G, 2005, J BIOL CHEM, V280, P30542, DOI 10.1074/jbc.M414126200; Goncalves VM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002469; Hall BS, 2000, MOL BIOL CELL, V11, P153, DOI 10.1091/mbc.11.1.153; Holscher C, 1998, INFECT IMMUN, V66, P1208; Hovsepian E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079445; Huang H, 1999, INFECT IMMUN, V67, P5434, DOI 10.1128/IAI.67.10.5434-5440.1999; KIERSZENBAUM F, 1984, J IMMUNOL, V132, P905; Koga R, 2006, J IMMUNOL, V177, P7059, DOI 10.4049/jimmunol.177.10.7059; Kovarik P, 2001, EMBO J, V20, P91, DOI 10.1093/emboj/20.1.91; Kumar A, 1997, SCIENCE, V278, P1630, DOI 10.1126/science.278.5343.1630; Lescure FX, 2010, LANCET INFECT DIS, V10, P556, DOI 10.1016/S1473-3099(10)70098-0; Lodige I, 2005, J BIOL CHEM, V280, P43087, DOI 10.1074/jbc.M509180200; Machado FS, 2012, SEMIN IMMUNOPATHOL, V34, P753, DOI 10.1007/s00281-012-0351-7; Machado FS, 2000, CIRCULATION, V102, P3003, DOI 10.1161/01.CIR.102.24.3003; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; Michailowsky V, 2001, AM J PATHOL, V159, P1723, DOI 10.1016/S0002-9440(10)63019-2; MULLER M, 1993, EMBO J, V12, P4221, DOI 10.1002/j.1460-2075.1993.tb06106.x; Nagajyothi F, 2012, CELL MICROBIOL, V14, P634, DOI 10.1111/j.1462-5822.2012.01764.x; Olivier M, 2005, CLIN MICROBIOL REV, V18, P293, DOI 10.1128/CMR.18.2.293-305.2005; Parisien JP, 2002, J VIROL, V76, P4190, DOI 10.1128/JVI.76.9.4190-4198.2002; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PLATA F, 1984, EUR J IMMUNOL, V14, P930, DOI 10.1002/eji.1830141013; Poncini CV, 2010, MOL IMMUNOL, V47, P1981, DOI 10.1016/j.molimm.2010.04.016; Ramachandran A, 2009, J INTERF CYTOK RES, V29, P531, DOI 10.1089/jir.2009.0070; Rodrigues AA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001598; Schneider AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060215; Sehgal PB, 2008, SEMIN CELL DEV BIOL, V19, P329, DOI 10.1016/j.semcdb.2008.07.003; Stahl P, 2013, APOPTOSIS, V18, P653, DOI 10.1007/s10495-013-0822-x; Stephanou A, 2001, J BIOL CHEM, V276, P28340, DOI 10.1074/jbc.M101177200; TRUYENS C, 1994, INFECT IMMUN, V62, P692, DOI 10.1128/IAI.62.2.692-696.1994; Varinou L, 2003, IMMUNITY, V19, P793, DOI 10.1016/S1074-7613(03)00322-4; Vinkemeier U, 2004, J CELL BIOL, V167, P197, DOI 10.1083/jcb.200407163; Sanchez LV, 2013, PARASITOLOGY, V140, P147, DOI 10.1017/S0031182012001394; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; WIRTH JJ, 1985, INFECT IMMUN, V49, P61, DOI 10.1128/IAI.49.1.61-66.1985	53	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110512	10.1371/journal.pone.0110512	http://dx.doi.org/10.1371/journal.pone.0110512			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340519	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662800039
J	Won, J; Ju, JW; Kim, SM; Shin, Y; Chung, S; Pak, JH				Won, Jihee; Ju, Jung-Won; Kim, Sun Min; Shin, Yoojin; Chung, Seok; Pak, Jhang Ho			Clonorchis sinensis Infestation Promotes Three-Dimensional Aggregation and Invasion of Cholangiocarcinoma Cells	PLOS ONE			English	Article							EXCRETORY-SECRETORY PRODUCTS; EXCRETORY/SECRETORY PRODUCTS; OPISTHORCHIS-VIVERRINI; MATRIX METALLOPROTEINASES; MICROFLUIDIC ASSAY; LIVER; VINCULIN; METASTASIS; EXPRESSION; INFECTION	Numerous experimental and epidemiological studies have demonstrated a correlation between Clonorchis sinensis (C. sinensis) infestation and cholangiocarcinoma (CCA). However, the role of C. sinensis in the increased invasiveness and proliferation involved in the malignancy of CCA has not been addressed yet. Here, we investigated the possibility that C. sinensis infestation promotes expression of focal and cell-cell adhesion proteins in CCA cells and secretion of matrix metalloproteinases (MMPs). Adhesion proteins help maintain cell aggregates, and MMPs promote the three-dimensional invasion of cells into the neighboring extracellular matrix (ECM). Using a novel microfluidic assay, we quantitatively addressed the role of excretory-secretory products (ESPs) gradients from C. sinensis in promoting the invasion of cells into the neighboring ECM.	[Won, Jihee; Shin, Yoojin; Chung, Seok] Korea Univ, Sch Mech Engn, Seoul, South Korea; [Ju, Jung-Won] Korea Ctr Dis Control & Prevent, Natl Inst Hlth, Div Malaria & Parasit Dis, Osong, South Korea; [Kim, Sun Min; Pak, Jhang Ho] Univ Ulsan, Coll Med, Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea	Korea University; Korea Centers for Disease Control & Prevention (KCDC); Korea CDC Center for Disease Prevention; Korea National Institute of Health (KNIH); University of Ulsan; Asan Medical Center	Chung, S (corresponding author), Korea Univ, Sch Mech Engn, Seoul, South Korea.	sidchung@gmail.com; jhpak@amc.seoul.kr	Chung, Seok/B-1501-2015	Ju, Jung-Won/0000-0001-5248-6995; Won, Jihee/0000-0003-0491-8620	Korea National Institute of Health, Ministry of Health and Welfare, Korea [2012-E54008-00]; Korea Ministry of Environment as Projects for Developing Eco-Innovation Technologies [GT-11-G-02-001-1]; Asan Institute for Life Sciences, Korea [2013-349]	Korea National Institute of Health, Ministry of Health and Welfare, Korea; Korea Ministry of Environment as Projects for Developing Eco-Innovation Technologies; Asan Institute for Life Sciences, Korea	This work was supported by a grant from the Korea National Institute of Health, Ministry of Health and Welfare, Korea (2012-E54008-00). S.C. was supported by Korea Ministry of Environment as Projects for Developing Eco-Innovation Technologies (GT-11-G-02-001-1) and J.H.P. was by Asan Institute for Life Sciences, Korea (2013-349). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chamberlain RS, 2000, ANN SURG ONCOL, V7, P55, DOI 10.1007/s10434-000-0055-4; Chen WJ, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-149; Choi D, 2006, J HEPATOL, V44, P1066, DOI 10.1016/j.jhep.2005.11.040; Critchley DR, 2004, BIOCHEM SOC T, V32, P831, DOI 10.1042/BST0320831; Curran S, 1999, J PATHOL, V189, P300, DOI 10.1002/(SICI)1096-9896(199911)189:3<300::AID-PATH456>3.0.CO;2-C; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; GUDESBLATT MS, 1984, CT-J COMPUT TOMOGR, V8, P191, DOI 10.1016/0149-936X(84)90059-6; Han S, 2012, LAB CHIP, V12, P3861, DOI 10.1039/c2lc40445a; Hong ST, 2012, PARASITOL INT, V61, P17, DOI 10.1016/j.parint.2011.06.007; ISHAK KG, 1994, HISTOLOGICAL TYPING; Jeong GS, 2011, ANAL CHEM, V83, P8454, DOI 10.1021/ac202170e; Jeong GS, 2011, BIOMED MICRODEVICES, V13, P717, DOI 10.1007/s10544-011-9541-7; Nam JH, 2012, INT J PARASITOL, V42, P103, DOI 10.1016/j.ijpara.2011.11.001; Ju JW, 2009, PROTEOMICS, V9, P3066, DOI 10.1002/pmic.200700613; Khan SA, 2005, LANCET, V366, P1303, DOI 10.1016/S0140-6736(05)67530-7; KIM YI, 1989, CANCER, V63, P1562, DOI 10.1002/1097-0142(19890415)63:8<1562::AID-CNCR2820630819>3.0.CO;2-8; Kim YJ, 2008, PARASITOL RES, V102, P411, DOI 10.1007/s00436-007-0778-2; Malemud CJ, 2006, FRONT BIOSCI-LANDMRK, V11, P1696, DOI 10.2741/1915; MARTINEZHERNANDEZ A, 1993, VIRCHOWS ARCH A, V423, P1, DOI 10.1007/BF01606425; Matsumoto K, 2006, INT J CANCER, V119, P477, DOI 10.1002/ijc.21808; MIYAGIWA M, 1989, IN VITRO CELL DEV B, V25, P503; Ninlawan K, 2010, PARASITOL INT, V59, P616, DOI 10.1016/j.parint.2010.09.008; Pak JH, 2009, J CELL BIOCHEM, V108, P1376, DOI 10.1002/jcb.22368; Pak J, 2009, PARASITOL RES, V104, P1035, DOI 10.1007/s00436-008-1286-8; PARKIN DM, 1991, INT J CANCER, V48, P323, DOI 10.1002/ijc.2910480302; Patel T, 2011, NAT REV GASTRO HEPAT, V8, P189, DOI 10.1038/nrgastro.2011.20; Peng X, 2010, J CELL SCI, V123, P567, DOI 10.1242/jcs.056432; Prakobwong S, 2009, INT J PARASITOL, V39, P825, DOI 10.1016/j.ijpara.2008.12.002; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Serradell MC, 2007, VET IMMUNOL IMMUNOP, V117, P197, DOI 10.1016/j.vetimm.2007.03.007; Shin HR, 2010, CANCER SCI, V101, P579, DOI 10.1111/j.1349-7006.2009.01458.x; Shin Y, 2012, NAT PROTOC, V7, P1247, DOI 10.1038/nprot.2012.051; Shin Y, 2011, LAB CHIP, V11, P2175, DOI 10.1039/c1lc20039a; Sirica AE, 2012, NAT REV GASTRO HEPAT, V9, P44, DOI 10.1038/nrgastro.2011.222; Sripa B, 2012, TRENDS PARASITOL, V28, P395, DOI 10.1016/j.pt.2012.07.006; Taylor-Robinson SD, 2001, GUT, V48, P816, DOI 10.1136/gut.48.6.816; Thuwajit C, 2004, PARASITOLOGY, V129, P455, DOI 10.1017/S0031182004005815; Watanapa P, 2002, BRIT J SURG, V89, P962, DOI 10.1046/j.1365-2168.2002.02143.x; Wu W, 2012, PARASITOL RES, V111, P1879, DOI 10.1007/s00436-012-3152-y	39	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110705	10.1371/journal.pone.0110705	http://dx.doi.org/10.1371/journal.pone.0110705			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340585	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662800049
J	Arrode-Bruses, G; Moussa, M; Baccard-Longere, M; Villinger, F; Chebloune, Y				Arrode-Bruses, Geraldine; Moussa, Maha; Baccard-Longere, Monique; Villinger, Francois; Chebloune, Yahia			Long-Term Central and Effector SHIV-Specific Memory T Cell Responses Elicited after a Single Immunization with a Novel Lentivector DNA Vaccine	PLOS ONE			English	Article							MAEDI-VISNA-VIRUS; MAURITIAN CYNOMOLGUS; ATTENUATED SIV; IMMUNE-RESPONSES; RHESUS MACAQUES; HIV-1 NEF; LIVE; AIDS; REPLICATION; PROTECTION	Prevention of HIV acquisition and replication requires long lasting and effective immunity. Given the state of HIV vaccine development, innovative vectors and immunization strategies are urgently needed to generate safe and efficacious HIV vaccines. Here, we developed a novel lentivirus-based DNA vector that does not integrate in the host genome and undergoes a single-cycle of replication. Viral proteins are constitutively expressed under the control of Tat-independent LTR promoter from goat lentivirus. We immunized six macaques once only with CAL-SHIV-IN- DNA using combined intramuscular and intradermal injections plus electroporation. Antigen-specific T cell responses were monitored for 47 weeks post-immunization (PI). PBMCs were assessed directly ex vivo or after 6 and 12 days of in vitro culture using antigenic and/or homeostatic proliferation. IFN-gamma ELISPOT was used to measure immediate cytokine secretion from antigen specific effector cells and from memory precursors with high proliferative capacity (PHPC). The memory phenotype and functions (proliferation, cytokine expression, lytic content) of specific T cells were tested using multiparametric FACS-based assays. All immunized macaques developed lasting peripheral CD8(+) and CD4(+) T cell responses mainly against Gag and Nef antigens. During the primary expansion phase, immediate effector cells as well as increasing numbers of proliferating cells with limited effector functions were detected which expressed markers of effector (EM) and central (CM) memory phenotypes. These responses contracted but then reemerged later in absence of antigen boost. Strong PHPC responses comprising vaccine-specific CM and EM T cells that readily expanded and acquired immediate effector functions were detected at 40/47 weeks PI. Altogether, our study demonstrated that a single immunization with a replication-limited DNA vaccine elicited persistent vaccine-specific CM and EM CD8(+) and CD4(+) T cells with immediate and readily inducible effector functions, in the absence of ongoing antigen expression.	[Arrode-Bruses, Geraldine; Moussa, Maha; Chebloune, Yahia] Univ Grenoble 1, INRA, ANRS, PAVAL Lab Nanobio 2, Grenoble, France; [Baccard-Longere, Monique] CHU Grenoble, Inst Biol & Pathol, F-38043 Grenoble, France; [Villinger, Francois] Emory Univ, Yerkes Natl Primate Res Ctr, Div Pathol, Atlanta, GA 30322 USA	INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Emory University	Chebloune, Y (corresponding author), Univ Grenoble 1, INRA, ANRS, PAVAL Lab Nanobio 2, Grenoble, France.	ychebloune@lyon.inra.fr	Chebloune, Yahia/AAN-8885-2020	Chebloune, Yahia/0000-0001-9179-6486	Agence Nationale de Recherche sur le SIDA (ANRS) [RA0000640]; Institut National de Recherche Agronomique (INRA) [2012-2013-YC-DC]; Universite Joseph Fourier (UJF) [AGIR 13CSV13]; ANRS [2011022]; Marie Curie International Reintegration Grant (IRG) program from European Commission (FP7-PEOPLE-RG) [276828-HIVNONILV]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	Agence Nationale de Recherche sur le SIDA (ANRS)(ANRSFrench National Research Agency (ANR)); Institut National de Recherche Agronomique (INRA); Universite Joseph Fourier (UJF); ANRS(ANRSFrench National Research Agency (ANR)); Marie Curie International Reintegration Grant (IRG) program from European Commission (FP7-PEOPLE-RG); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported by grants from Agence Nationale de Recherche sur le SIDA (ANRS, RA0000640), Institut National de Recherche Agronomique (INRA, 2012-2013-YC-DC) and Universite Joseph Fourier (UJF, AGIR 13CSV13) to YC. GAB was financially supported by a postdoctoral fellowship from ANRS (2011022) and Marie Curie International Reintegration Grant (IRG) program from European Commission (N<SUP>o</SUP> 276828-HIVNONILV, FP7-PEOPLE-2010-RG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnink A, 2011, IMMUNOGENETICS, V63, P267, DOI 10.1007/s00251-010-0504-6; Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; [Anonymous], NATURE; Arrode G, 2007, J IMMUNOL, V178, P2318, DOI 10.4049/jimmunol.178.4.2318; Arrode-Bruses G, 2012, VACCINE, V30, P2956, DOI 10.1016/j.vaccine.2012.02.050; Arrode-Bruses G, 2010, J VIROL, V84, P1243, DOI 10.1128/JVI.01846-09; Baba TW, 1999, NAT MED, V5, P194, DOI 10.1038/5557; BABA TW, 1995, SCIENCE, V267, P1820, DOI 10.1126/science.7892606; Beignon AS, 2009, J VIROL, V83, P10963, DOI 10.1128/JVI.01284-09; Belisle SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019681; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Blancher A, 2012, G3-GENES GENOM GENET, V2, P123, DOI 10.1534/g3.111.001248; Burwitz BJ, 2009, J VIROL, V83, P6011, DOI 10.1128/JVI.00199-09; Calarota SA, 2008, J IMMUNOL, V180, P5907, DOI 10.4049/jimmunol.180.9.5907; Callard RE, 2003, TRENDS IMMUNOL, V24, P370, DOI 10.1016/S1471-4906(03)00164-9; Casartelli N, 2003, AIDS, V17, P1291, DOI 10.1097/00002030-200306130-00003; DESROSIERS RC, 1994, AIDS RES HUM RETROV, V10, P331, DOI 10.1089/aid.1994.10.331; Di Nunzio F, 2012, VACCINE, V30, P2499, DOI 10.1016/j.vaccine.2012.01.089; Feinberg MB, 2012, NAT IMMUNOL, V13, P632, DOI 10.1038/ni.2351; Florese RH, 2008, VACCINE, V26, P3312, DOI 10.1016/j.vaccine.2008.03.100; Fukazawa Y, 2012, NAT MED, V18, P1673, DOI 10.1038/nm.2934; Genesca M, 2009, J INTERN MED, V265, P67, DOI 10.1111/j.1365-2796.2008.02051.x; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hofmann-Lehmann R, 2003, AIDS, V17, P157, DOI 10.1097/00002030-200301240-00004; Igarashi T, 1997, J GEN VIROL, V78, P985, DOI 10.1099/0022-1317-78-5-985; Jia B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000272; Kumar A, 2008, VIROLOGY, V371, P238, DOI 10.1016/j.virol.2007.10.008; Kutzler MA, 2008, NAT REV GENET, V9, P776, DOI 10.1038/nrg2432; Liard C, 2012, J INVEST DERMATOL, V132, P615, DOI 10.1038/jid.2011.346; Lisziewicz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035416; Liu ZQ, 2006, VIROLOGY, V351, P444, DOI 10.1016/j.virol.2006.03.033; Luckay A, 2007, J VIROL, V81, P5257, DOI 10.1128/JVI.00055-07; Lugli E, 2013, J CLIN INVEST; Martinon F, 2009, HUM GENE THER, V20, P1291, DOI 10.1089/hum.2009.044; Mee ET, 2009, IMMUNOGENETICS, V61, P327, DOI 10.1007/s00251-009-0369-8; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Ndhlovu ZM, 2012, J VIROL, V86, P6959, DOI 10.1128/JVI.00531-12; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Patel V, 2013, P NATL ACAD SCI USA, V110, P2975, DOI 10.1073/pnas.1215393110; Patel V, 2010, VACCINE, V28, P4827, DOI 10.1016/j.vaccine.2010.04.064; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; Ramirez LA, 2013, EXPERT OPIN BIOL TH, V13, P563, DOI 10.1517/14712598.2013.758709; Reynolds MR, 2008, J EXP MED, V205, P2537, DOI 10.1084/jem.20081524; Saksena N. K., 1996, Annals Academy of Medicine Singapore, V25, P848; Schwartz DH, 1996, IMMUNOL LETT, V51, P3, DOI 10.1016/0165-2478(96)02547-3; Singh DK, 2005, J VIROL, V79, P3419, DOI 10.1128/JVI.79.6.3419-3428.2005; Terry E, 2012, J MATH BIOL, V65, P263, DOI 10.1007/s00285-011-0459-8; Trible RP, 2007, J MOL BIOL, V374, P121, DOI 10.1016/j.jmb.2007.09.009; Villet S, 2003, J VIROL, V77, P9632, DOI 10.1128/JVI.77.17.9632-9638.2003; Villet S, 2003, VIROLOGY, V307, P317, DOI 10.1016/S0042-6822(02)00076-4; Yankee TM, 2009, VIROLOGY, V383, P103, DOI 10.1016/j.virol.2008.09.038	52	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110883	10.1371/journal.pone.0110883	http://dx.doi.org/10.1371/journal.pone.0110883			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337803	Green Published, Green Submitted, gold			2022-12-27	WOS:000343674800085
J	Castilla, JC; Manriquez, PH; Delgado, A; Ortiz, V; Jara, ME; Varas, M				Carlos Castilla, Juan; Manriquez, Patricio H.; Delgado, Alejandro; Ortiz, Veronica; Elisa Jara, Maria; Varas, Manuel			Rocky Intertidal Zonation Pattern in Antofagasta, Chile: Invasive Species and Shellfish Gathering	PLOS ONE			English	Article							MUSSEL MYTILUS-GALLOPROVINCIALIS; TUNICATE PYURA-PRAEPUTIALIS; HUMAN-EXCLUSION; COMMUNITY STRUCTURE; SOUTHERN CHILE; BAY; POPULATION; CONVERGENCE; RECRUITMENT; STOLONIFERA	Background: Biological invasions affecting rocky intertidal zonation patterns, yield information on species interactions. In the Bay of Antofagasta, northern Chile, the non-indigenous tunicate Pyura praeputialis, originally from Australia, has invaded (in the past century or so) and monopolized a major portion of the mid-intertidal rocky shore, displacing upshore the native mussel Perumytilus purpuratus. In Antofagasta the tunicate is subjected to intensive exploitation. Monitoring protocols show that in the past 10 years Antofagasta's tunicate population has experienced a drastic decline, affecting the intertidal zonation pattern. Methodology/Principal Findings: A 12.5 km of coastline, on the southern eastern shore of the Bay of Antofagasta, was studied. Eight sites were systematically (1993-1994) or sporadically (2003-2014) monitored for the seaward-shoreward expansion or reduction of the tunicate Pyura praeputialis, and native mussel and barnacle bands. A notable reduction in the mid-intertidal band of P. praeputialis and a seaward expansion of the mussel, Perumytilus purpuratus, and barnacle bands was observed. We suggest that the major cause for the decline in the tunicate is due to its intensive exploitation by rocky shore Pyura-gathers. The rate of extraction of tunicates by professional Pyura-gathers ranged between 256-740 tunicates hour(-1). Between 2009-2014 the density of professional Pyura-gather ranged between 0.5-4.5 km(-1) per low tide. Hence, 10 professional Pyura-gathers working 1 h for 10 low tides per month, during 6 months, will remove between 307-888 m(2) of tunicates. A drastic decline in tunicate recruitment was observed and several P. praeputialis ecosystems services have been lost. Conclusion and Significance: In Antofagasta, the continuous and intensive intertidal gathering of the invasive tunicate Pyura praeputialis, has caused a drastic reduction of its population modifying the zonation pattern. Thereby, native mussel Perumytilus purpuratus has regained its ecological center in the intertidal zone. We recorded a Pyura recruitment failure and loss of ecosystem services.	[Carlos Castilla, Juan; Delgado, Alejandro; Ortiz, Veronica; Varas, Manuel] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Estn Costera Invest Marinas, Ctr Conservac Marina, Santiago, Chile; [Manriquez, Patricio H.; Elisa Jara, Maria] Ctr Estudios Avanzados Zonas Aridas, Lab Ecol & Conducta Ontogenia Temprana, Coquimbo, Chile	Pontificia Universidad Catolica de Chile	Castilla, JC (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Estn Costera Invest Marinas, Ctr Conservac Marina, Alameda 340, Santiago, Chile.	jcastilla@bio.puc.cl		Manriquez, Patricio/0000-0001-6586-764X	Chilean Presidential Chair in Science; FONDAP-FONDECYT [1501-0001]; FONDECYT [3020035, 1050841, 1080023, 1130839]; Nucleo Milenio "Centro de Conservacion Marina'', Ministerio de Economia, Fomento y Turismo, Chile; Minera Escondida Limitada (MEL); biological research in the Bay of Antofagasta through a CREA project, Universidad Catolica de la Santisima Concepcion, Chile	Chilean Presidential Chair in Science; FONDAP-FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYTCONICYT FONDAP); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Nucleo Milenio "Centro de Conservacion Marina'', Ministerio de Economia, Fomento y Turismo, Chile; Minera Escondida Limitada (MEL); biological research in the Bay of Antofagasta through a CREA project, Universidad Catolica de la Santisima Concepcion, Chile	This long-term study was initially funded by a Chilean Presidential Chair in Science to JCC (1997-1999). Additional financial support was received from projects FONDAP-FONDECYT No 1501-0001, "Center for Advanced Studies in Ecology and Biodiversity'' (2000-2011); projects FONDECYT No 3020035 (2002-2005), FONDECYT No 1050841 (2005-2007), FONDECYT No 1080023 (2008-2011) to PHM, the Nucleo Milenio "Centro de Conservacion Marina'', Ministerio de Economia, Fomento y Turismo, Chile (2010-2014). MV received an undergraduate thesis grant from Minera Escondida Limitada (MEL) (1993-1995). Also MEL has supported biological research in the Bay of Antofagasta through a CREA project, Universidad Catolica de la Santisima Concepcion, Chile to JCC and PHM (2012-2014). During the final edition of this manuscript PHM was under the tenure of project FONDECYT No 1130839 (2013-2016). The funders had no role in the study design, data collection, data analysis, or decision to plan, prepare or publish the manuscript.	Alvarado JL, 2001, MAR ECOL PROG SER, V224, P93, DOI 10.3354/meps224093; BARKAI A, 1988, S AFR J MARINE SCI, V7, P117, DOI 10.2989/025776188784378982; BARKAI A, 1988, SCIENCE, V242, P62, DOI 10.1126/science.242.4875.62; BENDER EA, 1984, ECOLOGY, V65, P1, DOI 10.2307/1939452; Branch G.M., 1994, Ecological Studies, V103, P75; Bunting D, 2014, ECOL MANAG RESTOR, V15, P64, DOI 10.1111/emr.12072; Caro AU, 2011, MAR ECOL PROG SER, V428, P177, DOI 10.3354/meps09069; Caro AU, 2010, P NATL ACAD SCI USA, V107, P18528, DOI 10.1073/pnas.1007077107; Castilla J., 2002, OCEANOGRAPHY ECOLOGY, P179; CASTILLA JC, 1985, OIKOS, V45, P391, DOI 10.2307/3565575; Castilla JC, 2000, MAR ECOL-P S Z N I, V21, P161, DOI 10.1046/j.1439-0485.2000.00695.x; Castilla JC, 1999, TRENDS ECOL EVOL, V14, P280, DOI 10.1016/S0169-5347(99)01602-X; Castilla JC, 2004, P NATL ACAD SCI USA, V101, P8517, DOI 10.1073/pnas.0401921101; Castilla JC, 2004, MAR ECOL PROG SER, V268, P119, DOI 10.3354/meps268119; Castilla JC, 2002, MOL ECOL, V11, P1579, DOI 10.1046/j.1365-294X.2002.01524.x; Castilla JC, 2000, REV CHIL HIST NAT, V73, P585; CASTILLA JC, 1989, MAR ECOL PROG SER, V50, P203, DOI 10.3354/meps050203; CASTILLA JC, 1993, HUMANS AS COMPONENTS OF ECOSYSTEMS, P158; Castilla JC, 2005, BIOL INVASIONS, V7, P213, DOI 10.1007/s10530-004-0198-5; Castilla JC, 1997, ESTUDIOS OCEANOLOGIC, V16, P115; Castilla JC, 2001, SUSTENTABILIDAD BIOD, P719; Castilla JC, 1998, MINERIA COBRE ECOLOG, P221; Castilla Juan C., 2009, V204, P439; FAIRWEATHER P G, 1991, Ocean and Shoreline Management, V15, P125, DOI 10.1016/0951-8312(91)90027-Y; Ferraris F, 1978, HOJA ANTOFAGASTA REG; GODOY C, 1989, OIKOS, V54, P101, DOI 10.2307/3565902; GRAHAM WM, 1993, ESTUARIES, V16, P83, DOI 10.2307/1352766; Griffiths Charles L., 2009, V204, P393; GRIFFITHS CL, 1992, S AFR J MARINE SCI, V12, P713; Guiler E. R., 1959, PAPERS P ROYAL SOC T, V93, P33; Guinez R, 1999, AM NAT, V154, P341, DOI 10.1086/303234; Guinez R, 2001, ECOLOGY, V82, P2331, DOI 10.2307/2680235; Hanekom N, 2013, AFR ZOOL, V48, P167; HOCKEY PAR, 1992, T ROY SOC S AFR, V48, P123, DOI 10.1080/00359199209520258; KINGSFORD MJ, 1991, MAR ECOL PROG SER, V72, P1, DOI 10.3354/meps072001; MORENO CA, 1986, OIKOS, V46, P359, DOI 10.2307/3565835; Moreno CA, 1993, THESIS PONTIFICIA U; NAVARRETE SA, 1990, MAR ECOL PROG SER, V68, P113, DOI 10.3354/meps068113; Pacheco CJ, 2001, J ETHOL, V19, P23, DOI 10.1007/s101640170013; PAINE RT, 1983, EVOLUTION, V37, P821, DOI 10.1111/j.1558-5646.1983.tb05603.x; Pastorino Guido, 1993, Neotropica (La Plata), V39, P34; Rilov G, 2009, ECOLOGICAL STUDIES S; Rius Marc, 2011, Zootaxa, V2754, P27; Robinson TB, 2007, MAR ECOL PROG SER, V340, P163, DOI 10.3354/meps340163; Robinson TB, 2005, AFR J MAR SCI, V27, P297, DOI 10.2989/18142320509504088; Siegfried WR, 1994, ROCKY SORES EXPLOITA; Steffani CN, 2003, AFR J MAR SCI, V25, P213, DOI 10.2989/18142320309504011; Tablas de marea de la costa de Chile, 2014, PUBL SHOA, V300940; Vallarino EA, 1997, MAR ECOL-P S Z N I, V18, P319, DOI 10.1111/j.1439-0485.1997.tb00445.x; Varas M, 1996, THESIS U ARTURO PRAT	50	7	8	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110301	10.1371/journal.pone.0110301	http://dx.doi.org/10.1371/journal.pone.0110301			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338112	Green Submitted, Green Published, gold			2022-12-27	WOS:000343674800033
J	Crooks, MG; Fahim, A; Naseem, KM; Morice, AH; Hart, SP				Crooks, Michael G.; Fahim, Ahmed; Naseem, Khalid M.; Morice, Alyn H.; Hart, Simon P.			Increased Platelet Reactivity in Idiopathic Pulmonary Fibrosis Is Mediated by a Plasma Factor	PLOS ONE			English	Article							ALPHA-GRANULES; GROWTH-FACTOR; ACTIVATION; LUNG; FIBROBLASTS; BETA	Introduction: Idiopathic Pulmonary Fibrosis (IPF) is a progressive, incurable fibrotic interstitial lung disease with a prognosis worse than many cancers. Its pathogenesis is poorly understood. Activated platelets can release pro-fibrotic mediators that have the potential to contribute to lung fibrosis. We determine platelet reactivity in subjects with IPF compared to age-matched controls. Methods: Whole blood flow cytometry was used to measure platelet-monocyte aggregate formation, platelet P-selectin expression and platelet fibrinogen binding at basal levels and following stimulation with platelet agonists. A plasma swap approach was used to assess the effect of IPF plasma on control platelets. Results: Subjects with IPF showed greater platelet reactivity than controls. Platelet P-selectin expression was significantly greater in IPF patients than controls following stimulation with 0.1 mu M ADP (1.9% positive +/- 0.5 (mean +/- SEM) versus 0.7%+/- 0.1; p = 0.03), 1 mu M ADP (9.8%+/- 1.3 versus 3.3%+/- 0.8; p<0.01) and 10 mu M ADP (41.3%+/- 4.2 versus 22.5%+/- 2.6; p<0.01). Platelet fibrinogen binding was also increased, and platelet activation resulted in increased platelet-monocyte aggregate formation in IPF patients. Re-suspension of control platelets in plasma taken from subjects with IPF resulted in increased platelet activation compared to control plasma. Conclusions: IPF patients exhibit increased platelet reactivity compared with controls. This hyperactivity may result from the plasma environment since control platelets exhibit increased activation when exposed to IPF plasma.	[Crooks, Michael G.; Naseem, Khalid M.; Morice, Alyn H.; Hart, Simon P.] Hull York Med Sch, Ctr Cardiovasc & Metab Res, Cottingham, N Humberside, England; [Fahim, Ahmed] New Cross Hosp, Wolverhampton, W Midlands, England	University of Hull; University of York - UK; New Cross Hospital	Crooks, MG (corresponding author), Hull York Med Sch, Ctr Cardiovasc & Metab Res, Cottingham, N Humberside, England.	michael.crooks@nhs.net	Fahim, Ahmed/AAM-7648-2021	Hart, Simon/0000-0003-4606-9559; Crooks, Michael/0000-0001-6876-0258	National Institute for Health Research [CL-2012-03-001] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Bjoraker JA, 1998, AM J RESP CRIT CARE, V157, P199, DOI 10.1164/ajrccm.157.1.9704130; Bournazos S, 2008, ARTERIOSCL THROM VAS, V28, pE2, DOI 10.1161/ATVBAHA.107.153387; Bozza FA, 2009, AM J RESP CELL MOL, V40, P123, DOI 10.1165/rcmb.2008-0241TR; FAVA RA, 1990, BLOOD, V76, P1946; Fernandez Isis E, 2012, Proc Am Thorac Soc, V9, P111, DOI 10.1513/pats.201203-023AW; Fujii M, 2000, THROMB RES, V99, P111, DOI 10.1016/S0049-3848(00)00237-1; Gao CJ, 2011, BLOOD, V117, P4946, DOI 10.1182/blood-2010-09-307751; Hetzel M, 2005, LUNG, V183, P225, DOI 10.1007/s00408-004-2534-z; Hubbard RB, 2008, AM J RESP CRIT CARE, V178, P1257, DOI 10.1164/rccm.200805-725OC; KAPLAN DR, 1979, BLOOD, V53, P1043; KINKHARDT U, 2003, CLIN PHARMACOL THER, V73, P232; KOTANI I, 1995, THROMB RES, V77, P493, DOI 10.1016/0049-3848(95)00025-9; Maclay JD, 2011, THORAX, V66, P769, DOI 10.1136/thx.2010.157529; McCabe DJH, 2004, BRIT J HAEMATOL, V125, P777, DOI 10.1111/j.1365-2141.2004.04983.x; Michelson AD, 2001, CIRCULATION, V104, P1533, DOI 10.1161/hc3801.095588; Noth I, 2012, AM J RESP CRIT CARE, V186, P88, DOI 10.1164/rccm.201202-0314OC; O'Sullivan BP, 2005, BLOOD, V105, P4635, DOI 10.1182/blood-2004-06-2098; Pernerstorfer T, 1998, BRIT J HAEMATOL, V102, P1229; PIGUET PF, 1994, INT J EXP PATHOL, V75, P321; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Sarma J, 2002, CIRCULATION, V105, P2166, DOI 10.1161/01.CIR.0000015700.27754.6F; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; Sode BF, 2010, AM J RESP CRIT CARE, V181, P1085, DOI 10.1164/rccm.200912-1951OC	24	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e111347	10.1371/journal.pone.0111347	http://dx.doi.org/10.1371/journal.pone.0111347			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338090	Green Submitted, Green Published, gold			2022-12-27	WOS:000343674800118
J	Gravina, FS; van Helden, DF; Kerr, KP; de Oliveira, RB; Jobling, P				Gravina, Fernanda S.; van Helden, Dirk F.; Kerr, Karen P.; de Oliveira, Ramatis B.; Jobling, Phillip			Phasic Contractions of the Mouse Vagina and Cervix at Different Phases of the Estrus Cycle and during Late Pregnancy	PLOS ONE			English	Article							GUINEA-PIG STOMACH; OXYTOCIN-INDUCED CONTRACTIONS; UTERINE SMOOTH-MUSCLE; INTERSTITIAL-CELLS; GENE-EXPRESSION; HUMAN UTERUS; MYOMETRIAL CONTRACTILITY; SARCOPLASMIC-RETICULUM; ENDOPLASMIC-RETICULUM; ACTION-POTENTIALS	Background/Aims: The pacemaker mechanisms activating phasic contractions of vaginal and cervical smooth muscle remain poorly understood. Here, we investigate properties of pacemaking in vaginal and cervical tissues by determining whether: 1) functional pacemaking is dependent on the phase of the estrus cycle or pregnancy; 2) pacemaking involves Ca2+ release from sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA) -dependent intracellular Ca2+ stores; and 3) c-Kit and/or vimentin immunoreactive ICs have a role in pacemaking. Methodology/Principal Findings: Vaginal and cervical contractions were measured in vitro, as was the distribution of c-Kit and vimentin positive interstitial cells (ICs). Cervical smooth muscle was spontaneously active in estrus and metestrus but quiescent during proestrus and diestrus. Vaginal smooth muscle was normally quiescent but exhibited phasic contractions in the presence of oxytocin or the K+ channel blocker tetraethylammonium (TEA) chloride. Spontaneous contractions in the cervix and TEA-induced phasic contractions in the vagina persisted in the presence of cyclopiazonic acid (CPA), a blocker of the SERCA that refills intracellular SR Ca2+ stores, but were inhibited in low Ca2+ solution or in the presence of nifedipine, an inhibitor of L-type Ca2+ channels. ICs were found in small numbers in the mouse cervix but not in the vagina. Conclusions/Significance: Cervical smooth muscle strips taken from mice in estrus, metestrus or late pregnancy were generally spontaneously active. Vaginal smooth muscle strips were normally quiescent but could be induced to exhibit phasic contractions independent on phase of the estrus cycle or late pregnancy. Spontaneous cervical or TEA-induced vaginal phasic contractions were not mediated by ICs or intracellular Ca2+ stores. Given that vaginal smooth muscle is normally quiescent then it is likely that increases in hormones such as oxytocin, as might occur through sexual stimulation, enhance the effectiveness of such pacemaking until phasic contractile activity emerges.	[Gravina, Fernanda S.; van Helden, Dirk F.; Kerr, Karen P.; de Oliveira, Ramatis B.; Jobling, Phillip] Univ Newcastle, Fac Hlth & Med, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia	University of Newcastle	van Helden, DF (corresponding author), Univ Newcastle, Fac Hlth & Med, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia.	dirk.vanhelden@newcastle.edu.au			Hunter Medical Research Institute (HMRI)	Hunter Medical Research Institute (HMRI)	The study was supported by the Hunter Medical Research Institute (HMRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson PI, 2006, BRIT J PHARMACOL, V147, P815, DOI 10.1038/sj.bjp.0706644; Allix S, 2008, BIOL REPROD, V79, P510, DOI 10.1095/biolreprod.107.066373; Ascher-Landsberg J, 1999, BIOCHEM BIOPH RES CO, V264, P979, DOI 10.1006/bbrc.1999.1602; Basha M, 2009, AM J PHYSIOL-REG I, V297, pR1486, DOI 10.1152/ajpregu.90516.2008; Cambell B, 1976, CLITORIS, P33; CARMICHAEL MS, 1987, J CLIN ENDOCR METAB, V64, P27, DOI 10.1210/jcem-64-1-27; Ciontea SM, 2005, J CELL MOL MED, V9, P407, DOI 10.1111/j.1582-4934.2005.tb00366.x; Coleman HA, 2000, J PHYSIOL-LONDON, V523, P785, DOI 10.1111/j.1469-7793.2000.00785.x; Cretoiu SM, 2011, ACTA PHYSIOL HUNG, V98, P329, DOI 10.1556/APhysiol.98.2011.3.10; Dickens EJ, 1999, J PHYSIOL-LONDON, V514, P515, DOI 10.1111/j.1469-7793.1999.515ae.x; DUCHENS M, 1993, VET REC, V133, P546, DOI 10.1136/vr.133.22.546; Duquette RA, 2005, BIOL REPROD, V72, P276, DOI 10.1095/biolreprod.104.033506; Faussone-Pellegrini MS, 1999, MICROSC RES TECHNIQ, V47, P248, DOI 10.1002/(SICI)1097-0029(19991115)47:4<248::AID-JEMT4>3.0.CO;2-W; FOX CA, 1970, J REPROD FERTIL, V22, P243; Fuchs AR, 1996, BIOL REPROD, V54, P700, DOI 10.1095/biolreprod54.3.700; Fuchs AR, 1996, AM J OBSTET GYNECOL, V175, P1654, DOI 10.1016/S0002-9378(96)70121-7; GARCIAVILLAR R, 1982, J PHARMACOL METHOD, V7, P83, DOI 10.1016/0160-5402(82)90061-4; GARCIAVILLAR R, 1984, J REPROD FERTIL, V72, P143, DOI 10.1530/jrf.0.0720143; Giraldi A, 2002, INT J IMPOT RES, V14, P271, DOI 10.1038/sj.ijir.3900886; Giraldi A, 2004, J SEX MED, V1, P237, DOI 10.1111/j.1743-6109.04037.x; Giuliano F, 2001, AM J PHYSIOL-REG I, V281, pR140, DOI 10.1152/ajpregu.2001.281.1.R140; Gravina FS, 2010, BRIT J PHARMACOL, V161, P1375, DOI 10.1111/j.1476-5381.2010.00949.x; Griffiths AL, 2006, J ENDOCRINOL, V188, P569, DOI 10.1677/joe.1.06466; Helmer H, 1998, AM J OBSTET GYNECOL, V179, P1572, DOI 10.1016/S0002-9378(98)70027-4; Hirsbrunner G, 2003, J VET MED A, V50, P442, DOI 10.1046/j.1439-0442.2003.00583.x; Hirst GDS, 2002, J PHYSIOL-LONDON, V540, P1003, DOI 10.1113/jphysiol.2001.013672; HUIZINGA JD, 1995, NATURE, V373, P347, DOI 10.1038/373347a0; Hutchings G, 2006, GYNECOL OBSTET INVES, V62, P79, DOI 10.1159/000092530; Hutchings G, 2009, J CELL MOL MED, V13, P4268, DOI 10.1111/j.1582-4934.2009.00894.x; Jobling P, 2011, AUTON NEUROSCI-BASIC, V165, P113, DOI 10.1016/j.autneu.2010.07.004; Kito Y, 2002, PFLUG ARCH EUR J PHY, V445, P202, DOI 10.1007/s00424-002-0884-z; Kupittayanant S, 2002, BJOG-INT J OBSTET GY, V109, P289, DOI 10.1016/S1470-0328(02)01110-2; Lee SE, 2009, KOREAN J PHYSIOL PHA, V13, P241, DOI 10.4196/kjpp.2009.13.3.241; LIU LWC, 1995, J PHARMACOL EXP THER, V275, P1058; MAGGI M, 1988, ENDOCRINOLOGY, V122, P2970, DOI 10.1210/endo-122-6-2970; Mahendroo MS, 1999, MOL ENDOCRINOL, V13, P981, DOI 10.1210/me.13.6.981; Matthew A, 2004, J SOC GYNECOL INVEST, V11, P207, DOI 10.1016/j.jsgi.2003.10.009; McCallum LA, 2011, J CELL MOL MED, V15, P577, DOI 10.1111/j.1582-4934.2010.01021.x; MCKENNA KE, 1991, AM J PHYSIOL, V261, pR1276, DOI 10.1152/ajpregu.1991.261.5.R1276; MERSHON JL, 1994, BIOL REPROD, V51, P993, DOI 10.1095/biolreprod51.5.993; Meston CM, 2004, ANN REV SEX RES, V15, P173; Munarriz R, 2003, J UROLOGY, V170, pS40, DOI 10.1097/01.ju.0000075352.03144.15; Munarriz R, 2003, ARCH GYNECOL OBSTET, V170, pS44; Oh SJ, 2003, INT J IMPOT RES, V15, P142, DOI 10.1038/sj.ijir.3900986; PAPKA RE, 1985, CELL TISSUE RES, V242, P475; PARKINGTON HC, 1988, CLIN EXP PHARMACOL P, V15, P657, DOI 10.1111/j.1440-1681.1988.tb01125.x; Piekorz RP, 2005, MOL ENDOCRINOL, V19, P431, DOI 10.1210/me.2004-0302; Popescu LM, 2007, ANN NY ACAD SCI, V1101, P139, DOI 10.1196/annals.1389.022; Popescu LM, 2006, EUR J PHARMACOL, V546, P177, DOI 10.1016/j.ejphar.2006.06.068; Rahardjo HE, 2011, J SEX MED, V8, P35, DOI 10.1111/j.1743-6109.2010.01923.x; Ruddock NK, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.085; Shafik A, 2007, J OBSTET GYNAECOL, V27, P485, DOI 10.1080/01443610701405689; Shafik A, 2005, INT J IMPOT RES, V17, P121, DOI 10.1038/sj.ijir.3901278; Shafik Ahmed, 2004, Archives of Gynecology and Obstetrics, V269, P282; Shmigol AV, 1999, J PHYSIOL-LONDON, V520, P153, DOI 10.1111/j.1469-7793.1999.00153.x; Staley K, 2005, NAT NEUROSCI, V8, P697, DOI 10.1038/nn0605-697; Suzuki H, 1999, J PHYSIOL-LONDON, V517, P563, DOI 10.1111/j.1469-7793.1999.0563t.x; Van Helden DF, 2000, J PHYSIOL-LONDON, V524, P245, DOI 10.1111/j.1469-7793.2000.00245.x; van Helden DF, 2003, J PHYSIOL-LONDON, V548, P271, DOI 10.1113/jphysiol.2002.033720; van Helden DF, 2009, CLIN EXP PHARM PHYSL; WARD SM, 1994, J PHYSIOL-LONDON, V480, P91, DOI 10.1113/jphysiol.1994.sp020343; Ward SM, 2000, J PHYSIOL-LONDON, V525, P355, DOI 10.1111/j.1469-7793.2000.t01-1-00355.x	62	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e111307	10.1371/journal.pone.0111307	http://dx.doi.org/10.1371/journal.pone.0111307			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337931	gold, Green Published			2022-12-27	WOS:000343674800115
J	Sumiya, N; Fujiwara, T; Kobayashi, Y; Misumi, O; Miyagishima, SY				Sumiya, Nobuko; Fujiwara, Takayuki; Kobayashi, Yusuke; Misumi, Osami; Miyagishima, Shin-ya			Development of a Heat-Shock Inducible Gene Expression System in the Red Alga Cyanidioschyzon merolae	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; CLUSTAL-W; DIVISION; DYNAMIN; GENOME; SEQUENCE; MITOCHONDRIA; INHERITANCE; CYCLE; TOOL	The cell of the unicellular red alga Cyanidioschyzon merolae contains a single chloroplast and mitochondrion, the division of which is tightly synchronized by a light/dark cycle. The genome content is extremely simple, with a low level of genetic redundancy, in photosynthetic eukaryotes. In addition, transient transformation and stable transformation by homologous recombination have been reported. However, for molecular genetic analyses of phenomena that are essential for cellular growth and survival, inducible gene expression/suppression systems are needed. Here, we report the development of a heat-shock inducible gene expression system in C. merolae. CMJ101C, encoding a small heat shock protein, is transcribed only when cells are exposed to an elevated temperature. Using a superfolder GFP as a reporter protein, the 200-bp upstream region of CMJ101C orf was determined to be the optimal promoter for heat-shock induction. The optimal temperature to induce expression is 50 degrees C, at which C. merolae cells are able to proliferate. At least a 30-min heat shock is required for the expression of a protein of interest and a 60-min heat shock yields the maximum level of protein expression. After the heat shock, the mRNA level decreases rapidly. As an example of the system, the expression of a dominant negative form of chloroplast division DRP5B protein, which has a mutation in the GTPase domain, was induced. Expression of the dominant negative DRP5B resulted in the appearance of aberrant-shaped cells in which two daughter chloroplasts and the cells are still connected by a small DRP5B positive tube-like structure. This result suggests that the dominant negative DRP5B inhibited the final scission of the chloroplast division site, but not the earlier stages of division site constriction. It is also suggested that cell cycle progression is not arrested by the impairment of chloroplast division at the final stage.	[Sumiya, Nobuko; Fujiwara, Takayuki; Miyagishima, Shin-ya] Natl Inst Genet, Frontier Res Ctr, Mishima, Shizuoka 411, Japan; [Sumiya, Nobuko; Misumi, Osami; Miyagishima, Shin-ya] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan; [Kobayashi, Yusuke; Misumi, Osami] Yamaguchi Univ, Fac Sci, Dept Biol Sci & Chem, Yamaguchi 753, Japan; [Miyagishima, Shin-ya] Grad Univ Adv Studies SOKENDAI, Dept Genet, Mishima, Shizuoka, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Japan Science & Technology Agency (JST); Yamaguchi University; Graduate University for Advanced Studies - Japan	Sumiya, N (corresponding author), Natl Inst Genet, Frontier Res Ctr, Mishima, Shizuoka 411, Japan.	nsumiya@nig.ac.jp; smiyagis@nig.ac.jp	Sumiya, Nobuko/B-2683-2009	Sumiya, Nobuko/0000-0003-3811-6052; Miyagishima, Shin-ya/0000-0002-9111-0832	Japan Society for the Promotion of Science [25251039]; Core Research for Evolutional Science and Technology (CREST) of Program of Japan Science and Technology Agency (JST); Grants-in-Aid for Scientific Research [25251039] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core Research for Evolutional Science and Technology (CREST) of Program of Japan Science and Technology Agency (JST); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding provided by a Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (no. 25251039 to S.M. http://www.jsps.go.jp/english/e-grants/), Core Research for Evolutional Science and Technology (CREST) of Program of Japan Science and Technology Agency (JST) (to S.M. http://www.jst.go.jp/kisoken/crest/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Casas-Mollano JA, 2008, GENETICS, V179, P69, DOI 10.1534/genetics.107.086546; Cava F, 2008, ENVIRON MICROBIOL, V10, P605, DOI 10.1111/j.1462-2920.2007.01482.x; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Fujiwara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073608; Fujiwara T, 2013, MOL BIOL CELL, V24, P2515, DOI 10.1091/mbc.E13-04-0208; Fujiwara T, 2010, PLANT CELL, V22, P772, DOI 10.1105/tpc.109.070227; Gao HB, 2003, P NATL ACAD SCI USA, V100, P4328, DOI 10.1073/pnas.0530206100; Imamura S, 2010, PLANT CELL PHYSIOL, V51, P707, DOI 10.1093/pcp/pcq043; Imamura S, 2009, P NATL ACAD SCI USA, V106, P12548, DOI 10.1073/pnas.0902790106; Kuroiwa T, 1998, INT REV CYTOL, V181, P1, DOI 10.1016/S0074-7696(08)60415-5; Kuroiwa T, 2010, P JPN ACAD B-PHYS, V86, P455, DOI 10.2183/pjab.86.455; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Minoda A, 2004, PLANT CELL PHYSIOL, V45, P667, DOI 10.1093/pcp/pch087; Misumi O, 2005, PLANT PHYSIOL, V137, P567, DOI 10.1104/pp.104.053991; Miyagishima S, 2003, PLANT CELL, V15, P655, DOI 10.1105/tpc.009373; Miyagishima SY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4807; Miyagishima S, 2012, MOL BIOL EVOL, V29, P2957, DOI 10.1093/molbev/mss102; Nozaki H, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-28; Ohnuma M, 2008, PLANT CELL PHYSIOL, V49, P117, DOI 10.1093/pcp/pcm157; Ohnuma M, 2009, PROTOPLASMA, V236, P107, DOI 10.1007/s00709-009-0056-5; Ohta N, 2003, DNA RES, V10, P67, DOI 10.1093/dnares/10.2.67; Ohta N, 1998, NUCLEIC ACIDS RES, V26, P5190, DOI 10.1093/nar/26.22.5190; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Reeb V, 2010, CELL ORIG LIFE EXTRE, V13, P409, DOI 10.1007/978-90-481-3795-4_22; Sakaguchi E, 2011, PLANT SCI, V180, P789, DOI 10.1016/j.plantsci.2011.02.003; Schoffl F, 1998, PLANT PHYSIOL, V117, P1135, DOI 10.1104/pp.117.4.1135; SUZUKI K, 1994, EUR J CELL BIOL, V63, P280; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Watanabe S, 2014, BIOSCI BIOTECH BIOCH, V78, P175, DOI 10.1080/09168451.2014.877823; Yagisawa F, 2013, PROTOPLASMA, V250, P943, DOI 10.1007/s00709-012-0467-6; Yagisawa F, 2012, PROTOPLASMA, V249, P1129, DOI 10.1007/s00709-011-0359-1; Yagisawa F, 2009, PLANT J, V60, P882, DOI 10.1111/j.1365-313X.2009.04008.x	36	19	19	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e111261	10.1371/journal.pone.0111261	http://dx.doi.org/10.1371/journal.pone.0111261			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337786	Green Published, gold, Green Submitted			2022-12-27	WOS:000343674800113
J	Velez, JCQ; Janech, MG; Hicks, MP; Morinelli, TA; Rodgers, J; Self, SE; Arthur, JM; Fitzgibbon, WR				Velez, Juan Carlos Q.; Janech, Michael G.; Hicks, Megan P.; Morinelli, Thomas A.; Rodgers, Jessalyn; Self, Sally E.; Arthur, John M.; Fitzgibbon, Wayne R.			Lack of Renoprotective Effect of Chronic Intravenous Angiotensin-(1-7) or Angiotensin-(2-10) in a Rat Model of Focal Segmental Glomerulosclerosis	PLOS ONE			English	Article							FAWN-HOODED RAT; HYPERTENSIVE-RATS; KIDNEY-DISEASE; FLUID CONCENTRATIONS; ENDOTHELIAL-CELLS; MASS-SPECTROMETRY; ANESTHETIZED RATS; AT(2) RECEPTORS; RENAL-DISEASE; RENIN	Unopposed angiotensin (Ang) II-mediated cellular effects may lead to progressive glomerulosclerosis. While Ang-II can be locally generated in the kidneys, we previously showed that glomerular podocytes primarily convert Ang-I, the precursor of Ang-II, to Ang-(1-7) and Ang-(2-10), peptides that have been independently implicated in biological actions opposing those of Ang-II. Therefore, we hypothesized that Ang-(1-7) and Ang-(2-10) could be renoprotective in the fawn-hooded hypertensive rat, a model of focal segmental glomerulosclerosis. We evaluated the ability of 8-12 week-long intravenous administration of either Ang-(1-7) or Ang-(2-10) (100-400 ng/kg/min) to reduce glomerular injury in uni-nephrectomized fawn-hooded hypertensive rats, early or late in the disease. Vehicle-treated rats developed hypertension and lesions of focal segmental glomerulosclerosis. No reduction in glomerular damage was observed, as measured by either 24-hour urinary protein excretion or histological examination of glomerulosclerosis, upon Ang-(1-7) or Ang-(2-10) administration, regardless of peptide dose or disease stage. On the contrary, when given at 400 ng/kg/min, both peptides induced a further increase in systolic blood pressure. Content of Ang peptides was measured by parallel reaction monitoring in kidneys harvested at sacrifice. Exogenous administration of Ang-(1-7) and Ang-(2-10) did not lead to a significant increase in their corresponding intrarenal levels. However, the relative abundance of Ang-(1-7) with respect to Ang-II was increased in kidney homogenates of Ang-(1-7)-treated rats. We conclude that chronic intravenous administration of Ang-(1-7) or Ang-(2-10) does not ameliorate glomerular damage in a rat model of focal segmental glomerulosclerosis and may induce a further rise in blood pressure, potentially aggravating glomerular injury.	[Velez, Juan Carlos Q.; Janech, Michael G.; Hicks, Megan P.; Morinelli, Thomas A.; Rodgers, Jessalyn; Arthur, John M.; Fitzgibbon, Wayne R.] Med Univ S Carolina, Dept Med, Div Nephrol, Charleston, SC 29425 USA; [Velez, Juan Carlos Q.; Arthur, John M.] Ralph H Johnson Vet Affairs Med Ctr, Med Serv, Charleston, SC USA; [Self, Sally E.] Med Univ S Carolina, Dept Pathol, Charleston, SC 29425 USA	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina	Velez, JCQ (corresponding author), Med Univ S Carolina, Dept Med, Div Nephrol, Charleston, SC 29425 USA.	velezj@musc.edu	Velez, Juan Carlos/N-3782-2016; janech, michael/AAA-1011-2019	Arthur, John/0000-0003-4342-4762; Janech, Michael/0000-0002-3202-4811	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institute of Health [DK080944]; American Recovery and Reinvestment Act [DK080944]; Nephcure Foundation; Dialysis Clinics Incorporated; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK080944] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Recovery and Reinvestment Act; Nephcure Foundation; Dialysis Clinics Incorporated; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was partially funded by a grant from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institute of Health (DK080944) (JCV), American Recovery and Reinvestment Act supplement to DK080944 (MPH and WRF), and The Nephcure Foundation (MGJ), and Dialysis Clinics Incorporated (JCV and TAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benter IF, 2008, AM J NEPHROL, V28, P25, DOI 10.1159/000108758; BENTER IF, 1995, AM J PHYSIOL-HEART C, V269, pH313, DOI 10.1152/ajpheart.1995.269.1.H313; BENTER IF, 1993, PEPTIDES, V14, P679, DOI 10.1016/0196-9781(93)90097-Z; Bosnyak S, 2011, CLIN SCI, V121, P297, DOI 10.1042/CS20110036; CAMPBELL DJ, 1991, HYPERTENSION, V18, P763, DOI 10.1161/01.HYP.18.6.763; Colucci JA, 2011, J RENIN-ANGIO-ALDO S, V12, P15, DOI 10.1177/1470320310375456; DEKEIJZER MH, 1989, J HYPERTENS, V7, P525, DOI 10.1097/00004872-198907000-00003; Dhande I, 2013, HYPERTENSION, V61, P1218, DOI 10.1161/HYPERTENSIONAHA.111.00422; Dilauro M, 2010, AM J PHYSIOL-RENAL, V298, pF1523, DOI 10.1152/ajprenal.00426.2009; Ferrario CM, 2010, AM J PHYSIOL-RENAL, V298, pF1297, DOI 10.1152/ajprenal.00110.2010; Fukuda A, 2012, KIDNEY INT, V81, P40, DOI 10.1038/ki.2011.306; Giani JF, 2012, AM J PHYSIOL-RENAL, V302, pF1606, DOI 10.1152/ajprenal.00063.2012; Grobe JL, 2007, AM J PHYSIOL-HEART C, V292, pH736, DOI 10.1152/ajpheart.00937.2006; Grobe N, 2013, AM J PHYSIOL-CELL PH, V304, pC945, DOI 10.1152/ajpcell.00346.2012; Handa RK, 1996, AM J PHYSIOL-RENAL, V270, pF141, DOI 10.1152/ajprenal.1996.270.1.F141; Haulica I, 2003, J RENIN-ANGIO-ALDO S, V4, P124, DOI 10.3317/jraas.2003.013; Ibrahim HN, 1997, SEMIN NEPHROL, V17, P431; Ji H, 2008, EXP PHYSIOL, V93, P648, DOI 10.1113/expphysiol.2007.041392; Joyner J, 2008, AM J PHYSIOL-REG I, V294, pR1073, DOI 10.1152/ajpregu.00572.2007; Kemp BA, 2012, HYPERTENSION, V60, P387, DOI 10.1161/HYPERTENSIONAHA.112.191403; KREISBERG JI, 1978, AM J PATHOL, V92, P637; KUIJPERS MHM, 1984, BRIT J EXP PATHOL, V65, P181; Lortie M, 2009, ANAL BIOCHEM, V394, P164, DOI 10.1016/j.ab.2009.07.021; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Min L, 2000, REGUL PEPTIDES, V95, P93, DOI 10.1016/S0167-0115(00)00162-2; Moon JY, 2011, AM J PHYSIOL-RENAL, V300, pF1271, DOI 10.1152/ajprenal.00065.2010; Morinelli TA, 2007, AM J PHYSIOL-CELL PH, V292, pC1398, DOI 10.1152/ajpcell.00337.2006; NAVAR LG, 1994, J AM SOC NEPHROL, V5, P1153; Nishiyama A, 2002, HYPERTENSION, V39, P129, DOI 10.1161/hy0102.100536; OLIVER JD, 1994, AM J PHYSIOL-RENAL, V267, pF917, DOI 10.1152/ajprenal.1994.267.6.F917; Prieto MC, 2011, AM J PHYSIOL-RENAL, V300, pF749, DOI 10.1152/ajprenal.00383.2009; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; SEIKALY MG, 1990, J CLIN INVEST, V86, P1352, DOI 10.1172/JCI114846; Shao Y, 2008, ACTA PHARMACOL SIN, V29, P829, DOI 10.1111/j.1745-7254.2008.00812.x; Silva ACSE, 1998, REGUL PEPTIDES, V74, P177, DOI 10.1016/S0167-0115(98)00038-X; SIMONS JL, 1993, J AM SOC NEPHROL, V4, P1362; Tallant EA, 2005, AM J PHYSIOL-HEART C, V289, pH1560, DOI 10.1152/ajpheart.00941.2004; van der Wouden EA, 2005, J RENIN-ANGIO-ALDO S, V6, P96, DOI 10.3317/jraas.2005.016; Velez JCQ, 2007, AM J PHYSIOL-RENAL, V293, pF398, DOI 10.1152/ajprenal.00050.2007; Velez JCQ, 2012, AM J PHYSIOL-RENAL, V302, pF1583, DOI 10.1152/ajprenal.00087.2012; Velez JCQ, 2009, HYPERTENSION, V53, P790, DOI 10.1161/HYPERTENSIONAHA.109.128819; Velkoska E, 2011, CLIN SCI, V120, P335, DOI 10.1042/CS20100280; Yoshida M, 2002, THROMB RES, V105, P531, DOI 10.1016/S0049-3848(02)00056-7; Zhang JD, 2010, AM J PHYSIOL-RENAL, V298, pF579, DOI 10.1152/ajprenal.00548.2009; Zimmerman D, 2012, CLIN SCI, V123, P333, DOI 10.1042/CS20120111; Zimpelmann J, 2009, AM J PHYSIOL-RENAL, V296, pF337, DOI 10.1152/ajprenal.90437.2008	46	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110083	10.1371/journal.pone.0110083	http://dx.doi.org/10.1371/journal.pone.0110083			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337950	Green Published, gold, Green Submitted			2022-12-27	WOS:000343674800024
J	Xia, LZ; Ren, YW; Fang, X; Yin, ZH; Li, XL; Wu, W; Guan, P; Zhou, BS				Xia, Lingzi; Ren, Yangwu; Fang, Xue; Yin, Zhihua; Li, Xuelian; Wu, Wei; Guan, Peng; Zhou, Baosen			Prognostic Role of Common MicroRNA Polymorphisms in Cancers: Evidence from a Meta-Analysis	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; CELL LUNG-CANCER; GASTRIC-CANCER; GENETIC-VARIANTS; HEPATOCELLULAR-CARCINOMA; COLORECTAL-CANCER; PRE-MICRORNA; FUNCTIONAL POLYMORPHISM; SEQUENCE POLYMORPHISM; ENDOTHELIAL-CELLS	Background: The morbidity and mortality of cancer increase remarkably every year. It's a heavy burden for family and society. The detection of prognostic biomarkers can help to improve the theraputic effect and prolong the lifetime of patients. microRNAs have an influential role in cancer prognosis. The results of articles discussing the relationship between microRNA polymorphisms and cancer prognosis are inconsistent. Methods: We conduct a meta-analysis of 19 publications concerning the association of four common polymorphisms, mir-146a rs2910164, mir-149 rs2292832, mir-196a2 rs11614913 and mir-499 rs3746444, with cancer prognosis. Pooled Hazard Ratios with 95% Confidence Intervals for the relationship between four genetic polymorphisms and Overall Survival, Recurrence-free Survival, Disease-free survival, recurrence are calculated. Subgroup analysis by population and type of tumor are conducted. Results: GG genotype of mir-146a may be the protective factor for overall survival, especially in Caucasian population. C-containing genotypes of mir-196a2 act as a risk role for overall survival. The same result exists in Asian population, in Non-Small Cell Lung Cancer and digestive cancer. The patients with C allele of mir-149 have a better overall survival, especially in Non-Small Cell Lung Cancer. No significant results are obtained for mir-499 polymorphisms. Conclusions: Genetic polymorphisms in mir-146a, mir-196a2 and mir-149 may be associated with overall survival. This effect varies with different types of cancer. Genetic polymorphism in mir-499 may have nothing to do with cancer prognosis.	[Xia, Lingzi; Ren, Yangwu; Fang, Xue; Yin, Zhihua; Li, Xuelian; Wu, Wei; Guan, Peng; Zhou, Baosen] China Med Univ, Sch Publ Hlth, Dept Epidemiol, Shenyang, Liaoning Provin, Peoples R China; [Xia, Lingzi; Ren, Yangwu; Fang, Xue; Yin, Zhihua; Li, Xuelian; Wu, Wei; Guan, Peng; Zhou, Baosen] Univ Liaoning Prov, Key Lab Canc Etiol & Intervent, Shenyang, Peoples R China	China Medical University	Zhou, BS (corresponding author), China Med Univ, Sch Publ Hlth, Dept Epidemiol, Shenyang, Liaoning Provin, Peoples R China.	bszhou@mail.cmu.edu.cn	Guan, Peng/GWM-9170-2022		National Natural Science Foundation of China [81272293, 81102194]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Grant no. 81272293 and no. 81102194 from National Natural Science Foundation of China. ZBS and YZH received the funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn DH, 2013, MOL CARCINOGEN, V52, P39, DOI 10.1002/mc.21962; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Chae YS, 2013, ANTICANCER RES, V33, P3233; Chae YS, 2013, ANTICANCER RES, V33, P513; Chaudhry MA, 2013, J RADIAT RES, V54, P808, DOI 10.1093/jrr/rrt014; [陈佳萍 CHEN Jia-ping], 2009, [南京医科大学学报. 自然科学版, Acta Universitatis Medicinalis Nanjing], V29, P762; Christensen BC, 2010, CLIN CANCER RES, V16, P3713, DOI 10.1158/1078-0432.CCR-10-0657; Dikeakos P, 2014, MOL BIOL REP, V41, P1075, DOI 10.1007/s11033-013-2953-0; Ding SL, 2013, J BIOL CHEM, V288, P26865, DOI 10.1074/jbc.M112.440453; Ferlay J, 2012, GLOBOCAN 2012 V1 0, V11; Guan XX, 2013, CANCER LETT, V330, P233, DOI 10.1016/j.canlet.2012.11.048; Hong MJ, 2013, J THORAC ONCOL, V8, P703, DOI 10.1097/JTO.0b013e318288dc0a; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Huang DZ, 2014, J CELL BIOCHEM, V115, P549, DOI 10.1002/jcb.24689; Jang MJ, 2011, EXP THER MED, V2, P1127, DOI 10.3892/etm.2011.321; Ke Y, 2013, BIOCHEM RES INT, V2013, DOI 10.1155/2013/506731; Kim HY, 2014, J MED VIROL, V86, P446, DOI 10.1002/jmv.23848; Kim WH, 2012, GENE, V504, P92, DOI 10.1016/j.gene.2012.05.014; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Li Y, 2010, CANCER RES, V70, P7894, DOI 10.1158/0008-5472.CAN-10-1675; Lin J, 2010, CARCINOGENESIS, V31, P1805, DOI 10.1093/carcin/bgq168; Lin RJ, 2010, MOL CARCINOGEN, V49, P719, DOI 10.1002/mc.20647; Liu CJ, 2013, ANN SURG ONCOL, V20, pS406, DOI 10.1245/s10434-012-2618-6; Navarro A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064716; Okubo M, 2010, EXP THER MED, V1, P1035, DOI 10.3892/etm.2010.154; Olivieri F, 2013, FREE RADICAL BIO MED, V63, P410, DOI 10.1016/j.freeradbiomed.2013.05.033; Omrani M, 2014, BIOMARK MED, V8, P259, DOI 10.2217/bmm.13.118; Pan SJ, 2012, INT J IMMUNOPATH PH, V25, P871, DOI 10.1177/039463201202500405; Permuth-Wey J, 2011, J NEURO-ONCOL, V105, P639, DOI 10.1007/s11060-011-0634-1; Ramkaran P, 2014, CELL BIOCHEM BIOPHYS, V68, P259, DOI 10.1007/s12013-013-9704-7; Stenholm L, 2013, ANN ONCOL, V24, P2581, DOI 10.1093/annonc/mdt330; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tu HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051606; Umar M, 2013, MOL CARCINOGEN, V52, P10, DOI 10.1002/mc.21931; Wang ML, 2012, CANCER RES, V72, P6173, DOI 10.1158/0008-5472.CAN-12-0688; Wang SZ, 2013, MOL CARCINOGEN, V52, P87, DOI [10.1002/mc.22017, 10.1002/mc.21930]; Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041693; Wu CH, 2014, CANCER CHEMOTH PHARM, V73, P335, DOI 10.1007/s00280-013-2364-x; Xia XC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080426; Xing JL, 2012, CANCER EPIDEM BIOMAR, V21, P217, DOI 10.1158/1055-9965.EPI-11-0624; Xiong XD, 2014, MUTAT RES-FUND MOL M, V761, P15, DOI 10.1016/j.mrfmmm.2014.01.001; Yao QY, 2013, CANCER LETT, V335, P219, DOI 10.1016/j.canlet.2013.02.031; Yoon KA, 2012, J THORAC CARDIOV SUR, V144, P794, DOI 10.1016/j.jtcvs.2012.06.030; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; Zhang B, 2013, SINGLE NUCLEOTIDE PO; Zheng J, 2013, CANCER RES, V73, P5151, DOI 10.1158/0008-5472.CAN-13-0395; Zhu K, 2013, CARCINOGENESIS, V34, P2071, DOI 10.1093/carcin/bgt160	48	22	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e106799	10.1371/journal.pone.0106799	http://dx.doi.org/10.1371/journal.pone.0106799			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337946	gold, Green Published, Green Submitted			2022-12-27	WOS:000343674800003
J	Zheng, YF; Hou, JX; Peng, L; Zhang, X; Jia, LF; Wang, XE; Wei, SC; Meng, HX				Zheng, Yunfei; Hou, Jianxia; Peng, Lei; Zhang, Xin; Jia, Lingfei; Wang, Xian'e; Wei, Shicheng; Meng, Huanxin			The Pro-Apoptotic and Pro-Inflammatory Effects of Calprotectin on Human Periodontal Ligament Cells	PLOS ONE			English	Article							GINGIVAL CREVICULAR FLUID; GENERALIZED AGGRESSIVE PERIODONTITIS; DEPENDENT PATHWAY; S100A8; PROTEIN; NEUTROPHILS; MRP14; DISEASE; CANCER; S100A8/S100A9	Calprotectin, a heterodimer of S100A8 and S100A9 subunits, is associated with inflammatory disorders such as rheumatoid arthritis and cystic fibrosis. Although calprotectin levels are increased significantly in the gingival crevicular fluid (GCF) of periodontitis patients, its effects on periodontal ligament cells (PDLCs) remain largely unknown. The aim of this study was to evaluate calprotectin levels in the GCF of generalized aggressive periodontitis (AgP) patients and to investigate the effects of recombinant human calprotectin (rhS100A8/A9) and its subunits (rhS100A8 and rhS100A9) in PDLCs. Both the concentration and amount of crevicular calprotectin were significantly higher in the AgP group compared with healthy controls. In addition, the GCF calprotectin levels were correlated positively with clinical periodontal parameters including bleeding index, probing depth, and clinical attachment loss. rhS100A8/A9 promoted cell apoptosis, whereas rhS100A8 and rhS100A9 individually exerted little effect on apoptosis in PDLCs. rhS100A9 and rhS100A8/A9 increased the activation of nuclear factor-kappa B (NF-kappa B) by promoting the nuclear translocation of p65 in PDLCs, subsequently inducing expression of the pro-inflammatory cytokines IL-6, IL-8, TNF alpha, and COX2. Treatment with an NF-kappa B inhibitor partially reversed the rhS100A9-and rhS100A8/A9-induced upregulation of the pro-inflammatory cytokines. rhS100A9, and not rhS100A8, was mainly responsible for the pro-inflammatory role of calprotectin. Collectively, our results suggest that calprotectin promotes apoptosis and the inflammatory response in PDLCs via rhS100A9. These findings might help identify novel treatments for periodontitis.	[Zheng, Yunfei; Jia, Lingfei; Wei, Shicheng] Peking Univ, Sch & Hosp Stomatol, Dept Oral & Maxillofacial Surg, Beijing 100871, Peoples R China; [Zheng, Yunfei; Hou, Jianxia; Wang, Xian'e; Meng, Huanxin] Peking Univ, Sch & Hosp Stomatol, Dept Periodontol, Beijing 100871, Peoples R China; [Peng, Lei] Capital Med Univ, Beijing Friendship Hosp, Dept Stomatol, Beijing, Peoples R China; [Zhang, Xin] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Stomatol, Beijing 100730, Peoples R China; [Jia, Lingfei] Peking Univ, Sch & Hosp Stomatol, Mol Biol Lab, Beijing 100871, Peoples R China	Peking University; Peking University; Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Peking University	Meng, HX (corresponding author), Peking Univ, Sch & Hosp Stomatol, Dept Periodontol, Beijing 100871, Peoples R China.	kqhxmeng@bjmu.edu.cn	Wei, Shicheng/F-9552-2017; zheng, yunfei/M-4172-2018; hou, joye/AAT-9545-2020	Wei, Shicheng/0000-0001-6024-9615; 	National Natural Science Foundation of China [30271411, 30471882, 30973319]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (30271411, 30471882, 30973319), and HX Meng received the funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abtin A, 2010, J INVEST DERMATOL, V130, P2423, DOI 10.1038/jid.2010.158; Amano A, 2010, PERIODONTOL 2000, V54, P9, DOI 10.1111/j.1600-0757.2010.00376.x; Boyd JH, 2008, CIRC RES, V102, P1239, DOI 10.1161/CIRCRESAHA.107.167544; Cesaro A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045478; Cheung WY, 2012, BONE, V50, P104, DOI 10.1016/j.bone.2011.09.052; Driemel O, 2010, ANAL QUANT CYTOL, V32, P219; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Ghavami S, 2004, J LEUKOCYTE BIOL, V76, P169, DOI 10.1189/jlb.0903435; Ghavami S, 2008, J LEUKOCYTE BIOL, V83, P1484, DOI 10.1189/jlb.0607397; HESSIAN PA, 1993, J LEUKOCYTE BIOL, V53, P197, DOI 10.1002/jlb.53.2.197; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Ikeda H, 2011, ANN BIOMED ENG, V39, P26, DOI 10.1007/s10439-010-0115-2; Jonsson D, 2011, J PERIODONTAL RES, V46, P153, DOI 10.1111/j.1600-0765.2010.01331.x; Kaner D, 2006, J PERIODONTAL RES, V41, P132, DOI 10.1111/j.1600-0765.2005.00849.x; Kaner D, 2011, J PERIODONTAL RES, V46, P417, DOI 10.1111/j.1600-0765.2011.01355.x; Kerkhoff C, 1998, BBA-MOL CELL RES, V1448, P200, DOI 10.1016/S0167-4889(98)00144-X; Kido J, 1999, J CLIN PERIODONTOL, V26, P653, DOI 10.1034/j.1600-051X.1999.261004.x; Kou XX, 2011, ARTHRITIS RHEUM-US, V63, P1888, DOI 10.1002/art.30334; Liu KN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039878; Liu KN, 2010, J PERIODONTOL, V81, P260, DOI 10.1902/jop.2009.090355; MITSUYAMA K, 1994, CLIN EXP IMMUNOL, V96, P432; MOSKOW BS, 1991, J CLIN PERIODONTOL, V18, P534, DOI 10.1111/j.1600-051X.1991.tb00086.x; MURTHY ARK, 1993, J IMMUNOL, V151, P6291; Nakamura T, 2000, J PERIODONTOL, V71, P361, DOI 10.1902/jop.2000.71.3.361; Newton RA, 1998, J IMMUNOL, V160, P1427; Nishii K, 2013, J PERIODONTAL RES, V48, P235, DOI 10.1111/jre.12000; Nishimura E, 1999, J DENT RES, V78, P1251, DOI 10.1177/00220345990780060901; Nishimura F, 1998, ANN PERIODONTOL, V3, P10; Rammes A, 1997, J BIOL CHEM, V272, P9496; Reynolds JJ, 1997, PERIODONTOL 2000, V14, P144, DOI 10.1111/j.1600-0757.1997.tb00195.x; Riva M, 2012, IMMUNOLOGY, V137, P172, DOI 10.1111/j.1365-2567.2012.03619.x; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Sun X, 2011, J PERIODONTAL RES, V46, P354, DOI 10.1111/j.1600-0765.2011.01350.x; Vandal K, 2003, J IMMUNOL, V171, P2602, DOI 10.4049/jimmunol.171.5.2602; Viemann D, 2007, BLOOD, V109, P2453, DOI 10.1182/blood-2006-08-040444; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Volz HC, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0250-z; Voss A, 2011, FEBS LETT, V585, P440, DOI 10.1016/j.febslet.2010.12.037; Yin HP, 2013, ANTI-CANCER DRUG, V24, P587, DOI 10.1097/CAD.0b013e3283611395; Yui S, 2003, BIOL PHARM BULL, V26, P753; Yui S, 2002, MEDIAT INFLAMM, V11, P165, DOI 10.1080/09622935020138208; Zali Hakimeh, 2008, Iran Biomed J, V12, P7; Zhang X, 2013, J PERIODONTAL RES, V48, P74, DOI 10.1111/j.1600-0765.2012.01505.x	43	20	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110421	10.1371/journal.pone.0110421	http://dx.doi.org/10.1371/journal.pone.0110421			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338166	Green Published, gold			2022-12-27	WOS:000343674800041
J	Richardson-Harman, N; Hendrix, CW; Bumpus, NN; Mauck, C; Cranston, RD; Yang, K; Elliott, J; Tanner, K; McGowan, I; Kashuba, A; Anton, PA				Richardson-Harman, Nicola; Hendrix, Craig W.; Bumpus, Namandje N.; Mauck, Christine; Cranston, Ross D.; Yang, Kuo; Elliott, Julie; Tanner, Karen; McGowan, Ian; Kashuba, Angela; Anton, Peter A.			Correlation between Compartmental Tenofovir Concentrations and an Ex Vivo Rectal Biopsy Model of Tissue Infectibility in the RMP-02/MTN-006 Phase 1 Study	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CANDIDATE MICROBICIDES; TOPICAL MICROBICIDES; HIV-INFECTION; TRANSMISSION; CULTURE; SAFETY	Objectives: This study was designed to assess the dose-response relationship between tissue, blood, vaginal and rectal compartment concentrations of tenofovir (TFV) and tenofovir diphosphate (TFVdp) and ex vivo rectal HIV suppression following oral tenofovir disoproxil fumarate (TDF) and rectal administration of TFV 1% vaginally-formulated gel. Design: Phase 1, randomized, two-site (US), double-blind, placebo-controlled study of sexually-abstinent males and females. Methods: Eighteen participants received a single 300 mg exposure of oral TDF and were then randomized 2: 1 to receive a single then seven-daily rectal exposures of TFV 1% gel (40 mg TFV per 4 ml gel application) or hydroxyethyl-cellulose (HEC) placebo gel. Blood and rectal biopsies were collected for pharmacokinetic TDF and TFVdp analyses and ex vivo HIV-1 challenge. Results: There was a significant fit for the TFVdp dose-response model for rectal tissue (p = 0.0004), CD4(MMC)(+) (p<0.0001), CD4(MMC)(-) (p<0.0001), and Total(MMC) (p<0.0001) compartments with r(2) ranging 0.36-0.64. Higher concentrations of TFVdp corresponded with lower p24, consistent with drug-mediated virus suppression. The single oral treatment failed to provide adequate compartment drug exposure to reach the EC50 of rectal tissue TFVdp predicted to be necessary to suppress HIV in rectal tissue. The EC50 for CD4(MMC)(+) was within the single topical treatment range, providing evidence that a 1% topical, vaginally-formulated TFV gel provided in-vivo doses predicted to provide for 50% efficacy in the ex vivo assay. The 7-daily topical TFV gel treatment provided TFVdp concentrations that reached EC90 biopsy efficacy for CD4(MMC)(-), CD4(MMC)(+) and TotalMMC compartments. Conclusion: The TFVdp MMC compartment (CD4+, CD4- and Total) provided the best surrogate for biopsy infectibility and the 7-daily topical TFV gel treatment provided the strongest PK profile for HIV suppression.	[Richardson-Harman, Nicola] Alpha StatConsult LLC, Damascus, MD 20872 USA; [Hendrix, Craig W.; Bumpus, Namandje N.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Hendrix, Craig W.; Bumpus, Namandje N.] Johns Hopkins Univ, Sch Med, Dept Pharmacol, Baltimore, MD 21205 USA; [Mauck, Christine] CONRAD, Arlington, VA USA; [Cranston, Ross D.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [McGowan, Ian] Univ Pittsburgh, Sch Med, Magee Womens Res Inst, Pittsburgh, PA USA; [Elliott, Julie; Tanner, Karen; Anton, Peter A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Ctr HIV Prevent Res,UCLA AIDS Inst, Los Angeles, CA 90095 USA; [Yang, Kuo; Kashuba, Angela] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC USA	Johns Hopkins University; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of North Carolina; University of North Carolina Chapel Hill	Richardson-Harman, N (corresponding author), Alpha StatConsult LLC, Damascus, MD 20872 USA.	nicola@alphastatconsult.com	Hendrix, Craig W/G-4182-2014; M, i/HCI-9242-2022; M, Ian/AAP-1032-2021	Hendrix, Craig W/0000-0002-5696-8665; M, Ian/0000-0002-6470-8476; Cranston, Ross/0000-0002-2687-6217	Integrated Preclinical-Clinical Program for HIV Topical Microbicides (IPCP-HTM), Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) [U19, AI060614]; NIAID's Microbicide Trials Network [5UM1AI068633]; Gilead Sciences Inc.; University of California, Los Angeles Center for AIDS Research [5P30 AI28697]; Cores of Mucosal Immunology, Flow Cytometry and Biostatistics; University of North Carolina-Chapel Hill Center for AIDS Research, Clinical Pharmacology/Analytical Chemistry Core [P30 AI50410]; Johns Hopkins Clinical Pharmacology Analytical Laboratory; CONRAD; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI106707, UM1AI068633, P30AI050410, U19AI060614, P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301] Funding Source: NIH RePORTER	Integrated Preclinical-Clinical Program for HIV Topical Microbicides (IPCP-HTM), Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH); NIAID's Microbicide Trials Network; Gilead Sciences Inc.(Gilead Sciences); University of California, Los Angeles Center for AIDS Research; Cores of Mucosal Immunology, Flow Cytometry and Biostatistics; University of North Carolina-Chapel Hill Center for AIDS Research, Clinical Pharmacology/Analytical Chemistry Core; Johns Hopkins Clinical Pharmacology Analytical Laboratory; CONRAD(United States Agency for International Development (USAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was funded by a U19 grant under the Integrated Preclinical-Clinical Program for HIV Topical Microbicides (IPCP-HTM), Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) (AI060614) and the NIAID's Microbicide Trials Network (5UM1AI068633). Additional support was provided by Gilead Sciences Inc.; the University of California, Los Angeles Center for AIDS Research (5P30 AI28697) Cores of Mucosal Immunology, Flow Cytometry and Biostatistics; the University of North Carolina-Chapel Hill Center for AIDS Research, Clinical Pharmacology/Analytical Chemistry Core (P30 AI50410); the Johns Hopkins Clinical Pharmacology Analytical Laboratory and CONRAD. The RMP-02/MTN-006 study was registered at http://www.ClinicalTrials.gov (NCT00984971) and the protocol can be found at http://www.mtnstopshiv.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author Nicola Richardson-Harman is employed by Apha StatConsult, LLC. Alpha StatConsult, LLC provided support in the form of salary for author NR-H, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The co-author NR-H, as a statistical consultant, analyzed data and contributed to the statistical sections of the manuscript. The specific role of this author is articulated in the "author contributions" section.	Abner SR, 2005, J INFECT DIS, V192, P1545, DOI 10.1086/462424; Anton PA, 2000, AIDS, V14, P1761, DOI 10.1097/00002030-200008180-00011; Anton PA, 2012, AIDS RES HUM RETROV, V28, P1412, DOI [10.1089/aid.2012.0262, 10.1089/AID.2012.0262]; Anton PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023243; BATMAN PA, 1994, AIDS, V8, P161, DOI 10.1097/00002030-199402000-00003; Fischetti L, 2009, AIDS, V23, P319, DOI 10.1097/QAD.0b013e328321b778; Fletcher PS, 2006, AIDS, V20, P1237, DOI 10.1097/01.aids.0000232230.96134.80; Glatting G, 2007, MED PHYS, V34, P4285, DOI 10.1118/1.2794176; Greenhead P, 2000, J VIROL, V74, P5577, DOI 10.1128/JVI.74.12.5577-5586.2000; Hendrix CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055013; Hladik F, 2010, ANTIVIR RES, V88, pS3, DOI 10.1016/j.antiviral.2010.09.011; Richardson-Harman N, 2012, AIDS RES HUM RETROV, V28, P1422, DOI [10.1089/aid.2012.0073, 10.1089/AID.2012.0073]; Richardson-Harman N, 2009, J CLIN MICROBIOL, V47, P3530, DOI 10.1128/JCM.00673-09; SAS Institute, 1999, SAS STAT US GUID VER, P1903; Tebit DM, 2012, CURR HIV RES, V10, P3, DOI 10.2174/157016212799304689; Tien D, 2005, AIDS RES HUM RETROV, V21, P845, DOI 10.1089/aid.2005.21.845; Yang K-H, PLOS ONE	17	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111507	10.1371/journal.pone.0111507	http://dx.doi.org/10.1371/journal.pone.0111507			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350130	Green Published, Green Accepted, gold			2022-12-27	WOS:000343943100076
J	Li, P; Shi, P; Lai, CH; Li, J; Zheng, YY; Xiong, Y; Zhang, LH; Tian, CL				Li, Pan; Shi, Pan; Lai, Chaohua; Li, Juan; Zheng, Yuanyuan; Xiong, Ying; Zhang, Longhua; Tian, Changlin			Solution NMR of MPS-1 Reveals a Random Coil Cytosolic Domain Structure	PLOS ONE			English	Article							GATED POTASSIUM CHANNELS; MINK-RELATED PEPTIDE-1; PROTEIN-KINASES; BETA-SUBUNIT; CAENORHABDITIS-ELEGANS; ACCESSORY SUBUNITS; K+ CHANNELS; COMPLEX; FAMILY; MECHANISMS	Caenorhabditis elegans MPS1 is a single transmembrane helical auxiliary subunit that co-localizes with the voltage-gated potassium channel KVS1 in the nematode nervous system. MPS-1 shares high homology with KCNE (potassium voltagegated channel subfamily E member) auxiliary subunits, and its cytosolic domain was reported to have a serine/threonine kinase activity that modulates KVS1 channel function via phosphorylation. In this study, NMR spectroscopy indicated that the full length and truncated MPS-1 cytosolic domain (134-256) in the presence or absence of n-dodecylphosphocholine detergent micelles adopted a highly flexible random coil secondary structure. In contrast, protein kinases usually adopt a stable folded conformation in order to implement substrate recognition and phosphoryl transfer. The highly flexible random coil secondary structure suggests that MPS-1 in the free state is unstructured but may require a substrate or binding partner to adopt stable structure required for serine/threonine kinase activity.	[Li, Pan; Lai, Chaohua; Li, Juan; Zheng, Yuanyuan; Xiong, Ying; Zhang, Longhua; Tian, Changlin] Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Microscale Phys Sci, Hefei 230026, Anhui, Peoples R China; [Shi, Pan; Tian, Changlin] Chinese Acad Sci, Hefei Inst Phys Sci, High Field Magnet Lab, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS	Zhang, LH (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Microscale Phys Sci, Hefei 230026, Anhui, Peoples R China.	zlhustc@ustc.edu.cn; cltian@ustc.edu.cn	Tian, Changlin/P-1469-2014; Zhang, Longhua/P-1417-2014		National Natural Science Foundation of China [U1332138, 31300685]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China grant U1332138 to CT and National Natural Science Foundation of China young investigator grant 31300685 to PS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Bianchi L, 2003, J BIOL CHEM, V278, P12415, DOI 10.1074/jbc.M212788200; Blunck R, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00166; Cai SQ, 2006, CELL BIOCHEM BIOPHYS, V46, P91, DOI 10.1385/CBB:46:1:91; Cai SQ, 2009, EMBO J, V28, P1601, DOI 10.1038/emboj.2009.112; Cai SQ, 2005, NAT NEUROSCI, V8, P1503, DOI 10.1038/nn1557; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Kosinska U, 2005, FEBS J, V272, P6365, DOI 10.1111/j.1742-4658.2005.05030.x; Li P, 2014, SCI REP-UK, V4, DOI 10.1038/srep04973; Li Y, 2006, NEUROSCIENTIST, V12, P199, DOI 10.1177/1073858406287717; Mine S, 2000, PROTEIN SCI, V9, P1669, DOI 10.1110/ps.9.9.1669; Park KH, 2005, J BIOL CHEM, V280, P21893, DOI 10.1074/jbc.M502732200; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Shah NH, 2014, TRANSL STROKE RES, V5, P38, DOI 10.1007/s12975-013-0297-7; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Tian CL, 2007, BIOCHEMISTRY-US, V46, P11459, DOI 10.1021/bi700705j; Tian CL, 2005, METHOD ENZYMOL, V394, P321, DOI 10.1016/S0076-6879(05)94012-3; Tinel N, 2000, EMBO J, V19, P6326, DOI 10.1093/emboj/19.23.6326; Torres YP, 2007, J BIOL CHEM, V282, P24485, DOI 10.1074/jbc.R700022200; Wang Y, 2007, BIOPHYS J, V93, P3083, DOI 10.1529/biophysj.107.110320; Xiang SQ, 2013, STRUCTURE, V21, P2162, DOI 10.1016/j.str.2013.09.014; Yu H, 2001, CIRC RES, V88, pE84, DOI 10.1161/hh1201.093511; Zhang M, 2001, CIRC RES, V88, P1012, DOI 10.1161/hh1001.090839; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	28	0	0	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111035	10.1371/journal.pone.0111035	http://dx.doi.org/10.1371/journal.pone.0111035			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347290	Green Submitted, gold, Green Published			2022-12-27	WOS:000347994900039
J	Santamaria, RD; Shao, MR; Wang, GM; Nino-Liu, DO; Kundariya, H; Wamboldt, Y; Dweikat, I; Mackenzie, SA				Santamaria, Roberto de la Rosa; Shao, Mon-Ray; Wang, Guomei; Nino-Liu, David O.; Kundariya, Hardik; Wamboldt, Yashitola; Dweikat, Ismail; Mackenzie, Sally A.			MSH1-Induced Non-Genetic Variation Provides a Source of Phenotypic Diversity in Sorghum bicolor	PLOS ONE			English	Article							MITOCHONDRIAL GENOME; DNA METHYLATION; EPIGENETICS; VERNALIZATION	MutS Homolog 1 (MSH1) encodes a plant-specific protein that functions in mitochondria and chloroplasts. We showed previously that disruption or suppression of the MSH1 gene results in a process of developmental reprogramming that is heritable and non-genetic in subsequent generations. In Arabidopsis, this developmental reprogramming process is accompanied by striking changes in gene expression of organellar and stress response genes. This developmentally reprogrammed state, when used in crossing, results in a range of variation for plant growth potential. Here we investigate the implications of MSH1 modulation in a crop species. We found that MSH1-mediated phenotypic variation in Sorghum bicolor is heritable and potentially valuable for crop breeding. We observed phenotypic variation for grain yield, plant height, flowering time, panicle architecture, and above-ground biomass. Focusing on grain yield and plant height, we found some lines that appeared to respond to selection. Based on amenability of this system to implementation in a range of crops, and the scope of phenotypic variation that is derived, our results suggest that MSH1 suppression provides a novel approach for breeding in crops.	[Santamaria, Roberto de la Rosa; Shao, Mon-Ray; Kundariya, Hardik; Wamboldt, Yashitola; Mackenzie, Sally A.] Univ Nebraska, Ctr Plant Sci Innovat, Lincoln, NE 68588 USA; [Santamaria, Roberto de la Rosa; Shao, Mon-Ray; Dweikat, Ismail; Mackenzie, Sally A.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE USA; [Wang, Guomei; Nino-Liu, David O.] Monsanto Co, Chesterfield Village Res Ctr, Chesterfield, MO USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Monsanto	Mackenzie, SA (corresponding author), Univ Nebraska, Ctr Plant Sci Innovat, Lincoln, NE 68588 USA.	smackenzie2@unl.edu	Kundariya, Hardik/AAE-1911-2021	Kundariya, Hardik/0000-0002-4065-3888	Bill & Melinda Gates Foundation [OPP1059119]; National Science Foundation [IOS-1126935]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Science Foundation(National Science Foundation (NSF))	This work was supported by grants from the Bill & Melinda Gates Foundation (OPP1059119, http://www. gatesfoundation. org) and the National Science Foundation (IOS-1126935, http://www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelnoor RV, 2003, P NATL ACAD SCI USA, V100, P5968, DOI 10.1073/pnas.1037651100; Brown PJ, 2008, GENETICS, V180, P629, DOI 10.1534/genetics.108.092239; Cheptou PO, 2013, HEREDITY, V110, P205, DOI 10.1038/hdy.2012.66; Colome-Tatche M, 2012, P NATL ACAD SCI USA, V109, P16240, DOI 10.1073/pnas.1212955109; Cowling WA, 2013, PLANT BREEDING, V132, P1, DOI 10.1111/pbr.12026; Dooner HK, 2007, CURR OPIN GENET DEV, V17, P486, DOI 10.1016/j.gde.2007.08.010; El-Soda M, 2014, TRENDS PLANT SCI, V19, P390, DOI 10.1016/j.tplants.2014.01.001; Gressel J., 2008, GENETIC GLASS CEILIN; Groszmann M, 2011, BBA-GENE REGUL MECH, V1809, P427, DOI 10.1016/j.bbagrm.2011.03.006; Hauben M, 2009, P NATL ACAD SCI USA, V106, P20109, DOI 10.1073/pnas.0908755106; Heo JB, 2011, EPIGENETICS-US, V6, P544, DOI 10.4161/epi.6.5.15235; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Li ML, 2009, MOL BREEDING, V24, P41, DOI 10.1007/s11032-009-9270-2; Migicovsky Z, 2013, BIOCHEM CELL BIOL, V91, P1, DOI 10.1139/bcb-2012-0046; MILLER FR, 1984, CROP SCI, V24, P1224, DOI 10.2135/cropsci1984.0011183X002400060074x; Multani DS, 2003, SCIENCE, V302, P81, DOI 10.1126/science.1086072; Pinheiro J., 2019, NLME LINEAR NONLINEA; Reinders J, 2009, GENE DEV, V23, P939, DOI 10.1101/gad.524609; Schloss SJ, 2002, THEOR APPL GENET, V105, P912, DOI 10.1007/s00122-002-0991-4; Schmitz RJ, 2007, BBA-GENE STRUCT EXPR, V1769, P269, DOI 10.1016/j.bbaexp.2007.02.003; Shedge V, 2010, PLANT PHYSIOL, V152, P1960, DOI 10.1104/pp.109.152827; Shivaprasad PV, 2012, EMBO J, V31, P257, DOI 10.1038/emboj.2011.458; Smith AM, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00006; Stroud H, 2013, ELIFE, V2, DOI 10.7554/eLife.00354; Tsaftaris AS, 2007, PLANT BREEDING REV, DOI [10.1002/9780470380130.ch2, DOI 10.1002/9780470380130.CH2]; Xu YZ, 2012, PLANT PHYSIOL, V159, P710, DOI 10.1104/pp.112.196055; Xu YZ, 2011, PLANT CELL, V23, P3428, DOI 10.1105/tpc.111.089136; Zhang YY, 2013, NEW PHYTOL, V197, P314, DOI 10.1111/nph.12010	28	23	28	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e108407	10.1371/journal.pone.0108407	http://dx.doi.org/10.1371/journal.pone.0108407			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347794	Green Published, gold			2022-12-27	WOS:000347994900004
J	Novotna, A; Krasulova, K; Bartonkova, I; Korhonova, M; Bachleda, P; Anzenbacher, P; Dvorak, Z				Novotna, Aneta; Krasulova, Kristyna; Bartonkova, Iveta; Korhonova, Martina; Bachleda, Petr; Anzenbacher, Pavel; Dvorak, Zdenek			Dual Effects of Ketoconazole cis-Enantiomers on CYP3A4 in Human Hepatocytes and HepG2 Cells	PLOS ONE			English	Article							PREGNANE-X-RECEPTOR; DIABETES-MELLITUS; IN-VITRO; INHIBITION; EXPRESSION; METABOLISM; ACTIVATION; LINES	Antifungal drug ketoconazole causes severe drug-drug interactions by influencing gene expression and catalytic activity of major drug-metabolizing enzyme cytochrome P450 CYP3A4. Ketoconazole is administered in the form of racemic mixture of two cis-enantiomers, i.e. (+)-ketoconazole and (-)-ketoconazole. Many enantiopure drugs were introduced to human pharmacotherapy in last two decades. In the current paper, we have examined the effects of ketoconazole cis-enantiomers on the expression of CYP3A4 in human hepatocytes and HepG2 cells and on catalytic activity of CYP3A4 in human liver microsomes. We show that both ketoconazole enantiomers induce CYP3A4 mRNA and protein in human hepatocytes and HepG2 cells. Gene reporter assays revealed partial agonist activity of ketoconazole enantiomers towards pregnane X receptor PXR. Catalytic activity of CYP3A4/5 towards two prototypic substrates of CYP3A enzymes, testosterone and midazolam, was determined in presence of both (+)-ketoconazole and (-)-ketoconazole in human liver microsomes. Overall, both ketoconazole cis-enantiomers induced CYP3A4 in human cells and inhibited CYP3A4 in human liver microsomes. While interaction of ketoconazole with PXR and induction of CYP3A4 did not display enantiospecific pattern, inhibition of CYP3A4 catalytic activity by ketoconazole differed for ketoconazole cis-enantiomers ((+)-ketoconazole IC50 1.69 mu M, K-i 0.92 mu M for testosterone, IC50 1.46 mu M, K-i 2.52 mu M for midazolam; (-)-ketoconazole IC50 0.90 mu M, K-i 0.17 mu M for testosterone, IC50 1.04 mu M, K-i 1.51 mu M for midazolam).	[Novotna, Aneta; Bartonkova, Iveta; Korhonova, Martina; Dvorak, Zdenek] Palacky Univ, Fac Sci, Reg Ctr Adv Technol & Mat, CR-77147 Olomouc, Czech Republic; [Krasulova, Kristyna; Anzenbacher, Pavel] Palacky Univ, Fac Med & Dent, Inst Pharmacol, CR-77147 Olomouc, Czech Republic; [Bachleda, Petr] Univ Hosp Olomouc, Dept Surg 2, Olomouc, Czech Republic	Palacky University Olomouc; Palacky University Olomouc; University Hospital Olomouc	Dvorak, Z (corresponding author), Palacky Univ, Fac Sci, Reg Ctr Adv Technol & Mat, CR-77147 Olomouc, Czech Republic.	moulin@email.cz	Grycova, Aneta/AGH-1515-2022	Grycova, Aneta/0000-0002-2134-1125; Dvorak, Zdenek/0000-0002-3938-3585; Krasulova, Kristyna/0000-0002-8303-6847	Czech Science Agency [GACR 13-01809S]; Palacky University [PrF-2014-004]	Czech Science Agency; Palacky University	This research was supported by the Czech Science Agency [Grant GACR 13-01809S] and by the student project from Palacky University [PrF-2014-004]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allqvist A, 2007, EUR J CLIN PHARMACOL, V63, P173, DOI 10.1007/s00228-006-0230-z; Arakaki R, 2010, EXPERT OPIN INV DRUG, V19, P185, DOI 10.1517/13543780903381411; Caner H, 2004, DRUG DISCOV TODAY, V9, P105, DOI 10.1016/S1359-6446(03)02904-0; Dilmaghanian S, 2004, CHIRALITY, V16, P79, DOI 10.1002/chir.10294; Duret C, 2006, MOL PHARMACOL, V70, P329, DOI 10.1124/mol.105.022046; Dvorak Z, 2011, TOXICOL LETT, V202, P129, DOI 10.1016/j.toxlet.2011.01.027; Greenblatt DJ, 2011, J PHARM PHARMACOL, V63, P214, DOI 10.1111/j.2042-7158.2010.01202.x; Greenblatt DJ, 2010, XENOBIOTICA, V40, P713, DOI 10.3109/00498254.2010.506224; Gubbins PO, 2010, MYCOSES, V53, P95, DOI 10.1111/j.1439-0507.2009.01820.x; Heeres J, 2010, MOLECULES, V15, P4129, DOI 10.3390/molecules15064129; Huang H, 2007, ONCOGENE, V26, P258, DOI 10.1038/sj.onc.1209788; Korashy HM, 2007, TOXICOL SCI, V97, P32, DOI 10.1093/toxsci/kfm012; Li H, 2013, J BIOL CHEM, V288, P13655, DOI 10.1074/jbc.M113.455485; Lim YP, 2009, PHARMACOGENET GENOM, V19, P11, DOI 10.1097/FPC.0b013e32831665ea; Novotna A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101832; Novotna A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098711; Phillips I.R., 2006, CYTOCHROME P450 PROT; ROTSTEIN DM, 1992, J MED CHEM, V35, P2818, DOI 10.1021/jm00093a015; Schwartz SL, 2008, CLIN THER, V30, P1081, DOI 10.1016/j.clinthera.2008.05.021; Smith SW, 2009, TOXICOL SCI, V110, P4, DOI 10.1093/toxsci/kfp097; Stresser DM, 2000, DRUG METAB DISPOS, V28, P1440; Svecova L, 2008, DRUG METAB DISPOS, V36, P339, DOI 10.1124/dmd.107.018341; Venkatesh M, 2011, MOL PHARMACOL, V80, P124, DOI 10.1124/mol.111.071787; Vrzal R, 2013, J BIOCHEM MOL TOXIC, V27, P515, DOI 10.1002/jbt.21516; Wang HW, 2007, CLIN CANCER RES, V13, P2488, DOI 10.1158/1078-0432.CCR-06-1592	25	21	21	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111286	10.1371/journal.pone.0111286	http://dx.doi.org/10.1371/journal.pone.0111286			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343516	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943500096
J	Quan, JH; Kang, BH; Cha, GH; Zhou, W; Koh, YB; Yang, JB; Yoo, HJ; Lee, MA; Ryu, JS; Noh, HT; Kwon, J; Lee, YH				Quan, Juan-Hua; Kang, Byung-Hun; Cha, Guang-Ho; Zhou, Wei; Koh, Young-Bok; Yang, Jung-Bo; Yoo, Heon-Jong; Lee, Min-A; Ryu, Jae-Sook; Noh, Heung-Tae; Kwon, Jaeyul; Lee, Young-Ha			Trichonomas vaginalis Metalloproteinase Induces Apoptosis of SiHa Cells through Disrupting the Mcl-1/Bim and Bcl-xL/Bim Complexes	PLOS ONE			English	Article							TRICHOMONAS-VAGINALIS; DEPENDENT APOPTOSIS; LEISHMANIA-MEXICANA; HUMAN NEUTROPHILS; EPITHELIAL-CELLS; DEGRADATION; CASPASE-3; 1,10-PHENANTHROLINE; MAINTENANCE; INVOLVEMENT	To elucidate the roles of metalloproteinases and the Bcl-2 family of proteins in Trichovaginalis. vaginalis-induced apoptosis in human cervical cancer cells (SiHa cells) and vaginal epithelial cells (MS74 cells), SiHa cells and MS74 cells were incubated with live T. vaginalis, T. vaginalis excretory and secretory products (ESP), and T. vaginalis lysates, either with or without the specific metalloproteinase inhibitor 1,10-phenanthroline (1,10-PT), and examined apoptotic events and Bcl-2 signaling. The live T. vaginalis and the T. vaginalis ESP induced the release of cytochrome c into the cytosol, the activation of caspase-3 and caspase-9, and the cleavage of PARP. Additionally, the live T. vaginalis, but not the T. vaginalis lysate, induced the cleavage of the proapoptotic Bim protein. The live T. vaginalis and the T. vaginalis ESP, but not the T. vaginalis lysate, induced the dose-dependent cleavage of the antiapoptotic Bcl-xL and Mcl-1 proteins and decreased the association levels of Bcl-xL/Bim and Mcl-1/Bim complexes. We performed gelatin zymography and casein-hydrolysis assays on the live T. vaginalis and the T. vaginalis ESP to identify the apoptosis-inducing factor. Both the live T. vaginalis and the ESP contained high levels of metalloproteinases, of which activities were significantly inhibited by 1,10-PT treatment. Furthermore, the 1,10-PT blocked the cleavage of Bcl-xL, Mcl-1, PARP, caspase-3, and caspase-9, as well as the release of cytochrome c into the cytosol, and it significantly increased the association levels of the Bcl-xL/Bim and Mcl-1/Bim protein complexes, returning them to normal levels. Our results demonstrate that T. vaginalis induces mitochondria-dependent apoptosis in SiHa cells through the dissociation of Bcl-xL/Bim and Mcl-1/Bim complexes and that the apoptosis is blocked by the metalloproteinase inhibitor 1,10-PT. These results expand our understanding of the role of metalloproteinases in T. vaginalis-induced apoptosis and the signaling pathway in trichomoniasis of the cervicovaginal epithelial cells.	[Quan, Juan-Hua] Guangdong Med Coll, Affiliated Hosp, Dept Gastroenterol, Zhanjiang, Guangdong, Peoples R China; [Kang, Byung-Hun; Koh, Young-Bok; Yang, Jung-Bo; Yoo, Heon-Jong; Lee, Min-A; Noh, Heung-Tae] Chungnam Natl Univ Hosp, Dept Obstet & Gynecol, Taejon, South Korea; [Cha, Guang-Ho; Zhou, Wei; Lee, Young-Ha] Chungnam Natl Univ, Sch Med, Dept Infect Biol, Taejon, South Korea; [Ryu, Jae-Sook] Hanyang Univ, Coll Med, Dept Environm Biol & Med Parasitol, Seoul 133791, South Korea; [Kwon, Jaeyul] Chungnam Natl Univ, Sch Med, Dept Med Educ, Taejon, South Korea	Guangdong Medical University; Chungnam National University; Chungnam National University Hospital; Chungnam National University; Hanyang University; Chungnam National University	Lee, YH (corresponding author), Chungnam Natl Univ, Sch Med, Dept Infect Biol, Taejon, South Korea.	yhalee@cnu.ac.kr		Kang, Byung Hun/0000-0001-5037-3225; Kwon, Jaeyul/0000-0002-2452-4111; Yoo, Heon Jong/0000-0003-4808-3450; Cha, Guang-Ho/0000-0003-2639-1727	National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [2007-0054932]; National Natural Science Foundation of China [81300368]	National Research Foundation of Korea (NRF) grant - Korea government (MSIP); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2007-0054932), and National Natural Science Foundation of China (Grant No. 81300368 to Juan-Hua Quan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderete JF, 1999, MICROB PATHOGENESIS, V27, P93, DOI 10.1006/mpat.1999.0281; BOUVIER J, 1995, METHOD ENZYMOL, V248, P614; Chang JH, 2004, PARASITE IMMUNOL, V26, P141, DOI 10.1111/j.0141-9838.2004.00693.x; CHAUDHURI G, 1989, J BIOL CHEM, V264, P7483; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Correa LM, 2000, DEV BIOL, V225, P124, DOI 10.1006/dbio.2000.9825; FELBER JP, 1962, BIOCHEMISTRY-US, V1, P231, DOI 10.1021/bi00908a006; Figueroa-Angulo EE, 2012, MICROBES INFECT, V14, P1411, DOI 10.1016/j.micinf.2012.09.004; Fujita N, 1998, ONCOGENE, V17, P1295, DOI 10.1038/sj.onc.1202065; Han IH, 2012, PARASITE IMMUNOL, V34, P8, DOI 10.1111/j.1365-3024.2011.01338.x; Han J, 2004, J BIOL CHEM, V279, P22020, DOI 10.1074/jbc.M313234200; Joshi PB, 2002, MOL BIOCHEM PARASIT, V120, P33, DOI 10.1016/S0166-6851(01)00432-7; Kang JH, 2006, PARASITE IMMUNOL, V28, P439, DOI 10.1111/j.1365-3024.2006.00884.x; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kucknoor A, 2005, CELL MICROBIOL, V7, P887, DOI 10.1111/j.1462-5822.2005.00522.x; Ma LN, 2011, PARASITOL RES, V109, P71, DOI 10.1007/s00436-010-2222-2; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Opferman JT, 2003, NAT IMMUNOL, V4, P410, DOI 10.1038/ni0503-410; Quan JH, 2013, EXP PARASITOL, V133, P462, DOI 10.1016/j.exppara.2013.01.005; Ryan CM, 2011, ESSAYS BIOCHEM, V51, P161, DOI [10.1042/BSE0510161, 10.1042/bse0510161]; Seay MB, 1996, INFECT IMMUN, V64, P5129, DOI 10.1128/IAI.64.12.5129-5137.1996; Sinha K, 2013, ARCH TOXICOL, V87, P1157, DOI 10.1007/s00204-013-1034-4; Sommer U, 2005, J BIOL CHEM, V280, P23853, DOI 10.1074/jbc.M501752200; Song HO, 2008, EXP PARASITOL, V118, P59, DOI 10.1016/j.exppara.2007.06.010; Song HO, 2010, KOREAN J PARASITOL, V48, P1, DOI 10.3347/kjp.2010.48.1.1; Soper D, 2004, AM J OBSTET GYNECOL, V190, P281, DOI 10.1016/j.ajog.2003.08.023; Van der Pol B, 2007, CLIN INFECT DIS, V44, P23, DOI 10.1086/509934; Weng CJ, 2005, J BIOL CHEM, V280, P10491, DOI 10.1074/jbc.M412819200; Wuilleme-Toumi S, 2007, BIOCHEM BIOPH RES CO, V361, P865, DOI 10.1016/j.bbrc.2007.07.070; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang Z, 2012, J BIOL INORG CHEM, V17, P1257, DOI 10.1007/s00775-012-0940-x; Zimmermann KC, 2001, J ALLERGY CLIN IMMUN, V108, pS99, DOI 10.1067/mai.2001.117819; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	33	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110659	10.1371/journal.pone.0110659	http://dx.doi.org/10.1371/journal.pone.0110659			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343522	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943500042
J	Buskirk, AD; Green, BJ; Lemons, AR; Nayak, AP; Goldsmith, WT; Kashon, ML; Anderson, SE; Hettick, JM; Templeton, SP; Germolec, DR; Beezhold, DH				Buskirk, Amanda D.; Green, Brett J.; Lemons, Angela R.; Nayak, Ajay P.; Goldsmith, W. Travis; Kashon, Michael L.; Anderson, Stacey E.; Hettick, Justin M.; Templeton, Steven P.; Germolec, Dori R.; Beezhold, Donald H.			A Murine Inhalation Model to Characterize Pulmonary Exposure to Dry Aspergillus fumigatus Conidia	PLOS ONE			English	Article							RESPONSES; CELLS; ALLERGENS; ASTHMA	Most murine models of fungal exposure are based on the delivery of uncharacterized extracts or liquid conidia suspensions using aspiration or intranasal approaches. Studies that model exposure to dry fungal aerosols using whole body inhalation have only recently been described. In this study, we aimed to characterize pulmonary immune responses following repeated inhalation of conidia utilizing an acoustical generator to deliver dry fungal aerosols to mice housed in a nose only exposure chamber. Immunocompetent female BALB/cJ mice were exposed to conidia derived from Aspergillus fumigatus wild-type (WT) or a melanin-deficient (Delta alb1) strain. Conidia were aerosolized and delivered to mice at an estimated deposition dose of 1 x 10(5) twice a week for 4 weeks (8 total). Histopathological and immunological endpoints were assessed 4, 24, 48, and 72 hours after the final exposure. Histopathological analysis showed that conidia derived from both strains induced lung inflammation, especially at 24 and 48 hour time points. Immunological endpoints evaluated in bronchoalveolar lavage fluid (BALF) and the mediastinal lymph nodes showed that exposure to WT conidia led to elevated numbers of macrophages, granulocytes, and lymphocytes. Importantly, CD8(+) IL17(+) (Tc17) cells were significantly higher in BALF and positively correlated with germination of A. fumigatus WT spores. Germination was associated with specific IgG to intracellular proteins while Delta alb1 spores elicited antibodies to cell wall hydrophobin. These data suggest that inhalation exposures may provide a more representative analysis of immune responses following exposures to environmentally and occupationally prevalent fungal contaminants.	[Buskirk, Amanda D.; Green, Brett J.; Lemons, Angela R.; Nayak, Ajay P.; Anderson, Stacey E.; Hettick, Justin M.; Templeton, Steven P.; Beezhold, Donald H.] NIOSH, Allergy & Clin Immunol Branch, Hlth Effects Lab Div, Ctr Dis Control & Prevent, Morgantown, WV 26505 USA; [Goldsmith, W. Travis] NIOSH, Pathol & Physiol Res Branch, Hlth Effects Lab Div, Ctr Dis Control & Prevent, Morgantown, WV USA; [Kashon, Michael L.] NIOSH, Biostat & Epidemiol Branch, Hlth Effects Lab Div, Ctr Dis Control & Prevent, Morgantown, WV USA; [Germolec, Dori R.] Natl Inst Environm Hlth Sci, Natl Toxicol Program Div, Toxicol Branch, Res Triangle Pk, NC USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Beezhold, DH (corresponding author), NIOSH, Allergy & Clin Immunol Branch, Hlth Effects Lab Div, Ctr Dis Control & Prevent, Morgantown, WV 26505 USA.	zec1@cdc.gov	; Templeton, Steven/I-6635-2013	Beezhold, Donald/0000-0001-5543-5747; Lemons, Angela/0000-0003-3057-9888; Templeton, Steven/0000-0003-3430-7011	intramural National Institute for Occupational Safety and Health (NIOSH); NIEHS IAA [AES 12007-00100000]	intramural National Institute for Occupational Safety and Health (NIOSH)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NIEHS IAA	This study was supported by intramural National Institute for Occupational Safety and Health (NIOSH) funding and by an interagency agreement with NIEHS IAA# AES 12007-00100000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Bakker-Woudenberg IAJM, 2003, J MICROBIOL METH, V54, P295, DOI 10.1016/S0167-7012(03)00118-0; Black PN, 2000, ALLERGY, V55, P501, DOI 10.1034/j.1398-9995.2000.00293.x; Breitenbach M, 2008, INT ARCH ALLERGY IMM, V145, P58, DOI 10.1159/000107578; Buskirk AD, 2014, J IMMUNOTOXICOL, V11, P180, DOI 10.3109/1547691X.2013.819054; Carvalho A, 2012, BLOOD, V119, P967, DOI 10.1182/blood-2011-06-362582; Chai LYA, 2010, IMMUNOBIOLOGY, V215, P915, DOI 10.1016/j.imbio.2009.10.002; Chakraborty AB, 2007, RAPID COMMUN MASS SP, V21, P730, DOI 10.1002/rcm.2888; Collins C, 2013, J PROTEOME RES, V12, P2552, DOI 10.1021/pr301131t; Crameri R, 2006, CHEM IMMUNOL ALLERGY, V91, P121; Devereux G, 2006, NAT REV IMMUNOL, V6, P869, DOI 10.1038/nri1958; Eduard W, 2009, CRIT REV TOXICOL, V39, P799, DOI 10.3109/10408440903307333; FOGELMARK B, 1991, INT J EXP PATHOL, V72, P387; Foster Barbara, 2007, Curr Protoc Immunol, VChapter 6, DOI 10.1002/0471142735.im0624s78; Green BJ, 2011, CLIN EXP ALLERGY, V41, P1022, DOI 10.1111/j.1365-2222.2011.03756.x; Green BJ, 2005, J ALLERGY CLIN IMMUN, V115, P1043, DOI 10.1016/j.jaci.2005.02.009; Green BJ, 2003, J ALLERGY CLIN IMMUN, V111, P285, DOI 10.1067/mai.2003.57; Green BJ, 2006, MED MYCOL, V44, pS245, DOI 10.1080/13693780600776308; Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814; Heseltine E., 2009, WHO GUID IND AIR QUA; Hoselton SA, 2010, MED MYCOL, V48, P1056, DOI 10.3109/13693786.2010.485582; Huppler AR, 2014, J IMMUNOL, V192, P1745, DOI 10.4049/jimmunol.1302265; Institute of Medicine (US) Committee on Damp Indoor Spaces and Health, 2004, DAMP IND SPAC HLTH; Jarvis BB, 1998, APPL ENVIRON MICROB, V64, P3620; Lambrecht BN, 2003, NAT REV IMMUNOL, V3, P994, DOI 10.1038/nri1249; Liang SC, 2007, J IMMUNOL, V179, P7791, DOI 10.4049/jimmunol.179.11.7791; McKinney W, 2009, INHAL TOXICOL, V21, P1053, DOI 10.1080/08958370802712713; Millon L, 2012, J ALLERGY CLIN IMMUN, V130, P803, DOI 10.1016/j.jaci.2012.03.039; Mitakakis TZ, 2001, J ALLERGY CLIN IMMUN, V107, P388, DOI 10.1067/mai.2001.112602; Murdock BJ, 2011, INFECT IMMUN, V79, P125, DOI 10.1128/IAI.00508-10; Nanjappa SG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002771; Obst R, 2005, J EXP MED, V201, P1555, DOI 10.1084/jem.20042521; Raabe OG, 1988, ANN OCCUP HYG, V32, P53, DOI DOI 10.1093/ANNHYG/32.INHALED_; Samarasinghe AE, 2011, FUNGAL BIOL-UK, V115, P21, DOI 10.1016/j.funbio.2010.09.013; Shreiner AB, 2012, INFECT IMMUN, V80, P388, DOI 10.1128/IAI.05530-11; Shvedova AA, 2008, AM J PHYSIOL-LUNG C, V295, pL552, DOI 10.1152/ajplung.90287.2008; Stevens WW, 2007, J IMMUNOL METHODS, V327, P63, DOI 10.1016/j.jim.2007.07.011; Templeton SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018777; Templeton SP, 2010, MED MYCOL, V48, P217, DOI 10.3109/13693780903420658; Tsai HF, 1999, J BACTERIOL, V181, P6469, DOI 10.1128/JB.181.20.6469-6477.1999; van de Veerdonk FL, 2009, BMB REP, V42, P776, DOI 10.5483/BMBRep.2009.42.12.776	41	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e109855	10.1371/journal.pone.0109855	http://dx.doi.org/10.1371/journal.pone.0109855			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340353	Green Submitted, Green Published, gold			2022-12-27	WOS:000343662800019
J	Schwegmann, A; Lindemann, JP; Egelhaaf, M				Schwegmann, Alexander; Lindemann, Jens Peter; Egelhaaf, Martin			Temporal Statistics of Natural Image Sequences Generated by Movements with Insect Flight Characteristics	PLOS ONE			English	Article							OPTIC FLOW; BLOWFLY FLIGHT; VISUAL-SYSTEM; POWER SPECTRA; MOTION-DETECTION; DROSOPHILA; INFORMATION; CONTRAST; BEHAVIOR; REPRESENTATION	Many flying insects, such as flies, wasps and bees, pursue a saccadic flight and gaze strategy. This behavioral strategy is thought to separate the translational and rotational components of self-motion and, thereby, to reduce the computational efforts to extract information about the environment from the retinal image flow. Because of the distinguishing dynamic features of this active flight and gaze strategy of insects, the present study analyzes systematically the spatiotemporal statistics of image sequences generated during saccades and intersaccadic intervals in cluttered natural environments. We show that, in general, rotational movements with saccade-like dynamics elicit fluctuations and overall changes in brightness, contrast and spatial frequency of up to two orders of magnitude larger than translational movements at velocities that are characteristic of insects. Distinct changes in image parameters during translations are only caused by nearby objects. Image analysis based on larger patches in the visual field reveals smaller fluctuations in brightness and spatial frequency composition compared to small patches. The temporal structure and extent of these changes in image parameters define the temporal constraints imposed on signal processing performed by the insect visual system under behavioral conditions in natural environments.	[Schwegmann, Alexander; Lindemann, Jens Peter; Egelhaaf, Martin] Univ Bielefeld, Neurobiol & Cognit Interact Technol Ctr Excellenc, D-33615 Bielefeld, Germany	University of Bielefeld	Schwegmann, A (corresponding author), Univ Bielefeld, Neurobiol & Cognit Interact Technol Ctr Excellenc, D-33615 Bielefeld, Germany.	neurobiologie@uni-bielefeld.de	Egelhaaf, Martin/A-9824-2010	Egelhaaf, Martin/0000-0002-9336-4270; Lindemann, Jens Peter/0000-0002-5441-7931	Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atick JJ, 1990, NEURAL COMPUT, V2, P308, DOI 10.1162/neco.1990.2.3.308; Balboa RM, 2003, VISION RES, V43, P2527, DOI 10.1016/S0042-6989(03)00471-1; BEERSMA DGM, 1977, J COMP PHYSIOL, V119, P207, DOI 10.1007/BF00656634; Betsch BY, 2004, BIOL CYBERN, V90, P41, DOI 10.1007/s00422-003-0434-6; Boeddeker N, 2005, J COMP PHYSIOL A, V191, P1143, DOI 10.1007/s00359-005-0038-9; Boeddeker N, 2010, P ROY SOC B-BIOL SCI, V277, P1899, DOI 10.1098/rspb.2009.2326; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Borst A, 2002, J COMP PHYSIOL A, V188, P419, DOI 10.1007/s00359-002-0316-8; BORST A, 1989, TRENDS NEUROSCI, V12, P297, DOI 10.1016/0166-2236(89)90010-6; Borst A, 2012, E NEUROFORUM, V3, P59; Braun E, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00001; Braun E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009361; Brinkworth RSA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000555; Bruce NDB, 2006, NEUROCOMPUTING, V69, P1301, DOI 10.1016/j.neucom.2005.12.096; Calow D, 2007, NETWORK-COMP NEURAL, V18, P343, DOI 10.1080/09548980701642277; Collett T.S., 1982, P111; COLLETT TS, 1975, J COMP PHYSIOL, V99, P1, DOI 10.1007/BF01464710; Coppola DM, 1998, P NATL ACAD SCI USA, V95, P4002, DOI 10.1073/pnas.95.7.4002; DONG DW, 1995, NETWORK-COMP NEURAL, V6, P345, DOI 10.1088/0954-898X/6/3/003; Dror RO, 2001, J OPT SOC AM A, V18, P241, DOI 10.1364/JOSAA.18.000241; Durant S, 2012, NEURAL COMPUT, V24, P1781, DOI 10.1162/NECO_a_00294; Eckert MP, 2001, MOTION VISION, P333; ECKERT MP, 1993, J OPT SOC AM A, V10, P1582, DOI 10.1364/JOSAA.10.001582; EGELHAAF M, 1989, J OPT SOC AM A, V6, P1070, DOI 10.1364/JOSAA.6.001070; Egelhaaf M, 2006, INVERTEBRATE VISION, P399; Egelhaaf Martin, 1993, Reviews of Oculomotor Research, V5, P53; Egelhaaf M, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00108; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; Frazor RA, 2006, VISION RES, V46, P1585, DOI 10.1016/j.visres.2005.06.038; Geisler WS, 2008, ANNU REV PSYCHOL, V59, P167, DOI 10.1146/annurev.psych.58.110405.085632; Geurten BRH, 2010, J EXP BIOL, V213, P2461, DOI 10.1242/jeb.036079; HARDIE RC, 1979, J COMP PHYSIOL, V129, P19, DOI 10.1007/BF00679908; HEISENBERG M, 1977, J COMP PHYSIOL, V117, P127, DOI 10.1007/BF00612784; Hennig P, 2012, FRONT NEURAL CIRCUIT, V6, DOI [10.3389/fncir.2012.00014, 10.3389/fncir.2012.00108]; Hornstein EP, 2000, P ROY SOC B-BIOL SCI, V267, P2111, DOI 10.1098/rspb.2000.1257; Hoyer P.O, NATURAL IMAGE STAT P; Jinggang Huang, 1999, Proceedings. 1999 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (Cat. No PR00149), P541, DOI 10.1109/CVPR.1999.786990; Karmeier K, 2006, J NEUROPHYSIOL, V96, P1602, DOI 10.1152/jn.00023.2006; Kern R, 2006, J EXP BIOL, V209, P1251, DOI 10.1242/jeb.02127; Kern R, 2005, PLOS BIOL, V3, P1130, DOI 10.1371/journal.pbio.0030171; Kern R, 2012, J EXP BIOL, V215, P2501, DOI 10.1242/jeb.061713; KOENDERINK JJ, 1986, VISION RES, V26, P161, DOI 10.1016/0042-6989(86)90078-7; Kurtz R, 2012, FRONTIERS IN SENSING: FROM BIOLOGY TO ENGINEERING, P115; LAND MF, 1985, J COMP PHYSIOL A, V156, P525, DOI 10.1007/BF00613976; LAUGHLIN SB, 1993, J COMP PHYSIOL A, V172, P593, DOI 10.1007/BF00213682; LAUGHLIN SB, 1994, PROG RETIN EYE RES, V13, P165, DOI 10.1016/1350-9462(94)90009-4; Lindemann JP, 2013, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00092; Meyer HG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021488; Moller R, 2002, J THEOR BIOL, V214, P619, DOI 10.1006/jtbi.2001.2484; Mronz M, 2008, J EXP BIOL, V211, P2026, DOI 10.1242/jeb.008268; NVIDIA Corp, 2001, HIGH RES ANT MULT; O'Carroll DC, 2011, J VISION, V11, DOI 10.1167/11.14.20; OCARROLL D, 1993, NATURE, V362, P541, DOI 10.1038/362541a0; OCarroll DC, 1997, VISION RES, V37, P3427, DOI 10.1016/S0042-6989(97)00170-3; Okamura JY, 2007, J COMP NEUROL, V500, P189, DOI 10.1002/cne.21195; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; Pamplona D, 2013, VISION RES, V83, P66, DOI 10.1016/j.visres.2013.01.011; Perkel D. H., 1968, Bulletin Neurosci Res Progr, V6, P221; Petrowitz R, 2000, J COMP PHYSIOL A, V186, P737, DOI 10.1007/s003590000127; Rieke F, 2009, NEURON, V64, P605, DOI 10.1016/j.neuron.2009.11.028; Rister J, 2007, NEURON, V56, P155, DOI 10.1016/j.neuron.2007.09.014; Rothkopf C. A., 2009, ICDL 2009, P1, DOI DOI 10.1109/DEVLRN.2009.5175534; Rothkopf CA, 2009, VISUAL NEUROSCI, V26, P81, DOI 10.1017/S0952523808080978; Rucci M, 2007, NATURE, V447, P851, DOI 10.1038/nature05866; Ruderman DL, 1994, NETWORK-COMP NEURAL, V5, P598; Rufli M, 2008, 2008 IEEE/RSJ INTERNATIONAL CONFERENCE ON ROBOTS AND INTELLIGENT SYSTEMS, VOLS 1-3, CONFERENCE PROCEEDINGS, P3121, DOI 10.1109/IROS.2008.4650703; Scaramuzza D., 2006, IEEE INT C COMP VIS, P45, DOI DOI 10.1109/ICVS.2006.3; Scaramuzza D, 2006, 2006 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-12, P5695, DOI 10.1109/IROS.2006.282372; Schilstra C, 1999, J EXP BIOL, V202, P1481; Schwegmann A, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00083; Single S, 1998, SCIENCE, V281, P1848, DOI 10.1126/science.281.5384.1848; Spalthoff C, 2012, FRONT NEURAL CIRCUIT, V6, P1, DOI 10.3389/fncir.2012.00072; Stavenga DG, 2004, J EXP BIOL, V207, P1703, DOI 10.1242/jeb.00949; Stavenga DG, 2002, J COMP PHYSIOL A, V188, P337, DOI 10.1007/s00359-002-0307-9; Straw AD, 2006, J EXP BIOL, V209, P4339, DOI 10.1242/jeb.02517; Stuerzl W, 2010, BIOINSPIR BIOMIM, V5, DOI 10.1088/1748-3182/5/3/036002; SWITKES E, 1978, VISION RES, V18, P1393, DOI 10.1016/0042-6989(78)90232-8; Tammero LF, 2002, J EXP BIOL, V205, P327; Taylor GK, 2007, ADV INSECT PHYSIOL, V34, P231, DOI 10.1016/S0065-2806(07)34005-8; Thomas G, 1999, RAD TRANSFER ATMOSPH, DOI 101063/ 11333301; TOLHURST DJ, 1992, OPHTHAL PHYSL OPT, V12, P229, DOI 10.1111/j.1475-1313.1992.tb00296.x; Van Hateren JH, 1999, J EXP BIOL, V202, P1491; van Hateren JH, 2001, VISION RES, V41, P1851, DOI 10.1016/S0042-6989(01)00052-9; VANHATEREN JH, 1993, VISION RES, V33, P257, DOI 10.1016/0042-6989(93)90163-Q; vanHateren JH, 1996, P SOC PHOTO-OPT INS, V2657, P139, DOI 10.1117/12.238709; VANHATEREN JH, 1992, J COMP PHYSIOL A, V171, P157, DOI 10.1007/BF00188924; VanHateren JH, 1997, VISION RES, V37, P3407, DOI 10.1016/S0042-6989(97)00105-3; Wainwright MJ, 1999, VISION RES, V39, P3960, DOI 10.1016/S0042-6989(99)00101-7; Wardill TJ, 2012, SCIENCE, V336, P925, DOI 10.1126/science.1215317; Wark B, 2007, CURR OPIN NEUROBIOL, V17, P423, DOI 10.1016/j.conb.2007.07.001; Warzecha AK, 2001, MOTION VISION, P239; Yamaguchi S, 2008, P NATL ACAD SCI USA, V105, P4910, DOI 10.1073/pnas.0711484105; Zeil J, 2006, J COMP PHYSIOL A, V192, P1, DOI 10.1007/s00359-005-0048-7; Zeil J, 1997, VISION RES, V37, P3417, DOI 10.1016/S0042-6989(97)00106-5; Zeil J, 2012, CURR OPIN NEUROBIOL, V22, P285, DOI 10.1016/j.conb.2011.12.008; Zeil J, 2009, FLYING INSECTS AND ROBOTS, P87, DOI 10.1007/978-3-540-89393-6_7; Zheng L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004307	100	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110386	10.1371/journal.pone.0110386	http://dx.doi.org/10.1371/journal.pone.0110386			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340761	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662800033
J	Tanida, I; Ueno, T; Uchiyama, Y				Tanida, Isei; Ueno, Takashi; Uchiyama, Yasuo			A Super-Ecliptic, pHluorin-mKate2, Tandem Fluorescent Protein-Tagged Human LC3 for the Monitoring of Mammalian Autophagy	PLOS ONE			English	Article							CYSTEINE PROTEINASES; IN-VITRO; CELLS; HOMOLOG; GABARAP; GATE-16; COLOCALIZATION; TRANSMISSION; DISSECTION; EXPRESSION	Tandem fluorescent protein-tagged LC3s that were comprised of a protein tag that emits green fluorescence (e. g., EGFP or mWasabi) fused with another tag that emits red fluorescence (e. g. mCherry or TagRFP) were used for monitoring the maturation step of mammalian autophagosomes. A critical point for this tandem fluorescent-tagged LC3 was the sensitivity of green fluorescence at an acidic pH. EGFP and mWasabi continue to emit a weak, but significant, fluorescence at a pH of approximately 6. To overcome this issue, we focused on super-ecliptic pHluorin, which is a more pH-sensitive GFP variation. The green fluorescence of EGFP and mWasabi in the cells was still observed at weakly acidic levels (pH 6.0-6.5). In contrast, the fluorescence of pHluorin was more significantly quenched at pH 6.5, and was almost completely abolished at pH 5.5-6.0, indicating that pHluorin is more suitable for use in a tandem fluorescent protein-tag for monitoring autophagy. A pHluorin-mKate2 tandem fluorescence protein showed pH-sensitive green fluorescence and pH-resistant far-red fluorescence. We therefore generated expression plasmids for pHluorin-mKate2-tagged human LC3 (PK-hLC3), which could be used as a modifier for LC3-lipidation. The green and far-red fluorescent puncta of PK-hLC3 were increased under starvation conditions. Puncta that were green-negative, but far-red positive, were increased when autolysosomes accumulated, but few puncta of the mutant PK-hLC3 Delta G that lacked the carboxyl terminal Gly essential for autophagy were observed in the cells under the same conditions. These results indicated that the PK-hLC3 were more appropriate for the pH-sensitive monitoring of the maturation step of autophagosomes.	[Tanida, Isei] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, Tokyo 1628640, Japan; [Tanida, Isei; Ueno, Takashi] Juntendo Univ, Sch Med, Lab Prote & Biomol Sci,Res Support Ctr, Bunkyo Ku, Tokyo 113, Japan; [Uchiyama, Yasuo] Juntendo Univ, Sch Med, Dept Cellular & Mol Neuropathol, Bunkyo Ku, Tokyo 113, Japan	National Institute of Infectious Diseases (NIID); Juntendo University; Juntendo University	Tanida, I (corresponding author), Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, Tokyo 1628640, Japan.	tanida@nih.go.jp; y-uchi@juntendo.ac.jp		Tanida, Isei/0000-0001-8999-3990	Japan Society for the Promotion of Science [10049091, 18076005]; Ministry of Education, Science, Sports and Culture of Japan (MEXT) [23111004, 23110517]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, [21570155, 14380308, 23390041, 25670099]; Ministry of Health, Labor and Welfare [16271401]; Takeda Science Foundation; Ministry of Health, Labor and Welfare	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Sports and Culture of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan,(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by Grants-in-Aids for Challenging Exploratory Research (10049091 to YU), Scientific Researches on Priority Areas "Proteolysis in the Regulation of Biological Processes'' (18076005 to IT and TU), Scientific Researches on Innovative Area from the Japan Society for the Promotion of Science and the Ministry of Education, Science, Sports and Culture of Japan (MEXT) (23111004 and 23110517 to YU), a Grant-in-Aid for Scientific Research (C) (21570155 to IT), Grant-in-Aids for Scientific Research (B) (14380308 to TU; 23390041 to YU), a Grant-in-Aid for challenging Exploratory Research (25670099 to YU), a Grant-in-Aid for the "High-Tech Research Center'' Project for Private Universities, a matching fund subsidy (TU) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, the MEXT-supported Program for the Strategic Research Foundation at Private Universities (YU), a Grant-in-Aid for the Third-Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health, Labor and Welfare (16271401 to TU), a Research Grant from the Takeda Science Foundation (TU), and by the Ministry of Health, Labor and Welfare (IT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HW, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-13; Ai HW, 2006, BIOCHEM J, V400, P531, DOI 10.1042/BJ20060874; Bains M, 2009, METHOD ENZYMOL, V453, P145, DOI 10.1016/S0076-6879(08)04007-X; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Demarchi F, 2006, J CELL BIOL, V175, P595, DOI 10.1083/jcb.200601024; FEDORKO ME, 1968, J CELL BIOL, V38, P392, DOI 10.1083/jcb.38.2.392; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Iwai-Kanai E, 2008, AUTOPHAGY, V4, P322, DOI 10.4161/auto.5603; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Katayama H, 2008, CELL STRUCT FUNCT, V33, P1, DOI 10.1247/csf.07011; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu M, 2001, J BIOL CHEM, V276, P9846, DOI 10.1074/jbc.M007737200; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; MANN SS, 1994, J BIOL CHEM, V269, P11492; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sou Y, 2006, J BIOL CHEM, V281, P3017, DOI 10.1074/jbc.M505888200; TAMAI M, 1987, CHEM PHARM BULL, V35, P1098; TAMAI M, 1986, J PHARMACOBIO-DYNAM, V9, P672, DOI 10.1248/bpb1978.9.672; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; Tanida I, 2002, BIOCHEM BIOPH RES CO, V292, P256, DOI 10.1006/bbrc.2002.6645; Tanida I, 2002, J BIOL CHEM, V277, P13739, DOI 10.1074/jbc.M200385200; Tanida I, 2001, J BIOL CHEM, V276, P1701, DOI 10.1074/jbc.C000752200; Tanida I, 2008, AUTOPHAGY, V4, P131, DOI 10.4161/auto.5233; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tanida I, 2011, MICROBIOL IMMUNOL, V55, P1, DOI 10.1111/j.1348-0421.2010.00271.x; Tanida I, 2010, METHODS MOL BIOL, V648, P193, DOI 10.1007/978-1-60761-756-3_13; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; UMEZAWA H, 1970, J ANTIBIOT, V23, P514, DOI 10.7164/antibiotics.23.514; Zhou CH, 2012, AUTOPHAGY, V8, P1215, DOI 10.4161/auto.20284	38	46	46	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110600	10.1371/journal.pone.0110600	http://dx.doi.org/10.1371/journal.pone.0110600			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340751	gold, Green Published, Green Submitted			2022-12-27	WOS:000343662800042
J	Baum, SH; Beauchamp, MS				Baum, Sarah H.; Beauchamp, Michael S.			Greater BOLD Variability in Older Compared with Younger Adults during Audiovisual Speech Perception	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; VISUAL CORTICAL-CELLS; PERFORMANCE VARIABILITY; FUNCTIONAL MRI; HUMAN BRAIN; AGE; CONNECTIVITY; ACTIVATION; DECLINE; DEGRADATION	Older adults exhibit decreased performance and increased trial-to-trial variability on a range of cognitive tasks, including speech perception. We used blood oxygen level dependent functional magnetic resonance imaging (BOLD fMRI) to search for neural correlates of these behavioral phenomena. We compared brain responses to simple speech stimuli (audiovisual syllables) in 24 healthy older adults (53 to 70 years old) and 14 younger adults (23 to 39 years old) using two independent analysis strategies: region-of-interest (ROI) and voxel-wise whole-brain analysis. While mean response amplitudes were moderately greater in younger adults, older adults had much greater within-subject variability. The greatly increased variability in older adults was observed for both individual voxels in the whole-brain analysis and for ROIs in the left superior temporal sulcus, the left auditory cortex, and the left visual cortex. Increased variability in older adults could not be attributed to differences in head movements between the groups. Increased neural variability may be related to the performance declines and increased behavioral variability that occur with aging.	[Baum, Sarah H.; Beauchamp, Michael S.] Univ Texas Houston, Sch Med, Dept Neurobiol & Anat, Houston, TX 77225 USA; [Baum, Sarah H.] Vanderbilt Univ, Vanderbilt Brain Inst, Nashville, TN 37235 USA	University of Texas System; University of Texas Health Science Center Houston; Vanderbilt University	Baum, SH (corresponding author), Univ Texas Houston, Sch Med, Dept Neurobiol & Anat, Houston, TX 77225 USA.	Sarah.H.Baum@vanderbilt.edu	Miller, Sarah H. Baum/H-3252-2019; Beauchamp, Michael/AAK-9813-2020	Miller, Sarah H. Baum/0000-0002-5588-5876; Beauchamp, Michael/0000-0002-7599-9934	National Institutes of Health (NIH) [1T32EB006350-04, R01NS065395, TL1RR024147]; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB006350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065395] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding was provided by National Institutes of Health (NIH) (http://www.nih.gov/) 1T32EB006350-04, to SHB; and NIH (http://www.nih.gov/) R01NS065395, TL1RR024147, to MSB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson S, 2012, J NEUROSCI, V32, P14156, DOI 10.1523/JNEUROSCI.2176-12.2012; Anderson S, 2011, EAR HEARING, V32, P750, DOI 10.1097/AUD.0b013e31822229d3; Argall BD, 2006, HUM BRAIN MAPP, V27, P14, DOI 10.1002/hbm.20158; Beck JM, 2012, NEURON, V74, P30, DOI 10.1016/j.neuron.2012.03.016; Bielak AA, 2013, INTRAINDIVIDUAL VARI; BRANT LJ, 1990, J ACOUST SOC AM, V88, P813, DOI 10.1121/1.399731; Butts DA, 2006, PLOS BIOL, V4, P639, DOI 10.1371/journal.pbio.0040092; Caspers S, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00149; CERELLA J, 1994, ACTA PSYCHOL, V86, P109, DOI 10.1016/0001-6918(94)90002-7; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; D'Esposito M, 1999, NEUROIMAGE, V10, P6, DOI 10.1006/nimg.1999.0444; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Divenyi PL, 2005, J ACOUST SOC AM, V118, P1089, DOI 10.1121/1.1953207; DUBNO JR, 1984, J ACOUST SOC AM, V76, P87, DOI 10.1121/1.391011; Fang HCH, 1976, NEUROBIOL AGING, V3, P155; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Friston KJ, 2006, NEUROIMAGE, V30, P1077, DOI 10.1016/j.neuroimage.2005.08.012; Garrett DD, 2013, CEREB CORTEX, V23, P684, DOI 10.1093/cercor/bhs055; Garrett DD, 2011, J NEUROSCI, V31, P4496, DOI 10.1523/JNEUROSCI.5641-10.2011; Gosselin PA, 2011, INT J AUDIOL, V50, P786, DOI 10.3109/14992027.2011.599870; Grady CL, 2014, BRAIN IMAGING BEHAV, V8, P274, DOI 10.1007/s11682-013-9253-0; Grant KW, 2000, J ACOUST SOC AM, V108, P1197, DOI 10.1121/1.1288668; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; Hua TM, 2006, NEUROBIOL AGING, V27, P155, DOI 10.1016/j.neurobiolaging.2004.11.012; Huettel SA, 2001, NEUROIMAGE, V13, P161, DOI 10.1006/nimg.2000.0675; Hultsch DF, 2002, J GERONTOL B-PSYCHOL, V57, pP101, DOI 10.1093/geronb/57.2.P101; Jenkins L, 2000, PSYCHOL AGING, V15, P157, DOI 10.1037//0882-7974.15.1.157; Jimura K, 2012, NEUROPSYCHOLOGIA, V50, P544, DOI 10.1016/j.neuropsychologia.2011.11.007; JONES AKP, 1992, SCIENCE, V255, P215, DOI 10.1126/science.1553549; Kerchner GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050425; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Li SC, 2001, TRENDS COGN SCI, V5, P479, DOI 10.1016/S1364-6613(00)01769-1; Liang Z, 2010, NEUROBIOL AGING, V31, P863, DOI 10.1016/j.neurobiolaging.2008.06.013; Lovden M, 2007, NEUROPSYCHOLOGIA, V45, P2827, DOI 10.1016/j.neuropsychologia.2007.05.005; Lovden M, 2013, NEUROIMAGE, V64, P209, DOI 10.1016/j.neuroimage.2012.09.039; Lu PH, 2011, J CLIN EXP NEUROPSYC, V33, P1059, DOI 10.1080/13803395.2011.595397; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; MacDonald SWS, 2006, TRENDS NEUROSCI, V29, P474, DOI 10.1016/j.tins.2006.06.011; MacDonald SWS, 2012, J NEUROSCI, V32, P8186, DOI 10.1523/JNEUROSCI.5474-11.2012; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Murphy KJ, 2007, AGING NEUROPSYCHOL C, V14, P70, DOI 10.1080/138255890969726; Nath AR, 2011, J NEUROSCI, V31, P1704, DOI 10.1523/JNEUROSCI.4853-10.2011; Peich MC, 2013, PSYCHOL AGING, V28, P729, DOI 10.1037/a0033236; Poldrack RA, 2007, SOC COGN AFFECT NEUR, V2, P67, DOI 10.1093/scan/nsm006; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; PRICE LL, 1963, J SPEECH HEAR RES, V6, P64, DOI 10.1044/jshr.0601.64; Saad ZS, 2009, NEUROIMAGE, V44, P839, DOI 10.1016/j.neuroimage.2008.09.037; Samanez-Larkin GR, 2010, J NEUROSCI, V30, P1426, DOI 10.1523/JNEUROSCI.4902-09.2010; Saxe R, 2006, NEUROIMAGE, V30, P1088, DOI 10.1016/j.neuroimage.2005.12.062; Schmolesky MT, 2000, NAT NEUROSCI, V3, P384, DOI 10.1038/73957; Skudlarski P, 1999, NEUROIMAGE, V9, P311, DOI 10.1006/nimg.1999.0402; Stephan KE, 2003, SCIENCE, V301, P384, DOI 10.1126/science.1086025; Stewart JC, 2014, NEUROIMAGE, V86, P326, DOI 10.1016/j.neuroimage.2013.10.016; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vandermorris S, 2013, NEUROPSYCHOLOGY DE B; West R, 2002, BRAIN COGNITION, V49, P402, DOI 10.1006/brcg.2001.1507; WILSON M, 1988, BEHAV RES METH INSTR, V20, P6, DOI 10.3758/BF03202594; Xiong JH, 1995, HUM BRAIN MAPP, V3, P287, DOI 10.1002/hbm.460030404; Yang Y, 2009, BRAIN RES, V1274, P21, DOI 10.1016/j.brainres.2009.04.015	65	15	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e111121	10.1371/journal.pone.0111121	http://dx.doi.org/10.1371/journal.pone.0111121			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6DY	25337918	Green Published, Green Submitted, gold			2022-12-27	WOS:000343674800107
J	Phadke, SS; Feretzaki, M; Clancey, SA; Mueller, O; Heitman, J				Phadke, Sujal S.; Feretzaki, Marianna; Clancey, Shelly Applen; Mueller, Olaf; Heitman, Joseph			Unisexual Reproduction of Cryptococcus gattii	PLOS ONE			English	Article							FUNGAL PATHOGEN CRYPTOCOCCUS; NEOFORMANS VAR. GATTII; ALPHA-MATING-TYPE; SEXUAL REPRODUCTION; VANCOUVER-ISLAND; BRITISH-COLUMBIA; MICROBIAL PATHOGENS; GENETIC EXCHANGE; AIDS PATIENTS; SEROTYPE-C	Cryptococcus gattii is a basidiomycetous human fungal pathogen that typically causes infection in tropical and subtropical regions and is responsible for an ongoing outbreak in immunocompetent individuals on Vancouver Island and in the Pacific Northwest of the US. Pathogenesis of this species may be linked to its sexual cycle that generates infectious propagules called basidiospores. A marked predominance of only one mating type (alpha) in clinical and environmental isolates suggests that a-alpha opposite-sex reproduction may be infrequent or geographically restricted, raising the possibility of an alternative unisexual cycle involving cells of only alpha mating type, as discovered previously in the related pathogenic species Cryptococcus neoformans. Here we report observation of hallmark features of unisexual reproduction in a clinical isolate of C. gattii (isolate 97/433) and describe genetic and environmental factors conducive to this sexual cycle. Our results are consistent with population genetic evidence of recombination in the largely unisexual populations of C. gattii and provide a useful genetic model for understanding how novel modes of sexual reproduction may contribute to evolution and virulence in this species.	[Phadke, Sujal S.; Feretzaki, Marianna; Clancey, Shelly Applen; Mueller, Olaf; Heitman, Joseph] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC 27708 USA	Duke University	Heitman, J (corresponding author), Duke Univ, Dept Mol Genet & Microbiol, Durham, NC 27708 USA.	heitm001@duke.edu	Heitman, Joseph/ABC-6006-2021		Duke University Center for AIDS Research (CFAR) (National Institutes of Health [NIH]-funded program) [2P30 AI64518-07]; NIH/NIAID R01 [AI50113-10]; R37 MERIT award [AI39115-17]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI039115, P30AI064518, R01AI050113] Funding Source: NIH RePORTER	Duke University Center for AIDS Research (CFAR) (National Institutes of Health [NIH]-funded program); NIH/NIAID R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); R37 MERIT award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Marianna Feretzaki was supported by the Duke University Center for AIDS Research (CFAR) (National Institutes of Health [NIH]-funded program [2P30 AI64518-07 to M.F.]). This research was supported by NIH/NIAID R01 grant AI50113-10 and R37 MERIT award AI39115-17 (to J.H.). The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	ALANO P, 1990, ANNU REV MICROBIOL, V44, P429, DOI 10.1146/annurev.mi.44.100190.002241; Alby K, 2009, NATURE, V460, P890, DOI 10.1038/nature08252; Alspaugh JA, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P153; Billmyre RB, MBIO IN PRESS; Botts MR, 2010, CURR OPIN MICROBIOL, V13, P437, DOI 10.1016/j.mib.2010.05.003; Bui T, 2008, EUKARYOT CELL, V7, P1771, DOI 10.1128/EC.00097-08; Byrnes EJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000850; Byrnes EJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002205; Byrnes EJ, 2009, J INFECT DIS, V199, P1081, DOI 10.1086/597306; Campbell LT, 2005, EUKARYOT CELL, V4, P1410, DOI 10.1128/EC.4.8.1410-1419.2005; Carriconde F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016936; Olivares LRC, 2009, MED MYCOL, V47, P713, DOI 10.3109/13693780802559031; Chaturvedi S, 2005, EMERG INFECT DIS, V11, P1686, DOI 10.3201/eid1111.040875; Chen S, 2000, CLIN INFECT DIS, V31, P499, DOI 10.1086/313992; Chowdhary A, 2012, CRIT REV MICROBIOL, V38, P1, DOI 10.3109/1040841X.2011.606426; Cogliati M, 2012, MYCOSES, V55, P262, DOI 10.1111/j.1439-0507.2011.02082.x; D'Souza CA, 2011, MBIO, V2, DOI 10.1128/mBio.00342-10; Davidson RC, 2003, MOL MICROBIOL, V49, P469, DOI 10.1046/j.1365-2958.2003.03563.x; Feretzaki M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003688; Firacative C, 2011, BIOMEDICA, V31, P118, DOI 10.1590/S0120-41572011000100014; Colom MF, 2012, MED MYCOL, V50, P67, DOI 10.3109/13693786.2011.574239; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Fries BC, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P515; Fu J, 2011, MOL MICROBIOL, V79, P990, DOI 10.1111/j.1365-2958.2010.07501.x; Fu JM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003335; Gaunt MW, 2003, NATURE, V421, P936, DOI 10.1038/nature01438; GIMENO CJ, 1992, SCIENCE, V257, P626, DOI 10.1126/science.1496375; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Grigg ME, 2001, SCIENCE, V294, P161, DOI 10.1126/science.1061888; Heitman J, 2006, CURR BIOL, V16, pR711, DOI 10.1016/j.cub.2006.07.064; Heitman J, 2013, MYCOLOGIA, V105, P1, DOI 10.3852/12-253; Heitman J, 2010, CELL HOST MICROBE, V8, P86, DOI 10.1016/j.chom.2010.06.011; Hoang LMN, 2004, J MED MICROBIOL, V53, P935, DOI 10.1099/jmm.0.05427-0; Hsueh YP, 2007, MOL BIOL CELL, V18, P3237, DOI 10.1091/mbc.E07-02-0133; Hsueh YP, 2009, EMBO J, V28, P1220, DOI 10.1038/emboj.2009.68; Hull CM, 2002, ANNU REV GENET, V36, P557, DOI 10.1146/annurev.genet.36.052402.152652; Idnurm A, 2005, NAT REV MICROBIOL, V3, P753, DOI 10.1038/nrmicro1245; Karstaedt AS, 2002, MED MYCOL, V40, P7, DOI 10.1080/mmy.40.1.7.11; Kent CR, 2008, APPL ENVIRON MICROB, V74, P6248, DOI 10.1128/AEM.00970-08; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Kozubowski L, 2012, FEMS MICROBIOL REV, V36, P78, DOI 10.1111/j.1574-6976.2011.00286.x; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; KWONCHUNG KJ, 1978, AM J EPIDEMIOL, V108, P337, DOI 10.1093/oxfordjournals.aje.a112628; KWONCHUNG KJ, 1976, MYCOLOGIA, V68, P942, DOI 10.2307/3758813; KWONCHUNG KJ, 1992, INFECT IMMUN, V60, P602, DOI 10.1128/IAI.60.2.602-605.1992; Lee SC, 2012, EUKARYOT CELL, V11, P1391, DOI 10.1128/EC.00242-12; Li L, 2007, MOL BIOL CELL, V18, P4201, DOI 10.1091/mbc.E07-02-0136; Lin X, 2007, PLOS GENET, V3, P1975, DOI 10.1371/journal.pgen.0030186; Lin XR, 2006, ANNU REV MICROBIOL, V60, P69, DOI 10.1146/annurev.micro.60.080805.142102; Lin XR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000953; Lin XR, 2009, INFECT GENET EVOL, V9, P401, DOI 10.1016/j.meegid.2009.01.013; Lin XR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000283; Lin XR, 2005, NATURE, V434, P1017, DOI 10.1038/nature03448; Lockhart SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074737; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; MacDougall L, 2007, EMERG INFECT DIS, V13, P42, DOI 10.3201/eid1301.060827; MITCHELL TG, 1995, CLIN MICROBIOL REV, V8, P515, DOI 10.1128/CMR.8.4.515; Morgan J, 2006, CLIN INFECT DIS, V43, P1077, DOI 10.1086/507897; Nielsen K, 2003, INFECT IMMUN, V71, P4831, DOI 10.1128/IAI.71.9.4831-4841.2003; Perfect JR, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P17; PERFECT JR, 1993, J CLIN MICROBIOL, V31, P3305, DOI 10.1128/JCM.31.12.3305-3309.1993; Saul N, 2008, EUKARYOT CELL, V7, P727, DOI 10.1128/EC.00020-08; Springer DJ, 2012, CURR FUNGAL INFECT R, V6, P245, DOI 10.1007/s12281-012-0111-0; Springer DJ, PLOS PATHOG IN PRESS; Stephen C, 2002, CAN VET J, V43, P792; Thomas CF, 2004, NEW ENGL J MED, V350, P2487, DOI 10.1056/NEJMra032588; Velagapudi R, 2009, INFECT IMMUN, V77, P4345, DOI 10.1128/IAI.00542-09; Voelz K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003771; Wang P, 2004, EUKARYOT CELL, V3, P1028, DOI 10.1128/EC.3.4.1028-1035.2004; Wickes BL, 1996, P NATL ACAD SCI USA, V93, P7327, DOI 10.1073/pnas.93.14.7327; Xie J, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001525; Xue CY, 2008, FEMS MICROBIOL REV, V32, P1010, DOI 10.1111/j.1574-6976.2008.00131.x; Xue CY, 2008, MOL MICROBIOL, V70, P379, DOI 10.1111/j.1365-2958.2008.06417.x; Xue CY, 2007, CELL HOST MICROBE, V1, P263, DOI 10.1016/j.chom.2007.05.005; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	76	16	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e111089	10.1371/journal.pone.0111089	http://dx.doi.org/10.1371/journal.pone.0111089			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337713	Green Submitted, gold, Green Published			2022-12-27	WOS:000343674800105
J	Yan, XH; Sasi, SP; Gee, H; Lee, JY; Yang, YY; Mehrzad, R; Onufrak, J; Song, J; Enderling, H; Agarwal, A; Rahimi, L; Morgan, J; Wilson, PF; Carrozza, J; Walsh, K; Kishore, R; Goukassian, DA				Yan, Xinhua; Sasi, Sharath P.; Gee, Hannah; Lee, JuYong; Yang, Yongyao; Mehrzad, Raman; Onufrak, Jillian; Song, Jin; Enderling, Heiko; Agarwal, Akhil; Rahimi, Layla; Morgan, James; Wilson, Paul F.; Carrozza, Joseph; Walsh, Kenneth; Kishore, Raj; Goukassian, David A.			Cardiovascular Risks Associated with Low Dose Ionizing Particle Radiation	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; FAILING HUMAN MYOCARDIUM; ISCHEMIC-HEART-DISEASE; BREAST-CANCER; CARDIAC-HYPERTROPHY; CELLULAR MECHANISMS; NA+-CA2+ EXCHANGE; FAILURE; RADIOTHERAPY; MICE	Previous epidemiologic data demonstrate that cardiovascular (CV) morbidity and mortality may occur decades after ionizing radiation exposure. With increased use of proton and carbon ion radiotherapy and concerns about space radiation exposures to astronauts on future long-duration exploration-type missions, the long-term effects and risks of low-dose charged particle irradiation on the CV system must be better appreciated. Here we report on the long-term effects of whole-body proton (1 H; 0.5 Gy, 1 GeV) and iron ion (56 Fe; 0.15 Gy, 1GeV/nucleon) irradiation with and without an acute myocardial ischemia (AMI) event in mice. We show that cardiac function of proton-irradiated mice initially improves at 1 month but declines by 10 months post-irradiation. In AMI-induced mice, prior proton irradiation improved cardiac function restoration and enhanced cardiac remodeling. This was associated with increased pro-survival gene expression in cardiac tissues. In contrast, cardiac function was significantly declined in 56 Fe ion-irradiated mice at 1 and 3 months but recovered at 10 months. In addition, 56 Fe ion-irradiation led to poorer cardiac function and more adverse remodeling in AMI-induced mice, and was associated with decreased angiogenesis and pro-survival factors in cardiac tissues at any time point examined up to 10 months. This is the first study reporting CV effects following low dose proton and iron ion irradiation during normal aging and post-AMI. Understanding the biological effects of charged particle radiation qualities on the CV system is necessary both for the mitigation of space exploration CV risks and for understanding of long-term CV effects following charged particle radiotherapy.	[Yan, Xinhua; Sasi, Sharath P.; Gee, Hannah; Lee, JuYong; Yang, Yongyao; Onufrak, Jillian; Song, Jin; Agarwal, Akhil; Rahimi, Layla; Carrozza, Joseph; Goukassian, David A.] GeneSys Res Inst, Cardiovasc Res Ctr, Boston, MA 02131 USA; [Lee, JuYong] Univ Connecticut, Ctr Hlth, Calhoun Cardiol Ctr, Farmington, CT USA; [Yan, Xinhua; Morgan, James; Carrozza, Joseph; Goukassian, David A.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Mehrzad, Raman; Morgan, James] Steward Carney Hosp, Dorchester, MA USA; [Enderling, Heiko] H Lee Moffitt Canc Ctr & Res Inst, Dept Integrated Math Oncol, Tampa, FL USA; [Wilson, Paul F.] Brookhaven Natl Lab, Biosci Dept, Upton, NY 11973 USA; [Carrozza, Joseph] Steward St Elizabeths Med Ctr, Boston, MA USA; [Walsh, Kenneth; Goukassian, David A.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Kishore, Raj] Northwestern Univ, Feinberg Cardiovasc Inst, Chicago, IL 60611 USA	University of Connecticut; Tufts University; H Lee Moffitt Cancer Center & Research Institute; United States Department of Energy (DOE); Brookhaven National Laboratory; St. Elizabeth's Medical Center; Boston University; Northwestern University	Yan, XH (corresponding author), GeneSys Res Inst, Cardiovasc Res Ctr, Boston, MA 02131 USA.	xinhua.yan@tufts.edu; david.goukassian@tufts.edu	Enderling, Heiko/AAA-2423-2021	Enderling, Heiko/0000-0002-9696-6410; Goukassian, David/0000-0001-5270-5270	National Aeronautic and Space Administration [NNJ10ZSA001N]; AHA [14GRNT18860032, 10GRNT4710003]; NHLBI [HL106098]; NIH [HL091983]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL106098, R01HL091983] Funding Source: NIH RePORTER	National Aeronautic and Space Administration(National Aeronautics & Space Administration (NASA)); AHA(American Heart Association); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This material is based upon work supported by the National Aeronautic and Space Administration under Grant No. NNJ10ZSA001N to DAG and in part by grants from AHA 14GRNT18860032 to DAG, AHA grant 10GRNT4710003 and NHLBI HL106098 to XY, and NIH HL091983 to RK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bose AS, 2009, J AM SOC ECHOCARDIOG, V22; Bushdid PB, 2003, CIRC RES, V92, P1305, DOI 10.1161/01.RES.0000077045.84609.9F; Convertino VA, 2009, RESP PHYSIOL NEUROBI, V169, pS34, DOI 10.1016/j.resp.2009.04.010; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; Deuse T, 2009, CIRCULATION, V120, pS247, DOI 10.1161/CIRCULATIONAHA.108.843680; Ding B, 2000, CIRCULATION, V101, P2854, DOI 10.1161/01.CIR.101.24.2854; EMERIT I, 1994, J CANCER RES CLIN, V120, P558, DOI 10.1007/BF01221035; Gayed IW, 2006, J NUCL MED, V47, P1756; GYENES G, 1994, INT J RADIAT ONCOL, V28, P1235, DOI 10.1016/0360-3016(94)90500-2; Hasenfuss G, 1999, CIRCULATION, V99, P641, DOI 10.1161/01.CIR.99.5.641; Hoffman SJ., 1997, AM ASTRONAUT SOC SCI, V98, P121; Jermann M, 2014, INT J PARTICLE THERA, V1, P40, DOI DOI 10.14338/IJPT.14-EDITORIAL-2.1; Kass DA, 2004, CIRC RES, V94, P1533, DOI 10.1161/01.RES.0000129254.25507.d6; Lemke LE, 2001, J MOL CELL CARDIOL, V33, P1527, DOI 10.1006/jmcc.2001.1415; Li CL, 2011, J BIOL CHEM, V286, P40782, DOI 10.1074/jbc.M111.263046; Marber MS, 2011, J MOL CELL CARDIOL, V51, P485, DOI 10.1016/j.yjmcc.2010.10.021; MEWALDT RA, 1994, ADV SPACE RES, V14, P737, DOI 10.1016/0273-1177(94)90536-3; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Mungrue IN, 2002, J CLIN INVEST, V109, P735, DOI 10.1172/JCI200213265; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; *NASA, 1998, STRAT PROGR PLAN SPA; PANT GS, 1977, HIROSHIMA J MED SCI, V26, P149; Patten RD, 1998, AM J PHYSIOL-HEART C, V274, pH1812, DOI 10.1152/ajpheart.1998.274.5.H1812; Reltz G, 2008, Z MED PHYS, V18, P233, DOI 10.1016/j.zemedi.2008.06.015; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Schillinger W, 2003, CARDIOVASC RES, V57, P921, DOI 10.1016/S0008-6363(02)00826-X; Shigekawa M, 2001, CIRC RES, V88, P864, DOI 10.1161/hh0901.090298; Shorofsky SR, 1999, CIRC RES, V84, P424, DOI 10.1161/01.RES.84.4.424; Sun Y, 2009, CARDIOVASC RES, V81, P482, DOI 10.1093/cvr/cvn333; Takagawa J, 2007, J APPL PHYSIOL, V102, P2104, DOI 10.1152/japplphysiol.00033.2007; Taylor CW, 2006, CLIN ONCOL-UK, V18, P236, DOI 10.1016/j.clon.2005.11.003; Tenhunen O, 2006, FASEB J, V20, P1907, DOI 10.1096/fj.05-5618fje; Vilahur G, 2011, J MOL CELL CARDIOL, V50, P522, DOI 10.1016/j.yjmcc.2010.12.021; Vilahur G, 2009, ATHEROSCLEROSIS, V206, P95, DOI 10.1016/j.atherosclerosis.2009.02.009; Yang TTC, 2002, MOL CELL BIOL, V22, P3892, DOI 10.1128/MCB.22.11.3892-3904.2002; Zeitlin C, 2013, SCIENCE, V340, P1080, DOI 10.1126/science.1235989; ZOLOTAREVA AG, 1978, COR VASA, V20, P308	38	42	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110269	10.1371/journal.pone.0110269	http://dx.doi.org/10.1371/journal.pone.0110269			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337914	Green Published, gold, Green Submitted			2022-12-27	WOS:000343674800030
J	Aachmann-Andersen, NJ; Christensen, SJ; Lisbjerg, K; Oturai, P; Meinild-Lundby, AK; Holstein-Rathlou, NH; Lundby, C; Olsen, NV				Aachmann-Andersen, Niels Jacob; Christensen, Soren Just; Lisbjerg, Kristian; Oturai, Peter; Meinild-Lundby, Anne-Kristine; Holstein-Rathlou, Niels-Henrik; Lundby, Carsten; Olsen, Niels Vidiendal			Recombinant Erythropoietin in Humans Has a Prolonged Effect on Circulating Erythropoietin Isoform Distribution	PLOS ONE			English	Article							STIMULATING AGENTS; URINE; CAPACITY; PLASMA; LIVER; SERUM	The membrane-assisted isoform immunoassay (MAIIA) quantitates erythropoietin (EPO) isoforms as percentages of migrated isoforms (PMI). We evaluated the effect of recombinant human EPO (rhEPO) on the distribution of EPO isoforms in plasma in a randomized, placebo-controlled, double-blinded, cross-over study. 16 healthy subjects received either low-dose Epoetin beta (5000 IU on days 1, 3, 5, 7, 9, 11 and 13); high-dose Epoetin beta (30.000 IU on days 1, 2 and 3 and placebo on days 5, 7, 9, 11 and 13); or placebo on all days. PMI on days 4, 11 and 25 was determined by interaction of N-acetyl glucosamine with the glycosylation dependent desorption of EPO isoforms. At day 25, plasma-EPO in both rhEPO groups had returned to values not different from the placebo group. PMI with placebo, reflecting the endogenous EPO isoforms, averaged 82.5 (10.3) % (mean (SD)). High-dose Epoetin beta decreased PMI on days 4 and 11 to 31.0 (4.2)% (p < 0.00001) and 45.2 (7.3)% (p < 0.00001). Low-dose Epoetin beta decreased PMI on days 4 and 11 to 46.0 (12.8)% (p <0.00001) and 46.1 (10.4)% (p < 0.00001). In both rhEPO groups, PMI on day 25 was still decreased (high-dose Epoetin beta: 72.9 (19.4)% (p = 0.029); low-dose Epoetin beta: 73.1 (17.8)% (p = 0.039)). In conclusion, Epoetin beta leaves a footprint in the plasma-EPO isoform pattern. MAIIA can detect changes in EPO isoform distribution up til at least three weeks after administration of Epoetin beta even though the total EPO concentration has returned to normal.	[Aachmann-Andersen, Niels Jacob; Christensen, Soren Just; Lisbjerg, Kristian; Olsen, Niels Vidiendal] Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Oturai, Peter] Rigshosp, Ctr Clin Investigat, Clin Clin Physiol Nucl Med & PET, DK-2100 Copenhagen, Denmark; [Meinild-Lundby, Anne-Kristine; Lundby, Carsten] Univ Zurich, Ctr Integrat Human Physiol ZIHP, Inst Physiol, Zurich, Switzerland; [Holstein-Rathlou, Niels-Henrik] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Olsen, Niels Vidiendal] Univ Copenhagen, Ctr Neurosci, Dept Neuroanaesthesia, Copenhagen, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Copenhagen; University of Copenhagen	Aachmann-Andersen, NJ (corresponding author), Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark.	andersenscience@gmail.com		Christensen, Soren/0000-0002-2083-3347; Holstein-Rathlou, Niels-Henrik/0000-0003-1683-3464; Oturai, Peter/0000-0002-9828-9185	Danish Society of Anaesthesiology and Intensive Care Medicine; Danish Kidney Society	Danish Society of Anaesthesiology and Intensive Care Medicine; Danish Kidney Society	This study was supported by grants by the Danish Society of Anaesthesiology and Intensive Care Medicine and The Danish Kidney Society both obtained by NJAA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashenden M, 2012, J PHARMACEUT BIOMED, V67-68, P123, DOI 10.1016/j.jpba.2012.04.025; Ashenden M, 2011, EUR J APPL PHYSIOL, V111, P2307, DOI 10.1007/s00421-011-1867-6; Ashenden MJ, 2001, J SPORT SCI, V19, P831, DOI 10.1080/026404101753113778; Borno A, 2010, EUR J APPL PHYSIOL, V109, P537, DOI 10.1007/s00421-010-1370-5; Cazzola M, 2000, HAEMATOLOGICA, V85, P561; ECKARDT KU, 1992, J CLIN INVEST, V89, P753, DOI 10.1172/JCI115652; Fraguas LF, 2008, J CHROMATOGR A, V1212, P82, DOI 10.1016/j.chroma.2008.10.036; HALSTENSON CE, 1991, CLIN PHARMACOL THER, V50, P702, DOI 10.1038/clpt.1991.210; Jelkmann W, 2009, CURR MED CHEM, V16, P1236, DOI 10.2174/092986709787846668; JELKMANN W, 1992, PHYSIOL REV, V72, P449, DOI 10.1152/physrev.1992.72.2.449; Jelkmann W, 2007, EUR J HAEMATOL, V78, P183, DOI 10.1111/j.1600-0609.2007.00818.x; Jelkmann W, 2011, BLOOD, V118, P2395, DOI 10.1182/blood-2011-02-303271; Kristensen PL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059672; Lasne F, 2002, ANAL BIOCHEM, V311, P119, DOI 10.1016/S0003-2697(02)00407-4; Lonnberg M, 2000, J IMMUNOL METHODS, V246, P25, DOI 10.1016/S0022-1759(00)00287-8; Lonnberg M, 2013, ANAL BIOANAL CHEM, V405, P9685, DOI 10.1007/s00216-013-6997-8; Lonnberg M, 2012, ANAL BIOCHEM, V420, P101, DOI 10.1016/j.ab.2011.09.021; Lonnberg M, 2008, J IMMUNOL METHODS, V339, P236, DOI 10.1016/j.jim.2008.09.022; Loonberg M, 2006, J CHROMATOGR A, V1127, P175, DOI 10.1016/j.chroma.2006.06.016; Lundby AKM, 2014, EUR J APPL PHYSIOL, V114, P1107, DOI 10.1007/s00421-014-2844-7; Lundby C, 2008, J APPL PHYSIOL, V105, P417, DOI 10.1152/japplphysiol.90529.2008; Lundby C, 2012, BRIT J PHARMACOL, V165, P1306, DOI 10.1111/j.1476-5381.2011.01822.x; Lundby C, 2011, J PHYSIOL-LONDON, V589, P1265, DOI 10.1113/jphysiol.2010.195917; Morkeberg J, 2013, SCAND J MED SCI SPOR, P1; Olsen NV, 2011, J PHYSIOL-LONDON, V589, P1273, DOI 10.1113/jphysiol.2010.194241; Parisotto R, 2000, INT J SPORTS MED, V21, P471, DOI 10.1055/s-2000-7421; Rasmussen P, 2010, J APPL PHYSIOL, V109, P476, DOI 10.1152/japplphysiol.00234.2010; Rasmussen P, 2012, FASEB J, V26, P1343, DOI 10.1096/fj.11-193508; Reichel C, 2011, FORENSIC SCI INT; Reichel C, 2011, ANAL BIOANAL CHEM, V401, P463, DOI 10.1007/s00216-011-5116-y; Sottas PE, 2011, CLIN CHEM, V57, P969, DOI 10.1373/clinchem.2011.162271; Thomsen JJ, 2007, EUR J APPL PHYSIOL, V101, P481, DOI 10.1007/s00421-007-0522-8; WIDE L, 1990, BRIT J HAEMATOL, V76, P121, DOI 10.1111/j.1365-2141.1990.tb07846.x; ZANJANI ED, 1981, J CLIN INVEST, V67, P1183, DOI 10.1172/JCI110133	34	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110903	10.1371/journal.pone.0110903	http://dx.doi.org/10.1371/journal.pone.0110903			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25335123	Green Published, Green Submitted, gold			2022-12-27	WOS:000343731200090
J	Torrance, JS; Wincenciak, J; Hahn, AC; DeBruine, LM; Jones, BC				Torrance, Jaimie S.; Wincenciak, Joanna; Hahn, Amanda C.; DeBruine, Lisa M.; Jones, Benedict C.			The Relative Contributions of Facial Shape and Surface Information to Perceptions of Attractiveness and Dominance	PLOS ONE			English	Article							MENS FACES; SEXUAL-DIMORPHISM; BEAUTY; MASCULINITY; SYMMETRY; COLOR; RECOGNITION; COOPERATION; TEXTURES; HEALTH	Although many studies have investigated the facial characteristics that influence perceptions of others' attractiveness and dominance, the majority of these studies have focused on either the effects of shape information or surface information alone. Consequently, the relative contributions of facial shape and surface characteristics to attractiveness and dominance perceptions are unclear. To address this issue, we investigated the relationships between ratings of original versions of faces and ratings of versions in which either surface information had been standardized (i.e., shape-only versions) or shape information had been standardized (i.e., surface-only versions). For attractiveness and dominance judgments of both male and female faces, ratings of shape-only and surface-only versions independently predicted ratings of the original versions of faces. The correlations between ratings of original and shape-only versions and between ratings of original and surface-only versions differed only in two instances. For male attractiveness, ratings of original versions were more strongly related to ratings of surface-only than shape-only versions, suggesting that surface information is particularly important for men's facial attractiveness. The opposite was true for female physical dominance, suggesting that shape information is particularly important for women's facial physical dominance. In summary, our results indicate that both facial shape and surface information contribute to judgments of others' attractiveness and dominance, suggesting that it may be important to consider both sources of information in research on these topics.	[Torrance, Jaimie S.; Wincenciak, Joanna; Hahn, Amanda C.; DeBruine, Lisa M.; Jones, Benedict C.] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland	University of Glasgow	Jones, BC (corresponding author), Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland.	ben.jones@glasgow.ac.uk	DeBruine, Lisa M/A-6990-2008; Hahn, Amanda C/H-8779-2013; Wincenciak, Joanna/N-4422-2013; Jones, Benedict C/A-7850-2008; Hahn, Amanda C/AAH-1106-2021	DeBruine, Lisa M/0000-0002-7523-5539; Hahn, Amanda C/0000-0002-4555-7924; Wincenciak, Joanna/0000-0003-2083-9447; Jones, Benedict C/0000-0001-7777-0220; Hahn, Amanda C/0000-0002-4555-7924	Economic and Social Research Council [ES/I031022/1]; European Research Council [282655]; ESRC [ES/I031022/2, ES/I031022/1] Funding Source: UKRI; Economic and Social Research Council [ES/I031022/2] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); European Research Council(European Research Council (ERC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by Economic and Social Research Council grant ES/I031022/1, which was awarded to LMD and BCJ, and European Research Council Starting Grant 282655 (OCMATE), which was awarded to BCJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Coetzee V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048116; DeBruine LM, 2010, J EXP PSYCHOL HUMAN, V36, P751, DOI 10.1037/a0016457; Dixson BJ, 2013, EVOL HUM BEHAV, V34, P236, DOI 10.1016/j.evolhumbehav.2013.02.003; Dixson BJ, 2012, BEHAV ECOL, V23, P481, DOI 10.1093/beheco/arr214; Fink B, 2001, J COMP PSYCHOL, V115, P92, DOI 10.1037//0735-7036.115.1.92; HILL H, 1995, P ROY SOC B-BIOL SCI, V261, P367, DOI 10.1098/rspb.1995.0161; Hong GW, 2001, COLOR RES APPL, V26, P76, DOI 10.1002/1520-6378(200102)26:1<76::AID-COL8>3.0.CO;2-3; Hume DK, 2001, EVOL HUM BEHAV, V22, P93, DOI 10.1016/S1090-5138(00)00065-9; Jones BC, 2005, P ROY SOC B-BIOL SCI, V272, P347, DOI 10.1098/rspb.2004.2962; Jones BC, 2007, EVOL HUM BEHAV, V28, P439, DOI 10.1016/j.evolhumbehav.2007.07.006; Jones BC, 2010, P ROY SOC B-BIOL SCI, V277, P617, DOI 10.1098/rspb.2009.1575; Langlois JH, 2000, PSYCHOL BULL, V126, P390, DOI 10.1037/0033-2909.126.3.390; Lefevre CE, 2014, EUROPEAN J IN PRESS; Little AC, 2002, BRIT J PSYCHOL, V93, P451, DOI 10.1348/000712602761381349; Neave N, 2008, PERS INDIV DIFFER, V45, P373, DOI 10.1016/j.paid.2008.05.007; O'Toole AJ, 1999, VISION RES, V39, P3145, DOI 10.1016/S0042-6989(99)00034-6; O'Toole AJ, 1999, IMAGE VISION COMPUT, V18, P9, DOI 10.1016/S0262-8856(99)00012-8; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Perrett DI, 1999, EVOL HUM BEHAV, V20, P295, DOI 10.1016/S1090-5138(99)00014-8; Puts DA, 2010, EVOL HUM BEHAV, V31, P157, DOI 10.1016/j.evolhumbehav.2010.02.005; Puts DA, 2006, EVOL HUM BEHAV, V27, P283, DOI 10.1016/j.evolhumbehav.2005.11.003; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Rhodes G, 1999, PSYCHOL SCI, V10, P52, DOI 10.1111/1467-9280.00106; Rhodes G, 1998, PSYCHON B REV, V5, P659, DOI 10.3758/BF03208842; Rhodes G, 2000, BRIT J PSYCHOL, V91, P125, DOI 10.1348/000712600161718; Russell R, 2003, PERCEPTION, V32, P1093, DOI 10.1068/p5101; Russell R, 2012, NEUROPSYCHOLOGIA, V50, P334, DOI 10.1016/j.neuropsychologia.2011.12.004; Russell R, 2009, PERCEPTION, V38, P1211, DOI 10.1068/p6331; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Stephen ID, 2012, EVOL PSYCHOL-US, V10, P562; Stephen ID, 2012, EVOL HUM BEHAV, V33, P260, DOI 10.1016/j.evolhumbehav.2011.10.003; Stephen ID, 2009, INT J PRIMATOL, V30, P845, DOI 10.1007/s10764-009-9380-z; Stirrat M, 2012, PSYCHOL SCI, V23, P718, DOI 10.1177/0956797611435133; Stirrat M, 2010, PSYCHOL SCI, V21, P349, DOI 10.1177/0956797610362647; Tiddeman B, 2001, IEEE COMPUT GRAPH, V21, P42, DOI 10.1109/38.946630; Watkins CD, 2012, EUR J PERSONALITY, V26, P79, DOI 10.1002/per.837; Watkins CD, 2010, PERS INDIV DIFFER, V49, P967, DOI 10.1016/j.paid.2010.08.006	37	20	21	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e104415	10.1371/journal.pone.0104415	http://dx.doi.org/10.1371/journal.pone.0104415			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BH	25349994	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000343943100003
J	Chen, HC; Zou, W; Lu, TP; Chen, JJ				Chen, Hung-Chia; Zou, Wen; Lu, Tzu-Pin; Chen, James J.			A Composite Model for Subgroup Identification and Prediction via Bicluster Analysis	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; HIGH-DIMENSIONAL DATA; SINGULAR-VALUE DECOMPOSITION; GENE-EXPRESSION DATA; ACUTE LYMPHOBLASTIC-LEUKEMIA; SALMONELLA-SEROTYPES; CLUSTER-ANALYSIS; MICROARRAY DATA; CLASSIFICATION; PATTERNS	Background: A major challenges in the analysis of large and complex biomedical data is to develop an approach for 1) identifying distinct subgroups in the sampled populations, 2) characterizing their relationships among subgroups, and 3) developing a prediction model to classify subgroup memberships of new samples by finding a set of predictors. Each subgroup can represent different pathogen serotypes of microorganisms, different tumor subtypes in cancer patients, or different genetic makeups of patients related to treatment response. Methods: This paper proposes a composite model for subgroup identification and prediction using biclusters. A biclustering technique is first used to identify a set of biclusters from the sampled data. For each bicluster, a subgroup-specific binary classifier is built to determine if a particular sample is either inside or outside the bicluster. A composite model, which consists of all binary classifiers, is constructed to classify samples into several disjoint subgroups. The proposed composite model neither depends on any specific biclustering algorithm or patterns of biclusters, nor on any classification algorithms. Results: The composite model was shown to have an overall accuracy of 97.4% for a synthetic dataset consisting of four subgroups. The model was applied to two datasets where the sample's subgroup memberships were known. The procedure showed 83.7% accuracy in discriminating lung cancer adenocarcinoma and squamous carcinoma subtypes, and was able to identify 5 serotypes and several subtypes with about 94% accuracy in a pathogen dataset. Conclusion: The composite model presents a novel approach to developing a biclustering-based classification model from unlabeled sampled data. The proposed approach combines unsupervised biclustering and supervised classification techniques to classify samples into disjoint subgroups based on their associated attributes, such as genotypic factors, phenotypic outcomes, efficacy/safety measures, or responses to treatments. The procedure is useful for identification of unknown species or new biomarkers for targeted therapy.	[Chen, Hung-Chia; Zou, Wen; Lu, Tzu-Pin; Chen, James J.] US FDA, Natl Ctr Toxicol Res, Div Bioinformat & Biostat, Jefferson, AR 72079 USA; [Chen, Hung-Chia; Chen, James J.] China Med Univ, Grad Inst Biostat, Taichung, Taiwan; [Chen, Hung-Chia; Chen, James J.] China Med Univ, Ctr Biostat, Taichung, Taiwan; [Lu, Tzu-Pin] Natl Taiwan Univ, Grad Inst Epidemiol & Prevent Med, Dept Publ Hlth, Taipei 10764, Taiwan	US Food & Drug Administration (FDA); China Medical University Taiwan; China Medical University Taiwan; National Taiwan University	Chen, JJ (corresponding author), US FDA, Natl Ctr Toxicol Res, Div Bioinformat & Biostat, Jefferson, AR 72079 USA.	jamesj.chen@fda.hhs.gov	Lu, Tzupin/ABC-2195-2021	Lu, Tzupin/0000-0003-3697-0386; Zou, Wen/0000-0002-3735-1133	USDOE; USFDA	USDOE(United States Department of Energy (DOE)); USFDA	The research by Hung-Chia and Tzu-Pin was supported by the Post-doctoral Fellowship Program at the NCTR administered by the Oak Ridge Institute for Science and Education through an interagency agreement between USDOE and USFDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek S, 2009, BRIEF BIOINFORM, V10, P537, DOI 10.1093/bib/bbp016; Baker EJ, 2012, NUCLEIC ACIDS RES, V40, pD1067, DOI 10.1093/nar/gkr968; Baker EJ, 2009, GENOMICS, V94, P377, DOI 10.1016/j.ygeno.2009.08.016; Barkow S, 2006, BIOINFORMATICS, V22, P1282, DOI 10.1093/bioinformatics/btl099; Barrett TJ, 2006, FOODBORNE PATHOG DIS, V3, P20, DOI 10.1089/fpd.2006.3.20; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Brieman L, 1995, CART CLASSIFICATION; Busygin S, 2008, COMPUT OPER RES, V35, P2964, DOI 10.1016/j.cor.2007.01.005; Carreiro AV, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-175; Chen DT, 2011, JNCI-J NATL CANCER I, V103, P1859, DOI 10.1093/jnci/djr420; Chen HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071680; Chen JJ, 2013, PHARMACOGENOMICS, V14, P969, DOI [10.2217/PGS.13.75, 10.2217/pgs.13.75]; Cheng Y, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P93; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fang G, 2010, BIOCOMPUT-PAC SYM, P145; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Gaul SB, 2007, J CLIN MICROBIOL, V45, P472, DOI 10.1128/JCM.00962-06; Geraci J, 2014, BIOINFORMATICS, V30, P712, DOI 10.1093/bioinformatics/btt602; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hochreiter S, 2010, BIOINFORMATICS, V26, P1520, DOI 10.1093/bioinformatics/btq227; Jiang DX, 2004, IEEE T KNOWL DATA EN, V16, P1370, DOI 10.1109/TKDE.2004.68; Kluger Y, 2003, GENOME RES, V13, P703, DOI 10.1101/gr.648603; Kriegel HP, 2009, ACM T KNOWL DISCOV D, V3, DOI 10.1145/1497577.1497578; Langreth, 1999, Oncologist, V4, P426; Lee M, 2010, BIOMETRICS, V66, P1087, DOI 10.1111/j.1541-0420.2010.01392.x; LI J, 1994, P NATL ACAD SCI USA, V91, P2552, DOI 10.1073/pnas.91.7.2552; Liebana E, 2001, J CLIN MICROBIOL, V39, P3609, DOI 10.1128/JCM.39.10.3609-3616.2001; Lin WJ, 2013, BRIEF BIOINFORM, V14, P13, DOI 10.1093/bib/bbs006; Lipkovich I, 2011, STAT MED, V30, P2601, DOI 10.1002/sim.4289; Madeira SC, 2004, IEEE ACM T COMPUT BI, V1, P24, DOI 10.1109/TCBB.2004.2; Odibat M, 2013, KNOW INF SYST, DOI 101007/s10115-013-0684-0; Prelic A, 2006, BIOINFORMATICS, V22, P1122, DOI 10.1093/bioinformatics/btl060; Pui CH, 1999, J CLIN ONCOL, V17, P438, DOI 10.1200/JCO.1999.17.2.438; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; Rothenberg ML, 2003, NAT REV CANCER, V3, P303, DOI 10.1038/nrc1047; Ruberg SJ, 2010, CLIN TRIALS, V7, P574, DOI 10.1177/1740774510369350; Schloss PD, 2003, CURR OPIN BIOTECH, V14, P303, DOI 10.1016/S0958-1669(03)00067-3; Shabalin AA, 2009, ANN APPL STAT, V3, P985, DOI 10.1214/09-AOAS239; Sill M, 2011, BIOINFORMATICS, V27, P2089, DOI 10.1093/bioinformatics/btr322; Swaminathan B, 2001, EMERG INFECT DIS, V7, P382; Tagkopoulos I, 2005, BIBE 2005: 5TH IEEE SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING, P89; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Tanay Amos, 2002, Bioinformatics, V18 Suppl 1, pS136; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Urisman A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r78; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vapnik V., 1998, STAT LEARNING THEORY; Wang SJ, 2010, CLIN TRIALS, V7, P525, DOI 10.1177/1740774510375455; Yang WH, 2007, LECT NOTES COMPUT SC, V4819, P194; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Zhang Y, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-110; Zou W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059224; Zou W, 2012, J CLIN MICROBIOL, V50, P1524, DOI 10.1128/JCM.00111-12; Zou W, 2010, J CLIN MICROBIOL, V48, P3122, DOI 10.1128/JCM.00645-10	60	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111318	10.1371/journal.pone.0111318	http://dx.doi.org/10.1371/journal.pone.0111318			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347824	Green Published, gold, Green Submitted			2022-12-27	WOS:000347994900060
J	Li, SY; Zhai, X; Rong, PJ; McCabe, MF; Zhao, JJ; Ben, H; Wang, X; Wang, SX				Li, Shaoyuan; Zhai, Xu; Rong, Peijing; McCabe, Michael F.; Zhao, Jingjun; Ben, Hui; Wang, Xing; Wang, Shuxing			Transcutaneous Auricular Vagus Nerve Stimulation Triggers Melatonin Secretion and Is Antidepressive in Zucker Diabetic Fatty Rats	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; NMDA RECEPTORS; ACUPUNCTURE; HYPNOSIS; INSOMNIA; BEHAVIOR; SYSTEM; MOUSE; TRIAL	Decreased circulating melatonin is implicated in depression. We recently found that Zucker diabetic fatty rats (ZDF, fa/fa) develop depression-like behaviors and that transcutaneous auricular vagus nerve stimulation (taVNS) is antidepressive in ZDF rats. Here we studied whether the ZDF rats could be used as a depression rodent model and whether the antidepressive effect of taVNS is mediated through modulation of melatonin secretion. Adult male ZDF and Zucker lean (ZL, fa/+) littermates were used. 30 min-taVNS procedures (2/15 Hz, 2 mA) were administered once daily under anesthesia for 34 consecutive days in pineal intact ZDF (n = 8) and ZL (n = 6) rats, as well as in pinealectomized ZDF rats (n = 8). Forced swimming test (FST) was used to determine depression-like behavior and ELISA to detect plasma melatonin concentration on day 35. We found that naive ZDF rats had a longer immobility time in FST and that long-term (34 days) taVNS treatment ameliorated the depression-like behavior. In both pineal intact and pinealectomized ZDF rats, taVNS induced acute melatonin secretion, both during and after the taVNS session. A low melatonin level is related to the poor FST performance in ZDF rats (R = -0.544) in contrast to ZL rats (R = 0.247). In conclusion, our results show that ZDF rats are ideal candidates of innate depression and that taVNS is antidepressive through triggering melatonin secretion and increasing its production.	[Li, Shaoyuan; Zhai, Xu; Rong, Peijing; Zhao, Jingjun; Ben, Hui; Wang, Shuxing] China Acad Chinese Med Sci, Inst Acupuncture & Moxibust, Dept Physiol, Beijing, Peoples R China; [Li, Shaoyuan; Wang, Xing; Wang, Shuxing] Xinxiang Med Univ, Dept Anat, Xinxiang, Henan Province, Peoples R China; [McCabe, Michael F.; Wang, Shuxing] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Anesthesia Crit Care & Pain Med, Boston, MA USA	China Academy of Chinese Medical Sciences; Institute of Acupuncture & Moxibustion, CACMS; Xinxiang Medical University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Rong, PJ (corresponding author), China Acad Chinese Med Sci, Inst Acupuncture & Moxibust, Dept Physiol, Beijing, Peoples R China.	rongpj@hotmail.com; wshuxing@mgh.harvard.edu	zhao, jing/B-3868-2019		National Natural Science Foundation of China [81271243, 81473780]; Natural Science Foundation of Beijing [7111007]; National Basic Research Program of China (973 Program) [2012CB518503]; Project Supported National Science and Technology Ministry [2012BAF14B10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Project Supported National Science and Technology Ministry	This work was supported by National Natural Science Foundation of China-81271243, 81473780; Natural Science Foundation of Beijing, 7111007; National Basic Research Program of China (973 Program)-2012CB518503; and Project Supported National Science and Technology Ministry-2012BAF14B10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardgett ME, 2010, HYPERTENSION, V55, P284, DOI 10.1161/HYPERTENSIONAHA.109.146605; Brzezinski Amnon, 1997, New England Journal of Medicine, V336, P186; Bubenik GA, 2002, DIGEST DIS SCI, V47, P2336, DOI 10.1023/A:1020107915919; Cardinali DP, 2012, J PINEAL RES, V52, P365, DOI 10.1111/j.1600-079X.2011.00962.x; Chao DM, 2001, ACUPUNCTURE ELECTRO, V26, P39, DOI 10.3727/036012901816356027; Conti A, 2000, J PINEAL RES, V28, P193, DOI 10.1034/j.1600-079X.2000.280401.x; DEBENEDITTIS G, 1994, INT J CLIN EXP HYP, V42, P140, DOI 10.1080/00207149408409347; Dubocovich ML, 2010, PHARMACOL REV, V62, P343, DOI 10.1124/pr.110.002832; Esposito E, 2010, CURR NEUROPHARMACOL, V8, P228, DOI 10.2174/157015910792246155; Ghasemi M, 2010, J PSYCHOPHARMACOL, V24, P585, DOI 10.1177/0269881109104845; Guo M, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.9; Huang F, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-203; Kaster MP, 2012, PHARMACOL REP, V64, P706, DOI 10.1016/S1734-1140(12)70865-4; La Marca R, 2010, CLIN SCI, V118, P537, DOI 10.1042/CS20090264; Lee JH, 2013, CLIN J PAIN, V29, P172, DOI 10.1097/AJP.0b013e31824909f9; Liu RP, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/789674; Lyons Zaza, 2012, Complement Ther Clin Pract, V18, P216, DOI 10.1016/j.ctcp.2012.06.003; Maganhin CC, 2009, ACTA CIR BRAS, V24, P321, DOI 10.1590/S0102-86502009000400013; Mathews DC, 2012, DRUGS, V72, P1313, DOI 10.2165/11633130-000000000-00000; MAURIZI CP, 1984, SOUTH MED J, V77, P1516, DOI 10.1097/00007611-198412000-00010; Mischoulon D, 2012, J AFFECT DISORDERS, V141, P469, DOI 10.1016/j.jad.2012.03.023; NELSON E, 1994, PHARMACOL BIOCHEM BE, V49, P327, DOI 10.1016/0091-3057(94)90429-4; Paul P, 1999, J PHARMACOL EXP THER, V290, P334; Preiss K, 2013, OBES REV, V14, P906, DOI 10.1111/obr.12052; Rong PJ, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-255; Samuels N, 2005, AM J CLIN HYPN, V47, P243, DOI 10.1080/00029157.2005.10403638; Spence DW, 2004, J NEUROPSYCH CLIN N, V16, P19, DOI 10.1176/appi.neuropsych.16.1.19; Wang SX, 2012, PAIN, V153, P2448, DOI 10.1016/j.pain.2012.08.016; Wang SX, 2009, BRAIN RES, V1288, P42, DOI 10.1016/j.brainres.2009.06.094; Ward KR, 2011, HYPERTENSION, V57, P435, DOI 10.1161/HYPERTENSIONAHA.110.160671; Yeung AS, 2011, J AFFECT DISORDERS, V130, P285, DOI 10.1016/j.jad.2010.07.025; Zeng Q, 2008, BRAIN RES, V1200, P27, DOI 10.1016/j.brainres.2008.01.038; Zhang ZJ, 2010, J AFFECT DISORDERS, V124, P9, DOI 10.1016/j.jad.2009.07.005	33	16	20	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111100	10.1371/journal.pone.0111100	http://dx.doi.org/10.1371/journal.pone.0111100			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347185	gold, Green Published, Green Submitted			2022-12-27	WOS:000347994900046
J	Macleod, CA; Meng, L; Conway, BA; Porr, B				Macleod, Catherine A.; Meng, Lin; Conway, Bernard A.; Porr, Bernd			Reflex Control of Robotic Gait Using Human Walking Data	PLOS ONE			English	Article							SPINAL-CORD-INJURY; FUNCTIONAL ELECTRICAL-STIMULATION; CENTRAL PATTERN GENERATORS; SWING PHASE; STEP CYCLE; CUTANEOUS AFFERENTS; NERVE-STIMULATION; SENSORY FEEDBACK; BIPED LOCOMOTION; ASSESSMENT-TOOL	Control of human walking is not thoroughly understood, which has implications in developing suitable strategies for the retraining of a functional gait following neurological injuries such as spinal cord injury (SCI). Bipedal robots allow us to investigate simple elements of the complex nervous system to quantify their contribution to motor control. RunBot is a bipedal robot which operates through reflexes without using central pattern generators or trajectory planning algorithms. Ground contact information from the feet is used to activate motors in the legs, generating a gait cycle visually similar to that of humans. Rather than developing a more complicated biologically realistic neural system to control the robot's stepping, we have instead further simplified our model by measuring the correlation between heel contact and leg muscle activity (EMG) in human subjects during walking and from this data created filter functions transferring the sensory data into motor actions. Adaptive filtering was used to identify the unknown transfer functions which translate the contact information into muscle activation signals. Our results show a causal relationship between ground contact information from the heel and EMG, which allows us to create a minimal, linear, analogue control system for controlling walking. The derived transfer functions were applied to RunBot II as a proof of concept. The gait cycle produced was stable and controlled, which is a positive indication that the transfer functions have potential for use in the control of assistive devices for the retraining of an efficient and effective gait with potential applications in SCI rehabilitation.	[Macleod, Catherine A.; Conway, Bernard A.] Univ Strathclyde, Dept Biomed Engn, Glasgow, Lanark, Scotland; [Meng, Lin; Porr, Bernd] Univ Glasgow, Sch Engn, Glasgow, Lanark, Scotland	University of Strathclyde; University of Glasgow	Macleod, CA (corresponding author), Univ Strathclyde, Dept Biomed Engn, Glasgow, Lanark, Scotland.	c.a.macleod@strath.ac.uk	Conway, Bernard/A-9625-2016; Meng, Lin/C-9628-2017	Conway, Bernard/0000-0002-0069-0131; Meng, Lin/0000-0001-9787-9936; Porr, Bernd/0000-0001-8157-998X	Engineering and Physical Sciences Research Council (EPSRC) through the Doctoral Training Centre (DTC) in Medical Devices, University of Strathclyde; CAM	Engineering and Physical Sciences Research Council (EPSRC) through the Doctoral Training Centre (DTC) in Medical Devices, University of Strathclyde; CAM	Funding was provided by the Engineering and Physical Sciences Research Council (EPSRC) (http://www.epsrc.ac.uk/Pages/default.aspx) through the Doctoral Training Centre (DTC) in Medical Devices, University of Strathclyde (http://www.strath.ac.uk/simd/dtc/). This funding was received by CAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANISS AM, 1992, J NEUROPHYSIOL, V67, P1375, DOI 10.1152/jn.1992.67.5.1375; BAJD T, 1983, PHYS THER, V63, P1116, DOI 10.1093/ptj/63.7.1116; Beer RD, 1997, COMMUN ACM, V40, P31; Bouyer LJG, 2003, J NEUROPHYSIOL, V90, P3640, DOI 10.1152/jn.00497.2003; Braitenberg V., 1984, VEHICLES EXPT SYNTHE; Braz GP, 2009, NEUROMODULATION, V12, P180, DOI 10.1111/j.1525-1403.2009.00213.x; Chiel HJ, 1997, TRENDS NEUROSCI, V20, P553, DOI 10.1016/S0166-2236(97)01149-1; Collins S, 2005, SCIENCE, V307, P1082, DOI 10.1126/science.1107799; Conway BA, 1995, ALPHA AND GAMMA MOTOR SYSTEMS, P593; Conway BA, 2008, CLIN NEUROPHYSIOL, V119, P892, DOI 10.1016/j.clinph.2007.12.015; Cruse H, 1998, NEURAL NETWORKS, V11, P1435, DOI 10.1016/S0893-6080(98)00067-7; Davidson AG, 2007, J NEUROSCI METH, V163, P283, DOI 10.1016/j.jneumeth.2007.03.010; Dietz V, 2002, BRAIN, V125, P2626, DOI 10.1093/brain/awf273; Donelan JM, 2004, CAN J PHYSIOL PHARM, V82, P589, DOI 10.1139/Y04-043; Duysens J, 2000, PHYSIOL REV, V80, P83, DOI 10.1152/physrev.2000.80.1.83; DUYSENS J, 1977, J NEUROPHYSIOL, V40, P737, DOI 10.1152/jn.1977.40.4.737; Duysens J, 2002, J BIOMECH, V35, P447, DOI 10.1016/S0021-9290(01)00187-7; DUYSENS J, 1976, EXP BRAIN RES, V24, P245; EIDELBERG E, 1981, BRAIN, V104, P647, DOI 10.1093/brain/104.4.647-a; Endo G, 2008, INT J ROBOT RES, V27, P213, DOI 10.1177/0278364907084980; Endo Gen, 2005, P 20 NAT C ART INT, P1267; Esquenazi A, 2012, AM J PHYS MED REHAB, V91, P911, DOI 10.1097/PHM.0b013e318269d9a3; Faist M, 2006, BRAIN RES, V1076, P87, DOI 10.1016/j.brainres.2005.12.069; Fouad K, 2004, PROG NEUROBIOL, V73, P107, DOI 10.1016/j.pneurobio.2004.04.003; Galen SS, 2011, MED ENG PHYS, V33, P626, DOI 10.1016/j.medengphy.2011.01.003; Geng T, 2006, INT J ROBOT RES, V25, P243, DOI 10.1177/0278364906063822; Geng T, 2006, ADV NEURAL INFORM PR, V18, P243; Geng T, 2014, IEEE T IND ELECTRON, V61, P2326, DOI 10.1109/TIE.2013.2272274; Geyer H, 2003, P ROY SOC B-BIOL SCI, V270, P2173, DOI 10.1098/rspb.2003.2454; GRANAT MH, 1993, J BIOMED ENG, V15, P51, DOI 10.1016/0141-5425(93)90093-E; GRANAT MH, 1995, MED ENG PHYS, V17, P390, DOI 10.1016/1350-4533(95)97321-F; Graupe D, 1997, NEUROL RES, V19, P323, DOI 10.1080/01616412.1997.11740820; Graupe D, 1994, FUNCTIONAL ELECT STI; GRILLNER S, 1978, BRAIN RES, V146, P269, DOI 10.1016/0006-8993(78)90973-3; GRILLNER S, 1985, SCIENCE, V228, P143, DOI 10.1126/science.3975635; Grillner S, 1975, ANNU REV NEUROSCI, V8, P233; Hardin E, 2007, J REHABIL RES DEV, V44, P333, DOI 10.1682/JRRD.2007.03.0333; Harkema SJ, 1997, J NEUROPHYSIOL, V77, P797, DOI 10.1152/jn.1997.77.2.797; Hermens H.J., 1999, ROESSINGH RES DEV, V8, P11; Hiebert GW, 1996, J NEUROPHYSIOL, V75, P1126, DOI 10.1152/jn.1996.75.3.1126; Hobbelen D.G., 2007, HUMANOID ROBOTS HUMA, P277; Hof AL, 2002, GAIT POSTURE, V16, P78, DOI 10.1016/S0966-6362(01)00206-5; Hultborn H, 2007, ACTA PHYSIOL, V189, P111, DOI 10.1111/j.1748-1716.2006.01651.x; Iida F, 2008, J BIOMECH, V41, P656, DOI 10.1016/j.jbiomech.2007.09.033; Ijspeert AJ, 2008, NEURAL NETWORKS, V21, P642, DOI 10.1016/j.neunet.2008.03.014; Interlink Electronics, 2013, INT EL FSR FORC SENS; Jezernik S, 2003, NEUROMODULATION, V6, P108, DOI 10.1046/j.1525-1403.2003.03017.x; Kobetic R, 1997, IEEE Trans Rehabil Eng, V5, P23, DOI 10.1109/86.559346; Kojovic J, 2009, J NEUROSCI METH, V181, P100, DOI 10.1016/j.jneumeth.2009.04.005; Kralj A.R., 1989, FUNCTIONAL ELECT STI, DOI DOI 10.1201/9780203755402; Lyons GM, 2002, IEEE T NEUR SYS REH, V10, P260, DOI 10.1109/TNSRE.2002.806832; Macleod CA, 2014, MED ENG PHYS, V36, P541, DOI 10.1016/j.medengphy.2013.11.011; Manoonpong P, 2007, PLOS COMPUT BIOL, V3, P1305, DOI 10.1371/journal.pcbi.0030134; Marchand-Pauvert V, 2002, J PHYSIOL-LONDON, V538, P647, DOI 10.1113/jphysiol.2001.012675; Marchand-Pauvert V, 2002, EXP BRAIN RES, V142, P402, DOI 10.1007/s00221-001-0942-3; MARSOLAIS EB, 1987, J BONE JOINT SURG AM, V69A, P728, DOI 10.2106/00004623-198769050-00014; McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1; MCGEER T, 1990, INT J ROBOT RES, V9, P62, DOI 10.1177/027836499000900206; McVea DA, 2005, J NEUROPHYSIOL, V94, P3497, DOI 10.1152/jn.00511.2005; MILNERBR.HS, 1973, J PHYSIOL-LONDON, V228, P285, DOI 10.1113/jphysiol.1973.sp010087; Nakanishi J, 2004, ROBOT AUTON SYST, V47, P79, DOI 10.1016/j.robot.2004.03.003; Neptune RR, 2001, J BIOMECH, V34, P1387, DOI 10.1016/S0021-9290(01)00105-1; Nielsen JB, 2002, ADV EXP MED BIOL, V508, P369; Owaki D, 2011, IEEE T ROBOT, V27, P156, DOI 10.1109/TRO.2010.2098610; Pang MYC, 2000, J PHYSIOL-LONDON, V528, P389, DOI 10.1111/j.1469-7793.2000.00389.x; Pang MYC, 2001, J PHYSIOL-LONDON, V533, P617, DOI 10.1111/j.1469-7793.2001.0617a.x; Pappas IPI, 2001, IEEE T NEUR SYS REH, V9, P113, DOI 10.1109/7333.928571; Park HW, 2012, IEEE INT CONF ROBOT, P45, DOI 10.1109/ICRA.2012.6225056; Pearson KG, 2004, PROG BRAIN RES, V143, P123, DOI 10.1016/S0079-6123(03)43012-4; Petiot E, 2001, J PHYSIOL-LONDON, V537, P949; Popovic D, 2003, MED ENG PHYS, V25, P63, DOI 10.1016/S1350-4533(02)00188-1; Popovic D., 2005, PROC 10 ANN C INT FU, P86; Pratt J, 2001, INT J ROBOT RES, V20, P129, DOI 10.1177/02783640122067309; Ragnarsson KT, 2008, SPINAL CORD, V46, P255, DOI 10.1038/sj.sc.3102091; Reeve RE, 2003, PHILOS T R SOC A, V361, P2245, DOI 10.1098/rsta.2003.1274; Rummel J, 2010, IEEE INT CONF ROBOT, P5250, DOI 10.1109/ROBOT.2010.5509500; Sakagami Y, 2002, 2002 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-3, PROCEEDINGS, P2478, DOI 10.1109/IRDS.2002.1041641; Seyfarth A., 2009, International Journal of Robotics Research, V28, P257, DOI 10.1177/0278364908095843; Shiavi R, 1981, Bull Prosthet Res, V10-35, P5; Shiavi R, 1987, J Rehabil Res Dev, V24, P13; SINKJAER T, 1994, EXP BRAIN RES, V98, P542; Sinkjaer T, 2003, MED ENG PHYS, V25, P29, DOI 10.1016/S1350-4533(02)00178-9; Stephens MJ, 1999, EXP BRAIN RES, V124, P363, DOI 10.1007/s002210050633; Thrasher TA, 2006, SPINAL CORD, V44, P357, DOI 10.1038/sj.sc.3101864; Vaughan CL, 2003, J BIOMECH, V36, P513, DOI 10.1016/S0021-9290(02)00419-0; Vukobratovi M., 2004, INT J HUM ROBOT, V01, P157, DOI DOI 10.1142/S0219843604000083; WILLEMSEN ATM, 1990, IEEE T BIO-MED ENG, V37, P1201, DOI 10.1109/10.64463; Williams G, 2010, J HEAD TRAUMA REHAB, V25, P366, DOI 10.1097/HTR.0b013e3181cd3600; Williamson R, 2000, IEEE T REHABIL ENG, V8, P312, DOI 10.1109/86.867873; Wilson D. M., 1966, Symposia of the Society for Experimental Biology, V20, P199; WILSON DM, 1961, J EXP BIOL, V38, P471; WILSON DM, 1965, BIOPHYS J, V5, P121, DOI 10.1016/S0006-3495(65)86706-6; WINTER DA, 1987, ELECTROEN CLIN NEURO, V67, P402, DOI 10.1016/0013-4694(87)90003-4; YANG JF, 1990, J NEUROPHYSIOL, V63, P1109, DOI 10.1152/jn.1990.63.5.1109; ZAJAC FE, 1989, CRIT REV BIOMED ENG, V17, P359; Zehr EP, 1999, PROG NEUROBIOL, V58, P185, DOI 10.1016/S0301-0082(98)00081-1	96	6	7	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e109959	10.1371/journal.pone.0109959	http://dx.doi.org/10.1371/journal.pone.0109959			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347544	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000347994900017
J	Bastianelli, G; Bouillon, A; Nguyen, C; Le-Nguyen, D; Nilges, M; Barale, JC				Bastianelli, Giacomo; Bouillon, Anthony; Nguyen, Christophe; Le-Nguyen, Dung; Nilges, Michael; Barale, Jean-Christophe			Computational Design of Protein-Based Inhibitors of Plasmodium vivax Subtilisin-Like 1 Protease	PLOS ONE			English	Article							ELATERIUM TRYPSIN-INHIBITOR; IN-VITRO; SERINE-PROTEASE; CYSTINE KNOT; STRUCTURAL SCAFFOLD; MALARIA PARASITES; PHAGE-DISPLAY; SUB1 PROTEASE; PEPTIDES; SEQUENCE	Background: Malaria remains a major global health concern. The development of novel therapeutic strategies is critical to overcome the selection of multiresistant parasites. The subtilisin-like protease (SUB1) involved in the egress of daughter Plasmodium parasites from infected erythrocytes and in their subsequent invasion into fresh erythrocytes has emerged as an interesting new drug target. Findings: Using a computational approach based on homology modeling, protein-protein docking and mutation scoring, we designed protein-based inhibitors of Plasmodium vivax SUB1 (PvSUB1) and experimentally evaluated their inhibitory activity. The small peptidic trypsin inhibitor EETI-II was used as scaffold. We mutated residues at specific positions (P4 and P1) and calculated the change in free-energy of binding with PvSUB1. In agreement with our predictions, we identified a mutant of EETI-II (EETI-II-P4LP1W) with a Ki in the medium micromolar range. Conclusions: Despite the challenges related to the lack of an experimental structure of PvSUB1, the computational protocol we developed in this study led to the design of protein-based inhibitors of PvSUB1. The approach we describe in this paper, together with other examples, demonstrates the capabilities of computational procedures to accelerate and guide the design of novel proteins with interesting therapeutic applications.	[Bastianelli, Giacomo; Nilges, Michael] Inst Pasteur, Dept Biol Struct & Chim, Unite Bioinformat Struct, Paris, France; [Bastianelli, Giacomo; Nilges, Michael] CNRS, UMR 3528, Paris, France; [Bouillon, Anthony; Barale, Jean-Christophe] Inst Pasteur, Dept Parasitol & Mycol, Unite Immunol Mol Parasites, Paris, France; [Bouillon, Anthony; Barale, Jean-Christophe] CNRS, URA 2581, Paris, France; [Nguyen, Christophe; Le-Nguyen, Dung] CNRS, BioRad, SYSDIAG, UMR3145, Montpellier, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS)	Nilges, M (corresponding author), Inst Pasteur, Dept Biol Struct & Chim, Unite Bioinformat Struct, Paris, France.	nilges@pasteur.fr; jcb@pasteur.fr	Nilges, Michael/E-4803-2011	Nilges, Michael/0000-0002-1451-8092	Marie Curie Early Stage Research Training Fellowship (EIMID) of European Commission [MEST-CT-05-020311]; "Fond dedie: combattre les maladies parasitaires" - Sanofi-Aventis; French Ministry of Research; Institut Carnot-Pasteur Maladies Infectieuses; SYSDIAG, CNRS UMR3145 CNRS-BioRad	Marie Curie Early Stage Research Training Fellowship (EIMID) of European Commission; "Fond dedie: combattre les maladies parasitaires" - Sanofi-Aventis; French Ministry of Research(Ministry of Research, FranceEuropean Commission); Institut Carnot-Pasteur Maladies Infectieuses; SYSDIAG, CNRS UMR3145 CNRS-BioRad	This work was partly supported by MEST-CT-05-020311, a Marie Curie Early Stage Research Training Fellowship (EIMID) of the Framework Program 6 by the European Commission. AB is a fellow of the "Direction Generale pour l'Armement" from the French Ministry of Defense. This work was partly supported by the "Fond dedie: combattre les maladies parasitaires" granted by Sanofi-Aventis and the French Ministry of Research and the Institut Carnot-Pasteur Maladies Infectieuses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SYSDIAG, CNRS UMR3145 CNRS-BioRad provided support in the form of salaries and operating costs for authors CN and DLN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bastianelli G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021812; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bouillon A, 2013, J BIOL CHEM, V288, P18561, DOI 10.1074/jbc.M113.456764; Case D. A., 2006, AMBER9; Christmann A, 1999, PROTEIN ENG, V12, P797, DOI 10.1093/protein/12.9.797; Chung SY, 1996, STRUCTURE, V4, P1123, DOI 10.1016/S0969-2126(96)00119-0; Craik DJ, 2007, EXPERT OPIN INV DRUG, V16, P595, DOI 10.1517/13543784.16.5.595; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; Dagan A, 2002, ANTIMICROB AGENTS CH, V46, P1059, DOI 10.1128/AAC.46.4.1059-1066.2002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Monerri NCS, 2011, INFECT IMMUN, V79, P1086, DOI 10.1128/IAI.00902-10; DEBRABANT A, 1992, MOL BIOCHEM PARASIT, V53, P89, DOI 10.1016/0166-6851(92)90010-H; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Fulle S, 2013, J CHEM INF MODEL; Genheden S, 2010, J COMPUT CHEM, V31, P837, DOI 10.1002/jcc.21366; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Greenwood BM, 2011, CLIN MICROBIOL INFEC, V17, P1600, DOI 10.1111/j.1469-0691.2011.03612.x; He Mingyue, 2002, Briefings in Functional Genomics & Proteomics, V1, P204, DOI 10.1093/bfgp/1.2.204; HEIDRICH HG, 1989, MOL BIOCHEM PARASIT, V34, P147, DOI 10.1016/0166-6851(89)90006-6; HEITZ A, 1989, BIOCHEMISTRY-US, V28, P2392, DOI 10.1021/bi00432a009; Hilpert K, 2003, J BIOL CHEM, V278, P24986, DOI 10.1074/jbc.M212152200; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jha RK, 2010, J MOL BIOL, V400, P257, DOI 10.1016/j.jmb.2010.05.006; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Keizer DW, 2003, BIOCHEMISTRY-US, V42, P9915, DOI 10.1021/bi034376b; Kolmar H, 2009, CURR OPIN PHARMACOL, V9, P608, DOI 10.1016/j.coph.2009.05.004; Komiyama T, 2003, P NATL ACAD SCI USA, V100, P8205, DOI 10.1073/pnas.1032865100; Koussis K, 2009, EMBO J, V28, P725, DOI 10.1038/emboj.2009.22; LENGUYEN D, 1989, BIOCHEM BIOPH RES CO, V162, P1425, DOI 10.1016/0006-291X(89)90833-4; Lippow SM, 2007, NAT BIOTECHNOL, V25, P1171, DOI 10.1038/nbt1336; Mishra SK, 2009, NAT REV NEUROL, V5, P189, DOI 10.1038/nrneurol.2009.23; Noedl H, 2009, NEW ENGL J MED, V361, P540, DOI 10.1056/NEJMc0900231; ODEA KP, 1995, MOL BIOCHEM PARASIT, V72, P111, DOI 10.1016/0166-6851(95)00090-N; Otlewski J, 2005, EMBO J, V24, P1303, DOI 10.1038/sj.emboj.7600611; Reiss S, 2006, PLATELETS, V17, P153, DOI 10.1080/09537100500436663; Ritchie DW, 2000, PROTEINS, V39, P178, DOI 10.1002/(SICI)1097-0134(20000501)39:2<178::AID-PROT8>3.3.CO;2-Y; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sajid M, 2000, J BIOL CHEM, V275, P631, DOI 10.1074/jbc.275.1.631; Smith GP, 1997, CHEM REV, V97, P391, DOI 10.1021/cr960065d; Souriau C, 2005, BIOCHEMISTRY-US, V44, P7143, DOI 10.1021/bi0481592; STAFFORD WHL, 1994, MOL BIOCHEM PARASIT, V66, P157, DOI 10.1016/0166-6851(94)90048-5; Tawk L, 2013, J BIOL CHEM, V288, P33336, DOI 10.1074/jbc.M113.513234; Tsui V, 2001, BIOPOLYMERS, V56, P275, DOI 10.1002/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wentzel A, 1999, J BIOL CHEM, V274, P21037, DOI 10.1074/jbc.274.30.21037; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049; Zhu S, 2002, J MED CHEM, V45, P3491, DOI 10.1021/jm020104f	52	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e109269	10.1371/journal.pone.0109269	http://dx.doi.org/10.1371/journal.pone.0109269			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343504	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943500011
J	Chandrasekaran, S; Marshall, JR; Messing, JA; Hsu, JW; King, MR				Chandrasekaran, Siddarth; Marshall, Jocelyn R.; Messing, James A.; Hsu, Jong-Wei; King, Michael R.			TRAIL-Mediated Apoptosis in Breast Cancer Cells Cultured as 3D Spheroids	PLOS ONE			English	Article							TUMOR-CELLS; STEM-CELLS; IN-VITRO; DRUG-RESISTANCE; DEATH RECEPTORS; CYCLOOXYGENASE-2; EXPRESSION; INHIBITION; HYPOXIA; COX-2	TNF-alpha-related-apoptosis-inducing-ligand (TRAIL) has been explored as a therapeutic drug to kill cancer cells. Cancer cells in the circulation are subjected to apoptosis-inducing factors. Despite the presence of these factors, cells are able to extravasate and metastasize. The homotypic and heterotypic cell-cell interactions in a tumor are known to play a crucial role in bestowing important characteristics to cancer cells that leave the primary site. Spheroid cell culture has been extensively used to mimic these physiologically relevant interactions. In this work, we show that the breast cancer cell lines BT20 and MCF7, cultured as 3D tumor spheroids, are more resistant to TRAIL-mediated apoptosis by downregulating the expression of death receptors (DR4 and DR5) that initiate TRAIL-mediated apoptosis. For comparison, we also investigated the effect of TRAIL on cells cultured as a 2D monolayer. Our results indicate that tumor spheroids are enriched for CD44(hi)CD24(lo)ALDH1(hi) cells, a phenotype that is predominantly known to be a marker for breast cancer stem cells. Furthermore, we attribute the TRAIL-resistance and cancer stem cell phenotype observed in tumor spheroids to the upregulation of cyclooxygenase-2 (COX-2)/prostaglandin E-2 (PGE(2)) pathway. We show that inhibition of the COX-2/PGE(2) pathway by treating tumor spheroids with NS-398, a selective COX-2 inhibitor, reverses the TRAIL-resistance and decreases the incidence of a CD44(hi)CD24(lo) population. Additionally, we show that siRNA mediated knockdown of COX-2 expression in MCF7 cells render them sensitive to TRAIL by increasing the expression of DR4 and DR5. Collectively, our results show the effect of the third-dimension on the response of breast cancer cells to TRAIL and suggest a therapeutic target to overcome TRAIL-resistance.	[Chandrasekaran, Siddarth; Marshall, Jocelyn R.; Messing, James A.; Hsu, Jong-Wei; King, Michael R.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14850 USA	Cornell University	King, MR (corresponding author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14850 USA.	mike.king@cornell.edu			National Institutes of Health [U54CA143876]; NATIONAL CANCER INSTITUTE [U54CA143876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by the following: National Institutes of Health (nih.gov) U54CA143876. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulghani J, 2010, EXPERT OPIN THER TAR, V14, P1091, DOI 10.1517/14728222.2010.519701; Bhardwaj N, 2007, J CLIN INVEST, V117, P1130, DOI 10.1172/JCI32136; Bockhorn M, 2007, LANCET ONCOL, V8, P444, DOI 10.1016/S1470-2045(07)70140-7; Cavallo F, 2011, CANCER IMMUNOL IMMUN, V60, P319, DOI 10.1007/s00262-010-0968-0; Chance S, 2012, BIOMATERIALS, P1; Chandrasekaran S., 2012, J BIOENG BIOMED SCI, V2, pe109, DOI [10.4172/2155-9538.1000e109, DOI 10.4172/2155-9538.1000E109]; Chandrasekaran S, 2014, LAB CHIP, V14, P118, DOI 10.1039/c3lc50584g; Chandrasekaran S, 2011, BIOMATERIALS, V32, P9316, DOI 10.1016/j.biomaterials.2011.08.056; Chandrasekaran S, 2011, BIOMATERIALS, V32, P7159, DOI 10.1016/j.biomaterials.2011.06.013; Cui DD, 2009, BRAZ J MED BIOL RES, V42, P854, DOI 10.1590/S0100-879X2009000900013; de Beca FF, 2013, J CLIN PATHOL, V66, P187, DOI 10.1136/jclinpath-2012-201169; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dean M, 2009, J MAMMARY GLAND BIOL, V14, P3, DOI 10.1007/s10911-009-9109-9; Dougan M, 2009, ANNU REV IMMUNOL, V27, P83, DOI 10.1146/annurev.immunol.021908.132544; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; Geng Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054959; Geng Y, 2012, ANN BIOMED ENG, V40, P790, DOI 10.1007/s10439-011-0463-6; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Hall MA, 2007, CANCER CELL, V12, P4, DOI 10.1016/j.ccr.2007.06.011; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Joki T, 2000, CANCER RES, V60, P4926; Kaidi A, 2006, CANCER RES, V66, P6683, DOI 10.1158/0008-5472.CAN-06-0425; Kern MA, 2006, CANCER RES, V66, P7059, DOI 10.1158/0008-5472.CAN-06-0325; Koci L, 2011, CYTOKINE, V55, P34, DOI 10.1016/j.cyto.2011.03.013; Kruyt FAE, 2008, CANCER LETT, V263, P14, DOI 10.1016/j.canlet.2008.02.003; Lane D, 2008, INT J GYNECOL CANCER, V18, P670, DOI 10.1111/j.1525-1438.2007.01062.x; LeBlanc HN, 2003, CELL DEATH DIFFER, V10, P66, DOI 10.1038/sj.cdd.4401187; Li JM, 2012, FRONT ONCOL, V2, P1, DOI [10.3389/fonc.2012.00079, 10.3389/fonc.2012.00029]; Li ZZ, 2010, CURR TOP MICROBIOL, V345, P21, DOI 10.1007/82_2010_75; Levy EM, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/676198; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Mitchell MJ, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/1/015008; Mitchell MJ, 2014, P NATL ACAD SCI USA, V2013, P1; Munoz-Pinedo C, 2003, J BIOL CHEM, V278, P12759, DOI 10.1074/jbc.M212392200; Nagane M, 2001, APOPTOSIS, V6, P191, DOI 10.1023/A:1011336726649; Nakamoto N, 2006, INT J ONCOL, V29, P625; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Philip B, 2013, CARCINOGENESIS, V34, P1699, DOI 10.1093/carcin/bgt209; Rahman M, 2009, BREAST CANCER RES TR, V113, P217, DOI 10.1007/s10549-008-9924-5; Rana K, 2009, BIOTECHNOL BIOENG, V102, P1692, DOI 10.1002/bit.22204; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricardo S, 2011, J CLIN PATHOL, V64, P937, DOI 10.1136/jcp.2011.090456; Robertson FM, 2010, J BIOMOL SCREEN, V15, P820, DOI 10.1177/1087057110376541; Rudnick JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024605; Sanlioglu AD, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-54; Seguin L, 2014, NAT CELL BIOL, V16, P457, DOI 10.1038/ncb2953; Shi J, 2003, CURR MOL MED, V3, P727, DOI 10.2174/1566524033479401; Subarsky P, 2003, CLIN EXP METASTAS, V20, P237, DOI 10.1023/A:1022939318102; Szliszka E, 2009, FOLIA HISTOCHEM CYTO, V47, P579, DOI 10.2478/v10042-009-0111-2; Tang XM, 2002, CANCER RES, V62, P4903; Totzke G, 2003, ONCOGENE, V22, P8021, DOI 10.1038/sj.onc.1206837; van Dijk M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.214; Van Geelen CMM, 2010, INT J ONCOL, V37, P1031, DOI 10.3892/ijo_00000755; Vinogradov S, 2012, NANOMEDICINE-UK, V7, P597, DOI [10.2217/NNM.12.22, 10.2217/nnm.12.22]; Vorsmann H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.249; Xu J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010226; Xue X, 2013, CARCINOGENESIS, V34, P163, DOI 10.1093/carcin/bgs313; Yagita H, 2004, CANCER SCI, V95, P777, DOI 10.1111/j.1349-7006.2004.tb02181.x; Yamanaka Y, 2006, INT J MOL MED, V18, P41; Zamai L, 2007, J IMMUNOL, V178, P4011, DOI 10.4049/jimmunol.178.7.4011; Zatelli MC, 2007, ENDOCR-RELAT CANCER, V14, P1029, DOI 10.1677/ERC-07-0114; Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792; Zhang S, 2013, ORTHOGONAL POLARIZATION IN LASERS: PHYSICAL PHENOMENA AND ENGINEERING APPLICATIONS, P1, DOI 10.1002/9781118346501; Zhang YQ, 2008, MOL CANCER RES, V6, P1861, DOI 10.1158/1541-7786.MCR-08-0313	66	33	35	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111487	10.1371/journal.pone.0111487	http://dx.doi.org/10.1371/journal.pone.0111487			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343626	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943500103
J	Meersch, M; Schmidt, C; Van Aken, H; Rossaint, J; Gorlich, D; Stege, D; Malec, E; Januszewska, K; Zarbock, A				Meersch, Melanie; Schmidt, Christoph; Van Aken, Hugo; Rossaint, Jan; Goerlich, Dennis; Stege, Dirk; Malec, Edward; Januszewska, Katarzyna; Zarbock, Alexander			Validation of Cell-Cycle Arrest Biomarkers for Acute Kidney Injury after Pediatric Cardiac Surgery	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; CHILDREN; SENESCENCE	Background: The lack of early biomarkers for acute kidney injury (AKI) seriously inhibits the initiation of preventive and therapeutic measures for this syndrome in a timely manner. We tested the hypothesis that insulin-like growth factor-binding protein 7 (IGFBP7) and tissue inhibitor of metalloproteinases-2 (TIMP-2), both inducers of G1 cell cycle arrest, function as early biomarkers for AKI after congenital heart surgery with cardiopulmonary bypass (CPB). Methods: We prospectively studied 51 children undergoing cardiac surgery with CPB. Serial urine samples were analyzed for TIMP-2].[IGFBP7]. The primary outcome measure was AKI defined by the pRIFLE criteria within 72 hours after surgery. Results: 12 children (24%) developed AKI within 1.67 (SE 0.3) days after surgery. Children who developed AKI after cardiac surgery had a significant higher urinary [TIMP-2].[IGFBP7] as early as 4 h after the procedure, compared to children who did not develop AKI (mean of 1.93 ((ng/ml)(2)/1000) (SE 0.4) vs 0.47 ((ng/ml)(2)/1000) (SE 0.1), respectively; p<0.05). Urinary [TIMP-2].[IGFBP7] 4 hours following surgery demonstrated an area under the receiver-operating characteristic curve of 0.85. Sensitivity was 0.83, and specificity was 0.77 for a cutoff value of 0.70 ((ng/ml)(2)/1000). Conclusions: Urinary [TIMP-2].[IGFBP7] represent sensitive, specific, and highly predictive early biomarkers for AKI after surgery for congenital heart disease.	[Meersch, Melanie; Schmidt, Christoph; Van Aken, Hugo; Rossaint, Jan; Zarbock, Alexander] Univ Munster, Dept Anaesthesiol Intens Care & Pain Med, D-48149 Munster, Germany; [Goerlich, Dennis] Univ Munster, Inst Biostat & Clin Res, D-48149 Munster, Germany; [Stege, Dirk] Univ Munster, Dept Pediat Cardiol, D-48149 Munster, Germany; [Malec, Edward; Januszewska, Katarzyna] Univ Munster, Dept Pediat Heart Surg, D-48149 Munster, Germany	University of Munster; University of Munster; University of Munster; University of Munster	Zarbock, A (corresponding author), Univ Munster, Dept Anaesthesiol Intens Care & Pain Med, D-48149 Munster, Germany.	zarbock@uni-muenster.de	Görlich, Dennis/C-8950-2012	Görlich, Dennis/0000-0002-2574-9419	German Research Foundation [ZA428/6-1]	German Research Foundation(German Research Foundation (DFG))	This study was supported by the German Research Foundation (ZA428/6-1 to A.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcan-Arikan A, 2007, KIDNEY INT, V71, P1028, DOI 10.1038/sj.ki.5002231; American Society of Nephrology, 2005, J Am Soc Nephrol, V16, P1886; Bihorac A, 2014, AM J RESP CRIT CARE, V189, P932, DOI 10.1164/rccm.201401-0077OC; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Boonstra J, 2004, GENE, V337, P1, DOI 10.1016/j.gene.2004.04.032; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dent CL, 2007, CRIT CARE, V11, DOI 10.1186/cc6192; Devarajan P, 2006, J AM SOC NEPHROL, V17, P1503, DOI 10.1681/ASN.2006010017; Jenkins Kathy J, 2004, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V7, P180, DOI 10.1053/j.pcsu.2004.02.009; Kashani K, 2013, CRIT CARE, V17, DOI 10.1186/cc12503; Krawczeski CD, 2011, J AM COLL CARDIOL, V58, P2301, DOI 10.1016/j.jacc.2011.08.017; Meersch M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093460; Molitoris BA, 2003, J AM SOC NEPHROL, V14, P265, DOI 10.1097/01.ASN.0000048852.53881.D9; Murray PT, 2014, KIDNEY INT, V85, P513, DOI 10.1038/ki.2013.374; Park M, 2010, AM J NEPHROL, V31, P408, DOI 10.1159/000296277; Pedersen KR, 2008, KIDNEY INT, V73, pS81, DOI 10.1038/sj.ki.5002607; Price PM, 2009, KIDNEY INT, V76, P604, DOI 10.1038/ki.2009.224; Rodier F, 2007, NUCLEIC ACIDS RES, V35, P7475, DOI 10.1093/nar/gkm744; Schwartz GJ, 2009, J AM SOC NEPHROL, V20, P629, DOI 10.1681/ASN.2008030287; Seo DW, 2006, J BIOL CHEM, V281, P3711, DOI 10.1074/jbc.M509932200; Seo DW, 2003, CELL, V114, P171, DOI 10.1016/S0092-8674(03)00551-8; Siegel NJ, 2003, J AM SOC NEPHROL, V14, P2176, DOI 10.1097/01.ASN.0000079043.01987.34; Stetler-Stevenson WG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127re6; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Yang QH, 2009, J INFECTION, V58, P459, DOI 10.1016/j.jinf.2009.04.003; Zappitelli M, 2009, KIDNEY INT, V76, P885, DOI 10.1038/ki.2009.270; Zuo SG, 2012, J CANCER RES CLIN, V138, P1045, DOI 10.1007/s00432-012-1153-y	28	65	71	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110865	10.1371/journal.pone.0110865	http://dx.doi.org/10.1371/journal.pone.0110865			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343505	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943500060
J	Unverzagt, S; Peinemann, F; Oemler, M; Braun, K; Klement, A				Unverzagt, Susanne; Peinemann, Frank; Oemler, Matthias; Braun, Kristin; Klement, Andreas			Meta-Regression Analyses to Explain Statistical Heterogeneity in a Systematic Review of Strategies for Guideline Implementation in Primary Health Care	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; BLOOD-PRESSURE CONTROL; CORONARY-ARTERY DISEASE; DECISION-SUPPORT-SYSTEM; CHRONIC HEART-FAILURE; QUALITY-OF-CARE; SECONDARY PREVENTION; GENERAL-PRACTICE; MYOCARDIAL-INFARCTION; CLINICAL REMINDERS	This study is an in-depth-analysis to explain statistical heterogeneity in a systematic review of implementation strategies to improve guideline adherence of primary care physicians in the treatment of patients with cardiovascular diseases. The systematic review included randomized controlled trials from a systematic search in MEDLINE, EMBASE, CENTRAL, conference proceedings and registers of ongoing studies. Implementation strategies were shown to be effective with substantial heterogeneity of treatment effects across all investigated strategies. Primary aim of this study was to explain different effects of eligible trials and to identify methodological and clinical effect modifiers. Random effects meta-regression models were used to simultaneously assess the influence of multimodal implementation strategies and effect modifiers on physician adherence. Effect modifiers included the staff responsible for implementation, level of prevention and definition pf the primary outcome, unit of randomization, duration of follow-up and risk of bias. Six clinical and methodological factors were investigated as potential effect modifiers of the efficacy of different implementation strategies on guideline adherence in primary care practices on the basis of information from 75 eligible trials. Five effect modifiers were able to explain a substantial amount of statistical heterogeneity. Physician adherence was improved by 62% (95% confidence interval (95% CI) 29 to 104%) or 29% (95% CI 5 to 60%) in trials where other non-medical professionals or nurses were included in the implementation process. Improvement of physician adherence was more successful in primary and secondary prevention of cardiovascular diseases by around 30% (30%; 95% CI -2 to 71% and 31%; 95% CI 9 to 57%, respectively) compared to tertiary prevention. This study aimed to identify effect modifiers of implementation strategies on physician adherence. Especially the cooperation of different health professionals in primary care practices might increase efficacy and guideline implementation seems to be more difficult in tertiary prevention of cardiovascular diseases.	[Unverzagt, Susanne] Univ Halle Wittenberg, Inst Med Epidemiol Biostat & Informat, D-06108 Halle, Germany; [Peinemann, Frank] Univ Cologne, Childrens Hosp, D-50931 Cologne, Germany; [Oemler, Matthias; Braun, Kristin; Klement, Andreas] Univ Halle Wittenberg, Inst Med Epidemiol Biostat & Informat, Sect Gen Practice, D-06108 Halle, Germany	Martin Luther University Halle Wittenberg; University of Cologne; Martin Luther University Halle Wittenberg	Unverzagt, S (corresponding author), Univ Halle Wittenberg, Inst Med Epidemiol Biostat & Informat, D-06108 Halle, Germany.	susanne.unverzagt@medizin.uni-halle.de	Peinemann, Frank/H-2800-2019; Unverzagt, Susanne/AGE-2574-2022	Peinemann, Frank/0000-0002-4727-1313; 				AHA, 2014, ACC AHA JOINT GUID; Guirado EA, 2011, GAC SANIT, V25, P62, DOI 10.1016/j.gaceta.2010.09.015; Sanchez MA, 2010, REV ESP CARDIOL, V63, P677, DOI 10.1016/S0300-8932(10)70160-3; Baig AA, 2010, J GEN INTERN MED, V25, P701, DOI 10.1007/s11606-010-1326-9; BAILEY KR, 1994, CONTROL CLIN TRIALS, V15, P15, DOI 10.1016/0197-2456(94)90024-8; Balk EM, 2002, JAMA-J AM MED ASSOC, V287, P2973, DOI 10.1001/jama.287.22.2973; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Beaulieu MD, 2004, QJM-INT J MED, V97, P21, DOI 10.1093/qjmed/hch006; Bebb C, 2007, BRIT J GEN PRACT, V57, P136; Benner JS, 2008, INT J CLIN PRACT, V62, P1484, DOI 10.1111/j.1742-1241.2008.01872.x; Bogden PE, 1997, J GEN INTERN MED, V12, P158, DOI 10.1007/s11606-006-5023-7; Bond C.M., 2007, INT J PHARM PRACT, V15, P39, DOI [10.1211/ijpp.15.1.0007, DOI 10.1211/ijpp.15.1.0007]; Bonds DE, 2009, AM HEART J, V157, P278, DOI 10.1016/j.ahj.2008.09.021; Borenstein JE, 2003, PHARMACOTHERAPY, V23, P209, DOI 10.1592/phco.23.2.209.32096; Borenstein M, 2009, INTRO META ANAL; Bower P, 2006, BRIT J PSYCHIAT, V189, P484, DOI 10.1192/bjp.bp.106.023655; Campbell MK, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5661; Carter BL, 2009, ARCH INTERN MED, V169, P1996, DOI 10.1001/archinternmed.2009.358; Casebeer LL, 1999, ACAD MED, V74, P1334, DOI 10.1097/00001888-199912000-00018; CDC, 2014, PREV GUID REC; Chen EH, 2010, J GEN INTERN MED, V25, pS610, DOI 10.1007/s11606-010-1390-1; Cobos A, 2005, DIS MANAG HEALTH OUT, V13, P421, DOI 10.2165/00115677-200513060-00007; De Muylder R, 2005, ACTA CARDIOL, V60, P199, DOI 10.2143/AC.60.2.2005032; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Eccles M, 2002, BMJ-BRIT MED J, V325, P941, DOI 10.1136/bmj.325.7370.941; Egger M, 2003, Health Technol Assess, V7, P1; ESC, 2014, ESC CLIN PRACT GUID; Feder G, 1999, BRIT MED J, V318, P1522, DOI 10.1136/bmj.318.7197.1522; Feldman RD, 2009, HYPERTENSION, V53, P646, DOI 10.1161/HYPERTENSIONAHA.108.123455; Fihn SD, 2011, ARCH INTERN MED, V171, P1471, DOI 10.1001/archinternmed.2011.372; Fiscella K, 2010, J NATL MED ASSOC, V102, P1231, DOI 10.1016/S0027-9684(15)30778-1; Frances CD, 2001, WESTERN J MED, V175, P165, DOI 10.1136/ewjm.175.3.165; Francke AL, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-38; Frankenstein L, 2010, EUR J HEART FAIL, V12, P574, DOI 10.1093/eurjhf/hfq047; Fretheim A, 2006, PLOS MED, V3, P783, DOI 10.1371/journal.pmed.0030134; Frijling BD, 2003, QUAL SAF HEALTH CARE, V12, P181, DOI 10.1136/qhc.12.3.181; Gagnier JJ, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-106; Gill JM, 2009, POPUL HEALTH MANAG, V12, P221, DOI 10.1089/pop.2009.0003; Gilutz H, 2009, ISR MED ASSOC J, V11, P23; Giraudeau B, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000065; Glasziou PP, 2002, STAT MED, V21, P1503, DOI 10.1002/sim.1183; Goff DC, 2003, AM HEART J, V146, P1045, DOI 10.1016/S0002-8703(03)00522-2; Goldberg H I, 1998, Jt Comm J Qual Improv, V24, P130; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Grover SA, 2007, ARCH INTERN MED, V167, P2296, DOI 10.1001/archinte.167.21.2296; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1283, DOI 10.1016/j.jclinepi.2011.01.012; Hasenbein U, 2007, GESUNDHEITSWESEN, V69, P427, DOI 10.1055/s-2007-985388; Heidenreich PA, 2007, CIRCULATION, V115, P2829, DOI 10.1161/CIRCULATIONAHA.106.684753; Hicks LS, 2008, J GEN INTERN MED, V23, P429, DOI 10.1007/s11606-007-0403-1; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins Julian, 2002, J Health Serv Res Policy, V7, P51, DOI 10.1258/1355819021927674; Holbrook A, 2011, ARCH INTERN MED, V171, P1736, DOI 10.1001/archinternmed.2011.471; Hung CS, 2008, J EVAL CLIN PRACT, V14, P861, DOI 10.1111/j.1365-2753.2008.01066.x; Hunt JS, 2008, J GEN INTERN MED, V23, P1966, DOI 10.1007/s11606-008-0791-x; Jafar TH, 2009, ANN INTERN MED, V151, P593, DOI 10.7326/0003-4819-151-9-200911030-00004; Jaffray M, 2007, FAM PRACT, V24, P189, DOI 10.1093/fampra/cml075; Jolly K, 1999, BMJ-BRIT MED J, V318, P706; Kaczorowski J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d442; Kasje WN, 2006, J EVAL CLIN PRACT, V12, P613, DOI 10.1111/j.1365-2753.2005.00625.x; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; Kiessling A, 2002, BMJ-BRIT MED J, V325, P877, DOI 10.1136/bmj.325.7369.877; Kogan JR, 2003, TEACH LEARN MED, V15, P25, DOI 10.1207/S15328015TLM1501_06; Komajda M, 2005, EUR HEART J, V26, P1653, DOI 10.1093/eurheartj/ehi251; Kuepper-Nybelen J, 2012, EUR J CLIN PHARMACOL, V68, P1451, DOI 10.1007/s00228-012-1274-x; Langham J, 2002, BRIT J GEN PRACT, V52, P818; Lapointe F, 2006, CAN J CARDIOL, V22, P761, DOI 10.1016/S0828-282X(06)70292-6; Lester WT, 2006, J GEN INTERN MED, V21, P22, DOI 10.1111/j.1525-1497.2005.00268.x; Levine DA, 2011, ARCH INTERN MED, V171, P1910, DOI 10.1001/archinternmed.2011.498; Lobo CM, 2002, PREV MED, V35, P422, DOI 10.1006/pmed.2002.1095; Luders S, 2010, EUR J CARDIOV PREV R, V17, P271, DOI 10.1097/HJR.0b013e328330be62; Martensson J, 2005, EUR J HEART FAIL, V7, P393, DOI 10.1016/j.ejheart.2004.01.016; McAlister FA, 2009, CAN MED ASSOC J, V181, P897, DOI 10.1503/cmaj.090917; McBride P, 2000, J FAM PRACTICE, V49, P115; MCINNES GT, 1995, J HUM HYPERTENS, V9, P429; McManus R, 2010, LANCET, V376, P163, DOI 10.1016/S0140-6736(10)60964-6; McManus RJ, 2005, BMJ-BRIT MED J, V331, P493, DOI 10.1136/bmj.38558.393669.E0; Mehler PS, 2005, AM J MED, V118; Mitchell E, 2004, STUD HLTH TECHNOL IN, V107, P2; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Montgomery AA, 2003, BRIT J GEN PRACT, V53, P446; Montgomery AA, 2000, BRIT MED J, V320, P686, DOI 10.1136/bmj.320.7236.686; MUHLHAUSER I, 1993, CLIN EXP HYPERTENS, V15, P125, DOI 10.3109/10641969309041615; Munoz MA, 2007, INT J CARDIOL, V118, P312, DOI 10.1016/j.ijcard.2006.07.015; Murray CJL, 1996, SCIENCE, V274, P740, DOI 10.1126/science.274.5288.740; Murray MD, 2004, PHARMACOTHERAPY, V24, P324, DOI 10.1592/phco.24.4.324.33173; Nieuwlaat R, 2013, EUR HEART J, V34, P1262, DOI 10.1093/eurheartj/ehs481; O'Hare JP, 2004, DIABETIC MED, V21, P1357, DOI 10.1111/j.1464-5491.2004.01373.x; Oddone E Z, 1999, Eff Clin Pract, V2, P201; Parati G, 2009, J HYPERTENS, V27, P198, DOI 10.1097/HJH.0b013e3283163caf; Petticrew M, 2013, J CLIN EPIDEMIOL, V66, P1209, DOI 10.1016/j.jclinepi.2013.06.004; Petticrew M, 2013, J CLIN EPIDEMIOL, V66, P1230, DOI 10.1016/j.jclinepi.2013.06.005; Pigott T, 2013, J CLIN EPIDEMIOL, V66, P1244, DOI 10.1016/j.jclinepi.2013.06.013; Ploeg J, 2007, WORLDV EVID-BASED NU, V4, P210, DOI 10.1111/j.1741-6787.2007.00106.x; Prior M, 2008, J EVAL CLIN PRACT, V14, P888, DOI 10.1111/j.1365-2753.2008.01014.x; Puffer S, 2003, BMJ-BRIT MED J, V327, P785, DOI 10.1136/bmj.327.7418.785; Rosen M, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-34; Rossi RA, 1997, J GEN INTERN MED, V12, P672, DOI 10.1046/j.1525-1497.1997.07140.x; Rucker G, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-79; Santschi V, 2008, EUR J INTERN MED, V19, P427, DOI 10.1016/j.ejim.2007.12.007; SAUNDERS LD, 1991, MED CARE, V29, P669, DOI 10.1097/00005650-199107000-00007; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Sequist TD, 2005, J AM MED INFORM ASSN, V12, P431, DOI 10.1197/jamia.M1788; Shojania KG, 2004, CLOSING QUALITY GAP, V1; Shojania KG, 2004, AHRQ PUBLICATION, V1; Simon SR, 2005, AM J MED, V118, P521, DOI 10.1016/j.amjmed.2004.12.023; Simpson SH, 2011, DIABETES CARE, V34, P20, DOI 10.2337/dc10-1294; Sondergaard J, 2006, FAM PRACT, V23, P198, DOI 10.1093/fampra/cmi090; The Cochrane Collaboration, 2011, COCHRANE HDB SYSTEMA; The Scottish Intercollegiate Guidelines Network, 2019, SIGN 50 GUID DEV HDB; THOMPSON SG, 1994, BMJ-BRIT MED J, V309, P1351, DOI 10.1136/bmj.309.6965.1351; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Tierney WM, 2003, J GEN INTERN MED, V18, P967, DOI 10.1111/j.1525-1497.2003.30635.x; Unverzagt S, 2014, FAM PRACT, V31, P247, DOI 10.1093/fampra/cmt080; van Wyk JT, 2008, CIRCULATION, V117, P371, DOI 10.1161/CIRCULATIONAHA.107.697201; Verstappen WHJM, 2003, JAMA-J AM MED ASSOC, V289, P2407, DOI 10.1001/jama.289.18.2407; Villeneuve J, 2010, CAN MED ASSOC J, V182, P447, DOI 10.1503/cmaj.090533; Wensing M, 1998, BRIT J GEN PRACT, V48, P991; WHO, 2014, PREV CARD DIS CVDS; Wood DA, 2008, LANCET, V371, P1999, DOI 10.1016/S0140-6736(08)60868-5; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; Zillich AJ, 2008, J EVAL CLIN PRACT, V14, P854, DOI 10.1111/j.1365-2753.2008.01035.x	123	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110619	10.1371/journal.pone.0110619	http://dx.doi.org/10.1371/journal.pone.0110619			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343450	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943500040
J	Borges, AF; Fonseca, C; Ferreira, RB; Lourenco, AM; Monteiro, S				Borges, Alexandre Filipe; Fonseca, Catarina; Ferreira, Ricardo Boavida; Lourenco, Ana Maria; Monteiro, Sara			Reference Gene Validation for Quantitative RT-PCR during Biotic and Abiotic Stresses in Vitis vinifera	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; REAL-TIME PCR; EXPRESSION ANALYSIS; HOUSEKEEPING GENES; INTERNAL CONTROL; GRAPEVINE; NORMALIZATION; SELECTION; PATHOGEN; IDENTIFICATION	Grapevine is one of the most cultivated fruit crop worldwide with Vitis vinifera being the species with the highest economical importance. Being highly susceptible to fungal pathogens and increasingly affected by environmental factors, it has become an important agricultural research area, where gene expression analysis plays a fundamental role. Quantitative reverse transcription polymerase chain reaction (qRT-PCR) is currently amongst the most powerful techniques to perform gene expression studies. Nevertheless, accurate gene expression quantification strongly relies on appropriate reference gene selection for sample normalization. Concerning V. vinifera, limited information still exists as for which genes are the most suitable to be used as reference under particular experimental conditions. In this work, seven candidate genes were investigated for their stability in grapevine samples referring to four distinct stresses (Erysiphe necator, wounding and UV-C irradiation in leaves and Phaeomoniella chlamydospora colonization in wood). The expression stability was evaluated using geNorm, NormFinder and BestKeeper. In all cases, full agreement was not observed for the three methods. To provide comprehensive rankings integrating the three different programs, for each treatment, a consensus ranking was created using a non-weighted unsupervised rank aggregation method. According to the last, the three most suitable reference genes to be used in grapevine leaves, regardless of the stress, are UBC, VAG and PEP. For the P. chlamydospora treatment, EF1, CYP and UBC were the best scoring genes. Acquaintance of the most suitable reference genes to be used in grapevine samples can contribute for accurate gene expression quantification in forthcoming studies.	[Borges, Alexandre Filipe; Ferreira, Ricardo Boavida] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Dis & Stress Biol Lab, Oeiras, Portugal; [Borges, Alexandre Filipe; Fonseca, Catarina; Ferreira, Ricardo Boavida; Monteiro, Sara] Univ Lisbon, Dis & Stress Biol Lab, Inst Super Agron, P-1699 Lisbon, Portugal; [Lourenco, Ana Maria] Univ Nova Lisboa, Fac Ciencias & Tecnol, REQUIMTE, Dept Quim, Caparica, Portugal	Universidade Nova de Lisboa; Universidade de Lisboa; Universidade Nova de Lisboa	Borges, AF (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Dis & Stress Biol Lab, Oeiras, Portugal.	afgborges@isa.utl.pt	Lourenço, Ana/C-9024-2013	Lourenço, Ana/0000-0001-7358-3428; Ferreira, Ricardo Boavida/0000-0002-5027-7564; Borges, Alexandre/0000-0002-8130-764X; Monteiro, Sara/0000-0002-7069-0591	Fundacao para a Ciencia e a Tecnologia [PTDC/AGR PRO/112340/2009, SFRH/BD/61903/2009]	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	Financial support was provided by Project PTDC/AGR PRO/112340/2009 from Fundacao para a Ciencia e a Tecnologia (http://www.fct.pt/index.phtml.en). AFB was supported by Fundacao para a Ciencia e a Tecnologia, PhD grant SFRH/BD/61903/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Bertsch C, 2013, PLANT PATHOL, V62, P243, DOI 10.1111/j.1365-3059.2012.02674.x; Bonomelli A, 2004, AM J ENOL VITICULT, V55, P51; Borges AF, 2013, PLANT PHYSIOL BIOCH, V68, P71, DOI 10.1016/j.plaphy.2013.03.024; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Castro-Quezada P, 2013, PLANT MOL BIOL REP, V31, P936, DOI 10.1007/s11105-013-0566-3; Chao WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042839; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; Coito Joao L, 2012, BMC Res Notes, V5, P220, DOI 10.1186/1756-0500-5-220; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Ferreira RB, 2004, TRENDS BIOTECHNOL, V22, P168, DOI 10.1016/j.tibtech.2004.02.001; Figueiredo A, 2008, J EXP BOT, V59, P3371, DOI 10.1093/jxb/ern187; Figueiredo Andreia, 2013, BMC Res Notes, V6, P388, DOI 10.1186/1756-0500-6-388; Fischer M, 2003, VITIS, V42, P109; Gaforio L, 2011, VITIS, V50, P123; Gambino G, 2008, PHYTOCHEM ANALYSIS, V19, P520, DOI 10.1002/pca.1078; Gamm M, 2011, MOL GENET GENOMICS, V285, P273, DOI 10.1007/s00438-011-0607-2; Gantasala Nagavara Prasad, 2013, BMC Res Notes, V6, P312, DOI 10.1186/1756-0500-6-312; Gjetting T, 2004, MOL PLANT MICROBE IN, V17, P729, DOI 10.1094/MPMI.2004.17.7.729; Gonzalez-Aguero M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-878; Goulao LF, 2012, PLANT MOL BIOL REP, V30, P741, DOI 10.1007/s11105-011-0382-6; Iandolino A, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-53; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Kunz BA, 2006, INT REV CYTOL, V255, P1, DOI 10.1016/S0074-7696(06)55001-6; Le Henanff G, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-54; Leon J, 2001, J EXP BOT, V52, P1, DOI 10.1093/jexbot/52.354.1; Lima MRM, 2012, EUR J PLANT PATHOL, V132, P133, DOI 10.1007/s10658-011-9857-4; Logemann E, 2002, P NATL ACAD SCI USA, V99, P2428, DOI 10.1073/pnas.042692199; Lovdal T, 2009, ANAL BIOCHEM, V387, P238, DOI 10.1016/j.ab.2009.01.024; MacDonald MJ, 2007, BIOCHEM CELL BIOL, V85, P273, DOI 10.1139/O07-018; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; Mellway RD, 2009, PLANT PHYSIOL, V150, P924, DOI 10.1104/pp.109.139071; Monteiro F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072998; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Pezet R, 2003, J AGR FOOD CHEM, V51, P5488, DOI 10.1021/jf030227o; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pihur V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-62; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Reddy DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078555; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Reymond P, 2000, PLANT CELL, V12, P707, DOI 10.1105/tpc.12.5.707; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Selim M, 2012, PLANT CELL REP, V31, P205, DOI 10.1007/s00299-011-1156-1; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wu G, 2010, J AGR FOOD CHEM, V58, P2812, DOI 10.1021/jf904255b; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Xu M, 2011, ANAL BIOCHEM, V408, P337, DOI 10.1016/j.ab.2010.08.044; Zhu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054411, 10.1371/journal.pone.0053196]; [No title captured]	51	31	33	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111399	10.1371/journal.pone.0111399	http://dx.doi.org/10.1371/journal.pone.0111399			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340748	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662800105
J	Chang, SW; Liu, WC; Liao, KY; Tsao, YP; Hsu, PH; Chen, SL				Chang, Szu-Wei; Liu, Wei-Chen; Liao, Kuan-Yu; Tsao, Yeou-Ping; Hsu, Pang-Hung; Chen, Show-Li			Phosphorylation of HPV-16 E2 at Serine 243 Enables Binding to Brd4 and Mitotic Chromosomes	PLOS ONE			English	Article							PAPILLOMAVIRUS E2; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; FUNCTIONAL INTERACTION; ACETYLATED CHROMATIN; BROMODOMAIN PROTEIN; HOST CHROMOSOMES; VIRAL-DNA; GENOME; MITOSIS	The papillomavirus E2 protein is involved in the maintenance of persistent infection and known to bind either to cellular factors or directly to mitotic chromosomes in order to partition the viral genome into the daughter cells. However, how the HPV-16 E2 protein acts to facilitate partitioning of the viral genome remains unclear. In this study, we found that serine 243 of HPV-16 E2, located in the hinge region, is crucial for chromosome binding during mitosis. Bromodomain protein 4 (Brd4) has been identified as a cellular binding target through which the E2 protein of bovine papillomavirus type 1 (BPV-1) tethers the viral genome to mitotic chromosomes. Mutation analysis showed that, when the residue serine 243 was substituted by glutamic acid or aspartic acid, whose negative charges mimic the effect of constitutive phosphorylation, the protein still can interact with Brd4 and colocalize with Brd4 in condensed metaphase and anaphase chromosomes. However, substitution by the polar uncharged residues asparagine or glutamine abrogated Brd4 and mitotic chromosome binding. Moreover, following treatment with the inhibitor JQ1 to release Brd4 from the chromosomes, Brd4 and E2 formed punctate foci separate from the chromosomes, further supporting the hypothesis that the association of the HPV-16 E2 protein with the chromosomes is Brd4-dependent. In addition, the S243A E2 protein has a shorter half-life than the wild type, indicating that phosphorylation of the HPV-16 E2 protein at serine 243 also increases its half-life. Thus, phosphorylation of serine 243 in the hinge region of HPV-16 E2 is essential for interaction with Brd4 and required for host chromosome binding.	[Chang, Szu-Wei; Liu, Wei-Chen; Liao, Kuan-Yu; Chen, Show-Li] Natl Taiwan Univ, Coll Med, Grad Inst Microbiol, Taipei 10764, Taiwan; [Tsao, Yeou-Ping] Mackay Mem Hosp, Dept Ophthalmol, Taipei, Taiwan; [Hsu, Pang-Hung] Natl Taiwan Ocean Univ, Coll Life Sci, Dept Biosci & Biotechnol, Keelung, Taiwan	National Taiwan University; Mackay Memorial Hospital; National Taiwan Ocean University	Chen, SL (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Microbiol, Taipei 10764, Taiwan.	showlic@ntu.edu.tw	Hsu, Pang-Hung/C-5587-2018	Hsu, Pang-Hung/0000-0001-6873-6434	National Taiwan University [10R891903]; National Science Council [NSC101-2321-B-002-061, NSC102-2320-B-002-033MY3, NSC101-102-2325-B-002-065]; National Health Research Institute [NHRI-EX101-10148SI]	National Taiwan University(National Taiwan University); National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institute(National Health Research Institutes - Taiwan)	This work was supported by the National Taiwan University (10R891903), National Science Council (NSC101-2321-B-002-061, NSC102-2320-B-002-033MY3, NSC101-102-2325-B-002-065), and National Health Research Institute (NHRI-EX101-10148SI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate EA, 2006, MOL CELL, V24, P877, DOI 10.1016/j.molcel.2006.11.002; Abroi A, 2004, J VIROL, V78, P2100, DOI 10.1128/JVI.78.4.2100-2113.2004; Baxter MK, 2005, J VIROL, V79, P4806, DOI 10.1128/JVI.79.8.4806-4818.2005; Brannon AR, 2005, P NATL ACAD SCI USA, V102, P2998, DOI 10.1073/pnas.0407818102; Chang SW, 2012, VIROLOGY, V423, P38, DOI 10.1016/j.virol.2011.11.015; Chang SW, 2011, J VIROL, V85, P6750, DOI 10.1128/JVI.02453-10; Dao LD, 2006, J VIROL, V80, P4792, DOI 10.1128/JVI.80.10.4792-4800.2006; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Donaldson MM, 2007, J VIROL, V81, P4338, DOI 10.1128/JVI.02353-06; Gagnon D, 2009, J VIROL, V83, P4127, DOI 10.1128/JVI.02468-08; Gammoh N, 2006, J VIROL, V80, P1787, DOI 10.1128/JVI.80.4.1787-1797.2006; Hamid NA, 2009, CELL MOL LIFE SCI, V66, P1700, DOI 10.1007/s00018-009-8631-7; Helfer CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077994; Ilves I, 1999, J VIROL, V73, P4404, DOI 10.1128/JVI.73.5.4404-4412.1999; Lee AY, 2009, J BIOL CHEM, V284, P2778, DOI 10.1074/jbc.M805835200; Lee D, 2002, J BIOL CHEM, V277, P6483, DOI 10.1074/jbc.M105085200; Lehman CW, 1998, P NATL ACAD SCI USA, V95, P4338, DOI 10.1073/pnas.95.8.4338; MCBRIDE AA, 1991, J BIOL CHEM, V266, P18411; McBride AA, 2013, VIROLOGY, V445, P57, DOI 10.1016/j.virol.2013.06.006; McBride AA, 2008, ADV VIRUS RES, V72, P155, DOI 10.1016/S0065-3527(08)00404-1; McPhillips MG, 2006, J VIROL, V80, P9530, DOI 10.1128/JVI.01105-06; McPhillips MG, 2005, J VIROL, V79, P8920, DOI 10.1128/JVI.79.14.8920-8932.2005; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Muller A, 2002, J VIROL, V76, P11042, DOI 10.1128/JVI.76.21.11042-11053.2002; Nishiyama A, 2006, MOL BIOL CELL, V17, P814, DOI 10.1091/mbc.E05-08-0729; Parish JL, 2006, MOL CELL, V24, P867, DOI 10.1016/j.molcel.2006.11.005; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Penrose KJ, 2000, J VIROL, V74, P6031, DOI 10.1128/JVI.74.13.6031-6038.2000; Penrose KJ, 2004, J BIOL CHEM, V279, P22430, DOI 10.1074/jbc.M314340200; Poddar A, 2009, J VIROL, V83, P640, DOI 10.1128/JVI.01936-08; Rehtanz M, 2004, MOL CELL BIOL, V24, P2153, DOI 10.1128/MCB.24.5.2153-2168.2004; Schweiger MR, 2006, J VIROL, V80, P4276, DOI 10.1128/JVI.80.9.4276-4285.2006; Sekhar V, 2012, J VIROL, V86, P10047, DOI 10.1128/JVI.01140-12; Sekhar V, 2010, J VIROL, V84, P543, DOI 10.1128/JVI.01908-09; Senechal H, 2007, VIROLOGY, V358, P10, DOI 10.1016/j.virol.2006.08.035; Thierry F, 2009, VIROLOGY, V384, P375, DOI 10.1016/j.virol.2008.11.014; Vosa L, 2012, J VIROL, V86, P348, DOI 10.1128/JVI.05606-11; Wang X, 2013, J VIROL, V87, P3871, DOI 10.1128/JVI.03068-12; Wu MH, 2007, INT J BIOCHEM CELL B, V39, P413, DOI 10.1016/j.biocel.2006.09.008; Yang ZY, 2008, MOL CELL BIOL, V28, P967, DOI 10.1128/MCB.01020-07; Yao JM, 1998, J VIROL, V72, P1013, DOI 10.1128/JVI.72.2.1013-1019.1998; You J, 2004, CELL, V117, P349, DOI 10.1016/S0092-8674(04)00402-7; You JX, 2005, J VIROL, V79, P14956, DOI 10.1128/JVI.79.23.14956-14961.2005; Yu T, 2007, J VIROL, V81, P1736, DOI 10.1128/JVI.01638-06; Zheng G, 2009, J VIROL, V83, P8683, DOI 10.1128/JVI.00674-09; Zheng PS, 2005, J VIROL, V79, P1500, DOI 10.1128/JVI.79.3.1500-1509.2005; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	47	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110882	10.1371/journal.pone.0110882	http://dx.doi.org/10.1371/journal.pone.0110882			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340539	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662800066
J	Ligmann-Zielinska, A; Kramer, DB; Cheruvelil, KS; Soranno, PA				Ligmann-Zielinska, Arika; Kramer, Daniel B.; Cheruvelil, Kendra Spence; Soranno, Patricia A.			Using Uncertainty and Sensitivity Analyses in Socioecological Agent-Based Models to Improve Their Analytical Performance and Policy Relevance	PLOS ONE			English	Article							LAND-COVER CHANGE; CONSERVATION RESERVE PROGRAM; GLOBAL SENSITIVITY; THEORETICAL FRAMEWORK; COMPLEX; SYSTEMS; SIMULATIONS; MANAGEMENT; ECOSYSTEM; DYNAMICS	Agent-based models (ABMs) have been widely used to study socioecological systems. They are useful for studying such systems because of their ability to incorporate micro-level behaviors among interacting agents, and to understand emergent phenomena due to these interactions. However, ABMs are inherently stochastic and require proper handling of uncertainty. We propose a simulation framework based on quantitative uncertainty and sensitivity analyses to build parsimonious ABMs that serve two purposes: exploration of the outcome space to simulate low-probability but high-consequence events that may have significant policy implications, and explanation of model behavior to describe the system with higher accuracy. The proposed framework is applied to the problem of modeling farmland conservation resulting in land use change. We employ output variance decomposition based on quasi-random sampling of the input space and perform three computational experiments. First, we perform uncertainty analysis to improve model legitimacy, where the distribution of results informs us about the expected value that can be validated against independent data, and provides information on the variance around this mean as well as the extreme results. In our last two computational experiments, we employ sensitivity analysis to produce two simpler versions of the ABM. First, input space is reduced only to inputs that produced the variance of the initial ABM, resulting in a model with output distribution similar to the initial model. Second, we refine the value of the most influential input, producing a model that maintains the mean of the output of initial ABM but with less spread. These simplifications can be used to 1) efficiently explore model outcomes, including outliers that may be important considerations in the design of robust policies, and 2) conduct explanatory analysis that exposes the smallest number of inputs influencing the steady state of the modeled system.	[Ligmann-Zielinska, Arika] Michigan State Univ, Dept Geog, E Lansing, MI 48824 USA; [Kramer, Daniel B.] Michigan State Univ, James Madison Coll, E Lansing, MI 48824 USA; [Kramer, Daniel B.; Cheruvelil, Kendra Spence; Soranno, Patricia A.] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Cheruvelil, Kendra Spence] Michigan State Univ, Lyman Briggs Coll, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University	Ligmann-Zielinska, A (corresponding author), Michigan State Univ, Dept Geog, E Lansing, MI 48824 USA.	ligmannz@msu.edu		Soranno, Patricia/0000-0003-1668-9271; Spence Cheruvelil, Kendra/0000-0003-1880-2880	Center for Water Sciences and the Environmental Science; Policy Program at Michigan State University; National Science Foundation Geography and Spatial Sciences Program [BCS 1263477]	Center for Water Sciences and the Environmental Science; Policy Program at Michigan State University; National Science Foundation Geography and Spatial Sciences Program	Financial support for this work was provided by the Center for Water Sciences and the Environmental Science and Policy Program at Michigan State University, as well as the National Science Foundation Geography and Spatial Sciences Program Grant No. BCS 1263477. Any opinion, findings, conclusions, and recommendations expressed in this material are those of the authors(s) and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER ER, 1989, J AM PLANN ASSOC, V55, P323, DOI 10.1080/01944368908975419; An L, 2005, ANN ASSOC AM GEOGR, V95, P54, DOI 10.1111/j.1467-8306.2005.00450.x; Baroni G, 2014, ENVIRON MODELL SOFTW, V51, P26, DOI 10.1016/j.envsoft.2013.09.022; BECKER BJ, 1994, HDB RES SYNTHESIS; Bennett D, 2008, GEOFORUM, V39, P833, DOI 10.1016/j.geoforum.2007.05.009; Berger T, 2001, AGR ECON-BLACKWELL, V25, P245, DOI 10.1111/j.1574-0862.2001.tb00205.x; Bert FE, 2011, ECOL MODEL, V222, P3486, DOI 10.1016/j.ecolmodel.2011.08.007; Beven K, 2002, P ROY SOC A-MATH PHY, V458, P2465, DOI 10.1098/rspa.2002.0986; Beven K. J., 2008, ENV MODELLING UNCERT; Bousquet F, 2004, ECOL MODEL, V176, P313, DOI 10.1016/j.ecolmodel.2004.01.011; Brady M, 2009, ANN M AGR APPL EC AS, P27; Brown DG, 2006, ECOL SOC, V11; Brown DG, 2013, CURR OPIN ENV SUST, V5, P452, DOI 10.1016/j.cosust.2013.07.012; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Campolongo F, 2000, SENSITIVITY ANAL, P15; Chan K., 2000, SENSITIVITY ANAL; Chang HH, 2008, AGR ECON-BLACKWELL, V38, P201, DOI 10.1111/j.1574-0862.2008.00294.x; Chen Y, 2013, ENVIRON MODELL SOFTW, V48, P129, DOI 10.1016/j.envsoft.2013.06.010; Chu-Agor ML, 2011, ENVIRON MODELL SOFTW, V26, P593, DOI 10.1016/j.envsoft.2010.12.003; Convertino M, 2014, ENVIRON MODELL SOFTW, V51, P296, DOI 10.1016/j.envsoft.2013.10.001; Couclelis H., 2003, T GIS, V7, P165, DOI [10.1111/1467-9671.00138, DOI 10.1111/1467-9671.00138]; Dancik GM, 2010, J THEOR BIOL, V262, P398, DOI 10.1016/j.jtbi.2009.10.007; DANIEL C, 1958, BIOMETRICS, V14, P430, DOI 10.2307/2527884; Epstein JM, 2008, JASSS-J ARTIF SOC S, V11; Estrada V, 2010, ENVIRON MODELL SOFTW, V25, P1539, DOI 10.1016/j.envsoft.2010.06.009; Evans TP, 2011, J LAND USE SCI, V6, P151, DOI 10.1080/1747423X.2011.558602; Fisher P, 1991, PRINCIPLES APPL, V1, P191; Fonoberova M, 2013, RELIAB ENG SYST SAFE, V118, P8, DOI 10.1016/j.ress.2013.04.004; Goodchild MF, 2008, ENCY GIS; Granger M.., 2009, CLIMATE CHANGE SCI P, P96; Greiner R, 2009, AGR SYST, V99, P86, DOI 10.1016/j.agsy.2008.10.003; Guzy MR, 2008, ECOL SOC, V13; Happe K., 2006, Ecology and Society, V11, P49; Hellerstein D, 2010, CHALLENGES FACING US; Heppenstall AJ, 2012, AGENT BASED MODEL GE, DOI [DOI 10.1007/978-90-481-8927-4, 10.1007/978-90-481-8927-4]; Homma T, 1996, RELIAB ENG SYST SAFE, V52, P1, DOI 10.1016/0951-8320(96)00002-6; Hosack GR, 2009, ECOL MODEL, V220, P1054, DOI 10.1016/j.ecolmodel.2009.01.033; Huang QX, 2013, COMPUT ENVIRON URBAN, V41, P188, DOI 10.1016/j.compenvurbsys.2013.06.004; INSUA DR, 1991, EUR J OPER RES, V54, P176, DOI 10.1016/0377-2217(91)90296-8; Jager W, 2000, ECOL ECON, V35, P357, DOI 10.1016/S0921-8009(00)00220-2; Kingsbury L, 1999, ANN M AM AGR EC ASS, P15; Kocabas V, 2006, COMPUT ENVIRON URBAN, V30, P921, DOI 10.1016/j.compenvurbsys.2006.01.001; Lambert D., 2006, CONSERVATION COMPATI, P14; Lambert D. M., 2007, Journal of Agricultural and Applied Economics, V39, P151; Lambert DM, 2007, LAND USE POLICY, V24, P72, DOI 10.1016/j.landusepol.2005.12.002; Larocque GR, 2008, ECOL MODEL, V219, P400, DOI 10.1016/j.ecolmodel.2008.07.024; Lempert R, 2002, P NATL ACAD SCI USA, V99, P7195, DOI 10.1073/pnas.072079399; Lempert R. J., 2003, MR1626RPC RAND CORP; Ligmann-Zielinska A, 2010, ENCY GEOGRAPHY SAGE; Ligmann-Zielinska A, 2008, LECT NOTES COMPUT SC, V5266, P217; Ligmann-Zielinska A, 2010, INT J GEOGR INF SCI, V24, P1829, DOI 10.1080/13658816.2010.490533; Ligmann-Zielinska A, 2013, INT J GEOGR INF SCI, V27, P1764, DOI 10.1080/13658816.2013.782613; Lilburne L, 2009, INT J GEOGR INF SCI, V23, P151, DOI 10.1080/13658810802094995; Makler-Pick V, 2011, ENVIRON MODELL SOFTW, V26, P124, DOI 10.1016/j.envsoft.2010.06.010; Malczewski J, 1999, GIS MULTICRITERIA DE; Matthews RB, 2007, LANDSCAPE ECOL, V22, P1447, DOI 10.1007/s10980-007-9135-1; McGarigal K., 1995, General Technical Report - Pacific Northwest Research Station, USDA Forest Service; Melbourne-Thomas J, 2011, ECOL MODEL, V222, P3320, DOI 10.1016/j.ecolmodel.2011.07.014; Menard A, 2005, ENVIRON PLANN B, V32, P693, DOI 10.1068/b31163; Mosler HJ, 2008, J ENVIRON MANAGE, V88, P805, DOI 10.1016/j.jenvman.2007.04.013; Nossent J, 2011, ENVIRON MODELL SOFTW, V26, P1515, DOI 10.1016/j.envsoft.2011.08.010; Nrc, 2013, ADV LAND CHANG MOD O; Pannell DJ, 1997, AGR ECON, V16, P139, DOI 10.1016/S0169-5150(96)01217-0; Parker DC, 2008, J LAND USE SCI, V3, P41, DOI 10.1080/17474230802048151; Parker DC, 2003, ANN ASSOC AM GEOGR, V93, P314, DOI 10.1111/1467-8306.9302004; Parry HR, 2013, ENVIRON MODELL SOFTW, V45, P104, DOI 10.1016/j.envsoft.2012.08.006; Perez L, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-50; Polasky S, 2011, TRENDS ECOL EVOL, V26, P398, DOI 10.1016/j.tree.2011.04.007; Pontius RG, 2000, PHOTOGRAMM ENG REM S, V66, P1011; Pontius RG, 2010, SUSTAIN SCI, V5, P39, DOI 10.1007/s11625-009-0095-z; Rindfuss RR, 2008, J LAND USE SCI, V3, P1, DOI 10.1080/17474230802047955; Rinner C, 2002, J GEOGRAPH SYST, V4, P385, DOI [10.1007/s101090300095, DOI 10.1007/S101090300095]; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Saltelli A., 2008, GLOBAL SENSITIVITY A; Saltelli A., 2004, SENSITIVITY ANAL PRA, V1, DOI 10.1002/0470870958; Saltelli A., 2013, INT J INNOV POL, V9, P213, DOI DOI 10.1504/IJFIP.2013.058610; Saltelli A, 2014, ISSUES SCI TECHNOL, V30, P79; Saltelli A, 2010, ENVIRON MODELL SOFTW, V25, P1508, DOI 10.1016/j.envsoft.2010.04.012; Saltelli A, 2010, GLOBAL ENVIRON CHANG, V20, P298, DOI 10.1016/j.gloenvcha.2009.12.003; Saltelli A, 2010, COMPUT PHYS COMMUN, V181, P259, DOI 10.1016/j.cpc.2009.09.018; Schaetzl RJ, 2012, SOIL SCI, V177, P288, DOI 10.1097/SS.0b013e3182446c88; Schindler J, 2013, JASSS-J ARTIF SOC S, V16, DOI 10.18564/jasss.2274; Schluter M, 2007, ECOL SOC, V12; Schreinemachers P, 2011, ENVIRON MODELL SOFTW, V26, P845, DOI 10.1016/j.envsoft.2011.02.004; Segovia-Juarez JL, 2004, J THEOR BIOL, V231, P357, DOI 10.1016/j.jtbi.2004.06.031; Sengupta R, 2005, ENVIRON PLANN B, V32, P821, DOI 10.1068/b31193; Sobol I.M., 1993, MATH MODEL COMPUT EX, V1, P407, DOI DOI 10.18287/0134-2452-2015-39-4-459-461; Soboll A, 2011, MITIG ADAPT STRAT GL, V16, P477, DOI 10.1007/s11027-010-9274-6; Soil Survey Staff, 2013, GRIDD SOIL SURV GEOG; USDA, 2013, US CENS AGR; USDA, 2011, AGR RES MAN SURV ARM; USDA FSA, 2011, CONS RES PROGR SIGN; USDA FSA, 2013, CONS PROGR REP STAT; USDA FSA, 2010, CONS RES PROGR SIGN; USDA FSA, 2010, CRP663 DC US DEP AGR; USDA FSA, 2012, CONS RES PROGR OV; USDA NASS, 2012, CORPL DAT LAY CDL; USGS, 2013, LANDFIRE NAT EL DAT; USGS, 2012, NAT HYDR DAT NHD; Vanuytrecht E, 2014, ENVIRON MODELL SOFTW, V51, P323, DOI 10.1016/j.envsoft.2013.10.017; Verburg PH, 2006, LANDSCAPE ECOL, V21, P1171, DOI 10.1007/s10980-006-0029-4; Verburg PH, 2006, GLO CH IGBP, P117; Warmink JJ, 2010, ENVIRON MODELL SOFTW, V25, P1518, DOI 10.1016/j.envsoft.2010.04.011; Wossink GAA, 2003, EUR REV AGRIC ECON, V30, P461, DOI 10.1093/erae/30.4.461; YAGER RR, 1988, IEEE T SYST MAN CYB, V18, P183, DOI 10.1109/21.87068; Yang J, 2011, ENVIRON MODELL SOFTW, V26, P444, DOI 10.1016/j.envsoft.2010.10.007; Zhang J., 2002, UNCERTAINTY GEOGRAPH	107	46	47	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e109779	10.1371/journal.pone.0109779	http://dx.doi.org/10.1371/journal.pone.0109779			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR5ZY	25340764	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662800016
J	Bonnington, C; Gaston, KJ; Evans, KL				Bonnington, Colin; Gaston, Kevin J.; Evans, Karl L.			Relative Roles of Grey Squirrels, Supplementary Feeding, and Habitat in Shaping Urban Bird Assemblages	PLOS ONE			English	Article							AVIAN SPECIES-DIVERSITY; SCIURUS-CAROLINENSIS; RED SQUIRRELS; COMMUNITIES; PRODUCTIVITY; DENSITIES; VULGARIS; BEHAVIOR; FOREST; SCALE	Non-native species are frequently considered to influence urban assemblages. The grey squirrel Sciurus carolinensis is one such species that is widespread in the UK and is starting to spread across Europe; it predates birds' nests and can compete with birds for supplementary food. Using distance sampling across the urbanisation intensity gradient in Sheffield (UK) we test whether urban grey squirrels influence avian species richness and density through nest predation and competition for supplementary food sources. We also assess how urban bird assemblages respond to supplementary feeding. We find that grey squirrels slightly reduced the abundance of breeding bird species most sensitive to squirrel nest predation by reducing the beneficial impact of woodland cover. There was no evidence that grey squirrel presence altered relationships between supplementary feeding and avian assemblage structure. This may be because, somewhat surprisingly, supplementary feeding was not associated with the richness or density of wintering bird assemblages. These associations were positive during the summer, supporting advocacy to feed birds during the breeding season and not just winter, but explanatory capacity was limited. The amount of green space and its quality, assessed as canopy cover, had a stronger influence on avian species richness and population size than the presence of grey squirrels and supplementary feeding stations. Urban bird populations are thus more likely to benefit from investment in improving the availability of high quality habitats than controlling squirrel populations or increased investment in supplementary feeding.	[Bonnington, Colin; Evans, Karl L.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Gaston, Kevin J.] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England	University of Sheffield; University of Exeter	Evans, KL (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	karl.evans@sheffield.ac.uk		Gaston, Kevin J./0000-0002-7235-7928				Baillie S.R., 2013, 644 BTO; Bayne E, 2000, CAN J ZOOL, V78, P359, DOI 10.1139/cjz-78-3-359; Blair RB, 1996, ECOL APPL, V6, P506, DOI 10.2307/2269387; Bonnington C, 2014, URBAN ECOSYST, V17, P533, DOI 10.1007/s11252-013-0331-2; Bonnington C, 2014, IBIS, V156, P220, DOI 10.1111/ibi.12107; Buckland S., 2004, ADV DISTANCE SAMPLIN; Daniels GD, 2006, BIOL CONSERV, V133, P326, DOI 10.1016/j.biocon.2006.06.011; Davies ZG, 2009, BIOL CONSERV, V142, P761, DOI 10.1016/j.biocon.2008.12.016; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Evans KL, 2011, GLOBAL CHANGE BIOL, V17, P32, DOI 10.1111/j.1365-2486.2010.02247.x; Evans KL, 2009, IBIS, V151, P19, DOI 10.1111/j.1474-919X.2008.00898.x; Faeth SH, 2005, BIOSCIENCE, V55, P399, DOI 10.1641/0006-3568(2005)055[0399:TDIUC]2.0.CO;2; Fuller RA, 2008, DIVERS DISTRIB, V14, P131, DOI 10.1111/j.1472-4642.2007.00439.x; Fuller RA, 2009, DIVERS DISTRIB, V15, P328, DOI 10.1111/j.1472-4642.2008.00537.x; Game and Wildlife Conservancy Trust, 2013, PHEAS NEST PRED; Gregory RD, 1998, J APPL ECOL, V35, P785, DOI 10.1046/j.1365-2664.1998.355349.x; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Gurnell J, 2004, MAMMAL REV, V34, P51, DOI 10.1046/j.0305-1838.2003.00028.x; Harris S., 2008, MAMMALS BRIT ISLES H, V4th; Harrison TJE, 2010, OECOLOGIA, V164, P311, DOI 10.1007/s00442-010-1645-x; Hewson Chris, 2004, British Wildlife, V15, P183; Jokimaki J, 2002, J BIOGEOGR, V29, P69, DOI 10.1046/j.1365-2699.2002.00649.x; Jokimaki J, 2003, J BIOGEOGR, V30, P1183, DOI 10.1046/j.1365-2699.2003.00896.x; Jones DN, 2008, J AVIAN BIOL, V39, P265, DOI 10.1111/j.0908-8857.2008.04271.x; Koprowski JL, 2005, ANIM CONSERV, V8, P369, DOI 10.1017/S1367943005002416; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; MOLLER H, 1983, MAMMAL REV, V13, P81, DOI 10.1111/j.1365-2907.1983.tb00270.x; Newson SE, 2008, J APPL ECOL, V45, P1330, DOI 10.1111/j.1365-2664.2008.01480.x; Newson SE, 2010, J APPL ECOL, V47, P244, DOI 10.1111/j.1365-2664.2010.01771.x; Newson SE, 2010, J ORNITHOL, V151, P211, DOI 10.1007/s10336-009-0445-8; Office for National Statistics, 2010, POP EST UK ENGL WAL; Parker Tommy S., 2008, Urban Ecosystems, V11, P243, DOI 10.1007/s11252-008-0060-0; Parsons H, 2006, AUSTRAL ECOL, V31, P217, DOI 10.1111/j.1442-9993.2006.01584.x; Plummer KE, 2013, J ANIM ECOL, V82, P673, DOI 10.1111/1365-2656.12025; R Development Core Team, 2012, R LANG ENV STAT COMP; Robb GN, 2008, FRONT ECOL ENVIRON, V6, P476, DOI 10.1890/060152; Robb GN, 2008, BIOL LETTERS, V4, P220, DOI 10.1098/rsbl.2007.0622; Russell RE, 2010, J WILDLIFE MANAGE, V74, P12, DOI 10.2193/2008-342; Shochat E, 2010, BIOSCIENCE, V60, P199, DOI 10.1525/bio.2010.60.3.6; Sieving KE, 1998, ECOLOGY, V79, P2391, DOI 10.1890/0012-9658(1998)079[2391:NPAASD]2.0.CO;2; Sims V, 2008, DIVERS DISTRIB, V14, P387, DOI 10.1111/j.1472-4642.2007.00444.x; Thomas L., 2009, DISTANCE 6 0 RELEASE; Tratalos J, 2007, GLOBAL CHANGE BIOL, V13, P1685, DOI 10.1111/j.1365-2486.2007.01390.x; Zhou DQ, 2012, J ORNITHOL, V153, P1101, DOI 10.1007/s10336-012-0839-x	45	8	9	6	134	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e109397	10.1371/journal.pone.0109397	http://dx.doi.org/10.1371/journal.pone.0109397			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338062	Green Published, gold, Green Accepted			2022-12-27	WOS:000343674800011
J	Chang, JJ; Strauss, JF; Deshazo, JP; Rigby, FB; Chelmow, DP; Macones, GA				Chang, Jen Jen; Strauss, Jerome F., III; Deshazo, Jon P.; Rigby, Fidelma B.; Chelmow, David P.; Macones, George A.			Reassessing the Impact of Smoking on Preeclampsia/Eclampsia: Are There Age and Racial Differences?	PLOS ONE			English	Article							ENDOTHELIAL-CELL APOPTOSIS; AFRICAN-AMERICAN WOMEN; BODY-MASS INDEX; THE-ART LECTURE; NEW-YORK-CITY; CARBON-MONOXIDE; RISK-FACTORS; HYPERTENSIVE DISORDERS; PREGNANCY OUTCOMES; MATERNAL ETHNICITY	Objective: To investigate the association between cigarette use during pregnancy and pregnancy-induced hypertension/preeclampsia/eclampsia (PIH) by maternal race/ethnicity and age. Methods: This retrospective cohort study was based on the U.S. 2010 natality data. Our study sample included U. S. women who delivered singleton pregnancies between 20 and 44 weeks of gestation without major fetal anomalies in 2010 (n = 3,113,164). Multivariate logistic regression models were fit to estimate crude and adjusted odds ratios and the corresponding 95% confidence intervals. Results: We observed that the association between maternal smoking and PIH varied by maternal race/ethnicity and age. Compared with non-smokers, reduced odds of PIH among pregnant smokers was only evident for non-Hispanic white and non-Hispanic American Indian women aged less than 35 years. Non-Hispanic Asian/Pacific Islander women who smoked during pregnancy had increased odds of PIH regardless of maternal age. Non-Hispanic white and non-Hispanic black women 35 years or older who smoked during pregnancy also had increased odds of PIH. Conclusion: Our study findings suggest important differences by maternal race/ethnicity and age in the association between cigarette use during pregnancy and PIH. More research is needed to establish the biologic and social mechanisms that might explain the variations with maternal age and race/ethnicity that were observed in our study.	[Chang, Jen Jen] St Louis Univ, Coll Publ Hlth & Social Justice, Dept Epidemiol, St Louis, MO 63103 USA; [Strauss, Jerome F., III] Virginia Commonwealth Univ, VCU Med Ctr, Sch Med, Richmond, VA USA; [Deshazo, Jon P.] Virginia Commonwealth Univ, Dept Hlth Adm, Sch Allied Hlth Profess, Richmond, VA USA; [Rigby, Fidelma B.; Chelmow, David P.] Virginia Commonwealth Univ, Dept Obstet & Gynecol, Richmond, VA USA; [Macones, George A.] Washington Univ, Dept Obstet & Gynecol, St Louis, MO USA	Saint Louis University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Washington University (WUSTL)	Chang, JJ (corresponding author), St Louis Univ, Coll Publ Hlth & Social Justice, Dept Epidemiol, St Louis, MO 63103 USA.	jjchang@slu.edu			National Institute of Health [P60 MD002256]; National Institute on Minority Health and Health Disparities [P60MD002256] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by the National Institute of Health (Grant P60 MD002256). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AM, 2008, PUBLIC HEALTH REP, V123, P586, DOI 10.1177/003335490812300508; Ananth CV, 2011, EUR J OBSTET GYN R B, V159, P77, DOI 10.1016/j.ejogrb.2011.07.025; Anderson NH, 2012, AUST NZ J OBSTET GYN, V52, P552, DOI 10.1111/j.1479-828X.2012.01475.x; [Anonymous], 2011, HCUP NIS REL REP; [Anonymous], 1996, INT J GYNAECOL OBSTE, V53, P175; [Anonymous], 2004, LANCET, V363, P157; Bloch JR, 2009, PUBLIC HEALTH NURS, V26, P449, DOI 10.1111/j.1525-1446.2009.00803.x; Bouthoorn SH, 2012, HYPERTENSION, V60, P198, DOI 10.1161/HYPERTENSIONAHA.112.194365; Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015; Caughey AB, 2005, OBSTET GYNECOL, V106, P156, DOI 10.1097/01.AOG.0000164478.91731.06; Conde-Agudelo A, 1999, AM J OBSTET GYNECOL, V181, P1026, DOI 10.1016/S0002-9378(99)70341-8; Cudmore M, 2007, CIRCULATION, V115, P1789, DOI 10.1161/CIRCULATIONAHA.106.660134; Division of Reproductive Health U.S. Centers for Disease Control and Prevention., TOB US PREGN; Division of Vital Statistics, 2001, TECHN APP VIT STAT U; DOSEMECI M, 1990, AM J EPIDEMIOL, V132, P746, DOI 10.1093/oxfordjournals.aje.a115716; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; El Sahly HM, 2004, SCAND J INFECT DIS, V36, P106, DOI 10.1080/00365540310018860; Engel SM, 2009, AM J EPIDEMIOL, V169, P33, DOI 10.1093/aje/kwn293; England L, 2007, FRONT BIOSCI-LANDMRK, V12, P2471, DOI 10.2741/2248; England LJ, 2007, NICOTINE TOB RES, V9, P1005, DOI 10.1080/14622200701491255; FALKNER B, 1990, HYPERTENSION, V15, P681, DOI 10.1161/01.HYP.15.6.681; Fink AK, 2003, CANCER CAUSE CONTROL, V14, P497, DOI 10.1023/A:1024922824237; FROHLICH ED, 1990, HYPERTENSION, V15, P675, DOI 10.1161/01.HYP.15.6.675; FROST F, 1984, AM J PUBLIC HEALTH, V74, P505, DOI 10.2105/AJPH.74.5.505; Fujita T, 2001, NAT MED, V7, P598, DOI 10.1038/87929; Geller SE, 2004, AM J OBSTET GYNECOL, V190, P1629, DOI 10.1016/j.ajog.2004.03.061; Gillum RF, 1996, AM HEART J, V131, P385, DOI 10.1016/S0002-8703(96)90371-3; Gong J, 2012, PAEDIATR PERINAT EP, V26, P45, DOI 10.1111/j.1365-3016.2011.01222.x; Goodwin AA, 2005, AM J OBSTET GYNECOL, V193, P973, DOI 10.1016/j.ajog.2005.05.047; Gregory KD, 2003, AM J OBSTET GYNECOL, V188, P1602, DOI 10.1067/mob.2003.391; Janakiraman V, 2009, NICOTINE TOB RES, V11, P679, DOI 10.1093/ntr/ntp049; Khalil A, 2013, ULTRASOUND OBSTET GY; Knuist M, 1998, OBSTET GYNECOL, V92, P174, DOI 10.1016/S0029-7844(98)00143-4; Liu XM, 2002, CARDIOVASC RES, V55, P396, DOI 10.1016/S0008-6363(02)00410-8; Llurba E, 2013, HYPERTENS PREGNANCY, V32, P50, DOI 10.3109/10641955.2012.704107; Marshall NE, 2013, J MATERN FETAL NEONA; MISRA DP, 1995, EARLY HUM DEV, V40, P95, DOI 10.1016/0378-3782(94)01593-E; Nejatizadeh A, 2008, BIOCHEM GENET, V46, P451, DOI 10.1007/s10528-008-9163-9; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Palei AC, 2013, ACTA PHYSIOL, V208, P224, DOI 10.1111/apha.12106; Pegoraro RJ, 2003, ACTA OBSTET GYN SCAN, V82, P313, DOI 10.1034/j.1600-0412.2003.00085.x; Perreira KM, 2006, AM J PUBLIC HEALTH, V96, P1629, DOI 10.2105/AJPH.2004.056598; PERRY IJ, 1995, BMJ-BRIT MED J, V310, P436, DOI 10.1136/bmj.310.6977.436; Powers RW, 2005, AM J OBSTET GYNECOL, V193, P185, DOI 10.1016/j.ajog.2004.11.038; Prasmusinto D, 2004, EUR J OBSTET GYN R B, V112, P162, DOI 10.1016/S0301-2115(03)00314-2; Roberts J, 2009, PREGNANCY RELATED HY, P650; Tanaka M, 2007, AM J PUBLIC HEALTH, V97, P163, DOI 10.2105/AJPH.2005.068577; TUCK SM, 1983, BRIT J OBSTET GYNAEC, V90, P892, DOI 10.1111/j.1471-0528.1983.tb06759.x; Waldenstrom U, 2014, OBSTET GYNECOL, V123, P104, DOI 10.1097/AOG.0000000000000062; Wang X, 2007, J BIOL CHEM, V282, P1718, DOI 10.1074/jbc.M607610200; Watkins ML, 1996, AM J PUBLIC HEALTH, V86, P731, DOI 10.2105/AJPH.86.5.731; WATTIGNEY WA, 1995, PREV MED, V24, P617, DOI 10.1006/pmed.1995.1097; Williams KP, 1997, J PERINAT MED, V25, P498, DOI 10.1515/jpme.1997.25.6.498; Wolf M, 2004, J AM SOC NEPHROL, V15, P1330, DOI 10.1097/01.ASN.0000125615.35046.59; Zhang F, 2001, AM J HYPERTENS, V14, p62S, DOI 10.1016/S0895-7061(01)02071-4	55	16	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e106446	10.1371/journal.pone.0106446	http://dx.doi.org/10.1371/journal.pone.0106446			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6DY	25337852	Green Submitted, Green Published, gold			2022-12-27	WOS:000343674800002
J	Chen, CL; Teng, YL; Lou, SZ; Lin, CH; Chen, FF; Yeung, KT				Chen, Chiung-Ling; Teng, Ya-Ling; Lou, Shu-Zon; Lin, Chung-Hui; Chen, Fen-Fen; Yeung, Kwok-Tak			User Satisfaction with Orthotic Devices and Service in Taiwan	PLOS ONE			English	Article							ASSISTIVE TECHNOLOGY; PATIENT SATISFACTION; ADOLESCENTS; ORTHOSES; VALIDATION; SCOLIOSIS; VALIDITY; VERSION; BRACE	User satisfaction is afforded considerable importance as an outcome measurement in evidence-based healthcare and the client-centered approach. Several studies have investigated user satisfaction with orthoses. Few studies have investigated user satisfaction with orthoses in Taiwan. Therefore, the purpose of this study was to investigate the user satisfaction with orthotic devices and service using the Taiwanese version of Quebec User Evaluation of Satisfaction with Assistive Technology. We conducted a cross-sectional study of 280 subjects who had used orthoses and received services. The results showed that the mean satisfaction score was 3.74 for the devices and 3.56 for service. Concerning the participants, 69.1% and 59.6% were quite satisfied or very satisfied with their devices and service, respectively. The satisfaction score of orthotic service was lower than that of the devices. Regarding demographic characteristics, participants living in different areas differed only in service score (p = 0.002). The participants living in eastern area and offshore islands were the least satisfied with the orthotic service. For clinical characteristics, there was a significant difference in satisfaction scores among severity of disability (all p = 0.015), types of orthoses (all p = 0.001), and duration of usage (all p = 0.001). The participants with mild disability, wearing the pressure garment and using the orthosis for less than one year, were the most satisfied with their orthotic devices and service. There is a need for improved orthotic devices and services, especially with respect to the comfort of the devices and the provision of subsidy funding.	[Chen, Chiung-Ling; Teng, Ya-Ling; Lou, Shu-Zon; Lin, Chung-Hui; Chen, Fen-Fen; Yeung, Kwok-Tak] Chung Shan Med Univ, Sch Occupat Therapy, Taichung, Taiwan; [Chen, Chiung-Ling; Teng, Ya-Ling; Lou, Shu-Zon; Lin, Chung-Hui; Chen, Fen-Fen; Yeung, Kwok-Tak] Chung Shan Med Univ Hosp, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Yeung, KT (corresponding author), Chung Shan Med Univ, Sch Occupat Therapy, Taichung, Taiwan.	gordon@csmu.edu.tw			Orthotic Prosthetic & Mobility Assistive Device Resource & Promotion Center, Ministry of the Interior in Taiwan	Orthotic Prosthetic & Mobility Assistive Device Resource & Promotion Center, Ministry of the Interior in Taiwan	This study was supported by a grant from the Orthotic Prosthetic & Mobility Assistive Device Resource & Promotion Center, Ministry of the Interior in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsancak S, 2003, PROSTHET ORTHOT INT, V27, P139, DOI 10.1080/03093640308726670; American Academy of Orthotists and Prosthetists, O P TRENDS STAT; Bernhardt KA, 2006, PROSTHET ORTHOT INT, V30, P246, DOI 10.1080/03093640600618818; Borsci S, 2012, ASSIST TECHNOL, P337; Chan SCC, 2006, ASSIST TECHNOL, V18, P25, DOI 10.1080/10400435.2006.10131904; Cheng S, 1996, BURNS, V22, P623, DOI 10.1016/S0305-4179(96)00037-X; Climent JM, 1999, SPINE, V24, P1903, DOI 10.1097/00007632-199909150-00007; Condie DN, 2008, AAOS ATLAS ORTHOSES, P4; Coppard BM, 2008, INTRO SPLINTING CLIN; De Boer IG, 2008, DISABIL REHABIL, V30, P286, DOI 10.1080/09638280701257031; Demers L, 2001, J REHABIL MED, V33, P187, DOI 10.1080/165019701750300663; Demers L, 2000, ASSIST TECHNOL, V12, P96, DOI 10.1080/10400435.2000.10132015; Demers L, 1996, Assist Technol, V8, P3; Demers L., 2002, TECHNOL DISABIL, V14, P101, DOI [10.3233/TAD-2002-14304, DOI 10.3233/TAD-2002-14304]; DeRuyter F, 1995, Assist Technol, V7, P3; Elwood ET, 2005, CLEFT PALATE-CRAN J, V42, P340, DOI 10.1597/04-004.1; Federici S, 2011, ASSIST TECHNOL RES S, V29, P979, DOI 10.3233/978-1-60750-814-4-979; FISHER LR, 1989, PROSTHET ORTHOT INT, V13, P29; Geertzen JHB, 2002, PROSTHET ORTHOT INT, V26, P64, DOI 10.1080/03093640208726623; HALL JA, 1993, MED CARE, V31, P84, DOI 10.1097/00005650-199301000-00007; HALL JA, 1990, SOC SCI MED, V30, P811, DOI 10.1016/0277-9536(90)90205-7; Hovorka CF, 2007, ORTHOTICS PROSTHET, P135; Johnson J, 1994, J Burn Care Rehabil, V15, P180, DOI 10.1097/00004630-199403000-00015; Keith RA, 1998, ARCH PHYS MED REHAB, V79, P1122, DOI 10.1016/S0003-9993(98)90182-4; Lee SJ, 2008, DISABIL REHABIL-ASSI, V3, P344, DOI 10.1080/17483100802281327; MACLEAN WE, 1989, J PEDIATR ORTHOPED, V9, P257; Magnusson L, 2013, J REHABIL MED, V45, P385, DOI 10.2340/16501977-1117; Mao HF, 2010, CLIN REHABIL, V24, P412, DOI 10.1177/0269215509347438; Nielsen C., 2002, ISSUES AFFECTING FUT; Nielsen CC, 2007, ORTHOTICS PROSTHET, P5; Peaco A, 2011, JPO J PROSTHETICS OR, V23, P95, DOI [10.1097/JPO.0b013-318217a0fe, DOI 10.1097/JPO.0B013-318217A0FE]; Sapountzi-Krepia DS, 2001, J ADV NURS, V35, P683, DOI 10.1046/j.1365-2648.2001.01900.x; Stern EB, 1997, ARTHRIT CARE RES, V10, P27, DOI 10.1002/art.1790100105; Tyson SF, 2001, CLIN REHABIL, V15, P53, DOI 10.1191/026921501673858908; Walter JH, 2004, J AM PODIAT MED ASSN, V94, P363, DOI 10.7547/0940363; Wessels RD, 2003, DISABIL REHABIL, V25, P267, DOI 10.1080/0963828021000031197; Wressle E., 2004, SCAND J OCCUP THER, V11, P143, DOI DOI 10.1080/11038120410020728	37	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110661	10.1371/journal.pone.0110661	http://dx.doi.org/10.1371/journal.pone.0110661			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6DY	25338026	Green Published, Green Submitted, gold			2022-12-27	WOS:000343674800067
J	Demuro, M; Arnold, LJ; Pares, JM; Perez-Gonzalez, A; Ortega, AI; Arsuaga, JL; de Castro, JMB; Carbonell, E				Demuro, Martina; Arnold, Lee J.; Pares, Josep M.; Perez-Gonzalez, Alfredo; Ortega, Ana I.; Arsuaga, Juan L.; Bermudez de Castro, Jose M.; Carbonell, Eudald			New Luminescence Ages for the Galeria Complex Archaeological Site: Resolving Chronological Uncertainties on the Acheulean Record of the Sierra de Atapuerca, Northern Spain	PLOS ONE			English	Article							MIDDLE PALEOLITHIC SITE; TT-OSL; LOS-HUESOS; DOSE DISTRIBUTIONS; MULTIPLE GRAINS; CAVE SEDIMENTS; CHINESE LOESS; DE-ATAPUERCA; SOUTH-AFRICA; K-FELDSPARS	The archaeological karstic infill site of Galeria Complex, located within the Atapuerca system (Spain), has produced a large faunal and archaeological record (Homo sp. aff. heidelbergensis fossils and Mode II lithic artefacts) belonging to the Middle Pleistocene. Extended-range luminescence dating techniques, namely post-infrared infrared stimulated luminescence (pIR-IR) dating of K-feldspars and thermally transferred optically stimulated luminescence (TT-OSL) dating of individual quartz grains, were applied to fossil-bearing sediments at Galeria. The luminescence dating results are in good agreement with published chronologies derived using alternative radiometric dating methods (i.e., ESR and U-series dating of bracketing speleothems and combined ESR/U-series dating of herbivore teeth), as well as biochronology and palaeoenvironmental reconstructions inferred from proxy records (e.g., pollen data). For the majority of samples dated, however, the new luminescence ages are significantly (similar to 50%) younger than previously published polymineral thermoluminescence (TL) chronologies, suggesting that the latter may have overestimated the true burial age of the Galeria deposits. The luminescence ages obtained indicate that the top of the basal sterile sands (GIb) at Galeria have an age of up to similar to 370 thousand years (ka), while the lowermost sub-unit containing Mode II Acheulean lithics (base of unit GIIa) was deposited during MIS 9 (mean age = 313 +/- 14 ka; n = 4). The overlying units GIIb-GIV, which contain the richest archaeopalaeontological remains, were deposited during late MIS 8 or early MIS 7 (similar to 240 ka). Galeria Complex may be correlative with other Middle Pleistocene sites from Atapuerca, such as Gran Dolina level TD10 and unit TE19 from Sima del Elefante, but the lowermost archaeological horizons are similar to 100 ka younger than the hominin-bearing clay breccias at the Sima de los Huesos site. Our results suggest that both pIR-IR and single-grain TT-OSL dating are suitable for resolving Middle Pleistocene chronologies for the Sierra de Atapuerca karstic infill sequences.	[Demuro, Martina; Arnold, Lee J.] Univ Adelaide, Inst Photon & Adv Sensing, Sch Chem & Phys, Adelaide, SA, Australia; [Demuro, Martina; Arnold, Lee J.; Pares, Josep M.; Perez-Gonzalez, Alfredo; Ortega, Ana I.; Bermudez de Castro, Jose M.] Ctr Nacl Invest Evoluc Humana, Burgos, Spain; [Arnold, Lee J.] Univ Adelaide, Inst Environm, Adelaide, SA, Australia; [Arnold, Lee J.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia; [Arsuaga, Juan L.] Univ Complutense, Ctr Mixto, Inst Salud Carlos Evoluc & Comportamiento Humanos, E-28040 Madrid, Spain; [Arsuaga, Juan L.] Univ Complutense Madrid, Fac Ciencias Geol, Dept Paleontol, Madrid, Spain; [Carbonell, Eudald] Univ Rovira & Virgili, Inst Catala Paleoecol Humana & Evolucio Social, Area Prehist, E-43007 Tarragona, Spain	University of Adelaide; Centro Nacional de Investigacion de La Evolucion Humana (CENIEH); University of Adelaide; University of Adelaide; Complutense University of Madrid; Complutense University of Madrid; ICREA; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES)	Demuro, M (corresponding author), Univ Adelaide, Inst Photon & Adv Sensing, Sch Chem & Phys, Adelaide, SA, Australia.	martina.demuro@adelaide.edu.au	Demuro, Martina/AAV-9757-2021; Carbonell, Eudald/G-3003-2015; Arnold, Lee J/J-4356-2018; Demuro, Martina/AAD-9985-2019; Ortega, Ana Isabel/B-2498-2017	Demuro, Martina/0000-0002-5799-4216; Arnold, Lee J/0000-0001-9603-3824; Demuro, Martina/0000-0002-5799-4216; Arsuaga, Juan Luis/0000-0001-5361-2295; Ortega, Ana Isabel/0000-0002-4034-0128; Bermudez de Castro, Jose Maria/0000-0003-1314-3273	Ministerio de Economia y Competitividad (Spain) [CGL2010-16821]; Marie Curie Reintegration grant within the 7th European Community Framework Programme [PIRG08-GA-2010-276810]; Australian Research Council (ARC) [FT130100195]; Juan de la Cierva Subprogram [JCI-2010-06792]	Ministerio de Economia y Competitividad (Spain); Marie Curie Reintegration grant within the 7th European Community Framework Programme; Australian Research Council (ARC)(Australian Research Council); Juan de la Cierva Subprogram	JMP, LJA and MD were financially supported by a grant (CGL2010-16821) from the Ministerio de Economia y Competitividad (Spain). MD was supported by a Marie Curie Reintegration grant (PIRG08-GA-2010-276810) within the 7th European Community Framework Programme. LA received additional support from an Australian Research Council (ARC) Future Fellowship grant (FT130100195). AIO has been supported by a postdoctoral grant from Juan de la Cierva Subprogram (JCI-2010-06792). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamiec G, 2010, RADIAT MEAS, V45, P768, DOI 10.1016/j.radmeas.2010.03.009; Aguirre E, 1987, HOMBRE FOSIL IBEAS P, P201; Aitken M.J., 1998, INTRO OPTICAL DATING; Aitken MJ, 1985, THERMOLUMINESCENCE D; Alappat L, 2010, GEOCHRONOMETRIA, V37, P37, DOI 10.2478/v10003-010-0025-1; Aleixandre T., 1999, CONTRIBUCION ESTUDIO, P231; Arnold LJ, 2007, QUAT GEOCHRONOL, V2, P162, DOI 10.1016/j.quageo.2006.05.003; Arnold LJ, 2012, RADIAT MEAS, V47, P6, DOI 10.1016/j.radmeas.2011.09.001; Arnold LJ, 2009, QUAT GEOCHRONOL, V4, P204, DOI 10.1016/j.quageo.2008.12.001; Arnold LJ, 2014, J HUM EVOL, V67, P85, DOI 10.1016/j.jhevol.2013.12.001; Arnold LJ, 2013, BOREAS, V42, P285, DOI 10.1111/j.1502-3885.2012.00262.x; Arnold LJ, 2014, QUAT INT IN PRESS; Arsuaga JL, 2014, SCIENCE, V344, P1358, DOI 10.1126/science.1253958; Arsuaga J.L., 1999, ATAPUERCA OCUPACIONE, V7, P233; Arsuaga JL, 1997, J HUM EVOL, V33, P109, DOI 10.1006/jhev.1997.0132; Auclair M, 2003, RADIAT MEAS, V37, P487, DOI 10.1016/S1350-4487(03)00018-0; Bailey RM, 2006, QUATERNARY SCI REV, V25, P2475, DOI 10.1016/j.quascirev.2005.09.012; Banerjee D, 2001, RADIAT MEAS, V33, P73, DOI 10.1016/S1350-4487(00)00101-3; Benito-Calvo A, 2008, EARTH SURF PROC LAND, V33, P196, DOI 10.1002/esp.1534; Berger GW, 2008, J HUM EVOL, V55, P300, DOI 10.1016/j.jhevol.2008.02.012; Bowler JM, 2003, NATURE, V421, P837, DOI 10.1038/nature01383; Brennan BJ, 2003, RADIAT MEAS, V37, P299, DOI 10.1016/S1350-4487(03)00011-8; Buylaert JP, 2009, RADIAT MEAS, V44, P560, DOI 10.1016/j.radmeas.2009.02.007; Buylaert JP, 2012, BOREAS, V41, P435, DOI 10.1111/j.1502-3885.2012.00248.x; Buylaert JP, 2011, GEOCHRONOMETRIA, V38, P432, DOI 10.2478/s13386-011-0047-0; Carbonell E, 2008, NATURE, V452, P465, DOI 10.1038/nature06815; Clark-Balzan LA, 2012, QUAT GEOCHRONOL, V12, P53, DOI 10.1016/j.quageo.2012.06.006; Constantin S, 2013, QUATERN INT, V339-340, P25; Cuenca-Bescos G., 1999, ATAPUERCA OCUPACIONE, P189; Cuenca-Bescos G, 2010, QUATERN INT, V212, P109, DOI 10.1016/j.quaint.2009.06.007; deCastro JMB, 1997, SCIENCE, V276, P1392; Demeter F, 2012, P NATL ACAD SCI USA, V109, P14375, DOI 10.1073/pnas.1208104109; Duller GAT, 2012, QUAT GEOCHRONOL, V7, P6, DOI 10.1016/j.quageo.2011.09.003; Duller GAT, 2003, RADIAT MEAS, V37, P161, DOI 10.1016/S1350-4487(02)00170-1; Duller GAT, 2008, BOREAS, V37, P589, DOI 10.1111/j.1502-3885.2008.00051.x; Falgueres C, 1999, J HUM EVOL, V37, P343, DOI 10.1006/jhev.1999.0326; Falgueres C, 2001, ANTHROPOLOGIE, V105, P71; Falgueres C., 1986, THESIS; Falgueres C, 2013, J HUM EVOL, V65, P168, DOI 10.1016/j.jhevol.2013.05.005; Feathers JK, 2012, RADIAT MEAS, V47, P201, DOI 10.1016/j.radmeas.2012.01.003; Forman S. L., 1989, QUATERN INT, V1, P47, DOI DOI 10.1016/1040-6182(89)90008-6; Gaar D, 2012, QUAT GEOCHRONOL, V10, P257, DOI 10.1016/j.quageo.2012.02.007; Galbraith RF, 2012, QUAT GEOCHRONOL, V11, P1, DOI 10.1016/j.quageo.2012.04.020; GALBRAITH RF, 1990, NUCL TRACKS RAD MEAS, V17, P197; Galbraith RF, 1999, ARCHAEOMETRY, V41, P339, DOI 10.1111/j.1475-4754.1999.tb00987.x; Garcia-Medrano P, 2014, QUAT INT IN PRESS; GARCIAANTON M, 1991, PALAEOGEOGR PALAEOCL, V85, P199, DOI 10.1016/0031-0182(91)90159-O; Gil E., 1987, HOMBRE FOSIL IBEAS P; Gliganic LA, 2012, ARCHAEOL ANTHROP SCI, V4, P115, DOI 10.1007/s12520-011-0085-9; GODFREYSMITH DI, 1988, QUATERNARY SCI REV, V7, P373, DOI 10.1016/0277-3791(88)90032-7; Goldberg P, 2006, EVOL ANTHROPOL, V15, P20, DOI 10.1002/evan.20094; Grun R., 1987, HOMBRE FOSIL IBEAS P, P201; Guerin G, 2011, ANCIENT TL, V29, P5; Hoffmann DL, 2013, QUATERN INT, V294, P168, DOI 10.1016/j.quaint.2012.05.027; Huntley D.J., 2001, ANCIENT TL, V19, P43; Huntley D.J., 1997, ANCIENT TL, V15, P11; Huntley DJ, 1996, QUATERNARY RES, V46, P127, DOI 10.1006/qres.1996.0053; Huntley DJ, 2001, CAN J EARTH SCI, V38, P1093, DOI 10.1139/e01-013; Huntley DJ., 1999, HOLOCENE CLIMATE ENV, P211; Huntley DJ, 1999, ATAPUERCA OCUPACIONE, V534, P211; Jacobs Z, 2008, J ARCHAEOL SCI, V35, P1808, DOI 10.1016/j.jas.2007.11.027; Jacobs Z, 2007, EVOL ANTHROPOL, V16, P210, DOI 10.1002/evan.20150; Jacobs Z, 2006, J HUM EVOL, V51, P255, DOI 10.1016/j.jhevol.2006.03.007; Jacobs Z, 2011, QUAT GEOCHRONOL, V6, P491, DOI 10.1016/j.quageo.2011.04.003; Karkanas P, 2000, J ARCHAEOL SCI, V27, P915, DOI 10.1006/jasc.1999.0506; Kars RH, 2012, QUAT GEOCHRONOL, V12, P74, DOI 10.1016/j.quageo.2012.05.001; Lang A, 2003, QUATERNARY SCI REV, V22, P953, DOI 10.1016/S0277-3791(03)00035-0; Lang A, 1997, QUATERNARY SCI REV, V16, P393, DOI 10.1016/S0277-3791(96)00106-0; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Lopez-Garcia JM, 2011, GEOL ACTA, V9, P29, DOI 10.1344/105.000001644; Lowick SE, 2012, QUAT GEOCHRONOL, V8, P33, DOI 10.1016/j.quageo.2011.12.003; Arsuaga JL, 2012, J HUM EVOL, V62, P629, DOI 10.1016/j.jhevol.2012.02.002; Castro JMB, 2013, QUATERNARY SCI REV, V76, P53, DOI 10.1016/j.quascirev.2013.06.023; Martin-Chivelet J, 2011, GLOBAL PLANET CHANGE, V77, P1, DOI 10.1016/j.gloplacha.2011.02.002; MEJDAHL V, 1979, ARCHAEOMETRY, V21, P61, DOI 10.1111/j.1475-4754.1979.tb00241.x; Mejdahl V., 1987, ANCIENT TL, V5, P10; Meyer M, 2014, NATURE, V505, P403, DOI 10.1038/nature12788; Michel V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082394; Moncel MH, 2011, CURR ANTHROPOL, V52, P37, DOI 10.1086/658179; Monnier GF, 2006, CURR ANTHROPOL, V47, P709, DOI 10.1086/506280; Mosquera M, 2013, QUATERN INT, V295, P130, DOI 10.1016/j.quaint.2012.01.031; Muttoni G, 2010, PALAEOGEOGR PALAEOCL, V296, P79, DOI 10.1016/j.palaeo.2010.06.016; Olle A, 1999, ATAPUERCA OCUPACIONE, P55; OLLE A, 2005, BAR INT SERIES S, V1364, P269; Olle A, 2013, QUATERN INT, V295, P138, DOI 10.1016/j.quaint.2011.11.009; Ortega AI, 2013, GEOMORPHOLOGY, V196, P122, DOI 10.1016/j.geomorph.2012.05.031; Ortega A.I., 2009, THESIS; Pares JM, 2013, J ARCHAEOL SCI, V40, P4586, DOI 10.1016/j.jas.2013.06.013; Perez-Gonzalez A, 2001, ANTHROPOLOGIE, V105, P27; Perez-Gonzalez A., 1999, ATAPUERCA OCUPACIONE, P31; Perez-Gonzalez A., 1995, EVOLUCION HUMANA EUR; Pickering R, 2013, QUATERNARY SCI REV, V65, P39, DOI 10.1016/j.quascirev.2012.12.016; Porat N, 2009, RADIAT MEAS, V44, P538, DOI 10.1016/j.radmeas.2008.12.004; PRESCOTT JR, 1994, RADIAT MEAS, V23, P497, DOI 10.1016/1350-4487(94)90086-8; Readhead M.L., 2002, ANCIENT TL, V20, P25; Rees-Jones J, 1995, ANCIENT TL, V13, P9; ReesJones J, 1997, ARCHAEOMETRY, V39, P177, DOI 10.1111/j.1475-4754.1997.tb00797.x; Rink WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054608; Roberts DL, 2012, EARTH PLANET SC LETT, V357, P226, DOI 10.1016/j.epsl.2012.09.006; Roberts HM, 2012, RADIAT MEAS, V47, P716, DOI 10.1016/j.radmeas.2012.03.022; Rodriguez J, 2011, QUATERNARY SCI REV, V30, P1396, DOI 10.1016/j.quascirev.2010.02.021; Rosas A., 1999, ATAPUERCA OCUPACIONE, V7, P237; ROSAS A., 1999, ATAPUERCA OCUPACIONE, V7, P377; Rosas Antonio, 1998, Revista Espanola de Paleontologia, V13, P71; Santonja M., 2006, AXE AGE ACHEULIAN TO, P429; Santonja M, 2014, J ARCHAEOL SCI, V49, P556, DOI 10.1016/j.jas.2014.06.003; Santonja M, 2010, QUATERN INT, V223, P154, DOI 10.1016/j.quaint.2010.02.010; Shahack-Gross R, 2004, J ARCHAEOL SCI, V31, P1259, DOI 10.1016/j.jas.2004.02.004; Sohbati R, 2012, BOREAS, V41, P250, DOI 10.1111/j.1502-3885.2011.00230.x; Stevens T, 2009, RADIAT MEAS, V44, P639, DOI 10.1016/j.radmeas.2009.02.015; Sun XF, 2013, QUATERNARY RES, V79, P168, DOI 10.1016/j.yqres.2012.10.003; Sun XF, 2010, QUAT GEOCHRONOL, V5, P342, DOI 10.1016/j.quageo.2009.05.004; Thiel C, 2010, QUATERN INT, V222, P36, DOI 10.1016/j.quaint.2009.12.020; Thomsen KJ, 2008, RADIAT MEAS, V43, P414, DOI 10.1016/j.radmeas.2008.01.003; Thomsen KJ, 2008, RADIAT MEAS, V43, P1474, DOI 10.1016/j.radmeas.2008.06.002; Tsukamoto S, 2008, RADIAT MEAS, V43, P1204, DOI 10.1016/j.radmeas.2008.02.018; Van der Made J., 1999, ARQUEOLOGIA CASTILLA, P143; Vasiliniuc S, 2012, QUAT GEOCHRONOL, V10, P75, DOI 10.1016/j.quageo.2012.02.014; Villa P, 2009, SOURCEBOOK OF PALEOLITHIC TRANSITIONS, P265, DOI 10.1007/978-0-387-76487-0_17; Wang XL, 2006, RADIAT MEAS, V41, P649, DOI 10.1016/j.radmeas.2006.01.001; White WB, 2007, J CAVE KARST STUD, V69, P76; WINTLE AG, 1993, GEOLOGY, V21, P568, DOI 10.1130/0091-7613(1993)021<0568:DLUTKB>2.3.CO;2; Wintle AG, 1997, RADIAT MEAS, V27, P769, DOI 10.1016/S1350-4487(97)00220-5	123	62	62	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110169	10.1371/journal.pone.0110169	http://dx.doi.org/10.1371/journal.pone.0110169			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AR6DY	25338076	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000343674800026
J	Moreira, DD; Leite, GR; de Siqueira, MF; Coutinho, BR; Zanon, MS; Mendes, SL				Moreira, Danielle de Oliveira; Leite, Gustavo Rocha; de Siqueira, Marinez Ferreira; Coutinho, Bruno Rocha; Zanon, Mariana Santos; Mendes, Sergio Lucena			The Distributional Ecology of the Maned Sloth: Environmental Influences on Its Distribution and Gaps in Knowledge	PLOS ONE			English	Article							SPECIES GEOGRAPHIC DISTRIBUTIONS; BRADYPUS-TORQUATUS XENARTHRA; SPINY POCKET MICE; ATLANTIC FOREST; DISTRIBUTION MODELS; CONSERVATION STATUS; PREDICTION; EVOLUTION; MAMMALIA; IMPROVE	The maned sloth Bradypus torquatus (Pilosa, Bradypodidae) is endemic to a small area in the Atlantic Forest of coastal Brazil. It has been listed as a threatened species because of its restricted geographic range, habitat loss and fragmentation, and declining populations. The major objectives of this study were to estimate its potential geographic distribution, the climatic conditions across its distributional range, and to identify suitable areas and potential species strongholds. We developed a model of habitat suitability for the maned sloth using two methods, Maxent and Mahalanobis Distance, based on 42 occurrence points. We evaluated environmental variable importance and the predictive ability of the generated distribution models. Our results suggest that the species distribution could be strongly influenced by environmental factors, mainly temperature seasonality. The modeled distribution of the maned sloth included known areas of occurrence in the Atlantic Forest (Sergipe, Bahia, Espirito Santo, and Rio de Janeiro), but did not match the observed distributional gaps in northern Rio de Janeiro, northern Espirito Santo or southern Bahia. Rather, the model showed that these areas are climatically suitable for the maned sloth, and thus suggests that factors other than climate might be responsible for the absence of species. Suitable areas for maned sloth were located mainly in the mountainous region of central Rio de Janeiro throughout Espirito Santo and to the coastal region of southern Bahia. We indicate 17 stronghold areas and recommended survey areas for the maned sloth. In addition, we highlight specific areas for conservation, including the current network protected areas. Our results can be applied for novel surveys and discovery of unknown populations, and help the selection of priority areas for management and conservation planning, especially of rare and relatively cryptic species directed associated with forested habitats.	[Moreira, Danielle de Oliveira; Zanon, Mariana Santos; Mendes, Sergio Lucena] Univ Fed Espirito Santo, Dept Ciencias Biol, Programa Posgrad Ciencias Biol Biol Anim, Vitoria, ES, Brazil; [Leite, Gustavo Rocha] Univ Fed Espirito Santo, Dept Patol, Unidade Med Trop, Vitoria, ES, Brazil; [de Siqueira, Marinez Ferreira] Inst Pesquisas Jardim Bot Rio de Janeiro, Inst Pesquisas, Rio De Janeiro, Brazil; [Coutinho, Bruno Rocha] Minist Meio Ambiente, Secretaria Extrativismo & Desenvolvimento Rural S, Brasilia, DF, Brazil	Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo; Jardim Botanico do Rio de Janeiro	Moreira, DD (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	daniomoreira@gmail.com	Leite, Gustavo/H-1292-2012; de Siqueira, Marinez Ferreira/I-9205-2012; Coutinho, Bruno/HHM-5631-2022; Moreira, Danielle/X-5046-2019	Leite, Gustavo/0000-0003-4320-3804; de Siqueira, Marinez Ferreira/0000-0002-6869-0293; Coutinho, Bruno/0000-0002-9980-1857; Moreira, Danielle/0000-0002-5968-9573				Aguiar JM, 2004, EDENTATA, V2004, P3; Allouche O, 2008, J APPL ECOL, V45, P599, DOI 10.1111/j.1365-2664.2007.01445.x; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Anderson RP, 2010, J BIOGEOGR, V37, P1378, DOI 10.1111/j.1365-2699.2010.02290.x; Anderson RP, 2002, GLOBAL ECOL BIOGEOGR, V11, P131, DOI 10.1046/j.1466-822X.2002.00275.x; Anderson RP, 2001, P BIOL SOC WASH, V114, P1; Anderson RP, 2004, BIOL CONSERV, V116, P167, DOI 10.1016/S0006-3207(03)00187-3; Boffy ACM, 2010, EDENTATA, V11, P78, DOI DOI 10.1896/020.011.0115; Cayuela L, 2009, TROP CONSERV SCI, V2, P319, DOI 10.1177/194008290900200304; Chagas Renata Rocha Deda, 2009, Edentata, V8-10, P21; Chiarello A.G., 2014, IUCN RED LIST THREAT; Chiarello AG, 2004, BIOL CONSERV, V118, P421, DOI 10.1016/j.biocon.2003.09.019; Chiarello AG, 1998, J ZOOL, V246, P1; da Silva Guilherme C., 2001, Revista Brasileira de Botanica, V24, P51, DOI 10.1590/S0100-84042001000100006; Pena JCD, 2014, BIOL CONSERV, V170, P130, DOI 10.1016/j.biocon.2013.12.015; de Moraes-Barros N, 2006, GENETICA, V126, P189, DOI 10.1007/s10709-005-1448-x; Dias BB, 2009, J ETHOL, V27, P97, DOI 10.1007/s10164-008-0089-9; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; EMMONS LH, 1990, NEOTROPICAL RAINFORE; Farber O, 2003, ECOL MODEL, V160, P115, DOI 10.1016/S0304-3800(02)00327-7; Fonseca GAB, 2004, EDENTATA, V6, P3; Fundacao SOS Mata Atlantica & Instituto Nacional de Pesquisas Espaciais, 2013, ATL REM FLOR MAT ATL; Garay I, 2003, FLORESTA ATLANTICA T; Gardner A.L., 2007, MAMMALS S AM MARSUPI; Gardner A.L., 2007, MAMMALS S AM; Gaubert P, 2006, BIOL CONSERV, V130, P106, DOI 10.1016/j.biocon.2005.12.006; Genard M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079948; Gilmore DP, 2000, BRAZ J MED BIOL RES, V33, P129, DOI 10.1590/S0100-879X2000000200001; Graham CH, 2008, J APPL ECOL, V45, P239, DOI 10.1111/j.1365-2664.2007.01408.x; Guisan A, 2006, CONSERV BIOL, V20, P501, DOI 10.1111/j.1523-1739.2006.00354.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirsch A, 2012, MAMMAL REV, V42, P35, DOI 10.1111/j.1365-2907.2011.00188.x; IBGE [Instituto Brasileiro de Geografia e Estatistica], 2002, MAP VEG BRAS ATL NAC; IBGE-INSTITUTO BRASILEIRO DE GEOGRAFIA E ESTATiSTICA, 1992, MAP VEG BRAS; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; Janekovi F, 2012, PRINCIPAL COMPONENT, P127; Jenkins CN, 2013, P NATL ACAD SCI USA, V110, pE2602, DOI 10.1073/pnas.1302251110; Jones CC, 2010, ECOL APPL, V20, P311, DOI 10.1890/08-2261.1; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; Lara-Ruiz P, 2004, EDENTATA, V6, P54; Lara-Ruiz P, 2008, BIOL CONSERV, V141, P1332, DOI 10.1016/j.biocon.2008.03.002; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lobo JM, 2011, J NAT CONSERV, V19, P1, DOI 10.1016/j.jnc.2010.03.002; Loiselle BA, 2003, CONSERV BIOL, V17, P1591, DOI 10.1111/j.1523-1739.2003.00233.x; Machado ABM, 2008, LIVRO VERMELHO FAUNA; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; Mateo-Tomas P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012374; Ferraz KMPMD, 2012, NAT CONSERVACAO, V10, P214, DOI 10.4322/natcon.2012.032; Michel MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044932; Morellato LPC, 2000, BIOTROPICA, V32, P786, DOI 10.1111/j.1744-7429.2000.tb00618.x; Morueta-Holme N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010360; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Newbold T, 2010, PROG PHYS GEOG, V34, P3, DOI 10.1177/0309133309355630; Oliver WLR, 1991, THREATENED ENDEMIC M; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Papes M, 2007, DIVERS DISTRIB, V13, P890, DOI 10.1111/j.1472-4642.2007.00392.x; Parsons PA, 2005, BIOL REV, V80, P589, DOI 10.1017/S1464793105006822; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peixoto AL, 2007, ESPECIES FLORA AMEAC, P33; Peterson A. T., 2011, ECOLOGICAL NICHES GE; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2001, CONDOR, V103, P599, DOI 10.1650/0010-5422(2001)103[0599:PSGDBO]2.0.CO;2; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Pinder L, 1986, CONSERVATION M UNPUB; Ponder WF, 2001, CONSERV BIOL, V15, P648, DOI 10.1046/j.1523-1739.2001.015003648.x; Rizzini CT, 1997, TRATADO FITOGEOGRAFI; RUSCHI A, 1950, B MUSEU BIOL MELLO L, V1, P1; Siqueira Marinez Ferreira de, 2007, Braz. J. Bot., V30, P233, DOI 10.1590/S0100-84042007000200008; Thorn JS, 2009, DIVERS DISTRIB, V15, P289, DOI 10.1111/j.1472-4642.2008.00535.x; Tranter G, 2009, GEODERMA, V149, P421, DOI 10.1016/j.geoderma.2009.01.006; Veloso HP, 1991, MANUAL TECNICO VEGET; Wetzel R.M., 1985, P5; Wetzel RM, 1982, SPECIAL PUBLICATION, P345	76	12	12	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110929	10.1371/journal.pone.0110929	http://dx.doi.org/10.1371/journal.pone.0110929			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338139	Green Published, Green Submitted, gold			2022-12-27	WOS:000343674800090
J	Schweizer, M; Aye, R; Kashkarov, R; Roth, T				Schweizer, Manuel; Aye, Raffael; Kashkarov, Roman; Roth, Tobias			Conservation Action Based on Threatened Species Capture Taxonomic and Phylogenetic Richness in Breeding and Wintering Populations of Central Asian Birds	PLOS ONE			English	Article							EVOLUTIONARY DIVERSITY; RED LIST; AREAS; EXTINCTION; SELECTION; PATTERNS	Although phylogenetic diversity has been suggested to be relevant from a conservation point of view, its role is still limited in applied nature conservation. Recently, the practice of investing conservation resources based on threatened species was identified as a reason for the slow integration of phylogenetic diversity in nature conservation planning. One of the main arguments is based on the observation that threatened species are not evenly distributed over the phylogenetic tree. However this argument seems to dismiss the fact that conservation action is a spatially explicit process, and even if threatened species are not evenly distributed over the phylogenetic tree, the occurrence of threatened species could still indicate areas with above average phylogenetic diversity and consequently could protect phylogenetic diversity. Here we aim to study the selection of important bird areas in Central Asia, which were nominated largely based on the presence of threatened bird species. We show that although threatened species occurring in Central Asia do not capture phylogenetically more distinct species than expected by chance, the current spatially explicit conservation approach of selecting important bird areas covers above average taxonomic and phylogenetic diversity of breeding and wintering birds. We conclude that the spatially explicit processes of conservation actions need to be considered in the current discussion of whether new prioritization methods are needed to complement conservation action based on threatened species.	[Schweizer, Manuel] Nat Hist Museum Burgergemeinde Bern, Bern, Switzerland; [Aye, Raffael] SVS BirdLife Switzerland, Zurich, Switzerland; [Kashkarov, Roman] Natl Univ Uzbekistan, Tashkent, Uzbekistan; [Kashkarov, Roman] Uzbekistan Soc Protect Birds, Tashkent, Uzbekistan; [Roth, Tobias] Univ Basel, Inst Zool, CH-4051 Basel, Switzerland; [Roth, Tobias] Hintermann & Weber AG, Reinach, Switzerland	National University of Uzbekistan; University of Basel	Schweizer, M (corresponding author), Nat Hist Museum Burgergemeinde Bern, Bern, Switzerland.	manuel.schweizer@nmbe.ch	Roth, Tobias/H-7927-2019	Roth, Tobias/0000-0001-9742-8297	Basler Stiftung fur Biologische Forschung; SchweizerischeVogelwarte/Arcatours Fonds	Basler Stiftung fur Biologische Forschung; SchweizerischeVogelwarte/Arcatours Fonds	The Basler Stiftung fur Biologische Forschung and the SchweizerischeVogelwarte/Arcatours Fonds provided financial support for the data collection relevant to this study. TR is working for the commercial company Hintermann & Weber AG. Hintermann & Weber AG provided support in the form of salary for author TR. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of TR is articulated in the 'author contributions' section.	Ay? R., 2012, BIRDS CENTRAL ASIA; Aye Raffael, 2013, Ornithologische Beobachter, V110, P465; Aye R, 2010, J AVIAN BIOL, V41, P452, DOI 10.1111/j.1600-048X.2010.05031.x; Breckle S.W., 2007, BASIC APPLDRYLAND RE, V1, P155, DOI DOI 10.1127/BADR/1/2007/155; Brodier S, 2014, ANIM CONSERV, V17, P204, DOI 10.1111/acv.12077; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Butchart SHM, 2012, PLOS ONE, V7; Cadotte MW, 2012, ECOLOGY, V93, pS223, DOI 10.1890/11-0426.1; Caro T. M, 2010, CONSERVATION PROXY I; Carvalho SB, 2011, DIVERS DISTRIB, V17, P408, DOI 10.1111/j.1472-4642.2011.00752.x; Devictor V, 2010, ECOL LETT, V13, P1030, DOI 10.1111/j.1461-0248.2010.01493.x; Eken G, 2004, BIOSCIENCE, V54, P1110, DOI 10.1641/0006-3568(2004)054[1110:KBAASC]2.0.CO;2; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Harris DJ, 2013, TRENDS ECOL EVOL, V28, P321, DOI 10.1016/j.tree.2013.03.006; Hecker S, 2008, PIPING PLOVER UMBREL; Hidasi-Neto J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073431; Hijmans RJ, 2013, RASTER GEOGRAPHIC DA; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; IUCN, 2013, RED LIST THREAT SPEC; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Kamp J, 2011, BIOL CONSERV, V144, P2607, DOI 10.1016/j.biocon.2011.07.010; Kashkarov R, 2008, IMPORTANT BIRD AREAS; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Morlon H, 2011, ECOL LETT, V14, P141, DOI 10.1111/j.1461-0248.2010.01563.x; Mouquet N, 2012, BIOL REV, V87, P769, DOI 10.1111/j.1469-185X.2012.00224.x; Murray KA, 2014, GLOBAL CHANGE BIOL, V20, P483, DOI 10.1111/gcb.12366; Osieck ER, 1981, IMPORTANT BIRD AREAS; Pakkala T, 2003, WILDLIFE BIOL, V9, P309, DOI 10.2981/wlb.2003.019; Possingham HP, 2002, TRENDS ECOL EVOL, V17, P503, DOI 10.1016/S0169-5347(02)02614-9; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Redding DW, 2006, CONSERV BIOL, V20, P1670, DOI 10.1111/j.1523-1739.2006.00555.x; Robertson MP, 2010, DIVERS DISTRIB, V16, P363, DOI 10.1111/j.1472-4642.2010.00639.x; Rodrigues ASL, 2005, CONSERV BIOL SER, V8, P101; Rodrigues ASL, 2002, BIOL CONSERV, V105, P103, DOI 10.1016/S0006-3207(01)00208-7; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Rolland J, 2012, BIOL LETTERS, V8, P692, DOI 10.1098/rsbl.2011.1024; Rosauer DF, 2013, TRENDS ECOL EVOL, V28, P322, DOI 10.1016/j.tree.2013.01.014; Safi K, 2011, PHILOS T R SOC B, V366, P2536, DOI 10.1098/rstb.2011.0024; Schatz GE, 2009, TRENDS PLANT SCI, V14, P638, DOI 10.1016/j.tplants.2009.08.012; Schweiger O, 2008, OECOLOGIA, V157, P485, DOI 10.1007/s00442-008-1082-2; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; Sklyarenko S., 2008, IMPORTANT BIRD AREAS; Team QDC, 2013, QGIS GEOGR INF SYST; Warwick RM, 1998, J APPL ECOL, V35, P532, DOI 10.1046/j.1365-2664.1998.3540532.x; Williams P, 1996, CONSERV BIOL, V10, P155, DOI 10.1046/j.1523-1739.1996.10010155.x; Winter M, 2013, TRENDS ECOL EVOL, V28, P323, DOI 10.1016/j.tree.2013.02.011; Winter M, 2013, TRENDS ECOL EVOL, V28, P199, DOI 10.1016/j.tree.2012.10.015; Zingg S, 2010, ARDEA, V98, P67, DOI 10.5253/078.098.0109; [No title captured]	51	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110511	10.1371/journal.pone.0110511	http://dx.doi.org/10.1371/journal.pone.0110511			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337861	Green Submitted, Green Published, gold			2022-12-27	WOS:000343674800051
J	Wielstra, B; Arntzen, JW; van der Gaag, KJ; Pabijan, M; Babik, W				Wielstra, Ben; Arntzen, Jan W.; van der Gaag, Kristiaan J.; Pabijan, Maciej; Babik, Wieslaw			Data Concatenation, Bayesian Concordance and Coalescent-Based Analyses of the Species Tree for the Rapid Radiation of Triturus Newts	PLOS ONE			English	Article							CRESTED NEWTS; GENE FLOW; MITOCHONDRIAL-DNA; MULTIPLE NUCLEAR; CRISTATUS; ACCURACY; RECONSTRUCTION; PHYLOGEOGRAPHY; SYSTEMATICS; PHYLOGENY	The phylogenetic relationships for rapid species radiations are difficult to disentangle. Here we study one such case, namely the genus Triturus, which is composed of the marbled and crested newts. We analyze data for 38 genetic markers, positioned in 3-prime untranslated regions of protein-coding genes, obtained with 454 sequencing. Our dataset includes twenty Triturus newts and represents all nine species. Bayesian analysis of population structure allocates all individuals to their respective species. The branching patterns obtained by data concatenation, Bayesian concordance analysis and coalescent-based estimations of the species tree differ from one another. The data concatenation based species tree shows high branch support but branching order is considerably affected by allele choice in the case of heterozygotes in the concatenation process. Bayesian concordance analysis expresses the conflict between individual gene trees for part of the Triturus species tree as low concordance factors. The coalescent-based species tree is relatively similar to a previously published species tree based upon morphology and full mtDNA and any conflicting internal branches are not highly supported. Our findings reflect high gene tree discordance due to incomplete lineage sorting (possibly aggravated by hybridization) in combination with low information content of the markers employed (as can be expected for relatively recent species radiations). This case study highlights the complexity of resolving rapid radiations and we acknowledge that to convincingly resolve the Triturus species tree even more genes will have to be consulted.	[Wielstra, Ben; Arntzen, Jan W.] Nat Biodivers Ctr, Leiden, Netherlands; [Wielstra, Ben] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [van der Gaag, Kristiaan J.] Leiden Univ, Med Ctr, Forens Lab DNA Res, Leiden, Netherlands; [Pabijan, Maciej; Babik, Wieslaw] Jagiellonian Univ, Inst Environm Sci, Krakow, Poland; [Pabijan, Maciej] Jagiellonian Univ, Inst Zool, PL-30060 Krakow, Poland	Naturalis Biodiversity Center; University of Sheffield; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Jagiellonian University; Jagiellonian University	Wielstra, B (corresponding author), Nat Biodivers Ctr, Leiden, Netherlands.	b.wielstra@sheffield.ac.uk	Wielstra, Ben/G-3773-2015; Arntzen, Jan/E-7108-2016	Wielstra, Ben/0000-0002-7112-5965; Arntzen, Jan/0000-0003-3229-5993; Babik, Wieslaw/0000-0002-1698-6615; van der Gaag, Kristiaan/0000-0001-7976-1977	Natural Environmental Research Council, UK	Natural Environmental Research Council, UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	*BEAST was run on the molecol-ICEBERG high performance computing cluster of the NERC Biomolecular Analysis Facility at the University of Sheffield, which is funded by the Natural Environmental Research Council, UK. We thank K. Hendriks, C. Kuepper, C. McInerney and V. Soria-Carrasco for help with data analysis.	Ane C, 2007, MOL BIOL EVOL, V24, P412; Arntzen JW, 2008, J BIOGEOGR, V35, P1177, DOI 10.1111/j.1365-2699.2007.01875.x; Arntzen JW, 2007, CONTRIB ZOOL, V76, P261, DOI 10.1163/18759866-07604005; Arntzen JW, 2010, AMPHIBIA-REPTILIA, V31, P311; Arntzen JW, 2014, BIOL J LINN SOC, V113, P604, DOI 10.1111/bij.12358; Arntzen JW, 1999, J HERPETOL, V33, P567, DOI 10.2307/1565573; ARNTZEN JW, 1991, EVOLUTION, V45, P805, DOI 10.1111/j.1558-5646.1991.tb04352.x; Arntzen JW, 2003, HDB REPTILIEN AMPHIB, VIIA, P421, DOI DOI 10.2307/1565573; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Baum DA, 2007, TAXON, V56, P417, DOI 10.1002/tax.562013; Belfiore NM, 2008, SYST BIOL, V57, P294, DOI 10.1080/10635150802044011; Carstens B, 2012, SYST BIOL, V61, P713, DOI 10.1093/sysbio/sys050; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Eckert AJ, 2008, MOL PHYLOGENET EVOL, V49, P832, DOI 10.1016/j.ympev.2008.09.008; Edwards SV, 2007, P NATL ACAD SCI USA, V104, P5936, DOI 10.1073/pnas.0607004104; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Glor RE, 2010, ANNU REV ECOL EVOL S, V41, P251, DOI 10.1146/annurev.ecolsys.39.110707.173447; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Huang HT, 2010, SYST BIOL, V59, P573, DOI 10.1093/sysbio/syq047; Kubatko LS, 2007, SYSTEMATIC BIOL, V56, P17, DOI 10.1080/10635150601146041; Kutschera VE, 2014, MOL BIOL EVOL, V31, P2004, DOI 10.1093/molbev/msu186; Lanier HC, 2014, MOL PHYLOGENET EVOL, V70, P112, DOI 10.1016/j.ympev.2013.09.006; Larget BR, 2010, BIOINFORMATICS, V26, P2910, DOI 10.1093/bioinformatics/btq539; Leache AD, 2014, SYST BIOL, V63, P17, DOI 10.1093/sysbio/syt049; Leache AD, 2011, SYST BIOL, V60, P126, DOI 10.1093/sysbio/syq073; Lemmon AR, 2009, SYST BIOL, V58, P130, DOI 10.1093/sysbio/syp017; Lemmon EM, 2013, ANNU REV ECOL EVOL S, V44, P99, DOI 10.1146/annurev-ecolsys-110512-135822; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lischer HEL, 2014, MOL BIOL EVOL, V31, P817, DOI 10.1093/molbev/mst271; Maddison D. R., 2005, MACCLADE 4 08A ANAL, DOI [DOI 10.1046/J.1420-9101.1996.9020153.X, DOI 10.1007/s13592-012-0141-1]; Miller M.A., 2010, P GAT COMP ENV WORKS; Ronquist F., 2012, SYST BIOL; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Stuglik MT, 2014, ECOL EVOL, V4, P623, DOI 10.1002/ece3.965; Themudo GE, 2009, MOL PHYLOGENET EVOL, V52, P321, DOI 10.1016/j.ympev.2009.03.024; Weisrock DW, 2012, MOL BIOL EVOL, V29, P1615, DOI 10.1093/molbev/mss008; Whitfield JB, 2007, TRENDS ECOL EVOL, V22, P258, DOI 10.1016/j.tree.2007.01.012; Wielstra B, 2014, MOL ECOL RESOUR, V14, P1080, DOI 10.1111/1755-0998.12242; Wielstra B, 2013, ZOOTAXA, V3682, P441, DOI 10.11646/zootaxa.3682.3.5; Wielstra B, 2013, MOL PHYLOGENET EVOL, V67, P167, DOI 10.1016/j.ympev.2013.01.009; Wielstra B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095504; Wielstra B, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-13; Wielstra B, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-161; Wielstra B, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-162; Williams JS, 2013, MOL PHYLOGENET EVOL, V68, P671, DOI 10.1016/j.ympev.2013.04.013; You FM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-253; Zielinski P, 2014, MOL ECOL RESOUR, V14, P352, DOI 10.1111/1755-0998.12171	50	12	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e111011	10.1371/journal.pone.0111011	http://dx.doi.org/10.1371/journal.pone.0111011			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337997	Green Accepted, Green Published, gold			2022-12-27	WOS:000343674800094
J	Zhang, A; Wang, C; Wang, SJ; Li, L; Liu, ZM; Tian, SY				Zhang, Ao; Wang, Chi; Wang, Shiji; Li, Liang; Liu, Zhongmin; Tian, Suyan			Visualization-Aided Classification Ensembles Discriminate Lung Adenocarcinoma and Squamous Cell Carcinoma Samples Using Their Gene Expression Profiles	PLOS ONE			English	Article							SELECTION; REGULARIZATION; VERIFICATION; MULTICLASS; IMPROVER; IMPACT	Introduction: The widespread application of microarray experiments to cancer research is astounding including lung cancer, one of the most common fatal human tumors. Among non-small cell lung carcinoma (NSCLC), there are two major histological types of NSCLC, adenocarcinoma (AC) and squamous cell carcinoma (SCC). Results: In this paper, we proposed to integrate a visualization method called Radial Coordinate Visualization (Radviz) with a suitable classifier, aiming at discriminating two NSCLC subtypes using patients' gene expression profiles. Our analyses on simulated data and a real microarray dataset show that combining with a classification method, Radviz may play a role in selecting relevant features and ameliorating parsimony, while the final model suffers no or least loss of accuracy. Most importantly, a graphic representation is more easily understandable and implementable for a clinician than statistical methods and/or mathematic equations. Conclusion: To conclude, using the NSCLC microarray data presented here as a benchmark, the comprehensive understanding of the underlying mechanism associated with NSCLC and of the mechanisms with its subtypes and respective stages will become reality in the near future.	[Zhang, Ao; Wang, Shiji; Liu, Zhongmin] Jilin Univ, Hosp 1, ICU, Changchun, Jilin, Peoples R China; [Tian, Suyan] Jilin Univ, Hosp 1, Div Clin Epidemiol, Changchun, Jilin, Peoples R China; [Wang, Chi] Univ Kentucky, Dept Biostat, Lexington, KY USA; [Wang, Chi] Univ Kentucky, Markey Canc Ctr, Lexington, KY USA; [Li, Liang] LLX Solut LLC, Waltham, MA USA	Jilin University; Jilin University; University of Kentucky; University of Kentucky	Liu, ZM (corresponding author), Jilin Univ, Hosp 1, ICU, Changchun, Jilin, Peoples R China.	iculiuzhongmin@hotmail.com; stian@rockefeller.edu	Tian, Suyan/W-3273-2019	Tian, Suyan/0000-0002-5942-1542	Jilin University [450060491885]; NATIONAL CANCER INSTITUTE [P30CA177558] Funding Source: NIH RePORTER	Jilin University(Jilin University); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by a seed fund from Jilin University (No 450060491885). Co- author Dr. Liang Li is affiliated with LLX Solutions LLC. LLX Solutions LLC. provided support in the form of salary for author LL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Ben-hamo R, 2013, SYST BIOMED, V1, P83, DOI DOI 10.4161/sysb.25983; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Chen C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017238; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cui T, 2012, J CLIN PATHOL, V65, P1100, DOI 10.1136/jclinpath-2011-200630; Demsar J, 2007, J BIOMED INFORM, V40, P661, DOI 10.1016/j.jbi.2007.03.010; FRIEDMAN JH, 2004, GRADIENT DIRECTED RE; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Hoffman P, 1997, VISUALIZATION '97 - PROCEEDINGS, P437, DOI 10.1109/VISUAL.1997.663916; Kuner R, 2009, LUNG CANCER, V63, P32, DOI 10.1016/j.lungcan.2008.03.033; Leban G, 2005, BIOINFORMATICS, V21, P413, DOI 10.1093/bioinformatics/bti016; Lim WK, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P504; Ma SG, 2005, BIOINFORMATICS, V21, P4356, DOI 10.1093/bioinformatics/bti724; Ma SG, 2007, BIOINFORMATICS, V23, P466, DOI 10.1093/bioinformatics/btl632; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Meyer P, 2012, BIOINFORMATICS, V28, P1193, DOI 10.1093/bioinformatics/bts116; Meyer P, 2011, NAT BIOTECHNOL, V29, P811, DOI 10.1038/nbt.1968; Mramor M, 2007, BIOINFORMATICS, V23, P2147, DOI 10.1093/bioinformatics/btm312; Sanchez-Palencia A, 2011, INT J CANCER, V129, P355, DOI 10.1002/ijc.25704; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Tarca AL, 2013, BIOINFORMATICS, V29, P2892, DOI 10.1093/bioinformatics/btt492; Tian SY, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-97; Tian SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078302; Wang ZF, 2007, BIOINFORMATICS, V23, P2788, DOI 10.1093/bioinformatics/btm442; Yang P, 2005, CHEST, V128, P452, DOI 10.1378/chest.128.1.452; Yeung KY, 2005, BIOINFORMATICS, V21, P2394, DOI 10.1093/bioinformatics/bti319	26	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110052	10.1371/journal.pone.0110052	http://dx.doi.org/10.1371/journal.pone.0110052			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25335090	Green Published, gold, Green Submitted			2022-12-27	WOS:000346766200084
J	Volpicelli, F; Caiazzo, M; Moncharmont, B; di Porzio, U; Colucci-D'Amato, L				Volpicelli, Floriana; Caiazzo, Massimiliano; Moncharmont, Bruno; di Porzio, Umberto; Colucci-D'Amato, Luca			Neuronal Differentiation Dictates Estrogen-Dependent Survival and ERK1/2 Kinetic by Means of Caveolin-1	PLOS ONE			English	Article							ESTRADIOL-MEDIATED PROTECTION; BETA MESSENGER-RNA; A1 CELL-LINE; RECEPTOR-ALPHA; EMBRYONIC MESENCEPHALON; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; PRIMARY CULTURES; GENE-EXPRESSION; BRAIN-INJURY	Estrogens promote a plethora of effects in the CNS that profoundly affect both its development and mature functions and are able to influence proliferation, differentiation, survival and neurotransmission. The biological effects of estrogens are cell-context specific and also depend on differentiation and/or proliferation status in a given cell type. Furthermore, estrogens activate ERK1/2 in a variety of cellular types. Here, we investigated whether ERK1/2 activation might be influenced by estrogens stimulation according to the differentiation status and the molecular mechanisms underling this phenomenon. ERK1/2 exert an opposing role on survival and death, as well as on proliferation and differentiation depending on different kinetics of phosphorylation. Hence we report that mesencephalic primary cultures and the immortalized cell line mes-c-myc A1 express estrogen receptor a and activate ERK1/2 upon E-2 stimulation. Interestingly, following the arrest of proliferation and the onset of differentiation, we observe a change in the kinetic of ERKs phosphorylation induced by estrogens stimulation. Moreover, caveolin-1, a main constituent of caveolae, endogenously expressed and co-localized with ER-alpha on plasma membrane, is consistently up-regulated following differentiation and cell growth arrest. In addition, we demonstrate that siRNA-induced caveolin-1 down-regulation or disruption by means of beta-cyclodextrin treatment changes ERK1/2 phosphorylation in response to estrogens stimulation. Finally, caveolin-1 down-regulation abolishes estrogens-dependent survival of neurons. Thus, caveolin-1 appears to be an important player in mediating, at least, some of the non-genomic action of estrogens in neurons, in particular ERK1/2 kinetics of activation and survival.	[Volpicelli, Floriana] Univ Naples Federico II, Dept Pharm, Naples, Italy; [Volpicelli, Floriana; Caiazzo, Massimiliano; di Porzio, Umberto] CNR, Inst Genet & Biophys Adriano Buzzati Traverso, I-80125 Naples, Italy; Univ Molise, Dept Med & Hlth Sci, Campobasso, Italy; Inter Univ Ctr Res Neurosci, CIRN, Naples, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Molise	Colucci-D'Amato, L (corresponding author), Univ Naples 2, Dept Environm Biol & Pharmaceut Sci & Technol, Caserta, Italy.	luca.colucci@unina2.it	Caiazzo, Massimiliano/C-1722-2016	Caiazzo, Massimiliano/0000-0002-8975-3257; di Porzio, Umberto/0000-0002-2139-8754; Volpicelli, Floriana/0000-0003-0618-5504	Fondo per gli Investimenti di Ricerca di Base [FIRB-RBIN062YH4]; Medical Research Italy [MERITRBNE08LN4P]; "Progetti di Ricerca di Interesse Nazionale" PRIN [2009TBCZJB_003]	Fondo per gli Investimenti di Ricerca di Base(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Medical Research Italy; "Progetti di Ricerca di Interesse Nazionale" PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by "Fondo per gli Investimenti di Ricerca di Base" FIRB-RBIN062YH4, "Medical Research Italy" MERITRBNE08LN4P, "Progetti di Ricerca di Interesse Nazionale" PRIN 2009TBCZJB_003. The funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acconcia F, 2005, J CELL PHYSIOL, V203, P193, DOI 10.1002/jcp.20219; Arevalo MA, 2010, BBA-GEN SUBJECTS, V1800, P1106, DOI 10.1016/j.bbagen.2009.10.002; Barha CK, 2010, BBA-GEN SUBJECTS, V1800, P1056, DOI 10.1016/j.bbagen.2010.01.006; Behl C, 2002, J STEROID BIOCHEM, V83, P195, DOI 10.1016/S0960-0760(02)00271-6; Bi RF, 2000, P NATL ACAD SCI USA, V97, P3602, DOI 10.1073/pnas.060034497; Bosch M, 2011, CURR BIOL, V21, P681, DOI 10.1016/j.cub.2011.03.030; Bourque M, 2009, FRONT NEUROENDOCRIN, V30, P142, DOI 10.1016/j.yfrne.2009.04.014; Brunaldi K, 2010, J LIPID RES, V51, P120, DOI [10.1194/M900200-JLR200, 10.1194/jlr.M900200-JLR200]; Castoria G, 2010, STEROIDS, V75, P524, DOI 10.1016/j.steroids.2009.10.007; Chambery A, 2009, J PROTEOME RES, V8, P227, DOI 10.1021/pr800454n; Colucci-D'Amato GL, 2000, J BIOL CHEM, V275, P19306, DOI 10.1074/jbc.275.25.19306; Colucci-D'Amato GL, 1999, EXP CELL RES, V252, P383, DOI 10.1006/excr.1999.4636; Colucci-D'Amato L, 2003, BIOESSAYS, V25, P1085, DOI 10.1002/bies.10355; Cordey M, 2005, BRAIN RES, V1045, P217, DOI 10.1016/j.brainres.2005.03.032; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Dubal DB, 2001, P NATL ACAD SCI USA, V98, P1952, DOI 10.1073/pnas.98.4.1952; Dubal DB, 2006, ENDOCRINOLOGY, V147, P3076, DOI 10.1210/en.2005-1177; Engelman JA, 1997, J BIOL CHEM, V272, P16374, DOI 10.1074/jbc.272.26.16374; Fester L, 2006, J NEUROCHEM, V97, P1136, DOI 10.1111/j.1471-4159.2006.03809.x; Fiocchetti M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00073; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; Galbiati F, 2001, CELL, V106, P403, DOI 10.1016/S0092-8674(01)00472-X; Garnier M, 1997, J NEUROSCI, V17, P4591; Gaudreault SB, 2005, J NEUROCHEM, V92, P831, DOI 10.1111/j.1471-4159.2004.02917.x; Gaudreault SB, 2004, NEUROBIOL AGING, V25, P753, DOI 10.1016/j.neurobiolaging.2003.07.004; Greco D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004977; Head BP, 2008, FASEB J, V22, P828, DOI 10.1096/fj.07-9299com; Head BP, 2011, J BIOL CHEM, V286, P33310, DOI 10.1074/jbc.M111.255976; Head BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015697; Indrigo M, 2010, METHODS MOL BIOL, V661, P205, DOI 10.1007/978-1-60761-795-2_12; JUNGTESTAS I, 1992, J STEROID BIOCHEM, V41, P621, DOI 10.1016/0960-0760(92)90394-X; Kuppers E, 1999, NEUROSCI LETT, V276, P95, DOI 10.1016/S0304-3940(99)00815-0; Lebesgue D, 2009, STEROIDS, V74, P555, DOI 10.1016/j.steroids.2009.01.003; Liu J, 2002, J BIOL CHEM, V277, P10661, DOI 10.1074/jbc.M110354200; Luchetti S, 2011, NEUROSCIENCE, V191, P6, DOI 10.1016/j.neuroscience.2011.04.010; Maggi A, 2004, ANNU REV PHYSIOL, V66, P291, DOI 10.1146/annurev.physiol.66.032802.154945; Maggi A, 2011, BBA-MOL BASIS DIS, V1812, P1054, DOI 10.1016/j.bbadis.2011.05.001; McEwen BS, 2010, ANN NY ACAD SCI, V1204, pE38, DOI 10.1111/j.1749-6632.2010.05568.x; Migliaccio A, 2002, J STEROID BIOCHEM, V83, P31, DOI 10.1016/S0960-0760(02)00264-9; Nilsson S, 2011, CLIN PHARMACOL THER, V89, P44, DOI 10.1038/clpt.2010.226; Okada M, 2008, BIOMED RES-TOKYO, V29, P163, DOI 10.2220/biomedres.29.163; Patrone C, 2000, ENDOCRINOLOGY, V141, P1839, DOI 10.1210/en.141.5.1839; Peiro S, 2000, J BIOL CHEM, V275, P37846, DOI 10.1074/jbc.M000487200; Podar K, 2003, J BIOL CHEM, V278, P5794, DOI 10.1074/jbc.M208636200; Raab H, 1999, NEUROSCI LETT, V275, P21, DOI 10.1016/S0304-3940(99)00723-5; Schlegel A, 2001, BIOCHEM J, V359, P203, DOI 10.1042/0264-6021:3590203; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Severino V, 2013, BBA-PROTEINS PROTEOM, V1834, P2385, DOI 10.1016/j.bbapap.2012.12.005; Shen JG, 2006, J NEUROCHEM, V96, P1078, DOI 10.1111/j.1471-4159.2005.03589.x; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Srivastava DP, 2011, J NEUROSCI, V31, P16056, DOI 10.1523/JNEUROSCI.4097-11.2011; Stanciu M, 2000, J BIOL CHEM, V275, P12200, DOI 10.1074/jbc.275.16.12200; Takayasu Y, 2010, P NATL ACAD SCI USA, V107, P21778, DOI 10.1073/pnas.1015553107; Volpicelli F, 2004, J NEUROCHEM, V88, P1283, DOI 10.1046/j.1471-4159.2003.02254.x; Volpicelli Floriana, 2004, Neural Plasticity, V11, P45, DOI 10.1155/NP.2004.45; Zhang QG, 2014, MOL CELL ENDOCRINOL	56	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e109671	10.1371/journal.pone.0109671	http://dx.doi.org/10.1371/journal.pone.0109671			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350132	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943100013
J	Gavish, Y; Kedem, H; Messika, I; Cohen, C; Toh, E; Munro, D; Dong, QF; Fuqua, C; Clay, K; Hawlena, H				Gavish, Yoni; Kedem, Hadar; Messika, Irit; Cohen, Carmit; Toh, Evelyn; Munro, Daniel; Dong, Qunfeng; Fuqua, Clay; Clay, Keith; Hawlena, Hadas			Association of Host and Microbial Species Diversity across Spatial Scales in Desert Rodent Communities	PLOS ONE			English	Article							HABITAT HETEROGENEITY; ENVIRONMENTAL HETEROGENEITY; EVOLUTION; BACTERIA; FLEAS; BIODIVERSITY; ARTHROPOD; RICHNESS; PATTERNS; DISEASE	Relationships between host and microbial diversity have important ecological and applied implications. Theory predicts that these relationships will depend on the spatio-temporal scale of the analysis and the niche breadth of the organisms in question, but representative data on host-microbial community assemblage in nature is lacking. We employed a natural gradient of rodent species richness and quantified bacterial communities in rodent blood at several hierarchical spatial scales to test the hypothesis that associations between host and microbial species diversity will be positive in communities dominated by organisms with broad niches sampled at large scales. Following pyrosequencing of rodent blood samples, bacterial communities were found to be comprised primarily of broad niche lineages. These communities exhibited positive correlations between host diversity, microbial diversity and the likelihood for rare pathogens at the regional scale but not at finer scales. These findings demonstrate how microbial diversity is affected by host diversity at different spatial scales and suggest that the relationships between host diversity and overall disease risk are not always negative, as the dilution hypothesis predicts.	[Gavish, Yoni; Kedem, Hadar; Messika, Irit; Cohen, Carmit; Hawlena, Hadas] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Toh, Evelyn] Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Munro, Daniel; Dong, Qunfeng] Univ N Texas, Dept Biol, Denton, TX 76203 USA; [Dong, Qunfeng] Univ N Texas, Dept Comp Sci & Engn, Denton, TX 76203 USA; [Fuqua, Clay; Clay, Keith] Indiana Univ, Dept Biol, Bloomington, IN USA	Ben Gurion University; Indiana University System; Indiana University-Purdue University Indianapolis; University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton; Indiana University System; Indiana University Bloomington	Hawlena, H (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	hadashaw@bgu.ac.il	Clay, Keith/C-8730-2012; Gavish, Yoni/J-2173-2019; Hawlena, Hadas/F-1669-2012	Gavish, Yoni/0000-0002-6025-5668; Munro, Daniel/0000-0002-0724-218X; Hawlena, Hadas/0000-0002-0634-2920; Toh, Evelyn/0000-0003-2932-4060	Marie Curie Career Integration Grant [FP7-293713]; United States-Israel Binational Science Foundation [2012063]	Marie Curie Career Integration Grant; United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation)	This study was supported by Marie Curie Career Integration Grant number FP7-293713 and by United States-Israel Binational Science Foundation (grant number 2012063). The authors declare that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexy KJ, 2003, AM MIDL NAT, V149, P237, DOI 10.1674/0003-0031(2003)149[0237:BFOTTT]2.0.CO;2; Allouche O, 2012, P NATL ACAD SCI USA, V109, P17495, DOI 10.1073/pnas.1208652109; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amar J, 2011, EMBO MOL MED, V3, P559, DOI 10.1002/emmm.201100159; Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Bernard K, 2012, J CLIN MICROBIOL, V50, P3152, DOI 10.1128/JCM.00796-12; Brooks GF, 1995, JAWETZ MELNICK ADELB; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Caporaso JG, 2011, GENOME BIOL, V12; Carvalho GD, 2008, BIOSCI J, V24, P121; Chevret P, 2005, MOL PHYLOGENET EVOL, V35, P674, DOI 10.1016/j.ympev.2005.01.001; DEGEN AA, 1992, OECOLOGIA, V90, P586, DOI 10.1007/BF01875454; Dehio C, 2004, J CLIN MICROBIOL, V42, P5320, DOI 10.1128/JCM.42.11.5320-5323.2004; Eribe ERK, 2008, ANAEROBE, V14, P131, DOI 10.1016/j.anaerobe.2008.04.004; Fulde M, 2013, CURR TOP MICROBIOL, V368, P49, DOI 10.1007/82_2012_277; Gaastra W, 2010, VET MICROBIOL, V140, P339, DOI 10.1016/j.vetmic.2009.01.040; Gilbert B, 2004, P NATL ACAD SCI USA, V101, P7651, DOI 10.1073/pnas.0400814101; Greischar MA, 2007, ECOL LETT, V10, P418, DOI 10.1111/j.1461-0248.2007.01028.x; Gutierrez R, 2014, ISME J; Hawlena H, 2005, OECOLOGIA, V146, P200, DOI 10.1007/s00442-005-0187-0; Hawlena H, 2013, ISME J, V7, P221, DOI 10.1038/ismej.2012.71; Hortal J, 2009, AM NAT, V174, pE205, DOI 10.1086/645085; Hubbell Stephen P., 2001, V32, pi; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jenkins DG, 2011, GLOBAL ECOL BIOGEOGR, V20, P486, DOI 10.1111/j.1466-8238.2010.00617.x; Johnson PTJ, 2013, NATURE, V494, P230, DOI 10.1038/nature11883; Kadmon R, 2007, AM NAT, V170, P443, DOI 10.1086/519853; Kedem H, 2014, ECOLOGY, V95, P1173, DOI 10.1890/13-0678.1; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Kerr JT, 1997, NATURE, V385, P252, DOI 10.1038/385252a0; Khokhlova IS, 2012, PARASITOLOGY, V139, P60, DOI 10.1017/S0031182011001703; Krasnov B.R., 2008, FUNCTIONAL EVOLUTION; Kueneman JG, 2014, MOL ECOL, V23, P1238, DOI 10.1111/mec.12510; Leclaire S, 2014, BEHAV ECOLOGY; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lockhart PB, 2008, CIRCULATION, V117, P3118, DOI 10.1161/CIRCULATIONAHA.107.758524; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Maidak BL, 1996, NUCLEIC ACIDS RES, V24, P82, DOI 10.1093/nar/24.1.82; Martin MO, 2010, SYMBIOSIS, V51, P97, DOI 10.1007/s13199-010-0078-y; McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495; Motoshima M, 2012, J MED MICROBIOL, V61, P1556, DOI 10.1099/jmm.0.049163-0; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Murphy EC, 2013, FEMS MICROBIOL REV, V37, P520, DOI 10.1111/1574-6976.12005; Ostfeld RS, 2012, ANNU REV ECOL EVOL S, V43, P157, DOI 10.1146/annurev-ecolsys-102710-145022; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Poulin R, 1997, ANNU REV ECOL SYST, V28, P341, DOI 10.1146/annurev.ecolsys.28.1.341; Richard M, 2000, ECOGRAPHY, V23, P231, DOI 10.1111/j.1600-0587.2000.tb00279.x; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; Saag P, 2011, MICROBIAL E IN PRESS; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Snyder LAS, 2005, PLASMID, V54, P191, DOI 10.1016/j.plasmid.2005.04.005; Soininen J, 2012, ENV MICROBIOL REP, V4, P10, DOI 10.1111/j.1758-2229.2011.00308.x; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Tamme R, 2010, J VEG SCI, V21, P796, DOI 10.1111/j.1654-1103.2010.01185.x; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; van Dongen WFD, 2013, BMC ECOLOGY, V13; Voigt CC, 2005, J MAMMAL, V86, P745, DOI 10.1644/1545-1542(2005)086[0745:BBABSS]2.0.CO;2; Wasserberg G, 2007, EVOL ECOL RES, V9, P299	60	12	12	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e109677	10.1371/journal.pone.0109677	http://dx.doi.org/10.1371/journal.pone.0109677			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343259	gold, Green Submitted, Green Published			2022-12-27	WOS:000343943500020
J	Jiang, HL; Chan, CP; Leung, Y; Li, YM; Graham, CA; Rainer, TH				Jiang, Hui-lin; Chan, Cangel Pui-yee; Leung, Yuk-ki; Li, Yun-mei; Graham, Colin A.; Rainer, Timothy H.			Evaluation of the Recognition of Stroke in the Emergency Room (ROSIER) Scale in Chinese Patients in Hong Kong	PLOS ONE			English	Article							TRANSIENT ISCHEMIC ATTACK; VALIDATION; TRENDS; EPIDEMIOLOGY; SUBTYPES; IDENTIFICATION; POPULATION; INSTRUMENT; DIAGNOSIS; PROJECT	Background and Purpose: The objective of this study was to determine the performance of the Recognition Of Stroke In the Emergency Room (ROSIER) scale in risk-stratifying Chinese patients with suspected stroke in Hong Kong. Methods: This was a prospective cohort study in an urban academic emergency department (ED) over a 7-month period. Patients over 18 years of age with suspected stroke were recruited between June 2011 and December 2011. ROSIER scale assessment was performed in the ED triage area. Logistic regression analysis was used to estimate the impacts of diagnostic variables, including ROSIER scale, past history and ED characteristics. Findings: 715 suspected stroke patients were recruited for assessment, of whom 371 (52%) had acute cerebrovascular disease (302 ischaemic strokes, 24 transient ischaemic attacks (TIA), 45 intracerebral haemorrhages), and 344 (48%) had other illnesses i.e. stroke mimics. Common stroke mimics were spinal neuropathy, dementia, labyrinthitis and sepsis. The suggested cut-off score of. 0 for the ROSIER scale for stroke diagnosis gave a sensitivity of 87% (95% CI 83-90), a specificity of 41% (95% CI 36-47), a positive predictive value of 62% (95% CI 57-66), and a negative predictive value of 75% (95% CI 6881), and the AUC was 0.723. The overall accuracy at cut off>0 was 65% i.e. (323+141)/715. Interpretation: The ROSIER scale was not as effective at differentiating acute stroke from stroke mimics in Chinese patients in Hong Kong as it was in the original studies, primarily due to a much lower specificity. If the ROSIER scale is to be clinically useful in Chinese suspected stroke patients, it requires further refinement.	[Jiang, Hui-lin; Chan, Cangel Pui-yee; Leung, Yuk-ki; Li, Yun-mei; Graham, Colin A.; Rainer, Timothy H.] Chinese Univ Hong Kong, Accid & Emergency Med Acad Unit, Hong Kong, Hong Kong, Peoples R China; [Jiang, Hui-lin; Li, Yun-mei] Guangzhou Med Univ, Affiliated Hosp 2, Emergency Dept, Guangzhou, Guangdong, Peoples R China	Chinese University of Hong Kong; Guangzhou Medical University	Rainer, TH (corresponding author), Chinese Univ Hong Kong, Accid & Emergency Med Acad Unit, Hong Kong, Hong Kong, Peoples R China.	thrainer@cuhk.edu.hk	Graham, Colin A/B-4535-2013; Rainer, Timothy/I-2591-2013	Graham, Colin A/0000-0002-4381-7470; Rainer, Timothy/0000-0003-3355-3237	Chinese University of Hong Kong [2041589]	Chinese University of Hong Kong(Chinese University of Hong Kong)	This research study was supported by a Direct Grant for Research of the Chinese University of Hong Kong (reference no. 2041589) (http://www.cuhk.edu.hk/rao/rao_service.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bejot Y, 2010, CEREBROVASC DIS, V30, P346, DOI 10.1159/000319569; Bonita R, 2004, LANCET NEUROL, V3, P391, DOI 10.1016/S1474-4422(04)00800-2; BRATINA P, 1995, STROKE, V26, P409, DOI 10.1161/01.STR.26.3.409; Bray JE, 2005, CEREBROVASC DIS, V20, P28, DOI 10.1159/000086201; Byrne B, 2011, INT J NURS STUD, V48, P979, DOI 10.1016/j.ijnurstu.2011.01.015; Census and Statistics Department of Hong Kong, 2007, 2006 POP BY CENS MAI, VI; Chau PH, 2011, CEREBROVASC DIS, V31, P138, DOI 10.1159/000321734; [陈晓辉 Chen Xiaohui], 2013, [中国急救医学, Chinese Journal of Critical Care Medicine], V33, P539; Corso G, 2009, NEUROEPIDEMIOLOGY, V32, P186, DOI 10.1159/000195688; Crocco T J, 1999, Prehosp Emerg Care, V3, P201, DOI 10.1080/10903129908958937; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Fothergill RT, 2013, STROKE, V44, P3007, DOI 10.1161/STROKEAHA.13.000851; Hand PJ, 2006, STROKE, V37, P769, DOI 10.1161/01.STR.0000204041.13466.4c; Hatzitolios A, 2008, HIPPOKRATIA, V12, P98; He MF, 2012, ANN INDIAN ACAD NEUR, V15, P191, DOI 10.4103/0972-2327.99713; Huff JS, 2002, EMERG MED CLIN N AM, V20, P583, DOI 10.1016/S0733-8627(02)00012-3; Islam SM, 2008, STROKE, V39, P776, DOI 10.1161/STROKEAHA.107.493643; Jackson A, 2008, IRISH J MED SCI, V177, P189, DOI 10.1007/s11845-008-0159-6; Jiang B, 2006, STROKE, V37, P63, DOI 10.1161/01.STR.0000194955.34820.78; Kidwell CS, 2000, STROKE, V31, P71, DOI 10.1161/01.STR.31.1.71; KOTHARI R, 1995, STROKE, V26, P937, DOI 10.1161/01.STR.26.6.937; Kothari R, 1999, ANN EMERG MED, V33, P3, DOI 10.1016/S0196-0644(99)70431-2; Kothari RU, 1999, ANN EMERG MED, V33, P373, DOI 10.1016/S0196-0644(99)70299-4; Lacy CR, 2001, STROKE, V32, P63, DOI 10.1161/01.STR.32.1.63; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Nor AM, 2005, LANCET NEUROL, V4, P727, DOI 10.1016/S1474-4422(05)70201-5; Nor AM, 2004, STROKE, V35, P1355, DOI 10.1161/01.STR.0000128529.63156.c5; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; SIGN, 2008, 108 SIGN; Smith W S, 1998, Prehosp Emerg Care, V2, P170, DOI 10.1080/10903129808958866; Stone J, 2005, J NEUROL NEUROSUR PS, V76, pI2, DOI 10.1136/jnnp.2004.061655; Tsai CF, 2013, NEUROLOGY, V81, P264, DOI 10.1212/WNL.0b013e31829bfde3; Wein TH, 2000, STROKE, V31, P1925, DOI 10.1161/01.STR.31.8.1925; Whiteley WN, 2011, J NEUROL NEUROSUR PS, V82, P1006, DOI 10.1136/jnnp.2010.235010; Wojner AW, 2003, AM J CRIT CARE, V12, P411, DOI 10.4037/ajcc2003.12.5.411; Wu ZS, 2001, CIRCULATION, V103, P462; Zhang LF, 2003, STROKE, V34, P2091, DOI 10.1161/01.STR.0000087149.42294.8C; Zhang XF, 2006, EUR J CARDIOV PREV R, V13, P429, DOI 10.1097/00149831-200606000-00020	38	17	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e109762	10.1371/journal.pone.0109762	http://dx.doi.org/10.1371/journal.pone.0109762			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343496	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000343943500023
J	Chen, X; Sanayei, M; Thiele, A				Chen, Xing; Sanayei, Mehdi; Thiele, Alexander			Stimulus Roving and Flankers Affect Perceptual Learning of Contrast Discrimination in Macaca mulatta	PLOS ONE			English	Article							SPATIAL INTEGRATION; SUPPRESSION; ATTENTION	Stimulus roving' refers to a paradigm in which the properties of the stimuli to be discriminated vary from trial to trial, rather than being kept constant throughout a block of trials. Rhesus monkeys have previously been shown to improve their contrast discrimination performance on a non-roving task, in which they had to report the contrast of a test stimulus relative to that of a fixed-contrast sample stimulus. Human psychophysics studies indicate that roving stimuli yield little or no perceptual learning. Here, we investigate how stimulus roving influences perceptual learning in macaque monkeys and how the addition of flankers alters performance under roving conditions. Animals were initially trained on a contrast discrimination task under non-roving conditions until their performance levels stabilized. The introduction of roving contrast conditions resulted in a pronounced drop in performance, which suggested that subjects initially failed to heed the sample contrast and performed the task using an internal memory reference. With training, significant improvements occurred, demonstrating that learning is possible under roving conditions. To investigate the notion of flanker-induced perceptual learning, flanker stimuli (30% fixed-contrast iso-oriented collinear gratings) were presented jointly with central (roving) stimuli. Presentation of flanker stimuli yielded substantial performance improvements in one subject, but deteriorations in the other. Finally, after the removal of flankers, performance levels returned to their pre-flanker state in both subjects, indicating that the flanker-induced changes were contingent upon the continued presentation of flankers.	[Chen, Xing; Sanayei, Mehdi; Thiele, Alexander] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Thiele, A (corresponding author), Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	alex.thiele@ncl.ac.uk	c, x/AAH-5686-2021	Chen, Xing/0000-0002-3589-1750; Thiele, Alexander/0000-0003-4894-0213	Medical Research Council, UK [G0700976]; Medical Research Council [G0700976] Funding Source: researchfish; MRC [G0700976] Funding Source: UKRI	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by Medical Research Council, UK, G0700976 (http://www.mrc.ac.uk/index.htm) to Author: AT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adab HZ, 2011, CURR BIOL, V21, P1661, DOI 10.1016/j.cub.2011.08.037; Adini Y, 2004, J VISION, V4, P993, DOI 10.1167/4.12.2; Adini Y, 2002, NATURE, V415, P790, DOI 10.1038/415790a; Ahissar M, 2004, TRENDS COGN SCI, V8, P457, DOI 10.1016/j.tics.2004.08.011; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chen X, 2013, J VISION, V13, DOI 10.1167/13.13.22; Crist RE, 2001, NAT NEUROSCI, V4, P519, DOI 10.1038/87470; Dorais A, 1997, VISION RES, V37, P1725, DOI 10.1016/S0042-6989(96)00329-X; Fine I, 2002, J VISION, V2, P190, DOI 10.1167/2.2.5; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Gieselmann MA, 2008, EUR J NEUROSCI, V28, P447, DOI 10.1111/j.1460-9568.2008.06358.x; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; Kuai SG, 2005, NAT NEUROSCI, V8, P1497, DOI 10.1038/nn1546; Otto TU, 2006, VISION RES, V46, P3223, DOI 10.1016/j.visres.2006.03.021; Parkosadze K, 2008, J VISION, V8, DOI 10.1167/8.1.5; PELLI DG, 1991, VISION RES, V31, P1337, DOI 10.1016/0042-6989(91)90055-A; POLAT U, 1993, VISION RES, V33, P993, DOI 10.1016/0042-6989(93)90081-7; Roberts M, 2007, NAT NEUROSCI, V10, P1483, DOI 10.1038/nn1967; Tsodyks M, 2004, NEURAL NETWORKS, V17, P823, DOI 10.1016/j.neunet.2004.03.004; Xiao L.-Q., 2008, CURR BIOL, V18, P1; Yu C, 2004, J VISION, V4, P169, DOI 10.1167/4.3.4; Zhang JY, 2010, J NEUROSCI, V30, P12323, DOI 10.1523/JNEUROSCI.0704-10.2010; Zhang JY, 2008, PLOS BIOL, V6, P1651, DOI 10.1371/journal.pbio.0060197	24	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e109604	10.1371/journal.pone.0109604	http://dx.doi.org/10.1371/journal.pone.0109604			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340335	gold, Green Published, Green Submitted			2022-12-27	WOS:000343662800010
J	Duthoo, W; Abrahamse, EL; Braem, S; Boehler, CN; Notebaert, W				Duthoo, Wout; Abrahamse, Elger L.; Braem, Senne; Boehler, C. Nico; Notebaert, Wim			The Congruency Sequence Effect 3.0: A Critical Test of Conflict Adaptation	PLOS ONE			English	Article							COGNITIVE CONTROL; SIMON TASK; PROPORTION CONGRUENT; RESPONSE ACTIVATION; FLANKER TASK; CONTINGENCY; INTEGRATION	Over the last two decades, the congruency sequence effect (CSE) -the finding of a reduced congruency effect following incongruent trials in conflict tasks-has played a central role in advancing research on cognitive control. According to the influential conflict-monitoring account, the CSE reflects adjustments in selective attention that enhance task focus when needed, often termed conflict adaptation. However, this dominant interpretation of the CSE has been called into question by several alternative accounts that stress the role of episodic memory processes: feature binding and (stimulus-response) contingency learning. To evaluate the notion of conflict adaptation in accounting for the CSE, we construed versions of three widely used experimental paradigms (the colour-word Stroop, picture-word Stroop and flanker task) that effectively control for feature binding and contingency learning. Results revealed that a CSE can emerge in all three tasks. This strongly suggests a contribution of attentional control to the CSE and highlights the potential of these unprecedentedly clean paradigms for further examining cognitive control.	[Duthoo, Wout; Abrahamse, Elger L.; Braem, Senne; Boehler, C. Nico; Notebaert, Wim] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium	Ghent University	Duthoo, W (corresponding author), Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium.	wout.duthoo@ugent.be	Boehler, Carsten/J-8619-2015	Boehler, Carsten/0000-0001-5963-2780; Abrahamse, Elger/0000-0002-9361-2916; Braem, Senne/0000-0002-2619-8225	Research Foundation Flanders (FWO) [OPR2013013301, 12C4712N]; Netherlands Organisation for Scientific Research (NWO) [446-10-025]	Research Foundation Flanders (FWO)(FWO); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	WD was supported by grant no. OPR2013013301 of the Research Foundation Flanders (FWO - http://www.fwo.be/Default.aspx). ELA was supported by the Netherlands Organisation for Scientific Research (NWO - http://www.nwo.nl/) by grant number 446-10-025 and by the Research Foundation Flanders (FWO - http://www.fwo.be/Default.aspx) by grant number 12C4712N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcay C, 2007, PSYCHON B REV, V14, P742, DOI 10.3758/BF03196831; Akcay C, 2011, PSYCHON B REV, V18, P505, DOI 10.3758/s13423-011-0084-y; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bugg JM, 2014, J EXP PSYCHOL LEARN, V40, P567, DOI 10.1037/a0035032; Chen SF, 2009, BRAIN RES, V1297, P89, DOI 10.1016/j.brainres.2009.08.003; Duthoo W, 2013, NEUROPSYCHOLOGY, V27, P556, DOI 10.1037/a0033377; Duthoo W, 2012, Q J EXP PSYCHOL, V65, P1993, DOI 10.1080/17470218.2012.676655; Duyck W, 2008, J EXP PSYCHOL HUMAN, V34, P1317, DOI 10.1037/0096-1523.34.5.1317; Egner T, 2008, TRENDS COGN SCI, V7, P380; Egner T, 2007, COGN AFFECT BEHAV NE, V7, P380, DOI 10.3758/CABN.7.4.380; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Holmes AJ, 2008, NEUROPSYCHOLOGIA, V46, P2904, DOI 10.1016/j.neuropsychologia.2008.05.028; Hommel B, 2004, PSYCHOL RES-PSYCH FO, V68, P1, DOI 10.1007/s00426-003-0132-y; Hommel B, 1998, VIS COGN, V5, P183, DOI 10.1080/713756773; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Mattler U, 2003, EXP BRAIN RES, V151, P272, DOI 10.1007/s00221-003-1486-5; Mayr U, 2003, NAT NEUROSCI, V6, P450, DOI 10.1038/nn1051; Mayr U, 2009, PSYCHOL RES-PSYCH FO, V73, P794, DOI 10.1007/s00426-008-0191-1; Mordkoff JT, 2012, PSYCHON B REV, V19, P750, DOI 10.3758/s13423-012-0257-3; Nieuwenhuis S, 2006, MEM COGNITION, V34, P1260, DOI 10.3758/BF03193270; Notebaert W, 2008, COGNITION, V106, P1071, DOI 10.1016/j.cognition.2007.04.011; Notebaert W, 2006, PSYCHON B REV, V13, P1078, DOI 10.3758/BF03213929; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Schlaghecken F, 2012, J EXP PSYCHOL HUMAN, V38, P272, DOI 10.1037/a0025791; Schmidt JR, 2008, J EXP PSYCHOL LEARN, V34, P514, DOI 10.1037/0278-7393.34.3.514; Schmidt JR, 2013, PSYCHON B REV, V20, P615, DOI 10.3758/s13423-012-0373-0; Schmidt JR, 2012, Q J EXP PSYCHOL, V65, P408, DOI 10.1080/17470218.2011.632486; Schmidt JR, 2011, ACTA PSYCHOL, V138, P176, DOI 10.1016/j.actpsy.2011.06.002; Severens E, 2005, ACTA PSYCHOL, V119, P159, DOI 10.1016/j.actpsy.2005.01.002; Stevens M, 2006, BEHAV RES METHODS, V38, P280, DOI 10.3758/BF03192779; Sturmer B, 2002, J EXP PSYCHOL HUMAN, V28, P1345, DOI 10.1037//0096-1523.28.6.1345; Ullsperger M, 2005, COGN AFFECT BEHAV NE, V5, P467, DOI 10.3758/CABN.5.4.467; Verguts T, 2008, PSYCHOL REV, V115, P518, DOI 10.1037/0033-295X.115.2.518; Verguts T, 2011, PSYCHON B REV, V18, P76, DOI 10.3758/s13423-010-0016-2; Verguts T, 2009, TRENDS COGN SCI, V13, P252, DOI 10.1016/j.tics.2009.02.007; Wuhr P, 2005, PSYCHON B REV, V12, P282, DOI 10.3758/BF03196373	36	64	65	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110462	10.1371/journal.pone.0110462	http://dx.doi.org/10.1371/journal.pone.0110462			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR5ZY	25340396	gold, Green Published, Green Submitted			2022-12-27	WOS:000343662800038
J	Gorman, CE; Potts, BM; Schweitzer, JA; Bailey, JK				Gorman, Courtney E.; Potts, Brad M.; Schweitzer, Jennifer A.; Bailey, Joseph K.			Shifts in Species Interactions Due to the Evolution of Functional Differences between Endemics and Non-Endemics: An Endemic Syndrome Hypothesis	PLOS ONE			English	Article							HIGHER-LEVEL RELATIONSHIPS; GENETIC-VARIATION; COMMUNITY; BIODIVERSITY; PATTERNS; DIVERSITY; RICHNESS; BIOLOGY; PLANTS; TRAIT	Species ranges have been shifting since the Pleistocene, whereby fragmentation, isolation, and the subsequent reduction in gene flow have resulted in local adaptation of novel genotypes and the repeated evolution of endemic species. While there is a wide body of literature focused on understanding endemic species, very few studies empirically test whether or not the evolution of endemics results in unique function or ecological differences relative to their widespread congeners; in particular while controlling for environmental variation. Using a common garden composed of 15 Eucalyptus species within the subgenus Symphyomyrtus (9 endemic to Tasmania, 6 non-endemic), here we hypothesize and show that endemic species are functionally and ecologically different from non-endemics. Compared to non-endemics, endemic Eucalyptus species have a unique suite of functional plant traits that have extended effects on herbivores. We found that while endemics occupy many diverse habitats, they share similar functional traits potentially resulting in an endemic syndrome of traits. This study provides one of the first empirical datasets analyzing the functional differences between endemics and non-endemics in a common garden setting, and establishes a foundation for additional studies of endemic/non-endemic dynamics that will be essential for understanding global biodiversity in the midst of rapid species extinctions and range shifts as a consequence of global change.	[Gorman, Courtney E.; Schweitzer, Jennifer A.; Bailey, Joseph K.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; [Potts, Brad M.; Bailey, Joseph K.] Univ Tasmania, Sch Plant Sci, Hobart, Tas, Australia	University of Tennessee System; University of Tennessee Knoxville; University of Tasmania	Gorman, CE (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.	cgorman5@utk.edu	Potts, Brad M/C-6489-2013; Gorman, Courtney/M-5219-2019	Potts, Brad M/0000-0001-6244-289X; Gorman, Courtney/0000-0001-7310-8803	Australian Research Council	Australian Research Council(Australian Research Council)	The Australian Research Council funded the Future Fellowship (to JKB), http://www.arc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JK, 2006, ECOL LETT, V9, P78, DOI 10.1111/j.1461-0248.2005.00844.x; Cadotte MW, 2010, ECOL LETT, V13, P96, DOI 10.1111/j.1461-0248.2009.01405.x; Caujape-Castells J, 2010, PERSPECT PLANT ECOL, V12, P107, DOI 10.1016/j.ppees.2009.10.001; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cole CT, 2003, ANNU REV ECOL EVOL S, V34, P213, DOI 10.1146/annurev.ecolsys.34.030102.151717; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Cowling R.M., 2000, ENCY BIODIVERSITY, V2, P497; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Dungey H, 2001, AUST FORESTRY, V65, P23; Dynesius M, 2000, P NATL ACAD SCI USA, V97, P9115, DOI 10.1073/pnas.97.16.9115; Ferreira PMA, 2011, CONSERV BIOL, V25, P672, DOI 10.1111/j.1523-1739.2011.01675.x; Gitzendanner MA, 2000, AM J BOT, V87, P783, DOI 10.2307/2656886; Gottlieb L. D., 1979, Topics in plant population biology., P264; Gulias J, 2003, ANN BOT-LONDON, V92, P215, DOI 10.1093/aob/mcg123; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Jansson R, 2002, ANNU REV ECOL SYST, V33, P741, DOI 10.1146/annurev.ecolsys.33.010802.150520; Jansson R, 2003, P ROY SOC B-BIOL SCI, V270, P583, DOI 10.1098/rspb.2002.2283; Johnson MTJ, 2005, ECOLOGY, V86, P874, DOI 10.1890/04-1068; Jump AS, 2005, ECOL LETT, V8, P1010, DOI 10.1111/j.1461-0248.2005.00796.x; Karron JD, 1987, EVOL ECOL, V1, P47, DOI 10.1007/BF02067268; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; KRUCKEBERG AR, 1985, ANNU REV ECOL SYST, V16, P447, DOI 10.1146/annurev.es.16.110185.002311; KUNIN WE, 1993, TRENDS ECOL EVOL, V8, P298, DOI 10.1016/0169-5347(93)90259-R; Lavergne S, 2004, OIKOS, V107, P505, DOI 10.1111/j.0030-1299.2004.13423.x; McIntyre S, 1999, J VEG SCI, V10, P621, DOI 10.2307/3237077; McKinnon GE, 2008, AM J BOT, V95, P368, DOI 10.3732/ajb.95.3.368; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; O'Reilly-Wapstra JM, 2002, OECOLOGIA, V130, P289, DOI 10.1007/s004420100797; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; R Core Team, 2021, R LANGUAGE ENV STAT; Reich PB, 2005, ECOL LETT, V8, P811, DOI 10.1111/j.1461-0248.2005.00779.x; Ricketts TH, 2005, P NATL ACAD SCI USA, V102, P18497, DOI 10.1073/pnas.0509060102; Schweitzer JA, 2004, ECOL LETT, V7, P127, DOI 10.1111/j.1461-0248.2003.00562.x; Steane DA, 2002, AUST SYST BOT, V15, P49, DOI 10.1071/SB00039; Steane DA, 1999, MOL PHYLOGENET EVOL, V12, P215, DOI 10.1006/mpev.1999.0612; Stebbins G. Ledyard, 1942, MADRONO, V6, P241; Wagner H., 2013, PACKAGE VEGAN COMMUN, V2, P1; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; Williams K. J., 1996, Tasforests, V8, P39; Wimp GM, 2004, ECOL LETT, V7, P776, DOI 10.1111/j.1461-0248.2004.00635.x	41	15	15	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111190	10.1371/journal.pone.0111190	http://dx.doi.org/10.1371/journal.pone.0111190			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340402	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662800092
J	Schirmel, J; Alt, M; Rudolph, I; Entling, MH				Schirmel, Jens; Alt, Martin; Rudolph, Isabell; Entling, Martin H.			Effects of Traditional Flood Irrigation on Invertebrates in Lowland Meadows	PLOS ONE			English	Article							AGRI-ENVIRONMENT SCHEMES; BIODIVERSITY; GRASSLAND; SPIDERS; PLANT; HETEROGENEITY; CONSERVATION; COMMUNITIES; DISTURBANCE; INDICATORS	Lowland meadow irrigation used to be widespread in Central Europe, but has largely been abandoned during the 20th century. As a result of agri-environment schemes and nature conservation efforts, meadow irrigation is now being re-established in some European regions. In the absence of natural flood events, irrigation is expected to favour fauna typical of lowland wet meadows. We analysed the effects of traditional flood irrigation on diversity, densities and species composition of three invertebrate indicator taxa in lowland meadows in Germany. Unexpectedly, alpha diversity (species richness and Simpson diversity) and beta diversity (multivariate homogeneity of group dispersions) of orthopterans, carabids, and spiders were not significantly different between irrigated and non-irrigated meadows. However, spider densities were significantly higher in irrigated meadows. Furthermore, irrigation and elevated humidity affected species composition and shifted assemblages towards moisture-dependent species. The number of species of conservation concern, however, did not differ between irrigated and non-irrigated meadows. More variable and intensive (higher duration and/or frequency) flooding regimes might provide stronger conservation benefits, additional species and enhance habitat heterogeneity on a landscape scale.	[Schirmel, Jens; Alt, Martin; Rudolph, Isabell; Entling, Martin H.] Univ Koblenz Landau, Inst Environm Sci, Landau, Germany	University of Koblenz & Landau	Schirmel, J (corresponding author), Univ Koblenz Landau, Inst Environm Sci, Landau, Germany.	schirmel@uni-landau.de	Entling, Martin H/C-6953-2008; Schirmel, Jens/I-3467-2012	Schirmel, Jens/0000-0003-0330-3376	research initiative 'AufLand' of the federal state of Rhineland-Palatinate' (Germany); research and development fund of the University of Koblenz-Landau	research initiative 'AufLand' of the federal state of Rhineland-Palatinate' (Germany); research and development fund of the University of Koblenz-Landau	The study was funded by the research initiative 'AufLand' of the federal state of Rhineland-Palatinate' (Germany) and the research and development fund of the University of Koblenz-Landau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; [Anonymous], 1996, SPIDERS BRITAIN NO E; Bailey D, 2010, J APPL ECOL, V47, P1003, DOI 10.1111/j.1365-2664.2010.01858.x; Baldi A, 1997, AGR ECOSYST ENVIRON, V66, P121, DOI 10.1016/S0167-8809(97)00068-6; Baur B, 2006, BIOL CONSERV, V132, P261, DOI 10.1016/j.biocon.2006.04.018; Bellmann H., 2006, KOSMOS HEUSCHRECKENF; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Bonn A, 2002, RIVER RES APPL, V18, P43, DOI 10.1002/rra.632; Bonn Aletta, 1999, Zeitschrift fuer Oekologie und Naturschutz, V8, P109; Briem E, 2008, HAARDT WEINSTRASSE Q, P114; Curry J.P., 1994, GRASSLAND INVERTEBRA; Duelli P, 2003, BASIC APPL ECOL, V4, P129, DOI 10.1078/1439-1791-00140; Dziock F, 2011, AGR ECOSYST ENVIRON, V145, P85, DOI 10.1016/j.agee.2011.07.015; Ellenberg H., 2012, VEGETATION MITTELEUR; Entling W, 2007, GLOBAL ECOL BIOGEOGR, V16, P440, DOI 10.1111/j.1466-8238.2006.00305.x; Gardiner Tim, 2005, Journal of Insect Conservation, V9, P151, DOI 10.1007/s10841-005-2854-1; Gerisch M, 2012, OIKOS, V121, P508, DOI 10.1111/j.1600-0706.2011.19749.x; Google, 2011, GOOGL EARTH 6 1 0 50; Hassler DM, 1995, WASSERWIESEN GESCH T; Horvath R, 2009, AGR ECOSYST ENVIRON, V130, P16, DOI 10.1016/j.agee.2008.11.011; Ingrisch S, 1998, NEUE BREHM BUCHEREI, V629; Irmler Ulrich, 2004, Faunistisch-Oekologische Mitteilungen Supplement, V32, P1; Isselstein J., 2005, Agronomy Research, V3, P139; Kleijn D, 2003, J APPL ECOL, V40, P947, DOI 10.1111/j.1365-2664.2003.00868.x; Kleijn D, 2006, ECOL LETT, V9, P243, DOI 10.1111/j.1461-0248.2005.00869.x; Lambeets K, 2008, J ANIM ECOL, V77, P1162, DOI 10.1111/j.1365-2656.2008.01443.x; Leibundgut C, 2004, IAHS-AISH P, P77; Leibundgut C., 2011, JB OBERAARGAUS, V54, P121; Maas S, 2002, GEFAHRDUNGSANALYSE H; MAC ARTHUR ROBERT H., 1967; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; Muller S, 2002, AGR ECOSYST ENVIRON, V89, P261, DOI 10.1016/S0167-8809(01)00235-3; Muller-Motzfeld G, 2006, KAFER MITTELEUROPAS, V2; Nahrig D, 2003, ROTE LISTEN CHECKLIS; Nyffeler M, 1999, J ARACHNOL, V27, P317; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Pfeifer MA, 2011, FLORA FAUNA RHEINLAN, V41, P1; Plum N, 2005, WETLANDS, V25, P721, DOI 10.1672/0277-5212(2005)025[0721:TIIFGA]2.0.CO;2; Pollock MM, 1998, ECOLOGY, V79, P94; Poschlod P, 2002, BIOL CONSERV, V104, P361, DOI 10.1016/S0006-3207(01)00201-4; Rainio J, 2003, BIODIVERS CONSERV, V12, P487, DOI 10.1023/A:1022412617568; Riedener E, 2013, AGR ECOSYST ENVIRON, V164, P62, DOI 10.1016/j.agee.2012.09.020; Rounsevell MDA, 2005, AGR ECOSYST ENVIRON, V107, P117, DOI 10.1016/j.agee.2004.12.002; Schellberg S, 2005, INTEGRATED LAND WATE, V2, P123; Schirmel J, 2011, BIODIVERS CONSERV, V20, P1469, DOI 10.1007/s10531-011-0038-8; Schirmel J, 2011, J INSECT CONSERV, V15, P633, DOI 10.1007/s10841-010-9362-7; Schule P, 2000, ROTE LISTE RHEINLAND; Scott AG, 2006, BIOL CONSERV, V127, P420, DOI 10.1016/j.biocon.2005.09.001; Siemann E, 1998, ECOLOGY, V79, P2057, DOI 10.1890/0012-9658(1998)079[2057:ETOEOP]2.0.CO;2; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Ssymank Axel, 1998, Schriftenreihe fuer Landschaftspflege und Naturschutz, V53, P1; Strijker D, 2005, BASIC APPL ECOL, V6, P99, DOI 10.1016/j.baae.2005.01.001; Thiele H. -U., 1977, CARABID BEETLES THEI, DOI 10.1007/978-3-642-81154-8; Vanbergen AJ, 2005, ECOGRAPHY, V28, P3, DOI 10.1111/j.0906-7590.2005.03991.x; VANWINGERDEN WKRE, 1992, J APPL ENTOMOL, V113, P138, DOI 10.1111/j.1439-0418.1992.tb00647.x; Wise DH, 1993, SPIDERS ECOLOGICAL W; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751; Zuur Alain F., 2009, P1; [No title captured]	59	6	7	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e0110854	10.1371/journal.pone.0110854	http://dx.doi.org/10.1371/journal.pone.0110854			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340872	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662800063
J	Singh, SM; Bandi, S; Shah, DD; Armstrong, G; Mallela, KMG				Singh, Surinder M.; Bandi, Swati; Shah, Dinen D.; Armstrong, Geoffrey; Mallela, Krishna M. G.			Missense Mutation Lys18Asn in Dystrophin that Triggers X-Linked Dilated Cardiomyopathy Decreases Protein Stability, Increases Protein Unfolding, and Perturbs Protein Structure, but Does Not Affect Protein Function	PLOS ONE			English	Article							CALPONIN-HOMOLOGY DOMAIN; ACTIN-BINDING DOMAINS; SPECTRIN-LIKE REPEAT; FREE-ENERGY CHANGES; THERMODYNAMIC STABILITY; LINEAR EXTRAPOLATION; GENE; UTROPHIN; DUCHENNE; FAMILY	Genetic mutations in a vital muscle protein dystrophin trigger X-linked dilated cardiomyopathy (XLDCM). However, disease mechanisms at the fundamental protein level are not understood. Such molecular knowledge is essential for developing therapies for XLDCM. Our main objective is to understand the effect of disease-causing mutations on the structure and function of dystrophin. This study is on a missense mutation K18N. The K18N mutation occurs in the N-terminal actin binding domain (N-ABD). We created and expressed the wild-type (WT) N-ABD and its K18N mutant, and purified to homogeneity. Reversible folding experiments demonstrated that both mutant and WT did not aggregate upon refolding. Mutation did not affect the protein's overall secondary structure, as indicated by no changes in circular dichroism of the protein. However, the mutant is thermodynamically less stable than the WT (denaturant melts), and unfolds faster than the WT (stopped-flow kinetics). Despite having global secondary structure similar to that of the WT, mutant showed significant local structural changes at many amino acids when compared with the WT (heteronuclear NMR experiments). These structural changes indicate that the effect of mutation is propagated over long distances in the protein structure. Contrary to these structural and stability changes, the mutant had no significant effect on the actin-binding function as evident from co-sedimentation and depolymerization assays. These results summarize that the K18N mutation decreases thermodynamic stability, accelerates unfolding, perturbs protein structure, but does not affect the function. Therefore, K18N is a stability defect rather than a functional defect. Decrease in stability and increase in unfolding decrease the net population of dystrophin molecules available for function, which might trigger XLDCM. Consistently, XLDCM patients have decreased levels of dystrophin in cardiac muscle.	[Singh, Surinder M.; Bandi, Swati; Shah, Dinen D.; Mallela, Krishna M. G.] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Aurora, CO USA; [Armstrong, Geoffrey] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Mallela, Krishna M. G.] Univ Colorado, Program Struct Biol & Biochem, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Anschutz Medical Campus	Mallela, KMG (corresponding author), Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Anschutz Med Campus, Aurora, CO USA.	krishna.mallela@ucdenver.edu		Mallela, Krishna/0000-0001-8308-5318	American Heart Association [11SDG4880046]; Jane and Charlie Butcher grants in Genomics and Biotechnology; ALSAM Foundation through the Skaggs	American Heart Association(American Heart Association); Jane and Charlie Butcher grants in Genomics and Biotechnology; ALSAM Foundation through the Skaggs	This work was funded by the American Heart Association grant 11SDG4880046, Jane and Charlie Butcher grants in Genomics and Biotechnology, and the ALSAM Foundation through the Skaggs Scholars Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsma-Rus A, 2006, MUSCLE NERVE, V34, P135, DOI 10.1002/mus.20586; Acsadi G, 2012, J BIOL CHEM, V287, P18153, DOI 10.1074/jbc.M111.284521; Bandi S, 2014, BIOCHEMISTRY-US, V53, P2209, DOI 10.1021/bi500120e; BERKO BA, 1987, NEW ENGL J MED, V316, P1186, DOI 10.1056/NEJM198705073161904; Bies RD, 1997, J MOL CELL CARDIOL, V29, P3175, DOI 10.1006/jmcc.1997.0568; Chen Y, 1998, BIOCHEMISTRY-US, V37, P9976, DOI 10.1021/bi980274n; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Ervasti JM, 2007, BBA-MOL BASIS DIS, V1772, P108, DOI 10.1016/j.bbadis.2006.05.010; Feng JN, 2002, MOL GENET METAB, V77, P119, DOI 10.1016/S1096-7192(02)00153-1; Ferlini A, 1998, AM J HUM GENET, V63, P436, DOI 10.1086/301952; FRANZ WM, 1995, ANN NY ACAD SCI, V752, P470, DOI 10.1111/j.1749-6632.1995.tb17457.x; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Henderson DM, 2011, HUM MOL GENET, V20, P2955, DOI 10.1093/hmg/ddr199; Henderson DM, 2010, P NATL ACAD SCI USA, V107, P9632, DOI 10.1073/pnas.1001517107; Huang X, 2000, NAT STRUCT BIOL, V7, P634, DOI 10.1038/77923; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Kahana E, 1997, CELL MOTIL CYTOSKEL, V36, P246; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Legardinier S, 2009, J BIOL CHEM, V284, P8822, DOI 10.1074/jbc.M805846200; Lehrer SS, 1997, METHOD ENZYMOL, V278, P286; Mayer S, 2007, J MOL BIOL, V372, P268, DOI 10.1016/j.jmb.2007.06.044; Milasin J, 1996, HUM MOL GENET, V5, P73, DOI 10.1093/hmg/5.1.73; Mirza A, 2008, BBA-PROTEINS PROTEOM, V1784, P1301, DOI 10.1016/j.bbapap.2008.05.010; Mirza A, 2010, BBA-PROTEINS PROTEOM, V1804, P1796, DOI 10.1016/j.bbapap.2010.03.009; MUNTONI F, 1995, AM J HUM GENET, V56, P151; MUNTONI F, 1995, J CLIN INVEST, V96, P693, DOI 10.1172/JCI118112; Muntoni F, 1997, HEART, V78, P608, DOI 10.1136/hrt.78.6.608; MUNTONI F, 1993, NEW ENGL J MED, V329, P921, DOI 10.1056/NEJM199309233291304; Muthu M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040066; Norwood FLM, 2000, STRUCTURE, V8, P481, DOI 10.1016/S0969-2126(00)00132-5; OrtizLopez R, 1997, CIRCULATION, V95, P2434, DOI 10.1161/01.CIR.95.10.2434; Pace C N, 1986, Methods Enzymol, V131, P266; Royer CA, 2006, CHEM REV, V106, P1769, DOI 10.1021/cr0404390; Ruszczak C, 2009, BBA-PROTEINS PROTEOM, V1794, P921, DOI 10.1016/j.bbapap.2009.02.016; Rybakova IN, 2006, J BIOL CHEM, V281, P9996, DOI 10.1074/jbc.M513121200; Sahni N, 2012, BBA-PROTEINS PROTEOM, V1824, P1080, DOI 10.1016/j.bbapap.2012.06.011; SANTORO MM, 1992, BIOCHEMISTRY-US, V31, P4901, DOI 10.1021/bi00135a022; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Singh SM, 2014, BIOCHEMISTRY-US, V53, P1801, DOI 10.1021/bi500149q; Singh SM, 2012, BIOPHYS J, V103, P1970, DOI 10.1016/j.bpj.2012.08.066; Singh SM, 2012, PROTEINS, V80, P1377, DOI 10.1002/prot.24033; Singh SM, 2010, P NATL ACAD SCI USA, V107, P15069, DOI 10.1073/pnas.1008818107; Sutherland-Smith AJ, 2003, J MOL BIOL, V329, P15, DOI 10.1016/S0022-2836(03)00422-4; Sweeney HL, 2000, P NATL ACAD SCI USA, V97, P13464, DOI 10.1073/pnas.011510597; TAL M, 1985, J BIOL CHEM, V260, P9976; Thibodeau PH, 2005, NAT STRUCT MOL BIOL, V12, P10, DOI 10.1038/nsmb881; Toledo D, 2011, J BIOL CHEM, V286, P39993, DOI 10.1074/jbc.M110.201517; TOWBIN JA, 1993, CIRCULATION, V87, P1854, DOI 10.1161/01.CIR.87.6.1854; WAY M, 1992, J CELL BIOL, V119, P835, DOI 10.1083/jcb.119.4.835; Winder SJ, 1997, J MUSCLE RES CELL M, V18, P617, DOI 10.1023/A:1018627705273; Yoshida K, 1998, HUM MOL GENET, V7, P1129, DOI 10.1093/hmg/7.7.1129; Yue P, 2005, J MOL BIOL, V353, P459, DOI 10.1016/j.jmb.2005.08.020	54	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110439	10.1371/journal.pone.0110439	http://dx.doi.org/10.1371/journal.pone.0110439			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340340	gold, Green Published, Green Submitted			2022-12-27	WOS:000343662800037
J	Upadhyaya, JD; Singh, N; Sikarwar, AS; Chakraborty, R; Pydi, SP; Bhullar, RP; Dakshinamurti, S; Chelikani, P				Upadhyaya, Jasbir D.; Singh, Nisha; Sikarwar, Anurag S.; Chakraborty, Raja; Pydi, Sai P.; Bhullar, Rajinder P.; Dakshinamurti, Shyamala; Chelikani, Prashen			Dextromethorphan Mediated Bitter Taste Receptor Activation in the Pulmonary Circuit Causes Vasoconstriction	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; GASTROINTESTINAL-TRACT; NORMOTENSIVE RATS; CELLS; VESSELS; MODULATION; EXPRESSION; RESPONSES; MYOCYTES; INSIGHTS	Activation of bitter taste receptors (T2Rs) in human airway smooth muscle cells leads to muscle relaxation and bronchodilation. This finding led to our hypothesis that T2Rs are expressed in human pulmonary artery smooth muscle cells and might be involved in regulating the vascular tone. RT-PCR was performed to reveal the expression of T2Rs in human pulmonary artery smooth muscle cells. Of the 25 T2Rs, 21 were expressed in these cells. Functional characterization was done by calcium imaging after stimulating the cells with different bitter agonists. Increased calcium responses were observed with most of the agonists, the largest increase seen for dextromethorphan. Previously in site-directed mutational studies, we have characterized the response of T2R1 to dextromethorphan, therefore, T2R1 was selected for further analysis in this study. Knockdown with T2R1 specific shRNA decreased mRNA levels, protein levels and dextromethorphan-induced calcium responses in pulmonary artery smooth muscle cells by up to 50%. To analyze if T2Rs are involved in regulating the pulmonary vascular tone, ex vivo studies using pulmonary arterial and airway rings were pursued. Myographic studies using porcine pulmonary arterial and airway rings showed that stimulation with dextromethorphan led to contraction of the pulmonary arterial and relaxation of the airway rings. This study shows that dextromethorphan, acting through T2R1, causes vasoconstrictor responses in the pulmonary circuit and relaxation in the airways.	[Upadhyaya, Jasbir D.; Singh, Nisha; Chakraborty, Raja; Pydi, Sai P.; Bhullar, Rajinder P.; Chelikani, Prashen] Univ Manitoba, Dept Oral Biol, Winnipeg, MB, Canada; [Sikarwar, Anurag S.; Dakshinamurti, Shyamala] Univ Manitoba, Dept Pediat, Winnipeg, MB R3T 2N2, Canada; [Dakshinamurti, Shyamala; Chelikani, Prashen] Manitoba Inst Child Hlth, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba	Chelikani, P (corresponding author), Univ Manitoba, Dept Oral Biol, Winnipeg, MB, Canada.	Prashen.Chelikani@umanitoba.ca	Upadhyaya, Jasbir/L-4724-2019; Chakraborty, Raja/L-6316-2017; Pydi, sai Prasad/M-9017-2016	Upadhyaya, Jasbir/0000-0003-0815-2108; Pydi, sai Prasad/0000-0001-7170-6519; Chelikani, Prashen/0000-0003-1129-7957; Singh, Nisha/0000-0003-0330-6411	Manitoba Institute of Child Health [OG 2011-0]; Natural Sciences and Engineering Research Council of Canada [RGPIN 356285]; MHRC/MICH; MMSF Allen Rouse Career Award	Manitoba Institute of Child Health; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); MHRC/MICH; MMSF Allen Rouse Career Award	This work was supported by grants from the Manitoba Institute of Child Health (OG 2011-0), and Natural Sciences and Engineering Research Council of Canada (RGPIN 356285) to PC. Graduate studentships from MHRC/MICH to AS, RC and PSP, and a MMSF Allen Rouse Career Award to PC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Y, 2008, BRIT J PHARMACOL, V153, P926, DOI 10.1038/sj.bjp.0707575; Angus JA, 2000, J PHARMACOL TOX MET, V44, P395, DOI 10.1016/S1056-8719(00)00121-0; Born S, 2013, J NEUROSCI, V33, P201, DOI 10.1523/JNEUROSCI.3248-12.2013; Carrillo-Sepulveda MA, 2010, MOL CELL BIOCHEM, V341, P279, DOI 10.1007/s11010-010-0459-9; Chakraborty R, 2013, MOL CELL BIOL, V33, P184, DOI 10.1128/MCB.00725-12; Clark AA, 2012, FASEB J, V26, P4827, DOI 10.1096/fj.12-215087; Colombo M, 2012, J ANIM SCI, V90, P128, DOI 10.2527/jas.53793; Conte C, 2002, CYTOGENET GENOME RES, V98, P45, DOI 10.1159/000068546; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Dotson CD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003974; Fediuk J, 2012, AM J PHYSIOL-LUNG C, V302, pL13, DOI 10.1152/ajplung.00016.2011; Finger TE, 2003, P NATL ACAD SCI USA, V100, P8981, DOI 10.1073/pnas.1531172100; Foster SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064579; Glendinning JI, 2008, PHYSIOL BEHAV, V93, P757, DOI 10.1016/j.physbeh.2007.11.029; Gong Y, 2010, FREE RADICAL BIO MED, V48, P882, DOI 10.1016/j.freeradbiomed.2010.01.009; Hao S, 2009, AM J PHYSIOL-REG I, V296, pR528, DOI 10.1152/ajpregu.90423.2008; Hinton M, 2007, AM J PHYSIOL-LUNG C, V292, pL654, DOI 10.1152/ajplung.00229.2006; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Lund TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058945; Manson ML, 2014, EUR J PHARMACOL, V740, P302, DOI 10.1016/j.ejphar.2014.07.005; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; Munzel T, 2002, ARTERIOSCL THROM VAS, V22, P1761, DOI 10.1161/01.ATV.0000034022.11764.EC; Pydi SP, 2012, CURR PROTEIN PEPT SC, V13, P501; Pydi SP, 2012, J NEUROCHEM, V122, P537, DOI 10.1111/j.1471-4159.2012.07808.x; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Shi P, 2003, MOL BIOL EVOL, V20, P805, DOI 10.1093/molbev/msg083; Shimoda LA, 2000, AM J PHYSIOL-LUNG C, V279, pL884, DOI 10.1152/ajplung.2000.279.5.L884; SILVER PJ, 1986, J CARDIOVASC PHARM, V8, pS34; Singh N, 2011, J BIOL CHEM, V286, P36032, DOI 10.1074/jbc.M111.246983; Singh N, 2011, BIOCHEM BIOPH RES CO, V406, P146, DOI 10.1016/j.bbrc.2011.02.016; Tizzano M, 2010, P NATL ACAD SCI USA, V107, P3210, DOI 10.1073/pnas.0911934107; Upadhyaya J, 2010, BIOCHEM BIOPH RES CO, V398, P331, DOI 10.1016/j.bbrc.2010.06.097; Wu SV, 2002, P NATL ACAD SCI USA, V99, P2392, DOI 10.1073/pnas.042617699; Wu TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046067; Xu J, 2013, MOL HUM REPROD, V19, P17, DOI 10.1093/molehr/gas040; Zhang CH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001501; Zhang W, 2004, FASEB J, V18, P395, DOI 10.1096/fj.04-1586fje	38	30	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110373	10.1371/journal.pone.0110373	http://dx.doi.org/10.1371/journal.pone.0110373			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340739	Green Submitted, Green Published, gold			2022-12-27	WOS:000343662800032
J	Chao, YH; Wu, HP; Wu, KH; Tsai, YG; Peng, CT; Lin, KC; Chao, WR; Lee, MS; Fu, YC				Chao, Yu-Hua; Wu, Han-Ping; Wu, Kang-Hsi; Tsai, Yi-Giien; Peng, Ching-Tien; Lin, Kuan-Chia; Chao, Wan-Ru; Lee, Maw-Sheng; Fu, Yun-Ching			An Increase in CD3+CD4+CD25+Regulatory T Cells after Administration of Umbilical Cord-Derived Mesenchymal Stem Cells during Sepsis	PLOS ONE			English	Article							STROMAL CELLS; BACTERIAL CLEARANCE; SURVIVAL; COTRANSPLANTATION; REDUCE; TRANSPLANTATION; INFLAMMATION; MECHANISMS; GENERATION; MSCS	Sepsis remains an important cause of death worldwide, and vigorous immune responses during sepsis could be beneficial for bacterial clearance but at the price of collateral damage to self tissues. Mesenchymal stem cells (MSCs) have been found to modulate the immune system and attenuate sepsis. In the present study, MSCs derived from bone marrow and umbilical cord were used and compared. With a cecal ligation and puncture (CLP) model, the mechanisms of MSC-mediated immunoregulation during sepsis were studied by determining the changes of circulating inflammation-associated cytokine profiles and peripheral blood mononuclear cells 18 hours after CLP-induced sepsis. In vitro, bone marrow-derived MSCs (BMMSCs) and umbilical cord-derived MSCs (UCMSCs) showed a similar morphology and surface marker expression. UCMSCs had stronger potential for osteogenesis but lower for adipogenesis than BMMSCs. Compared with rats receiving PBS only after CLP, the percentage of circulating CD3+CD4+CD25+ regulatory T (Treg) cells and the ratio of Treg cells/T cells were elevated significantly in rats receiving MSCs. Further experiment regarding Treg cell function demonstrated that the immunosuppressive capacity of Treg cells from rats with CLP-induced sepsis was decreased, but could be restored by administration of MSCs. Compared with rats receiving PBS only after CLP, serum levels of interleukin-6 and tumor necrosis factor-a were significantly lower in rats receiving MSCs after CLP. There were no differences between BMMSCs and UCMSCs. In summary, this work provides the first in vivo evidence that administering BMMSCs or UCMSCs to rats with CLP-induced sepsis could increase circulating CD3+CD4+CD25+ Treg cells and Treg cells/T cells ratio, enhance Treg cell suppressive function, and decrease serum levels of interleukin-6 and tumor necrosis factor-a, suggesting the immunomodulatory association of Treg cells and MSCs during sepsis.	[Chao, Yu-Hua; Chao, Wan-Ru; Lee, Maw-Sheng] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Chao, Yu-Hua] Chung Shan Med Univ Hosp, Dept Pediat, Taichung, Taiwan; [Chao, Yu-Hua; Tsai, Yi-Giien; Chao, Wan-Ru] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Wu, Han-Ping] Buddhist Med Fdn, Taichung Tzuchi Hosp, Dept Pediat, Taichung, Taiwan; [Wu, Han-Ping] Tzu Chi Univ, Dept Med, Hualien, Taiwan; [Wu, Kang-Hsi; Peng, Ching-Tien] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Wu, Kang-Hsi; Peng, Ching-Tien] China Med Univ, China Med Univ Hosp, Childrens Hosp, Dept Hematooncol, Taichung, Taiwan; [Tsai, Yi-Giien] Changhua Christian Hosp, Dept Pediat, Changhua, Taiwan; [Tsai, Yi-Giien] Kaohsiung Med Univ, Sch Med, Kaohsiung, Taiwan; [Peng, Ching-Tien] Asia Univ, Dept Biotechnol & Bioinformat, Taichung, Taiwan; [Lin, Kuan-Chia] Natl Taipei Univ Nursing & Hlth Sci, Sch Nursing, Taipei, Taiwan; [Lin, Kuan-Chia] Natl Taipei Univ Nursing & Hlth Sci, Life Course Epidemiol & Human Dev Res Grp, Taipei, Taiwan; [Chao, Wan-Ru] Chung Shan Med Univ Hosp, Dept Pathol, Taichung, Taiwan; [Lee, Maw-Sheng] Chung Shan Med Univ Hosp, Dept Obstet & Gynecol, Taichung, Taiwan; [Fu, Yun-Ching] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Fu, Yun-Ching] Taichung Vet Gen Hosp, Dept Pediat, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Tzu Chi University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Changhua Christian Hospital; Kaohsiung Medical University; Asia University Taiwan; National Taipei University of Nursing & Health Science (NTUNHS); National Taipei University of Nursing & Health Science (NTUNHS); Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital	Lee, MS (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.	kso579@hotmail.com.tw; 8850ar@hotmail.com.tw		Chao, Yu-Hua/0000-0003-1727-5847	Chung Shan Medical University Hospital [CSH-2014-C-029]; China Medical University Hospital [DMR-103-037]; Research Laboratory of Pediatrics, Children's Hospital, China Medical University; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW103-TDU-B-212-113002]	Chung Shan Medical University Hospital; China Medical University Hospital; Research Laboratory of Pediatrics, Children's Hospital, China Medical University; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence	The study was supported by the Chung Shan Medical University Hospital (CSH-2014-C-029), the China Medical University Hospital (DMR-103-037), the Research Laboratory of Pediatrics, Children's Hospital, China Medical University, and the Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW103-TDU-B-212-113002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Ball LM, 2007, BLOOD, V110, P2764, DOI 10.1182/blood-2007-04-087056; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; Cambos M, 2008, INT J PARASITOL, V38, P229, DOI 10.1016/j.ijpara.2007.07.006; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Casiraghi F, 2008, J IMMUNOL, V181, P3933, DOI 10.4049/jimmunol.181.6.3933; Chan CK, 2012, TRANSPLANTATION, V94, P132, DOI 10.1097/TP.0b013e31825940a4; Chao YH, 2011, BONE MARROW TRANSPL, V46, P1391, DOI 10.1038/bmt.2010.305; Chao YH, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/759503; Chao YH, 2010, ANN HEMATOL, V89, P715, DOI 10.1007/s00277-009-0892-6; Engela AU, 2013, CLIN EXP IMMUNOL, V173, P343, DOI 10.1111/cei.12120; English K, 2009, CLIN EXP IMMUNOL, V156, P149, DOI 10.1111/j.1365-2249.2009.03874.x; English K, 2013, IMMUNOL CELL BIOL, V91, P19, DOI 10.1038/icb.2012.56; Fry DE, 2012, AM SURGEON, V78, P1; Ge W, 2010, TRANSPLANTATION, V90, P1312, DOI 10.1097/TP.0b013e3181fed001; Gonzalez MA, 2009, GASTROENTEROLOGY, V136, P978, DOI 10.1053/j.gastro.2008.11.041; Gonzalez-Rey E, 2009, GUT, V58, P929, DOI 10.1136/gut.2008.168534; Hall SRR, 2013, STEM CELLS, V31, P397, DOI 10.1002/stem.1270; Heuer JG, 2005, J IMMUNOL, V174, P7141, DOI 10.4049/jimmunol.174.11.7141; Ivanova-Todorova E, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/295167; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Kavanagh H, 2011, ALLERGY, V66, P523, DOI 10.1111/j.1398-9995.2010.02509.x; Krasnodembskaya A, 2012, AM J PHYSIOL-LUNG C, V302, pL1003, DOI 10.1152/ajplung.00180.2011; Kuhlhorn F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065109; Kyriakou C, 2008, HAEMATOL-HEMATOL J, V93, P1457, DOI 10.3324/haematol.12553; Lazarus HM, 2005, BIOL BLOOD MARROW TR, V11, P389, DOI 10.1016/j.bbmt.2005.02.001; Lee WI, 2011, IMMUNOBIOLOGY, V216, P1286, DOI 10.1016/j.imbio.2011.06.002; Mei SHJ, 2010, AM J RESP CRIT CARE, V182, P1047, DOI 10.1164/rccm.201001-0010OC; Moghadasali R, 2013, EXP TOXICOL PATHOL, V65, P595, DOI 10.1016/j.etp.2012.06.002; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Perico N, 2011, CLIN J AM SOC NEPHRO, V6, P412, DOI 10.2215/CJN.04950610; Rasmusson I, 2006, EXP CELL RES, V312, P2169, DOI 10.1016/j.yexcr.2006.03.019; Sun J, 2011, CELL PHYSIOL BIOCHEM, V27, P587, DOI 10.1159/000329980; Sze SK, 2007, MOL CELL PROTEOMICS, V6, P1680, DOI 10.1074/mcp.M600393-MCP200; Tsai YG, 2010, J IMMUNOL, V184, P7229, DOI 10.4049/jimmunol.1000083; Wisnoski N, 2007, SHOCK, V27, P251, DOI 10.1097/01.shk.0000239780.33398.e4; Wu HP, 2012, WORLD J SURG, V36, P216, DOI 10.1007/s00268-011-1310-5; Wu KH, 2013, CELL TRANSPLANT, V22, P723, DOI 10.3727/096368912X655217; Wu KH, 2013, TRANSPLANTATION, V95, P773, DOI 10.1097/TP.0b013e31827a93dd; Wu KH, 2011, TRANSPLANTATION, V91, P1412, DOI 10.1097/TP.0b013e31821aba18; Yagi H, 2010, CELL TRANSPLANT, V19, P667, DOI 10.3727/096368910X508762	42	52	60	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110338	10.1371/journal.pone.0110338	http://dx.doi.org/10.1371/journal.pone.0110338			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337817	Green Published, gold, Green Submitted			2022-12-27	WOS:000343674800036
J	Madella, M; Garcia-Granero, JJ; Out, WA; Ryan, P; Usai, D				Madella, Marco; Jose Garcia-Granero, Juan; Out, Welmoed A.; Ryan, Philippa; Usai, Donatella			Microbotanical Evidence of Domestic Cereals in Africa 7000 Years Ago	PLOS ONE			English	Article							INFLORESCENCE PHYTOLITHS	The study of plant exploitation and early use of cereals in Africa has seen over the years a great input from charred and desiccated macrobotanical remains. This paper presents the results of one of the few examples in Africa of microbotanical analyses. Three grave contexts of phytolith-rich deposits and the dental calculus of 20 individuals were analysed from two Neolithic cemeteries in North and Central Sudan. The radiocarbon-dated phytoliths from the burial samples show the presence of Near East domestic cereals in Northern Sudan at least 7000 years ago. Phytoliths also indicate the exploitation of wild, savannah-adapted millets in Central Sudan between 7500 and 6500 years ago. The calculus samples contained starch grains from wheat/barley, pulses and millets, as well as panicoid phytoliths. This evidence shows that Near East domestic cereals were consumed in Northern Africa at least 500 years earlier than previously thought.	[Madella, Marco; Jose Garcia-Granero, Juan] Complex & Socio Ecol Dynam Res Grp CaSEs, Barcelona, Spain; [Madella, Marco] Univ Pompeu Fabra, Dept Humanities, ICREA, Barcelona, Spain; [Jose Garcia-Granero, Juan] Spanish Natl Res Council, CSIC, Inst Mila & Fontanals, Dept Archaeol & Anthropol, Barcelona, Spain; [Out, Welmoed A.] Univ Kiel, Grad Sch Human Dev Landscapes, Kiel, Germany; [Ryan, Philippa] British Museum, Dept Conservat & Sci Res, London WC1B 3DG, England; [Ryan, Philippa] UCL, Inst Archaeol, London, England; [Usai, Donatella] Ctr Studi Sudanesi & Sub Sahariani, Treviso, Italy	ICREA; Pompeu Fabra University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institucion Mila y Fontanals (IMF); University of Kiel; Natural History Museum London; University of London; University College London	Madella, M (corresponding author), Complex & Socio Ecol Dynam Res Grp CaSEs, Barcelona, Spain.	marco.madella@icrea.cat	Madella, Marco/M-3320-2014; Usai, Donatella/AAY-4536-2020; 稳稳, 余/O-9090-2014; Out, Welmoed/K-5144-2017	Madella, Marco/0000-0002-9324-1545; Usai, Donatella/0000-0001-9379-9015; Out, Welmoed/0000-0001-7262-5358; ryan, philippa/0000-0001-6645-9744; Garcia-Granero, Juan Jose/0000-0002-7546-2176	Spanish National Research Council; European Social Fund; E. U. Marie Curie Intra-European Fellowship [273610]; AHRC Research Grant [AH/K006193/1]; ICREA Funding Source: Custom; AHRC [AH/K006193/1] Funding Source: UKRI; Arts and Humanities Research Council [AH/K006193/1] Funding Source: researchfish	Spanish National Research Council; European Social Fund(European Social Fund (ESF)); E. U. Marie Curie Intra-European Fellowship; AHRC Research Grant(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); ICREA(ICREA); AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))	J. J. G. G. received a salary from a JAE Predoc scholarship from the Spanish National Research Council and the European Social Fund. W. A. O. received a salary from an E. U. Marie Curie Intra-European Fellowship (273610). P. R. received a salary from an AHRC Research Grant (AH/K006193/1). The authors received no specific research funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, COMPLUTUM; Ball TB, 1999, AM J BOT, V86, P1615, DOI 10.2307/2656798; Barakat H, 1999, THE EXPLOITATION OF, P33; Barich BE, 1998, PEOPLE WATER AND GRA; Caneva I, 1988, THE HISTORY OF A MID; Castelletti L., 1999, UAN AFUDA CAVE HUNTE, V1, P131; Clark JD, 1984, HUNTERS FARMERS CAUS, P113; Crowther A, 2009, ARCHAEOBOTANICAL ONL; Dittrich A, 2011, ZUR NEOLITHISIERUNG; Edwards DN, 2007, ANNU REV ANTHROPOL, V36, P211, DOI 10.1146/annurev.anthro.36.081406.094305; Fuller DQ, 2004, PROCEEDINGS OF THE N, P265; Haland R, 1987, SOCIO ECONOMIC DIFFE; Harlan J, 1987, FORAGING AND FARMING, P335; Haslam M, 2004, J ARCHAEOL SCI, V31, P1715, DOI 10.1016/j.jas.2004.05.006; Iacumin P, 2008, NEOLITHIC CEMETERY N, P113; Judd M, 2008, NEOLITHIC CEMETERY N, P83; KRZYZANIAK L, 1991, ANTIQUITY, V65, P515, DOI 10.1017/S0003598X0008011X; Lu HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004448; Macklin MG, 2013, GEOLOGY, V41, P695, DOI 10.1130/G34037.1; Madella M, 1998, J ARCHAEOL SCI, V25, P801, DOI 10.1006/jasc.1997.0226; Madella M, 2016, ARCHAEOL ANTHROP SCI, V8, P17, DOI 10.1007/s12520-013-0130-y; Magid AA, 1989, AN ARCHAEOETHNOBOTAN; Mercuri AM, 2007, FIELDS OF CHANGE PRO, P87; Mohammed-Ali A., 1991, THE LATE PREHISTORY, P193; NEUMANN K, 2005, AFRICAN ARCHAEOLOGY, P249; Neumann K, 2000, WOODS OF THE SAHARA; Parr JF, 2005, SOIL BIOL BIOCHEM, V37, P117, DOI 10.1016/j.soilbio.2004.06.013; Pollath N., 2008, NEOLITHIC CEMETERY N, P59; Portillo M, 2006, ECON BOT, V60, P121, DOI 10.1663/0013-0001(2006)60[121:MAOIPP]2.0.CO;2; Radomski KU., 2011, WINDOWS AFRICAN CURR, P153; Reinold J, 2000, ARCHEOLOGIE AU SOUDA, P144; Reinold J., 1994, HOMMAGES A JEAN LECL, P351; Rosen A.M., 1992, PHYTOLITH SYSTEMATIC, P129; Ryan P, 2011, J ANTHROPOL ARCHAEOL, V30, P292, DOI 10.1016/j.jaa.2011.06.002; Salvatori S, 2008, NEOLITHIC CEMETERY N, P147; Salvatori S., 2007, CRIPPEL, V26, P323; Salvatori S, 2008, NEOLITHIC CEMETERY N, P161; Salvatori S., 2008, NEOLITHIC CEMETERY N, P1; Salvatori S, 2012, AFR ARCHAEOL REV, V29, P399, DOI 10.1007/s10437-012-9119-7; Tsartsidou G, 2007, J ARCHAEOL SCI, V34, P1262, DOI 10.1016/j.jas.2006.10.017; Usai D, 2005, J AFR ARCHAEOL, V3, P103, DOI DOI 10.3213/1612-1651-10039; Usai D, 2008, J AFR ARCHAEOL, V6, P219, DOI 10.3213/1612-1651-10112; Wasylikowa K., 1992, ORIGINI, V16, P125; Wendrich W, 2010, NUCL INSTRUM METH B, V268, P999, DOI 10.1016/j.nimb.2009.10.083; Wetterstrom W, 1998, REV ARCHAEOLOGY, V19, P30; WILDING LP, 1967, SCIENCE, V156, P66, DOI 10.1126/science.156.3771.66; Williams MAJ, 2010, QUATERNARY SCI REV, V29, P1116, DOI 10.1016/j.quascirev.2010.02.018; Young R, 1999, VEG HIST ARCHAEOBOT, V8, P31, DOI 10.1007/BF02042840; Zhang JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019726; Zohary D, 2012, DOMESTICATION OF PLANTS IN THE OLD WORLD: THE ORIGIN AND SPREAD OF DOMESTICATED PLANTS IN SOUTH-WEST ASIA, EUROPE, AND THE MEDITERRANEAN BASIN, 4TH EDITION, P1, DOI 10.1093/acprof:osobl/9780199549061.001.0001	50	52	54	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110177	10.1371/journal.pone.0110177	http://dx.doi.org/10.1371/journal.pone.0110177			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AR6DY	25338096	gold, Green Published, Green Submitted			2022-12-27	WOS:000343674800027
J	Nuti, SV; Wayda, B; Ranasinghe, I; Wang, SS; Dreyer, RP; Chen, SI; Murugiah, K				Nuti, Sudhakar V.; Wayda, Brian; Ranasinghe, Isuru; Wang, Sisi; Dreyer, Rachel P.; Chen, Serene I.; Murugiah, Karthik			The Use of Google Trends in Health Care Research: A Systematic Review	PLOS ONE			English	Article							INTERNET SEARCH TRENDS; ENGINE QUERY DATA; SEASONAL-VARIATION; SUICIDE DEATH; SURVEILLANCE; DISEASE; INFORMATION; INFECTION; BEHAVIOR; FLU	Background: Google Trends is a novel, freely accessible tool that allows users to interact with Internet search data, which may provide deep insights into population behavior and health-related phenomena. However, there is limited knowledge about its potential uses and limitations. We therefore systematically reviewed health care literature using Google Trends to classify articles by topic and study aim; evaluate the methodology and validation of the tool; and address limitations for its use in research. Methods and Findings: PRISMA guidelines were followed. Two independent reviewers systematically identified studies utilizing Google Trends for health care research from MEDLINE and PubMed. Seventy studies met our inclusion criteria. Google Trends publications increased seven-fold from 2009 to 2013. Studies were classified into four topic domains: infectious disease (27% of articles), mental health and substance use (24%), other non-communicable diseases (16%), and general population behavior (33%). By use, 27% of articles utilized Google Trends for casual inference, 39% for description, and 34% for surveillance. Among surveillance studies, 92% were validated against a reference standard data source, and 80% of studies using correlation had a correlation statistic >= 0.70. Overall, 67% of articles provided a rationale for their search input. However, only 7% of articles were reproducible based on complete documentation of search strategy. We present a checklist to facilitate appropriate methodological documentation for future studies. A limitation of the study is the challenge of classifying heterogeneous studies utilizing a novel data source. Conclusion: Google Trends is being used to study health phenomena in a variety of topic domains in myriad ways. However, poor documentation of methods precludes the reproducibility of the findings. Such documentation would enable other researchers to determine the consistency of results provided by Google Trends for a well-specified query over time. Furthermore, greater transparency can improve its reliability as a research tool.	[Nuti, Sudhakar V.; Ranasinghe, Isuru; Dreyer, Rachel P.; Murugiah, Karthik] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Wayda, Brian; Chen, Serene I.] Yale Univ, Sch Med, New Haven, CT USA; [Wang, Sisi] Yale Univ, Sch Publ Hlth, New Haven, CT USA	Yale University; Yale University; Yale University	Murugiah, K (corresponding author), Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA.	karthik.murugiah@yale.edu	PAN, ZEQIANG/X-6341-2018	Murugiah, Karthik/0000-0001-7932-382X; Wayda, Brian/0000-0001-7005-9938; Dreyer, Rachel/0000-0003-2861-1383; Ranasinghe, Isuru/0000-0003-0982-1561				Althouse BM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001258; [Anonymous], 2011, CIT AV 2000 2010 FIE; Asendorpf JB, 2013, EUR J PERSONALITY, V27, P108, DOI 10.1002/per.1919; Ayers JW, 2014, PREV MED, V58, P81, DOI 10.1016/j.ypmed.2013.11.007; Ayers JW, 2013, AM J PREV MED, V44, P520, DOI 10.1016/j.amepre.2013.01.012; Ayers JW, 2012, J AFFECT DISORDERS, V142, P323, DOI 10.1016/j.jad.2012.05.005; Ayers JW, 2012, J MED INTERNET RES, V14, P288, DOI 10.2196/jmir.2148; Ayers JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016777; Ayers JW, 2011, AM J PREV MED, V40, P448, DOI 10.1016/j.amepre.2010.12.007; Ayers JW, 2013, NICOTINE TOB RES; Barrett-Connor E., 2011, NATIONWIDE FRAMEWORK; Bentley RA, 2010, SOC SCI MED, V71, P482, DOI 10.1016/j.socscimed.2010.03.042; Bragazzi NL, 2014, PSYCHOL RES BEHAV MA, V7, P1, DOI 10.2147/PRBM.S44084; Bragazzi NL, 2013, MULT SCLER INT, V2013, DOI DOI 10.1155/2013/924029; Braun T, 2013, EUR ARCH OTO-RHINO-L, V270, P2157, DOI 10.1007/s00405-013-2532-y; Breyer BN, 2010, EPIDEMIOLOGY, V21, P584, DOI 10.1097/EDE.0b013e3181e080cd; Bright SJ, 2013, INT J DRUG POLICY, V24, P231, DOI 10.1016/j.drugpo.2012.12.002; Brigo F, 2014, EPILEPSY BEHAV, V31, P67, DOI 10.1016/j.yebeh.2013.11.020; Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; Carneiro HA, 2009, CLIN INFECT DIS, V49, P1557, DOI 10.1086/630200; Carr LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048158; Cho SI, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067618, 10.1371/journal.pone.0081422]; Choi HY, 2012, ECON REC, V88, P2, DOI 10.1111/j.1475-4932.2012.00809.x; Connolly MP, 2009, REPROD BIOMED ONLINE, V19, P767, DOI 10.1016/j.rbmo.2009.09.032; Davis NF, 2013, UROLOGY, V82, P1189, DOI 10.1016/j.urology.2013.06.027; Davis NF, 2012, BJU INT, V110, pE939, DOI 10.1111/j.1464-410X.2012.11237.x; Desai R, 2012, CLIN INFECT DIS, V55, pE75, DOI 10.1093/cid/cis579; Desai R, 2012, CLIN INFECT DIS, V54, pCP8, DOI 10.1093/cid/cis121; Dukic VM, 2011, EMERG INFECT DIS, V17, P1068, DOI [10.3201/eid1706.101451, 10.3201/eid/1706.101451]; Fenichel EP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058249; Forsyth AJM, 2012, INT J DRUG POLICY, V23, P198, DOI 10.1016/j.drugpo.2011.12.003; Frijters P, 2013, SOC SCI MED, V84, P61, DOI 10.1016/j.socscimed.2013.01.028; Gallagher CT, 2012, HUM PSYCHOPHARM CLIN, V27, P106, DOI 10.1002/hup.1255; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Glynn RW, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-442; Google, 2014, GOOGL TRENDS HELP; Google, 2014, TYP YOUR SEARCH TERM; Google, 2014, GOOGLE TRENDS; Gunn JF, 2013, J AFFECT DISORDERS, V148, P411, DOI 10.1016/j.jad.2012.11.004; Hagihara A, 2012, EUR ARCH PSY CLIN N, V262, P39, DOI 10.1007/s00406-011-0212-8; Harsha AK, 2014, J VASC INTERV RADIOL, V25, P53, DOI 10.1016/j.jvir.2013.09.015; Hill S, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1722; Huang JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065577; Ingram DG, 2013, SLEEP MED, V14, P1364, DOI 10.1016/j.sleep.2013.06.016; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jena AB, 2013, CLIN INFECT DIS, V56, P1352, DOI 10.1093/cid/cit022; Johnson AK, 2014, SEX TRANSM DIS, V41, P61, DOI 10.1097/OLQ.0000000000000065; Kang MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079823; Kerr N L, 1998, Pers Soc Psychol Rev, V2, P196, DOI 10.1207/s15327957pspr0203_4; Kicinski M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081823; Kostkova P, 2013, J MED INTERNET RES, V15, P167, DOI 10.2196/jmir.2146; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; Leffler CT, 2010, CAN J OPHTHALMOL, V45, P274, DOI 10.3129/i10-022; Leonhardt David, 2006, NY TIMES; Liu R, 2012, J ANESTH CLIN RES, V3; Markey PM, 2013, ARCH SEX BEHAV, V42, P515, DOI 10.1007/s10508-012-9996-5; McCarthy MJ, 2010, J AFFECT DISORDERS, V122, P277, DOI 10.1016/j.jad.2009.08.015; McDonnell WM, 2012, AM J EMERG MED, V30, P275, DOI 10.1016/j.ajem.2010.11.027; Metcalfe D, 2011, J PUBLIC HEALTH-UK, V33, P80, DOI 10.1093/pubmed/fdq052; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mondria J, 2013, CAN J ECON, V46, P310, DOI 10.1111/caje.12013; Murugiah K, 2014, SURG OBES RELAT DIS, V10, P369, DOI 10.1016/j.soard.2013.12.013; Murugiah K, 2010, RESUSCITATION, V81, P1733, DOI 10.1016/j.resuscitation.2010.07.020; Mytton OT, 2012, EUROSURVEILLANCE, V17, P11; Page A, 2011, AUST NZ J PSYCHIAT, V45, P1020, DOI 10.3109/00048674.2011.623660; Pelat C, 2009, EMERG INFECT DIS, V15, P1327, DOI 10.3201/eid1508.090299; Polkowska A, 2012, EUROSURVEILLANCE, V17, P8; Popper K.R., 1959, LOGIC SCI DISCOVERY; Reis BY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-514; Rossignol L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076020; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; Samaras L, 2012, INFORM HEALTH SOC CA, V37, P106, DOI 10.3109/17538157.2011.647934; Schuster NM, 2010, AM J MANAG CARE, V16, pE215; Seifter A, 2010, GEOSPATIAL HEALTH, V4, P135, DOI 10.4081/gh.2010.195; Song TM, 2014, YONSEI MED J, V55, P254, DOI 10.3349/ymj.2014.55.1.254; Stein JD, 2013, CORNEA, V32, P1015, DOI 10.1097/ICO.0b013e318283c85a; Steppan M, 2013, INT J DRUG POLICY, V24, P23, DOI 10.1016/j.drugpo.2012.05.002; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sueki H, 2011, PSYCHIAT CLIN NEUROS, V65, P392, DOI 10.1111/j.1440-1819.2011.02216.x; Tefft N, 2011, J HEALTH ECON, V30, P258, DOI 10.1016/j.jhealeco.2011.01.006; Valdivia A, 2010, EMERG INFECT DIS, V16, P168, DOI 10.3201/eid1601.091308; Viswanathan M, 2008, METHODS GUIDE EFFECT; Walcott BP, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.2.FOCUS1124; Willard SD, 2013, UROLOGY, V81, P37, DOI 10.1016/j.urology.2011.04.024; Yang AC, 2011, J AFFECT DISORDERS, V132, P179, DOI 10.1016/j.jad.2011.01.019; Yang AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013728; Yin S, 2012, CLIN TOXICOL, V50, P818, DOI 10.3109/15563650.2012.729667; Zheluk A, 2013, J MED INTERNET RES, V15; Zhou XC, 2013, IEEE T BIO-MED ENG, V60, P446, DOI 10.1109/TBME.2012.2228264; Zhou XC, 2011, IEEE T BIO-MED ENG, V58, DOI 10.1109/TBME.2011.2132132	90	478	482	8	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e109583	10.1371/journal.pone.0109583	http://dx.doi.org/10.1371/journal.pone.0109583			49	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6DY	25337815	Green Published, gold			2022-12-27	WOS:000343674800015
J	Patsouris, D; Cao, JWJ; Vial, G; Bravard, A; Lefai, E; Durand, A; Durand, C; Chauvin, MA; Laugerette, F; Debard, C; Michalski, MC; Laville, M; Vidal, H; Rieusset, J				Patsouris, David; Cao, Jingwei-Ji; Vial, Guillaume; Bravard, Amelie; Lefai, Etienne; Durand, Annie; Durand, Christine; Chauvin, Marie-Agnes; Laugerette, Fabienne; Debard, Cyrille; Michalski, Marie-Caroline; Laville, Martine; Vidal, Hubert; Rieusset, Jennifer			Insulin Resistance is Associated with MCP1-Mediated Macrophage Accumulation in Skeletal Muscle in Mice and Humans	PLOS ONE			English	Article							ADIPOSE-TISSUE; KAPPA-B; CHRONIC INFLAMMATION; UP-REGULATION; FATTY-ACIDS; OBESITY; EXPRESSION; OVEREXPRESSION; SENSITIVITY; ADIPOCYTES	Inflammation is now recognized as a major factor contributing to type 2 diabetes (T2D). However, while the mechanisms and consequences associated with white adipose tissue inflammation are well described, very little is known concerning the situation in skeletal muscle. The aim of this study was to investigate, in vitro and in vivo, how skeletal muscle inflammation develops and how in turn it modulates local and systemic insulin sensitivity in different mice models of T2D and in humans, focusing on the role of the chemokine MCP1. Here, we found that skeletal muscle inflammation and macrophage markers are increased and associated with insulin resistance in mice models and humans. In addition, we demonstrated that intramuscular TNF alpha expression is exclusively restricted to the population of intramuscular leukocytes and that the chemokine MCP1 was associated with skeletal muscle inflammatory markers in these models. Furthermore, we demonstrated that exposure of C2C12 myotubes to palmitate elevated the production of the chemokine MCP1 and that the muscle-specific overexpression of MCP1 in transgenic mice induced the local recruitment of macrophages and altered local insulin sensitivity. Overall our study demonstrates that skeletal muscle inflammation is clearly increased in the context of T2D in each one of the models we investigated, which is likely consecutive to the lipotoxic environment generated by peripheral insulin resistance, further increasing MCP1 expression in muscle. Consequently, our results suggest that MCP1-mediated skeletal muscle macrophages recruitment plays a role in the etiology of T2D.	[Patsouris, David; Cao, Jingwei-Ji; Vial, Guillaume; Bravard, Amelie; Lefai, Etienne; Durand, Annie; Durand, Christine; Chauvin, Marie-Agnes; Laugerette, Fabienne; Debard, Cyrille; Michalski, Marie-Caroline; Laville, Martine; Vidal, Hubert; Rieusset, Jennifer] Univ Lyon 1, INSERM, Unite Mixte Rech 1060, Lab CarMeN,Fac Med Charles Merieux Lyon Sud, F-69365 Lyon, France; [Lefai, Etienne; Michalski, Marie-Caroline; Laville, Martine; Vidal, Hubert; Rieusset, Jennifer] Ctr Rech Nutr Humaine, Rhone Alpes, France; [Lefai, Etienne; Michalski, Marie-Caroline; Laville, Martine; Vidal, Hubert; Rieusset, Jennifer] Ctr European Nutr Safety & Hlth, Pierre Benite, France; [Laville, Martine] Hosp Civils Lyon, Serv Nutr & Diabetol, Pierre Benite, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon	Patsouris, D (corresponding author), Univ Toronto, Sunnybrook Hlth Sci Ctr, Ross Tilley Burn Ctr, Toronto, ON, Canada.	david.patsouris@sunnybrook.ca	Carmen, Team2/Y-7383-2019; Carmen, Team1/Y-7382-2019; Lefai, Etienne/L-7961-2019; Vidal, Hubert/M-6674-2017; Rieusset, Jennifer/F-1595-2018; Lefai, Etienne/E-9615-2019; MICHALSKI, Marie-Caroline/Q-4613-2017	Carmen, Team2/0000-0001-9867-5724; Carmen, Team1/0000-0003-4234-1746; Lefai, Etienne/0000-0002-3042-7801; Vidal, Hubert/0000-0002-9467-0317; Rieusset, Jennifer/0000-0002-1587-2253; Lefai, Etienne/0000-0002-3042-7801; Vial, Guillaume/0000-0002-7333-8526; BERGER, Marie-Agnes/0000-0003-4189-6029; Lab, Carmen/0000-0002-5935-3236; Ji-Cao, Jingwei/0000-0002-1491-5266; MICHALSKI, Marie-Caroline/0000-0002-2956-901X	INSERM; Agence Nationale de la Recherche [ANR-09-RPDOC-018-01, ANR-09-JCJC-0116]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by INSERM and the Agence Nationale de la Recherche (ANR-09-RPDOC-018-01 to D.P. and ANR-09-JCJC-0116 to J.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abshagen K, 2009, J BIOMED MATER RES A, V91A, P557, DOI 10.1002/jbm.a.32237; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Bosma M, 2012, DIABETES, V61, P2679, DOI 10.2337/db11-1402; Bouzakri K, 2011, DIABETES, V60, P1111, DOI 10.2337/db10-1178; Bravard A, 2011, DIABETES, V60, P258, DOI 10.2337/db10-0281; Chavey C, 2009, CELL METAB, V9, P339, DOI 10.1016/j.cmet.2009.03.002; Chiang SH, 2009, CELL, V138, P961, DOI 10.1016/j.cell.2009.06.046; Dirks AJ, 2006, J NUTR BIOCHEM, V17, P501, DOI 10.1016/j.jnutbio.2005.11.002; Ducluzeau PH, 2001, DIABETES, V50, P1134, DOI 10.2337/diabetes.50.5.1134; Eguchi K, 2012, CELL METAB, V15, P518, DOI 10.1016/j.cmet.2012.01.023; Fink LN, 2013, DIABETOLOGIA, V56, P1623, DOI 10.1007/s00125-013-2897-x; Jiao P, 2009, DIABETES, V58, P104, DOI 10.2337/db07-1344; Kahn BB, 1998, NAT GENET, V20, P223, DOI 10.1038/3018; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Keophiphath M, 2010, ARTERIOSCL THROM VAS, V30, P39, DOI 10.1161/ATVBAHA.109.197442; Laugerette F, 2012, AM J PHYSIOL-ENDOC M, V302, pE374, DOI 10.1152/ajpendo.00314.2011; Lecomte V, 2010, MOL CELL BIOL, V30, P1182, DOI 10.1128/MCB.00690-09; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; Lu HY, 2011, FASEB J, V25, P358, DOI 10.1096/fj.10-171579; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064; Neels JG, 2009, J BIOL CHEM, V284, P20692, DOI 10.1074/jbc.M109.018556; Nguyen MTA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034976; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Park SW, 2007, DIABETES CARE, V30, P1507, DOI 10.2337/dc06-2537; Pedersen L, 2012, AM J PHYSIOL-ENDOC M, V302, pE831, DOI 10.1152/ajpendo.00339.2011; Phillips T, 2005, FASEB J, V19, P668, DOI 10.1096/fj.04-2870fje; Remels AHV, 2009, AM J PHYSIOL-ENDOC M, V297, pE174, DOI 10.1152/ajpendo.90632.2008; Rieusset J, 2012, BIOCHEM BIOPH RES CO, V417, P439, DOI 10.1016/j.bbrc.2011.11.135; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Takahashi K, 2008, AM J PHYSIOL-ENDOC M, V294, pE898, DOI 10.1152/ajpendo.00131.2007; Tam CS, 2012, OBESITY, V20, P1530, DOI 10.1038/oby.2012.24; Tomkowiak M, 2013, GENESIS, V51, P193, DOI 10.1002/dvg.22364; Varma V, 2009, AM J PHYSIOL-ENDOC M, V296, pE1300, DOI 10.1152/ajpendo.90885.2008; Watkins SM, 2002, J LIPID RES, V43, P1809, DOI 10.1194/jlr.M200169-JLR200; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007	40	64	65	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110653	10.1371/journal.pone.0110653	http://dx.doi.org/10.1371/journal.pone.0110653			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337938	gold, Green Published, Green Submitted			2022-12-27	WOS:000343674800066
J	Wang, J; Hu, GD; Lin, Z; He, L; Xu, L; Zhang, YM				Wang, Jing; Hu, Guangdong; Lin, Zhi; He, Lei; Xu, Lei; Zhang, Yanming			Characteristic and Functional Analysis of a Newly Established Porcine Small Intestinal Epithelial Cell Line	PLOS ONE			English	Article							ENTERICA SEROVARS TYPHIMURIUM; LONG-TERM CULTURE; SALMONELLA-TYPHIMURIUM; IMMUNE-RESPONSE; IN-VITRO; CYTOKINE EXPRESSION; TELOMERASE ACTIVITY; GROWTH; INFECTION; COLON	The mucosal surface of intestine is continuously exposed to both potential pathogens and beneficial commensal microorganisms. Recent findings suggest that intestinal epithelial cells, which once considered as a simple physical barrier, are a crucial cell lineage necessary for maintaining intestinal immune homeostasis. Therefore, establishing a stable and reliable intestinal epithelial cell line for future research on the mucosal immune system is necessary. In the present study, we established a porcine intestinal epithelial cell line (ZYM-SIEC02) by introducing the human telomerase reverse transcriptase (hTERT) gene into small intestinal epithelial cells derived from a neonatal, unsuckled piglet. Morphological analysis revealed a homogeneous cobblestone-like morphology of the epithelial cell sheets. Ultrastructural indicated the presence of microvilli, tight junctions, and a glandular configuration typical of the small intestine. Furthermore, ZYM-SIEC02 cells expressed epithelial cell-specific markers including cytokeratin 18, pan-cytokeratin, sucrase-isomaltase, E-cadherin and ZO-1. Immortalized ZYM-SIEC02 cells remained diploid and were not transformed. In addition, we also examined the host cell response to Salmonella and LPS and verified the enhanced expression of mRNAs encoding IL-8 and TNF-alpha by infection with Salmonella enterica serovars Typhimurium (S. Typhimurium). Results showed that IL-8 protein expression were upregulated following Salmonella invasion. TLR4, TLR6 and IL-6 mRNA expression were upregulated following stimulation with LPS, ZYM-SIEC02 cells were hyporeponsive to LPS with respect to IL-8 mRNA expression and secretion. TNF alpha mRNA levels were significantly decreased after LPS stimulation and TNF-alpha secretion were not detected challenged with S. Typhimurium neither nor LPS. Taken together, these findings demonstrate that ZYM-SIEC02 cells retained the morphological and functional characteristics typical of primary swine intestinal epithelial cells and thus provide a relevant in vitro model system for future studies on porcine small intestinal pathogen-host cell interactions.	[Wang, Jing; Hu, Guangdong; Lin, Zhi; He, Lei; Xu, Lei; Zhang, Yanming] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Zhang, YM (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China.	zhangym@nwsuaf.edu.cn			Doctoral Scientific Fund Project of the Ministry of Education of China [20110204110015]	Doctoral Scientific Fund Project of the Ministry of Education of China	This work was supported by Basic Research grants from the Doctoral Scientific Fund Project of the Ministry of Education of China (No. 20110204110015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arce C, 2010, COMP IMMUNOL MICROB, V33, P161, DOI 10.1016/j.cimid.2008.08.003; BATEN A, 1992, FASEB J, V6, P2726, DOI 10.1096/fasebj.6.9.1377141; BERSCHNEIDER H M, 1989, Gastroenterology, V96, pA41; Birkner S, 2004, ATLA-ALTERN LAB ANIM, V32, P555, DOI 10.1177/026119290403200607; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Booth C, 1995, EPITHELIAL CELL BIOL, V4, P76; BOOTH C, 1995, IN VITRO CELL DEV-AN, V31, P234; BURCH DGS, 1982, VET REC, V110, P244, DOI 10.1136/vr.110.11.244; Burkey TE, 2009, VET IMMUNOL IMMUNOP, V130, P96, DOI 10.1016/j.vetimm.2008.12.027; Chassin C, 2012, EMBO MOL MED, V4, P1308, DOI 10.1002/emmm.201201298; Cho WS, 2003, J VET MED A, V50, P484, DOI 10.1111/j.1439-0442.2004.00588.x; Collado-Romero M, 2010, VET RES, V41, DOI 10.1051/vetres/2009072; Costello CM, 2014, BIOTECHNOL BIOENG; COUNTER CM, 1995, BLOOD, V85, P2315, DOI 10.1182/blood.V85.9.2315.bloodjournal8592315; EVANS GS, 1992, J CELL SCI, V101, P219; Follmann W, 2000, TOXICOL IN VITRO, V14, P435, DOI 10.1016/S0887-2333(00)00033-3; Geens MM, 2011, CYTOTECHNOLOGY, V63, P415, DOI 10.1007/s10616-011-9362-9; Geens MM, 2010, COMP FUNCT GENOM, DOI 10.1155/2010/469583; GIBSONDAMBROSIO RE, 1986, IN VITRO CELL DEV B, V22, P529; Golaz JL, 2007, IN VITRO CELL DEV-AN, V43, P176, DOI 10.1007/s11626-007-9034-4; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hoey DEE, 2003, CELL MICROBIOL, V5, P85, DOI 10.1046/j.1462-5822.2003.00254.x; Hong HX, 2007, MOL CELLS, V24, P358; Hyland KA, 2006, MOL IMMUNOL, V43, P1890, DOI 10.1016/j.molimm.2005.10.011; Jourdan N, 1998, J VIROL, V72, P7228, DOI 10.1128/JVI.72.9.7228-7236.1998; Kaeffer B, 1998, IN VITRO CELL DEV-AN, V34, P622; Kaeffer B, 1997, CELL BIOL INT, V21, P303, DOI 10.1006/cbir.1997.0141; Kaeffer B, 2002, IN VITRO CELL DEV-AN, V38, P123; Kaushik RS, 2008, J VIROL METHODS, V148, P182, DOI 10.1016/j.jviromet.2007.11.006; LEE CA, 1990, P NATL ACAD SCI USA, V87, P4304, DOI 10.1073/pnas.87.11.4304; Lu S, 2006, J BIOL CHEM, V281, P3473, DOI 10.1074/jbc.M502501200; Macartney KK, 2000, J VIROL, V74, P5597, DOI 10.1128/JVI.74.12.5597-5603.2000; MCCORMICK BA, 1993, J CELL BIOL, V123, P895, DOI 10.1083/jcb.123.4.895; Miyazawa K, 2010, HISTOCHEM CELL BIOL, V133, P125, DOI 10.1007/s00418-009-0648-3; Moue M, 2008, BBA-GEN SUBJECTS, V1780, P134, DOI 10.1016/j.bbagen.2007.11.006; Ornish D, 2008, LANCET ONCOL, V9, P1048, DOI 10.1016/S1470-2045(08)70234-1; Panja A, 2000, LAB INVEST, V80, P1473, DOI 10.1038/labinvest.3780154; Parthasarathy G, 2005, VET PARASITOL, V131, P317, DOI 10.1016/j.vetpar.2005.03.043; Parthasarathy G, 2009, MICROB PATHOGENESIS, V47, P38, DOI 10.1016/j.micpath.2009.04.011; Perreault N, 1996, EXP CELL RES, V224, P354, DOI 10.1006/excr.1996.0145; Perreault N, 1998, EXP CELL RES, V245, P34, DOI 10.1006/excr.1998.4221; Redmer T, 2011, EMBO REP, V12, P720, DOI 10.1038/embor.2011.88; Rusu D, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-42; Schierack P, 2006, HISTOCHEM CELL BIOL, V125, P293, DOI 10.1007/s00418-005-0067-z; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Simon-Assman P, 2007, CELL BIOL TOXICOL, V23, P241, DOI 10.1007/s10565-006-0175-0; Skjolaas KA, 2006, VET IMMUNOL IMMUNOP, V111, P199, DOI 10.1016/j.vetimm.2006.01.002; Su Feng, 2013, PLoS One, V8, pe76036, DOI 10.1371/journal.pone.0076036; Sun Z, 2012, J GEN VIROL, V93, P2008, DOI 10.1099/vir.0.044388-0; Tavelin S, 1999, J PHARMACOL EXP THER, V290, P1212; Vandenbroucke V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023871; Verbrugghe Elin, 2012, Vet Res, V43, P22, DOI 10.1186/1297-9716-43-22; VIDRICH A, 1988, IN VITRO CELL DEV B, V24, P188; Watson PR, 2000, MICROBIOL-UK, V146, P1639, DOI 10.1099/00221287-146-7-1639; Whitehead RH, 1999, GASTROENTEROLOGY, V117, P858, DOI 10.1016/S0016-5085(99)70344-6	56	22	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110916	10.1371/journal.pone.0110916	http://dx.doi.org/10.1371/journal.pone.0110916			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337908	Green Submitted, Green Published, gold			2022-12-27	WOS:000343674800086
J	Hedley, JD; McMahon, K; Fearns, P				Hedley, John D.; McMahon, Kathryn; Fearns, Peter			Seagrass Canopy Photosynthetic Response Is a Function of Canopy Density and Light Environment: A Model for Amphibolis griffithii	PLOS ONE			English	Article							RADIATIVE-TRANSFER MODEL; THALASSIA-TESTUDINUM; AQUATIC VEGETATION; OPTICAL-PROPERTIES; WATER-QUALITY; ECOSYSTEMS; THRESHOLDS; IRRADIANCE; GROWTH; FLOW	A three-dimensional computer model of canopies of the seagrass Amphibolis griffithii was used to investigate the consequences of variations in canopy structure and benthic light environment on leaf-level photosynthetic saturation state. The model was constructed using empirical data of plant morphometrics from a previously conducted shading experiment and validated well to in-situ data on light attenuation in canopies of different densities. Using published values of the leaf-level saturating irradiance for photosynthesis, results show that the interaction of canopy density and canopy-scale photosynthetic response is complex and non-linear, due to the combination of self-shading and the non-linearity of photosynthesis versus irradiance (P-I) curves near saturating irradiance. Therefore studies of light limitation in seagrasses should consider variation in canopy structure and density. Based on empirical work, we propose a number of possible measures for canopy scale photosynthetic response that can be plotted to yield isoclines in the space of canopy density and light environment. These plots can be used to interpret the significance of canopy changes induced as a response to decreases in the benthic light environment: in some cases canopy thinning can lead to an equivalent leaf level light environment, in others physiological changes may also be required but these alone may be inadequate for canopy survival. By providing insight to these processes the methods developed here could be a valuable management tool for seagrass conservation during dredging or other coastal developments.	[Hedley, John D.] Environm Comp Sci Ltd, Tiverton, Devon, England; [McMahon, Kathryn] Edith Cowan Univ, Sch Nat Sci, Joondalup, WA, Australia; [McMahon, Kathryn] Edith Cowan Univ, Ctr Marine Ecosyst Res, Joondalup, WA, Australia; [Fearns, Peter] Curtin Univ Technol, Dept Imaging & Appl Phys, Perth, WA, Australia	Edith Cowan University; Edith Cowan University; Curtin University	Hedley, JD (corresponding author), Environm Comp Sci Ltd, Tiverton, Devon, England.	j.d.hedley@envirocs.com	McMahon, Kathryn M/A-6619-2008	McMahon, Kathryn M/0000-0003-4355-6247	Edith Cowan University (ECU) Industry Collaboration Scheme; BMT Oceanica Pty. Ltd.; ECU Faculty Visiting Fellow Scheme; ECU Collaborative Research Network; Environmental Computer Science Ltd.	Edith Cowan University (ECU) Industry Collaboration Scheme; BMT Oceanica Pty. Ltd.; ECU Faculty Visiting Fellow Scheme; ECU Collaborative Research Network; Environmental Computer Science Ltd.	This research was funded by an Edith Cowan University (ECU) Industry Collaboration Scheme with BMT Oceanica Pty. Ltd., the industry partner, awarded to KM, JH, and PF. ECU Faculty Visiting Fellow Scheme supported JH for travel to ECU. KM was supported by the ECU Collaborative Research Network. Environmental Computer Science Ltd. provided support in the form of salary for author JH. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Brun FG, 2003, FUNCT PLANT BIOL, V30, P551, DOI 10.1071/FP03010; Carruthers TJB, 1997, OECOLOGIA, V109, P335, DOI 10.1007/s004420050091; Cayabyab NM, 2007, NEW PHYTOL, V176, P108, DOI 10.1111/j.1469-8137.2007.02147.x; Collier CJ, 2012, ECOL INDIC, V23, P211, DOI 10.1016/j.ecolind.2012.04.005; Collier CJ, 2007, MAR ECOL PROG SER, V337, P103, DOI 10.3354/meps337103; Collier CJ, 2012, MAR POLLUT BULL, V65, P342, DOI 10.1016/j.marpolbul.2011.06.017; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; DENNISON WC, 1985, MAR ECOL PROG SER, V25, P51, DOI 10.3354/meps025051; DENNISON WC, 1993, BIOSCIENCE, V43, P86, DOI 10.2307/1311969; Duarte CM, 2007, ESTUAR COAST, V30, P652, DOI 10.1007/BF02841962; Durako MJ, 2007, AQUAT BOT, V87, P83, DOI 10.1016/j.aquabot.2007.03.005; Enriquez S, 2002, MAR BIOL, V140, P891, DOI 10.1007/s00227-001-0760-y; Fourqurean JW, 2012, NAT GEOSCI, V5, P505, DOI 10.1038/ngeo1477; FOURQUREAN JW, 1991, MAR ECOL PROG SER, V69, P161, DOI 10.3354/meps069161; Gacia E, 2012, MAR ECOL PROG SER, V466, P69, DOI 10.3354/meps09928; Grant RH, 1996, AGR FOREST METEOROL, V82, P267, DOI 10.1016/0168-1923(95)02327-5; Grech A, 2011, MAR POLICY, V35, P560, DOI 10.1016/j.marpol.2011.03.003; Grech A, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/2/024006; Hedley J, 2010, LIMNOL OCEANOGR, V55, P1537, DOI 10.4319/lo.2010.55.4.1537; Hedley J, 2008, OPT EXPRESS, V16, P21887, DOI 10.1364/OE.16.021887; Hedley JD, 2012, REMOTE SENS-BASEL, V4, P271, DOI 10.3390/rs4010271; House DH, 2000, CLOTH MODELLING ANIM; Kemp WM, 2004, ESTUARIES, V27, P363; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; Koch EW, 1999, MAR ECOL PROG SER, V184, P63, DOI 10.3354/meps184063; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3_9; Lavery PS, 2009, MAR ECOL PROG SER, V394, P21, DOI 10.3354/meps08242; Masini RJ, 1997, AQUAT BOT, V58, P21, DOI 10.1016/S0304-3770(97)00008-9; Mayer B, 2005, ATMOS CHEM PHYS, V5, P1855, DOI 10.5194/acp-5-1855-2005; McMahon K, 2014, J EXP MAR BIOL ECOL, V455, P38, DOI 10.1016/j.jembe.2014.02.015; McMahon K, 2013, ECOL INDIC, V30, P7, DOI 10.1016/j.ecolind.2013.01.030; Mobley C.D., 1994, LIGHT WATER; MOBLEY CD, 2000, HYDROLIGHT 4 1 USERS; O'Brien KR, 2011, 19TH INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION (MODSIM2011), P4127; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Pedersen TM, 2012, ESTUAR COAST SHELF S, V106, P93, DOI 10.1016/j.ecss.2012.04.027; Ralph PJ, 2007, J EXP MAR BIOL ECOL, V350, P176, DOI 10.1016/j.jembe.2007.06.017; Short, 2004, WORLD ATLAS SEAGRASS; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Zimmerman RC, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P303	40	11	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111454	10.1371/journal.pone.0111454	http://dx.doi.org/10.1371/journal.pone.0111454			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347849	gold, Green Published, Green Submitted			2022-12-27	WOS:000347994900076
J	Gradoville, MR; White, AE; Letelier, RM				Gradoville, Mary R.; White, Angelicque E.; Letelier, Ricardo M.			Physiological Response of Crocosphaera watsonii to Enhanced and Fluctuating Carbon Dioxide Conditions	PLOS ONE			English	Article							NITROGEN-FIXATION; OCEAN ACIDIFICATION; N-2 FIXATION; CALCIUM-CARBONATE; ELEVATED CO2; GROWTH; TRICHODESMIUM; PCO(2); SEAWATER; ACID	We investigated the effects of elevated pCO(2) on cultures of the unicellular N-2-fixing cyanobacterium Crocosphaera watsonii WH8501. Using CO2-enriched air, cultures grown in batch mode under high light intensity were exposed to initial conditions approximating current atmospheric CO2 concentrations (similar to 400 ppm) as well as CO2 levels corresponding to low-and high-end predictions for the year 2100 (similar to 750 and 1000 ppm). Following acclimation to CO2 levels, the concentrations of particulate carbon (PC), particulate nitrogen (PN), and cells were measured over the diurnal cycle for a six-day period spanning exponential and early stationary growth phases. High rates of photosynthesis and respiration resulted in biologically induced pCO(2) fluctuations in all treatments. Despite this observed pCO(2) variability, and consistent with previous experiments conducted under stable pCO(2) conditions, we observed that elevated mean pCO(2) enhanced rates of PC production, PN production, and growth. During exponential growth phase, rates of PC and PN production increased by similar to 1.2-and similar to 1.5-fold in the mid-and high-CO2 treatments, respectively, when compared to the low-CO2 treatment. Elevated pCO(2) also enhanced PC and PN production rates during early stationary growth phase. In all treatments, PC and PN cellular content displayed a strong diurnal rhythm, with particulate C:N molar ratios reaching a high of 22:1 in the light and a low of 5.5:1 in the dark. The pCO(2) enhancement of metabolic rates persisted despite pCO(2) variability, suggesting a consistent positive response of Crocosphaera to elevated and fluctuating pCO(2) conditions.	[Gradoville, Mary R.; White, Angelicque E.; Letelier, Ricardo M.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA	Oregon State University	Gradoville, MR (corresponding author), Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA.	rgradoville@coas.oregonstate.edu	Letelier, Ricardo/A-6953-2009	Letelier, Ricardo/0000-0003-3376-4026; Gradoville, Mary/0000-0002-2468-000X; White, angelicque/0000-0002-0938-7948	National Science Foundation [OCE 08-50827]; Center for Microbial Oceanography: Research and Education (C-MORE); Alfred P. Sloan Foundation	National Science Foundation(National Science Foundation (NSF)); Center for Microbial Oceanography: Research and Education (C-MORE); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	Support for this project was provided by the National Science Foundation (nsf.gov) grant OCE 08-50827 (to RML), the Center for Microbial Oceanography: Research and Education (C-MORE, to RML and AW), and the Alfred P. Sloan Foundation (to AW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badger MR, 1998, CAN J BOT, V76, P1052, DOI 10.1139/b98-074; Bandstra L, 2006, MAR CHEM, V100, P24, DOI 10.1016/j.marchem.2005.10.009; Ramos JBE, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002898; Beardall J, 2009, PLANT ECOL DIVERS, V2, P191, DOI 10.1080/17550870903271363; Bottjer D, 2014, GLOBAL BIOGEOCHEM CY, V28, P601, DOI 10.1002/2013GB004690; Chen YB, 1996, J PHYCOL, V32, P916, DOI 10.1111/j.0022-3646.1996.00916.x; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dore JE, 2009, P NATL ACAD SCI USA, V106, P12235, DOI 10.1073/pnas.0906044106; Dron A, 2012, AQUAT MICROB ECOL, V68, P43, DOI 10.3354/ame01600; Dron A, 2012, ENVIRON MICROBIOL, V14, P967, DOI 10.1111/j.1462-2920.2011.02675.x; Egleston ES, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2008GB003407; Flynn KJ, 2012, NAT CLIM CHANGE, V2, P510, DOI 10.1038/NCLIMATE1489; Fu FX, 2014, AQUAT MICROB ECOL, V72, P33, DOI 10.3354/ame01683; Fu FX, 2008, LIMNOL OCEANOGR, V53, P2472, DOI 10.4319/lo.2008.53.6.2472; GALLON JR, 1992, NEW PHYTOL, V122, P571; Garcia NS, 2013, LIMNOL OCEANOGR, V58, P1501, DOI 10.4319/lo.2013.58.4.1501; Geider RJ, 2009, PLANT ECOL DIVERS, V2, P165, DOI 10.1080/17550870903300949; Goebel NL, 2008, J PHYCOL, V44, P1212, DOI 10.1111/j.1529-8817.2008.00581.x; Gradoville MR, 2014, LIMNOL OCEANOGR, V59, P645, DOI 10.4319/lo.2014.59.3.0645; Hutchins DA, 2007, LIMNOL OCEANOGR, V52, P1293, DOI 10.4319/lo.2007.52.4.1293; Hutchins DA, 2013, NAT GEOSCI, V6, P790, DOI [10.1038/NGEO1858, 10.1038/ngeo1858]; Hutchins DA, 2009, OCEANOGRAPHY, V22, P128, DOI 10.5670/oceanog.2009.103; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Joint I, 2011, ISME J, V5, P1, DOI 10.1038/ismej.2010.79; Karl D, 1997, NATURE, V388, P533, DOI 10.1038/41474; Kranz SA, 2010, LIMNOL OCEANOGR, V55, P2563, DOI 10.4319/lo.2010.55.6.2563; Kranz SA, 2009, LIMNOL OCEANOGR, V54, P548, DOI 10.4319/lo.2009.54.2.0548; Law CS, 2012, GLOBAL CHANGE BIOL, V18, P3004, DOI 10.1111/j.1365-2486.2012.02777.x; Levitan O, 2007, GLOBAL CHANGE BIOL, V13, P531, DOI 10.1111/j.1365-2486.2006.01314.x; Lomas MW, 2012, AQUAT MICROB ECOL, V66, P211, DOI 10.3354/ame01576; Luo YW, 2012, EARTH SYST SCI DATA, V4, P47, DOI 10.5194/essd-4-47-2012; Mahadevan A, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002102; Marie D, 1997, APPL ENVIRON MICROB, V63, P186, DOI 10.1128/AEM.63.1.186-193.1997; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Mohr W, 2010, ENVIRON MICROBIOL, V12, P412, DOI 10.1111/j.1462-2920.2009.02078.x; Moisander PH, 2010, SCIENCE, V327, P1512, DOI 10.1126/science.1185468; Raven JA, 2012, PHILOS T R SOC B, V367, P493, DOI 10.1098/rstb.2011.0212; REDDY MM, 1977, J CRYST GROWTH, V41, P287, DOI 10.1016/0022-0248(77)90057-4; REDFIELD AC, 1958, AM SCI, V46, P205; Riebesell U., 2010, GUIDE BEST PRACTICES, DOI 10.2777/58454; Robbins L.L., 2010, CO2CALC USER FRIENDL, DOI 10.3133/ofr20101280; Shi DL, 2012, P NATL ACAD SCI USA, V109, pE3094, DOI 10.1073/pnas.1216012109; Strickland J.D.H., 1972, PRACTICAL HDB SEWATE, DOI [10.2307/1979241, DOI 10.2307/1979241]; *US EPA, 1983, 3501 US EPA; Wolf-Gladrow DA, 2007, MAR CHEM, V106, P287, DOI 10.1016/j.marchem.2007.01.006	46	10	10	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110660	10.1371/journal.pone.0110660	http://dx.doi.org/10.1371/journal.pone.0110660			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343645	gold, Green Submitted, Green Published			2022-12-27	WOS:000343943500043
J	Wang, W; He, M; Zhang, XL				Wang, Wei; He, Miao; Zhang, Xiulan			Combined Intravitreal Anti-VEGF and Photodynamic Therapy versus Photodynamic Monotherapy for Polypoidal Choroidal Vasculopathy: A Systematic Review and Meta-Analysis of Comparative Studies	PLOS ONE			English	Article							COMBINATION THERAPY; RANIBIZUMAB; BEVACIZUMAB; VERTEPORFIN; EFFICACY	Purpose: The aim of this study was to evaluate the efficacy and safety of photodynamic therapy (PDT) combined with intravitreal vascular endothelial growth factor (VEGF) inhibitors compared to those of PDT alone in the treatment of polypoidal choroidal vasculopathy (PCV). Methods: A systematic search of Pubmed, Embase, and the Cochrane Library was performed to identify all comparative studies that compared the outcomes of the two approaches. Outcomes of interest included visual outcomes, anatomic variables, and adverse events. Results: Two randomised controlled trials and nine retrospective studies including a total of 543 cases were identified. At three and six months post-injection, no significant difference in visual acuity was found in the combined therapy group compared with the PDT monotherapy group, with pooled weighted mean differences (WMDs) of 0.074 (-0.021, 0.17) at three months and 0.082 (-0.013, 0.18) at six months. However, the mean changes in visual acuity at month 12 in the combined therapy group were significantly better than those in the PDT monotherapy group, with pooled WMDs of 0.11 (0.012, 0.21). Similar efficacy was found at 24 months (WMD: 0.21; 95% CI: 0.054, 0.36; P = 0.008). Patients in the combined therapy group also might benefit from reduced retinal haemorrhage (OR: 0.32; 95% CI: 0.14, 0.74; P = 0.008). Polyp regression, recurrence of PCV, central retinal thickness reduction, and pigment epithelial detachment resolution did not differ significantly between the two treatments. Conclusions: Combined treatment appeared to result in better visual acuity and lower retinal haemorrhage. However, combined treatment did not affect the resolution and recurrence of lesions. Given the inherent limitations of the included studies, future well-designed RCTs are awaited to confirm and update the findings of this analysis.	[Wang, Wei; He, Miao; Zhang, Xiulan] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Zhang, XL (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	zhangxl2@mail.sysu.edu.cn			National Natural Science Foundation of China [81170849, 81371008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (81170849, 81371008). No additional external funding was received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chakravarthy U, 2013, LANCET, V382, P1258, DOI 10.1016/S0140-6736(13)61501-9; Cheung CMG, 2013, AM J OPHTHALMOL, V155, P295, DOI 10.1016/j.ajo.2012.08.002; de Crecchio G, 2011, CURR DRUG TARGETS, V12, P206, DOI 10.2174/138945011794182782; Englander M, 2013, CURR OPIN OPHTHALMOL, V24, P233, DOI 10.1097/ICU.0b013e32835f8eaa; Gomi F, 2008, CURR OPIN OPHTHALMOL, V19, P208, DOI 10.1097/ICU.0b013e3282fb7c33; Gomi F, 2010, AM J OPHTHALMOL, V150, P48, DOI 10.1016/j.ajo.2010.02.008; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Imamura Y, 2010, SURV OPHTHALMOL, V55, P501, DOI 10.1016/j.survophthal.2010.03.004; Inoue M, 2013, EYE, V27, P1013, DOI 10.1038/eye.2013.179; Kang HM, 2014, OPHTHALMOLOGICA, V231, P86, DOI 10.1159/000354546; Kim SJ, 2011, RETINA-J RET VIT DIS, V31, P1827, DOI 10.1097/IAE.0b013e318214d01e; Kodjikian L, 2013, OPHTHALMOLOGY, V120, P2300, DOI 10.1016/j.ophtha.2013.06.020; Koh A, 2012, RETINA-J RET VIT DIS, V32, P1453, DOI 10.1097/IAE.0b013e31824f91e8; Koh AHC, 2013, RETINA-J RET VIT DIS, V33, P686, DOI 10.1097/IAE.0b013e3182852446; Krebs I, 2013, BRIT J OPHTHALMOL, V97, P266, DOI 10.1136/bjophthalmol-2012-302391; Lai TYY, 2008, BRIT J OPHTHALMOL, V92, P661, DOI 10.1136/bjo.2007.135103; Lai TYY, 2011, RETINA-J RET VIT DIS, V31, P1581, DOI 10.1097/IAE.0b013e31820d3f3f; Lee MY, 2013, AM J OPHTHALMOL, V156, P343, DOI 10.1016/j.ajo.2013.04.001; Lee YA, 2012, AM J OPHTHALMOL, V154, P872, DOI 10.1016/j.ajo.2012.03.051; Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053; Maruko I, 2011, AM J OPHTHALMOL, V151, P594, DOI 10.1016/j.ajo.2010.10.030; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Nowak-Sliwinska P, 2013, PROG RETIN EYE RES; Oishi A, 2013, AM J OPHTHALMOL, V156, P644, DOI 10.1016/j.ajo.2013.05.024; Rouvas AA, 2011, RETINA-J RET VIT DIS, V31, P464, DOI 10.1097/IAE.0b013e3181f274ec; Ruamviboonsuk P, 2010, BRIT J OPHTHALMOL, V94, P1045, DOI 10.1136/bjo.2009.173120; Saito M, 2013, GRAEF ARCH CLIN EXP, V251, P2099, DOI 10.1007/s00417-013-2323-6; Saito M, 2012, RETINA-J RET VIT DIS, V32, P1272, DOI 10.1097/IAE.0b013e318236e624; Sakurada Y, 2013, J OCUL PHARMACOL TH, V29, P832, DOI 10.1089/jop.2013.0044; Sakurada Y, 2013, RETINA-J RET VIT DIS, V33, P841, DOI 10.1097/IAE.0b013e31826ffe9d; Sato T, 2013, AM J OPHTHALMOL, V156, P95, DOI 10.1016/j.ajo.2013.02.006; Song MH, 2011, OPHTHALMOLOGICA, V226, DOI 10.1159/000329466; Spaide RF, 2002, RETINA-J RET VIT DIS, V22, P529, DOI 10.1097/00006982-200210000-00001; Tomita K, 2012, AM J OPHTHALMOL, V153, P68, DOI 10.1016/j.ajo.2011.07.001; Wells G.A., NEWCASTLE OTTAWA SCA	36	43	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110667	10.1371/journal.pone.0110667	http://dx.doi.org/10.1371/journal.pone.0110667			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343244	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943500044
J	Merceron, C; Mangiavini, L; Robling, A; Wilson, TL; Giaccia, AJ; Shapiro, IM; Schipani, E; Risbud, MV				Merceron, Christophe; Mangiavini, Laura; Robling, Alexander; Wilson, Tremika LeShan; Giaccia, Amato J.; Shapiro, Irving M.; Schipani, Ernestina; Risbud, Makarand V.			Loss of HIF-1 alpha in the Notochord Results in Cell Death and Complete Disappearance of the Nucleus Pulposus	PLOS ONE			English	Article							HUMAN INTERVERTEBRAL DISC; MOUSE IMPLICATIONS; GROWTH-FACTOR; FACTOR-I; HYPOXIA; DEGENERATION; EXPRESSION; CARTILAGE; COLLAGEN; HIF-1	The intervertebral disc (IVD) is one of the largest avascular organs in vertebrates. The nucleus pulposus (NP), a highly hydrated and proteoglycan-enriched tissue, forms the inner portion of the IVD. The NP is surrounded by a multi-lamellar fibrocartilaginous structure, the annulus fibrosus (AF). This structure is covered superior and inferior side by cartilaginous endplates (CEP). The NP is a unique tissue within the IVD as it results from the differentiation of notochordal cells, whereas, AF and CEP derive from the sclerotome. The hypoxia inducible factor-1 alpha (HIF-1 alpha) is expressed in NP cells but its function in NP development and homeostasis is largely unknown. We thus conditionally deleted HIF-1 alpha in notochordal cells and investigated how loss of this transcription factor impacts NP formation and homeostasis at E15.5, birth, 1 and 4 months of age, respectively. Histological analysis, cell lineage studies, and TUNEL assay were performed. Morphologic changes of the mutant NP cells were identified as early as E15.5, followed, postnatally, by the progressive disappearance and replacement of the NP with a novel tissue that resembles fibrocartilage. Notably, lineage studies and TUNEL assay unequivocally proved that NP cells did not transdifferentiate into chondrocyte-like cells but they rather underwent massive cell death, and were completely replaced by a cell population belonging to a lineage distinct from the notochordal one. Finally, to evaluate the functional consequences of HIF-1 alpha deletion in the NP, biomechanical testing of mutant IVD was performed. Loss of the NP in mutant mice significantly reduced the IVD biomechanical properties by decreasing its ability to absorb mechanical stress. These findings are similar to the changes usually observed during human IVD degeneration. Our study thus demonstrates that HIF-1 alpha is essential for NP development and homeostasis, and it raises the intriguing possibility that this transcription factor could be involved in IVD degeneration in humans.	[Merceron, Christophe; Mangiavini, Laura; Wilson, Tremika LeShan; Schipani, Ernestina] Univ Michigan, Sch Med, Dept Orthopaed Surg, Ann Arbor, MI 48109 USA; [Merceron, Christophe] INSERM, Ctr Osteoarticular & Dent Tissue Engn, Grp STEP Skeletal Tissue Engn & Physiopathol, UMRS LIOAD 791, Nantes, France; [Merceron, Christophe] Univ Nantes, Fac Dent Surg, LUNAM, Nantes, France; [Mangiavini, Laura] Milano Bicocca Univ, Dept Orthopaed & Traumatol, Monza, MB, Italy; [Robling, Alexander] Indiana Univ, Sch Med, Dept Anat & Cell Biol, Indianapolis, IN USA; [Giaccia, Amato J.] Stanford Univ, Sch Med, Dept Radiat Oncol, Div Radiat & Canc Biol, Stanford, CA 94305 USA; [Shapiro, Irving M.; Risbud, Makarand V.] Thomas Jefferson Univ, Dept Orthopaed Surg, Philadelphia, PA 19107 USA; [Shapiro, Irving M.; Risbud, Makarand V.] Thomas Jefferson Univ, Grad Program Cell & Dev Biol, Philadelphia, PA 19107 USA; [Schipani, Ernestina] Univ Michigan, Sch Med, Dept Med, Div Endocrinol, Ann Arbor, MI 48104 USA	University of Michigan System; University of Michigan; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; University of Milano-Bicocca; Indiana University System; Indiana University-Purdue University Indianapolis; Stanford University; Jefferson University; Jefferson University; University of Michigan System; University of Michigan	Schipani, E (corresponding author), Univ Michigan, Sch Med, Dept Orthopaed Surg, Ann Arbor, MI 48109 USA.	eschipan@med.umich.edu; Makarand.Risbud@jefferson.edu	Mangiavini, Laura/K-6340-2016; merceron, christophe/P-1306-2014	Mangiavini, Laura/0000-0003-1892-1249; 	National Institutes of Health R01 [AR050087, AR055655]; People Program (Marie Curie Actions) of the European Union's Seventh Framework Program (FP7) under the Research Executive Agency [300388]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050087, R01AR055655, R01AR065403] Funding Source: NIH RePORTER	National Institutes of Health R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); People Program (Marie Curie Actions) of the European Union's Seventh Framework Program (FP7) under the Research Executive Agency; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health R01 grants AR050087 and AR055655 (to MVR). CM received funding from the People Program (Marie Curie Actions) of the European Union's Seventh Framework Program (FP7/2007-2013) registered under the Research Executive Agency grant agreement no300388. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c; Agrawal A, 2007, AM J PHYSIOL-CELL PH, V293, pC621, DOI 10.1152/ajpcell.00538.2006; Agrawal A, 2008, ARTHRITIS RHEUM-US, V58, P3798, DOI 10.1002/art.24073; Aro E, 2012, J BIOL CHEM, V287, P37134, DOI 10.1074/jbc.M112.352872; Bedore J, 2013, ARTHRITIS RHEUM-US, V65, P2634, DOI 10.1002/art.38075; Chan WCW, 2011, ORTHOP CLIN N AM, V42, P447, DOI 10.1016/j.ocl.2011.07.012; Choi KS, 2011, P NATL ACAD SCI USA, V108, P9484, DOI 10.1073/pnas.1007566108; Choi KS, 2008, DEV DYNAM, V237, P3953, DOI 10.1002/dvdy.21805; Clouet J, 2009, JOINT BONE SPINE, V76, P614, DOI 10.1016/j.jbspin.2009.07.002; Gruber HE, 2005, SPINE, V30, P2593, DOI 10.1097/01.brs.0000187877.30149.83; Grunhagen T, 2006, J BONE JOINT SURG AM, V88A, P30, DOI 10.2106/JBJS.E.01290; HASSLER O, 1969, ACTA ORTHOP SCAND, V40, P765, DOI 10.3109/17453676908989540; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Maes C, 2012, NAT REV RHEUMATOL, V8, P358, DOI 10.1038/nrrheum.2012.36; Maes C, 2012, J BONE MINER RES, V27, P596, DOI 10.1002/jbmr.1487; McCann MR, 2012, DIS MODEL MECH, V5, P73, DOI 10.1242/dmm.008128; Melrose J, 2008, EUR SPINE J, V17, P314, DOI 10.1007/s00586-007-0538-0; Moon SM, 2013, EUR SPINE J, V22, P1820, DOI 10.1007/s00586-013-2798-1; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Park JB, 2001, SPINE, V26, P618, DOI 10.1097/00007632-200103150-00011; Pfander D, 2003, J CELL SCI, V116, P1819, DOI 10.1242/jcs.00385; Pfander D, 2005, INT ORTHOP, V29, P6, DOI 10.1007/s00264-004-0618-2; Provot S, 2007, J CELL BIOL, V177, P451, DOI 10.1083/jcb.200612023; Raj P Prithvi, 2008, Pain Pract, V8, P18, DOI 10.1111/j.1533-2500.2007.00171.x; Rajpurohit R, 2002, CELL TISSUE RES, V308, P401, DOI 10.1007/s00441-002-0563-6; Rankin EB, 2012, CELL, V149, P63, DOI 10.1016/j.cell.2012.01.051; Risbud MV, 2010, DEV DYNAM, V239, P2141, DOI 10.1002/dvdy.22350; Risbud MV, 2006, J CELL BIOCHEM, V98, P152, DOI 10.1002/jcb.20765; Roberts S, 1995, SPINE, V20, P2645, DOI 10.1097/00007632-199512150-00005; RUDERT M, 1993, ACTA ORTHOP SCAND, V64, P37, DOI 10.3109/17453679308994524; Schipani E, 2001, GENE DEV, V15, P2865; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Uetzmann L, 2008, GENESIS, V46, P515, DOI 10.1002/dvg.20410; Urban JPG, 2004, SPINE, V29, P2700, DOI 10.1097/01.brs.0000146499.97948.52	34	67	72	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110768	10.1371/journal.pone.0110768	http://dx.doi.org/10.1371/journal.pone.0110768			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338007	gold, Green Published, Green Submitted			2022-12-27	WOS:000343674800073
J	Seah, S; Asad, AA; Baumgartner, R; Feng, D; Williams, DS; Manigbas, E; Beaver, JD; Reese, T; Henry, B; Evelhoch, JL; Chin, CL				Seah, Stephanie; Asad, Abu Bakar Ali; Baumgartner, Richard; Feng, Dai; Williams, Donald S.; Manigbas, Elaine; Beaver, John D.; Reese, Torsten; Henry, Brian; Evelhoch, Jeffrey L.; Chin, Chih-Liang			Investigation of Cross-Species Translatability of Pharmacological MRI in Awake Nonhuman Primate - A Buprenorphine Challenge Study	PLOS ONE			English	Article							FUNCTIONAL MRI; DRUG DISCOVERY; CONTRAST AGENT; BRAIN ACTIVITY; FMRI; BOLD; PHARMACOKINETICS; ACTIVATION; MACAQUES; MONKEYS	Background: Pharmacological MRI (phMRI) is a neuroimaging technique where drug-induced hemodynamic responses can represent a pharmacodynamic biomarker to delineate underlying biological consequences of drug actions. In most preclinical studies, animals are anesthetized during image acquisition to minimize movement. However, it has been demonstrated anesthesia could attenuate basal neuronal activity, which can confound interpretation of drug-induced brain activation patterns. Significant efforts have been made to establish awake imaging in rodents and nonhuman primates (NHP). Whilst various platforms have been developed for imaging awake NHP, comparison and validation of phMRI data as translational biomarkers across species remain to be explored. Methodology: We have established an awake NHP imaging model that encompasses comprehensive acclimation procedures with a dedicated animal restrainer. Using a cerebral blood volume (CBV)-based phMRI approach, we have determined differential responses of brain activation elicited by the systemic administration of buprenorphine (0.03 mg/kg i.v.), a partial mu-opioid receptor agonist, in the same animal under awake and anesthetized conditions. Additionally, region-of-interest analyses were performed to determine regional drug-induced CBV time-course data and corresponding area-under-curve (AUC) values from brain areas with high density of mu-opioid receptors. Principal Findings: In awake NHPs, group-level analyses revealed buprenorphine significantly activated brain regions including, thalamus, striatum, frontal and cingulate cortices (paired t-test, versus saline vehicle, p<0.05, n = 4). This observation is strikingly consistent with mu-opioid receptor distribution depicted by [6-O-[C-11] methyl] buprenorphine ([C-11]BPN) positron emission tomography imaging study in baboons. Furthermore, our findings are consistent with previous buprenorphine phMRI studies in humans and conscious rats which collectively demonstrate the cross-species translatability of awake imaging. Conversely, no significant change in activated brain regions was found in the same animals imaged under the anesthetized condition. Conclusions: Our data highlight the utility and importance of awake NHP imaging as a translational imaging biomarker for drug research.	[Seah, Stephanie; Asad, Abu Bakar Ali; Williams, Donald S.; Evelhoch, Jeffrey L.; Chin, Chih-Liang] Merck & Co Inc, Imaging, West Point, PA 19486 USA; [Seah, Stephanie; Asad, Abu Bakar Ali; Reese, Torsten; Henry, Brian; Chin, Chih-Liang] MSD, Translat Med Res Ctr, Singapore, Singapore; [Baumgartner, Richard; Feng, Dai] Merck & Co Inc, Rahway, NJ 07065 USA; [Manigbas, Elaine; Beaver, John D.] Maccine Pte Ltd, Imaging, Singapore, Singapore	Merck & Company; Merck & Company; Merck & Company	Seah, S (corresponding author), Merck & Co Inc, Imaging, West Point, PA 19486 USA.	stephanie.seah@merck.com	Evelhoch, Jeffrey/R-2619-2019; biomaGUNE, CIC/J-9136-2014	biomaGUNE, CIC/0000-0001-7690-0660	Merck Co.	Merck Co.(Merck & Company)	This research was funded by Merck & Co. The authors would like to declare that the following individuals are current or former employees of the funder - Stephanie Seah, Abu Bakar Ali Asad, Richard Baumgartner, Dai Feng, Don Williams, Torsten Reese, Brian Henry, Jeff Evelhoch and Chih-Liang Chin. Their roles include study design, data collection and analysis, decision to publish and preparation of the manuscript.	Andaluz A, 2009, VET J, V181, P299, DOI 10.1016/j.tvjl.2008.03.001; Andersen AH, 2002, J NEUROSCI METH, V118, P141, DOI 10.1016/S0165-0270(02)00123-1; Austin VC, 2005, NEUROIMAGE, V24, P92, DOI 10.1016/j.neuroimage.2004.08.011; Baker S, 2012, J PHARMACOL EXP THER, V341, P263, DOI 10.1124/jpet.111.188797; Becerra L, 2013, J PHARMACOL EXP THER, V345, P41, DOI 10.1124/jpet.112.201145; Borsook D, 2006, NAT REV DRUG DISCOV, V5, P411, DOI 10.1038/nrd2027; Chen G, 2012, MAGN RESON IMAGING, V30, P36, DOI 10.1016/j.mri.2011.09.010; Chen YCI, 1997, MAGNET RESON MED, V38, P389, DOI 10.1002/mrm.1910380306; Chin CL, 2008, BRIT J PHARMACOL, V153, P367, DOI 10.1038/sj.bjp.0707506; Chin CL, 2008, SYNAPSE, V62, P159, DOI 10.1002/syn.20474; De Simoni S, 2013, NEUROIMAGE, V64, P75, DOI 10.1016/j.neuroimage.2012.09.037; Dubowitz DJ, 1998, NEUROREPORT, V9, P2213, DOI 10.1097/00001756-199807130-00012; Febo M, 2005, NEUROPSYCHOPHARMACOL, V30, P936, DOI 10.1038/sj.npp.1300653; Ferris CF, 2011, REV NEUROSCIENCE, V22, P665, DOI 10.1515/RNS.2011.050; Fish R, 2011, ANESTHESIA ANALGESIA, P350; Frey S, 2011, NEUROIMAGE, V55, P1435, DOI 10.1016/j.neuroimage.2011.01.040; Galynker I, 1996, NUCL MED BIOL, V23, P325, DOI 10.1016/0969-8051(95)02087-X; Gozzi A, 2008, MAGN RESON IMAGING, V26, P999, DOI 10.1016/j.mri.2008.01.012; Gozzi A, 2006, NEUROPSYCHOPHARMACOL, V31, P1690, DOI 10.1038/sj.npp.1300955; Greenwald MK, 2003, NEUROPSYCHOPHARMACOL, V28, P2000, DOI 10.1038/sj.npp.1300251; Hargreaves RJ, 2008, CLIN PHARMACOL THER, V83, P349, DOI 10.1038/sj.clpt.6100467; HEEL RC, 1979, DRUGS, V17, P81, DOI 10.2165/00003495-197917020-00001; Hodkinson Duncan J, 2012, Br J Med Med Res, V2, P373; Jenkins BG, 2012, NEUROIMAGE, V62, P1072, DOI 10.1016/j.neuroimage.2012.03.075; Jenkinson M, 2011, NEUROIMAGE; Keliris GA, 2007, NEUROIMAGE, V36, P550, DOI 10.1016/j.neuroimage.2007.02.057; Lahti KM, 1999, MAGNET RESON MED, V41, P412, DOI 10.1002/(SICI)1522-2594(199902)41:2<412::AID-MRM28>3.0.CO;2-3; Lee JI, 2013, J MED PRIMATOL, V42, P10, DOI 10.1111/jmp.12023; Leite FP, 2002, NEUROIMAGE, V16, P283, DOI 10.1006/nimg.2002.1110; Leppa M, 2006, NEUROIMAGE, V31, P661, DOI 10.1016/j.neuroimage.2005.12.019; Leslie RA, 2000, TRENDS PHARMACOL SCI, V21, P314, DOI 10.1016/S0165-6147(00)01507-8; LEWIS JW, 1985, DRUG ALCOHOL DEPEN, V14, P363, DOI 10.1016/0376-8716(85)90067-5; Liu JJV, 2013, NEUROIMAGE, V78, P186, DOI 10.1016/j.neuroimage.2013.03.038; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Mandeville JB, 1998, MAGNET RESON MED, V39, P615, DOI 10.1002/mrm.1910390415; Mandeville JB, 1999, MAGNET RESON MED, V42, P591, DOI 10.1002/(SICI)1522-2594(199909)42:3<591::AID-MRM23>3.0.CO;2-8; Mandeville JB, 2011, NEUROPSYCHOPHARMACOL, V36, P1187, DOI 10.1038/npp.2011.1; MANSOUR A, 1988, TRENDS NEUROSCI, V11, P308, DOI 10.1016/0166-2236(88)90093-8; MCCLURE HM, 1984, ADV VET SCI COMP MED, V28, P267; Mueggler T, 2001, MAGNET RESON MED, V46, P292, DOI 10.1002/mrm.1190; Murnane KS, 2010, J NEUROSCI METH, V191, P11, DOI 10.1016/j.jneumeth.2010.06.001; Nakahara K, 2007, TRENDS COGN SCI, V11, P84, DOI 10.1016/j.tics.2006.11.006; Nunamaker EA, 2013, J AM ASSOC LAB ANIM, V52, P48; Petrides M, 2002, EUR J NEUROSCI, V16, P291, DOI 10.1046/j.1460-9568.2001.02090.x; PFEIFFER A, 1982, BRAIN RES, V248, P87, DOI 10.1016/0006-8993(82)91150-7; Pinsk MA, 2005, J NEUROSCI METH, V143, P179, DOI 10.1016/j.jneumeth.2004.10.003; REUNING RH, 1989, DRUG METAB DISPOS, V17, P583; SADEE W, 1982, J PHARMACOL EXP THER, V223, P157; Schwarz AJ, 2011, DRUG DISCOV TODAY, V16, P671, DOI 10.1016/j.drudis.2011.03.011; Shen Q, 2008, J MAGN RESON IMAGING, V27, P599, DOI 10.1002/jmri.21203; Smith HR, 2006, NEUROSCIENCE, V138, P703, DOI 10.1016/j.neuroscience.2005.11.033; Srihasam K, 2010, NEUROIMAGE, V51, P267, DOI 10.1016/j.neuroimage.2010.01.082; Stefanacci L, 1998, NEURON, V20, P1051, DOI 10.1016/S0896-6273(00)80485-7; Stoewer S, 2011, MAGN RESON IMAGING, V29, P1390, DOI 10.1016/j.mri.2011.05.003; Thrall M. A., 2012, VET HEMATOLOGY CLIN, V2nd; Upadhyay J, 2011, NEUROPSYCHOPHARMACOL, V36, P2659, DOI 10.1038/npp.2011.156; Vanduffel W, 2001, NEURON, V32, P565, DOI 10.1016/S0896-6273(01)00502-5; Wey HY, 2010, NEUROIMAGE, V52, P1420, DOI 10.1016/j.neuroimage.2010.05.014; Wise RG, 2004, NEUROPSYCHOPHARMACOL, V29, P626, DOI 10.1038/sj.npp.1300364; Wise RG, 2006, J MAGN RESON IMAGING, V23, P862, DOI 10.1002/jmri.20584; Wong DF, 2009, NEUROPSYCHOPHARMACOL, V34, P187, DOI 10.1038/npp.2008.166; Wu EX, 2004, NMR BIOMED, V17, P478, DOI 10.1002/nbm.923; Zhang ZM, 2000, BRAIN RES, V852, P290, DOI 10.1016/S0006-8993(99)02243-X	63	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110432	10.1371/journal.pone.0110432	http://dx.doi.org/10.1371/journal.pone.0110432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337714	Green Submitted, gold, Green Published			2022-12-27	WOS:000343674800042
J	Song, HB; Wu, F; Zhang, Y; Zhang, YZ; Wang, F; Jiang, M; Wang, ZD; Zhang, MX; Li, SW; Yang, LJ; Wang, XL; Cui, TX; Tang, DQ				Song, Haibo; Wu, Fei; Zhang, Yuan; Zhang, Yuzhu; Wang, Fang; Jiang, Miao; Wang, Zhongde; Zhang, Mingxiang; Li, Shiwu; Yang, Lijun; Wang, Xing Li; Cui, Taixing; Tang, Dongqi			Irisin Promotes Human Umbilical Vein Endothelial Cell Proliferation through the ERK Signaling Pathway and Partly Suppresses High Glucose-Induced Apoptosis	PLOS ONE			English	Article							CIRCULATING IRISIN; SURVIVAL; KINASE; BCL-2; CYCLE; BAX	Irisin is a newly discovered myokine that links exercise with metabolic homeostasis. It is involved in modest weight loss and improves glucose intolerance. However, the direct effects and mechanisms of irisin on vascular endothelial cells (ECs) are not fully understood. In the current study, we demonstrated that irisin promoted Human Umbilical Vein Endothelial Cell (HUVEC) proliferation. It was further demonstrated that this pro-proliferation effect was mediated by irisin-induced activation of extracellular signal-related kinase (ERK) signaling pathways. Inhibition of ERK signaling with U0126 decreased the pro-proliferation effect of irisin on HUVECs. It was also demonstrated that irisin reduced high glucose-induced apoptosis by up-regulating Bcl-2 expression and down-regulating Bax, Caspase-9 and Caspase-3 expression. In summary, these results suggested that irisin plays a novel role in sustaining endothelial homeostasis by promoting HUVEC proliferation via the ERK signaling pathway and protects the cell from high glucose-induced apoptosis by regulating Bcl-2, Bax and Caspase expression.	[Song, Haibo; Wu, Fei; Zhang, Yuan; Zhang, Yuzhu; Wang, Fang; Jiang, Miao; Li, Shiwu; Yang, Lijun; Tang, Dongqi] Shandong Univ, Hosp 2, Ctr Stem Cell & Regenerat Med, Jinan 250100, Peoples R China; [Song, Haibo; Wu, Fei; Zhang, Yuan; Zhang, Yuzhu; Zhang, Mingxiang; Wang, Xing Li; Cui, Taixing; Tang, Dongqi] Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Res Ctr Cell Therapy, Jinan 250100, Peoples R China; [Cui, Taixing] Univ S Carolina, Dept Cell Biol & Anat, Columbia, SC 29208 USA; [Song, Haibo; Wang, Zhongde] Zibo Maternal & Child Hlth Hosp, Ctr Reprod Med, Zibo, Peoples R China	Shandong University; Shandong University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Cui, TX (corresponding author), Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Res Ctr Cell Therapy, Jinan 250100, Peoples R China.	Taixing.Cui@uscmed.sc.edu; tangdq@sdu.edu.cn	Zhang, Yuan/B-3806-2019	Cui, Taixing/0000-0002-9528-7299; Tang, Dongqi/0000-0002-1429-9467	Shandong University National Qianren Scholar Fund; Taishan Scholar Fund	Shandong University National Qianren Scholar Fund; Taishan Scholar Fund	This work was supported by the Shandong University National Qianren Scholar Fund, and the Taishan Scholar Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydin S, 2013, PEPTIDES, V47, P66, DOI 10.1016/j.peptides.2013.07.001; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Brady HJM, 1998, INT J BIOCHEM CELL B, V30, P647, DOI 10.1016/S1357-2725(98)00006-5; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Choi YK, 2013, DIABETES RES CLIN PR, V100, P96, DOI 10.1016/j.diabres.2013.01.007; Colaianni G, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/902186; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Hamilton Sandra J, 2007, Diab Vasc Dis Res, V4, P89; Kisielewska J, 2009, DEV BIOL, V334, P383, DOI 10.1016/j.ydbio.2009.07.043; Liu JJ, 2013, J DIABETES COMPLICAT, V27, P365, DOI 10.1016/j.jdiacomp.2013.03.002; Mendizabal Y, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/230868; Moon HS, 2013, METABOLISM, V62, P1131, DOI 10.1016/j.metabol.2013.04.007; Novelle MG, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/746281; Pardo M, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/857270; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; REED JC, 1995, HEMATOL ONCOL CLIN N, V9, P451, DOI 10.1016/S0889-8588(18)30104-7; Sanchis-Gomar F, 2014, HORM METAB RES, V46, P591, DOI 10.1055/s-0033-1363283; Sanchis-Gomar F, 2014, ENDOCRINE, V46, P674, DOI 10.1007/s12020-014-0170-9; Strasser B, 2013, ANN NY ACAD SCI, V1281, P141, DOI 10.1111/j.1749-6632.2012.06785.x; Toi M, 2011, CANCER SCI, V102, P858, DOI 10.1111/j.1349-7006.2011.01867.x; Triggle CR, 2012, CAN J PHYSIOL PHARM, V90, P713, DOI [10.1139/Y2012-073, 10.1139/y2012-073]; Wang YF, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-84; Wen MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064025; Wrann CD, 2013, CELL METAB, V18, P649, DOI 10.1016/j.cmet.2013.09.008; Yamaguchi H, 2001, ONCOGENE, V20, P7779, DOI 10.1038/sj.onc.1204984; Zhang Y, 2014, DIABETES, V63, P514, DOI 10.2337/db13-1106; Zhang YS, 2014, ONCOL LETT, V7, P295, DOI 10.3892/ol.2013.1696	27	91	95	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110273	10.1371/journal.pone.0110273	http://dx.doi.org/10.1371/journal.pone.0110273			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338001	Green Published, Green Submitted, gold			2022-12-27	WOS:000343674800031
J	Yang, KH; Hendrix, C; Bumpus, N; Elliott, J; Tanner, K; Mauck, C; Cranston, R; McGowan, I; Richardson-Harman, N; Anton, PA; Kashuba, ADM				Yang, Kuo-Hsiung; Hendrix, Craig; Bumpus, Namandje; Elliott, Julie; Tanner, Karen; Mauck, Christine; Cranston, Ross; McGowan, Ian; Richardson-Harman, Nicola; Anton, Peter A.; Kashuba, Angela D. M.			A Multi-Compartment Single and Multiple Dose Pharmacokinetic Comparison of Rectally Applied Tenofovir 1% Gel and Oral Tenofovir Disoproxil Fumarate	PLOS ONE			English	Article							ANTIRETROVIRAL PROPHYLAXIS; CLINICAL-APPLICATIONS; HIV PREVENTION; DRUGS	This Phase 1, randomized, two-site (United States), double-blind, placebo-controlled study enrolled 18 sexually abstinent men and women. All received a single 300-mg dose of oral tenofovir disoproxil fumarate (TDF) and were then randomized 2: 1 to receive single and then seven daily rectal exposures of vaginally-formulated tenofovir (TFV) 1% gel or a hydroxyethyl cellulose (HEC) placebo gel. Blood, colonic biopsies and rectal and vaginal mucosal fluids were collected after the single oral TDF, the single topical TFV gel dose, and after 7 days of topical TFV gel dosing for extracellular analysis of TFV and intracellular analysis of the active metabolite tenofovir diphosphate (TFVdp) in peripheral blood mononuclear cells (PBMCs) and isolated mucosal mononuclear cells (MMC), including CD4+ and CD4-cell subsets. With a single rectal dose, TFV plasma concentrations were 24-33 fold lower and half-life was 5 h shorter compared to a single oral dose (p = 0.02). TFVdp concentrations were also undetectable in PBMCs with rectal dosing. Rectal tissue exposure to both TFV and TFVdp was 2 to 4-log(10) higher after a single rectal dose compared to a single oral dose, and after 7 daily doses, TFVdp accumulated 4.5 fold in tissue. TFVdp in rectal tissue homogenate was predictive (residual standard error, RSE = 0.47) of tissue MMC intracellular TFVdp concentration, with the CD4+ cells having a 2-fold higher TFVdp concentration than CD4-cells. TFV concentrations from rectal sponges was a modest surrogate indicator for both rectal tissue TFV and TFVdp (RSE = 0.67, 0.66, respectively) and plasma TFV (RSE = 0.38). TFV penetrates into the vaginal cavity after oral and rectal dosing, with rectal dosing leading to higher vaginal TFV concentrations (p<0.01).	[Yang, Kuo-Hsiung; Kashuba, Angela D. M.] UNC, Eshelman Sch Pharm, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC 27599 USA; [Hendrix, Craig; Bumpus, Namandje] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Hendrix, Craig; Bumpus, Namandje] Johns Hopkins Univ, Sch Med, Dept Pharmacol, Baltimore, MD 21205 USA; [Elliott, Julie; Anton, Peter A.] Univ Calif Los Angeles, David Geffen Sch Med, Ctr HIV Prevent Res, Los Angeles, CA 90095 USA; [Tanner, Karen] Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90024 USA; [Mauck, Christine] CONRAD, Arlington, VA USA; [McGowan, Ian] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Richardson-Harman, Nicola] Alpha StatConsult LLC, Damascus, Syria	University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; Johns Hopkins University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yang, KH (corresponding author), UNC, Eshelman Sch Pharm, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC 27599 USA.	kuohyang@email.unc.edu	Hendrix, Craig W/G-4182-2014; M, Ian/AAP-1032-2021; M, i/HCI-9242-2022	Hendrix, Craig W/0000-0002-5696-8665; M, Ian/0000-0002-6470-8476; Cranston, Ross/0000-0002-2687-6217	U19 grant Integrated Preclinical-Clinical Program for HIV Topical Microbicides (IPCP-HTM), Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) [AI060614]; NIAID's Microbicide Trials Network [5UM1AI068633]; Gilead Sciences Inc.; University of California, Los Angeles Center for AIDS Research Cores of Mucosal Immunology, Flow Cytometry and Biostatistics [5P30 AI28697]; University of North Carolina-Chapel Hill Center for AIDS Research, Clinical Pharmacology/Analytical Chemistry Core [P30 AI50410]; Johns Hopkins Clinical Pharmacology Analytical Laboratory; CONRAD; Advanced BioScience Laboratories, Inc., Rockville, Maryland; NIH/NIAID/DAIDS [HHSN272201000001C]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI060614, UM1AI106707, P30AI028697, UM1AI068633, P30AI050410] Funding Source: NIH RePORTER	U19 grant Integrated Preclinical-Clinical Program for HIV Topical Microbicides (IPCP-HTM), Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH); NIAID's Microbicide Trials Network; Gilead Sciences Inc.(Gilead Sciences); University of California, Los Angeles Center for AIDS Research Cores of Mucosal Immunology, Flow Cytometry and Biostatistics; University of North Carolina-Chapel Hill Center for AIDS Research, Clinical Pharmacology/Analytical Chemistry Core; Johns Hopkins Clinical Pharmacology Analytical Laboratory; CONRAD(United States Agency for International Development (USAID)); Advanced BioScience Laboratories, Inc., Rockville, Maryland; NIH/NIAID/DAIDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was funded by a U19 grant under the Integrated Preclinical-Clinical Program for HIV Topical Microbicides (IPCP-HTM), Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) (AI060614) and the NIAID's Microbicide Trials Network (5UM1AI068633). Additional support was provided by Gilead Sciences Inc.; the University of California, Los Angeles Center for AIDS Research (5P30 AI28697) Cores of Mucosal Immunology, Flow Cytometry and Biostatistics; the University of North Carolina-Chapel Hill Center for AIDS Research, Clinical Pharmacology/Analytical Chemistry Core (P30 AI50410); the Johns Hopkins Clinical Pharmacology Analytical Laboratory and CONRAD. The RMP-02/MTN-006 study was registered at www.ClinicalTrials.gov (NCT00984971) and the protocol can be http://www.mtnstopshiv.org. This analysis was supported by a contract with Advanced BioScience Laboratories, Inc., Rockville, Maryland, and its subcontractor, Alpha StatConsult LLC, through a NIH/NIAID/DAIDS contract: "Comprehensive Resources for HIV Microbicides and Biomedical Prevention" (#HHSN272201000001C). This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; Anton PA, 2012, AIDS RES HUM RETROV, V28, P1412, DOI [10.1089/aid.2012.0262, 10.1089/AID.2012.0262]; Anton PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023243; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Beigi R, 2011, J INFECT DIS, V204, P1527, DOI 10.1093/infdis/jir562; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; DEBOER AG, 1982, CLIN PHARMACOKINET, V7, P285, DOI 10.2165/00003088-198207040-00002; Fung HB, 2002, CLIN THER, V24, P1515, DOI 10.1016/S0149-2918(02)80058-3; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hampel FR, 2005, ROBUST STAT; Hendrix CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055013; Imaoka T, 2007, MOL PHARMACOL, V71, P619, DOI 10.1124/mol.106.028233; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2011, LANCET, V378, P279, DOI 10.1016/S0140-6736(11)60878-7; Kearney BP, 2004, CLIN PHARMACOKINET, V43, P595, DOI 10.2165/00003088-200443090-00003; Keller MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016475; King T, 2006, J CHROMATOGR B, V843, P147, DOI 10.1016/j.jchromb.2006.05.043; Louissaint NA, 2013, AIDS RES HUM RETROVI; Louissaint NA, 2012, J INFECT DIS, V205, P725, DOI 10.1093/infdis/jir841; Nuttall J, 2012, ANTIMICROB AGENTS CH, V56, P103, DOI 10.1128/AAC.00597-11; Patterson KB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003174; R Core Team, 2021, R LANGUAGE ENV STAT; Ray AS, 2006, ANTIMICROB AGENTS CH, V50, P3297, DOI 10.1128/AAC.00251-06; Robbins BL, 2003, PHARMACOTHERAPY, V23, P695, DOI 10.1592/phco.23.6.695.32189; Rodriguez-Novoa S, 2009, CLIN INFECT DIS, V48, pE108, DOI 10.1086/598507; Sarkar D., LATTICE MULTIVARIATE; Sarkar D, 2012, LATTICEEXTRA EXTRA G; VANGINNEKEN CAM, 1989, CLIN PHARMACOKINET, V16, P38, DOI 10.2165/00003088-198916010-00003; VANHOOGDALEM EJ, 1991, CLIN PHARMACOKINET, V21, P110, DOI 10.2165/00003088-199121020-00003; VANHOOGDALEM EJ, 1991, CLIN PHARMACOKINET, V21, P11, DOI 10.2165/00003088-199121010-00002; Wickham H, 2007, J STAT SOFTW; Wickham H, 2011, J STAT; Yanez JA, 2011, THER DELIV, V2, P643, DOI [10.4155/TDE.11.19, 10.4155/tde.11.19]	33	46	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e106196	10.1371/journal.pone.0106196	http://dx.doi.org/10.1371/journal.pone.0106196			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350119	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000343943100004
J	Connolly, CG; Bischoff-Grethe, A; Jordan, SJ; Woods, SP; Ellis, RJ; Paulus, MP; Grant, I				Connolly, Colm G.; Bischoff-Grethe, Amanda; Jordan, Stephan J.; Woods, Steven Paul; Ellis, Ronald J.; Paulus, Martin P.; Grant, Igor		Translational Methamphetamine AIDS	Altered Functional Response to Risky Choice in HIV Infection	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; TRANSCRANIAL MAGNETIC STIMULATION; IMMUNODEFICIENCY-VIRUS-INFECTION; OBSESSIVE-COMPULSIVE DISORDER; SOMATIC MARKER HYPOTHESIS; TAKING DECISION-MAKING; PREFRONTAL CORTEX; NEUROCOGNITIVE IMPAIRMENT; ANTIRETROVIRAL THERAPY; SENSATION SEEKING	Background: Risky decision-making is commonly observed in persons at risk for and infected with HIV and is associated with executive dysfunction. Yet it is currently unknown whether HIV alters brain processing of risk-taking decision-making. Methods: This study examined the neural substrate of a risky decision-making task in 21 HIV seropositive (HIV+) and 19 seronegative (HIV-) comparison participants. Functional magnetic resonance imaging was conducted while participants performed the risky-gains task, which involves choosing among safe (20 cents) and risky (40/80 cent win or loss) choices. Linear mixed effects analyses examining group and decision type were conducted. Robust regressions were performed to examine the relationship between nadir CD4 count and Kalichman sexual compulsivity and brain activation in the HIV+ group. The overlap between the task effects and robust regressions was explored. Results: Although there were no serostatus effects in behavioral performance on the risky-gains task, HIV+ individuals exhibited greater activation for risky choices in the basal ganglia, i.e. the caudate nucleus, but also in the anterior cingulate, dorsolateral prefrontal cortex, and insula relative to the HIV-group. The HIV+ group also demonstrated reduced functional responses to safe choices in the anterior cingulate and dorsolateral prefrontal cortex relative to the HIV-group. HIV+ individuals with higher nadir CD4 count and greater sexual compulsivity displayed lower differential responses to safe versus risky choices in many of these regions. Conclusions: This study demonstrated fronto-striatal loop dysfunction associated with HIV infection during risky decision-aking. Combined with similar between-group task behavior, this suggests an adaptive functional response in regions critical to reward and behavioral control in the HIV+ group. HIV-infected individuals with higher CD4 nadirs demonstrated activation patterns more similar to seronegative individuals. This suggests that the severity of past immunosuppression (CD4 nadir) may exert a legacy effect on processing of risky choices in the HIV-infected brain.	[Connolly, Colm G.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Bischoff-Grethe, Amanda; Jordan, Stephan J.; Woods, Steven Paul; Paulus, Martin P.; Grant, Igor] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Paulus, Martin P.] VA San Diego Healthcare Syst, Psychiat Serv, La Jolla, CA USA; [Woods, Steven Paul; Grant, Igor] Univ Calif San Diego, HIV Neurobehav Res Program, San Diego, CA 92103 USA; [Ellis, Ronald J.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA	University of California System; University of California San Francisco; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of California System; University of California San Diego	Bischoff-Grethe, A (corresponding author), Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.	agrethe@ucsd.edu; igrant@ucsd.edu	Ellis, Ronald/K-3543-2015; Connolly, Colm G./H-5917-2019	Ellis, Ronald/0000-0003-4931-752X; Connolly, Colm G./0000-0002-4051-3682; Scadeng, Miriam/0000-0002-9593-2956; Fennema-Notestine, Christine/0000-0002-6527-6361; Woods, Steven Paul/0000-0003-0776-4233	National Institute on Drug Abuse (NIDA) [P50DA026306]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA026306] Funding Source: NIH RePORTER	National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The Translational Methamphetamine AIDS Research Center (TMARC) is supported by Center award P50DA026306 from the National Institute on Drug Abuse (NIDA). The funding agency played no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. The views expressed in this article are those of the authors and do not reflect the official policy or position of the United States Government.	ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Alexander WH, 2010, TOP COGN SCI, V2, P658, DOI 10.1111/j.1756-8765.2010.01085.x; Allais M, 1979, THEORY DECISION LIB, V21, P437, DOI [10.1007/978-94-015-7629-1_17, DOI 10.1007/978-94-015-7629-1_17]; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Andersson JLR, 2007, NONLINEAR OPTIMISATI; Andersson JLR, 2007, NONLINEAR REGISTRATI; ATKINSON JW, 1957, PSYCHOL REV, V64, P359, DOI 10.1037/h0043445; Basso MR, 2003, J CLIN EXP NEUROPSYC, V25, P893, DOI 10.1076/jcen.25.7.893.16489; BAXTER LR, 1992, ARCH GEN PSYCHIAT, V49, P681; Bechara A, 2005, GAME ECON BEHAV, V52, P336, DOI 10.1016/j.geb.2004.06.010; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Becker JT, 2012, J NEUROVIROL, V18, P423, DOI 10.1007/s13365-012-0115-0; Becker JT, 2012, BRAIN IMAGING BEHAV, V6, P366, DOI 10.1007/s11682-012-9149-4; Becker JT, 2012, J NEUROSCI METH, V206, P176, DOI 10.1016/j.jneumeth.2012.02.022; Becker JT, 2011, BRAIN IMAGING BEHAV, V5, P77, DOI 10.1007/s11682-011-9113-8; Benotsch EG, 2001, SEXUAL ADDICTION COM, V8, P83, DOI [DOI 10.1080/10720160127561, 10.1080/10720160127561]; Berger JR, 2000, J PSYCHOPHARMACOL, V14, P214, DOI 10.1177/026988110001400304; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Breiter HC, 1996, ARCH GEN PSYCHIAT, V53, P595; Brown JW, 2007, COGN AFFECT BEHAV NE, V7, P266, DOI 10.3758/CABN.7.4.266; Brown JW, 2011, NEUROIMAGE, V57, P314, DOI 10.1016/j.neuroimage.2011.04.028; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carey CL, 2004, J CLIN EXP NEUROPSYC, V26, P307, DOI 10.1080/13803390490510031; Chang L, 2008, J NEUROIMMUNE PHARM, V3, P95, DOI 10.1007/s11481-007-9092-0; Chang L, 2004, ANN NEUROL, V56, P259, DOI 10.1002/ana.20190; Chang L, 2001, NEUROLOGY, V57, P1001, DOI 10.1212/WNL.57.6.1001; Cohen RA, 2010, J NEUROVIROL, V16, P25, DOI 10.3109/13550280903552420; Cooper ML, 2002, J STUD ALCOHOL, P101, DOI 10.15288/jsas.2002.s14.101; Costafreda SG, 2007, J MAGN RESON IMAGING, V26, P1122, DOI 10.1002/jmri.21118; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Croxson PL, 2009, J NEUROSCI, V29, P4531, DOI 10.1523/JNEUROSCI.4515-08.2009; Cysique LAJ, 2006, NEUROLOGY, V66, P1447, DOI 10.1212/01.wnl.0000210477.63851.d3; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; Delgado MR, 2007, ANN NY ACAD SCI, V1104, P70, DOI 10.1196/annals.1390.002; Du Plessis S, 2014, AIDS, V28, P803, DOI 10.1097/QAD.0000000000000151; Duarte NA, 2012, J PSYCHIATR RES, V46, P492, DOI 10.1016/j.jpsychires.2012.01.006; Ellis R, 2007, NAT REV NEUROSCI, V8, P33, DOI 10.1038/nrn2040; Ellis RJ, 2011, AIDS, V25, P1747, DOI 10.1097/QAD.0b013e32834a40cd; Erceg-Hurn DM, 2008, AM PSYCHOL, V63, P591, DOI 10.1037/0003-066X.63.7.591; Ernst M, 2004, NEUROPSYCHOLOGIA, V42, P1585, DOI 10.1016/j.neuropsychologia.2004.05.011; Ernst T, 2002, NEUROLOGY, V59, P1343, DOI 10.1212/01.WNL.0000031811.45569.B0; Ernst T, 2009, ANN NEUROL, V65, P316, DOI 10.1002/ana.21594; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Fecteau S, 2007, J NEUROSCI, V27, P6212, DOI 10.1523/JNEUROSCI.0314-07.2007; Fillmore MT, 2002, DRUG ALCOHOL DEPEN, V66, P265, DOI 10.1016/S0376-8716(01)00206-X; Fox J, 2002, COX PROPORTIONAL HAZ; Fukunaga R, 2012, COGN AFFECT BEHAV NE, V12, P479, DOI 10.3758/s13415-012-0102-1; Glover GH, 2012, J MAGN RESON IMAGING, V36, P39, DOI 10.1002/jmri.23572; Gonzalez R, 2005, J INT NEUROPSYCH SOC, V11, P121, DOI 10.1017/S1355617705050186; Gountouna VE, 2010, NEUROIMAGE, V49, P552, DOI 10.1016/j.neuroimage.2009.07.026; Groenewegen HJ, 1999, ANN NY ACAD SCI, V877, P49, DOI 10.1111/j.1749-6632.1999.tb09260.x; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hampton AN, 2007, P NATL ACAD SCI USA, V104, P1377, DOI 10.1073/pnas.0606297104; Hardy DJ, 2006, NEUROPSYCHOLOGY, V20, P355, DOI 10.1037/0894-4105.20.3.355; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Heaton R K, 1995, J Int Neuropsychol Soc, V1, P231; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Heaton RK., 1994, NEUROPSYCHOLOGY HIV, P188; Hedges LV, 2014, STAT METHODS META AN; Hershberger SL, 2004, ADDICT BEHAV, V29, P623, DOI 10.1016/j.addbeh.2003.08.016; Hester R, 2004, J NEUROSCI, V24, P11017, DOI 10.1523/JNEUROSCI.3321-04.2004; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Hu SH, 2014, J SEX MED, V11, P2474, DOI 10.1111/jsm.12639; HUBER PJ, 1964, ANN MATH STAT, V35, P73, DOI 10.1214/aoms/1177703732; Iudicello JE, 2013, CLIN NEUROPSYCHOL, V27, P256, DOI 10.1080/13854046.2012.740077; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenkinson M, 2003, MAGNET RESON MED, V49, P193, DOI 10.1002/mrm.10354; Jernigan TL, 2011, J NEUROVIROL, V17, P248, DOI 10.1007/s13365-011-0032-7; Jernigan TL, 2005, AM J PSYCHIAT, V162, P1461, DOI 10.1176/appi.ajp.162.8.1461; KALICHMAN SC, 1994, J PERS ASSESS, V62, P385, DOI 10.1207/s15327752jpa6203_1; Kalichman SC, 1996, ARCH SEX BEHAV, V25, P141, DOI 10.1007/BF02437933; Kaul M, 1999, P NATL ACAD SCI USA, V96, P8212, DOI 10.1073/pnas.96.14.8212; Knoch D, 2006, J NEUROSCI, V26, P6469, DOI 10.1523/JNEUROSCI.0804-06.2006; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Lau B, 2008, NEURON, V58, P451, DOI 10.1016/j.neuron.2008.02.021; Lee TMC, 2008, SOC COGN AFFECT NEUR, V3, P7, DOI 10.1093/scan/nsm033; LEIGH BC, 1993, AM PSYCHOL, V48, P1035, DOI 10.1037/0003-066X.48.10.1035; Leland DS, 2005, DRUG ALCOHOL DEPEN, V78, P83, DOI 10.1016/j.drugalcdep.2004.10.001; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; LYNDBALTA E, 1994, NEUROSCIENCE, V59, P625, DOI 10.1016/0306-4522(94)90182-1; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Maki PM, 2009, NEUROLOGY, V72, P1661, DOI 10.1212/WNL.0b013e3181a55f65; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; Martin EM, 2004, J INT NEUROPSYCH SOC, V10, P931, DOI 10.1017/S1355617704107054; Martin EM, 2003, NEUROPSYCHOLOGY, V17, P283, DOI 10.1037/0894-4105.17.2.283; Mellers BA, 1997, CHOICE, DECISION, AND MEASUREMENT: ESSAYS IN HONOR OF R. DUNCAN LUCE, P57; Melrose RJ, 2008, BEHAV BRAIN RES, V188, P337, DOI 10.1016/j.bbr.2007.11.021; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Munoz-Moreno JA, 2008, AIDS RES HUM RETROV, V24, P1301, DOI 10.1089/aid.2007.0310; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Paulus MP, 2006, NEUROIMAGE, V30, P668, DOI 10.1016/j.neuroimage.2005.09.061; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; Paulus MP, 2001, NEUROIMAGE, V13, P91, DOI 10.1006/nimg.2000.0667; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Platt ML, 2008, NAT NEUROSCI, V11, P398, DOI 10.1038/nn2062; POLLOCK V, 1979, J NERV MENT DIS, V167, P612, DOI 10.1097/00005053-197910000-00004; Preuschoff K, 2006, NEURON, V51, P381, DOI 10.1016/j.neuron.2006.06.024; R Development Core Team, 2012, R LANG ENV STAT COMP; Rabkin Judith G, 2008, Curr HIV/AIDS Rep, V5, P163, DOI 10.1007/s11904-008-0025-1; Rajah MN, 2005, BRAIN, V128, P1964, DOI 10.1093/brain/awh608; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Rangel A, 2010, CURR OPIN NEUROBIOL, V20, P262, DOI 10.1016/j.conb.2010.03.001; RAUCH SL, 1994, ARCH GEN PSYCHIAT, V51, P62; Reynolds NR, 2009, AIDS EDUC PREV, V21, P106, DOI 10.1521/aeap.2009.21.3_supp.106; Rogers RD, 2004, BIOL PSYCHIAT, V55, P594, DOI 10.1016/j.biopsych.2003.11.012; Ruchsow M, 2002, NEUROSCI LETT, V325, P203, DOI 10.1016/S0304-3940(02)00288-4; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Saad ZS, 2009, NEUROIMAGE, V44, P839, DOI 10.1016/j.neuroimage.2008.09.037; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Savic I, 2008, P NATL ACAD SCI USA, V105, P9403, DOI 10.1073/pnas.0801566105; Saxena S, 2000, PSYCHIAT CLIN N AM, V23, P563, DOI 10.1016/S0193-953X(05)70181-7; Shuter J, 2008, NICOTINE TOB RES, V10, P731, DOI 10.1080/14622200801908190; Slovic P, 2004, RISK ANAL, V24, P311, DOI 10.1111/j.0272-4332.2004.00433.x; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Stewart JL, 2014, PSYCHIAT RES-NEUROIM, V223, P129, DOI 10.1016/j.pscychresns.2014.04.014; Stewart JL, 2014, ADDICTION, V109, P460, DOI 10.1111/add.12403; Stout JC, 1998, ARCH NEUROL-CHICAGO, V55, P161, DOI 10.1001/archneur.55.2.161; Suckling J, 2008, HUM BRAIN MAPP, V29, P1111, DOI 10.1002/hbm.20451; Sutton BP, 2008, J MAGN RESON IMAGING, V28, P21, DOI 10.1002/jmri.21419; Talairach J., 1988, COPLANAR STEREOTAXIC; Tesoriero JM, 2010, AIDS BEHAV, V14, P824, DOI 10.1007/s10461-008-9449-2; Thompson PM, 2005, P NATL ACAD SCI USA, V102, P15647, DOI 10.1073/pnas.0502548102; Tozzi V, 2005, J NEUROVIROL, V11, P265, DOI 10.1080/13550280590952790; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; Ullsperger M, 2001, NEUROIMAGE, V14, P1387, DOI 10.1006/nimg.2001.0935; Ursu S, 2003, PSYCHOL SCI, V14, P347, DOI 10.1111/1467-9280.24411; Utz KS, 2010, NEUROPSYCHOLOGIA, V48, P2789, DOI 10.1016/j.neuropsychologia.2010.06.002; Valcour V, 2006, J NEUROVIROL, V12, P387, DOI 10.1080/13550280600915339; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837; van't Wout M, 2005, NEUROREPORT, V16, P1849, DOI 10.1097/01.wnr.0000183907.08149.14; Walsh V, 2005, TRANSCRANIAL MAGNETI; Weinhardt L S, 2000, Annu Rev Sex Res, V11, P125; Wilkinson GS, 2006, WRAT 4 4; Wilson TW, 2013, J NEUROIMMUNE PHARM, V8, P965, DOI 10.1007/s11481-013-9477-1; Wilson TW, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0066241, 10.137/journal.pone.0066241]; World Health Organization (WHO), 1998, COMP INT DIAGN INT C	150	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111583	10.1371/journal.pone.0111583	http://dx.doi.org/10.1371/journal.pone.0111583			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ1JF	25347679	Green Published, gold, Green Submitted			2022-12-27	WOS:000347994900082
J	Murgiano, L; Jagannathan, V; Calderoni, V; Joechler, M; Gentile, A; Drogemuller, C				Murgiano, Leonardo; Jagannathan, Vidhya; Calderoni, Valerio; Joechler, Monika; Gentile, Arcangelo; Droegemueller, Cord			Looking the Cow in the Eye: Deletion in the NID1 Gene Is Associated with Recessive Inherited Cataract in Romagnola Cattle	PLOS ONE			English	Article							BASEMENT-MEMBRANE PROTEIN; CONGENITAL CATARACTS; MOLECULAR-GENETICS; MOUSE NIDOGEN-2; GENOME; CRYSTALLIN; BINDING; PSEUDOMYOTONIA; PREVALENCE; EXPRESSION	Cataract is a known condition leading to opacification of the eye lens causing partial or total blindness. Mutations are known to cause autosomal dominant or recessive inherited forms of cataracts in humans, mice, rats, guinea pigs and dogs. The use of large-sized animal models instead of those using mice for the study of this condition has been discussed due to the small size of rodent lenses. Four juvenile-onset cases of bilateral incomplete immature nuclear cataract were recently observed in Romagnola cattle. Pedigree analysis suggested a monogenic autosomal recessive inheritance. In addition to the cataract, one of the cases displayed abnormal head movements. Genome-wide association and homozygosity mapping and subsequent whole genome sequencing of a single case identified two perfectly associated sequence variants in a critical interval of 7.2 Mb on cattle chromosome 28: a missense point mutation located in an uncharacterized locus and an 855 bp deletion across the exon 19/intron 19 border of the bovine nidogen 1 (NID1) gene (c.3579_3604+829del). RT-PCR showed that NID1 is expressed in bovine lenses while the transcript of the second locus was absent. The NID1 deletion leads to the skipping of exon 19 during transcription and is therefore predicted to cause a frameshift and premature stop codon (p.1164fs27X). The truncated protein lacks a C-terminal domain essential for binding with matrix assembly complexes. Nidogen 1 deficient mice show neurological abnormalities and highly irregular crystal lens alterations. This study adds NID1 to the list of candidate genes for inherited cataract in humans and is the first report of a naturally occurring mutation leading to non-syndromic catarct in cattle provides a potential large animal model for human cataract.	[Murgiano, Leonardo; Jagannathan, Vidhya; Droegemueller, Cord] Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland; [Joechler, Monika; Gentile, Arcangelo] Univ Bologna, Dept Vet Med Sci, Ozzano Dellemilia, Italy	University of Bern; University of Bologna	Drogemuller, C (corresponding author), Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland.	cord.droegemueller@vetsuisse.unibe.ch	Jagannathan, Vidhya/P-1055-2019	Jagannathan, Vidhya/0000-0002-8155-0041; Drogemuller, Cord/0000-0001-9773-522X				Aszodi A, 2006, ANNU REV CELL DEV BI, V22, P591, DOI 10.1146/annurev.cellbio.22.010305.104258; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; AUMAILLEY M, 1993, KIDNEY INT, V43, P7, DOI 10.1038/ki.1993.3; Bader BL, 2005, MOL CELL BIOL, V25, P6846, DOI 10.1128/MCB.25.15.6846-6856.2005; Bose K, 2006, J BIOL CHEM, V281, P39620, DOI 10.1074/jbc.M607886200; Breitkreutz D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/179784; CARLIN B, 1981, J BIOL CHEM, V256, P5209; Chang TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016867; Chew EY, 2013, INVEST OPHTH VIS SCI, V54, DOI 10.1167/iovs.13-12914; Churchill A, 2011, PHILOS T R SOC B, V366, P1234, DOI 10.1098/rstb.2010.0227; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Clark JI, 1999, EYE, V13, P417, DOI 10.1038/eye.1999.116; Darbro BW, 2013, HUM MUTAT, V34, P1075, DOI 10.1002/humu.22351; Deng H, 2014, EUR J MED GENET, V57, P113, DOI 10.1016/j.ejmg.2013.12.006; Detlefson JA, 1920, AM NAT, V54, P277, DOI 10.1086/279759; FOX JW, 1991, EMBO J, V10, P3137, DOI 10.1002/j.1460-2075.1991.tb04875.x; GELATT KN, 1984, CURR EYE RES, V3, P765, DOI 10.3109/02713688409065600; Gregory PW, 1943, J HERED, V34, P125, DOI 10.1093/oxfordjournals.jhered.a105263; Gresham HD, 1996, J BIOL CHEM, V271, P30587, DOI 10.1074/jbc.271.48.30587; Hassig M, 2009, SCHWEIZ ARCH TIERH, V151, P471, DOI 10.1024/0036-7281.151.10.471; He WG, 2000, HUM GENET, V106, P1, DOI 10.1007/s004390051002; Hejtmancik JF, 2008, SEMIN CELL DEV BIOL, V19, P134, DOI 10.1016/j.semcdb.2007.10.003; Hirano T, 2012, ANIM GENET, V43, P11, DOI 10.1111/j.1365-2052.2011.02209.x; Huang BY, 2010, EUR J MED GENET, V53, P347, DOI 10.1016/j.ejmg.2010.07.001; Hunter L, 2006, MOL VIS, V12, P588; Kimura N, 1998, EXP CELL RES, V241, P36, DOI 10.1006/excr.1998.4016; Koenigsberg R, 1989, CHURCHILLS MED DICT; Kohfeldt E, 1998, J MOL BIOL, V282, P99, DOI 10.1006/jmbi.1998.2004; Krump L, 2014, IRISH VET J, V67, DOI 10.1186/2046-0481-67-2; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang JJN, 2004, PROTEIN SCI, V13, P2476, DOI 10.1110/ps.04815104; Liu BF, 2008, EXP EYE RES, V87, P515, DOI 10.1016/j.exer.2008.08.021; Marchitti SA, 2008, AN MOD EYE RES; May CA, 2012, ISRN OPHTHALMOL, DOI 10.5402; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mesa R, 2013, INVEST OPHTH VIS SCI, V54, P6789, DOI 10.1167/iovs.13-12644; Miosge N, 2002, MATRIX BIOL, V21, P611, DOI 10.1016/S0945-053X(02)00070-7; Miosge N, 2001, HISTOCHEM J, V33, P523, DOI 10.1023/A:1014995523521; Morton JD, 2013, INVEST OPHTH VIS SCI, V54, P389, DOI 10.1167/iovs.12-11088; Murgiano L, 2014, VET J, V200, P459, DOI 10.1016/j.tvjl.2014.03.020; Murgiano L, 2013, VET J, V195, P238, DOI 10.1016/j.tvjl.2012.04.021; Murgiano L, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-186; Murshed M, 2000, MOL CELL BIOL, V20, P7007, DOI 10.1128/MCB.20.18.7007-7012.2000; Neu R, 2006, DIFFERENTIATION, V74, P573, DOI 10.1111/j.1432-0436.2006.00100.x; Petrash JM, 2013, INVEST OPHTH VIS SCI, V54, DOI 10.1167/iovs.13-12940; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Salmivirta K, 2002, EXP CELL RES, V279, P188, DOI 10.1006/excr.2002.5611; Schymeinsky J, 2002, MOL CELL BIOL, V22, P6820, DOI 10.1128/MCB.22.19.6820-6830.2002; Shiels A, 2010, MOL VIS, V16, P2007; Sinha R, 2009, INDIAN J OPHTHALMOL, V57, P245; Takagi J, 2003, NATURE, V424, P969, DOI 10.1038/nature01873; Talla V, 2006, INVEST OPHTH VIS SCI, V47, P5212, DOI 10.1167/iovs.06-0427; Testoni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045634; TIMPL R, 1983, EUR J BIOCHEM, V137, P455, DOI 10.1111/j.1432-1033.1983.tb07849.x; Tripathi B J, 1991, Lens Eye Toxic Res, V8, P373; Untergrasser A, 2012, NUCLEIC ACIDS RES, V40, pe115; Vasudevan A, 2010, HIPPOCAMPUS, V20, P608, DOI 10.1002/hipo.20660; Wilson GRS, 2012, MOL VIS, V18, P1384; Yi J, 2011, INT J OPHTHALMOL-CHI, V4, P422, DOI 10.3980/j.issn.2222-3959.2011.04.20; Yurchenco PD, 2004, MATRIX BIOL, V22, P521, DOI 10.1016/j.matbio.2003.10.006; Yurchenco PD, 2009, CURR PHARM DESIGN, V15, P1277, DOI 10.2174/138161209787846766	62	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e110628	10.1371/journal.pone.0110628	http://dx.doi.org/10.1371/journal.pone.0110628			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347398	Green Published, Green Submitted, gold			2022-12-27	WOS:000347994900024
J	Stangl, M; Unger, S; Keller, S; Schneider, D				Stangl, Michael; Unger, Sebastian; Keller, Sandro; Schneider, Dirk			Sequence-Specific Dimerization of a Transmembrane Helix in Amphipol A8-35	PLOS ONE			English	Article							INTEGRAL MEMBRANE-PROTEINS; RESONANCE ENERGY-TRANSFER; SECONDARY STRUCTURE ANALYSES; SODIUM DODECYL-SULFATE; MIXED MICELLES; ALPHA-HELICES; AQUEOUS-SOLUTIONS; STABILITY; POLYMERS; ASSOCIATION	As traditional detergents might destabilize or even denature membrane proteins, amphiphilic polymers have moved into the focus of membrane-protein research in recent years. Thus far, Amphipols are the best studied amphiphilic copolymers, having a hydrophilic backbone with short hydrophobic chains. However, since stabilizing as well as destabilizing effects of the Amphipol belt on the structure of membrane proteins have been described, we systematically analyze the impact of the most commonly used Amphipol A8-35 on the structure and stability of a well-defined transmembrane protein model, the glycophorin A transmembrane helix dimer. Amphipols are not able to directly extract proteins from their native membranes, and detergents are typically replaced by Amphipols only after protein extraction from membranes. As Amphipols form mixed micelles with detergents, a better understanding of Amphipol-detergent interactions is required. Therefore, we analyze the interaction of A8-35 with the anionic detergent sodium dodecyl sulfate and describe the impact of the mixed-micelle-like system on the stability of a transmembrane helix dimer. As A8-35 may highly stabilize and thereby rigidify a transmembrane protein structure, modest destabilization by controlled addition of detergents and formation of mixed micellar systems might be helpful to preserve the function of a membrane protein in Amphipol environments.	[Stangl, Michael; Schneider, Dirk] Johannes Gutenberg Univ Mainz, Dept Biochem & Pharm, D-55122 Mainz, Germany; [Unger, Sebastian; Keller, Sandro] Univ Kaiserslautern, D-67663 Kaiserslautern, Germany	Johannes Gutenberg University of Mainz; University of Kaiserslautern	Schneider, D (corresponding author), Johannes Gutenberg Univ Mainz, Dept Biochem & Pharm, D-55122 Mainz, Germany.	Dirk.Schneider@uni-mainz.de	Keller, Sandro/T-3487-2019; Keller, Sandro/G-7202-2016	Keller, Sandro/0000-0001-5469-8772; Keller, Sandro/0000-0001-5469-8772				ADAIR BD, 1994, BIOCHEMISTRY-US, V33, P5539, DOI 10.1021/bi00184a024; Anbazhagan V, 2010, BBA-BIOMEMBRANES, V1798, P1899, DOI 10.1016/j.bbamem.2010.06.027; Anbazhagan V, 2010, ARCH BIOCHEM BIOPHYS, V495, P159, DOI 10.1016/j.abb.2010.01.006; Bordag N, 2010, CHEM PHYS LIPIDS, V163, P1, DOI 10.1016/j.chemphyslip.2009.07.009; Diab C, 2007, BBA-BIOMEMBRANES, V1768, P2737, DOI 10.1016/j.bbamem.2007.07.007; Diab C, 2007, LANGMUIR, V23, P3025, DOI 10.1021/la062522j; Duarte AMS, 2008, J PEPT SCI, V14, P389, DOI 10.1002/psc.996; Etzkorn M, 2014, J MEMBR BIOL; Faham S, 2004, J MOL BIOL, V335, P297, DOI 10.1016/j.jmb.2003.10.041; Fisher LE, 1999, J MOL BIOL, V293, P639, DOI 10.1006/jmbi.1999.3126; Fisher LE, 2003, BIOPHYS J, V85, P3097, DOI 10.1016/S0006-3495(03)74728-6; Giusti F, 2012, LANGMUIR, V28, P10372, DOI 10.1021/la300774d; Gohon Y, 2006, LANGMUIR, V22, P1281, DOI 10.1021/la052243g; Gohon Y, 2008, BIOPHYS J, V94, P3523, DOI 10.1529/biophysj.107.121848; Hong H, 2011, J AM CHEM SOC, V133, P11389, DOI 10.1021/ja204524c; Keller S, 2006, J AM CHEM SOC, V128, P1279, DOI 10.1021/ja056389d; Keller S, 2006, BIOPHYS J, V90, P4509, DOI 10.1529/biophysj.105.077867; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Kemmer G, 2010, NAT PROTOC, V5, P267, DOI 10.1038/nprot.2009.182; Lau FW, 1997, BIOCHEMISTRY-US, V36, P5884, DOI 10.1021/bi963095j; LEMMON MA, 1992, J BIOL CHEM, V267, P7683; LEMMON MA, 1994, NAT STRUCT BIOL, V1, P157, DOI 10.1038/nsb0394-157; LEMMON MA, 1992, BIOCHEMISTRY-US, V31, P12719, DOI 10.1021/bi00166a002; MacKenzie KR, 2006, CHEM REV, V106, P1931, DOI 10.1021/cr0404388; Merzlyakov M, 2008, METHOD ENZYMOL, V450, P107, DOI 10.1016/S0076-6879(08)03406-X; Otzen DE, 2003, J MOL BIOL, V330, P641, DOI 10.1016/S0022-2836(03)00624-7; Picard M, 2006, BIOCHEMISTRY-US, V45, P1861, DOI 10.1021/bi051954a; Planchard N, 2014, J MEMBR BIOL; Pocanschi CL, 2013, EUR BIOPHYS J; Pocanschi CL, 2006, BIOCHEMISTRY-US, V45, P13954, DOI 10.1021/bi0616706; Popot JL, 2011, ANNU REV BIOPHYS, V40, P379, DOI 10.1146/annurev-biophys-042910-155219; Popot JL, 2010, ANNU REV BIOCHEM, V79, P737, DOI 10.1146/annurev.biochem.052208.114057; Popot JL, 2003, CELL MOL LIFE SCI, V60, P1559, DOI 10.1007/s00018-003-3169-6; Sehgal P, 2006, PROTEIN SCI, V15, P890, DOI 10.1110/ps.052031306; Senes A, 2001, P NATL ACAD SCI USA, V98, P9056, DOI 10.1073/pnas.161280798; SHIRAKI K, 1995, J MOL BIOL, V245, P180, DOI 10.1006/jmbi.1994.0015; Stangl M, 2014, BIOCHEMISTRY-US, V53, P1410, DOI 10.1021/bi401611f; Stangl M, 2012, BIOPHYS J, V103, P2455, DOI 10.1016/j.bpj.2012.11.004; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Tribet C, 1996, P NATL ACAD SCI USA, V93, P15047, DOI 10.1073/pnas.93.26.15047; Tribet C, 2009, LANGMUIR, V25, P12623, DOI 10.1021/la9018772; Tribet C, 1997, LANGMUIR, V13, P5570, DOI 10.1021/la970136j; Weber M, 2011, J MOL BIOL, V407, P594, DOI 10.1016/j.jmb.2011.02.005; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Yohannan S, 2004, J MOL BIOL, V341, P1, DOI 10.1016/j.jmb.2004.06.025; Zoonens M, 2007, BIOCHEMISTRY-US, V46, P10392, DOI 10.1021/bi7007596; Zoonens M, 2013, J AM CHEM SOC, V135, P15174, DOI 10.1021/ja407424v	48	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e110970	10.1371/journal.pone.0110970	http://dx.doi.org/10.1371/journal.pone.0110970			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347769	Green Published, gold, Green Submitted			2022-12-27	WOS:000347994900035
J	Franco, JS; Molano-Gonzalez, N; Rodriguez-Jimenez, M; Acosta-Ampudia, Y; Mantilla, RD; Amaya-Amaya, J; Rojas-Villarraga, A; Anaya, JM				Franco, Juan-Sebastian; Molano-Gonzalez, Nicolas; Rodriguez-Jimenez, Monica; Acosta-Ampudia, Yeny; Mantilla, Ruben D.; Amaya-Amaya, Jenny; Rojas-Villarraga, Adriana; Anaya, Juan-Manuel			The Coexistence of Antiphospholipid Syndrome and Systemic Lupus Erythematosus in Colombians	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS PATIENTS; PRIMARY SJOGRENS-SYNDROME; ANTICARDIOLIPIN ANTIBODIES; CLINICAL-SIGNIFICANCE; RISK-FACTORS; CLASSIFICATION CRITERIA; AUTOIMMUNE-DISEASES; CHILEAN PATIENTS; PREGNANCY LOSS; PREVALENCE	Objectives: To examine the prevalence and associated factors related to the coexistence of antiphospholipid syndrome (APS) and systemic lupus erythematosus (SLE) in a cohort of Colombian patients with SLE, and to discuss the coexistence of APS with other autoimmune diseases (ADs). Method: A total of 376 patients with SLE were assessed for the presence of the following: 1) confirmed APS; 2) positivity for antiphospholipid (aPL) antibodies without a prior thromboembolic nor obstetric event; and 3) SLE patients without APS nor positivity for aPL antibodies. Comparisons between groups 1 and 3 were evaluated by bivariate and multivariate analysis. Results: Although the prevalence of aPL antibodies was 54%, APS was present in just 9.3% of SLE patients. In our series, besides cardiovascular disease (AOR 3.38, 95% CI 1.11-10.96, p = 0.035), pulmonary involvement (AOR 5.06, 95% CI 1.56-16.74, p = 0.007) and positivity for rheumatoid factor (AOR 4.68, 95%IC 1.63-14.98, p = 0.006) were factors significantly associated with APS-SLE. APS also may coexist with rheumatoid arthritis, Sjogren's syndrome, autoimmune thyroid diseases, systemic sclerosis, systemic vasculitis, dermatopolymyositis, primary biliary cirrhosis and autoimmune hepatitis. Conclusions: APS is a systemic AD that may coexist with other ADs, the most common being SLE. Awareness of this polyautoimmunity should be addressed promptly to establish strategies for controlling modifiable risk factors in those patients.	[Franco, Juan-Sebastian; Molano-Gonzalez, Nicolas; Rodriguez-Jimenez, Monica; Acosta-Ampudia, Yeny; Mantilla, Ruben D.; Amaya-Amaya, Jenny; Rojas-Villarraga, Adriana; Anaya, Juan-Manuel] Univ Rosario, Sch Med & Hlth Sci, Ctr Autoimmune Dis Res CREA, Bogota, Colombia; [Franco, Juan-Sebastian; Mantilla, Ruben D.; Amaya-Amaya, Jenny; Rojas-Villarraga, Adriana; Anaya, Juan-Manuel] Hosp Univ Mayor, Bogota, Colombia	Universidad del Rosario	Franco, JS (corresponding author), Univ Rosario, Sch Med & Hlth Sci, Ctr Autoimmune Dis Res CREA, Bogota, Colombia.	francoa.juan@gmail.com; juan.anaya@urosario.edu.co	Rodríguez-Jiménez, Mónica/J-1899-2016; Molano-Gonzalez, Nicolas/I-6806-2016; Anaya, Juan-Manuel/J-1960-2016; Acosta-Ampudia, Yeny/J-2401-2016; Rojas-Villarraga, Adriana/T-7070-2018; Rojas-Villarraga, Adriana/J-2404-2016	Rodríguez-Jiménez, Mónica/0000-0002-8536-1491; Molano-Gonzalez, Nicolas/0000-0001-7002-8795; Anaya, Juan-Manuel/0000-0002-6444-1249; Acosta-Ampudia, Yeny/0000-0001-8491-9134; Rojas-Villarraga, Adriana/0000-0003-3145-2440; Rojas-Villarraga, Adriana/0000-0003-3145-2440; Universidad del Rosario, Biblioteca/0000-0003-3491-9392	School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia	School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia	This work was supported by the School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agmon-Levin N, 2012, AUTOIMMUN REV, V11, P593, DOI 10.1016/j.autrev.2011.10.020; Agmon-Levin N, 2014, CLIN RHEUMATOL, V33, P293, DOI 10.1007/s10067-014-2486-5; Aguirre V, 2001, LUPUS, V10, P75, DOI 10.1191/096120301674376357; ALARCONSEGOVIA D, 1989, MEDICINE, V68, P353, DOI 10.1097/00005792-198911000-00003; ALARCONSEGOVIA D, 1992, SEMIN ARTHRITIS RHEU, V21, P275, DOI 10.1016/0049-0172(92)90021-5; Amaya-Amaya J, 2013, AUTOIMMUN DIS, V2013, DOI 10.1155/2013/794383; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; Anaya JM, 2014, AUTOIMMUN REV, V4-5, P4; Anaya JM, 2013, AUTOIMUNITY BENCH, P237; Anaya JM, 2012, AUTOIMMUNE DIS, V2012; Anaya Juan-Manuel, 2007, Expert Rev Clin Immunol, V3, P623, DOI 10.1586/1744666X.3.4.623; Anaya JM, 2012, CLIN REV ALLERG IMMU, V43, P256, DOI 10.1007/s12016-012-8317-z; Anaya JM, 2012, AUTOIMMUN REV, V11, P781, DOI 10.1016/j.autrev.2012.02.002; Anaya JM, 2011, CLIN REV ALLERG IMMU, V40, P199, DOI 10.1007/s12016-010-8249-4; Anaya JM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3175; [Anonymous], 1999, Arthritis Rheum, V42, P1785; ASHERSON RA, 1990, J RHEUMATOL, V17, P1292; Assous N, 2005, CLIN EXP RHEUMATOL, V23, P199; Calixto OJ, 2014, AUTOIMMUN REV, V13, P641, DOI 10.1016/j.autrev.2013.12.002; Cardenas-Roldan J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-73; Cefle A, 2011, RHEUMATOL INT, V31, P183, DOI 10.1007/s00296-009-1255-2; Cervera R, 1997, CLIN EXP RHEUMATOL, V15, P361; Cifuentes RA, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/792106; Clowse MEB, 2006, OBSTET GYNECOL, V107, P293, DOI 10.1097/01.AOG.0000194205.95870.86; Cuadrado MJ, 1997, ARTHRITIS RHEUM-US, V40, P834, DOI 10.1002/art.1780400509; Cugno M, 2010, J AUTOIMMUN, V34, P105, DOI 10.1016/j.jaut.2009.07.004; Diez J J, 1993, J Clin Lab Immunol, V40, P125; Efe C, 2012, EUR J GASTROEN HEPAT, V24, P531, DOI 10.1097/MEG.0b013e328350f95b; Enzenauer RJ, 2006, JCR-J CLIN RHEUMATOL, V12, P324, DOI 10.1097/01.rhu.0000250295.34519.b9; Esdaile JM, 2001, ARTHRITIS RHEUM, V44, P2331, DOI 10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I; Fauchais AL, 2004, LUPUS, V13, P245, DOI 10.1191/0961203304lu1006oa; FELDMAN D, 1989, J RHEUMATOL, V16, P618; Gao N, 2013, LUPUS, V22, P453, DOI 10.1177/0961203313477226; Gould T, 2006, SCAND J RHEUMATOL, V35, P29, DOI 10.1080/03009740510026913; Gupta R, 2009, RHEUMATOL INT, V30, P277, DOI 10.1007/s00296-009-1107-0; Hasunuma Y, 1997, CLIN EXP IMMUNOL, V107, P569, DOI 10.1046/j.1365-2249.1997.d01-948.x; HERRICK AL, 1994, ANN RHEUM DIS, V53, P540, DOI 10.1136/ard.53.8.540; HILL GS, 1978, AM J MED, V64, P61, DOI 10.1016/0002-9343(78)90180-8; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; JEDRYKAGORAL A, 1992, ANN RHEUM DIS, V51, P889, DOI 10.1136/ard.51.7.889; Jeleniewicz R, 2012, POL ARCH MED WEWN, V122, P480, DOI 10.20452/pamw.1415; Jones DW, 2004, HYPERTENSION, V43, P1, DOI 10.1161/01.HYP.0000110061.06674.ca; Liaskos C, 2005, J AUTOIMMUN, V24, P251, DOI 10.1016/j.jaut.2005.01.016; Lopez-Pedrera C, 2008, ARTHRITIS RHEUM-US, V58, P2835, DOI 10.1002/art.23756; Pego-Reigosa JM, 2009, BEST PRACT RES CL RH, V23, P469, DOI 10.1016/j.berh.2009.01.002; McClain MT, 2004, ARTHRITIS RHEUM-US, V50, P1226, DOI 10.1002/art.20120; Merkel PA, 1996, AM J MED, V101, P576, DOI 10.1016/S0002-9343(96)00335-X; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Mok CC, 2013, MEDICINE, V92, P217, DOI 10.1097/MD.0b013e31829cae47; Murthy V, 2013, ARTHRITIS RHEUM-US, V65, P3186, DOI 10.1002/art.38131; Nabriski D, 2000, AM J HEMATOL, V64, P73, DOI 10.1002/(SICI)1096-8652(200005)64:1<73::AID-AJH14>3.0.CO;2-U; Nikpour M, 2013, LUPUS, V22, P1243, DOI 10.1177/0961203313493031; Nikpour Mandana, 2009, Curr Rheumatol Rep, V11, P248; Osundeko O, 2001, Endocr Pract, V7, P181; PAGGI A, 1994, CLIN ENDOCRINOL, V40, P329; Palomo I, 2006, J CLIN LAB ANAL, V20, P190, DOI 10.1002/jcla.20131; Paran D, 2004, AUTOIMMUN REV, V3, P70, DOI 10.1016/S1568-9972(03)00090-9; Pasoto SG, 2012, CLIN RHEUMATOL, V31, P1331, DOI 10.1007/s10067-012-2019-z; Perez-Sanchez C, 2015, ANN RHEUM DIS, V74, P1441, DOI 10.1136/annrheumdis-2013-204600; Perez-Sanchez C, 2012, BLOOD, V119, P5859, DOI 10.1182/blood-2011-12-400986; Picillo U, 1997, CLIN RHEUMATOL, V16, P378, DOI 10.1007/BF02242455; Ramos-Casals M, 2006, SEMIN ARTHRITIS RHEU, V35, P312, DOI 10.1016/j.semarthrit.2005.12.004; Rees JD, 2006, ANN RHEUM DIS, V65, P109, DOI 10.1136/ard.2004.034231; Rojas-Villarraga A, 2013, AUTOIMUNITY BENCH BE, P322; Rojas-Villarraga A, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/254319; Rojas-Villarraga A, 2010, AUTOIMMUN REV, V9, P229, DOI 10.1016/j.autrev.2009.10.001; Ruiz-Irastorza G, 2004, ARCH INTERN MED, V164, P77, DOI 10.1001/archinte.164.1.77; Sato S, 2003, ANN RHEUM DIS, V62, P771, DOI 10.1136/ard.62.8.771; Seriolo B, 1999, RHEUMATOLOGY, V38, P675, DOI 10.1093/rheumatology/38.7.675; Seriolo B, 2001, CLIN EXP RHEUMATOL, V19, P561; Sherer Y, 2000, LUPUS, V9, P42, DOI 10.1177/096120330000900108; SHOENFELD Y, 1989, IMMUNOL TODAY, V10, P123, DOI 10.1016/0167-5699(89)90245-4; Signorelli F. V., 2011, LUPUS, V20; Skare TL, 2009, CLIN EXP RHEUMATOL, V27, P894; Soares M, 2003, LUPUS, V12, P788, DOI 10.1191/0961203303lu447xx; Spadaro A, 2000, LUPUS, V9, P56, DOI 10.1177/096120330000900110; Stoianovich L, 2006, AUTOIMMUN REV, V5, P344, DOI 10.1016/j.autrev.2006.02.002; Stone NJ, 2005, AM J CARDIOL, V96, p53E, DOI 10.1016/j.amjcard.2005.06.006; Taraborelli M, 2012, BEST PRACT RES CL RH, V26, P79, DOI 10.1016/j.berh.2012.01.006; Team RC, 2013, R LANGUAGE ENV STAT; Toloza SMA, 2004, ARTHRITIS RHEUM-US, V50, P3947, DOI 10.1002/art.20622; Toure AO, 2013, TURK J HEMATOL, V30, P32, DOI 10.4274/tjh.2012.0059; UROWITZ MB, 1976, AM J MED, V60, P221, DOI 10.1016/0002-9343(76)90431-9; Urowitz MB, 2008, J RHEUMATOL, V35, P2152, DOI 10.3899/jrheum.080214; VIANNA JL, 1992, ANN RHEUM DIS, V51, P160, DOI 10.1136/ard.51.2.160; Vittecoq O, 2000, RHEUMATOLOGY, V39, P481, DOI 10.1093/rheumatology/39.5.481; WOLF P, 1994, BRIT J DERMATOL, V131, P48, DOI 10.1111/j.1365-2133.1994.tb08456.x; Zachou K, 2006, CLIN IMMUNOL, V119, P203, DOI 10.1016/j.clim.2006.01.002	88	19	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110242	10.1371/journal.pone.0110242	http://dx.doi.org/10.1371/journal.pone.0110242			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343509	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943500029
J	Mi, RS; Wang, XJ; Huang, Y; Zhou, P; Liu, YX; Chen, YJ; Chen, J; Zhu, W; Chen, ZG				Mi, Rongsheng; Wang, Xiaojuan; Huang, Yan; Zhou, Peng; Liu, Yuxuan; Chen, Yongjun; Chen, Jun; Zhu, Wei; Chen, Zhaoguo			Prevalence and Molecular Characterization of Cryptosporidium in Goats across Four Provincial Level Areas in China	PLOS ONE			English	Article							GIARDIA-DUODENALIS; RISK-FACTORS; SPP.; PARVUM; HUMANS; EPIDEMIOLOGY; INFECTION; SUBTYPES; KIDS; GENOTYPES	This study assessed the prevalence, species and subtypes of Cryptosporidium in goats from Guangdong Province, Hubei Province, Shandong Province, and Shanghai City of China. Six hundred and four fecal samples were collected from twelve goat farms, and the overall infection rate was 11.4% (69/604). Goats infected with Cryptosporidium were found in eleven farms across four provincial areas, and the infection rate ranged from 2.9% (1/35) to 25.0% (9/36). Three Cryptosporidium species were identified. Cryptosporidium xiaoi (45/69, 65.2%) was the dominant species, followed by C. parvum (14/69, 20.3%) and C. ubiquitum (10/69, 14.5%). The infection rate of Cryptosporidium spp. was varied with host age and goat kids were more susceptible to be infected than adult goats. Subtyping C. parvum and C. ubiquitum positive samples revealed C. parvum subtype IIdA19G1 and C. ubiquitum subtype XIIa were the most common subtypes. Other C. parvum subtypes were detected as well, such as IIaA14G2R1, IIaA15G1R1, IIaA15G2R1 and IIaA17G2R1. All of these subtypes have also been detected in humans, suggesting goats may be a potential source of zoonotic cryptosporidiosis. This was the first report of C. parvum subtypes IIaA14G2R1, IIaA15G1R1 and IIaA17G2R1 infecting in goats and the first molecular identification of C. parvum and its subtypes in Chinese goats.	[Mi, Rongsheng; Wang, Xiaojuan; Huang, Yan; Zhou, Peng; Liu, Yuxuan; Chen, Yongjun; Chen, Zhaoguo] Chinese Acad Agr Sci, Anim Borne Food Safety Res Ctr, Shanghai Vet Res Inst, Key Lab Anim Parasitol,Minist Agr, Shanghai, Peoples R China; [Mi, Rongsheng; Wang, Xiaojuan; Huang, Yan; Zhou, Peng; Liu, Yuxuan; Chen, Yongjun; Chen, Zhaoguo] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Peoples R China; [Chen, Jun] Lvxiang Town Agr Technol Extens Stn Jinshan Dist, Shanghai, Peoples R China; [Zhu, Wei] Tengzhou Anim Husb & Vet Technol Serv Ctr, Tengzhou, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Chen, ZG (corresponding author), Chinese Acad Agr Sci, Anim Borne Food Safety Res Ctr, Shanghai Vet Res Inst, Key Lab Anim Parasitol,Minist Agr, Shanghai, Peoples R China.	zhaoguochen@shvri.ac.cn			National S & T Major Program of the People's Republic of China [2012ZX10004220]; Opening Foundation of State Key Laboratory of Veterinary Etiological Biology [SKLVEB2013KFKT017]; Shanghai Municipal Agriculture Commission [2005-3-4]; Minhang District Human Resources and Social Security; Basic Foundation for Scientific Research of State-level Public Welfare Institutes of China [2013JB13]	National S & T Major Program of the People's Republic of China; Opening Foundation of State Key Laboratory of Veterinary Etiological Biology; Shanghai Municipal Agriculture Commission; Minhang District Human Resources and Social Security; Basic Foundation for Scientific Research of State-level Public Welfare Institutes of China	This study was supported in part by National S & T Major Program of the People's Republic of China (Grant No. 2012ZX10004220), Opening Foundation of State Key Laboratory of Veterinary Etiological Biology (Grant No. SKLVEB2013KFKT017), Shanghai Municipal Agriculture Commission (Grant No. 2005-3-4), Minhang District Human Resources and Social Security and Basic Foundation for Scientific Research of State-level Public Welfare Institutes of China (Grant No. 2013JB13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamu H, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002831; Alves M, 2006, PARASITOL RES, V99, P287, DOI 10.1007/s00436-006-0164-5; Banda Z, 2009, ONDERSTEPOORT J VET, V76, P363; Bomfim TCB, 2005, VET PARASITOL, V134, P9, DOI 10.1016/j.vetpar.2005.05.067; Broglia A, 2008, VET PARASITOL, V154, P8, DOI 10.1016/j.vetpar.2008.02.029; Brook EJ, 2009, VET J, V179, P378, DOI 10.1016/j.tvjl.2007.10.023; Castro-Hermida JA, 2007, PARASITOL RES, V101, P1443, DOI 10.1007/s00436-007-0624-6; Chalmers RM, 2011, PARASITOL RES, V108, P1321, DOI 10.1007/s00436-010-2199-x; Chen ZG, 2011, VET PARASITOL, V181, P113, DOI 10.1016/j.vetpar.2011.04.037; Cicek Mutalip, 2008, Turkiye Parazitoloji Dergisi, V32, P8; Diaz P, 2010, VET PARASITOL, V172, P132, DOI 10.1016/j.vetpar.2010.04.029; Drumo R, 2012, APPL ENVIRON MICROB, V78, P3523, DOI 10.1128/AEM.07686-11; Fayer R, 2010, EXP PARASITOL, V124, P90, DOI 10.1016/j.exppara.2009.03.005; Feltus DC, 2006, J CLIN MICROBIOL, V44, P4303, DOI 10.1128/JCM.01067-06; Feng Y, 2007, APPL ENVIRON MICROB, V73, P6475, DOI 10.1128/AEM.01034-07; Feng YY, 2013, INT J PARASITOL, V43, P1141, DOI 10.1016/j.ijpara.2013.09.002; Galvan AL, 2014, SCI TOTAL ENVIRON, V468, P368, DOI 10.1016/j.scitotenv.2013.08.053; Geurden T, 2007, PARASITOLOGY, V134, P1981, DOI 10.1017/S0031182007003460; Geurden T, 2008, VET PARASITOL, V155, P142, DOI 10.1016/j.vetpar.2008.05.002; Giadinis ND, 2012, TROP ANIM HEALTH PRO, V44, P1561, DOI 10.1007/s11250-012-0106-4; Goma FY, 2007, SMALL RUMINANT RES, V72, P77, DOI 10.1016/j.smallrumres.2006.08.010; Hajdusek O, 2004, VET PARASITOL, V122, P183, DOI 10.1016/j.vetpar.2004.04.005; Helmy YA, 2013, VET PARASITOL, V193, P15, DOI 10.1016/j.vetpar.2012.12.015; Karanis P, 2007, PARASITOL RES, V101, P1575, DOI 10.1007/s00436-007-0681-x; Koinari M, 2014, EXP PARASITOL, V141, P134, DOI 10.1016/j.exppara.2014.03.021; Lange H, 2013, EPIDEMIOL INFECT; Li N, 2014, EMERG INFECT DIS, V20, P217, DOI 10.3201/eid2002.121797; Ma JB, 2014, VET PARASITOL, V202, P113, DOI 10.1016/j.vetpar.2014.03.030; Ma L, 2014, PARASITOL RES; MASON RW, 1981, AUST VET J, V57, P386, DOI 10.1111/j.1751-0813.1981.tb00529.x; Maurya PS, 2013, TROP ANIM HEALTH PRO, V45, P941, DOI 10.1007/s11250-012-0311-1; Mi RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074985; Ng J, 2010, EXP PARASITOL, V125, P348, DOI 10.1016/j.exppara.2010.02.017; Ngouanesavanh T, 2006, J EUKARYOT MICROBIOL, V53, pS33, DOI 10.1111/j.1550-7408.2006.00166.x; Noordeen F, 2002, VET PARASITOL, V103, P217, DOI 10.1016/S0304-4017(01)00578-7; Noordeen F, 2001, VET PARASITOL, V99, P79, DOI 10.1016/S0304-4017(01)00449-6; Paraud C, 2014, VET PARASITOL, V202, P301, DOI 10.1016/j.vetpar.2014.03.024; Park Jae-Hwan, 2006, Korean Journal of Parasitology, V44, P27, DOI 10.3347/kjp.2006.44.1.27; Quilez J, 2008, APPL ENVIRON MICROB, V74, P6026, DOI 10.1128/AEM.00606-08; Rieux A, 2013, VET PARASITOL, V192, P268, DOI 10.1016/j.vetpar.2012.11.008; Santin M, 2013, NEW ZEAL VET J, V61, P1, DOI 10.1080/00480169.2012.731681; Ceballos LS, 2009, PARASITE, V16, P315, DOI 10.1051/parasite/2009164315; Shoukry Nahla M., 2009, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V39, P479; Smith RP, 2010, PREV VET MED, V94, P9, DOI 10.1016/j.prevetmed.2009.12.005; Soba B, 2008, PARASITOLOGY, V135, P1263, DOI 10.1017/S0031182008004800; Sulaiman IM, 2005, J CLIN MICROBIOL, V43, P2805, DOI 10.1128/JCM.43.6.2805-2809.2005; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trotz-Williams LA, 2006, PARASITOL RES, V99, P346, DOI 10.1007/s00436-006-0157-4; Tzanidakis N, 2014, PARASITE, V21, DOI 10.1051/parasite/2014048; Waldron LS, 2009, EXP PARASITOL, V122, P124, DOI 10.1016/j.exppara.2009.02.006; Waldron LS, 2011, APPL ENVIRON MICROB, V77, P7757, DOI 10.1128/AEM.00615-11; Wang L, 2013, J CLIN MICROBIOL, V51, P557, DOI 10.1128/JCM.02758-12; Wang RJ, 2014, EXP PARASITOL, V142, P11, DOI 10.1016/j.exppara.2014.04.001; Wang RJ, 2011, J CLIN MICROBIOL, V49, P1077, DOI 10.1128/JCM.02194-10; Wang YL, 2010, PARASITOL RES, V106, P341, DOI 10.1007/s00436-009-1664-x; Wielinga PR, 2008, INT J PARASITOL, V38, P809, DOI 10.1016/j.ijpara.2007.10.014; Xiao LH, 2001, J INFECT DIS, V183, P492, DOI 10.1086/318090; Xiao LH, 1999, APPL ENVIRON MICROB, V65, P3386; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018; Ye JB, 2013, VET PARASITOL, V197, P627, DOI 10.1016/j.vetpar.2013.07.021	60	33	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111164	10.1371/journal.pone.0111164	http://dx.doi.org/10.1371/journal.pone.0111164			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343501	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943500083
J	Yamamichi, N; Hirano, C; Shimamoto, T; Minatsuki, C; Takahashi, Y; Nakayama, C; Matsuda, R; Fujishiro, M; Konno-Shimizu, M; Kato, J; Kodashima, S; Ono, S; Niimi, K; Mochizuki, S; Tsuji, Y; Sakaguchi, Y; Asada-Hirayama, I; Takeuchi, C; Yakabi, S; Kakimoto, H; Wada, R; Mitsushima, T; Ichinose, M; Koike, K				Yamamichi, Nobutake; Hirano, Chigaya; Shimamoto, Takeshi; Minatsuki, Chihiro; Takahashi, Yu; Nakayama, Chiemi; Matsuda, Rie; Fujishiro, Mitsuhiro; Konno-Shimizu, Maki; Kato, Jun; Kodashima, Shinya; Ono, Satoshi; Niimi, Keiko; Mochizuki, Satoshi; Tsuji, Yosuke; Sakaguchi, Yoshiki; Asada-Hirayama, Itsuko; Takeuchi, Chihiro; Yakabi, Seiichi; Kakimoto, Hikaru; Wada, Ryoichi; Mitsushima, Toru; Ichinose, Masao; Koike, Kazuhiko			Associated Factors of Atrophic Gastritis Diagnosed by Double-Contrast Upper Gastrointestinal Barium X-Ray Radiography: A Cross-Sectional Study Analyzing 6,901 Healthy Subjects in Japan	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; SERUM PEPSINOGEN TEST; INTESTINAL METAPLASIA; RANDOMIZED-TRIAL; STOMACH-CANCER; ERADICATION; RISK; PREVALENCE; EPIDEMIOLOGY; PROGRESSION	Background: Double-contrast upper gastrointestinal barium X-ray radiography (UGI-XR) is one of the most widely conducted gastric cancer screening methods. It has been executed to find gastric cancer, but has not been usually executed to detect premalignant atrophic mucosa of stomach. To understand the meaning of UGI-XR-based atrophic gastritis, we analyzed its association with several causative factors including Helicobacter pylori (HP) infection. Methods: We evaluated 6,901 healthy adults in Japan. UGI-XR-based atrophic gastritis was diagnosed based on the irregular shape of areae gastricae and its expansion in the stomach. Results: Of the 6,433 subjects with no history of HP eradication and free from gastric acid suppressants, 1,936 were diagnosed as UGI-XR-based atrophic gastritis (mild: 234, moderate: 822, severe: 880). These were univariately associated with serum HP IgG and serum pepsinogen I/II ratio with statistical significance. The multiple logistic analysis calculating standardized coefficients (beta) and odds ratio (OR) demonstrated that serum HP IgG (beta = 1.499, OR = 4.48), current smoking (beta = 0.526, OR = 1.69), age (beta = 0.401, OR = 1.49), low serum pepsinogen I/II ratio (beta = 0.339, OR = 1.40), and male gender (beta = 0.306, OR = 1.36) showed significant positive association with UGI-XR-based atrophic gastritis whereas drinking and body mass index did not. Among the age/sex/smoking/drinking-matched 227 pairs derived from chronically HP-infected and successfully HP-eradicated subjects, UGI-XR-based atrophic gastritis was detected in 99.1% of the former but in only 59.5% of the latter subjects (p<0.0001). Contrastively, UGI-XR-based atrophic gastritis was detected in 13 of 14 HP-positive proton pump inhibitor users (92.9%) and 33 of 34 HP-positive histamine H-2-receptor antagonist users (97.1%), which are not significantly different from gastric acid suppressant-free subjects. Conclusions: The presence of UGI-XR-based atrophic gastritis is positively associated with Helicobacter pylori infection, current smoking, age, decreased serum pepsinogen I/II ratio, and male gender. Eradication of Helicobacter pylori seems to superficially improve UGI-XR-based atrophic gastritis whereas intake of gastric acid suppressants does not.	[Yamamichi, Nobutake; Shimamoto, Takeshi; Minatsuki, Chihiro; Takahashi, Yu; Nakayama, Chiemi; Matsuda, Rie; Fujishiro, Mitsuhiro; Konno-Shimizu, Maki; Kodashima, Shinya; Ono, Satoshi; Niimi, Keiko; Mochizuki, Satoshi; Tsuji, Yosuke; Sakaguchi, Yoshiki; Asada-Hirayama, Itsuko; Takeuchi, Chihiro; Yakabi, Seiichi; Kakimoto, Hikaru; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan; [Hirano, Chigaya; Shimamoto, Takeshi; Wada, Ryoichi; Mitsushima, Toru] Kameda Med Ctr Makuhari, Dept Gastroenterol, Chiba, Japan; [Kato, Jun; Ichinose, Masao] Wakayama Med Univ, Dept Internal Med 2, Wakayama, Japan	University of Tokyo; Wakayama Medical University	Yamamichi, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan.	nyamamic-tky@umin.ac.jp	Ono, Satoshi/H-7900-2019; 藤城, 光弘/AAN-3131-2020; Ono, Satoshi/AFP-6208-2022; Ichinose, Masao/HAB-1645-2022; Takahashi, Yu/I-4665-2015	Ono, Satoshi/0000-0002-9864-348X; Takahashi, Yu/0000-0002-3066-9501; Takeuchi, Chihiro/0000-0002-2746-9189	Takeda Science Foundation; Daiwa Security Health Foundation; Japan Society for the Promotion of Science	Takeda Science Foundation(Takeda Science Foundation (TSF)); Daiwa Security Health Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a research grant from Takeda Science Foundation, in part by a research grant from the Daiwa Security Health Foundation, and also in part by Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science. All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Brown LM, 2000, EPIDEMIOL REV, V22, P283, DOI 10.1093/oxfordjournals.epirev.a018040; Bures J, 2012, WORLD J GASTROENTERO, V18, P4412, DOI 10.3748/wjg.v18.i32.4412; Correa P, 2000, JNCI-J NATL CANCER I, V92, P1881, DOI 10.1093/jnci/92.23.1881; Correa P, 2007, GASTROENTEROLOGY, V133, P659, DOI 10.1053/j.gastro.2007.06.026; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Dheer S, 2002, BRIT J RADIOL, V75, P805, DOI 10.1259/bjr.75.898.750805; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Fuccio L, 2009, ANN INTERN MED, V151, P121, DOI 10.7326/0003-4819-151-2-200907210-00009; Hamashima C, 2008, JPN J CLIN ONCOL, V38, P259, DOI 10.1093/jjco/hyn017; HISAMICHI S, 1984, JPN J CLIN ONCOL, V14, P211; Hosokawa O, 2008, SCAND J GASTROENTERO, V43, P1112, DOI 10.1080/00365520802085395; Ito M, 2002, ALIMENT PHARM THER, V16, P1449, DOI 10.1046/j.1365-2036.2002.01311.x; Kato M, 2013, DIGEST ENDOSC, V25, P264, DOI 10.1111/j.1443-1661.2012.01385.x; KIMURA K, 1972, GASTROENTEROLOGY, V63, P584; Kimura K, 1969, ENDOSCOPY, V1, P87, DOI DOI 10.1055/S-0028-1098086; Lee KJ, 2006, INT J CANCER, V118, P2315, DOI 10.1002/ijc.21664; Lee SY, 2007, HEPATO-GASTROENTEROL, V54, P630; Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X; Leung WK, 2004, GUT, V53, P1244, DOI 10.1136/gut.2003.034629; Miki K, 2003, AM J GASTROENTEROL, V98, P735, DOI 10.1016/S0002-9270(03)00128-X; Miki Kazumasa, 2006, Gastric Cancer, V9, P245, DOI 10.1007/s10120-006-0397-0; Minatsuki C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069891; Mizoue T, 2003, INT J CANCER, V106, P103, DOI 10.1002/ijc.11183; Nakajima S, 2010, J GASTROEN HEPATOL, V25, pS99, DOI 10.1111/j.1440-1746.2009.06214.x; Ohata H, 2004, INT J CANCER, V109, P138, DOI 10.1002/ijc.11680; Ohkusa T, 2001, ANN INTERN MED, V134, P380, DOI 10.7326/0003-4819-134-5-200103060-00010; Oishi Y, 2006, AM J EPIDEMIOL, V163, P629, DOI 10.1093/aje/kwj088; OSHIMA A, 1986, INT J CANCER, V38, P829, DOI 10.1002/ijc.2910380608; Polk DB, 2010, NAT REV CANCER, V10, P403, DOI 10.1038/nrc2857; Rubesin SE, 2008, RADIOLOGY, V246, P33, DOI 10.1148/radiol.2461061245; Satoh K, 1996, AM J GASTROENTEROL, V91, P963; Shimamoto T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065996; Shiota S, 2010, EXPERT REV GASTROENT, V4, P149, DOI [10.1586/egh.10.7, 10.1586/EGH.10.7]; Sung JJY, 2000, GASTROENTEROLOGY, V119, P7, DOI 10.1053/gast.2000.8550; Takahashi Y, 2013, J GASTROENTEROL; Tatemichi M, 2009, HELICOBACTER, V14, P231, DOI 10.1111/j.1523-5378.2009.00681.x; Tsubono Yoshitaka, 2000, Gastric Cancer, V3, P9, DOI 10.1007/PL00011692; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Watabe H, 2005, GUT, V54, P764, DOI 10.1136/gut.2004.055400; Wong BCY, 2004, JAMA-J AM MED ASSOC, V291, P187, DOI 10.1001/jama.291.2.187; Yamaji Y, 2001, GUT, V49, P335, DOI 10.1136/gut.49.3.335; Yamamichi N, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-140; Yarnamichi N, 2007, CANCER RES, V67, P10727, DOI 10.1158/0008-5472.CAN-07-2601	43	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111359	10.1371/journal.pone.0111359	http://dx.doi.org/10.1371/journal.pone.0111359			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343257	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943500098
J	Burrell, TC; Divekar, SD; Weeber, EJ; Rebeck, GW				Burrell, Teal C.; Divekar, Shailaja D.; Weeber, Edwin J.; Rebeck, G. William			Fyn Tyrosine Kinase Increases Apolipoprotein E Receptor 2 Levels and Phosphorylation	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; AMYLOID PRECURSOR PROTEIN; REELIN SIGNALING PATHWAY; FAMILY-MEMBERS VLDLR; SYNAPTIC PLASTICITY; BRAIN-DEVELOPMENT; PLASMA-MEMBRANE; DIFFERENTIAL FUNCTIONS; CORTICAL-NEURONS; KNOCKOUT MICE	Apolipoprotein E Receptor 2 (ApoER2) and the tyrosine kinase Fyn are both members of the Reelin pathway, a signaling pathway essential for the laminar formation of the cortex during development and proper dendritic spine density and long-term potential (LTP) in the adult brain. In the presence of extracellular Reelin, ApoER2 binds the intracellular protein Dab1, an adaptor protein that is phosphorylated by Fyn. However, direct interactions between ApoER2 and Fyn are not well defined. Here, we show that total levels of ApoER2 and surface levels of ApoER2 are increased by active Fyn. Via a separate mechanism, ApoER2 is also phosphorylated by Fyn, an event that peaks in the postnatal cortex at day 5 and can occur at multiple ApoER2 tyrosine residues. Dab1 is also involved in this phosphorylation, promoting the phosphorylation of ApoER2 by Fyn when it is itself phosphorylated. These results elucidate some of the intracellular mechanisms that give rise to a functional Reelin pathway.	[Burrell, Teal C.; Divekar, Shailaja D.; Rebeck, G. William] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA; [Weeber, Edwin J.] Univ S Florida, Univ South Florida Hlth Byrd Alzheimers Inst, Dept Mol Pharmacol & Physiol, Tampa, FL USA	Georgetown University; State University System of Florida; University of South Florida	Rebeck, GW (corresponding author), Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA.	gwr2@georgetown.edu	Rebeck, George William/J-2192-2012; Weeber, Edwin J/A-5396-2012	Rebeck, George William/0000-0001-6276-248X; 	National Institutes of Health [R01 AG035379, R01 AG030128, T32 NS041218]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS041218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG035379, P01AG030128] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding provided by National Institutes of Health, R01 AG035379 (GWR EJW); National Institutes of Health, R01 AG030128 (GWT EJW); National Institutes of Health T32 NS041218 (TCB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud L, 2003, CURR BIOL, V13, P9, DOI 10.1016/S0960-9822(02)01397-0; Arnaud L, 2003, MOL CELL BIOL, V23, P9293, DOI 10.1128/MCB.23.24.9293-9302.2003; Babus LW, 2011, BRAIN RES, V1415, P96, DOI 10.1016/j.brainres.2011.07.059; Ballif BA, 2004, CURR BIOL, V14, P606, DOI 10.1016/j.cub.2004.03.038; Beffert U, 2006, J NEUROSCI, V26, P2041, DOI 10.1523/JNEUROSCI.4566-05.2006; Beffert U, 2005, NEURON, V47, P567, DOI 10.1016/j.neuron.2005.07.007; Beffert U, 2002, J BIOL CHEM, V277, P49958, DOI 10.1074/jbc.M209205200; Bock HH, 2003, CURR BIOL, V13, P18, DOI 10.1016/S0960-9822(02)01403-3; Chai XJ, 2009, J NEUROSCI, V29, P288, DOI 10.1523/JNEUROSCI.2934-08.2009; Chen KL, 2004, J CELL SCI, V117, P4527, DOI 10.1242/jcs.01320; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; Chen Y, 2005, J NEUROSCI, V25, P8209, DOI 10.1523/JNEUROSCI.1951-05.2005; Chen Y, 2010, P NATL ACAD SCI USA, V107, P12011, DOI 10.1073/pnas.0914984107; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Divekar SD, 2014, J BIOL CHEM, V289, P15894, DOI 10.1074/jbc.M113.537548; Duit S, 2010, J BIOL CHEM, V285, P4896, DOI 10.1074/jbc.M109.025973; Dumanis SB, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-9; Dumanis SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017203; Feng L, 2007, GENE DEV, V21, P2717, DOI 10.1101/gad.1604207; Feng LB, 2009, MOL CELL BIOL, V29, P324, DOI 10.1128/MCB.00663-08; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Hack I, 2007, DEVELOPMENT, V134, P3883, DOI 10.1242/dev.005447; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Hoe HS, 2006, J BIOL CHEM, V281, P3425, DOI 10.1074/jbc.M509380200; Hoe HS, 2008, J BIOL CHEM, V283, P6288, DOI 10.1074/jbc.M704140200; Hoe HS, 2006, J BIOL CHEM, V281, P35176, DOI 10.1074/jbc.M602162200; Hong C, 2010, J BIOL CHEM, V285, P19720, DOI 10.1074/jbc.M110.123729; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; Howell BW, 1999, MOL CELL BIOL, V19, P5179; Huang YC, 2004, BIOCHEM BIOPH RES CO, V318, P204, DOI 10.1016/j.bbrc.2004.04.023; Kramer-Albers EM, 2011, CELL MOL LIFE SCI, V68, P2003, DOI 10.1007/s00018-010-0616-z; Kuo G, 2005, J NEUROSCI, V25, P8578, DOI 10.1523/JNEUROSCI.1656-05.2005; Lajoie P, 2010, INT REV CEL MOL BIO, V282, P135, DOI 10.1016/S1937-6448(10)82003-9; Li YH, 2001, J BIOL CHEM, V276, P18000, DOI 10.1074/jbc.M101589200; Liu ML, 2010, J LIPID RES, V51, P2611, DOI 10.1194/jlr.M006635; Mayer H, 2006, MOL CELL BIOL, V26, P19, DOI 10.1128/MCB.26.1.19-27.2006; Minami SS, 2011, J NEUROCHEM, V118, P879, DOI 10.1111/j.1471-4159.2011.07296.x; Niu S, 2004, NEURON, V41, P71, DOI 10.1016/S0896-6273(03)00819-5; Niu SY, 2008, J NEUROSCI, V28, P10339, DOI 10.1523/JNEUROSCI.1917-08.2008; Park TJ, 2008, J NEUROSCI, V28, P13551, DOI 10.1523/JNEUROSCI.4323-08.2008; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Reddy SS, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-30; Rice DS, 1998, DEVELOPMENT, V125, P3719; Riddell DR, 2001, J LIPID RES, V42, P998; Sekine K, 2012, NEURON, V76, P353, DOI 10.1016/j.neuron.2012.07.020; Sekine K, 2011, J NEUROSCI, V31, P9426, DOI 10.1523/JNEUROSCI.0650-11.2011; Strasser V, 2004, MOL CELL BIOL, V24, P1378, DOI 10.1128/MCB.24.3.1378-1386.2004; Sun XM, 1999, EUR J BIOCHEM, V262, P230, DOI 10.1046/j.1432-1327.1999.00394.x; SUZUKI T, 1995, BIOCHEM BIOPH RES CO, V216, P582, DOI 10.1006/bbrc.1995.2662; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Trotter J, 2013, J NEUROSCI, V33, P15652, DOI 10.1523/JNEUROSCI.2010-13.2013; vantHof W, 1997, J CELL BIOL, V136, P1023, DOI 10.1083/jcb.136.5.1023; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zhou J, 2006, J PROTEOME RES, V5, P2547, DOI 10.1021/pr060112a	57	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e0110845	10.1371/journal.pone.0110845	http://dx.doi.org/10.1371/journal.pone.0110845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340851	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662800062
J	Liu, TT; Shen, CF; Wang, Y; Huang, CK; Shi, JY				Liu, Tingting; Shen, Chaofeng; Wang, Yi; Huang, Canke; Shi, Jiyan			New Insights into Regulation of Proteome and Polysaccharide in Cell Wall of Elsholtzia splendens in Response to Copper Stress	PLOS ONE			English	Article							HEAVY-METAL DETOXIFICATION; LEAF APOPLAST; PECTIN METHYLESTERASE; EXTRACELLULAR-MATRIX; MALATE-DEHYDROGENASE; OXIDATIVE STRESS; PROTEINS; PLANT; GROWTH; IDENTIFICATION	Background and Aims: Copper (Cu) is an essential micronutrient for plants. However, excess amounts of Cu are toxic and result in a wide range of harmful effects on the physiological and biochemical processes of plants. Cell wall has a crucial role in plant defense response to toxic metals. To date, the process of cell wall response to Cu and the detoxification mechanism have not been well documented at the proteomic level. Methods: An recently developed 6-plex Tandem Mass Tag was used for relative and absolute quantitation methods to achieve a comprehensive understanding of Cu tolerance/detoxification molecular mechanisms in the cell wall. LC-MS/MS approach was performed to analyze the Cu-responsive cell wall proteins and polysaccharides. Key Results: The majority of the 22 up-regulated proteins were involved in the antioxidant defense pathway, cell wall polysaccharide remodeling, and cell metabolism process. Changes in polysaccharide amount, composition, and distribution could offer more binding sites for Cu ions. The 33 down-regulated proteins were involved in the signal pathway, energy, and protein synthesis. Conclusions: Based on the abundant changes in proteins and polysaccharides, and their putative functions, a possible protein interaction network can provide new insights into Cu stress response in root cell wall. Cu can facilitate further functional research on target proteins associated with metal response in the cell wall.	[Liu, Tingting; Shen, Chaofeng; Wang, Yi; Huang, Canke; Shi, Jiyan] Zhejiang Univ, Coll Environm & Resource Sci, Inst Environm Sci & Technol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Shi, JY (corresponding author), Zhejiang Univ, Coll Environm & Resource Sci, Inst Environm Sci & Technol, Hangzhou 310003, Zhejiang, Peoples R China.	shijiyan@zju.edu.cn	Shen, Chaofeng/I-7138-2013	Shen, Chaofeng/0000-0002-6394-7416	National Natural Science Foundation of China [11179025, 21177109]; Program for New Century Excellent Talents in University [NCET-11-0455]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	The work was supported by the National Natural Science Foundation of China (11179025, 21177109) and Program for New Century Excellent Talents in University (NCET-11-0455). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan N, 2007, CHEMOSPHERE, V67, P1182, DOI 10.1016/j.chemosphere.2006.10.075; Alves M, 2006, PLANT SOIL, V279, P1, DOI 10.1007/s11104-005-3154-y; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; Bhushan D, 2007, MOL CELL PROTEOMICS, V6, P1868, DOI 10.1074/mcp.M700015-MCP200; Blinda A, 1997, PLANT CELL ENVIRON, V20, P969, DOI 10.1111/j.1365-3040.1997.tb00674.x; Bona E, 2007, PROTEOMICS, V7, P1121, DOI 10.1002/pmic.200600712; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNE A, 1994, J EXP BOT, V45, P1189, DOI 10.1093/jxb/45.9.1189; Carafoli E, 2009, HDB NEUROCHEMISTRY M, P581; Chivasa S, 2005, PLANT CELL, V17, P3019, DOI 10.1105/tpc.105.036806; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; Dani V, 2005, PROTEOMICS, V5, P737, DOI 10.1002/pmic.200401119; Day A, 2013, PROTEOMICS; Dronnet VM, 1996, PROGR BIOTECHNOL, V14, P535, DOI 10.1016/S0921-0423(96)80283-8; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Fecht-Christoffers MM, 2006, PLANT PHYSIOL, V140, P1451, DOI 10.1104/pp.105.070474; Fecht-Christoffers MM, 2003, PLANT PHYSIOL, V133, P1935, DOI 10.1104/pp.103.029215; Feiz L, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-10; Floerl S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-129; Fry SC, 2001, BIOCHEM J, V357, P729, DOI 10.1042/0264-6021:3570729; Goulet C, 2010, PROTEOMICS, V10, P2536, DOI 10.1002/pmic.200900382; GROSS GG, 1977, PHYTOCHEMISTRY, V16, P319, DOI 10.1016/0031-9422(77)80055-1; HALL A, 1994, ANNU REV CELL BIOL, V10, P31, DOI 10.1146/annurev.cb.10.110194.000335; Hall JL, 2002, J EXP BOT, V53, P1, DOI 10.1093/jexbot/53.366.1; HARRISON SJ, 1979, Z PFLANZENPHYSIOL, V94, P27, DOI 10.1016/S0044-328X(79)80245-7; Hossain Z, 2012, J PROTEOME RES, V11, P37, DOI 10.1021/pr200863r; Howard LR, 2000, J AGR FOOD CHEM, V48, P1713, DOI 10.1021/jf990916t; Imin N, 2004, PROTEOMICS, V4, P1873, DOI 10.1002/pmic.200300738; Jamet E, 2006, TRENDS PLANT SCI, V11, P33, DOI 10.1016/j.tplants.2005.11.006; Jamet Elisabeth, 2008, V425, P187, DOI 10.1007/978-1-60327-210-0_17; Jarvis MC, 2009, STRUCT CHEM, V20, P245, DOI 10.1007/s11224-009-9427-y; Jensen KA, 2001, APPL ENVIRON MICROB, V67, P2705, DOI 10.1128/AEM.67.6.2705-2711.2001; Kataoka T, 2003, BIOL PLANTARUM, V46, P445, DOI 10.1023/A:1024302924984; KEITH B, 1991, P NATL ACAD SCI USA, V88, P8821, DOI 10.1073/pnas.88.19.8821; Komatsu S, 2010, AMINO ACIDS, V39, P1435, DOI 10.1007/s00726-010-0608-1; Kong FJ, 2010, BBA-PROTEINS PROTEOM, V1804, P124, DOI 10.1016/j.bbapap.2009.09.023; Krzeslowska M, 2011, ACTA PHYSIOL PLANT, V33, P35, DOI 10.1007/s11738-010-0581-z; Kwon HK, 2005, PLANT CELL PHYSIOL, V46, P843, DOI 10.1093/pcp/pci089; Li F, 2009, PLANT MOL BIOL, V71, P251, DOI 10.1007/s11103-009-9521-y; LI ZC, 1989, PLANT PHYSIOL, V90, P185, DOI 10.1104/pp.90.1.185; Liszkay A, 2003, PLANTA, V217, P658, DOI 10.1007/s00425-003-1028-1; Lou LQ, 2004, ENVIRON EXP BOT, V51, P111, DOI 10.1016/j.envexpbot.2003.08.002; Maksymiec W, 1997, PHOTOSYNTHETICA, V34, P321, DOI 10.1023/A:1006818815528; Massari P, 2000, P NATL ACAD SCI USA, V97, P9070, DOI 10.1073/pnas.97.16.9070; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; NELSON H, 1990, P NATL ACAD SCI USA, V87, P3503, DOI 10.1073/pnas.87.9.3503; Odou MF, 1998, FEMS MICROBIOL LETT, V166, P347, DOI 10.1111/j.1574-6968.1998.tb13911.x; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pandey A, 2010, J PROTEOME RES, V9, P3443, DOI 10.1021/pr901098p; Paynel F, 2009, ANN BOT-LONDON, V104, P1363, DOI 10.1093/aob/mcp254; Pelloux J, 2007, TRENDS PLANT SCI, V12, P267, DOI 10.1016/j.tplants.2007.04.001; Petersen J, 2003, J MOL EVOL, V57, P16, DOI 10.1007/s00239-002-2441-y; Qu ZL, 2006, PLANT CELL PHYSIOL, V47, P1058, DOI 10.1093/pcp/pcj076; Rittinger K, 1997, NATURE, V388, P693, DOI 10.1038/41805; Sharma SS, 2006, J EXP BOT, V57, P711, DOI 10.1093/jxb/erj073; Soares NC, 2009, J PROTEOME RES, V8, P2298, DOI 10.1021/pr8009353; SPAIN JC, 1979, BIOCHEM BIOPH RES CO, V88, P634, DOI 10.1016/0006-291X(79)92095-3; SZE H, 1992, J BIOENERG BIOMEMBR, V24, P371, DOI 10.1007/BF00762530; Teisseire H, 2000, PLANT SCI, V153, P65, DOI 10.1016/S0168-9452(99)00257-5; Thounaojam TC, 2012, PLANT PHYSIOL BIOCH, V53, P33, DOI 10.1016/j.plaphy.2012.01.006; Timperio AM, 2008, J PROTEOMICS, V71, P391, DOI 10.1016/j.jprot.2008.07.005; Vinit-Dunand F, 2002, PLANT SCI, V163, P53, DOI 10.1016/S0168-9452(02)00060-2; Vorwerk S, 2004, TRENDS PLANT SCI, V9, P203, DOI 10.1016/j.tplants.2004.02.005; Wang SB, 2004, PROTEOMICS, V4, P692, DOI 10.1002/pmic.200300634; Watson BS, 2004, PHYTOCHEMISTRY, V65, P1709, DOI 10.1016/j.phytochem.2004.04.026; Xiong J, 2009, PLANTA, V230, P755, DOI 10.1007/s00425-009-0984-5; Yang JL, 2011, PLANT PHYSIOL, V155, P1885, DOI 10.1104/pp.111.172221; Yang MJ, 2002, J PLANT NUTR, V25, P1359, DOI 10.1081/PLN-120005395; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yu M, 2009, J PLANT NUTR SOIL SC, V172, P528, DOI 10.1002/jpln.200800039; Zhang HX, 2009, ANN BOT-LONDON, V103, P923, DOI 10.1093/aob/mcp012; ZHONG HL, 1993, J EXP BOT, V44, P773, DOI 10.1093/jxb/44.4.773; Zhou L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016723; Zhou XJ, 2010, PLANT MOL BIOL REP, V28, P692, DOI 10.1007/s11105-010-0200-6; Zhu JM, 2006, PLANT PHYSIOL, V140, P311, DOI 10.1104/pp.105.070219	76	25	28	3	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e109573	10.1371/journal.pone.0109573	http://dx.doi.org/10.1371/journal.pone.0109573			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340800	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662800009
J	Morais-de-Jesus, M; Daltro-Oliveira, R; Pettersen, KM; Dantas-Duarte, A; Amaral, LD; Cavalcanti-Ribeiro, P; Santos, CT; Schinoni, MI; Netto, LR; Araujo-de-Freitas, L; Parana, R; Miranda-Scippa, A; Koenen, KC; Quarantini, LC				Morais-de-Jesus, Mychelle; Daltro-Oliveira, Renato; Pettersen, Karine Miranda; Dantas-Duarte, Adriana; Amaral, Luciana Di-Domizio; Cavalcanti-Ribeiro, Patricia; Santos, Carlos Teles; Schinoni, Maria Isabel; Netto, Liana R.; Araujo-de-Freitas, Lucas; Parana, Raymundo; Miranda-Scippa, Angela; Koenen, Karestan C.; Quarantini, Lucas C.			Hepatitis C Virus Infection as a Traumatic Experience	PLOS ONE			English	Article							QUALITY-OF-LIFE; POSTTRAUMATIC-STRESS-DISORDER; CENTRAL-NERVOUS-SYSTEM; CROATIAN WAR VETERANS; VIROLOGICAL RESPONSE; COGNITIVE FUNCTION; ADVANCED FIBROSIS; IMPACT; HCV; DEPRESSION	Objective: The purpose of this study was to evaluate whether individuals consider their HCV infection to be a potentially traumatic experience. Additionally, we investigated its association with Post-Traumatic Stress Disorder (PTSD) and the impact of PTSD diagnosis on health-related quality of life (HRQoL) in HCV infected subjects. Methods: We conducted a cross-sectional survey of 127 HCV-infected outpatients recruited at a University Hospital in Salvador, Brazil. All subjects answered an orally-administered questionnaire to gather clinical and socio-demographic data. We investigated traumatic experiences and the subject's perception of the disease using the Trauma History Questionnaire. PTSD and other psychiatric diagnoses were assessed through the Mini International Neuropsychiatric Interview-Brazilian Version 5.0.0 (M.I.N.I. PLUS). HRQoL was assessed using Short-Form 36 (SF-36). Results: Approximately 38.6% of the patients considered hepatitis C to be a traumatic experience. Of these, 60.7% had a PTSD diagnosis. PTSD was associated with significant impairment in quality of life for individuals in seven SF-36 domains as shown bymultivariate analysis: Role-Physical (beta: -24.85; 95% CI: -42.08; -27.61), Bodily Pain (beta: -19.36; 95% CI: -31.28; -7.45), General Health (beta: -20.79; 95% CI: -29.65; -11.92), Vitality (beta: -11.92; 95% CI: -20.74; -3.1), Social Functioning (beta: -34.73; 95% CI: -46.79; -22.68), Role-Emotional (beta: -26.07; 95% CI: -44.61; -7.53), Mental Health (beta: -17.46; 95% CI: -24.38; -10.54). Conclusion: HCV is frequently a traumatic experience and it is strongly associated with PTSD diagnosis. PTSD significantly impaired HRQoL.	[Morais-de-Jesus, Mychelle; Pettersen, Karine Miranda; Dantas-Duarte, Adriana; Cavalcanti-Ribeiro, Patricia; Schinoni, Maria Isabel; Netto, Liana R.; Parana, Raymundo; Miranda-Scippa, Angela; Quarantini, Lucas C.] Univ Fed Bahia, Fac Med, Programa Posgrad Med & Saude, Salvador, BA, Brazil; [Daltro-Oliveira, Renato; Parana, Raymundo] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil; [Amaral, Luciana Di-Domizio] Pontificia Univ Catolica Sao Paulo, Sao Paulo, Brazil; [Santos, Carlos Teles] Univ Estadual Feira de Santana, Dept Ciencias Exatas, Feira De Santana, BA, Brazil; [Santos, Carlos Teles] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil; [Araujo-de-Freitas, Lucas; Miranda-Scippa, Angela; Quarantini, Lucas C.] Univ Fed Bahia, Univ Hosp, Salvador, BA, Brazil; [Araujo-de-Freitas, Lucas; Miranda-Scippa, Angela; Quarantini, Lucas C.] Univ Fed Bahia, Fac Med Bahia, Dept Neurociencias & Saude Mental, Salvador, BA, Brazil; [Koenen, Karestan C.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	Universidade Federal da Bahia; Universidade Federal da Bahia; Pontificia Universidade Catolica de Sao Paulo; Universidade Estadual de Feira de Santana; Universidade Federal da Bahia; Universidade Federal da Bahia; Universidade Federal da Bahia; Columbia University	Quarantini, LC (corresponding author), Univ Fed Bahia, Fac Med, Programa Posgrad Med & Saude, Salvador, BA, Brazil.	lcq@ufba.br	quarantini, l/K-8483-2014	Daltro de Oliveira, Renato/0000-0002-8940-9130	National Council of Technological and Scientific Development (CNPq) - Edital Universal MCT/CNPq [474869/2010-5, 14/2010]; Coordination for the Improvement of Higher Level Personnel (CAPES)	National Council of Technological and Scientific Development (CNPq) - Edital Universal MCT/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Level Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This project was partially supported by the National Council of Technological and Scientific Development (CNPq): [474869/2010-5] - Edital Universal MCT/CNPq 14/2010. The rest of the funding (totalizing 100% with the funding above) was supported by the scholarships of the Coordination for the Improvement of Higher Level Personnel (CAPES) of the following authors: Mychelle Morais-de-Jesus; Karine Miranda Pettersen; Adriana Dantas-Duarte; Patricia Cavalcanti-Ribeiro; and Liana R. Netto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Amodio P, 2012, WORLD J GASTROENTERO, V18, P2295, DOI 10.3748/wjg.v18.i19.2295; Amorim Patricia, 2000, Revista Brasileira de Psiquiatria, V22, P106; Ayuso-Mateos JL., 2002, GLOBAL BURDEN POSTTR; Batista-Neves S, 2009, BRAZ J INFECT DIS, V13, P40, DOI 10.1590/S1413-86702009000100009; Batista-Neves SC, 2008, GEN HOSP PSYCHIAT, V30, P80, DOI 10.1016/j.genhosppsych.2007.08.014; Bonkovsky HL, 2007, J HEPATOL, V46, P420, DOI 10.1016/j.jhep.2006.10.009; Bonkovsky HL, 1999, HEPATOLOGY, V29, P264, DOI 10.1002/hep.510290124; Bras M, 2011, COLLEGIUM ANTROPOL, V35, P681; Butt AA, 2006, J HEPATOL, V44, P864, DOI 10.1016/j.jhep.2006.01.024; Cavalcanti-Ribeire P, 2012, EXPERT REV NEUROTHER, V12, P1023, DOI 10.1586/ERN.12.77; Chopra MP, 2012, AM J GERIAT IN PRESS; Ciconelli RM, 1999, REV BRAS REUMATOL, V39, P143, DOI DOI 10.1590/S0482-50042010000300005; Cordoba J, 2003, J HEPATOL, V39, P231, DOI 10.1016/S0168-8278(03)00189-2; Daltron-Oliveira R, 2013, ANN HEPATOL, V12, P399, DOI 10.1016/S1665-2681(19)31002-6; Dieperink E, 2008, PSYCHOSOMATICS, V49, P225, DOI 10.1176/appi.psy.49.3.225; Fiszman Adriana, 2005, Rev. Bras. Psiquiatr., V27, P63, DOI 10.1590/S1516-44462005000100014; Fontana RJ, 2005, J HEPATOL, V43, P614, DOI 10.1016/j.jhep.2005.04.006; Forton DA, 2005, AIDS, V19, pS53, DOI 10.1097/01.aids.0000192071.72948.77; Forton DM, 2004, J VIROL, V78, P5170, DOI 10.1128/JVI.78.10.5170-5183.2004; Foster GR, 2009, J VIRAL HEPATITIS, V16, P605, DOI 10.1111/j.1365-2893.2009.01154.x; Foster GR, 1998, HEPATOLOGY, V27, P209, DOI 10.1002/hep.510270132; Fry M, 2012, PSYCHOL HEALTH, V27, P460, DOI 10.1080/08870446.2011.592982; Gallegos-Orozco JF, 2003, ARCH MED RES, V34, P124, DOI 10.1016/S0188-4409(03)00003-1; Giacco D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060991; Ginzburg K, 2011, GEN HOSP PSYCHIAT, V33, P565, DOI 10.1016/j.genhosppsych.2011.08.015; Glaesmer H, 2011, GEN HOSP PSYCHIAT, V33, P177, DOI 10.1016/j.genhosppsych.2010.12.006; Goenjian AK, 2011, J AFFECT DISORDERS, V133, P509, DOI 10.1016/j.jad.2011.04.053; Golden J, 2005, GEN HOSP PSYCHIAT, V27, P431, DOI 10.1016/j.genhosppsych.2005.06.006; Helbling B, 2008, GUT, V57, P1597, DOI 10.1136/gut.2007.142844; Hilsabeck RC, 2003, J INT NEUROPSYCH SOC, V9, P847, DOI 10.1017/S1355617703960048; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Lekas HM, 2011, QUAL HEALTH RES, V21, P1205, DOI 10.1177/1049732311405684; Lim JK, 2006, J CLIN GASTROENTEROL, V40, P528, DOI 10.1097/00004836-200607000-00012; Mak IWC, 2010, GEN HOSP PSYCHIAT, V32, P590, DOI 10.1016/j.genhosppsych.2010.07.007; Martins T, 2011, REV ASSOC MED BRAS, V57, P107, DOI 10.1590/S0104-42302011000100024; Navines R, 2012, J AFFECT DISORDERS, V138, P343, DOI 10.1016/j.jad.2012.01.018; Netto LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078677; Oser M, 2012, J BEHAV MED; Pantalone DW, 2012, J BEHAV MED, V35, P520, DOI 10.1007/s10865-011-9381-1; Papic N, 2011, CROAT MED J, V52, P35, DOI 10.3325/cmj.2011.52.35; Quarantini LC, 2008, LIVER INT, V28, P893, DOI 10.1111/j.1478-3231.2008.01719.x; Quarantini LC, 2008, J MED VIROL, V80, P419, DOI 10.1002/jmv.21094; Quarantini Lucas C., 2006, Braz J Infect Dis, V10, P406, DOI 10.1590/S1413-86702006000600010; Quarantini LC, 2007, MOVEMENT DISORD, V22, P747, DOI 10.1002/mds.21302; Quarantini LC, 2009, J MED VIROL, V81, P1184, DOI 10.1002/jmv.21508; Radkowski M, 2002, J VIROL, V76, P600, DOI 10.1128/JVI.76.2.600-608.2002; Ramos-Casals M, 2005, CURR OPIN RHEUMATOL, V17, P447; Ribeiro WS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063545; Rodger AJ, 1999, HEPATOLOGY, V30, P1299, DOI 10.1002/hep.510300504; Scott KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080573; Seeff Leonard B, 2003, Clin Liver Dis, V7, P261, DOI 10.1016/S1089-3261(02)00078-8; Spiegel BMR, 2005, HEPATOLOGY, V41, P790, DOI 10.1002/hep.20659; Stein MB, 2000, BEHAV RES THER, V38, P619, DOI 10.1016/S0005-7967(99)00098-4; Strauss E, 2006, LIVER INT, V26, P755, DOI 10.1111/j.1478-3231.2006.01331.x; Tassiopoulos K, 2013, ADDICT SCI CLIN PRAC, V8, DOI 10.1186/1940-0640-8-20; Ware JE, 1994, INT J MENT HLTH; Westphal M, 2011, DEPRESS ANXIETY, V28, P686, DOI 10.1002/da.20842; World Health Organization, 2004, PROM MENT HLTH CONC; World Health Organization and World Organization of Family Doctors (Wonca), 2008, INT MENT HLTH PRIM C, V89, P89; Zaidi MA, 2012, CULT HEALTH SEX, V14, P379, DOI 10.1080/13691058.2011.646304	61	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110529	10.1371/journal.pone.0110529	http://dx.doi.org/10.1371/journal.pone.0110529			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR5ZY	25340574	Green Submitted, Green Published, gold			2022-12-27	WOS:000343662800040
J	Eun, JR; Jung, YJ; Zhang, YL; Zhang, YH; Tschudy-Seney, B; Ramsamooj, R; Wan, YJY; Theise, ND; Zern, MA; Duan, YY				Eun, Jong Ryeol; Jung, Yong Jin; Zhang, Yanling; Zhang, Yanhong; Tschudy-Seney, Benjamin; Ramsamooj, Rajen; Wan, Yu-Jui Yvonne; Theise, Neil D.; Zern, Mark A.; Duan, Yuyou			Hepatoma SK Hep-1 Cells Exhibit Characteristics of Oncogenic Mesenchymal Stem Cells with Highly Metastatic Capacity	PLOS ONE			English	Article							PROGENITOR CELLS; CANCER; ORIGIN; LIVER; DIFFERENTIATION; GROWTH	Background: SK Hep-1 cells (SK cells) derived from a patient with liver adenocarcinoma have been considered a human hepatoma cell line with mesenchymal origin characteristics, however, SK cells do not express liver genes and exhibit liver function, thus, we hypothesized whether mesenchymal cells might contribute to human liver primary cancers. Here, we characterized SK cells and its tumourigenicity. Methods and Principal Findings: We found that classical mesenchymal stem cell (MSC) markers were presented on SK cells, but endothelial marker CD31, hematopoietic markers CD34 and CD45 were negative. SK cells are capable of differentiate into adipocytes and osteoblasts as adipose-derived MSC (Ad-MSC) and bone marrow-derived MSC (BM-MSC) do. Importantly, a single SK cell exhibited a substantial tumourigenicity and metastatic capacity in immunodefficient mice. Metastasis not only occurred in circulating organs such as lung, liver, and kidneys, but also in muscle, outer abdomen, and skin. SK cells presented greater in vitro invasive capacity than those of Ad-MSC and BM-MSC. The xenograft cells from subcutaneous and metastatic tumors exhibited a similar tumourigenicity and metastatic capacity, and showed the same relatively homogenous population with MSC characteristics when compared to parental SK cells. SK cells could unlimitedly expand in vitro without losing MSC characteristics, its tumuorigenicity and metastatic capacity, indicating that SK cells are oncogenic MSC with enhanced self-renewal capacity. We believe that this is the first report that human MSC appear to be transformed into cancer stem cells (CSC), and that their derivatives also function as CSCs. Conclusion: Our findings demonstrate that SK cells represent a transformation mechanism of normal MSC into an enhanced self-renewal CSC with metastasis capacity, SK cells and their xenografts represent a same relative homogeneity of CSC with substantial metastatic capacity. Thus, it represents a novel mechanism of tumor initiation, development and metastasis by CSCs of non-epithelial and endothelia origin.	[Eun, Jong Ryeol; Jung, Yong Jin; Zhang, Yanling; Tschudy-Seney, Benjamin; Zern, Mark A.; Duan, Yuyou] Univ Calif Davis, Med Ctr, Dept Internal Med, Sacramento, CA 95817 USA; [Eun, Jong Ryeol; Jung, Yong Jin; Zhang, Yanling; Tschudy-Seney, Benjamin; Zern, Mark A.; Duan, Yuyou] Univ Calif Davis, Med Ctr, Inst Regenerat Cures, Sacramento, CA 95817 USA; [Zhang, Yanhong; Ramsamooj, Rajen; Wan, Yu-Jui Yvonne] Univ Calif Davis, Med Ctr, Dept Pathol & Lab Med, Sacramento, CA 95817 USA; [Eun, Jong Ryeol] Yeungnam Univ, Coll Med, Dept Internal Med, Taegu, South Korea; [Jung, Yong Jin] Seoul Natl Univ, Coll Med, Dept Internal Med, SMG SNU Boramae Med Ctr, Seoul 151, South Korea; [Zhang, Yanling] Southern Med Univ, Sch Biotechnol, Guangzhou, Guangdong, Peoples R China; [Theise, Neil D.] Albert Einstein Coll Med, Beth Israel Med Ctr, Dept Pathol & Med, New York, NY USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Yeungnam University; Seoul National University (SNU); Seoul National University Hospital; Southern Medical University - China; Harvard University; Beth Israel Deaconess Medical Center; Yeshiva University	Duan, YY (corresponding author), Univ Calif Davis, Med Ctr, Dept Internal Med, Sacramento, CA 95817 USA.	yduan@ucdavis.edu	Duan, Yuyou/L-2301-2015	Duan, Yuyou/0000-0002-1402-7402	National Institutes of Health [DK075415]; GlaxoSmithline Research Fund of the Korean Association for the Study of the Liver; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075415] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GlaxoSmithline Research Fund of the Korean Association for the Study of the Liver; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant DK075415 (to M.A.Z.), and by the GlaxoSmithline Research Fund of the Korean Association for the Study of the Liver (to J.R.E. and Y.J.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arciniegas E, 2000, ANAT RECORD, V258, P47, DOI 10.1002/(SICI)1097-0185(20000101)258:1<47::AID-AR6>3.0.CO;2-W; Arii S, 2000, J Hepatobiliary Pancreat Surg, V7, P40, DOI 10.1007/s005340050152; Asahina K, 2012, J GASTROEN HEPATOL, V27, P80, DOI 10.1111/j.1440-1746.2011.07001.x; Bagley RG, 2005, CANCER RES, V65, P9741, DOI 10.1158/0008-5472.CAN-04-4337; Bjerkvig R, 2005, NAT REV CANCER, V5, P899, DOI 10.1038/nrc1740; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Chiba T, 2007, GASTROENTEROLOGY, V133, P937, DOI 10.1053/j.gastro.2007.06.016; Cogle CR, 2007, STEM CELLS, V25, P1881, DOI 10.1634/stemcells.2007-0163; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dan YY, P NATL ACAD SCI US, V103, P9912; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Duan YY, 2010, STEM CELLS, V28, P674, DOI 10.1002/stem.315; Duncan AW, 2009, GASTROENTEROLOGY, V137, P466, DOI 10.1053/j.gastro.2009.05.044; Fogh J., 1975, HUMAN TUMOR CELLS IN, P115, DOI 10.1007/978-1-4757-1647-4_5; Ghaedi M, 2012, CELL MOL BIOL LETT, V17, P89, DOI 10.2478/s11658-011-0040-x; Hass R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-12; HEFFELFINGER SC, 1992, IN VITRO CELL DEV-AN, V28A, P136; Houghton J, 2004, SCIENCE, V306, P1568, DOI 10.1126/science.1099513; Mansuroglu T, 2009, HISTOCHEM CELL BIOL, V132, P11, DOI 10.1007/s00418-009-0596-y; P Mafi, 2011, Open Orthop J, V5, P253, DOI 10.2174/1874325001105010253; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Stecca B, 2013, CURR PROTOC STEM CEL, V24; Turner BM, 1988, SOMATIC CELL GENETIC, V6, P1; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Yao ZX, 2009, CANCER BIOL THER, V8, P1691, DOI 10.4161/cbt.8.18.9843; Zhao R, 2005, HEPATOLOGY, V41, P956, DOI 10.1002/hep.20691	30	32	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110744	10.1371/journal.pone.0110744	http://dx.doi.org/10.1371/journal.pone.0110744			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338121	Green Submitted, Green Published, gold			2022-12-27	WOS:000343674800069
J	Michael, DR; Banks, SC; Piggott, MP; Cunningham, RB; Crane, M; MacGregor, C; McBurney, L; Lindenmayer, DB				Michael, Damian R.; Banks, Sam C.; Piggott, Maxine P.; Cunningham, Ross B.; Crane, Mason; MacGregor, Christopher; McBurney, Lachlan; Lindenmayer, David B.			Geographical Variation in Body Size and Sexual Size Dimorphism in an Australian Lizard, Boulenger's Skink (Morethia boulengeri)	PLOS ONE			English	Article							BERGMANNS RULE; LIFE-HISTORY; PATTERNS; CLIMATE; SCALE; FOLLOW; POPULATIONS; AMPHIBIANS; REPTILES; SNAKES	Ecogeographical rules help explain spatial and temporal patterns in intraspecific body size. However, many of these rules, when applied to ectothermic organisms such as reptiles, are controversial and require further investigation. To explore factors that influence body size in reptiles, we performed a heuristic study to examine body size variation in an Australian lizard, Boulenger's Skink Morethia boulengeri from agricultural landscapes in southern New South Wales, south-eastern Australia. We collected tissue and morphological data on 337 adult lizards across a broad elevation and climate gradient. We used a model-selection procedure to determine if environmental or ecological variables best explained body size variation. We explored the relationship between morphology and phylogenetic structure before modeling candidate variables from four broad domains: (1) geography (latitude, longitude and elevation), (2) climate (temperature and rainfall), (3) habitat (vegetation type, number of logs and ground cover attributes), and (4) management (land use and grazing history). Broad phylogenetic structure was evident, but on a scale larger than our study area. Lizards were sexually dimorphic, whereby females had longer snout-vent length than males, providing support for the fecundity selection hypothesis. Body size variation in M. boulengeri was correlated with temperature and rainfall, a pattern consistent with larger individuals occupying cooler and more productive parts of the landscape. Climate change forecasts, which predict warmer temperature and increased aridity, may result in reduced lizard biomass and decoupling of trophic interactions with potential implications for community organization and ecosystem function.	[Michael, Damian R.] Australian Natl Univ, ARC Ctr Excellence Environm Decis, Fenner Sch Environm & Soc, Canberra, ACT, Australia; Australian Natl Univ, Natl Environm Res Program, Canberra, ACT, Australia	Australian National University; Australian National University	Michael, DR (corresponding author), Australian Natl Univ, ARC Ctr Excellence Environm Decis, Fenner Sch Environm & Soc, Canberra, ACT, Australia.	damian.michael@anu.edu.au	Piggott, Maxine P/AFN-2433-2022; Lindenmayer, David B/P-7183-2017; Banks, Sam/K-4907-2012; Piggott, Maxine P/AFN-2257-2022; MacGregor, Christopher/AFQ-6785-2022; Crane, Mason/AAQ-1810-2021	Piggott, Maxine P/0000-0002-7307-708X; Lindenmayer, David B/0000-0002-4766-4088; Banks, Sam/0000-0003-2415-0057; MacGregor, Christopher/0000-0002-7908-204X; 	Murray Catchment Management Authority; Australian Research Council; Australian Government's Caring for Country Program	Murray Catchment Management Authority; Australian Research Council(Australian Research Council); Australian Government's Caring for Country Program(Australian Government)	The work was supported by major grants from the Murray Catchment Management Authority, the Australian Research Council and the Australian Government's Caring for Country Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2008, EVOLUTION, V62, P413, DOI 10.1111/j.1558-5646.2007.00297.x; Amo L, 2007, BIOL CONSERV, V135, P77, DOI 10.1016/j.biocon.2006.09.020; Angilletta MJ, 2004, AM NAT, V164, pE168, DOI 10.1086/425222; [Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; Ashton KG, 2000, AM NAT, V156, P390, DOI 10.1086/303400; Ashton KG, 2003, EVOLUTION, V57, P1151, DOI 10.1111/j.0014-3820.2003.tb00324.x; Ashton KG, 2002, GLOBAL ECOL BIOGEOGR, V11, P505, DOI 10.1046/j.1466-822X.2002.00313.x; Ashton KG, 2001, EVOLUTION, V55, P2523; Blackburn Tim M., 1999, Diversity and Distributions, V5, P165, DOI 10.1046/j.1472-4642.1999.00046.x; Blois JL, 2008, J BIOGEOGR, V35, P602, DOI 10.1111/j.1365-2699.2007.01836.x; BOGERT CM, 1949, EVOLUTION, V3, P195, DOI 10.2307/2405558; Brandt R, 2013, J ZOOL, V290, P192, DOI 10.1111/jzo.12024; Cabrera MP, 2013, ZOOL ANZ, V252, P299, DOI 10.1016/j.jcz.2012.08.003; Chown SL, 2010, BIOL REV, V85, P139, DOI 10.1111/j.1469-185X.2009.00097.x; Clauss M, 2013, OIKOS, V122, P1465, DOI 10.1111/j.1600-0706.2013.00463.x; Cruz FB, 2005, J EVOLUTION BIOL, V18, P1559, DOI 10.1111/j.1420-9101.2005.00936.x; CUSHMAN JH, 1993, OECOLOGIA, V95, P30, DOI 10.1007/BF00649503; Cvetkovic D, 2009, J ZOOL SYST EVOL RES, V47, P171, DOI 10.1111/j.1439-0469.2008.00504.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Forsman A, 1996, OECOLOGIA, V108, P669, DOI 10.1007/BF00329041; Galway N. W., 2006, INTRO MIXED MODELLIN; Gardner JL, 2011, TRENDS ECOL EVOL, V26, P285, DOI 10.1016/j.tree.2011.03.005; Gaston K.J., 2000, PATTERN PROCESS MACR, DOI [10.1002/9780470999592, DOI 10.1002/9780470999592]; Gaston KJ, 2008, J BIOGEOGR, V35, P483, DOI 10.1111/j.1365-2699.2007.01772.x; Gates J, 2002, ECOLOGICAL STUDY BUS; Goodman RM, 2013, INTEGR ZOOL, V8, P184, DOI 10.1111/1749-4877.12041; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Greaves SNJ, 2007, MOL PHYLOGENET EVOL, V45, P729, DOI 10.1016/j.ympev.2007.06.008; Griffiths D, 2012, GLOBAL ECOL BIOGEOGR, V21, P383, DOI 10.1111/j.1466-8238.2011.00680.x; HENLE K, 1989, OECOLOGIA, V78, P521, DOI 10.1007/BF00378744; Herrel A, 2008, P NATL ACAD SCI USA, V105, P4792, DOI 10.1073/pnas.0711998105; Houlder D. J., 2000, ANUCLIM USERS GUIDE; Iglesias S, 2012, J HERPETOL, V46, P297, DOI 10.1670/11-084; Jin YT, 2013, J ZOOL, V290, P293, DOI 10.1111/jzo.12042; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lomolino MV, 2006, J BIOGEOGR, V33, P1503, DOI 10.1111/j.1365-2699.2006.01593.x; Lurgi M, 2012, PHILOS T R SOC B, V367, P3050, DOI 10.1098/rstb.2012.0239; Meiri S, 2003, J BIOGEOGR, V30, P331, DOI 10.1046/j.1365-2699.2003.00837.x; Meiri S, 2007, GLOBAL ECOL BIOGEOGR, V16, P788, DOI 10.1111/j.1466-8238.2007.00330.x; Michael D., 2010, REPTILES NSW MURRAY; Michael DR, 2014, J APPL ECOL, V51, P494, DOI 10.1111/1365-2664.12215; Michael Damian R., 2011, Check List, V7, P25; Michael DR, 2010, AUSTRAL ECOL, V35, P215, DOI 10.1111/j.1442-9993.2009.02029.x; Mok HF, 2012, GLOBAL CHANGE BIOL, V18, P1053, DOI 10.1111/j.1365-2486.2011.02591.x; Olalla-Tarraga MA, 2006, J BIOGEOGR, V33, P781, DOI 10.1111/j.1365-2699.2006.01435.x; Olsson M, 2002, EVOLUTION, V56, P1538; Pincheira-Donoso D, 2013, EVOL BIOL, V2013, P1; Pincheira-Donoso D, 2011, EVOL BIOL, V38, P197, DOI 10.1007/s11692-011-9118-7; Pincheira-Donoso D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-68; Prober SM, 2012, BIODIVERS CONSERV, V21, P1627, DOI 10.1007/s10531-012-0268-4; Rodriguez MA, 2006, GLOBAL ECOL BIOGEOGR, V15, P173, DOI 10.1111/j.1466-822x.2006.00206.x; ROSENZWEIG ML, 1968, AM MIDL NAT, V80, P299, DOI 10.2307/2423529; Schauble CS, 2004, BIOL J LINN SOC, V82, P39, DOI 10.1111/j.1095-8312.2004.00315.x; Solis R, 2013, Complete Guide to Physical Security, P175; Sumner J, 1999, BIOL CONSERV, V91, P159, DOI 10.1016/S0006-3207(99)00089-0; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Watt C, 2010, OIKOS, V119, P89, DOI 10.1111/j.1600-0706.2009.17959.x; Yom-Tov Y, 2006, OIKOS, V112, P91, DOI 10.1111/j.0030-1299.2006.14183.x; Yom-Tov Y, 2001, P ROY SOC B-BIOL SCI, V268, P947, DOI 10.1098/rspb.2001.1592	62	9	9	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e109830	10.1371/journal.pone.0109830	http://dx.doi.org/10.1371/journal.pone.0109830			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337999	Green Published, Green Submitted, gold			2022-12-27	WOS:000343674800017
J	Pond, DW; Tarling, GA; Mayor, DJ				Pond, David W.; Tarling, Geraint A.; Mayor, Daniel J.			Hydrostatic Pressure and Temperature Effects on the Membranes of a Seasonally Migrating Marine Copepod	PLOS ONE			English	Article							HOMEOVISCOUS ADAPTATION; BIOLOGICAL-MEMBRANES; FATTY-ACIDS; DEEP; SEA; LIPIDS; GROWTH; LIFE	Marine planktonic copepods of the order Calanoida are central to the ecology and productivity of high latitude ecosystems, representing the interface between primary producers and fish. These animals typically undertake a seasonal vertical migration into the deep sea, where they remain dormant for periods of between three and nine months. Descending copepods are subject to low temperatures and increased hydrostatic pressures. Nothing is known about how these organisms adapt their membranes to these environmental stressors. We collected copepods (Calanoides acutus) from the Southern Ocean at depth horizons ranging from surface waters down to 1000 m. Temperature and/or pressure both had significant, additive effects on the overall composition of the membrane phospholipid fatty acids (PLFAs) in C. acutus. The most prominent constituent of the PLFAs, the polyunsaturated fatty acid docosahexanoic acid [DHA - 22: 6(n-3)], was affected by a significant interaction between temperature and pressure. This moiety increased with pressure, with the rate of increase being greater at colder temperatures. We suggest that DHA is key to the physiological adaptations of vertically migrating zooplankton, most likely because the biophysical properties of this compound are suited to maintaining membrane order in the cold, high pressure conditions that persist in the deep sea. As copepods cannot synthesise DHA and do not feed during dormancy, sufficient DHA must be accumulated through ingestion before migration is initiated. Climate-driven changes in the timing and abundance of the flagellated microplankton that supply DHA to copepods have major implications for the capacity of these animals to undertake their seasonal life cycle successfully.	[Pond, David W.] Scottish Assoc Marine Sci, Oban, Argyll, Scotland; [Tarling, Geraint A.] British Antarctic Survey, NERC, Cambridge CB3 0ET, England; [Mayor, Daniel J.] Univ Aberdeen, Oceanlab, Inst Biol & Environm Sci, Newburgh, Aberdeen, Scotland	UHI Millennium Institute; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Aberdeen	Pond, DW (corresponding author), Scottish Assoc Marine Sci, Oban, Argyll, Scotland.	David.Pond@sams.ac.uk	Mayor, Daniel/HDN-8520-2022	Mayor, Daniel/0000-0002-1295-0041	Marine Alliance for Science and Technology for Scotland (MASTS); NERC [NE/J007803/1]; NERC [bas0100025, NE/K001833/1, NE/G014744/1] Funding Source: UKRI; Natural Environment Research Council [NE/G014744/1, NE/J007803/1, NE/K001833/1, bas0100025] Funding Source: researchfish	Marine Alliance for Science and Technology for Scotland (MASTS); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors thank the officers and crew of the RRS James Clark Ross for their assistance and professionalism whilst at sea. This research was supported by grants from the Marine Alliance for Science and Technology for Scotland (MASTS) and the NERC (NE/J007803/1). The research is also a contribution to the ECOSYSTEMS programme of the British Antarctic Survey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], [No title captured]; Bell MV, 2007, J PLANKTON RES, V29, P417, DOI 10.1093/plankt/fbm025; Casadei MA, 2002, APPL ENVIRON MICROB, V68, P5965, DOI 10.1128/AEM.68.12.5965-5972.2002; COSSINS AR, 1989, J BIOENERG BIOMEMBR, V21, P115, DOI 10.1007/BF00762215; COSSINS AR, 1986, BIOCHIM BIOPHYS ACTA, V860, P325, DOI 10.1016/0005-2736(86)90529-8; Dahms U.C., 1995, HYDOBIOLOGIA, V306, P199, DOI DOI 10.1007/BF00017691; DELONG EF, 1985, SCIENCE, V228, P1101, DOI 10.1126/science.3992247; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRASER PJ, 1994, NATURE, V371, P383, DOI 10.1038/371383b0; Guschina IA, 2006, FEBS LETT, V580, P5477, DOI 10.1016/j.febslet.2006.06.066; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; HAZEL JR, 1990, PROG LIPID RES, V29, P167, DOI 10.1016/0163-7827(90)90002-3; Hirche HJ, 1996, OPHELIA, V44, P129, DOI 10.1080/00785326.1995.10429843; Hulbert AJ, 2007, LIPIDS, V42, P811, DOI 10.1007/s11745-007-3058-0; Hulbert AJ, 2003, J EXP BIOL, V206, P2303, DOI 10.1242/jeb.00399; Jamieson AJ, 2010, TRENDS ECOL EVOL, V25, P190, DOI 10.1016/j.tree.2009.09.009; Kawamoto J, 2009, J BACTERIOL, V191, P632, DOI 10.1128/JB.00881-08; Kaye JZ, 2004, APPL ENVIRON MICROB, V70, P6220, DOI 10.1128/AEM.70.10.6220-6229.2004; Li LN, 1998, FEMS MICROBIOL LETT, V159, P159, DOI 10.1111/j.1574-6968.1998.tb12855.x; Longhurst, 2006, ECOLOGICAL GEOGRAPHY; LOWE ESTHER, 1935, TRANS ROY SOC EDINBURGH, V58, P561; Mayor DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064940; Mayor DJ, 2012, ISME J, V6, P1740, DOI 10.1038/ismej.2012.14; Murray P, 2007, P NATL ACAD SCI USA, V104, P5489, DOI 10.1073/pnas.0609590104; Oksanen J., 2013, R PACKAGE VERSION 2, P292; Pond DW, 2012, J PLANKTON RES, V34, P443, DOI 10.1093/plankt/fbs027; Pond DW, 2012, DEEP-SEA RES PT II, V59, P93, DOI 10.1016/j.dsr2.2011.05.009; Pond DW, 2011, LIMNOL OCEANOGR, V56, P1310, DOI 10.4319/lo.2011.56.4.1310; Purac J, 2011, PHYSIOL ENTOMOL, V36, P135, DOI 10.1111/j.1365-3032.2010.00772.x; RABINOVICH AL, 1990, DOKL AKAD NAUK SSSR+, V314, P752; Sargent J. R., 1995, Proceedings of the 6th International Colloquium: Phospholipids: characterization, metabolism, and novel biological applications., P248; SINENSKY M, 1974, P NATL ACAD SCI USA, V71, P522, DOI 10.1073/pnas.71.2.522; Tarling GA, 2004, MAR ECOL PROG SER, V272, P165, DOI 10.3354/meps272165; Valentine RC, 2004, PROG LIPID RES, V43, P383, DOI 10.1016/j.plipres.2004.05.004; Vettier A, 2006, UNDERSEA HYPERBAR M, V33, P149; Yano Y, 1998, APPL ENVIRON MICROB, V64, P479; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; [No title captured]	40	29	29	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e111043	10.1371/journal.pone.0111043	http://dx.doi.org/10.1371/journal.pone.0111043			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338196	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000343674800097
J	Shepard, DS; Halasa, YA; Fonseca, DM; Farajollahi, A; Healy, SP; Gaugler, R; Bartlett-Healy, K; Strickman, DA; Clark, GG				Shepard, Donald S.; Halasa, Yara A.; Fonseca, Dina M.; Farajollahi, Ary; Healy, Sean P.; Gaugler, Randy; Bartlett-Healy, Kristen; Strickman, Daniel A.; Clark, Gary G.			Economic Evaluation of an Area-Wide Integrated Pest Management Program to Control the Asian Tiger Mosquito in New Jersey	PLOS ONE			English	Article							AGRICULTURAL-RESEARCH SERVICE; ALBOPICTUS DIPTERA-CULICIDAE; DEPARTMENT-OF-AGRICULTURE; WILLINGNESS-TO-PAY; ADJUSTED LIFE-YEAR; AEDES-ALBOPICTUS; UNITED-STATES; DENGUE-FEVER; POPULATIONS; SUPPRESSION	Aedes albopictus is the most invasive mosquito in the world, an important disease vector, and a biting nuisance that limits outdoor activities. Area-wide integrated pest management (AW-IPM) is the recommended control strategy. We conducted an economic evaluation of the AW-IPM project in Mercer and Monmouth Counties, New Jersey with a controlled design (AW-IPM vs. control) from 2009 through 2011. The study analyzed financial documents and staff time for AW-IPM and surveyed an average of 415 randomly chosen households in AW-IPM and control areas each fall from 2008 through 2011. Hours lost from yard and porch activities were calculated as differences between actual and potential hours of these activities in an average summer week if there had been no mosquito concerns. Net estimated benefits of AW-IPM were based on cross-over and difference-in-difference analyses. Reductions in hours lost were valued based on respondents' willingness to pay for a hypothetical extra hour free of mosquitoes spent on yard or porch activities and literature on valuation of a quality adjusted life year (QALY). The incremental cost of AW-IPM per adult was $41.18 per year. Number of hours lost due to mosquitoes in AW-IPM areas between the base year (2008) and the intervention years (2009-2011) declined by 3.30 hours per summer week in AW-IPM areas compared to control areas. Survey respondents valued this improvement at $27.37 per adult per summer week. Over the 13-week summer, an average adult resident gained 42.96 hours of yard and porch time, worth $355.82. The net benefit over the summer was $314.63. With an average of 0.0027 QALYs gained per adult per year, AW-IPM was cost effective at $15,300 per QALY gained. The benefit-cost ratio from hours gained was 8.64, indicating that each $1 spent on AW-IPM gave adults additional porch and yard time worth over $8.	[Shepard, Donald S.; Halasa, Yara A.] Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA 02453 USA; [Fonseca, Dina M.; Gaugler, Randy; Bartlett-Healy, Kristen] Rutgers State Univ, Ctr Vector Biol, New Brunswick, NJ 08903 USA; [Farajollahi, Ary] Mercer Cty Mosquito Control, West Trenton, NJ USA; [Farajollahi, Ary] Salt Lake City Mosquito Abatement Dist, Salt Lake City, UT USA; [Healy, Sean P.] Monmouth Cty Mosquito Exterminat Commiss, Eatontown, NJ USA; [Healy, Sean P.; Bartlett-Healy, Kristen] Louisiana State Univ, Ctr Agr, Dept Entomol, Baton Rouge, LA 70803 USA; [Strickman, Daniel A.] ARS, USDA, Beltsville, MD USA; [Strickman, Daniel A.] Bill & Melinda Gates Fdn, Seattle, WA USA; [Clark, Gary G.] ARS, USDA, Gainesville, FL USA	Brandeis University; Rutgers State University New Brunswick; Louisiana State University System; Louisiana State University; United States Department of Agriculture (USDA); Bill & Melinda Gates Foundation; United States Department of Agriculture (USDA)	Shepard, DS (corresponding author), Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA 02453 USA.	shepard@brandeis.edu	Fonseca, Dina/HHS-1320-2022; Fonseca, Dina Madeira/B-9951-2011	Fonseca, Dina Madeira/0000-0003-4726-7100; Healy, Kristen/0000-0002-3208-6537	 [USDA-ARS-58-6615-8-105]		This work was funded by Cooperative Agreement USDA-ARS-58-6615-8-105 to Brandeis University (PI: GGC; PI at Brandeis: DSS). Two authors (DAS and GGC) are employed by the sponsoring agency. However, all views expressed are those of the authors and not necessarily those of their institutions nor of the sponsor. The sponsor, as an institution, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson G, 1999, P 19 INT S BIOL CONT, p15 ; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Bethlehem J., 2009, APPL SURVEY METHODS; Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003; Braithwaite RS, 2008, MED CARE, V46, P349, DOI 10.1097/MLR.0b013e31815c31a7; Calkins CO, 2003, PEST MANAG SCI, V59, P601, DOI 10.1002/ps.712; Chandler LD, 2003, PEST MANAG SCI, V59, P605, DOI 10.1002/ps.683; Chokshi DA, 2012, NEW ENGL J MED, V367, P295, DOI 10.1056/NEJMp1206268; Curco N, 2008, ACTAS DERMO-SIFILOGR, V99, P708, DOI 10.1016/S0001-7310(08)76175-1; Drummond MF, 2015, METHODS EC EVALUATIO; Effler PV, 2005, EMERG INFECT DIS, V11, P742; Eritja R, 2005, BIOL INVASIONS, V7, P87, DOI 10.1007/s10530-004-9637-6; Farajollahi A, 2009, J MED ENTOMOL, V46, P1220, DOI 10.1603/033.046.0533; Faust R, 2001, AGR RES, V49, P2; Fonseca DM, 2013, PEST MANAG SCI; Gjenero-Margan I, 2011, EURO SURVEILL, V16; Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Haddix AC, 2003, PREVENTION EFFECTIVE; Hagstrum David W., 1999, Integrated Pest Management Reviews, V4, P127, DOI 10.1023/A:1009682410810; Halasa YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089221; Halasa YA, 2012, J AM MOSQUITO CONTR, V28, P225, DOI 10.2987/12-6243R.1; Higa Yukiko, 2011, Tropical Medicine and Health, V39, P17, DOI 10.2149/tmh.2011-S04; Hirth RA, 2000, MED DECIS MAKING, V20, P332, DOI 10.1177/0272989X0002000310; Holder P, 2010, J MED ENTOMOL, V47, P600, DOI 10.1603/ME09111; Internal Revenue Service, 2010, INT REV MAN PROP EQ; Lizzi KM, 2014, TRENDS PARASITOL, V30, P394, DOI 10.1016/j.pt.2014.06.001; Moore CG, 1997, EMERG INFECT DIS, V3, P329, DOI 10.3201/eid0303.970309; New Jersey Weather and Climate Network, 2014, MONTL PREC SO NEW JE; Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005; Ratigan C, 2000, THESIS VIRGINIA POLY; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; StataCorp, 2011, STAT STAT SOFTW REL, P173; Unlu I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077999; Unlu I, 2011, PEST MANAG SCI, V67, P965, DOI 10.1002/ps.2140; US Department of Agriculture, 2008, AR WID PEST MAN EFF; Vargas RI, 2001, J ECON ENTOMOL, V94, P817, DOI 10.1603/0022-0493-94.4.817; Vargas RI, 2008, HAWAII FRUIT FLY ARE; Vogt JT, 2003, J AGR URBAN ENTOMOL, V20, P105; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Wooldridge Jeffrey M., 2012, INTRO ECONOMETRICS M, VFifth; World Bank, 2022, GDP PER CAP CURR US	42	18	18	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e111014	10.1371/journal.pone.0111014	http://dx.doi.org/10.1371/journal.pone.0111014			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338065	Green Published, Green Submitted, gold			2022-12-27	WOS:000343674800095
J	Vidovic, SU; Martill, DM				Vidovic, Steven U.; Martill, David M.			Pterodactylus scolopaciceps Meyer, 1860 (Pterosauria, Pterodactyloidea) from the Upper Jurassic of Bavaria, Germany: The Problem of Cryptic Pterosaur Taxa in Early Ontogeny	PLOS ONE			English	Article							LONG-TAILED PTEROSAUR; CHINA; GERMANODACTYLUS; MORPHOLOGY; SOLNHOFEN; REVISION; GENUS; SKULL	The taxonomy of the Late Jurassic pterodactyloid pterosaur Pterodactylus scolopaciceps Meyer, 1860 from the Solnhofen Limestone Formation of Bavaria, Germany is reviewed. Its nomenclatural history is long and complex, having been synonymised with both P. kochi (Wagner, 1837), and P. antiquus (Sommerring, 1812). The majority of pterosaur species from the Solnhofen Limestone, including P. scolopaciceps are represented by juveniles. Consequently, specimens can appear remarkably similar due to juvenile characteristics detracting from taxonomic differences that are exaggerated in later ontogeny. Previous morphological and morphometric analyses have failed to separate species or even genera due to this problem, and as a result many species have been subsumed into a single taxon. A hypodigm for P. scolopaciceps, comprising of the holotype (BSP AS V 29 a/b) and material Broili referred to the taxon is described. P. scolopaciceps is found to be a valid taxon, but placement within Pterodactylus is inappropriate. Consequently, the new genus Aerodactylus is erected to accommodate it. Aerodactylus can be diagnosed on account of a unique suite of characters including jaws containing 16 teeth per-jaw, per-side, which are more sparsely distributed caudally and terminate rostral to the nasoantorbital fenestra; dorsal surface of the skull is subtly depressed rostral of the cranial table; rostrum very elongate (RI = similar to 7), terminating in a point; orbits correspondingly low and elongate; elongate cervical vertebrae (approximately three times the length of their width); wing-metacarpal elongate, but still shorter than the ulna and first wing-phalanx; and pteroid approximately 65% of the total length of the ulna, straight and extremely thin (less than one third the width of the ulna). A cladistic analysis demonstrates that Aerodactylus is distinct from Pterodactylus, but close to Cycnorhamphus Seeley, 1870, Ardeadactylus Bennett, 2013a and Aurorazhdarcho Frey, Meyer and Tischlinger, 2011, consequently we erect the inclusive taxon Aurorazhdarchidae for their reception.	[Vidovic, Steven U.; Martill, David M.] Univ Portsmouth, Sch Earth & Environm Sci, Portsmouth, Hants, England	University of Portsmouth	Vidovic, SU (corresponding author), Univ Portsmouth, Sch Earth & Environm Sci, Portsmouth, Hants, England.	steven.vidovic@port.ac.uk	Vidovic, Steven Uros/I-1141-2019	Vidovic, Steven Uros/0000-0002-4726-8018; Martill, David/0000-0002-3208-5702	Systematics Association; Linnean Society, London, through the "Systematics Research Fund"	Systematics Association; Linnean Society, London, through the "Systematics Research Fund"	SUV received a small grant to visit the natural history museum in Basel, in aid of this project. The funding was provided by the Systematics Association and Linnean Society, London, through the "Systematics Research Fund" http://www.systass.org/awards/srf11-12results.shtml. No funds were provided for publication costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres BB, 2013, LONE STAR PTEROSAURS; Andres B, 2008, PALAEONTOLOGY, V51, P453, DOI 10.1111/j.1475-4983.2008.00761.x; Bennett SC, 2006, J VERTEBR PALEONTOL, V26, P872, DOI 10.1671/0272-4634(2006)26[872:JSOTPG]2.0.CO;2; Bennett SC, 2013, PALAEONTOL Z, V87, P269, DOI 10.1007/s12542-012-0159-8; Bennett SC, 2013, NEUES JAHRB GEOL P-A, V267, P23, DOI 10.1127/0077-7749/2012/0295; Bennett SC, 1996, J VERTEBR PALEONTOL, V16, P432, DOI 10.1080/02724634.1996.10011332; Bennett SC, 2002, J VERTEBR PALEONTOL, V22, P43, DOI 10.1671/0272-4634(2002)022[0043:STPOTC]2.0.CO;2; Brazeau MD, 2011, BIOL J LINN SOC, V104, P489, DOI 10.1111/j.1095-8312.2011.01755.x; Broili F, 1938, SITZUNGSBERICHTE BAY, P139; CAMPOS DD, 1985, AN ACAD BRAS CIENC, V57, P453; CUVIER G, 1809, ANN MUSEUM HIST NATU, V13, P424; Cuvier G, 1819, PTERODACTYLUS LONGIR; Frey E, 1998, NEUES JAHRB GEOL P-A, V210, P421, DOI [10.1127/njgpa/210/1998/421, DOI 10.1127/NJGPA/210/1998/421]; Frey Eberhard, 2003, Geological Society Special Publication, V217, P233, DOI 10.1144/GSL.SP.2003.217.01.14; Frey E, 2011, SWISS J GEOSCI, V104, pS35, DOI 10.1007/s00015-011-0073-1; Frickhinger K.A., 1994, FOSSILS SOLNHOFEN; Frickhinger KA., 1999, FOSSILIEN SOLNHOFEN; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; HOWSE SCB, 1986, ZOOL J LINN SOC-LOND, V88, P307, DOI 10.1111/j.1096-3642.1986.tb02249.x; Howse Stafford C.B., 2001, Palaeontological Association Field Guides to Fossils, V10, P324; Jouve S, 2004, J VERTEBR PALEONTOL, V24, P542, DOI 10.1671/0272-4634(2004)024[0542:DOTSOA]2.0.CO;2; Kaup S.S., 1834, ISIS, P311; Kellner A.W.A., 1989, Anais da Academia Brasileira de Ciencias, V61, P439; Kellner Alexander W.A., 2003, Geological Society Special Publication, V217, P105, DOI 10.1144/GSL.SP.2003.217.01.10; Kellner AWA, 1996, DESCRIPTION NEW MAT; Lu JC, 2012, CRETACEOUS RES, V34, P26, DOI 10.1016/j.cretres.2011.09.010; Lu JC, 2010, P ROY SOC B-BIOL SCI, V277, P383, DOI 10.1098/rspb.2009.1603; Maisch MW, 2004, CRETACEOUS RES, V25, P625, DOI 10.1016/j.cretres.2004.06.002; Marsh O.C., 1876, AM J SCI, P479; Mateer N.J., 1976, Acta Univ Upsaliensis, V6, P97; Meyer H, 1850, NEUES JB MINERALOGIE, P199; Meyer H, 1856, MITTHEILUNGEN PROFES, P826; Meyer H, 1854, MITTHEILUNGEN PROFES, P51; Meyer H, 1860, FAUNA VORWELT REPTIL, P1; Nessov L.A., 1984, PALEONTOL J+, V18, P38; Nopcsa Baron F., 1928, Palaeobiologica Wien, V1, P163; Plieninger F, 1901, PALAEONTOGRAPHICA, V48, P65; Seeley H. G., 1891, Annals of Natural History, V(6), P237; Seeley H. G., 1901, DRAGONS AIR ACCOUNT; Seeley HG., 1870, J NAT HIST, V7, P20; Sommerring T von, 1812, DENKSCHRIFTEN KONIGL, V3, P89; Unwin David M., 2003, Geological Society Special Publication, V217, P139, DOI 10.1144/GSL.SP.2003.217.01.11; Unwin DM., 2006, PTEROSAURS DEEP TIME; Unwin DM, 1992, J VERTEBRATE PALEO S, V12; WAGNER A, 1837, ABHANDLUNGEN BAYE MN, V2, P165; Wang XL, 2009, AN ACAD BRAS CIENC, V81, P793, DOI 10.1590/S0001-37652009000400016; Wellnhofer P., 1970, ABH BAYER AKAD WISS, V141, P1; Wellnhofer P., 1987, ANN NATURHIST MUS A, V88, P149; Wiman C, 1925, B GEOLOGICAL I U UPP, V20, P1; Zittel KA, 1883, PALAEONTOGRAPHICA, V29, P47	52	21	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110646	10.1371/journal.pone.0110646	http://dx.doi.org/10.1371/journal.pone.0110646			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337830	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000343674800065
J	Flynn, N; Getz, A; Visser, F; Janes, TA; Syed, NI				Flynn, Nichole; Getz, Angela; Visser, Frank; Janes, Tara A.; Syed, Naweed I.			Menin: A Tumor Suppressor That Mediates Postsynaptic Receptor Expression and Synaptogenesis between Central Neurons of Lymnaea stagnalis	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; NEOPLASIA TYPE-1 MEN1; GENE-EXPRESSION; SYNAPTIC PLASTICITY; TYROSINE KINASES; MOLLUSK LYMNAEA; MURINE HOMOLOG; NUCLEUS; CASCADE; PROTEIN	Neurotrophic factors (NTFs) support neuronal survival, differentiation, and even synaptic plasticity both during development and throughout the life of an organism. However, their precise roles in central synapse formation remain unknown. Previously, we demonstrated that excitatory synapse formation in Lymnaea stagnalis requires a source of extrinsic NTFs and receptor tyrosine kinase (RTK) activation. Here we show that NTFs such as Lymnaea epidermal growth factor (L-EGF) act through RTKs to trigger a specific subset of intracellular signalling events in the postsynaptic neuron, which lead to the activation of the tumor suppressor menin, encoded by Lymnaea MEN1 (L-MEN1) and the expression of excitatory nicotinic acetylcholine receptors (nAChRs). We provide direct evidence that the activation of the MAPK/ERK cascade is required for the expression of nAChRs, and subsequent synapse formation between pairs of neurons in vitro. Furthermore, we show that L-menin activation is sufficient for the expression of postsynaptic excitatory nAChRs and subsequent synapse formation in media devoid of NTFs. By extending our findings in situ, we reveal the necessity of EGFRs in mediating synapse formation between a single transplanted neuron and its intact presynaptic partner. Moreover, deficits in excitatory synapse formation following EGFR knock-down can be rescued by injecting synthetic L-MEN1 mRNA in the intact central nervous system. Taken together, this study provides the first direct evidence that NTFs functioning via RTKs activate the MEN1 gene, which appears sufficient to regulate synapse formation between central neurons. Our study also offers a novel developmental role for menin beyond tumour suppression in adult humans.	[Syed, Naweed I.] Univ Calgary, Fac Med, Dept Cell Biol & Anat, Calgary, AB, Canada; Univ Calgary, Fac Med, Hotchkiss Brain Inst, Calgary, AB, Canada	University of Calgary; University of Calgary	Syed, NI (corresponding author), Univ Calgary, Fac Med, Dept Cell Biol & Anat, Calgary, AB, Canada.	nisyed@ucalgary.ca		Flynn, Nichole/0000-0002-4876-1103; Getz, Angela/0000-0003-1332-2941	Natural Sciences and Engineering Research Council of Canada (NSERC); Alberta Innovates - Health Solutions (AI-HS); NSERC; Alberta Innovates [201000307, 200900656] Funding Source: researchfish	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates - Health Solutions (AI-HS); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates	This work was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) grant to NIS. NF was funded by Alberta Innovates - Health Solutions (AI-HS), NSERC, and Dr. T. Chen Fong studentships. AG was funded by AI-HS and NSERC studentships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal SK, 2007, NEOPLASIA, V9, P101, DOI 10.1593/neo.06706; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Balogh K, 2006, TRENDS ENDOCRIN MET, V17, P357, DOI 10.1016/j.tem.2006.09.004; Bassett JHD, 1999, J BONE MINER RES, V14, P3, DOI 10.1359/jbmr.1999.14.1.3; Citri A, 2012, NAT PROTOC, V7, P118, DOI 10.1038/nprot.2011.430; Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Falchetti A, 2009, GENET MED, V11, P825, DOI 10.1097/GIM.0b013e3181be5c97; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Guru SC, 1999, MAMM GENOME, V10, P592, DOI 10.1007/s003359901051; Guru SC, 2001, GENE, V263, P31, DOI 10.1016/S0378-1119(00)00562-X; Hamakawa T, 1999, J NEUROSCI, V19, P9306; Hermann PM, 2000, J NEUROSCI, V20, P6355, DOI 10.1523/JNEUROSCI.20-17-06355.2000; Karges W, 1999, BBA-GENE STRUCT EXPR, V1446, P286, DOI 10.1016/S0167-4781(99)00089-5; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; Kharchenko OA, 2010, NEUROBIOL LEARN MEM, V94, P158, DOI 10.1016/j.nlm.2010.05.002; Kim H, 2003, CANCER RES, V63, P6135; La P, 2006, ONCOGENE, V25, P3537, DOI 10.1038/sj.onc.1209400; Lopez-Egido JR, 2002, EXP CELL RES, V278, P175, DOI 10.1006/excr.2002.5575; Manganelli F, 2014, J NEUROL; Manickam P, 2000, MAMM GENOME, V11, P448, DOI 10.1007/s003350010085; Maruyama K, 1999, MOL CELL ENDOCRINOL, V156, P25, DOI 10.1016/S0303-7207(99)00150-1; Matkar S, 2013, TRENDS BIOCHEM SCI, V38, P394, DOI [10.1016/j.tibs.2013.0S.005, 10.1016/j.tibs.2013.05.005]; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; RIDGWAY RL, 1991, J NEUROBIOL, V22, P377, DOI 10.1002/neu.480220406; Scacheri PC, 2006, PLOS GENET, V2, P406, DOI 10.1371/journal.pgen.0020051; Shi L, 2012, TRENDS NEUROSCI, V35, P441, DOI 10.1016/j.tins.2012.04.005; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; Stewart C, 1998, ONCOGENE, V17, P2485, DOI 10.1038/sj.onc.1202164; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; SYED NI, 1989, COMP BIOCHEM PHYS A, V93, P633, DOI 10.1016/0300-9629(89)90024-8; SYED NI, 1990, SCIENCE, V250, P282, DOI 10.1126/science.2218532; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; van Kesteren RE, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0004.2001; van Kesteren RE, 2008, EUR J NEUROSCI, V27, P2043, DOI 10.1111/j.1460-9568.2008.06189.x; van Nierop P, 2006, J BIOL CHEM, V281, P1680, DOI 10.1074/jbc.M508571200; van Nierop P, 2005, J NEUROSCI, V25, P10617, DOI 10.1523/JNEUROSCI.2015-05.2005; Wautot V, 2000, INT J CANCER, V85, P877, DOI 10.1002/(SICI)1097-0215(20000315)85:6<877::AID-IJC23>3.0.CO;2-F; Wuescher L, 2011, AM J PHYSIOL-ENDOC M, V301, pE474, DOI 10.1152/ajpendo.00022.2011; Xu FL, 2009, J NEUROSCI, V29, P2167, DOI 10.1523/JNEUROSCI.4682-08.2009; Xu S, 2012, NEUROSCIENCE, V223, P473, DOI 10.1016/j.neuroscience.2012.07.036; Zhang H, 2011, CHINESE MED J-PEKING, V124, P1556, DOI 10.3760/cma.j.issn.0366-6999.2011.10.022; Zhang XQ, 2010, CELL MOL NEUROBIOL, V30, P885, DOI 10.1007/s10571-010-9517-9	43	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111103	10.1371/journal.pone.0111103	http://dx.doi.org/10.1371/journal.pone.0111103			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347295	gold, Green Submitted, Green Published			2022-12-27	WOS:000347994900047
J	Spenle, C; Lefebvre, O; Lacroute, J; Mechine-Neuville, A; Barreau, F; Blottiere, HM; Duclos, B; Arnold, C; Hussenet, T; Hemmerle, J; Gullberg, D; Kedinger, M; Sorokin, L; Orend, G; Simon-Assmann, P				Spenle, Caroline; Lefebvre, Olivier; Lacroute, Joel; Mechine-Neuville, Agnes; Barreau, Frederick; Blottiere, Herve M.; Duclos, Bernard; Arnold, Christiane; Hussenet, Thomas; Hemmerle, Joseph; Gullberg, Donald; Kedinger, Michele; Sorokin, Lydia; Orend, Gertraud; Simon-Assmann, Patricia			The Laminin Response in Inflammatory Bowel Disease: Protection or Malignancy?	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; NF-KAPPA-B; ULCERATIVE-COLITIS; BASEMENT-MEMBRANE; EXTRACELLULAR-MATRIX; COLORECTAL-CARCINOMA; ALTERED EXPRESSION; TREFOIL PEPTIDES; GENE-EXPRESSION; CROHNS-DISEASE	Laminins (LM), basement membrane molecules and mediators of epithelial-stromal communication, are crucial in tissue homeostasis. Inflammatory Bowel Diseases (IBD) are multifactorial pathologies where the microenvironment and in particular LM play an important yet poorly understood role in tissue maintenance, and in cancer progression which represents an inherent risk of IBD. Here we showed first that in human IBD colonic samples and in murine colitis the LM alpha 1 and LM alpha 5 chains are specifically and ectopically overexpressed with a concomitant nuclear p53 accumulation. Linked to this observation, we provided a mechanism showing that p53 induces LM alpha 1 expression at the promoter level by ChIP analysis and this was confirmed by knockdown in cell transfection experiments. To mimic the human disease, we induced colitis and colitis-associated cancer by chemical treatment (DSS) combined or not with a carcinogen (AOM) in transgenic mice overexpressing LM alpha 1 or LM alpha 5 specifically in the intestine. We demonstrated that high LM alpha 1 or LM alpha 5 expression decreased susceptibility towards experimentally DSS-induced colon inflammation as assessed by histological scoring and decrease of pro-inflammatory cytokines. Yet in a pro-oncogenic context, we showed that LM would favor tumorigenesis as revealed by enhanced tumor lesion formation in both LM transgenic mice. Altogether, our results showed that nuclear p53 and associated overexpression of LM alpha 1 and LM alpha 5 protect tissue from inflammation. But in a mutation setting, the same LM molecules favor progression of IBD into colitis-associated cancer. Our transgenic mice represent attractive new models to acquire knowledge about the paradoxical effect of LM that mediate either tissue reparation or cancer according to the microenvironment. In the early phases of IBD, reinforcing basement membrane stability/ organization could be a promising therapeutic approach.	[Spenle, Caroline; Lefebvre, Olivier; Lacroute, Joel; Arnold, Christiane; Hussenet, Thomas; Kedinger, Michele; Orend, Gertraud; Simon-Assmann, Patricia] MNT3 Team, Inserm U1109, Strasbourg, France; [Spenle, Caroline; Lefebvre, Olivier; Lacroute, Joel; Arnold, Christiane; Hussenet, Thomas; Hemmerle, Joseph; Kedinger, Michele; Orend, Gertraud; Simon-Assmann, Patricia] Univ Strasbourg, Strasbourg, France; [Spenle, Caroline; Lefebvre, Olivier; Arnold, Christiane; Hussenet, Thomas; Orend, Gertraud; Simon-Assmann, Patricia] Univ Strasbourg, LabEx Med, Strasbourg, France; [Spenle, Caroline; Lefebvre, Olivier; Arnold, Christiane; Hussenet, Thomas; Hemmerle, Joseph; Orend, Gertraud; Simon-Assmann, Patricia] FMTS, Strasbourg, France; [Lacroute, Joel; Duclos, Bernard] CHRU Hautepierre, Dept Gastroenterol, Strasbourg, France; [Mechine-Neuville, Agnes] CHRU Hautepierre, Dept Anat & Pathol, Strasbourg, France; [Barreau, Frederick] Inserm U843, Paris, France; [Blottiere, Herve M.] INRA, UMR1319, Jouy En Josas, France; [Blottiere, Herve M.] AgroParisTech, UMR Micalis, Jouy En Josas, France; [Hemmerle, Joseph] Inserm U1121, Strasbourg, France; [Gullberg, Donald] Univ Bergen, Dept Biomed, Bergen, Norway; [Sorokin, Lydia] Univ Munster, Inst Physiol Chem & Pathobiochem, D-48149 Munster, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; CHU Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Bergen; University of Munster	Simon-Assmann, P (corresponding author), MNT3 Team, Inserm U1109, Strasbourg, France.	Patricia.Simon-Assmann@inserm.fr	Spenlé, Caroline/Z-6177-2019; BLOTTIERE, Hervé M/C-6120-2011; Lefebvre, Olivier/I-2388-2016; Lefebvre, Olivier/S-6436-2019; Spenle, Caroline/P-6284-2016; Orend, Gertraud/E-8446-2015; Gullberg, Donald/H-2495-2016	Spenlé, Caroline/0000-0002-6353-3109; BLOTTIERE, Hervé M/0000-0002-8390-0607; Lefebvre, Olivier/0000-0001-9130-9174; Lefebvre, Olivier/0000-0001-9130-9174; Spenle, Caroline/0000-0002-6353-3109; Orend, Gertraud/0000-0003-2522-1195; Gullberg, Donald/0000-0002-7245-4437; Barreau, Frederick/0000-0002-7150-9619; Sorokin, Lydia/0000-0001-7704-7921	Ligue Contre le Cancer; Association pour La Recherche sur le Cancer; Institut National du Cancer; Inserm and the University of Strasbourg; Cells-in-Motion Cluster of Excellence, University of Muenster, Germany; French Ministry of Research and Education	Ligue Contre le Cancer(Ligue nationale contre le cancer); Association pour La Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Institut National du Cancer(Institut National du Cancer (INCA) France); Inserm and the University of Strasbourg; Cells-in-Motion Cluster of Excellence, University of Muenster, Germany; French Ministry of Research and Education	This work has been supported in part by research grants from the Ligue Contre le Cancer (PSA), the Association pour La Recherche sur le Cancer (GO), the Institut National du Cancer (PSA, GO) and by institutional funding from Inserm and the University of Strasbourg. LS is supported by the Cells-in-Motion Cluster of Excellence, University of Muenster, Germany. CS was recipient of fellowships from the French Ministry of Research and Education and the Ligue contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberdam D, 2000, MICROSC RES TECHNIQ, V51, P228, DOI 10.1002/1097-0029(20001101)51:3<228::AID-JEMT3>3.0.CO;2-9; Adair-Kirk TL, 2008, INT J BIOCHEM CELL B, V40, P1101, DOI 10.1016/j.biocel.2007.12.005; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; Behrens DT, 2012, J BIOL CHEM, V287, P18700, DOI 10.1074/jbc.M111.336073; Bouatrouss Y, 2000, AM J PATHOL, V156, P45, DOI 10.1016/S0002-9440(10)64704-9; BRENTNALL TA, 1994, GASTROENTEROLOGY, V107, P369, DOI 10.1016/0016-5085(94)90161-9; Burstein E, 2008, J CLIN INVEST, V118, P464, DOI [10.1172/JC134831, 10.1172/JCI34831]; Cooks T, 2013, CANCER CELL, V23, P634, DOI 10.1016/j.ccr.2013.03.022; De Arcangelis A, 2001, INT J CANCER, V94, P44, DOI 10.1002/ijc.1444; Dieckgraefe BK, 2000, PHYSIOL GENOMICS, V4, P1; Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2; Francoeur C, 2004, AM J PHYSIOL-GASTR L, V287, pG592, DOI 10.1152/ajpgi.00535.2003; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Halfter W, 2013, CELL ADHES MIGR, V7, P64, DOI 10.4161/cam.22479; Herrinton LJ, 2012, GASTROENTEROLOGY, V143, P382, DOI 10.1053/j.gastro.2012.04.054; Holmberg J, 2013, CELL ADHES MIGR, V7, P111, DOI 10.4161/cam.22618; Itzkowitz SH, 2004, GASTROENTEROLOGY, V126, P1634, DOI 10.1053/j.gastro.2004.03.025; Kaci G, 2011, APPL ENVIRON MICROB, V77, P4681, DOI 10.1128/AEM.03021-10; Kaneko Y, 2008, J MOL HISTOL, V39, P161, DOI 10.1007/s10735-007-9149-7; Katz E, 2007, INT J BIOCHEM CELL B, V39, P715, DOI 10.1016/j.biocel.2006.11.004; Kjellev S, 2009, CELL MOL LIFE SCI, V66, P1350, DOI 10.1007/s00018-008-8646-5; Kraus S, 2009, CURR OPIN PHARMACOL, V9, P405, DOI 10.1016/j.coph.2009.06.006; Lange K, 2007, CANCER RES, V67, P6163, DOI 10.1158/0008-5472.CAN-06-3348; Lashner BA, 1999, AM J GASTROENTEROL, V94, P456, DOI 10.1016/S0002-9270(98)00758-8; Leedham SJ, 2009, GASTROENTEROLOGY, V136, P542, DOI 10.1053/j.gastro.2008.10.086; Longman RJ, 2000, GUT, V47, P792, DOI 10.1136/gut.47.6.792; Lotz MM, 1997, AM J PATHOL, V150, P747; Midwood KS, 2009, J CELL COMMUN SIGNAL, V3, P287, DOI 10.1007/s12079-009-0075-1; Neufert C, 2007, NAT PROTOC, V2, P1998, DOI 10.1038/nprot.2007.279; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Orian-Rousseau V, 1998, J CELL SCI, V111, P1993; Piccinni SA, 2004, J BIOL CHEM, V279, P9103, DOI 10.1074/jbc.M305804200; Pinto D, 1999, J BIOL CHEM, V274, P6476, DOI 10.1074/jbc.274.10.6476; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; RIEDL SE, 1992, GASTROENTEROLOGY, V103, P400, DOI 10.1016/0016-5085(92)90827-L; RILEY SA, 1991, GUT, V32, P174, DOI 10.1136/gut.32.2.174; Schmehl K, 2000, INT J COLORECTAL DIS, V15, P39, DOI 10.1007/s003840050006; Schreiber S, 2005, NAT REV GENET, V6, P376, DOI 10.1038/nrg1607; Simon-Assmann P, 2010, PROG MOL BIOL TRANSL, V96, P175, DOI 10.1016/S1877-1173(10)96008-0; Simon-Assmann P, 2013, CELL ADHES MIGR, V7, P44, DOI 10.4161/cam.23276; Soussi T, 2000, ANN NY ACAD SCI, V910, P121; Spenle C, 2012, PATHOL BIOL, V60, P41, DOI 10.1016/j.patbio.2011.10.005; Takeba Y, 2007, J PHARMACOL SCI, V104, P232, DOI 10.1254/jphs.FP0070442; Teller I C, 2001, Expert Rev Mol Med, V3, P1, DOI 10.1017/S1462399401003623; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Thompson AI, 2011, INFLAMM BOWEL DIS, V17, P831, DOI 10.1002/ibd.21375; Turck N, 2005, EXP CELL RES, V303, P494, DOI 10.1016/j.yexcr.2004.10.025; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wong WM, 1999, GUT, V44, P890, DOI 10.1136/gut.44.6.890; WRIGHT NA, 1990, NATURE, V343, P82, DOI 10.1038/343082a0; WRIGHT NA, 1992, SCAND J GASTROENTERO, V27, P76, DOI 10.3109/00365529209096010; Wullaert A, 2011, CELL RES, V21, P146, DOI 10.1038/cr.2010.175; Xie JL, 2008, WORLD J GASTROENTERO, V14, P378, DOI 10.3748/wjg.14.378; Yoshida T, 2003, J PATHOL, V199, P166, DOI 10.1002/path.1264; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695; Yurchenco P.D., 2011, COLD SPRING HARB PER, V3; Yurchenco PD, 2009, CURR PHARM DESIGN, V15, P1277, DOI 10.2174/138161209787846766	57	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111336	10.1371/journal.pone.0111336	http://dx.doi.org/10.1371/journal.pone.0111336			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347196	Green Published, gold, Green Submitted			2022-12-27	WOS:000347994900062
J	Wieske, L; Witteveen, E; Verhamme, C; Dettling-Ihnenfeldt, DS; van der Schaaf, M; Schultz, MJ; van Schaik, IN; Horn, J				Wieske, Luuk; Witteveen, Esther; Verhamme, Camiel; Dettling-Ihnenfeldt, Daniela S.; van der Schaaf, Marike; Schultz, Marcus J.; van Schaik, Ivo N.; Horn, Janneke			Early Prediction of Intensive Care Unit-Acquired Weakness Using Easily Available Parameters: A Prospective Observational Study	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; CRITICAL ILLNESS POLYNEUROPATHY; RISK-FACTORS; INTEROBSERVER AGREEMENT; INTERNAL VALIDATION; MUSCLE STRENGTH; SEVERE SEPSIS; MYOPATHY; MODELS; POLYNEUROMYOPATHY	Introduction: An early diagnosis of Intensive Care Unit-acquired weakness (ICU-AW) using muscle strength assessment is not possible in most critically ill patients. We hypothesized that development of ICU-AW can be predicted reliably two days after ICU admission, using patient characteristics, early available clinical parameters, laboratory results and use of medication as parameters. Methods: Newly admitted ICU patients mechanically ventilated >= 2 days were included in this prospective observational cohort study. Manual muscle strength was measured according to the Medical Research Council (MRC) scale, when patients were awake and attentive. ICU-AW was defined as an average MRC score < 4. A prediction model was developed by selecting predictors from an a-priori defined set of candidate predictors, based on known risk factors. Discriminative performance of the prediction model was evaluated, validated internally and compared to the APACHE IV and SOFA score. Results: Of 212 included patients, 103 developed ICU-AW. Highest lactate levels, treatment with any aminoglycoside in the first two days after admission and age were selected as predictors. The area under the receiver operating characteristic curve of the prediction model was 0.71 after internal validation. The new prediction model improved discrimination compared to the APACHE IV and the SOFA score. Conclusion: The new early prediction model for ICU-AW using a set of 3 easily available parameters has fair discriminative performance. This model needs external validation.	[Wieske, Luuk; Witteveen, Esther; Schultz, Marcus J.; Horn, Janneke] Univ Amsterdam, Acad Med Ctr, Dept Intens Care Med, NL-1105 AZ Amsterdam, Netherlands; [Wieske, Luuk; Verhamme, Camiel; van Schaik, Ivo N.] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands; [Wieske, Luuk; Witteveen, Esther; Schultz, Marcus J.] Univ Amsterdam, Acad Med Ctr, Lab Expt Anesthesiol & Intens Care LEICA, NL-1105 AZ Amsterdam, Netherlands; [Dettling-Ihnenfeldt, Daniela S.; van der Schaaf, Marike] Univ Amsterdam, Acad Med Ctr, Dept Rehabil, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Wieske, L (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Intens Care Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	L.Wieske@amc.uva.nl	Schultz, Marcus/AAB-6379-2021; Wieske, Luuk/AAF-1899-2020; Horn, Janneke/ACB-3607-2022	Schultz, Marcus/0000-0003-3969-7792; Verhamme, Anne/0000-0002-2201-1865	Netherlands Organization for Health Research and Development [40-00703-98-11636]	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development)	The authors received no specific funding for this work. Dr.L. Wieske is supported by a personal grant (ZonMw-AGIKO grant [project number 40-00703-98-11636]) from the Netherlands Organization for Health Research and Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Ali NA, 2008, AM J RESP CRIT CARE, V178, P261, DOI 10.1164/rccm.200712-1829OC; Anastasopoulos D, 2011, CRIT CARE, V15, DOI 10.1186/cc10505; Bednarik J, 2005, J NEUROL, V252, P343, DOI 10.1007/s00415-005-0654-x; Bolton CF, 2005, MUSCLE NERVE, V32, P140, DOI 10.1002/mus.20304; Bossuyt PM, 2003, CROAT MED J, V44, P639; Brunelli A, 2006, J THORAC CARDIOV SUR, V131, P1243, DOI 10.1016/j.jtcvs.2006.02.002; Brunner R, 2013, CRIT CARE, V17, DOI 10.1186/cc13028; Cartwright MS, 2013, MUSCLE NERVE, V47, P255, DOI 10.1002/mus.23525; De Jonghe B, 1998, INTENS CARE MED, V24, P1242, DOI 10.1007/s001340050757; de Letter MACJ, 2001, CRIT CARE MED, V29, P2281, DOI 10.1097/00003246-200112000-00008; Erbas O, 2013, J INVEST SURG, V26, P312, DOI 10.3109/08941939.2013.797056; Erbas O, 2013, J SURG RES, V183, P313, DOI 10.1016/j.jss.2012.11.043; Grimm A, 2013, CRIT CARE, V17, DOI 10.1186/cc13050; Hermans G, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006832.pub3; Heymans MW, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-33; Hough CL, 2011, CRIT CARE, V15, DOI 10.1186/cc10005; Khan J, 2006, NEUROLOGY, V67, P1421, DOI 10.1212/01.wnl.0000239826.63523.8e; Latronico N, 2005, CURR OPIN CRIT CARE, V11, P381, DOI 10.1097/01.ccx.0000168530.30702.3e; Latronico N, 2011, LANCET NEUROL, V10, P931, DOI 10.1016/S1474-4422(11)70178-8; Latronico Nicola, 2009, Crit Care Med, V37, pS316, DOI 10.1097/CCM.0b013e3181b6f9f3; Maramattom BV, 2006, CRIT CARE MED, V34, P2835, DOI 10.1097/01.CCM.0000239436.63452.81; Marshall JC, 2001, CRIT CARE MED, V29, pS99, DOI 10.1097/00003246-200107001-00032; Moons KGM, 2012, HEART, V98, P691, DOI 10.1136/heartjnl-2011-301247; Moons KGM, 2012, HEART, V98, P683, DOI 10.1136/heartjnl-2011-301246; Nanas S, 2008, ACTA NEUROL SCAND, V118, P175, DOI 10.1111/j.1600-0404.2008.00996.x; Novak KR, 2009, J CLIN INVEST, V119, P1150, DOI 10.1172/JCI36570; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Puthucheary Z, 2010, J PHYSIOL-LONDON, V588, P4641, DOI 10.1113/jphysiol.2010.197632; RUFF RL, 1984, J CLIN INVEST, V73, P1483, DOI 10.1172/JCI111352; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Sharshar T, 2009, CRIT CARE MED, V37, P3047, DOI 10.1097/CCM.0b013e3181b027e9; Stevens RD, 2007, INTENS CARE MED, V33, P1876, DOI 10.1007/s00134-007-0772-2; Stevens Robert D, 2009, Crit Care Med, V37, pS299, DOI 10.1097/CCM.0b013e3181b6ef67; Steyerberg EW, 2001, MED DECIS MAKING, V21, P45, DOI 10.1177/0272989X0102100106; Tennila A, 2000, INTENS CARE MED, V26, P1360, DOI 10.1007/s001340000586; Vanpee G, 2014, CRIT CARE MED, V42, P701, DOI 10.1097/CCM.0000000000000030; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Weber-Carstens S, 2010, CRIT CARE, V14, DOI 10.1186/cc9074; Weber-Carstens S, 2009, CRIT CARE MED, V37, P2632, DOI 10.1097/CCM.0b013e3181a92f28	40	18	26	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111259	10.1371/journal.pone.0111259	http://dx.doi.org/10.1371/journal.pone.0111259			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347675	Green Published, gold, Green Submitted			2022-12-27	WOS:000347994900058
J	Caljouw, SR; van Wijck, R				Caljouw, Simone R.; van Wijck, Ruud			Is the Glass Half Full or Half Empty? How to Reverse the Effect of Glass Elongation on the Volume Poured	PLOS ONE			English	Article							CONSUMPTION VOLUME; BEVERAGES; ILLUSION; BIAS	To reduce the volume of drinks and the risk of overconsumption, health professionals recommend the use of tall skinny instead of short wide glasses. Yet the results of the present study contradict this health advice. Participants who generously filled up a glass with lemonade served 9% more in tall narrow compared with short wide glasses (p<0.05). In addition, when pouring a small amount (i.e., a shot), participants poured 3% more in a short wide than in a tall narrow glass (p<0.05). Elongation may bias the perceived volume that is poured but also the perceived volume of the free space in the glass. We hypothesised that shifting attention from the bottom to the brim of the glass when filling it close to capacity might reverse the glass elongation effect on the quantity poured. This hypothesis was tested, by investigating two pouring tasks that differed in the required focus of attention. When the instruction was to match a reference volume, participants poured more liquid in the short wide compared with the tall narrow glass (p<0.05). The effect of glass elongation on poured volume was the opposite when the instruction was to leave space in the glasses for the reference volume. It seems likely that task and individual factors affect the pourer's viewing strategy and thus may determine the direction of the glass elongation effect on the volume poured.	[Caljouw, Simone R.; van Wijck, Ruud] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands	University of Groningen	Caljouw, SR (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.	s.r.caljouw@umcg.nl		Caljouw, Simone R./0000-0002-3004-9900				Duffey KJ, 2007, OBESITY, V15, P2739, DOI 10.1038/oby.2007.326; Eggink W, 2010, NEDERLANDS TIJDSCHRI, V36, P363; Elliott DB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004577; Endler JA, 2010, CURR BIOL, V20, P1679, DOI 10.1016/j.cub.2010.08.033; Godley S, 2004, ERGONOMICS, V47, P237, DOI 10.1080/00140130310001629711; Henrich J, 2010, BEHAV BRAIN SCI, V33, P61, DOI 10.1017/S0140525X0999152X; Krishna A, 2006, J CONSUM RES, V32, P557, DOI 10.1086/500486; Land MF, 2006, PROG RETIN EYE RES, V25, P296, DOI 10.1016/j.preteyeres.2006.01.002; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Milner AD, 2008, NEUROPSYCHOLOGIA, V46, P774, DOI 10.1016/j.neuropsychologia.2007.10.005; Piaget J., 1969, MECHS PERCEPTION; Raghubir P, 1999, J MARKETING RES, V36, P313, DOI 10.2307/3152079; Segall M.H., 1966, INFLUENCE CULTURE VI; van der Kamp J, 2008, PERCEPTION, V37, P951, DOI 10.1068/p6010; van Ittersum K, 2007, J AM DIET ASSOC, V107, P1107, DOI 10.1016/j.jada.2007.05.020; Wansink, 2006, MINDLESS EATING WHY; Wansink B, 2005, BRIT MED J, V331, P1512, DOI 10.1136/bmj.331.7531.1512; Wansink B, 2003, J CONSUM RES, V30, P455, DOI 10.1086/378621; Wansink B, 2004, ANNU REV NUTR, V24, P455, DOI 10.1146/annurev.nutr.24.012003.132140; Winfrey O, 2014, 10 MINUTE MAKEOVER E	20	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e109374	10.1371/journal.pone.0109374	http://dx.doi.org/10.1371/journal.pone.0109374			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BL	25343252	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943500014
J	Dong, Z; Luo, Y; Zhang, ZW; Cai, HS; Li, YB; Chan, T; Wu, L; Li, ZP; Feng, ST				Dong, Zhi; Luo, Yanji; Zhang, Zhongwei; Cai, Huasong; Li, Yanbing; Chan, Tao; Wu, Ling; Li, Zi-Ping; Feng, Shi-Ting			MR Quantification of Total Liver Fat in Patients with Impaired Glucose Tolerance and Healthy Subjects	PLOS ONE			English	Article							NONALCOHOLIC STEATOHEPATITIS; SAMPLING VARIABILITY; HEPATIC STEATOSIS; DISEASE; ADULTS; EPIDEMIOLOGY; SPECTROSCOPY; FIBROSIS	Objective: To explore the correlations between liver fat content and clinical index in patients with impaired glucose tolerance (IGT) and healthy subjects. Materials and Methods: 56 subjects were enrolled and each of them underwent upper-abdominal MRI examination that involved a T1 VIBE Dixon sequence. 14 was clinically diagnosed with IGT (collectively as IGT group) while 42 showed normal glucose tolerance,(collectively as NGT group). NGT group was further divided into NGTFat (BMI >= 25, 18 subjects) and NGTLean (BMI<25, 24 subjects). The total liver fat contents was measured and compared with clinical findings and laboratory results in order to determine statistical correlations between these parameters. Differences among IGT, NGTFat and NGTLean groups were evaluated. Results: For all the subjects, fat volume fractions (FVFs) ranged from 4.2% to 24.2%, positive correlations was observed with BMI, waist hip ratio(WHR), low density lipoprotein(LDL), fasting plasma insulin(FPI), homeostasis model assessment insulin resistance (HOMA-IR) and homeostasis model assessment beta(HOMA beta). FVFs of IGT group (p = 0.004) and NGTFat group (p = 0.006) were significantly higher than those of NGTLean group. Conclusions: People with higher BMI, WHR and LDL levels tend to have higher liver fat content. Patients with BMI >= 25 are more likely to develop IGT. Patients with higher FVF showed higher resistance to insulin, thus obtained a higher risk of developing type 2 diabetes mellitus.	[Dong, Zhi; Luo, Yanji; Cai, Huasong; Li, Zi-Ping; Feng, Shi-Ting] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Radiol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Zhongwei] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Li, Yanbing] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Endocrinol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Yanbing] Sun Yat Sen Univ, Affiliated Hosp 1, Ctr Diabet, Guangzhou 510275, Guangdong, Peoples R China; [Chan, Tao] Union Hosp, Dept Med Imaging, Hong Kong, Hong Kong, Peoples R China	Sun Yat Sen University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Sun Yat Sen University; Sun Yat Sen University	Li, ZP (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Radiol, Guangzhou 510275, Guangdong, Peoples R China.	liziping163@163.com; fst1977@163.com	li, yan/GTI-4638-2022		National Natural Science Foundation of China [81000626]; Natural Science Foundation of Guangdong Province [S2013010016004]; Zhujiang Scientific and Technological New Star Foundation [2012J2200084]; Fundamental Research Funds for the Central Universities [10ykpy11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Zhujiang Scientific and Technological New Star Foundation; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was funded by National Natural Science Foundation of China (81000626), Natural Science Foundation of Guangdong Province (S2013010016004), Zhujiang Scientific and Technological New Star Foundation (2012J2200084), and the Fundamental Research Funds for the Central Universities (10ykpy11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; BACON BR, 1994, GASTROENTEROLOGY, V107, P1103, DOI 10.1016/0016-5085(94)90235-6; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; Bernard CP, 2008, J MAGN RESON IMAGING, V27, P192, DOI 10.1002/jmri.21201; Bydder M, 2008, MAGN RESON IMAGING, V26, P347, DOI 10.1016/j.mri.2007.08.012; Clark JM, 2006, J CLIN GASTROENTEROL, V40, pS5; Cusi K, 2009, CURR OPIN ENDOCRINOL, V16, P141, DOI 10.1097/MED.0b013e3283293015; d'Assignies G, 2009, EUR RADIOL, V19, P2033, DOI 10.1007/s00330-009-1351-4; DIXON WT, 1984, RADIOLOGY, V153, P189, DOI 10.1148/radiology.153.1.6089263; El-Badry AM, 2009, ANN SURG, V250, P691, DOI 10.1097/SLA.0b013e3181bcd6dd; Fernandez-Salazar L, 2011, SCAND J GASTROENTERO, V46, P727, DOI 10.3109/00365521.2011.558112; Guiu B, 2009, RADIOLOGY, V250, P95, DOI 10.1148/radiol.2493080217; Hu HH, 2010, OBESITY, V18, P841, DOI 10.1038/oby.2009.352; Kammen BF, 2001, AM J ROENTGENOL, V177, P1035, DOI 10.2214/ajr.177.5.1771035; Kotronen A, 2009, GASTROENTEROLOGY, V137, P865, DOI 10.1053/j.gastro.2009.06.005; Leporq B, 2013, EUR RADIOL, V23, P2175, DOI 10.1007/s00330-013-2826-x; Ligabue G, 2013, QUANT IMAGING MED SU, V3, P192, DOI 10.3978/j.issn.2223-4292.2013.08.01; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Meisamy S, 2011, RADIOLOGY, V258, P767, DOI 10.1148/radiol.10100708; Monteiro Paula A, 2013, BMC Res Notes, V6, P89, DOI 10.1186/1756-0500-6-89; Petta S, 2012, ALIMENT PHARM THER, V35, P238, DOI 10.1111/j.1365-2036.2011.04929.x; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Reeder SB, 2011, J MAGN RESON IMAGING, V34, P729, DOI 10.1002/jmri.22580; Reeder SB, 2009, J MAGN RESON IMAGING, V29, P1332, DOI 10.1002/jmri.21751; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Wieckowska A, 2007, HEPATOLOGY, V46, P582, DOI 10.1002/hep.21768; Yokoo T, 2011, RADIOLOGY, V258, P749, DOI 10.1148/radiol.10100659; Yokoo T, 2009, RADIOLOGY, V251, P67, DOI 10.1148/radiol.2511080666	28	20	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111283	10.1371/journal.pone.0111283	http://dx.doi.org/10.1371/journal.pone.0111283			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343445	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943500094
J	Goncalves, E; Herrera, I; Duarte, M; Bustamante, RO; Lampo, M; Velasquez, G; Sharma, GP; Garcia-Rangel, S				Goncalves, Estefany; Herrera, Ileana; Duarte, Milen; Bustamante, Ramiro O.; Lampo, Margarita; Velasquez, Grisel; Sharma, Gyan P.; Garcia-Rangel, Shaenandhoa			Global Invasion of Lantana camara : Has the Climatic Niche Been Conserved across Continents?	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; RANGE EXPANSION; EVOLUTION; SHIFTS; PREDICTION; RARE	Lantana camara, a native plant from tropical America, is considered one of the most harmful invasive species worldwide. Several studies have identified potentially invasible areas under scenarios of global change, on the assumption that niche is conserved during the invasion process. Recent studies, however, suggest that many invasive plants do not conserve their niches. Using Principal Components Analyses (PCA), we tested the hypothesis of niche conservatism for L. camara by comparing its native niche in South America with its expressed niche in Africa, Australia and India. Using MaxEnt, the estimated niche for the native region was projected onto each invaded region to generate potential distributions there. Our results demonstrate that while L. camara occupied subsets of its original native niche in Africa and Australia, in India its niche shifted significantly. There, 34% of the occurrences were detected in warmer habitats nonexistent in its native range. The estimated niche for India was also projected onto Africa and Australia to identify other vulnerable areas predicted from the observed niche shift detected in India. As a result, new potentially invasible areas were identified in central Africa and southern Australia. Our findings do not support the hypothesis of niche conservatism for the invasion of L. camara. The mechanisms that allow this species to expand its niche need to be investigated in order to improve our capacity to predict long-term geographic changes in the face of global climatic changes.	[Goncalves, Estefany; Herrera, Ileana; Lampo, Margarita; Velasquez, Grisel] Inst Venezolano Invest Cient, Ctr Ecol, Caracas, Venezuela; [Goncalves, Estefany; Garcia-Rangel, Shaenandhoa] Univ Simon Bolivar, Dept Estudios Ambientales, Caracas, Venezuela; [Duarte, Milen; Bustamante, Ramiro O.] Univ Chile, Fac Ciencias, Dept Cs Ecol, Santiago, Chile; [Duarte, Milen; Bustamante, Ramiro O.] Univ Chile, Fac Ciencias, Inst Ecol & Biodiversidad, Santiago, Chile; [Sharma, Gyan P.] Univ Delhi, Dept Environm Studies, Delhi 110007, India	Venezuelan Institute Science Research; Simon Bolivar University; Universidad de Chile; Universidad de Chile; University of Delhi	Herrera, I (corresponding author), Inst Venezolano Invest Cient, Ctr Ecol, Caracas, Venezuela.	herrera.ita@gmail.com; rbustama@uchile.cl; mlampo@ivic.gob.ve	BUSTAMANTE, RAMIRO/I-7353-2019; Herrera, Ileana/F-8732-2017	Herrera, Ileana/0000-0002-7201-7085; Duarte, Milen/0000-0003-4784-9880; Lampo, Margarita/0000-0002-3669-701X	Instituto Venezolano de Investigaciones Cientificas, Venezuela; Instituto de Ecologia y Biodiversidad-Universidad de Chile, Chile [ICM P05-002]; Centre of Excellence for Invasion Biology (CIB), University of Stellenbosch, South Africa; University of Delhi, India	Instituto Venezolano de Investigaciones Cientificas, Venezuela; Instituto de Ecologia y Biodiversidad-Universidad de Chile, Chile; Centre of Excellence for Invasion Biology (CIB), University of Stellenbosch, South Africa; University of Delhi, India(University of Delhi)	This project received financial support from Instituto Venezolano de Investigaciones Cientificas, Venezuela (to IH); Instituto de Ecologia y Biodiversidad-Universidad de Chile, Chile (project ICM P05-002 to ROB), Centre of Excellence for Invasion Biology (CIB), University of Stellenbosch, South Africa for the Post Doctoral funding (to GPS) and a seed and research grant -University of Delhi, India (to GPS). UniSig-Instituto Venezolano de Investigaciones Cientificas provided the computers used in modeling. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2003, ACIAR MONOGRAPH; [Anonymous], 2011, ECOLOGICAL NICHES GE; Baars JR, 2003, BIOCONTROL, V48, P743, DOI 10.1023/A:1026389207517; BAKER AJ, 1987, EVOLUTION, V41, P525, DOI 10.1111/j.1558-5646.1987.tb05823.x; Bhagwat SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032407; Bradley BA, 2013, BIOL INVASIONS, V15, P1417, DOI 10.1007/s10530-012-0380-0; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; Colwell RK, 2009, P NATL ACAD SCI USA, V106, P19651, DOI 10.1073/pnas.0901650106; De Marco P, 2008, BIOL LETTERS, V4, P577, DOI 10.1098/rsbl.2008.0210; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; EASTEAL S, 1989, BIOL J LINN SOC, V37, P281, DOI 10.1111/j.1095-8312.1989.tb01906.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Ensbey R, 2003, MANAGING LANTANA; Ficetola GF, 2007, DIVERS DISTRIB, V13, P476, DOI 10.1111/j.1472-4642.2007.00377.x; Gallagher RV, 2010, J ECOL, V98, P790, DOI 10.1111/j.1365-2745.2010.01677.x; Gallien L, 2012, GLOBAL ECOL BIOGEOGR, V21, P1126, DOI 10.1111/j.1466-8238.2012.00768.x; GISIN, 2013, GLOB INV SPEC INF NE; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HOLT RD, 1992, EVOL ECOL, V6, P433, DOI 10.1007/BF02270702; HOWARD R A, 1969, Arnoldia (Jamaica Plain), V29, P73; Johnson S, 2008, REV DECLARATION LANT; Lowe S., 2000, ENCY BIOL INVASIONS; Lui XiangRong, 2011, Computational Ecology and Software, V1, P60; Maron JL, 2004, ECOL MONOGR, V74, P261, DOI 10.1890/03-4027; Mukherjee A, 2012, BIOL INVASIONS, V14, P1415, DOI 10.1007/s10530-011-0168-7; Munoz AR, 2006, DIVERS DISTRIB, V12, P656, DOI 10.1111/j.1472-4642.2006.00272.x; Parsons W.T., 2001, NOXIOUS WEEDS AUSTR, Vsecond; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Petitpierre B, 2012, SCIENCE, V335, P1344, DOI 10.1126/science.1215933; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Prinzing A, 2001, P ROY SOC B-BIOL SCI, V268, P2383, DOI 10.1098/rspb.2001.1801; Ray A, 2014, PLANT BIOLOGY, V16, P651, DOI 10.1111/plb.12087; Rouget M, 2004, DIVERS DISTRIB, V10, P475, DOI 10.1111/j.1366-9516.2004.00118.x; Sanders Roger W., 2006, SIDA Contributions to Botany, V22, P381; SANDERS RW, 1987, AM J BOT, V74, P914, DOI 10.2307/2443872; Sharma GR, 2005, WEED BIOL MANAG, V5, P157, DOI 10.1111/j.1445-6664.2005.00178.x; Smith L.S., 1982, QUEENSLAND BOT B, V1, P1; Stirton C. H., 1977, Proceedings of the Second National Weeds Conference of South Africa., P321; Swarbrick J. T., 1995, Plant Protection Quarterly, V10, P82; Taylor S, 2012, WEED RES, V52, P391, DOI 10.1111/j.1365-3180.2012.00930.x; Taylor S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035565; Tingley R, 2014, P NATL ACAD SCI USA, V111, P10233, DOI 10.1073/pnas.1405766111; Van Oosterhout E., 2004, LANTANA CONTROL MANU; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Webber BL, 2012, SCIENCE, V338, DOI 10.1126/science.1225980; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x	51	48	49	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111468	10.1371/journal.pone.0111468	http://dx.doi.org/10.1371/journal.pone.0111468			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343481	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943500101
J	Shen, HS; Hu, YC; Ma, YC; Zhou, X; Xu, ZH; Shui, Y; Li, CY; Xu, P; Sun, XW				Shen, Huaishun; Hu, Yacheng; Ma, Yuanchao; Zhou, Xin; Xu, Zenghong; Shui, Yan; Li, Chunyan; Xu, Peng; Sun, Xiaowen			In-Depth Transcriptome Analysis of the Red Swamp Crayfish Procambarus clarkii	PLOS ONE			English	Article							SPOT SYNDROME VIRUS; VITELLOGENIN GENE; MACROBRACHIUM-ROSENBERGII; SHRIMP VITELLOGENIN; OVARIAN DEVELOPMENT; ERIOCHEIR-SINENSIS; MESSENGER-RNA; EXPRESSION; HEPATOPANCREAS; CRUSTACEAN	The red swamp crayfish Procambarus clarkii is a highly adaptable, tolerant, and fecund freshwater crayfish that inhabits a wide range of aquatic environments. It is an important crustacean model organism that is used in many research fields, including animal behavior, environmental stress and toxicity, and studies of viral infection. Despite its widespread use, knowledge of the crayfish genome is very limited and insufficient for meaningful research. This is the use of next-generation sequencing techniques to analyze the crayfish transcriptome. A total of 324.97 million raw reads of 100 base pairs were generated, and a total of 88,463 transcripts were assembled de novo using Trinity software, producing 55,278 non-redundant transcripts. Comparison of digital gene expression between four different tissues revealed differentially expressed genes, in which more overexpressed genes were found in the hepatopancreas than in other tissues, and more underexpressed genes were found in the testis and the ovary than in other tissues. Gene ontology ( GO) and KEGG enrichment analysis of differentially expressed genes revealed that metabolite- and immune-related pathway genes were enriched in the hepatopancreas, and DNA replication-related pathway genes were enriched in the ovary and the testis, which is consistent with the important role of the hepatopancreas in metabolism, immunity, and the stress response, and with that of the ovary and the testis in reproduction. It was also found that 14 vitellogenin transcripts were highly expressed specifically in the hepatopancreas, and 6 transcripts were highly expressed specifically in the ovary, but no vitellogenin transcripts were highly expressed in both the hepatopancreas and the ovary. These results provide new insight into the role of vitellogenin in crustaceans. In addition, 243,764 SNP sites and 43,205 microsatellite sequences were identified in the sequencing data. We believe that our results provide an important genome resource for the crayfish.	[Shen, Huaishun; Hu, Yacheng; Ma, Yuanchao; Zhou, Xin; Xu, Zenghong; Shui, Yan] Chinese Acad Fishery Sci, Freshwater Fisheries Res Ctr, Key Lab Freshwater Fisheries & Germplasm Resource, Minist Agr, Wuxi, Peoples R China; [Shen, Huaishun; Hu, Yacheng; Ma, Yuanchao] Nanjing Agr Univ, Wuxi Fisheries Coll, Nanjing, Jiangsu, Peoples R China; [Li, Chunyan; Xu, Peng; Sun, Xiaowen] Chinese Acad Fishery Sci, Ctr Appl Aquat Genom, Beijing, Peoples R China	Chinese Academy of Fishery Sciences; Freshwater Fisheries Research Center, CAFS; Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Chinese Academy of Fishery Sciences	Shen, HS (corresponding author), Chinese Acad Fishery Sci, Freshwater Fisheries Res Ctr, Key Lab Freshwater Fisheries & Germplasm Resource, Minist Agr, Wuxi, Peoples R China.	shenhs@ffrc.cn; zhoux@ffrc.cn	Shen, Huaishun/K-4100-2019; Xu, Peng/J-4018-2012	Xu, Peng/0000-0002-1531-5078	Science & Technology Pillar Program of Jiangsu Province [BE2013316]; Natural Science Foundation of Jiangsu Province [BK2012534]	Science & Technology Pillar Program of Jiangsu Province; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work is supported by the Science & Technology Pillar Program of Jiangsu Province (BE2013316) (http://www.jskjjh.gov.cn/13kjskj2/) and the Natural Science Foundation of Jiangsu Province (BK2012534) (http://www.jskjjh.gov.cn/13kjskj2/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Kaddissi S, 2012, ECOTOX ENVIRON SAFE, V80, P266, DOI 10.1016/j.ecoenv.2012.03.010; Al Kaddissi S, 2012, ECOTOX ENVIRON SAFE, V78, P218, DOI 10.1016/j.ecoenv.2011.11.026; AMEYAWAKUMFI C, 1975, SCIENCE, V190, P1225, DOI 10.1126/science.1198111; Araki M, 2013, J EXP BIOL, V216, P681, DOI 10.1242/jeb.075689; Banci Karina R.S., 2013, Herpetology Notes, V6, P339; Barbee GC, 2010, PEST MANAG SCI, V66, P996, DOI 10.1002/ps.1972; Belfiore NM, 2000, MOL ECOL, V9, P2231, DOI 10.1046/j.1365-294X.2000.105339.x; Bonvillain CP, 2012, COMP BIOCHEM PHYS A, V163, P15, DOI 10.1016/j.cbpa.2012.04.015; Buscaino G, 2012, J ACOUST SOC AM, V132, P1792, DOI 10.1121/1.4742744; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Celi M, 2013, J EXP BIOL, V216, P709, DOI 10.1242/jeb.078865; Chen AJ, 2013, J VIROL, V87, P636, DOI 10.1128/JVI.01671-12; Chen XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073218; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cruz MJ, 2007, HYDROBIOLOGIA, V575, P191, DOI 10.1007/s10750-006-0376-9; Du HH, 2013, FISH SHELLFISH IMMUN, V34, P332, DOI 10.1016/j.fsi.2012.11.007; El-Din Abdel-Hakim S, 2013, J Egypt Soc Parasitol, V43, P71; Erlich Y, 2008, NAT METHODS, V5, P679, DOI 10.1038/nmeth.1230; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Ferre LE, 2012, REV BIOL TROP, V60, P253; Gherardi F, 2006, MAR FRESHW BEHAV PHY, V39, P175, DOI 10.1080/10236240600869702; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; He L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033735, 10.1371/journal.pone.0045607]; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Jia XW, 2013, GENE, V520, P119, DOI 10.1016/j.gene.2013.02.035; Kawahara-Miki R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026043; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lemgruber Rde S, 2013, PLOS ONE, V8; LEUNG TS, 1980, B ENVIRON CONTAM TOX, V25, P465, DOI 10.1007/BF01985555; Li CZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047442; Li EC, 2014, PHYSIOL GENOMICS, V46, P177, DOI 10.1152/physiolgenomics.00191.2013; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li K, 2006, COMP BIOCHEM PHYS B, V143, P453, DOI 10.1016/j.cbpb.2005.12.019; Li SH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058627, 10.1371/journal.pone.0076131]; Li XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068233; Li YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040652; Lin LJ, 2013, COMP BIOCHEM PHYS A, V164, P327, DOI 10.1016/j.cbpa.2012.11.009; Lv JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094055; Ma KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039727; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mohd-Shamsudin MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060839; Nagaraju GPC, 2007, AQUACULTURE, V272, P39, DOI 10.1016/j.aquaculture.2007.05.014; Nagaraju GPC, 2011, J EXP BIOL, V214, P3, DOI 10.1242/jeb.047183; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Phiriyangkul P, 2007, MOL REPROD DEV, V74, P1198, DOI 10.1002/mrd.20629; QUELLER DC, 1993, TRENDS ECOL EVOL, V8, P285, DOI 10.1016/0169-5347(93)90256-O; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Revathi Peranandam, 2012, International Journal of Aquatic Science, V3, P13; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Roth Z, 2012, MOL REPROD DEV, V79, P478, DOI 10.1002/mrd.22055; Rottensteiner H, 2006, BBA-MOL CELL RES, V1763, P1527, DOI 10.1016/j.bbamcr.2006.08.012; Sookruksawong S, 2013, DEV COMP IMMUNOL, V41, P523, DOI 10.1016/j.dci.2013.07.020; Tan Shu-hua, 2012, Yingyong Shengtai Xuebao, V23, P2595; Tattersall GJ, 2012, J EXP BIOL, V215, P1892, DOI 10.1242/jeb.065946; Tierney AJ, 2013, BEHAV PROCESSES; Tiu SHK, 2008, BIOL REPROD, V79, P66, DOI 10.1095/biolreprod.107.066258; Tiu SHK, 2006, MOL REPROD DEV, V73, P424, DOI 10.1002/mrd.20433; Tokishita S, 2006, BIOCHEM BIOPH RES CO, V345, P362, DOI 10.1016/j.bbrc.2006.04.102; Tomina Y, 2013, BEHAV BRAIN RES, V249, P90, DOI 10.1016/j.bbr.2013.04.029; Tsang WS, 2003, GENE, V303, P99, DOI 10.1016/S0378-1119(02)01139-3; Wang W, 2005, FEMS MICROBIOL LETT, V249, P131, DOI 10.1016/j.femsle.2005.06.005; Wang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084921; Wu P, 2009, COMP BIOCHEM PHYS D, V4, P111, DOI 10.1016/j.cbd.2008.12.004; Wu XG, 2012, DIS AQUAT ORGAN, V102, P13, DOI 10.3354/dao02532; Yue GH, 2008, INT J BIOL SCI, V4, P279; Yue GH, 2010, INT J BIOL SCI, V6, P107; Zeng DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057515; Zmora N, 2007, BIOL REPROD, V77, P138, DOI 10.1095/biolreprod.106.055483	71	54	56	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110548	10.1371/journal.pone.0110548	http://dx.doi.org/10.1371/journal.pone.0110548			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338101	gold, Green Published, Green Submitted			2022-12-27	WOS:000343674800055
J	Wang, SP; Geng, ZR; Shi, N; Li, XL; Wang, ZL				Wang, Shuping; Geng, Zhirong; Shi, Nan; Li, Xiangli; Wang, Zhilin			The Functions of Crucial Cysteine Residues in the Arsenite Methylation Catalyzed by Recombinant Human Arsenic (III) Methyltransferase	PLOS ONE			English	Article							OXIDATION-STATE METHYLTRANSFERASE; S-ADENOSYLMETHIONINE METHYLTRANSFERASE; TRIVALENT ARSENICALS; PROTEIN FUNCTION; SERUM-ALBUMIN; BINDING; CARCINOGENESIS; IDENTIFICATION; FLUORESCENCE; GLUTATHIONE	Arsenic (III) methyltransferase (AS3MT) is a cysteine (Cys)-rich enzyme that catalyzes the biomethylation of arsenic. To investigate how these crucial Cys residues promote catalysis, we used matrix-assisted laser desorption ionization-time of flight-mass spectrometry (MALDI-TOF-MS) to analyze Cys residues in recombinant human arsenic (III) methyltransferase (hAS3MT). We detected two disulfide bonds, Cys250-Cys32 and Cys368-Cys369, in hAS3MT. The Cys250-Cys32 disulfide bond was reduced by glutathione (GSH) or other disulfide bond reductants before the enzymatic methylation of arsenite (iAs(3+)). In addition to exposing residues around the active sites, cleavage of the Cys250-Cys32 pair modulated the conformation of hAS3MT. This adjustment may stabilize the binding of S-Adenosyl-L-methionine (AdoMet) and favor iAs(3+) binding to hAS3MT. Additionally, we observed the intermediate of Cys250-S-adenosylhomocysteine (AdoHcy), suggesting that Cys250 is involved in the transmethylation. In recovery experiments, we confirmed that trivalent arsenicals were substrates for hAS3MT, methylation of arsenic occurred on the enzyme, and an intramolecular disulfide bond might be formed after iAs(3+) was methylated to dimethylarsinous acid (DMA(3+)). In this work, we clarified both the functional roles of GSH and the crucial Cys residues in iAs(3+) methylation catalyzed by hAS3MT.	[Wang, Shuping; Geng, Zhirong; Shi, Nan; Li, Xiangli; Wang, Zhilin] Nanjing Univ, Sch Chem & Chem Engn, State Key Lab Coordinat Chem, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University	Geng, ZR (corresponding author), Nanjing Univ, Sch Chem & Chem Engn, State Key Lab Coordinat Chem, Nanjing 210008, Jiangsu, Peoples R China.	gengzr@nju.edu.cn; wangzl@nju.edu.cn	Geng, Zhirong/HGC-1447-2022	Geng, Zhirong/0000-0003-3766-9034	National Basic Research Program of China [2013CB922102]; National Natural Science Foundation of China [21275072, 21201101]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Basic Research Program of China (2013CB922102) and the National Natural Science Foundation of China (21275072 and 21201101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajees AA, 2012, BIOCHEMISTRY-US, V51, P5476, DOI 10.1021/bi3004632; Beeby M, 2005, PLOS BIOL, V3, P1549, DOI 10.1371/journal.pbio.0030309; Bi SY, 2005, SPECTROCHIM ACTA A, V61, P629, DOI 10.1016/j.saa.2004.05.028; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN CJ, 1992, BRIT J CANCER, V66, P888, DOI 10.1038/bjc.1992.380; CHEN CJ, 1995, HYPERTENSION, V25, P53, DOI 10.1161/01.HYP.25.1.53; Cui FL, 2008, PESTIC BIOCHEM PHYS, V90, P126, DOI 10.1016/j.pestbp.2007.11.002; Cui X, 2008, CURR MED CHEM, V15, P2293, DOI 10.2174/092986708785747526; Cullen W.R., 2014, CHEM RES TOXICOL, V176, P127; CULLEN WR, 1984, J INORG BIOCHEM, V21, P179, DOI 10.1016/0162-0134(84)83002-0; Ding L, 2012, TOXICOL APPL PHARM, V264, P121, DOI 10.1016/j.taap.2012.07.024; Domon B, 2006, SCIENCE, V312, P212, DOI 10.1126/science.1124619; Douer D, 2005, J CLIN ONCOL, V23, P2396, DOI 10.1200/JCO.2005.10.217; Fomenko DE, 2007, SCIENCE, V315, P387, DOI 10.1126/science.1133114; Geng ZR, 2009, J BIOL INORG CHEM, V14, P485, DOI 10.1007/s00775-008-0464-6; Giles NM, 2003, CHEM BIOL, V10, P677, DOI 10.1016/S1074-5521(03)00174-1; Hayakawa T, 2005, ARCH TOXICOL, V79, P183, DOI 10.1007/s00204-004-0620-x; Hogg PJ, 2003, TRENDS BIOCHEM SCI, V28, P210, DOI 10.1016/S0968-0004(03)00057-4; Kitchin KT, 2008, J INORG BIOCHEM, V102, P532, DOI 10.1016/j.jinorgbio.2007.10.021; Lee CJ, 2004, NAT STRUCT MOL BIOL, V11, P1179, DOI 10.1038/nsmb856; Li JX, 2005, TOXICOL APPL PHARM, V204, P164, DOI 10.1016/j.taap.2004.12.002; Li XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084231; Li XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076709; Li XL, 2013, FEBS LETT, V587, P2232, DOI 10.1016/j.febslet.2013.05.052; Marapakala K, 2012, BIOCHEMISTRY-US, V51, P944, DOI 10.1021/bi201500c; Nagahara N, 2011, AMINO ACIDS, V41, P59, DOI 10.1007/s00726-010-0508-4; Nakanishi T, 2005, J PROTEOME RES, V4, P743, DOI 10.1021/pr0497834; Naranmandura H, 2006, CHEM RES TOXICOL, V19, P1010, DOI 10.1021/tx060053f; Song XL, 2011, BIOCHIMIE, V93, P369, DOI 10.1016/j.biochi.2010.10.010; Song XL, 2010, BIOCHIMIE, V92, P1397, DOI 10.1016/j.biochi.2010.07.002; Song XL, 2009, CHEM-BIOL INTERACT, V179, P321, DOI 10.1016/j.cbi.2008.12.018; Suzuki KT, 2007, TOXICOL APPL PHARM, V218, P166, DOI 10.1016/j.taap.2006.10.027; Tapio S, 2006, MUTAT RES-REV MUTAT, V612, P215, DOI 10.1016/j.mrrev.2006.02.001; Thomas DJ, 2007, TOXICOL APPL PHARM, V222, P365, DOI 10.1016/j.taap.2007.02.007; Thomas DJ, 2010, TOXICOL SCI, V113, P70, DOI 10.1093/toxsci/kfp250; Thomas DJ, 2009, TOXICOL SCI, V107, P309, DOI 10.1093/toxsci/kfn257; Thomas DJ, 2004, TOXICOL APPL PHARM, V198, P319, DOI 10.1016/j.taap.2003.10.020; Watanabe T, 2013, ARCH TOXICOL, V87, P969, DOI 10.1007/s00204-012-0904-5; YANG JT, 1986, METHOD ENZYMOL, V130, P208; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424; Zhang YZ, 2008, J FLUORESC, V18, P109, DOI 10.1007/s10895-007-0247-4	41	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110924	10.1371/journal.pone.0110924	http://dx.doi.org/10.1371/journal.pone.0110924			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25349987	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943100048
J	de la Iglesia, D; Garcia-Remesal, M; Anguita, A; Munoz-Marmol, M; Kulikowski, C; Maojo, V				de la Iglesia, Diana; Garcia-Remesal, Miguel; Anguita, Alberto; Munoz-Marmol, Miguel; Kulikowski, Casimir; Maojo, Victor			A Machine Learning Approach to Identify Clinical Trials Involving Nanodrugs and Nanodevices from ClinicalTrials.gov	PLOS ONE			English	Article							REGISTRATION; NANOINFORMATICS; ALGORITHM; DRUG; CLASSIFICATION; DATABASE; LASSO; STATE; NEED; SIZE	Background: Clinical Trials (CTs) are essential for bridging the gap between experimental research on new drugs and their clinical application. Just like CTs for traditional drugs and biologics have helped accelerate the translation of biomedical findings into medical practice, CTs for nanodrugs and nanodevices could advance novel nanomaterials as agents for diagnosis and therapy. Although there is publicly available information about nanomedicine-related CTs, the online archiving of this information is carried out without adhering to criteria that discriminate between studies involving nanomaterials or nanotechnology-based processes (nano), and CTs that do not involve nanotechnology (non-nano). Finding out whether nanodrugs and nanodevices were involved in a study from CT summaries alone is a challenging task. At the time of writing, CTs archived in the well-known online registry ClinicalTrials.gov are not easily told apart as to whether they are nano or non-nano CTs-even when performed by domain experts, due to the lack of both a common definition for nanotechnology and of standards for reporting nanomedical experiments and results. Methods: We propose a supervised learning approach for classifying CT summaries from ClinicalTrials.gov according to whether they fall into the nano or the non-nano categories. Our method involves several stages: i) extraction and manual annotation of CTs as nano vs. non-nano, ii) pre-processing and automatic classification, and iii) performance evaluation using several state-of-the-art classifiers under different transformations of the original dataset. Results and Conclusions: The performance of the best automated classifier closely matches that of experts (AUC over 0.95), suggesting that it is feasible to automatically detect the presence of nanotechnology products in CT summaries with a high degree of accuracy. This can significantly speed up the process of finding whether reports on ClinicalTrials.gov might be relevant to a particular nanoparticle or nanodevice, which is essential to discover any precedents for nanotoxicity events or advantages for targeted drug therapy.	[de la Iglesia, Diana; Garcia-Remesal, Miguel; Anguita, Alberto; Munoz-Marmol, Miguel; Maojo, Victor] Univ Politecn Madrid, Escuela Tecn Super Ingenieros Informat, Dept Inteligencia Artificial, Biomed Informat Grp, Madrid, Spain; [Kulikowski, Casimir] Rutgers State Univ, Dept Comp Sci, Piscataway, NJ USA	Universidad Politecnica de Madrid; Rutgers State University New Brunswick	de la Iglesia, D (corresponding author), Univ Politecn Madrid, Escuela Tecn Super Ingenieros Informat, Dept Inteligencia Artificial, Biomed Informat Grp, Madrid, Spain.	diglesia@infomed.dia.fi.upm.es	Garcia-Remesal, Miguel/ABG-6470-2020		European Commission; Spanish Ministry of Economy and Competitiveness [FIS/AES PS09/00069]; Consejo Social of the Universidad Politecnica de Madrid	European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Ministry of Economy and Competitiveness(Spanish Government); Consejo Social of the Universidad Politecnica de Madrid	This work has been partially funded by the European Commission (p-medicine FP7-ICT-270089, EURECA FP7-ICT-288048), the Spanish Ministry of Economy and Competitiveness (FIS/AES PS09/00069) and the Consejo Social of the Universidad Politecnica de Madrid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, PLoS Med, V1, pe46; Bach FR, 2008, J MACH LEARN RES, V9, P1179; Baker JR, 2011, WIRES NANOMED NANOBI, V3, P341, DOI 10.1002/wnan.141; Baker NA, 2013, NAT NANOTECHNOL, V8, P73, DOI 10.1038/nnano.2013.12; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Bawa R, 2007, NANOMEDICINE-UK, V2, P351, DOI 10.2217/17435889.2.3.351; Bawarski WE, 2008, NANOMED-NANOTECHNOL, V4, P273, DOI 10.1016/j.nano.2008.06.002; Bird S., 2009, NATURAL LANGUAGE PRO; Bottou L, 2010, COMPSTAT'2010: 19TH INTERNATIONAL CONFERENCE ON COMPUTATIONAL STATISTICS, P177, DOI 10.1007/978-3-7908-2604-3_16; Bourgeois FT, 2010, ANN INTERN MED, V153, P158, DOI 10.7326/0003-4819-153-3-201008030-00006; Cancedda N, 2003, J MACH LEARN RES, V3, P1059, DOI 10.1162/153244303322533197; Candes EJ, 2009, ANN STAT, V37, P2145, DOI 10.1214/08-AOS653; Carroll RJ, 2012, J AM MED INFORM ASSN, V19, pE162, DOI 10.1136/amiajnl-2011-000583; Cepeda MS, 2013, CLIN TRIALS, V10, P347, DOI 10.1177/1740774513475849; Chan AW, 2008, PLOS MED, V5, P1533, DOI 10.1371/journal.pmed.0050230; Chen CY, 2012, RECENT PAT NANOTECH, V6, P114, DOI 10.2174/187221012800270144; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Covitz PA, 2003, BIOINFORMATICS, V19, P2404, DOI 10.1093/bioinformatics/btg335; de la Iglesia D, 2011, METHOD INFORM MED, V50, P84, DOI 10.3414/ME10-02-0012; de la lglesia D., 2013, COMPUT SCI DISCOV, V6, DOI [10.1088/1749-4699/6/1/014011., DOI 10.1088/1749-4699/6/1/014011]; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; Etheridge ML, 2013, NANOMED-NANOTECHNOL, V9, P1, DOI 10.1016/j.nano.2012.05.013; European Commission, 2010, DRAFT COMM REC DEF T; European Commission - Directorate General for Health & Consumers, 2010, SCI BAS DEF TERM NAN; European Commission - Joint Research Centre, 2010, CONS DEF NAN REG PUR; Evans T, 2004, LANCET, V363, P1413, DOI 10.1016/S0140-6736(04)16136-9; Fadeel B, 2010, J INTERN MED, V267, P2, DOI 10.1111/j.1365-2796.2009.02186.x; Fischer HC, 2007, CURR OPIN BIOTECH, V18, P565, DOI 10.1016/j.copbio.2007.11.008; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Fukunaga K., 1972, INTRO STAT PATTERN R, V2nd; Gabizon AA, 2001, CANCER INVEST, V19, P424, DOI 10.1081/CNV-100103136; Garcia-Remesal M, 2013, BIOMED RES INT, V2013; Garla V, 2013, J BIOMED INFORM, V46, P869, DOI 10.1016/j.jbi.2013.06.014; Green DM, 1966, SIGNAL DETECTION THE; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Hahn U, 2012, BRIEF BIOINFORM, V13, P460, DOI 10.1093/bib/bbs018; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Horton R, 1999, LANCET, V354, P1138, DOI 10.1016/S0140-6736(99)00328-1; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; International Organization for Standardization, 2010, 8000412010 ISOTS; Joachims T., 2002, SPRINGER INT SERIES, V668; Joachims T., 1998, EUROPEAN C MACHINE L, V1398, P137, DOI [DOI 10.1007/BFB0026683, 10.1007/BFb0026683]; Jones DE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083932; Karve S, 2012, P NATL ACAD SCI USA, V109, P8230, DOI 10.1073/pnas.1120508109; Keerthi SS, 2001, NEURAL COMPUT, V13, P637, DOI 10.1162/089976601300014493; Kibriya AM, 2004, LECT NOTES ARTIF INT, V3339, P488; Kirillova O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037847; Krall R, 2005, BMJ-BRIT MED J, V330, P479, DOI 10.1136/bmj.330.7489.479-b; Krleza-Jeric K, 2005, PLOS MED, V2, P1093, DOI 10.1371/journal.pmed.0020378; LACHENBRUCH PA, 1968, BIOMETRICS, V24, P823, DOI 10.2307/2528873; Lasko TA, 2005, J BIOMED INFORM, V38, P404, DOI 10.1016/j.jbi.2005.02.008; LECESSIE S, 1992, APPL STAT-J ROY ST C, V41, P191; Li ZH, 2009, CHEM MATER, V21, P5578, DOI 10.1021/cm9020673; Lin C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056499, 10.1371/journal.pone.0080883, 10.1371/journal.pone.0065734, 10.1371/journal.pone.0070187]; Luo L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082119; Maojo V, 2012, INT J NANOMED, V7, P3867, DOI 10.2147/IJN.S24582; Maojo V, 2012, COMPUTING, V94, P521, DOI 10.1007/s00607-012-0191-2; Maojo V, 2010, PEDIATR RES, V67, P481, DOI 10.1203/PDR.0b013e3181d6245e; Marshall MJ, 2012, MICROSC MICROANAL, V18, P844; Moon Sungrim, 2012, AMIA Annu Symp Proc, V2012, P1310; National Nanotechnology Initiative, 2007, WHAT IS NAN; Ostraat M, 2012, NANOTECHNOLOGY 2012, VOL 3: BIO SENSORS, INSTRUMENTS, MEDICAL, ENVIRONMENT AND ENERGY, P273; Platt J, 1998, ADV KERNEL METHODS S, V185, P208; PORTER MF, 1980, PROGRAM-AUTOM LIBR, V14, P130, DOI 10.1108/eb046814; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Rennie J.D., 2003, P 20 INT C MACH LEAR, DOI 10.5555/3041838.3041916; Roco MC, 2000, NANOTECHNOLOGY RES D, P153; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; SALTON G, 1988, INFORM PROCESS MANAG, V24, P513, DOI 10.1016/0306-4573(88)90021-0; Salton G, 1983, INTRO MODERN INFORM; Scalf K, 2009, INTRO NANOPART UNPUB; SIMES RJ, 1986, J CLIN ONCOL, V4, P1529, DOI 10.1200/JCO.1986.4.10.1529; Slomkowski S, 2011, PURE APPL CHEM, V83, P2229, DOI 10.1351/PAC-REC-10-06-03; Tahan C, 2007, ADV COMPUT, V71, P251, DOI 10.1016/S0065-2458(06)71005-1; Tasneem A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033677; Theis T, 2006, NAT NANOTECHNOL, V1, P8, DOI 10.1038/nnano.2006.77; Thomas DG, 2011, WIRES NANOMED NANOBI, V3, P511, DOI 10.1002/wnan.152; Thomas DG, 2011, J BIOMED INFORM, V44, P59, DOI 10.1016/j.jbi.2010.03.001; Tibshirani RJ, 2013, ELECTRON J STAT, V7, P1456, DOI 10.1214/13-EJS815; U.S. FDA, 2011, CONS WHETH FDA REG P; Wang RB, 2013, J NANOMATER, V2013, DOI 10.1155/2013/629681; Waterhouse Dawn N., 2001, Drug Safety, V24, P903, DOI 10.2165/00002018-200124120-00004; Watson Rory, 2006, BMJ, V332, P1232, DOI 10.1136/bmj.332.7552.1232-c; Whitesides GM, 2003, NAT BIOTECHNOL, V21, P1161, DOI 10.1038/nbt872; Witten I. H., 2005, MORGAN KAUFMANN SERI; Wood AJJ, 2009, NEW ENGL J MED, V360, P824, DOI 10.1056/NEJMsr0806582; Zarin DA, 2008, SCIENCE, V319, P1340, DOI 10.1126/science.1153632; Zarin DA, 2011, NEW ENGL J MED, V364, P852, DOI 10.1056/NEJMsa1012065	89	7	7	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e110331	10.1371/journal.pone.0110331	http://dx.doi.org/10.1371/journal.pone.0110331			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347075	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000347994900021
J	Lv, MY; Wang, JW; Zhang, JY; Zhang, B; Wang, XD; Zhu, YZ; Zuo, T; Liu, DL; Li, XJ; Wu, JX; Zhang, HH; Yu, B; Wu, H; Zhao, XH; Kong, W; Yu, XH				Lv, Mingyu; Wang, Jiawen; Zhang, Jingyao; Zhang, Biao; Wang, Xiaodan; Zhu, Yingzi; Zuo, Tao; Liu, Donglai; Li, Xiaojun; Wu, Jiaxin; Zhang, Haihong; Yu, Bin; Wu, Hui; Zhao, Xinghong; Kong, Wei; Yu, Xianghui			Epitope Tags beside the N-Terminal Cytoplasmic Tail of Human BST-2 Alter Its Intracellular Trafficking and HIV-1 Restriction	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; INHIBITS HIV-1; VPU PROTEIN; ENVELOPE GLYCOPROTEIN; KAPPA-B; MEMBRANE-PROTEIN; PARTICLE RELEASE; FACTOR SAMHD1; HOST-CELL; TETHERIN	BST-2 blocks the particle release of various enveloped viruses including HIV-1, and this antiviral activity is dependent on the topological arrangement of its four structural domains. Several functions of the cytoplasmic tail (CT) of BST-2 have been previously discussed, but the exact role of this domain remains to be clearly defined. In this study, we investigated the impact of truncation and commonly-used tags addition into the CT region of human BST-2 on its intracellular trafficking and signaling as well as its anti-HIV-1 function. The CT-truncated BST-2 exhibited potent inhibition on Vpu-defective HIV-1 and even wild-type HIV-1. However, the N-terminal HA-tagged CT-truncated BST-2 retained little antiviral activity and dramatically differed from its original protein in the cell surface level and intracellular localization. Further, we showed that the replacement of the CT domain with a hydrophobic tag altered BST-2 function possibly by preventing its normal vesicular trafficking. Notably, we demonstrated that a positive charged motif "KRXK'' in the conjunctive region between the cytotail and the transmembrane domain which is conserved in primate BST-2 is important for the protein trafficking and the antiviral function. These results suggest that although the CT of BST-2 is not essential for its antiviral activity, the composition of residues in this region may play important roles in its normal trafficking which subsequently affected its function. These observations provide additional implications for the structure-function model of BST-2.	[Lv, Mingyu; Wang, Jiawen; Zhang, Jingyao; Wang, Xiaodan; Zhu, Yingzi; Zuo, Tao; Liu, Donglai; Li, Xiaojun; Wu, Jiaxin; Zhang, Haihong; Yu, Bin; Wu, Hui; Zhao, Xinghong; Kong, Wei; Yu, Xianghui] Jilin Univ, Sch Life Sci, Natl Engn Lab AIDS Vaccine, Changchun 130023, Peoples R China; [Wang, Jiawen] Changchun Univ Chinese Med, Ctr New Med Res, Changchun, Peoples R China; [Zhang, Biao] Jilin Univ, Sch Pharmaceut Sci, Changchun 130023, Peoples R China	Jilin University; Changchun University of Chinese Medicine; Jilin University	Kong, W (corresponding author), Jilin Univ, Sch Life Sci, Natl Engn Lab AIDS Vaccine, Changchun 130023, Peoples R China.	weikong@jlu.edu.cn; xianghui@jlu.edu.cn	Wu, Jiaxin/GVT-3486-2022		National Natural Science Foundation of China: NSFC [31270807]; NSFC-NIH [812111027]; Jilin University [20121054]	National Natural Science Foundation of China: NSFC(National Natural Science Foundation of China (NSFC)); NSFC-NIH; Jilin University(Jilin University)	This work was supported by grants from the National Natural Science Foundation of China: NSFC Project (31270807) of XY, NSFC-NIH International Project (812111027) of XY and Graduate Innovation Fund of Jilin University (20121054) of J. Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2012, J BIOL CHEM, V287, P12550, DOI 10.1074/jbc.M112.340711; Arnaud F, 2010, J VIROL, V84, P4415, DOI 10.1128/JVI.00029-10; Billcliff PG, 2013, BIOL OPEN, V2, P1253, DOI 10.1242/bio.20135793; Celestino M, 2012, J VIROL, V86, P6688, DOI 10.1128/JVI.07037-11; Cocka LJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002931; Douglas JL, 2009, J VIROL, V83, P7931, DOI 10.1128/JVI.00242-09; Dube M, 2009, J VIROL, V83, P4574, DOI 10.1128/JVI.01800-08; Freed EO, 2004, TRENDS MICROBIOL, V12, P170, DOI 10.1016/j.tim.2004.02.001; Fukuma A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018247; Galao RP, 2012, CELL HOST MICROBE, V12, P633, DOI 10.1016/j.chom.2012.10.007; Goff SP, 2007, NAT REV MICROBIOL, V5, P253, DOI 10.1038/nrmicro1541; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Gupta RK, 2009, P NATL ACAD SCI USA, V106, P20889, DOI 10.1073/pnas.0907075106; Gustin JK, 2012, J BIOL CHEM, V287, P14837, DOI 10.1074/jbc.M112.349928; Hauser H, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-85; Hinz A, 2010, CELL HOST MICROBE, V7, P314, DOI 10.1016/j.chom.2010.03.005; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; HUET T, 1990, NATURE, V345, P356, DOI 10.1038/345356a0; Huthoff H, 2008, TRENDS MICROBIOL, V16, P612, DOI 10.1016/j.tim.2008.08.013; Iwabu Y, 2009, J BIOL CHEM, V284, P35060, DOI 10.1074/jbc.M109.058305; Jia B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000429; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Kaletsky RL, 2009, P NATL ACAD SCI USA, V106, P2886, DOI 10.1073/pnas.0811014106; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Le Tortorec A, 2009, J VIROL, V83, P11966, DOI 10.1128/JVI.01515-09; Lim ES, 2010, J VIROL, V84, P7124, DOI 10.1128/JVI.00468-10; Lv MY, 2013, PROTEIN EXPRES PURIF, V91, P112, DOI 10.1016/j.pep.2013.07.015; Lv MY, 2013, FEBS LETT, V587, P37, DOI 10.1016/j.febslet.2012.11.022; Lv MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020890; MALDARELLI F, 1993, J VIROL, V67, P5056, DOI 10.1128/JVI.67.8.5056-5061.1993; Mangeat B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000574; Masuyama N, 2009, J BIOL CHEM, V284, P15927, DOI 10.1074/jbc.M109.005124; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Mattiuzzo G, 2010, J VIROL, V84, P2618, DOI 10.1128/JVI.01928-09; Miyakawa K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000700; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neil SJD, 2007, CELL HOST MICROBE, V2, P193, DOI 10.1016/j.chom.2007.08.001; Ohno H, 1997, VIROLOGY, V238, P305, DOI 10.1006/viro.1997.8839; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Sakuma T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006934; Sakuma T, 2009, J VIROL, V83, P2382, DOI 10.1128/JVI.01607-08; Schubert HL, 2010, P NATL ACAD SCI USA, V107, P17951, DOI 10.1073/pnas.1008206107; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; STREBEL K, 1988, SCIENCE, V241, P1221, DOI 10.1126/science.3261888; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Swiecki M, 2011, J BIOL CHEM, V286, P2987, DOI 10.1074/jbc.M110.190538; Tirabassi RS, 1999, J VIROL, V73, P2717, DOI 10.1128/JVI.73.4.2717-2728.1999; Tokarev A, 2013, J VIROL, V87, P2046, DOI 10.1128/JVI.02272-12; Tokarev AA, 2011, J VIROL, V85, P51, DOI 10.1128/JVI.01795-10; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Wang JW, 2011, J VIROL, V85, P12482, DOI 10.1128/JVI.05218-11; Yang HT, 2010, P NATL ACAD SCI USA, V107, P18428, DOI 10.1073/pnas.1011485107; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang FW, 2009, CELL HOST MICROBE, V6, P54, DOI 10.1016/j.chom.2009.05.008	57	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111422	10.1371/journal.pone.0111422	http://dx.doi.org/10.1371/journal.pone.0111422			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347789	Green Submitted, Green Published, gold			2022-12-27	WOS:000347994900067
J	Mesentier-Louro, LA; Zaverucha-do-Valle, C; da Silva, AJ; Nascimento-dos-Santos, G; Gubert, F; de Figueiredo, ABP; Torres, AL; Paredes, BD; Teixeira, C; Tovar-Moll, F; Mendez-Otero, R; Santiago, MF				Mesentier-Louro, Louise Alessandra; Zaverucha-do-Valle, Camila; da Silva-Junior, Almir Jordao; Nascimento-dos-Santos, Gabriel; Gubert, Fernanda; Padilha de Figueiredo, Ana Beatriz; Torres, Ana Luiza; Paredes, Bruno D.; Teixeira, Camila; Tovar-Moll, Fernanda; Mendez-Otero, Rosalia; Santiago, Marcelo F.			Distribution of Mesenchymal Stem Cells and Effects on Neuronal Survival and Axon Regeneration after Optic Nerve Crush and Cell Therapy	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; MARROW MONONUCLEAR-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CILIARY NEUROTROPHIC FACTOR; AMYLOID-BETA DEPOSITION; BONE-MARROW; STROMAL CELLS; LENS INJURY; SPINAL-CORD; ALZHEIMERS-DISEASE	Bone marrow-derived cells have been used in different animal models of neurological diseases. We investigated the therapeutic potential of mesenchymal stem cells (MSC) injected into the vitreous body in a model of optic nerve injury. Adult (3-5 months old) Lister Hooded rats underwent unilateral optic nerve crush followed by injection of MSC or the vehicle into the vitreous body. Before they were injected, MSC were labeled with a fluorescent dye or with superparamagnetic iron oxide nanoparticles, which allowed us to track the cells in vivo by magnetic resonance imaging. Sixteen and 28 days after injury, the survival of retinal ganglion cells was evaluated by assessing the number of Tuj1-or Brn3a-positive cells in flat-mounted retinas, and optic nerve regeneration was investigated after anterograde labeling of the optic axons with cholera toxin B conjugated to Alexa 488. Transplanted MSC remained in the vitreous body and were found in the eye for several weeks. Cell therapy significantly increased the number of Tuj1-and Brn3a-positive cells in the retina and the number of axons distal to the crush site at 16 and 28 days after optic nerve crush, although the RGC number decreased over time. MSC therapy was associated with an increase in the FGF-2 expression in the retinal ganglion cells layer, suggesting a beneficial outcome mediated by trophic factors. Interleukin-1 beta expression was also increased by MSC transplantation. In summary, MSC protected RGC and stimulated axon regeneration after optic nerve crush. The long period when the transplanted cells remained in the eye may account for the effect observed. However, further studies are needed to overcome eventually undesirable consequences of MSC transplantation and to potentiate the beneficial ones in order to sustain the neuroprotective effect overtime.	[Mesentier-Louro, Louise Alessandra; Zaverucha-do-Valle, Camila; da Silva-Junior, Almir Jordao; Nascimento-dos-Santos, Gabriel; Gubert, Fernanda; Padilha de Figueiredo, Ana Beatriz; Torres, Ana Luiza; Paredes, Bruno D.; Mendez-Otero, Rosalia; Santiago, Marcelo F.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil; [Mesentier-Louro, Louise Alessandra; Zaverucha-do-Valle, Camila; da Silva-Junior, Almir Jordao; Nascimento-dos-Santos, Gabriel; Gubert, Fernanda; Padilha de Figueiredo, Ana Beatriz; Torres, Ana Luiza; Paredes, Bruno D.; Mendez-Otero, Rosalia; Santiago, Marcelo F.] INBEB, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Rio De Janeiro, Brazil; [Teixeira, Camila; Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Natl Ctr Struct Biol & Bioimaging CENABIO, Rio De Janeiro, Brazil; [Tovar-Moll, Fernanda] DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil; [Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Inst Biomed Sci ICB, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; IDOR - Instituto D'Or de Ensino e Pesquisa; Universidade Federal do Rio de Janeiro	Santiago, MF (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil.	marcelo.santiago@biof.ufrj.br	Santiago, Marcelo Felippe/AAZ-3553-2020; Santiago, Marcelo F/H-3943-2011; Moll, Fernanda Tovar/N-3320-2018; Silva-Junior, Almir/AAX-5736-2020; Mendez-Otero, Rosalia/AAL-7551-2020; Paredes, Bruno/ABE-6217-2021; Moll, Fernanda Tovar/AAF-8477-2021; Gubert, Fernanda/G-7619-2014	Santiago, Marcelo Felippe/0000-0003-2428-9606; Santiago, Marcelo F/0000-0003-2428-9606; Moll, Fernanda Tovar/0000-0002-0292-5985; Mendez-Otero, Rosalia/0000-0002-1798-9930; Paredes, Bruno/0000-0001-5711-0604; Moll, Fernanda Tovar/0000-0002-0292-5985; Nascimento dos Santos, Gabriel/0000-0001-6362-8573; Gubert, Fernanda/0000-0002-0568-7935	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro; Brazilian Ministry of Health; Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem, INBEB	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Brazilian Ministry of Health; Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem, INBEB	This study was supported by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (www.capes.gov.br), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (www. faperj. br), and the Brazilian Ministry of Health (www. saude. gov. br). The study was supported from grants from the Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem, INBEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2010, NEUROBIOL DIS, V37, P441, DOI 10.1016/j.nbd.2009.10.024; Akiyama Y, 2002, J NEUROSCI, V22, P6623; Bahr M, 2000, TRENDS NEUROSCI, V23, P483, DOI 10.1016/S0166-2236(00)01637-4; Bai L, 2012, NAT NEUROSCI, V15, P862, DOI 10.1038/nn.3109; da Fonseca LMB, 2010, EXP NEUROL, V221, P122, DOI 10.1016/j.expneurol.2009.10.010; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; Benowitz L, 2008, EXP NEUROL, V209, P389, DOI 10.1016/j.expneurol.2007.05.025; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028; Brenneman M, 2010, J CEREBR BLOOD F MET, V30, P140, DOI 10.1038/jcbfm.2009.198; Cen LP, 2012, NEUROREPORT, V23, P692, DOI 10.1097/WNR.0b013e328355f1d6; Chen Q, 2005, J NEUROSCI RES, V80, P611, DOI 10.1002/jnr.20494; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; Crigler L, 2006, EXP NEUROL, V198, P54, DOI 10.1016/j.expneurol.2005.10.029; Cui Q, 2003, MOL CELL NEUROSCI, V22, P49, DOI 10.1016/S1044-7431(02)00037-4; de Lima S, 2012, INT REV NEUROBIOL, V106, P153, DOI 10.1016/B978-0-12-407178-0.00007-7; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Diem R, 2003, MOL CELL NEUROSCI, V22, P487, DOI 10.1016/S1044-7431(02)00042-8; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; dos Santos AD, 2010, BRAIN RES, V1306, P149, DOI 10.1016/j.brainres.2009.09.094; Dreyfus H, 1998, ANN NY ACAD SCI, V845, P240, DOI 10.1111/j.1749-6632.1998.tb09677.x; English K, 2013, IMMUNOL CELL BIOL, V91, P19, DOI 10.1038/icb.2012.56; Fischer D, 2000, INVEST OPHTH VIS SCI, V41, P3943; Fischer D, 2004, J NEUROSCI, V24, P1646, DOI 10.1523/JNEUROSCI.5119-03.2004; Fischer D, 2008, MOL CELL NEUROSCI, V37, P471, DOI 10.1016/j.mcn.2007.11.002; Furtado JM, 2012, SURV OPHTHALMOL, V57, P149, DOI 10.1016/j.survophthal.2011.07.002; Giraldi-Guimaraes A., 2009, BRAIN RES; Giunti D, 2012, STEM CELLS, V30, P2044, DOI 10.1002/stem.1174; Hauk TG, 2010, INVEST OPHTH VIS SCI, V51, P459, DOI 10.1167/iovs.09-4203; Hawryluk GWJ, 2012, STEM CELLS DEV, V21, P2222, DOI 10.1089/scd.2011.0596; Heile AMB, 2009, NEUROSCI LETT, V463, P176, DOI 10.1016/j.neulet.2009.07.071; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Isenmann S, 1997, EUR J NEUROSCI, V9, P1763, DOI 10.1111/j.1460-9568.1997.tb01534.x; Jasmin, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-4; JOHNSON EM, 1993, ANNU REV NEUROSCI, V16, P31, DOI 10.1146/annurev.ne.16.030193.000335; Johnson TV, 2010, INVEST OPHTH VIS SCI, V51, P2051, DOI 10.1167/iovs.09-4509; Johnson TV, 2010, INVEST OPHTH VIS SCI, V51, P960, DOI 10.1167/iovs.09-3884; Karussis D, 2008, J NEUROL SCI, V265, P131, DOI 10.1016/j.jns.2007.05.005; Kassis I, 2008, ARCH NEUROL-CHICAGO, V65, P753, DOI 10.1001/archneur.65.6.753; Kassis I, 2011, CURR STEM CELL RES T, V6, P63, DOI 10.2174/157488811794480762; Kaushik DK, 2013, J NEUROCHEM, V127, P233, DOI 10.1111/jnc.12382; Kermer P, 2000, MOL BRAIN RES, V85, P144, DOI 10.1016/S0169-328X(00)00256-4; Kermer P, 1999, FEBS LETT, V453, P361, DOI 10.1016/S0014-5793(99)00747-4; Kikuchi M, 2000, J NEUROSCI, V20, P5037; Kim H, 2010, NEUROSCI LETT, V468, P190, DOI 10.1016/j.neulet.2009.10.074; Kim YJ, 2009, GLIA, V57, P13, DOI 10.1002/glia.20731; Kurimoto T, 2013, J NEUROSCI, V33, P14816, DOI 10.1523/JNEUROSCI.5511-12.2013; Kurimoto T, 2010, J NEUROSCI, V30, P15654, DOI 10.1523/JNEUROSCI.4340-10.2010; Laroni A., 2013, J NEUROIMMUNE PHARM; Lee JK, 2012, STEM CELLS, V30, P1544, DOI 10.1002/stem.1125; Lee JK, 2010, STEM CELLS, V28, P329, DOI 10.1002/stem.277; Lee JK, 2009, NEUROSCI LETT, V450, P136, DOI 10.1016/j.neulet.2008.11.059; Leibinger M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.310; Leibinger M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.126; Leibinger M, 2012, NEUROBIOL DIS, V46, P314, DOI 10.1016/j.nbd.2012.01.004; Leibinger M, 2009, J NEUROSCI, V29, P14334, DOI 10.1523/JNEUROSCI.2770-09.2009; Leon S, 2000, J NEUROSCI, V20, P4615, DOI 10.1523/JNEUROSCI.20-12-04615.2000; Levkovitch-Verbin H, 2004, EYE, V18, P1066, DOI 10.1038/sj.eye.6701576; Levkovitch-Verbin H, 2006, INVEST OPHTH VIS SCI, V47, P2491, DOI 10.1167/iovs.05-0996; Levkovitch-Verbin H, 2010, INVEST OPHTH VIS SCI, V51, P6394, DOI 10.1167/iovs.09-4310; Li N, 2009, GRAEF ARCH CLIN EXP, V247, P503, DOI 10.1007/s00417-008-1009-y; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Lingor P, 2008, BRAIN, V131, P250, DOI 10.1093/brain/awm284; Lingor P, 2007, J NEUROCHEM, V103, P181, DOI 10.1111/j.1471-4159.2007.04756.x; Liu R, 2013, STEM CELLS DEV, V22, P1053, DOI 10.1089/scd.2012.0463; Lorber B, 2005, EUR J NEUROSCI, V21, P2029, DOI 10.1111/j.1460-9568.2005.04034.x; Lu LL, 2005, BRAIN RES PROTOC, V15, P46, DOI 10.1016/j.brainresprot.2005.03.002; Magharious M, 2011, J PROTEOME RES, V10, P3344, DOI 10.1021/pr2004055; Mesentier-Louro LA, 2012, INVEST OPHTH VIS SCI, V53, P4720, DOI 10.1167/iovs.11-8198; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; Muller A, 2007, BRAIN, V130, P3308, DOI 10.1093/brain/awm257; Muller A, 2009, MOL CELL NEUROSCI, V41, P233, DOI 10.1016/j.mcn.2009.03.002; Nadal-Nicolas FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049830; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Ohtaki H, 2008, P NATL ACAD SCI USA, V105, P14638, DOI 10.1073/pnas.0803670105; Osaka M, 2010, BRAIN RES, V1343, P226, DOI 10.1016/j.brainres.2010.05.011; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Parrilla-Reverter G, 2009, EXP EYE RES, V89, P32, DOI 10.1016/j.exer.2009.02.015; PERRY VH, 1980, PROC R SOC SER B-BIO, V208, P415, DOI 10.1098/rspb.1980.0060; Petcu EB, 2008, CURR NEUROVASC RES, V5, P214, DOI 10.2174/156720208786413424; Pickering M, 2007, PROG BRAIN RES, V163, P339, DOI 10.1016/S0079-6123(07)63020-9; Pirouzmand F, 2012, J CRANIOFAC SURG, V23, P516, DOI 10.1097/SCS.0b013e31824cd4a7; Pousset F, 2000, EUR CYTOKINE NETW, V11, P427; Quertainmont R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039500; Reddy SAG, 1997, J BIOL CHEM, V272, P29167, DOI 10.1074/jbc.272.46.29167; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ribeiro-Resende VT, 2009, NEUROSCIENCE, V159, P540, DOI 10.1016/j.neuroscience.2008.12.059; Rosado-de-Castro PH, 2013, STEM CELLS DEV; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Sanchez-Migallon MC, 2011, EXP EYE RES, V92, P260, DOI 10.1016/j.exer.2011.02.001; Shi YF, 2012, TRENDS IMMUNOL, V33, P136, DOI 10.1016/j.it.2011.11.004; Smith JNP, 2013, STEM CELLS, V31, P1044, DOI 10.1002/stem.1370; Smith PD, 2009, NEURON, V64, P617, DOI 10.1016/j.neuron.2009.11.021; Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594; Suzuki M, 2008, MOL THER, V16, P2002, DOI 10.1038/mt.2008.197; Tuttolomondo A, 2008, CURR PHARM DESIGN, V14, P3574, DOI 10.2174/138161208786848739; Uccelli A, 2007, TRENDS IMMUNOL, V28, P219, DOI 10.1016/j.it.2007.03.001; Uccelli A, 2012, MOL MED, V18, P794, DOI 10.2119/molmed.2011.00498; Wong EV, 2003, J NEUROSCI, V23, P3112; Wright KT, 2011, STEM CELLS, V29, P169, DOI 10.1002/stem.570; XIANG MQ, 1995, J NEUROSCI, V15, P4762; Yanai A, 2012, CELL TRANSPLANT, V21, P1137, DOI 10.3727/096368911X627435; Yin YQ, 2003, J NEUROSCI, V23, P2284; Yin YQ, 2006, NAT NEUROSCI, V9, P843, DOI 10.1038/nn1701; Yin YQ, 2009, P NATL ACAD SCI USA, V106, P19587, DOI 10.1073/pnas.0907085106; Yoshihara T, 2007, J NEUROTRAUM, V24, P1026, DOI 10.1089/neu.2007.132R; Yu S, 2006, BIOCHEM BIOPH RES CO, V344, P1071, DOI 10.1016/j.bbrc.2006.03.231; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496; Zaverucha-do-Valle C, 2011, CELL TRANSPLANT, V20, P391, DOI 10.3727/096368910X524764; Zhao CP, 2007, CYTOTHERAPY, V9, P414, DOI 10.1080/14653240701376413	111	71	73	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e110722	10.1371/journal.pone.0110722	http://dx.doi.org/10.1371/journal.pone.0110722			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347773	Green Published, gold, Green Submitted			2022-12-27	WOS:000347994900027
J	Bertelli, R; Di Donato, A; Cioni, M; Grassi, F; Ikehata, M; Bonanni, A; Rastaldi, MP; Ghiggeri, GM				Bertelli, Roberta; Di Donato, Armando; Cioni, Michela; Grassi, Fabio; Ikehata, Masami; Bonanni, Alice; Rastaldi, Maria Pia; Ghiggeri, Gian Marco			LPS Nephropathy in Mice Is Ameliorated by IL-2 Independently of Regulatory T Cells Activity	PLOS ONE			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; MONOCLONAL-ANTIBODY; RECEPTOR; INFLAMMATION; MUTATIONS; INDUCTION; EXPANSION; INJURY; PATHOGENESIS; ADRIAMYCIN	Immunosuppressive regulatory T cells (Tregs) have been hypothesized to exert a protective role in animal models of spontaneous (Buffalo/Mna) and/or drug induced (Adriamycin) nephrotic syndrome. In this study, we thought to define whether Tregs can modify the outcome of LPS nephropathy utilizing IL-2 as inducer of tissue and circulating Tregs. LPS (12 mg/Kg) was given as single shot in C57BL/6, p2rx7(-/-) and Foxp3(EGFP); free IL-2 (18.000 U) or, in alternative, IL-2 coupled with JES6-1 mAb (IL-2/anti-IL-2) were injected before LPS. Peripheral and tissue Tregs/total CD4+ cell ratio, urinary parameters and renal histology were evaluated for 15 days. IL-2 administration to wild type mice had no effect on peripheral Tregs number, whereas a significant increase was induced by the IL-2/anti-IL-2 immunocomplex after 5 days. Spleen and lymph nodes Tregs were comparably increased. In p2rx7(-/-) mice, IL-2/anti-IL-2 treatment resulted in increase of peripheral Tregs but did not modify the spleen and lymph nodes quota. LPS induced comparable and transient proteinuria in both wild type and p2rx7(-/-) mice. Proteinuria was inhibited by co-infusion of human IL-2, with reduction at each phase of the disease (24 248 and 72 hours) whereas IL-2/anti-IL-2 produced weaker effects. In all mice (wild type and p2rx7(-/-)) and irrespective of treatment (IL-2, IL-2/anti-IL-2), LPS was associated with progressive signs of renal pathologic involvement resulting in glomerulosclerosis. In conclusion, IL-2 plays a transient protective effect on proteinuria induced by LPS independent of circulating or tissue Tregs but does not modify the outcome of renal degenerative renal lesions.	[Bertelli, Roberta; Di Donato, Armando; Cioni, Michela; Bonanni, Alice; Ghiggeri, Gian Marco] Giannina Gaslini Children Hosp, Div Nephrol Dialysis Transplantat, Genoa, Italy; [Grassi, Fabio] Inst Res Biomed, Bellinzona, Switzerland; [Grassi, Fabio; Ikehata, Masami] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy; [Rastaldi, Maria Pia] Ca Granda Osped Maggiore Policlinico, Fdn Ist Ric & Cura Carattere Sci IRCCS, Renal Res Lab, Milan, Italy; [Rastaldi, Maria Pia] Fdn DAmico Ric Malattie Renali, Milan, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; Universita della Svizzera Italiana; University of Milan	Ghiggeri, GM (corresponding author), Giannina Gaslini Children Hosp, Div Nephrol Dialysis Transplantat, Genoa, Italy.	GMarcoGhiggeri@ospedale-gaslini.ge.it	cioni, michela/AAA-4554-2019; Bertelli, Roberta/AAA-7207-2020; IKEHATA, Masami/HHR-9052-2022; Ghiggeri, Gian Marco/N-4712-2015; Coviello, Domenico/J-9477-2016; Bonanni, Alice/K-4453-2016	cioni, michela/0000-0003-3628-014X; IKEHATA, Masami/0000-0001-9835-9991; Ghiggeri, Gian Marco/0000-0003-3659-9062; Coviello, Domenico/0000-0001-8440-865X; Bonanni, Alice/0000-0002-4878-6271; GRASSI, FABIO/0000-0003-3348-1712	Italian Ministry of Health 'Ricerca Corrente'; Renal Child Foundation; Fondazione La Nuova Speranza	Italian Ministry of Health 'Ricerca Corrente'(Ministry of Health, Italy); Renal Child Foundation; Fondazione La Nuova Speranza	This work was also supported by the Italian Ministry of Health 'Ricerca Corrente' and from contributions derived from 'Cinque per mille dell'IRPEF'(5xMIL RIC 12 D.74/13L.2.). Contributions also were obtained from the Renal Child Foundation (FMRB; www.fmrb.it) and from Fondazione La Nuova Speranza (www.lanuovasperanza.org) supporting the grant:'Progetto integrato per la definizione dei meccanismi implicati nella glomerulosclerosi focale'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alachkar N, 2014, NEW ENGL J MED, V370, P1263, DOI 10.1056/NEJMc1400502; Araya C, 2009, PEDIATR NEPHROL, V24, P1691, DOI 10.1007/s00467-009-1214-x; BERTANI T, 1982, LAB INVEST, V46, P16; Bertelli R, 2011, CLIN EXP IMMUNOL, V166, P55, DOI 10.1111/j.1365-2249.2011.04441.x; BERTELLI R, 1991, IN VITRO CELL DEV B, V27, P799; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; BRENNER BM, 1978, NEW ENGL J MED, V298, P826, DOI 10.1056/NEJM197804132981507; BRENNER BM, 1977, NEW ENGL J MED, V297, P148; Candiano G, 2006, J AM SOC NEPHROL, V17, P3139, DOI 10.1681/ASN.2006050486; Caridi G, 2014, NEPHROL DIAL TRANSPL, V29, P80, DOI 10.1093/ndt/gfu071; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Couser WG, 2012, J AM SOC NEPHROL, V23, P381, DOI 10.1681/ASN.2011030304; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Frascoli M, 2012, J IMMUNOL, V189, P174, DOI 10.4049/jimmunol.1101582; Geertsen PF, 1998, CLIN SCI, V95, P73, DOI 10.1042/CS19980015; Ghiggeri GM, 2003, AM J KIDNEY DIS, V41, P95, DOI 10.1053/ajkd.2003.50028; Huang GH, 2012, CELL MOL IMMUNOL, V9, P287, DOI 10.1038/cmi.2012.10; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kim MG, 2013, J AM SOC NEPHROL, V24, P1529, DOI 10.1681/ASN.2012080784; KOYAMA A, 1991, KIDNEY INT, V40, P453, DOI 10.1038/ki.1991.232; Kurts C, 2013, NAT REV IMMUNOL, V13, P738, DOI 10.1038/nri3523; Le Berre L, 2009, J AM SOC NEPHROL, V20, P57, DOI 10.1681/ASN.2007111244; Mai JT, 2010, FRONT BIOSCI-LANDMRK, V15, P986, DOI 10.2741/3657; Musante L, 2007, J AM SOC NEPHROL, V18, P799, DOI 10.1681/ASN.2006090965; Musante L, 2006, BIOCHEM BIOPH RES CO, V349, P668, DOI 10.1016/j.bbrc.2006.08.079; Ohkura N, 2011, TRENDS PHARMACOL SCI, V32, P158, DOI 10.1016/j.tips.2010.12.004; Polhill T, 2012, J AM SOC NEPHROL, V23, P1303, DOI 10.1681/ASN.2011111130; Reiser J, 2004, J CLIN INVEST, V113, P1390, DOI 10.1172/JCI200420402; Rosin DL, 2011, J AM SOC NEPHROL, V22, P416, DOI 10.1681/ASN.2010040430; Saadoun D, 2011, NEW ENGL J MED, V365, P2067, DOI 10.1056/NEJMoa1105143; Sanna-Cherchi S, 2011, KIDNEY INT, V80, P389, DOI 10.1038/ki.2011.148; Schenk U, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001270; SHALHOUB RJ, 1974, LANCET, V2, P556; Shevach EM, 2012, TRENDS IMMUNOL, V33, P626, DOI 10.1016/j.it.2012.07.007; Solini A, 2013, J PATHOL, V231, P342, DOI 10.1002/path.4237; Takabatake Y, 2011, MOL MED, V17, P686, DOI 10.2119/molmed.2010.00229; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Vincenti F, 2005, AM J TRANSPLANT, V5, P1179, DOI 10.1111/j.1600-6143.2005.00968.x; Wang YM, 2006, J AM SOC NEPHROL, V17, P697, DOI 10.1681/ASN.2005090978; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Wei C, 2008, NAT MED, V14, P55, DOI 10.1038/nm1696; Wei CL, 2012, J AM SOC NEPHROL, V23, P2051, DOI 10.1681/ASN.2012030302; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; Wilson MS, 2008, J IMMUNOL, V181, P6942, DOI 10.4049/jimmunol.181.10.6942; Yu CC, 2013, NEW ENGL J MED, V369, P2416, DOI 10.1056/NEJMoa1304572; Zhao JJ, 2013, ARTHRITIS RHEUM-US, V65, P3176, DOI 10.1002/art.38174	47	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111285	10.1371/journal.pone.0111285	http://dx.doi.org/10.1371/journal.pone.0111285			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343479	gold, Green Published			2022-12-27	WOS:000343943500095
J	Karp, NA; Speak, AO; White, JK; Adams, DJ; de Angelis, MH; Herault, Y; Mott, RF				Karp, Natasha A.; Speak, Anneliese O.; White, Jacqueline K.; Adams, David J.; de Angelis, Martin Hrabe; Herault, Yann; Mott, Richard F.			Impact of Temporal Variation on Design and Analysis of Mouse Knockout Phenotyping Studies	PLOS ONE			English	Article							GENE-FUNCTION; GENOME-WIDE; STANDARDIZATION; CONSORTIUM	A significant challenge facing high-throughput phenotyping of in-vivo knockout mice is ensuring phenotype calls are robust and reliable. Central to this problem is selecting an appropriate statistical analysis that models both the experimental design (the workflow and the way control mice are selected for comparison with knockout animals) and the sources of variation. Recently we proposed a mixed model suitable for small batch-oriented studies, where controls are not phenotyped concurrently with mutants. Here we evaluate this method both for its sensitivity to detect phenotypic effects and to control false positives, across a range of workflows used at mouse phenotyping centers. We found the sensitivity and control of false positives depend on the workflow. We show that the phenotypes in control mice fluctuate unexpectedly between batches and this can cause the false positive rate of phenotype calls to be inflated when only a small number of batches are tested, when the effect of knockout becomes confounded with temporal fluctuations in control mice. This effect was observed in both behavioural and physiological assays. Based on this analysis, we recommend two approaches (workflow and accompanying control strategy) and associated analyses, which would be robust, for use in high-throughput phenotyping pipelines. Our results show the importance in modelling all sources of variability in high-throughput phenotyping studies.	[Karp, Natasha A.; Speak, Anneliese O.; White, Jacqueline K.; Adams, David J.] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [de Angelis, Martin Hrabe] Helmholtz Zentrum Munchen, Inst Expt Genet, German Mouse Clin, Neuherberg, Germany; [de Angelis, Martin Hrabe] Tech Univ Munich, Freising Weihenstephan, Germany; [de Angelis, Martin Hrabe] German Ctr Diabet Res, Neuherberg, Germany; [Herault, Yann] Univ Strasbourg, Inst Clin Souris, Illkirch Graffenstaden, France; [Mott, Richard F.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, Oxon, England	Wellcome Trust Sanger Institute; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Oxford; Wellcome Centre for Human Genetics	Karp, NA (corresponding author), Wellcome Trust Sanger Inst, Hinxton, Cambs, England.	nk3@sanger.ac.uk	de Angelis, Martin Hrabe/F-5531-2012; Herault, Yann/B-5500-2012	de Angelis, Martin Hrabe/0000-0002-7898-2353; Herault, Yann/0000-0001-7049-6900; Karp, Natasha/0000-0002-8404-2907; Speak, Anneliese/0000-0003-4890-4685; Mott, Richard/0000-0002-1022-9330; Adams, David/0000-0001-9490-0306	Wellcome Trust [WT098051, 083573/Z/07/Z, 090532/Z/09/Z]; National Institutes of Health [1 U54 HG006370-01]; German Federal Ministry of Education and Research [01KX1012]; French National Agency for Research [ANR-10-INBS-07]; European Commission [LSHG-CT-2006-037188]; INFRAFRONTIER I3 [FP7-INFRASTRUCTURES-2012-1.1.4/312325]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006370] Funding Source: NIH RePORTER; Cancer Research UK [13031] Funding Source: researchfish; Medical Research Council [MR/L007428/1] Funding Source: researchfish; MRC [MR/L007428/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); French National Agency for Research(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre); INFRAFRONTIER I3; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work of JKW and AOS was funded by the Wellcome Trust (www.wellcome.ac.uk) grant WT098051. RM was funded by Wellcome Trust through grants 083573/Z/07/Z and 090532/Z/09/Z. NAK was funded by the National Institutes of Health (www.nih.gov grant number: 1 U54 HG006370-01). MHA was funded by the German Federal Ministry of Education and Research (www.bmbf.de Infrafrontier grant: 01KX1012). YH was funded by the French National Agency for Research (www.cnrs.fr PHENOMIN, ANR-10-INBS-07) and by European Commission (http://ec.europa.eu EUMODIC (LSHG-CT-2006-037188)) and INFRAFRONTIER I3 (FP7-INFRASTRUCTURES-2012-1.1.4/312325). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown SDM, 2012, DIS MODEL MECH, V5, P289, DOI 10.1242/dmm.009878; Brown SDM, 2009, ANNU REV GENET, V43, P305, DOI 10.1146/annurev-genet-102108-134143; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Karp NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052410; Paylor R, 2009, NAT METHODS, V6, P253, DOI 10.1038/nmeth0409-253; Richter SH, 2009, NAT METHODS, V6, P257, DOI [10.1038/NMETH.1312, 10.1038/nmeth.1312]; Ringwald M, 2011, NUCLEIC ACIDS RES, V39, pD849, DOI 10.1093/nar/gkq879; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Team RDC, 2019, R LANG ENV STAT COMP; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022	12	27	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111239	10.1371/journal.pone.0111239	http://dx.doi.org/10.1371/journal.pone.0111239			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343444	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943500088
J	Ming, AG; Jia, HY; Zhao, JL; Tao, Y; Li, YF				Ming, Angang; Jia, Hongyan; Zhao, Jinlong; Tao, Yi; Li, Yuanfa			Above- and Below-Ground Carbon Stocks in an Indigenous Tree (Mytilaria laosensis) Plantation Chronosequence in Subtropical China	PLOS ONE			English	Article							MIXED STANDS; ACACIA PLANTATIONS; PINE PLANTATIONS; FOREST BIOMASS; ORGANIC-CARBON; EUROPEAN BEECH; AGE-SEQUENCE; STORAGE; SOIL; ALLOCATION	More than 60% of the total area of tree plantations in China is in subtropical, and over 70% of subtropical plantations consist of pure stands of coniferous species. Because of the poor ecosystem services provided by pure coniferous plantations and the ecological instability of these stands, a movement is under way to promote indigenous broadleaf plantation cultivation as a promising alternative. However, little is known about the carbon (C) stocks in indigenous broadleaf plantations and their dependence on stand age. Thus, we studied above-and below-ground biomass and C stocks in a chronosequence of Mytilaria laosensis plantations in subtropical China; stands were 7, 10, 18, 23, 29 and 33 years old. Our assessments included tree, shrub, herb and litter layers. We used plot-level inventories and destructive tree sampling to determine vegetation C stocks. We also measured soil C stocks by analyses of soil profiles to 100 cm depth. C stocks in the tree layer dominated the above-ground ecosystem C pool across the chronosequence. C stocks increased with age from 7 to 29 years and plateaued thereafter due to a reduction in tree growth rates. Minor C stocks were found in the shrub and herb layers of all six plantations and their temporal fluctuations were relatively small. C stocks in the litter and soil layers increased with stand age. Total above-ground ecosystem C also increased with stand age. Most increases in C stocks in below-ground and total ecosystems were attributable to increases in soil C content and tree biomass. Therefore, considerations of C sequestration potential in indigenous broadleaf plantations must take stand age into account.	[Ming, Angang; Jia, Hongyan; Tao, Yi] Chinese Acad Forestry, Expt Ctr Trop Forestry, Pingxiang, Guangxi, Peoples R China; [Ming, Angang] Chinese Acad Forestry, Inst Forest Ecol Environm & Protect, Beijing, Peoples R China; [Ming, Angang; Jia, Hongyan] Guangxi Youyiguan Forest Ecosyst Res Stn, Pingxiang, Guangxi, Peoples R China; [Zhao, Jinlong] Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China; [Li, Yuanfa] Guangxi Univ, Coll Forestry, Nanning 530004, Guangxi, Peoples R China	Chinese Academy of Forestry; Experimental Center of Tropical Forestry, CAF; Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF; Beijing Forestry University; Guangxi University	Li, YF (corresponding author), Guangxi Univ, Coll Forestry, Nanning 530004, Guangxi, Peoples R China.	43294659@qq.com		Li, Yuanfa/0000-0001-9677-0752	Fundamental Research Funds for the Central Non-profit Research Institution of CAF [CAFYBB2014QA033]; Nature Science Foundation of Guangxi [2014jjBA30073]; Ministry of Science and Technology [2012BAD22B01]; National Science Foundation of China [31400542]; Director Foundation Project of the Experimental Centre of Tropical Forestry, Chinese Academy of Forestry [RL2011-02]	Fundamental Research Funds for the Central Non-profit Research Institution of CAF; Nature Science Foundation of Guangxi; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Director Foundation Project of the Experimental Centre of Tropical Forestry, Chinese Academy of Forestry	Our research was financially supported by the Fundamental Research Funds for the Central Non-profit Research Institution of CAF (No. CAFYBB2014QA033), Nature Science Foundation of Guangxi (No 2014jjBA30073), The Ministry of Science and Technology (2012BAD22B01), National Science Foundation of China (No 31400542), and the Director Foundation Project of the Experimental Centre of Tropical Forestry, Chinese Academy of Forestry (No. RL2011-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borken W, 2006, EUR J SOIL SCI, V57, P617, DOI 10.1111/j.1365-2389.2005.00752.x; Borken W, 2005, CAN J FOREST RES, V35, P2756, DOI 10.1139/X05-192; Brown S, 2002, ENVIRON POLLUT, V116, P363, DOI 10.1016/S0269-7491(01)00212-3; Choi SD, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001914; Cleveland CC, 2011, ECOL LETT, V14, P939, DOI 10.1111/j.1461-0248.2011.01658.x; Department of Forest Resources Management S, 2010, FOR RESOUR MANAG, V1, P3; Goodale CL, 2002, ECOL APPL, V12, P891, DOI 10.2307/3060997; Gower ST, 2003, ANNU REV ENV RESOUR, V28, P169, DOI 10.1146/annurev.energy.28.050302.105515; GRIGAL DF, 1992, SOIL SCI SOC AM J, V56, P935, DOI 10.2136/sssaj1992.03615995005600030042x; Guo Wen-fu, 2006, Forest Research, V19, P585; He YJ, 2013, FOREST ECOL MANAG, V295, P193, DOI 10.1016/j.foreco.2013.01.020; He YouJun, 2008, Chinese Forestry Science and Technology, V7, P1; Houghton RA, 2007, ANNU REV EARTH PL SC, V35, P313, DOI 10.1146/annurev.earth.35.031306.140057; Houghton RA, 2005, GLOBAL CHANGE BIOL, V11, P945, DOI 10.1111/j.1365-2486.2005.00955.x; Jagger P, 2003, FOREST POLICY ECON, V5, P83, DOI 10.1016/S1389-9341(01)00078-8; Jandl R, 2007, GEODERMA, V137, P253, DOI 10.1016/j.geoderma.2006.09.003; Jonard M, 2007, ANN FOREST SCI, V64, P141, DOI 10.1051/forest:2006098; Kang B, 2006, ACTA ECOL SIN, V26, P1321; Kasel S, 2007, GEODERMA, V137, P401, DOI 10.1016/j.geoderma.2006.09.002; Kraenzel M, 2002, FOREST ECOL MANAG, V5863, P1; Kurz WA, 1996, CAN J FOREST RES, V26, P1973, DOI 10.1139/x26-223; Laclau P, 2003, FOREST ECOL MANAG, V180, P317, DOI 10.1016/S0378-1127(02)00580-7; Li X, 2011, J PLANT BIOL, V54, P33, DOI 10.1007/s12374-010-9140-9; Li Y. X., 1988, Forest Research, V1, P206; [梁宏温 LIANG Hong-Wen], 2009, [生态学报, Acta Ecologica Sinica], V29, P4242; Liang R. L., 2007, GUANGXI FORESTRY SCI, V36, P5; Lin DeXi, 2000, Journal of Fujian College of Forestry, V20, P62; Lin Jin-guo, 2004, Journal of Plant Resources and Environment, V13, P50; Litton CM, 2007, GLOBAL CHANGE BIOL, V13, P2089, DOI 10.1111/j.1365-2486.2007.01420.x; Liu En, 2012, Yingyong Shengtai Xuebao, V23, P335; Lu LiHua, 2009, Scientia Silvae Sinicae, V45, P1; Ming An-gang, 2014, Yingyong Shengtai Xuebao, V25, P940; Ming An-gang, 2012, Shengtaixue Zazhi, V31, P1050; Paquette A, 2010, FRONT ECOL ENVIRON, V8, P27, DOI 10.1890/080116; Peichl M, 2007, FOREST ECOL MANAG, V253, P68, DOI 10.1016/j.foreco.2007.07.003; Peichl M, 2006, AGR FOREST METEOROL, V140, P51, DOI 10.1016/j.agrformet.2006.08.004; [彭舜磊 PENG Shunlei], 2008, [西北林学院学报, Journal of Northwest Forestry College], V23, P184; POORE MED, 1985, FAO FOREST, V59, P1; SFA (State Forestry Administration), 2007, CHIN FOR 1999 2005; Soil Survey Staff of USDA, 2006, KEYS SOIL TAX; State Soil Survey Service of China, 1998, CHIN SOIL; Taylor AR, 2007, CAN J FOREST RES, V37, P2260, DOI 10.1139/X07-080; [田大伦 Tian Dalun], 2010, [生态学报, Acta Ecologica Sinica], V30, P6297; Vesterdal L, 2008, FOREST ECOL MANAG, V255, P35, DOI 10.1016/j.foreco.2007.08.015; VOGT K, 1991, TREE PHYSIOL, V9, P69, DOI 10.1093/treephys/9.1-2.69; Wang FQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062988, 10.1371/journal.pone.0061792, 10.1371/journal.pone.0069284, 10.1371/journal.pone.0064373, 10.1371/journal.pone.0080480, 10.1371/journal.pone.0078025]; Wang H, 2013, FOREST ECOL MANAG, V300, P43, DOI 10.1016/j.foreco.2012.12.015; Wang H, 2010, PLANT SOIL, V335, P213, DOI 10.1007/s11104-010-0408-0; Wang H, 2010, ECOL RES, V25, P1071, DOI 10.1007/s11284-010-0730-2; [王卫霞 Wang Weixia], 2013, [生态学报, Acta Ecologica Sinica], V33, P925; Yuan SF, 2013, J TROP FOR SCI, V25, P79; Zhang H, 2012, FOREST ECOL MANAG, V277, P90, DOI 10.1016/j.foreco.2012.04.016; Zhao JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094966; Zhou Y.R., 2000, CHIN J PLANT ECOL, V24, P518	54	25	27	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e109730	10.1371/journal.pone.0109730	http://dx.doi.org/10.1371/journal.pone.0109730			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343446	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943500022
J	Schwenk, R; Debot, M; Porter, M; Nikki, J; Rein, L; Spaccapelo, R; Crisanti, A; Wightman, PD; Ockenhouse, CF; Dutta, S				Schwenk, Robert; Debot, Margot; Porter, Michael; Nikki, Jennifer; Rein, Lisa; Spaccapelo, Roberta; Crisanti, Andrea; Wightman, Paul D.; Ockenhouse, Christian F.; Dutta, Sheetij			IgG2 Antibodies against a Clinical Grade Plasmodium falciparum CSP Vaccine Antigen Associate with Protection against Transgenic Sporozoite Challenge in Mice	PLOS ONE			English	Article							T-CELL RESPONSES; MALARIA-NAIVE ADULTS; RECEPTOR 4 AGONIST; PHASE 2A TRIAL; CIRCUMSPOROZOITE PROTEIN; ESCHERICHIA-COLI; DENDRITIC CELLS; SIGNALING PATHWAY; INFLUENZA VACCINE; TLR SYNERGY	The availability of a highly purified and well characterized circumsporozoite protein (CSP) is essential to improve upon the partial success of recombinant CSP-based malaria vaccine candidates. Soluble, near full-length, Plasmodium falciparum CSP vaccine antigen (CS/D) was produced in E. coli under bio-production conditions that comply with current Good Manufacturing Practices (cGMP). A mouse immunogenicity study was conducted using a stable oil-in-water emulsion (SE) of CS/D in combination with the Toll-Like Receptor 4 (TLR4) agonist Glucopyranosyl Lipid A (GLA/SE), or one of two TLR7/8 agonists: R848 (un-conjugated) or 3M-051 (covalently conjugated). Compared to Alum and SE, GLA/SE induced higher CS/D specific antibody response in Balb/c mice. Subclass analysis showed higher IgG2:IgG1 ratio of GLA/SE induced antibodies as compared to Alum and SE. TLR synergy was not observed when soluble R848 was mixed with GLA/SE. Antibody response of 3M051 formulations in Balb/c was similar to GLA/SE, except for the higher IgG2: IgG1 ratio and a trend towards higher T cell responses in 3M051 containing groups. However, no synergistic enhancement of antibody and T cell response was evident when 3M051 conjugate was mixed with GLA/SE. In C57Bl/6 mice, CS/D adjuvanted with 3M051/SE or GLA/SE induced higher CSP repeat specific titers compared to SE. While, 3M051 induced antibodies had high IgG2c:IgG1 ratio, GLA/SE promoted high levels of both IgG1 and IgG2c. GLA/SE also induced more potent T-cell responses compared to SE in two independent C57/BL6 vaccination studies, suggesting a balanced and productive T-H1/T-H2 response. GLA and 3M-051 similarly enhanced the protective efficacy of CS/D against challenge with a transgenic P. berghei parasite and most importantly, high levels of cytophilic IgG2 antibodies were associated with protection in this model. Our data indicated that the cGMP-grade, soluble CS/D antigen combined with the TLR4-containing adjuvant GLA/SE warrants further evaluation for protective responses in humans.	[Schwenk, Robert; Debot, Margot; Porter, Michael; Nikki, Jennifer; Rein, Lisa; Ockenhouse, Christian F.; Dutta, Sheetij] Walter Reed Army Inst Res, Malaria Vaccine Branch, Silver Spring, MD 20910 USA; [Wightman, Paul D.] 3M Drug Delivery Syst, St Paul, MN USA; [Spaccapelo, Roberta] Univ Perugia, Dept Expt Med, I-06100 Perugia, Italy; [Crisanti, Andrea] Univ London Imperial Coll Sci Technol & Med, London, England	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); 3M; University of Perugia; Imperial College London	Dutta, S (corresponding author), Walter Reed Army Inst Res, Malaria Vaccine Branch, Silver Spring, MD 20910 USA.	Sheetij.dutta.civ@mail.mil		Nicki, Jennifer/0000-0002-5440-2991; Crisanti, Andrea/0000-0002-2406-4426; Spaccapelo, Roberta/0000-0003-2100-6172	US Army; United States Agency for International Development Malaria Vaccine Program	US Army(United States Department of DefenseUnited States Army); United States Agency for International Development Malaria Vaccine Program(United States Agency for International Development (USAID))	Funding for this work was provided by the US Army and the United States Agency for International Development Malaria Vaccine Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032524; Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782; Bagchi A, 2007, J IMMUNOL, V178, P1164, DOI 10.4049/jimmunol.178.2.1164; Behzad H, 2012, J INFECT DIS, V205, P466, DOI 10.1093/infdis/jir769; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; BLUMTIROUVANZIAM U, 1995, J IMMUNOL, V154, P3922; BLUMTIROUVANZIAM U, 1994, J IMMUNOL, V153, P4134; Clegg CH, 2012, P NATL ACAD SCI USA, V109, P17585, DOI 10.1073/pnas.1207308109; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Cohen J, 2010, HUM VACCINES, V6, P90, DOI 10.4161/hv.6.1.9677; Coler RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016333; Coppi A, 2005, J EXP MED, V201, P27, DOI 10.1084/jem.20040989; Darko CA, 2005, INFECT IMMUN, V73, P287, DOI 10.1128/IAI.73.1.287-297.2005; DOOLAN DL, 1992, INFECT IMMUN, V60, P675, DOI 10.1128/IAI.60.2.675-682.1992; Doud MB, 2012, P NATL ACAD SCI USA, V109, P7817, DOI 10.1073/pnas.1205737109; Fujita Y, 2012, THER DELIV, V3, P749, DOI 10.4155/TDE.12.52; Gautier G, 2005, J EXP MED, V201, P1435, DOI 10.1084/jem.20041964; GROUX H, 1990, RES IMMUNOL, V141, P529, DOI 10.1016/0923-2494(90)90021-P; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; John CC, 2005, AM J TROP MED HYG, V73, P222, DOI 10.4269/ajtmh.2005.73.222; Kaba SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048304; Kastenmuller K, 2013, INFECT IMMUN, V81, P789, DOI 10.1128/IAI.01108-12; Kastenmuller K, 2011, J CLIN INVEST, V121, P1782, DOI 10.1172/JCI45416; Kester KE, 2008, VACCINE, V26, P2191, DOI 10.1016/j.vaccine.2008.02.048; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Kolodny N, 2001, J CHROMATOGR B, V762, P77, DOI 10.1016/S0378-4347(01)00340-1; Mckee AS, 2007, IMMUNITY, V27, P687, DOI 10.1016/j.immuni.2007.11.003; Moorthy VS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-312; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Orr MT, 2013, EUR J IMMUNOL; Othoro C, 2009, INFECT IMMUN, V77, P739, DOI 10.1128/IAI.00974-08; Ouyang XS, 2007, BIOCHEM BIOPH RES CO, V354, P1045, DOI 10.1016/j.bbrc.2007.01.090; Plassmeyer ML, 2009, J BIOL CHEM, V284, P26951, DOI 10.1074/jbc.M109.013706; Porter MD, 2013, CLIN VACCINE IMMUNOL, V20, P803, DOI 10.1128/CVI.00066-13; Raman VS, 2010, J IMMUNOL, V185, P1701, DOI 10.4049/jimmunol.1000238; Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006; Sorensen LN, 2008, J IMMUNOL, V181, P8604, DOI 10.4049/jimmunol.181.12.8604; Tafalla C, 2008, MOL IMMUNOL, V45, P1439, DOI 10.1016/j.molimm.2007.08.015; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tewari R, 2002, J BIOL CHEM, V277, P47613, DOI 10.1074/jbc.M208453200; Tomai MA, 2011, EXPERT REV VACCINES, V10, P405, DOI [10.1586/erv.11.26, 10.1586/ERV.11.26]; Vandepapeliere P, 2008, VACCINE, V26, P1375, DOI 10.1016/j.vaccine.2007.12.038; Vaughan K, 2009, PARASITE IMMUNOL, V31, P78, DOI 10.1111/j.1365-3024.2008.01077.x; WALDMANN H, 1989, ANNU REV IMMUNOL, V7, P407, DOI 10.1146/annurev.iy.07.040189.002203; Weiss WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031247; Wille-Reece U, 2005, J IMMUNOL, V174, P7676, DOI 10.4049/jimmunol.174.12.7676; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; YOUNG JF, 1985, SCIENCE, V228, P958, DOI 10.1126/science.2988125	50	48	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111020	10.1371/journal.pone.0111020	http://dx.doi.org/10.1371/journal.pone.0111020			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343487	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943500077
J	Yperzeele, L; Van Hooff, RJ; De Smedt, A; Espinoza, AV; Van Dyck, R; Van de Casseye, R; Convents, A; Hubloue, I; Lauwaert, D; De Keyser, J; Brouns, R				Yperzeele, Laetitia; Van Hooff, Robbert-Jan; De Smedt, Ann; Espinoza, Alexis Valenzuela; Van Dyck, Rita; Van de Casseye, Rohny; Convents, Andre; Hubloue, Ives; Lauwaert, Door; De Keyser, Jacques; Brouns, Raf			Feasibility of AmbulanCe-Based Telemedicine (FACT) Study: Safety, Feasibility and Reliability of Third Generation Ambulance Telemedicine	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; UNASSISTED ASSESSMENT; TELESTROKE; MANAGEMENT; IMPLEMENTATION; GUIDELINES; TRAUMA; SYSTEM	Background: Telemedicine is currently mainly applied as an in-hospital service, but this technology also holds potential to improve emergency care in the prehospital arena. We report on the safety, feasibility and reliability of in-ambulance teleconsultation using a telemedicine system of the third generation. Methods: A routine ambulance was equipped with a system for real-time bidirectional audio-video communication, automated transmission of vital parameters, glycemia and electronic patient identification. All patients (>= 18 years) transported during emergency missions by a Prehospital Intervention Team of the Universitair Ziekenhuis Brussel were eligible for inclusion. To guarantee mobility and to facilitate 24/7 availability, the teleconsultants used lightweight laptop computers to access a dedicated telemedicine platform, which also provided functionalities for neurological assessment, electronic reporting and prehospital notification of the in-hospital team. Key registrations included any safety issue, mobile connectivity, communication of patient information, audiovisual quality, user-friendliness and accuracy of the prehospital diagnosis. Results: Prehospital teleconsultation was obtained in 41 out of 43 cases (95.3%). The success rates for communication of blood pressure, heart rate, blood oxygen saturation, glycemia, and electronic patient identification were 78.7%, 84.8%, 80.6%, 64.0%, and 84.2%. A preliminary prehospital diagnosis was formulated in 90.2%, with satisfactory agreement with final in-hospital diagnoses. Communication of a prehospital report to the in-hospital team was successful in 94.7% and prenotification of the in-hospital team via SMS in 90.2%. Failures resulted mainly from limited mobile connectivity and to a lesser extent from software, hardware or human error. The user acceptance was high. Conclusions: Ambulance-based telemedicine of the third generation is safe, feasible and reliable but further research and development, especially with regard to high speed broadband access, is needed before this approach can be implemented in daily practice.	[Yperzeele, Laetitia; Van Hooff, Robbert-Jan; De Smedt, Ann; Van Dyck, Rita; De Keyser, Jacques; Brouns, Raf] Univ Ziekenhuis Brussel, Dept Neurol, Brussels, Belgium; [Yperzeele, Laetitia; Van Hooff, Robbert-Jan; De Smedt, Ann; Espinoza, Alexis Valenzuela; Convents, Andre; De Keyser, Jacques; Brouns, Raf] Vrije Univ Brussel, Ctr Neurosci C4N, Brussels, Belgium; [Van de Casseye, Rohny] Flanders Dist Creat, Leuven, Belgium; [Hubloue, Ives; Lauwaert, Door] Univ Ziekenhuis Brussel, Dept Emergency Med, Brussels, Belgium; [Hubloue, Ives; Lauwaert, Door] Vrije Univ Brussel, Res Grp Emergency & Disaster Med ReGEDiM, Brussels, Belgium; [De Keyser, Jacques] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands	University Hospital Brussels; Vrije Universiteit Brussel; Vrije Universiteit Brussel; University Hospital Brussels; Vrije Universiteit Brussel; Vrije Universiteit Brussel; University of Groningen	Yperzeele, L (corresponding author), Univ Ziekenhuis Brussel, Dept Neurol, Brussels, Belgium.	laetitiayperzeele@outlook.be	De Keyser, Jacques/AAA-8721-2021; Brouns, Raf/E-1044-2013; Van+Hooff, Robbert-Jan/AAG-5136-2019; De Keyser, Jacques/D-3725-2013; Hubloue, Ives/GYR-0901-2022; Espinoza, Alexis Valenzuela/B-3833-2016; Yperzeele, Laetitia/AAQ-7742-2020	De Keyser, Jacques/0000-0002-3394-7757; Brouns, Raf/0000-0001-6540-5699; Van+Hooff, Robbert-Jan/0000-0003-2712-2772; De Keyser, Jacques/0000-0002-3394-7757; Espinoza, Alexis Valenzuela/0000-0003-4759-9068; Yperzeele, Laetitia/0000-0002-5503-5724; De Smedt, Ann/0000-0003-0252-0600	Vrije Universiteit Brussel Industrial Research Fund (IOF) [IOFPOC9/INTGINK70]; Scientific Fund Willy Gepts [71045/G145]; Brussels Institute for Research and Innovation (INNOVIRIS) [INNOVIRIS/2011SOIB02/KM/MV/VG/LV/2013/1937]	Vrije Universiteit Brussel Industrial Research Fund (IOF); Scientific Fund Willy Gepts; Brussels Institute for Research and Innovation (INNOVIRIS)(Innoviris)	This study was conducted as part of the Prehospital Stroke Study at the Universitair Ziekenhuis Brussel (PreSSUB). The PreSSUB project is supported by the following grants: Grant by the Vrije Universiteit Brussel (www.vub.ac.be) Industrial Research Fund (IOF) for funding of a 'Proof-of-Concept Project' for the research project 'Prehospital Stroke Study at the Universitair ziekenhuis Brussel' (2013); grant number IOFPOC9/INTGINK70; grant obtained by RB. Grant by the Scientific Fund Willy Gepts (www.vub.ac.be) for the research project 'Prehospital Stroke Study at the Universitair ziekenhuis Brussel' (2013); grant number 71045/G145; grant obtained by RB. Grant by the Brussels Institute for Research and Innovation (INNOVIRIS, www.innoviris.be) for the research project 'Prehospital Stroke Study at the Universitair ziekenhuis Brussel - Spin Off in Brussels' (2011-2014); grant number INNOVIRIS/2011SOIB02/KM/MV/VG/LV/2013/1937; grant obtained by RB. All researchers were fully independent from the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aita MC, 2013, STROKE, V44, P3602, DOI 10.1161/STROKEAHA.113.001889; Bergrath S, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-54; Bergrath S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036796; Bergrath S, 2011, J TELEMED TELECARE, V17, P371, DOI 10.1258/jtt.2011.110203; Blomstrom-Lundqvist C, 2003, CIRCULATION, V108, P1871, DOI 10.1161/01.CIR.0000091380.04100.84; Boniface KS, 2011, AM J EMERG MED, V29, P477, DOI 10.1016/j.ajem.2009.12.001; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Clemmensen P, 2013, J ELECTROCARDIOL, V46, P546, DOI 10.1016/j.jelectrocard.2013.07.004; Demaerschalk BM, 2011, CURR NEUROL NEUROSCI, V11, P42, DOI 10.1007/s11910-010-0147-x; Ducas RA, 2012, CAN J CARDIOL, V28, P423, DOI 10.1016/j.cjca.2012.02.005; Hess DC, 2013, NAT REV NEUROL, V9, P340, DOI 10.1038/nrneurol.2013.86; Hess DC, 2006, LANCET NEUROL, V5, P275, DOI 10.1016/S1474-4422(06)70377-5; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; LaMonte M P, 2000, J Stroke Cerebrovasc Dis, V9, P128, DOI 10.1053/jscd.2000.5867; LaMonte Marian P, 2004, J Stroke Cerebrovasc Dis, V13, P148, DOI 10.1016/j.jstrokecerebrovasdis.2004.03.004; Latifi R, 2007, SCAND J SURG, V96, P281, DOI 10.1177/145749690709600404; Levine SR, 1999, STROKE, V30, P464, DOI 10.1161/01.STR.30.2.464; Likert R, 1932, ARCH PSYCHOL, V22, P55, DOI DOI 10.4135/9781412961288.N454; Liman TG, 2012, STROKE, V43, P2086, DOI 10.1161/STROKEAHA.112.657270; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Roine R, 2001, CAN MED ASSOC J, V165, P765; Rubin MN, 2013, POSTGRAD MED, V125, P45, DOI 10.3810/pgm.2013.01.2623; Sejersten M, 2008, AM J CARDIOL, V101, P941, DOI 10.1016/j.amjcard.2007.11.038; Tatlisumak Turgut, 2009, Cerebrovasc Dis, V27 Suppl 4, P21, DOI 10.1159/000213055; Van Hooff RJ, 2013, STROKE, V44, P2907, DOI 10.1161/STROKEAHA.113.002079; Van Hooff RJ, 2013, STROKE, V44, P1249, DOI 10.1161/STROKEAHA.111.680868; Walter S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013758	27	37	37	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110043	10.1371/journal.pone.0110043	http://dx.doi.org/10.1371/journal.pone.0110043			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343246	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943500026
J	Hu, LP; Xiang, LX; Zhang, L; Zhou, XT; Zou, ZR; Hu, XH				Hu, Lipan; Xiang, Lixia; Zhang, Li; Zhou, Xiaoting; Zou, Zhirong; Hu, Xiaohui			The Photoprotective Role of Spermidine in Tomato Seedlings under Salinity-Alkalinity Stress	PLOS ONE			English	Article							CHLOROPHYLL FLUORESCENCE; XANTHOPHYLL CYCLE; EXOGENOUS SPERMIDINE; SALT STRESS; THYLAKOID MEMBRANES; CUCUMIS-SATIVUS; ABIOTIC STRESS; POLYAMINES; ZEAXANTHIN; LEAVES	Polyamines are small, ubiquitous, nitrogenous compounds that scavenge reactive oxygen species and stabilize the structure and function of the photosynthetic apparatus in response to abiotic stresses. Molecular details underlying polyamine-mediated photoprotective mechanisms are not completely resolved. This study investigated the role of spermidine (Spd) in the structure and function of the photosynthetic apparatus. Tomato seedlings were subjected to salinity-alkalinity stress with and without foliar application of Spd, and photosynthetic and morphological parameters were analyzed. Leaf dry weight and net photosynthetic rate were reduced by salinity-alkalinity stress. Salinity-alkalinity stress reduced photochemical quenching parameters, including maximum photochemistry efficiency of photosystem II, quantum yield of linear electron flux, and coefficient of photochemical quenching (qP). Salinity-alkalinity stress elevated nonphotochemical quenching parameters, including the de-epoxidation state of the xanthophyll cycle and nonphotochemical quenching (NPQ). Microscopic analysis revealed that salinity-alkalinity stress disrupted the internal lamellar system of granal and stromal thylakoids. Exogenous Spd alleviated the stress-induced reduction of leaf dry weight, net photosynthetic rate, and qP parameters. The NPQ parameters increased by salinity-alkalinity stress were also alleviated by Spd. Seedlings treated with exogenous Spd had higher zeaxanthin (Z) contents than those without Spd under salinity-alkalinity stress. The chloroplast ultrastructure had a more ordered arrangement in seedlings treated with exogenous Spd than in those without Spd under salinity-alkalinity stress. These results indicate that exogenous Spd can alleviate the growth inhibition and thylakoid membrane photodamage caused by salinity-alkalinity stress. The Spd-induced accumulation of Z also may have an important role in stabilizing the photosynthetic apparatus.	[Hu, Lipan; Xiang, Lixia; Zhang, Li; Zhou, Xiaoting; Zou, Zhirong; Hu, Xiaohui] Northwest Agr & Forest Univ, Coll Hort, Yangling, Peoples R China; [Hu, Lipan; Xiang, Lixia; Zhang, Li; Zhou, Xiaoting; Zou, Zhirong; Hu, Xiaohui] Minist Agr, Key Lab Protected Hort Engn Northwest, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs	Zou, ZR (corresponding author), Northwest Agr & Forest Univ, Coll Hort, Yangling, Peoples R China.	zouzhirong2005@hotmail.com; hxh1977@163.com			National Key Technology R&D Program in the 12th Five-year Plan of China [2011BAD29B01]; Scientific Research Special Fund of Northwest Agriculture & Forestry University [QN2013018]; China Agriculture Research System [CARS-25-D-02]	National Key Technology R&D Program in the 12th Five-year Plan of China(National Key Technology R&D Program); Scientific Research Special Fund of Northwest Agriculture & Forestry University; China Agriculture Research System	This work was supported by grants from the National Key Technology R&D Program in the 12th Five-year Plan of China (No. 2011BAD29B01), the Scientific Research Special Fund of Northwest Agriculture & Forestry University (QN2013018), and the China Agriculture Research System (No. CARS-25-D-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Austin JR, 2006, PLANT CELL, V18, P1693, DOI 10.1105/tpc.105.039859; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Begcy K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044697; Belle NAV, 2004, BRAIN RES, V1008, P245, DOI 10.1016/j.brainres.2004.02.036; BILGER W, 1990, PHOTOSYNTH RES, V25, P173, DOI 10.1007/BF00033159; Bouchereau A, 1999, PLANT SCI, V140, P103, DOI 10.1016/S0168-9452(98)00218-0; Chen CS, 2012, PLANT PHYSIOL BIOCH, V60, P12, DOI 10.1016/j.plaphy.2012.07.016; Childs AC, 2003, CELL MOL LIFE SCI, V60, P1394, DOI 10.1007/s00018-003-2332-4; Demmig-Adams B, 2006, NEW PHYTOL, V172, P11, DOI 10.1111/j.1469-8137.2006.01835.x; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; DemmigAdams B, 1996, TRENDS PLANT SCI, V1, P21, DOI 10.1016/S1360-1385(96)80019-7; Deng C, 2011, J AGR SCI TECH-IRAN, V13, P687; Dernetriou G, 2007, BBA-BIOENERGETICS, V1767, P272, DOI 10.1016/j.bbabio.2007.02.020; FARQUHAR GD, 1982, ANNU REV PLANT PHYS, V33, P317, DOI 10.1146/annurev.pp.33.060182.001533; GALSTON AW, 1990, PLANT PHYSIOL, V94, P406, DOI 10.1104/pp.94.2.406; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Goss R, 2010, PHOTOSYNTH RES, V106, P103, DOI 10.1007/s11120-010-9536-x; Groppa MD, 2008, AMINO ACIDS, V34, P35, DOI 10.1007/s00726-007-0501-8; Guo YP, 2006, PHOTOSYNTHETICA, V44, P439, DOI 10.1007/s11099-006-0048-z; Ha HC, 1998, P NATL ACAD SCI USA, V95, P11140, DOI 10.1073/pnas.95.19.11140; Hamdani S, 2011, J PHOTOCH PHOTOBIO B, V104, P314, DOI 10.1016/j.jphotobiol.2011.02.007; Hamdani S, 2011, PLANT CELL PHYSIOL, V52, P866, DOI 10.1093/pcp/pcr040; Havaux M, 2007, PLANT PHYSIOL, V145, P1506, DOI 10.1104/pp.107.108480; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Hu XH, 2012, PLANT PHYSIOL BIOCH, V57, P200, DOI 10.1016/j.plaphy.2012.05.015; Hussain SS, 2011, BIOTECHNOL ADV, V29, P300, DOI 10.1016/j.biotechadv.2011.01.003; Jahns P, 2012, BBA-BIOENERGETICS, V1817, P182, DOI 10.1016/j.bbabio.2011.04.012; Li RL, 2010, SOIL SCI PLANT NUTR, V56, P725, DOI 10.1111/j.1747-0765.2010.00506.x; Liu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078196; Liu ZX, 2012, PHOTOSYNTHETICA, V50, P152, DOI 10.1007/s11099-012-0007-9; Mittal S, 2012, PLANT PHYSIOL BIOCH, V54, P17, DOI 10.1016/j.plaphy.2012.02.003; Murata N, 2007, BBA-BIOENERGETICS, V1767, P414, DOI 10.1016/j.bbabio.2006.11.019; Naeem MS, 2012, PLANT PHYSIOL BIOCH, V57, P84, DOI 10.1016/j.plaphy.2012.05.018; Nilkens M, 2010, BBA-BIOENERGETICS, V1797, P466, DOI 10.1016/j.bbabio.2010.01.001; Ogweno JO, 2010, PLANT GROWTH REGUL, V60, P175, DOI 10.1007/s10725-009-9439-z; Paramonova NV, 2004, RUSS J PLANT PHYSL+, V51, P86, DOI 10.1023/B:RUPP.0000011307.95130.8f; Parida AK, 2003, PHOTOSYNTHETICA, V41, P191, DOI 10.1023/B:PHOT.0000011951.37231.69; Shu S, 2013, PLANT PHYSIOL BIOCH, V63, P209, DOI 10.1016/j.plaphy.2012.11.028; Shu S, 2012, PHYSIOL PLANTARUM, V146, P285, DOI 10.1111/j.1399-3054.2012.01623.x; Shu Sheng, 2012, African Journal of Biotechnology, V11, P6064; Tian J, 2012, J AM SOC HORTIC SCI, V137, P11, DOI 10.21273/JASHS.137.1.11; Triantaphylides C, 2008, PLANT PHYSIOL, V148, P960, DOI 10.1104/pp.108.125690; Wrona M, 2004, FREE RADICAL BIO MED, V36, P1094, DOI 10.1016/j.freeradbiomed.2004.02.005; Yadav DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045883; Yang JY, 2011, PHOTOSYNTHETICA, V49, P275, DOI 10.1007/s11099-011-0037-8; [李阳 Yang Li], 2009, [植物学报, Chinese Bulletin of Botany], V44, P571; Yin Y, 2010, J PLANT PHYSIOL, V167, P959, DOI 10.1016/j.jplph.2009.12.021; Zhang R, 2011, PHOTOSYNTH RES, V108, P171, DOI 10.1007/s11120-011-9672-y; Zhang RH, 2009, PHOTOSYNTH RES, V100, P155, DOI 10.1007/s11120-009-9441-3; Zhang Y, 2013, J AM SOC HORTIC SCI, V138, P38, DOI 10.21273/JASHS.138.1.38	51	28	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e0110855	10.1371/journal.pone.0110855	http://dx.doi.org/10.1371/journal.pone.0110855			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340351	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662800064
J	Zwerling, A; White, RG; Vassall, A; Cohen, T; Dowdy, DW; Houben, RMGJ				Zwerling, Alice; White, Richard G.; Vassall, Anna; Cohen, Ted; Dowdy, David W.; Houben, Rein M. G. J.			Modeling of Novel Diagnostic Strategies for Active Tuberculosis - A Systematic Review: Current Practices and Recommendations	PLOS ONE			English	Article							COST-EFFECTIVENESS ANALYSIS; DRUG-RESISTANT TUBERCULOSIS; SOUTH-AFRICA; PULMONARY TUBERCULOSIS; ANTIRETROVIRAL THERAPY; MATHEMATICAL-MODEL; POTENTIAL IMPACT; HIV; TB; EPIDEMICS	Introduction: The field of diagnostics for active tuberculosis (TB) is rapidly developing. TB diagnostic modeling can help to inform policy makers and support complicated decisions on diagnostic strategy, with important budgetary implications. Demand for TB diagnostic modeling is likely to increase, and an evaluation of current practice is important. We aimed to systematically review all studies employing mathematical modeling to evaluate cost-effectiveness or epidemiological impact of novel diagnostic strategies for active TB. Methods: Pubmed, personal libraries and reference lists were searched to identify eligible papers. We extracted data on a wide variety of model structure, parameter choices, sensitivity analyses and study conclusions, which were discussed during a meeting of content experts. Results & Discussion: From 5619 records a total of 36 papers were included in the analysis. Sixteen papers included population impact/transmission modeling, 5 were health systems models, and 24 included estimates of cost-effectiveness. Transmission and health systems models included specific structure to explore the importance of the diagnostic pathway (n = 4), key determinants of diagnostic delay (n = 5), operational context (n = 5), and the pre-diagnostic infectious period (n = 1). The majority of models implemented sensitivity analysis, although only 18 studies described multi-way sensitivity analysis of more than 2 parameters simultaneously. Among the models used to make cost-effectiveness estimates, most frequent diagnostic assays studied included Xpert MTB/RIF (n = 7), and alternative nucleic acid amplification tests (NAATs) (n = 4). Most (n = 16) of the cost-effectiveness models compared new assays to an existing baseline and generated an incremental cost-effectiveness ratio (ICER). Conclusion: Although models have addressed a small number of important issues, many decisions regarding implementation of TB diagnostics are being made without the full benefits of insight from mathematical models. Further models are needed that address a wider array of diagnostic and epidemiological settings, that explore the inherent uncertainty of models and that include additional epidemiological data on transmission implications of false-negative	[Zwerling, Alice; Dowdy, David W.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [White, Richard G.; Houben, Rein M. G. J.] London Sch Hyg & Trop Med, TB Ctr, TB Modelling Grp, London WC1, England; [Vassall, Anna] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England; [Cohen, Ted] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Harvard University; Harvard T.H. Chan School of Public Health	Zwerling, A (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	alice.zwerlin@jhsph.edu	White, Richard G/D-5407-2009	White, Richard G/0000-0003-4410-6635; Vassall, Anna/0000-0002-2911-1375; Cohen, Ted/0000-0002-8091-7198	Canadian Institutes of Health Research; TB Modelling and Analysis Consortium (TB MAC) [OPP1084276]; Bill and Melinda Gates Foundation; Medical Research Council (UK) (Methodology Research) [G0802414, MR/J005088/1]; CDC/PEPFAR via the Aurum Institute [U2GPS0008111]; Medical Research Council [G0802414, MR/J005088/1] Funding Source: researchfish; MRC [G0802414, MR/J005088/1] Funding Source: UKRI	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); TB Modelling and Analysis Consortium (TB MAC); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council (UK) (Methodology Research); CDC/PEPFAR via the Aurum Institute; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	AZ is funded through a Canadian Institutes of Health Research post-doctoral fellowship. RGW, AV, DWD, TC, and RMGJH are funded by the TB Modelling and Analysis Consortium (TB MAC) grant (OPP1084276) from the Bill and Melinda Gates Foundation. RGW is also funded by the Medical Research Council (UK) (Methodology Research Fellowship: G0802414 and grant MR/J005088/1) and CDC/PEPFAR via the Aurum Institute (U2GPS0008111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abimbola TO, 2012, JAIDS-J ACQ IMM DEF, V60, pE1, DOI 10.1097/QAI.0b013e318246538f; Abu-Raddad LJ, 2009, P NATL ACAD SCI USA, V106, P13980, DOI 10.1073/pnas.0901720106; Acuna-Villaorduna C, 2008, CLIN INFECT DIS, V47, P487, DOI 10.1086/590010; Albert H, 2004, INT J TUBERC LUNG D, V8, P240; Andrews JR, 2012, AIDS, V26, P987, DOI 10.1097/QAD.0b013e3283522d47; Bacaer N, 2008, J MATH BIOL, V57, P557, DOI 10.1007/s00285-008-0177-z; Barter DM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-980; Basu S, 2009, P NATL ACAD SCI USA, V106, P7672, DOI 10.1073/pnas.0812472106; Boehme CC, 2013, SEMIN RESP CRIT CARE, V34, P17, DOI 10.1055/s-0032-1333468; Bonnet M, 2010, INT J TUBERC LUNG D, V14, P571; Dowdy DW, 2008, INT J TUBERC LUNG D, V12, P1021; Dowdy DW, 2008, P NATL ACAD SCI USA, V105, P11293, DOI 10.1073/pnas.0800965105; Dowdy DW, 2013, AM J RESP CRIT CARE, V187, P543, DOI 10.1164/rccm.201207-1217OC; Dowdy DW, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001074; Dowdy DW, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001063; Dowdy DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004057; Dowdy DW, 2006, AIDS, V20, P751, DOI 10.1097/01.aids.0000216376.07185.cc; Dowdy DW, 2003, J CLIN MICROBIOL, V41, P948, DOI 10.1128/JCM.41.3.948-953.2003; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Dye C, 2012, INDIAN J MED RES, V135, P737; Garnett GP, 2011, LANCET, V378, P515, DOI 10.1016/S0140-6736(10)61505-X; Guerra RL, 2008, J CLIN MICROBIOL, V46, P3811, DOI 10.1128/JCM.01682-08; Hughes R, 2012, RESP MED, V106, P300, DOI 10.1016/j.rmed.2011.10.005; Jones TF, 2001, AM J RESP CRIT CARE, V164, P77, DOI 10.1164/ajrccm.164.1.2010108; Langley I, 2012, HEALTH CARE MANAG SC, V15, P239, DOI 10.1007/s10729-012-9201-3; Legrand J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002100; Lim T K, 2000, Respirology, V5, P403, DOI 10.1046/j.1440-1843.2000.00284.x; Lin HH, 2011, INT J TUBERC LUNG D, V15, P996, DOI 10.5588/ijtld.11.0062; Lin HH, 2012, B WORLD HEALTH ORGAN, V90, P739, DOI 10.2471/BLT.11.101436; Maheswaran H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030457; McNerney R, 2012, J INFECT DIS, V205, pS147, DOI 10.1093/infdis/jir860; Menzies NA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001347; Meyer-Rath G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036966; Millen SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001933; Pai M, 2008, SEMIN RESP CRIT CARE, V29, P560, DOI 10.1055/s-0028-1085707; Pai M, 2010, CURR OPIN PULM MED, V16, P271, DOI 10.1097/MCP.0b013e328338094f; Rajalahti I, 2004, EUR RESPIR J, V23, P446, DOI 10.1183/09031936.04.00009704; Resch SC, 2006, PLOS MED, V3, P1048, DOI 10.1371/journal.pmed.0030241; Samandari T, 2011, AM J RESP CRIT CARE, V183, P1103, DOI 10.1164/rccm.201004-0620OC; Schnippel K, 2013, SAMJ S AFR MED J, V103, P101, DOI [10.7196/SAMJ.6182, 10.7196/samj.6182]; Sun D, 2013, INT J TUBERC LUNG D, V17, P552, DOI 10.5588/ijtld.12.0627; Uys PW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000757; Uys PW, 2009, J CLIN MICROBIOL, V47, P1484, DOI 10.1128/JCM.02289-08; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; Winetsky DE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001348	45	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110558	10.1371/journal.pone.0110558	http://dx.doi.org/10.1371/journal.pone.0110558			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340701	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000343662800041
J	Germanov, ES; Marshall, AD				Germanov, Elitza S.; Marshall, Andrea D.			Running the Gauntlet: Regional Movement Patterns of Manta alfredi through a Complex of Parks and Fisheries	PLOS ONE			English	Article							PHOTOGRAPHIC IDENTIFICATION; RAYS; AFFINITY; BIOLOGY; ECOLOGY	Manta rays (Genus Manta) are economically important for fisheries and tourism in Indonesia. These species have been listed by the International Union for the Conservation of Nature Red List as Vulnerable to extinction; therefore, human exploitation of manta rays must be regulated. A better understanding of the habitat use and movement patterns of manta rays in Indonesia is needed in order to employ effective conservation measures. To gain better insight into the movements of Manta alfredi we used 'Manta Matcher', an online database with an integrated automated matching algorithm, to compare photographs from 2,604 encounters of M. alfredi collected by recreational divers and dive operators throughout Indonesia over a nine-year period. This photographic comparison revealed that manta rays migrated between regional sanctuaries such as Nusa Penida, the Gili Islands, and the Komodo National Park (up to 450 km straight-line distance). The areas between these sanctuaries are heavily fished and trafficked by ships, and when manta rays travel through these regions they risk being fished and injured by ship strikes. These long-range manta ray movements suggest connectivity between M. alfredi populations in neighboring islands and raise concerns about the future management of regional populations. It is recommended that a national conservation strategy be developed to protect the remaining populations in the country.	[Germanov, Elitza S.; Marshall, Andrea D.] Marine Megafauna Fdn, Truckee, CA 96161 USA		Germanov, ES (corresponding author), Marine Megafauna Fdn, Truckee, CA 96161 USA.	germanov@dal.ca		Germanov, Elitza/0000-0002-8797-4451; Marshall, Andrea/0000-0003-1886-5355	development of 'Manta Matcher'	development of 'Manta Matcher'	We are indebted to H. Mitchell and P. Bassett for their tremendous contribution enabling this project. We are thankful to G. Winstanley for his support regarding 'Manta Matcher'. We are grateful to the numerous citizen scientists, dive industry professionals and dive operators who have enabled this large-scale data collection. In particular, we would like to acknowledge D. Arriaga, J. Arriaga, T. Birkett, J. Green, R. Horner, L. Johnston, K. Klingeler, P. Kuijper, N. Longfellow, J. Marlow, F. Nompas, N. Prest and Barefoot Conservation for their contributions, as well as F. Claassen, M. Cobussen and L. Ellevog for the tremendous assistance in data processing and analysis. We are thankful to L. Couturier, J. Musick and one anonymous reviewer for their comments on the manuscript. We thank P. Bassett and V. Brakalova for their figure design and formatting. ADM would like to thank A. Rooney and J. Artendale for the generous funding which supported the development of 'Manta Matcher'.	Anderson RC, 2011, FISH OCEANOGR, V20, P104, DOI 10.1111/j.1365-2419.2011.00571.x; Bonney R, 2009, BIOSCIENCE, V59, P977, DOI 10.1525/bio.2009.59.11.9; Couturier LIE, 2014, CORAL REEFS, V33, P329, DOI 10.1007/s00338-014-1126-5; Couturier LIE, 2012, J FISH BIOL, V80, P1075, DOI 10.1111/j.1095-8649.2012.03264.x; Couturier LIE, 2011, MAR FRESHWATER RES, V62, P628, DOI 10.1071/MF10148; Deakos MH, 2011, MAR ECOL PROG SER, V429, P245, DOI 10.3354/meps09085; Dewar H, 2008, MAR BIOL, V155, P121, DOI 10.1007/s00227-008-0988-x; Game ET, 2009, TRENDS ECOL EVOL, V24, P360, DOI 10.1016/j.tree.2009.01.011; Gaston KJ, 2008, ANNU REV ECOL EVOL S, V39, P93, DOI 10.1146/annurev.ecolsys.39.110707.173529; Graham RT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036834; Gruss A, 2011, BIOL CONSERV, V144, P692, DOI 10.1016/j.biocon.2010.12.015; Heinrichs S, 2011, MANTA RAY HOPE; Jaine FRA, 2014, MAR ECOL PROG SER, V510, P73, DOI 10.3354/meps10910; Jaine FRA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046170; Kitchen-Wheeler AM, 2012, ENVIRON BIOL FISH, V93, P557, DOI 10.1007/s10641-011-9950-8; Marshall AD, 2012, J FISH BIOL, V80, P1361, DOI 10.1111/j.1095-8649.2012.03244.x; Marshall AD, 2011, MAR BIOL, V158, P1111, DOI 10.1007/s00227-011-1634-6; Marshall AD, 2010, J FISH BIOL, V77, P169, DOI 10.1111/j.1095-8649.2010.02669.x; Marshall AD, 2011, IUCN RED LIST THREAT; Marshall AD, 2014, MANTA FISHERY SOLOR; Marshall AD, 2009, ZOOTAXA, P1; Miller-Rushing A, 2012, FRONT ECOL ENVIRON, V10, P285, DOI 10.1890/110278; O'Malley MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065051; Rohner CA, 2013, MAR ECOL PROG SER, V482, P153, DOI 10.3354/meps10290; Town C, 2013, ECOL EVOL, V3, P1902, DOI 10.1002/ece3.587; Ward-Paige CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074835; White WT, 2006, FISH RES, V82, P65, DOI 10.1016/j.fishres.2006.08.008	27	35	38	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110071	10.1371/journal.pone.0110071	http://dx.doi.org/10.1371/journal.pone.0110071			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337865	Green Submitted, Green Published, gold			2022-12-27	WOS:000343674800023
J	Han, L; Zhang, YJ; Zhang, L; Cui, X; Yu, JP; Zhang, ZD; Liu, MS				Han, Lei; Zhang, Yong-Jun; Zhang, Long; Cui, Xu; Yu, Jinpu; Zhang, Ziding; Liu, Ming S.			Operating Mechanism and Molecular Dynamics of Pheromone-Binding Protein ASP1 as Influenced by pH	PLOS ONE			English	Article							ODORANT-BINDING; CRYSTAL-STRUCTURE; LIGAND-RELEASE; NMR STRUCTURE; SECONDARY STRUCTURE; SEXUAL ATTRACTION; SILKWORM MOTH; RECOGNITION; SIMULATIONS; RECEPTION	Odorant binding protein (OBP) is a vital component of the olfactory sensation system. It performs the specific role of ferrying odorant molecules to odorant receptors. OBP helps insects and types of animal to sense and transport stimuli molecules. However, the molecular details about how OBPs bind or release its odorant ligands are unclear. For some OBPs, the systems' pH level is reported to impact on the ligands' binding or unbinding capability. In this work we investigated the operating mechanism and molecular dynamics in bee antennal pheromone-binding protein ASP1 under varying pH conditions. We found that conformational flexibility is the key factor for regulating the interaction of ASP1 and its ligands, and the odorant binds to ASP1 at low pH conditions. Dynamics, once triggered by pH changes, play the key roles in coupling the global conformational changes with the odorant release. In ASP1, the C-terminus, the N-terminus, helix alpha 2 and the region ranging from helices alpha 4 to alpha 5 form a cavity with a novel 'entrance' of binding. These are the major regions that respond to pH change and regulate the ligand release. Clearly there are processes of dynamics and hydrogen bond network propagation in ASP1 in response to pH stimuli. These findings lead to an understanding of the mechanism and dynamics of odorant-OBP interaction in OBP, and will benefit chemsensory-related biotech and agriculture research and development.	[Han, Lei; Yu, Jinpu] Tianjin Med Univ, Ctr Canc Mol Diag, Canc Inst & Hosp, Natl Clin Res Ctr Canc, Tianjin, Peoples R China; [Han, Lei; Zhang, Ziding] China Agr Univ, State Key Lab Agrobiotechnol, Coll Biol Sci, Beijing 100094, Peoples R China; [Zhang, Yong-Jun] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Zhang, Long] China Agr Univ, Minist Agr, Key Lab Biol Control, Beijing 100094, Peoples R China; [Cui, Xu] Beijing Comp Ctr, Beijing, Peoples R China; [Liu, Ming S.] CSIRO Computat Informat & Digital Product Flagshi, Clayton, Australia	Tianjin Medical University; China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; China Agricultural University; Ministry of Agriculture & Rural Affairs; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Zhang, ZD (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Coll Biol Sci, Beijing 100094, Peoples R China.	zidingzhang@cau.edu.cn; ming.liu@csiro.au	, zidingzhang/E-9320-2011	, zidingzhang/0000-0002-9296-571X	National Key Basic Research Program of China [2009CB918802, 2012CB114104]; State Education Ministry of China [20120008110014]	National Key Basic Research Program of China(National Basic Research Program of China); State Education Ministry of China(Ministry of Education, China)	This work was partially supported by the National Key Basic Research Program of China (2009CB918802 and 2012CB114104) and the State Education Ministry of China (20120008110014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Carey AF, 2011, P NATL ACAD SCI USA, V108, P12987, DOI 10.1073/pnas.1103472108; Chu WT, 2013, J MOL MODEL, V19, P1301, DOI 10.1007/s00894-012-1680-0; Golebiowski J, 2007, PROTEINS, V67, P448, DOI 10.1002/prot.21307; Grater F, 2006, STRUCTURE, V14, P1567, DOI 10.1016/j.str.2006.08.012; Hajjar E, 2006, J BIOL CHEM, V281, P29929, DOI 10.1074/jbc.M604869200; Han L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041370; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiang QY, 2009, INSECT BIOCHEM MOLEC, V39, P440, DOI 10.1016/j.ibmb.2009.04.004; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Klusak V, 2003, CHEM BIOL, V10, P331, DOI 10.1016/S1074-5521(03)00074-7; Krieger J, 1999, SCIENCE, V286, P720, DOI 10.1126/science.286.5440.720; Kruse SW, 2003, NAT STRUCT BIOL, V10, P694, DOI 10.1038/nsb960; Lartigue A, 2004, J BIOL CHEM, V279, P4459, DOI 10.1074/jbc.M311212200; Lartigue A, 2003, J BIOL CHEM, V278, P30213, DOI 10.1074/jbc.M304688200; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Leal WS, 2005, P NATL ACAD SCI USA, V102, P5386, DOI 10.1073/pnas.0501447102; Leite NR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008006; Lobanov MY, 2008, MOL BIOL+, V42, P623, DOI 10.1134/S0026893308040195; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Manoharan M, 2014, J BIOMOL STRUCT DYN, V32, P1742, DOI 10.1080/07391102.2013.834118; Mao Y, 2010, P NATL ACAD SCI USA, V107, P19102, DOI 10.1073/pnas.1012274107; Mohanty S, 2004, J MOL BIOL, V337, P443, DOI 10.1016/j.jmb.2004.01.009; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Myers JK, 1996, BIOPHYS J, V71, P2033, DOI 10.1016/S0006-3495(96)79401-8; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; PELOSI P, 1995, COMP BIOCHEM PHYS B, V111, P503, DOI 10.1016/0305-0491(95)00019-5; Pesenti ME, 2008, J MOL BIOL, V380, P158, DOI 10.1016/j.jmb.2008.04.048; Pesenti ME, 2009, J MOL BIOL, V390, P981, DOI 10.1016/j.jmb.2009.05.067; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Seeber M, 2007, BIOINFORMATICS, V23, P2625, DOI 10.1093/bioinformatics/btm378; Shatsky M, 2004, PROTEINS, V56, P143, DOI 10.1002/prot.10628; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Wang SY, 2013, INSECT MOL BIOL, V22, P172, DOI 10.1111/imb.12012; Wogulis M, 2006, BIOCHEM BIOPH RES CO, V339, P157, DOI 10.1016/j.bbrc.2005.10.191; Xu XZ, 2010, BIOCHEMISTRY-US, V49, P1469, DOI 10.1021/bi9020132; Zubkov S, 2005, J MOL BIOL, V354, P1081, DOI 10.1016/j.jmb.2005.10.015	40	23	23	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110565	10.1371/journal.pone.0110565	http://dx.doi.org/10.1371/journal.pone.0110565			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337796	Green Submitted, gold, Green Published			2022-12-27	WOS:000343674800057
J	Jaakkola, ST; Zerulla, K; Guo, QG; Liu, Y; Ma, HL; Yang, CH; Bamford, DH; Chen, XD; Soppa, J; Oksanen, HM				Jaakkola, Salla T.; Zerulla, Karolin; Guo, Qinggong; Liu, Ying; Ma, Hongling; Yang, Chunhe; Bamford, Dennis H.; Chen, Xiangdong; Soppa, Joerg; Oksanen, Hanna M.			Halophilic Archaea Cultivated from Surface Sterilized Middle-Late Eocene Rock Salt Are Polyploid	PLOS ONE			English	Article							HALOBACTERIUM SP NRC-1; SALIFODINAE SP-NOV; FLUID INCLUSIONS; HALOTOLERANT BACTERIUM; HALOCOCCUS-DOMBROWSKII; GENE CONVERSION; ANCIENT HALITE; UV-RADIATION; DEATH-VALLEY; DNA	Live bacteria and archaea have been isolated from several rock salt deposits of up to hundreds of millions of years of age from all around the world. A key factor affecting their longevity is the ability to keep their genomic DNA intact, for which efficient repair mechanisms are needed. Polyploid microbes are known to have an increased resistance towards mutations and DNA damage, and it has been suggested that microbes from deeply buried rock salt would carry several copies of their genomes. Here, cultivable halophilic microbes were isolated from a surface sterilized middle-late Eocene (38-41 million years ago) rock salt sample, drilled from the depth of 800 m at Yunying salt mine, China. Eight unique isolates were obtained, which represented two haloarchaeal genera, Halobacterium and Halolamina. We used real-time PCR to show that our isolates are polyploid, with genome copy numbers of 11-14 genomes per cell in exponential growth phase. The ploidy level was slightly downregulated in stationary growth phase, but the cells still had an average genome copy number of 6-8. The polyploidy of halophilic archaea living in ancient rock salt might be a factor explaining how these organisms are able to overcome the challenge of prolonged survival during their entombment.	[Jaakkola, Salla T.; Bamford, Dennis H.; Oksanen, Hanna M.] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Jaakkola, Salla T.; Bamford, Dennis H.; Oksanen, Hanna M.] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Zerulla, Karolin; Soppa, Joerg] Goethe Univ Frankfurt, Inst Mol Biol, D-60054 Frankfurt, Germany; [Guo, Qinggong; Liu, Ying; Chen, Xiangdong] Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China; [Ma, Hongling; Yang, Chunhe] Chinese Acad Sci, Inst Rock & Soil Mech, Wuhan, Hubei, Peoples R China	University of Helsinki; University of Helsinki; Goethe University Frankfurt; Wuhan University; Chinese Academy of Sciences; Wuhan Institute of Rock & Soil Mechanics, CAS	Chen, XD (corresponding author), Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China.	xdchen@whu.edu.cn; soppa@bio.uni-frankfurt.de; hanna.oksanen@helsinki.fi	Oksanen, Hanna M/Y-7379-2019	Oksanen, Hanna M/0000-0003-3047-8294; Bamford, Dennis/0000-0002-6438-8118; Soppa, Jorg/0000-0002-6132-5840	Academy of Finland [255342, 256518]; German Research Council (DFG); National Basic Research Program of China (973 Program) [2011CB808800]; Ministry of Science and Technology of the People's Republic of China;  [So264/16]	Academy of Finland(Academy of Finland); German Research Council (DFG)(German Research Foundation (DFG)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); 	This study was supported by Academy Professor (Academy of Finland; http://www.aka.fi) funding grants 255342 and 256518 (to DHB), the German Research Council (DFG; http://www.dfg.de) with the project So264/16 (to JS), and by grants from the National Basic Research Program of China (973 Program) no. 2011CB808800 (http://www.973.gov.cn/Default_3.aspx), Ministry of Science and Technology of the People's Republic of China (to XC). STJ is a University of Helsinki fellow of the Integrative Life Science Doctoral Program (ILS; http://www.finbionet.fi/ils/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arahal DR, 1996, APPL ENVIRON MICROB, V62, P3779, DOI 10.1128/AEM.62.10.3779-3786.1996; Atanasova NS, 2012, ENVIRON MICROBIOL, V14, P426, DOI 10.1111/j.1462-2920.2011.02603.x; Baliga NS, 2004, GENOME RES, V14, P1025, DOI 10.1101/gr.1993504; Breuert S, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000092; Cha IT, 2014, ANTON LEEUW INT J G, V105, P907, DOI 10.1007/s10482-014-0145-0; Cui HL, 2011, INT J SYST EVOL MICR, V61, P1617, DOI 10.1099/ijs.0.026799-0; DALY MJ, 1995, J BACTERIOL, V177, P5495, DOI 10.1128/jb.177.19.5495-5505.1995; DELEY J, 1966, ANTON VAN LEE J M S, V32, P315, DOI 10.1007/BF02097474; DENNER EBM, 1994, INT J SYST BACTERIOL, V44, P774, DOI 10.1099/00207713-44-4-774; Dyall-Smith M. L., 2009, HALOHANDBOOK; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Fendrihan S, 2004, ESA SP PUBL, V545, P203; Fendrihan S, 2012, GEOBIOLOGY, V10, P424, DOI 10.1111/j.1472-4669.2012.00337.x; Fendrihan S, 2009, ASTROBIOLOGY, V9, P104, DOI 10.1089/ast.2007.0234; Fish SA, 2002, NATURE, V417, P432, DOI 10.1038/417432a; Gramain A, 2011, ENVIRON MICROBIOL, V13, P2105, DOI 10.1111/j.1462-2920.2011.02435.x; Grant WD, 1998, EXTREMOPHILES, V2, P279, DOI 10.1007/s007920050070; Gruber C, 2004, EXTREMOPHILES, V8, P431, DOI 10.1007/s00792-004-0403-6; HANSEN MT, 1978, J BACTERIOL, V134, P71, DOI 10.1128/JB.134.1.71-75.1978; Hazen RM, 2001, NATURE, V411, P155, DOI 10.1038/35075663; Hebsgaard MB, 2005, TRENDS MICROBIOL, V13, P212, DOI 10.1016/j.tim.2005.03.010; Hildenbrand C, 2011, J BACTERIOL, V193, P734, DOI 10.1128/JB.01016-10; HOLMES ML, 1990, J BACTERIOL, V172, P756, DOI 10.1128/jb.172.2.756-761.1990; Huang X, 2009, DISCUSSION UNDERGROU; Johnson SS, 2007, P NATL ACAD SCI USA, V104, P14401, DOI 10.1073/pnas.0706787104; Karl DM, 2000, NATURE, V406, P31, DOI 10.1038/35017683; KENNEDY MJ, 1994, MICROBIOL-SGM, V140, P2513, DOI 10.1099/00221287-140-10-2513; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Kottemann M, 2005, EXTREMOPHILES, V9, P219, DOI 10.1007/s00792-005-0437-4; KRASIN F, 1977, J MOL BIOL, V116, P81, DOI 10.1016/0022-2836(77)90120-6; Lange C, 2011, MOL MICROBIOL, V80, P666, DOI 10.1111/j.1365-2958.2011.07600.x; Mackwan RR, 2007, GENETICS, V176, P697, DOI 10.1534/genetics.106.069666; Mancinelli RL, 2000, PLANET SPACE SCI, V48, P1093, DOI 10.1016/S0032-0633(00)00083-0; Maughan H, 2002, MOL BIOL EVOL, V19, P1637, DOI 10.1093/oxfordjournals.molbev.a004227; McCready S, 1996, MUTAT RES-DNA REPAIR, V364, P25, DOI 10.1016/0921-8777(96)00018-3; McGenity TJ, 2000, ENVIRON MICROBIOL, V2, P243, DOI 10.1046/j.1462-2920.2000.00105.x; Mendell JE, 2008, P NATL ACAD SCI USA, V105, P6730, DOI 10.1073/pnas.0707522105; Meng FW, 2014, J ASIAN EARTH SCI, V85, P97, DOI 10.1016/j.jseaes.2014.01.024; Meng FW, 2013, J ASIAN EARTH SCI, V67-68, P46, DOI 10.1016/j.jseaes.2013.02.008; Miteva VI, 2004, APPL ENVIRON MICROB, V70, P202, DOI 10.1128/AEM.70.1.202-213.2004; Mormile MR, 2003, ENVIRON MICROBIOL, V5, P1094, DOI 10.1046/j.1462-2920.2003.00509.x; Nattwongasem D, 2010, GCEP PROGR REPORT CO; NORTON CF, 1993, J GEN MICROBIOL, V139, P1077, DOI 10.1099/00221287-139-5-1077; OLKKONEN VM, 1989, VIROLOGY, V171, P229, DOI 10.1016/0042-6822(89)90530-8; Pecoraro V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016392; Pietila MK, 2009, MOL MICROBIOL, V72, P307, DOI 10.1111/j.1365-2958.2009.06642.x; Powers DW, 2001, NATURE, V411, P155, DOI 10.1038/35075665; Rosenzweig WD, 2000, GEOMICROBIOL J, V17, P185; Sankaranarayanan K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020683; Satterfield CL, 2005, GEOLOGY, V33, P265, DOI 10.1130/G21106.1; Schubert BA, 2010, ENVIRON MICROBIOL, V12, P440, DOI 10.1111/j.1462-2920.2009.02086.x; Schubert BA, 2010, GEOMICROBIOL J, V27, P61, DOI 10.1080/01490450903232207; Schubert BA, 2009, GEOLOGY, V37, P1059, DOI 10.1130/G30448A.1; Schubert BA, 2009, ASTROBIOLOGY, V9, P467, DOI 10.1089/ast.2008.0282; Sheridan PP, 2003, APPL ENVIRON MICROB, V69, P2153, DOI 10.1128/AEM.69.4.2153-2160.2003; Slade D, 2009, CELL, V136, P1044, DOI 10.1016/j.cell.2009.01.018; Soppa J, 2013, BIOCHEM SOC T, V41, P339, DOI 10.1042/BST20120315; Soppa J, 2011, BIOCHEM SOC T, V39, P150, DOI 10.1042/BST0390150; Stan-Lotter H, 2002, INT J SYST EVOL MICR, V52, P1807, DOI 10.1099/ijs.0.02278-0; STOECKENIUS W, 1967, J CELL BIOL, V34, P365, DOI 10.1083/jcb.34.1.365; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Vreeland RH, 2007, GEOMICROBIOL J, V24, P275, DOI 10.1080/01490450701456917; Vreeland RH, 2000, NATURE, V407, P897, DOI 10.1038/35038060; Wierzchos J, 2012, INT MICROBIOL, V15, P172, DOI 10.2436/20.1501.01.170; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; Woyke T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010314; Yachai M, 2008, INT J SYST EVOL MICR, V58, P2136, DOI 10.1099/ijs.0.65592-0; Yang Y, 2006, INT J SYST EVOL MICR, V56, P2353, DOI 10.1099/ijs.0.64437-0; Zerulla K, 2014, HALOPHILES: GENETICS AND GENOMES, P145; Zerulla K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094819; Zhang GM, 2014, ACTA GEOTECH, V9, P161, DOI 10.1007/s11440-013-0227-6; Zhang WY, 2013, INT J SYST EVOL MICR, V63, P4380, DOI 10.1099/ijs.0.050864-0	73	24	25	5	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110533	10.1371/journal.pone.0110533	http://dx.doi.org/10.1371/journal.pone.0110533			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338080	Green Published, Green Submitted, gold			2022-12-27	WOS:000343674800054
J	Karp-Boss, L; Gueta, R; Rousso, I				Karp-Boss, Lee; Gueta, Rachel; Rousso, Itay			Judging Diatoms by Their Cover: Variability in Local Elasticity of Lithodesmium undulatum Undergoing Cell Division	PLOS ONE			English	Article							ATOMIC-FORCE; NANOSTRUCTURE; MORPHOLOGY; AFM	Unique features of diatoms are their intricate cell covers (frustules) made out of hydrated, amorphous silica. The frustule defines and maintains cell shape and protects cells against grazers and pathogens, yet it must allow for cell expansion during growth and division. Other siliceous structures have also evolved in some chain-forming species as means for holding neighboring cells together. Characterization and quantification of mechanical properties of these structures are crucial for the understanding of the relationship between form and function in diatoms, but thus far only a handful of studies have addressed this issue. We conducted micro-indentation experiments, using atomic force microscopy (AFM), to examine local variations in elastic (Young's) moduli of cells and linking structures in the marine, chain-forming diatom Lithodesmium undulatum. Using a fluorescent tracer that is incorporated into new cell wall components we tested the hypothesis that new siliceous structures differ in elastic modulus from their older counterparts. Results show that the local elastic modulus is a highly dynamic property. Elastic modulus of stained regions was significantly lower than that of unstained regions, suggesting that newly formed cell wall components are generally softer than the ones inherited from the parent cells. This study provides the first evidence of differentiation in local elastic properties in the course of the cell cycle. Hardening of newly formed regions may involve incorporation of additional, possibly organic, material but further studies are needed to elucidate the processes that regulate mechanical properties of the frustule during the cell cycle.	[Karp-Boss, Lee] Univ Maine, Sch Marine Sci, Orono, ME 04469 USA; [Gueta, Rachel] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Rousso, Itay] Ben Gurion Univ Negev, Dept Physiol & Cell Biol, Beer Sheva, Israel	University of Maine System; University of Maine Orono; Weizmann Institute of Science; Ben Gurion University	Karp-Boss, L (corresponding author), Univ Maine, Sch Marine Sci, Orono, ME 04469 USA.	lee.karp-boss@maine.edu	Rousso, Itay/A-7662-2013	Rousso, Itay/0000-0002-4399-9171	USA National Science Foundation [NSF0724744]	USA National Science Foundation(National Science Foundation (NSF))	This work was supported by the USA National Science Foundation NSF0724744. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almqvist N, 2001, J MICROSC-OXFORD, V202, P518, DOI 10.1046/j.1365-2818.2001.00887.x; Bosak S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044851; Chiovitti A, 2005, J PHYCOL, V41, P1154, DOI 10.1111/j.1529-8817.2005.00140.x; Crawford SA, 2001, J PHYCOL, V37, P543, DOI 10.1046/j.1529-8817.2001.037004543.x; Durkin CA, 2009, EUKARYOT CELL, V8, P1038, DOI 10.1128/EC.00079-09; Francius G, 2008, ENVIRON MICROBIOL, V10, P1344, DOI 10.1111/j.1462-2920.2007.01551.x; GUILLARD RRL, 1993, PHYCOLOGIA, V32, P234, DOI 10.2216/i0031-8884-32-3-234.1; Hamm CE, 2003, NATURE, V421, P841, DOI 10.1038/nature01416; Hazelaar S, 2005, J PHYCOL, V41, P354, DOI 10.1111/j.1529-8817.2005.04131.x; Hildebrand M, 2008, CHEM REV, V108, P4855, DOI 10.1021/cr078253z; Hildebrand M, 2008, PFLUG ARCH EUR J PHY, V456, P127, DOI 10.1007/s00424-007-0388-y; Hildebrand M, 2006, J MATER RES, V21, P2689, DOI 10.1557/JMR.2006.0333; Karp-Boss L, 1998, LIMNOL OCEANOGR, V43, P1767, DOI 10.4319/lo.1998.43.8.1767; Kasas S, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/13/133001; Kroger N, 2008, ANNU REV GENET, V42, P83, DOI 10.1146/annurev.genet.41.110306.130109; Kroger N, 2000, PROTIST, V151, P263, DOI 10.1078/1434-4610-00024; Leblanc K, 2005, LIMNOL OCEANOGR-METH, V3, P462, DOI 10.4319/lom.2005.3.462; Losic D, 2007, LANGMUIR, V23, P5014, DOI 10.1021/la062666y; PICKETT-HEAPS J.D, 1990, PROGR PHYCOLOGICAL R; Pletikapic G, 2012, J PHYCOL, V48, P174, DOI 10.1111/j.1529-8817.2011.01093.x; Raven JA, 2004, NEW PHYTOL, V162, P45, DOI 10.1111/j.1469-8137.2004.01022.x; Round F.E., 1990, DIATOMS; Shimizu K, 2001, CHEM BIOL, V8, P1051, DOI 10.1016/S1074-5521(01)00072-2; Shrestha RP, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-499; Smetacek V, 2001, NATURE, V411, P745, DOI 10.1038/35081210; Tesson B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061675; Tesson B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014300; Tesson B, 2010, J STRUCT BIOL, V169, P62, DOI 10.1016/j.jsb.2009.08.013; Tomas CR, 1997, IDENTIFYING MARINE P; Vinckier A, 1998, FEBS LETT, V430, P12, DOI 10.1016/S0014-5793(98)00592-4; Vrieling EG, 2007, P NATL ACAD SCI USA, V104, P10441, DOI 10.1073/pnas.0608980104; Wilken S, 2011, LIMNOL OCEANOGR, V56, P1399, DOI 10.4319/lo.2011.56.4.1399; Young AM, 2012, LIMNOL OCEANOGR, V57, P1789, DOI 10.4319/lo.2012.57.6.1789	34	5	5	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e109089	10.1371/journal.pone.0109089	http://dx.doi.org/10.1371/journal.pone.0109089			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337801	Green Published, Green Submitted, gold			2022-12-27	WOS:000343674800008
J	Kulkarni, V; Valentin, A; Rosati, M; Rolland, M; Mullins, JI; Pavlakis, GN; Felber, BK				Kulkarni, Viraj; Valentin, Antonio; Rosati, Margherita; Rolland, Morgane; Mullins, James I.; Pavlakis, George N.; Felber, Barbara K.			HIV-1 Conserved Elements p24CE DNA Vaccine Induces Humoral Immune Responses with Broad Epitope Recognition in Macaques	PLOS ONE			English	Article							T-LYMPHOCYTE RESPONSES; CELL RESPONSES; REGIONS; BREADTH; ANTIBODIES; PROTEINS; COVERAGE; DESIGN	To target immune responses towards invariable regions of the virus, we engineered DNA-based immunogens encoding conserved elements (CE) of HIV-1 p24(gag). This conserved element vaccine is designed to avoid decoy epitopes by focusing responses to critical viral elements. We previously reported that vaccination of macaques with p24CE DNA induced robust cellular immune responses to CE that were not elicited upon wild type p55(gag) DNA vaccination. p24CE DNA priming followed by p55(gag) DNA boost provided a novel strategy to increase the magnitude and breadth of the cellular immune responses to HIV-1 Gag, including the induction of strong, multifunctional T-cell responses targeting epitopes within CE. Here, we examined the humoral responses induced upon p24CE DNA or p55(gag) DNA vaccination in macaques and found that although both vaccines induced robust p24(gag) binding antibody responses, the responses induced by p24CE DNA showed a unique broad range of linear epitope recognition. In contrast, antibodies elicited by p55(gag) DNA vaccine failed to recognize p24CE protein and did not recognize linear epitopes spanning the CE. Interestingly, boosting of p24CE DNA primed animals with p55(gag) DNA resulted in augmentation of antibodies able to recognize p24(gag) as well as the p24CE proteins, thereby inducing broadest immunity. Our results indicate that an effectively directed vaccine strategy that includes priming with the conserved element vaccine followed by boost with the complete immunogen induces broad cellular and humoral immunity focused on the conserved regions of the virus. This novel and effective strategy to broaden responses could be applied against other antigens of highly diverse pathogens.	[Kulkarni, Viraj; Felber, Barbara K.] NCI, Human Retrovirus Pathogenesis Sect, Vaccine Branch, Ctr Canc Res, Frederick, MD 21701 USA; [Valentin, Antonio; Rosati, Margherita; Pavlakis, George N.] NCI, Human Retrovirus Sect, Vaccine Branch, Ctr Canc Res, Frederick, MD 21701 USA; [Rolland, Morgane; Mullins, James I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Rolland, Morgane; Mullins, James I.] Univ Washington, Dept Med, Seattle, WA USA; [Rolland, Morgane; Mullins, James I.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Pavlakis, GN (corresponding author), NCI, Human Retrovirus Sect, Vaccine Branch, Ctr Canc Res, Frederick, MD 21701 USA.	george.pavlakis@nih.gov; barbara.felber@nih.gov			Intramural Research Program of the National Cancer Institute, National Institutes of Health (NCI/NIH); Public Health Services [AI57005]; NATIONAL CANCER INSTITUTE [ZIABC010350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057005] Funding Source: NIH RePORTER	Intramural Research Program of the National Cancer Institute, National Institutes of Health (NCI/NIH); Public Health Services(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Intramural Research Program of the National Cancer Institute, National Institutes of Health (NCI/NIH) (BKF, GNP) and by Public Health Services grant AI57005 (to JIM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045267; Banerjee K, 2010, AIDS RES HUM RETROV, V26, P445, DOI 10.1089/aid.2009.0223; Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Dahirel V, 2011, P NATL ACAD SCI USA, V108, P11530, DOI 10.1073/pnas.1105315108; De Groot AS, 2008, VACCINE, V26, P3059, DOI 10.1016/j.vaccine.2007.12.004; Doria-Rose NA, 2005, J VIROL, V79, P11214, DOI 10.1128/JVI.79.17.11214-11224.2005; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Fischer W, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040015; French MA, 2013, AIDS, V27, P519, DOI 10.1097/QAD.0b013e32835cb720; French MA, 2010, AIDS, V24, P1983, DOI 10.1097/QAD.0b013e32833c1ce0; Janes H, 2013, J INFECT DIS, V208, P1231, DOI 10.1093/infdis/jit322; Kaufman DR, 2012, VACCINE, V30, P506, DOI 10.1016/j.vaccine.2011.11.079; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kulkarni V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086254; Kulkarni V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060245; Letourneau S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000984; Masemola A, 2004, J VIROL, V78, P3233, DOI 10.1128/JVI.78.7.3233-3243.2004; Mothe B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029717; Mothe B, 2009, DIS MARKERS, V27, P105, DOI [10.1155/2009/360362, 10.3233/DMA-2009-0655]; Mullins James I, 2004, Expert Rev Vaccines, V3, pS151, DOI 10.1586/14760584.3.4.S151; Nickle DC, 2007, PLOS COMPUT BIOL, V3, P754, DOI 10.1371/journal.pcbi.0030075; Nickle DC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040025; Nickle DC, 2003, SCIENCE, V299, P1515; Niu LG, 2011, VACCINE, V29, P2110, DOI 10.1016/j.vaccine.2010.12.131; Ranasinghe S, 2013, NAT MED, V19, P930, DOI 10.1038/nm.3229; Ranasinghe S, 2012, J VIROL, V86, P277, DOI 10.1128/JVI.05577-11; Ribeiro SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011072; Rolland M, 2007, PLOS PATHOG, V3, P1551, DOI 10.1371/journal.ppat.0030157; Rosa DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016921; Rosario M, 2012, AIDS, V26, P275, DOI 10.1097/QAD.0b013e32834ed9b2; Rosario M, 2010, EUR J IMMUNOL, V40, P1973, DOI 10.1002/eji.201040344; Santra S, 2010, NAT MED, V16, P324, DOI 10.1038/nm.2108; Stephenson KE, 2012, J VIROL, V86, P11434, DOI 10.1128/JVI.01779-12; Wilson CC, 2003, J IMMUNOL, V171, P5611, DOI 10.4049/jimmunol.171.10.5611; Zuniga R, 2006, J VIROL, V80, P3122, DOI 10.1128/JVI.80.6.3122-3125.2006	35	29	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e111085	10.1371/journal.pone.0111085	http://dx.doi.org/10.1371/journal.pone.0111085			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338098	Green Published, gold, Green Submitted			2022-12-27	WOS:000343674800103
J	Robles, MD; Marshall, RM; O'Donnell, F; Smith, EB; Haney, JA; Gori, DF				Robles, Marcos D.; Marshall, Robert M.; O'Donnell, Frances; Smith, Edward B.; Haney, Jeanmarie A.; Gori, David F.			Effects of Climate Variability and Accelerated Forest Thinning on Watershed-Scale Runoff in Southwestern USA Ponderosa Pine Forests	PLOS ONE			English	Article							FIRE SEVERITY; ARIZONA; INCREASE; FUELS; PRECIPITATION; RESTORATION; MANAGEMENT; PATTERNS; GRADIENT; SNOWPACK	The recent mortality of up to 20% of forests and woodlands in the southwestern United States, along with declining stream flows and projected future water shortages, heightens the need to understand how management practices can enhance forest resilience and functioning under unprecedented scales of drought and wildfire. To address this challenge, a combination of mechanical thinning and fire treatments are planned for 238,000 hectares (588,000 acres) of ponderosa pine (Pinus ponderosa) forests across central Arizona, USA. Mechanical thinning can increase runoff at fine scales, as well as reduce fire risk and tree water stress during drought, but the effects of this practice have not been studied at scales commensurate with recent forest disturbances or under a highly variable climate. Modifying a historical runoff model, we constructed scenarios to estimate increases in runoff from thinning ponderosa pine at the landscape and watershed scales based on driving variables: pace, extent and intensity of forest treatments and variability in winter precipitation. We found that runoff on thinned forests was about 20% greater than unthinned forests, regardless of whether treatments occurred in a drought or pluvial period. The magnitude of this increase is similar to observed declines in snowpack for the region, suggesting that accelerated thinning may lessen runoff losses due to warming effects. Gains in runoff were temporary (six years after treatment) and modest when compared to mean annual runoff from the study watersheds (0-3%). Nonetheless gains observed during drought periods could play a role in augmenting river flows on a seasonal basis, improving conditions for water-dependent natural resources, as well as benefit water supplies for downstream communities. Results of this study and others suggest that accelerated forest thinning at large scales could improve the water balance and resilience of forests and sustain the ecosystem services they provide.	[Robles, Marcos D.; Marshall, Robert M.; Haney, Jeanmarie A.] Nat Conservancy Ctr Sci & Publ Policy, Tucson, AZ 85719 USA; [O'Donnell, Frances] No Arizona Univ, Flagstaff, AZ 86011 USA; [Smith, Edward B.] Nat Conservancy Calif, Sacramento, CA USA; [Gori, David F.] Nat Conservancy New Mexico, Santa Fe, NM USA	Nature Conservancy; Northern Arizona University; Nature Conservancy; Nature Conservancy	Robles, MD (corresponding author), Nat Conservancy Ctr Sci & Publ Policy, Tucson, AZ 85719 USA.	mrobles@tnc.org		O'Donnell, Frances/0000-0002-5886-8270; Gori, Davide/0000-0003-4954-9419				Arizona Department of Water Resources, 2010, AR WAT ATL, V8; Arizona Geological Survey, 2011, GEOL MAP AR; Ault TR, 2014, J CLIMATE, V27, P7529, DOI 10.1175/JCLI-D-12-00282.1; BAKER MB, 1986, WATER RESOUR RES, V22, P67, DOI 10.1029/WR022i001p00067; Baker MB, 2003, ECOLOGICAL RESTORATION OF SOUTHWESTERN PONDEROSA PINE FORESTS, P161; Barr GW, 1956, RECOVERING RAINFALL; BOSCH JM, 1982, J HYDROL, V55, P3, DOI 10.1016/0022-1694(82)90117-2; Breshears DD, 2005, P NATL ACAD SCI USA, V102, P15144, DOI 10.1073/pnas.0505734102; Brown HE, 1974, RM129 USDA FOR SERV; BROWN TC, 1987, WATER RESOUR BULL, V23, P1149; Campbell R. E., 1977, Research Paper, USDA Forest Service; Cochrane MA, 2012, INT J WILDLAND FIRE, V21, P357, DOI 10.1071/WF11079; Cocke AE, 2005, J APPL ECOL, V42, P814, DOI 10.1111/j.1365-2664.2005.01077.x; Conservation Biology Institute, 2010, PROT AR DAT US VERS; Cook ER, 2007, EARTH-SCI REV, V81, P93, DOI 10.1016/j.earscirev.2006.12.002; COVINGTON WW, 1994, J FOREST, V92, P39; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Dominguez F, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050762; Dore S, 2012, GLOBAL CHANGE BIOL, V18, P3171, DOI 10.1111/j.1365-2486.2012.02775.x; Eidenshink J., 2007, FIRE ECOL, V3, P3, DOI [DOI 10.4996/FIREECOLOGY.0301003, 10.4996/fireecology.0301003]; Enfield DB, 2006, INT J CLIMATOL, V26, P885, DOI 10.1002/joc.1293; Ffolliott PF, 1977, RM44 USDA FOR SERV R; Fule PZ, 2007, J APPL ECOL, V44, P136, DOI 10.1111/j.1365-2664.2006.01254.x; Fule PZ, 2012, FOREST ECOL MANAG, V269, P68, DOI 10.1016/j.foreco.2011.12.025; Fule PZ, 2003, INT J WILDLAND FIRE, V12, P129, DOI 10.1071/WF02060; Gangopadhyay S, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044513; Garfin G, 2013, NCA REGION INPUT REP, P1, DOI 10.5822/978-1-61091-484-0; Gesch D, 2002, PHOTOGRAMM ENG REM S, V68, P5; Gitlin AR, 2006, CONSERV BIOL, V20, P1477, DOI 10.1111/j.1523-1739.2006.00424.x; Grant GE, 2013, FRONT ECOL ENVIRON, V11, P314, DOI 10.1890/120209; Haire SL, 2010, LANDSCAPE ECOL, V25, P1055, DOI 10.1007/s10980-010-9480-3; Hampton HM, 2011, J FOREST, V109, P15; Hibbert AR, 1987, RM149 USDA FOR SERV, P189; Hunter ME, 2011, FIRE ECOL, V7, P108, DOI 10.4996/fireecology.0703108; Jaeger KL, 2014, P NATL ACAD SCI USA, V111, P13894, DOI 10.1073/pnas.1320890111; Kennedy MC, 2014, FOREST ECOL MANAG, V318, P122, DOI 10.1016/j.foreco.2014.01.014; Mantua NJ, 2002, J OCEANOGR, V58, P35, DOI 10.1023/A:1015820616384; Marshall RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011687; Mote PW, 2006, J CLIMATE, V19, P6209, DOI 10.1175/JCLI3971.1; Murphy KW, 2014, J HYDROL, V509, P454, DOI 10.1016/j.jhydrol.2013.11.056; Neary D, 2011, MANAGING ARID SEMIAR; Ni FB, 2002, INT J CLIMATOL, V22, P1645, DOI 10.1002/joc.804; Pearson GA, 1931, TECHNICAL B USDA, V247; Pierce DW, 2008, J CLIMATE, V21, P6425, DOI 10.1175/2008JCLI2405.1; Propst DL, 2008, ECOL APPL, V18, P1236, DOI 10.1890/07-1489.1; RICH LR, 1976, WATER RESOUR RES, V12, P1053, DOI 10.1029/WR012i005p01053; RICH LR, 1972, WATER RESOUR RES, V8, P422, DOI 10.1029/WR008i002p00422; Sheppard PR, 2002, CLIM RES, V21, P219, DOI 10.3354/cr021219; Stahle DW., 2000, EOS, V81, P121, DOI [10.1029/00EO00076, DOI 10.1029/00EO00076]; Stefferud JA, 2011, FRESHWATER BIOL, V56, P1403, DOI 10.1111/j.1365-2427.2011.02577.x; Stephens SL, 2009, ECOL APPL, V19, P305, DOI 10.1890/07-1755.1; Thomas BE, 2006, 1712 US GEOL SURV; Timmons D, 2006, PRESCOTT AMA GROUNDW; Turner DS, 2007, AQUAT CONSERV, V17, P737, DOI 10.1002/aqc.802; United States Department of Agriculture Forest Service, 2013, DRAFT ENV IMP STAT 4; United States Department of Agriculture Forest Service, 2013, GIS DAT SW REG; United States Department of Interior Bureau of Reclamation, 2012, COL RIV BAS WAT SUPP; US Geological Survey Gap Analysis Program, 2010, NAT LAND COV VERS 1; van Mantgem PJ, 2009, SCIENCE, V323, P521, DOI 10.1126/science.1165000; Vano JA, 2014, B AM METEOROL SOC, V95, P59, DOI 10.1175/BAMS-D-12-00228.1; Water Resources Development Commission, 2011, WAT RES DEV COMM FIN; Webb RH, 2007, RIBBON GREEN CHANGE; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Williams AP, 2010, P NATL ACAD SCI USA, V107, P21289, DOI 10.1073/pnas.0914211107; Woodhouse CA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022413; Woodhouse CA, 1998, B AM METEOROL SOC, V79, P2693, DOI 10.1175/1520-0477(1998)079<2693:YODVIT>2.0.CO;2; Zausen GL, 2005, FOREST ECOL MANAG, V218, P291, DOI 10.1016/j.foreco.2005.08.023; Zou CB, 2008, ECOHYDROLOGY, V1, P309, DOI 10.1002/eco.17	68	24	24	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e111092	10.1371/journal.pone.0111092	http://dx.doi.org/10.1371/journal.pone.0111092			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337823	Green Submitted, Green Published, gold			2022-12-27	WOS:000343674800106
J	Tunnicliffe, V; Germain, CS; Hilario, A				Tunnicliffe, Verena; Germain, Candice St.; Hilario, Ana			Phenotypic Variation and Fitness in a Metapopulation of Tubeworms (Ridgeia piscesae Jones) at Hydrothermal Vents	PLOS ONE			English	Article							DE-FUCA RIDGE; MARGINAL HABITATS; NORTHEAST PACIFIC; SPERM TRANSFER; PLASTICITY; VESTIMENTIFERA; ADAPTATION; EVOLUTION; FERTILIZATION; SIBOGLINIDAE	We examine the nature of variation in a hot vent tubeworm, Ridgeia piscesae, to determine how phenotypes are maintained and how reproductive potential is dictated by habitat. This foundation species at northeast Pacific hydrothermal sites occupies a wide habitat range in a highly heterogeneous environment. Where fluids supply high levels of dissolved sulphide for symbionts, the worm grows rapidly in a "short-fat'' phenotype characterized by lush gill plumes; when plumes are healthy, sperm package capture is higher. This form can mature within months and has a high fecundity with continuous gamete output and a lifespan of about three years in unstable conditions. Other phenotypes occupy low fluid flux habitats that are more stable and individuals grow very slowly; however, they have low reproductive readiness that is hampered further by small, predator cropped branchiae, thus reducing fertilization and metabolite uptake. Although only the largest worms were measured, only 17% of low flux worms were reproductively competent compared to 91% of high flux worms. A model of reproductive readiness illustrates that tube diameter is a good predictor of reproductive output and that few low flux worms reached critical reproductive size. We postulate that most of the propagules for the vent fields originate from the larger tubeworms that live in small, unstable habitat patches. The large expanses of worms in more stable low flux habitat sustain a small, but long-term, reproductive output. Phenotypic variation is an adaptation that fosters both morphological and physiological responses to differences in chemical milieu and predator pressure. This foundation species forms a metapopulation with variable growth characteristics in a heterogeneous environment where a strategy of phenotypic variation bestows an advantage over specialization.	[Tunnicliffe, Verena; Germain, Candice St.] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada; [Tunnicliffe, Verena] Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC, Canada; [Hilario, Ana] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Hilario, Ana] Univ Aveiro, Ctr Estudos Ambiente & Mar, P-3800 Aveiro, Portugal	University of Victoria; University of Victoria; Universidade de Aveiro; Universidade de Aveiro	Tunnicliffe, V (corresponding author), Univ Victoria, Dept Biol, POB 1700, Victoria, BC V8W 2Y2, Canada.	verenat@uvic.ca	Hilário, Ana/C-1260-2008	Hilário, Ana/0000-0001-8287-1528	Natural Sciences and Engineering Research Council of Canada through the Canadian Healthy Oceans Network; Discovery Grants programme [PC-11]	Natural Sciences and Engineering Research Council of Canada through the Canadian Healthy Oceans Network; Discovery Grants programme	Natural Sciences and Engineering Research Council of Canada (nserc.ca) funding through the Canadian Healthy Oceans Network (http://www.chone.ca/)(PC-11) and Discovery Grants programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates AE, 2005, MAR ECOL PROG SER, V305, P1, DOI 10.3354/meps305001; Black MB, 1998, DEEP-SEA RES PT II, V45, P365, DOI 10.1016/S0967-0645(97)00076-3; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boschen RE, 2013, OCEAN COAST MANAGE, V84, P54, DOI 10.1016/j.ocecoaman.2013.07.005; Brand GL, 2007, MAR ECOL-EVOL PERSP, V28, P208, DOI 10.1111/j.1439-0485.2006.00113.x; BUTTERFIELD DA, 1990, J GEOPHYS RES-SOLID, V95, P12895, DOI 10.1029/JB095iB08p12895; Carney SL, 2002, CAH BIOL MAR, V43, P363; Carney SL, 2007, COMP BIOCHEM PHYS B, V146, P326, DOI 10.1016/j.cbpb.2006.11.002; Chevin LM, 2011, J EVOLUTION BIOL, V24, P1462, DOI 10.1111/j.1420-9101.2011.02279.x; Dancette R, 2007, BIODIVERSITY RES IMP; Dias PC, 1996, TRENDS ECOL EVOL, V11, P326, DOI 10.1016/0169-5347(96)10037-9; Dudley S.A., 2004, PHENOTYPIC PLASTICIT, P151; Embley RW, 1999, GEOPHYS RES LETT, V26, P3425, DOI 10.1029/1999GL002328; Figueira WF, 2006, POPUL ECOL, V48, P215, DOI 10.1007/s10144-006-0265-0; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18286, DOI 10.1073/pnas.0906473107; Galkin SV, 1998, RUSS J MAR BIOL+, V24, P313; Hanski I., 1999, METAPOPULATION ECOLO; Hanski I, 2011, AM NAT, V177, P29, DOI 10.1086/657625; Hilario A, 2005, BIOL BULL-US, V208, P20, DOI 10.2307/3593097; Hilario A, 2008, J MAR BIOL ASSOC UK, V88, P909, DOI 10.1017/S0025315408001586; Johnson HP, 2000, NATURE, V407, P174, DOI 10.1038/35025040; Jones M., 1985, B BIOL SOC WASH, V6, P117; Kawecki TJ, 2008, ANNU REV ECOL EVOL S, V39, P321, DOI 10.1146/annurev.ecolsys.38.091206.095622; KAWECKI TJ, 1995, EVOL ECOL, V9, P38, DOI 10.1007/BF01237695; Liao L, 2014, MOL ECOL, V23, P1544, DOI 10.1111/mec.12460; Macdonald IR, 2002, CAH BIOL MAR, V43, P395; Miner BG, 2005, TRENDS ECOL EVOL, V20, P685, DOI 10.1016/j.tree.2005.08.002; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; Puetz L., 2014, CONNECTIVITY METAPOP; Sarrazin J, 1997, MAR ECOL PROG SER, V153, P5, DOI 10.3354/meps153005; Sarrazin J, 1999, MAR ECOL PROG SER, V185, P1, DOI 10.3354/meps185001; Scott KM, 1999, MAR BIOL, V135, P25, DOI 10.1007/s002270050597; SOUTHWARD EC, 1989, CAN J ZOOL, V67, P2776, DOI 10.1139/z89-393; SOUTHWARD EC, 1995, CAN J ZOOL, V73, P282, DOI 10.1139/z95-033; Southward Eve C., 1996, Geological Society Special Publication, V118, P211, DOI 10.1144/GSL.SP.1996.118.01.13; Sultan SE, 2002, AM NAT, V160, P271, DOI 10.1086/341015; Thiebaut E, 2002, MAR ECOL PROG SER, V234, P147, DOI 10.3354/meps234147; THOMPSON JD, 1991, TRENDS ECOL EVOL, V6, P246, DOI 10.1016/0169-5347(91)90070-E; Tienderen PHV, 1997, EVOLUTION, V51, P1372; Tsurumi M, 2003, DEEP-SEA RES PT I, V50, P611, DOI 10.1016/S0967-0637(03)00039-6; Tunnicliffe V, 1997, DEEP-SEA RES PT I, V44, P1627, DOI 10.1016/S0967-0637(97)00041-1; TUNNICLIFFE V, 1990, DEEP-SEA RES, V37, P103, DOI 10.1016/0198-0149(90)90031-P; TUNNICLIFFE V, 1990, PROG OCEANOGR, V24, P1, DOI 10.1016/0079-6611(90)90015-T; Urcuyo IA, 2003, DEEP-SEA RES PT I, V50, P763, DOI 10.1016/S0967-0637(03)00061-X; Urcuyo IA, 2007, MAR ECOL PROG SER, V344, P143, DOI 10.3354/meps06710; Vrijenhoek RC, 2009, DEEP-SEA RES PT II, V56, P1713, DOI 10.1016/j.dsr2.2009.05.016; Wiens JA, 2011, SOURCES SINKS SUSTAI; Wilcox C, 2006, ECOLOGY, V87, P855, DOI 10.1890/05-0587	48	11	12	2	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110578	10.1371/journal.pone.0110578	http://dx.doi.org/10.1371/journal.pone.0110578			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25337895	Green Published, Green Submitted, gold			2022-12-27	WOS:000343674800058
J	Zhao, XS; Yin, XJ; Li, X; Yan, LLJ; Lam, CT; Li, SS; He, F; Xie, WX; Ba, S; Luobu, G; Ke, L; Wu, YF				Zhao, Xingshan; Yin, Xuejun; Li, Xian; Yan, Lijing L.; Lam, Christopher T.; Li, Shenshen; He, Feng; Xie, Wuxiang; Ba, Sang; Luobu, Gesang; Ke, Liang; Wu, Yangfeng			Using a Low-Sodium, High-Potassium Salt Substitute to Reduce Blood Pressure among Tibetans with High Blood Pressure: A Patient-Blinded Randomized Controlled Trial	PLOS ONE			English	Article							LIFE-STYLE MODIFICATION; RISK-FACTORS; CHINA; HYPERTENSION; METAANALYSIS; TEMPERATURE; ALTITUDES; DISEASES; STATINS; PEOPLES	Objectives: To evaluate the effects of a low-sodium and high-potassium salt-substitute on lowering blood pressure (BP) among Tibetans living at high altitude (4300 meters). Method: The study was a patient-blinded randomized controlled trial conducted between February and May 2009 in Dangxiong County, Tibetan Autonomous Region, China. A total of 282 Tibetans aged 40 or older with known hypertension (systolic BP >= 140 mmHg) were recruited and randomized to intervention (salt-substitute, 65% sodium chloride, 25% potassium chloride and 10% magnesium sulfate) or control (100% sodium chloride) in a 1: 1 allocation ratio with three months' supply. Primary outcome was defined as the change in BP levels measured from baseline to followed-up with an automated sphygmomanometer. Per protocol (PP) and intention to treat (ITT) analyses were conducted. Results: After the three months' intervention period, the net reduction in SBP/DBP in the intervention group in comparison to the control group was -8.2/-3.4 mmHg (all p<0.05) in PP analysis, after adjusting for baseline BP and other variables. ITT analysis showed the net reduction in SBP/DBP at -7.6/-3.5 mmHg with multiple imputations (all p<0.05). Furthermore, the whole distribution of blood pressure showed an overall decline in SBP/DBP and the proportion of patients with BP under control (SBP/DBP, 140 mmHg) was significantly higher in salt-substitute group in comparison to the regular salt group (19.2% vs. 8.8%, p=0.027). Conclusion: Low sodium high potassium salt-substitute is effective in lowering both systolic and diastolic blood pressure and offers a simple, low-cost approach for hypertension control among Tibetans in China.	[Zhao, Xingshan; He, Feng] Peking Univ, Beijing Jishuitan Hosp, Coll Med 4, Dept Cardiol, Beijing 100871, Peoples R China; [Yin, Xuejun; Li, Xian; Yan, Lijing L.; Li, Shenshen; Ke, Liang; Wu, Yangfeng] Peking Univ, George Inst Global Hlth, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Yan, Lijing L.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Lam, Christopher T.] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Xie, Wuxiang; Wu, Yangfeng] Peking Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Beijing 100871, Peoples R China; [Ba, Sang] Dangxiong Peoples Hosp, Dangxiong, Tibet, Peoples R China; [Luobu, Gesang] Tibet Autonomous Reg Peoples Hosp, Lhasa, Tibet, Peoples R China	Peking University; Peking University; Northwestern University; Feinberg School of Medicine; Duke University; Peking University	Wu, YF (corresponding author), Peking Univ, George Inst Global Hlth, Hlth Sci Ctr, Beijing 100871, Peoples R China.	ywu@georgeinstitute.org.cn	Yin, Xuejun/AAG-6604-2019; Xie, Wuxiang/GYU-3990-2022; Yin, Xuejun/AAA-7460-2019	Yin, Xuejun/0000-0001-8446-9591; Xie, Wuxiang/0000-0001-7527-1022; Li, Xian/0000-0001-5445-4022	Bureau of Science and Technology of Tibet Autonomous Region [08-04-06]; United States National Heart, Lung, and Blood Institute (National Institutes of Health) [HHSN268200900027C]; UnitedHealth Group Chronic Disease Initiative; People's Republic of China Ministry of Science and Technology [2013BAI05B04]	Bureau of Science and Technology of Tibet Autonomous Region; United States National Heart, Lung, and Blood Institute (National Institutes of Health); UnitedHealth Group Chronic Disease Initiative; People's Republic of China Ministry of Science and Technology	This study was supported by the Bureau of Science and Technology of Tibet Autonomous Region Grant 08-04-06, by the United States National Heart, Lung, and Blood Institute (National Institutes of Health) (Contract HHSN268200900027C), the UnitedHealth Group Chronic Disease Initiative and The People's Republic of China Ministry of Science and Technology (Contract 2013BAI05B04). The funder was not involved in the study design, data collection, analysis, and interpretation.	Alperovitch A, 2009, ARCH INTERN MED, V169, P75, DOI 10.1001/archinternmed.2008.512; Appel LJ, 2003, JAMA-J AM MED ASSOC, V289, P2083, DOI 10.1001/jama.289.16.2083; Banach M, 2013, INT J CARDIOL, V168, P2816, DOI 10.1016/j.ijcard.2013.03.068; Cao J, 2003, FOOD CHEM TOXICOL, V41, P535, DOI 10.1016/S0278-6915(02)00285-5; Elmer PJ, 2006, ANN INTERN MED, V144, P485, DOI 10.7326/0003-4819-144-7-200604040-00007; Ezzati M, 2005, PLOS MED, V2, P404, DOI 10.1371/journal.pmed.0020133; HE J, 1995, STROKE, V26, P2222, DOI 10.1161/01.STR.26.12.2222; Li Li-ming, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P478; Li N, 2007, J HYPERTENS, V25, P2011, DOI 10.1097/HJH.0b013e3282b9714b; Li N, 2009, BRIT J NUTR, V101, P1088, DOI 10.1017/S0007114508042360; Li SS, 2012, BLOOD PRESS MONIT, V17, P62, DOI 10.1097/MBP.0b013e328351371c; Liu LJ, 2001, HYPERTENS RES, V24, P315, DOI 10.1291/hypres.24.315; Moore LL, 2005, EPIDEMIOLOGY, V16, P4, DOI 10.1097/01.ede.0000147106.32027.3e; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; NARA Y, 1990, J CARDIOVASC PHARM, V16, pS40, DOI 10.1097/00005344-199006168-00017; National Research Council (U.S.). Panel on Handling Missing Data in Clinical Trials. National Research Council (U.S.). Committee on National Statistics. National Academies Press (U.S.), 2010, PREV TREATM MISS DAT; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; SEHGAL AK, 1968, CIRCULATION, V37, P36, DOI 10.1161/01.CIR.37.1.36; Smith C, 1999, AM J HUM BIOL, V11, P469, DOI 10.1002/(SICI)1520-6300(1999)11:4<469::AID-AJHB6>3.3.CO;2-V; Sterne JA, 2009, BMJ, V29; Strazzullo P, 2007, HYPERTENSION, V49, P792, DOI 10.1161/01.HYP.0000259737.43916.42; SUN S, 1986, HUM BIOL, V58, P507; Tian HG, 1995, J HUM HYPERTENS, V9, P959; Tripathy V, 2007, ANN HUM BIOL, V34, P470, DOI 10.1080/03014460701412284; Webb DJ, 1999, AM J CARDIOL, V83, p21C; WHO, 2010, GLOB STAT REP NONC D; WOODHOUSE PR, 1993, J HYPERTENS, V11, P1267; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zhao XS, 2012, AM J HYPERTENS, V25, P583, DOI 10.1038/ajh.2012.9; Zhou BF, 2003, J HUM HYPERTENS, V17, P623, DOI 10.1038/sj.jhh.1001605	30	37	38	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2014	9	10							e110131	10.1371/journal.pone.0110131	http://dx.doi.org/10.1371/journal.pone.0110131			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6DY	25338053	Green Published, Green Submitted, gold			2022-12-27	WOS:000343674800025
J	Verhoog, N; Allie-Reid, F; Berghe, WV; Smith, C; Haegeman, G; Hapgood, J; Louw, A				Verhoog, Nicolette; Allie-Reid, Fatima; Berghe, Wim Vanden; Smith, Carine; Haegeman, Guy; Hapgood, Janet; Louw, Ann			Inhibition of Corticosteroid-Binding Globulin Gene Expression by Glucocorticoids Involves C/EBP beta	PLOS ONE			English	Article							ALPHA-1-ACID GLYCOPROTEIN GENE; FREE HORMONE HYPOTHESIS; ACUTE-PHASE RESPONSE; CIS-REGULATORY ELEMENTS; PROXIMAL PROMOTER; TRANSCRIPTION FACTORS; MATHEMATICAL-MODEL; PLASMA-CORTISOL; SEPTIC SHOCK; RECEPTOR	Corticosteroid-binding globulin (CBG), a negative acute phase protein produced primarily in the liver, is responsible for the transport of glucocorticoids (GCs). It also modulates the bioavailability of GCs, as only free or unbound steroids are biologically active. Fluctuations in CBG levels therefore can directly affect GC bioavailability. This study investigates the molecular mechanism whereby GCs inhibit the expression of CBG. GCs regulate gene expression via the glucocorticoid receptor (GR), which either directly binds to DNA or acts indirectly via tethering to other DNA-bound transcription factors. Although no GC-response elements (GRE) are present in the Cbg promoter, putative binding sites for C/EBP beta, able to tether to the GR, as well as HNF3 alpha involved in GR signaling, are present. C/EBP beta, but not HNF3 alpha, was identified as an important mediator of DEX-mediated inhibition of Cbg promoter activity by using specific deletion and mutant promoter reporter constructs of Cbg. Furthermore, knockdown of C/EBP beta protein expression reduced DEX-induced repression of CBG mRNA, confirming C/EBP beta's involvement in GC-mediated CBG repression. Chromatin immunoprecipitation (ChIP) after DEX treatment indicated increased co-recruitment of C/EBP beta and GR to the Cbg promoter, while C/EBP beta knockdown prevented GR recruitment. Together, the results suggest that DEX repression of CBG involves tethering of the GR to C/EBP beta.	[Verhoog, Nicolette; Allie-Reid, Fatima; Louw, Ann] Univ Stellenbosch, Dept Biochem, Western Cape, South Africa; [Berghe, Wim Vanden] Univ Antwerp, PPES, Dept Biomed Sci, B-2020 Antwerp, Belgium; [Berghe, Wim Vanden; Haegeman, Guy] Univ Ghent, LEGEST, B-9000 Ghent, Belgium; [Smith, Carine] Univ Stellenbosch, Dept Physiol Sci, Western Cape, South Africa; [Hapgood, Janet] Univ Cape Town, Dept Mol & Cell Biol, ZA-7700 Rondebosch, Western Cape, South Africa	Stellenbosch University; University of Antwerp; Ghent University; Stellenbosch University; University of Cape Town	Louw, A (corresponding author), Univ Stellenbosch, Dept Biochem, Western Cape, South Africa.	al@sun.ac.za	Louw, Ann/A-7620-2012; Hapgood, Janet P/P-2549-2018; Berghe, Wim Vanden/S-6425-2018; Vanden Berghe, Wim/HGE-4696-2022; Smith, Carine/D-7159-2012	Louw, Ann/0000-0002-1021-6732; Hapgood, Janet P/0000-0002-4414-4861; Berghe, Wim Vanden/0000-0003-0161-7355; Smith, Carine/0000-0001-5924-9204; Verhoog, Nicolette/0000-0002-3786-6452	Flemish South African Bilateral Agreement; National Research Foundation of South Africa; Claude Leon Foundation	Flemish South African Bilateral Agreement; National Research Foundation of South Africa(National Research Foundation - South Africa); Claude Leon Foundation	This work is based upon research supported by The Flemish South African Bilateral Agreement and the National Research Foundation of South Africa (www.nrf.ac.za). N. Verhoog was supported by the Claude Leon Foundation (www.leonfoundation.co.za). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIRA S, 1992, IMMUNOL REV, V127, P25, DOI 10.1111/j.1600-065X.1992.tb01407.x; ALAM T, 1993, J BIOL CHEM, V268, P15681; Aparicio O, 2004, CURRENT PROTOCOLS CE, V17; Beishuizen A, 2002, CRIT CARE, V6, P434, DOI 10.1186/cc1530; Boruk M, 1998, MOL ENDOCRINOL, V12, P1749, DOI 10.1210/me.12.11.1749; Boudreau F, 1998, DNA CELL BIOL, V17, P669, DOI 10.1089/dna.1998.17.669; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cappelletti M, 1996, CELL DEATH DIFFER, V3, P29; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cizza G, 2012, J CLIN ENDOCR METAB, V97, P77, DOI 10.1210/jc.2011-3090; Cole TJ, 1999, MOL CELL ENDOCRINOL, V154, P29, DOI 10.1016/S0303-7207(99)00105-7; COOLENS JL, 1987, J STEROID BIOCHEM, V26, P197, DOI 10.1016/0022-4731(87)90071-9; Deak T, 1997, AM J PHYSIOL-REG I, V273, pR1998; Dey R, 2003, J MOL MODEL, V9, P183, DOI 10.1007/s00894-003-0130-4; Emptoz-Bonneton A, 2000, J CLIN ENDOCR METAB, V85, P361, DOI 10.1210/jc.85.1.361; EmptozBonneton A, 1997, J CLIN ENDOCR METAB, V82, P3758, DOI 10.1210/jc.82.11.3758; Fernandez-Real JM, 2005, METABOLISM, V54, P584, DOI 10.1016/j.metabol.2004.11.015; FLESHNER M, 1995, ENDOCRINOLOGY, V136, P5336, DOI 10.1210/en.136.12.5336; Gagliardi L, 2010, MOL CELL ENDOCRINOL, V316, P24, DOI 10.1016/j.mce.2009.07.015; Garrel DR, 1996, HORM RES, V45, P245, DOI 10.1159/000184796; Grigorov I, 1998, CELL BIOL INT, V22, P685, DOI 10.1006/cbir.1998.0307; Grontved L, 2013, EMBO J, V32, P1568, DOI 10.1038/emboj.2013.106; HAMMOND GL, 1990, ENDOCR REV, V11, P65, DOI 10.1210/edrv-11-1-65; Heitzer MD, 2007, REV ENDOCR METAB DIS, V8, P321, DOI 10.1007/s11154-007-9059-8; Henley DE, 2011, NEUROSCIENCE, V180, P1, DOI 10.1016/j.neuroscience.2011.02.053; Ho JT, 2006, J CLIN ENDOCR METAB, V91, P105, DOI 10.1210/jc.2005-0265; Johansson-Haque K, 2008, J MOL ENDOCRINOL, V41, P239, DOI 10.1677/JME-08-0015; Koj A, 1996, BBA-MOL BASIS DIS, V1317, P84, DOI 10.1016/S0925-4439(96)00048-8; Kumsta R, 2007, PSYCHONEUROENDOCRINO, V32, P1153, DOI 10.1016/j.psyneuen.2007.08.007; Kurash JK, 2004, EXP CELL RES, V292, P342, DOI 10.1016/j.yexcr.2003.09.002; Lesage J, 2002, J NEUROENDOCRINOL, V14, P135, DOI 10.1046/j.0007-1331.2001.00753.x; Lewis JG, 2006, HORM METAB RES, V38, P241, DOI 10.1055/s-2006-925338; Li Y, 2012, SCI CHINA LIFE SCI, V55, P699, DOI 10.1007/s11427-012-4365-0; MENDEL CM, 1989, ENDOCRINOLOGY, V124, P468, DOI 10.1210/endo-124-1-468; MENDEL CM, 1992, J ANDROL, V13, P107; MENDEL CM, 1989, ENDOCR REV, V10, P232, DOI 10.1210/edrv-10-3-232; MIESFELD R, 1986, CELL, V46, P389, DOI 10.1016/0092-8674(86)90659-8; Moisan MP, 2010, MOL CELL ENDOCRINOL, V316, P35, DOI 10.1016/j.mce.2009.07.017; Mouthiers A, 2005, MOL ENDOCRINOL, V19, P1135, DOI 10.1210/me.2004-0188; NISHIO Y, 1993, MOL CELL BIOL, V13, P1854, DOI 10.1128/MCB.13.3.1854; ORAVA M, 1994, GENE, V144, P259, DOI 10.1016/0378-1119(94)90387-5; Ousova O, 2004, MOL ENDOCRINOL, V18, P1687, DOI 10.1210/me.2004-0005; Perogamvros I, 2012, NAT REV ENDOCRINOL, V8, P717, DOI 10.1038/nrendo.2012.134; Petersen HH, 2006, MOL CELL BIOL, V26, P7236, DOI 10.1128/MCB.00400-06; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; PUGEAT M, 1989, CLIN CHEM, V35, P1675; Raison CL, 2003, AM J PSYCHIAT, V160, P1554, DOI 10.1176/appi.ajp.160.9.1554; RAMJI DP, 1993, NUCLEIC ACIDS RES, V21, P289, DOI 10.1093/nar/21.2.289; Richard EM, 2010, ENDOCRINOLOGY, V151, P649, DOI 10.1210/en.2009-0862; Robertson S, 2010, J BIOL CHEM, V285, P8061, DOI 10.1074/jbc.M109.087866; Roos AB, 2012, J ENDOCRINOL, V212, P291, DOI 10.1530/JOE-11-0369; Roth-Isigkeit AK, 2000, STEROIDS, V65, P513, DOI 10.1016/S0039-128X(00)00133-1; Ruminy P, 2001, INFLAMM RES, V50, P383, DOI 10.1007/PL00000260; Savoldi G, 1997, DNA CELL BIOL, V16, P1467, DOI 10.1089/dna.1997.16.1467; SCHLECHTE JA, 1987, CLIN ENDOCRINOL, V27, P197, DOI 10.1111/j.1365-2265.1987.tb01145.x; SMITH CL, 1992, ENDOCRINOLOGY, V130, P2245, DOI 10.1210/en.130.4.2245; Spencer RL, 1996, PSYCHONEUROENDOCRINO, V21, P95, DOI 10.1016/0306-4530(95)00020-8; Strehl C, 2013, MOL CELL ENDOCRINOL; Sun HP, 2008, AM J PHYSIOL-CELL PH, V295, pC915, DOI 10.1152/ajpcell.90646.2007; Tinnikov AA, 1999, ENDOCRINE, V11, P145, DOI 10.1385/ENDO:11:2:145; Torpy DJ, 2012, J CLIN ENDOCR METAB, V97, pE151, DOI 10.1210/jc.2011-2022; UNDERHILL DA, 1995, GENE, V162, P205, DOI 10.1016/0378-1119(95)00337-6; UNDERHILL DA, 1989, MOL ENDOCRINOL, V3, P1448, DOI 10.1210/mend-3-9-1448; Visser K, 2010, ENDOCRINOLOGY, V151, P5279, DOI 10.1210/en.2010-0368; Vogeser M, 2000, CLIN BIOCHEM, V33, P157, DOI 10.1016/S0009-9120(00)00051-5; Wang JC, 1999, MOL ENDOCRINOL, V13, P604, DOI 10.1210/me.13.4.604; Waterman WR, 2006, MOL IMMUNOL, V43, P773, DOI 10.1016/j.molimm.2005.07.003; Zha QQ, 2011, J NEUROCHEM, V119, P654, DOI 10.1111/j.1471-4159.2011.07448.x; Zhang N, 2007, J IMMUNOL, V179, P578, DOI 10.4049/jimmunol.179.1.578; Zhao XF, 1997, MOL CELL ENDOCRINOL, V126, P203, DOI 10.1016/S0303-7207(96)03992-5	71	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110702	10.1371/journal.pone.0110702	http://dx.doi.org/10.1371/journal.pone.0110702			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25335188	Green Published, gold			2022-12-27	WOS:000343731200069
J	Liu, HH; Rossi, S; Zhou, HX; Chen, BG				Liu, Huanhuan; Rossi, Sonja; Zhou, Huixia; Chen, Baoguo			Electrophysiological Evidence for Domain-General Inhibitory Control during Bilingual Language Switching	PLOS ONE			English	Article							HIGHLY PROFICIENT BILINGUALS; COGNITIVE CONTROL; BRAIN; PERFORMANCE; MECHANISMS; ATTENTION; ERP	This paper presents an experiment that explored the role of domain-general inhibitory control on language switching. Reaction times (RTs) and event-related brain potentials (ERPs) were recorded when low-proficient bilinguals with high and low inhibitory control (IC) switched between overt picture naming in both their L1 and L2. Results showed that the language switch costs of bilinguals with high-IC were symmetrical, while that of bilinguals with low-IC were not. The N2 component failed to show a significant interaction between group, language and task, indicating that inhibition may not comes into play during the language task schema competition phase. The late positive component (LPC), however, showed larger amplitudes for L2 repeat and switch trials than for L1 trials in the high-IC group, indicating that inhibition may play a key role during the lexical response selection phase. These findings suggest that domain-general inhibitory control plays an important role in modulating language switch costs and its influence can be specified in lexical selection phase.	[Liu, Huanhuan; Zhou, Huixia; Chen, Baoguo] Beijing Normal Univ, Sch Psychol, Beijing 100875, Peoples R China; [Rossi, Sonja] Med Univ Innsbruck, Dept Med Psychol, A-6020 Innsbruck, Austria; [Rossi, Sonja] Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany	Beijing Normal University; Medical University of Innsbruck; Max Planck Society	Chen, BG (corresponding author), Beijing Normal Univ, Sch Psychol, Beijing 100875, Peoples R China.	Chenbg@bnu.edu.cn	Rossi, Sonja/D-1453-2016	Rossi, Sonja/0000-0002-3278-8993	National Social Science Fund [11BYY039]; Program for New Century Excellent Talents of Ministry of Education in China [NECT-11-0028]; Beijing Key Laboratory of Applied Experimental Psychology	National Social Science Fund; Program for New Century Excellent Talents of Ministry of Education in China; Beijing Key Laboratory of Applied Experimental Psychology	This research was supported by the National Social Science Fund [11BYY039], the Program for New Century Excellent Talents of Ministry of Education in China [NECT-11-0028] and Beijing Key Laboratory of Applied Experimental Psychology to Baoguo Chen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Berkman ET, 2009, NEUROIMAGE, V47, P705, DOI 10.1016/j.neuroimage.2009.04.084; Bialystok E, 2006, CAN J EXP PSYCHOL, V60, P68, DOI 10.1037/cjep2006008; Bialystok E, 2004, PSYCHOL AGING, V19, P290, DOI 10.1037/0882-7974.19.2.290; Brysbaert M, 2009, BEHAV RES METHODS, V41, P977, DOI 10.3758/BRM.41.4.977; Cai Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010729; Calabria M, 2012, FRONT PSYCHOL, V2, P1, DOI DOI 10.HTTP://DX.D0I.0RG/10.3389/FPSYG.2011; Christoffels IK, 2007, BRAIN RES, V1147, P192, DOI 10.1016/j.brainres.2007.01.137; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Costa A, 2004, J MEM LANG, V50, P491, DOI 10.1016/j.jml.2004.02.002; Costa A, 2006, J EXP PSYCHOL LEARN, V32, P1057, DOI 10.1037/0278-7393.32.5.1057; de Bruin A, 2014, NEUROIMAGE, V90, P348, DOI 10.1016/j.neuroimage.2013.12.049; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Green D., 1998, BILING-LANG COGN, V1, P67, DOI [DOI 10.1017/S1366728998000133, 10.1017/S1366728998000133]; Guo TM, 2013, ACTA PSYCHOL, V143, P277, DOI 10.1016/j.actpsy.2013.04.002; Hilchey MD, 2011, PSYCHON B REV, V18, P625, DOI 10.3758/s13423-011-0116-7; Hosoda C, 2012, J NEUROLINGUIST, V25, P44, DOI 10.1016/j.jneuroling.2011.08.007; Jackson GM, 2001, BILING-LANG COGN, V4, P169, DOI [10.1017/S1366728901000268, DOI 10.1017/S1366728901000268]; Linck JA, 2012, BILING-LANG COGN, V15, P651, DOI 10.1017/S136672891100054X; Luk G, 2012, LANG COGNITIVE PROC, V27, P1479, DOI 10.1080/01690965.2011.613209; Martin CD, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00815; Sakai K, 2008, ANNU REV NEUROSCI, V31, P219, DOI 10.1146/annurev.neuro.31.060407.125642; Umebayashi K, 2010, BRAIN RES, V1346, P165, DOI 10.1016/j.brainres.2010.05.050; Verhoef K, 2009, COGNITION, V110, P84, DOI 10.1016/j.cognition.2008.10.013; Verhoef KMW, 2010, J COGNITIVE NEUROSCI, V22, P1832, DOI 10.1162/jocn.2009.21291; [张清芳 Zhang Qingfang], 2003, [心理学报, Acta Psychologica Sinica], V35, P447	28	86	93	7	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110887	10.1371/journal.pone.0110887	http://dx.doi.org/10.1371/journal.pone.0110887			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BL	25369471	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943500062
J	Liu, HX; Su, YY; Zhu, L; Xing, JN; Wu, J; Wang, N				Liu, Huixin; Su, Yingying; Zhu, Lin; Xing, Jiannan; Wu, Jing; Wang, Ning			Effectiveness of ART and Condom Use for Prevention of Sexual HIV Transmission in Serodiscordant Couples: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							HETEROSEXUAL TRANSMISSION; ANTIRETROVIRAL TREATMENT; INFECTION; THERAPY; DECLINE; COHORT; RISK; INITIATION; PROVINCE; IMPACT	Background: Consistent and correct condom use and suppressive antiretroviral therapy for the infected partner are two of the primary strategies recommended for prevention of heterosexual HIV transmission in serodiscordant couples today. The applied effectiveness of treatment as a prevention strategy in China is still under investigation, and much less is known about its effects in the presence of other prevention strategies such as consistent condom use. Methods: We conducted a systematic search in PubMed and three Chinese language databases to identify relevant articles for the estimation of relative effectiveness of a) consistent condom use and b) ART use by index partners for preventing HIV transmission in serodiscordant couples. We also estimated the prevention effectiveness of ART stratified by condom use level and the prevention effectiveness of consistent condom use stratified by ART use level. Results: Pooled results from the eleven eligible studies found a pooled HIV seroconversion incidence of 0.92 cases per 100 person years (PY) among HIV-negative spouses whose index partners were taking ART versus 2.45 cases per 100 PY in untreated couples. The IRR comparing seroconversion in couples where the index-partner was on ART versus not on ART was 0.47 (95% CI: 0.43, 0.52), while stratified by condom use, the IRR was 0.33(0.17, 0.64). The IRR comparing incidence in couples reporting "consistent condom use'' versus those reporting otherwise was 0.02(95% CI: 0.01, 0.04), after stratified by ART use level, the IRR was 0.01(95% CI: 0.00, 0.06). Conclusions: ART use by index partners could reduce HIV transmission in serodiscordant couples, and the effectiveness of this prevention strategy could be further increased with consistent condom use.	[Liu, Huixin; Su, Yingying; Zhu, Lin; Xing, Jiannan; Wu, Jing; Wang, Ning] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Wang, N (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	wangnbj@163.com	Rossi, Sonja/D-1453-2016	Rossi, Sonja/0000-0002-3278-8993	mega-projects of national science research for the 12th Five-Year Plan of China [2012ZX10001-001]	mega-projects of national science research for the 12th Five-Year Plan of China	Supported by the mega-projects of national science research for the 12th Five-Year Plan (2012ZX10001-001) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; Baeten JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001888; Baggaley RF, 2013, EPIDEMIOLOGY, V24, P110, DOI 10.1097/EDE.0b013e318276cad7; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohen MS, 2013, LANCET, V382, P1515, DOI 10.1016/S0140-6736(13)61998-4; Del Romero J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2205; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Duan Song, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P997; El-Sadr WM, 2011, AIDS, V25, P2295, DOI 10.1097/QAD.0b013e32834c4c22; Graham SM, 2007, AIDS, V21, P501, DOI 10.1097/QAD.0b013e32801424bd; Gray R, 2011, AIDS, V25, P863, DOI 10.1097/QAD.0b013e3283448790; GREENBLATT RM, 1988, AIDS, V2, P47, DOI 10.1097/00002030-198802000-00008; Hallett TB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001123; He N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077981; Heymer KJ, 2011, SEX HEALTH, V8, P280, DOI 10.1071/SH10084; Jia ZW, 2013, LANCET, V382, P1195, DOI 10.1016/S0140-6736(12)61898-4; Li Jing-yun, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P192; Liao LJ, 2013, AIDS, V27, P1815, DOI 10.1097/QAD.0b013e3283611931; Ma Y, 2010, CLIN INFECT DIS, V50, P264, DOI 10.1086/649215; [毛宇嵘 Mao Yurong], 2004, [中华流行病学杂志, Chinese Journal of Epidemiology], V25, P322; Ministry of Health of the People's Republic of China Joint United Nations Program on HIV/AIDS WHO, 2011, 2011 EST HIV AIDS EP; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Pan Xiao-hong, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P1023; Porco TC, 2004, AIDS, V18, P81, DOI 10.1097/00002030-200401020-00010; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Qiao XiaoChun, 2009, Chinese Preventive Medicine, V10, P976; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; R Core Team, 2021, R LANGUAGE ENV STAT; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Vernazza PL, 2000, AIDS, V14, P117, DOI 10.1097/00002030-200001280-00006; Wang L, 2013, CHINESE MED J-PEKING, V126, P3694, DOI 10.3760/cma.j.issn.0366-6999.20123311; Wang L, 2010, JAIDS-J ACQ IMM DEF, V55, P232, DOI 10.1097/QAI.0b013e3181e9b6b7; Weller S, 2002, Cochrane Database Syst Rev, pCD003255; Wells G., 2014, S SYST REV BAS; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4; Zhang K, 2001, CHINA J AIDS STD, V7, P286; Zheng Xi-Wen, 1993, Biomedical and Environmental Sciences, V6, P348; Zheng XW, 1994, CHIN J EPID, V15, P3	39	86	93	7	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111175	10.1371/journal.pone.0111175	http://dx.doi.org/10.1371/journal.pone.0111175			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369471	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402000041
J	Wang, AT; Fan, JQ; Van Houten, HK; Tilburt, JC; Stout, NK; Montori, VM; Shah, ND				Wang, Amy T.; Fan, Jiaquan; Van Houten, Holly K.; Tilburt, Jon C.; Stout, Natasha K.; Montori, Victor M.; Shah, Nilay D.			Impact of the 2009 US Preventive Services Task Force Guidelines on Screening Mammography Rates on Women in Their 40s	PLOS ONE			English	Article							BREAST-CANCER; RECOMMENDATIONS; OLDER	Background: The 2009 US Preventive Services Task Force breast cancer screening update recommended against routine screening mammography for women aged 40-49; confusion and release of conflicting guidelines followed. We examined the impact of the USPSTF update on population-level screening mammography rates in women ages 40-49. Methods and Findings: We conducted a retrospective, interrupted time-series analysis using a nationally representative, privately-insured population from 1/1/2006-12/31/2011. Women ages 40-64 enrolled for >= 1 month were included. The primary outcome was receipt of screening mammography, identified using administrative claims-based algorithms. Time-series regression models were estimated to determine the effect of the guideline change on screening mammography rates. 5.5 million women ages 40-64 were included. A 1.8 per 1,000 women (p = 0.003) decrease in monthly screening mammography rates for 40-49 year-old women was observed two months following the guideline change; no initial effect was seen for 50-64 year-old women. However, two years following the guideline change, a slight increase in screening mammography rates above expected was observed in both age groups. Conclusions: We detected a modest initial drop in screening mammography rates in women ages 40-49 immediately after the 2009 USPSTF guideline followed by an increase in screening rates. Unfavorable public reactions and release of conflicting statements may have tempered the initial impact. Renewal of the screening debate may have brought mammography to the forefront of women's minds, contributing to the observed increase in mammography rates two years after the guideline change. This pattern is unlikely to reflect informed choice and underscores the need for improved translation of evidence-based care and guidelines into practice.	[Wang, Amy T.; Tilburt, Jon C.] Mayo Clin, Div Gen Internal Med, Rochester, MN USA; [Wang, Amy T.; Tilburt, Jon C.; Montori, Victor M.; Shah, Nilay D.] Mayo Clin, Knowledge & Evaluat Res Unit, Rochester, MN 55905 USA; [Fan, Jiaquan; Van Houten, Holly K.; Montori, Victor M.; Shah, Nilay D.] Mayo Clin, Div Hlth Care Policy & Res, Rochester, MN USA; [Stout, Natasha K.] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA USA; [Stout, Natasha K.] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Montori, Victor M.] Mayo Clin, Div Endocrinol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Mayo Clinic	Shah, ND (corresponding author), Mayo Clin, Knowledge & Evaluat Res Unit, Rochester, MN 55905 USA.	shah.nilay@mayo.edu	amy.tu.wang, amy.tu.wang/F-8331-2014	amy.tu.wang, amy.tu.wang/0000-0002-0929-1399; Montori, Victor/0000-0003-0595-2898	Small Grants Program; Division of General Internal Medicine, Mayo Clinic, Rochester, Minnesota	Small Grants Program; Division of General Internal Medicine, Mayo Clinic, Rochester, Minnesota	This work was supported by the Small Grants Program sponsored by the Division of General Internal Medicine, Mayo Clinic, Rochester, Minnesota. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM COLL OBST GYN, 2009, OBSTET GYNECOL, V114, P1409; American College of Obstetricians and Gynecologists, 2012, OBSTET GYNECOL, V120, P1222, DOI DOI 10.1097/AOG.1220B1013-318277C318292A; American College of Surgeons, 2010, B AM COLL SURG, V95, P51; Bevers TB, 2009, J NATL COMPR CANC NE, V7, P1060, DOI 10.6004/jnccn.2009.0070; Block LD, 2013, J GEN INTERNAL MED; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Dorn SD, 2012, CLIN GASTROENTEROL H, V10, P278, DOI 10.1016/j.cgh.2011.11.020; Fenton JJ, 2012, MED CARE; IMS Health, 2012, IMS RXBENCHMARK PHAR; Institute KPCM, 2010, BREAST CANC SCREEN C; Lee CH, 2010, J AM COLL RADIOL, V7, P18, DOI 10.1016/j.jacr.2009.09.022; Pace LE, 2013, CANCER-AM CANCER SOC, V119, P2518, DOI 10.1002/cncr.28105; Qaseem A, 2007, ANN INTERN MED, V146, P511, DOI 10.7326/0003-4819-146-7-200704030-00007; Randolph WM, 2002, HEALTH SERV RES, V37, P1643, DOI 10.1111/1475-6773.10912; Smith-Bindman R, 2006, MED CARE, V44, P463, DOI 10.1097/01.mlr.0000207436.07513.79; Squiers LB, 2011, AM J PREV MED, V40, P497, DOI 10.1016/j.amepre.2010.12.027; Stempel DA, 2001, RESP MED, V95, P227, DOI 10.1053/rmed.2000.1027; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x	18	127	128	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91399	10.1371/journal.pone.0091399	http://dx.doi.org/10.1371/journal.pone.0091399			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	25343354	Green Published, Green Submitted, gold			2022-12-27	WOS:000332842400087
J	Wang, MC; Chien, HF; Tsai, YL; Liu, MC; Liaw, SJ				Wang, Min-Cheng; Chien, Hsiung-Fei; Tsai, Yi-Lin; Liu, Ming-Che; Liaw, Shwu-Jen			The RNA Chaperone Hfq Is Involved in Stress Tolerance and Virulence in Uropathogenic Proteus mirabilis	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; POLYMYXIN-B RESISTANCE; ESCHERICHIA-COLI; OUTER-MEMBRANE; PSEUDOMONAS-AERUGINOSA; BIOFILM FORMATION; EPITHELIAL-CELLS; MOUSE MODEL; BACTERIA; MACROPHAGES	Hfq is a bacterial RNA chaperone involved in the riboregulation of diverse genes via small noncoding RNAs. Here, we show that Hfq is critical for the uropathogenic Proteus mirabilis to effectively colonize the bladder and kidneys in a murine urinary tract infection (UTI) model and to establish burned wound infection of the rats. In this regard, we found the hfq mutant induced higher IL-8 and MIF levels of uroepithelial cells and displayed reduced intra-macrophage survival. The loss of hfq affected bacterial abilities to handle H2O2 and osmotic pressures and to grow at 50 degrees C. Relative to wild-type, the hfq mutant had reduced motility, fewer flagella and less hemolysin expression and was less prone to form biofilm and to adhere to and invade uroepithelial cells. The MR/P fimbrial operon was almost switched to the off phase in the hfq mutant. In addition, we found the hfq mutant exhibited an altered outer membrane profile and had higher RpoE expression, which indicates the hfq mutant may encounter increased envelope stress. With the notion of envelope disturbance in the hfq mutant, we found increased membrane permeability and antibiotic susceptibilities in the hfq mutant. Finally, we showed that Hfq positively regulated the RpoS level and tolerance to H2O2 in the stationary phase seemed largely mediated through the Hfq-dependent RpoS expression. Together, our data indicate that Hfq plays a critical role in P. mirabilis to establish UTIs by modulating stress responses, surface structures and virulence factors. This study suggests Hfq may serve as a scaffold molecule for development of novel anti-P. mirabilis drugs and P. mirabilis hfq mutant is a vaccine candidate for preventing UTIs.	[Wang, Min-Cheng; Tsai, Yi-Lin; Liu, Ming-Che; Liaw, Shwu-Jen] Natl Taiwan Univ, Coll Med, Dept & Grad Inst Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Chien, Hsiung-Fei] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Liaw, Shwu-Jen] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Liaw, SJ (corresponding author), Natl Taiwan Univ, Coll Med, Dept & Grad Inst Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan.	sjliaw@ntu.edu.tw		LIAW, SHWU-JEN/0000-0002-2666-5284	National Science Council [NSC101-2320-B-002-028]; National Taiwan University Hospital, Taipei, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital, Taipei, Taiwan	This work was supported by grants from National Science Council (NSC101-2320-B-002-028) and National Taiwan University Hospital, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agace WW, 1996, EUR RESPIR J, V9, P1713, DOI 10.1183/09031936.96.09081713; Alamuri P, 2010, INFECT IMMUN, V78, P4882, DOI 10.1128/IAI.00718-10; Asakawa R, 2003, MOL MICROBIOL, V50, P1125, DOI 10.1046/j.1365-2958.2003.03748.x; Bohn C, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-10; Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015; Caiola MG, 2004, ANN MICROBIOL, V54, P365; Chao YJ, 2010, CURR OPIN MICROBIOL, V13, P24, DOI 10.1016/j.mib.2010.01.001; Chiang MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022248; Christiansen JK, 2004, J BACTERIOL, V186, P3355, DOI 10.1128/JB.186.11.3355-3362.2004; Clinical and Laboratory Standards Institute, 2009, M07A8 CLSI; De Lay N, 2013, J BIOL CHEM, V288, P7996, DOI 10.1074/jbc.R112.441386; De Lay N, 2012, MOL MICROBIOL, V86, P524, DOI 10.1111/j.1365-2958.2012.08209.x; Ding YP, 2004, MOL MICROBIOL, V53, P345, DOI 10.1111/j.1365-2958.2004.04142.x; Figueroa-Bossi N, 2006, MOL MICROBIOL, V62, P838, DOI 10.1111/j.1365-2958.2006.05413.x; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; FUKUOKA T, 1991, ANTIMICROB AGENTS CH, V35, P529, DOI 10.1128/AAC.35.3.529; Geng J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006213; Gottesman S, 2005, TRENDS GENET, V21, P399, DOI 10.1016/j.tig.2005.05.008; Guillier M, 2006, GENE DEV, V20, P2338, DOI 10.1101/gad.1457506; Hamrick TS, 2000, INFECT IMMUN, V68, P125, DOI 10.1128/IAI.68.1.125-132.2000; Jacobsen SM, 2008, CLIN MICROBIOL REV, V21, P26, DOI 10.1128/CMR.00019-07; Jansen AM, 2004, INFECT IMMUN, V72, P7294, DOI 10.1128/IAI.72.12.7294-7305.2004; Jiang SS, 2010, ANTIMICROB AGENTS CH, V54, P2000, DOI 10.1128/AAC.01384-09; Jiang SS, 2010, ANTIMICROB AGENTS CH, V54, P1564, DOI 10.1128/AAC.01219-09; Jones BV, 2004, INFECT IMMUN, V72, P3941, DOI 10.1128/IAI.72.7.3941-3950.2004; Kulesus RR, 2008, INFECT IMMUN, V76, P3019, DOI 10.1128/IAI.00022-08; Li X, 2002, MOL MICROBIOL, V45, P865, DOI 10.1046/j.1365-2958.2002.03067.x; LISSNER CR, 1985, J IMMUNOL, V135, P544; Meibom KL, 2009, INFECT IMMUN, V77, P1866, DOI 10.1128/IAI.01496-08; Mobley HLT, 1996, INFECT IMMUN, V64, P5332, DOI 10.1128/IAI.64.12.5332-5340.1996; Nielubowicz GR, 2010, NAT REV UROL, V7, P430, DOI 10.1038/nrurol.2010.101; Nishino K, 2011, J ANTIMICROB CHEMOTH, V66, P291, DOI 10.1093/jac/dkq420; Odenbreit S, 2009, INFECT IMMUN, V77, P3782, DOI 10.1128/IAI.00364-09; Papenfort K, 2006, MOL MICROBIOL, V62, P1674, DOI 10.1111/j.1365-2958.2006.05524.x; Pearson MM, 2007, J MED MICROBIOL, V56, P1277, DOI 10.1099/jmm.0.47314-0; Richards GR, 2011, BBA-GENE REGUL MECH, V1809, P525, DOI 10.1016/j.bbagrm.2011.07.013; Rocha SPD, 2007, FEMS IMMUNOL MED MIC, V51, P319, DOI 10.1111/j.1574-695X.2007.00308.x; Roger T, 2013, J INFECT DIS, V207, P331, DOI 10.1093/infdis/jis673; Roscetto E, 2012, J BACTERIOL, V194, P5864, DOI 10.1128/JB.00746-12; Rowley G, 2006, NAT REV MICROBIOL, V4, P383, DOI 10.1038/nrmicro1394; Schiano CA, 2010, INFECT IMMUN, V78, P2034, DOI 10.1128/IAI.01046-09; Simonsen KT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016387; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Sonnleitner E, 2003, MICROB PATHOGENESIS, V35, P217, DOI 10.1016/S0882-4010(03)00149-9; Thompson KM, 2007, J BACTERIOL, V189, P4243, DOI 10.1128/JB.00020-07; TSUI HCT, 1994, MOL MICROBIOL, V13, P35, DOI 10.1111/j.1365-2958.1994.tb00400.x; Van Puyvelde S, 2013, RNA BIOL, V10, P185, DOI 10.4161/rna.23341; Vogel J, 2009, MOL MICROBIOL, V73, P737, DOI 10.1111/j.1365-2958.2009.06806.x; Xiao B, 2009, CURR MICROBIOL, V58, P258, DOI 10.1007/s00284-008-9318-2; Yamada J, 2010, J ANTIMICROB CHEMOTH, V65, P853, DOI 10.1093/jac/dkq067; Zhong M, 2013, J BACTERIOL, V195, P1061, DOI 10.1128/JB.01143-12	52	49	57	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85626	10.1371/journal.pone.0085626	http://dx.doi.org/10.1371/journal.pone.0085626			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454905	Green Submitted, Green Published, gold			2022-12-27	WOS:000330235100108
